Citrus Sinensis ID: 005443
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 696 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SX31 | 708 | Proline-rich receptor-lik | yes | no | 0.625 | 0.614 | 0.747 | 0.0 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.609 | 0.556 | 0.757 | 0.0 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.627 | 0.641 | 0.648 | 1e-175 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.597 | 0.585 | 0.565 | 1e-149 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.591 | 0.572 | 0.568 | 1e-148 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.623 | 0.604 | 0.559 | 1e-139 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.484 | 0.516 | 0.639 | 1e-139 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.576 | 0.598 | 0.526 | 1e-132 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.479 | 0.527 | 0.620 | 1e-129 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.481 | 0.467 | 0.6 | 1e-126 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 723 bits (1866), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/439 (74%), Positives = 381/439 (86%), Gaps = 4/439 (0%)
Query: 258 SSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSST 317
+S +N+GIGT V I+VAV ++ F+L G+ VWCLR+R+K +S ++G + PSP+ S++
Sbjct: 269 NSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTAR 328
Query: 318 TDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGE 377
+DS++ + QSSAP+ S + GGLG+S+++F+YEELVKAT+GF+ +NLLGE
Sbjct: 329 SDSAFFRMQSSAPVGASKRSGSY---QSQSGGLGNSKALFSYEELVKATNGFSQENLLGE 385
Query: 378 GGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437
GGFG VYKG LPDGR VA+KQLKIGGGQG+REFKAEVE +SRIHHRHLVS+VG+CIS DR
Sbjct: 386 GGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDR 445
Query: 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 497
RLLIYDYV NN LYFHLHGE + VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS
Sbjct: 446 RLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 504
Query: 498 NILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGV 557
NILL++NF+A+VSDFGLA+LALD NTHITTRV+GTFGYMAPEYASSGKLTEKSDVFSFGV
Sbjct: 505 NILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGV 564
Query: 558 VLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRM 617
VLLELITGRKPVD SQPLGDESLVEWARPL+SHA+E EEFD+LADP+LG NYVE EMFRM
Sbjct: 565 VLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRM 624
Query: 618 IEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQQSAEIRWFRRM 677
IEAA ACVRH A KRPRMGQ+VR F+SLA DL NGM++GESEVFNSAQQSAEIR FRRM
Sbjct: 625 IEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNGMRLGESEVFNSAQQSAEIRLFRRM 684
Query: 678 AFGSQNYSTDFFTQGSLDS 696
AFGSQNYSTDFF+ S +S
Sbjct: 685 AFGSQNYSTDFFSHSSYNS 703
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 700 bits (1806), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/425 (75%), Positives = 366/425 (86%), Gaps = 1/425 (0%)
Query: 270 TVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSS-TTDSSYIKTQSS 328
V +++ V ++ +LIG+VV CL++RKK +S + G Y+MP+P+ SSS +DS+ +KTQSS
Sbjct: 330 VVGVSIGVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSS 389
Query: 329 APLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYL 388
APL+G+ + S +PGG G SR +F+YEELV AT+GF+D+NLLGEGGFG VYKG L
Sbjct: 390 APLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 389 PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448
PD R VA+KQLKIGGGQG+REFKAEV+ ISR+HHR+L+S+VGYCIS++RRLLIYDYVPNN
Sbjct: 450 PDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNN 509
Query: 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508
LYFHLH G P LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL+NNF A
Sbjct: 510 NLYFHLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHAL 569
Query: 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
VSDFGLAKLALD NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP
Sbjct: 570 VSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 629
Query: 569 VDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHS 628
VDASQPLGDESLVEWARPLLS+A E EEF LADP+LG NYV EMFRMIEAAAAC+RHS
Sbjct: 630 VDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHS 689
Query: 629 AAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTDF 688
A KRPRM Q+VR FDSLA DL NGM++GESE+ NSAQQSAEIR FRRMAFGSQNYSTD
Sbjct: 690 ATKRPRMSQIVRAFDSLAEEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFGSQNYSTDS 749
Query: 689 FTQGS 693
T+ S
Sbjct: 750 LTRNS 754
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 615 bits (1585), Expect = e-175, Method: Compositional matrix adjust.
Identities = 295/455 (64%), Positives = 356/455 (78%), Gaps = 18/455 (3%)
Query: 246 GNGTNPSSPESSSSPSNNGIGTAGTVV----IAVAVGIIAFSLIGLVVWCLRRRKKEVSG 301
GN T PSS S GI G +V + SL + VW R+RK++ G
Sbjct: 219 GNNTLPSSSPGKSEVGTGGIVAIGVIVGLVFL---------SLFVMGVWFTRKRKRKDPG 269
Query: 302 LNGVYIM-PSPLGSSSTTDSSYIKTQSSA-PLIGSGPGSDFVNSPQDPGGLGHSRSMFTY 359
Y M PS S +D ++SSA P + S GSD++ + D G + + RS F+Y
Sbjct: 270 TFVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSY 329
Query: 360 EELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR 419
+EL + T GF+++NLLGEGGFG VYKG L DGREVA+KQLKIGG QGEREFKAEVEIISR
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISR 389
Query: 420 IHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+HHRHLV+LVGYCIS+ RLL+YDYVPNNTL++HLH GRPV+ W TRV++AAGAARG+A
Sbjct: 390 VHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAARGIA 449
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA--LDANTHITTRVMGTFGYMA 537
YLHEDCHPRIIHRDIKSSNILLDN+FEA V+DFGLAK+A LD NTH++TRVMGTFGYMA
Sbjct: 450 YLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMA 509
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597
PEYA+SGKL+EK+DV+S+GV+LLELITGRKPVD SQPLGDESLVEWARPLL A+ENEEF
Sbjct: 510 PEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEF 569
Query: 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL-ATSDLNNGMKV 656
D L DPRLG+N++ GEMFRM+EAAAACVRHSAAKRP+M QVVR D+L +D+ NGM+
Sbjct: 570 DELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDITNGMRP 629
Query: 657 GESEVFNSAQQSAEIRWFRRMAFGSQNYSTDFFTQ 691
G+S+VF+S QQSA+IR F+RMAFGSQ+YS+DFF +
Sbjct: 630 GQSQVFDSRQQSAQIRMFQRMAFGSQDYSSDFFDR 664
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 529 bits (1362), Expect = e-149, Method: Compositional matrix adjust.
Identities = 271/479 (56%), Positives = 324/479 (67%), Gaps = 63/479 (13%)
Query: 260 PSNNGIGTAGTVVIAVAVGIIAFSLIGL--VVWCLRRRKKEVSGLNGVYIMPSPLGSSST 317
P+N+G G G + A I F++I L VV+ +RR+KK +
Sbjct: 224 PANSGGGYQGKTMAGFA--IAGFAVIALMAVVFLVRRKKKR--------------NIDAY 267
Query: 318 TDSSYI-----KTQSSAPLIG-------SGPGSDFVNSPQDP----------GGLGHSRS 355
+DS Y+ +S L G SGPG NS Q GG G++RS
Sbjct: 268 SDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGG--YNSQQQSNSGNSFGSQRGGGGYTRS 325
Query: 356 --------------MFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKI 401
FTYEEL T+GF+ N+LGEGGFG VYKG L DG+ VA+KQLK+
Sbjct: 326 GSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKV 385
Query: 402 GGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV 461
G GQG+REFKAEVEIISR+HHRHLVSLVGYCI+D RLLIY+YVPN TL HLHG+GRPV
Sbjct: 386 GSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPV 445
Query: 462 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521
L+WA RV+IA G+A+GLAYLHEDCHP+IIHRDIKS+NILLD+ FEAQV+DFGLAKL
Sbjct: 446 LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDST 505
Query: 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
TH++TRVMGTFGY+APEYA SGKLT++SDVFSFGVVLLELITGRKPVD QPLG+ESLV
Sbjct: 506 QTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLV 565
Query: 582 EWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641
EWARPLL A+E +F L D RL ++YVE E+FRMIE AAACVRHS KRPRM QVVR
Sbjct: 566 EWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRA 625
Query: 642 FDSLA-TSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFG------SQNYSTDFFTQGS 693
DS D++NG KVG+S ++S Q + + FR+MAFG S YS D+ Q S
Sbjct: 626 LDSEGDMGDISNGNKVGQSSAYDSGQYNNDTMKFRKMAFGFDDSSDSGMYSGDYSVQDS 684
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 525 bits (1351), Expect = e-148, Method: Compositional matrix adjust.
Identities = 252/443 (56%), Positives = 309/443 (69%), Gaps = 31/443 (6%)
Query: 270 TVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSA 329
T+V G +LIG+V R++K+ + N +P P + S ++ Q
Sbjct: 246 TMVGMAVAGFAIMALIGVVFLVRRKKKRNIDSYNHSQYLPHP--NFSVKSDGFLYGQDPG 303
Query: 330 PLIGSGP-GSDFVNSPQ---------------------------DPGGLGHSRSMFTYEE 361
SGP GS + NS Q D LG ++ F+YEE
Sbjct: 304 KGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEE 363
Query: 362 LVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH 421
L + T GFA +N+LGEGGFG VYKG L DG+ VA+KQLK G GQG+REFKAEVEIISR+H
Sbjct: 364 LAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVH 423
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
HRHLVSLVGYCISD RLLIY+YV N TL HLHG+G PVL+W+ RV+IA G+A+GLAYL
Sbjct: 424 HRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAYL 483
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
HEDCHP+IIHRDIKS+NILLD+ +EAQV+DFGLA+L TH++TRVMGTFGY+APEYA
Sbjct: 484 HEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYA 543
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601
SSGKLT++SDVFSFGVVLLEL+TGRKPVD +QPLG+ESLVEWARPLL A+E + L
Sbjct: 544 SSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELI 603
Query: 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS-DLNNGMKVGESE 660
D RL + YVE E+FRMIE AAACVRHS KRPRM QVVR D S D++NG+K+G+S
Sbjct: 604 DTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGDISNGIKIGQST 663
Query: 661 VFNSAQQSAEIRWFRRMAFGSQN 683
++S Q + +I FR+MAFG N
Sbjct: 664 TYDSGQYNEDIMKFRKMAFGGDN 686
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 495 bits (1275), Expect = e-139, Method: Compositional matrix adjust.
Identities = 258/461 (55%), Positives = 323/461 (70%), Gaps = 27/461 (5%)
Query: 243 NTPGNGTNPSSPESSSSPSNN----GIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKE 298
N NG +S +S+ S GIG AG +V I+ I V + R++KK
Sbjct: 240 NANSNGDGGTSQQSNESNYTEKTVIGIGIAGVLV------IL---FIAGVFFVRRKQKKG 290
Query: 299 VSG-LNGVYIMPSPLGSSSTTDSSYIKT----QSSAPLIGSGPGSDFVNSPQ------DP 347
S + Y+ P+ + ++ Y + SSA S P ++ + +P+ D
Sbjct: 291 SSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQ--NSSPDTNSLGNPKHGRGTPDS 348
Query: 348 GGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE 407
+G S+ FTYEEL + T+GF ++GEGGFG VYKG L +G+ VAIKQLK +G
Sbjct: 349 AVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGY 408
Query: 408 REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
REFKAEVEIISR+HHRHLVSLVGYCIS+ R LIY++VPNNTL +HLHG+ PVL+W+ R
Sbjct: 409 REFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRR 468
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527
V+IA GAA+GLAYLHEDCHP+IIHRDIKSSNILLD+ FEAQV+DFGLA+L A +HI+T
Sbjct: 469 VRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIST 528
Query: 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587
RVMGTFGY+APEYASSGKLT++SDVFSFGVVLLELITGRKPVD SQPLG+ESLVEWARP
Sbjct: 529 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPR 588
Query: 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL-A 646
L A+E + + DPRL +YVE E+++MIE AA+CVRHSA KRPRM QVVR D+
Sbjct: 589 LIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRDD 648
Query: 647 TSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTD 687
SDL NG+KVG+S V++S Q S EIR FRR + S + T+
Sbjct: 649 LSDLTNGVKVGQSRVYDSGQYSNEIRIFRRASEDSSDLGTN 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 495 bits (1274), Expect = e-139, Method: Compositional matrix adjust.
Identities = 222/347 (63%), Positives = 284/347 (81%), Gaps = 10/347 (2%)
Query: 350 LGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE 409
LG S+S FTYEEL +AT+GF++ NLLG+GGFG V+KG LP G+EVA+KQLK G GQGERE
Sbjct: 261 LGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGERE 320
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
F+AEVEIISR+HHRHLVSL+GYC++ +RLL+Y++VPNN L FHLHG+GRP ++W+TR+K
Sbjct: 321 FQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLK 380
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
IA G+A+GL+YLHEDC+P+IIHRDIK+SNIL+D FEA+V+DFGLAK+A D NTH++TRV
Sbjct: 381 IALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRV 440
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589
MGTFGY+APEYA+SGKLTEKSDVFSFGVVLLELITGR+PVDA+ D+SLV+WARPLL+
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD-SLATS 648
A E +F+ LAD ++G Y EM RM+ AAACVRHSA +RPRM Q+VR + +++ S
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLS 560
Query: 649 DLNNGMKVGESEVFNS---------AQQSAEIRWFRRMAFGSQNYST 686
DLN GM+ G S V++S +Q + ++ FR+MA G+Q Y T
Sbjct: 561 DLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGT 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1216), Expect = e-132, Method: Compositional matrix adjust.
Identities = 230/437 (52%), Positives = 309/437 (70%), Gaps = 36/437 (8%)
Query: 287 LVVWCLRRRKKEVSGLNGV-YIMPSPLGSSSTTDSSYIKTQSSAPLIG------------ 333
+ + C R++KK+ +N + Y +P G + + + Y K ++
Sbjct: 207 ICICCNRKKKKKSPQVNHMHYYNNNPYGGAPSGNGGYYKGTPQDHVVNMAGQGGGNWGPQ 266
Query: 334 ---SGPGSDFVN--------SPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGS 382
SGP SD N SPQ LGH++S FTY+EL AT+GFA NLLG+GGFG
Sbjct: 267 QPVSGPHSDASNLTGRTAIPSPQ-AATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGY 325
Query: 383 VYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442
V+KG LP G+EVA+K LK+G GQGEREF+AEV+IISR+HHRHLVSLVGYCIS +RLL+Y
Sbjct: 326 VHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVY 385
Query: 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502
+++PNNTL FHLHG+GRPVLDW TRVKIA G+ARGLAYLHEDCHPRIIHRDIK++NILLD
Sbjct: 386 EFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLD 445
Query: 503 NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLEL 562
+FE +V+DFGLAKL+ D TH++TRVMGTFGY+APEYASSGKL++KSDVFSFGV+LLEL
Sbjct: 446 FSFETKVADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLEL 505
Query: 563 ITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAA 622
ITGR P+D + + D SLV+WARPL A ++ +++ LADPRL NY EM +M AA
Sbjct: 506 ITGRPPLDLTGEMED-SLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAA 564
Query: 623 ACVRHSAAKRPRMGQVVRVFD-SLATSDLNNGMKVGESEV---------FNSAQQSAEIR 672
A +RHSA +RP+M Q+VR + ++ DL+ G + G+S ++++ +A+++
Sbjct: 565 AAIRHSARRRPKMSQIVRALEGDMSMDDLSEGTRPGQSTYLSPGSVSSEYDASSYTADMK 624
Query: 673 WFRRMAFGSQNYSTDFF 689
F+++A ++ Y + +
Sbjct: 625 KFKKLALENKEYQSSEY 641
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1194), Expect = e-129, Method: Compositional matrix adjust.
Identities = 214/345 (62%), Positives = 272/345 (78%), Gaps = 11/345 (3%)
Query: 350 LGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE 409
LG ++S FTY+EL AT GF D NLLG+GGFG V+KG LP G+EVA+K LK G GQGERE
Sbjct: 265 LGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGERE 324
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
F+AEV+IISR+HHR+LVSLVGYCI+D +R+L+Y++VPN TL +HLHG+ PV++++TR++
Sbjct: 325 FQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLR 384
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
IA GAA+GLAYLHEDCHPRIIHRDIKS+NILLD NF+A V+DFGLAKL D NTH++TRV
Sbjct: 385 IALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRV 444
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589
MGTFGY+APEYASSGKLTEKSDVFS+GV+LLELITG++PVD S + D++LV+WARPL++
Sbjct: 445 MGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITM-DDTLVDWARPLMA 503
Query: 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649
ALE+ F+ LAD RL NY EM RM+ AAA +RHS KRP+M Q+VR + + D
Sbjct: 504 RALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVSLD 563
Query: 650 -LNNGMKVGESEVFNSAQQS---------AEIRWFRRMAFGSQNY 684
LN G+K G S V+ S S A+++ FR++A SQ +
Sbjct: 564 ALNEGVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQEF 608
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 454 bits (1168), Expect = e-126, Method: Compositional matrix adjust.
Identities = 207/345 (60%), Positives = 271/345 (78%), Gaps = 10/345 (2%)
Query: 349 GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGER 408
GLG + F YEEL +AT+GF++ NLLG+GGFG V+KG L +G+EVA+KQLK G QGER
Sbjct: 334 GLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGER 393
Query: 409 EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV 468
EF+AEV IISR+HHRHLV+LVGYCI+D +RLL+Y++VPNNTL FHLHG+GRP ++W++R+
Sbjct: 394 EFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRL 453
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
KIA G+A+GL+YLHE+C+P+IIHRDIK+SNIL+D FEA+V+DFGLAK+A D NTH++TR
Sbjct: 454 KIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTR 513
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588
VMGTFGY+APEYASSGKLTEKSDVFSFGVVLLELITGR+P+D + D SLV+WARPLL
Sbjct: 514 VMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLL 573
Query: 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD-SLAT 647
+ E F+ + D +L Y + EM RM+ AAACVR +A +RPRM QV RV + +++
Sbjct: 574 NQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISP 633
Query: 648 SDLNNGMKVGESEV---------FNSAQQSAEIRWFRRMAFGSQN 683
SDLN G+ G S V ++S+Q + + FR++ +Q+
Sbjct: 634 SDLNQGITPGHSNVYGSSGGSTDYDSSQDNEGMNKFRKVGLETQD 678
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 696 | ||||||
| 225423802 | 726 | PREDICTED: proline-rich receptor-like pr | 0.637 | 0.611 | 0.824 | 0.0 | |
| 255546929 | 811 | ATP binding protein, putative [Ricinus c | 0.642 | 0.551 | 0.807 | 0.0 | |
| 356494796 | 724 | PREDICTED: proline-rich receptor-like pr | 0.636 | 0.611 | 0.766 | 0.0 | |
| 356502698 | 747 | PREDICTED: proline-rich receptor-like pr | 0.695 | 0.647 | 0.703 | 0.0 | |
| 15221470 | 708 | protein kinase-like protein [Arabidopsis | 0.625 | 0.614 | 0.747 | 0.0 | |
| 224101629 | 685 | predicted protein [Populus trichocarpa] | 0.627 | 0.637 | 0.766 | 0.0 | |
| 79352581 | 762 | proline-rich extensin-like receptor kina | 0.609 | 0.556 | 0.757 | 0.0 | |
| 12321185 | 760 | Pto kinase interactor, putative [Arabido | 0.606 | 0.555 | 0.757 | 0.0 | |
| 356567172 | 756 | PREDICTED: proline-rich receptor-like pr | 0.701 | 0.645 | 0.643 | 0.0 | |
| 298204391 | 436 | unnamed protein product [Vitis vinifera] | 0.577 | 0.922 | 0.770 | 0.0 |
| >gi|225423802|ref|XP_002277905.1| PREDICTED: proline-rich receptor-like protein kinase PERK9 [Vitis vinifera] gi|297737910|emb|CBI27111.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2017), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/445 (82%), Positives = 406/445 (91%), Gaps = 1/445 (0%)
Query: 249 TNPSSPESS-SSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYI 307
N S+P S +S S GIGT GTV I + +G++ LIG+ CLR+RKK+VSGLNG Y+
Sbjct: 281 VNNSTPNGSPNSTSKGGIGTVGTVAIGLVLGLVVLVLIGVAFLCLRKRKKKVSGLNGGYV 340
Query: 308 MPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATD 367
MP+ LGSS +DSS+ KT SSAPLIGSG GSDFV SP +PGGLG+SRS FTYEELVKAT+
Sbjct: 341 MPATLGSSPRSDSSFTKTLSSAPLIGSGSGSDFVYSPSEPGGLGNSRSWFTYEELVKATN 400
Query: 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
GF+ QNLLGEGGFGSVYKGYLPDGRE+A+KQLKIGG QGEREFKAEVEIISRIHHRHLVS
Sbjct: 401 GFSTQNLLGEGGFGSVYKGYLPDGREIAVKQLKIGGAQGEREFKAEVEIISRIHHRHLVS 460
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
LVGYCIS+ +RLL+YDYVPNNTLYFHLHGEGRPV+DWATRVK+AAGAARG+AYLHEDCHP
Sbjct: 461 LVGYCISESQRLLVYDYVPNNTLYFHLHGEGRPVMDWATRVKVAAGAARGIAYLHEDCHP 520
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
R+IHRDIKSSNILL+ NFEAQVSDFGLAKLALDA+TH+TTRVMGTFGYMAPEYASSGKLT
Sbjct: 521 RVIHRDIKSSNILLNYNFEAQVSDFGLAKLALDADTHVTTRVMGTFGYMAPEYASSGKLT 580
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607
EKSDVFSFGVVLLELITGRKPVDASQP+GDESLVEWARPLLSHALENEEF+ L DPRL +
Sbjct: 581 EKSDVFSFGVVLLELITGRKPVDASQPVGDESLVEWARPLLSHALENEEFEGLTDPRLEK 640
Query: 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQQ 667
NYVE EMFRM+EAAAACVRHSAAKRPRMGQVVR FDS+ TSDL+NGM+VGESEVFNSAQQ
Sbjct: 641 NYVESEMFRMLEAAAACVRHSAAKRPRMGQVVRAFDSMGTSDLSNGMRVGESEVFNSAQQ 700
Query: 668 SAEIRWFRRMAFGSQNYSTDFFTQG 692
S EIRWF+RMAFGSQ+YSTDFF+QG
Sbjct: 701 SEEIRWFQRMAFGSQDYSTDFFSQG 725
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255546929|ref|XP_002514522.1| ATP binding protein, putative [Ricinus communis] gi|223546126|gb|EEF47628.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/447 (80%), Positives = 402/447 (89%)
Query: 250 NPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMP 309
N S+PE+S SP + GIGT G V I V VGII S++GL V C+R+R+KE GLNG Y+MP
Sbjct: 365 NTSAPENSKSPGDGGIGTGGIVAIGVVVGIIMLSIVGLAVLCMRKRRKEAHGLNGGYVMP 424
Query: 310 SPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGF 369
SPLGSS TD + K Q++ PL+GSG +D+V SP GGLG+SRS F YEEL+K+T+GF
Sbjct: 425 SPLGSSPRTDLNLSKAQTTIPLMGSGSSTDYVYSPSGSGGLGNSRSWFMYEELLKSTNGF 484
Query: 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
+ QNLLGEGGFGSVYKG LPDGREVA+KQLK+GGGQGEREFKAEVEIISRIHHRHLVSLV
Sbjct: 485 SSQNLLGEGGFGSVYKGCLPDGREVAVKQLKVGGGQGEREFKAEVEIISRIHHRHLVSLV 544
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
GYCISD+RRLL+YDYVPNNTL+FHLHGEGRPVL+WA RVKIAAGAARG+AYLHEDCHPR+
Sbjct: 545 GYCISDNRRLLVYDYVPNNTLHFHLHGEGRPVLNWAARVKIAAGAARGIAYLHEDCHPRV 604
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
IHRDIKSSNILLDNNFEA+VSDFGLAKLA+DA+TH+TTRVMGTFGYMAPEYASSGKLT+K
Sbjct: 605 IHRDIKSSNILLDNNFEAKVSDFGLAKLAIDADTHVTTRVMGTFGYMAPEYASSGKLTDK 664
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENY 609
SDVFS+GVVLLELITGRKPVDASQPLGDESLV+WARPLL HAL NEEFD L DPRL +NY
Sbjct: 665 SDVFSYGVVLLELITGRKPVDASQPLGDESLVQWARPLLGHALANEEFDGLVDPRLEKNY 724
Query: 610 VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQQSA 669
VE EMF MIEAAAACVRHSAAKRPRMGQVVR FD LA +DL+NGM+VGESE+FNSAQQSA
Sbjct: 725 VESEMFTMIEAAAACVRHSAAKRPRMGQVVRAFDGLAAADLSNGMRVGESEIFNSAQQSA 784
Query: 670 EIRWFRRMAFGSQNYSTDFFTQGSLDS 696
EIR FRRMAFGSQNYSTDFF+QGSLDS
Sbjct: 785 EIRLFRRMAFGSQNYSTDFFSQGSLDS 811
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356494796|ref|XP_003516269.1| PREDICTED: proline-rich receptor-like protein kinase PERK10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/449 (76%), Positives = 390/449 (86%), Gaps = 6/449 (1%)
Query: 247 NGTNPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVY 306
NGT SSP+ G V I+V G + IG+++WC+RR+K++V ++G Y
Sbjct: 281 NGTENSSPDGGGDGIG----IGGVVAISVVAGFLLLGFIGVLIWCMRRKKRKVL-VSGDY 335
Query: 307 IMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKAT 366
+MPS L SS +DSS+ KT SSAPL+ SG GSD V +P +PGGLGHSRS F+YEEL+KAT
Sbjct: 336 VMPSTLASSPESDSSFFKTHSSAPLVQSGSGSDVVYTPSEPGGLGHSRSWFSYEELIKAT 395
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+GF+ QNLLGEGGFG VYKG LPDGRE+A+KQLKIGGGQGEREFKAEVEIISRIHHRHLV
Sbjct: 396 NGFSTQNLLGEGGFGCVYKGCLPDGREIAVKQLKIGGGQGEREFKAEVEIISRIHHRHLV 455
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
SLVGYCI D++RLL+YDYVPNNTLYFHLHGEG+PVL+WA RVKIAAGAARGL YLHEDC+
Sbjct: 456 SLVGYCIEDNKRLLVYDYVPNNTLYFHLHGEGQPVLEWANRVKIAAGAARGLTYLHEDCN 515
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
PRIIHRDIKSSNILLD N+EA+VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL
Sbjct: 516 PRIIHRDIKSSNILLDFNYEAKVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 575
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606
TEKSDV+SFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL+ EEFD+LADPRL
Sbjct: 576 TEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALDTEEFDSLADPRLE 635
Query: 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQ 666
+NYVE E++ MIE AAACVRHSAAKRPRMGQVVR FDSL SDL NGM++GESEVF+ AQ
Sbjct: 636 KNYVESELYCMIEVAAACVRHSAAKRPRMGQVVRAFDSLGGSDLTNGMRLGESEVFD-AQ 694
Query: 667 QSAEIRWFRRMAFGSQNYSTDFFTQGSLD 695
QS EIR FRRMAFG+Q+YSTDFF++ SL+
Sbjct: 695 QSEEIRLFRRMAFGNQDYSTDFFSRASLN 723
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502698|ref|XP_003520154.1| PREDICTED: proline-rich receptor-like protein kinase PERK10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1890), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/513 (70%), Positives = 413/513 (80%), Gaps = 29/513 (5%)
Query: 200 TQTPPTPASPIAPRPSNSSP----------NSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
T TPPTP+S AP +++ N PPP ++ LS P +P P+ NGT
Sbjct: 246 TSTPPTPSSQPAPTSNSTPRSSPPSPPSTTNLAPPPPSRVLSSP--LPSPAQ-----NGT 298
Query: 250 NPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMP 309
SP+ T G V I+V G + IG+++WC+RR+K+++ ++G Y+MP
Sbjct: 299 KNPSPDGGGDGIG----TGGVVAISVVAGFLLLGFIGVLIWCMRRQKRKLP-VSGGYVMP 353
Query: 310 SPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGF 369
S L SS +DSS+ KT SSAPL+ SG GSD V +P DPGGLG+SRS F+YEEL+K T+GF
Sbjct: 354 STLASSPESDSSFFKTHSSAPLVQSGSGSDVVYTPSDPGGLGNSRSWFSYEELIKVTNGF 413
Query: 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
+ QNLLGEGGFG VYKG LPDGR++A+KQLKIGGGQGEREFKAEVEII RIHHRHLVSLV
Sbjct: 414 STQNLLGEGGFGCVYKGCLPDGRDIAVKQLKIGGGQGEREFKAEVEIIGRIHHRHLVSLV 473
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
GYCI D RRLL+YDYVPNN LYFHLHGEG+PVL+WA RVKIAAGAARGLAYLHEDC+PRI
Sbjct: 474 GYCIEDSRRLLVYDYVPNNNLYFHLHGEGQPVLEWANRVKIAAGAARGLAYLHEDCNPRI 533
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
IHRDIKSSNILLD NFEA+VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK
Sbjct: 534 IHRDIKSSNILLDFNFEAKVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 593
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVEW-------ARPLLSHALENEEFDNLAD 602
SDV+SFGVVLLELITGRKPVDASQPLGDESLVE ARPLLSHAL+ EEFD+LAD
Sbjct: 594 SDVYSFGVVLLELITGRKPVDASQPLGDESLVEMDAATFFQARPLLSHALDTEEFDSLAD 653
Query: 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVF 662
PRL +NYVE E++ MIE AAACVRHSAAKRPRMGQVVR FDSL SDL NGM++GES+VF
Sbjct: 654 PRLEKNYVESELYCMIEVAAACVRHSAAKRPRMGQVVRAFDSLGGSDLTNGMRLGESQVF 713
Query: 663 NSAQQSAEIRWFRRMAFGSQNYSTDFFTQGSLD 695
+SAQQS EIR FRRMAFGSQNYSTDFF++ SL+
Sbjct: 714 DSAQQSEEIRLFRRMAFGSQNYSTDFFSRASLN 746
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15221470|ref|NP_177036.1| protein kinase-like protein [Arabidopsis thaliana] gi|75337798|sp|Q9SX31.1|PERK9_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK9; AltName: Full=Proline-rich extensin-like receptor kinase 9; Short=AtPERK9 gi|5734709|gb|AAD49974.1|AC008075_7 Contains PF|00069 Eukaryotic protein kinase domain [Arabidopsis thaliana] gi|14334806|gb|AAK59581.1| putative protein kinase [Arabidopsis thaliana] gi|21280865|gb|AAM44925.1| putative protein kinase [Arabidopsis thaliana] gi|332196707|gb|AEE34828.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1866), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/439 (74%), Positives = 381/439 (86%), Gaps = 4/439 (0%)
Query: 258 SSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSST 317
+S +N+GIGT V I+VAV ++ F+L G+ VWCLR+R+K +S ++G + PSP+ S++
Sbjct: 269 NSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTAR 328
Query: 318 TDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGE 377
+DS++ + QSSAP+ S + GGLG+S+++F+YEELVKAT+GF+ +NLLGE
Sbjct: 329 SDSAFFRMQSSAPVGASKRSGSY---QSQSGGLGNSKALFSYEELVKATNGFSQENLLGE 385
Query: 378 GGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437
GGFG VYKG LPDGR VA+KQLKIGGGQG+REFKAEVE +SRIHHRHLVS+VG+CIS DR
Sbjct: 386 GGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDR 445
Query: 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 497
RLLIYDYV NN LYFHLHGE + VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS
Sbjct: 446 RLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 504
Query: 498 NILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGV 557
NILL++NF+A+VSDFGLA+LALD NTHITTRV+GTFGYMAPEYASSGKLTEKSDVFSFGV
Sbjct: 505 NILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGV 564
Query: 558 VLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRM 617
VLLELITGRKPVD SQPLGDESLVEWARPL+SHA+E EEFD+LADP+LG NYVE EMFRM
Sbjct: 565 VLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRM 624
Query: 618 IEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQQSAEIRWFRRM 677
IEAA ACVRH A KRPRMGQ+VR F+SLA DL NGM++GESEVFNSAQQSAEIR FRRM
Sbjct: 625 IEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNGMRLGESEVFNSAQQSAEIRLFRRM 684
Query: 678 AFGSQNYSTDFFTQGSLDS 696
AFGSQNYSTDFF+ S +S
Sbjct: 685 AFGSQNYSTDFFSHSSYNS 703
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101629|ref|XP_002312360.1| predicted protein [Populus trichocarpa] gi|222852180|gb|EEE89727.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1820), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/442 (76%), Positives = 381/442 (86%), Gaps = 5/442 (1%)
Query: 247 NGTNPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVY 306
N T P+SPESS+S N GIG G V I A+GII L+GL +WC+R+++KE+SGLNGVY
Sbjct: 249 NNTAPNSPESSNSTGNGGIGIGGIVAIGAAIGIIMLILVGLALWCMRKQRKEISGLNGVY 308
Query: 307 IMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKAT 366
+MPS LGSS + Y K + I S DF+ + +SR +F +EELVKAT
Sbjct: 309 VMPSSLGSSPRS-GIYFKQHFA---ISSLTCYDFLQQYHSY-SISNSRPLFAFEELVKAT 363
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
+GF+ QNLLGEGGFG+VYKGYLPDGR+VA+KQLKIGGGQGEREFKAEVEIISRIHHRHLV
Sbjct: 364 NGFSSQNLLGEGGFGTVYKGYLPDGRDVAVKQLKIGGGQGEREFKAEVEIISRIHHRHLV 423
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
SLVGYCIS+ RRLL+YDYVPNNTL+FHLHG+ P LDWATRVKIAAGAARGLAYLHEDCH
Sbjct: 424 SLVGYCISETRRLLVYDYVPNNTLHFHLHGKAMPALDWATRVKIAAGAARGLAYLHEDCH 483
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
PRIIHRDIKSSNILLD NFEA+VSDFGLAKLALD NTH+TTRVMGTFGYMAPEYASSGKL
Sbjct: 484 PRIIHRDIKSSNILLDINFEAKVSDFGLAKLALDTNTHVTTRVMGTFGYMAPEYASSGKL 543
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606
T+KSDVFS+GVVLLELITGRKPVDASQP+GDESLVEWARPLL+HALENEEF++LADPRL
Sbjct: 544 TDKSDVFSYGVVLLELITGRKPVDASQPVGDESLVEWARPLLNHALENEEFESLADPRLE 603
Query: 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQ 666
+NY+E EMF+MIEAAA CVRHSA KRPRMGQVVR F +LA +DL NGM+VGESE+FNSAQ
Sbjct: 604 KNYIESEMFQMIEAAAVCVRHSATKRPRMGQVVRAFHTLANADLTNGMRVGESELFNSAQ 663
Query: 667 QSAEIRWFRRMAFGSQNYSTDF 688
QS EIR FRRMAFGSQNYSTDF
Sbjct: 664 QSEEIRLFRRMAFGSQNYSTDF 685
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79352581|ref|NP_173940.2| proline-rich extensin-like receptor kinase 10 [Arabidopsis thaliana] gi|310947343|sp|Q9C660.2|PEK10_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK10; AltName: Full=Proline-rich extensin-like receptor kinase 10; Short=AtPERK10 gi|332192534|gb|AEE30655.1| proline-rich extensin-like receptor kinase 10 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1806), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/425 (75%), Positives = 366/425 (86%), Gaps = 1/425 (0%)
Query: 270 TVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSS-TTDSSYIKTQSS 328
V +++ V ++ +LIG+VV CL++RKK +S + G Y+MP+P+ SSS +DS+ +KTQSS
Sbjct: 330 VVGVSIGVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSS 389
Query: 329 APLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYL 388
APL+G+ + S +PGG G SR +F+YEELV AT+GF+D+NLLGEGGFG VYKG L
Sbjct: 390 APLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 389 PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448
PD R VA+KQLKIGGGQG+REFKAEV+ ISR+HHR+L+S+VGYCIS++RRLLIYDYVPNN
Sbjct: 450 PDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNN 509
Query: 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508
LYFHLH G P LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL+NNF A
Sbjct: 510 NLYFHLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHAL 569
Query: 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
VSDFGLAKLALD NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP
Sbjct: 570 VSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 629
Query: 569 VDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHS 628
VDASQPLGDESLVEWARPLLS+A E EEF LADP+LG NYV EMFRMIEAAAAC+RHS
Sbjct: 630 VDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHS 689
Query: 629 AAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTDF 688
A KRPRM Q+VR FDSLA DL NGM++GESE+ NSAQQSAEIR FRRMAFGSQNYSTD
Sbjct: 690 ATKRPRMSQIVRAFDSLAEEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFGSQNYSTDS 749
Query: 689 FTQGS 693
T+ S
Sbjct: 750 LTRNS 754
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|12321185|gb|AAG50687.1|AC079829_20 Pto kinase interactor, putative [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1795), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/425 (75%), Positives = 366/425 (86%), Gaps = 3/425 (0%)
Query: 270 TVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSS-TTDSSYIKTQSS 328
V +++ V ++ +LIG+VV CL++RKK +S + G Y+MP+P+ SSS +DS+ +KTQSS
Sbjct: 330 VVGVSIGVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSS 389
Query: 329 APLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYL 388
APL+G+ + S +PGG G SR +F+YEELV AT+GF+D+NLLGEGGFG VYKG L
Sbjct: 390 APLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 389 PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448
PD R VA+KQLKIGGGQG+REFKAEV+ ISR+HHR+L+S+VGYCIS++RRLLIYDYVPNN
Sbjct: 450 PDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNN 509
Query: 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508
LYFHLHG P LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL+NNF A
Sbjct: 510 NLYFHLHGT--PGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHAL 567
Query: 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
VSDFGLAKLALD NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP
Sbjct: 568 VSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 627
Query: 569 VDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHS 628
VDASQPLGDESLVEWARPLLS+A E EEF LADP+LG NYV EMFRMIEAAAAC+RHS
Sbjct: 628 VDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHS 687
Query: 629 AAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTDF 688
A KRPRM Q+VR FDSLA DL NGM++GESE+ NSAQQSAEIR FRRMAFGSQNYSTD
Sbjct: 688 ATKRPRMSQIVRAFDSLAEEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFGSQNYSTDS 747
Query: 689 FTQGS 693
T+ S
Sbjct: 748 LTRNS 752
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567172|ref|XP_003551795.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/525 (64%), Positives = 404/525 (76%), Gaps = 37/525 (7%)
Query: 201 QTPPTPASP--------------------------IAPRPSNSSPNSPPPPSTKRLSPPP 234
+T P+ ASP P S+ + P PP+ K + P
Sbjct: 209 KTTPSHASPPSVSETPPKPPSSDVPPPSTLPSTPPSDPSGSSPPASLPDPPTNKTVVGGP 268
Query: 235 GIPVPS------TENTPGNGTNPSSPESSSSPSNN-GIGTAGTVVIAVAVGIIAFSLIGL 287
+ +PS T +GTN S S+++PS++ G+ T G+V I + VG I SL+ +
Sbjct: 269 KVSLPSLPTEKPTARPTNDGTNSMS--SNNTPSHSGGLSTGGSVAIGIVVGFIVLSLLVM 326
Query: 288 VVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDP 347
VW +++KK+ +G G Y PSP SS + + +++ QS A +GSG GSDFV SP +P
Sbjct: 327 AVWFAQKKKKKGTGSRGSYAAPSPFTSSHNSGTLFLRPQSPANFLGSGSGSDFVYSPSEP 386
Query: 348 GGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE 407
GG+ SRS FTYEEL++AT+GF+ QNLLGEGGFG VYKG L DGREVA+KQLKIGGGQGE
Sbjct: 387 GGVSSSRSWFTYEELIQATNGFSAQNLLGEGGFGCVYKGLLIDGREVAVKQLKIGGGQGE 446
Query: 408 REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
REF+AEVEIISR+HHRHLVSLVGYCIS+ +RLL+YDYVPN+TL++HLHGE RPVLDW TR
Sbjct: 447 REFRAEVEIISRVHHRHLVSLVGYCISEHQRLLVYDYVPNDTLHYHLHGENRPVLDWPTR 506
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527
VK+AAGAARG+AYLHEDCHPRIIHRDIKSSNILLD N+EAQVSDFGLAKLALD+NTH+TT
Sbjct: 507 VKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDLNYEAQVSDFGLAKLALDSNTHVTT 566
Query: 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587
RVMGTFGYMAPEYA+SGKLTEKSDV+SFGVVLLELITGRKPVDASQP+GDESLVEWARPL
Sbjct: 567 RVMGTFGYMAPEYATSGKLTEKSDVYSFGVVLLELITGRKPVDASQPIGDESLVEWARPL 626
Query: 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL-A 646
L+ AL+NE+F+ L DPRLG+NY EMFRMIEAAAACVRHS+ KRPRM QVVR DSL
Sbjct: 627 LTEALDNEDFEILVDPRLGKNYDRNEMFRMIEAAAACVRHSSVKRPRMSQVVRALDSLDE 686
Query: 647 TSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTDFFTQ 691
+DLNNGMK G+S VF+SAQQSA+IR FRRMAFGSQ+ S+ FF +
Sbjct: 687 FTDLNNGMKPGQSSVFDSAQQSAQIRMFRRMAFGSQD-SSGFFNE 730
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204391|emb|CBI16871.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 312/405 (77%), Positives = 357/405 (88%), Gaps = 3/405 (0%)
Query: 287 LVVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPL-IGSGPGSDFVNSPQ 345
+ W +++RKK+ +GLN Y MPSP SS +DS +++ SS+ L +GSG GSDFV SP
Sbjct: 18 MAAWFVQKRKKKRAGLNIGYTMPSPFASSQNSDSVFLRPHSSSALPLGSGSGSDFVYSPP 77
Query: 346 DPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ 405
DP G +SR F+YEELV+ATDGF+ QNLLGEGGFG VYKG+L DGREVA+KQLKIGGGQ
Sbjct: 78 DPVG-SNSRPWFSYEELVEATDGFSSQNLLGEGGFGCVYKGFLADGREVAVKQLKIGGGQ 136
Query: 406 GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA 465
GEREFKAEVEIISR+HHRHLVSLVGYCIS+ +RLL+YD+VPN+TL++HLHGEGRPV+DWA
Sbjct: 137 GEREFKAEVEIISRVHHRHLVSLVGYCISEHQRLLVYDFVPNDTLHYHLHGEGRPVMDWA 196
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
TRVK+AAGAARG+AYLHEDCHPRIIHRDIKSSNILLD NFEAQVSDFGLAKLALDANTH+
Sbjct: 197 TRVKVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDMNFEAQVSDFGLAKLALDANTHV 256
Query: 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 585
TTRVMGTFGYMAPEYASSGKLTEKSDV+SFGVVLLELITGRKPVDASQPLGDESLVEWAR
Sbjct: 257 TTRVMGTFGYMAPEYASSGKLTEKSDVYSFGVVLLELITGRKPVDASQPLGDESLVEWAR 316
Query: 586 PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
PLL+ AL++ F+ L DPRL +N+VE EMFRMIEAAAACVRHSA+KRPRM VVR DS+
Sbjct: 317 PLLAQALDSGNFEGLIDPRLEKNFVENEMFRMIEAAAACVRHSASKRPRMSLVVRALDSM 376
Query: 646 -ATSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTDFF 689
SDL NGMK G+SEVF+SAQ SA+IR F+RMAFGSQ YS++FF
Sbjct: 377 DELSDLTNGMKPGQSEVFDSAQHSAQIRMFQRMAFGSQEYSSEFF 421
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 696 | ||||||
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.590 | 0.580 | 0.761 | 3.1e-170 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.590 | 0.539 | 0.764 | 2.5e-168 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.594 | 0.607 | 0.675 | 1.8e-151 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.515 | 0.505 | 0.661 | 7.8e-126 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.511 | 0.550 | 0.622 | 1.3e-123 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.502 | 0.486 | 0.655 | 3.5e-123 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.510 | 0.544 | 0.621 | 5.1e-122 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.573 | 0.555 | 0.587 | 3.6e-121 | |
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.502 | 0.552 | 0.606 | 5.3e-117 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.504 | 0.523 | 0.592 | 3.5e-114 |
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1655 (587.6 bits), Expect = 3.1e-170, P = 3.1e-170
Identities = 316/415 (76%), Positives = 359/415 (86%)
Query: 282 FSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGXXXXXXXXYIKTQSSAPLIGSGPGSDFV 341
F+L G+ VWCLR+R+K +S ++G + PSP+ + + QSSAP +G+ S
Sbjct: 293 FTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSSAP-VGASKRSGSY 351
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKI 401
S GGLG+S+++F+YEELVKAT+GF+ +NLLGEGGFG VYKG LPDGR VA+KQLKI
Sbjct: 352 QSQS--GGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKI 409
Query: 402 GGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV 461
GGGQG+REFKAEVE +SRIHHRHLVS+VG+CIS DRRLLIYDYV NN LYFHLHGE + V
Sbjct: 410 GGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGE-KSV 468
Query: 462 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521
LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL++NF+A+VSDFGLA+LALD
Sbjct: 469 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDC 528
Query: 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
NTHITTRV+GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD SQPLGDESLV
Sbjct: 529 NTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLV 588
Query: 582 EWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641
EWARPL+SHA+E EEFD+LADP+LG NYVE EMFRMIEAA ACVRH A KRPRMGQ+VR
Sbjct: 589 EWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRA 648
Query: 642 FDSLATSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTDFFTQGSLDS 696
F+SLA DL NGM++GESEVFNSAQQSAEIR FRRMAFGSQNYSTDFF+ S +S
Sbjct: 649 FESLAAEDLTNGMRLGESEVFNSAQQSAEIRLFRRMAFGSQNYSTDFFSHSSYNS 703
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1637 (581.3 bits), Expect = 2.5e-168, P = 2.5e-168
Identities = 315/412 (76%), Positives = 352/412 (85%)
Query: 283 SLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGXXX-XXXXXYIKTQSSAPLIGSGPGSDFV 341
+LIG+VV CL++RKK +S + G Y+MP+P+ +KTQSSAPL+G+ +
Sbjct: 343 TLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSSAPLVGNRSSNRTY 402
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKI 401
S +PGG G SR +F+YEELV AT+GF+D+NLLGEGGFG VYKG LPD R VA+KQLKI
Sbjct: 403 LSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKI 462
Query: 402 GGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV 461
GGGQG+REFKAEV+ ISR+HHR+L+S+VGYCIS++RRLLIYDYVPNN LYFHLH G P
Sbjct: 463 GGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG 522
Query: 462 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521
LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL+NNF A VSDFGLAKLALD
Sbjct: 523 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDC 582
Query: 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV
Sbjct: 583 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 642
Query: 582 EWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641
EWARPLLS+A E EEF LADP+LG NYV EMFRMIEAAAAC+RHSA KRPRM Q+VR
Sbjct: 643 EWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRA 702
Query: 642 FDSLATSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTDFFTQGS 693
FDSLA DL NGM++GESE+ NSAQQSAEIR FRRMAFGSQNYSTD T+ S
Sbjct: 703 FDSLAEEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFGSQNYSTDSLTRNS 754
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1478 (525.3 bits), Expect = 1.8e-151, P = 1.8e-151
Identities = 283/419 (67%), Positives = 341/419 (81%)
Query: 283 SLIGLVVWCLRRRKKEVSGLNGVYIMP-SPLGXXXXXXXXYIKTQSSAP-LIGSGPGSDF 340
SL + VW R+RK++ G Y MP S ++SSAP + S GSD+
Sbjct: 251 SLFVMGVWFTRKRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDY 310
Query: 341 VNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLK 400
+ + D G + + RS F+Y+EL + T GF+++NLLGEGGFG VYKG L DGREVA+KQLK
Sbjct: 311 MYASSDSGMVSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLK 370
Query: 401 IGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRP 460
IGG QGEREFKAEVEIISR+HHRHLV+LVGYCIS+ RLL+YDYVPNNTL++HLH GRP
Sbjct: 371 IGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRP 430
Query: 461 VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-- 518
V+ W TRV++AAGAARG+AYLHEDCHPRIIHRDIKSSNILLDN+FEA V+DFGLAK+A
Sbjct: 431 VMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQE 490
Query: 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578
LD NTH++TRVMGTFGYMAPEYA+SGKL+EK+DV+S+GV+LLELITGRKPVD SQPLGDE
Sbjct: 491 LDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDE 550
Query: 579 SLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQV 638
SLVEWARPLL A+ENEEFD L DPRLG+N++ GEMFRM+EAAAACVRHSAAKRP+M QV
Sbjct: 551 SLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQV 610
Query: 639 VRVFDSLA-TSDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTDFFTQGSLDS 696
VR D+L +D+ NGM+ G+S+VF+S QQSA+IR F+RMAFGSQ+YS+DFF + S
Sbjct: 611 VRALDTLEEATDITNGMRPGQSQVFDSRQQSAQIRMFQRMAFGSQDYSSDFFDRSQSHS 669
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1236 (440.2 bits), Expect = 7.8e-126, P = 7.8e-126
Identities = 242/366 (66%), Positives = 284/366 (77%)
Query: 335 GPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREV 394
G G S D +G ++ FTYEEL T+GF+ N+LGEGGFG VYKG L DG+ V
Sbjct: 319 GGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLV 378
Query: 395 AIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL 454
A+KQLK+G GQG+REFKAEVEIISR+HHRHLVSLVGYCI+D RLLIY+YVPN TL HL
Sbjct: 379 AVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHL 438
Query: 455 HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
HG+GRPVL+WA RV+IA G+A+GLAYLHEDCHP+IIHRDIKS+NILLD+ FEAQV+DFGL
Sbjct: 439 HGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGL 498
Query: 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
AKL TH++TRVMGTFGY+APEYA SGKLT++SDVFSFGVVLLELITGRKPVD QP
Sbjct: 499 AKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQP 558
Query: 575 LGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR 634
LG+ESLVEWARPLL A+E +F L D RL ++YVE E+FRMIE AAACVRHS KRPR
Sbjct: 559 LGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPR 618
Query: 635 MGQVVRVFDSLAT-SDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFG------SQNYSTD 687
M QVVR DS D++NG KVG+S ++S Q + + FR+MAFG S YS D
Sbjct: 619 MVQVVRALDSEGDMGDISNGNKVGQSSAYDSGQYNNDTMKFRKMAFGFDDSSDSGMYSGD 678
Query: 688 FFTQGS 693
+ Q S
Sbjct: 679 YSVQDS 684
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 1215 (432.8 bits), Expect = 1.3e-123, P = 1.3e-123
Identities = 231/371 (62%), Positives = 296/371 (79%)
Query: 330 PLIGSGPGSDF----VNSPQDPG-GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVY 384
P + S GSD+ V P PG LG S+S FTYEEL +AT+GF++ NLLG+GGFG V+
Sbjct: 231 PFMSSSGGSDYSDRPVLPPPSPGLVLGFSKSTFTYEELARATNGFSEANLLGQGGFGYVH 290
Query: 385 KGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444
KG LP G+EVA+KQLK+G GQGEREF+AEVEIISR+HHRHLVSLVGYCI+ +RLL+Y++
Sbjct: 291 KGVLPSGKEVAVKQLKVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEF 350
Query: 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504
VPNN L HLHGEGRP ++W+TR+KIA G+A+GL+YLHEDC+P+IIHRDIK+SNIL+D
Sbjct: 351 VPNNNLELHLHGEGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFK 410
Query: 505 FEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
FEA+V+DFGLAK+A D NTH++TRVMGTFGY+APEYA+SGKLTEKSDVFSFGVVLLELIT
Sbjct: 411 FEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELIT 470
Query: 565 GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAAC 624
GR+PVDA+ D+SLV+WARPLL+ A E +F+ LAD ++ Y EM RM+ AAAC
Sbjct: 471 GRRPVDANNVYVDDSLVDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAAC 530
Query: 625 VRHSAAKRPRMGQVVRVFD-SLATSDLNNGMKVGESEVFNS---------AQQSAEIRWF 674
VRHSA +RPRM Q+VR + +++ SDLN GM+ G+S V++S +Q + +++ F
Sbjct: 531 VRHSARRRPRMSQIVRALEGNVSLSDLNEGMRPGQSNVYSSYGGSTDYDSSQYNEDMKKF 590
Query: 675 RRMAFGSQNYS 685
R+MA G+Q Y+
Sbjct: 591 RKMALGTQEYN 601
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
Identities = 234/357 (65%), Positives = 282/357 (78%)
Query: 346 DPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ 405
D LG ++ F+YEEL + T GFA +N+LGEGGFG VYKG L DG+ VA+KQLK G GQ
Sbjct: 348 DSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQ 407
Query: 406 GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA 465
G+REFKAEVEIISR+HHRHLVSLVGYCISD RLLIY+YV N TL HLHG+G PVL+W+
Sbjct: 408 GDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWS 467
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
RV+IA G+A+GLAYLHEDCHP+IIHRDIKS+NILLD+ +EAQV+DFGLA+L TH+
Sbjct: 468 KRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHV 527
Query: 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 585
+TRVMGTFGY+APEYASSGKLT++SDVFSFGVVLLEL+TGRKPVD +QPLG+ESLVEWAR
Sbjct: 528 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWAR 587
Query: 586 PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
PLL A+E + L D RL + YVE E+FRMIE AAACVRHS KRPRM QVVR D
Sbjct: 588 PLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCD 647
Query: 646 ATS-DLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQN------YSTDFFTQGSLD 695
S D++NG+K+G+S ++S Q + +I FR+MAFG N YS ++ + S D
Sbjct: 648 GDSGDISNGIKIGQSTTYDSGQYNEDIMKFRKMAFGGDNSVESGLYSGNYSAKSSSD 704
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1200 (427.5 bits), Expect = 5.1e-122, P = 5.1e-122
Identities = 230/370 (62%), Positives = 294/370 (79%)
Query: 332 IGSGPGSDF----VNSPQDPG-GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKG 386
+ S GSD+ V P PG LG S+S FTYEEL +AT+GF++ NLLG+GGFG V+KG
Sbjct: 238 MSSSGGSDYSDLPVLPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKG 297
Query: 387 YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446
LP G+EVA+KQLK G GQGEREF+AEVEIISR+HHRHLVSL+GYC++ +RLL+Y++VP
Sbjct: 298 ILPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVP 357
Query: 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506
NN L FHLHG+GRP ++W+TR+KIA G+A+GL+YLHEDC+P+IIHRDIK+SNIL+D FE
Sbjct: 358 NNNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFE 417
Query: 507 AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
A+V+DFGLAK+A D NTH++TRVMGTFGY+APEYA+SGKLTEKSDVFSFGVVLLELITGR
Sbjct: 418 AKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGR 477
Query: 567 KPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVR 626
+PVDA+ D+SLV+WARPLL+ A E +F+ LAD ++G Y EM RM+ AAACVR
Sbjct: 478 RPVDANNVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVR 537
Query: 627 HSAAKRPRMGQVVRVFD-SLATSDLNNGMKVGESEVFNS---------AQQSAEIRWFRR 676
HSA +RPRM Q+VR + +++ SDLN GM+ G S V++S +Q + ++ FR+
Sbjct: 538 HSARRRPRMSQIVRALEGNVSLSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRK 597
Query: 677 MAFGSQNYST 686
MA G+Q Y T
Sbjct: 598 MALGTQEYGT 607
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1192 (424.7 bits), Expect = 3.6e-121, P = 3.6e-121
Identities = 241/410 (58%), Positives = 303/410 (73%)
Query: 289 VWCLRRRKKEVSGL--NGVYIMPSPLGXXXXXXXXYIKT--QSSAPLIGSGPGSDFVNSP 344
V+ +RR++K+ S + Y+ P+ + Y + ++ S P ++ + +P
Sbjct: 280 VFFVRRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNP 339
Query: 345 Q------DPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQ 398
+ D +G S+ FTYEEL + T+GF ++GEGGFG VYKG L +G+ VAIKQ
Sbjct: 340 KHGRGTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQ 399
Query: 399 LKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEG 458
LK +G REFKAEVEIISR+HHRHLVSLVGYCIS+ R LIY++VPNNTL +HLHG+
Sbjct: 400 LKSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKN 459
Query: 459 RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518
PVL+W+ RV+IA GAA+GLAYLHEDCHP+IIHRDIKSSNILLD+ FEAQV+DFGLA+L
Sbjct: 460 LPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLN 519
Query: 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578
A +HI+TRVMGTFGY+APEYASSGKLT++SDVFSFGVVLLELITGRKPVD SQPLG+E
Sbjct: 520 DTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEE 579
Query: 579 SLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQV 638
SLVEWARP L A+E + + DPRL +YVE E+++MIE AA+CVRHSA KRPRM QV
Sbjct: 580 SLVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQV 639
Query: 639 VRVFDSLAT-SDLNNGMKVGESEVFNSAQQSAEIRWFRRMAFGSQNYSTD 687
VR D+ SDL NG+KVG+S V++S Q S EIR FRR + S + T+
Sbjct: 640 VRALDTRDDLSDLTNGVKVGQSRVYDSGQYSNEIRIFRRASEDSSDLGTN 689
|
|
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 5.3e-117, Sum P(2) = 5.3e-117
Identities = 219/361 (60%), Positives = 279/361 (77%)
Query: 334 SGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE 393
SGP + P LG ++S FTY+EL AT GF D NLLG+GGFG V+KG LP G+E
Sbjct: 249 SGPSRPVLPPPSPALALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKE 308
Query: 394 VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFH 453
VA+K LK G GQGEREF+AEV+IISR+HHR+LVSLVGYCI+D +R+L+Y++VPN TL +H
Sbjct: 309 VAVKSLKAGSGQGEREFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYH 368
Query: 454 LHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513
LHG+ PV++++TR++IA GAA+GLAYLHEDCHPRIIHRDIKS+NILLD NF+A V+DFG
Sbjct: 369 LHGKNLPVMEFSTRLRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFG 428
Query: 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573
LAKL D NTH++TRVMGTFGY+APEYASSGKLTEKSDVFS+GV+LLELITG++PVD S
Sbjct: 429 LAKLTSDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSI 488
Query: 574 PLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP 633
+ D++LV+WARPL++ ALE+ F+ LAD RL NY EM RM+ AAA +RHS KRP
Sbjct: 489 TM-DDTLVDWARPLMARALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRP 547
Query: 634 RMGQVVRVFDSLATSD-LNNGMKVGESEVFNS-------AQQS--AEIRWFRRMAFGSQN 683
+M Q+VR + + D LN G+K G S V+ S +Q S A+++ FR++A SQ
Sbjct: 548 KMSQIVRALEGEVSLDALNEGVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQE 607
Query: 684 Y 684
+
Sbjct: 608 F 608
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1126 (401.4 bits), Expect = 3.5e-114, P = 3.5e-114
Identities = 220/371 (59%), Positives = 285/371 (76%)
Query: 334 SGPGSDFVN--------SPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYK 385
SGP SD N SPQ LGH++S FTY+EL AT+GFA NLLG+GGFG V+K
Sbjct: 270 SGPHSDASNLTGRTAIPSPQ-AATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHK 328
Query: 386 GYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445
G LP G+EVA+K LK+G GQGEREF+AEV+IISR+HHRHLVSLVGYCIS +RLL+Y+++
Sbjct: 329 GVLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFI 388
Query: 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505
PNNTL FHLHG+GRPVLDW TRVKIA G+ARGLAYLHEDCHPRIIHRDIK++NILLD +F
Sbjct: 389 PNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSF 448
Query: 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565
E +V+DFGLAKL+ D TH++TRVMGTFGY+APEYASSGKL++KSDVFSFGV+LLELITG
Sbjct: 449 ETKVADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITG 508
Query: 566 RKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACV 625
R P+D + + D SLV+WARPL A ++ +++ LADPRL NY EM +M AAA +
Sbjct: 509 RPPLDLTGEMED-SLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAI 567
Query: 626 RHSAAKRPRMGQVVRVFDS-LATSDLNNGMKVGESEV---------FNSAQQSAEIRWFR 675
RHSA +RP+M Q+VR + ++ DL+ G + G+S ++++ +A+++ F+
Sbjct: 568 RHSARRRPKMSQIVRALEGDMSMDDLSEGTRPGQSTYLSPGSVSSEYDASSYTADMKKFK 627
Query: 676 RMAFGSQNYST 686
++A ++ Y +
Sbjct: 628 KLALENKEYQS 638
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9SX31 | PERK9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7471 | 0.625 | 0.6144 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00030240001 | SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (386 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 696 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-59 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-51 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-44 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-36 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-32 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-30 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-28 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-27 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 5e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-25 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-24 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-23 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-22 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-22 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-21 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-21 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-21 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-20 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-20 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 9e-20 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-19 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 6e-19 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-18 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-18 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-18 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-17 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-17 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-17 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-16 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-16 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-16 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-16 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 6e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-16 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 9e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-16 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 1e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-15 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-15 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-15 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-15 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 9e-15 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-14 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 1e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-14 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-14 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-14 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 1e-13 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-13 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-13 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 5e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-13 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-13 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 6e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-12 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-12 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-12 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-12 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 6e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-12 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 8e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-12 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 8e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 9e-12 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 9e-12 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 9e-12 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-11 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-11 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-11 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-11 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-11 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 6e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-11 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 8e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-11 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-10 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-10 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-10 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-10 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 4e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 5e-10 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-10 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-09 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-09 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-09 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 4e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 4e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-09 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 5e-09 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 5e-09 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 5e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 6e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 8e-09 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 8e-09 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 8e-09 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 9e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-08 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-08 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-08 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 3e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-08 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 4e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-08 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 5e-08 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-08 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-08 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 8e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 8e-08 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 8e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-08 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 8e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 9e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 9e-08 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 9e-08 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 9e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-08 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-07 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 1e-07 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 1e-07 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 1e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 2e-07 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-07 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 3e-07 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 3e-07 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 3e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-07 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 3e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 4e-07 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 4e-07 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 4e-07 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 4e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 5e-07 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 6e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 6e-07 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 6e-07 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 6e-07 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 7e-07 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 7e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 7e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-07 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 8e-07 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 8e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 8e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 9e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 9e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 1e-06 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 1e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-06 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 1e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-06 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 2e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-06 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 2e-06 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 2e-06 | |
| pfam03326 | 500 | pfam03326, Herpes_TAF50, Herpesvirus transcription | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-06 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-06 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 3e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 4e-06 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 4e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-06 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 4e-06 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 4e-06 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 4e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 5e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 5e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 5e-06 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 5e-06 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 6e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 6e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 6e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 7e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 7e-06 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 7e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 7e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 7e-06 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 7e-06 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 8e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 8e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 9e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 9e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 9e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-06 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 9e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 1e-05 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 1e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 1e-05 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 1e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-05 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 1e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 1e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 1e-05 | |
| pfam09507 | 427 | pfam09507, CDC27, DNA polymerase subunit Cdc27 | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 1e-05 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| PHA03321 | 694 | PHA03321, PHA03321, tegument protein VP11/12; Prov | 1e-05 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 1e-05 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 2e-05 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 2e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 2e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 2e-05 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 2e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 2e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 2e-05 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 2e-05 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 2e-05 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 2e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 2e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 3e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-05 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 3e-05 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 3e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 3e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 3e-05 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 3e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 3e-05 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 3e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 4e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 4e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 4e-05 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 4e-05 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 4e-05 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 4e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 4e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 4e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 4e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 4e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 4e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 4e-05 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 5e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 5e-05 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 5e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 5e-05 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 5e-05 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 5e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-05 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 6e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 6e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 6e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 6e-05 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 6e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| PTZ00441 | 576 | PTZ00441, PTZ00441, sporozoite surface protein 2 ( | 6e-05 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 6e-05 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 6e-05 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 7e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 7e-05 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 7e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 7e-05 | |
| TIGR01628 | 562 | TIGR01628, PABP-1234, polyadenylate binding protei | 7e-05 | |
| PRK13335 | 356 | PRK13335, PRK13335, superantigen-like protein; Rev | 7e-05 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 7e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 8e-05 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 8e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 8e-05 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 8e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 8e-05 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 9e-05 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 9e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 9e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 9e-05 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 9e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 9e-05 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 9e-05 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 1e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-04 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 1e-04 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 1e-04 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 1e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 1e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 1e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 1e-04 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 1e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 1e-04 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 1e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 1e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 1e-04 | |
| pfam04621 | 336 | pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain t | 1e-04 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 1e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 1e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 1e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 1e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 1e-04 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 1e-04 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 1e-04 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 1e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-04 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 2e-04 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 2e-04 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 2e-04 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 2e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-04 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 2e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 2e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 2e-04 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 2e-04 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 2e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 2e-04 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 2e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 2e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-04 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 2e-04 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 2e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 2e-04 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 2e-04 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 2e-04 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 2e-04 | |
| pfam05044 | 908 | pfam05044, Prox1, Homeobox prospero-like protein ( | 2e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 2e-04 | |
| COG3147 | 226 | COG3147, DedD, Uncharacterized protein conserved i | 2e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-04 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 3e-04 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 3e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 3e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 3e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 3e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 3e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 3e-04 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 3e-04 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 3e-04 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 3e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 3e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 3e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 3e-04 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 3e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 3e-04 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 3e-04 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 3e-04 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 3e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 3e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 3e-04 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 3e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 3e-04 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 3e-04 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 3e-04 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 3e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 3e-04 | |
| PHA03309 | 2033 | PHA03309, PHA03309, transcriptional regulator ICP4 | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 4e-04 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 4e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 4e-04 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 4e-04 | |
| pfam09507 | 427 | pfam09507, CDC27, DNA polymerase subunit Cdc27 | 4e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 4e-04 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 4e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 4e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 4e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 4e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 4e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 4e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 4e-04 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 4e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| PHA01929 | 306 | PHA01929, PHA01929, putative scaffolding protein | 4e-04 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 5e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 5e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 5e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 5e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 5e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 5e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 5e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-04 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 6e-04 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 6e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 6e-04 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 6e-04 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 6e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 6e-04 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 6e-04 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 6e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-04 | |
| PHA03379 | 935 | PHA03379, PHA03379, EBNA-3A; Provisional | 6e-04 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 7e-04 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 7e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 7e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 7e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 7e-04 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 7e-04 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 7e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| pfam03359 | 342 | pfam03359, GKAP, Guanylate-kinase-associated prote | 7e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 8e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 8e-04 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 8e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 8e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 8e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 8e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 8e-04 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 8e-04 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 8e-04 | |
| PLN02328 | 808 | PLN02328, PLN02328, lysine-specific histone demeth | 8e-04 | |
| PTZ00108 | 1388 | PTZ00108, PTZ00108, DNA topoisomerase 2-like prote | 8e-04 | |
| PRK12727 | 559 | PRK12727, PRK12727, flagellar biosynthesis regulat | 8e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 9e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 9e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 9e-04 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 9e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 0.001 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.001 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 0.001 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.001 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.001 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 0.001 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 0.001 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 0.001 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.001 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 0.001 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.001 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 0.001 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.001 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.001 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 0.001 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 0.001 | |
| pfam05044 | 908 | pfam05044, Prox1, Homeobox prospero-like protein ( | 0.001 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 0.001 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.001 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.001 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.001 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.001 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.001 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.001 | |
| PTZ00108 | 1388 | PTZ00108, PTZ00108, DNA topoisomerase 2-like prote | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.001 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.001 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.001 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 0.001 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 0.001 | |
| pfam04502 | 321 | pfam04502, DUF572, Family of unknown function (DUF | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 0.002 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 0.002 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.002 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 0.002 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 0.002 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 0.002 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 0.002 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 0.002 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.002 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 0.002 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 0.002 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 0.002 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.002 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.002 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.002 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 0.002 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 0.002 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.002 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.002 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.002 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 0.002 | |
| pfam04621 | 336 | pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain t | 0.002 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 0.002 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.002 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.002 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.002 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.002 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.002 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.002 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.002 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.002 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.002 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.002 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| pfam05505 | 717 | pfam05505, Ebola_NP, Ebola nucleoprotein | 0.002 | |
| pfam11711 | 377 | pfam11711, Tim54, Inner membrane protein import co | 0.002 | |
| COG3266 | 292 | COG3266, DamX, Uncharacterized protein conserved i | 0.002 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.002 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.002 | |
| PHA03419 | 200 | PHA03419, PHA03419, E4 protein; Provisional | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 0.002 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 0.002 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 0.003 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.003 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 0.003 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.003 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 0.003 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.003 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 0.003 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 0.003 | |
| pfam05044 | 908 | pfam05044, Prox1, Homeobox prospero-like protein ( | 0.003 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.003 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.003 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.003 | |
| PHA01929 | 306 | PHA01929, PHA01929, putative scaffolding protein | 0.003 | |
| PLN02328 | 808 | PLN02328, PLN02328, lysine-specific histone demeth | 0.003 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.003 | |
| pfam00802 | 263 | pfam00802, Glycoprotein_G, Pneumovirus attachment | 0.003 | |
| pfam03353 | 316 | pfam03353, Lin-8, Ras-mediated vulval-induction an | 0.003 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.003 | |
| PRK11907 | 814 | PRK11907, PRK11907, bifunctional 2',3'-cyclic nucl | 0.003 | |
| pfam12868 | 135 | pfam12868, DUF3824, Domain of unknwon function (DU | 0.003 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 0.004 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 0.004 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.004 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.004 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.004 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.004 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.004 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 0.004 | |
| pfam04621 | 336 | pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain t | 0.004 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.004 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.004 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 0.004 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.004 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 0.004 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 0.004 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.004 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.004 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.004 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 0.004 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.004 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.004 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 0.004 | |
| PRK12757 | 256 | PRK12757, PRK12757, cell division protein FtsN; Pr | 0.004 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 0.004 | |
| pfam11702 | 509 | pfam11702, DUF3295, Protein of unknown function (D | 0.004 | |
| TIGR03895 | 602 | TIGR03895, protease_PatA, cyanobactin maturation p | 0.004 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 1e-59
Identities = 72/192 (37%), Positives = 107/192 (55%), Gaps = 9/192 (4%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGYC 432
LGEGGFG+VY G++VAIK +K E E+EI+ +++H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
++ L+ +Y +L L E L ++I GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS--NG-IIHR 116
Query: 493 DIKSSNILLDN-NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEKS 550
D+K NILLD+ N + +++DFGL+KL L ++ + ++GT YMAPE G +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 551 DVFSFGVVLLEL 562
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 72/209 (34%), Positives = 103/209 (49%), Gaps = 9/209 (4%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLV 426
+ LGEG FG VY G+ VAIK +K + +RE E++I+ ++ H ++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
L +D+ L+ +Y L+ L GR D A L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLHSK-- 116
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
I+HRD+K NILLD + +++DFGLA+ LD +TT V GT YMAPE
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGY 173
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ D++S GV+L EL+TG+ P L
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQL 202
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 3e-52
Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 28/274 (10%)
Query: 375 LGEGGFGSVYKGYL-----PDGREVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG VYKG L EVA+K LK Q EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G C ++ +++ +Y+P L +L L + + A ARG+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
IHRD+ + N L+ N ++SDFGL++ D + + +MAPE GK T
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608
KSDV+SFGV+L E+ T +P S E + L+ L P
Sbjct: 184 KSDVWSFGVLLWEIFT-----LGEEPYPGMSNAE-----VLEYLKKGYR--LPKP----P 227
Query: 609 YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642
E+++++ C RP ++V +
Sbjct: 228 NCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 3e-52
Identities = 79/201 (39%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFK-----AEVEIISRIHHRHLVSL 428
LG G FG+VYK G+ VA+K LK + E+ K E+ I+ R+ H ++V L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKK---RSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ D L+ +Y L+ +L G L KIA RGL YLH +
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN---G 118
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLT 547
IIHRD+K NILLD N +++DFGLAK L +++ +TT V GT YMAPE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 548 EKSDVFSFGVVLLELITGRKP 568
K DV+S GV+L EL+TG+ P
Sbjct: 178 PKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 375 LGEGGFGSVYKGYL-----PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LGEG FG VYKG L +VA+K LK G + ER EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G C + ++ +Y+P L L G L +++A A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESK---N 122
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKL 546
+HRD+ + N L+ N ++SDFGL++ + + + R G +MAPE GK
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-RKRGGGKLPIKWMAPESLKDGKF 181
Query: 547 TEKSDVFSFGVVLLELIT-GRKP 568
T KSDV+SFGV+L E+ T G +P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-51
Identities = 83/276 (30%), Positives = 122/276 (44%), Gaps = 33/276 (11%)
Query: 375 LGEGGFGSVYKGYL-----PDGREVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG VYKG L EVA+K LK Q EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
+G C ++ ++ +Y+ L Y + RP L + + A ARG+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
IHRD+ + N L+ N ++SDFGL++ D + + +MAPE GK
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606
T KSDV+SFGV+L E+ T QP S E + L+N L P
Sbjct: 181 TSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNEE-----VLEYLKNGYR--LPQP--- 225
Query: 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642
E++ ++ C RP ++V +
Sbjct: 226 -PNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 8e-51
Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 37/285 (12%)
Query: 373 NLLGEGGFGSVYKGYLPDG----REVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LGEG FG VYKG L EVA+K LK + ER +F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL-------HGEGRPVLDWATRVKIAAGAARGLAY 480
L+G C ++ L+ +Y+ L +L + L + A A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAP 538
L + +HRD+ + N L+ + ++SDFGL++ + + + + G +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRD-VYDDDYYRKKTGGKLPIRWMAP 176
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598
E G T KSDV+SFGV+L E+ T + P S E + L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT-----LGATPYPGLSNEE-----VLEYLRKGYR- 225
Query: 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643
L P Y E++ ++ +C + RP ++V +
Sbjct: 226 -LPKPE----YCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 373 NLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLV 429
LLG G FGSVY D G +A+K +++ G E + E+ I+S + H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 430 GYCISDDRR-LLIY-DYVPNNTLYFHLHGEGR---PVL-DWATRVKIAAGAARGLAYLHE 483
G +++ L I+ +YV +L L G+ PV+ + ++ GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------LEGLAYLHS 119
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYAS 542
+ I+HRDIK +NIL+D++ +++DFG AK L T V GT +MAPE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
+ +D++S G ++E+ TG+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGG-GQGEREF-KAEVEIISRIHHRHL 425
+ +G+G FG VY DG+ +K++ + + ERE EV+I+ +++H ++
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLH---GEGRP-----VLDWATRVKIAAGAARG 477
+ + ++ +Y L + EG+P +LDW ++ +A
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------ 115
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L YLH +I+HRDIK NI L +N ++ DFG++K+ L + + V+GT Y++
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVVGTPYYLS 171
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572
PE + KSD++S G VL EL T + P +
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
F +G+GGFG VYK + G+EVAIK +K+ + + + E++I+ + H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G + D ++ ++ +L L + L + + +GL YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN--- 117
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
IIHRDIK++NILL ++ E ++ DFGL+ D T +GT +MAPE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKPYD 175
Query: 548 EKSDVFSFGVVLLELITGRKP 568
K+D++S G+ +EL G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 72/207 (34%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 375 LGEGGFGSVY----KGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVS 427
LG+G FG V K G+ A+K LK I + E I+SRI+H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 428 LVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDC 485
L Y + +L L+ +Y P L+ HL EGR R + AA L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGR--FS-EERARFYAAEIVLALEYLHSL- 112
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
II+RD+K NILLD + +++DFGLAK + T GT Y+APE
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDAS 572
+ D +S GV+L E++TG+ P A
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 373 NLLGEGGFGSVYKG-YLPD----GREVAIKQLKI-GGGQGEREFKAEVEIISRIHHRHLV 426
LGEG FG V Y P G +VA+K L G Q +F+ E+EI+ + H ++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 427 SLVGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
G C R LI +Y+P+ +L +L R ++ + ++ +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG---TFGYMAPEYA 541
R IHRD+ + NIL+++ ++SDFGLAK+ + + + G F Y APE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 542 SSGKLTEKSDVFSFGVVLLELIT 564
+ K + SDV+SFGV L EL T
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 70/202 (34%), Positives = 110/202 (54%), Gaps = 16/202 (7%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
F + LG G FG V++G + VAIK LK +++F+ EV+ + R+ H+HL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
C + +I + + +L L EG+ VL A+ + +A A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD-----ANTHITTRVMGTFGYMAPEYAS 542
IHRD+ + NIL+ + +V+DFGLA+L + ++ I + + APE AS
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAAS 177
Query: 543 SGKLTEKSDVFSFGVVLLELIT 564
G + KSDV+SFG++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 64/198 (32%), Positives = 105/198 (53%), Gaps = 14/198 (7%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G FG V G G++VA+K LK + F AE +++ + H +LV L+G +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+ ++ +Y+ +L +L GR V+ A ++ A G+ YL E +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSD 551
+ + N+L+ + A+VSDFGLAK +A+ + G + APE K + KSD
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFSTKSD 181
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L E+ + GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 375 LGEGGFGSVYKGY-LPDGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSL 428
LG G FG+VYKG +P+G VAIK L+ + +E E +++ + H H+V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGE-----GRPVLDWATRVKIAAGAARGLAYLHE 483
+G C+S + LI +P L ++ + +L+W ++ A+G++YL E
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYAS 542
R++HRD+ + N+L+ +++DFGLAK L +D + +MA E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 543 SGKLTEKSDVFSFGVVLLELIT-GRKPVD 570
T KSDV+S+GV + EL+T G KP +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLV 429
N +G G FG VY L G +A+K+++I + +E E++++ + H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G + ++ + +Y TL L GR +LD GLAYLH I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH-GR-ILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV---MGTFGYMAPEYASSGKL 546
+HRDIK +NI LD+N ++ DFG A + T + V GT YMAPE + GK
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 547 TEK---SDVFSFGVVLLELITGRKP 568
+D++S G V+LE+ TG++P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHL 425
F N +G+G FG V+K D R A+KQ+ + +A E +++++ ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE-GRPVLD---WATRVKIAAGAARGLAYL 481
+ + + ++ +Y N L+ L + GRP+ + W + GLA+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHL 117
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H +I+HRDIKS N+ LD ++ D G+AKL L NT+ ++GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPELC 173
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
EKSDV++ GVVL E TG+ P DA
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 372 QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSL 428
+L+G G FG VYKG L G VAIKQ+ + + E + E++++ + H ++V
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 429 VGYCISDDRRLLIYDYVPNNTLY-----FHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
+G + D +I +Y N +L F E V + +V +GLAYLHE
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE-SLVAVYVYQV------LQGLAYLHE 117
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
+IHRDIK++NIL + +++DFG+A L+ + V+GT +MAPE
Sbjct: 118 Q---GVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 544 GKLTEKSDVFSFGVVLLELITGRKP 568
+ SD++S G ++EL+TG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V++G + VA+K LK G + +F AE +I+ ++ H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ ++ + + +L +L G L + +AA A G+AYL + IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDL 129
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+ N+L+ N +V+DFGLA++ + + + R F + APE A + + KSDV
Sbjct: 130 AARNVLVGENNICKVADFGLARV-IKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 74/198 (37%), Positives = 106/198 (53%), Gaps = 11/198 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ G +VA+K LK G E F E +I+ ++ H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 435 DDRRLLIYDYVPNNTLYFHLH-GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
++ ++ +Y+ +L L GEG+ L V +AA A G+AYL IHRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLESR---NYIHRD 128
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSD 551
+ + NIL+ N +++DFGLA+L D T R F + APE A+ G+ T KSD
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L E++T GR P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-29
Identities = 67/252 (26%), Positives = 94/252 (37%), Gaps = 8/252 (3%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P P P A S++P PP + P + P + P P + P + P PP + P
Sbjct: 2708 PEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPAT-PGGPARPARPPTTAGP 2766
Query: 64 TSSSPP---ASSPPTSSPPPASNPPTSSPP--PSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ +PP A+ PP PA + S PSP + P + P + P + P
Sbjct: 2767 PAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAG 2826
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-- 176
PP ++ P+ P PP PP ++ P PP RSP + P PP
Sbjct: 2827 PLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRL 2886
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ P + A+PP PP P P P P P PPPP + P
Sbjct: 2887 ARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPT 2946
Query: 237 PVPSTENTPGNG 248
P+ P
Sbjct: 2947 TDPAGAGEPSGA 2958
|
Length = 3151 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 4e-29
Identities = 73/228 (32%), Positives = 105/228 (46%), Gaps = 19/228 (8%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHR 423
+ LGEG FG VY D + VA+K L + F E++I++ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRP-VLDWATRVKIAAGAARGLAYLH 482
++V L + + L+ +YV +L L GR L + + I A L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 483 EDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTH-----ITTRVMGTFGYM 536
IIHRDIK NILLD + ++ DFGLAKL D + + + +GT GYM
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 537 APEYASSGKL---TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
APE L + SD++S G+ L EL+TG P + + S
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223
|
Length = 384 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 6/197 (3%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + R+VAIK ++ G E +F E +++ ++ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
L+++++ + L +L + R T + + G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFS 554
+ N L+ N +VSDFG+ + LD +T + +PE S K + KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 555 FGVVLLELIT-GRKPVD 570
FGV++ E+ + G+ P +
Sbjct: 187 FGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 68/209 (32%), Positives = 110/209 (52%), Gaps = 21/209 (10%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
+ ++G G FG V +G L P +E VAIK LK G +R +F E I+ + H +++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL-HGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
L G ++I +Y+ N +L L +G+ V + G A G+ YL E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMN 126
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR-----VMGTFGYMAPEY 540
+ +HRD+ + NIL+++N +VSDFGL++ D+ TT+ + T APE
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 541 ASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ K T SDV+SFG+V+ E+++ G +P
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 74/207 (35%), Positives = 112/207 (54%), Gaps = 24/207 (11%)
Query: 375 LGEGGFGSVYKGY--LPDGRE--VAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLV 429
LG G FGSV KG + G+E VA+K LK G++EF E +++++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGR-PVLD---WATRVKIAAGAARGLAYLHEDC 485
G C + +L+ + P L +L PV D A +V A G+AYL E
Sbjct: 63 GVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYL-ESK 114
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA-NTHITTRVMGTF--GYMAPEYAS 542
H +HRD+ + N+LL N +A++SDFG+++ AL A + + G + + APE +
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 543 SGKLTEKSDVFSFGVVLLELIT-GRKP 568
GK + KSDV+S+GV L E + G KP
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 27/263 (10%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG+G G VYK + P G+ A+K++ + G + ++ E++ + ++V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV--KIAAGAARGLAYLHEDCHPRII 490
+ ++ +Y+ +L + V V IA +GL YLH H II
Sbjct: 69 YKEGEISIVLEYMDGGSL----ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--II 122
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
HRDIK SN+L+++ E +++DFG++K+ + T V GT YM+PE + +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAA 181
Query: 551 DVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610
D++S G+ LLE G+ P P G S E L+ + P L
Sbjct: 182 DIWSLGLTLLECALGKFPF---LPPGQPSFFE----LMQAICDGP------PPSLPAEEF 228
Query: 611 EGEMFRMIEAAAACVRHSAAKRP 633
E I +AC++ KRP
Sbjct: 229 SPEFRDFI---SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 66/198 (33%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+GGFG V + G+ A K+L ++ +GE+ E +I+ ++ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ D L+ + L +H++ G P A + AA GL +LH+ RI+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
+RD+K N+LLD++ ++SD GLA + L I R GT GYMAPE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEVYDFSV 175
Query: 551 DVFSFGVVLLELITGRKP 568
D F+ G L E+I GR P
Sbjct: 176 DWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 375 LGEGGFGSVYKGYL----PDGRE--VAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVS 427
LGEG FG V+ G P+ + VA+K LK R+ F+ E E+++ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 428 LVGYCISDDRRLLIYDYVPNNTL--YFHLHG--------EGRPV--LDWATRVKIAAGAA 475
G C D +++++Y+ + L + HG P+ L + ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT--- 532
G+ YL +HRD+ + N L+ + ++ DFG+++ D T RV G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTML 186
Query: 533 -FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SDV+SFGVVL E+ T G++P
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-27
Identities = 79/281 (28%), Positives = 105/281 (37%), Gaps = 17/281 (6%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
PGP AA +SP P + P P P + + P PP + P PP+ PA+ PP
Sbjct: 2723 PGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRR 2782
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPS----PPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ PA + + S +P + PP+ P A+ PP SP P+ P + P P
Sbjct: 2783 LTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPP 2842
Query: 122 PPPNSPPSP------PSDPPANSPPPSNP---PSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
P P P P P PP +P P+ PP + P S + PP
Sbjct: 2843 PGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPP 2902
Query: 173 PPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
P P +PP P P PP P PP P P P + P PS P
Sbjct: 2903 DQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQP 2962
Query: 233 PPGIPVPSTENTPGNGTNPSSPE----SSSSPSNNGIGTAG 269
G VP P +P +SS+P G +
Sbjct: 2963 WLGALVPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLSR 3003
|
Length = 3151 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 47/216 (21%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-----FKAEVEIISRIHHRHLVSL 428
+GEG +G VYK G VA+K++++ + E+E E++++ ++ H ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GL 478
S + ++++Y+ ++ E VK + GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE----------VKFTESQIKCYMKQLLEGL 113
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMA 537
YLH I+HRDIK SNIL++N+ +++DFGLA + T RV+ T Y
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 538 PE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
PE Y + D++S G +L EL G+
Sbjct: 170 PELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 70/201 (34%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 374 LLGEGGFGSVYK-GYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LG+G FGSV Y P G VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C S RR L+ +Y+P +L +L + R LD + A+ +G+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK-- 127
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG---TFGYMAPEYASS 543
R +HRD+ + NIL+++ ++ DFGL K+ + R G F Y APE +
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185
Query: 544 GKLTEKSDVFSFGVVLLELIT 564
K + SDV+SFGVVL EL T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 35/209 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+GEG G VYK G+EVAIK++++ Q + E+ I+ H ++V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK-----IAAGAA---RGLAYLHEDC 485
D ++ +Y+ +L ++ V+ IA +GL YLH
Sbjct: 86 VGDELWVVMEYMDGGSL--------TDIITQ-NFVRMNEPQIAYVCREVLQGLEYLHSQ- 135
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR------VMGTFGYMAPE 539
+IHRDIKS NILL + +++DFG A +T V+GT +MAPE
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKRNSVVGTPYWMAPE 186
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKP 568
K D++S G++ +E+ G P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 23/215 (10%)
Query: 368 GFADQNLLGEGGFGSVYK-GYLPDGREVAIKQLKIGG-GQGEREFKA-EVEIISRIHHRH 424
F LG+G +GSVYK L D + A+K++ +G Q ERE E+ I++ ++H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHL---HGEGRPV---LDWATRVKIAAGAARGL 478
++S + ++ ++ +Y P L + + + + W +++ RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYM 536
LHE +I+HRD+KS+NILL N ++ D G++K+ A T I GT YM
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
APE + KSD++S G +L E+ T P +A
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 75/198 (37%), Positives = 109/198 (55%), Gaps = 12/198 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ G +VA+K LK G E F E +I+ ++ H LV L +S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 435 DDRRLLIYDYVPNNTLY-FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
++ ++ +Y+ +L F GEGR L V +AA A G+AY+ + IHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMNY---IHRD 127
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSD 551
++S+NIL+ + +++DFGLA+L D T R F + APE A G+ T KSD
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 30/210 (14%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIG--GGQGE---REFKAEVEIISRIHHRHLVS 427
LLG G FGSVY+G L DG A+K++ + G G+ ++ + E+ ++S++ H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---PVLDWATRVKIAAGAARGLAYLHED 484
+G +D + + VP +L L G PV+ TR + GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-----GTFGYMAPE 539
+HRDIK +NIL+D N +++DFG+AK + G+ +MAPE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAPE 171
Query: 540 Y-ASSGKLTEKSDVFSFGVVLLELITGRKP 568
A G +D++S G +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 375 LGEGGFGSVYKGYL--PDGRE----VAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVS 427
LGEG FG VYKG L P+ R VAIK LK + ++EF+ E E++S + H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL--------------HGEGRPVLDWATRVKIAAG 473
L+G C + ++++Y+ + L+ L + LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT- 532
A G+ YL +HRD+ + N L+ ++SDFGL++ A+ + RV
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY---RVQSKS 186
Query: 533 ---FGYMAPEYASSGKLTEKSDVFSFGVVLLEL 562
+M PE GK T +SD++SFGVVL E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-25
Identities = 71/267 (26%), Positives = 101/267 (37%), Gaps = 17/267 (6%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNP------PKSSPPPPPVSKPPTTSPPP 55
+ PSP PP ++ PPPP +P P P P+ P P VS+P
Sbjct: 2612 APPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLG 2671
Query: 56 SPP-ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
AS+PP A+ P S ++PP P P P + + +P PP ++
Sbjct: 2672 RAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQA 2731
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P + P P + P+ P+ P + P P + PP P P +P + PP+ P
Sbjct: 2732 SPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAP-----APPAAPAAGPPRRLTRP 2786
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+S ++ P P PP P A P A P + PPP S + +PPP
Sbjct: 2787 AVASLSESRESLP--SPWDPADPPAAVLAPAAALPPAASP---AGPLPPPTSAQPTAPPP 2841
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPS 261
P G P PS
Sbjct: 2842 PPGPPPPSLPLGGSVAPGGDVRRRPPS 2868
|
Length = 3151 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPDGREV-AIKQL---KIGGGQGEREFKAEVEIISRIHHR 423
F ++G+G FG V D +++ A+K + K R E I+ ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 424 HLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYL 481
LV+L Y D+ + L+ D + L +HL + V +VK L YL
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYL 116
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H IIHRDIK NILLD ++DF +A + +T T+ GT GYMAPE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTS-GTPGYMAPEVL 171
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
+ D +S GV E + G++P
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 69/204 (33%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKA---EVEIISRIHHRHLVS 427
LLG+G FG VY Y D GRE+A+KQ+ E +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 428 LVGYCISDDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C+ DD L I+ +Y+P ++ L G + + TR K G+ YLH +
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTR-KYTRQILEGVEYLHSN-- 123
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT--TRVMGTFGYMAPEYASSG 544
I+HRDIK +NIL D+ ++ DFG +K + T V GT +M+PE S
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
K+DV+S G ++E++T + P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 64/239 (26%), Positives = 100/239 (41%), Gaps = 50/239 (20%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYK-GYLPDGREVAIKQLKIGG-GQGERE-FKAEVE 415
YE L +G+G FG+V K DG+ + K++ G + E++ +EV
Sbjct: 2 YEVL----------ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 416 IISRIHHRHLVSLVG---------------YCISDDRRLLIYDYVPNNTLYFHLHGEGRP 460
I+ + H ++V YC D LI Y E
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK-YI----EEEF 106
Query: 461 VLDWATRVKIAAGAARGLAYLHEDCH------PRIIHRDIKSSNILLDNNFEAQVSDFGL 514
+ T++ +A L+E CH ++HRD+K +NI LD N ++ DFGL
Sbjct: 107 IWRILTQLLLA---------LYE-CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156
Query: 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573
AK+ L ++ +GT YM+PE + EKSD++S G ++ EL P A
Sbjct: 157 AKI-LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-24
Identities = 70/244 (28%), Positives = 87/244 (35%), Gaps = 21/244 (8%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSN---PPKSSPPPPPVSKPPTTSPPPSPPA 59
P+P PPAA ++ PP ++ P S + P + PP V P PP + PA
Sbjct: 2766 PPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPA 2825
Query: 60 SN-PPTSSSPPASSPPTSSPPPASNPPTSS----------PPPSPPASSPPTISPPPPVS 108
PP +S+ P + PP PPP S P S PP PA+ P + PP
Sbjct: 2826 GPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRR 2885
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
S P P P P A PP P PP P PP R P + P
Sbjct: 2886 LARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAP 2945
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
P P A+ P V P + P P PS +P S PP T
Sbjct: 2946 TTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQ-------PAPSREAPASSTPPLTG 2998
Query: 229 RLSP 232
Sbjct: 2999 HSLS 3002
|
Length = 3151 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 36/210 (17%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LGEG +GSVYK + G+ VAIK + + +E E+ I+ + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSY 67
Query: 433 ISDDRRLLIYDY-----------VPNNTLYFHLHGEGRPVLDWATRVKIAA---GAARGL 478
+ ++ +Y + N TL T +IAA +GL
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTL---------------TEEEIAAILYQTLKGL 112
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
YLH + + IHRDIK+ NILL+ +A+++DFG++ D T V+GT +MAP
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAP 168
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E K+D++S G+ +E+ G+ P
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 9/195 (4%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ G +VAIK ++ G E +F E +++ ++ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ +Y+ N L +L E + L + + + + YL + IHRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+ N L+ + +VSDFGLA+ LD T+ F + PE + + KSDV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLD--DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 553 FSFGVVLLELITGRK 567
+SFGV++ E+ + K
Sbjct: 185 WSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHH 422
D LG G G V K P G+ +A+K +++ E K E++I+ + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNS 58
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTL-YFHLHGEGR---PVLDWATRVKIAAGAARGL 478
++V G ++ + +Y+ +L +GR +L KIA +GL
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGL 113
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYM 536
YLHE IIHRD+K SNIL+++ + ++ DFG++ ++ A T + GT YM
Sbjct: 114 TYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYM 166
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570
APE + KSD++S G+ L+EL TGR P
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 73/197 (37%), Positives = 106/197 (53%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G VAIK LK G E F E +++ ++ H LV L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ ++ +Y+ +L L GE L V +AA A G+AY+ + +HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 128
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+++NIL+ N +V+DFGLA+L D T R F + APE A G+ T KSDV
Sbjct: 129 RAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L EL T GR P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKI--GGGQGEREFKA-------EVEIISRIHHR 423
L+G G FGSVY G G +A+KQ+++ + ++ E+ ++ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++V +G + D + +YVP ++ L+ G + +GL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN 124
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR------VMGTFGYMA 537
IIHRDIK +NIL+DN ++SDFG++K L+AN+ T + G+ +MA
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
PE T K+D++S G +++E++TG+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 34/208 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA----EVEIISRIHHRHLVSLV 429
LGEG +G VYK G VA+K++++ E + E+ ++ + H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDCHPR 488
++ + L+++Y + L +L P+ +K I RGLAY H H R
Sbjct: 65 DVIHTERKLYLVFEYCDMD-LKKYLDKRPGPLS--PNLIKSIMYQLLRGLAYCHS--H-R 118
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAK---LALDANTHITTRVMGTFGYMAPE------ 539
I+HRD+K NIL++ + +++DFGLA+ + L TH V+ T Y APE
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRAPEILLGSK 174
Query: 540 -YASSGKLTEKSDVFSFGVVLLELITGR 566
Y+++ D++S G + E+ITG+
Sbjct: 175 HYSTA------VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 69/197 (35%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VAIK LK G E F AE ++ ++ H LV L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+ +I +Y+ N +L L L + +AA A G+A++ + IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+++NIL+ +++DFGLA+L D T R F + APE + G T KSDV
Sbjct: 129 RAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L E++T GR P
Sbjct: 187 WSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 71/220 (32%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 373 NLLGEGGFGSVYKG----YLPDGRE---VAIKQLKIGGGQGER-EFKAEVEIISRIHHRH 424
N LG G FG VY+G L G VA+K L+ G E+ EF E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE-----GRPVLDWATRVKIAAGAARGLA 479
+V L+G C+ ++ + +I + + L +L G P+L + I A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 480 YLHEDCHPRIIHRDIKSSNILL-----DNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
YL E H IHRD+ + N L+ D + ++ DFGLA+ + + + G
Sbjct: 121 YL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLP 176
Query: 535 --YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDA 571
+MAPE GK T +SDV+SFGV++ E++T G++P A
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 375 LGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY+G VAIK + ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG-----EGRPVLDWATRVKI---AAGAARGLA 479
L+G + L++ + + L +L E P L T K AA A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH----ITTRVMGTFGY 535
YL + +HRD+ + N ++ + ++ DFG+ + D + + +
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYRKGGKGLLPVRW 187
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
MAPE G T KSDV+SFGVVL E+ T A QP
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATL-----AEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 374 LLGEGGFGSVYKGYL-PDGREVAIKQL-KIGGGQGEREFKA-----EVEIISRI-HHRHL 425
++GEG F +V +E AIK L K Q +E K E E+++R+ H +
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKR---QLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+ L Y D+ L + +Y PN L ++ G LD AA L YLH
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSK 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL-----------ALDANTHITTRVM--- 530
IIHRD+K NILLD + +++DFG AK+ N
Sbjct: 122 ---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 531 -----GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572
GT Y++PE + + SD+++ G ++ +++TG+ P S
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-24
Identities = 67/267 (25%), Positives = 89/267 (33%), Gaps = 11/267 (4%)
Query: 3 APSPGPPAANSSSP--PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
A G A SS P P + PT+ +++PP P P P + S P PP
Sbjct: 2667 ARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEP-APHALVSATPLPPGP 2725
Query: 61 NPPTSSSPPASSPPTSSPPPAS--NPPTSSPPPSPPASSPPTISPPP--PVSNPPTRSPP 116
+SP + P PA P + P PP ++ P PP P + PP R
Sbjct: 2726 AAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTR 2785
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP--PSSVEPPKRSPPSVPPQNPPPP 174
P ++ + P PA+ P P+ PP P+ PP S P PP P
Sbjct: 2786 PAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGP 2845
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P S P AP PP PA+P P + + + PP
Sbjct: 2846 PPPSLPLGGSVAPGG--DVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPD 2903
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPS 261
P P P P
Sbjct: 2904 QPERPPQPQAPPPPQPQPQPPPPPQPQ 2930
|
Length = 3151 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 86/286 (30%), Positives = 138/286 (48%), Gaps = 36/286 (12%)
Query: 370 ADQNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRH 424
Q ++G G FG V++G L P +E VAIK LK G + +R +F +E I+ + H +
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL--YFHLH-GEGRPVLDWATRVKIAAGAARGLAYL 481
++ L G ++I +Y+ N L Y H GE V + G A G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY----QLVGMLRGIAAGMKYL 123
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYMAPE 539
+ + +HRD+ + NIL+++N E +VSDFGL+++ D T+ T+ + APE
Sbjct: 124 SDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599
+ K T SDV+SFG+V+ E+++ +P D S E + + N+ F
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMSNHEVMKAI------NDGF-R 228
Query: 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
L P + V M + C + A+RPR +V + D L
Sbjct: 229 LPAPMDCPSAVYQLMLQ-------CWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 73/205 (35%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 372 QNLLGEGGFGSV--YKGYLPD----GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRH 424
+LGEG FG V Y Y P G VA+K LK GQ +K E+ I+ ++H +
Sbjct: 9 IRVLGEGHFGKVSLYC-YDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 425 LVSLVGYCIS--DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
+V G C LI +YVP +L +L + L+ A + A G+AYLH
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG---TFGYMAPE 539
IHRD+ + N+LLDN+ ++ DFGLAK + + + R G F Y A E
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180
Query: 540 YASSGKLTEKSDVFSFGVVLLELIT 564
K + SDV+SFGV L EL+T
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 64/217 (29%), Positives = 113/217 (52%), Gaps = 22/217 (10%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ---GEREFKA---EVEIISRIHHRHLV 426
+LG+G +G+VY G G+ +A+KQ+++ E+E++ EV+++ + H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEG---RPVLDWATRVKIAAGAARGLAYLHE 483
+G C+ D+ + ++VP ++ L+ G PV T+ + G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-----GTFGYMAP 538
+C ++HRDIK +N++L N ++ DFG A+ H T M GT +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
E + KSD++S G + E+ TG+ P+ + L
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 372 QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLV 429
++G G VY LP+ +VAIK++ + Q E + EV+ +S+ +H ++V
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHL--HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
+ D L+ Y+ +L + R LD A + +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTR--VMGTFGYMAPEYASSG 544
IHRDIK+ NILL + +++DFG+ A LA + R +GT +MAPE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 545 K-LTEKSDVFSFGVVLLELITGRKP 568
K+D++SFG+ +EL TG P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-23
Identities = 75/281 (26%), Positives = 132/281 (46%), Gaps = 23/281 (8%)
Query: 371 DQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
++N++ G G+ YKG + +G + +K++ E + ++ H ++V L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G C S+ LI++Y+ L L L W R KIA G A+ L +LH C P +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
+ ++ I++D E + +L+L T+ + Y+APE + +TEK
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEK 858
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENY 609
SD++ FG++L+EL+TG+ P DA S+VEWAR + + D DP + +
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWAR----YCYSDCHLDMWIDPSIRGDV 913
Query: 610 V--EGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648
+ E+ ++ A C RP V++ +S + S
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954
|
Length = 968 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ LP+ + VA+K LK ++F+ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRV-----------KIAAGAA 475
G C L++++Y+ + L + HG +L V IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFG 534
G+ YL H +HRD+ + N L+ ++ DFG+++ + + + R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SD++SFGVVL E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 378 GGFGSVY---KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
G +G V+ K G AIK +K I Q ++ E +I+S+ ++V L
Sbjct: 4 GAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQ-VLTERDILSQAQSPYVVKLY- 59
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
Y + L L+ +Y+P L L G LD A L YLH + I
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GI 114
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLAL--------DANTHITTRVMGTFGYMAPEYA 541
IHRD+K NIL+D+N +++DFGL+K+ L D R++GT Y+APE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDYIAPEVI 173
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
++ D +S G +L E + G P P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 375 LGEGGFGS--VYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G FG +Y+ D V K++ + + R+ E+ I+S + H ++++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 431 YCISDDRRLLI-YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ + DD LLI +Y TLY + + + + + ++Y+H+ I
Sbjct: 67 HFM-DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GI 122
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
+HRDIK+ NI L ++ DFG++K+ + T V+GT YM+PE K K
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181
Query: 550 SDVFSFGVVLLELITGRKPVDASQPL 575
SD+++ G VL EL+T ++ DA+ PL
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-23
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ ++ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ +Y+ N L +L E + +++ G+AYL + IHRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDL 126
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+ N L+D+ +VSDFGL++ LD T+ V F + PE K + KSDV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 553 FSFGVVLLELIT-GRKPVD 570
++FGV++ E+ + G+ P +
Sbjct: 185 WAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 375 LGEGGFGSV----YKGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLV 426
LG G FG V +K G+ A+K L + Q E E I+ I H LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIRHPFLV 64
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHED 484
+L G DD L L+ +YVP L+ HL GR A + AA L YLH
Sbjct: 65 NLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA---RFYAAQVVLALEYLH-S 119
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM---GTFGYMAPEYA 541
I++RD+K N+LLD++ +++DFG AK + R GT Y+APE
Sbjct: 120 LD--IVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPEII 170
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
S + D ++ G+++ E++ G P P+
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 374 LLGEGGFGSVYKG--YLPDGR--EVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSL 428
LG+G FG V +G G+ VA+K LK +F E I+ + H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL------DWATRVKIAAGAARGLAYLH 482
G + +++ + P +L L + D+A ++ A G+ YL
Sbjct: 62 YG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYLE 114
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT----RVMGTFGYMAP 538
R IHRD+ + NILL ++ + ++ DFGL + H +V F + AP
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAP 169
Query: 539 EYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
E + + SDV+ FGV L E+ T G +P
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-23
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 13/209 (6%)
Query: 372 QNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
++ LG G +G VY+G VA+K LK + E EF E ++ I H +LV L+G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C + +I +++ L +L R ++ + +A + + YL + I
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTE 548
HRD+ + N L+ N +V+DFGL++L + +T+ T F + APE + K +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRL-MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 549 KSDVFSFGVVLLELIT-GRKP---VDASQ 573
KSDV++FGV+L E+ T G P +D SQ
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 73/288 (25%), Positives = 94/288 (32%), Gaps = 22/288 (7%)
Query: 3 APSPGPPAANS-----SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP 57
AP P PA S +PP + P SP PP P P PSP
Sbjct: 2574 APRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSP 2633
Query: 58 PASNPPTSSSPPASSPP----TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
A+ P P P +P S P + +S P P + P
Sbjct: 2634 AANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVG 2693
Query: 114 S------PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
S PPPP TP P + P P P+ P P + P + P+ P
Sbjct: 2694 SLTSLADPPPPPPTPEPAPHALVSATPL--PPGPAAARQASPALPAAPAPPAVPAGPATP 2751
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
P + PAP A P + PP T P AS R S SP P P
Sbjct: 2752 GGPARPARPPTTAGPPAPAPPAAPAA--GPPRRLTRPAVASLSESRESLPSPWDPADPPA 2809
Query: 228 KRLSPPPGIPV---PSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVV 272
L+P +P P+ P P++P P + G+V
Sbjct: 2810 AVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVA 2857
|
Length = 3151 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 8/195 (4%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGYC 432
+G+G FG VYKG L EVA+K + + F E EI+ + H ++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ ++ + VP +L L + L ++++ AA G+ YL IHR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKS 550
D+ + N L+ N ++SDFG+++ + + + + + APE + G+ T +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREE-EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 551 DVFSFGVVLLELITG 565
DV+S+G++L E +
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 9/204 (4%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRH 424
F +LG+GGFG V + G+ A K+L +I +GE E +I+ +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+VSL + D L+ + L FH++ G + V AA GL LH++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
RI++RD+K NILLD++ ++SD GLA + T I RV GT GYMAPE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
+ T D ++ G +L E+I G+ P
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 3e-22
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ P+ + VA+K LK ++F E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHG-------EGRPV--LDWATRVKIAAGAARG 477
G C+ D +++++Y+ + L + HG EG L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYM 536
+ YL +HRD+ + N L+ N ++ DFG+++ + + + M +M
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
PE K T +SDV+S GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 375 LGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ D VA+K LK ++F+ E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 429 VGYCISDDRRLLIYDYVPNNTL--YFHLHG-------EGRPV-----LDWATRVKIAAGA 474
G C D +++++Y+ + L + HG +G+P L + + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTF 533
A G+ YL +HRD+ + N L+ N ++ DFG+++ + + + M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRH 424
F +LG+GGFG V + G+ A K+L +I +GE E +I+ +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+VSL + D L+ + L FH++ G P D V AA GL LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
RI++RD+K NILLD+ ++SD GLA + + I RV GT GYMAPE +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKNE 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
+ T D + G ++ E+I G+ P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 62/199 (31%), Positives = 110/199 (55%), Gaps = 20/199 (10%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+GEG FG+V +G Y G++VA+K +K + F E +++++HH++LV L+G I
Sbjct: 14 IGEGEFGAVLQGEYT--GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLG-VI 68
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+ ++ + + L L GR ++ ++ + A G+ YL +++HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 494 IKSSNILLDNNFEAQVSDFGLAKL---ALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
+ + NIL+ + A+VSDFGLA++ +D N+ + + + APE K + KS
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVD-NSKLPVK------WTAPEALKHKKFSSKS 178
Query: 551 DVFSFGVVLLELIT-GRKP 568
DV+S+GV+L E+ + GR P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 373 NLLGEGGFGSVYKGYL--PDGREV--AIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
++G+G FG VY G L DG+++ A+K L +I + +F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR---VKIAAG----AARGLAY 480
L+G C+ + P L + HG+ R + T VK G A+G+ Y
Sbjct: 61 LLGICLPSEG-------SPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA---NTHITTRVMGTFGYMA 537
L + +HRD+ + N +LD +F +V+DFGLA+ D + H T +MA
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELIT 564
E + K T KSDV+SFGV+L EL+T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 28/214 (13%)
Query: 372 QNLLGEGGFGSVYKGYL-PDG--REVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
Q+++GEG FG V K + DG + AIK++K + + R+F E+E++ ++ HH +++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHG----EGRPVLDWATR----------VKIAA 472
+L+G C L +Y P+ L L E P A + AA
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
ARG+ YL + + IHRD+ + NIL+ N+ A+++DFGL++ + MG
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 184
Query: 533 FG--YMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MA E + T SDV+S+GV+L E+++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 9e-22
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G+G FG V G G +VA+K +K + F AE +++++ H +LV L+G
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 432 CISDDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + L I +Y+ +L +L GR VL +K + + YL + +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
HRD+ + N+L+ + A+VSDFGL K A ++T T ++ + APE K + KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKL--PVKWTAPEALREKKFSTKS 180
Query: 551 DVFSFGVVLLELIT-GRKP 568
DV+SFG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-21
Identities = 74/275 (26%), Positives = 100/275 (36%), Gaps = 18/275 (6%)
Query: 12 NSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSP---PPSPPASNPPTSSSP 68
++ PPPP+ PP P P + P P P P S+P TS P +PP S P +
Sbjct: 2547 DAGDPPPPL--PPAAPPAAPDRSVPPPRPAPRP-SEPAVTSRARRPDAPPQSARPRAPVD 2603
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP-PTRSPPPPSSTPPPNSP 127
P +PP P T +P P PP+ SP P P P P P S
Sbjct: 2604 DRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSR 2663
Query: 128 P---SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP----- 179
P S PP P P S+ PP P P P S
Sbjct: 2664 PRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPP 2723
Query: 180 -PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP--RPSNSSPNSPPPPSTKRLSPPPGI 236
P + A A+P + PP P TP P P P+ + P +P PP+ PP +
Sbjct: 2724 GPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRL 2783
Query: 237 PVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTV 271
P+ + + + SP + P + A +
Sbjct: 2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAAAL 2818
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-21
Identities = 73/285 (25%), Positives = 98/285 (34%), Gaps = 32/285 (11%)
Query: 3 APSPGP-PAANSSSPPPPVSNPPTISPPPPVSNP--------------------PKSSPP 41
AP PG + +PP P P I P PV P PP
Sbjct: 2495 APDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEELASDDAGDPPPP 2554
Query: 42 PPPVSKPPTT--SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
PP + P S PP PA P + + P + P A P +PP
Sbjct: 2555 LPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPP 2614
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
SP PP ++ P PPPPS +P N P P P + P+ P
Sbjct: 2615 --SPLPPDTHAP--DPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRL 2670
Query: 160 KRSP-PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP-PTQTPPTPASPIAPRPSNS 217
R+ S PPQ P ++ P +A PP P P P A+P+ P P+ +
Sbjct: 2671 GRAAQASSPPQRPRRR--AARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAA 2728
Query: 218 SPNSPPPPSTKRLSPPPGIPV-PSTENTPGNGTNPSSPESSSSPS 261
SP P+ P P P P + P + + P+
Sbjct: 2729 RQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPA 2773
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 69/280 (24%), Positives = 94/280 (33%), Gaps = 24/280 (8%)
Query: 3 APSPGPPAANSSSPPP-PVSNP-----------PTISPPPPVSNPPKSSPPPPPVSKPPT 50
P+ P A + S PPP P P P P P P PP+
Sbjct: 2556 PPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPPS 2615
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
PP + PP S SP A+ P PP P P+P S P +
Sbjct: 2616 PLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRL--GRA 2673
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
S PP P A+ PPP P P P P P+ Q
Sbjct: 2674 AQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPE--PAPHALVSATPLPPGPAAARQA 2731
Query: 171 PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL 230
P P++ +PPA A P + P PPT A P AP P + PP RL
Sbjct: 2732 SPALPAAP----APPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPR----RL 2783
Query: 231 SPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGT 270
+ P + + + + +P+ P ++ + A +
Sbjct: 2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAAS 2823
|
Length = 3151 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 64/206 (31%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 375 LGEGGFGSVYK-GYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG GGFG V R A+K +K + GQ + +E EI+ +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
D + + ++ +Y L+ L G D T A YLH
Sbjct: 60 RT-FKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNR---G 113
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYASSGKLT 547
II+RD+K N+LLD+N ++ DFG AK L T T GT Y+APE +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYD 170
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQ 573
D +S G++L EL+TGR P
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 72/238 (30%), Positives = 117/238 (49%), Gaps = 37/238 (15%)
Query: 375 LGEGGFGSVY----KGYLP---------DGRE--VAIKQLKIGGGQGER-EFKAEVEIIS 418
LGEG FG V+ +G DG+ VA+K L+ + R +F E++I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 419 RIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL----------HGEGRPVLDWATRV 468
R+ + +++ L+G C+SDD +I +Y+ N L L H P + A +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITT 527
+A A G+ YL +HRD+ + N L+ N++ +++DFG+++ + + I
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP---LGDESLVE 582
R + +MA E GK T SDV++FGV L E+ T K QP L DE ++E
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK----EQPYSLLSDEQVIE 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 73/198 (36%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG+G FG V+ G +VAIK LK G E F E +I+ ++ H LV L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 435 DDRRLLIYDYVPNNTLY-FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
++ ++ +++ +L F G+G+ L V +AA A G+AY+ + IHRD
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIERMNY---IHRD 127
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSD 551
++++NIL+ +N +++DFGLA+L D T R F + APE A G+ T KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 84/287 (29%), Positives = 127/287 (44%), Gaps = 50/287 (17%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFK---AEVEIISRIHHRH 424
F D +G G FG+VY E VAIK++ G Q +++ EV + ++ H +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR----VKIAA---GAARG 477
+ G + + L+ +Y G +L+ + V+IAA GA +G
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL---------GSASDILEVHKKPLQEVEIAAICHGALQG 127
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
LAYLH IHRDIK+ NILL +++DFG A L AN+ + GT +MA
Sbjct: 128 LAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMA 179
Query: 538 PEY---ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD----ESLVEWAR---PL 587
PE G+ K DV+S G+ +EL RKP PL + +L A+ P
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP-----PLFNMNAMSALYHIAQNDSPT 233
Query: 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR 634
LS ++ F N D L + + R ++ ++H R R
Sbjct: 234 LSSNDWSDYFRNFVDSCLQKIPQD----RP--SSEELLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 25/272 (9%)
Query: 375 LGEGGFGSVYK-GYLPDGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYC 432
LG G GSV K ++P G +A K + IG ++ E++I+ ++VS G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV----KIAAGAARGLAYLHEDCHPR 488
++++ + +++ +L ++ +G P+ V KIA GL YL+ + H R
Sbjct: 73 LNENNICMCMEFMDCGSLD-RIYKKGGPI-----PVEILGKIAVAVVEGLTYLY-NVH-R 124
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I+HRDIK SNIL+++ + ++ DFG++ +++ I +GT YM+PE GK T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKYTV 181
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608
KSDV+S G+ ++EL G+ P S D L + E PRL +
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-----PPRLPSS 236
Query: 609 YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
++ ++ AC+ +RP Q+
Sbjct: 237 DFPEDLRDFVD---ACLLKDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY + +VA+K LK G + F E ++ + H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ +I +Y+ +L L + + + +A A G+AY+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDL 129
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+++N+L+ + +++DFGLA++ D T R F + APE + G T KSDV
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L E++T G+ P
Sbjct: 188 WSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVG 430
++GEG +G V K G VAIK+ K + + A EV+++ ++ H ++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
R L+++YV L L L + +AY H II
Sbjct: 68 AFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NII 122
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPE----YASSGK 545
HRDIK NIL+ + ++ DFG A+ L + +T V T Y APE + GK
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNYGK 181
Query: 546 LTEKSDVFSFGVVLLELITGR 566
DV++ G ++ EL+ G
Sbjct: 182 ---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 40/240 (16%)
Query: 375 LGEGGFGSVY------------KGYLPDGRE-----VAIKQLKIGGGQGER-EFKAEVEI 416
LGEG FG V+ K + + VA+K L+ R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL--YFHLH-------GEGRPVLDWATR 467
+SR+ ++ L+G C D +I +Y+ N L + H L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-IT 526
+ +A A G+ YL +HRD+ + N L+ N+ +++DFG+++ ++ + +
Sbjct: 133 LYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQP---LGDESLVE 582
R +MA E GK T KSDV++FGV L E++T R+ QP L D+ ++E
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-----QPYEHLTDQQVIE 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 5e-21
Identities = 73/211 (34%), Positives = 115/211 (54%), Gaps = 23/211 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGREV----AIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVS 427
+LG G FG+VYKG ++P+G V AIK L + G + EF E I++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTL--YFHLHGE---GRPVLDWATRVKIAAGAARGLAYLH 482
L+G C+S +L + +P+ L Y H H + + +L+W ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYA 541
E R++HRD+ + N+L+ + +++DFGLA+L D + +MA E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 542 SSGKLTEKSDVFSFGVVLLELIT-GRKPVDA 571
K T +SDV+S+GV + EL+T G KP D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 25/212 (11%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE----------FKAEVEIISRIHH 422
L+G+G +G VY + G +A+KQ+++ R ++E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---PVLDWATRVKIAAGAARGLA 479
++V +G+ +++ + +YVP ++ L GR ++ + T + GLA
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAP 538
YLH I+HRD+K+ N+L+D + ++SDFG++K + D + M G+ +MAP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 539 EYASSGK--LTEKSDVFSFGVVLLELITGRKP 568
E S + K D++S G V+LE+ GR+P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRH 424
F +LG+GGFG V + G+ A K+L +I +GE E I+ +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+VSL + D L+ + L FH++ G P D + AA GL L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
RI++RD+K NILLD+ ++SD GLA + T + RV GT GYMAPE ++
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNE 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
K T D + G ++ E+I G+ P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 75/281 (26%), Positives = 118/281 (41%), Gaps = 37/281 (13%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRH 424
+ + + LGEG GSV K L + + + + ++ E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 425 LVSLVGYCISDDRRLL--IYDYVPNNTLYFHLHGEGRPVLDWATRV------KIAAGAAR 476
+V G + + + +Y +L + V R+ KIA +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL----DSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFG 534
GL+YLH +IIHRDIK SNILL + ++ DFG++ ++ A T GT
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSF 168
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPV--DASQPLGDESLVEWARPLLSHAL 592
YMAPE + SDV+S G+ LLE+ R P + PLG +E LLS+ +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIE----LLSYIV 221
Query: 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP 633
+ +P G + E E I+ C+ +RP
Sbjct: 222 NMPNPELKDEPGNGIKWSE-EFKDFIK---QCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLV 426
F +G+G FG VYK + VAIK + + + E E E++ +S+ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
G +L +I +Y + L G+ LD I GL YLHE+
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSC-LDLLKPGK--LDETYIAFILREVLLGLEYLHEE- 117
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFG----LAKLALDANTHITTRVMGTFGYMAPEYA 541
IHRDIK++NILL + +++DFG L NT + GT +MAPE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMAPEVI 170
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
EK+D++S G+ +EL G P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-20
Identities = 60/276 (21%), Positives = 92/276 (33%), Gaps = 10/276 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSP-PPSPPAS 60
SP PP +S PPPP P + P P P P P + P + PA+
Sbjct: 102 REGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAA 161
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP-PS 119
++S ++ P SSP + P+S P PP++ P SP PP + P + P+
Sbjct: 162 VASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPA 221
Query: 120 STPPPNSPPSPPSDPPANSPPPS-----NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P ++ + +S S P + P P P+ + P R + P
Sbjct: 222 PAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSR 281
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP---PPPSTKRLS 231
P + +SP P + P AS + SS +S S
Sbjct: 282 PGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAV 341
Query: 232 PPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGT 267
P P S + S + +
Sbjct: 342 SPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSS 377
|
Length = 1352 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 9/209 (4%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRH 424
F +LG+GGFG V + G+ A K+L +I +GE E +I+ +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+V+L + D L+ + L FH++ G P + + AA GL LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
++RD+K NILLD+ ++SD GLA + + I RV GT GYMAPE ++
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-GTVGYMAPEVLNNQ 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQ 573
+ T D + G ++ E+I G+ P +
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 44/218 (20%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE---FKA--EVEIISRIHHRHLV 426
LGEG + VYK GR VAIK++K+G + ++ F A E++++ + H +++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 427 SLVGYCISDDRRLLIYDYVP--------NNTLYFHLHGEGRPVLDWATRVK-IAAGAARG 477
L+ L+++++ + ++ +K RG
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLT-----------PADIKSYMLMTLRG 114
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L YLH + I+HRD+K +N+L+ ++ +++DFGLA+ N +T +V+ T Y A
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRA 170
Query: 538 PE-------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
PE Y D++S G + EL+ R P
Sbjct: 171 PELLFGARHYGVG------VDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 65/222 (29%), Positives = 113/222 (50%), Gaps = 23/222 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGRE----VAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVS 427
LLG G FG+V+KG ++P+G VAIK ++ G Q +E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLH---GEGRP--VLDWATRVKIAAGAARGLAYLH 482
L+G C +L + P +L H+ P +L+W ++ A+G+ YL
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYA 541
E ++HR++ + NILL ++ Q++DFG+A L D + + +MA E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 542 SSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVE 582
G+ T +SDV+S+GV + E+++ G +P +P L+E
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 375 LGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVS 427
LGEG FG V K VA+K LK E R+ +E ++ +++H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV-----------------------LDW 464
L G C D LLI +Y +L L E R V L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLR-ESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 465 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524
+ A +RG+ YL E +++HRD+ + N+L+ + ++SDFGL++ + +++
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 525 IT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+ ++ +MA E T +SDV+SFGV+L E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 7e-20
Identities = 49/213 (23%), Positives = 70/213 (32%), Gaps = 3/213 (1%)
Query: 20 VSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPP 79
V P + P SS PP ++P + P +P A P +++ PA + +P
Sbjct: 587 VVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPG 646
Query: 80 PASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP---PA 136
A+ P AS P P PP P+ P + P+ P PA
Sbjct: 647 VAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPA 706
Query: 137 NSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP 196
+PP PP ++ SP + P PP P P PA PP+ P
Sbjct: 707 ATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAP 766
Query: 197 PPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
P P+ P +R
Sbjct: 767 AAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRR 799
|
Length = 824 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 9e-20
Identities = 45/230 (19%), Positives = 73/230 (31%), Gaps = 14/230 (6%)
Query: 1 MSAPSPGPPAANSSSPPP---PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP 57
M A PG + PV+ P + P + P ++PP P + P +
Sbjct: 360 MLAFRPGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAP-AAAPAAAAAARA 418
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
A+ P S P + +P P+P A+ P P +
Sbjct: 419 VAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAA 478
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
P +P + P+ + PP P P P+ + +P ++ P P ++
Sbjct: 479 A---PARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDA---APAGWVAESIPDPATA 532
Query: 178 SPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
P A + P T P APRP +S + P
Sbjct: 533 DPDDAFETLAPAPAAAPAPRAAAATEPVV----APRPPRASASGLPDMFD 578
|
Length = 700 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 41/222 (18%), Positives = 60/222 (27%), Gaps = 10/222 (4%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNP----PKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P + + P + P P P + P P + PP + P + A+ P
Sbjct: 365 PGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPA 424
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP--PPVSNPPTRSPPPPSST 121
S P + +P P+P A+ P P + P +
Sbjct: 425 RRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAA 484
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P P+ PP PP P P P S+P P +
Sbjct: 485 PAAAPAPADDDPPPWEELPPEFA---SPAPAQPDAAPAGWVAESIPDPATADPDDAFETL 541
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
PA P + P P P A + P
Sbjct: 542 APAPAAAPAPRAAAATEP-VVAPRPPRASASGLPDMFDGDWP 582
|
Length = 700 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 30/215 (13%)
Query: 372 QNLLGEGGFGSVYKGYLP-DGREV--AIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLV 426
++++GEG FG V + + DG ++ AIK LK + + R+F E+E++ ++ HH +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL---------------HGEGRPVLDWATRVKIA 471
+L+G C + + +Y P L L HG L ++ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS-TLTSQQLLQFA 125
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
+ A G+ YL E + IHRD+ + N+L+ N ++++DFGL++ + MG
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMG 178
Query: 532 TFG--YMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MA E + T KSDV+SFGV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 78/308 (25%), Positives = 122/308 (39%), Gaps = 74/308 (24%)
Query: 357 FTYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLK-IGGGQGEREFKAEV 414
FT E+L D +G G FG+V K + P G +A+K+++ + ++ ++
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 415 EIISRIHHRHLVSLV---------GYC--------ISDDRRLLIYDYVPNNTLYFHLHGE 457
+++ R +V G C IS D+ Y +++
Sbjct: 54 DVVMR--SSDCPYIVKFYGALFREGDCWICMELMDISLDK------------FYKYVYEV 99
Query: 458 GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517
+ V+ KIA + L YL E+ IIHRD+K SNILLD N ++ DFG++
Sbjct: 100 LKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157
Query: 518 ALDANTHITTRVMGTFGYMAPE-YASSG--KLTEKSDVFSFGVVLLELITGRKPVDASQP 574
+D+ TR G YMAPE S +SDV+S G+ L E+ TG+ P
Sbjct: 158 LVDSIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP---- 211
Query: 575 LGDESLVEWARPLLSHALENEEFDNLAD------PRLGENYVEGEMFRMIEAAAACVRHS 628
+W N FD L P L + + C+
Sbjct: 212 -------KW----------NSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKD 254
Query: 629 AAKRPRMG 636
+KRP+
Sbjct: 255 ESKRPKYK 262
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 374 LLGEGGFGSVYKGYL--PDGR--EVAIKQLKIGG-GQGE-REFKAEVEIISRIHHRHLVS 427
+LGEG FGSV +G L DG +VA+K +K+ E EF +E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 428 LVGYCISDDRR------LLIYDYVPNNTLY---FHLHGEGRPV-LDWATRVKIAAGAARG 477
L+G C ++I ++ + L+ + G P L T +K A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT-FGYM 536
+ YL IHRD+ + N +L + V+DFGL+K + + R+ ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
A E + T KSDV++FGV + E+ T G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 68/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
+ ++G G FG V +G L P RE VAIK LK G + +R +F +E I+ + H +++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL-YFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHED 484
L G ++I +++ N L F +G+ V+ V + G A G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSEM 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT-TRVMG---TFGYMAPEY 540
+ +HRD+ + NIL+++N +VSDFGL++ D + T T +G + APE
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 541 ASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ K T SDV+S+G+V+ E+++ G +P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-19
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 391 GREVAIKQLKIGGGQGERE---FKAEVEIISRIHHRHLVSLV--GYCISDDRRLLIYDYV 445
G EVAIK L+ + E + F+ E + +R++H ++V+L+ G +++YV
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---D 502
P TL L +G L ++ LA H I+HRD+K NI++
Sbjct: 62 PGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 503 NNFEAQVSDFGLAKL------ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFG 556
A+V DFG+ L A A TT V+GT Y APE +T SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 557 VVLLELITGRKPV 569
++ LE +TG++ V
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 375 LGEGGFGSVYKG-YLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVG 430
LG G FG V KG Y ++ VAIK LK + R E E EI+ ++ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C ++ +L+ + L L G+ + + + V++ + G+ YL +
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFV 117
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDA-NTHITTRVMGTF--GYMAPEYASSGKLT 547
HRD+ + N+LL N A++SDFGL+K AL A +++ R G + + APE + K +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 548 EKSDVFSFGVVLLELIT-GRKP 568
+SDV+S+G+ + E + G+KP
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 69/222 (31%), Positives = 117/222 (52%), Gaps = 24/222 (10%)
Query: 362 LVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVE 415
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL--YFHLHGE---GRPVLDWATRVKI 470
+++ + + H+ L+G C++ +L I +P L Y H + + +L+W ++
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRV 529
A+G+ YL E R++HRD+ + N+L+ +++DFGLAK L D +
Sbjct: 119 ----AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVD 570
+MA E T +SDV+S+GV + EL+T G KP D
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKI----GGGQGE--REFKAEVEIISRIHHRHLV 426
LG G F S Y+ + G +A+KQ+ Q E + E+ +++R++H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
++G D L +++ ++ L G A + RGL+YLHE+
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 487 PRIIHRDIKSSNILLDNNFE-AQVSDFGLA-KLALDAN--THITTRVMGTFGYMAPEYAS 542
+IIHRD+K +N+L+D+ + +++DFG A +LA +++GT +MAPE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDA 571
+ DV+S G V++E+ T + P +A
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 61/190 (32%), Positives = 98/190 (51%), Gaps = 7/190 (3%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGYC 432
LLG+G FG V+KG L D VA+K K Q + +F +E I+ + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH-EDCHPRIIH 491
++ + VP L + + L VK A AA G+AYL ++C IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD+ + N L+ N ++SDFG+++ D + + APE + G+ + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 552 VFSFGVVLLE 561
V+S+G++L E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 4e-19
Identities = 43/210 (20%), Positives = 69/210 (32%), Gaps = 7/210 (3%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP-PASN 61
A +P A +++ P + P P P + P ++ + P SP P A+
Sbjct: 378 AAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPEALAAAR 437
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
++ P + P +P A P ++ P + + P P +P P
Sbjct: 438 QASARGPGGAPAPAPAPAAA--PAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADDD 495
Query: 122 PPP--NSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV--PPQNPPPPPSS 177
PPP PP S PA P P++ +P P P P ++
Sbjct: 496 PPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAAA 555
Query: 178 SPPKNSPPAPIAVPPSNVPPPPTQTPPTPA 207
+ P P S +P P A
Sbjct: 556 ATEPVVAPRPPRASASGLPDMFDGDWPALA 585
|
Length = 700 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 373 NLLGEGGFGSVYKGYLP-DGREV--AIKQLKIGGGQGE-REFKAEVEIISRI-HHRHLVS 427
+++GEG FG V K + DG + AIK++K + + R+F E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL---------------HGEGRPVLDWATRVKIAA 472
L+G C L +Y P+ L L + L + AA
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLHFAA 119
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
ARG+ YL + + IHRD+ + NIL+ N+ A+++DFGL++ + MG
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 172
Query: 533 FG--YMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MA E + T SDV+S+GV+L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+GGFG V + G+ A K+L ++ +G E I++++H R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
Y L L+ + L +H++ E P A GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
RII+RD+K N+LLDN+ ++SD GLA D + T GT G+MAPE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 548 EKSDVFSFGVVLLELITGRKP 568
D F+ GV L E+I R P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-19
Identities = 44/208 (21%), Positives = 72/208 (34%), Gaps = 6/208 (2%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
+ P + P P+P A+ P ++ PA+ P + PA+ + +P SP
Sbjct: 372 AGPATAAAAPVAQ---PAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSP 428
Query: 99 PTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
+ P+ P P + P+ + P A P P + P +
Sbjct: 429 APEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAA 488
Query: 159 PKRSPPSVPP-QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS 217
P + PP + PP +S P AP ++P P T P +AP P+ +
Sbjct: 489 PAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAA 548
Query: 218 SPNSPPPPSTKRLSPPPGIPVPSTENTP 245
+P + P P S P
Sbjct: 549 P--APRAAAATEPVVAPRPPRASASGLP 574
|
Length = 700 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-18
Identities = 57/264 (21%), Positives = 81/264 (30%), Gaps = 8/264 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A S A SSP P + PP S PP ++ P PP P ++ SP +
Sbjct: 165 DAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAP 224
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+++ +S SS +S P P P P
Sbjct: 225 GRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGP 284
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
+S P S P+ PS+P S P P + S S SS
Sbjct: 285 ASSSSSPRERSPSPS----PSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAA 340
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS----SPNSPPPPSTKRLSPPPGIP 237
SP + PS PPP P +P P + S S P +
Sbjct: 341 VSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARR 400
Query: 238 VPSTENTPGNGTNPSSPESSSSPS 261
+T P PS ++ ++
Sbjct: 401 RDATGRFPAGRPRPSPLDAGAASG 424
|
Length = 1352 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 375 LGEGGFGSV-YKGYLPDG----REVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V Y P+G +VA+K LK GG + K E+EI+ ++H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C D LI +++P+ +L +L + ++ ++K A +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT---RVMGTFGYMAPEYASS 543
+ +HRD+ + N+L+++ + ++ DFGL K + T F Y APE
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQ 186
Query: 544 GKLTEKSDVFSFGVVLLELIT 564
K SDV+SFGV L EL+T
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 54/204 (26%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 374 LLGEGGFGSVY--KGYLPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLV 429
++G G FG V+ + D + V IKQ+ + + A E +++ + H +++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ D +++ +Y P TL ++ +LD T + L ++H I
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LI 122
Query: 490 IHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+HRD+K+ NILLD + ++ DFG++K+ L + + T V+GT Y++PE +
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKI-LSSKSKAYT-VVGTPCYISPELCEGKPYNQ 180
Query: 549 KSDVFSFGVVLLELITGRKPVDAS 572
KSD+++ G VL EL + ++ +A+
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 371 DQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
++ +LG+G +G VY L +AIK++ + + E+ + S + HR++V +
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLD-WATRVKIAAGAARGLAYLHEDCHPR 488
G + + + VP +L L + P+ D T + GL YLH++ +
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128
Query: 489 IIHRDIKSSNILLDNNFEA--QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK- 545
I+HRDIK N+L+ N + ++SDFG +K N T GT YMAPE G
Sbjct: 129 IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPR 186
Query: 546 -LTEKSDVFSFGVVLLELITGRKP 568
+D++S G ++E+ TG+ P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 16/207 (7%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
+ ++G G FG V G L P RE VAIK LK G + +R +F +E I+ + H +++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
L G +++ +Y+ N +L + H V+ V + G A G+ YL +
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLSDM 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG--YMAPEYAS 542
+ +HRD+ + NIL+++N +VSDFGL+++ D T G + APE +
Sbjct: 126 GY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 543 SGKLTEKSDVFSFGVVLLELIT-GRKP 568
K T SDV+S+G+V+ E+++ G +P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 2e-18
Identities = 47/219 (21%), Positives = 69/219 (31%), Gaps = 4/219 (1%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P P AA PP P S+ P P + P P P + P+ ++ P
Sbjct: 587 VVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAA---PAAPAAPAPAGAAAAPAEASAAP 643
Query: 63 PTSSSPPASSP-PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ P P + P + A + P +P P P + P +
Sbjct: 644 APGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAP 703
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P +PP+ +D PA PP + ++ P P P P P P PP
Sbjct: 704 APAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPA 763
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN 220
+P A A P PP + +P
Sbjct: 764 PAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRRDAE 802
|
Length = 824 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-18
Identities = 58/204 (28%), Positives = 71/204 (34%), Gaps = 24/204 (11%)
Query: 2 SAPSPGPPAANSSSPP---PPVSNPPTISPPPPVSNPPKSSPPPPPVS------------ 46
S P P A +P PP ++P PPP + P PPP P
Sbjct: 2800 SPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPG 2859
Query: 47 -----KPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
+PP+ SP P A P + S+ A P PP P A PP
Sbjct: 2860 GDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQP 2919
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP-PANSPPPSNPPSNLPPPPPSSVEPPK 160
P PP P PPPP P P P +P +DP A P + P L P V P+
Sbjct: 2920 QPQPPPPPQPQPPPPPP---PRPQPPLAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPR 2976
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSP 184
P P P S+ P
Sbjct: 2977 FRVPQPAPSREAPASSTPPLTGHS 3000
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-18
Identities = 50/213 (23%), Positives = 76/213 (35%), Gaps = 9/213 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A GPPA SS PP + P + P + P + P +P + P +
Sbjct: 594 AAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHH 653
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P + P AS P A ++PPP+P ++P + P P + PP+
Sbjct: 654 PKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAG- 712
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
+ PP S P +P PP P P+ PP P P P+++P
Sbjct: 713 QADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAA 772
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
PP+P P + A +
Sbjct: 773 APPPSP--------PSEEEEMAEDDAPSMDDED 797
|
Length = 824 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 70/265 (26%), Positives = 125/265 (47%), Gaps = 32/265 (12%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLVGY 431
L+G G +G+VY+G +P GR VA+K + + + + + EV ++S++ ++ Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 432 --CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
RL +I +Y ++ + + P+ + V I L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISV-IIREVLVALKYIHKV---G 121
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+IHRDIK++NIL+ N ++ DFG+A L L+ N+ + +GT +MAPE + GK +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180
Query: 549 -KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607
K+D++S G+ + E+ TG P L+ ++P PRL +
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP----------------PRLED 224
Query: 608 NYVEGEMFRMIEAAAACVRHSAAKR 632
N + + AAC+ +R
Sbjct: 225 NGYSKLLREFV---AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 375 LGEGGFGSVYKGYL----PDGREVAIKQLKIGGGQG-ER-EFKAEVEIISRIHHRHLVSL 428
+GEG FG K L DG++ IK++ I ER E + EV ++S + H ++V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 429 VGYCISDDRRLLIY---DYVPNNTLYFHLHGEG------RPVLDWATRVKIAAGAARGLA 479
Y S + +Y DY LY ++ + +LDW ++ +A L
Sbjct: 64 --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LK 115
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
++H+ +I+HRDIKS NI L + ++ DFG+A++ L++ + +GT Y++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPE 171
Query: 540 YASSGKLTEKSDVFSFGVVLLELIT 564
+ KSD+++ G VL E+ T
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-18
Identities = 43/221 (19%), Positives = 66/221 (29%), Gaps = 10/221 (4%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
+ P + P + P P + P +PPA+ PA++ A+ P
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAA----APAAAAAA--RAVAAAPAR 425
Query: 87 SSPPPSP-PASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
SP P A+ + P P P++ P + P A + P P
Sbjct: 426 RSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAP 485
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT 205
+ P P P + PP P P A P+ P
Sbjct: 486 AAAPAPADDDPPPWEELPPEFA---SPAPAQPDAAPAGWVAESIPDPATADPDDAFETLA 542
Query: 206 PASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPG 246
PA AP P ++ P + G+P + P
Sbjct: 543 PAPAAAPAPRAAAATEPVVAPRPPRASASGLPDMFDGDWPA 583
|
Length = 700 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 62/213 (29%), Positives = 111/213 (52%), Gaps = 23/213 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVS 427
+LG G FG+VYKG ++PDG VAIK L+ + +E E +++ + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGE-----GRPVLDWATRVKIAAGAARGLAYLH 482
L+G C++ +L + +P L ++ + +L+W ++ A+G++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-LDANTHITTRVMGTFGYMAPEYA 541
E R++HRD+ + N+L+ + +++DFGLA+L +D + +MA E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 542 SSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQ 573
+ T +SDV+S+GV + EL+T G KP D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 374 LLGEGGFGSVYKG-YL---PDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL 428
+GEG FG VY+G Y+ + VA+K K RE F E I+ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G +++ ++ + P L +L + LD A+ + + + LAYL R
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---R 127
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+HRDI + N+L+ + ++ DFGL++ D + + ++ +MAPE + + T
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 549 KSDVFSFGVVLLE-LITGRKP 568
SDV+ FGV + E L+ G KP
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 375 LGEGGFGSVYKG--YLP---DGREVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGE FG +YKG YLP + VAIK LK I Q EF+ E +++ +HH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHL---------------HGEGRPVLDWATRVKIAAG 473
+G + ++++Y+ L+ L G + LD + IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGT 532
A G+ YL +H+D+ + NIL+ ++SD GL++ A+ + + + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE GK + SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 67/237 (28%), Positives = 108/237 (45%), Gaps = 20/237 (8%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+GGFG V + + G+ A K+L ++ GE+ E EI+ +++ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
S L+ + L +H++ G L+ + +A G+ +LH I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
+RD+K N+LLD+ ++SD GLA D T T+ GT GYMAPE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 551 DVFSFGVVLLELITGRKPV-DASQPLGDESLVEWARPLLSHALENE---EFDNLADP 603
D F+ G + E++ GR P D + + E L LE+E E N +
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEE-------LKRRTLEDEVKFEHQNFTEE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 372 QNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G G +G VYK + G VAIK +K+ G + E+ ++ H ++V+ G
Sbjct: 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIA---AGAARGLAYLHEDCHP 487
+ D+ ++ +Y +L P+ + ++IA +GLAYLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETLKGLAYLHET--- 120
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA-----NTHITTRVMGTFGYMAPEYA- 541
IHRDIK +NILL + + +++DFG++ L A + I GT +MAPE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ-LTATIAKRKSFI-----GTPYWMAPEVAA 174
Query: 542 --SSGKLTEKSDVFSFGVVLLELITGRKP 568
G K D+++ G+ +EL + P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 70/213 (32%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 375 LGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHR-HL 425
LG G +G V+ G G+ A+K LK + + + E +++ + L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
V+L Y D +L LI DYV L+ HL+ RV IA L +LH+
Sbjct: 68 VTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAE-IVLALDHLHQ- 123
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
II+RDIK NILLD+ ++DFGL+K L GT YMAPE G
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 545 KLTEKS--DVFSFGVVLLELITGRKP--VDASQ 573
D +S GV+ EL+TG P VD Q
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 66/236 (27%), Positives = 113/236 (47%), Gaps = 32/236 (13%)
Query: 375 LGEGGFGSVY------------KGYLPDGRE-----VAIKQLKIGGGQGER-EFKAEVEI 416
LGEG FG V+ K + D VA+K L+ + R +F E++I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL--YFHLH-------GEGRPVLDWATR 467
+SR+ +++ L+ CI+ D +I +Y+ N L + H + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-IT 526
+ +A A G+ YL +HRD+ + N L+ N+ +++DFG+++ + + I
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
R + +M+ E GK T SDV++FGV L E++T K SQ L DE ++E
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ-LSDEQVIE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 64/289 (22%), Positives = 97/289 (33%), Gaps = 33/289 (11%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A A + P + PP +N +S+P + P + P
Sbjct: 51 AAVTVVAGAAACDRFEPPTGPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPG 110
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P+S PP +PP +SPPP+ P S + PP + PP P S
Sbjct: 111 PSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASP---AAVASDAA 167
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
P S P + PS+PP+ PP P + P+ S P P+ +P ++
Sbjct: 168 SSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRS 227
Query: 183 S------------------------------PPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
+ PAPI +P P + P +
Sbjct: 228 AADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASS 287
Query: 213 RPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
S + P PS+ P P P S+ ++ ++ SS SSS S
Sbjct: 288 SSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESS 336
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 72/285 (25%), Positives = 92/285 (32%), Gaps = 45/285 (15%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
A P SSP PP PP SPPP P S PV P P A
Sbjct: 99 SPAREGSPTPPGPSSPDPPPPTPPPASPPPSP--APDLSEMLRPVGSPGPPPAASPPAAG 156
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP--PP 118
P + + A+S ++ P +S T+ P SPPA PP+ P PP RS P
Sbjct: 157 ASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISAS 216
Query: 119 SSTPPPNSPPSPPSDPPANS-------------------PPPSNPPSNLPPPPPSSVEP- 158
+S+P P S D A+S P P P LP +
Sbjct: 217 ASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWN 276
Query: 159 -PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP--------------------SNVPP 197
P P + P S SP +SP + A S+
Sbjct: 277 GPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESS 336
Query: 198 PPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTE 242
P P+ +P PS P + P KR P P+
Sbjct: 337 RGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAAS 381
|
Length = 1352 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 45/206 (21%), Positives = 70/206 (33%), Gaps = 12/206 (5%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ P T+++ P + P ++ PA+ P + PP+ PA++P + V+ P R P P
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPE 431
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+ + P P P P ++ P P V P ++P
Sbjct: 432 ALAAARQ--ASARGPGGAPAPAPAP----AAAPAAAARPAAAGPRPVAAAAAAAPARAAP 485
Query: 180 PKNSPPAPIAVPPSNVPPP------PTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
PA PP PP P Q PA +A + + P P
Sbjct: 486 AAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAP 545
Query: 234 PGIPVPSTENTPGNGTNPSSPESSSS 259
P P P P +S+S
Sbjct: 546 AAAPAPRAAAATEPVVAPRPPRASAS 571
|
Length = 700 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 30/213 (14%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFK---AEVEIISRIHHRH 424
F + +G G FG+VY E VA+K++ G Q +++ EV+ + ++ H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 425 LVSLVGYCISDDRRLLIYDYV---PNNTLYFHLHGEGRPVLDWATRVKIAA---GAARGL 478
+ G + + L+ +Y ++ L H +P+ + V+IAA GA +GL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQE----VEIAAITHGALQGL 134
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
AYLH +IHRDIK+ NILL + +++DFG A + AN+ + GT +MAP
Sbjct: 135 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAP 186
Query: 539 EY---ASSGKLTEKSDVFSFGVVLLELITGRKP 568
E G+ K DV+S G+ +EL RKP
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 70/213 (32%), Positives = 108/213 (50%), Gaps = 27/213 (12%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGEREFK---AEVEIISRIHH 422
F D +G G FG+VY + D R VAIK++ G Q +++ EV+ + RI H
Sbjct: 27 FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAA---GAARGLA 479
+ + G + + L+ +Y + L +P+ + V+IAA GA +GLA
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDL-LEVHKKPLQE----VEIAAITHGALQGLA 139
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
YLH +IHRDIK+ NILL + +++DFG A +A AN+ + GT +MAPE
Sbjct: 140 YLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPE 191
Query: 540 Y---ASSGKLTEKSDVFSFGVVLLELITGRKPV 569
G+ K DV+S G+ +EL + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVGY 431
+GEG +G VYK G VAIK++K+ A E++++ ++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65
Query: 432 CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDCHPRI 489
L L+++++ + LY + R + + + +K +GLA+ H I
Sbjct: 66 VFRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPE--SLIKSYLYQLLQGLAFCHSH---GI 119
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTE 548
+HRD+K N+L++ +++DFGLA+ T V+ T Y APE +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYST 178
Query: 549 KSDVFSFGVVLLELITGR 566
D++S G + EL++ R
Sbjct: 179 PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 24/269 (8%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ G +VAIK + G E +F E +++ ++ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
++ +++ N L +L + + L + + G+ YL + IHRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDL 126
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFS 554
+ N L+ + +VSDFG+ + LD ++ + PE + K + KSDV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 555 FGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEM 614
FGV++ E+ T + P +S E + L P+L V M
Sbjct: 187 FGVLMWEVFT-----EGKMPFEKKSNYEVVEMI-------SRGFRLYRPKLASMTVYEVM 234
Query: 615 FRMIEAAAACVRHSAAKRPRMGQVVRVFD 643
+ C RP +++R
Sbjct: 235 YS-------CWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 43/224 (19%)
Query: 375 LGEGGFGSVYK----GYLPDGRE--VAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVS 427
+G+G FG V++ G LP VA+K LK + +F+ E +++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 428 LVGYCISDDRRLLIYDYV--------------------PNNTLYFHLHGEGRPVLDWATR 467
L+G C L+++Y+ ++T G L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-------LALD 520
+ IA A G+AYL E + +HRD+ + N L+ N +++DFGL++
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
N I R +M PE + T +SDV+++GVVL E+ +
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-17
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 18/215 (8%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
L+G G +G VYKG ++ G+ AIK + + G + E E K E+ ++ + HHR++ + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 432 CIS------DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
I DD+ L+ ++ ++ + L I RGL++LH+
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
++IHRDIK N+LL N E ++ DFG++ LD +GT +MAPE + +
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 546 LTE-----KSDVFSFGVVLLELITGRKPVDASQPL 575
+ KSD++S G+ +E+ G P+ P+
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 19/207 (9%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKA---EVEIISRIHHRHLVS 427
LLG G FG VY Y D GRE+A+KQ+ E +E A E++++ + H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 428 LVGYCISD--DRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
G C+ D +++L I+ +Y+P ++ L G + + TR + +G++YLH +
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTR-RYTRQILQGVSYLHSN 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD---ANTHITTRVMGTFGYMAPEYA 541
I+HRDIK +NIL D+ ++ DFG +K + T I + V GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVI 181
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
S K+DV+S ++E++T + P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 372 QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLV 429
Q +LG G G+VYK Y L R +A+K + + + +++ +E+EI+ + +++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 430 GYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G ++R + +++ +L Y + VL +IA +GL YL
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKI---PEHVLG-----RIAVAVVKGLTYLWS---L 114
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+I+HRD+K SN+L++ + ++ DFG++ +++ I +GT YMAPE S +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYG 171
Query: 548 EKSDVFSFGVVLLELITGRKP 568
SDV+S G+ +EL GR P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKA---EVEIISRIHHRHLVS 427
LLG+G FG VY Y D GRE+A KQ++ E +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 428 LVGYCISD--DRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
G C+ D ++ L I+ +Y+P ++ L G L + K G++YLH +
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTR-VMGTFGYMAPEYAS 542
I+HRDIK +NIL D+ ++ DFG +K L + R V GT +M+PE S
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
K+DV+S G ++E++T + P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQ--LKIGGGQGEREFKAEVEIISRIHHRHLVSL--- 428
+GEG G V+K G VA+K+ L+ G + E++ + H ++V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 429 --VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G L+ +Y+P+ L L E RP+ + + +G+AY+H +
Sbjct: 68 FPHGSGFV-----LVMEYMPS-DLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHAN-- 118
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE--YASSG 544
I+HRD+K +N+L+ + +++DFGLA+L + + + + T Y APE Y +
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR- 176
Query: 545 KLTEKSDVFSFGVVLLELITGR 566
K D+++ G + EL+ G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 46/249 (18%)
Query: 375 LGEGGFGSVYKGYLPDGRE-----------------VAIKQLKIGGGQGER-EFKAEVEI 416
LGEG FG V+ + + ++ VA+K L+ + R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL--YFHLH------GEGR--------- 459
+SR+ +++ L+G C+ +D +I +Y+ N L + H G
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 460 PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LA 518
P + +++ + +A A G+ YL +HRD+ + N L+ N +++DFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG-- 576
I R + +MA E GK T SDV++FGV L E++ + QP G
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGEL 245
Query: 577 -DESLVEWA 584
DE ++E A
Sbjct: 246 TDEQVIENA 254
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKI----GGGQGEREFKAEVEIISRI 420
F + +G+G F VYK L DGR VA+K+++I + K E++++ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYF---HLHGEGRPVLD---WATRVKIAAGA 474
H +++ + I ++ ++ + L H + R + + W V++
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC--- 116
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
L ++H RI+HRDIK +N+ + ++ D GL + + T ++GT
Sbjct: 117 -SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPY 171
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
YM+PE KSD++S G +L E+ + P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
++GEG +G VYK + G+ VAIK + I + E E K E I+ + +H ++ + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 432 CISDDRRLLIYDYVPNNTLYFHLH-GEGRPVLDWATRVK-------------IAAGAARG 477
I + ++ L+ + G V D ++ I RG
Sbjct: 72 FIKKNPP------GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
LAYLHE+ ++IHRDIK NILL N E ++ DFG++ LD+ +GT +MA
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMA 181
Query: 538 PEY-ASSGKLTE----KSDVFSFGVVLLELITGRKP 568
PE A + +SDV+S G+ +EL G+ P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 374 LLGEGGFGSVYKGYLPDGRE------VAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLV 426
LG G FG V+ E V +K L K + EF+ E+++ ++ H+++V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL-------HGEGRPVLDWATRVKIAAGAARGLA 479
L+G C + +I +Y L L P L +V + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+L R +HRD+ + N L+ + E +VS L+K ++ + + ++APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 540 YASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVE 582
+ KSDV+SFGV++ E+ T G P L DE ++
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPF---YGLSDEEVLN 229
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG VYK + G A K ++I + +F E++I+S H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+++ ++ ++ L + R + + R + L +LH ++IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHRD 128
Query: 494 IKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTRVMGTFGYMAPEYA-----SSGKLT 547
+K+ NILL + + +++DFG+ AK T +GT +MAPE
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ L+EL P P+
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 28/134 (20%), Positives = 36/134 (26%), Gaps = 3/134 (2%)
Query: 78 PPPASNPPTSSPP--PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
P P +S + + S PP SS P+ P P
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 136 ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP-PQNPPPPPSSSPPKNSPPAPIAVPPSN 194
+ PS+ P +P P P PPPPP P S P S
Sbjct: 207 PSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASA 266
Query: 195 VPPPPTQTPPTPAS 208
P P +
Sbjct: 267 TPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 373 NLLGEGGFGSVYKGYL------PDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHL 425
LG G FG VY+G +VA+K L + Q E +F E I+S+ +H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR------VKIAAGAARGLA 479
V L+G R ++ + + L L E RP + + + A A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGLAKLALDANTH-ITTRVMGTFGY 535
YL E+ IHRDI + N LL A+++DFG+A+ A+ + R M +
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
M PE G T K+DV+SFGV+L E+ + G P
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 40/221 (18%)
Query: 374 LLGEGGFGSVYKGYL-----PDGR-EVAIKQLKIGGGQGEREFK---AEVEIISRI-HHR 423
LGEG FG V K P+ VA+K LK E++ +E+E++ I H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR---------------V 468
++++L+G C + ++ +Y + L L RP ++A+ V
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDLV 135
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI--- 525
A ARG+ +L + IHRD+ + N+L+ + +++DFGLA+ D + HI
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR---DIH-HIDYY 188
Query: 526 --TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
TT +MAPE T +SDV+SFGV+L E+ T
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 59/266 (22%), Positives = 85/266 (31%), Gaps = 9/266 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ P S S VS+ ++ V+ PP P P PA+
Sbjct: 26 ATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPP--TGPPPGPGTEAPANE 83
Query: 62 PPTSSSP------PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
++ + PAS SP P PPP+PP +SPP P
Sbjct: 84 SRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGS 143
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P P P + + P+ +++ + P + P P PP PP
Sbjct: 144 PGPPPAASPPAAGASPAAVASDAASSR-QAALPLSSPEETARAPSSPPAEPPPSTPPAAA 202
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPG 235
S PP+ S P + P + AS S SS P + L P
Sbjct: 203 SPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAP 262
Query: 236 IPVPSTENTPGNGTNPSSPESSSSPS 261
I +P+ PSS +S S
Sbjct: 263 ITLPTRIWEASGWNGPSSRPGPASSS 288
|
Length = 1352 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 71/250 (28%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGEREFK---AEVEIISRIHH 422
F+D +G G FG+VY + D R VAIK++ G Q +++ EV + ++ H
Sbjct: 17 FSDLREIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 423 RHLVSLVGYCISDDRRLLIYDY-VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
+ + G + + L+ +Y + + + +H + ++ A + GA +GLAYL
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYL 131
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY- 540
H +IHRD+K+ NILL ++ DFG A + AN + GT +MAPE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 541 --ASSGKLTEKSDVFSFGVVLLELITGRKPV---DASQPLGDESLVEWARPLLSHALENE 595
G+ K DV+S G+ +EL + P+ +A L + + P L +E
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNESPALQSGHWSE 241
Query: 596 EFDNLADPRL 605
F N D L
Sbjct: 242 YFRNFVDSCL 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 64/209 (30%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLK---------IGGGQGEREFKAEVEIISRIHHR 423
+LG+G FG V L E+ A+K LK + E+ A H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHP 56
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
L L + DR + +YV L FH+ GR D AA GL +LHE
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHE 114
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-LDANTHITTRVMGTFGYMAPEYAS 542
II+RD+K N+LLD+ +++DFG+ K L T T+ GT Y+APE S
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILS 169
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDA 571
D ++ GV+L E++ G+ P +
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 21/208 (10%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE--REFKA---EVEIISRIHHRHLVS 427
LLG+G FG VY Y D GRE+A+KQ++ E +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 428 LVGYCISD--DRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
G C+ D +R L I+ +++P ++ L G + + TR K G++YLH +
Sbjct: 69 YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTR-KYTRQILEGVSYLHSN 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK----LALDANTHITTRVMGTFGYMAPEY 540
I+HRDIK +NIL D+ ++ DFG +K + L + V GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMSPEV 180
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKP 568
S K+D++S G ++E++T + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 375 LGEGGFGSVYKGYLPD-GRE-----VAIKQLKIGGGQGERE-FKAEVEIISRI-HHRHLV 426
LG G FG V + + VA+K LK ERE +E++I+S + +H ++V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL-HEDC 485
+L+G C L+I +Y L L + L + + A+G+A+L ++C
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI---TTRVMGTFGYMAPEYAS 542
IHRD+ + N+LL + ++ DFGLA+ ++ + ++ R+ +MAPE
Sbjct: 163 ----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIF 216
Query: 543 SGKLTEKSDVFSFGVVLLELIT 564
+ T +SDV+S+G++L E+ +
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 43/217 (19%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHH-RHLVSLVG 430
+G G G VYK + G +A+KQ+ + G + + +++++ + H ++V G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 431 YCISD--------------DRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA 475
Y I+D D+ L I +P + L G K+
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDIL-------G----------KMTVAIV 124
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+ L YL E H +IHRD+K SNILLD + ++ DFG++ +D+ TR G Y
Sbjct: 125 KALHYLKEK-H-GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAY 180
Query: 536 MAPEYASSGKLTEK----SDVFSFGVVLLELITGRKP 568
MAPE K +DV+S G+ L+EL TG+ P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 375 LGEGGFGSVYKGYLPDGR---EVAIKQLKIG-GGQGERE-FKAEVEIISRIHHRHLVSLV 429
LGEG FGSV +G L +VA+K +KI + E E F +E + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 430 GYCISDDRR------LLIYDYVPNNTLYFHLH----GEGRPVLDWATRVKIAAGAARGLA 479
G C+ ++I ++ + L+ L G+ L VK A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT-FGYMAP 538
YL IHRD+ + N +L+ N V+DFGL+K + + + R+ ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 539 EYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
E + T KSDV+SFGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 68/245 (27%), Positives = 114/245 (46%), Gaps = 51/245 (20%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGERE-FKA----EVEIISRI 420
D F +GEG +G VYK D G VA+K++++ E+E F E++I+ ++
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIREIKILRQL 63
Query: 421 HHRHLVSLVGYCISDDRRL----------LIYDYVPNNTLYF-----------HLHGEGR 459
+HR++V+L L L+++Y+ ++ + H+ +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 460 PVLDWATRVKIAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKL- 517
+L+ GL Y CH + +HRDIK SNILL+N + +++DFGLA+L
Sbjct: 124 QLLE-------------GLNY----CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 518 ALDANTHITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
+ + T +V+ T Y PE + DV+S G +L EL T + A+Q L
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225
Query: 577 DESLV 581
L+
Sbjct: 226 QLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 368 GFADQNLLGEGGFGSVYKGYL---PDGREVAIKQLKIGGGQGE-------REFKAEVEII 417
+ + +G G +G VYK DG+E AIK+ K Q RE + ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALL 56
Query: 418 SRIHHRHLVSLVGYCISD-DRRL-LIYDYVPNNTLY---FHLHGEGRPVLDWATRVKIAA 472
+ H ++VSLV + D+ + L++DY ++ FH + + + +
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPP-SMVKSLLW 115
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLA-------KLALDA 521
G+ YLH + ++HRD+K +NIL+ + + D GLA K D
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 522 NTHITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELIT 564
+ V+ T Y APE + T+ D+++ G + EL+T
Sbjct: 173 D-----PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 63/203 (31%), Positives = 87/203 (42%), Gaps = 17/203 (8%)
Query: 378 GGFGSVYKGY-LPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
G FGSVY G AIK LK I Q KAE I+ V+ + Y
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 433 I-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S D L+ +Y+ + G DWA + A G+ LH+ IIH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR---GIIH 120
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RDIK N+L+D +++DFGL++ L + +GT Y+APE + SD
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 552 VFSFGVVLLELITGRKPVDASQP 574
+S G V+ E + G P A P
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 374 LLGEGGFGSVYKGYLPDGRE----VAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
+LG+GG+G V++ G + A+K LK + + KAE I+ + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWA----TRVKIAAGAARGLAY 480
V L+ Y +L LI +Y+ L+ HL EG + D A + + +A L +
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
LH II+RD+K NILLD +++DFGL K ++ T +T GT YMAPE
Sbjct: 116 LH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEI 171
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
+ D +S G ++ +++TG P A
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-16
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 12/139 (8%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A + A +P P + P +P + P + P + P P +PPA
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPA-- 424
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P ++P ++P A P ++P A +PP + P V+ P +P P ++
Sbjct: 425 -------PVAAPAAAAPAAA---PAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVAS 474
Query: 122 PPPNSPPSPPSDPPANSPP 140
P +P + +
Sbjct: 475 AAPAPAAAPAAARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 375 LGEGGFGSVY--KGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVG 430
+GEG FG +Y K D IK++ + + + K EV +++++ H ++V+
Sbjct: 8 IGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 431 YCISDDRRLLIYDYVPNNTLYFHL---HG---EGRPVLDWATRVKIAAGAARGLAYLHED 484
+ R ++ +Y L + G +L W ++ + GL ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDR 120
Query: 485 CHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
+I+HRDIKS NI L N A++ DFG+A+ L+ + + +GT Y++PE +
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDAS 572
K+D++S G VL EL T + P + +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 34/132 (25%), Positives = 42/132 (31%), Gaps = 2/132 (1%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P P + + P S + PP+S P PS P P S
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP-PPPTQT 202
S+LPP P S P P NP PPP + P P + + P PP
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPT-NPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASA 266
Query: 203 PPTPASPIAPRP 214
P P I
Sbjct: 267 TPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 374 LLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLV 429
+G G FG V+ A+K + I + E+ E ++ + H ++ L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL- 66
Query: 430 GYCISDDRRLL--IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
+ D+R L + +YVP L+ +L GR +T + A+ L YLH
Sbjct: 67 -FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSK--- 120
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
I++RD+K NILLD +++DFG AK D T + GT Y+APE S
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHN 176
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQPLG 576
+ D ++ G+++ E++ G P P G
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ +VA+K +K G E F AE ++ + H LV L ++
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+ +I +++ +L L + + +A A G+A++ + + IHRD+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 128
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKSDV 552
+++NIL+ + +++DFGLA++ D T R F + APE + G T KSDV
Sbjct: 129 RAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L+E++T GR P
Sbjct: 187 WSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 49/230 (21%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA--------------EVEII 417
LGEG +G V K Y G+ VAIK++KI + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 418 SRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR-----VK-IA 471
+ I H +++ LV + D L+ D + + + V+D R VK I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKVVDRKIRLTESQVKCIL 125
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA----------KLALDA 521
GL LH+ +HRD+ +NI +++ +++DFGLA L+ D
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 522 NT----HITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
+T++V+ T Y APE + K D++S G + EL+TG+
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 32/220 (14%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVS 427
LGE FG VYKG+L + VAIK LK G EFK E + SR+ H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL-----HGEG---------RPVLDWATRVKIAAG 473
L+G + +I+ Y ++ L+ L H + + L+ A V I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT- 532
A G+ +L ++H+D+ + N+L+ + ++SD GL + A+ + ++MG
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNS 186
Query: 533 ---FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M+PE GK + SD++S+GVVL E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 375 LGEGGFGSVY----KGYLPDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY KG + D E VAIK + ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHG-----EGRPVLDWAT---RVKIAAGAARGLA 479
L+G L+I + + L +L E PV + +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT-RVMGTFGYMAP 538
YL+ + + +HRD+ + N ++ +F ++ DFG+ + + + + + + +M+P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 539 EYASSGKLTEKSDVFSFGVVLLELIT 564
E G T SDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDG-----REVAIKQLKIGGGQGERE-FKAEVEIISRI 420
D +LL EG FG ++ G L D EV +K +K + + E ++ +
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 421 HHRHLVSLVGYCISD-DRRLLIYDYVPNNTLYFHL----HGEGRPVLDWATR--VKIAAG 473
H++++ ++ CI D + ++Y Y+ L L GE +T+ V +A
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT- 532
A G++YLH+ +IH+DI + N ++D + +++D L++ + H +G
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH----CLGDN 178
Query: 533 ----FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MA E + + + SDV+SFGV+L EL+T G+ P
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-16
Identities = 45/272 (16%), Positives = 77/272 (28%), Gaps = 39/272 (14%)
Query: 2 SAPSPGP-----PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPS 56
+ P+PG A++ V+ + P + ++ P + P PP +
Sbjct: 379 AVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPA---PPAT 435
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP---PASSPPTISPPPPVSNPPTR 113
+ P + + S P AS+P + +PP P R
Sbjct: 436 ADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPR 495
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANS--PPPSNPPSNLPPPPPSSVEPPKR---------- 161
+ P ++TP P+ + P PP P++ P R
Sbjct: 496 AAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDV 555
Query: 162 --------SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
S P+++P PA P Q P A
Sbjct: 556 LRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAA--------PRVAVQVPTPRARAATGD 607
Query: 214 PSNSSPNSPPPPSTKRLSPPPGIPVPSTENTP 245
+ + R +PPP +P + P
Sbjct: 608 APPNGAARAEQAAESRGAPPPWEDIPPDDYVP 639
|
Length = 830 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGERE-FKAEVEIISRIHHRH 424
F +G+G FG V+KG D R VAIK + + + E E + E+ ++S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+ G + + +I +Y+ + L AT +K +GL YLH +
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE 120
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
+ IHRDIK++N+LL + +++DFG+A D T V GT +MAPE
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ +EL G P P+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 368 GFADQNLLGEGGFGSVYKGYLPDG-------REVAIKQLKIGGGQGERE-----FKAEVE 415
+A LG G FG VYK + +E+ + G + ER+ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 416 II-SRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL------HGEGRPVLDWATRV 468
II ++ H ++V + +DR ++ D + L H W V
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
++ L YLH++ RI+HRD+ +NI+L + + ++DFGLAK + +T+
Sbjct: 121 QMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKLTS- 172
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
V+GT Y PE + EK+DV++FG +L ++ T + P
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGG--GQGERE-FKAE---VEIISRIHHRHLVS 427
LG G FG V Y G AIK LK G + E E E E + H LV+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
L ++D + +Y L H+H + V V AA GL YLHE+
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN--- 120
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+I++RD+K N+LLD +++DFGL K + +T GT ++APE + T
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVLTETSYT 179
Query: 548 EKSDVFSFGVVLLELITGRKP 568
D + GV++ E++ G P
Sbjct: 180 RAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 8e-16
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 51/224 (22%)
Query: 371 DQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVEIISRI 420
+G G +G V GR+VAIK KI F E++++ +
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIK--KI-----SNVFDDLIDAKRILREIKLLRHL 56
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPN-NTLYF-------HLHG---EGRPVLDWATRVK 469
H +++ L +L + N +Y LH +P+ D ++
Sbjct: 57 RHENIIGL--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD--DHIQ 106
Query: 470 -IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
RGL YLH + +IHRD+K SNIL+++N + ++ DFGLA+ + +
Sbjct: 107 YFLYQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARG---VDPDEDEK 160
Query: 529 VMGTFG-----YMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
T Y APE SS + T+ D++S G + EL+T +
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLVSLVGYC 432
LGEG + +VYKG E VA+K++ + +G E+ ++ + H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 433 ISDDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
++++ +L+++Y+ + Y HG LD T +G+A+ HE+ R++H
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN---RVLH 123
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
RD+K N+L++ E +++DFGLA+ + NT V T Y AP+ + S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYSTS 181
Query: 551 -DVFSFGVVLLELITGR 566
D++S G ++ E+ITGR
Sbjct: 182 IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-16
Identities = 33/189 (17%), Positives = 53/189 (28%), Gaps = 1/189 (0%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A P A + +P + P S P P + P +
Sbjct: 616 AAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGG 675
Query: 63 PTSSSPPASSPPTSSPPPASNPPTS-SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
++PP + P + PA P +P P+ + P + P +
Sbjct: 676 AAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAA 735
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P P P DPP + P+ PP P P ++ P + + S
Sbjct: 736 DDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDD 795
Query: 182 NSPPAPIAV 190
V
Sbjct: 796 EDRRDAEEV 804
|
Length = 824 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 41/114 (35%), Positives = 65/114 (57%), Gaps = 9/114 (7%)
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHIT 526
KI+ RGL YL E +I+HRD+K SNIL+++ E ++ DFG++ +D AN+ +
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160
Query: 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 580
TR YM+PE T +SD++S G+ L+E+ GR P+ E++
Sbjct: 161 TR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 374 LLGEGGFGSVY---KGYLPD-GREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVS 427
+LG+G FG V+ K PD G+ A+K LK + K E +I++ ++H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 428 LVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHEDC 485
L Y + +L LI D++ L+ L E V+ VK A A L +LH
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS-- 116
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
II+RD+K NILLD +++DFGL+K ++D GT YMAPE +
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNRRG 174
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
T+ +D +SFGV++ E++TG P
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-15
Identities = 49/229 (21%), Positives = 56/229 (24%), Gaps = 18/229 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
P P PP A S P P +S + + P P P PP
Sbjct: 130 PKPEPQPPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPP--- 186
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
A+ P P P PP P P P P P PP
Sbjct: 187 ------RQAAFPQQGPPEQPPGYP--QPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQ 238
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
PP PPP P PP P PP P P P
Sbjct: 239 QPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQP---PPQNQPTPHPGLPQGQNAP 295
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL 230
PP + P P Q P + S S +
Sbjct: 296 LPPPQQPQLLPLVQQPQGQQRGPQF----REQLVQLSQQQREALSQEEA 340
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVA------IKQLKIGGGQGEREFKAEVE--IISRIHHR 423
Q LG+G FG+VY + D + VA +K++ +G +A E ++S++ H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLH-----GEGRP---VLDWATRVKIAAGAA 475
+V + D +I +Y L L G+ V +W ++ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
G+ Y+H+ RI+HRD+K+ NI L NN ++ DFG+++L L + + T GT Y
Sbjct: 118 -GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYY 171
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLEL 562
M+PE KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 60/241 (24%)
Query: 351 GHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGERE 409
G RS+ +E+L N +GEG +G VY+ E VA+K++++ + E
Sbjct: 1 GRCRSVTEFEKL----------NRIGEGTYGIVYRARDTTSGEIVALKKVRM-----DNE 45
Query: 410 FKA-------EVEIISRIHHRHLVSL---------------VGYCISDDRRLLIYDYVPN 447
E+ ++ + H ++V L + YC D LL N
Sbjct: 46 RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----DN 100
Query: 448 NTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506
F ++VK + RGL YLHE+ IIHRD+K SN+LL +
Sbjct: 101 MPTPFS-----------ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGC 146
Query: 507 AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITG 565
+++DFGLA+ +T +V+ T Y APE T D+++ G +L EL+
Sbjct: 147 LKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
Query: 566 R 566
+
Sbjct: 206 K 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 11/210 (5%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGERE-FKAEVEIISRIHHRHLV 426
F +G+G FG VYKG +EV AIK + + + E E + E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRP-VLDWATRVKIAAGAARGLAYLHEDC 485
G + + +I +Y+ + L +P L+ I +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE- 120
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
R IHRDIK++N+LL + +++DFG+A D T V GT +MAPE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ +EL G P P+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGERE-FKAEVEIISRIHHRH 424
F +G+G FG V+KG D R VAIK + + + E E + E+ ++S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+ G + D + +I +Y+ + L E P LD I +GL YLH +
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGP-LDETQIATILREILKGLDYLHSE 120
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
+ IHRDIK++N+LL + E +++DFG+A D +GT +MAPE
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQS 176
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ +EL G P P+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-15
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 43/230 (18%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLV 429
L+G+GG G VY Y P R VA+K+++ ++ F E +I + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV- 67
Query: 430 GYCISDDRRLLIYD--YVPNNTLYFHL------------HGEGRPVLDWATRVKIAAGAA 475
Y I D + Y Y+ TL L E V + I
Sbjct: 68 -YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIFHKIC 123
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK---------LALDANTH-- 524
+ Y+H ++HRD+K NILL E + D+G A L +D +
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 525 ------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
I +++GT YMAPE +E +D+++ GV+L +++T P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-15
Identities = 44/234 (18%), Positives = 70/234 (29%), Gaps = 15/234 (6%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
P P + P P+ + P A + P + PA P ++ P+ +++P
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAAR-PAAPAAPAAPAAPA--PAGAAAAPAEASAAPAPG 646
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
P P P PA PP P P + P +
Sbjct: 647 VAAPEHHPKHVAVPDASDGGDG--WPAKAGGAAPAAPPPAPAP----AAPAAPAGAAPAQ 700
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
P+ P + A A PS P PP P P P + + P
Sbjct: 701 PAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPP 760
Query: 222 PPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAV 275
PP P P P + +P + + + + S + A V + +
Sbjct: 761 PPAP------APAAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRRDAEEVAMEL 808
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 38/141 (26%), Positives = 46/141 (32%), Gaps = 11/141 (7%)
Query: 47 KPPTTSPPPS---PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
+ P PP A T+S + + P SS P P SPP
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P S+ P P P S ++PP P P SPPP PPPPP PP +
Sbjct: 206 SPSDSSLP---PAPSS--FQSDTPPPSPESPTNPSPPPGPAA---PPPPPVQQVPPLSTA 257
Query: 164 PSVPPQNPPPPPSSSPPKNSP 184
PP P
Sbjct: 258 KPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-15
Identities = 30/139 (21%), Positives = 51/139 (36%), Gaps = 8/139 (5%)
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
P A+ + + + + PA+ P + PA++P + P PP +PP
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAA--PPAAAPP 423
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
P + P +P + P+ PA PP P +V P R P + P P+
Sbjct: 424 APVAAPAAAAPAAAPAAAPAAVALAPAPP---AQAAPETVAIPVRVAPEPAVASAAPAPA 480
Query: 177 SSPPKNSPPAPIAVPPSNV 195
++P +V
Sbjct: 481 AAPA---AARLTPTEEGDV 496
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-15
Identities = 25/129 (19%), Positives = 46/129 (35%), Gaps = 6/129 (4%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
+ P P+ P ++ P +P + P + P ++ P +PP+ P + P
Sbjct: 371 EAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPV-AAP 429
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
+ P+ P P++V + PP P + P + +P +A P
Sbjct: 430 AAAAPAAAPAAAPAAV-----ALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPA 484
Query: 201 QTPPTPASP 209
TP
Sbjct: 485 AARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 34/212 (16%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
++G GGFG VY D G+ A+K L +I QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 430 --GYCI----------SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
G C + D+ I D + L++HL G V A G
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILG 109
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L ++H +++RD+K +NILLD + ++SD GLA H + +GT GYMA
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 163
Query: 538 PEYASSGKLTEKS-DVFSFGVVLLELITGRKP 568
PE G + S D FS G +L +L+ G P
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
++G G +G VYKG ++ G+ AIK + + + E E K E+ ++ + HHR++ + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 432 CIS------DDRRLLIYDYVPNNTLYFHLHGEGRPVL--DWATRVKIAAGAARGLAYLHE 483
I DD+ L+ ++ ++ + L DW I RGLA+LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
++IHRDIK N+LL N E ++ DFG++ LD +GT +MAPE +
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 544 GKLTE-----KSDVFSFGVVLLELITGRKPVDASQPL 575
+ + +SD++S G+ +E+ G P+ P+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGEREFKAEV----EIISRIHHRHLVSL 428
+LG+G FG V L E AIK LK K V ++ + R +++L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK----------KDVVLEDDDVECTMVERRVLAL 51
Query: 429 VG--------YCI--SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGL 478
+C + + + +Y+ L FH+ GR A AA GL
Sbjct: 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY--AAEIICGL 109
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
+LH+ II+RD+K N+LLD + +++DFG+ K ++ +T GT Y+AP
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAP 165
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E K E D +SFGV+L E++ G+ P
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 31/132 (23%), Positives = 43/132 (32%), Gaps = 2/132 (1%)
Query: 105 PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
P PP + NS S P + + + P + P PS PP+
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 165 SVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPP 224
PP P S ++PP P + PPP PP P P S + P P
Sbjct: 207 PSDSSLPPAPS--SFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSA 264
Query: 225 PSTKRLSPPPGI 236
+T +
Sbjct: 265 SATPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 374 LLGEGGFGSVY-----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRH 424
+LG G +G V+ G+ G+ A+K LK + + + E +++ I
Sbjct: 7 VLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 425 LVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA-ARGLAYLH 482
+ + Y D +L LI DY+ L+ HL R V+I +G L +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLH 122
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
+ II+RDIK NILLD+N ++DFGL+K + GT YMAP+
Sbjct: 123 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 543 SGKLTEKS--DVFSFGVVLLELITGRKP 568
G D +S GV++ EL+TG P
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKA----EVEIISRIHHRHLVSL 428
L+GEG +G V K + G+ VAIK K + ++ K E+ ++ ++ H +LV+L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK--KFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 429 VGYCISDDRRLLIYDYVPN---NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
+ R L++++V + + L + +G LD + K RG+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH- 119
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY-ASSG 544
IIHRDIK NIL+ + ++ DFG A+ L A + T + T Y APE
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 545 KLTEKSDVFSFGVVLLELITG 565
K D+++ G ++ E++TG
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-15
Identities = 36/182 (19%), Positives = 58/182 (31%), Gaps = 1/182 (0%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A P A +++ P S P P +P + P + +
Sbjct: 621 PAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA 680
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
PP + +P A + P + P P ++ PP+ A P P SP
Sbjct: 681 PPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASA-PSPAADDPV 739
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P P P PP A + PP P P ++ P S ++ P +
Sbjct: 740 PLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRR 799
Query: 182 NS 183
++
Sbjct: 800 DA 801
|
Length = 824 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 375 LGEGGFGSVYKGYLPDGRE-VAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G+GG+G V+ D E VA+K++K + R E +I++ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE------ 483
Y DD L L +YVP G+ R +L+ V ++ AR Y+ E
Sbjct: 68 YAFQDDEYLYLAMEYVPG--------GDFRTLLN-NLGV-LSEDHAR--FYMAEMFEAVD 115
Query: 484 DCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALD-ANTHITTRVMGTFGYMAPEYA 541
H IHRD+K N L+D + +++DFGL+K + AN+ V+G+ YMAPE
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVL 170
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
D +S G +L E + G P S P
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 63/243 (25%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKA---- 412
YE L K LGEG FG VYK + GR VA+K++ + E++ F
Sbjct: 10 YEILGK----------LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALR 56
Query: 413 EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL-----DWA-- 465
E++I+ ++ H ++V L+ + + + G V D +
Sbjct: 57 EIKILKKLKHPNVVPLID---------MAVERPDKSK---RKRGSVYMVTPYMDHDLSGL 104
Query: 466 ---TRVKIAAGAAR--------GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
VK+ + G+ YLHE+ I+HRDIK++NIL+DN +++DFGL
Sbjct: 105 LENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161
Query: 515 AKLALD----------ANTHITTRVMGTFGYMAPEY-ASSGKLTEKSDVFSFGVVLLELI 563
A+ T T ++ T Y PE + T D++ G V E+
Sbjct: 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
Query: 564 TGR 566
T R
Sbjct: 222 TRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
++G GGFG VY D G+ A+K L +I QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 430 G-------YCIS-----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
C+S D+ I D + L++HL G V A AA G
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILG 109
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L ++H +++RD+K +NILLD + ++SD GLA H + +GT GYMA
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 163
Query: 538 PEYASSGKLTEKS-DVFSFGVVLLELITGRKP 568
PE G + S D FS G +L +L+ G P
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-15
Identities = 47/260 (18%), Positives = 88/260 (33%), Gaps = 6/260 (2%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
AP G PA + + P P + V + P + + A
Sbjct: 366 GAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEA 425
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
PP + +PPA++ P + A S P ++ + S P +
Sbjct: 426 PPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAP 485
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P P+P + P+ + P + P + P P +PP+ P PP P +++P
Sbjct: 486 PDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPA-PEARPPTPAAAAPAA 544
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
+ A A+ + + A +P+ + P + K +P + VP+
Sbjct: 545 RAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPA-----AAPAAAPKPAAPRVAVQVPTP 599
Query: 242 ENTPGNGTNPSSPESSSSPS 261
G P + + + +
Sbjct: 600 RARAATGDAPPNGAARAEQA 619
|
Length = 830 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 25/122 (20%), Positives = 42/122 (34%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
+ P P P + P + PA+ P ++S PA+ P + P P + P
Sbjct: 372 AAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAPAA 431
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
++P +P A+ P P + + P P + S P A P+
Sbjct: 432 AAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAAARLTPT 491
Query: 147 NL 148
Sbjct: 492 EE 493
|
Length = 618 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 43/246 (17%), Positives = 68/246 (27%), Gaps = 37/246 (15%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
++A + AA +P + T + PP + P PP +
Sbjct: 399 VTAVTGAAGAA--LAPKAAAAAAATRAEAPPAA-------PAPPATADRGDDAADGD--- 446
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P + A + S P + AS+P + +PP P R+ P ++
Sbjct: 447 -APVPAKANARASADSRCDERDAQPPADS---GSASAPASDAPPDAAFEPAPRAAAPSAA 502
Query: 121 TPPPNSPPSPPSDPPANS--PPPSNPPSNLPPPPPSSVEPPKR----------------- 161
TP P+ + P PP P++ P R
Sbjct: 503 TPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMR 562
Query: 162 --SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
S P ++ P AP P T P + A +
Sbjct: 563 VSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRARAATGDAPPNGAARAEQAAES 622
Query: 220 NSPPPP 225
PPP
Sbjct: 623 RGAPPP 628
|
Length = 830 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 69/213 (32%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS------ 427
+G+G FG VY+ D R A+K L ++E A+ E+ I R+++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS------KKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 428 ---LVGYCIS---DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
+VG S D L+ DY+ L++HL EGR D A + IA L +L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-KFYIAE-LVLALEHL 112
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H+ I++RD+K NILLD + DFGL+K L N T GT Y+APE
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVL 168
Query: 542 SSGK-LTEKSDVFSFGVVLLELITGRKPVDASQ 573
K T+ D +S GV++ E+ G P A
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 375 LGEGGFGSV-YKGYLPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHRHLVSLVG 430
+G+G +G V + DG++ IK+L + RE KA E +++S++ H ++V+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLH---GEGRP---VLDWATRVKIAAGAARGLAYLHE 483
+D L ++ + LY L G+ P V++W ++ +A L YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLHE 120
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
I+HRD+K+ N+ L +V D G+A++ L+ + + ++GT YM+PE S+
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMASTLIGTPYYMSPELFSN 176
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDA 571
KSDV++ G + E+ T + +A
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 38/136 (27%), Positives = 49/136 (36%), Gaps = 5/136 (3%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
P P A T+S P + P + P PP+ SP PS PP P
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSD---PPSSSPGVPSFPSPPEDP 204
Query: 128 PSP--PSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
SP S PPA S S+ P P P + PP + P PP PP S++ P
Sbjct: 205 SSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSA 264
Query: 186 APIAVPPSNVPPPPTQ 201
+ P +
Sbjct: 265 SATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 31/131 (23%), Positives = 44/131 (33%), Gaps = 4/131 (3%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P PP+ + + S P +++P S P SPP + P+
Sbjct: 150 PGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSD 209
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
S P P S PPP PT PPP PP P + P+ P ++
Sbjct: 210 SSLPPAP--SSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLS--TAKPTPPSAS 265
Query: 148 LPPPPPSSVEP 158
P P +
Sbjct: 266 ATPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 43/273 (15%), Positives = 71/273 (26%), Gaps = 26/273 (9%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP 68
PA P V P + S P + + ++
Sbjct: 360 PAVTGGGAPGGGVPA---RVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAA 416
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
A++ +PP A PP ++ A + + PP +S
Sbjct: 417 AAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGS 476
Query: 129 S--PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
+ P SD P ++ P + P + P R+P + ++ P + P+ PP
Sbjct: 477 ASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPT 536
Query: 187 PIAVPPS------------------NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
P A P+ V A P A + P P
Sbjct: 537 PAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAA---APKPAAPRVA 593
Query: 229 RLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
P P + + P S
Sbjct: 594 VQVPTPRARAATGDAPPNGAARAEQAAESRGAP 626
|
Length = 830 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 41/229 (17%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
++G G FG V+ D +V A+K L+ I Q +AE +I++ +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66
Query: 429 VGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
Y D+ L L+ +Y+P L L + + A R IA L +H+
Sbjct: 67 Y-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVL-ALDSVHKLGF- 122
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAK-----------------LALDANTHITTR-- 528
IHRDIK NIL+D + +++DFGL K L N + R
Sbjct: 123 --IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 529 ---------VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
+GT Y+APE + D +S GV+L E++ G P
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 67/231 (29%), Positives = 118/231 (51%), Gaps = 41/231 (17%)
Query: 354 RSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FK 411
RS+ YE+L N + EG +G VY+ G VA+K+LK+ + E+E F
Sbjct: 2 RSVDEYEKL----------NRIEEGTYGVVYRARDKKTGEIVALKKLKM---EKEKEGFP 48
Query: 412 A----EVEIISRIHHRHLVSL----VGYCISD-DRRLLIYDYVPNN--TLYFHLHGEGRP 460
E+ I+ ++ H ++V++ VG S+ D+ ++ +YV ++ +L +
Sbjct: 49 ITSLREINILLKLQHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQ 105
Query: 461 VLDWATRVK-IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519
+ VK + G+A+LH++ I+HRD+K+SN+LL+N ++ DFGLA+
Sbjct: 106 -----SEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157
Query: 520 DANTHITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGRKPV 569
T V+ T Y APE + + + D++S G + EL+T +KP+
Sbjct: 158 SPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFK---AEVEI-ISRIHHRHLVSLV 429
+G+G FG V + DG+ A+K L+ ++E K AE + + + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ D+ + DYV L+FHL E R + R AA A L YLH I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARF-YAAEIASALGYLHS---LNI 117
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
I+RD+K NILLD+ ++DFGL K ++ + T+ GT Y+APE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 550 SDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 375 LGEGGFGSVYKGYL---PDGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KG + VA+K LK + E E ++ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 430 GYCISDDRRLL--IYDYVP-NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C ++ L+ + + P N L + H + + + +V + G+ YL E
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEET-- 114
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF--GYMAPEYASS 543
+HRD+ + N+LL A++SDFGL+K L D N + + G + + APE +
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN-YYKAKTHGKWPVKWYAPECMNY 172
Query: 544 GKLTEKSDVFSFGVVLLELIT-GRKP 568
K + KSDV+SFGV++ E + G+KP
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHRHLVSLV 429
+LG+G FG V L GR A+K LK + + + E I+S + ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 430 GYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
C + DR + ++V L FH+ R D A AA L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---G 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
II+RD+K N+LLD+ +++DFG+ K + N T+ GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI-FNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 549 KSDVFSFGVVLLELITGRKPVDA 571
D ++ GV+L E++ G P +A
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 30/135 (22%), Positives = 43/135 (31%), Gaps = 5/135 (3%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
P ++ T + P P ++ PS P+ SS
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
+S PP S + PP S P+ P+ P +PPPP PP ST P P
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPV-----QQVPPLSTAKPTPP 262
Query: 128 PSPPSDPPANSPPPS 142
+ + P
Sbjct: 263 SASATPAPIGGITLD 277
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-14
Identities = 57/250 (22%), Positives = 70/250 (28%), Gaps = 39/250 (15%)
Query: 2 SAPSPGPPAANSSSPPPP-------VSNPPTISPPPPV-SNPPKSSPPPPPVSKPPTTSP 53
S ++ SP P + P P + PK P PP +
Sbjct: 88 GPDSDLSQKTSTFSPCQSGYEASTDPEYIPDLQPDPSLWGTAPKPEPQPPQAPESQPQPQ 147
Query: 54 PPS-------------PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P+ P PP P PP + P PP PP
Sbjct: 148 TPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQPPGY---- 203
Query: 101 ISPPPPVSNPPTRSPP-----PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
P PP +P P P + P PP P PP P S PPPP
Sbjct: 204 --PQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPPP-- 259
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
+PP++ PQ PPP P N P PP Q P P+
Sbjct: 260 PQPPQQQQQPPQPQAQPPP---QNQPTPHPGLPQ--GQNAPLPPPQQPQLLPLVQQPQGQ 314
Query: 216 NSSPNSPPPP 225
P
Sbjct: 315 QRGPQFREQL 324
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 375 LGEGGFGSVYKGYL-------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
LG+G FG VY+G + R VA+K + ER EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHL--------HGEGRPVLDWATRVKIAAGAARGL 478
L+G L++ + + + L +L + GRP +++AA A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT-RVMGTFGYMA 537
AYL+ + +HRD+ + N ++ ++F ++ DFG+ + + + + + + +MA
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELIT 564
PE G T SD++SFGVVL E+ +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 65/203 (32%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 373 NLLGEGGFGSV----YKGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHL 425
LG G FG V +KG G AIK LK I + + E I+ + H +
Sbjct: 24 ETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
V+++ ++R + ++V L+ HL GR D A A YLH
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFY--HAELVLAFEYLHSK- 137
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
II+RD+K N+LLDN +V+DFG AK D T + GT Y+APE S
Sbjct: 138 --DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQSKG 191
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
+ D ++ GV+L E I G P
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 44/229 (19%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE------REFK 411
YEEL +GEG +G+VYK L GR VA+K++++ + RE
Sbjct: 1 YEEL----------AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI- 49
Query: 412 AEVEIISRIHHRHLVSLVGYC--ISDDRRL---LIYDYVPNN-TLYFHLHGEGRPVLDWA 465
A ++ + H ++V L+ C DR L L++++V + Y + P L
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK--PGLPPE 107
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
T + RG+ +LH H RI+HRD+K NIL+ ++ + +++DFGLA++ +
Sbjct: 108 TIKDLMRQLLRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARI-YSFEMAL 163
Query: 526 TTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
T+ V+ T Y APE YA+ D++S G + EL R+P
Sbjct: 164 TSVVV-TLWYRAPEVLLQSSYATP------VDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQLK-IGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG V+ G L D VA+K + + +F E I+ + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
++ + V L EG P L +++ AA G+ YL IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTEKS 550
D+ + N L+ ++SDFG+++ D + +T M + APE + G+ + +S
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDG-VYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 551 DVFSFGVVLLE 561
DV+SFG++L E
Sbjct: 178 DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 42/232 (18%), Positives = 66/232 (28%), Gaps = 24/232 (10%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
AP AA + + PP + P + +P P + + + P
Sbjct: 411 APKAAAAAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQP 470
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P S AS+P + +PP A+ P A+ P + +P +
Sbjct: 471 PADSGS-ASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPA 529
Query: 123 PPNSPPSPPSDPPA-----------------------NSPPPSNPPSNLPPPPPSSVEPP 159
P PP+P + PA + P +
Sbjct: 530 PEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAA 589
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
R VP +PP + A A PPP PP P++
Sbjct: 590 PRVAVQVPTPRARAATGDAPPNGAARAEQAAESRGAPPPWEDIPPDDYVPLS 641
|
Length = 830 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-13
Identities = 48/242 (19%), Positives = 55/242 (22%), Gaps = 20/242 (8%)
Query: 24 PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN 83
SP S P P S + P PP A
Sbjct: 86 SVGPDSDLSQKTSTFSP----CQSGYEASTDPEYIPDLQPDPSLWGTAPKPEPQPPQA-- 139
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP--SPPSDPPANSPPP 141
P P + +S + R P PP P PP P
Sbjct: 140 ---PESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGP 196
Query: 142 SNPPSNLPPPPPSSVEPPK-----RSPPSVPPQNPPPPPSSSPPKN----SPPAPIAVPP 192
P P PP E + +P P Q P PP P P P
Sbjct: 197 PEQPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMP 256
Query: 193 SNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPS 252
P PP Q P P P N P P + PP
Sbjct: 257 PPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPLPPPQQPQLLPLVQQPQGQQR 316
Query: 253 SP 254
P
Sbjct: 317 GP 318
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 64/223 (28%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA--------EVEIISRI-HHRH 424
LG+G FGSVY G VAIK++K ++F + EV+ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR-------- 476
+V L +D +++Y+ N +G+P + R
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKP---------FSESVIRSIIYQILQ 110
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI------TTRVM 530
GLA++H+ H HRD+K N+L+ +++DFGLA+ I T V
Sbjct: 111 GLAHIHK--H-GFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYV- 159
Query: 531 GTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
T Y APE Y+S D+++ G ++ EL T R
Sbjct: 160 STRWYRAPEILLRSTSYSS------PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 65/200 (32%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 374 LLGEGGFGSV-YKGYLPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLV 429
LLG+G FG V G+ A+K LK + E E ++ H L SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ DR + +YV L+FHL E R + TR A L YLH +I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRF-YGAEIVSALDYLHSG---KI 116
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYASSGKLTE 548
++RD+K N++LD + +++DFGL K + DA T T GT Y+APE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYGR 174
Query: 549 KSDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+GEG G V GR+VA+K++ + Q EV I+ H ++V + +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK--------IAAGAARGLAYLHEDC 485
D ++ +++ EG + D T + + + L++LH
Sbjct: 87 VGDELWVVMEFL-----------EGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ- 134
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTR--VMGTFGYMAPEYAS 542
+IHRDIKS +ILL ++ ++SDFG A+++ + + R ++GT +MAPE S
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPEVIS 188
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ D++S G++++E++ G P PL
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-13
Identities = 56/240 (23%), Positives = 73/240 (30%), Gaps = 24/240 (10%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP----------- 90
P P P P PP +PPA S + P P
Sbjct: 2483 PAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEE 2542
Query: 91 -PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP-PSNPPSNL 148
S A PP PP P RS PPP P P+ P ++PP + P + +
Sbjct: 2543 LASDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPV 2602
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P P PPPPS SP N P PPP + PA
Sbjct: 2603 DDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPT----VPPPERPRDDPAP 2658
Query: 209 PIAPRPSNSS-------PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
RP + +SPP +R + P + S + P P + +
Sbjct: 2659 GRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSA 2718
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-13
Identities = 41/204 (20%), Positives = 60/204 (29%), Gaps = 12/204 (5%)
Query: 59 ASNPPTSSSPPASSPPTS--SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
P ++ P S P A+ P + P +P A +P + P ++
Sbjct: 588 VGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGV 647
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
P + SD P P++ P P P
Sbjct: 648 AAPEHHPKHVAVPDASDGGDGWPAK------AGGAAPAAPPPAPAPAAPAAPAGAAPAQP 701
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ P +PPA A P+ PP Q AS +P + P P P + P
Sbjct: 702 APAPAATPPAGQADDPAAQPPQAAQG----ASAPSPAADDPVPLPPEPDDPPDPAGAPAQ 757
Query: 237 PVPSTENTPGNGTNPSSPESSSSP 260
P P P + P S S
Sbjct: 758 PPPPPAPAPAAAPAAAPPPSPPSE 781
|
Length = 824 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 24/134 (17%), Positives = 48/134 (35%), Gaps = 4/134 (2%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
A P ++ +P P P + P +P ++ P + + +PP
Sbjct: 363 AFKPAAAAEAAAPAEKKTPA----RPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPP 418
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
+ PP+ + P ++ + P+ P PP ++P + P +A P+ P
Sbjct: 419 AAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPA 478
Query: 201 QTPPTPASPIAPRP 214
A+ + P
Sbjct: 479 PAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLV 426
LLG+G FG V K G+ A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
+L + DR + +Y L+FHL E R + R A L YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARF-YGAEIVSALGYLHSC-- 114
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYASSGK 545
+++RD+K N++LD + +++DFGL K + D T GT Y+APE
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDND 171
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-13
Identities = 23/142 (16%), Positives = 38/142 (26%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P P+ P P + T+ P + A + PP +S P +P TS
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
+ + S P S P ++ P+ P
Sbjct: 421 QLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYR 480
Query: 148 LPPPPPSSVEPPKRSPPSVPPQ 169
P V+ + P +
Sbjct: 481 WKATNPVEVKKEPVATPKALKK 502
|
Length = 647 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 375 LGEGGFGSVYKGYLPDGREVA---IKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVG 430
+G G FG V G G A +K+L+ E+ F EV+ ++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGE-GRPVLDWATRV--KIAAGAARGLAYLHEDCHP 487
CI LL+ ++ P L +L G V ++A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT-FGYMAPEYASS--- 543
IH D+ N L + ++ D+GLA + +IT ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 544 ----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579
T+KS+++S GV + EL T A QP D S
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLS 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-13
Identities = 22/127 (17%), Positives = 42/127 (33%), Gaps = 9/127 (7%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP---PSPPASS 97
P K P +P A+ +++ PA + P A+ ++PP P P ++
Sbjct: 373 AAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAA----PAAAASAPAAPPAAAPPAPVAA 428
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P +P + P P+ P + P +P P+ + P +
Sbjct: 429 PAAAAPAAAPAAAPAAVALAPAPPAQA--APETVAIPVRVAPEPAVASAAPAPAAAPAAA 486
Query: 158 PPKRSPP 164
+
Sbjct: 487 RLTPTEE 493
|
Length = 618 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 39/214 (18%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA-------EVEIISRIHHRHLV 426
+GEG +G VYKG G+ VA+K++++ E E + E+ ++ + H ++V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRL-----ESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV---LDWATRVKIAAGAARGLAYLHE 483
L + + R LI++++ ++ + + P +D A VK +YL++
Sbjct: 63 CLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMD-AELVK---------SYLYQ 109
Query: 484 D------CHP-RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
CH R++HRD+K N+L+DN +++DFGLA+ A + T + T Y
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYR 168
Query: 537 APE-YASSGKLTEKSDVFSFGVVLLELITGRKPV 569
APE S + + D++S G + E+ T +KP+
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-13
Identities = 55/219 (25%), Positives = 76/219 (34%), Gaps = 13/219 (5%)
Query: 24 PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN 83
P+ PP S+ P P P PSPP P P +
Sbjct: 324 PSQRVPPKESDAADGPKPVPTKPVTPE---APSPPIEEEPPQPKAVVPRPLSPYTAYEDL 380
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P +SP P+PP+SSP + V+ P PS N P P+ A P +
Sbjct: 381 KPPTSPIPTPPSSSPASSKSVDAVAKPAE-PDVVPSPGSASNVPEVEPAQVEAKKTRPLS 439
Query: 144 P---------PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P P++ P P+ V P S SVP P +++ +PP P S
Sbjct: 440 PYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSP 499
Query: 195 VPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
PPT SP AP + ++ +PP
Sbjct: 500 YAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPP 538
|
Length = 576 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G +G VYK L G A+K +K+ G + E+ ++ H ++V+ G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 434 SDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S ++ + +Y +L +H+ G L + +GLAYLH +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS---SGKLTE 548
RDIK +NILL +N + +++DFG+A + A +GT +MAPE A+ +G +
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPL 575
D+++ G+ +EL + P+ P+
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 52/224 (23%)
Query: 375 LGEGGFGSVYK-GYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G V K ++P G +A+K+++ A V S+ R L+ L
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR-----------ATVN--SQEQKRLLMDL----- 50
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEG-----------------RPVLDWATRV------KI 470
D + D T Y L EG + V D + KI
Sbjct: 51 --DISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKI 108
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
A + L YLH +IHRD+K SN+L++ N + ++ DFG++ +D+ T
Sbjct: 109 AVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDA 164
Query: 531 GTFGYMAPEY----ASSGKLTEKSDVFSFGVVLLELITGRKPVD 570
G YMAPE + KSDV+S G+ ++EL TGR P D
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA-----EVEIISRIHHRHLVSL 428
+GEG +G VYK G VA+K++++ + E E E+ ++ ++H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL---ETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP- 487
+ S+++ L+++++ + L ++ LD +G+AY CH
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY----CHSH 118
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAK---LALDANTHITTRVMGTFGYMAPEYASSG 544
R++HRD+K N+L+D +++DFGLA+ + + TH V+ T Y APE
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLGS 174
Query: 545 KLTEKS-DVFSFGVVLLELITGRKP 568
+ D++S G + E++ R+P
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLV 426
+ +LG G FG + +G L P RE VAI L+ G +R F AE + + H ++V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
L G + +++ +Y+ N L + H EG+ L + + G A G+ YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQ--LVAGQLMGMLPGLASGMKYLSEM 126
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG--TFGYMAPEYAS 542
+ +H+ + + +L++++ ++S F +L D + I T + G + APE
Sbjct: 127 GY---VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 543 SGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ SDV+SFG+V+ E+++ G +P
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G G+VY + G+EVAIKQ+ + + E+ ++ H ++V+ + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D ++ +Y+ +L + +D + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 140
Query: 494 IKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
IKS NILL + +++DFG A++ + + T ++GT +MAPE + K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 553 FSFGVVLLELITGRKPVDASQPL 575
+S G++ +E++ G P PL
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-13
Identities = 25/127 (19%), Positives = 44/127 (34%)
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P ++ + P+ P A +P + P P++ S P+ PP PP P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPG 235
++P +P A A P+ V P +A + + + + P
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAA 485
Query: 236 IPVPSTE 242
+ TE
Sbjct: 486 ARLTPTE 492
|
Length = 618 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 375 LGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLVG 430
+G+G FG V + D + + A+K ++ E AE ++++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHEDCHPRI 489
S ++ L+ ++ L+ HL EGR L +R + A L LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRARFYTAELLCALENLHK---FNV 114
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
I+RD+K NILLD + DFGL KL + + T GT Y+APE T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNM-KDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592
D ++ GV+L E++TG P DE++ E R +L L
Sbjct: 174 VDWWTLGVLLYEMLTGLP------PFYDENVNEMYRKILQEPL 210
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-13
Identities = 29/101 (28%), Positives = 41/101 (40%), Gaps = 10/101 (9%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
P P PT+++P P +P P++ P ++ PP + PPPV
Sbjct: 362 PVPAPQPAKPTAAAPSPVRP---TPAPSTRPKAAAAANIPPKEPVRETATPPPV------ 412
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
PP P + P P++P S P A P P P PP
Sbjct: 413 -PPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 32/170 (18%)
Query: 421 HHRHLVSLVGYCISDDRR-LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+ + + L Y ++ + +LI DY+ + L+ L EG+ L A KI L
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALN 123
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVM--GTFGY 535
LH+ H IIH DIK N+L D + ++ D+GL K I T GT Y
Sbjct: 124 DLHK--H-NIIHNDIKLENVLYD-RAKDRIYLCDYGLCK-------IIGTPSCYDGTLDY 172
Query: 536 MAPEYASSGKLTEKSDVFSF-----GVVLLELITGRKPVDASQPLGDESL 580
+PE K+ + SF GV+ EL+TG+ P + DE L
Sbjct: 173 FSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEEL 214
|
Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 45/265 (16%)
Query: 382 SVYKGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLVGYC--ISDD 436
S+YKG + +EV I+ K G + E++ + RI +++ + G+ I DD
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 437 --RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRD 493
R LI +Y L L E L + T++ +A +GL L++ P +++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKN 148
Query: 494 IKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYASS--GKLTEKS 550
+ S + L+ N++ ++ GL K L+ ++ V Y + + + + T K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKD 203
Query: 551 DVFSFGVVLLELITGRKPVD--ASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608
D++S GVVL E+ TG+ P + ++ + D + + N L P +
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK----------NNSLKLPLDCPLEIKC 253
Query: 609 YVEGEMFRMIEAAAACVRHSAAKRP 633
VE AC H + KRP
Sbjct: 254 IVE-----------ACTSHDSIKRP 267
|
Length = 283 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 6e-13
Identities = 38/161 (23%), Positives = 59/161 (36%), Gaps = 5/161 (3%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
+P P P PP S++P AS+ T++P A PP + P PPAS+P P
Sbjct: 363 APLPEPEV--PPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
+ + S+P A S P N +SV P + P +
Sbjct: 421 QLLAARQQLQRAQGATKAKKSEPAAASRA---RPVNSALERLASVRPAPSALEKAPAKKE 477
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
++ P P+A P + + P A+ +A
Sbjct: 478 AYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAAKLAA 518
|
Length = 647 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 20/206 (9%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLVGYC 432
LG+G +GSVYK + P G +A+K++++ + + + E++I+ + ++V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPV--LDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + +Y+ +L L+ G + +I +GL +L E+ + II
Sbjct: 69 FIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAK--LALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
HRD+K +N+L++ N + ++ DFG++ +A A T+I G YMAPE SG +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQ 180
Query: 549 ------KSDVFSFGVVLLELITGRKP 568
+SDV+S G+ +LE+ GR P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLV 429
+LG+G FG V L G A+K LK + + + E +++ ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 430 GYCI--SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
YC + + + +++ L FH+ +GR L AT AA GL +LH
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSK--- 115
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
II+RD+K N++LD + +++DFG+ K + + +T GT Y+APE K T
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 548 EKSDVFSFGVVLLELITGRKP 568
D +SFGV+L E++ G+ P
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K + VA+K LK + + + +E+E++ I H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA---TRV-----------KI 470
+++L+G C D +I +Y L +L P ++++ RV
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRV 529
ARG+ YL + IHRD+ + N+L+ N +++DFGLA+ + + + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T +SDV+SFGV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 30/131 (22%), Positives = 44/131 (33%), Gaps = 10/131 (7%)
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
A + A++ P +P P + P + P P++ P P P+P PP+ +
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
+ PPP + P P P + P PAP A P P
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPA----------PAPAAAPEPTAAPAPAPPAAPAPAAAPA 495
Query: 199 PTQTPPTPASP 209
P PA
Sbjct: 496 APAAPAAPAGA 506
|
Length = 824 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 28/135 (20%), Positives = 46/135 (34%), Gaps = 9/135 (6%)
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P A++ P + P + + P+P + P A + P+ PP+ PP P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 153 PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
+ + P P P++ PAP A P + P PA A
Sbjct: 426 VA------APAAAAPAAAPAAAPAAVAL---APAPPAQAAPETVAIPVRVAPEPAVASAA 476
Query: 213 RPSNSSPNSPPPPST 227
++P + T
Sbjct: 477 PAPAAAPAAARLTPT 491
|
Length = 618 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 51/202 (25%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G G+V+ + G+EVAIKQ+ + + E+ ++ + + ++V+ + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D ++ +Y+ +L + +D A + + L +LH + ++IHRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVF 553
IKS N+LL + +++DFG + +T V GT +MAPE + K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 554 SFGVVLLELITGRKPVDASQPL 575
S G++ +E++ G P PL
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 374 LLGEGGFGSVYKGYLP----DGREVAIKQLK--IGGGQGEREFKAEVEIISRIHHRHLVS 427
+LG+G FGSV + L ++VA+K LK I EF E + H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGE-----------GRPV-LDWATRVKIAAGAA 475
L+G +S R +P L F HG+ P L T V+ A
Sbjct: 66 LIG--VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG-TFG 534
G+ YL IHRD+ + N +L+ N V+DFGL+K + +
Sbjct: 124 SGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
++A E + T SDV++FGV + E++T G+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 68/227 (29%), Positives = 80/227 (35%), Gaps = 10/227 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S + P P PP + P I PPP P + SP P P++
Sbjct: 322 SQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNL 381
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP--------PPPVSNPPTR 113
PP + P SS PT PP A PP P S P S P P PP S P
Sbjct: 382 PPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHS 441
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS--VEPPKRSPPSVPPQNP 171
P P PA PPPS P S PP +S +PP + PS
Sbjct: 442 GLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAG 501
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSS 218
P PP P A P + PPPP P P P ++ S
Sbjct: 502 PGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHASQS 548
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 63/236 (26%), Positives = 85/236 (36%), Gaps = 4/236 (1%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
PGPP ++ P P+ +PP P PP P S+ S P ++ P
Sbjct: 271 PGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQ 330
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPAS--SPPTISPPPPVSNPPTRSPPPPSSTPP 123
PP S P PPT+ P P S PP + P P P+ PPPP+ P
Sbjct: 331 PPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPL 390
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
+ P P P A+ PP P + P + P S+PP+ P S
Sbjct: 391 SSLPTHHP--PSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPP 448
Query: 184 PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P ++ P PP+ + P +S S PP S S P P
Sbjct: 449 QSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGP 504
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 8/202 (3%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G G+VY + G+EVAIKQ+ + + E+ ++ + ++V+ + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D ++ +Y+ +L + +D + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVF 553
IKS NILL + +++DFG + +T V GT +MAPE + K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 554 SFGVVLLELITGRKPVDASQPL 575
S G++ +E++ G P PL
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFK---AEVEIISRI-HHRHLVSL 428
+LG+G FG V+ L + AIK LK + + + E ++S H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 429 VGYCISDDRRLLIY--DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
YC + L + +Y+ L FH+ + L AT AA GL +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHSK-- 115
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
I++RD+K NILLD + +++DFG+ K + + T GT Y+APE K
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY 173
Query: 547 TEKSDVFSFGVVLLELITGRKP 568
D +SFGV+L E++ G+ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 33/136 (24%), Positives = 47/136 (34%), Gaps = 4/136 (2%)
Query: 35 PPKSSPPPP-PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP 93
P PP + + + S P SS P + P+ PS
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 94 PASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP 153
P+ S +P S+ P SP P++ PP P +PP P PP S P PP
Sbjct: 207 PSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAK---PTPPS 263
Query: 154 SSVEPPKRSPPSVPPQ 169
+S P ++
Sbjct: 264 ASATPAPIGGITLDDD 279
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 31/131 (23%), Positives = 41/131 (31%), Gaps = 9/131 (6%)
Query: 30 PPVSNPPK--------SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPA 81
P PP + S P + P S S+PP+SS S P P +
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
+ + P PS S P SP P +NP P PP P + P
Sbjct: 207 PSDSSLPPAPSSFQSDTPPPSPESP-TNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 142 SNPPSNLPPPP 152
+ P
Sbjct: 266 ATPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 32/105 (30%), Positives = 44/105 (41%), Gaps = 3/105 (2%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
P +A+ S PP P+ PP + P S PP S + +PPPSP PT+
Sbjct: 177 ADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPE---SPTN 233
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
SPP PP PP S+ P+PP++S +
Sbjct: 234 PSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 49/244 (20%), Positives = 76/244 (31%), Gaps = 38/244 (15%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP----PPPPVSKPPTTSPPPSP 57
+A P A +++ S PP + S+P PP +P + PS
Sbjct: 442 AADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSA 501
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS--------------- 102
+ PA++ +P A+ P + PP+P A++P +
Sbjct: 502 ATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGM 561
Query: 103 -------------PPPPVSNPPTRSPPPPS---STPPPNSPPSPPSDPPANS-PPPSNPP 145
P + P P P P + + PP +
Sbjct: 562 RVSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRARAATGDAPPNGAARAEQAAE 621
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP--APIAVPPSNVPPPPTQTP 203
S PPP + P P S P P +S P +A P++ P PP T
Sbjct: 622 SRGAPPPWEDIPPDDYVPLSADEGFGGPDDGFVPVFDSGPDDVRVAPKPADAPAPPVDTR 681
Query: 204 PTPA 207
P P
Sbjct: 682 PLPP 685
|
Length = 830 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-12
Identities = 25/151 (16%), Positives = 36/151 (23%), Gaps = 2/151 (1%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P + P PP S+ P AS T++P A PPPP S P P T
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTA-AVAPPQAPAVPPPPASAPQQAPAVPLPETT 419
Query: 123 PPNSPPSPP-SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
+ + P+ P + + + P P+
Sbjct: 420 SQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAY 479
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
P P
Sbjct: 480 RWKATNPVEVKKEPVATPKALKKALEHEKTP 510
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-12
Identities = 27/154 (17%), Positives = 44/154 (28%), Gaps = 12/154 (7%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
P + P P V P+ A ++ A + PPP ++ P +P P
Sbjct: 361 PAAPLPEPEVPPQSA---APAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE 417
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
++ ++ + + S P + P NS P P
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKS------EPAAASRARPVNSALERLASVR-PAPSALE 470
Query: 156 VEPPKRSPPSVPPQNPP--PPPSSSPPKNSPPAP 187
P K+ NP + PK A
Sbjct: 471 KAPAKKEAYRWKATNPVEVKKEPVATPKALKKAL 504
|
Length = 647 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-12
Identities = 68/273 (24%), Positives = 94/273 (34%), Gaps = 31/273 (11%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
PP + PP + P P S+ PP P P P P +P + S P+ P
Sbjct: 175 PQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHP 234
Query: 74 PTSSPPP-------ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP---PPPSSTPP 123
P AS P PS P PP+ + + P PSS PP
Sbjct: 235 QRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPP 294
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLP---------------PPPPSSVEPPKRSPPSVPP 168
+ PP P + P S+ P P PP+ P + PP+ P
Sbjct: 295 QPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPI 354
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
P PP P+P PSN+PPPP P++ P++ P++ PPP
Sbjct: 355 PQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPA------LKPLSSLPTHHPPSAHPPPLQL 408
Query: 229 RLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
P VP+ + S+ S
Sbjct: 409 MPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHS 441
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG VYK + G A K ++ + ++ E+EI++ +H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D + ++ ++ P + + R + + +V I L YLH +IIHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHSM---KIIHRD 135
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR---VMGTFGYMAPEYASSGKLTE-- 548
+K+ N+LL + + +++DFG++ N R +GT +MAPE + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 549 ---KSDVFSFGVVLLELITGRKPVDASQPL 575
K+D++S G+ L+E+ P P+
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPM 221
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 10/96 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM----G 531
RGL Y+H ++HRD+K SN+LL+ N + ++ DFGLA++A H T +
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLTEYVA 171
Query: 532 TFGYMAPEYASSGKLTEKS-DVFSFGVVLLELITGR 566
T Y APE + K K+ D++S G +L E+++ R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 50/202 (24%), Positives = 97/202 (48%), Gaps = 8/202 (3%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G+G G+VY + G+EVAI+Q+ + + E+ ++ + ++V+ + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D ++ +Y+ +L + +D + + L +LH + ++IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVF 553
IKS NILL + +++DFG + + ++GT +MAPE + K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 554 SFGVVLLELITGRKPVDASQPL 575
S G++ +E+I G P PL
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 18/103 (17%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT--------HITT 527
RGL Y+H +IHRD+K SN+L++ + E ++ DFG+A+ + T ++ T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 528 RVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGRKPV 569
R Y APE S + T D++S G + E++ GR+ +
Sbjct: 175 R-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 374 LLGEGGFGSVYKGYLP-DGREVAIKQLK---IGGGQGEREFKAEVEIISR-IHHRHLVSL 428
++G+G FG V DG+ A+K L+ + + ++ AE ++ + + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ ++ + D+V L+FHL E R + R A A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAE-IASALGYLHS---IN 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I++RD+K NILLD+ ++DFGL K + A + TT GT Y+APE
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 549 KSDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 3e-12
Identities = 30/138 (21%), Positives = 54/138 (39%), Gaps = 11/138 (7%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+ A P ++ A++ P ++P PA+ P ++ P+P A+ P +P
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAP---------- 435
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P P+ P + P+ + P + PS P+ P P P +PP+ P P
Sbjct: 436 -APAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAP 494
Query: 174 PPSSSPPKNSPPAPIAVP 191
++P + A
Sbjct: 495 AAPAAPAAPAGADDAATL 512
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 35/128 (27%), Positives = 45/128 (35%), Gaps = 12/128 (9%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A + NS + S PP S S P PP P+ S P P+
Sbjct: 161 ADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPS--S 218
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
S +PP S ++P S PP PP PP + PT PP S+TP
Sbjct: 219 FQSDTPPPSPESPTNP--------SPPPGPAAPPPPPVQQVPPLSTAKPT--PPSASATP 268
Query: 123 PPNSPPSP 130
P +
Sbjct: 269 APIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 38/102 (37%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFG 534
RGL YLH I+HRDIK N+L+++N ++ DFGLA++ D + H+T V+ +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 535 YMAPE-YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
Y APE S T D++S G + EL+ R A P+
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-12
Identities = 26/132 (19%), Positives = 47/132 (35%), Gaps = 15/132 (11%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
P+ AA +++P + P + P + P PP + PP P + PA+
Sbjct: 379 KTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASA---PAAPPAAAPP---APVAAPAAA 432
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P + P ++P + P +P + P P P + +P P ++
Sbjct: 433 APA-------AAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEP--AVASAAPAPAAAP 483
Query: 122 PPPNSPPSPPSD 133
P+ D
Sbjct: 484 AAARLTPTEEGD 495
|
Length = 618 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-12
Identities = 28/157 (17%), Positives = 44/157 (28%), Gaps = 9/157 (5%)
Query: 91 PSPPASSP--PTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
P+ P P P S P S T +P + P + P PP+ P +P P
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE--- 417
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
+ + P ++S + A + P + P
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKE 477
Query: 209 PIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTP 245
+ +N P +T P E TP
Sbjct: 478 AYRWKATNPVEVKKEPVAT----PKALKKALEHEKTP 510
|
Length = 647 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVYK----GYLPDGRE----VAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V + G + VA+K LK + + +E+E++ I H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA---TR-----------VKI 470
+++L+G C + +I +Y L L P D+ T+ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRV 529
A ARG+ YL R IHRD+ + N+L+ + +++DFGLA+ D + + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T +SDV+SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 22/99 (22%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFG 534
RGL Y+H IIHRD+K SNI ++ + E ++ DFGLA+ D T ++ TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 535 YMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
Y APE Y + D++S G ++ EL+TG+
Sbjct: 181 YRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 11/203 (5%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGEREFK---AEVEIIS-RIHHRHLVSL 428
+LG+G FG V L EV AIK LK + + E I++ H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ DR + +YV L F + + D AA L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRH---G 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+I+RD+K NILLD +++DFG+ K + N TT GT Y+APE +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGI-LNGVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 549 KSDVFSFGVVLLELITGRKPVDA 571
D ++ GV++ E++ G+ P +A
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 374 LLGEGGFG-SVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGY 431
++GEG FG ++ ++ ++ A+K++++ E + E +++++ H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGE-GR-----PVLDWATRVKIAAGAARGLAYLHEDC 485
+D ++ +Y L + + G+ +L W ++ + G+ ++HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
R++HRDIKS NI L N + ++ DFG A+L + T V GT Y+ PE +
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDAS 572
KSD++S G +L EL T + P A+
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-12
Identities = 35/84 (41%), Positives = 53/84 (63%), Gaps = 1/84 (1%)
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFGYMAPEYASSGKL 546
+IHRDIKS+NILL +N ++ DFG +K+ A + + GT Y+APE
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222
Query: 547 TEKSDVFSFGVVLLELITGRKPVD 570
++K+D+FS GV+L EL+T ++P D
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K +VA+K LK + + + +E+E++ I H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR--------------VKI 470
+++L+G C D +I +Y L +L P +++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
A ARG+ YL + IHRD+ + N+L+ + +++DFGLA+ D + HI
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR---DIH-HIDYYKK 198
Query: 531 GTFG-----YMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
T G +MAPE T +SDV+SFGV+L E+ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 45/136 (33%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495
DR + +YV L +H+ G+ V AA A GL +LH II+RD+K
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLK 128
Query: 496 SSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASSGKLTEKSDVFS 554
N++LD +++DFG+ K + TTR GT Y+APE + + D ++
Sbjct: 129 LDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 555 FGVVLLELITGRKPVD 570
FGV+L E++ G+ P D
Sbjct: 187 FGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
RGL Y+H ++HRD+K SN+LL+ N + ++ DFGLA+ + +T V+ T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 536 MAPE-YASSGKLTEKSDVFSFGVVLLELITGRKPV 569
APE + + T DV+S G + EL+ GRKP+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-12
Identities = 58/263 (22%), Positives = 85/263 (32%), Gaps = 27/263 (10%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P P P + + PP S+ P S P P + P P +P T + P PP
Sbjct: 596 PWPVPHPSQTPEPPTTQSHIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPTPHQPP 655
Query: 64 T--------------------SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
S + + P P PP +P P P ++PP +
Sbjct: 656 QVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQ 715
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P + R P P + + PPA +P + PP+ P P
Sbjct: 716 RPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPT 775
Query: 164 PSVPPQNPPPP-------PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P PPQ PP P P+ PP + P + + P P T +
Sbjct: 776 PQPPPQAPPAPQQRPRGAPTPQPPPQAGPTSMQLMPRAAPGQQGPTKQILRQLLTGGVKR 835
Query: 217 SSPNSPPPPSTKRLSPPPGIPVP 239
P+ P + +R + P P
Sbjct: 836 GRPSLKKPAALERQAAAGPTPSP 858
|
Length = 991 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 59/199 (29%), Positives = 86/199 (43%), Gaps = 10/199 (5%)
Query: 374 LLGEGGFGSV-YKGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LLG+G FG V GR A+K L+ I E ++ H L +L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ DR + +Y L+FHL E R + R A L YLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARF-YGAEIVSALEYLHSR---DV 116
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
++RDIK N++LD + +++DFGL K + + T GT Y+APE
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 550 SDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLK---IGGGQGEREFKAEVEIISR-IHHRHLVSL 428
++G+G FG V + + + A+K L+ I + E+ +E ++ + + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ D+ + DY+ L++HL E R L+ R AA A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARF-YAAEIASALGYLHS---LN 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I++RD+K NILLD+ ++DFGL K ++ N T+ GT Y+APE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 549 KSDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-12
Identities = 28/125 (22%), Positives = 50/125 (40%), Gaps = 3/125 (2%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
G A +++ P + P +P P + P ++ P P + P +P P+P P
Sbjct: 385 LGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPA---P 441
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P+ + + S PP A+ +P P+ +P PP + P +P P++
Sbjct: 442 PSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPA 501
Query: 123 PPNSP 127
P
Sbjct: 502 APAGA 506
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 32/130 (24%), Positives = 43/130 (33%), Gaps = 5/130 (3%)
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLP-----PPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
PN P + +N ++ P P S +PP SP +PP PSS
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 178 SPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIP 237
+ PPAP + PP P P P PP ST + +PP
Sbjct: 207 PSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASA 266
Query: 238 VPSTENTPGN 247
P+
Sbjct: 267 TPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGG---GQGEREFKAEV 414
YE+L K +GEG +G+V+K + E VA+K++++ G + E+
Sbjct: 2 YEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EI 50
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN-TLYF-HLHGEGRPVLDWATRVKIAA 472
++ + H+++V L SD + L+++Y + YF +G+ +D
Sbjct: 51 CLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGD----IDPEIVKSFMF 106
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG- 531
+GLA+ H ++HRD+K N+L++ N E +++DFGLA+ I R
Sbjct: 107 QLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSA 158
Query: 532 ---TFGYMAPEYASSGKLTEKS-DVFSFGVVLLELITGRKPV 569
T Y P+ KL S D++S G + EL +P+
Sbjct: 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 374 LLGEGGFGSVY---KGYLPD-GREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
+LG G +G V+ K D G+ A+K L+ + + + E ++ +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA-RGLAYLHE 483
+ + Y + +L LI DYV ++ HL+ D V+ +G L +LH+
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILALEHLHK 123
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA-S 542
I++RDIK NILLD+ ++DFGL+K L T GT YMAPE
Sbjct: 124 ---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
G + D +S G+++ EL+TG P
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-12
Identities = 41/201 (20%), Positives = 55/201 (27%), Gaps = 11/201 (5%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSP-PASNPPTSSSPPASSPPTSSPPPASNPPTSSPP-PSP 93
P + P PP TS P P P P P + P PT+ P P+
Sbjct: 90 PSAGEPAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYPAY 149
Query: 94 PASSPPTISPPPPVSNPP--TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
P P R PP + + +P + P +
Sbjct: 150 QQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYDQRRR 209
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
P P P PPP + P P + V P P
Sbjct: 210 DYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAP-------G 262
Query: 212 PRPSNSSPNSPPPPSTKRLSP 232
P + +P P T RL+P
Sbjct: 263 PLAAQPAPAPGPGEPTARLNP 283
|
Length = 617 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 9e-12
Identities = 25/146 (17%), Positives = 40/146 (27%), Gaps = 3/146 (2%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPAS-SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
A P P P P +++P S A+ +P PP P P P P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE 417
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
+ A + + R S + P+ S + +P
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKE 477
Query: 189 AVP--PSNVPPPPTQTPPTPASPIAP 212
A +N + TP +
Sbjct: 478 AYRWKATNPVEVKKEPVATPKALKKA 503
|
Length = 647 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-12
Identities = 77/288 (26%), Positives = 97/288 (33%), Gaps = 16/288 (5%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSP---PPSPP 58
SAPS P S P P P T S P P S P P P P
Sbjct: 228 SAPSLHPQRLPS---PHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPV 284
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
P+S+ P S PP P + P P S PP P +P P
Sbjct: 285 FLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMP 344
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP-----PPPSSVEPPKRSPPSVPPQNPPP 173
PPP +P + PP PS P PPP +++P P PP PP
Sbjct: 345 HIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAHPP 404
Query: 174 P----PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
P P S P ++ P P + S PP T P P P + P
Sbjct: 405 PLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGP-PQSPFAQHPFTSGGLP 463
Query: 230 LSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAVAV 277
PP ST P ++ S P S+ PS+ G G + + +
Sbjct: 464 AIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQI 511
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-12
Identities = 65/239 (27%), Positives = 85/239 (35%), Gaps = 16/239 (6%)
Query: 1 MSAPSPGPPAANSSSPPPP----VSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPS 56
+ AP GP + P S P P PV +P ++ PP S P TS P
Sbjct: 564 LPAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQSHIPETSAPRQ 623
Query: 57 PPASNPPTSSSP----PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
P P P P + P P P P P + I P + T
Sbjct: 624 WPMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANT 683
Query: 113 RSPP---PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
P P + PPP +P P PPA P + P+ P R+ P
Sbjct: 684 MLPIQWAPGTMQPPPRAPT--PMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAP 741
Query: 170 NPPPPPSSSPPKNSPPAPI---AVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPP 225
PP+++P + PPA A PP+ P PT PP A P + +P PPP
Sbjct: 742 GRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPPP 800
|
Length = 991 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 63/228 (27%), Positives = 86/228 (37%), Gaps = 12/228 (5%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
++K P+ PP + + P P P A +PP PP P A P +SP
Sbjct: 320 LAKIPSQRVPPKESDA-----ADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPY 374
Query: 105 PPVSN--PPTRSPPPPSSTPPPNSPPSPPSDPPA--NSPPPSNPPSNLPPPPPSSVEPPK 160
+ PPT P P S+ P +S PA + P SN+P P+ VE K
Sbjct: 375 TAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKK 434
Query: 161 RSP--PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA-PRPSNS 217
P P ++ PP S SP + +P S+VP P P T A+ A P P+N
Sbjct: 435 TRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANM 494
Query: 218 SPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGI 265
P SP P P + TN +S+P
Sbjct: 495 RPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALA 542
|
Length = 576 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 26/200 (13%)
Query: 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506
++ LY +L RP L + I GL YLH RIIHRD+K+ NI +++ +
Sbjct: 140 SSDLYTYLTKRSRP-LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQ 195
Query: 507 AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
+ D G A+ + A + + GT APE + K K+D++S G+VL E++
Sbjct: 196 VCIGDLGAAQFPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253
Query: 567 KPVDASQPLGDESLVEWARPLLSHALE--------NEEFDNLADPRLGENYVEGEMFRMI 618
+ P E E+ + SH L+ EEF RL ++E
Sbjct: 254 STIFEDPPSTPE---EYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIE------- 303
Query: 619 EAAAACVRHSAAKRPRMGQV 638
A+ R + P +V
Sbjct: 304 --YASLERQPYTRYPCFQRV 321
|
Length = 357 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G +G VYK + G AIK +K+ G+ + E+ ++ H ++V+ G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 434 SDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
D+ + ++ +L +H+ G L + ++ +GL YLH +H
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSKGK---MH 129
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS---SGKLTE 548
RDIK +NILL +N +++DFG++ + A +GT +MAPE A+ G +
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSA-QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPL 575
D+++ G+ +EL + P+ P+
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVY--------KGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LGEG FG V K VA+K LK + + +E+E++ I H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA--------------TRVKI 470
+++L+G C D ++ +Y L +L P +D++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-TTRV 529
A ARG+ YL + IHRD+ + N+L+ + +++DFGLA+ + + + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T +SDV+SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 9/199 (4%)
Query: 374 LLGEGGFGSV-YKGYLPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLV 429
LLG+G FG V GR A+K LK + E E ++ H L +L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ DR + +Y L+FHL E R + R A L YLH + +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARF-YGAEIVSALDYLHSE--KNV 117
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
++RD+K N++LD + +++DFGL K + + T GT Y+APE
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 176
Query: 550 SDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-11
Identities = 28/138 (20%), Positives = 50/138 (36%), Gaps = 4/138 (2%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
++ P + P +P P+ A + +P A+ P +P PA PP+ +
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
+ SPPP + +P P ++ P +P P PA + P+ P +
Sbjct: 446 GNAPAGGAP----SPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPA 501
Query: 149 PPPPPSSVEPPKRSPPSV 166
P + P +
Sbjct: 502 APAGADDAATLRERWPEI 519
|
Length = 824 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 65/244 (26%), Positives = 82/244 (33%), Gaps = 19/244 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A S PP S P PP+ S P PP+ P PP S P PP +P
Sbjct: 299 LAQSQVPPLPLPSQAQPHSHTPPSQSALQP-QQPPREQPLPPAPSMPHIKPPPTTPIPQL 357
Query: 62 PPTS--------SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
P S P P++ PPP + P SS P P S + PPP+ P
Sbjct: 358 PNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPS-----AHPPPLQLMPQS 412
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP-----PPSSVEPPKRSPPSVPP 168
P PP S P A++ P S S P P +S P PP P
Sbjct: 413 QPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLP 472
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
+ P P + + PP P PP + + PPPP +
Sbjct: 473 TSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSP 532
Query: 229 RLSP 232
P
Sbjct: 533 SPEP 536
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 374 LLGEGGFGSVY-KGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISR-IHHRHLVSL 428
++G+G FG V DG A+K L+ I + + AE ++ + + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+ ++ + DYV L+FHL E R L+ R AA A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARF-YAAEVASAIGYLHS---LN 116
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
II+RD+K NILLD+ ++DFGL K ++ T+ GT Y+APE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 549 KSDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGYC 432
LGEG + +V+KG VA+K++++ +G EV ++ + H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAA-GAARGLAYLHEDCHPRIIH 491
++ L+++Y+ ++ L +L G L VKI RGL+Y H +I+H
Sbjct: 73 HTERCLTLVFEYL-DSDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILH 126
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEKS 550
RD+K N+L++ E +++DFGLA+ A T + + T Y P+ S + +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 551 DVFSFGVVLLELITGR 566
D++ G +L E+ TGR
Sbjct: 186 DMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 43/137 (31%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495
DR + +YV L +H+ G+ V AA + GL +LH II+RD+K
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLK 128
Query: 496 SSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASSGKLTEKSDVFS 554
N++LD+ +++DFG+ K + +TTR GT Y+APE + + D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 555 FGVVLLELITGRKPVDA 571
+GV+L E++ G+ P D
Sbjct: 187 YGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-11
Identities = 29/125 (23%), Positives = 49/125 (39%), Gaps = 2/125 (1%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
+P A+ P +++ PA++P ++ PA+ + PA +P PP +
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
P S PP +P + P+ PA +P P+ P+ PP P+ P P
Sbjct: 446 GNAPAGGAP--SPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAP 503
Query: 169 QNPPP 173
Sbjct: 504 AGADD 508
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-11
Identities = 35/193 (18%), Positives = 54/193 (27%), Gaps = 8/193 (4%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
P P + P P+ P P + P + P P+ + S P
Sbjct: 587 VVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAA-PAAPAAPAPAGAAAAPAEASAAPAP 645
Query: 135 PANSPPPSNPPSNLPPPP-PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP-P 192
+P +P P K + P P P++ P P
Sbjct: 646 GVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 193 SNVPPPPTQTPPTPASPIAP----RPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG 248
+ PP P P A PS ++ + P P P P P
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPA 765
Query: 249 TNPSSPESSSSPS 261
++P ++ PS
Sbjct: 766 -PAAAPAAAPPPS 777
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 3e-11
Identities = 29/159 (18%), Positives = 44/159 (27%), Gaps = 6/159 (3%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
P P P S P S T +P V+ P + PPPP S P P P +
Sbjct: 363 APLPEPEVPPQ---SAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETT 419
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
+ ++ ++ S P +S P S+ ++ P P P
Sbjct: 420 SQLLAARQQLQRAQGATKAKKSEPAAASRAR-PVNSALERLASVRPA--PSALEKAPAKK 476
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
+P P L +
Sbjct: 477 EAYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAAK 515
|
Length = 647 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
+H LV L ++ R + +YV L FH+ + R + + R +A + L Y
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARF-YSAEISLALNY 111
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
LHE II+RD+K N+LLD+ +++D+G+ K L T+ GT Y+APE
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEI 167
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVD 570
D ++ GV++ E++ GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG VYK + +A ++ + E E + E++I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
++ ++ ++ + + RP+ + RV + L YLHE+ +IIHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIHRD 128
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR---VMGTFGYMAPEYASSGKLTE-- 548
+K+ NIL + + +++DFG++ NT R +GT +MAPE +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 549 ---KSDVFSFGVVLLELITGRKPVDASQPL 575
K+DV+S G+ L+E+ P P+
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 42/120 (35%), Positives = 69/120 (57%), Gaps = 7/120 (5%)
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
K++ RGLAYL E +I+HRD+K SNIL+++ E ++ DFG++ +D+ +
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588
+GT YM+PE + +SD++S G+ L+EL GR P+ P E + RP++
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI--PPPDAKELEAIFGRPVV 219
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 61/284 (21%), Positives = 128/284 (45%), Gaps = 37/284 (13%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKI---GGGQGEREFKAEVEIISRIHHRH 424
F + +G G F VY+ L D + VA+K+++I + ++ E++++ +++H +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL---YFHLHGEGRPVLD---WATRVKIAAGAARGL 478
++ + I D+ ++ + L + + R + + W V++ + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA----V 119
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
++H R++HRDIK +N+ + ++ D GL + + T ++GT YM+P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSP 175
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEWARPLLSHALENEEF 597
E KSD++S G +L E+ + P GD+ +L L +E ++
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLFS-----LCQKIEQCDY 225
Query: 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641
P E+Y E ++ E + C+ +RP +G V ++
Sbjct: 226 ----PPLPTEHYSE----KLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 23/193 (11%)
Query: 391 GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
G++VA+K++ + Q EV I+ HH ++V + + D ++ +++
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL----- 101
Query: 451 YFHLHGEGRPVLDWATRVK--------IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502
EG + D T + + R L+YLH +IHRDIKS +ILL
Sbjct: 102 ------EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 152
Query: 503 NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLEL 562
++ ++SDFG + ++GT +MAPE S + D++S G++++E+
Sbjct: 153 SDGRIKLSDFGFCA-QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 563 ITGRKPVDASQPL 575
I G P PL
Sbjct: 212 IDGEPPYFNEPPL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 25/92 (27%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
P P P ++ P P P ++ P + A+N P ++ P PP PP
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPV 421
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
P S P + I PV P +PP P
Sbjct: 422 PHTPESAPKLTRAAI----PVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-11
Identities = 65/247 (26%), Positives = 93/247 (37%), Gaps = 27/247 (10%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPP-----------PVSKPPTT 51
AP+P P + P + T PPPP + P + PP P++ P
Sbjct: 254 APAPPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPP 313
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
PPP PA + + S P P P P PT +PP + +
Sbjct: 314 DPPPPAPAGDAEEEDDEDGAMEVVSPLPR----PRQHYPLGFPKRRRPTWTPPSSLEDLS 369
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
P ++ P S A +P P + P + V P SVP P
Sbjct: 370 AGRHHPKRASLPTRKRRSARH---AATPFARGPGGDDQTRPAAPV------PASVPTPAP 420
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNV--PPPPTQTPPTPASPIA-PRPSNSSPNSPPPPSTK 228
P P+S+PP + P P A P S+ PPP + PP PA+ A P +++ + +
Sbjct: 421 TPVPASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRKALDALRER 480
Query: 229 RLSPPPG 235
R PPG
Sbjct: 481 RPPEPPG 487
|
Length = 3151 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 6e-11
Identities = 30/167 (17%), Positives = 47/167 (28%), Gaps = 13/167 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+AP P P S+ P + T +P V+ P + PPPP S P +P P
Sbjct: 362 AAPLPEPEVPPQSAAPAASA-QATAAPTAAVAPPQAPAVPPPPASAPQQ-APAVPLP--- 416
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
TS A + + S + V P+ P+
Sbjct: 417 ETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKK 476
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
+ P + P ++E K +P
Sbjct: 477 EAYRWKATNPVEVKKEPVAT-------PKALKKALEHEK-TPELAAK 515
|
Length = 647 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 49/210 (23%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKI---GGGQGEREFKAEVEIISRIHHRH 424
F + +G G F VY+ L DG VA+K+++I + + E++++ +++H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL---YFHLHGEGRPVLD---WATRVKIAAGAARGL 478
++ I D+ ++ + L H + R + + W V++ + L
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA----L 119
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
++H R++HRDIK +N+ + ++ D GL + + T ++GT YM+P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSP 175
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E KSD++S G +L E+ + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-11
Identities = 45/208 (21%), Positives = 65/208 (31%), Gaps = 9/208 (4%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
P PPA+ + + S A + + A+ P P P T +
Sbjct: 22 PRPPATPGDAADDLLSGSQGQLVSDSA--ELAAVTVVAGAAACDRFEPPTGPPPGPGTEA 79
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P S + P S + PA P+ P + P PPP + P P P +
Sbjct: 80 PANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLR 139
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P SP +P A S A+ P ++ PP+ S PP
Sbjct: 140 PVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPP 199
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPSN 262
SSP S+S+ S
Sbjct: 200 AAA-------SPRPPRRSSPISASASSP 220
|
Length = 1352 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 9/186 (4%)
Query: 391 GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450
GR+VA+K + + Q EV I+ H+++V + + + ++ +++ L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510
+ + R L+ + + L YLH +IHRDIKS +ILL + ++S
Sbjct: 106 T-DIVSQTR--LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLS 159
Query: 511 DFGL-AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPV 569
DFG A+++ D ++GT +MAPE S + D++S G++++E++ G P
Sbjct: 160 DFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
Query: 570 DASQPL 575
+ P+
Sbjct: 218 FSDSPV 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 41/202 (20%), Positives = 58/202 (28%), Gaps = 16/202 (7%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
PS G PA P ++ P + P P + P +PP P + P
Sbjct: 90 PSAGEPAPPP--PHARRTSEPELPRPGR--RPYEGYGGPRADDRPPGLPRQDQLPTARP- 144
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP--PPPSST 121
+ PA P PP P S P + P +
Sbjct: 145 ---AYPAYQQR-PEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAG 200
Query: 122 PPPNSPPSPPSDPPA-NSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
P D P + P ++ P PPP + + P + P P
Sbjct: 201 RPEYDQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPS- 259
Query: 181 KNSPPAPIAVPPSNVPPPPTQT 202
P P+A P+ P P T
Sbjct: 260 ---APGPLAAQPAPAPGPGEPT 278
|
Length = 617 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 48/146 (32%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 428 LVGY--CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
LVG C RL L+ +YV L FH+ + R + + R AA L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARF-YAAEICIALNFLHER 115
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
II+RD+K N+LLD + +++D+G+ K L T+ GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTSTFCGTPNYIAPEILRGE 171
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVD 570
+ D ++ GV++ E++ GR P D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 375 LGEGGFGSVYKGYLPDG---REVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVG 430
+G G FG V G + G +V +K+L++ Q + +F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL---DWATRVKIAAGAARGLAYLHEDCHP 487
C LL+ ++ P L +L + L D T ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT-RVMGTFGYMAPEYASS--G 544
IH D+ N LL + ++ D+GL+ + ++T ++ ++APE G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 545 KL-----TEKSDVFSFGVVLLELIT-GRKP 568
L T++S+V+S GV + EL G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 65/240 (27%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQL----------KIGGGQGE 407
YE+L K +GEG +G V+K + G+ VAIK+ KI
Sbjct: 3 YEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA----- 47
Query: 408 REFKAEVEIISRIHHRHLVSLVGYCISDDRRL-LIYDYVPN---NTLYFHLHGEGRPVLD 463
E+ ++ ++ H +LV+L+ R+L L+++Y + N L + G +
Sbjct: 48 ---LREIRMLKQLKHPNLVNLI-EVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VP 98
Query: 464 WATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522
KI + + + H+ +C IHRD+K NIL+ + ++ DFG A++
Sbjct: 99 EHLIKKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPG 154
Query: 523 THITTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
T V T Y APE Y DV++ G V EL+TG QPL
Sbjct: 155 DDYTDYV-ATRWYRAPELLVGDTQYGPP------VDVWAIGCVFAELLTG-------QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 30/82 (36%), Positives = 41/82 (50%)
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
++ ++PPPP +PPP +P P P A +PPP+ PP SS P + S P
Sbjct: 517 ASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSP 576
Query: 168 PQNPPPPPSSSPPKNSPPAPIA 189
P P P+ SP K+S P I
Sbjct: 577 PPPIPEEPTPSPTKDSSPEEID 598
|
Length = 620 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 8/96 (8%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK----LALDANTHITTRVMG 531
+ L Y+H +IHRD+K SNILL+++ +++DFGLA+ L + + T +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 532 TFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
T Y APE S + T+ D++S G +L E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 1e-10
Identities = 59/248 (23%), Positives = 87/248 (35%), Gaps = 6/248 (2%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P + +P P ++ + P S PT + + P PTS + A+ TS
Sbjct: 443 PHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPEDTSPTSRTTSATPNATSP 502
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
P + P +SP + +P SP P V T + PP+ T + SP
Sbjct: 503 TPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPTGTTSVPNATSP--QVTEE 560
Query: 138 SPPPSNPPSNLPPPPP---SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
SP + + P S+V + S P P PSSS + P
Sbjct: 561 SPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPGIPSSSHSTPRSNSTSTTPLLT 620
Query: 195 VPPPPTQTPPTPASPIAPRPSNSSPNSP-PPPSTKRLSPPPGIPVPSTENTPGNGTNPSS 253
P T +P P ++ S SP P P T PG S + T
Sbjct: 621 SAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMP 680
Query: 254 PESSSSPS 261
+++SPS
Sbjct: 681 NPNATSPS 688
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-10
Identities = 62/232 (26%), Positives = 81/232 (34%), Gaps = 30/232 (12%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
++ P+ + + PP PP PPP P+ PPP P PP P P
Sbjct: 2886 LARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPL-- 2943
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
PT+ P A P + P P A P V+ P R P P S
Sbjct: 2944 ------------APTTDPAGAGEPSGAVPQPWLGALVPGR------VAVPRFRVPQPAPS 2985
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNL-----PPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P S P + S+ S+L PPP S++ P +
Sbjct: 2986 REAPASSTPPLTGHSL--SRVSSWASSLALHEETDPPPVSLKQTLWPPDDTEDSDADSLF 3043
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA-PRPSNSSPNSPPPPS 226
S ++ A +PP P P P PA+P A R S SS PPP S
Sbjct: 3044 DSDSERSDLEALDPLPPE--PHDPFAHEPDPATPEAGARESPSSQFGPPPLS 3093
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-10
Identities = 28/137 (20%), Positives = 43/137 (31%), Gaps = 11/137 (8%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
A + P + + P P ++P P P PA
Sbjct: 384 RLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPA------- 436
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
P + P + PA P+ P +P A P + P P P P + P P +
Sbjct: 437 -PAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPE---PTAAPAPAPPAAPAPAA 492
Query: 127 PPSPPSDPPANSPPPSN 143
P+ P+ P A +
Sbjct: 493 APAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 23/93 (24%), Positives = 30/93 (32%), Gaps = 4/93 (4%)
Query: 15 SPPPPVSNPPTISPPPPVS-NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
P P PT + P PV P S+ P + P A+ PP P A
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPV 421
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPP 106
P + + P P +PP PP
Sbjct: 422 PHTPESAPKLTRAAIPVDEKPKYTPP---APPK 451
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 25/98 (25%), Positives = 32/98 (32%), Gaps = 6/98 (6%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P P P + PS P +P + P A + PP P PPP P
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPV 421
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQ 201
P P P ++ P P PP PP +
Sbjct: 422 PHTPESAPKLTRAAIP---VDEKPKYTPP---APPKEE 453
|
Length = 585 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 10/138 (7%)
Query: 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495
DR + +YV L + + GR V AA A GL +LH II+RD+K
Sbjct: 74 DRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLK 128
Query: 496 SSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVM-GTFGYMAPEYASSGKLTEKSDVF 553
N++LD+ +++DFG+ K + D +TT+ GT Y+APE + + D +
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 554 SFGVVLLELITGRKPVDA 571
+FGV+L E++ G+ P +
Sbjct: 186 AFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKA--EVEIISRIH---HRHLVSL 428
+G G +G+VYK P G VA+K +++ + EV ++ R+ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 429 VGYCIS--DDRRL---LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
+ C + DR L++++V + L +L P L T + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
+C I+HRD+K NIL+ + + +++DFGLA++ + T V+ T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVLLQ 181
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPV 569
D++S G + E+ RKP+
Sbjct: 182 STYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 39/187 (20%), Positives = 52/187 (27%), Gaps = 7/187 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ SS P P S+ + P +P P P S ++S S +S+
Sbjct: 267 TRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSS 326
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
TSSS +S SP P+ S P P P P P P +
Sbjct: 327 SSTSSSSESSRGAAVSPGPSP----SRSPSPSRPPPPAD--PSSPRKRPRPSRAPSSPAA 380
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP-PPSSSPP 180
A + P P + P PS P
Sbjct: 381 SAGRPTRRRARAAVAGRARRRDATGRFPAGRPRPSPLDAGAASGAFYARYPLLTPSGEPW 440
Query: 181 KNSPPAP 187
SPP P
Sbjct: 441 PGSPPPP 447
|
Length = 1352 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 55/235 (23%), Positives = 79/235 (33%), Gaps = 9/235 (3%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P P P + P P + +S P P S P T S P ++ P
Sbjct: 565 PAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQSHIPETSAPRQW 624
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSP--PPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
P P P P P + +P PP P + P P
Sbjct: 625 PMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANTM 684
Query: 147 NLPPPPPSSVEPPKRSP-PSVPPQNPP---PPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
P +++PP R+P P PP PP P+++ + PPA P +
Sbjct: 685 LPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRA 744
Query: 203 PPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPV---PSTENTPGNGTNPSSP 254
P A+P RP ++P PP+ +P P P P+ + P P P
Sbjct: 745 RPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPP 799
|
Length = 991 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFKA-- 412
M YE++ K GEG +G VYK E +A+K++++ E+E +
Sbjct: 1 MDQYEKVEKI----------GEGTYGVVYKARDRVTNETIALKKIRL-----EQEDEGVP 45
Query: 413 -----EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
E+ ++ + H ++V L S+ R L+++Y+ L H + P R
Sbjct: 46 STAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPR 102
Query: 468 V--KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA-QVSDFGLAKLALDANTH 524
+ RG+AY H R++HRD+K N+L+D A +++DFGLA+ A
Sbjct: 103 LIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVR 158
Query: 525 ITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
T + T Y APE S + D++S G + E++ +
Sbjct: 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 70/238 (29%), Positives = 107/238 (44%), Gaps = 19/238 (7%)
Query: 352 HSRSMFTYEELVKATDGFADQNLLGEGGFGSVYK-GYLPDGREVAIKQLKIGGGQGEREF 410
++ SM E L TD + +G+G +G VYK DG A+K L E E
Sbjct: 7 YNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EI 65
Query: 411 KAEVEIISRI-HHRHLVSLVGYCISDDRRL-----LIYDYVPNNTLYFHLHGEGR--PVL 462
+AE I+ + +H ++V G D+ + L+ + ++ + G L
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522
D A I GA GL +LH + RIIHRD+K +NILL ++ DFG++
Sbjct: 126 DEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 523 THITTRVMGTFGYMAPEYASSGKLTEKS-----DVFSFGVVLLELITGRKPVDASQPL 575
T V GT +MAPE + + + S DV+S G+ +EL G P+ P+
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVGY 431
+GEG +G VYK G VA+K++++ A E+ ++ ++H ++V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLAYLHE 483
++++ L++++ LH + + +D + I + GLA+
Sbjct: 68 IHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF--- 115
Query: 484 DCHP-RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
CH R++HRD+K N+L++ +++DFGLA+ A T + T Y APE
Sbjct: 116 -CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILL 173
Query: 543 SGKL-TEKSDVFSFGVVLLELITGR 566
K + D++S G + E++T R
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHR 423
D + LGEG + +VYKG +G+ VA+K +++ +G F A E ++ + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHA 63
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTL-YFHLHGEGRPVLDWATRVKIAA-GAARGLAYL 481
++V L + + L+++YV + Y H G VK+ RGL+Y+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLH----PENVKLFLFQLLRGLSYI 119
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-Y 540
H+ I+HRD+K N+L+ + E +++DFGLA+ A +H + + T Y P+
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 541 ASSGKLTEKSDVFSFGVVLLELITG 565
S + + D++ G + +E+I G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 45/147 (30%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 428 LVGY--CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
LVG C + RL + ++V L FH+ + R + + R +A + L +LHE
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARF-YSAEISLALNFLHER 115
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHITTRVMGTFGYMAPEYASS 543
II+RD+K N+LLD +++D+G+ K + +T T+ GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEILRG 170
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVD 570
D ++ GV++ E++ GR P D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 47/198 (23%), Positives = 64/198 (32%), Gaps = 9/198 (4%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P P + P++ P P+ +S+P S P+ S P S P P+S +SS
Sbjct: 258 PRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSS 317
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
S +SS T S P PS +P SP PP PPA+ P P
Sbjct: 318 SSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSP---SPSRPP--PPADPSSPRKRPRPS 372
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P + + + P P + + A
Sbjct: 373 RAPSSPAASAGRPTRRRARAAVAGRARRRDAT---GRFPAGRPRPSPLDAGAASGAFYAR 429
Query: 209 PIAPRPSNSS-PNSPPPP 225
PS P SPPPP
Sbjct: 430 YPLLTPSGEPWPGSPPPP 447
|
Length = 1352 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA-- 412
+ TY++L K LGEG + +VYKG G+ VA+K++++ +G F A
Sbjct: 4 LETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIR 52
Query: 413 EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIA 471
E ++ + H ++V+L + L+++Y+ + Y G G L
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFL 109
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
RGLAY H R++HRD+K N+L+ E +++DFGLA+ A + + +
Sbjct: 110 FQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV 165
Query: 532 TFGYMAP-------EYASSGKLTEKSDVFSFGVVLLELITGR 566
T Y P EY++S D++ G + E+ TGR
Sbjct: 166 TLWYRPPDVLLGSTEYSTS------LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 367 DGFADQNLLGEGGFGSVYK-GYLPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRH 424
D F + LG G G V+K + P G +A K + + R + E++++ + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
+V G SD + +++ +L L GR +V IA +GL YL E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 122
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
+I+HRD+K SNIL+++ E ++ DFG++ +D+ + +GT YM+PE
Sbjct: 123 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT 177
Query: 545 KLTEKSDVFSFGVVLLELITGRKPV 569
+ +SD++S G+ L+E+ GR P+
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-10
Identities = 39/166 (23%), Positives = 45/166 (27%), Gaps = 8/166 (4%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP---PPPPVSKPPTTSPPPSP 57
+ P AA PP P P PP +P + P P P P PP
Sbjct: 180 LPQGMPPRQAAFPQQGPPE---QPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQL 236
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP--TISPPPPVSNPPTRSP 115
P PP PPP P PP P A PP +P P +
Sbjct: 237 PQQPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPL 296
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
PPP P + S E KR
Sbjct: 297 PPPQQPQLLPLVQQPQGQQRGPQFREQLVQLSQQQREALSQEEAKR 342
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 58/260 (22%), Positives = 74/260 (28%), Gaps = 10/260 (3%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P V+ P N P P +P +PP+ P+ P
Sbjct: 53 PEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQ 112
Query: 77 SPPPASNP--PTSSPPPSPPASSPPTISPPPPVSNP--PTRSPPPPSSTPPPNSPPSPPS 132
P P P P S P PPA P P PP P PP N PP S
Sbjct: 113 QPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQS 172
Query: 133 DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP 192
P P P P S P + P S+ Q P S PP P
Sbjct: 173 APQ---VSGLYPEE--SPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYMY 227
Query: 193 SNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPS 252
P P+ P + S PPPS + + + PS
Sbjct: 228 GGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQS-YSTAYPS 286
Query: 253 SPESSSSPSNNGIGTAGTVV 272
P ++ P + +A
Sbjct: 287 LPAATVLPQALPMSSAPMSG 306
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 375 LGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGY 431
LGEG + +VYKG L D VA+K++++ +G EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-II 490
++ L+++Y+ + L +L G + ++ + RGL Y CH R ++
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ-LLRGLNY----CHRRKVL 126
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEK 549
HRD+K N+L++ E +++DFGLA+ A T + + T Y P+ S + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
D++ G + E+ TGR PL S VE
Sbjct: 186 IDMWGVGCIFYEMSTGR-------PLFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-10
Identities = 14/83 (16%), Positives = 30/83 (36%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
P + + +++ AS+P + A P +PP + ++PP + + P
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 112 TRSPPPPSSTPPPNSPPSPPSDP 134
P ++ P + P
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 7e-10
Identities = 26/122 (21%), Positives = 40/122 (32%), Gaps = 1/122 (0%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
+ P + P ++ P +P P + PA + P+ + P P P+ P
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPA-PAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSP 444
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
+ P P PP ++ P P A P P P PA AP +
Sbjct: 445 AGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPA 504
Query: 223 PP 224
Sbjct: 505 GA 506
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 3/94 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
P+P P +++P P P + P + PP PV + T P P P +
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAA--AAANIPPKEPVRETATPPPVPPRPVA- 418
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
PP +P ++ T + P P +PP P
Sbjct: 419 PPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+GEG G V + G+ VA+K++ + Q EV I+ H ++V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK--------IAAGAARGLAYLHEDC 485
D ++ +++ EG + D T + + + L+ LH
Sbjct: 88 VGDELWVVMEFL-----------EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ- 135
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPEYASS 543
+IHRDIKS +ILL ++ ++SDFG + + R ++GT +MAPE S
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKSLVGTPYWMAPELISR 190
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ D++S G++++E++ G P PL
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQL------KIGGGQGEREFKAEVEIIS 418
T+ + D +G G FG V G+ VAIK++ + + RE K ++
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LLK 64
Query: 419 RIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYF---------HLHGEGRPVLDWATRVK 469
+ H +++SL IS P +YF H RP+ +
Sbjct: 65 HLRHENIISLSDIFIS-----------PLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY- 112
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
RGL Y+H ++HRD+K SNIL++ N + ++ DFGLA++ T
Sbjct: 113 FLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGY 165
Query: 530 MGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPV 569
+ T Y APE + K + D++S G + E++ G KP+
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 30/140 (21%), Positives = 47/140 (33%), Gaps = 14/140 (10%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
P + PA+ P P A++ + SP +S P +P +++ P
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQ----PSAAAAASPSPSQSSAAA---QPSAPQSATQPAG 422
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
+PP +PP P P ST P P+ P S S P S P +
Sbjct: 423 TPPTVSVDPPAAVPVNPPSTAPQAVRPAQF--KEEKKIPVSKVSSLGP-----STLRPIQ 475
Query: 162 SPPSVPPQNPPPPPSSSPPK 181
N P+ + +
Sbjct: 476 EKAEQATGNIKEAPTGTQKE 495
|
Length = 614 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 31/150 (20%), Positives = 51/150 (34%), Gaps = 5/150 (3%)
Query: 94 PASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP 153
P++S + R + P + PS + PA +P P+ P
Sbjct: 365 PSASDDERGLLARLERLERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAA----PAAA 420
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
++ P P+ P P PPS + + AP PP+ P P A
Sbjct: 421 AAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSP-PPAAAPSAQPAPAPAAAPEPTAA 479
Query: 214 PSNSSPNSPPPPSTKRLSPPPGIPVPSTEN 243
P+ + P +P P + P P + +
Sbjct: 480 PAPAPPAAPAPAAAPAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 2e-09
Identities = 16/98 (16%), Positives = 33/98 (33%), Gaps = 6/98 (6%)
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
P +++ PT + + + P + P +P P + PA P P+
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAA-----AAA 91
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
++ P + + P +P + A +A
Sbjct: 92 AAAAPAAPPAAAAAAAPAAAAVEDEVTPLR-GAAAAVA 128
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 27/120 (22%), Positives = 39/120 (32%), Gaps = 12/120 (10%)
Query: 46 SKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP 105
K S P P + P A+ P+++ + +P SS P A P
Sbjct: 364 QKGDDASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSA--------PQ 415
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP--SSVEPPKRSP 163
+ P PP S PP + P P + P+ P SS+ P P
Sbjct: 416 SATQPAGT--PPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRP 473
|
Length = 614 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANTHIT-TRVMGTF 533
R L Y+H + HRD+K NIL + + + ++ DFGLA++A D T I T + T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 534 GYMAPEYASS--GKLTEKSDVFSFGVVLLELITGR 566
Y APE S K T D++S G + E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 53/190 (27%), Positives = 80/190 (42%), Gaps = 27/190 (14%)
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFH----LHGEGRPVLDWATRVKIAAGAARGLA 479
++V L Y +S+D L+ + L+ H L+ V WA + +A L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
LH + I+ RD+ +NILLD+ Q++ F D+ M Y APE
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG---------DESLVEWARPLLSH 590
+ TE D +S G +L EL+TG+ V+ P G E + E AR LL
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWVSEEARSLLQQ 211
Query: 591 ALENEEFDNL 600
L+ + L
Sbjct: 212 LLQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 375 LGEGGFGSVYKGYLPDGR--EVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LG G FG V + VAIK+ + I Q + F +E +I++ I+H V+L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G + L+ ++V + L R D AA YL
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY--AAQIVLIFEYLQS---LN 151
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I++RD+K N+LLD + +++DFG AK+ +D T+ + GT Y+APE + +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAPEILLNVGHGK 207
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPL 575
+D ++ G+ + E++ G P A++PL
Sbjct: 208 AADWWTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-09
Identities = 48/174 (27%), Positives = 62/174 (35%), Gaps = 22/174 (12%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK-- 160
P PV P + P ++ P+ P DP A P P+ LP P P+
Sbjct: 2475 PGAPVYRRPAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRML 2534
Query: 161 ---RSPPSVPPQNPPPPPSSSPPKNSPPAP-IAVPPSNVPPPPTQ-----------TPPT 205
R + + PP PP P AP +VPP P P++ PP
Sbjct: 2535 TWIRGLEELASDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQ 2594
Query: 206 PASPIAPR-----PSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
A P AP P +P SP PP T PPP P P+ + P
Sbjct: 2595 SARPRAPVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPP 2648
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-09
Identities = 24/111 (21%), Positives = 42/111 (37%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+APS A ++ P + +P P + P +P P P P + P S
Sbjct: 397 AAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSP 456
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
PP ++ +P ++ P + P +PP +P ++ P P
Sbjct: 457 PPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGAD 507
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 22/95 (23%), Positives = 32/95 (33%), Gaps = 3/95 (3%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
P P PT++ P + P+ P + P + PP PP P + P
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPP 420
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
P L E PK +PP+ P +
Sbjct: 421 V---PHTPESAPKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 60.2 bits (145), Expect = 3e-09
Identities = 66/277 (23%), Positives = 105/277 (37%), Gaps = 18/277 (6%)
Query: 4 PSPGPPAANSSSPPPPVSNPPT-ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P+ G P +SS P ++P + + P + P + P + P T +P A++P
Sbjct: 469 PTSGTPTGTTSSTLPEDTSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSP 528
Query: 63 P---TSSSPPASSPPTS--SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
+ A+SPPT S P A++P + P ++P S P +++ T
Sbjct: 529 TPIVIGVTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHG 588
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP---PSSVEPPKRSPPSVPPQNPPPP 174
S+ P + P PS ++S P SN S P P+ E PSVP
Sbjct: 589 TGSS-PTSQQPGIPS--SSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVST 645
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
S P + S+ P + T P N + SP PS ++ + P
Sbjct: 646 LSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMP------NPNATSPSAPSGQKTAVPT 699
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTV 271
N+ T+ S+ +S+SP N T
Sbjct: 700 VTSTGGKANSTTKETSGSTLMASTSPHTNEGAFRTTP 736
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 56/209 (26%), Positives = 107/209 (51%), Gaps = 14/209 (6%)
Query: 375 LGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGY 431
LGEG + +V+KG L + VA+K++++ +G EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-II 490
+D L+++Y+ + L ++ G + ++ + RGLAY CH R ++
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ-ILRGLAY----CHRRKVL 126
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEK 549
HRD+K N+L++ E +++DFGLA+ A T + + T Y P+ S + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDE 578
D++ G + E+ +GR P+ + DE
Sbjct: 186 IDMWGVGCIFFEMASGR-PLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 4e-09
Identities = 26/106 (24%), Positives = 46/106 (43%), Gaps = 1/106 (0%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNP-PKSSPPPPPVSKPPTTSPPPSPPA 59
+A +P A +++ P + P + P P P P +PP P + P +P P P A
Sbjct: 401 AAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPPAA 460
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP 105
+ + PA++P ++ P + P +P +P A + P
Sbjct: 461 APSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGA 506
|
Length = 824 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 63/255 (24%), Positives = 84/255 (32%), Gaps = 38/255 (14%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKS-----------------SPPPPPVS 46
P AA+ P P P PP PP+ PP P+
Sbjct: 329 PPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPPTSPIP 388
Query: 47 KPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP--- 103
PP++SP +S + + PA SP ASN P P + P +SP
Sbjct: 389 TPPSSSP----ASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRP-LSPYAR 443
Query: 104 ----PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS------PPPSNPPSNLPPPPP 153
PP S PT S +S P+ P PA + PPP+N P
Sbjct: 444 YEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVY 503
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
++PP P+ P P ++ K AP Q P P SP
Sbjct: 504 DDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADE--QHHAQPKPRPLSPY-TM 560
Query: 214 PSNSSPNSPPPPSTK 228
+ P + P PS
Sbjct: 561 YEDLKPPTSPTPSPV 575
|
Length = 576 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 26/98 (26%), Positives = 32/98 (32%), Gaps = 3/98 (3%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P P P + PSP PA S P + PP E P P PP
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPV 421
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
P P+++P A P + P T P A
Sbjct: 422 PH---TPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKA 456
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 21/79 (26%), Positives = 34/79 (43%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ S AS+P +P P +PP + PS P + +P PP + P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 120 STPPPNSPPSPPSDPPANS 138
T P +PP+ ++ P +
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 406 GEREFKA-EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR-PVLD 463
G+R A E I+ I+H ++ L G + LI + LY +L + + D
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD-LYCYLAAKRNIAICD 183
Query: 464 WATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523
+ I R + YLHE+ RIIHRDIK+ NI +++ + + DFG A +D N
Sbjct: 184 I---LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237
Query: 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
+ GT APE + D++S G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 36/207 (17%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFK--------AEVEIISRI-HHRH 424
+GEG F V K G+ AIK +K + FK E++ + R+ H +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 425 LVSL--VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYL 481
++ L V + R L+++ + N LY + G RP+ + RVK + L ++
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMN-LYELIKGRKRPLPE--KRVKSYMYQLLKSLDHM 116
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH---ITTRVMGTFGYMAP 538
H I HRDIK NIL+ ++ +++DFG + + I+TR Y AP
Sbjct: 117 H---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAP 167
Query: 539 E-YASSGKLTEKSDVFSFGVVLLELIT 564
E + G K D+++ G V E+++
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 23/88 (26%), Positives = 29/88 (32%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S P P+ P S+ P PP S P S PP + PP PP
Sbjct: 191 SPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQ 250
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSP 89
P S+ + P S+ P T
Sbjct: 251 VPPLSTAKPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 55/254 (21%), Positives = 78/254 (30%), Gaps = 4/254 (1%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A +P + P P +P + P P P + + P+P
Sbjct: 62 ADAPLQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPY 121
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
S P P PP P SPP P +S P S
Sbjct: 122 YPPPSQPQPPPAQQPQAQQPQPPP-QVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLY 180
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE---PPKRSPPSVPPQNPPPPPSSSP 179
P SP P S PP P S P S + PP+ SP P
Sbjct: 181 PEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFPS 240
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
+ PP+ PPP++ + AP+ S+ S ++ P P +P+
Sbjct: 241 GQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAATVLPQALPMS 300
Query: 240 STENTPGNGTNPSS 253
S + G +P S
Sbjct: 301 SAPMSGGGSGSPQS 314
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 47/271 (17%), Positives = 66/271 (24%), Gaps = 37/271 (13%)
Query: 4 PSPGPPAANSSSPPPPVSNPPT---ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
P PGP P P P P + P + P P P P
Sbjct: 362 PVPGPQTGEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYY 421
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P + P + + + T P + P
Sbjct: 422 APAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQP---AAQEPLY 478
Query: 121 TPPPNSPPSPPSDPP--ANSPPPSNPP------------------SNLPPPPPSSVEPPK 160
P P +P P+ PP + P P V+ P+
Sbjct: 479 QQPQPVEQQPVVEPEPVVEETKPARPPLYYFEEVEEKRAREREQLAAWYQPIPEPVKEPE 538
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP----ASPIAPRPSN 216
S+ + P P V + + T P A+ PRP
Sbjct: 539 PIKSSLKAPSVAAVPPVEAAAAVSPLASGVKKATLATGAAATVAAPVFSLANSGGPRPQV 598
Query: 217 SSPNSPPPPSTKRLSPPP-------GIPVPS 240
P P KR+ P GI +PS
Sbjct: 599 KEGIGPQLPRPKRIRVPTRRELASYGIKLPS 629
|
Length = 1355 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 32/128 (25%), Positives = 46/128 (35%), Gaps = 19/128 (14%)
Query: 20 VSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPP--PSPPASNPPTSSSPPASSPPTSS 77
V N ++P P S K P P + +P P P P + P SP ++ P
Sbjct: 374 VRNDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQ 433
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPP--------------VSNPPTRSPPPPSSTPP 123
PP A + P PPSP AS+P ++ P N + P SS+
Sbjct: 434 PPVARSAPL---PPSPQASAPRNVASGKPGVDLGSWQGKFMNFTRNGSRKQPVQASSSDA 490
Query: 124 PNSPPSPP 131
+
Sbjct: 491 AQTGVFEG 498
|
Length = 620 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 24/90 (26%), Positives = 30/90 (33%), Gaps = 1/90 (1%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
P P P + SP P P TR ++ PP P + PP P P PP
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPP 420
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P + P P+ PP P
Sbjct: 421 VP-HTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 6e-09
Identities = 14/80 (17%), Positives = 30/80 (37%), Gaps = 3/80 (3%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
++P ++ A+ + P+ A + P +PP +PP P++
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAA---AAPAAPPKPAAAAAAA 93
Query: 126 SPPSPPSDPPANSPPPSNPP 145
+ P+ P A + P +
Sbjct: 94 AAPAAPPAAAAAAAPAAAAV 113
|
Length = 1228 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS---- 543
+HRDIK N+LLD N +++DFG T ++ +GT Y++PE +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 544 -GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590
GK + D +S GV + E++ G P A ESLVE +++H
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 28/93 (30%), Positives = 35/93 (37%), Gaps = 1/93 (1%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
PS P + SPP S+P S PP S+ +PPP P S + PP
Sbjct: 186 DPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPP 245
Query: 62 PPTSSSPPASSP-PTSSPPPASNPPTSSPPPSP 93
PP PP S+ PT A+ P
Sbjct: 246 PPVQQVPPLSTAKPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-09
Identities = 57/197 (28%), Positives = 74/197 (37%), Gaps = 23/197 (11%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPP---PVSKPPTTSPPPSP 57
M P P P +PP + P P P + PPPP P+S PT PP +
Sbjct: 343 MPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAH 402
Query: 58 PA---------SNPPTSSSPPASSPPTSSPPPASNPPTSSP---PPSPPASSPPTIS--- 102
P + PP + S PP AS P S PP P + P S
Sbjct: 403 PPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGL 462
Query: 103 ---PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
PPP T + PP +S+ + PS P P PP + P E P
Sbjct: 463 PAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEP 522
Query: 160 KRSPPSVPPQNPPPPPS 176
+ PP PP++P P P+
Sbjct: 523 ESPPP--PPRSPSPEPT 537
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-09
Identities = 50/238 (21%), Positives = 62/238 (26%), Gaps = 12/238 (5%)
Query: 4 PSPGPPAANSSS----PPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
P P P P P P P+ P S
Sbjct: 520 PPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAKEHKPSKIPTLSKKP 579
Query: 60 SNPPTSSSPPASSPPTSSPPPAS-NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP- 117
P P P P S PT P P SP P S + PPP
Sbjct: 580 EFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPESPKSPKRPPPP 639
Query: 118 --PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
PSS P P S P SP P P ++ +S +
Sbjct: 640 QRPSSPERPEGPKIIKSPKPPKSPKPPFDPKFKEKFYDDYLDAAAKSKETKTTVVLDESF 699
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
S + P P + P PP P P P P++ P + +PP
Sbjct: 700 ESILKETLPETPGTPFTTPRPLPPKL-PRDEEFPFEPI---GDPDAEQPDDIEFFTPP 753
|
Length = 943 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 52/240 (21%), Positives = 64/240 (26%), Gaps = 7/240 (2%)
Query: 32 VSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP 91
+S+ S T PP + + +P P PA P
Sbjct: 29 LSHEEAQSSEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQ 88
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
A P + P P PPS P PPA P P P
Sbjct: 89 QSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVP 148
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPK-----NSPPAPIAVPPSNVPPPPTQTPPTP 206
+ P + P QNPPP S+P P P N P P + P
Sbjct: 149 QQQQYQSPPQQP--QYQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPP 206
Query: 207 ASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIG 266
S P P P P P PS + P + S PS G
Sbjct: 207 YSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHG 266
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 12/100 (12%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-----HITTRVM 530
GL Y+H ++HRD+K N+L++ + E ++ DFGLA+ N +T V
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYV- 170
Query: 531 GTFGYMAPEYASSGKLTEKS-DVFSFGVVLLELITGRKPV 569
T Y APE S + K+ DV+S G +L EL+ GRKPV
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 23/79 (29%), Positives = 33/79 (41%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
PS S +S+P +P + PP + S+P A++P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 115 PPPPSSTPPPNSPPSPPSD 133
P PS TPP N+ +PPS
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 30/85 (35%), Positives = 35/85 (41%), Gaps = 3/85 (3%)
Query: 37 KSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
+S PP P PPA PP + PPT PPP P + + PA
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPP---PTATQASSNAPAQ 569
Query: 97 SPPTISPPPPVSNPPTRSPPPPSST 121
P SPPPP+ PT SP SS
Sbjct: 570 IPADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 24/81 (29%), Positives = 34/81 (41%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
S + A +PPP P P P +P +PP PP PP +S +
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 189 AVPPSNVPPPPTQTPPTPASP 209
+ PP +P PT +P +SP
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 24/79 (30%), Positives = 32/79 (40%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPP 80
S T PPP P P PP+ +P T+PPP+PP P + + + +
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 81 ASNPPTSSPPPSPPASSPP 99
P P PSP S P
Sbjct: 576 PPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-08
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
P ++ PT++ + A+S P +P P +PP P +PP P + A +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAA---AAPAAPPKPAAAAAAAA 94
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSP 163
P + P + P ++ + +P
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-08
Identities = 14/82 (17%), Positives = 30/82 (36%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
P S +++ A++ S+P A + P P ++ +PP P + + P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 118 PSSTPPPNSPPSPPSDPPANSP 139
+ P+ + +P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 23/103 (22%), Positives = 35/103 (33%), Gaps = 3/103 (2%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS-PPSPPSDPPANSPPPSNP 144
+S P P + P + P + S +P +S P + A P + P
Sbjct: 368 DASGGRGPKQHIKPVFTQP--AAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPP 425
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP 187
++ PP V PP +P +V P K S P
Sbjct: 426 TVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGP 468
|
Length = 614 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 30/128 (23%), Positives = 36/128 (28%), Gaps = 5/128 (3%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPP-ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
A SP PP AS P P A PP +P P P
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQP- 128
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P+ P P P P P P + P P + +P + P P
Sbjct: 129 -VQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSA--PQPAQQAFQPAEPVAAPQPEPVAEP 185
Query: 174 PPSSSPPK 181
P PK
Sbjct: 186 APVMDKPK 193
|
Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 57/210 (27%)
Query: 358 TYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKA---- 412
YE+L K +G+G FG V+K + + VA+K++ + E E +
Sbjct: 13 KYEKLAK----------IGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPIT 57
Query: 413 ---EVEIISRIHHRHLVSLVGYC------ISDDRR--LLIYDY--------VPNNTLYFH 453
E++I+ + H ++V+L+ C + + L++++ + N + F
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT 117
Query: 454 LHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513
L E + K+ GL Y+H + +I+HRD+K++NIL+ + +++DFG
Sbjct: 118 L-SEIK---------KVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164
Query: 514 LAKL----ALDANTHITTRVMGTFGYMAPE 539
LA+ T RV+ T Y PE
Sbjct: 165 LARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 68/263 (25%), Positives = 115/263 (43%), Gaps = 44/263 (16%)
Query: 374 LLGEGGFGSVYKGYLPDGRE-VAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
L+ G +G+VY + R+ A+K++ I Q ++ F E +I++ + +VS+
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66
Query: 429 VGYCISDDRRLL--IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
+C + +R L + +YV L G +D A R+ A L YLH +
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-RMYFAE-TVLALEYLH---N 119
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL--------------DANTHITTRVMGT 532
I+HRD+K N+L+ + +++DFGL+K+ L D + +V GT
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP---------------VDASQPLGD 577
Y+APE + D ++ G++L E + G P D P GD
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239
Query: 578 ESLVEWARPLLSHALENEEFDNL 600
E+L A+ L+S L + L
Sbjct: 240 EALPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+GL Y+H IIHRD+K N+ ++ + E ++ DFGLA+ ++ +T V+ T Y
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWY 181
Query: 536 MAPEYASSG-KLTEKSDVFSFGVVLLELITGR 566
APE + T+ D++S G ++ E++TG+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 17/121 (14%), Positives = 36/121 (29%)
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
P+ P + P+ + P+ P + + A P PP
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 201 QTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
P A+P A + + + P + +P P + +P ++ +
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAA 485
Query: 261 S 261
+
Sbjct: 486 A 486
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 28/146 (19%), Positives = 47/146 (32%), Gaps = 14/146 (9%)
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
P + A +P P+ P++ + + P P +++ P AP A
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPA---AAPAAAASA---PAAPPA 419
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP----PGIPVPSTENTP 245
P P P A AP +P P + + ++ P P V S P
Sbjct: 420 AAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAP 479
Query: 246 GNGTNPSSPESSSSPSNNGIGTAGTV 271
+ + +P+ G TV
Sbjct: 480 A----AAPAAARLTPTEEGDVWHATV 501
|
Length = 618 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 20/81 (24%), Positives = 30/81 (37%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
++S P + PP P P + P TPPP P + + A + P++
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 145 PSNLPPPPPSSVEPPKRSPPS 165
P P + P K S P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 20/85 (23%), Positives = 31/85 (36%)
Query: 46 SKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP 105
S+ + S P + P + P A P PPP+ +S + P
Sbjct: 512 SQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSP 130
S+PP P P+ +P +S P
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-08
Identities = 18/82 (21%), Positives = 31/82 (37%), Gaps = 1/82 (1%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP-PSPPASSPPT 100
P + P + + AS P + + A + P +PP A+ P P + A++ P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 101 ISPPPPVSNPPTRSPPPPSSTP 122
P + P + TP
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-08
Identities = 17/78 (21%), Positives = 34/78 (43%)
Query: 47 KPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPP 106
P +T+ P + A+ +S+P A+ + PA PP ++ P +PP + + P
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 107 VSNPPTRSPPPPSSTPPP 124
+ P + P++
Sbjct: 97 AAPPAAAAAAAPAAAAVE 114
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-08
Identities = 19/77 (24%), Positives = 35/77 (45%)
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
P S+ ++ A+ S+P +P A +P +P PP + P P P ++ +P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 129 SPPSDPPANSPPPSNPP 145
+PP+ A +P +
Sbjct: 98 APPAAAAAAAPAAAAVE 114
|
Length = 1228 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 38/174 (21%), Positives = 53/174 (30%), Gaps = 8/174 (4%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP--PPSPPASSP-PTISPPPPVSNP 110
P P PP +S + PT + P P T P P+P + P N
Sbjct: 336 PVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPVIAPAPEGYPQQSQYAQPAVQYNE 395
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
P + P P + P P P P+ P P+ +P + Q
Sbjct: 396 PLQQPVQPQQPYYAPAAEQPAQQP--YYAPAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQ 453
Query: 171 PP-PPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
P S+ + + P A P P P P P + P PP
Sbjct: 454 STFAPQSTYQTEQTYQQPAAQEPLYQQPQP--VEQQPVVEPEPVVEETKPARPP 505
|
Length = 1355 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 390 DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV-GYCISDDRRLLIYDYVPNN 448
++V +K + GG RE ++I+ I HR +++L+ Y +++ Y
Sbjct: 118 QRKKVIVKAV-TGGKTPGRE----IDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KC 170
Query: 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508
L+ ++ G L+ + I LAYLH IIHRD+K+ NI LD A
Sbjct: 171 DLFTYVDRSGPLPLE--QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAV 225
Query: 509 VSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK 567
+ DFG A KL +T GT +PE + K+D++S G+VL E+
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
Query: 568 PVDASQPLGDES-LVEWARPLLSHALE 593
+ Q S L R + H LE
Sbjct: 286 TLFGKQVKSSSSQLRSIIRCMQVHPLE 312
|
Length = 392 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-08
Identities = 45/212 (21%), Positives = 66/212 (31%), Gaps = 19/212 (8%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
+PP + P + + PPP P A++P + PP + P + PP+
Sbjct: 256 APPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPDP 315
Query: 127 PPSPPSDPPANSP----------PPSNPPSNLPPPPPSSVEPPKRSPPSV--------PP 168
PP P+ P P + P P P P S+ P
Sbjct: 316 PPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSAGRHHP 375
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
+ P P A P P PAS P P+ ++PPPP+T
Sbjct: 376 KRASLPTRKRRSARHAATPFARGPGG-DDQTRPAAPVPASVPTPAPTPVPASAPPPPATP 434
Query: 229 RLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
S PG P++ + P
Sbjct: 435 LPSAEPGSDDGPAPPPERQPPAPATEPAPDDP 466
|
Length = 3151 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 48/192 (25%), Positives = 69/192 (35%), Gaps = 19/192 (9%)
Query: 2 SAPSPGPPAANSSSPPP--PVSNPPTISPPP---PVSNPPKSSPPPPPVSKPPTTSP--- 53
++P P PP+++ +S V+ P P SN P+ P K SP
Sbjct: 384 TSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYAR 443
Query: 54 -----PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS---PPPSPPASSPPTISPPP 105
PP+ P+ PT SP SS + P + P T++ P P P +
Sbjct: 444 YEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVY 503
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS--NLPPPPPSSVEPPKRSP 163
PPT SP P + + NS PP+ + P P + P
Sbjct: 504 DDLKPPT-SPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHAQPKPRPLSPYTMYE 562
Query: 164 PSVPPQNPPPPP 175
PP +P P P
Sbjct: 563 DLKPPTSPTPSP 574
|
Length = 576 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 22/88 (25%), Positives = 29/88 (32%), Gaps = 8/88 (9%)
Query: 149 PPPPPSSVEPPKRSP--PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P P P+ SP P+ P P +++ P P VPP P P
Sbjct: 364 PAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPVPH 423
Query: 207 ASPIAPR------PSNSSPNSPPPPSTK 228
AP+ P + P PP K
Sbjct: 424 TPESAPKLTRAAIPVDEKPKYTPPAPPK 451
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-08
Identities = 29/85 (34%), Positives = 37/85 (43%), Gaps = 4/85 (4%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
S ASN + PP SPP PPA PP P + P +PP P ++ +
Sbjct: 514 SGSASNTAKTPPPPQKSPP----PPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQ 569
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPP 140
P S+PPP P P P +S P
Sbjct: 570 IPADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 26/77 (33%), Positives = 35/77 (45%)
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
+ S + PP SPP P PP P + PP PPPPP++ + +P +P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 171 PPPPPSSSPPKNSPPAP 187
PPPP P SP
Sbjct: 575 SPPPPIPEEPTPSPTKD 591
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 21/81 (25%), Positives = 32/81 (39%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
+ S+ + P P + P P P A++PP PPPP + S P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 124 PNSPPSPPSDPPANSPPPSNP 144
+ PP P +P + S+P
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-08
Identities = 13/82 (15%), Positives = 30/82 (36%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P + P + + ++ P P +PP + + PP ++ A++ +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 77 SPPPASNPPTSSPPPSPPASSP 98
+PP A+ + +P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 3e-08
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 2/91 (2%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
PG AA +++ + + P P +P PP +PP A+
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPA--AAAPAAPPKPAAAAAAAA 94
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
+ + P ++ ++P A+ +P A
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTPLRGAAA 125
|
Length = 1228 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 31/232 (13%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGERE---FKAEVEIISRIHHRHLVSLV 429
++G G FG V L + +V A+K L E F+ E +++ ++ + +L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL- 66
Query: 430 GYCISDDRRL-LIYDY-VPNNTLYFHLHGEGRPVLDWA----TRVKIAAGAARGLAYLHE 483
Y D+ L L+ DY V + L E R D A + IA + L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
+HRDIK NIL+D N +++DFG ++ T ++ +GT Y++PE +
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 544 -----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590
GK + D +S GV + E++ G P A ESLVE +++H
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 375 LGEGGFGSVYKG--YLPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIH---HRHLVS 427
+GEG +G V+K GR VA+K++++ G+ EV ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 428 LVGYCI-----SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
L C + + L++++V + L +L P + T + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
R++HRD+K NIL+ ++ + +++DFGLA++ + T V+ T Y APE
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLL 182
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPV 569
D++S G + E+ RKP+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 31/139 (22%), Positives = 44/139 (31%), Gaps = 9/139 (6%)
Query: 2 SAPSPGP-PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
AP+ P AA ++ P + P P ++P P PP PP +
Sbjct: 452 PAPAAAPAAAARPAAAGPR--PVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASP 509
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P + PA S P PA+ P + P +P P + P
Sbjct: 510 APAQPDAAPAGWVAESIPDPATADP---DDAFETLAPAPAAAPAPRAAAATEPVVAP--- 563
Query: 121 TPPPNSPPSPPSDPPANSP 139
PP S P + P
Sbjct: 564 RPPRASASGLPDMFDGDWP 582
|
Length = 700 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 29/101 (28%), Positives = 39/101 (38%), Gaps = 5/101 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNP--PKSSPPPPPVSKPPTTSPPPSPPA 59
++ SP P ++S P S P S P S P P S P P + + P PP
Sbjct: 180 ASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPG 239
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P P PP S+ P PP++S P+P
Sbjct: 240 PAAP-PPPPVQQVPPLSTAKPT--PPSASATPAPIGGITLD 277
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 4e-08
Identities = 15/83 (18%), Positives = 29/83 (34%), Gaps = 2/83 (2%)
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
P S+ P + ++ S PA++P +P P P + P++ P P + + +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPA--PAPPAAAAPAAPPKPAAAAAAAAA 95
Query: 134 PPANSPPPSNPPSNLPPPPPSSV 156
P A +
Sbjct: 96 PAAPPAAAAAAAPAAAAVEDEVT 118
|
Length = 1228 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 26/129 (20%), Positives = 35/129 (27%), Gaps = 8/129 (6%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP--PVSNPPTRSPPPPSSTPP 123
A + +P PP A + PP V P P+ P
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPV 129
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
P + P P P P P P + + P P P P +
Sbjct: 130 QQPAYQPQPEQP---LQQPVSPQVAPAPQPVHSAPQP-AQQAFQPAEPVAAPQPEPV--A 183
Query: 184 PPAPIAVPP 192
PAP+ P
Sbjct: 184 EPAPVMDKP 192
|
Length = 333 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 5e-08
Identities = 23/81 (28%), Positives = 32/81 (39%), Gaps = 2/81 (2%)
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
S+ T+ PP P P+PP P +PPP PP +S+ P P+
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPP--TATQASSNAPAQIPAD 573
Query: 131 PSDPPANSPPPSNPPSNLPPP 151
S PP P+ P+ P
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 5e-08
Identities = 15/82 (18%), Positives = 29/82 (35%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P + P ++ + P +P PA+ P + A + P A+ +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 89 PPPSPPASSPPTISPPPPVSNP 110
PP+ A++ P + P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 32/122 (26%), Positives = 41/122 (33%), Gaps = 7/122 (5%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
S P + P P+ P P ++ P S S Q P P S++ P +PP
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQ-PSAPQSATQPAGTPPTVS 428
Query: 189 AVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG 248
PP+ VP P T P RP+ P S S P P E
Sbjct: 429 VDPPAAVPVNPPSTAPQAV-----RPAQFKEEKKIPVSKVS-SLGPSTLRPIQEKAEQAT 482
Query: 249 TN 250
N
Sbjct: 483 GN 484
|
Length = 614 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-08
Identities = 52/207 (25%), Positives = 73/207 (35%), Gaps = 36/207 (17%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKS----------SPPPPPVSKPPTT 51
+AP G A + P + PP PP P + + SP P P P
Sbjct: 291 AAPPDGVWGAALAGAPLALPAPPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLG 350
Query: 52 SPPPSPPASNPPTS--------SSPPASSPPTS---SPPPASNP--------PTSSPPPS 92
P P PP+S P +S PT S A+ P + P
Sbjct: 351 FPKRRRPTWTPPSSLEDLSAGRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAP 410
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
PAS P P P S PP + P PS+ P + P+PP P P P P
Sbjct: 411 VPASVPTPAPTPVPASAPPPPATPLPSAEPGSDDGPAPP-------PERQPPAPATEPAP 463
Query: 153 PSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+ +++ ++ + PP PP +
Sbjct: 464 DDPDDATRKALDALRERRPPEPPGADL 490
|
Length = 3151 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 6e-08
Identities = 26/81 (32%), Positives = 31/81 (38%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
S+S PP SPPPP PP P P PP + AS+ + P SS
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 73 PPTSSPPPASNPPTSSPPPSP 93
PP P + PT P
Sbjct: 576 PPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 6e-08
Identities = 11/81 (13%), Positives = 26/81 (32%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
++P + S P + PA+ P + +P + + PP ++
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 95 ASSPPTISPPPPVSNPPTRSP 115
+ + P + +P
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 24/109 (22%), Positives = 34/109 (31%), Gaps = 4/109 (3%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
PV P +P P + SP + P+ + PA PPT S
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
P ++ P P S P + P +S + P T P
Sbjct: 429 VDPPAAVPV---NPPSTAPQAVRPAQFKEEKKIPVSKVSSLG-PSTLRP 473
|
Length = 614 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFG 534
RGL Y+H IIHRD+K SN+ ++ + E ++ DFGLA+ D T ++ TR
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 535 YMAPEYASSG-KLTEKSDVFSFGVVLLELITGR 566
Y APE + + D++S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 7e-08
Identities = 19/137 (13%), Positives = 34/137 (24%), Gaps = 6/137 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSS---PPPPPVSKPPTTSPPPSPP 58
+A A + PP P S T S P
Sbjct: 384 TAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEP 443
Query: 59 ASNP---PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
A+ P +S+ + +P P A++P + P + +
Sbjct: 444 AAASRARPVNSALERLASVRPAPSALEKAPAKKEAYRWKATNPVEVKKEPVATPKALKKA 503
Query: 116 PPPSSTPPPNSPPSPPS 132
TP + + +
Sbjct: 504 LEHEKTPELAAKLAAEA 520
|
Length = 647 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 23/80 (28%), Positives = 29/80 (36%)
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA 207
LP S + P NP PPP+ P A PS P + P PA
Sbjct: 360 LPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 208 SPIAPRPSNSSPNSPPPPST 227
P P P+ + + PPS
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 26/83 (31%), Positives = 32/83 (38%), Gaps = 2/83 (2%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
S+ A PP P PPA +PP P P PPP ++ N+P P+D
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 136 ANSPPPSNPPSNLPPPPPSSVEP 158
PPP P SS E
Sbjct: 576 --PPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 374 LLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFKA----EVEIISRIHHRHLVSL 428
++GEG +G V K + +E VAIK+ K + E K E++++ + ++V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 429 VGYCISDDRRLLIYDYVPNNTL-YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
+ L+++YV N L G P K+ + + + +H CH
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP------PEKVRSYIYQLIKAIHW-CHK 118
Query: 488 R-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
I+HRDIK N+L+ +N ++ DFG A+ + + T + T Y +PE
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 547 TEKSDVFSFGVVLLELITGR 566
+ D++S G +L EL G+
Sbjct: 179 GKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 373 NLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGE----REFKAEVEIISRIHHRHLVS 427
N +G G G+VYK + P GR A LK+ G E R+ E+EI+ ++H ++V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYA---LKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
+ ++ +++ +L EG + D +A G+AYLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSL------EGTHIADEQFLADVARQILSGIAYLHRR--- 187
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS---- 543
I+HRDIK SN+L+++ +++DFG++++ L +GT YM+PE ++
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 544 GKLTEKS-DVFSFGVVLLELITGRKP 568
G + D++S GV +LE GR P
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 8e-08
Identities = 25/81 (30%), Positives = 34/81 (41%), Gaps = 2/81 (2%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
+ S + P PP + P + P + PPT PPPP++T S +P P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQA--SSNAPAQIP 571
Query: 135 PANSPPPSNPPSNLPPPPPSS 155
+SPPP P P P S
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDS 592
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 45/223 (20%), Positives = 57/223 (25%), Gaps = 54/223 (24%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
PS S S P + P SPPP P + P S P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 151 PPPSSVEPPKRSPPSVPPQNPPP----------PPS-----SSPPK----NSPPAPIAVP 191
P S PP + + P N PS S + +S A IAV
Sbjct: 421 PTEPSPTPPANAANAPPSLNLEELWQQILAKLELPSTRMLLSQQAELVSLDSNRAVIAVS 480
Query: 192 P-------------------------------SNVPPPPTQTPPTPASPIAPRPSNSSPN 220
P + T P P
Sbjct: 481 PNWLGMVQSRKPLLEQAFAKVLGRSIKLNLESQSGSASNTAKTPPPPQK----SPPPPAP 536
Query: 221 SPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNN 263
+PP P +PPP P P T + P+ + SSP
Sbjct: 537 TPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPPPP 579
|
Length = 620 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 53/261 (20%), Positives = 78/261 (29%), Gaps = 11/261 (4%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
A +S + V + P V+ + P V+ + PP+P +P
Sbjct: 34 AQSSEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVN----AALPPAPAPQSPQPDQQQQ 89
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ +PP+ P P P P PPP PP P P PP
Sbjct: 90 SQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQA---QQPQPPPQ 146
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
P SPP PPP S + P+ P P S PP P+ +A
Sbjct: 147 VPQQQQYQSPPQQPQYQQNPPPQAQSAPQV----SGLYPEESPYQPQSYPPNEPLPSSMA 202
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
+ P PP+Q P P + + PP + P
Sbjct: 203 MQPPYSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSK 262
Query: 250 NPSSPESSSSPSNNGIGTAGT 270
+S +P + +
Sbjct: 263 GNHGSVASYAPQGSSQSYSTA 283
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 31/126 (24%), Positives = 41/126 (32%), Gaps = 4/126 (3%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
P + + PSP P +S P PP A PP +P P+ PA P
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASA-QPRQPVQQPPEAQVPPQHAPRPAQPAPQP 128
Query: 99 PTISPPPPVSNPPTRSPPPPSSTPPPN--SPPSPPSDPPANSPPPSNPPSNLPPPPPS-S 155
P P + P P P P P+ P P P P+
Sbjct: 129 VQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPV 188
Query: 156 VEPPKR 161
++ PKR
Sbjct: 189 MDKPKR 194
|
Length = 333 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 8e-08
Identities = 42/135 (31%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 11 ANSSSPPPPVSNPPTISPP---PPVSNPPKSSPP--PPPVSKPPTTSPPPS-PPASNPPT 64
+N+ P SNP + P P +NPP S+ P PP S PP ++ P S P SN P
Sbjct: 410 SNAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTPYSNAPL 469
Query: 65 SSSPPASSPPTSSP-----------PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
S++PP+S+ S PA+N PT++ P + S P ++ P
Sbjct: 470 SNAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHGAAGNSVGNPFASRPFG 529
Query: 114 SPP---PPSSTPPPN 125
S P ++T PN
Sbjct: 530 SAPYGGNAATTADPN 544
|
Length = 1560 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF 533
ARG+ +L + IHRD+ + NILL N ++ DFGLA+ + D +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T +SDV+SFGV+L E+ +
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 65/242 (26%), Positives = 103/242 (42%), Gaps = 33/242 (13%)
Query: 363 VKATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQLKIGGGQGERE---FKAEVEIIS 418
+KA D F ++G G FG V ++V A+K L + F E +I++
Sbjct: 40 MKAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 419 RIHHRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWA----TRVKIAAG 473
+ +V L Y DD+ L ++ +Y+P L + P WA V +A
Sbjct: 99 HANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLALD 156
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGT 532
A + + IHRD+K N+LLD + +++DFG K+ + T V GT
Sbjct: 157 AIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 533 FGYMAPEYASS----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588
Y++PE S G + D +S GV L E++ G P +SLV ++
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG------DTPFYADSLVGTYSKIM 260
Query: 589 SH 590
H
Sbjct: 261 DH 262
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 32/148 (21%), Positives = 44/148 (29%), Gaps = 11/148 (7%)
Query: 12 NSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPAS 71
S PPPV+ P P P P ++ P + +P SP A+ P T + P
Sbjct: 51 PSPQAPPPVAQLPQ---PLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGP 107
Query: 72 SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
+ PT P P P T +P + P + P+
Sbjct: 108 AGPTIQTEPGQLYPVQVPVMV-------TQNPANSPLDQPAQQRALQQLQQRYG-APASG 159
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPP 159
P N S L P P
Sbjct: 160 QLPSQQQSAQKNDESQLQQQPNGETPPQ 187
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 34/130 (26%), Positives = 43/130 (33%), Gaps = 19/130 (14%)
Query: 149 PPPPPSSVEPPKR--------------SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P P P E + +P PPSSSP S P+P P S
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 195 VPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
P + S P S N PPP PPP VP P+ P
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAK-----PTPP 262
Query: 255 ESSSSPSNNG 264
+S++P+ G
Sbjct: 263 SASATPAPIG 272
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 26/81 (32%), Positives = 34/81 (41%)
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
+ S PP PPP + PP P + P PPPP + + S AP +P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 195 VPPPPTQTPPTPASPIAPRPS 215
PPPP PTP+ P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 33/157 (21%), Positives = 47/157 (29%), Gaps = 11/157 (7%)
Query: 24 PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN 83
P+ PPPV+ P+ P PPP + P + + SP A+ P T + P
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPP--TQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPA 108
Query: 84 PPTSSPPPSP--PASSPP--TISPPPPVSNPPTRSPPPPSSTPP---PNSPPSPPSDPPA 136
PT P P P T +P + P + P S P A
Sbjct: 109 GPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSA 168
Query: 137 NSPPPSNPPS--NLPPPPPSSVEPPKRSPPSVPPQNP 171
S N PP + ++
Sbjct: 169 QKNDESQLQQQPNGETPPQQTDGAGDDESEALVRLRE 205
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-08
Identities = 49/286 (17%), Positives = 78/286 (27%), Gaps = 23/286 (8%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPP---PPVSKPPTTSPPPSPPASN 61
+ G A +P V++ +I+ P P K + PPS +
Sbjct: 418 NSGILAWGLKTPGLAVNDERSIAVSSDGITDVLDPPSPLRLHSSDKVIDSVSPPSKRRVS 477
Query: 62 PPTSSSPPASSPPTSSPPPASNPP-----------TSSPPPSPPASSPPTISPPPPVSNP 110
P S A P ++ P +S TSS S + +P
Sbjct: 478 APASRLDDAKRPEVTATPESSGSDSEGGASGREDETSSDAESVVSIKELRPRIGFINKSP 537
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
P +SPP T + PS + P PS
Sbjct: 538 PPKSPPKSRRTLIVALSLASPSTAGSPRPKPSLGKF--VIGTDPFAFANTVRLTDNMRGG 595
Query: 171 PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP---PPPST 227
S P ++ P+ P S++ P T TP+S + N+ +S P
Sbjct: 596 NGVGSSVKPKGSASSKPLTGPGSDL-KPATLNGKTPSSSLVGAARNAGASSKVKIPSGLG 654
Query: 228 KRLSPPPG---IPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGT 270
SP + + P + G +
Sbjct: 655 GFTSPISLLESALEDVLTSATSTPVKKNDPYLWDTNGEKAGGGTES 700
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 13/109 (11%)
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV-MGTFGYMAPEYASS--- 543
+HRDIK N+LLD N +++DFG + L L A+ + + V +GT Y++PE +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 544 --GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590
G+ + D +S GV + E++ G P A ESLVE +++H
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 37/187 (19%), Positives = 52/187 (27%), Gaps = 5/187 (2%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP 89
P P K + + S P + P + A++ S
Sbjct: 760 NPSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKR 819
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
+ S P PPP S+ S P+ P P
Sbjct: 820 KSRSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEP 879
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN-----VPPPPTQTPP 204
P + PPK + + P P P P +P P P P VPP TP
Sbjct: 880 RARPGAAAPPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGGPDPRGGFRRVPPGDLHTPA 939
Query: 205 TPASPIA 211
A+ +A
Sbjct: 940 PSAAALA 946
|
Length = 1352 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 48/182 (26%), Positives = 65/182 (35%), Gaps = 18/182 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNP--------PTISPPPPVSNPPKSSPPPPPVSKPPTTS 52
+ PSP P S+ PPPP P P + PPP+ P+S P ++PP +
Sbjct: 368 LQGPSPFP-QMPSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLT 426
Query: 53 PPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
S P S S PP S P PP S P + PP ++ +
Sbjct: 427 QSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGS 486
Query: 113 RSPPPPSSTPPPNSPPSPPSDP---------PANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
+ P + + P PP P A P PP P P P+ V P +
Sbjct: 487 QPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHAS 546
Query: 164 PS 165
S
Sbjct: 547 QS 548
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-07
Identities = 20/78 (25%), Positives = 29/78 (37%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
S S A+ ++ PA +P P + P + + P+ P SPP PV P
Sbjct: 362 SAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEP 421
Query: 112 TRSPPPPSSTPPPNSPPS 129
T P P + P
Sbjct: 422 TEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-07
Identities = 22/80 (27%), Positives = 29/80 (36%), Gaps = 1/80 (1%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
S + S+P PA +P P S P T + +PPP P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKT-KQAATTPSPPPAKASPPIPVPA 419
Query: 136 ANSPPPSNPPSNLPPPPPSS 155
+ P PP+N PPS
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 24/81 (29%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
+ + PPP P PP+ P P + P PPPPP P S P P
Sbjct: 517 ASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPP----PTATQASSNAPAQIPA 572
Query: 174 PPSSSPPKNSPPAPIAVPPSN 194
S PP P P S+
Sbjct: 573 DSSPPPPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 23/80 (28%), Positives = 33/80 (41%), Gaps = 1/80 (1%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP 68
P+A S + +P P S PP P P +K T+P P P ++PP
Sbjct: 361 PSAFISEIANASAPANP-TPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 69 PASSPPTSSPPPASNPPTSS 88
+ P + P A+N P S
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 17/82 (20%), Positives = 26/82 (31%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
++S+ + PP PP P P P+ A P PPP + + +P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 123 PPNSPPSPPSDPPANSPPPSNP 144
P P P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 1e-07
Identities = 13/90 (14%), Positives = 26/90 (28%), Gaps = 2/90 (2%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
P + ++ S P +P A P ++ ++PP + A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAA--AAA 94
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
+ P A++ + P R
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTPLRGAA 124
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-07
Identities = 13/82 (15%), Positives = 26/82 (31%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P + PT + + + P + PP+ A P + A++ +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 78 PPPASNPPTSSPPPSPPASSPP 99
PPA+ + + P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 21/101 (20%), Positives = 33/101 (32%), Gaps = 2/101 (1%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
GP P + P + +P +SS P + T P +PP +
Sbjct: 371 GGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVD 430
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
++ P P S+ P A P P S ++ P
Sbjct: 431 PPAAVPV--NPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPS 469
|
Length = 614 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 29/164 (17%), Positives = 38/164 (23%), Gaps = 22/164 (13%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPP----TSSPPPASNPPTSSPPPSPPAS 96
P P P P P P + PA + P A+ P T + P P
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPA-- 108
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP--SDPPANSPPPSNPPSNLPPPPPS 154
PTI P P P + P NSP P P++
Sbjct: 109 -GPTIQTEPGQLYPVQV--PVMVTQNPANSPLDQPAQQRALQQLQQRYGAPAS------- 158
Query: 155 SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
+ Q P P +
Sbjct: 159 ----GQLPSQQQSAQKNDESQLQQQPNGETPPQQTDGAGDDESE 198
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 45/242 (18%), Positives = 73/242 (30%), Gaps = 21/242 (8%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP----ASNPPTS 65
+ SS P S+P + P + P S+ V P + S + PT
Sbjct: 388 SNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTL 447
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS---PPPPVSNPPTRSPPPPSSTP 122
+S P P S +SP S PP + N P + + +
Sbjct: 448 ASIPDEKPSNISVF---EDSETSPNSSTLLRDPPPKKCGEESGHLPNNPFFNKLKLTLSS 504
Query: 123 -PPNSPPSPP-SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
PP SP + P + P +L S P++ + S +
Sbjct: 505 IPPLSPRQSIITLPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLSFNRS 564
Query: 181 KNSPPAP----IAVPPSNVPPPPTQTPPTPASPIA---PRPSNSSPNSPPPPSTKR--LS 231
+ + P+ +P P + T +S + P P+ P L
Sbjct: 565 VSDIEGERIGRYNLLPTRIPALPFKAESTTSSRRSSSLPSPTGVIGFPGSVPRFDHENLL 624
Query: 232 PP 233
PP
Sbjct: 625 PP 626
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 29/82 (35%), Positives = 51/82 (62%), Gaps = 1/82 (1%)
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA-NTHITTRVMGTFGYMAPEYASSGKL 546
+++HRD+KS+NI L ++ DFG +K D+ + + + GT Y+APE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 547 TEKSDVFSFGVVLLELITGRKP 568
++K+D++S GV+L EL+T +P
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 27/171 (15%), Positives = 51/171 (29%), Gaps = 8/171 (4%)
Query: 95 ASSPPTISPPPPVSNP-PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP 153
A+ T+ PP S S P + +P N S
Sbjct: 450 ANKTSTVMEPPYGSTESSVPSTPSTRRNDRNITSNTPSLKRTPNLTKSSLSQEASLISK- 508
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP--PSNVPPPPT---QTPPTPAS 208
S+ K S P P P +S K + A S++ P + ++P
Sbjct: 509 STGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSPGSINSKSPEHSVP 568
Query: 209 PIAPRPSNSSPNSPPP-PSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSS 258
+ + ++ ST + + + +P + ++P +S
Sbjct: 569 LVRVFDIHLRASTTKGRHSTPSTNEKKKRLLKRSPLSPPKESVATTPRLNS 619
|
Length = 619 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 375 LGEGGFGSVYKGY---LPDGR-----EVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
LG+G F ++KG + D EV +K L F ++S++ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV-LDWATRVKIAAGAARGLAYLHEDC 485
G C+ D +++ +YV +L +L + + W ++++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK- 119
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR----VMGTFGYMAPEYA 541
+ H ++ + N+LL + + + KL+ D IT ++ ++ PE
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLS-DPGISITVLPKEILLERIPWVPPECI 176
Query: 542 SSGK-LTEKSDVFSFGVVLLELITG-RKPVDASQP 574
+ + L+ +D +SFG L E+ +G KP+ A
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 59/267 (22%), Positives = 90/267 (33%), Gaps = 44/267 (16%)
Query: 34 NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN--------PP 85
P +++PP P +++P P+ +S +SSS SS + S +S+ P
Sbjct: 377 PPSRNTPPSAP-----SSNPEPAASSSGSSSSSSGSESSSGSDSESESSSSDSEENEPPR 431
Query: 86 TSSPPPSPPAS------------SPPTISPPPPVSNPP---------------TRSPPPP 118
T+SP P PP++ +P +SP VS+ P P
Sbjct: 432 TASPEPEPPSTNKWQLDNWLNKVNPHKVSPAESVSSNPPIKQPMEKEGKVKSSGSQYHPE 491
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-- 176
S PPP S P P + P S P +R+ P+ P +
Sbjct: 492 SKEPPPKSSSKEKRRPRTAQKGPESGRGKQKSPAQSEAPPQRRTVGKKQPKKPEKASAGD 551
Query: 177 --SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+ S P + S PP T S + PP ++ P
Sbjct: 552 ERTGLRPESEPGTLPYGSSVQTPPDRPKAATKGSRKPSPRKEPKSSVPPAAEKRKYKSPS 611
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPS 261
I S E + ++ SPE S P
Sbjct: 612 KIVPKSREFIETDSSSSDSPEDESLPP 638
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 33/218 (15%), Positives = 45/218 (20%), Gaps = 7/218 (3%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
S GP A + P + K P +P P PP
Sbjct: 85 SKGPAAKTKPAKEPKNESGKEEEKEKEQVKEEKKKKKEKPKEEPKDRKPKEEAKEKRPPK 144
Query: 65 SSSPPASSPPTSSPPPASNPPTS-SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
P PP PP PP ++
Sbjct: 145 EK-EKEKEKKVEEPRDREEEKKRERVRAKSRPKKPPKKKPPNKKKEPPEEEKQRQAAREA 203
Query: 124 PNSPPSPPSDPP-----ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
P P + ++ S S + P P PS +
Sbjct: 204 VKGKPEEPDVNEEREKEEDDGKDRETTTSPMEEDESRQSSEISRRSSSSLKKPDPSPSMA 263
Query: 179 PPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P+ + P P A P PR
Sbjct: 264 SPETRESSKRTETRPRTSLRPPSARPASARPAPPRVKR 301
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 4/104 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISP----PPPVSNPPKSSPPPPPVSKPPTTSPPPSP 57
+ A +++P P + P +P PP + P S P+P
Sbjct: 409 APAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAP 468
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
+ P ++ PA +PP + P A+ ++P A T+
Sbjct: 469 APAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADDAATL 512
|
Length = 824 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 28/95 (29%), Positives = 34/95 (35%), Gaps = 9/95 (9%)
Query: 66 SSPPASSPPTSSPPPASNPP-TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
S S +S P P SPPP+P S P +PP PP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 125 NSPPSP-PSDPPANSPPPSNPP-------SNLPPP 151
+ PSP P AN+PP N + L P
Sbjct: 421 PTEPSPTPPANAANAPPSLNLEELWQQILAKLELP 455
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 27/82 (32%), Positives = 39/82 (47%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
G + + +PPPP +PP +P PP+ P ++PPP P PPT + S + P S
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 67 SPPASSPPTSSPPPASNPPTSS 88
SPP P +P P +
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 24/77 (31%), Positives = 30/77 (38%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
SN K+ PPP PP +PP P + P + PP T + A + P
Sbjct: 518 SNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPP 577
Query: 93 PPASSPPTISPPPPVSN 109
PP PT SP S
Sbjct: 578 PPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 16/77 (20%), Positives = 22/77 (28%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
S + T P P P S+P T+ PP + P P+ P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 96 SSPPTISPPPPVSNPPT 112
PT + P
Sbjct: 423 EPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 46/222 (20%), Positives = 83/222 (37%), Gaps = 17/222 (7%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P T+ P+ P S PP S+ P S+ +S P ++ P + P S + P
Sbjct: 443 PHKTTAVPTTP-SLPPASTGPTVSTADPTSGTPTGTTSSTLPEDTSPTSR---TTSATPN 498
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ PT + P++T P S + + +P + PP + P + P V
Sbjct: 499 ATSPTPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPTGTTSVPNATSPQVT 558
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
++P ++ ++P + + + PT P P S+S+P S ++
Sbjct: 559 EESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSS--PTSQQPGIPSSSHSTPRS----NS 612
Query: 228 KRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAG 269
+P P+ G + E+ S PS + T
Sbjct: 613 TSTTPLLTSAHPT-------GGENITEETPSVPSTTHVSTLS 647
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-07
Identities = 37/169 (21%), Positives = 57/169 (33%), Gaps = 18/169 (10%)
Query: 47 KPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP---PSPPASSPPTISP 103
K P +PP+ PP S S PASSP S + + S P ++ + S
Sbjct: 638 KSSADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSA 697
Query: 104 P--PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
P PPV +P R PP P S P++ + S ++ +VE
Sbjct: 698 PAPPPVPDPYDR--PPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQ--AVEQQAT 753
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
P V + P +++ + S V + I
Sbjct: 754 HQPQVQAEAQSPASTTALTQTSSE---------VQDTELNLVLLSSGSI 793
|
Length = 944 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 8/86 (9%)
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV-MGTFGYMAPEYASSGKLTE 548
+HRDIK N+L+D +++DFG A L AN + +++ +GT Y+APE ++
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 549 KS------DVFSFGVVLLELITGRKP 568
K D +S GV+ E+I GR P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 375 LGEGGFGSVYKGYL---PDGR--------EVAIKQLKIGGGQGEREFKAEVEIISRIHHR 423
LG+G F ++YKG L D V +K L F ++S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPV-LDWATRVKIAAGAARGLAYLH 482
HLV L G C+ D+ +++ +YV L LH E V L W ++ +A A L YL
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 483 EDCHPRIIHRDIKSSNILL-------DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+ +++H ++ NIL+ ++SD G+ L + +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPW 170
Query: 536 MAPEYASSG--KLTEKSDVFSFGVVLLEL 562
+APE +G LT +D +SFG LLE+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 11/135 (8%)
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A N +T V+ + Y
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-CTNFMMTPYVVTRY-YR 189
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596
APE E D++S G ++ EL+ G G + + +W + + + E
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ-----GTDHIDQWNKVIEQLGTPSAE 244
Query: 597 FDNLADPRLGENYVE 611
F N P + NYVE
Sbjct: 245 FMNRLQPTV-RNYVE 258
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 7/97 (7%)
Query: 475 ARGLAYL-HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGT 532
A+G+ +L ++C IHRD+ + N+LL + A++ DFGLA+ + D+N +
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MAPE T +SDV+S+G++L E+ + G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 32/222 (14%)
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWA--- 465
F E +I++ + +V L Y DDR L ++ +Y+P L + P WA
Sbjct: 90 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY 147
Query: 466 -TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANT 523
V +A A + + IHRD+K N+LLD + +++DFG K+ +
Sbjct: 148 TAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 524 HITTRVMGTFGYMAPEYASS----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579
T V GT Y++PE S G + D +S GV L E++ G P A +G S
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
Query: 580 LVEWARPLLSHALENE---EFDNLA-------DPRLGENYVE 611
+ + L+ +N+ E NL + RLG N VE
Sbjct: 258 KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVE 299
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 375 LGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G G +G VYK DG++ A+KQ++ G G + E+ ++ + H +++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 432 CISD-DRRL-LIYDYVPNN---TLYFHLHGEG--RPVLDWATRVK-IAAGAARGLAYLHE 483
+S DR++ L++DY ++ + FH + +PV VK + G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 484 DCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLAKLALDANTHIT--TRVMGTFGYMA 537
+ ++HRD+K +NIL+ +++D G A+L + V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 538 PEYASSGK-LTEKSDVFSFGVVLLELIT 564
PE + T+ D+++ G + EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-07
Identities = 51/233 (21%), Positives = 74/233 (31%), Gaps = 48/233 (20%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP------T 112
S+P + PP P T+ PP PP + P + PP
Sbjct: 244 ISHPLRGDIAAPAPPPVVGEGADRAPETARGATGPPP--PPEAAAPNGAAAPPDGVWGAA 301
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSP--------------PPSNPPSNLPP------PP 152
+ P + PP+ PP P+ P + P P P
Sbjct: 302 LAGAPLALPAPPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTP 361
Query: 153 PSSVE-------PPKRSPPSVPPQNPPP---------PPSSSPPKNSPPAPIAVPPSNVP 196
PSS+E PKR+ + P + + P P +VP
Sbjct: 362 PSSLEDLSAGRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPT 421
Query: 197 PPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
P P PP PA+P+ P S + P PP ++ PP + P + T
Sbjct: 422 PVPASAPPPPATPL-PSAEPGSDDGPAPPPERQ---PPAPATEPAPDDPDDAT 470
|
Length = 3151 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 3e-07
Identities = 19/76 (25%), Positives = 30/76 (39%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ A + +P P S PP P ++ P PP +K P P+ P
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 61 NPPTSSSPPASSPPTS 76
PT + A++PP+
Sbjct: 424 PSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 3e-07
Identities = 21/79 (26%), Positives = 31/79 (39%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
SA + PPP + P + P + PP PPPP ++ + +P P S+
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 62 PPTSSSPPASSPPTSSPPP 80
PP + PT P
Sbjct: 576 PPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 3e-07
Identities = 14/82 (17%), Positives = 27/82 (32%), Gaps = 3/82 (3%)
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
P + P ++ + AS+P + P P + PP + +
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 137 NSPPPSNPPSNLPPPPPSSVEP 158
+PP + P ++VE
Sbjct: 97 AAPPAAAAA---AAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 41/224 (18%), Positives = 59/224 (26%), Gaps = 9/224 (4%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS---SPPPASN 83
+P PV+ P + P ++P P P + P + P P S P N
Sbjct: 335 APVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPVIAPAPEGYPQQSQYAQPAVQYN 394
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P P P P P +P P + + +
Sbjct: 395 EPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQS 454
Query: 144 P--PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP----SNVPP 197
P + + +P + P PQ P P A PP V
Sbjct: 455 TFAPQSTYQTEQTYQQPAAQEPLYQQPQPVEQQPVVEPEPVVEETKPARPPLYYFEEVEE 514
Query: 198 PPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
+ A+ P P P S K S PV +
Sbjct: 515 KRAREREQLAAWYQPIPEPVKEPEPIKSSLKAPSVAAVPPVEAA 558
|
Length = 1355 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 39/139 (28%), Positives = 59/139 (42%), Gaps = 28/139 (20%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPS-PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP 91
SN S+P S P + P S P +NPP S++P S+PP S+PP ++ P +++
Sbjct: 410 SNAGYSNPG---NSNPGYNNAPNSNTPYNNPPNSNTP-YSNPPNSNPPYSNLPYSNT--- 462
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
P SN P + PP S+ ++ + AN P + P +N P
Sbjct: 463 --------------PYSNAPLSNAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAA 508
Query: 152 PP------SSVEPPKRSPP 164
+SV P S P
Sbjct: 509 NNFHGAAGNSVGNPFASRP 527
|
Length = 1560 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (126), Expect = 3e-07
Identities = 34/146 (23%), Positives = 62/146 (42%), Gaps = 6/146 (4%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
P K + P+ A+ P +++PPA + ++P A+ P + P A++PP +
Sbjct: 211 PSGKKSAKAAAPAKAAAAPAKAAAPPAKA--AAAPAKAAAAPAKAAAPPAKAAAPPAKAA 268
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
PP + PP + PP +PP+ A + P+ P + PP ++
Sbjct: 269 APPAK----AAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAA 324
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIA 189
PP +++PP + AP+
Sbjct: 325 APPAKAATPPAKAAAPPAKAAAAPVG 350
|
Length = 357 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 3e-07
Identities = 22/112 (19%), Positives = 37/112 (33%), Gaps = 5/112 (4%)
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPS-NLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
PP + P+ PPA +P + P+ P P VE KR + +++P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLT---AQREQLVARAAAP 108
Query: 180 PKNSPPAPIAVP-PSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL 230
AP A + + A+ PR + + R+
Sbjct: 109 AAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKARI 160
|
Length = 484 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 61/251 (24%), Positives = 78/251 (31%), Gaps = 29/251 (11%)
Query: 4 PSPGP-PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
PSP PA +S P + +SP K P P P S+
Sbjct: 72 PSPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRRRSSSPSDDEDEAERPSKRPRSDS 131
Query: 63 PTSSSPPASSPPTSSPPPASN--PPTSSPPPSPPASSPPTISPPPPVSNP---------- 110
+SSS PA P P PA++ S +P + + P + P
Sbjct: 132 ISSSSSPAKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPHTPTDTAPSGKRKRRLSD 191
Query: 111 ----PTRSPPPPSSTPPPNSPPSPPSDPPAN-------SPPPSNPPSNLPPPPPSSVEPP 159
P P SS P S P P + PPP SV P
Sbjct: 192 GFQLPAPKRPQTSSRPQTVSDPLPLHATTDWDTWFQATVSSSPSLLLTGDIPPPVSVFAP 251
Query: 160 KRSPP-SVPPQNPPPPPSSSPPKNSPPAPIAVPPS----NVPPPPTQTPPTPASPIAPRP 214
S P + N P P P PAP AV S VP + + A+P+
Sbjct: 252 DDSTPLDISLFNFPLIPLLPPEALDLPAPTAVSSSSSTFAVPALTSSSVDQSATPLDQGF 311
Query: 215 SNSSPNSPPPP 225
SN N P
Sbjct: 312 SNFGSNMYSEP 322
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 35/212 (16%)
Query: 373 NLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
N++G G FG VY+ D E VAIK++ Q + E+ I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 432 ----CISDDRRLL----IYDYVPNNT----LYFHLHGEGRPVLDWATRVKIAA-GAARGL 478
C + + + + +++P ++ + P+ VK+ + R L
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF----LVKLYSYQLCRAL 183
Query: 479 AYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDAN---THITTRVMGTFG 534
AY+H I HRD+K N+L+D N ++ DFG AK L ++I +R
Sbjct: 184 AYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF----- 235
Query: 535 YMAPEYA-SSGKLTEKSDVFSFGVVLLELITG 565
Y APE + T D++S G ++ E+I G
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 20/85 (23%), Positives = 27/85 (31%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN 109
+ S S A PP P PT P + PP PP ++ S P
Sbjct: 512 SQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDP 134
+ PPP P P+ +
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 4e-07
Identities = 14/82 (17%), Positives = 29/82 (35%)
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
P + P ++ + S P+ PA P + P+ P++ P + +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 171 PPPPPSSSPPKNSPPAPIAVPP 192
PP +++ + V P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 16/82 (19%), Positives = 28/82 (34%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P + P+ + A + P + PP + P+ PP+ +++ P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 182 NSPPAPIAVPPSNVPPPPTQTP 203
P A A P+ TP
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 22/106 (20%), Positives = 40/106 (37%), Gaps = 11/106 (10%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
I P + P ++ P P + + SP +S S+P +++ P
Sbjct: 370 SGGRGPKQHIKPV--FTQP--AAAPQPSAAAAASPSPSQ---SSAAAQPSAPQSATQPAG 422
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
+PP S P ++ P +PP+++P + P P S
Sbjct: 423 TPPTVSVDPPAAVPVNPPSTAPQAVRPAQ----FKEEKKIPVSKVS 464
|
Length = 614 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 37/163 (22%), Positives = 53/163 (32%), Gaps = 8/163 (4%)
Query: 53 PPPSPPASN-PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
PP P AS PP + S+ P P P P + P
Sbjct: 510 PPEGPEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAKEHKP 569
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
++ P + + P P P P + P P P+ + PK P++P
Sbjct: 570 SKIP---TLSKKPEFPKDPKH--PKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSP 624
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
P S PK PP P P + +P P +P+P
Sbjct: 625 KRPESPKSPKRPPPPQRPSSPER--PEGPKIIKSPKPPKSPKP 665
|
Length = 943 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 25/208 (12%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
P SN + + S+ S+ ++ +++ +P S+P + P SN P + PP
Sbjct: 383 PHSNA-SYNCAAYSNAAQSNAAQSNAGFSNAGYSNPGNSNPGYNNAP--NSNTPY-NNPP 438
Query: 118 PSSTP---PPNSPPSPPSDPPANSPPPSNPP-SNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
S+TP PPNS P P S+ P ++ P SN P SN PP S+ + + +
Sbjct: 439 NSNTPYSNPPNSNP-PYSNLPYSNTPYSNAPLSN--APPSSAKDHHSAYHAAYQHRAANQ 495
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
P ++ P N P A + +P A RP S+P +T + P
Sbjct: 496 PAANLPTANQPAA---------NNFHGAAGNSVGNPFASRPFGSAPYGGNAATT---ADP 543
Query: 234 PGIPVPSTENTPGNGTNPSSPESSSSPS 261
GI E+ P GTN E S S
Sbjct: 544 NGI--AKREDHPEGGTNRQKYEQSDEES 569
|
Length = 1560 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSN--PPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
P ++++ P P P ++ P ++ P P V PS + +
Sbjct: 163 PLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAAT 222
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
+P A + P + P PT S PA+ P
Sbjct: 223 PAPAAPATPDGAAP----LPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A + + T + T Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 184
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGR 566
APE E D++S G ++ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 18/69 (26%), Positives = 30/69 (43%), Gaps = 1/69 (1%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
+ P A+ + PA+ PP ++PP P A + P + P P P + PP+ +
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAP-APPAAAAPPARSAD 439
Query: 124 PNSPPSPPS 132
P + S
Sbjct: 440 PAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 5e-07
Identities = 23/80 (28%), Positives = 31/80 (38%)
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
S++ +PP P PP +P P P PPP+ PP + + P S
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 178 SPPKNSPPAPIAVPPSNVPP 197
SPP P P P + P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 5e-07
Identities = 23/99 (23%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 153 PSSVEPPKR------SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P+SV+P R P S +++ AP A P+ P P P
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPA-APAPAPPAAAAP 80
Query: 207 ASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTP 245
A+P P + ++ +P P + P E TP
Sbjct: 81 AAPPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 5e-07
Identities = 13/80 (16%), Positives = 25/80 (31%)
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
P S + A + + + P + P +PP+ PP P+++ + P
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 186 APIAVPPSNVPPPPTQTPPT 205
A + P
Sbjct: 97 AAPPAAAAAAAPAAAAVEDE 116
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 5e-07
Identities = 13/96 (13%), Positives = 22/96 (22%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
PP + PP + PA+ ++ +P A + P
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
P + + P P A
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADA 148
|
Length = 484 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 19/95 (20%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN 109
S P + P ++ PA+ T+ + ++P P+ P +N
Sbjct: 159 GQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNA--VVAPSQAN 216
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
T + P P++ P+ P+D S P ++P
Sbjct: 217 VDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFG 534
RGL Y+H IIHRD+K SN+ ++ + E ++ DFGLA+ A D T ++ TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 535 YMAPEYASSG-KLTEKSDVFSFGVVLLELITGR 566
Y APE + + D++S G ++ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 375 LGEGGFGSVYKGYLPDG---REVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G G +G VYK DG +E A+KQ++ G G + E+ ++ + H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 432 CIS-DDRRL-LIYDYVPNN---TLYFHLHGEG--RPVLDWATRVK-IAAGAARGLAYLHE 483
+S DR++ L++DY ++ + FH + +P+ + VK + G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 484 DCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLAKLALDANTHIT--TRVMGTFGYMA 537
+ ++HRD+K +NIL+ +++D G A+L + V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 538 PEYASSGK-LTEKSDVFSFGVVLLELIT 564
PE + T+ D+++ G + EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 56/219 (25%), Positives = 76/219 (34%), Gaps = 20/219 (9%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP-PASN 61
P P P PP S PT P S+ P SS V+KP PSP ASN
Sbjct: 367 VPRPLSPYTAYEDLKPPTSPIPT-----PPSSSPASSKSVDAVAKPAEPDVVPSPGSASN 421
Query: 62 PPTSSSPPASSPPTSSPPP----ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
P + T P P +SP P+ P P++S V P +P
Sbjct: 422 VPEVEPAQVEAKKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPAT 481
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
++ P + P PP++ P P P + V N PP +
Sbjct: 482 AATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTAL 541
Query: 178 SP------PKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
+ PK P +P + PP T PTP+ +
Sbjct: 542 ADEQHHAQPKPRPLSPYTMYEDLKPP----TSPTPSPVL 576
|
Length = 576 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 6e-07
Identities = 16/85 (18%), Positives = 32/85 (37%), Gaps = 2/85 (2%)
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
P +++ P + A++ S P P ++P P+ PP + P+ P P A + +
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAA--PAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAA 94
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVP 167
P + ++ P
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 34/105 (32%), Positives = 59/105 (56%), Gaps = 12/105 (11%)
Query: 475 ARGLAYL-HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGT 532
A+G+++L ++C IHRD+ + NILL + ++ DFGLA+ + D+N +
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELIT------GRKPVDA 571
+MAPE + T +SDV+S+G++L E+ + PVD+
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 30/84 (35%), Positives = 43/84 (51%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
A + + PA+ +PPP PP+++ +P P PP +PP P P +PP
Sbjct: 24 AGASAVAIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPP 83
Query: 130 PPSDPPANSPPPSNPPSNLPPPPP 153
PP+DP A PPP +P + PP P
Sbjct: 84 PPADPNAPPPPPVDPNAPPPPAPE 107
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 31/166 (18%), Positives = 48/166 (28%), Gaps = 28/166 (16%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP---PPPPVSKPPTTSPPPSPPASNP- 62
G + +S + P + T + P PP+S PT + PP P
Sbjct: 83 GSSSLSSGNQSSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQR 142
Query: 63 ---------------------PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
++ S+ PT PA+ P+ A + PT
Sbjct: 143 IELPGNISDALSQQQGQVNAASQNAQGNTSTLPT---APATVAPSKGAKVPATAETHPTP 199
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
P P + PP + P S + S P S+
Sbjct: 200 PQKPATKKPAVNHHKTATVAVPPATSGKPKSGAASARALSSAPASH 245
|
Length = 327 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 43/265 (16%), Positives = 67/265 (25%), Gaps = 28/265 (10%)
Query: 8 PPAANSSSPPPPVSNPPTI----SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
A P P + P ++ +S K P S P
Sbjct: 10 TKTAVQPEATPSAGAPTGLQQSSESPTQRASHSLASEGKKNRKKMPKVFQKSSAP---RQ 66
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
++PP + PT++ P +S PT + P T +P SP T
Sbjct: 67 IQAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPES--------SPSARRLTRS 118
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
D + L + +R P S P+++ +
Sbjct: 119 EGVARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALASAA 178
Query: 184 PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTEN 243
+ AS R S S N P P +P + S
Sbjct: 179 L-----FKDDEIRQEVDAARSDQASQ--SRLSRSRGNPPAIP--PDAAPRQPMLTRSAGG 229
Query: 244 TP----GNGTNPSSPESSSSPSNNG 264
N P+S + G
Sbjct: 230 RFEGEDENLERNLQPQSPITLDKKG 254
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 37/182 (20%), Positives = 48/182 (26%), Gaps = 12/182 (6%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P PG P PP + + P + P P + P P
Sbjct: 111 PRPGRRPYEGYGGPRADDRPPGLPRQDQL---PTARPAYPAYQQRPEPGAWPRAADDYGW 167
Query: 64 --TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS-- 119
P +P PAS P P + P + P P
Sbjct: 168 QQQRLGFPPRAPY---ASPASYAPEQERDREPYDAGRPEYDQRRRDYDHPRPDWDRPRRD 224
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
T P PP PP + + P PS+ P P P P P +
Sbjct: 225 RTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPGPLAAQPAPAP--GPGEPTARLN 282
Query: 180 PK 181
PK
Sbjct: 283 PK 284
|
Length = 617 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (122), Expect = 7e-07
Identities = 31/139 (22%), Positives = 56/139 (40%), Gaps = 3/139 (2%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS-STPPPNSPPSPPSDP 134
++ P ++ P A+ +PP + P ++ P+ + PP +PP+
Sbjct: 208 AAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKA 267
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS--PPAPIAVPP 192
A + PP+ PP + PP ++ + P +++ P + PPA A PP
Sbjct: 268 AAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPP 327
Query: 193 SNVPPPPTQTPPTPASPIA 211
+ PP + PA A
Sbjct: 328 AKAATPPAKAAAPPAKAAA 346
|
Length = 357 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 16/108 (14%), Positives = 35/108 (32%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
+PPA+ P ++ PP ++ P + PA+ +P A +P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
+ P + + + P +P ++V ++
Sbjct: 112 EAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKAR 159
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 8e-07
Identities = 21/75 (28%), Positives = 31/75 (41%)
Query: 26 ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPP 85
++ P + P P S PP P +P T+ SPP + P PA
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 86 TSSPPPSPPASSPPT 100
S PP+ A++PP+
Sbjct: 424 PSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 27/138 (19%), Positives = 35/138 (25%), Gaps = 12/138 (8%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
A + S P PP ++ P P P + P P
Sbjct: 70 RVNHAPANAQEHEAARPS--PQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQ 127
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
P P + P P Q P P + P+ AP P P P +
Sbjct: 128 PVQQ---PAYQPQPEQPLQQPVSPQVAPAPQPVHSAP-------QPAQQAFQPAEPVAAP 177
Query: 211 APRPSNSSPNSPPPPSTK 228
P P P K
Sbjct: 178 QPEPVAEPAPVMDKPKRK 195
|
Length = 333 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 8e-07
Identities = 39/133 (29%), Positives = 53/133 (39%), Gaps = 14/133 (10%)
Query: 31 PVSNPPKSSPP--PPPVSKPPTTSPPPS-PPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
SNP S+P P S P +PP S P SNPP S+ P ++ P +++P SN P S
Sbjct: 413 GYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTP--YSNAPLS 470
Query: 88 SPPPSPPASSPPTISPP-------PPVSNPPTRSPPP--PSSTPPPNSPPSPPSDPPANS 138
+ PPS P +N PT + P NS +P + P S
Sbjct: 471 NAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHGAAGNSVGNPFASRPFGS 530
Query: 139 PPPSNPPSNLPPP 151
P + P
Sbjct: 531 APYGGNAATTADP 543
|
Length = 1560 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 25/159 (15%), Positives = 31/159 (19%), Gaps = 18/159 (11%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P SP PP + P P + + P ++P SP PP
Sbjct: 48 PWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTP-----TGSPAA--NPPAT 100
Query: 108 SNPPTRSPPPPSSTPP-PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
P P T P P P N
Sbjct: 101 FALPAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRAL----------QQLQ 150
Query: 167 PPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT 205
P + S P T T
Sbjct: 151 QRYGAPASGQLPSQQQSAQKNDESQLQQQPNGETPPQQT 189
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 9e-07
Identities = 17/100 (17%), Positives = 29/100 (29%), Gaps = 7/100 (7%)
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
P + P ++ PPP + P+ S P A + P+ + E +
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 171 PPPPPSSS-------PPKNSPPAPIAVPPSNVPPPPTQTP 203
P + + + A A P VP
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAV 152
|
Length = 484 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
GL Y+H IIHRD+K N+ ++ + E ++ DFGLA+ A+ +T V+ T Y
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWY 180
Query: 536 MAPEYASSG-KLTEKSDVFSFGVVLLELITGR 566
APE + + D++S G ++ E++TG+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 41/162 (25%), Positives = 56/162 (34%), Gaps = 9/162 (5%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P V+ T S P S P S +P S P + L P + +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQ--GTT 225
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP-----PPTQTPPTPASPIAPRPSNS 217
S P PPPS P SP P + + TQ TP + R +S
Sbjct: 226 TSSNPEPQTEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHS 285
Query: 218 SPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
+ + PPP+TKR P P+ G+ SSP +
Sbjct: 286 T--ATPPPTTKRQETGRPTPRPTATTQSGSSPPHSSPPGVQA 325
|
Length = 408 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 25/85 (29%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 140 PPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPP 199
++ + PPPP S PP +PP PQ P +PP P A A + P
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPP--LPQPTATAPPPTPPPPPPTATQASSNAPAQIPA 572
Query: 200 TQTPPTPASPIAPRPSNSSPNSPPP 224
+PP PI P+ S P
Sbjct: 573 DSSPP---PPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 18/79 (22%), Positives = 26/79 (32%)
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
S S A++ +P P + P +P PS+ + +P P SPP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 147 NLPPPPPSSVEPPKRSPPS 165
P P P
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 1e-06
Identities = 14/76 (18%), Positives = 23/76 (30%), Gaps = 1/76 (1%)
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP 191
+P + + P++ K P P ++PPK + A A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAP-PAAAAPAAPPKPAAAAAAAAA 95
Query: 192 PSNVPPPPTQTPPTPA 207
P+ P P A
Sbjct: 96 PAAPPAAAAAAAPAAA 111
|
Length = 1228 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 27/123 (21%), Positives = 36/123 (29%), Gaps = 5/123 (4%)
Query: 27 SPPPPVSNPPKSSPPPPPV--SKPPTTSPPPSPPASNPPTSSSPPASS--PPTSSPPPAS 82
P + + P P +PP S P P PP + PP + P +P P
Sbjct: 71 VNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQ 130
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
P P P P P P + P P +P A P
Sbjct: 131 QPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQP-EPVAEPAPVM 189
Query: 143 NPP 145
+ P
Sbjct: 190 DKP 192
|
Length = 333 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 37/136 (27%), Positives = 51/136 (37%), Gaps = 29/136 (21%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPP---PPVSNPPKSSPP-------PPPVSKPPTT 51
+A P +N P SN P +PP P SNPP S+PP P S P +
Sbjct: 411 NAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTPYSNAPLS 470
Query: 52 SPPPSP-------------------PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+ PPS PA+N PT++ P A++ ++ NP S P S
Sbjct: 471 NAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHGAAGNSVGNPFASRPFGS 530
Query: 93 PPASSPPTISPPPPVS 108
P + P
Sbjct: 531 APYGGNAATTADPNGI 546
|
Length = 1560 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 32/136 (23%), Positives = 59/136 (43%), Gaps = 5/136 (3%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP 89
P K++ P + P + PP+ A+ P +++ PA + + P A+ PP +
Sbjct: 211 PSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKA--AAPPAKAAAPPAKAA 268
Query: 90 PPSPPASSPP--TISPPPPVSNPPTRSPPPPSST-PPPNSPPSPPSDPPANSPPPSNPPS 146
P A++PP +PP + PP ++ P+ P + P+ A + PP+
Sbjct: 269 APPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPA 328
Query: 147 NLPPPPPSSVEPPKRS 162
PP + PP ++
Sbjct: 329 KAATPPAKAAAPPAKA 344
|
Length = 357 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 35/159 (22%), Positives = 66/159 (41%), Gaps = 7/159 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPT-TSPPPSPPAS 60
+A + AA ++ P + +P + P K++ PP + P + P+ A+
Sbjct: 196 AAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAA 255
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P +++PPA + + P A+ PP + P A++PP + + P + P +
Sbjct: 256 PPAKAAAPPAKA--AAPPAKAAAPPAKAAAPPAKAAAPPAKA----AAAPAKAAAAPAKA 309
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
P +PP+ A + PP+ PP + P
Sbjct: 310 AAAPAKAAAPPAKAAAPPAKAATPPAKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 43/192 (22%), Positives = 58/192 (30%), Gaps = 23/192 (11%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP-PTSSPPPSPPASSPPTIS 102
P S + N S S SS SSP A+N + P IS
Sbjct: 61 PTEHESQQSSNNAGAEKNIDLSGSSSLSSGNQSSPSAANNTSDGHDASGVKNTAPPQDIS 120
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP-----------ANSPPPSNPPSNLPPP 151
PP +S PT++ PP TP P + A S S LP
Sbjct: 121 APP-ISPTPTQAAPPQ--TPNGQQRIELPGNISDALSQQQGQVNAASQNAQGNTSTLPTA 177
Query: 152 PPSSVEPPKRSPPSV---PPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P + P+ P P P + P N + PP T P +
Sbjct: 178 PATVAPSKGAKVPATAETHPTPPQKPATKKPAVNHHKT-----ATVAVPPATSGKPKSGA 232
Query: 209 PIAPRPSNSSPN 220
A S++ +
Sbjct: 233 ASARALSSAPAS 244
|
Length = 327 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 369 FADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
+ D LG G G V+ D + VA+K++ + Q + E++II R+ H ++V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 428 LVGYCISDDRRL--LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA---------- 475
+ L + N++Y + ++ + G
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYI-----VQEYMETDLANVLEQGPLSEEHARLFMY 121
Query: 476 ---RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTH--ITTRV 529
RGL Y+H ++HRD+K +N+ ++ + ++ DFGLA++ +H +
Sbjct: 122 QLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 530 MGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
+ T Y +P S T+ D+++ G + E++TG+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLVGY 431
LGEG + +VYKG +G+ VA+K + + +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 432 CISDDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + +++Y+ + Y H G L RGLAY+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLAYIH---GQHIL 125
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE-YASSGKLTEK 549
HRD+K N+L+ E +++DFGLA+ + ++ V+ T Y P+ + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 550 SDVFSFGVVLLELITGR 566
D++ G + +E++ G+
Sbjct: 185 LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 5/101 (4%)
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF 533
ARG+ +L + IHRD+ + NILL N ++ DFGLA+ + D +
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQ 573
+MAPE T +SDV+SFGV+L E+ + G P Q
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF 533
A+G+ +L + IHRD+ + NILL N ++ DFGLA+ + D +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MAPE T +SDV+SFGV+L E+ + G P
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 31/230 (13%)
Query: 375 LGEGGFGSVYKGYLPD---------GREVAIKQLKIGGGQGERE----FKAEVEIISRIH 421
LG G +Y G L E IK + R+ F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
H+H+V L G C+ D +++ ++V L +H + L + K+A A L+YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV-LTTPWKFKVAKQLASALSYL 121
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG-LAKLALDANTHITT----RVMGTFGYM 536
ED ++H ++ + NILL E + G KL+ D IT + ++
Sbjct: 122 -ED--KDLVHGNVCTKNILLAR--EGIDGECGPFIKLS-DPGIPITVLSRQECVERIPWI 175
Query: 537 APEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 585
APE K L+ +D +SFG L E+ + PL D++L E R
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLKDKTLAEKER 220
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASS---- 543
+IHRD+K N+LLD + +++DFG K+ T V GT Y++PE S
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581
G + D +S GV L E++ G P A +G S +
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 29/117 (24%), Positives = 40/117 (34%), Gaps = 5/117 (4%)
Query: 25 TISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP 84
++ PP + P + T P S PT P+SSP + S P
Sbjct: 147 SLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLES 206
Query: 85 PT--SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSP 139
P+ PP S T S +S+ S +T P S S S P + S
Sbjct: 207 PSNLQVTTDVPPPYSNGT-SRSSTMSSSANLSIISSLAT--PRSGESFRSTPTSGSS 260
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 17/78 (21%), Positives = 28/78 (35%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
S ++ + P P +PP + P++ + S PP + PP P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 98 PPTISPPPPVSNPPTRSP 115
P SP PP +
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 37/186 (19%), Positives = 50/186 (26%), Gaps = 11/186 (5%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP-----PVSNPPT 112
P N + P A + ++ + P +PP +S P PV P T
Sbjct: 309 PLLNGAPITEPVAVAAAATTATQSWAAPVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQT 368
Query: 113 RSP---PPPSSTPP--PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
P P P P + P+ + P P P P + +P P P
Sbjct: 369 GEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQP 428
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP-ASPIAPRPSNSSPNSPPPPS 226
Q P P+ P S P T P A P P
Sbjct: 429 AQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQPQPVEQQP 488
Query: 227 TKRLSP 232
P
Sbjct: 489 VVEPEP 494
|
Length = 1355 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 56/266 (21%), Positives = 73/266 (27%), Gaps = 29/266 (10%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
PGP + S P +S P P PK P +P + P P + P
Sbjct: 561 PGPAKEHKPSKIPTLSKKPEF---PKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPEL 617
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
P S SP PP P SP P I PP S PP +
Sbjct: 618 LDIPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKI---------IKSPKPPKSPKPPFD 668
Query: 126 ------------SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
+ + + S L P + P +P +PP+ P
Sbjct: 669 PKFKEKFYDDYLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKLPRD 728
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPP---PTQTPPTPASPIAPRPSNSSPNSPPPPS-TKR 229
P P A PP T TPA P + T
Sbjct: 729 EEFPFEPIGDPDAEQPDDIEFFTPPEEERTFFHETPADTPLPDILAEEFKEEDIHAETGE 788
Query: 230 LSPPPGIPVPSTENTP-GNGTNPSSP 254
P +E+ G +PS P
Sbjct: 789 PDEAMKRPDSPSEHEDKPPGDHPSLP 814
|
Length = 943 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 32/107 (29%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 8 PPAANSSSPPPPVSNPPTIS-PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
P S+ P PV PP PP P + +P P P P P P P +
Sbjct: 93 QPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQ---QPAYQPQPEQPLQQPVSPQ 149
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
PA P S+P PA P A P ++ P PV + P R
Sbjct: 150 VAPAPQPVHSAPQPA--QQAFQPAEPVAAPQPEPVAEPAPVMDKPKR 194
|
Length = 333 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 15/97 (15%), Positives = 25/97 (25%)
Query: 34 NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP 93
+ P S + P+P A T ++ + T+ P + PS
Sbjct: 155 SQNSGQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQ 214
Query: 94 PASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
P + P +P P P
Sbjct: 215 ANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P P S + P P + PP +PP P A P +++ PA +P PP A+ PP S
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARP-AAARPAPAPA---PPAAAAPPARS 437
Query: 89 PPPSPPASSPPT 100
P+ AS+
Sbjct: 438 ADPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 43/173 (24%), Positives = 61/173 (35%), Gaps = 10/173 (5%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
P K++ P VS P P P S P T A++ S S P +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTY--PSQVTPQSQPATQGHQTATANQRLS----STEPVGT 221
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
+ ++ P PPP P+ SP P ST + S D ++ PP+
Sbjct: 222 QGTTTSSNPEPQTEPPPS-QRGPSGSPQHPPSTTSQDQ--STTGDGQEHTQRRKTPPATS 278
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQ 201
P S P + P P P+++ S P P + PP P TQ
Sbjct: 279 NRRSPHSTATPPPTTKRQETGRPTPRPTATTQSGSSP-PHSSPPGVQANPTTQ 330
|
Length = 408 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 45/225 (20%), Positives = 67/225 (29%), Gaps = 13/225 (5%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN 109
T + S P +N SS + SP SS + A + P+ +PPP +S
Sbjct: 172 TPASSSSQPLTNLVVSSIKRFPYLTSLSPFFNYLIDPSSDSATASADTSPSFNPPPNLSP 231
Query: 110 PPTRSPPPPSSTPPPNS-------PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
S S P S S + + NL + V S
Sbjct: 232 NNLFSTSDLSPLPDTQSVENNIILNSSSSINELTSIYGSVPSIRNLRGLNSALVSFLNVS 291
Query: 163 PPSVPP---QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
S+ P+ SP S +P S+ T+ T +P PS +P
Sbjct: 292 SSSLAFSALNGKEVSPTGSPSTRSFARV--LPKSSPNNLLTEILTTGVNPPQSLPSLLNP 349
Query: 220 NSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNG 264
ST + +N N + S SS +
Sbjct: 350 VF-LSTSTGFSLTNLSGYLNPNKNLKKNTLSSLSNLGYSSNVPSP 393
|
Length = 777 |
| >gnl|CDD|217495 pfam03326, Herpes_TAF50, Herpesvirus transcription activation factor (transactivator) | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 53/224 (23%), Positives = 69/224 (30%), Gaps = 18/224 (8%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
+P P + P + P P S P+ S V T SP TS+ P A +
Sbjct: 215 GFTPHPSLPQPQSPLKPSPSSARPQQSESFSDVWPASTQSP-------REETSAEPLAPA 267
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
P+S P + + S P S+ P PS+T P PP+
Sbjct: 268 SPSSRRPSTAQEEQIACSSPQAEPEQGVQSYVPQSSDSRPSCFPAPSTTQPTFLPPNTNK 327
Query: 133 DPPANSPPPSNPPSNLPPPPPSSVEPPKRS-----PPSVPPQNPP---PPPSSSPPKNSP 184
+ P P S PS Q+PP P SS S
Sbjct: 328 KAKRDRRPQMVTPKQEGGAAVSQNHDGGTVRAPRGRPSGSGQSPPSNSPLLSSLADTPSG 387
Query: 185 PAPIAVPPSNVPPPPTQTPPTPASPIAPR-PSNSSPNSPPPPST 227
A P S +PP Q AS P P +S P
Sbjct: 388 AA--HQPASLLPPAVVQQQLEDASDKQPPTPGSSLVPQPDEQEL 429
|
This family includes EBV BRLF1 and similar ORF 50 proteins from other herpesviruses. Length = 500 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 62/250 (24%), Positives = 91/250 (36%), Gaps = 55/250 (22%)
Query: 375 LGEGGFGSVYKGYLPDGREV-AIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G G FG V D + A+K L+ + KAE +I++ + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 431 YCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR- 488
Y D L + DY+P + L G D A R IA L E H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYIAE-----LTCAIESVHKMG 121
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA--------------------------------- 515
IHRDIK NIL+D + +++DFGL
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 516 --------KLALDANTHITTR-VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
+ + ++GT Y+APE T+ D +S GV+L E++ G+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 567 KPVDASQPLG 576
P A P
Sbjct: 242 PPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 23/99 (23%), Positives = 39/99 (39%), Gaps = 16/99 (16%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
SAP+ PP +PP PV+ P ++P P + P + P+PPA
Sbjct: 411 ASAPAA----------------PPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQ 454
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
P + + P P + A+ P ++P + +
Sbjct: 455 AAPETVAIPVRVAPEPAVASAAPAPAAAPAAARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 3e-06
Identities = 25/111 (22%), Positives = 35/111 (31%), Gaps = 6/111 (5%)
Query: 153 PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT-PASPIA 211
P++ P P VPPQ+ P S+ A VPPPP P PA P+
Sbjct: 361 PAAPLPE----PEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLP 416
Query: 212 PRPSNSSPNSPPPPSTKRLSPPPGI-PVPSTENTPGNGTNPSSPESSSSPS 261
S + + P ++ P N +PS
Sbjct: 417 ETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPS 467
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 3e-06
Identities = 23/122 (18%), Positives = 37/122 (30%), Gaps = 6/122 (4%)
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P A P P PP + P + + + P PPP +S P+ +P P+ S
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSS 253
+ Q + A + P S R + S P +
Sbjct: 421 QLLAARQQLQRAQGATKAKKSE------PAAASRARPVNSALERLASVRPAPSALEKAPA 474
Query: 254 PE 255
+
Sbjct: 475 KK 476
|
Length = 647 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 15/78 (19%), Positives = 26/78 (33%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P + + P P + PPP +P + +PP + + P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 77 SPPPASNPPTSSPPPSPP 94
P+ PP ++ P
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 35/198 (17%), Positives = 52/198 (26%), Gaps = 25/198 (12%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
+ + + P+SS + P SN S +P + S +
Sbjct: 379 SISVSGSDYSNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVS-SRRVGTPGSKSDRVGAVL 437
Query: 105 P------PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP-PSSVE 157
P P S S SP S PPP P
Sbjct: 438 LRRMNIKPTLASIPDEKPSNISVFED-SETSPNSSTLLRDPPPKKCGEESGHLPNNPFFN 496
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS 217
K + S+PP +P + P + P + I+ S S S
Sbjct: 497 KLKLTLSSIPPLSPRQSIITLPTPSRPASRIS----------------SLSLRLGSYSGS 540
Query: 218 SPNSPPPPSTKRLSPPPG 235
+ PP P+ G
Sbjct: 541 IVSPPPYPTLVSRKGAAG 558
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 17/100 (17%), Positives = 33/100 (33%), Gaps = 2/100 (2%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
+ P A++P + PPPA+ P S P +P A P + ++ P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS 165
+P + + L ++ P + +
Sbjct: 112 EAQAPAAPAERAAAEN--AARRLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 19/103 (18%), Positives = 31/103 (30%), Gaps = 2/103 (1%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPP--PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT 75
PP + P + PPP + P S P P P A + A + P
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ P A ++ + + +P P V +
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADA 155
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 15/103 (14%), Positives = 33/103 (32%)
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
PP +++P A+ PP ++ P A + P + P R+ P +
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
+ P+ + + + + P P + +
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADA 155
|
Length = 484 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 9/107 (8%)
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
A GL +LH + + IHRD+K +NILL ++ DFG++ L + +GT
Sbjct: 133 ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSVGTP 188
Query: 534 GYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+MAPE + + DV+S G+ +EL G P+ P+
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 35/167 (20%), Positives = 50/167 (29%), Gaps = 14/167 (8%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
SNP + A + P SSPP A+ S
Sbjct: 759 SNPSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASK 818
Query: 120 STPPPNSP------PSPPSDPPANSPPP------SNPPSNLPPPPPSSVEPPKRSPPSVP 167
++P P P A + PP S+ + + +R P
Sbjct: 819 RKSRSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPE 878
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
P+ P +PPK + AP A P+ P P + P P P P
Sbjct: 879 PRARPGAA--APPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGGPDP 923
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 26/93 (27%), Positives = 32/93 (34%), Gaps = 8/93 (8%)
Query: 149 PPPPPSSVEPPKRSPPSVPPQ-NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA 207
P P P +P +P V P P P ++ N PP P P PP P
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKE----PVRETATPPPVPPRPV 417
Query: 208 SPIAPRPSNSSPNSPP---PPSTKRLSPPPGIP 237
+P P S+P P K PP P
Sbjct: 418 APPVPHTPESAPKLTRAAIPVDEKPKYTPPAPP 450
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 4e-06
Identities = 26/81 (32%), Positives = 34/81 (41%), Gaps = 1/81 (1%)
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
S + PPQ PPPP+ +PP P A A PP+ PPPPT T + +P
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTAT-APPPTPPPPPPTATQASSNAPAQIP 571
Query: 214 PSNSSPNSPPPPSTKRLSPPP 234
+S P P T +
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDS 592
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 19/75 (25%), Positives = 26/75 (34%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
AN+S+P P P PP P+ + PP P P PT
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 66 SSPPASSPPTSSPPP 80
SP + ++PP
Sbjct: 424 PSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 4e-06
Identities = 13/80 (16%), Positives = 24/80 (30%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
+ P + + ++ P P++ P +P P PP + + AP
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 189 AVPPSNVPPPPTQTPPTPAS 208
A P + P
Sbjct: 98 APPAAAAAAAPAAAAVEDEV 117
|
Length = 1228 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 32/180 (17%), Positives = 45/180 (25%), Gaps = 23/180 (12%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
A P SP P P + P + PP + P + +
Sbjct: 45 AEFPWDPSPQAPP---------PVAQLPQPLPQPPPTQALQALPAGDQQQHN---TPTGS 92
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
P+ P P P ++ P P + P NSP P
Sbjct: 93 PAANPPATFALPAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQ---PAQQRALQQL 149
Query: 201 QTP-PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
Q PAS P S+ + L P P +G E+
Sbjct: 150 QQRYGAPASGQLPSQQQSAQKNDESQ----LQQQPNGETP---PQQTDGAGDDESEALVR 202
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 36/226 (15%), Positives = 57/226 (25%), Gaps = 15/226 (6%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
+S P S PP S S P + + + P S P +
Sbjct: 398 SSSPSSSVIMTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTLASIPDEKPSN 457
Query: 111 PTRSPPP---PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP--PKRSPPS 165
+ P+S+ PP + P+NP N SS+ P P++S +
Sbjct: 458 ISVFEDSETSPNSSTLLRDPPPKKC-GEESGHLPNNPFFNKLKLTLSSIPPLSPRQSIIT 516
Query: 166 VPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA-------SPIAPRPSNSS 218
+P + P SS ++ P S I
Sbjct: 517 LPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLSFNRSVSDIEGERIGRY 576
Query: 219 PNSPP--PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSN 262
P P + S+ +P N
Sbjct: 577 NLLPTRIPALPFKAESTTSSRRSSSLPSPTGVIGFPGSVPRFDHEN 622
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 28/76 (36%), Positives = 35/76 (46%)
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
I+ P + P PPPPS+ +P +PP PP +PP P PPP +P
Sbjct: 30 AIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPN 89
Query: 160 KRSPPSVPPQNPPPPP 175
PP V P PPPP
Sbjct: 90 APPPPPVDPNAPPPPA 105
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 34/159 (21%), Positives = 47/159 (29%), Gaps = 6/159 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A S P A ++ P + K +S P PP +
Sbjct: 783 GAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSESSGPARPPGAA 842
Query: 62 ---PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
PP SS + S P ++ A P P + P + PP + + P
Sbjct: 843 ARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKAAAAAPPAGAPA 902
Query: 119 SSTPPPNSP---PSPPSDPPANSPPPSNPPSNLPPPPPS 154
P P PP P PP +L P PS
Sbjct: 903 PRPRPAPRVKLGPMPPGGPDPRGGFRRVPPGDLHTPAPS 941
|
Length = 1352 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-06
Identities = 21/78 (26%), Positives = 28/78 (35%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P +S +S P P P + PP S P T + SPP + P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 88 SPPPSPPASSPPTISPPP 105
PSP + +PP
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 18/87 (20%), Positives = 25/87 (28%), Gaps = 3/87 (3%)
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT 205
+ + PP P PP P PP P +PP PP + P
Sbjct: 513 QSGSASNTAKTPPP---PQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQ 569
Query: 206 PASPIAPRPSNSSPNSPPPPSTKRLSP 232
+ +P P +P P
Sbjct: 570 IPADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 13/110 (11%), Positives = 28/110 (25%), Gaps = 3/110 (2%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP 89
PP + P ++ PPP + + P P + + P +
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSP 139
+P A + + + P P + + +
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPR---PRVPADAAAAVADAVKAR 159
|
Length = 484 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 23/85 (27%), Positives = 33/85 (38%), Gaps = 1/85 (1%)
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP-PTPASPIAP 212
S+ P +P P + P S +P + PAP P N P+Q T A+P
Sbjct: 167 STTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPA 226
Query: 213 RPSNSSPNSPPPPSTKRLSPPPGIP 237
P+ +P P +S P P
Sbjct: 227 APATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 39/191 (20%), Positives = 61/191 (31%), Gaps = 15/191 (7%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
P + S P S P P P + + T++ +S P + +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
++ P PPP P+ SP P ST + S D ++ PP+ P
Sbjct: 228 SNPEPQTEPPPS-QRGPSGSPQHPPSTTSQDQ--STTGDGQEHTQRRKTPPATSNRRSPH 284
Query: 155 SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
S P + P P P+++ S P P + P A+P
Sbjct: 285 STATPPPTTKRQETGRPTPRPTATTQSGSSP------------PHSSPPGVQANPTTQNL 332
Query: 215 SNSSPNSPPPP 225
+ PP P
Sbjct: 333 VDCKELDPPKP 343
|
Length = 408 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 31/161 (19%), Positives = 40/161 (24%), Gaps = 16/161 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPP-PVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
+ P PA P P +P P S P P
Sbjct: 139 LPTARPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYD 198
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ P P P + P P PPP + P PP
Sbjct: 199 AGRPEYDQR---RRDYDHPRPDWDRPRRDRTDRP--------EPPPGAGHVHRGGPGPPE 247
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
+ P P P A P + P P P++ PK
Sbjct: 248 ----RDDAPVVPIRPSAPGPLAAQPAPAPGPGEPTARLNPK 284
|
Length = 617 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 6e-06
Identities = 18/86 (20%), Positives = 29/86 (33%), Gaps = 3/86 (3%)
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
P + P+ ++ P +P + P P P P ++ +PP P A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAA---AA 93
Query: 198 PPTQTPPTPASPIAPRPSNSSPNSPP 223
PP A+ AP + P
Sbjct: 94 AAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 6e-06
Identities = 13/86 (15%), Positives = 24/86 (27%), Gaps = 3/86 (3%)
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
P + P ++ + P + +P + AP A P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAA---AA 94
Query: 205 TPASPIAPRPSNSSPNSPPPPSTKRL 230
PA+P A + + + L
Sbjct: 95 APAAPPAAAAAAAPAAAAVEDEVTPL 120
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 6e-06
Identities = 13/78 (16%), Positives = 23/78 (29%)
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P ++ P+ + + P P+ P PP + + P A A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 195 VPPPPTQTPPTPASPIAP 212
PP A+ +
Sbjct: 98 APPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 31/126 (24%), Positives = 37/126 (29%), Gaps = 9/126 (7%)
Query: 20 VSNPPTISPPPPVSNPPKSSP----PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT 75
V + SP PP S P P A PP + PA P
Sbjct: 68 VHRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQ 127
Query: 76 SSPPPASNPPTSSP---PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN--SPPSP 130
PA P P P SP + P P P P + P P + P+P
Sbjct: 128 PVQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAP 187
Query: 131 PSDPPA 136
D P
Sbjct: 188 VMDKPK 193
|
Length = 333 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (115), Expect = 6e-06
Identities = 37/147 (25%), Positives = 66/147 (44%), Gaps = 12/147 (8%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPA--SNPPTSSPPPSPPASSPPT--ISPPPPVSNPPTRS 114
A+ P S A++P ++ PA + PP + A++ P +PP + PP ++
Sbjct: 208 AAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKA 267
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
PP+ +PP+ + PPA + + PP+ P + P ++ + PP
Sbjct: 268 AAPPAKAA---APPAKAAAPPAKA---AAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPA 321
Query: 175 PSSSPPKN--SPPAPIAVPPSNVPPPP 199
+++PP +PPA A PP+ P
Sbjct: 322 KAAAPPAKAATPPAKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 7e-06
Identities = 23/83 (27%), Positives = 30/83 (36%)
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
S + PPPP SPP +P P+ P + PPP PP A+ + P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 222 PPPPSTKRLSPPPGIPVPSTENT 244
PP P P S+
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 7e-06
Identities = 14/72 (19%), Positives = 26/72 (36%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ AA +S+P + +P P + PP P + + P +PPA+
Sbjct: 44 PTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAPPAAA 103
Query: 62 PPTSSSPPASSP 73
+ + A
Sbjct: 104 AAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 7e-06
Identities = 18/87 (20%), Positives = 31/87 (35%), Gaps = 1/87 (1%)
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP-PAPIAVPPSNVPPPPTQTPPTPASPI 210
P S+ P + + + P ++ +P PAP A PP P A+P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 211 APRPSNSSPNSPPPPSTKRLSPPPGIP 237
AP + ++ ++P G
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTPLRGAA 124
|
Length = 1228 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 34/180 (18%), Positives = 50/180 (27%), Gaps = 6/180 (3%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPP--PASNPPTSSPP 90
K + V +PP S S P S P T + + T S P + S
Sbjct: 444 KARKKLANKTSTVMEPPYGSTESSVP-STPSTRRNDRNITSNTPSLKRTPNLTKSSLSQE 502
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
S + S T P +S + ++ S S+P S
Sbjct: 503 ASLISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGAN-GNASSDLSSPGSINSK 561
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
P SV P + + S P + + S + PP TP
Sbjct: 562 SPEHSV--PLVRVFDIHLRASTTKGRHSTPSTNEKKKRLLKRSPLSPPKESVATTPRLNS 619
|
Length = 619 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 7e-06
Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 10/111 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPP---PPVSNPPKSSPPPPPV--SKPPTTSP-- 53
++A +P AA +++ PPP + P +S P P +
Sbjct: 48 LAALAPPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAA 107
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
P +P A P + A+ + ++P P PA + ++
Sbjct: 108 PAAPEAQAPAAPAERAAAENA---ARRLARAAAAAPRPRVPADAAAAVADA 155
|
Length = 484 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 20/73 (27%), Positives = 30/73 (41%), Gaps = 7/73 (9%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
AP+P A + +P P + PPP + PP P + P P A+ P
Sbjct: 381 APAPPSAAWGAPTPAAP-------AAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAP 433
Query: 63 PTSSSPPASSPPT 75
P S+ PA++
Sbjct: 434 PARSADPAAAASA 446
|
Length = 576 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 29/128 (22%), Positives = 34/128 (26%), Gaps = 9/128 (7%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
S PP + P P P PV P T+ P + P
Sbjct: 633 SGFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRV-------ARGDPVRP 685
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
+ A P PP PP P P S S T PP P PP
Sbjct: 686 TAHHAALRAPQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPP--EPEPPG 743
Query: 133 DPPANSPP 140
A+
Sbjct: 744 AEQADGAE 751
|
Length = 753 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 22/153 (14%), Positives = 33/153 (21%), Gaps = 8/153 (5%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP-PPPPVSKPPTTSPPPSP---- 57
+P PP A P P + P ++P P + P T + P P
Sbjct: 52 SPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGPT 111
Query: 58 --PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
P + P P S P +
Sbjct: 112 IQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSAQKN 171
Query: 116 PPPSSTPPPNSPPSPP-SDPPANSPPPSNPPSN 147
PN P +D + +
Sbjct: 172 DESQLQQQPNGETPPQQTDGAGDDESEALVRLR 204
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 11/82 (13%), Positives = 29/82 (35%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
+++ PA++P ++P + + +P + + V+ + P
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPAA 227
Query: 125 NSPPSPPSDPPANSPPPSNPPS 146
+ P + P + S P +
Sbjct: 228 PATPDGAAPLPTDQAGVSTPAA 249
|
Length = 331 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-06
Identities = 31/168 (18%), Positives = 48/168 (28%), Gaps = 10/168 (5%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
A + + P PPV P + + + S
Sbjct: 765 PAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRL---RRSGPAADAASRTASKRKS 821
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
+ S PA P ++ PP +S P ++ P P +
Sbjct: 822 RSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRA 881
Query: 127 PPSPPSDPP-ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P + P A + PP+ P+ P P P P +PP P P
Sbjct: 882 RPGAAAPPKAAAAAPPAGAPAPRPRPAPRVKLGP------MPPGGPDP 923
|
Length = 1352 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 9e-06
Identities = 16/105 (15%), Positives = 30/105 (28%), Gaps = 5/105 (4%)
Query: 20 VSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSP- 78
++ P +P P + P VS+P + P+P + +
Sbjct: 51 LAPPAAAAPAAA---QPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAA 107
Query: 79 PPASNPPTSSPPPSPPASSPPTI-SPPPPVSNPPTRSPPPPSSTP 122
P A + P A+ + P R P ++
Sbjct: 108 PAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAV 152
|
Length = 484 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 3/83 (3%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A +P P A ++P S P ++ P + P+ + P T+ P+P A
Sbjct: 173 ATTPAPAAPVDTTPTN--SQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPAAPAT 230
Query: 63 PTSSSP-PASSPPTSSPPPASNP 84
P ++P P S+P N
Sbjct: 231 PDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 3/72 (4%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
+PP A+ + P+ P PP +PP P + P + P+ P P + +PP+
Sbjct: 381 APAPPSAAWGAPTPAAPAAP---PPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARS 437
Query: 135 PANSPPPSNPPS 146
+ S
Sbjct: 438 ADPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A + + T + T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGR 566
APE E D++S G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 26/104 (25%), Positives = 36/104 (34%), Gaps = 5/104 (4%)
Query: 43 PPVSKPPTTSPPPSPPASNPPTSSSPP----ASSPPTSSPPPASNPPTSSPPPSPPASSP 98
P V KP P PA+ + PP + + P+ +P T +PP +P P
Sbjct: 42 PLVPKPGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEP 101
Query: 99 PTISPPPP-VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
+ PP P P P P P +P P P
Sbjct: 102 APVEPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-05
Identities = 23/80 (28%), Positives = 27/80 (33%), Gaps = 1/80 (1%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
P A S PT +P P P P T SPPP AS P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPP-AKASPPIPVPA 419
Query: 68 PPASSPPTSSPPPASNPPTS 87
P PT A+ PP+
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 16/80 (20%), Positives = 25/80 (31%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
PS ++S P + P SPPP P + P + P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 64 TSSSPPASSPPTSSPPPASN 83
+ P ++ PP+ N
Sbjct: 421 PTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 17/78 (21%), Positives = 25/78 (32%), Gaps = 1/78 (1%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
+ S + ++P P P P S P SPP + PP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 142 SNPPSNLPPPPPSSVEPP 159
+ PP ++ PP
Sbjct: 421 P-TEPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 45/240 (18%), Positives = 76/240 (31%), Gaps = 16/240 (6%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS- 67
++SPP ++ P + P P ++ P V+ P+ + SS
Sbjct: 535 VTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPT 594
Query: 68 ------PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P +S S ++ P +S P+ + P ++ T SP P T
Sbjct: 595 SQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGT 654
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
S P S P + +P P +S P +VP ++S K
Sbjct: 655 TSQVSGPGNSSTSR--YPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKANSTTK 712
Query: 182 NSPPAPIAVPPS-------NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+ + + S P T P S + + SPP + + P P
Sbjct: 713 ETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVPVP 772
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 31/119 (26%), Positives = 35/119 (29%), Gaps = 19/119 (15%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP---PNSPPSPPSDPPANSPPP 141
PSP S P P P R P P P P PSP S P PP
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPP 435
Query: 142 SNPPSNLPPPPPSSVEPPKRS-PPSV---------------PPQNPPPPPSSSPPKNSP 184
+ LPP P +S S P V + P SSS +
Sbjct: 436 VARSAPLPPSPQASAPRNVASGKPGVDLGSWQGKFMNFTRNGSRKQPVQASSSDAAQTG 494
|
Length = 620 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 43/223 (19%), Positives = 55/223 (24%), Gaps = 14/223 (6%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
S P S P + + P P PK PPP S P P + PP
Sbjct: 602 SAQRPTRPKSPKLPELLDIPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPK 661
Query: 65 SSSPPAS--------SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
S PP + + T+ S P P + T P
Sbjct: 662 SPKPPFDPKFKEKFYDDYLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPL 721
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV---EPPKRSPPSVPPQNPPP 173
PP P P DP A P + PP E P +P
Sbjct: 722 PPKLPRDEEFPFEPIGDPDAEQPDDIEFFT---PPEEERTFFHETPADTPLPDILAEEFK 778
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P + P S P+ P +
Sbjct: 779 EEDIHAETGEPDEAMKRPDSPSEHEDKPPGDHPSLPKKRHRLD 821
|
Length = 943 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 35/214 (16%), Positives = 53/214 (24%), Gaps = 16/214 (7%)
Query: 1 MSAPSPGPPAANSSS--PPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP 58
M+ P GP + SS P + + N + P + S
Sbjct: 407 MTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTLASIPDEKPSNISVFEDSET 466
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ N T P N P + +S PP ++ P P
Sbjct: 467 SPNSSTLLRDPPPKKCGEESGHLPNNPFFNKLKLTLSSIPPLSPRQSIITLPTPSRPASR 526
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS---SVE--------PPKRSPPSVP 167
S+ S P S S SV P +P
Sbjct: 527 ISSLSLRLGSYSGSIVSPPPYP--TLVSRKGAAGLSFNRSVSDIEGERIGRYNLLPTRIP 584
Query: 168 PQNPPPPPSSSPPKN-SPPAPIAVPPSNVPPPPT 200
++S ++ S P+P V P
Sbjct: 585 ALPFKAESTTSSRRSSSLPSPTGVIGFPGSVPRF 618
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 36/182 (19%), Positives = 52/182 (28%), Gaps = 13/182 (7%)
Query: 1 MSAPSPGPPAANSSS---PPPPVSNPPTI-SPPPPVSNPPKSSPPPPPVSKPPTTSPPPS 56
AN +S PP S ++ S P N + P + + P +
Sbjct: 440 KQRAKARKKLANKTSTVMEPPYGSTESSVPSTPSTRRNDRNITSNTPSLKRTPNLTKS-- 497
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
S +S S+ T T P+ SS + N +
Sbjct: 498 ---SLSQEASLISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSS 554
Query: 117 PPS--STPPPNS-PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P S S P +S P D + S P KRSP S P ++
Sbjct: 555 PGSINSKSPEHSVPLVRVFDIHLRASTTKGRHST-PSTNEKKKRLLKRSPLSPPKESVAT 613
Query: 174 PP 175
P
Sbjct: 614 TP 615
|
Length = 619 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-05
Identities = 22/106 (20%), Positives = 33/106 (31%), Gaps = 6/106 (5%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
PP + P + PPP P S P +P A P A ++
Sbjct: 53 PPAAAAPAAAQPPPAAA--PAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVAR----AA 106
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
P +P A +P + N R ++ P P P +
Sbjct: 107 APAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAV 152
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 17/115 (14%), Positives = 36/115 (31%), Gaps = 7/115 (6%)
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP--PPNSPPSPPSDP 134
+PP A+ P + PPP+ ++ + P P + + + P+ P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
A +P + P+ P +++ ++ A I
Sbjct: 112 EAQAPAAPAERAAAENAARRLARAAAA-----APRPRVPADAAAAVADAVKARIE 161
|
Length = 484 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 29/127 (22%), Positives = 37/127 (29%), Gaps = 10/127 (7%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
PP A P + + P P P + PS A P P
Sbjct: 634 GFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPV--RPTAHHAA 691
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
R+P P P PP PPP P + P P SS+ +PP P
Sbjct: 692 L-RAPQAP-------RPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPG 743
Query: 171 PPPPPSS 177
+
Sbjct: 744 AEQADGA 750
|
Length = 753 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 22/103 (21%), Positives = 31/103 (30%), Gaps = 3/103 (2%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
P P A+ + PP + + + P+ P T++PP P P
Sbjct: 47 PGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEP 106
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
P P P P +PP P P P P
Sbjct: 107 PKPKPVEKPKPKPKPQQKVEAPPAPKPE---PKPVVEEKAAPT 146
|
Length = 226 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 28/106 (26%), Positives = 34/106 (32%), Gaps = 9/106 (8%)
Query: 84 PPTSSPPPSPPASSPPTISPPPP--VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
P P PA++ + PP PS P +PP+ P +P P P
Sbjct: 47 PGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPE---PAP 103
Query: 142 SNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP 187
PP P P PK P P P P P AP
Sbjct: 104 VEPP----KPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|220271 pfam09507, CDC27, DNA polymerase subunit Cdc27 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 30/206 (14%), Positives = 50/206 (24%), Gaps = 26/206 (12%)
Query: 30 PPVSNP---PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
P++NP ++ PPV+ + + P+ P + SP T
Sbjct: 128 GPITNPNVKRRTGVGLPPVAPAASPALKPTANGKRPSSKPPKSIMSPEVKVKSAKKTQDT 187
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS-----STPPPNSPPSPPSDPPANSPPP 141
S + ++ NPP +S S + + S S
Sbjct: 188 SKETTTEKTEGKTSVKAASLKRNPPKKSNIMSSFFKKKTKEKKEKKEASESTVKEESEEE 247
Query: 142 SNP-PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP------------- 187
S L + P + S +
Sbjct: 248 SGKRDVILEDESAEPTGLDEDEDEDEPKPSGERSDSEEETEEKEKEKRKRLKKMMEDEDE 307
Query: 188 ----IAVPPSNVPPPPTQTPPTPASP 209
VP S V ++ P P P
Sbjct: 308 DEEMEIVPESPVEEEESEEPEPPPLP 333
|
This protein forms the C subunit of DNA polymerase delta. It carries the essential residues for binding to the Pol1 subunit of polymerase alpha, from residues 293-332, which are characterized by the motif D--G--VT, referred to as the DPIM motif. The first 160 residues of the protein form the minimal domain for binding to the B subunit, Cdc1, of polymerase delta, the final 10 C-terminal residues, 362-372, being the DNA sliding clamp, PCNA, binding motif. Length = 427 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 460 PVLDWATRVKIAAGAARGLAYL-HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-L 517
P L + V + A G+ +L ++C +HRD+ + N+L+ ++ DFGLA+ +
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
D+N +MAPE + T SDV+SFG++L E+ T
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 62/240 (25%), Positives = 73/240 (30%), Gaps = 38/240 (15%)
Query: 32 VSNPPKSSPPPPPVSK----PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPA------ 81
S + PP VS PP SPP P S P + P++ P +PP
Sbjct: 542 RSGRRQKRATPPKVSPSDRGPPKASPPVMAPPSTGPRVMATPSTGPRDMAPPSTGPRQQA 601
Query: 82 ---SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS--PPSPPSDPPA 136
PP S P P SS P P V S+ P P S D
Sbjct: 602 KCKDGPPASGPHEKQPPSSAPRDMAPSVVRMFLRERLLEQSTGPKPKSFWEMRAGRDGSG 661
Query: 137 NSPPPSN--PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI------ 188
PS+ P+ PP S P PSV P S SP PI
Sbjct: 662 IQQEPSSRRQPATQSTPPRPSWLPSVFVLPSVDAGRAQPSEESHLSSMSPTQPISHEEQP 721
Query: 189 -----------AVPPSNVPPPPTQTP----PTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
++ P PPP Q P P + AP P P P P P
Sbjct: 722 RYEDPDDPLDLSLHPDQAPPPSHQAPYSGHEEPQAQQAPYPGYWEPRPPQAPYLGYQEPQ 781
|
Length = 1000 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 20/90 (22%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP-PPPVSNP----PTRSPPP 117
P+ + AS + P + S PP ++S + PP + PT P
Sbjct: 87 PSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAATDPPATAAARDGPTPDPTA 146
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
+TP P P PS P ++
Sbjct: 147 QPATPDERRSPRQRPPVSGEPPTPSTPDAH 176
|
Length = 226 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 58/227 (25%), Positives = 88/227 (38%), Gaps = 35/227 (15%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRHLVSLV 429
LLG+G G V+ L G+ A+K L + K E EI++ + H L +L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
++ L+ DY P L+ L + L AA L YLH I
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GI 124
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI------------------------ 525
++RD+K NILL + +SDF L+K + +
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 526 -TTRVM---GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ R GT Y+APE S D ++ G++L E++ G P
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223041 PHA03321, PHA03321, tegument protein VP11/12; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 65/250 (26%), Positives = 82/250 (32%), Gaps = 33/250 (13%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPP----------PPVSNPPKSSPPPPPVSKPPTT 51
S PG PA + PPP S P + P P P
Sbjct: 427 SRQPPGAPAPRRDNDPPPPPRARPGSTPACARRARAQRARDAGPEYVDPLGALRRLPAGA 486
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS--- 108
+PPP P A+ P + P PP T P PPA++PP P +
Sbjct: 487 APPPEPAAAPSPATYYTRMGGGPPRLPPRNRATETLRPDWGPPAAAPPEQMEDPYLEPDD 546
Query: 109 -NPPTRSPPPPSSTPPPNSPPSPPSDPPANS------------PPPSNPPSNLPPPPPSS 155
R ++T P P+P DP P P + LP P +
Sbjct: 547 DRFDRRDGAAAAATSHPREAPAPDDDPIYEGVSDSEEPVYEEIPTPRVYQNPLPRPMEGA 606
Query: 156 VEPPKRSPPSVPPQNPPPPPSS--SPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA-P 212
EPP P+ P P P SPP P PP P +P PA P P
Sbjct: 607 GEPPDLDAPTSPWVEEENPIYGWGDSPLFSPPPAARFP----PPDPALSPEPPALPAHRP 662
Query: 213 RPSNSSPNSP 222
RP +P+ P
Sbjct: 663 RPGALAPDGP 672
|
Length = 694 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 28/112 (25%), Positives = 38/112 (33%), Gaps = 6/112 (5%)
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
PP + PPP P +P PP P +P P P PK P V P
Sbjct: 59 EPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIPKPEPKPKPKPKPKPKPVKKVEEQPK 118
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPS 226
P + P +P P + + A+ A +P S + P S
Sbjct: 119 REVKPVEPRPASP------FENTAPARPTSSTATAAASKPVTSVSSGPRALS 164
|
Length = 246 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 22/107 (20%), Positives = 38/107 (35%), Gaps = 15/107 (14%)
Query: 166 VPPQNPPPP---------PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P PP +++ + P ++ PP+ +P P+ P P +
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 217 SSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNN 263
S +S PP P + +P + TNPS P ++P
Sbjct: 206 SPSDSSLPP------APSSFQSDTPPPSPESPTNPSPPPGPAAPPPP 246
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 17/77 (22%), Positives = 27/77 (35%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
S + P P P P P A +++ P+ P +SPP
Sbjct: 362 SAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEP 421
Query: 87 SSPPPSPPASSPPTISP 103
+ P P+PPA++
Sbjct: 422 TEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 16/79 (20%), Positives = 22/79 (27%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
S + P + P P P S P T +P S P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 74 PTSSPPPASNPPTSSPPPS 92
PT P ++PP
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 40/199 (20%), Positives = 56/199 (28%), Gaps = 15/199 (7%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP------PPPSST 121
P + P + P + T++ P T +PP + P P P T
Sbjct: 309 PLLNGAPITEPVAVAAAATTATQSWAAPVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQT 368
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLP-----PPPPSSVEPPKRSPPSVPPQNPPPPPS 176
P P+P P + N P P P P P P P
Sbjct: 369 GEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQP 428
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ P +P V + Q+ P S + P + P P P
Sbjct: 429 AQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPL---YQQPQPVE 485
Query: 237 PVPSTENTPG-NGTNPSSP 254
P E P T P+ P
Sbjct: 486 QQPVVEPEPVVEETKPARP 504
|
Length = 1355 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 19/103 (18%), Positives = 29/103 (28%), Gaps = 16/103 (15%)
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
S+T P + P+P + P P P+V PQ S
Sbjct: 167 STTTDPATTPAPAAPVDTTPTNSQTPAVATAP------------APAVDPQQNAVVAPSQ 214
Query: 179 PPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
++ P P+ P P P + PN+
Sbjct: 215 ANVDTAATPAPAAPA----TPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 19/75 (25%), Positives = 32/75 (42%), Gaps = 7/75 (9%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
P+PP+++ +P P + PP +PP PP +P P + PA +P P + PP
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPP-----VPPAAPARPAAARPAPAPAPPAAAA--PP 434
Query: 151 PPPSSVEPPKRSPPS 165
+ +
Sbjct: 435 ARSADPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/77 (37%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
P ++ + PPP + ++P P+ P PP +PP P + P +PPPP + PN+P
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPA--DPNAP 91
Query: 128 PSPPSDPPANSPPPSNP 144
P PP DP A PP P
Sbjct: 92 PPPPVDPNAPPPPAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 45/280 (16%), Positives = 75/280 (26%), Gaps = 15/280 (5%)
Query: 12 NSSSPPPPVSNP--PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
SSS P + P S P + P S T S SP + PP S
Sbjct: 174 ASSSSQPLTNLVVSSIKRFPYLTSLSPFFNYLIDPSSDSATASADTSPSFNPPPNLSPNN 233
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
S SP P + ++ + +S S V S+ + S
Sbjct: 234 LFSTSDLSPLPDTQSVENNIILNSSSSINELTSIYGSV-PSIRNLRGLNSALVSFLNVSS 292
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
A + +P + PS+ + P S P ++ P
Sbjct: 293 SSLAFSALNGKEVSPTGS-----PSTRSFARVLPKSSPNNLLTEILTTG-VNPPQSLPSL 346
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSS-PNSPPPPSTKRLSPPPGIPVPSTENT---- 244
+ P + + + + P + S + P ST N
Sbjct: 347 LNPVFLSTSTGFSLTNLSGYLNPNKNLKKNTLSSLSNLGYSSNVPSPSSSESTRNILGNI 406
Query: 245 -PGNGTNPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFS 283
P T+ + +S ++ + I S
Sbjct: 407 SPNFKTSSNLTNLNSLLKEKLSNSSSVSATDILGPSIIVS 446
|
Length = 777 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 18/90 (20%), Positives = 25/90 (27%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P + PP + ++ P P T +PP +P P P
Sbjct: 57 PAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEPPKPKPVEKPK 116
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P P +PP P P P
Sbjct: 117 PKPKPQQKVEAPPAPKPEPKPVVEEKAAPT 146
|
Length = 226 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-05
Identities = 13/74 (17%), Positives = 24/74 (32%), Gaps = 3/74 (4%)
Query: 53 PPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
PP P +P ++ P A+ ++ P+ ++ P + P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 113 RSPPPPSSTPPPNS 126
+P P NS
Sbjct: 451 AAPQPA---VRLNS 461
|
Length = 598 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 44/221 (19%), Positives = 64/221 (28%), Gaps = 10/221 (4%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
P AA S + N SP + ++ P P P + A P ++S
Sbjct: 360 PLAAASCDANAVIENTELQSPSAQTAEKETAAKKPQPR--------PEAETAQTPVQTAS 411
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
A + P SN + PP A + ++ + + TPP N
Sbjct: 412 AAAMPSEGKTAGPVSNQENNDVPPWEDAPDEAQTAAGTAQTSAKSIQTASEAETPPENQV 471
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP 187
+ P S PS P + E + + P P + PP
Sbjct: 472 SKNKAADNETDAPLSEVPSENPIQATPNDEAVETETFAHEAPAEPFYGYGFPDNDCPPED 531
Query: 188 IA--VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPS 226
A PP P T A A N+P P
Sbjct: 532 GAEIPPPDWEHAAPADTAGGGADEEAEAGGIGGNNTPSAPP 572
|
Length = 709 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 33/115 (28%), Positives = 44/115 (38%), Gaps = 2/115 (1%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPP--PPVSKPPTTSPPPSPPASNPPT 64
G A + S+ P S P P P ++P P S P T P + P+ P
Sbjct: 377 GASAPSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPW 436
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+PPA P PA P +SP P P S PP + +P + PS
Sbjct: 437 DDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTPS 491
|
Length = 624 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 37/131 (28%), Positives = 56/131 (42%), Gaps = 10/131 (7%)
Query: 25 TISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP 84
++ P ++ P S P S T P P + PA+ SS PA+
Sbjct: 370 SLRPSGGGASAPSGSAAEGPASGGAATIPTPGTQG----PQGTAPAAGMTPSSAAPATPA 425
Query: 85 PTSSPPPSPP-ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P+++P P P +PP PP PP +P P ++P P +P S S +++PP
Sbjct: 426 PSAAPSPRVPWDDAPPA---PPRSGIPPRPAPRMPEASPVPGAPDSVAS--ASDAPPTLG 480
Query: 144 PPSNLPPPPPS 154
PS+ PS
Sbjct: 481 DPSDTAEHTPS 491
|
Length = 624 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 24/135 (17%), Positives = 32/135 (23%), Gaps = 4/135 (2%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSP-PPASNPPTS 87
PP + P P + P S PP +P PP S
Sbjct: 55 YPPRETGSGGGVATSTIYTVP-RPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGAS 113
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
SP ++SP + SS P
Sbjct: 114 SPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEHSRPPPS--ESLKVKNGGK 171
Query: 148 LPPPPPSSVEPPKRS 162
+ P S + KRS
Sbjct: 172 VYPKGFSKHKTHKRS 186
|
Length = 580 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 38/207 (18%), Positives = 51/207 (24%), Gaps = 18/207 (8%)
Query: 16 PPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSP--PPSPPASNP-PTSSSPPASS 72
PP + + P+ P P + P PP P P ASS
Sbjct: 55 YPPRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASS 114
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
P + + P A + S +S S PP S
Sbjct: 115 PRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELS-----EEEEHSRPPPSESLKVKNG 169
Query: 133 ---DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-------SSPPKN 182
P S ++ S + K S P Q S +
Sbjct: 170 GKVYPKGFSKHKTHKRSEFSGLTKKAARKRKGSFVFKPSQLKELSGSLKNLLHLDDSAET 229
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASP 209
P P +V PP T P P
Sbjct: 230 DPATRQVPVPVHVLYPPLLTEYVPYKP 256
|
Length = 580 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 23/75 (30%), Positives = 32/75 (42%), Gaps = 5/75 (6%)
Query: 10 AANSSSPPP-----PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
AAN+++P P S PP+ P S P ++PP V P T +P ++ T
Sbjct: 27 AANATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVET 86
Query: 65 SSSPPASSPPTSSPP 79
SP PT P
Sbjct: 87 PQSPTTKQVPTEINP 101
|
Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-----FKAEVEIISRIHHR-HLVS 427
+GEG +G VYK G+ VA+K+ ++ + + E E+ ++ + ++V
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRL---EMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 428 L--VGYCISDDRRLLIY---DYVPNNTLYF---HLHGEGRPVLDWATRVKIAAGAARGLA 479
L V + + + +Y +Y+ ++ F + G GRP L T +G+A
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQLLKGVA 124
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEA-QVSDFGLAK---LALDANTHITTRVMGTFG 534
+ CH ++HRD+K N+L+D +++D GL + + + + TH T
Sbjct: 125 H----CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLW 176
Query: 535 YMAPE-YASSGKLTEKSDVFSFGVVLLELITG 565
Y APE S + D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 25/116 (21%), Positives = 39/116 (33%), Gaps = 5/116 (4%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
S P P S PP P + P + P+ PA++ + S A +
Sbjct: 302 SDPEPLPASLPP--PPVRRPRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQN 359
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
+ S P S+ +S P + + + P P +S P P S P
Sbjct: 360 KDSGSTGPGSSLAAASSFLEDDDFGSPPLDLTTSLRHMP---SPSVTSAPEPPSIP 412
|
Length = 418 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 60/239 (25%), Positives = 93/239 (38%), Gaps = 52/239 (21%)
Query: 374 LLGEGGFGSVYKGYLPD-GREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
++G G FG V D G A+K+L+ + Q +AE +I++ + +V L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVA-HVRAERDILAEADNPWVVKL 66
Query: 429 VGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
Y D+ L LI +Y+P + L + + TR IA LA + H
Sbjct: 67 Y-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIAETI---LAI--DSIHK 119
Query: 488 -RIIHRDIKSSNILLDNNFEAQVSDFGL----------------AKLALDANTHITTRVM 530
IHRDIK N+LLD ++SDFGL + ++ M
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 531 ---------------------GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
GT Y+APE ++ D +S GV++ E++ G P
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 28/129 (21%), Positives = 46/129 (35%), Gaps = 10/129 (7%)
Query: 72 SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
+ P ++ P+S SS A+ P P V+ + +
Sbjct: 298 TVPVAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSD 357
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP 191
P P+ P N+ P P S+ E + S ++ +++ P S P A P
Sbjct: 358 VTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNI-------TSTANGPTTSLP---AAP 407
Query: 192 PSNVPPPPT 200
SN+P PT
Sbjct: 408 ASNIPVSPT 416
|
Length = 421 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 40/179 (22%), Positives = 60/179 (33%), Gaps = 7/179 (3%)
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPS--PPSDPPANSPPPSNPPS---NLPPPPPSS 155
+ P + + P TP SPP P P A P P +P + +L PP
Sbjct: 328 VPPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPPTSPI 387
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
PP SP S + P+ SP + VP + P SP A R
Sbjct: 388 PTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKT-RPLSPYA-RYE 445
Query: 216 NSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIA 274
+ P + P P+ P S P ++ ++++ P N + V
Sbjct: 446 DLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVYD 504
|
Length = 576 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 3e-05
Identities = 13/78 (16%), Positives = 21/78 (26%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPP 80
+ + + P P P P + S P +SPP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 81 ASNPPTSSPPPSPPASSP 98
+ P + P + A
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 33/123 (26%), Positives = 47/123 (38%), Gaps = 11/123 (8%)
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
N P+ + A P P + PP +S +P R P PP+ PP + P
Sbjct: 68 VHRVNHAPANAQEHEAARPSPQHQ----YQPPYASAQP--RQPVQQPPEAQVPPQHAPRP 121
Query: 181 KNSPPAPIAVPPSNVPPP-PTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P P+ P P P Q P +P AP+P +S P P+ + P + P
Sbjct: 122 AQPAPQPVQQPAYQPQPEQPLQQPVSPQVAPAPQPV----HSAPQPAQQAFQPAEPVAAP 177
Query: 240 STE 242
E
Sbjct: 178 QPE 180
|
Length = 333 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 22/114 (19%), Positives = 32/114 (28%)
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
R P++ + P + P + PP + V P P+ P P
Sbjct: 69 HRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQP 128
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPP 225
P+ P P P P P + P PA + P P
Sbjct: 129 VQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPV 182
|
Length = 333 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 32/188 (17%), Positives = 45/188 (23%), Gaps = 16/188 (8%)
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN-PPTRSPPPPSSTPPPNSP-- 127
S + S +P SP +S T P SN R P S + +
Sbjct: 379 SISVSGSDYSNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLL 438
Query: 128 ------PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P+ S P S + P S R PP + P
Sbjct: 439 RRMNIKPTLASIPDEKPSNISVFEDSETSPNSS---TLLRDPPP-KKCGEESGHLPNNPF 494
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
+ S++PP + + S S S S P
Sbjct: 495 FNKLKLT---LSSIPPLSPRQSIITLPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLV 551
Query: 242 ENTPGNGT 249
G
Sbjct: 552 SRKGAAGL 559
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 17/88 (19%), Positives = 29/88 (32%), Gaps = 3/88 (3%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST---PP 123
S P + T+ P P + +P + P P +P + PS
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTA 220
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPP 151
P+ P+ P +P P++ P
Sbjct: 221 ATPAPAAPATPDGAAPLPTDQAGVSTPA 248
|
Length = 331 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 33/165 (20%), Positives = 49/165 (29%), Gaps = 18/165 (10%)
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP-SNPPSNLPPPPPSS----VEPPKRS 162
N + S +S S + P S PP S P+ PP + +E P
Sbjct: 90 GNQSSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNI 149
Query: 163 PPSVPPQ----NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSS 218
++ Q N + P AP V PS P P P P +
Sbjct: 150 SDALSQQQGQVNAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPA 209
Query: 219 PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNN 263
N + G P S+ SS+P+++
Sbjct: 210 VNHHKTATVAVPPATSGKPKSGA---------ASARALSSAPASH 245
|
Length = 327 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 21/99 (21%), Positives = 29/99 (29%), Gaps = 6/99 (6%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSN------LPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P P P P A P+ PP S++P +PP+ P + P P
Sbjct: 45 PKPGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPV 104
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
PK P P P P + +
Sbjct: 105 EPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKA 143
|
Length = 226 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 16/74 (21%), Positives = 27/74 (36%), Gaps = 1/74 (1%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
PP + + P + +P + +PP A+ PP +P PP +P
Sbjct: 124 PPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPP-TPV 182
Query: 100 TISPPPPVSNPPTR 113
+ P P +R
Sbjct: 183 ARADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 35/150 (23%), Positives = 57/150 (38%), Gaps = 20/150 (13%)
Query: 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVS--LVG 430
LL G VY L E + LKI + + + EV I+ + + L ++
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYV--LKINPSREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-- 488
SD L+ +++ TL + + IA A LA LH+ P
Sbjct: 61 SGESDGWSYLLMEWIEGETLD---------EVSEEEKEDIAEQLAELLAKLHQ--LPLLV 109
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518
+ H D+ NIL+D+ + D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 71/287 (24%), Positives = 111/287 (38%), Gaps = 69/287 (24%)
Query: 411 KAEVEIISRIHHRHLVSLVGYCISD-DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
KAE +I++ + +V L Y D D + DY+P + L G D A R
Sbjct: 49 KAERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA-RFY 106
Query: 470 IAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLA------------- 515
IA L E H IHRDIK NIL+D + +++DFGL
Sbjct: 107 IAE-----LTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 516 ------KLALD------------------------ANTH---ITTRVMGTFGYMAPEYAS 542
+ ++D A H + ++GT Y+APE
Sbjct: 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL 221
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEWARPL---LSHALENEEFD 598
T+ D +S GV+L E++ G+ P A PL + ++ W L L E D
Sbjct: 222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASD 281
Query: 599 NL------ADPRLGENYVE----GEMFRMIEAAAACVRHSAAKRPRM 635
+ + RLG+N + F+ I+ ++ + SA P++
Sbjct: 282 LIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKI 328
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 34/140 (24%), Positives = 41/140 (29%), Gaps = 12/140 (8%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP 68
P S S P S P + P S S P P + P S
Sbjct: 210 PPPGSHSKSPSKSGIPDLPSSRDSEKTKPEKPQQETSSMDTEKSSAPKPRETLDPKSPEK 269
Query: 69 PASSPPTSSPPPAS-NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
T + P S S SP +SP P P P + SP
Sbjct: 270 APPIDTTEEELKSPEASPKESEEASARKRSPSLLSPSP------KAESPKPLA-----SP 318
Query: 128 PSPPSDPPANSPPPSNPPSN 147
P DP + P P +PP N
Sbjct: 319 GKSPRDPLSPRPKPQSPPVN 338
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 4e-05
Identities = 22/119 (18%), Positives = 34/119 (28%), Gaps = 4/119 (3%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ P A ++P P P P +P P + P+ + P
Sbjct: 683 PAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLP 742
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
P PA +P PPPA P + PP+ ++ S
Sbjct: 743 PEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPS----EEEEMAEDDAPSMDDED 797
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 20/80 (25%), Positives = 27/80 (33%), Gaps = 2/80 (2%)
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
P PQ P ++ P PAP P + P + P P P +PP
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETA-TPPPVPPRPVAPP 420
Query: 224 PPSTKRLSPP-PGIPVPSTE 242
P T +P +P E
Sbjct: 421 VPHTPESAPKLTRAAIPVDE 440
|
Length = 585 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 28/122 (22%), Positives = 39/122 (31%), Gaps = 4/122 (3%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP-PSNPPSNLPPPPPSSVEPPKR 161
V+ P SP P P P P P P P P+ L P P+S P++
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEP-DLPQPDRHPGPAKPEAPGARPAEL--PSPASAPTPEQ 432
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
PP PP P +S P+N V + + + S+S
Sbjct: 433 QPPVARSAPLPPSPQASAPRNVASGKPGVDLGSWQGKFMNFTRNGSRKQPVQASSSDAAQ 492
Query: 222 PP 223
Sbjct: 493 TG 494
|
Length = 620 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 19/87 (21%), Positives = 30/87 (34%), Gaps = 3/87 (3%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
+ P ++P P+ P + PT S P V+ P P +P D A P
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPA--PAVDPQQNAVVAPSQANVDTAATPAP 225
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ + P P+ P + P
Sbjct: 226 AAPATPDGAAPLPTDQAGVST-PAADP 251
|
Length = 331 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 21/71 (29%), Positives = 30/71 (42%), Gaps = 3/71 (4%)
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQN---PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
P PP ++ P + P+ PP P PP + + P + PAP PP+ PP
Sbjct: 379 RGAPAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSA 438
Query: 203 PPTPASPIAPR 213
P A+ R
Sbjct: 439 DPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 22/148 (14%), Positives = 37/148 (25%), Gaps = 31/148 (20%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN--------------- 83
S P + + P S+PP S PT + PP +
Sbjct: 93 SSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNISDA 152
Query: 84 ----------------PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
TS+ P +P +P + P + P P++ P +
Sbjct: 153 LSQQQGQVNAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPAVNH 212
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSS 155
+ + SS
Sbjct: 213 HKTATVAVPPATSGKPKSGAASARALSS 240
|
Length = 327 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 31/188 (16%), Positives = 39/188 (20%), Gaps = 18/188 (9%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
A PP + PT + P P P T +P SP A S
Sbjct: 60 KSSAPRQIQAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSARRLTRSE 119
Query: 67 S-------PPASSPPTSSPP----PASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
A P SS PP S S P + + +
Sbjct: 120 GVARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALASAAL 179
Query: 116 PPPSSTPPPNSP-------PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
S S N P + P S
Sbjct: 180 FKDDEIRQEVDAARSDQASQSRLSRSRGNPPAIPPDAAPRQPMLTRSAGGRFEGEDENLE 239
Query: 169 QNPPPPPS 176
+N P
Sbjct: 240 RNLQPQSP 247
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 24/121 (19%), Positives = 28/121 (23%), Gaps = 2/121 (1%)
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
PP A P + P P P P P
Sbjct: 634 GFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAALR 693
Query: 147 NLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P P PP PP + P +P +S A PP PP Q
Sbjct: 694 --APQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQADGAE 751
Query: 207 A 207
Sbjct: 752 N 752
|
Length = 753 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 18/80 (22%), Positives = 23/80 (28%), Gaps = 1/80 (1%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKP-PTTSPPPSPPAS 60
+ P G A + S P PP P+ +P PP KP P P P
Sbjct: 65 TQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEPPKPKPVEKPKPKPKPQQK 124
Query: 61 NPPTSSSPPASSPPTSSPPP 80
+ P P
Sbjct: 125 VEAPPAPKPEPKPVVEEKAA 144
|
Length = 226 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 26/107 (24%), Positives = 31/107 (28%), Gaps = 8/107 (7%)
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP 128
P P A + PP A + P +P T +PP P P
Sbjct: 47 PGDRDEPDMMPAA-TQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEP---- 101
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P +PP P P P P P PP P P P
Sbjct: 102 -APVEPP--KPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 24/100 (24%), Positives = 33/100 (33%), Gaps = 10/100 (10%)
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS 165
P + + PP + + + P+ P PP+ P P+ VEPPK P
Sbjct: 57 PAATQALPTQPPEGAAEAVRAGDAAA---PSLDPATVAPPNTPVEPEPAPVEPPKPKPVE 113
Query: 166 VPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT 205
P P P P P P P + PT
Sbjct: 114 KPKPKPKPQQKVEAPPAPKPEP-------KPVVEEKAAPT 146
|
Length = 226 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 4e-05
Identities = 13/70 (18%), Positives = 21/70 (30%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P PP +P + A +P + P + P + + P P
Sbjct: 392 PSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPAA 451
Query: 174 PPSSSPPKNS 183
P + NS
Sbjct: 452 APQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 19/70 (27%), Positives = 26/70 (37%), Gaps = 2/70 (2%)
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
S P + P +P +S PT +P PP S S P S+ + +
Sbjct: 75 SKPKTGTGKVAPPAATP--TSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAP 132
Query: 137 NSPPPSNPPS 146
SP S P S
Sbjct: 133 ESPSTSVPSS 142
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A + + T + T Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELI 563
APE E D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 22/93 (23%), Positives = 32/93 (34%), Gaps = 1/93 (1%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
PP+PP +P P S+ R P T P + +P P +P
Sbjct: 173 PPNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQP-TVQNPAQQPTVQNPAQQPQQQPQQ 231
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
P + +P ++P PPQ S N
Sbjct: 232 QPVQPAQQPTPQNPAQQPPQTEQGHKRSREQGN 264
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 47/231 (20%), Positives = 69/231 (29%), Gaps = 15/231 (6%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
PAA + PP + P PP + P ++PP +P + P + P + +
Sbjct: 716 RPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPT 775
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPT----ISPPPPVSNPPTRSPPPPSSTPP 123
P PP +PP P +P P PP + PT + P PT+ T
Sbjct: 776 P---QPPPQAPPAPQQRPRGAPTPQPPPQAGPTSMQLMPRAAPGQQGPTKQILRQLLTGG 832
Query: 124 PNS--PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P PS V+ P PP + P S
Sbjct: 833 VKRGRPSLKKPAALERQAAAGPTPSPGSGTSDKIVQAPVFYPPVLQPIQVMRQLGSVRAA 892
Query: 182 NSPPAPIAVPP------SNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPS 226
+ A P PT PP+ + + P+ S
Sbjct: 893 AASTVTQAPTEYTGERRGVGPMHPTDIPPSKRAKTDAYVESQPPHGGQSHS 943
|
Length = 991 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 5e-05
Identities = 24/91 (26%), Positives = 33/91 (36%), Gaps = 8/91 (8%)
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
S+S +PP P PP P PP P A P P PPPP+ + S
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTP--------PPPPPTATQASSNA 566
Query: 235 GIPVPSTENTPGNGTNPSSPESSSSPSNNGI 265
+P+ + P +P + S I
Sbjct: 567 PAQIPADSSPPPPIPEEPTPSPTKDSSPEEI 597
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 29/135 (21%), Positives = 47/135 (34%), Gaps = 13/135 (9%)
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
+ P P S + K++P PQ P + P P++ P P Q P
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPP 435
Query: 204 PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENT-PGNGTNPSSPE----SSS 258
++P+ P P S P + PG+ + S + N S + SSS
Sbjct: 436 VARSAPLPPSPQAS-----APRNVASGK--PGVDLGSWQGKFMNFTRNGSRKQPVQASSS 488
Query: 259 SPSNNGIGTAGTVVI 273
+ G+ G +
Sbjct: 489 DAAQTGVF-EGVAEL 502
|
Length = 620 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-05
Identities = 29/149 (19%), Positives = 39/149 (26%), Gaps = 6/149 (4%)
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
P S PPA S P SP AS P T P ++ ++P PP
Sbjct: 648 PPSRAPPA---SLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVP 704
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P + PP P + SV + + V
Sbjct: 705 DPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQAVEQ---QATHQPQVQAE 761
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
P T +S + N S
Sbjct: 762 AQSPASTTALTQTSSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 5e-05
Identities = 14/77 (18%), Positives = 22/77 (28%), Gaps = 1/77 (1%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
PP+ P P + P + P + P P A + P
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVP-DAAAAAAAP 446
Query: 141 PSNPPSNLPPPPPSSVE 157
P+ + P +S E
Sbjct: 447 PAPAAAPQPAVRLNSFE 463
|
Length = 598 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 20/82 (24%), Positives = 27/82 (32%), Gaps = 4/82 (4%)
Query: 127 PPSPPSDPPANSPPPSNPPSN----LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
PP+PP + PA P + S+ P P+ + QNP P P +
Sbjct: 173 PPNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQQ 232
Query: 183 SPPAPIAVPPSNVPPPPTQTPP 204
P N P QT
Sbjct: 233 PVQPAQQPTPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 31/118 (26%), Positives = 40/118 (33%), Gaps = 6/118 (5%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP----ASSPPTISPP 104
+TS S P S+ S S SS P N P S P SP +SS +S
Sbjct: 8 GSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSSFGLSKQ 67
Query: 105 PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P S R S P SP + S + + S S+ P + S
Sbjct: 68 RPSSLSRGRLSSRFVS-PSRGSPSAAASLNGSLA-TASTSGSSSPSRSRRTTSSDLSS 123
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 6e-05
Identities = 23/119 (19%), Positives = 45/119 (37%)
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
P ++ +P + P P +++ P + A P+ P PP+
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 203 PPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
PA P ++P++ P P+ P P P+ P P++P + ++P+
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPA 504
|
Length = 824 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 6e-05
Identities = 40/191 (20%), Positives = 66/191 (34%), Gaps = 10/191 (5%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPP---PVSKPPTTSPPPSPPASNPPTSSSPP 69
SSP P+ S P SN ++P P T PS P++ ++ SP
Sbjct: 590 GSSPTSQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSP- 648
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP----PTRSPPPPSSTPPPN 125
P + S P SS P P P ++P ++ P ++
Sbjct: 649 --GPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGK 706
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
+ + + ++P +N + PPS + P +SPP +
Sbjct: 707 ANSTTKETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQ 766
Query: 186 APIAVPPSNVP 196
A + VPP+ P
Sbjct: 767 ATVPVPPTQHP 777
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 26/130 (20%), Positives = 40/130 (30%), Gaps = 15/130 (11%)
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP--PSSVEPPKRSPPSVP 167
R P P P + P A + PS S+ P P S P +PP+V
Sbjct: 370 SGGRGPKQHIK-PVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 168 PQNPPP---PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPT------PASPIAPRPSNSS 218
P P S+ P+ PA P ++ P A + + +
Sbjct: 429 VDPPAAVPVNPPSTAPQAVRPAQFKEEK---KIPVSKVSSLGPSTLRPIQEKAEQATGNI 485
Query: 219 PNSPPPPSTK 228
+P +
Sbjct: 486 KEAPTGTQKE 495
|
Length = 614 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 24/99 (24%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
S P ++ P +P P T P S TP + P+P DP N+ PS
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTT---PTNSQTPAVATAPAPAVDPQQNAVVA---PSQ 214
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
++ P + P P S P P A
Sbjct: 215 ANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 24/103 (23%), Positives = 31/103 (30%), Gaps = 10/103 (9%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP 68
P S++ P T +P PV P +S P T P P N + S
Sbjct: 163 PLDTSTTTDPA----TTPAPAAPVDTTPTNSQTPAV----ATAPAPAVDPQQNAVVAPSQ 214
Query: 69 PASSPPTSSPPPASNPPTSSP--PPSPPASSPPTISPPPPVSN 109
+ P A P + P S P P V N
Sbjct: 215 ANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADPNALVMN 257
|
Length = 331 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 20/101 (19%), Positives = 33/101 (32%), Gaps = 1/101 (0%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
T+P + ++P + P A + P ++S P T +
Sbjct: 82 AEATAPSDAGSQASPDDDAQPAAEAEAADQSAPPE-ASSTSATDEAATDPPATAAARDGP 140
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
+ PT P P P P +PP S P ++ L
Sbjct: 141 TPDPTAQPATPDERRSPRQRPPVSGEPPTPSTPDAHVAGTL 181
|
Length = 226 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 475 ARGLAYL-HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
ARG+ +L ++C +HRD+ + N+LL ++ DFGLA+ + + +++ TF
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STF 300
Query: 534 ---GYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+MAPE T SDV+S+G++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240420 PTZ00441, PTZ00441, sporozoite surface protein 2 (SSP2); Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 62/255 (24%), Positives = 82/255 (32%), Gaps = 18/255 (7%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P P P PP+P NP + A NP PPP+ P
Sbjct: 283 PVEPEPLPVPAPVPPTPEDDNPRPTDDEFAVPNFNEGLDVPDNPQDPVPPPNEGKDGNPN 342
Query: 101 IS--PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
PP P S PP+ PPN P S+ ++ P NPP+ P P
Sbjct: 343 EENLFPPGDDEVPDESNVPPN---PPNVPGGSNSEFSSDVENPPNPPN--PDIPEQEPNI 397
Query: 159 PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSS 218
P+ S VP P P + P P P + + +
Sbjct: 398 PEDSNKEVPEDVPMEPEDDRDNNFNEPKKPENKGDGQNEPVIPKPLDNERDQSNKNKQVN 457
Query: 219 PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSS---------SPSNNGIGTAG 269
P + S R + P G + N P PE S SNNG AG
Sbjct: 458 PGN-RHNSEDRYTRPHGRNNENRNYNNKNSDIPKHPERSEHEQPEDKKKKSSNNGYKIAG 516
Query: 270 TVVIAVA-VGIIAFS 283
V+ +A VG + F+
Sbjct: 517 GVIAGLALVGCVGFA 531
|
Length = 576 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 23/87 (26%), Positives = 26/87 (29%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P A P P V + P P S P P PV +P + P P
Sbjct: 120 ETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEPVDSMAIAVPAIDTP 179
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSP 89
T PPA PP P S
Sbjct: 180 VTLELPPAPQPPPPVVPQPSTMVVHRR 206
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 26/107 (24%), Positives = 39/107 (36%), Gaps = 1/107 (0%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
+ A P +S +P +S P + S+ P+RS PS P+S
Sbjct: 110 FTVVSQAKKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRS-ASPSRKFSPSSTIQQSPQL 168
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
++ P S S P SS+ P S ++ P SS K
Sbjct: 169 TPSNKPASPSSSYQSPSYSSSLGPVNSSGNRSNLRSSPWALRSSGDK 215
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 34/188 (18%), Positives = 48/188 (25%), Gaps = 18/188 (9%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP----PNSPPSPP 131
S+ PA PP P P R+ P P P + P+ P
Sbjct: 91 SAGEPAPPPP---HARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYP 147
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS--PPAPIA 189
+ P ++ + P R+P + P P P ++ P
Sbjct: 148 AYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYDQR 207
Query: 190 VPPSNVPPPPTQTP---------PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPS 240
+ P P P P P + R P P PG
Sbjct: 208 RRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPGPLAAQ 267
Query: 241 TENTPGNG 248
PG G
Sbjct: 268 PAPAPGPG 275
|
Length = 617 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 15/69 (21%), Positives = 24/69 (34%), Gaps = 1/69 (1%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
P P + PP +++PP P + P A+ P + PP+ A + P
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVP-PAAPARPAAARPAPAPAPPAAAAPPARSADP 440
Query: 104 PPPVSNPPT 112
S
Sbjct: 441 AAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 17/72 (23%), Positives = 26/72 (36%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
P A +++ + P P PP +S P PP + P P + P P
Sbjct: 125 PAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVAR 184
Query: 66 SSPPASSPPTSS 77
+ P + P S
Sbjct: 185 ADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 20/77 (25%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
PP +P S P+ P SPP S P S + P S+V P + +
Sbjct: 83 KVAPPAATPTSAPT--PTPSPPAS-PASGMSAAPASAV------EEKSPSEESATATAPE 133
Query: 179 PPKNSPPAPIAVPPSNV 195
P S P+ + S +
Sbjct: 134 SPSTSVPSSGSDAASTL 150
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|130689 TIGR01628, PABP-1234, polyadenylate binding protein, human types 1, 2, 3, 4 family | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 25/132 (18%), Positives = 39/132 (29%), Gaps = 18/132 (13%)
Query: 140 PPSNPPSNLPPPPPSSVEPPKRSP------PSVP---PQNPPPPPSSSPPKNSPPAPIAV 190
P P + +PP P P+ P P P P +
Sbjct: 380 PRMRQLPMGSPMGGAMGQPPYYGQGPQQQFNGQPLGWPRMSMMPTPMGP--GGPLRPNGL 437
Query: 191 PPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP-STENTPGNGT 249
P + P A A +P PP+ + L +P P ST + G
Sbjct: 438 A----PMNAVRAPSRNAQNAAQKP--PMQPVMYPPNYQSLPLSQDLPQPQSTASQGGQNK 491
Query: 250 NPSSPESSSSPS 261
+ +S++P
Sbjct: 492 KLAQVLASATPQ 503
|
These eukaryotic proteins recognize the poly-A of mRNA and consists of four tandem RNA recognition domains at the N-terminus (rrm: pfam00076) followed by a PABP-specific domain (pfam00658) at the C-terminus. The protein is involved in the transport of mRNA's from the nucleus to the cytoplasm. There are four paralogs in Homo sapiens which are expressed in testis (GP:11610605_PABP3 ), platelets (SP:Q13310_PABP4 ), broadly expressed (SP:P11940_PABP1) and of unknown tissue range (SP:Q15097_PABP2). Length = 562 |
| >gnl|CDD|139494 PRK13335, PRK13335, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 16/82 (19%), Positives = 29/82 (35%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
P P+ S S P + T +P ++ + +P V+
Sbjct: 74 PKLEKAPNTNEEKTSASKIEKISQPKQEEQKSLNISATPAPKQEQSQTTTESTTPKTKVT 133
Query: 109 NPPTRSPPPPSSTPPPNSPPSP 130
PP+ + P P + ++P SP
Sbjct: 134 TPPSTNTPQPMQSTKSDTPQSP 155
|
Length = 356 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (105), Expect = 7e-05
Identities = 38/109 (34%), Positives = 48/109 (44%), Gaps = 5/109 (4%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
+P+ PA + P P P P + PP ++P PP + P +P PA P
Sbjct: 85 SPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCP--APARPAPACPP 142
Query: 63 PTSSSPPASSPPTSSPPPASNPP---TSSPPPSPPASSPPTISPPPPVS 108
T PPA PT P PA+ P PPP PA+S PTI P S
Sbjct: 143 STRQCPPAPPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAAS 191
|
Length = 280 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 8e-05
Identities = 22/107 (20%), Positives = 33/107 (30%), Gaps = 11/107 (10%)
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN--------- 182
SD A +PP + P+ PP + P S P+ P P P +
Sbjct: 46 SDLAALAPPAAAAPA--AAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVA 103
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
AP A P + A+ R + ++P P
Sbjct: 104 RAAAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAA 150
|
Length = 484 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 45/184 (24%), Positives = 53/184 (28%), Gaps = 6/184 (3%)
Query: 17 PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P +S P +PPP P P P P PP + P A S
Sbjct: 729 PLDLSLHPDQAPPPSHQAPYSGHEEPQAQQAPYPGYWEPRPPQAPYLGYQEPQAQGVQVS 788
Query: 77 SPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
S P + P P P P P PP S
Sbjct: 789 SYPGYAGPWGLRAQ-HPRYRHSWAYWSQYPGHGHPQGPWAPRPPHLPPQWDGSAGHGQDQ 847
Query: 137 NSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP 196
S P PP S P + P S + P SSP +P PI P+ P
Sbjct: 848 VSQFPHLQSETGPPRLQLSQVP--QLPYSQTLVSSSAPSWSSPQPRAPIRPI---PTRFP 902
Query: 197 PPPT 200
PPP
Sbjct: 903 PPPM 906
|
Length = 1000 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 8e-05
Identities = 11/71 (15%), Positives = 19/71 (26%)
Query: 37 KSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
+ PP P +P A + A++P P A + +
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPP 447
Query: 97 SPPTISPPPPV 107
+P P
Sbjct: 448 APAAAPQPAVR 458
|
Length = 598 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 30/161 (18%), Positives = 49/161 (30%), Gaps = 1/161 (0%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
+ +S P S P + + A++ T+ S P P P AS PP
Sbjct: 259 SSAFMLNSSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLP-ASLPPPPVR 317
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P V +P P + P+ P+ ++ S + P S S
Sbjct: 318 RPRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAAASSF 377
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
PP ++ ++ P + P P T
Sbjct: 378 LEDDDFGSPPLDLTTSLRHMPSPSVTSAPEPPSIPLTYLSD 418
|
Length = 418 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 26/93 (27%), Positives = 36/93 (38%), Gaps = 17/93 (18%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
VSKP T + +PP T +S P PT SPP + P S +P ++
Sbjct: 74 VSKPKTGTGKVAPP---AATPTSAPT---PTPSPPAS---PASGMSAAPASAVEE----- 119
Query: 105 PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
+P S + P S PS SD +
Sbjct: 120 ---KSPSEESATATAPESPSTSVPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 29/180 (16%), Positives = 37/180 (20%), Gaps = 15/180 (8%)
Query: 99 PTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
P+ P P P T P P P ++ P
Sbjct: 90 PSAGEPAP----PPPHAR---RTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTA 142
Query: 159 PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA----SPIAPRP 214
P P P ++ + PP P P A RP
Sbjct: 143 RPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRP 202
Query: 215 SNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG----TNPSSPESSSSPSNNGIGTAGT 270
P E PG G P PE +P +A
Sbjct: 203 EYDQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPG 262
|
Length = 617 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-05
Identities = 52/287 (18%), Positives = 90/287 (31%), Gaps = 21/287 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S P P ++ +PP S P PKSS PP + + P +
Sbjct: 560 SEPGTLPYGSSVQTPPDRPKAATKGSRKPSPRKEPKSSVPPAAEKRKYKSPSKIVPKSRE 619
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ S + SP S PP+S P ++ +S T P S+ +++
Sbjct: 620 FIETDSSSSDSPEDESLPPSSQSPGNTESSKESCASLRT---PVCRSSVGSQNDLSKDRL 676
Query: 122 PPP---NSPPSPPSDPPANSP----PPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P SP D + S +P P PPK +
Sbjct: 677 LSPMRETELLSPLRDSEERYSLWVKIDLDLLSRIPGHPYKKGVPPKPAEKDSLSAPKKQT 736
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQ---------TPPTPASPIAPRPSNSSPNSPPPP 225
++ K+S + +P+S + S+S+ S
Sbjct: 737 SKTASEKSSSKGKRKHKNDEEADKIESKKQRLEEKSSSCSPSSSSSHHHSSSNKESRKSS 796
Query: 226 STKR--LSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGT 270
K + P P P+ S+ P + + + S++G +A +
Sbjct: 797 RNKEEEMLPSPSSPLSSSSPKPEHPSRKRPRRQEDTSSSSGPFSASS 843
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 23/107 (21%), Positives = 36/107 (33%), Gaps = 8/107 (7%)
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
NS S P D + P + P P P + ++P P P +
Sbjct: 156 QNSGQSVPLDTSTTTDPATTPA---PAAPVDTTPTNSQTPAVATAPAPAVDPQQNAV--V 210
Query: 184 PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL 230
P+ V + P P P A+P+ P++ + S P L
Sbjct: 211 APSQANVDTAATPAPAAPATPDGAAPL---PTDQAGVSTPAADPNAL 254
|
Length = 331 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-05
Identities = 18/75 (24%), Positives = 32/75 (42%), Gaps = 7/75 (9%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
P+PP++ + ++PP ++ PP + P + PA +P PP + PP RS
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAP----APPAAAAPPARS 437
Query: 115 PPPPSSTPPPNSPPS 129
P ++
Sbjct: 438 ADP---AAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 23/124 (18%), Positives = 33/124 (26%), Gaps = 8/124 (6%)
Query: 102 SPPPPVSNPPTRSPPPPSSTP-PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
PP + P P P P P + P + P P++
Sbjct: 635 FPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSR--VARGDPVRPTAHHAAL 692
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN 220
R PQ P P PP P + P + +P +P P P +
Sbjct: 693 R-----APQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQA 747
Query: 221 SPPP 224
Sbjct: 748 DGAE 751
|
Length = 753 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 24/72 (33%), Positives = 32/72 (44%), Gaps = 2/72 (2%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P + K +PP + PT P PSPPAS S+ PAS+ SP S T+
Sbjct: 77 PKTGTGKVAPPAATPTSAPT--PTPSPPASPASGMSAAPASAVEEKSPSEESATATAPES 134
Query: 91 PSPPASSPPTIS 102
PS S + +
Sbjct: 135 PSTSVPSSGSDA 146
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 48/228 (21%), Positives = 75/228 (32%), Gaps = 33/228 (14%)
Query: 2 SAPSPGPPAANSSSP---PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP 58
SA PA S+P P V P T P P + P+++P P + PP+T+ P
Sbjct: 181 SADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTASPETTPTPSTTTSPPSTTIPAPST 240
Query: 59 ASNPPTSSSPPASSPPTSSPPPASN--PPTSSPPPSPPASSPPTISPPPPVSNPPT---- 112
P + + P + + P P PP ++ P + T++ ++ P +
Sbjct: 241 TIAAPQAGTTPEAEGTPAPPTPGGGEAPPANATPAPEASRYELTVTQIIQIAIPASIIAC 300
Query: 113 -----------------RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
R P PP P PS N + L PP S
Sbjct: 301 VFLGSCACCLHRRCRRRRRRPARIYRPP---SPVAPSISAVNEAALARLGDELKRHPPES 357
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
KR Q P ++ ++ PA + + S P
Sbjct: 358 PRRSKRR----SSQTMVPSLTAISEESEAPAVVELSRSPRRPGGPTAR 401
|
Length = 401 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 68/319 (21%), Positives = 96/319 (30%), Gaps = 59/319 (18%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSS-----PPPPPVSKPPT------------ 50
PP P P+S + P P+ +P + PP V +
Sbjct: 457 PPTQPLEGPTGPLSVQAPLEPWQPLPHPQVTPVILHQPPAQGVQAHGSMLDLLEKDDEDM 516
Query: 51 ------TSPPPSPP-------------------ASNPPTSSSPPASSPPTSSPPPASNPP 85
T PPSPP + P ++ P P P
Sbjct: 517 EQRVMATLLPPSPPQPRAGRRAPCVYTEDLDIESDEPASTEPVHDQLLPAPGLGPLQIQP 576
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS--STPPPNSPP--------SPPSDPP 135
+SP S ASS P+ + P P+++P PP+ S P S P P P
Sbjct: 577 LTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQSHIPETSAPRQWPMPLRPIPMRPL 636
Query: 136 ANSPPPSNPPSNLPPPPPSSVEPPKRSP-----PSVPPQNPPPPPSSSPPKNSPPAPIAV 190
P N P P VE P +P Q P ++ P P +
Sbjct: 637 RMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQP 696
Query: 191 PP-SNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
PP + P P PP A A + P + P + + PG PG
Sbjct: 697 PPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPG-RARPPAAAPGRAR 755
Query: 250 NPSSPESSSSPSNNGIGTA 268
P++ + P G
Sbjct: 756 PPAAAPGRARPPAAAPGAP 774
|
Length = 991 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 20/79 (25%), Positives = 32/79 (40%), Gaps = 3/79 (3%)
Query: 2 SAPSPGPPAANSSSPP--PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
+A SP P +++++ P P + P +PP +PP + P PP + P P
Sbjct: 396 AAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKE- 454
Query: 60 SNPPTSSSPPASSPPTSSP 78
S + P T P
Sbjct: 455 EKKIPVSKVSSLGPSTLRP 473
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 23/79 (29%), Positives = 30/79 (37%), Gaps = 5/79 (6%)
Query: 2 SAPSPGPPAANSSSP-PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
A +P P AA ++SP P S S P + P + PP VS P + P P S
Sbjct: 386 PAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQP---AGTPPTVSVDP-PAAVPVNPPS 441
Query: 61 NPPTSSSPPASSPPTSSPP 79
P + P P
Sbjct: 442 TAPQAVRPAQFKEEKKIPV 460
|
Length = 614 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 40/165 (24%), Positives = 55/165 (33%), Gaps = 13/165 (7%)
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNP---PTRSPPPPSSTPPPNSPPSPPSDPP 135
P +NP + P + P P+ P P + P P + P P P
Sbjct: 716 PAGANPFSLDDFEFSPMKALLDDGPHEPLFTPIVEPVQQPQQPVAPQQQYQQPQQPVAPQ 775
Query: 136 ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNV 195
P P P P +P + P Q P P + P P P+A P
Sbjct: 776 PQYQQPQQPV----APQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQ 831
Query: 196 PPPPTQTPPTPASPIAP---RPSNSSP---NSPPPPSTKRLSPPP 234
P P + + P R +S P + P PS L+PPP
Sbjct: 832 QPQQPVAPQPQDTLLHPLLMRNGDSRPLHKPTTPLPSLDLLTPPP 876
|
Length = 1355 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 28/142 (19%), Positives = 39/142 (27%), Gaps = 9/142 (6%)
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP 191
P SP P + LP P P Q P+ SP N P
Sbjct: 46 EFPWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFA--L 103
Query: 192 PSNVPPPPTQTPPTPASPIAPRPS----NSSPNSPPPPSTKRLSPP--PGIPVPSTENTP 245
P+ P QT P P P N + + P+ +R P++ P
Sbjct: 104 PAGPAGPTIQTEPGQLYP-VQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLP 162
Query: 246 GNGTNPSSPESSSSPSNNGIGT 267
+ + S T
Sbjct: 163 SQQQSAQKNDESQLQQQPNGET 184
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 32/200 (16%), Positives = 41/200 (20%), Gaps = 22/200 (11%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPP---KSSPPPPPVSKPPT--TSPPPSPPASNPPTSSSP 68
P PP K P + S P P
Sbjct: 126 EEPKDRKPKEEAKEKRPPKEKEKEKEKKVEEPRDREEEKKRERVRAKSRPKKPPKKKPPN 185
Query: 69 PASSPPTSSPPPASNPPTSSPPPSPPASSP-------------PTISPPPPVSNPPTRSP 115
PP + P P + T SP + +
Sbjct: 186 KKKEPPEEEKQRQAAREAVKGKPEEPDVNEEREKEEDDGKDRETTTSPMEEDESRQSSEI 245
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
SS+ PSP P P +S+ PP P S P P
Sbjct: 246 SRRSSSSLKKPDPSPSMASPETRESSKRTE----TRPRTSLRPPSARPASARPAPPRVKR 301
Query: 176 SSSPPKNSPPAPIAVPPSNV 195
+ SNV
Sbjct: 302 KEIVTVLQDAQGVGKIVSNV 321
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 2/65 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPT--ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
+ + G P + + PPP + PP +P P + P +P PP + PP S P+ A
Sbjct: 385 PSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADPAAAA 444
Query: 60 SNPPT 64
S
Sbjct: 445 SAGDR 449
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 18/69 (26%), Positives = 28/69 (40%), Gaps = 2/69 (2%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P P S P + PPP + P P P A + P + P+ P PP ++ P + +
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVP--PAAPARPAAARPAPAPAPPAAAAPPARSAD 439
Query: 164 PSVPPQNPP 172
P+
Sbjct: 440 PAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 1e-04
Identities = 12/71 (16%), Positives = 22/71 (30%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
PP+ PP P + + P ++ + P + ++ PP
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 128 PSPPSDPPANS 138
+P NS
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 24/159 (15%), Positives = 33/159 (20%), Gaps = 2/159 (1%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
SP + T+ P + TS+ PP
Sbjct: 20 SPEGSRDENFDAERDDFLTPLGSTSEATSEDDDDLYPPRETGSGGGVATSTIYTVPRPPR 79
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
S P PP P +S+P + + P + P P
Sbjct: 80 GPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPI 139
Query: 147 NLPPPP--PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
S E PP P S
Sbjct: 140 GESNSSSEELSEEEEHSRPPPSESLKVKNGGKVYPKGFS 178
|
Length = 580 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 14/64 (21%), Positives = 22/64 (34%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P + + KP +P P PPA++ PT + P + P P
Sbjct: 125 PAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVAR 184
Query: 88 SPPP 91
+ P
Sbjct: 185 ADPR 188
|
Length = 418 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 36/149 (24%), Positives = 46/149 (30%), Gaps = 10/149 (6%)
Query: 63 PTSSSPPASSPPTSSPPPASN--PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
S +PPP S+ P+ S P P+S + P + SS
Sbjct: 195 TNSFKEVTPVGLMRTPPPGSHSKSPSKSGIPDLPSSRDSEKTKPEKPQQETSSMDTEKSS 254
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
P P P S A PP + S E + + P S P
Sbjct: 255 APKPRETLDPKSPEKA-------PPIDTTEEELKSPEASPKESEEASARKRSPSLLSPSP 307
Query: 181 KNSPPAPIAVPPSNVPPPPTQTPPTPASP 209
K P P+A P P P P P SP
Sbjct: 308 KAESPKPLA-SPGKSPRDPLSPRPKPQSP 335
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 21/77 (27%), Positives = 30/77 (38%), Gaps = 2/77 (2%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
S P + +PP A+ +P PSPPAS +S P + ++ P S
Sbjct: 75 SKPKTGTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPES 134
Query: 127 PPSPPSDPPANSPPPSN 143
P S P + S S
Sbjct: 135 P--STSVPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 20/87 (22%), Positives = 27/87 (31%), Gaps = 1/87 (1%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
PP+PP P P + + PT P PA P +P P +
Sbjct: 173 PPNPP-REAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQ 231
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPP 140
P P+ P P +P P
Sbjct: 232 QPVQPAQQPTPQNPAQQPPQTEQGHKR 258
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|218181 pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain transcription factor N terminal domain | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 40/181 (22%), Positives = 51/181 (28%), Gaps = 11/181 (6%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ S P PPT P P + T+ P SPP P + P SP
Sbjct: 118 SYSAYDRKPASGFKPPTPPSTPCSPVNPQETVRQLQPSGPLSNSSPPSPHTPLPNQSPLP 177
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP-------PSSSPPKN 182
PP +SP S P + S P PP ++ PP P P
Sbjct: 178 PPM----SSPDSSYPSEHRFQRQLSEPCLPFPPPPGRGSRDGRPPYHRQMSEPLVPYPPQ 233
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTE 242
P P Q P I P + + +S P G E
Sbjct: 234 GFKQEYHDPLYEEAGVPNQGPFPHPMMIKQEPRDFTYDSEVPGCHSSYGRAEGFYSNRHE 293
Query: 243 N 243
Sbjct: 294 G 294
|
The N terminus of the PEA3 transcription factors is implicated in transactivation and in inhibition of DNA binding. Transactivation is potentiated by activation of the Ras/MAP kinase and protein kinase A signalling cascades. The N terminal region contains conserved MAP kinase phosphorylation sites. Length = 336 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 27/125 (21%), Positives = 35/125 (28%), Gaps = 16/125 (12%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P SS S S+ S P P I P N P P + P
Sbjct: 12 PISSISFLSVVSCSTTSSNSKQP----------EKKPEIKPN---ENTPKIPKKPDNKEP 58
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
N+ ++ P S P P P + E P P+ P P + P N
Sbjct: 59 SENNNNKSNNENKDEENPSSTNPEKKPDPSKNKEEI---EKPKDEPKKPDKKPQADQPNN 115
Query: 183 SPPAP 187
Sbjct: 116 VHADQ 120
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 29/106 (27%), Positives = 35/106 (33%), Gaps = 5/106 (4%)
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
P A PP P PP S PS++ P + S P P PS
Sbjct: 179 GGNIPGAIQPP--PPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAP 236
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P P+ PP + P P PPP P A P+N
Sbjct: 237 PASIPAPPIPPVIQYVAPP---PVPPPQPIIPIQHIRAVTGETPAN 279
|
Length = 582 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 34/121 (28%), Positives = 41/121 (33%), Gaps = 21/121 (17%)
Query: 53 PPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
P A PP P P S +P ASS P P NP
Sbjct: 179 GGNIPGAIQPP-------------PPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFL 225
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK--RSPPSVPPQN 170
P P + PP S P+PP PP + P PPP + P + R+ P N
Sbjct: 226 PGPSPAQPSAPPASIPAPP------IPPVIQYVAPPPVPPPQPIIPIQHIRAVTGETPAN 279
Query: 171 P 171
P
Sbjct: 280 P 280
|
Length = 582 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 22/86 (25%), Positives = 31/86 (36%), Gaps = 7/86 (8%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
S P + S S S+ + S PP SS P P + P+ S P+ P
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPP-------SSTSPRPRRRKPSASSLLHTPSILPL 53
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSP 89
S P+ T P + P +P
Sbjct: 54 PKLSSPSPPSVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 25/86 (29%), Positives = 33/86 (38%), Gaps = 7/86 (8%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
SSS +S S +S+ + S PPS ++SP P S+ P P
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPS--STSPRPRRRKPSASSLLH---TPSILPLPK 55
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPP 150
S PSPPS P + L P
Sbjct: 56 LSSPSPPSVTLP--PAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 31/149 (20%), Positives = 46/149 (30%), Gaps = 23/149 (15%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
S+ S +S+ P SSP A P S P + S+ ++ P T
Sbjct: 264 DPTETSSEDGYSFSRSSAYPNSSPRQALPPSISLPQNT---STSGSLHSAQTSRRPNTTF 320
Query: 115 PPPPSS---------------TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
SS PP+S P + PS+ P S
Sbjct: 321 DKAASSGTKDSLWSPSSLCGMATPPSSIGMSPLILSLS---PSHLSGRAPGTTGSG--KG 375
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
+ + S P +PPPP + + A
Sbjct: 376 EPASESTPSTSPPPPGLADDIVRAIFATS 404
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 33/127 (25%), Positives = 44/127 (34%), Gaps = 8/127 (6%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPP---PSPPASN-PPTSSSPPASSP 73
P S+P T SP VS+ + P P P A P S+ P S+
Sbjct: 109 PDESDPDTGSPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSAL 168
Query: 74 PTSS----PPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ S P PA P+ S P S P + PP +S P P P+
Sbjct: 169 QSESLIAQPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPT 228
Query: 130 PPSDPPA 136
+ PA
Sbjct: 229 ISASQPA 235
|
Length = 430 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 56/232 (24%), Positives = 77/232 (33%), Gaps = 34/232 (14%)
Query: 13 SSSPPPPVSNPPTISPPPPV-SNPPKSSPPPPPVSKPPTTSPPPSPPASNP----PTSSS 67
P PV + P I P P+ + + SPP P S+ P++ P P S P
Sbjct: 227 PLPSPQPVRHSPGILGPSPLHPHTTRPSPPRPAFSRSPSSPLSPLPRPSTRRGLLPNPRL 286
Query: 68 PPAS----SPPTSSPPP-------------ASNPPTSSPPPSPPASSPPTISPP------ 104
P AS PPTSS PP +S P + + P + +
Sbjct: 287 PRASRGHLPPPTSSAPPRPNGGLRRPLHLHSSRPNSPNLRPRRIRKNSLQQTRARLGHSK 346
Query: 105 ----PPVSNPPTRSPPPPSSTP-PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP- 158
P PP P PP + P P ++P P P S P
Sbjct: 347 SLGQSPNLRSSQLPPPTKRRLRLLPVPPPKVQALPLTALAPLVRHSPSIPLPHPPSALPS 406
Query: 159 PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
+ S + PP + P+P PPP +PPTP+ P
Sbjct: 407 HVGASSSKHHRLPPSVLPGPRLSSPSPSPSLPTRRPGTPPPPASPPTPSPPS 458
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 25/87 (28%), Positives = 32/87 (36%), Gaps = 7/87 (8%)
Query: 170 NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
+ PP+ SPP P P +P P PP P P + +S N+P
Sbjct: 517 ASNTAKTPPPPQKSPPPP--APTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 230 LSPPPGIPVPSTENTPGNGTNPSSPES 256
PPP P+ T SSPE
Sbjct: 575 SPPPPIPEEPTPSP-----TKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 42/168 (25%), Positives = 52/168 (30%), Gaps = 20/168 (11%)
Query: 80 PASNPPTSSPPPSPPASS--------PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
P P S PP P S P P + P + P
Sbjct: 510 PPEGPEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAKEHKP 569
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP 191
S P S P P P P + PKR P++ P PK P + +P
Sbjct: 570 SKIPTLSKKPEFPKDPKHPKDPEEPKKPKR------PRSAQRPTRPKSPKL--PELLDIP 621
Query: 192 PSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
S P ++P P P P SSP P P + PP P P
Sbjct: 622 KSPKRPESPKSPKRPPPPQRP----SSPERPEGPKIIKSPKPPKSPKP 665
|
Length = 943 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 41/200 (20%), Positives = 52/200 (26%), Gaps = 30/200 (15%)
Query: 5 SPGPPAANSSSPPPPVSNPPTI----------SPPPPVSNPPKSSPPPPPVSKPPTTSPP 54
A S S PP+ P P PPKSS + P
Sbjct: 456 PHKVSPAESVSSNPPIKQPMEKEGKVKSSGSQYHPESKEPPPKSSSKEKRRPRTAQKGPE 515
Query: 55 P------SPPASNPPTSSSPPASSPPTSSPPPASN-----PPTSSPPPSPPASSPPTISP 103
SP S P P ++ S P + P S P
Sbjct: 516 SGRGKQKSPAQSEAPPQRRTVGKKQPKKPEKASAGDERTGLRPESEPGTLPYGSSVQTPP 575
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P + P P P + PP+ S P S S
Sbjct: 576 DRPKAATKGSRKPSPRKEPKSSVPPAAEK---------RKYKSPSKIVPKSREFIETDSS 626
Query: 164 PSVPPQNPPPPPSSSPPKNS 183
S P++ PPSS P N+
Sbjct: 627 SSDSPEDESLPPSSQSPGNT 646
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 28/168 (16%), Positives = 44/168 (26%), Gaps = 12/168 (7%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ A SP SS PP+ +PP +S P S +
Sbjct: 626 LDALSPKEGDGKKSSADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQ 685
Query: 61 NPPTSSSPPASSP---PTSSP---PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
+ P ++ S+P P P PP P + P ++ +
Sbjct: 686 SVPEAALASGSAPAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSEL 745
Query: 115 PP-PPSSTPPPNSPPSPPSD-----PPANSPPPSNPPSNLPPPPPSSV 156
+T P S S + NL S+
Sbjct: 746 QAVEQQATHQPQVQAEAQSPASTTALTQTSSEVQDTELNLVLLSSGSI 793
|
Length = 944 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 36/219 (16%), Positives = 55/219 (25%), Gaps = 35/219 (15%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPP----------------------ASNPPTS 87
A P+S S S T++ A +P
Sbjct: 575 ANVQSAQSAAEAQPSSQSLSPISAVTTAAASLADDDILDAVLAARDSLLSDLDALSPKEG 634
Query: 88 SPPPSPPA---SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
S +PP+ +PP +S P + +S P + S P +
Sbjct: 635 DGKKSSADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELA--THQSVPEAAL 692
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
S P PP +P R PP P +S+ + A + S
Sbjct: 693 ASGSAPAPPPVPDPYDR-----PPWEEAPEVASANDGPNNAAEGNLSESV---EDASNSE 744
Query: 205 TPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTEN 243
A P++ V TE
Sbjct: 745 LQAVEQQATHQPQVQAEAQSPASTTALTQTSSEVQDTEL 783
|
Length = 944 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 20/122 (16%), Positives = 33/122 (27%), Gaps = 14/122 (11%)
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
+PPA++ P + PPP + P S P + P P +
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRP---AAPAAEPAP-WLVEHAKRLTAQREQLVARAAA 107
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
P + E + P+ + + P P P A +
Sbjct: 108 PAAP-EAQAPAAPAERAAAENAARRLARAAAAAPR---------PRVPADAAAAVADAVK 157
Query: 212 PR 213
R
Sbjct: 158 AR 159
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 13/104 (12%), Positives = 27/104 (25%), Gaps = 5/104 (4%)
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
+ P ++P A PP ++P ++P P P + R +P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAA-EPAPWLVEHAKRLTAQ--REQLVARAAAP 108
Query: 131 PSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
+ P+ + + + P
Sbjct: 109 AAPEAQAPAAPAERAA--AENAARRLARAAAAAPRPRVPADAAA 150
|
Length = 484 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 18/92 (19%), Positives = 31/92 (33%), Gaps = 3/92 (3%)
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
S P S + P + P +P + + A +P P+ P PS
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS---QANV 217
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
+ P P P + P + A ++ P +
Sbjct: 218 DTAATPAPAAPATPDGAAPLPTDQAGVSTPAA 249
|
Length = 331 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 21/73 (28%), Positives = 30/73 (41%), Gaps = 9/73 (12%)
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
PP + P + P+ P PPA +PP P P++ P +P PP PP
Sbjct: 384 PPSAAWGAPTPAAPAAP--PPAAAPPVPPAA----PARPAAARP---APAPAPPAAAAPP 434
Query: 175 PSSSPPKNSPPAP 187
S+ P + A
Sbjct: 435 ARSADPAAAASAG 447
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 20/65 (30%), Positives = 27/65 (41%), Gaps = 8/65 (12%)
Query: 127 PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
PPS P + P + PP+ PP PP++ P + P+ P P PPA
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAA--------PPA 435
Query: 187 PIAVP 191
A P
Sbjct: 436 RSADP 440
|
Length = 576 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 28/176 (15%), Positives = 40/176 (22%), Gaps = 6/176 (3%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
SS+P + PP P + P + P P S+P
Sbjct: 53 KMPKVFQKSSAPRQIQAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSA 112
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSP--PASSPPTISPP--PPVSNPPTRSPPPPSS 120
+ + P P S PPVS S P++
Sbjct: 113 RRLTRSEGVARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPAT 172
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
+ D + S P PP P+ P S
Sbjct: 173 ALASAALFKD--DEIRQEVDAARSDQASQSRLSRSRGNPPAIPPDAAPRQPMLTRS 226
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 28/131 (21%), Positives = 41/131 (31%), Gaps = 6/131 (4%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSS-SPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
PP + T+ P S A N P S P S PT P+S+P + S P + + S
Sbjct: 149 GPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLESPS 208
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
+ V P + S+ + S S P SS+
Sbjct: 209 NLQV--TTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRS---TPTSGSSSIN 263
Query: 158 PPKRSPPSVPP 168
P +
Sbjct: 264 PVSGLDEAEED 274
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 24/136 (17%), Positives = 36/136 (26%), Gaps = 10/136 (7%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
+S P ++ P+S ++P + +P P+ SP +
Sbjct: 146 SSLGPPLQHRKRDAVTASPSSMIARNTP---ISDRLRPRSVTPTRGRRPSSSPRSLSNPT 202
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN 170
SP T PP S + S S P RS S
Sbjct: 203 TLESPSNLQVTTD-----VPPPYSNGTSRSSTMSSSANLSIISSLATP--RSGESFRSTP 255
Query: 171 PPPPPSSSPPKNSPPA 186
S +P A
Sbjct: 256 TSGSSSINPVSGLDEA 271
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 4/95 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A S P ++ + + P ++ + PP + P P P A
Sbjct: 89 DAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAATDPPATAAARDGPTPDPTAQ- 147
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
++P P PP + PPT S P + A
Sbjct: 148 ---PATPDERRSPRQRPPVSGEPPTPSTPDAHVAG 179
|
Length = 226 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 32/201 (15%), Positives = 50/201 (24%), Gaps = 6/201 (2%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
T+ A+ P P P + + + A+ P PVSN PP P
Sbjct: 384 TAEKETAAKKP--QPRPEAETAQTPVQTASAAAMPSEGKTAGPVSNQENNDVPPWEDAPD 441
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
+ + A S ++ P S + + + P P + P N
Sbjct: 442 EAQTAAGTAQTSAKSIQTASEAETPPENQVSKNKAADNETDAPLSEVPSENPIQATP-ND 500
Query: 184 PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTEN 243
P P P P PPP E
Sbjct: 501 EAVETETFAHEAPAEPF---YGYGFPDNDCPPEDGAEIPPPDWEHAAPADTAGGGADEEA 557
Query: 244 TPGNGTNPSSPESSSSPSNNG 264
G ++P + +
Sbjct: 558 EAGGIGGNNTPSAPPPEFSTE 578
|
Length = 709 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 29/109 (26%), Positives = 45/109 (41%), Gaps = 2/109 (1%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
GP + +++ P P + P + P P ++P P S P+ P PP S
Sbjct: 387 EGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRS 446
Query: 66 SSPPASSP--PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
PP +P P +SP P + +S +PP P+ + S P T
Sbjct: 447 GIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTPSGPRT 495
|
Length = 624 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 20/72 (27%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL--PPPP 152
A++P + P S PP+ P S P +PPS + P +P + P S P
Sbjct: 30 ATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVETPQS 89
Query: 153 PSSVEPPKRSPP 164
P++ + P P
Sbjct: 90 PTTKQVPTEINP 101
|
Length = 291 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 26/116 (22%), Positives = 40/116 (34%), Gaps = 6/116 (5%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSP---PPASNPPTSSPPPSPPASSPPTISPPPP 106
T P+S SS+ SS SP P + +++ + + P
Sbjct: 298 TVPVAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSD 357
Query: 107 VSNPPTRSPP---PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
V+ P T + P P + P P S N +N P+ P P+S P
Sbjct: 358 VTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPV 413
|
Length = 421 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 16/80 (20%), Positives = 23/80 (28%), Gaps = 4/80 (5%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
T PP+ ++ P + TP P + P A P P+
Sbjct: 120 TGGAPPAAAPAAAAAAKAEKT----TPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAA 175
Query: 146 SNLPPPPPSSVEPPKRSPPS 165
P P + R P S
Sbjct: 176 KPPPTPVARADPRETRVPMS 195
|
Length = 418 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 18/80 (22%), Positives = 28/80 (35%), Gaps = 1/80 (1%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPP-TSSPPPSPPASSPPTIS 102
P+S+ T PP+ + + + + + P PP S P P A P
Sbjct: 114 PLSEIDTGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAP 173
Query: 103 PPPPVSNPPTRSPPPPSSTP 122
P P R+ P + P
Sbjct: 174 AAKPPPTPVARADPRETRVP 193
|
Length = 418 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 20/93 (21%), Positives = 27/93 (29%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P + P+ P V P PP P + + P P T
Sbjct: 123 ADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEPVDSMAIAVPAIDTPVTL 182
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
PP+P P P V + +R SS
Sbjct: 183 ELPPAPQPPPPVVPQPSTMVVHRRSRIKRTRSS 215
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 21/96 (21%), Positives = 29/96 (30%), Gaps = 3/96 (3%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPP--TSSPPPASNPPTSSPPPSPPASSPPTI 101
SK P P P + P P P ++ N +P + P P
Sbjct: 29 SNSKQPEKKPEIKPNENTPKIPKKPDNKEPSENNNNKSNNENKDEENPSSTNP-EKKPDP 87
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
S P P P P + P + +D P N
Sbjct: 88 SKNKEEIEKPKDEPKKPDKKPQADQPNNVHADQPNN 123
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 21/75 (28%), Positives = 33/75 (44%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
+S+ PTS S +S +SS +S P ++SP P S ++ P + P S P
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPS 60
Query: 118 PSSTPPPNSPPSPPS 132
P S P + +
Sbjct: 61 PPSVTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 26/120 (21%), Positives = 38/120 (31%), Gaps = 3/120 (2%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
P S+ A P PP P P P S +S S
Sbjct: 118 SPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSALQ--SESLIA 175
Query: 114 SPPPPSSTPPPNSP-PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
P P P + +P SDP + + P +L PP ++ P + P++ P
Sbjct: 176 QPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPTISASQPA 235
|
Length = 430 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 61/296 (20%), Positives = 77/296 (26%), Gaps = 46/296 (15%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P +SN + P S P P S P S N SS P
Sbjct: 151 PSLSNSRPVHELPKPSTPVLQPRRSPRKQLHRPLSLPRSLHLHNSRQHSSLHPRRSPRRQ 210
Query: 78 PPPASNPP------TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
PA P P P P I P P+ TR PP + S P P
Sbjct: 211 LQPAPRRPLLAENQLHPLPSPQPVRHSPGILGPSPLHPHTTRPSPPRPAFSRSPSSPLSP 270
Query: 132 SDPPANSPP-------PSNPPSNLPPPPPSSVEPPKRS---PPSVPPQNPPPP------- 174
P+ P +LPPP S+ P P + P P
Sbjct: 271 LPRPSTRRGLLPNPRLPRASRGHLPPPTSSAPPRPNGGLRRPLHLHSSRPNSPNLRPRRI 330
Query: 175 ---------------------PSSSPPKNSPPAPIAVPPSNVPPPPTQTPP--TPASPIA 211
P+ + PP + VPPP Q P A +
Sbjct: 331 RKNSLQQTRARLGHSKSLGQSPNLRSSQLPPPTKRRLRLLPVPPPKVQALPLTALAPLVR 390
Query: 212 PRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGT 267
PS P+ P + + PG + SP S G
Sbjct: 391 HSPSIPLPHPPSALPSHVGASSSKHHRLPPSVLPGPRLSSPSPSPSLPTRRPGTPP 446
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 28/87 (32%), Positives = 34/87 (39%), Gaps = 4/87 (4%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS----PPTSSPPPASNPPTSSPP 90
SP PP PP +PP SP AS T SPP P ++ P A P
Sbjct: 4 ARSRSPSPPRRPSPPRPTPPRSPDASPEETPPSPPGPGAEPPPGRAAGPAAPRRRPRGCP 63
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPP 117
SS PP + + P +PPP
Sbjct: 64 AGVTFSSSAPPRPPLGLDDAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|218397 pfam05044, Prox1, Homeobox prospero-like protein (PROX1) | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 33/170 (19%), Positives = 55/170 (32%), Gaps = 12/170 (7%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPP--PVSNPPKSSPPPPPVSKPPT--------TSPPP 55
P PP + ++ + N P P P P ++ V+ +P
Sbjct: 538 PKPPDSFANVAAAALYNSPFCMPQTPQPQDAPEQTEALSLVVTPKKKRHKVTDTRITPRT 597
Query: 56 SPPASNPPTSSSPPASS--PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+ P A + P +++ PP P P T++ P P +
Sbjct: 598 VSRILALRDAVGPAAGTHHQPLHPSSLSASMGFHPPPFRHPFPLPLTVAIPNPSLHQSEV 657
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P +P +P P +SP P ++L P S+ P SP
Sbjct: 658 FMGYPFQSPHLGAPSGSPPGKDRDSPDLPRPTTSLHPKLLSAHHHPGSSP 707
|
The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. Prox1 has been found to be an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. This family contains an atypical homeobox domain. Length = 908 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 22/40 (55%), Positives = 23/40 (57%), Gaps = 6/40 (15%)
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
PP N PPPPP PP PPS PP PPPPP + K S
Sbjct: 5 PPGNPPPPPP----PPGFEPPSQPP--PPPPPGVNVKKRS 38
|
Length = 2365 |
| >gnl|CDD|225689 COG3147, DedD, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 29/118 (24%), Positives = 39/118 (33%), Gaps = 7/118 (5%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A P PP P V P V + PP V++ + + + +P
Sbjct: 39 AAIPLPPKPQGDRDEPRVL-------PAVVQVVALPTQPPEGVAQEIQDAGDAAAASVDP 91
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
+ PP S P P A P PP PPA + P P P P P+
Sbjct: 92 QPVAQPPVESTPAGVPVAAQTPKPVKPPKQPPAGAVPAKPTPKPEPKPVAEPAAAPTG 149
|
Length = 226 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 31/164 (18%), Positives = 43/164 (26%), Gaps = 3/164 (1%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P+ P A + + P + + P S P+ A+
Sbjct: 760 NPSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKR 819
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
+ P S P R P + PPP SS S PA P
Sbjct: 820 KSRSHTPDGGSESSGPARPPGAAAR---PPPARSSESSKSKPAAAGGRARGKNGRRRPRP 876
Query: 204 PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGN 247
P P + + + PP P P V PG
Sbjct: 877 PEPRARPGAAAPPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGG 920
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 18/78 (23%), Positives = 29/78 (37%), Gaps = 4/78 (5%)
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
PAP P+ P P + P P++ + + P P T PP +P
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETA---TPPPVPPRPV 417
Query: 242 ENTPGNGTNPSSPESSSS 259
P T S+P+ + +
Sbjct: 418 A-PPVPHTPESAPKLTRA 434
|
Length = 585 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 47/221 (21%), Positives = 65/221 (29%), Gaps = 18/221 (8%)
Query: 8 PPAANSSSPPPPVSNPPTISPP---PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
PPAA PP + P PP P + PP ++P +P P PP PP
Sbjct: 726 PPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPA 785
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP-- 122
P +P PP A P + P PT + + P P
Sbjct: 786 PQQRPRGAPTPQPPPQAGPTSMQLMPRAAPGQQGPTKQILRQLLTGGVKRGRPSLKKPAA 845
Query: 123 -----PPNSPPSPPSDPPAN--SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
PSP S P PP P + + + S Q P
Sbjct: 846 LERQAAAGPTPSPGSGTSDKIVQAPVFYPPVLQPIQVMRQLGSVRAAAASTVTQAPTEYT 905
Query: 176 ------SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
P + PP+ A + V P + + +
Sbjct: 906 GERRGVGPMHPTDIPPSKRAKTDAYVESQPPHGGQSHSFSV 946
|
Length = 991 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 33/186 (17%), Positives = 49/186 (26%), Gaps = 10/186 (5%)
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
+P P P PP + P + P R + PP P + P+
Sbjct: 89 DPSAGEPAPPPP---HARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPA 145
Query: 143 NPPSNLPP-----PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP--PAPIAVPPSNV 195
P P P + ++ PP+ P P+S P+ A P
Sbjct: 146 YPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYD 205
Query: 196 PPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPE 255
P P R P PP P P + P
Sbjct: 206 QRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPGPLA 265
Query: 256 SSSSPS 261
+ +P+
Sbjct: 266 AQPAPA 271
|
Length = 617 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 22/62 (35%), Positives = 29/62 (46%), Gaps = 3/62 (4%)
Query: 172 PPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLS 231
P PPS++ +P AP A PP+ PP P P PA P A RP+ + R +
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVP---PAAPARPAAARPAPAPAPPAAAAPPARSA 438
Query: 232 PP 233
P
Sbjct: 439 DP 440
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 17/69 (24%), Positives = 25/69 (36%), Gaps = 2/69 (2%)
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
+P P + P P + PP +PP P P P+++ P +P P A P
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPP--VPPAAPARPAAARPAPAPAPPAAAAPPARSA 438
Query: 198 PPTQTPPTP 206
P
Sbjct: 439 DPAAAASAG 447
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 6/77 (7%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
P + + PPP + PP PP + P + P+P PPA + P
Sbjct: 378 ERGAPAPPSAAWGAPTPAAP-AAPPPAAAPP---VPPAAPARPAAARPAPAPAPPAAAAP 433
Query: 141 PSNPPSNLPPPPPSSVE 157
P+ S P S+ +
Sbjct: 434 PA--RSADPAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 25/69 (36%), Positives = 32/69 (46%)
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
PPP ++ P +PP PP PP P P +PP P A P + PPP P P +
Sbjct: 46 PPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAPPPPA 105
Query: 209 PIAPRPSNS 217
P R N+
Sbjct: 106 PEPGRIDNA 114
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 31/81 (38%), Positives = 37/81 (45%), Gaps = 4/81 (4%)
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
P PPPPPS++ +P AP PP PP P P A P P PN+PPPP
Sbjct: 41 PAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPAD----PNAPPPPPV 96
Query: 228 KRLSPPPGIPVPSTENTPGNG 248
+PPP P P + G
Sbjct: 97 DPNAPPPPAPEPGRIDNAVGG 117
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 37/154 (24%), Positives = 51/154 (33%), Gaps = 19/154 (12%)
Query: 16 PPPPVSNPPTISPPPPVSNP-------PKSSPPP----PPVSKPPTTSPPPSPPASNPPT 64
P V+ T S P VS+P P+S P + +S P +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASS-------PPTISPPPPVSNP-PTRSPP 116
S+ P + PP S P+ +P S S+ PP SN S
Sbjct: 228 SNPEPQTEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHSTA 287
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
P T P P A + S+PP + PP
Sbjct: 288 TPPPTTKRQETGRPTPRPTATTQSGSSPPHSSPP 321
|
Length = 408 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 31/153 (20%), Positives = 55/153 (35%), Gaps = 10/153 (6%)
Query: 11 ANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPA 70
+ ++S P VS+P S P S P ++ +++ P + +
Sbjct: 175 SKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTSS------ 228
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT-RSPPPPSSTPPPNSPPS 129
+ P + PPP+ P+ SP P +S + + ++PP S+ P+S +
Sbjct: 229 NPEPQTEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHSTAT 288
Query: 130 PPSDPPANS---PPPSNPPSNLPPPPPSSVEPP 159
PP P P + P PP
Sbjct: 289 PPPTTKRQETGRPTPRPTATTQSGSSPPHSSPP 321
|
Length = 408 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 35/181 (19%), Positives = 46/181 (25%), Gaps = 5/181 (2%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P P N S P T S + SS S ++
Sbjct: 225 PPPNLSPNNLFSTSDLSPLPDTQSVENNIILNSSSSINELTSIYGSVPSIRNLRGLNSAL 284
Query: 64 TSSSPPASSPPT-SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
S +SS S+ PT SP A P SP ++ T PP S P
Sbjct: 285 VSFLNVSSSSLAFSALNGKEVSPTGSPSTRSFARVLPKSSPNNLLTEILTTGVNPPQSLP 344
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
+P + P S + P PSSS
Sbjct: 345 SLLNPVF--LSTSTGFSLTNLSGYLNPNKNLKKNTLSSLSNLGYS--SNVPSPSSSESTR 400
Query: 183 S 183
+
Sbjct: 401 N 401
|
Length = 777 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-04
Identities = 14/76 (18%), Positives = 24/76 (31%), Gaps = 3/76 (3%)
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
P S PP P PA++ + P P + P + +
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAA---PAAGGPAAALAAVPDAAAAAAAPP 447
Query: 134 PPANSPPPSNPPSNLP 149
PA +P P+ ++
Sbjct: 448 APAAAPQPAVRLNSFE 463
|
Length = 598 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 31/120 (25%), Positives = 45/120 (37%), Gaps = 6/120 (5%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P+ S P + T +P P ++P P +++P P+++P SP P
Sbjct: 380 APSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAP---SPRVPW 436
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ P P PP S PP P P P P S ++ PP PS P
Sbjct: 437 DDAP---PAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 33/135 (24%), Positives = 53/135 (39%), Gaps = 9/135 (6%)
Query: 49 PTTSPPPSPPASNPPTSSSPP--ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPP 106
P S PS ++ P+ S+ AS + P P + P + P + S + P P
Sbjct: 367 PVESLRPSGGGASAPSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAP 426
Query: 107 VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
S P P ++PP+PP P P P ++ P P SV +PP++
Sbjct: 427 -------SAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTL 479
Query: 167 PPQNPPPPPSSSPPK 181
+ + S P+
Sbjct: 480 GDPSDTAEHTPSGPR 494
|
Length = 624 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 31/160 (19%), Positives = 41/160 (25%), Gaps = 1/160 (0%)
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
SS ++ P S P RS + D + P P++LPPPP
Sbjct: 259 SSAFMLNSSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPPPPVRR 318
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
P + P + + S T P + A
Sbjct: 319 PRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAAASSFL 378
Query: 216 NS-SPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
SPP T L P V S P S
Sbjct: 379 EDDDFGSPPLDLTTSLRHMPSPSVTSAPEPPSIPLTYLSD 418
|
Length = 418 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 19/71 (26%), Positives = 29/71 (40%), Gaps = 1/71 (1%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
PPAA +S P P +PP + P + P + T P P+++
Sbjct: 80 GTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATA-TAPESPSTS 138
Query: 62 PPTSSSPPASS 72
P+S S AS+
Sbjct: 139 VPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 23/130 (17%), Positives = 37/130 (28%), Gaps = 5/130 (3%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP--PSPPASSPPTISPPPPVSNPP 111
S + + +S P SS + SS P + PAS P + S+
Sbjct: 2 AASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSS 61
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
S+ S P SP + ++L ++ SP
Sbjct: 62 FGLSKQRPSSLSRGRLSSRFVSPSRGSPSAA---ASLNGSLATASTSGSSSPSRSRRTTS 118
Query: 172 PPPPSSSPPK 181
S + P
Sbjct: 119 SDLSSGNGPS 128
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 40/195 (20%), Positives = 61/195 (31%), Gaps = 17/195 (8%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
SPPAS T + P S S ++SP SS SP SN P
Sbjct: 117 KKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRSASPSRKFSPSSTIQQSPQLTPSNKP-A 175
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS--------------SVEPP 159
SP +P +S P + S S+P + V+
Sbjct: 176 SPSSSYQSPSYSSSLGPVNSSGNRSNLRSSPWALRSSGDKKDITTDEKYLETFLAEVDEE 235
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
+ S +N PP + + +S +P S ++ + ++P P S
Sbjct: 236 QHMITSSAGKNATPPETINSFGSS--SPSFWNYSRNASDAARSLKKRSYQLSPSPVPSKQ 293
Query: 220 NSPPPPSTKRLSPPP 234
+ P PP
Sbjct: 294 KASTSPKKGEGEPPN 308
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 29/109 (26%), Positives = 42/109 (38%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P P + P P +P A P + PA + P ++ P P P P + PP+
Sbjct: 84 PSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPARPAPACPPS 143
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
PP PT P P + ++ PP P A+ P P+ P
Sbjct: 144 TRQCPPAPPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAASP 192
|
Length = 280 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 24/82 (29%), Positives = 31/82 (37%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
+ PP S P P +SS P++S + P + P PSP S P
Sbjct: 179 GGNIPGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPA 238
Query: 102 SPPPPVSNPPTRSPPPPSSTPP 123
S P P P + PP PP
Sbjct: 239 SIPAPPIPPVIQYVAPPPVPPP 260
|
Length = 582 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 21/77 (27%), Positives = 32/77 (41%), Gaps = 4/77 (5%)
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
++ SS+ +SPPS S P P ++ + P P PK S PS P
Sbjct: 7 TSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPL----PKLSSPSPP 62
Query: 168 PQNPPPPPSSSPPKNSP 184
PP ++ P+ +P
Sbjct: 63 SVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 25/126 (19%), Positives = 34/126 (26%), Gaps = 21/126 (16%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVS---KPPTTSPPPSPPA------- 59
++ S+ S P P S P S TS P+
Sbjct: 268 TSSEDGYSFSRSSAYPNSSPRQALPPSISLPQNTSTSGSLHSAQTSRRPNTTFDKAASSG 327
Query: 60 --------SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
S+ ++PP+S + S S P S P S P
Sbjct: 328 TKDSLWSPSSLCGMATPPSSIGMSPLILSLSPSHLSGRAPGTTGSGKGE---PASESTPS 384
Query: 112 TRSPPP 117
T PPP
Sbjct: 385 TSPPPP 390
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 20/47 (42%), Positives = 26/47 (55%), Gaps = 4/47 (8%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
++ PP +PP PP PP PPS PP PPPP +V+ R S+
Sbjct: 2 ASLPPGNPPPPP--PPPGFEPPSQPP--PPPPPGVNVKKRSRKQLSI 44
|
Length = 2365 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 19/106 (17%), Positives = 33/106 (31%), Gaps = 4/106 (3%)
Query: 32 VSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP--ASSPPTSSPPPASNPPTSSP 89
+S P + P + P +PPA P + A++ ++P + P SP
Sbjct: 102 MSEPATENKPAEVTTPVEPMGLPETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKPRAKSP 161
Query: 90 PPSPPASSPPTISPPP--PVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
P+ A+ PT + P + P
Sbjct: 162 RPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATPAKKTTKKKKT 207
|
Length = 209 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 23/106 (21%), Positives = 35/106 (33%), Gaps = 4/106 (3%)
Query: 20 VSNPPTISPPPPVSNP--PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
+S P T + P V+ P P P PP P +P + A+ + PA S
Sbjct: 102 MSEPATENKPAEVTTPVEPMGLPETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKPRAKSP 161
Query: 78 PP--PASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P A+ PT + + P + P + T
Sbjct: 162 RPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATPAKKTTKKKKT 207
|
Length = 209 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 10/114 (8%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
P K P P + S +P S ++++ + SP T P S P + SPP
Sbjct: 551 PGKGVPYIPGLFAGNPGSTNSTPTGSAASSNTTFSSDSPSTVVAPSTS--PPAGHLGSPP 608
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
A+ +S P+ SPP P +P SP S S ++P S++
Sbjct: 609 ATPSKIVS--------PSTSPPASHLGSPSTTPSSPESSIKVASTETASPESSI 654
|
Length = 670 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 11/57 (19%), Positives = 17/57 (29%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPP 79
P +PP P + P P +P + P + P P P +
Sbjct: 16 QPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|165564 PHA03309, PHA03309, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (102), Expect = 3e-04
Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 13/199 (6%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
SSS +SS +SS P+S P S+ P P+ SPP +P + R PS+ P
Sbjct: 1816 SSSSSSSSSSSSSSSPSSRPSRSATPSLSPSPSPPRRAPVDRSRSGRRRERDRPSANPFR 1875
Query: 125 NSP-PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
+P +D + P + P NL + P R P P + PS S P++S
Sbjct: 1876 WAPRQRSRADHSPDGTAPGDAPLNLE-------DGPGRGRPIWTPSSATTLPSRSGPEDS 1928
Query: 184 ---PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP--NSPPPPSTKRLSPPPGIPV 238
+ PP+ + P P +T S + P S+P PP R + P
Sbjct: 1929 VDETETEDSAPPARLAPSPLETSRAEDSEDSEYPEYSNPRLGKSPPALKSREARRPSSKQ 1988
Query: 239 PSTENTPGNGTNPSSPESS 257
P ++ NG S S+
Sbjct: 1989 PRRPSSGKNGHTDVSAASA 2007
|
Length = 2033 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 13/83 (15%), Positives = 17/83 (20%)
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPG 235
S S + P P P P A+ P P P + S P
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 236 IPVPSTENTPGNGTNPSSPESSS 258
P +
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 21/97 (21%), Positives = 34/97 (35%), Gaps = 7/97 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ P+ P + +++ P +P S S P S P + P + PP+ N
Sbjct: 384 TQPAAAPQPSAAAAASP---SPSQSSAAAQPSAPQ--SATQPAGTPPTVSVDPPAAVPVN 438
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
PP S+ P + P P + P P
Sbjct: 439 PP--STAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRP 473
|
Length = 614 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 38/142 (26%), Positives = 44/142 (30%), Gaps = 11/142 (7%)
Query: 28 PPPPVSNP---PKSSPPPPPVSKPPTTSPP-PSPPASNPPTSSSPPASSPPTSSPP-PAS 82
P P+ P P P P + P P P P A P P P +
Sbjct: 740 PHEPLFTPIVEPVQQPQQPVAPQQQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVA 799
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP------SDPPA 136
P P P A P P PV+ P P P P P P
Sbjct: 800 PQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQDTLLHPLLMRNGDSRPL 859
Query: 137 NSPPPSNPPSNLPPPPPSSVEP 158
+ P P +L PPPS VEP
Sbjct: 860 HKPTTPLPSLDLLTPPPSEVEP 881
|
Length = 1355 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 23/61 (37%), Positives = 29/61 (47%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P P AA + +P P PP +PP P + P ++PPPPP PP P A P
Sbjct: 44 PPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAPPP 103
Query: 63 P 63
P
Sbjct: 104 P 104
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 67/319 (21%), Positives = 93/319 (29%), Gaps = 43/319 (13%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSN-------PPKSSPPPPPVSKPP----TTSPPP 55
+ S P S+ T + P++N SS P S +TS
Sbjct: 37 NSTPNSFSPIPSKASSSATFTLNLPINNSVNHKITSSSSSRRKPSGSWSVAISSSTSGSQ 96
Query: 56 SPPASNPPTSSSPPASS--------PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
S P +S +P SS T S+ SS S +S P P
Sbjct: 97 SLLMELPSSSFNPSTSSRNKSNSALSSTQQGNANSSVTLSSSTASSMFNSNKLPLPNPNH 156
Query: 108 SNPPTR---------SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
SN T +P SS P N S P + S P PSS
Sbjct: 157 SNSATTNQSGSSFINTPASSSSQPLTNLVVSSIKRFPYLT---SLSPFFNYLIDPSSDSA 213
Query: 159 PKRS--------PPSVPPQN--PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
+ PP++ P N S P S I + S+ T + S
Sbjct: 214 TASADTSPSFNPPPNLSPNNLFSTSDLSPLPDTQSVENNIILNSSSSINELTSIYGSVPS 273
Query: 209 PIAPRPSNSSPNS--PPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIG 266
R NS+ S S+ S G V T + P+SS + I
Sbjct: 274 IRNLRGLNSALVSFLNVSSSSLAFSALNGKEVSPTGSPSTRSFARVLPKSSPNNLLTEIL 333
Query: 267 TAGTVVIAVAVGIIAFSLI 285
T G ++ +
Sbjct: 334 TTGVNPPQSLPSLLNPVFL 352
|
Length = 777 |
| >gnl|CDD|220271 pfam09507, CDC27, DNA polymerase subunit Cdc27 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 27/197 (13%), Positives = 44/197 (22%), Gaps = 33/197 (16%)
Query: 15 SPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPP 74
+P + PT + P S PPKS P K + S + T +
Sbjct: 147 APAASPALKPTANGKRPSSKPPKSIMSPEVKVKSAKKTQDTSKETTTEKTEGKTSVKAAS 206
Query: 75 TSSPPPASNPPTSS----PPPSPPASSPPTISPPPPVSNPPTRSPP----PPSSTPPPNS 126
PP + SS + S S + S+ P
Sbjct: 207 LKRNPPKKSNIMSSFFKKKTKEKKEKKEASESTVKEESEEESGKRDVILEDESAEPTGLD 266
Query: 127 PPSPPSDPPANSPPPSNPPSN-------------------------LPPPPPSSVEPPKR 161
+P + + + P P E +
Sbjct: 267 EDEDEDEPKPSGERSDSEEETEEKEKEKRKRLKKMMEDEDEDEEMEIVPESPVEEEESEE 326
Query: 162 SPPSVPPQNPPPPPSSS 178
P P+ +
Sbjct: 327 PEPPPLPKKEEEKEEVT 343
|
This protein forms the C subunit of DNA polymerase delta. It carries the essential residues for binding to the Pol1 subunit of polymerase alpha, from residues 293-332, which are characterized by the motif D--G--VT, referred to as the DPIM motif. The first 160 residues of the protein form the minimal domain for binding to the B subunit, Cdc1, of polymerase delta, the final 10 C-terminal residues, 362-372, being the DNA sliding clamp, PCNA, binding motif. Length = 427 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 37/125 (29%), Positives = 50/125 (40%), Gaps = 8/125 (6%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP-PSDPPANSPP 140
++ P+ S P + TI P P + P + P TP +P +P PS P+
Sbjct: 378 ASAPSGSAAEGPASGGAATI--PTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPS---- 431
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
P P + PP PP S PP R P +P +P P S S P PS+
Sbjct: 432 PRVPWDDAPPAPPRSGIPP-RPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTP 490
Query: 201 QTPPT 205
P T
Sbjct: 491 SGPRT 495
|
Length = 624 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 24/160 (15%), Positives = 40/160 (25%), Gaps = 5/160 (3%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
A +P +++ TS S T PP + P S
Sbjct: 31 AERDDFLTPLGSTSEATSEDDDDLYPPRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDS 90
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
P+ P PP + SP + N P + NS
Sbjct: 91 LPASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPIGESNSS----- 145
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
+ ++ PP+ + + + KR
Sbjct: 146 SEELSEEEEHSRPPPSESLKVKNGGKVYPKGFSKHKTHKR 185
|
Length = 580 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 21/117 (17%), Positives = 33/117 (28%), Gaps = 6/117 (5%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
P + +++ PS A P ++ + + S
Sbjct: 304 VTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSAT---TTQASAVALSSAGVLPSDVTL 360
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP---PSNPPSNLPPPPPS 154
+ P P P ST + AN P P+ P SN+P P S
Sbjct: 361 PGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 19/78 (24%), Positives = 29/78 (37%), Gaps = 6/78 (7%)
Query: 16 PPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT 75
P + PK++ P P PP S P P A+ PP P ++ P
Sbjct: 125 PAAAPAAAAAAKAEKTTPEKPKAAAPTPE---PPAASKPTPPAAAKPPE---PAPAAKPP 178
Query: 76 SSPPPASNPPTSSPPPSP 93
+P ++P + P S
Sbjct: 179 PTPVARADPRETRVPMSR 196
|
Length = 418 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 23/95 (24%), Positives = 29/95 (30%), Gaps = 3/95 (3%)
Query: 43 PPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
PP PP +P P P + +S P + P P P PA P
Sbjct: 173 PP--NPPREAPAPGLPKTFT-SSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQP 229
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
PV +P P+ PP S N
Sbjct: 230 QQQPVQPAQQPTPQNPAQQPPQTEQGHKRSREQGN 264
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 20/92 (21%), Positives = 28/92 (30%), Gaps = 6/92 (6%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
PP +PP PA P + + +P P P +P P +P P
Sbjct: 173 PP--NPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNP----AQQPQ 226
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSP 139
P + P P N PP +
Sbjct: 227 QQPQQQPVQPAQQPTPQNPAQQPPQTEQGHKR 258
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 2/124 (1%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
+ AS P + + ++PP S P+ P S+P P V P T P
Sbjct: 153 ATNASLFPLGLAAFPAEGTLAAPPLGEGSADGSCDPALPLSAPRL--GPADVFVPATPRP 210
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P ++ P +P + P ++ P+ + P ++ E P P PP
Sbjct: 211 TPRTTASPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPPA 270
Query: 176 SSSP 179
+++P
Sbjct: 271 NATP 274
|
Length = 401 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 29/100 (29%), Positives = 38/100 (38%), Gaps = 7/100 (7%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
PPP + P S +P AS+ P + P S P P + P +PP S PA
Sbjct: 187 QPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPS--APPASIPAPP 244
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
P + PP PPP P + + PAN
Sbjct: 245 IPPVIQYVAP--PP---VPPPQPIIPIQHIRAVTGETPAN 279
|
Length = 582 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 18/76 (23%), Positives = 27/76 (35%), Gaps = 1/76 (1%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
P P S + S P+ S+P T +PPP+ + SPP + P++
Sbjct: 296 NGVEPEPTGSVSDRPRHLSSDSSPSPPDTSDSDPSTETPPPASLSHSPPA-AFERPLALS 354
Query: 111 PTRSPPPPSSTPPPNS 126
P R S
Sbjct: 355 PKRKREGDKKQKKKKS 370
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 13/58 (22%), Positives = 20/58 (34%), Gaps = 3/58 (5%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
P+ A P + S TS P A+ + PP P ++PP +
Sbjct: 271 QPATAAPAPSRMTDTNDSKSVTSQPAAAA---AAPAPPPNPPATPPEPPARRGRGSAA 325
|
Length = 656 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 23/101 (22%)
Query: 488 RIIHRDIKSSNILLD-------------NNFE----AQVSDFGLAK-LALDANTHITTRV 529
R++HRD+K NI L NN A++ DFGL+K + +++ H
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SC 201
Query: 530 MGTFGYMAPEYA--SSGKLTEKSDVFSFGVVLLELITGRKP 568
+GT Y +PE + +KSD+++ G ++ EL +G+ P
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|177328 PHA01929, PHA01929, putative scaffolding protein | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 31/103 (30%), Positives = 36/103 (34%), Gaps = 9/103 (8%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
PP ++ PP + TP PN P P P P P P
Sbjct: 9 PPGLAGLVANVPPAAAPTPQPN--PVIQPQAPVQPGQPGAPQQLAIPTQQPQPVPTSAMT 66
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN--VPPPPTQTPP 204
P V Q P + P +PPA A P VPPPP TP
Sbjct: 67 PHVVQQAP-----AQPAPAAPPAAGAALPEALEVPPPPAFTPN 104
|
Length = 306 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 43/167 (25%), Positives = 57/167 (34%), Gaps = 4/167 (2%)
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
+SSP SP S+ + + P S PP A S PP P + PP
Sbjct: 149 SSSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQ-- 206
Query: 155 SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
P + P+ PQ P P S P P + P P +Q P P +P + P
Sbjct: 207 --GSPIAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRHP 264
Query: 215 SNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
+S PP P + PS+ G S PS
Sbjct: 265 QSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPS 311
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 5e-04
Identities = 12/80 (15%), Positives = 23/80 (28%)
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
P S++ P + A A + P + P PA + ++P P + +P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 234 PGIPVPSTENTPGNGTNPSS 253
+
Sbjct: 98 APPAAAAAAAPAAAAVEDEV 117
|
Length = 1228 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (99), Expect = 5e-04
Identities = 29/129 (22%), Positives = 49/129 (37%), Gaps = 4/129 (3%)
Query: 111 PTRSPPPPSST-PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
P ++ P+ PP + P+ A + PP+ PP + PP ++
Sbjct: 222 PAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKA 281
Query: 170 NPPPPPSSSPPKN--SPPAPIAVPPSNVPPPPTQTPPTPA-SPIAPRPSNSSPNSPPPPS 226
PP +++PP + PA A P+ P + PA + P + + P P
Sbjct: 282 AAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAAPP 341
Query: 227 TKRLSPPPG 235
K + P G
Sbjct: 342 AKAAAAPVG 350
|
Length = 357 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 23/63 (36%), Positives = 27/63 (42%)
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
P PP + + PP P A P P PP PA P AP P PN+PP
Sbjct: 43 PPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAPP 102
Query: 224 PPS 226
PP+
Sbjct: 103 PPA 105
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 25/119 (21%), Positives = 41/119 (34%), Gaps = 3/119 (2%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
++ P + + + P + P + P V+ T+ S A + + P
Sbjct: 302 AAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLP 361
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
T + P A P S + + +N PT S P + P N P SP S
Sbjct: 362 GTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLP---AAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 4/117 (3%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
A + PP+ P P V P T P P AS P T+ +P
Sbjct: 167 PAEGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTAS-PETTPTPS 225
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
++ P S+ PA + ++P + T +PP P +PP ++ P S
Sbjct: 226 TTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGG---EAPPANATPAPEAS 279
|
Length = 401 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 23/111 (20%), Positives = 36/111 (32%), Gaps = 1/111 (0%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P + P S PA PA ++P P+P ++ P +P P
Sbjct: 167 PAEGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTASPETTPTPST 226
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
+ P + P ST + PP+ P PP ++ P
Sbjct: 227 TTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPT-PGGGEAPPANATPAP 276
|
Length = 401 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 18/72 (25%), Positives = 27/72 (37%)
Query: 46 SKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP 105
S P + S + +S+ + SSPP+S+ P S P P + SPP
Sbjct: 4 SNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSPPS 63
Query: 106 PVSNPPTRSPPP 117
P + P
Sbjct: 64 VTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 32/175 (18%), Positives = 48/175 (27%), Gaps = 21/175 (12%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTR--SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
P + P + +S + S + + + P
Sbjct: 19 EFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVA---------GAAACDRFEPPT 69
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA 207
PPP P + P S + P+S + SP P P PP
Sbjct: 70 GPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPP--------GPSSPDPPPPTP 121
Query: 208 SPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSN 262
P +P PS + S PPP P+ +P S SS +
Sbjct: 122 PPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAV--ASDAASSRQAAL 174
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 17/104 (16%), Positives = 29/104 (27%), Gaps = 1/104 (0%)
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS 217
+R + P S+ AP + P AP P+ +
Sbjct: 381 LERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPA 440
Query: 218 SPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
P+ PP PS + P P ++ +P+
Sbjct: 441 PPSPAGNAPAGGAPSPPPAAAPSAQPAPA-PAAAPEPTAAPAPA 483
|
Length = 824 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 22/145 (15%), Positives = 42/145 (28%), Gaps = 5/145 (3%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
PPS + + P ++ + S P + + S P P +
Sbjct: 648 PPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVPDPY 707
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASP 209
PP E P+ + + P N + ++ A + V T P A
Sbjct: 708 DRPP-WEEAPEVASANDGPNN---AAEGNLSESVEDASNS-ELQAVEQQATHQPQVQAEA 762
Query: 210 IAPRPSNSSPNSPPPPSTKRLSPPP 234
+P + + + L+
Sbjct: 763 QSPASTTALTQTSSEVQDTELNLVL 787
|
Length = 944 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 38/165 (23%), Positives = 51/165 (30%), Gaps = 11/165 (6%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+P S + SP SP SS +SP P V + P + S
Sbjct: 55 RQTPRQSRRSKRAAHAYPSPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRR--RSSS 112
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
P D P P S+ S P+ PP+ P P++S A A
Sbjct: 113 PSDDEDEAERPSKRPRSD---------SISSSSSPAKPPEACLPSPAASTQDELSEASAA 163
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P+ PP T S R + P P + S P
Sbjct: 164 PLPTPSLSPPHTPTDTAPSGKRKRRLSDGFQLPAPKRPQTSSRPQ 208
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 25/81 (30%), Positives = 35/81 (43%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP 89
P +N + PPPPP + +P PP P +P P + PPP ++P P
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPP 93
Query: 90 PPSPPASSPPTISPPPPVSNP 110
PP P + PP P + N
Sbjct: 94 PPVDPNAPPPPAPEPGRIDNA 114
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 17/76 (22%), Positives = 30/76 (39%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A S S+ P P + P+ P + +PP P +K P + + +
Sbjct: 161 NAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPAVNHHKTATVAV 220
Query: 62 PPTSSSPPASSPPTSS 77
PP +S P S ++
Sbjct: 221 PPATSGKPKSGAASAR 236
|
Length = 327 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 32/157 (20%), Positives = 45/157 (28%), Gaps = 5/157 (3%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
+ SS P + + A + S P PAS PP P
Sbjct: 259 SSAFMLNSSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPP--PPV 316
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPP--PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
P P P + P P +ST S + D + P S ++
Sbjct: 317 RRPRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAAASS 376
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
PP S+ P P +S+P S P
Sbjct: 377 FLEDDDFGSPPLDLTTSL-RHMPSPSVTSAPEPPSIP 412
|
Length = 418 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 19/35 (54%), Positives = 20/35 (57%), Gaps = 9/35 (25%)
Query: 140 PPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
PP NPP PPPPP EPP + PP PPPP
Sbjct: 5 PPGNPP---PPPPPPGFEPPSQPPP------PPPP 30
|
Length = 2365 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 28/110 (25%), Positives = 35/110 (31%), Gaps = 3/110 (2%)
Query: 37 KSSPPPPPVSKPPTTSPPPSPPASNP-PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
S P V + P ++ P P PA +P T+ PP
Sbjct: 351 ASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFC 410
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP-PSPPSDPPANSPPPSNP 144
P +SP P S P T P P PP P AN P +P
Sbjct: 411 GDPGLVSPYNPQS-PGTSYGPEPVGPVPPQPTNPYVMPISMANMVYPGHP 459
|
Length = 663 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 25/113 (22%), Positives = 34/113 (30%), Gaps = 7/113 (6%)
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P+ A+ + P + P P I P +P T PP P
Sbjct: 355 APSRVLAAAAKVAVIAAPQ----THTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFC 410
Query: 122 PPPN-SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P P P P + P P +PP P + P V P +P
Sbjct: 411 GDPGLVSPYNPQSPGTSYGPE--PVGPVPPQPTNPYVMPISMANMVYPGHPQE 461
|
Length = 663 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 413 EVEIISRIHHRHLVSLVGYCISDDRRLLI---YDYVPNNTLYFHLHGEG-----RPVLDW 464
E+ + R++H +++ + S+ +I YD+ LY ++ E RP+L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLL-K 267
Query: 465 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524
TR I + Y+H+ ++IHRDIK NI L+ + + + DFG A
Sbjct: 268 QTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564
+GT +PE + E +D++S G++LL++++
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|223066 PHA03379, PHA03379, EBNA-3A; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 43/231 (18%), Positives = 67/231 (29%), Gaps = 8/231 (3%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTT-SPPPSPPASNPPTS 65
+P PPV P P P S +S V +PP P P +
Sbjct: 407 KASEPTYGTPRPPVEKP---RPEVPQSLETATSHGSAQVPEPPPVHDLEPGPLHDQHSMA 463
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
P A PP + P +P P+ P S
Sbjct: 464 PCPVAQLPPGPLQDLEPGDQLPGVVQDGRPACAPVPAPAGPIVRPWEASLSQVPGVAFAP 523
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQN--PPPPPSSSPPKNS 183
P P P P + P PP +++ P + V + P P + +PP++
Sbjct: 524 VMPQPMPVEPVPVPTVALERPVCPAPPLIAMQGPGETSGIVRVRERWRPAPWTPNPPRSP 583
Query: 184 PPAPIAVPPSNVPPP--PTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
+ + + P Q P + S P P +++ P
Sbjct: 584 SQMSVRDRLARLRAEAQPYQASVEVQPPQLTQVSPQQPMEYPLEPEQQMFP 634
|
Length = 935 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 7e-04
Identities = 41/170 (24%), Positives = 58/170 (34%), Gaps = 12/170 (7%)
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN-SPPSPPSDPPANSPPPSNPPSN 147
PP P AS P +P S P P P P+ +
Sbjct: 510 PPEGPEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAK--EH 567
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA 207
P P+ + P+ P++P P P+ S P P S P P +P
Sbjct: 568 KPSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPR-SAQRPTR-PKSPKLPELLDIPKSPK 625
Query: 208 SPIAPRPSNSSPNSPPPPSTKRLSP--PPGIPVPSTENTPGNGTNPSSPE 255
P +P+ SP PPPP + SP P G + + P + P P+
Sbjct: 626 RPESPK----SPKRPPPP-QRPSSPERPEGPKIIKSPKPPKSPKPPFDPK 670
|
Length = 943 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 27/226 (11%), Positives = 51/226 (22%), Gaps = 1/226 (0%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S P + PPP S P + + S P KP
Sbjct: 522 SIKELRPRIGFINKSPPPKSPPKSRRTLIVALSLASPSTAGSPRPKPSLGKFVIGTDPFA 581
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ + + + P S+ P + +
Sbjct: 582 FANTVRLTDNMRGGNGVGSSVKPKGSASSKPLTGPGSDLKPATLNGKTPSSSLVGAARNA 641
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
+ P SP + ++ P K++ P + N +
Sbjct: 642 GASSKVKIPSGLGGFTSPISLLESALEDVLTSATSTPVKKNDPYLWDTNGEKAGGGTESA 701
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
++ N P P P P++ ++S
Sbjct: 702 STTDVFQNFAGLN-KKTPVGGPFQPKPPLSRALDSASSPGGSGGKP 746
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 15/67 (22%), Positives = 24/67 (35%), Gaps = 3/67 (4%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+ PP++ P+ +PPP+ P P PP + P P P P +
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAP---PVPPAAPARPAAARPAPAPAPPAAAAPPARS 437
Query: 180 PKNSPPA 186
+ A
Sbjct: 438 ADPAAAA 444
|
Length = 576 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 25/118 (21%), Positives = 46/118 (38%), Gaps = 4/118 (3%)
Query: 26 ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPP 85
++ P S +SS P + P+ + PS + T++ A + ++ P+
Sbjct: 301 VAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSD--- 357
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPP-SPPSDPPANSPPPS 142
+ P ++ P P P+S T+ + T N P S P+ P +N P
Sbjct: 358 VTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSP 415
|
Length = 421 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 27/101 (26%), Positives = 35/101 (34%), Gaps = 11/101 (10%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSP------PPPPVSKPPTTSPPPSP 57
P+ G S + PP NPP +P P + SS P P +P +P P
Sbjct: 159 PAGGTYILASGTYIPP--NPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQP 216
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
NP P P PA P +P PP +
Sbjct: 217 TVQNPA---QQPQQQPQQQPVQPAQQPTPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 22/111 (19%), Positives = 29/111 (26%), Gaps = 4/111 (3%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P + P + P P V P P P P P
Sbjct: 108 KVLGEEEPAPQEETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEPVD 167
Query: 182 NS-PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLS 231
+ P P + PP P P P+ P+PS + R S
Sbjct: 168 SMAIAVPAIDTPVTLELPPA---PQPPPPVVPQPSTMVVHRRSRIKRTRSS 215
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 18/98 (18%), Positives = 24/98 (24%)
Query: 25 TISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP 84
T S P ++ + T P P + P ++ PP
Sbjct: 350 TASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQF 409
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
SP P S P P P P P
Sbjct: 410 CGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPYVMP 447
|
Length = 663 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 23/58 (39%), Positives = 33/58 (56%), Gaps = 3/58 (5%)
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520
D VK + A L YLH IIHRD+K N+L+ N +++DFGL+K+ L+
Sbjct: 102 DEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|217512 pfam03359, GKAP, Guanylate-kinase-associated protein (GKAP) protein | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 24/154 (15%), Positives = 39/154 (25%), Gaps = 13/154 (8%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTT-------SPPPSPPASNPPTS 65
P +I S + P S+ T+
Sbjct: 2 GHKKAKKKRKPSSIGISDDESATDSEAEPKGFREFQSVGVQVEDEKLQRRRFKRSSSVTA 61
Query: 66 SSPPASSP---PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSN---PPTRSPPPPS 119
+ P + + P + PPP S+ TR+
Sbjct: 62 NVQADLELEGFPGLPVVRHVSTEDKALQFGPSFQRESSEDSPPPSSSTYSAGTRTVSTQG 121
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP 153
+ + P PS + S + S+LPPP P
Sbjct: 122 QSAYLSDPKRRPSSEASESETVAFDESDLPPPDP 155
|
Length = 342 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 15/102 (14%), Positives = 31/102 (30%), Gaps = 9/102 (8%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
S P + T +P + + +P + P + P +
Sbjct: 159 GQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAV--------ATAPAPAVDPQQNAVV 210
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
PS ++ P + P ++ P ++ S P +P
Sbjct: 211 APSQANVDTAATPAPAAP-ATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 26/121 (21%), Positives = 36/121 (29%), Gaps = 7/121 (5%)
Query: 77 SPPPASNPPTSSPPPSPPASSPP-TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
S + SS +P P + + P+ P+S P S+P
Sbjct: 146 SSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVT---PTRGRRPSSSPRSLSNPT 202
Query: 136 ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNV 195
PSN PPP S RS N S + P S + + P S
Sbjct: 203 TLE-SPSNLQVTTDVPPPYSNGTS-RSSTMSSSANLSIISSLATP-RSGESFRSTPTSGS 259
Query: 196 P 196
Sbjct: 260 S 260
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 22/156 (14%), Positives = 33/156 (21%), Gaps = 21/156 (13%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
PP + P P P P++ PP + PP
Sbjct: 55 YPPRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDSLPASREL----PPGPTPVPPGGFR 110
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
+ P S+SP P A S+ +
Sbjct: 111 GASSP--RLGADSTSPRFLYQVNF---------------PVILAPIGESNSSSEELSEEE 153
Query: 224 PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
S S + G + + S S
Sbjct: 154 EHSRPPPSESLKVKNGGKVYPKGFSKHKTHKRSEFS 189
|
Length = 580 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 38/175 (21%), Positives = 56/175 (32%), Gaps = 11/175 (6%)
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
L PP P++P P P+ +P P P TP
Sbjct: 168 AEGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPR-----PTPRTTASPETTP 222
Query: 204 PTPASPIAPRPSNSSPNSP--PPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
P++ +P + S P G P P T G P++ + S
Sbjct: 223 T-PSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPG--GGEAPPANATPAPEAS 279
Query: 262 NNGIGTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNG-VYIMPSPLGSS 315
+ + IA+ IIA +G CL RR + +Y PSP+ S
Sbjct: 280 RYELTVTQIIQIAIPASIIACVFLGSCACCLHRRCRRRRRRPARIYRPPSPVAPS 334
|
Length = 401 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 17/74 (22%), Positives = 27/74 (36%), Gaps = 1/74 (1%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
S ++ S + +SS + S PP+S P ASS P+ + SP
Sbjct: 3 SSNPTSRSQSHASSSSSSSSQSSPPSS-TSPRPRRRKPSASSLLHTPSILPLPKLSSPSP 61
Query: 116 PPPSSTPPPNSPPS 129
P + P +
Sbjct: 62 PSVTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 16/58 (27%), Positives = 24/58 (41%), Gaps = 1/58 (1%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP 93
P P P S +PPP + P T ++ PA++ P + P + P P P
Sbjct: 13 EAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAE-KPKKDKPRRERKPKP 69
|
Length = 475 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 17/58 (29%), Positives = 24/58 (41%), Gaps = 1/58 (1%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPP-PASN 83
P P P ++P PPP +K + + PA+ P + P P P PAS
Sbjct: 15 EQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 17/76 (22%), Positives = 25/76 (32%), Gaps = 3/76 (3%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
A + P P + + PPP P +P ++ P+ P PS
Sbjct: 49 KAAEQMAAPEAAEAAPL---PAAAESIASPEVPPPVPPAPAQEGEAPAAEQPSAVPAPSA 105
Query: 144 PPSNLPPPPPSSVEPP 159
P+ P PS P
Sbjct: 106 APAPAEPVEPSLAANP 121
|
Length = 931 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 24/61 (39%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
PPPP + PPP + P P PA+SPPP+ P S P P S PP +S
Sbjct: 144 PPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPT-PASPPPAKAPKSSHPPLKS 202
Query: 163 P 163
P
Sbjct: 203 P 203
|
Length = 274 |
| >gnl|CDD|215187 PLN02328, PLN02328, lysine-specific histone demethylase 1 homolog | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 32/115 (27%), Positives = 38/115 (33%), Gaps = 15/115 (13%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTS---SPPPASNPPTSSPPPSPPASSPPTISPPPP 106
T P P + S ASSP T SP + + SP SP T P P
Sbjct: 4 ETKEPEDPADNVNDVVSE--ASSPETDLSLSPSQSEQNIENDGQNSPETQSPLTELQPSP 61
Query: 107 VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
+ PP ++ P S P NP S P PPP KR
Sbjct: 62 L--------PPNTTLDAPVSDSQGDESSSEQ--QPQNPNSTEPAPPPKKRRRRKR 106
|
Length = 808 |
| >gnl|CDD|240271 PTZ00108, PTZ00108, DNA topoisomerase 2-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 23/155 (14%), Positives = 32/155 (20%), Gaps = 2/155 (1%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P +NSS P KS S +
Sbjct: 1210 DDKPDNKKSNSSGSDQEDDEEQKTKPKKSSVKRLKSKKNNSSKSSEDNDEFSSDDLSKEG 1269
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
++P S SPPP S P SSP + + +
Sbjct: 1270 KPKNAPKRVSAVQYSPPPPSKRPDGESNGGSKPSSPTKKKVKKRLE--GSLAALKKKKKS 1327
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
+ S S L P +
Sbjct: 1328 EKKTARKKKSKTRVKQASASQSSRLLRRPRKKKSD 1362
|
Length = 1388 |
| >gnl|CDD|237182 PRK12727, PRK12727, flagellar biosynthesis regulator FlhF; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 32/202 (15%), Positives = 52/202 (25%), Gaps = 7/202 (3%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
A S +P + P P + P + + S +
Sbjct: 57 TARSDTPATAAAPAPAPQAPTKPAAPVHAPLKLSANANMSQRQRVASAAEDMIAAMALRQ 116
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPP-----VSNPPTRSPPPPSSTPPP 124
S P +P A S P P+ A + P +S P + +T P
Sbjct: 117 PVSVPRQAPAAAPVRAASIPSPAAQALAHAAAVRTAPRQEHALSAVPEQLFADFLTTAPV 176
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP 184
P A +P P+ + + + + + P PP P
Sbjct: 177 PRAPVQAPVVAAPAPVPAIAAALAAHAAYAQDDDEQLDDDGFDLDDALPQ--ILPPAALP 234
Query: 185 PAPIAVPPSNVPPPPTQTPPTP 206
P +A P P
Sbjct: 235 PIVVAPAAPAALAAVAAAAPAP 256
|
Length = 559 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 9e-04
Identities = 34/173 (19%), Positives = 51/173 (29%), Gaps = 19/173 (10%)
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV--EPPKRSPPSVPPQNPPP 173
PPP + P PPP N PP V +P ++P PP
Sbjct: 257 PPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPDPP 316
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPP---------------PTQTPPTPASPIAPRPSNSS 218
PP+ + P P PT TPP+ ++
Sbjct: 317 PPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSA--GRHH 374
Query: 219 PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTV 271
P P+ KR S + + T P++P +S P+ +
Sbjct: 375 PKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASA 427
|
Length = 3151 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 9e-04
Identities = 26/85 (30%), Positives = 35/85 (41%), Gaps = 4/85 (4%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
PS PA + S P P +PP PP+S PP P + P SP P P S
Sbjct: 415 TPSSAAPATPAPSAAPSPRVPWDDAPP----APPRSGIPPRPAPRMPEASPVPGAPDSVA 470
Query: 63 PTSSSPPASSPPTSSPPPASNPPTS 87
S +PP P+ + + P +
Sbjct: 471 SASDAPPTLGDPSDTAEHTPSGPRT 495
|
Length = 624 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-04
Identities = 21/78 (26%), Positives = 29/78 (37%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
SS P S+ +S S S+PP+S+SP S+ P P S
Sbjct: 2 SSSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSP 61
Query: 98 PPTISPPPPVSNPPTRSP 115
P PP + P +P
Sbjct: 62 PSVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 9e-04
Identities = 21/78 (26%), Positives = 28/78 (35%), Gaps = 8/78 (10%)
Query: 140 PPSNPPSNLPPPPPSSVEPPKR---SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP 196
P + P ++ P + P PP PP+ + AP A PS VP
Sbjct: 45 GPVAKAAEQMAAPEAAEAAPLPAAAESIASPEVPPPVPPAPAQE---GEAPAAEQPSAVP 101
Query: 197 PPPTQTPPTPASPIAPRP 214
P P PA P+ P
Sbjct: 102 APSAA--PAPAEPVEPSL 117
|
Length = 931 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 16/97 (16%), Positives = 24/97 (24%), Gaps = 1/97 (1%)
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
P+ P + P +P A S P + A A +P+ + P
Sbjct: 370 SGGRGPKQHIKP-VFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 223 PPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
P PP + SS
Sbjct: 429 VDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSS 465
|
Length = 614 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (95), Expect = 0.001
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 3/129 (2%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN--SPPA 186
+ P+ A + PP+ P + P ++ PP +++PP +PPA
Sbjct: 220 AAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPA 279
Query: 187 PIAVPPSNVPPPPTQTPPTPA-SPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTP 245
A PP+ PP + PA + AP + ++P P K +PP P +
Sbjct: 280 KAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAA 339
Query: 246 GNGTNPSSP 254
++P
Sbjct: 340 PPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 55/260 (21%), Positives = 68/260 (26%), Gaps = 29/260 (11%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPT-------TSPP 54
S+ SP P P + P SPP P P+ +
Sbjct: 134 SSSSPAKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPHTPTDTAPSGKRKRRLSDGF 193
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
P P TSS P S P S S T PPPVS
Sbjct: 194 QLPAPKRPQTSSRPQTVSDPLPLHATTDWDTWFQATVSSSPSLLLTGDIPPPVSVFAPDD 253
Query: 115 PPPPSSTPP--PNSPPSPPSDPPANSPPPSNPPSNLPPPPP---SSVEPPKRS------- 162
P + P P PP +P + S+ P SSV+
Sbjct: 254 STPLDISLFNFPLIPLLPPEALDLPAPTAVSSSSSTFAVPALTSSSVDQSATPLDQGFSN 313
Query: 163 ------PPSVPPQNPPP----PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
+ P N P SSS N P S P + P+
Sbjct: 314 FGSNMYSEPLNPTNDSLLYGLPSSSSLYANRTIFPAWASTSVSPLDFSTLFNQPSPSPMA 373
Query: 213 RPSNSSPNSPPPPSTKRLSP 232
S +P P PS L
Sbjct: 374 SQSILAPAQPTSPSPVALPS 393
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 17/62 (27%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
P + P P++ PP +PP P A P P P PA+ P S + P +
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARS-ADPAA 442
Query: 222 PP 223
Sbjct: 443 AA 444
|
Length = 576 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 25/125 (20%), Positives = 37/125 (29%), Gaps = 6/125 (4%)
Query: 32 VSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP 91
+ N S PP K + PS + S T P SS P
Sbjct: 141 LRNAWSSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVT----PTRGRRPSSSPR 196
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
S S+P T+ P + PP + T ++ S + +S +
Sbjct: 197 SL--SNPTTLESPSNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRST 254
Query: 152 PPSSV 156
P S
Sbjct: 255 PTSGS 259
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 58/296 (19%), Positives = 80/296 (27%), Gaps = 51/296 (17%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPP-------------- 49
PS P + PV + I PP S P + P PP S+
Sbjct: 455 PSDQPSVPVEPAHLTPVEHTTVILHQPPQSPPTVAIKPAPPPSRRRRGACVVYDDDIIEV 514
Query: 50 ---------TTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS----NPPTSSPPPSPPAS 96
+ P+ P ++PP S PP +SPP P S
Sbjct: 515 IDVETTEEEESVTQPAKPHRKVQDGFQRSGRRQKRATPPKVSPSDRGPPKASPPVMAPPS 574
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP------ 150
+ P + P P P S P PP S P P
Sbjct: 575 TGPRVMATPSTGPRDMAPPSTGPRQQAKCKDGPPASGPHEKQPPSSAPRDMAPSVVRMFL 634
Query: 151 ----------PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP--------P 192
P P S + Q P +++PP P +P
Sbjct: 635 RERLLEQSTGPKPKSFWEMRAGRDGSGIQQEPSSRRQPATQSTPPRPSWLPSVFVLPSVD 694
Query: 193 SNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG 248
+ P ++ + SP P P P LS P P + P +G
Sbjct: 695 AGRAQPSEESHLSSMSPTQPISHEEQPRYEDPDDPLDLSLHPDQAPPPSHQAPYSG 750
|
Length = 1000 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 47/230 (20%), Positives = 68/230 (29%), Gaps = 9/230 (3%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP--A 59
S P P+ S P P P + PP+S PP + P S
Sbjct: 448 STPERPGPSDQPSVPVEPAHLTPVEHTTVILHQPPQS-PPTVAIKPAPPPSRRRRGACVV 506
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ + P S PP +P R PP
Sbjct: 507 YDDDIIEVIDVETTEEEESVTQPAKPHRKVQDGFQRSGRRQKRATPPKVSPSDRG--PPK 564
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
++PP +PPS + P + P + P PP + + P + PPSS+P
Sbjct: 565 ASPPVMAPPS--TGPRVMATPSTGPRDMAPPSTGPRQQAKCKDGPPASGPHEKQPPSSAP 622
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
+P + T P P S R PS++R
Sbjct: 623 RDMAPSVVRMFLRERLLEQSTG--PKPKSFWEMRAGRDGSGIQQEPSSRR 670
|
Length = 1000 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 0.001
Identities = 10/74 (13%), Positives = 19/74 (25%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
PP+ P P A + + ++ + V + + PP
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPP 447
Query: 119 SSTPPPNSPPSPPS 132
+ P S
Sbjct: 448 APAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 0.001
Identities = 12/71 (16%), Positives = 23/71 (32%)
Query: 34 NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP 93
PP P+ A+ +++P A P + ++ PP+P
Sbjct: 390 GPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAP 449
Query: 94 PASSPPTISPP 104
A+ P +
Sbjct: 450 AAAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 0.001
Identities = 13/70 (18%), Positives = 20/70 (28%)
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
PPS PP P A + + + P P + PP P+
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 177 SSPPKNSPPA 186
++P
Sbjct: 451 AAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 0.001
Identities = 15/71 (21%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP---PTISPPPPVS 108
P P PP P + ++P A+ P + P + A+ P + PP +
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 109 NPPTRSPPPPS 119
P + S
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 12/70 (17%), Positives = 23/70 (32%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P S PP P + +P A+ ++ PA++ A+ +P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 91 PSPPASSPPT 100
+P +
Sbjct: 451 AAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 12/66 (18%), Positives = 20/66 (30%)
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
PP+ PP P + + + P P ++ P + A P+
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 194 NVPPPP 199
P P
Sbjct: 451 AAPQPA 456
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 16/77 (20%), Positives = 24/77 (31%), Gaps = 6/77 (7%)
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
P P PP +P A A + P P A P + ++ P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAA--AAAPAAGGPAAALAAVPDAAAAAAAPPA 448
Query: 224 PPSTKRLSPPPGIPVPS 240
P + P P + + S
Sbjct: 449 PAAA----PQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 14/71 (19%), Positives = 20/71 (28%)
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS 165
P S PP P + A +P P + L P ++ P+
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 166 VPPQNPPPPPS 176
PQ S
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 31/155 (20%), Positives = 40/155 (25%), Gaps = 13/155 (8%)
Query: 11 ANSSSPPPPVSNPPTISPPPPVSNPPKS--------SPPPPPVSKPPTTSPPPSPPASNP 62
N+ PP + + KS +PP VSK P S
Sbjct: 429 ENNDVPPWEDAPDEAQTAAGTAQTSAKSIQTASEAETPPENQVSKNKAADNETDAPLSEV 488
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
P S P + P +P P PP PPP
Sbjct: 489 P--SENPIQATPNDEAVETETFAHEAPAEPFYGYGFPDNDCPP---EDGAEIPPPDWEHA 543
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P +D A + + PPP S E
Sbjct: 544 APADTAGGGADEEAEAGGIGGNNTPSAPPPEFSTE 578
|
Length = 709 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 22/139 (15%), Positives = 28/139 (20%), Gaps = 12/139 (8%)
Query: 131 PSDPPANSPPPSNPPSNLPPPPPSSVE-------PPKRSPPSVPPQNPPPPPSSSPPKNS 183
P + P S P R S +S+
Sbjct: 21 PEGSRDENFDAERDDFLTPLGSTSEATSEDDDDLYPPRETGS-----GGGVATSTIYTVP 75
Query: 184 PPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTEN 243
P + P + P P P S P SP V
Sbjct: 76 RPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVI 135
Query: 244 TPGNGTNPSSPESSSSPSN 262
G + SS E S
Sbjct: 136 LAPIGESNSSSEELSEEEE 154
|
Length = 580 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 21/73 (28%), Positives = 33/73 (45%), Gaps = 2/73 (2%)
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-SSPPKNSPPAPIAVPPSNVPPPP-TQTP 203
+N P + VE P+ +PPS + P P+ ++PP AP P + P +TP
Sbjct: 28 ANATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVETP 87
Query: 204 PTPASPIAPRPSN 216
+P + P N
Sbjct: 88 QSPTTKQVPTEIN 100
|
Length = 291 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 32/155 (20%), Positives = 46/155 (29%), Gaps = 8/155 (5%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S+ P S + + S P P P S PP P P +
Sbjct: 266 SSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPP--PPVRRPRVKH 323
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P P + + PA ++S S A + + S P S S
Sbjct: 324 PEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAAASSFLEDDDF 383
Query: 122 PPPNSPPSP-----PSDPPANSP-PPSNPPSNLPP 150
P + PS ++P PPS P + L
Sbjct: 384 GSPPLDLTTSLRHMPSPSVTSAPEPPSIPLTYLSD 418
|
Length = 418 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 24/117 (20%), Positives = 38/117 (32%), Gaps = 8/117 (6%)
Query: 9 PAANSSSPPPPVSNPPTISPPPPVSNP-PKSSPPPPPVSKPPTTSPPP--SPPASNPPTS 65
+S+ P + + P P P ++ P P +
Sbjct: 304 VTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLPGT 363
Query: 66 SSPPASSPPTSSPPPASNPPT--SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
+ PA+ P P P S T SS ++ PT S P + P + P P+S
Sbjct: 364 VALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLP---AAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 32/146 (21%), Positives = 45/146 (30%), Gaps = 5/146 (3%)
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
S +PPP + SP P S+ + P +S + S
Sbjct: 195 TNSFKEVTPVGLMRTPPPGSHSKSPSKSGIPDLPSSRDSEKTKPEKPQQETSSMDTEKSS 254
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P PP ++ E K S SP S P+P A P
Sbjct: 255 APKPRETLDPKSPEKAPPIDTTEEELKSPEASPKESEEASARKRSPSLLS-PSPKAESPK 313
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSP 219
+ P +P P++PRP SP
Sbjct: 314 PLASPGK----SPRDPLSPRPKPQSP 335
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 21/76 (27%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 115 PPPPSSTPPPNSPPSPPSD---PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNP 171
P PP P P P + S ++P P+ P+ P +V+ P + P P Q P
Sbjct: 174 PNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQQP 233
Query: 172 PPPPSSSPPKNSPPAP 187
P P+N P
Sbjct: 234 VQPAQQPTPQNPAQQP 249
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 19/73 (26%), Positives = 27/73 (36%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
AP+PG P +SS + P + P V NP + P +P +
Sbjct: 180 APAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQQPVQPAQQ 239
Query: 63 PTSSSPPASSPPT 75
PT +P P T
Sbjct: 240 PTPQNPAQQPPQT 252
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 28/132 (21%), Positives = 37/132 (28%), Gaps = 14/132 (10%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSP------PASSPPTSSPPPASN--PPTSSPPPSPPA 95
P P T P S +S P P + P ++ P S P
Sbjct: 109 PDESDPDTGSPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSAL 168
Query: 96 SSPPTISPPPP--VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPP 153
S I+ P P + +R+ P S P P + PP S PP P
Sbjct: 169 QSESLIAQPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPI--AAS--PPGPQ 224
Query: 154 SSVEPPKRSPPS 165
P
Sbjct: 225 EGPTISASQPAQ 236
|
Length = 430 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 32/100 (32%), Positives = 37/100 (37%), Gaps = 15/100 (15%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
S+ P+ PSPP PP S P AS T PP P A PP +
Sbjct: 4 ARSRSPSPPRRPSPPRPTPPRS-------------PDASPEETPPSPPGPGAEPPPGRAA 50
Query: 104 PPPVSNPPTRSPPP--PSSTPPPNSPPSPPSDPPANSPPP 141
P R P S+ P PP D PA +PPP
Sbjct: 51 GPAAPRRRPRGCPAGVTFSSSAPPRPPLGLDDAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|218397 pfam05044, Prox1, Homeobox prospero-like protein (PROX1) | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 38/209 (18%), Positives = 56/209 (26%), Gaps = 22/209 (10%)
Query: 11 ANSSSPPPPVSNPPTISPPPPV---SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
A P + P + S + P S PP S +
Sbjct: 486 AKPERAAPEQLFKDLMLPSQMLDRKSPRTHTVNDRGQCFGDPDISTAAMFIIPKPPDSFA 545
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP-------PVSNPPTRSPP---- 116
A++ +SP P P + ++P P T S
Sbjct: 546 NVAAAALYNSPFCMPQTPQPQDAPEQTEALSLVVTPKKKRHKVTDTRITPRTVSRILALR 605
Query: 117 ----PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP----PPPPSSVEPPKRSPPSVPP 168
P + T PS S PPP P LP P PS +
Sbjct: 606 DAVGPAAGTHHQPLHPSSLSASMGFHPPPFRHPFPLPLTVAIPNPSLHQSEVFMGYPFQS 665
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
+ P S P K+ + P +++ P
Sbjct: 666 PHLGAPSGSPPGKDRDSPDLPRPTTSLHP 694
|
The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. Prox1 has been found to be an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. This family contains an atypical homeobox domain. Length = 908 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 21/111 (18%), Positives = 36/111 (32%), Gaps = 3/111 (2%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
+ P N P + P PPA P +P P+ A++ + P + P
Sbjct: 99 ATSMSEPATENKPAEVTTPVEPMGLPETPPAV--PVPAPAPAVAAAAAQAAAAPKAPAKP 156
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
+SP P + P + + P P ++ P K+
Sbjct: 157 RAKSPRPAAKAAPKPTETITAKKAKKTAAAPK-PTADKTATPAKKTTKKKK 206
|
Length = 209 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 13/58 (22%), Positives = 21/58 (36%), Gaps = 4/58 (6%)
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
P +PP P++ P P P + + P + P P + P+R P
Sbjct: 16 QPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKK----DKPRRERKPKP 69
|
Length = 475 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 14/60 (23%), Positives = 18/60 (30%), Gaps = 2/60 (3%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
P + P S S TS PA++ +PPP PP S
Sbjct: 268 AAAQPATAAPAPSRMTDTNDSKSVTS--QPAAAAAAPAPPPNPPATPPEPPARRGRGSAA 325
|
Length = 656 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 17/96 (17%), Positives = 24/96 (25%), Gaps = 1/96 (1%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A P +++ V P + P P P S P + PP
Sbjct: 350 TASLTAPSRVLAAAAKVAVIAAPQ-THTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQ 408
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
+ P S P PP P
Sbjct: 409 FCGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPY 444
|
Length = 663 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 25/130 (19%), Positives = 33/130 (25%), Gaps = 6/130 (4%)
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP 184
N S + + + P + P R P P P P+ SP P
Sbjct: 345 NEILKTASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYP 404
Query: 185 PAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLS----PPPGIPVPS 240
P P + P P + P P P P P +S PG P
Sbjct: 405 PVPQFCGDPGLVSPYNPQSPGTSYG--PEPVGPVPPQPTNPYVMPISMANMVYPGHPQEH 462
Query: 241 TENTPGNGTN 250
Sbjct: 463 GHERKRKRGG 472
|
Length = 663 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 19/62 (30%), Positives = 25/62 (40%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
P P P P PP + PP S +P + P P + P +P +S PP
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLK 201
Query: 102 SP 103
SP
Sbjct: 202 SP 203
|
Length = 274 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 29/77 (37%), Positives = 36/77 (46%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P PP P PPPP + PP + P P S P +S P +SPP + P +S+PP
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLK 201
Query: 88 SPPPSPPASSPPTISPP 104
SP SP PP
Sbjct: 202 SPMAGTFYRSPAPGEPP 218
|
Length = 274 |
| >gnl|CDD|240271 PTZ00108, PTZ00108, DNA topoisomerase 2-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 27/181 (14%), Positives = 38/181 (20%), Gaps = 18/181 (9%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
S + V + K P +K +S S + + P SS
Sbjct: 1183 KSSADKSKKASVVGNSKRVDSDEKRKLDDKPDNKKSNSSG--SDQEDDEEQKTKPKKSSV 1240
Query: 74 PTSSPPPASNPPTS---SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
++ +S S S P + SPPPPS P S
Sbjct: 1241 KRLKSKKNNSSKSSEDNDEFSSDDLSKEGKPKNAPKRVSAVQYSPPPPSKRPDGESNGGS 1300
Query: 131 PSDPPANSPPPS--------NPPSNLPPPPP-----SSVEPPKRSPPSVPPQNPPPPPSS 177
P S + S P
Sbjct: 1301 KPSSPTKKKVKKRLEGSLAALKKKKKSEKKTARKKKSKTRVKQASASQSSRLLRRPRKKK 1360
Query: 178 S 178
S
Sbjct: 1361 S 1361
|
Length = 1388 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 26/90 (28%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV------MG 531
L Y+HE I H DIK NI++D N + D+G+A + HI G
Sbjct: 139 LEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRG 195
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLE 561
T Y + + +T + D+ S G +L+
Sbjct: 196 TLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 63/248 (25%), Positives = 98/248 (39%), Gaps = 47/248 (18%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGERE----FKAEVEIISRIH 421
D F ++G G FG V D G A+K L+ E+E +AE +I+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEAD 59
Query: 422 HRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
+V + Y D R L LI +++P + L + + + AT+ IA +
Sbjct: 60 GAWVVKMF-YSFQDKRNLYLIMEFLPGGDM-MTLLMKKDTLSEEATQFYIAE-TVLAIDA 116
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN--------TH-------- 524
+H+ IHRDIK N+LLD ++SDFGL A+ TH
Sbjct: 117 IHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 525 ------------------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
+ +GT Y+APE + D +S GV++ E++ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 567 KPVDASQP 574
P + P
Sbjct: 234 PPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 18/89 (20%), Positives = 26/89 (29%), Gaps = 7/89 (7%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
P +PPA +P ++ RS + + P P PP+
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPA- 404
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
P P S E P P+ P
Sbjct: 405 ------PEPARSAEAPPLVAPAAAPAGLA 427
|
Length = 504 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 15/80 (18%), Positives = 24/80 (30%), Gaps = 2/80 (2%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P +PP P + + ++ + A +P P +P PP
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAA--TAAGAPLPDFDPRPRGPP 403
Query: 91 PSPPASSPPTISPPPPVSNP 110
PA S P + P
Sbjct: 404 APEPARSAEAPPLVAPAAAP 423
|
Length = 504 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 22/63 (34%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 72 SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
+P T PP P ++ P+P +PP S P P + P P++ PPP+ PP PP
Sbjct: 80 APLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPP-APAAAVPAPAAAPPPSDPPQPP 138
Query: 132 SDP 134
P
Sbjct: 139 RAP 141
|
Length = 141 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 29/132 (21%), Positives = 39/132 (29%), Gaps = 9/132 (6%)
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
V PT P P PP P PP+ P P P+ P P P + P
Sbjct: 41 VFLLAAKVLEAPTEEPQPE--PEPPEEQPKPPT-EPETPPEPTPPKPKEKPKPEKKPKKP 97
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
K P P P P P + P P P S + + + P
Sbjct: 98 KPKPKPKPKPKPKVKPQPKP------KKPPSKTAAKAPAAPNQPARPPSAASASGAATGP 151
Query: 220 NSPPPPSTKRLS 231
++ +R
Sbjct: 152 SASYLSGLRRAI 163
|
Length = 244 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 15/59 (25%), Positives = 22/59 (37%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
+ P P P+ S P+ PA P + P P P P+ P + P + P
Sbjct: 208 AEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPVSSGDSGP 266
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|218115 pfam04502, DUF572, Family of unknown function (DUF572) | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 21/88 (23%), Positives = 31/88 (35%), Gaps = 3/88 (3%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
+ P+ +SS +S S S P+SS +S P +S+ R
Sbjct: 224 DNTPSPKSGSSSPAKPTSILKKSAAKRSEAPSSS---KAKKNSRGIPKPRDALSSLVVRK 280
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPS 142
P ST S P S+ P + S
Sbjct: 281 KAAPESTSQSPSSAEPTSESPQTAGNSS 308
|
Family of eukaryotic proteins with undetermined function. Length = 321 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.002
Identities = 17/68 (25%), Positives = 23/68 (33%), Gaps = 3/68 (4%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKS---SPPPPPVSKPPTTSPPPSPPA 59
P P P + PPT PPPP + S + P S PP P+P
Sbjct: 529 KSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPPPPIPEEPTPSP 588
Query: 60 SNPPTSSS 67
+ +
Sbjct: 589 TKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 17/80 (21%), Positives = 26/80 (32%), Gaps = 2/80 (2%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
+P+ P + P P P + + + P P S P PP +
Sbjct: 383 SPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPPVARS--A 440
Query: 63 PTSSSPPASSPPTSSPPPAS 82
P SP AS+P +
Sbjct: 441 PLPPSPQASAPRNVASGKPG 460
|
Length = 620 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 24/113 (21%), Positives = 33/113 (29%), Gaps = 16/113 (14%)
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
K+ PP S+ S P+ N+ TP +P + S S
Sbjct: 447 KKLANKTSTVMEPPYGSTESSVPSTPSTRR-NDRNITSN---TPSLKRTPNLTKSSLSQE 502
Query: 220 NSPPPPSTK------------RLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
S ST L P S N +G N ++ SSP
Sbjct: 503 ASLISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSP 555
|
Length = 619 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (93), Expect = 0.002
Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 2/101 (1%)
Query: 9 PAANSSSPPPPVSNPPT--ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
A +++PP + PP +PP + PP + PP + P +P + +
Sbjct: 249 APAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAK 308
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
+ A + + P A+ PP + P A++PP + PV
Sbjct: 309 AAAAPAKAAAPPAKAAAPPAKAATPPAKAAAPPAKAAAAPV 349
|
Length = 357 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 39/196 (19%), Positives = 55/196 (28%), Gaps = 7/196 (3%)
Query: 16 PPPPVSNPPTISPPPPVSNPPK---SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
P S P T+S P P+ S + PP S S P
Sbjct: 200 RPQTSSRPQTVSDPLPLHATTDWDTWFQATVSSSPSLLLTGDIPPPVSVFAPDDSTPLDI 259
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV---SNPPTRSPPPPSSTPPPNSPPS 129
+ P PP + P+P A S + + P S+ + P S
Sbjct: 260 SLFNFPLIPLLPPEALDLPAPTAVSSSSSTFAVPALTSSSVDQSATPLDQGFSNFGSNMY 319
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
P N PS+ ++ P S SV P + + P I
Sbjct: 320 SEPLNPTNDSLLYGLPSSSSLYANRTIFPAWAST-SVSPLDFSTLFNQPSPSPMASQSIL 378
Query: 190 VPPSNVPPPPTQTPPT 205
P P P P +
Sbjct: 379 APAQPTSPSPVALPSS 394
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 46/203 (22%), Positives = 61/203 (30%), Gaps = 29/203 (14%)
Query: 46 SKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPP 105
P + + P SP SS SP P S SP +SP T
Sbjct: 56 QTPRQSRRSKRAAHAYPSPERSPALSSERLLSPSP------SVLDLSPVLASPQTGK--- 106
Query: 106 PVSNPPTRSPPPPSSTPPPNSPPS--PPSDPPANSPPPSNPPSN-LPPPPPSSVE---PP 159
R PS PS P SD ++S P+ PP LP P S+ +
Sbjct: 107 ------RRRSSSPSDDEDEAERPSKRPRSDSISSSSSPAKPPEACLPSPAASTQDELSEA 160
Query: 160 KRSPPSVPPQNPPPPPSSSPPK--------NSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
+P P +PP P+ + P + P P P T + P P
Sbjct: 161 SAAPLPTPSLSPPHTPTDTAPSGKRKRRLSDGFQLPAPKRPQTSSRPQTVSDPLPLHATT 220
Query: 212 PRPSNSSPNSPPPPSTKRLSPPP 234
+ PS P
Sbjct: 221 DWDTWFQATVSSSPSLLLTGDIP 243
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 47/228 (20%), Positives = 69/228 (30%), Gaps = 15/228 (6%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P S + S + + P + SP ++P T +SSP S
Sbjct: 58 PRQSRRSKRAAHAYPSPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRRRSSSP--SD 115
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
+ P+ P +SS PP P S S P+P PP
Sbjct: 116 DEDEAERPSKRPRSDSISSSSSPAKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPHT 175
Query: 138 SPPPSNPPSNLPPPPPSSVEP---PKRSPPSVPPQ--NPPPPPSSSPPKNSPPAPIAVPP 192
P PS S PKR S PQ + P P ++ ++
Sbjct: 176 --PTDTAPSGKRKRRLSDGFQLPAPKRPQTSSRPQTVSDPLPLHATTDWDTWFQATVSSS 233
Query: 193 SNV------PPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
++ PPP + P ++P+ N PP L P
Sbjct: 234 PSLLLTGDIPPPVSVFAPDDSTPLDISLFNFPLIPLLPPEALDLPAPT 281
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 18/86 (20%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
+P P+ + P ++ P P P P P + +AP +N + P P+
Sbjct: 170 TDPATTPAPAAPVDTTPTNSQTPAVATAPAP-AVDPQQNAVVAPSQANVDTAATPAPAA- 227
Query: 229 RLSPPPGIPVPSTENTPGNGTNPSSP 254
P P + G T + P
Sbjct: 228 --PATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 36/161 (22%), Positives = 55/161 (34%), Gaps = 12/161 (7%)
Query: 6 PGPPAANSSSPPPPVSNPPTI------SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
P S P + S P + +S P P ++PP + PS
Sbjct: 188 TYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTSSNPEPQTEPPPSQRGPSGSP 247
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+PP+++S S+ + + P S S T +PPP T P P
Sbjct: 248 QHPPSTTSQDQSTTGDGQ--EHTQRRKTPPATSNRRSPHSTATPPPTTKRQETGRPTPRP 305
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPS----NLPPPPPSSV 156
+ + P S PP P+ L PP P+S+
Sbjct: 306 TATTQSGSSPPHSSPPGVQANPTTQNLVDCKELDPPKPNSI 346
|
Length = 408 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 31/133 (23%), Positives = 49/133 (36%), Gaps = 12/133 (9%)
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP--PPPPSSVE 157
++ PP PSS N+P S P + +P PS+ P P+++E
Sbjct: 147 SLGPPLQHRKRDAV-TASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLE 205
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKN--SPPAPIAVPPSNVPP-PPTQTPPTPASPIAPRP 214
P S V PPP + + + S A +++ S P TP S
Sbjct: 206 SP--SNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGS---- 259
Query: 215 SNSSPNSPPPPST 227
S+ +P S +
Sbjct: 260 SSINPVSGLDEAE 272
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 20/122 (16%), Positives = 29/122 (23%), Gaps = 6/122 (4%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
P + P P + P P P + A + P + +
Sbjct: 635 FPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAALRA 694
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P A P PPPP P S + + PP P
Sbjct: 695 PQAPR------PGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQAD 748
Query: 153 PS 154
+
Sbjct: 749 GA 750
|
Length = 753 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 19/88 (21%), Positives = 24/88 (27%), Gaps = 5/88 (5%)
Query: 9 PAANS---SSPPPPVSNPPTISPPPPVSNPPKSSPPP--PPVSKPPTTSPPPSPPASNPP 63
PAA + PP + S P + PP P +P PP P P
Sbjct: 57 PAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEPPKPKPVEKPK 116
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPP 91
P +P P P
Sbjct: 117 PKPKPQQKVEAPPAPKPEPKPVVEEKAA 144
|
Length = 226 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 33/121 (27%), Positives = 41/121 (33%), Gaps = 16/121 (13%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNP---PTISPPPPVSNP-----------PKSSPPPPPVS 46
M AP+ P PP PV P P P PP P PK P P PV
Sbjct: 52 MVAPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIPKPEPKPKPKPKPKPKPVK 111
Query: 47 KPPTTSPPPSPPASNPPTSS--SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
K P P S + + P +S+ A++ P +S P A S P
Sbjct: 112 KVEEQPKREVKPVEPRPASPFENTAPARPTSSTATAAASKPVTSVSSGPRALSRNQPQYP 171
Query: 105 P 105
Sbjct: 172 A 172
|
Length = 246 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 6/70 (8%), Positives = 15/70 (21%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
PP +P + + + + P + P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 182 NSPPAPIAVP 191
+P + +
Sbjct: 451 AAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 2/102 (1%)
Query: 1 MSAPSPGPPAANSS-SPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPA 59
SA +P A S P V+ + + P V+ P T + P + P
Sbjct: 313 SSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLPGTVALPAAEPV 372
Query: 60 SN-PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPT 100
+ P S+ T + +N PT+S P +P ++ P +
Sbjct: 373 NMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVS 414
|
Length = 421 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 20/66 (30%), Positives = 29/66 (43%), Gaps = 1/66 (1%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
P ++ P + A+ +P P + PT PP +S P P + PP PA PPP+
Sbjct: 124 PPAAAPAAAAAAKAEKTTPEKPKAAAPT-PEPPAASKPTPPAAAKPPEPAPAAKPPPTPV 182
Query: 145 PSNLPP 150
P
Sbjct: 183 ARADPR 188
|
Length = 418 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 36/149 (24%), Positives = 45/149 (30%), Gaps = 8/149 (5%)
Query: 12 NSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPAS 71
NS PV T P +P KS P P S+ + P P +S S
Sbjct: 196 NSFKEVTPVGLMRTPPPGSHSKSPSKSGIPDLPSSRDSEKTKPEKPQ--QETSSMDTEKS 253
Query: 72 SPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP-PTRSPPPPSSTPPPNSPPSP 130
S P P +PP + P S R P +P P +
Sbjct: 254 SAPKPRETLDPKSPEKAPPIDTTEEELKSPEASPKESEEASARKRSPSLLSPSPKAESPK 313
Query: 131 PSDPPANSP--PPSNPPSNLPPPPPSSVE 157
P P SP P S P P P +
Sbjct: 314 PLASPGKSPRDPLSPRP---KPQSPPVND 339
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 52/282 (18%), Positives = 75/282 (26%), Gaps = 35/282 (12%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ P S P S+ ++PP + PS P S
Sbjct: 57 SLSGRPASRLNREPSSRPGSSHSEATIVRQAKEGERPATPPEARPDEGFVRPSLPSHPRS 116
Query: 61 NPPTSSSPPASSPPTSSPPPASNP-------PTSSP--------PPSPPASSPPTISP-- 103
+ S+ P+ PP S PT + P SP P P
Sbjct: 117 RSASVSNSKDGDRPSDLPPSPSKTMDPRRWSPTKATWLESALNKPESPKHKPQPPQQPEW 176
Query: 104 ---------------PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
++ +P TPPP S PS P S
Sbjct: 177 KKDLSRLRQSRASVDLGRTNSFKEVTPVGLMRTPPPGSHSKSPSKSGIPDLPSSRDSEKT 236
Query: 149 PPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P P + S P+ SP K P + P ++ A
Sbjct: 237 KPEKPQQETSSMDTEKSSAPKPRETLDPKSPEKAPPIDTTEEELKSPEASPKESEEASAR 296
Query: 209 PIAPRPSNSSPNSPPP---PSTKRLSPPPGIPVPSTENTPGN 247
+P + SP + P S + P P P ++ P N
Sbjct: 297 KRSPSLLSPSPKAESPKPLASPGKSPRDPLSPRPKPQSPPVN 338
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 13/59 (22%), Positives = 20/59 (33%), Gaps = 3/59 (5%)
Query: 171 PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP---TPASPIAPRPSNSSPNSPPPPS 226
PP +S P +P P + P + + S A P + S + P S
Sbjct: 86 PPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPSSGS 144
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 18/73 (24%), Positives = 27/73 (36%), Gaps = 1/73 (1%)
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P + P ++ PT +P PP+S P +P S SP + + P P
Sbjct: 77 PKTGTGKVAPPAATPTSAPTPTPSPPAS-PASGMSAAPASAVEEKSPSEESATATAPESP 135
Query: 153 PSSVEPPKRSPPS 165
+SV S
Sbjct: 136 STSVPSSGSDAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 25/131 (19%), Positives = 34/131 (25%), Gaps = 4/131 (3%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
VS+ S P S S A + P SS P + +SS
Sbjct: 2 AASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSS 61
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNL 148
S S S + SP S + + S + + S PS
Sbjct: 62 FGLSKQRPS----SLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTT 117
Query: 149 PPPPPSSVEPP 159
S P
Sbjct: 118 SSDLSSGNGPS 128
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 19/91 (20%), Positives = 28/91 (30%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
P P + P ++P P S T P P+P
Sbjct: 108 KVLGEEEPAPQEETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEPVD 167
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
+++ P + P PP+ PPP P P
Sbjct: 168 SMAIAVPAIDTPVTLELPPAPQPPPPVVPQP 198
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|218181 pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain transcription factor N terminal domain | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 34/110 (30%), Positives = 39/110 (35%), Gaps = 8/110 (7%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP-PTSSPPPASNPPTSSPPPSPPASSPP 99
P KPPT P P + T S P SSPP P + P PP SSP
Sbjct: 125 KPASGFKPPTPPSTPCSPVNPQETVRQLQPSGPLSNSSPPSPHTPLPNQSPLPPPMSSPD 184
Query: 100 TISPPPP-----VSNPPTRSPPPPSSTPPPNSPP--SPPSDPPANSPPPS 142
+ P +S P PPPP PP S+P PP
Sbjct: 185 SSYPSEHRFQRQLSEPCLPFPPPPGRGSRDGRPPYHRQMSEPLVPYPPQG 234
|
The N terminus of the PEA3 transcription factors is implicated in transactivation and in inhibition of DNA binding. Transactivation is potentiated by activation of the Ras/MAP kinase and protein kinase A signalling cascades. The N terminal region contains conserved MAP kinase phosphorylation sites. Length = 336 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 18/37 (48%), Positives = 21/37 (56%), Gaps = 3/37 (8%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
PP + PP PPPPP +PP+ PPP PP N S
Sbjct: 5 PPGNPPP---PPPPPGFEPPSQPPPPPPPGVNVKKRS 38
|
Length = 2365 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 34/114 (29%), Positives = 47/114 (41%), Gaps = 13/114 (11%)
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS-SPPKNSPPA 186
P + P S SN + PS+V P SPP+ +PP PS P SPPA
Sbjct: 566 PGSTNSTPTGSAASSN--TTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPPA 623
Query: 187 PIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPS 240
S++ P T TP+SP + S+ + P S K S + + S
Sbjct: 624 ------SHLGSPST----TPSSPESSIKVASTETASPESSIKVASTESSVSMVS 667
|
Length = 670 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 31/104 (29%), Positives = 43/104 (41%), Gaps = 5/104 (4%)
Query: 7 GPPAANSSSP--PPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
G P + +S+P SN S P P +SPP + PP T P+++PP
Sbjct: 564 GNPGSTNSTPTGSAASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPPA 623
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
S SP T+ P S+ +S + P SS S VS
Sbjct: 624 SH---LGSPSTTPSSPESSIKVASTETASPESSIKVASTESSVS 664
|
Length = 670 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 26/116 (22%), Positives = 33/116 (28%), Gaps = 5/116 (4%)
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
S + V P ++ P+ P P P PA SP + PP
Sbjct: 354 TAPSRVLAAAAKVAVIAAP-QTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFCGD 412
Query: 153 PSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
P V P P P + P P P P P +P S P
Sbjct: 413 PGLVSP---YNPQSPGTSYGPEPVGPVPP-QPTNPYVMPISMANMVYPGHPQEHGH 464
|
Length = 663 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 20/99 (20%), Positives = 29/99 (29%), Gaps = 3/99 (3%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ + P+ A+ + P + + P S P S P
Sbjct: 352 SLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGI---PYSVPARSPMTAYPPVPQ 408
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
DP SP P P P PP+ + P V P
Sbjct: 409 FCGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPYVMP 447
|
Length = 663 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/77 (36%), Positives = 34/77 (44%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS 82
P P P V P PP S P P +P +S PPT +SPP + P SS PP
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLK 201
Query: 83 NPPTSSPPPSPPASSPP 99
+P + SP PP
Sbjct: 202 SPMAGTFYRSPAPGEPP 218
|
Length = 274 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 25/62 (40%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPP--PPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
P PP + + PPPP + PP P P S P + PP+P S PPA +P S+PP
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLK 201
Query: 148 LP 149
P
Sbjct: 202 SP 203
|
Length = 274 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 16/84 (19%), Positives = 24/84 (28%), Gaps = 2/84 (2%)
Query: 80 PASNPPTSSPPPSPPASSPPTISP--PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
P+ +PP PA ++ S + ++ P P PPA
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPAP 405
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKR 161
P S L P + R
Sbjct: 406 EPARSAEAPPLVAPAAAPAGLALR 429
|
Length = 504 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 15/82 (18%), Positives = 22/82 (26%), Gaps = 2/82 (2%)
Query: 19 PVSNPPTISPPPPVSNPPKSSPPP--PPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTS 76
P ++PP P V + + A P P PP
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPAP 405
Query: 77 SPPPASNPPTSSPPPSPPASSP 98
P ++ P P + PA
Sbjct: 406 EPARSAEAPPLVAPAAAPAGLA 427
|
Length = 504 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 18/89 (20%), Positives = 22/89 (24%), Gaps = 6/89 (6%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
P +PP PA S A ++ P P P
Sbjct: 346 PSEGVAAVAPPAPAPADLTQR---LNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGP 402
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
P P P RS P P +P
Sbjct: 403 PAPE---PARSAEAPPLVAPAAAPAGLAL 428
|
Length = 504 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 17/61 (27%), Positives = 23/61 (37%)
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNS 183
P +PP+PP + P PPP + PP + P PPP P +
Sbjct: 81 PLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPPRA 140
Query: 184 P 184
P
Sbjct: 141 P 141
|
Length = 141 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 45/210 (21%), Positives = 72/210 (34%), Gaps = 30/210 (14%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP------ 118
+ +P P A P +P P+P A +P +P S T P
Sbjct: 80 GEAGSEPAPAAPEPEAAPEPEAPAPAPTPAAEAPAPAAPQAGGSGEATEVKMPELGESVT 139
Query: 119 -----------SSTPPPNSPPSPPSDPPANSPPPSNPPSNL---PPPPPSSVE------- 157
T + P S ++ PS L P +VE
Sbjct: 140 EGTVTSWLKAVGDTVEVDEPLLEVSTDKVDTEIPSPVAGTLLEIRAPEDDTVEVGTVLAI 199
Query: 158 -PPKRSPPSVPPQNPPPPPSSSPPKNSP-PAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
+ P+ P + P PS + + +P PA A + PP P P A+P A P
Sbjct: 200 IGDANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPV 259
Query: 216 NSSPNSP-PPPSTKRLSPPPGIPVPSTENT 244
+S + P P ++L+ G+ + + + T
Sbjct: 260 SSGDSGPYVTPLVRKLAKDKGVDLSTVKGT 289
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 15/109 (13%)
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
I GA RGL YLH++ + IHR+IK+S+IL+ + VS GL+ L +V
Sbjct: 106 ILFGALRGLNYLHQNGY---IHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKV 160
Query: 530 MGTFG--------YMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKP 568
+ F +++PE KSD++S G+ EL TGR P
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 34/119 (28%), Positives = 47/119 (39%), Gaps = 34/119 (28%)
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLA-----------------KLALD-----------A 521
IHRDIK N+LLD+ ++SDFGL L D A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 522 NTHITTR------VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
T R +GT Y+APE + D +S GV++ E++ G P + P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|147601 pfam05505, Ebola_NP, Ebola nucleoprotein | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 44/228 (19%), Positives = 60/228 (26%), Gaps = 47/228 (20%)
Query: 4 PSPGP----PAANSSSPPPPVSNPPTISPPPPVSNP------------------------ 35
P PGP P S TI PP V +P
Sbjct: 410 PFPGPIEDDVQPRPMDDDPDDSRDTTI--PPGVVDPIDGESTEYSSYSDSFVGTNDDLVL 467
Query: 36 -------PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
S P P + + PP S P + S +N
Sbjct: 468 FNLDEDDDDSKPIPEQAASTYGQTSRERQGIPEPPPGSHQPGNR--ASQDLNNNNQKQED 525
Query: 89 PPPSPPASSPPTISPPPPV---SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
+P + PV P ++ SS PP S D P +
Sbjct: 526 ESTNPIGKTSLRYQELTPVQEEDEPEDQTDDDDSSLPPLES-----DDDPGSDNEQGVDL 580
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
+ + PP P + ++ P QNP P S +S PS
Sbjct: 581 TEVAPPAPVYRDEKEQDEIPHPAQNPQDPTGSIGNVDSDILRSNSKPS 628
|
This family consists of Ebola and Marburg virus nucleoproteins. These proteins are responsible for encapsidation of genomic RNA. It has been found that nucleoprotein DNA vaccines can offer protection from the virus. Length = 717 |
| >gnl|CDD|221179 pfam11711, Tim54, Inner membrane protein import complex subunit Tim54 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 21/93 (22%), Positives = 28/93 (30%), Gaps = 1/93 (1%)
Query: 26 ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPP 85
+ PP P + P V P P P T+ +P + P PP
Sbjct: 195 LDPPEPPEPTVDEAAPETEVEATPAAESPAEPAEETAETTPEETEDAPEEENNKPVK-PP 253
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
P SP + P P P+ P P
Sbjct: 254 VPKPYISPDEYPSAPLPPELPQLLQPSLVIPFP 286
|
Mitochondrial function depends on the import of hundreds of different proteins synthesised in the cytosol. Protein import is a multi-step pathway which includes the binding of precursor proteins to surface receptors, translocation of the precursor across one or both mitochondrial membranes, and folding and assembly of the imported protein inside the mitochondrion. Most precursor proteins carry amino-terminal targeting signals, called pre-sequences, and are imported into mitochondria via import complexes located in both the outer and the inner membrane (IM). The IM complex, TIM, is made up of at least two proteins which mediate translocation of proteins into the matrix by removing their signal peptide and another pair of proteins, Tim54 and Tim22, that insert the polytopic proteins, that carry internal targetting information, into the inner membrane. Length = 377 |
| >gnl|CDD|225805 COG3266, DamX, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 29/151 (19%), Positives = 49/151 (32%), Gaps = 7/151 (4%)
Query: 2 SAPSPGPPAANSSSPP---PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP 58
P+PGP +A ++S PP+S+ PT P + + ++ S
Sbjct: 60 QQPAPGPTSAENTSQDLSLPPISSTPTQGQEPLAQDGQQRVEVQGDLNNAAVQPQNLSQL 119
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP---PPPVSNPPTRSP 115
+ TS+ P + + AS P P + P + P P
Sbjct: 120 NNVAVTSTLPTEPA-TVAPVRNASVPTAERPAITRPVRAQAVSEPAVEPKAAKTATATEA 178
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
+++P P A S + PS
Sbjct: 179 KVQTASPAQTPATPPAGKGAAASGQLKSAPS 209
|
Length = 292 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 20/70 (28%), Positives = 27/70 (38%), Gaps = 1/70 (1%)
Query: 76 SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPP 135
+S P + + PP PPAS+ PPPP + PPP P P P
Sbjct: 45 ASIPGLEDVTVQTTPP-PPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPEAPA 103
Query: 136 ANSPPPSNPP 145
N+ + P
Sbjct: 104 ENTVTVAKDP 113
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 19/53 (35%), Positives = 24/53 (45%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT 75
+PPPP S PPPPP ++ SPPP + PP P A + T
Sbjct: 54 TVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPEAPAENT 106
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|223079 PHA03419, PHA03419, E4 protein; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 24/108 (22%), Positives = 31/108 (28%), Gaps = 1/108 (0%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
PP + P+S PPP P P + + PPP +
Sbjct: 52 CPPTTPHPSSQPPPCPPSPGHPPQTNDTHEKDLALQPPPGGKKKEKKKKETEKPAQGGEK 111
Query: 127 PPSPPSDPP-ANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
P P P +PP PPPP + P P P
Sbjct: 112 PDQGPEAKGEGEGHEPEDPPPEDTPPPPGGEGEVEGGPSPGPGPGPLD 159
|
Length = 200 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 44/211 (20%), Positives = 81/211 (38%), Gaps = 28/211 (13%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGER--EFKAEVEIISRIHHRHLVSLVGYC 432
+ + K + P VA+K++ + E + E+ ++ H +++ V
Sbjct: 10 FEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 433 ISDDRRLLIYDYVP----NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
I D ++ + + L H EG P L A I L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAF---ILKDVLNALDYIH---SKG 121
Query: 489 IIHRDIKSSNILLDNNFEAQVSDF---------GLAKLALDANTHITTRVMGTFGYMAPE 539
IHR +K+S+ILL + + +S G + + + + + +++PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPE 178
Query: 540 --YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ EKSD++S G+ EL G P
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 46/183 (25%), Positives = 82/183 (44%), Gaps = 20/183 (10%)
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE-GRPVLDWATRV 468
F ++S++ H HL + G C+ +++ ++V + L L E GR + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL------DNNFE-AQVSDFGLAKLALDA 521
+A A L+YL + ++H ++ + NILL + ++SD G++ AL
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 522 NTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLEL-ITGRKPVDASQPLGDES 579
+ ++APE G L+ +D +SFG LLE+ G P+ P E
Sbjct: 178 EERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232
Query: 580 LVE 582
E
Sbjct: 233 FYE 235
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 29/85 (34%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S SP A PP PP + PPPVS + PP S+P P P PP
Sbjct: 27 SCFSPPESAHPDDPPPVGDPRPPVVDTPPPVS----AVWVLPPPSEPAAPPPDPEPPVPG 82
Query: 62 PPTSSSPPASSPPTSSPPPASNPPT 86
P SP A P PP P
Sbjct: 83 PAGPPSPLAPPAPARKPPLPPPRPQ 107
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.002
Identities = 26/132 (19%), Positives = 44/132 (33%), Gaps = 7/132 (5%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP--TISPPPPV 107
+ + P TS++ P + AS P + P+ AS P +P P
Sbjct: 19 IANLNTNIPIPELHTSAATQKPDPAPAPHQAASRAPDPAVAPTSAASRKPDLAQAPTPAA 78
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP-----KRS 162
S +P P + P P A P + ++ + + K+
Sbjct: 79 SEKFDPAPAPHQAASRAPDPAVAPQLAAAPKPDAAEAFTSAAQAHEAPADAGTSAASKKP 138
Query: 163 PPSVPPQNPPPP 174
P+ Q+ PPP
Sbjct: 139 DPAAHTQHSPPP 150
|
Length = 566 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 40/192 (20%), Positives = 64/192 (33%), Gaps = 13/192 (6%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
+SSP S S S PP + PP + P + P P++ PP
Sbjct: 149 SSSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQGS 208
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P + P P P S +P P + P P P P S +P
Sbjct: 209 PIAAQPA-------PQPQQPSPLSLISAPSLHPQRLPSPHPPLQPQTASQQSPQP----- 256
Query: 195 VPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
P P ++ P + P ++ P +PP + ++ P + + P
Sbjct: 257 -PAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQP 315
Query: 255 ESSSSPSNNGIG 266
S + PS + +
Sbjct: 316 HSHTPPSQSALQ 327
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.003
Identities = 17/99 (17%), Positives = 26/99 (26%), Gaps = 8/99 (8%)
Query: 163 PPSVPP-------QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
P SV P P ++ + A A P+ P P PA P A
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPA-PPAAAAP 80
Query: 216 NSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
+ P + P + + +P
Sbjct: 81 AAPPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 59/306 (19%), Positives = 77/306 (25%), Gaps = 72/306 (23%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISP-------------------------------- 28
+ GPPA+ PP S P ++P
Sbjct: 600 QAKCKDGPPASGPHEKQPPSSAPRDMAPSVVRMFLRERLLEQSTGPKPKSFWEMRAGRDG 659
Query: 29 -----PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN 83
P P + PP S P+ PS A S SS + P
Sbjct: 660 SGIQQEPSSRRQPATQSTPPRPSWLPSVFVLPSVDAGRAQPSEESHLSSMSPTQPISHEE 719
Query: 84 PPTSSPPPSPP--ASSPPTISPPPPVSNPPTRSPPPPSSTPPPN--SPPSPPS------D 133
P P P + P PP + P P P P P + +
Sbjct: 720 QPRYEDPDDPLDLSLHPDQAPPPSHQAPYSGHEEPQAQQAPYPGYWEPRPPQAPYLGYQE 779
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP------ 187
P A S+ P P + P R + Q P P PP
Sbjct: 780 PQAQGVQVSSYPGYAGPWGLRAQHPRYRHSWAYWSQYPGHGHPQGPWAPRPPHLPPQWDG 839
Query: 188 ------------IAVPPSNVPPPPTQT-------PPTPASPIAPRPSNSSPNSPPPPSTK 228
+ PP + T S AP S+ P +P P
Sbjct: 840 SAGHGQDQVSQFPHLQSETGPPRLQLSQVPQLPYSQTLVSSSAPSWSSPQPRAPIRPIPT 899
Query: 229 RLSPPP 234
R PPP
Sbjct: 900 RFPPPP 905
|
Length = 1000 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.003
Identities = 10/67 (14%), Positives = 17/67 (25%)
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
P P P+ P ++ P P + P +++ P
Sbjct: 392 PSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPAA 451
Query: 186 APIAVPP 192
AP
Sbjct: 452 APQPAVR 458
|
Length = 598 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (92), Expect = 0.003
Identities = 32/118 (27%), Positives = 47/118 (39%), Gaps = 2/118 (1%)
Query: 26 ISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS--PPASSPPTSSPPPASN 83
++P P + P + P P + P + P PA P T+ + PPA P + P PA
Sbjct: 82 LAPSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPARPAPACP 141
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
P T PP+PP +P P+ PP + P +P + P P
Sbjct: 142 PSTRQCPPAPPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAASPVLEPRIP 199
|
Length = 280 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 32/98 (32%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
P + PPP P S P PP +S + S P P PS P P
Sbjct: 179 GGNIPGAIQPPP--PSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPS--PAQPS 234
Query: 173 PPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
PP+S P +PP P + PP P PP P PI
Sbjct: 235 APPASIP---APPIPPVIQYVAPPPVP---PPQPIIPI 266
|
Length = 582 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 20/80 (25%), Positives = 34/80 (42%), Gaps = 1/80 (1%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
SNP + S + +SS + S PP ++P R P S++ ++P P ++ PP
Sbjct: 4 SNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKP-SASSLLHTPSILPLPKLSSPSPP 62
Query: 142 SNPPSNLPPPPPSSVEPPKR 161
S + P +R
Sbjct: 63 SVTLPPAATTQTPQLNPLQR 82
|
Length = 590 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 25/132 (18%), Positives = 33/132 (25%), Gaps = 2/132 (1%)
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P S P T SP VS+ P P PP P P+ ++
Sbjct: 109 PDESDPDTGSPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSAL 168
Query: 153 PSSVEPPKRSPPSVPPQ--NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
S + P P P S P +VPP P P
Sbjct: 169 QSESLIAQPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPT 228
Query: 211 APRPSNSSPNSP 222
+ +
Sbjct: 229 ISASQPAQRDHA 240
|
Length = 430 |
| >gnl|CDD|218397 pfam05044, Prox1, Homeobox prospero-like protein (PROX1) | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 30/171 (17%), Positives = 44/171 (25%), Gaps = 11/171 (6%)
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV 156
P P P + P S + P PP S
Sbjct: 485 QAKPERAAPEQLFKDLMLPSQMLDRKSPRTHTVNDRGQCFGDPDISTAAMFIIPKPPDSF 544
Query: 157 EP-PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP-------SNVPPPPTQTPPTPAS 208
+ + P P P P+ + + V P ++ P A
Sbjct: 545 ANVAAAALYNSPFCMPQTPQPQDAPEQTEALSLVVTPKKKRHKVTDTRITPRTVSRILAL 604
Query: 209 PIAPRPSNSSPNSPPPPSTKRLSP---PPGIPVPSTENTPGNGTNPSSPES 256
A P+ + + P PS+ S PP P NPS +S
Sbjct: 605 RDAVGPAAGTHHQPLHPSSLSASMGFHPPPFRHPFPLPLTVAIPNPSLHQS 655
|
The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. Prox1 has been found to be an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. This family contains an atypical homeobox domain. Length = 908 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 29/99 (29%), Positives = 42/99 (42%), Gaps = 7/99 (7%)
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS-NPPSNL---PPPPPSSVEPPKRSPP 164
NP + + P S N+ S SD P+ PS +PP+ PP PS + P SPP
Sbjct: 565 NPGSTNSTPTGSAASSNTTFS--SDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPP 622
Query: 165 SVPPQNPPPPPSS-SPPKNSPPAPIAVPPSNVPPPPTQT 202
+ +P PSS A P S++ T++
Sbjct: 623 ASHLGSPSTTPSSPESSIKVASTETASPESSIKVASTES 661
|
Length = 670 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 15/61 (24%), Positives = 21/61 (34%), Gaps = 4/61 (6%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
PPSP A+ P + A+ ++ P A+ P P P P P S
Sbjct: 16 QPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRER----KPKPAS 71
Query: 109 N 109
Sbjct: 72 L 72
|
Length = 475 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 14/61 (22%), Positives = 22/61 (36%), Gaps = 2/61 (3%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
+ P P P +P PP P K++ P + P +P P + P P +
Sbjct: 14 AEQPAPAPPSPAAAPAPP--PPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPAS 71
Query: 74 P 74
Sbjct: 72 L 72
|
Length = 475 |
| >gnl|CDD|177328 PHA01929, PHA01929, putative scaffolding protein | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 24/96 (25%), Positives = 33/96 (34%), Gaps = 1/96 (1%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNP-PTSSPPPSPPASSPPT 100
PP ++ PP + P P P A P P PT P P P ++ P
Sbjct: 9 PPGLAGLVANVPPAAAPTPQPNPVIQPQAPVQPGQPGAPQQLAIPTQQPQPVPTSAMTPH 68
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA 136
+ P P P ++ P P PP+ P
Sbjct: 69 VVQQAPAQPAPAAPPAAGAALPEALEVPPPPAFTPN 104
|
Length = 306 |
| >gnl|CDD|215187 PLN02328, PLN02328, lysine-specific histone demethylase 1 homolog | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 22/105 (20%), Positives = 35/105 (33%), Gaps = 18/105 (17%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
+ P P + +S S P + P+ + NSP +P
Sbjct: 4 ETKEPEDPADNVNDVVS---------EASSPETDLSLSPSQSEQNIENDGQNSPETQSPL 54
Query: 146 SN---LPPPPPSSVEPP------KRSPPSVPPQNPPPPPSSSPPK 181
+ P PP ++++ P S PQNP + PPK
Sbjct: 55 TELQPSPLPPNTTLDAPVSDSQGDESSSEQQPQNPNSTEPAPPPK 99
|
Length = 808 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 20/55 (36%), Positives = 27/55 (49%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
PP PP P T+ P+P PP +S+P P ++ P + P S PP PP
Sbjct: 84 PPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|144411 pfam00802, Glycoprotein_G, Pneumovirus attachment glycoprotein G | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 31/181 (17%), Positives = 58/181 (32%), Gaps = 4/181 (2%)
Query: 24 PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASN 83
PT +P ++N ++ ++ P + + P + ++P T S +
Sbjct: 62 PTTTPTQQITNQIQNHTSTYLTQHNQLSTSPSNQSTTTPLIHTILDDTTPGTKSTYQHTT 121
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
T +P ++ P P SNPP + P S + PA
Sbjct: 122 VGTKGRTTTPAQTNKPPTKPRQ--SNPPEKPQDDFHFEVFNFVPCSICENNPACLSICKR 179
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
P P P++ P + P + ++ + + P + P T TP
Sbjct: 180 IPEKKPGKAPTTK--PTKKPKPKTTKKDTKTQTTKSKEATTHHPTSEPTKLTTKTNTTTP 237
Query: 204 P 204
Sbjct: 238 Q 238
|
This family includes attachment proteins from respiratory synctial virus. Glycoprotein G has not been shown to have any neuraminidase or hemagglutinin activity. The amino terminus is thought to be cytoplasmic, and the carboxyl terminus extracellular. The extracellular region contains four completely conserved cysteine residues. Length = 263 |
| >gnl|CDD|217509 pfam03353, Lin-8, Ras-mediated vulval-induction antagonist | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 21/75 (28%), Positives = 29/75 (38%), Gaps = 15/75 (20%)
Query: 154 SSVEPPKRSPPSVPPQNPPPPP---------------SSSPPKNSPPAPIAVPPSNVPPP 198
S++ P+ SVP Q PP P S+S + S P P + PP VP P
Sbjct: 190 STMSRPQEVKQSVPAQQAPPNPQQPMPSASSESATSKSASTSRESSPQPQSPPPRRVPAP 249
Query: 199 PTQTPPTPASPIAPR 213
+ A I +
Sbjct: 250 TVDSTAKEAEQITYQ 264
|
LIN-8 is a nuclear protein, present at the sites of transcriptional repressor complexes, which interacts with LIN-35 Rb.Lin35 Rb is a product of the class B synMuv gene lin-35 which silences genes required for vulval specification through chromatin modification and remodelling. The biological role of the interaction has not yet been determined however predictions have been made. The interaction shows that class A synMuv genes control vulval induction through the transcriptional regulation of gene expression. LIN-8 normally functions as part of a protein complex however when the complex is absent, other family members can partially replace LIN-8 activity. Length = 316 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 20/98 (20%), Positives = 30/98 (30%), Gaps = 7/98 (7%)
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
H + RRL + + + E L +AA A A
Sbjct: 106 HSVPPEALPLARRLRRRLKLLRQLAAALRR-LVAAELLDRLAELWERLLAALLALLPAL- 163
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFE-AQVSDFGLAKLA 518
++H D+ N+L+D V DF A L
Sbjct: 164 ----PLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLG 197
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|237019 PRK11907, PRK11907, bifunctional 2',3'-cyclic nucleotide 2'-phosphodiesterase/3'-nucleotidase precursor protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 13/90 (14%), Positives = 25/90 (27%), Gaps = 4/90 (4%)
Query: 38 SSPPPPPVSKPPTTSPPPSPP--ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
++ P + P+ A S + P A+ +P S A
Sbjct: 19 TASNPKLAQAEEIVTTTPATSTEAEQTTPVESDATEEADNTETPVAATTAAEAPSSSETA 78
Query: 96 SSPPTISPPPPVSNPPTRSPPPP--SSTPP 123
+ S + R+ P ++ P
Sbjct: 79 ETSDPTSEATDTTTSEARTVTPAATETSKP 108
|
Length = 814 |
| >gnl|CDD|221818 pfam12868, DUF3824, Domain of unknwon function (DUF3824) | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 26/88 (29%), Positives = 32/88 (36%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
S+ P PP+ P S+ P PP S+P P P NP PPP +
Sbjct: 47 SDSYEEPYDPTPYPPSPPVSDPRYYPNSNYFPPPPGSTPVPPPGPQPGYNPADYPPPPGA 106
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSN 147
PP N P P +P P N
Sbjct: 107 VPPPQNYPYPPGPGQDPYAPRPRRADEN 134
|
This is a repeating domain found in fungal proteins. It is proline-rich, and the function is not known. Length = 135 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 21/103 (20%), Positives = 32/103 (31%), Gaps = 10/103 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVS-NPPKSSPPPPPVSKPPTTS------- 52
A PG P P + P ++ PV ++ P +P
Sbjct: 652 GEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAALRAPQAPRPGGPPGGGGGLP 711
Query: 53 PPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
PPP PA+ P +S + + PP PP +
Sbjct: 712 PPPDLPAAAGPAPC--GSSLIASPTAPPEPEPPGAEQADGAEN 752
|
Length = 753 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 16/93 (17%), Positives = 25/93 (26%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSS 66
G A S S P +S+PP + + P +
Sbjct: 81 GAEATAPSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAATDPPATAAARDGP 140
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
+P ++ P + S PP S P
Sbjct: 141 TPDPTAQPATPDERRSPRQRPPVSGEPPTPSTP 173
|
Length = 226 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 11/78 (14%), Positives = 22/78 (28%), Gaps = 4/78 (5%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
SP PP P + + P+ + P +++
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAP----AAGGPAAALAAVPDAAAAA 443
Query: 70 ASSPPTSSPPPASNPPTS 87
A+ P ++ P + S
Sbjct: 444 AAPPAPAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 16/101 (15%), Positives = 33/101 (32%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
P++ + P + + T + + T + PA+ P
Sbjct: 317 TPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLPGTVALPAAEPVNMQP 376
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
P S+ T + T++ P + ++P + P P S
Sbjct: 377 QPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 18/68 (26%), Positives = 26/68 (38%)
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
V PP +P S P P PP S + ++ PA S T T P S P
Sbjct: 82 GKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPS 141
Query: 214 PSNSSPNS 221
+ + ++
Sbjct: 142 SGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 24/112 (21%), Positives = 38/112 (33%), Gaps = 3/112 (2%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS--STPPPNSPPSPPSDPPANSPPPS 142
++S S P SS +S + P + ++PP +SP S +
Sbjct: 8 GSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSSFGLSKQ 67
Query: 143 NPPSNLPPPPPS-SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P S S V P + SP + N +S+ +SP S
Sbjct: 68 RPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSS 119
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 23/126 (18%), Positives = 35/126 (27%), Gaps = 6/126 (4%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
+ ++S + + SS P SPP S PA N +S
Sbjct: 3 ASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRL---NAPASPPSSSPARNT-SS 58
Query: 66 SSPPASSPPTSSPPPASNPPTS--SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
SS S S + SP P+++ S + SP T
Sbjct: 59 SSSFGLSKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTS 118
Query: 124 PNSPPS 129
+
Sbjct: 119 SDLSSG 124
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (91), Expect = 0.004
Identities = 34/132 (25%), Positives = 50/132 (37%), Gaps = 8/132 (6%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
P + P P + + +P A +P + P PA P ++ P PP + P +
Sbjct: 76 PSGQSPLAPSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPAR 135
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P P P TR PP +PP P P + P PP P++ P +
Sbjct: 136 PAPACPPSTRQCPP--------APPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETA 187
Query: 164 PSVPPQNPPPPP 175
P+ P P P
Sbjct: 188 PAASPVLEPRIP 199
|
Length = 280 |
| >gnl|CDD|218181 pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain transcription factor N terminal domain | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 32/112 (28%), Positives = 38/112 (33%), Gaps = 10/112 (8%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
S P S+P PV+ T+ P SSPP P P + P PP +
Sbjct: 126 PASGFKPPTPPSTPCSPVNPQETVRQLQPSGPLSNSSPPSPHTPLPNQS---PLPPPMSS 182
Query: 63 PTSSSPPA-------SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P SS P S P PPP PP S P + PP
Sbjct: 183 PDSSYPSEHRFQRQLSEPCLPFPPPPGRGSRDGRPPYHRQMSEPLVPYPPQG 234
|
The N terminus of the PEA3 transcription factors is implicated in transactivation and in inhibition of DNA binding. Transactivation is potentiated by activation of the Ras/MAP kinase and protein kinase A signalling cascades. The N terminal region contains conserved MAP kinase phosphorylation sites. Length = 336 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 25/102 (24%), Positives = 33/102 (32%), Gaps = 8/102 (7%)
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
P PPPPSS P S + +++P P + P P +PP+ P
Sbjct: 183 PGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPASIPA 242
Query: 170 NPPPPPSSSPPKNSPPAPIAVPP--------SNVPPPPTQTP 203
P PP P P + P P P P
Sbjct: 243 PPIPPVIQYVAPPPVPPPQPIIPIQHIRAVTGETPANPRDIP 284
|
Length = 582 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 32/104 (30%), Positives = 37/104 (35%), Gaps = 5/104 (4%)
Query: 24 PTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP--PASSPPTSSPPPA 81
P PP S P PP S S +P P S +P P SP S PPA
Sbjct: 179 GGNIPGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPA 238
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
S P PP + PP PPP P + + P N
Sbjct: 239 SIPAPPIPPVIQYVAPPP---VPPPQPIIPIQHIRAVTGETPAN 279
|
Length = 582 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 28/83 (33%), Positives = 37/83 (44%), Gaps = 8/83 (9%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
++S P S S+ +SSS + S P SS P P P + P+I P P +S
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPSSTSP---RPRRRKPSASSLLHTPSILPLPKLS 57
Query: 109 NPPTRSPPPPSSTPPPNSPPSPP 131
SP PPS T PP + P
Sbjct: 58 -----SPSPPSVTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 14/63 (22%), Positives = 21/63 (33%), Gaps = 1/63 (1%)
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
+ P +PP P + P P + P + + P A P P P P S
Sbjct: 14 AEQPAPAPPSPAAAPAPPPPAKT-AAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
Query: 156 VEP 158
+
Sbjct: 73 WKL 75
|
Length = 475 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 12/80 (15%), Positives = 20/80 (25%), Gaps = 2/80 (2%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
P S + + P SPP + + PP +S+ P +
Sbjct: 289 ADSSVEANGVEPEPTGSVSDRPRHLSSDSSP--SPPDTSDSDPSTETPPPASLSHSPPAA 346
Query: 115 PPPPSSTPPPNSPPSPPSDP 134
P + P
Sbjct: 347 FERPLALSPKRKREGDKKQK 366
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 16/85 (18%), Positives = 26/85 (30%), Gaps = 5/85 (5%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
+ P P + + P SPP S P T +PPP+ + +PP +
Sbjct: 291 SSVEANGVEPEPTGSVSDRPRHLSSDSSP--SPPDTSDSDPSTETPPPASLSHSPPAAFE 348
Query: 68 PPASSPPT---SSPPPASNPPTSSP 89
P + P +
Sbjct: 349 RPLALSPKRKREGDKKQKKKKSKKL 373
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 22/88 (25%), Positives = 27/88 (30%), Gaps = 8/88 (9%)
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS----VPPQNPPPPPSSSPPKNSPP 185
P A +PP P +E RS S P P P PP
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNR--LEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPP 403
Query: 186 APIAVPPSNVPPPPTQTPPTPASPIAPR 213
AP P + PP P + +A R
Sbjct: 404 AP--EPARSAEAPPLVAPAAAPAGLALR 429
|
Length = 504 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.004
Identities = 21/63 (33%), Positives = 27/63 (42%), Gaps = 1/63 (1%)
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
P T PP TPP P+P P + P+ PP+ P + PP S P PP
Sbjct: 80 APLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPP-SDPPQPP 138
Query: 169 QNP 171
+ P
Sbjct: 139 RAP 141
|
Length = 141 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.004
Identities = 25/63 (39%), Positives = 32/63 (50%), Gaps = 2/63 (3%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
P P + P ++PP S P PPP+STP P+ PA +PPPS+PP PP
Sbjct: 81 PLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPP--QPP 138
Query: 151 PPP 153
P
Sbjct: 139 RAP 141
|
Length = 141 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 27/116 (23%), Positives = 32/116 (27%), Gaps = 9/116 (7%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P P P P +PP P PK P P K P P P P
Sbjct: 53 TEEPQPEPEPPEEQPKP--PTEPETPPEPTPPKPKEKPKPEKKPKKPKPKPKPKP----K 106
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
P P P PP+ + P+ PA P S + P
Sbjct: 107 PKPKVKPQ---PKPKKPPSKTAAKAPAAPNQPARPPSAASASGAATGPSASYLSGL 159
|
Length = 244 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 19/77 (24%), Positives = 24/77 (31%), Gaps = 13/77 (16%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
S P +PP P S PPP P PP PP+ P
Sbjct: 46 SIPGLEDVTVQTTPPPPASAITNGGPPPPPPARAEAASPP-------------PPEAPAE 92
Query: 174 PPSSSPPKNSPPAPIAV 190
PP+ P+ + V
Sbjct: 93 PPAEPEPEAPAENTVTV 109
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 16/48 (33%), Positives = 20/48 (41%)
Query: 165 SVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
V Q PPPP+S+ PP P PPP + P P + P
Sbjct: 52 DVTVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEP 99
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 26/112 (23%), Positives = 41/112 (36%), Gaps = 7/112 (6%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSS----PPPPPVSKPPTTSPPPS 56
P+P P A S +P P V+ S P ++ P + P P + P
Sbjct: 39 KPDPAPAPHQAASRAPDPAVAPTSAASRKPDLAQAPTPAASEKFDPAPAPHQAASRAPDP 98
Query: 57 PPASNPPTSSSPPASSPPTSSP---PPASNPPTSSPPPSPPASSPPTISPPP 105
A + P A+ TS+ ++ TS+ P ++ SPPP
Sbjct: 99 AVAPQLAAAPKPDAAEAFTSAAQAHEAPADAGTSAASKKPDPAAHTQHSPPP 150
|
Length = 566 |
| >gnl|CDD|237191 PRK12757, PRK12757, cell division protein FtsN; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 25/120 (20%), Positives = 35/120 (29%), Gaps = 21/120 (17%)
Query: 126 SPPSPPSDPPANSPPP----------------SNPPSNLPPPPPSSVEPP-KRSPPSVPP 168
+P P + NSP P+ L P + P RS +
Sbjct: 64 TPTEPSAGGEVNSPTQLTDEQRQLLEQMQADMRQQPTQLSEVPYNEQTPQVPRSTVQIQQ 123
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTK 228
Q P P + P P+ P P QTP P P + +P + K
Sbjct: 124 QAQQQQP---PATTAQPQPVTPPRQTTAPVQPQTPA-PVRTQPAAPVTQAVEAPKVEAEK 179
|
Length = 256 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 19/110 (17%), Positives = 40/110 (36%), Gaps = 2/110 (1%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPP--PPPVSKPPTTSPPPSPP 58
P+ P AA ++ ++ + P ++ P P K +P
Sbjct: 291 AEEPAVAPMAAIRAAHVETAADKGERAAKPAAADKAADKPADRPDAAEKAAEKPAEAAPR 350
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
A++ P + +S P +++ +P + A++P +PP S
Sbjct: 351 AADKPAGQAADPASSSADKPGASADAAARTPARARDAAAPDADTPPGGAS 400
|
Length = 413 |
| >gnl|CDD|221173 pfam11702, DUF3295, Protein of unknown function (DUF3295) | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 27/120 (22%), Positives = 39/120 (32%), Gaps = 1/120 (0%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS 82
P ++P P S+ P +PP + T P S TS++ + S P
Sbjct: 83 MPNLAPITPPSSEPTPAPPSSESTATRTPDPNQQALESTESTSTTSADCNDSEQSSTPNL 142
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPP-TRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
N +S S S + P RS + P P P + P A P
Sbjct: 143 NSSDTSTSSSGALPSTSVVRGFSPSHISSSYRSTAQLNKAPSPTKSAEPTAAPQAKPELP 202
|
This family is conserved in fungi but the function is not known. Length = 509 |
| >gnl|CDD|234383 TIGR03895, protease_PatA, cyanobactin maturation protease, PatA/PatG family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 21/92 (22%), Positives = 32/92 (34%), Gaps = 6/92 (6%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
S A+ S+ I P + +P PV+ P + P + A
Sbjct: 237 TSEQDGVEEASGCGVQGTIESSTSVIPPGRA----AEPAPVSIPVAAPGEGATPAA--AQ 290
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
++ P + P + PASN T S PS
Sbjct: 291 IELSAGVLPNAISPATPVRPASNGVTPSQAPS 322
|
This model describes a protease domain associated with the maturation of various members of the cyanobactin family of ribosomally produced, heavily modified bioactive metabolites. Members include the PatA protein and C-terminal domain of the PatG protein of Prochloron didemni, TenA and a region of TenG from Nostoc spongiaeforme var. tenue, etc. Length = 602 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 24/168 (14%), Positives = 44/168 (26%), Gaps = 13/168 (7%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPP-------PPPVSKPPTTSP 53
+ A P A P V + P V P+ P ++ P T P
Sbjct: 869 VVAEVPVAAAVEPVVSAPVVEAVAEVVEEPVVVAEPQPEEVVVVETTHPEVIAAPVTEQP 928
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+ + P ++ ++ + P ++ P
Sbjct: 929 QVITESDVAVAQEVAEHAEPVVEPQDETADIEEAAETAEVVVAEPEVVAQPAAPVVAEVA 988
Query: 114 SPPPPSSTPPPNSPPSPPSDPP-----ANSPPPSNP-PSNLPPPPPSS 155
+ + P P+ + A +P P P +P P S
Sbjct: 989 AEVETVTAVEPEVAPAQVPEATVEHNHATAPMTRAPAPEYVPEAPRHS 1036
|
Length = 1068 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 696 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.38 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.36 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.31 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.14 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.99 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.9 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.83 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.79 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.73 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.7 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.61 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.61 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.56 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.54 | |
| PHA03247 | 3151 | large tegument protein UL36; Provisional | 98.53 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.51 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.47 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.46 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.44 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.4 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.38 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.37 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.33 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.33 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.31 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 98.16 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.13 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 98.08 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 98.07 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 98.02 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.95 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.86 | |
| PLN02236 | 344 | choline kinase | 97.81 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.75 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.69 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.57 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.5 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.39 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 97.34 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 97.34 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 97.24 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.23 | |
| KOG3021 | 313 | consensus Predicted kinase [General function predi | 97.23 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=448.19 Aligned_cols=291 Identities=59% Similarity=1.006 Sum_probs=252.3
Q ss_pred CCcccCHHHHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEE
Q 005443 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432 (696)
Q Consensus 353 ~~~~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 432 (696)
....|.+++|..++++|...++||+|+||.||+|.+.+|..||||++........++|.+|+++|.+++|+|||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34569999999999999999999999999999999989999999988755433155699999999999999999999999
Q ss_pred eeCCc-eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEe
Q 005443 433 ISDDR-RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (696)
Q Consensus 433 ~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (696)
.+.+. .+||||||.+|+|.++|+......++|..+++|+.++|+||+|||+.+.+.|||||||+.|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 99984 99999999999999999986543689999999999999999999999877899999999999999999999999
Q ss_pred eccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 512 fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
||+++..............||.+|++||++..+..+.|+|||||||+|+||++|+.+.+.........+++|....+.+
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~- 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE- 299 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC-
Confidence 9999765431111111117999999999999999999999999999999999999988876655566689998666543
Q ss_pred hhhhhhhcccCcccC-CCcch-HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 592 LENEEFDNLADPRLG-ENYVE-GEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..+.+++|+.+. ..+.. .++.++.+++.+|++.++++||+|.||++.|+.+..
T Consensus 300 ---~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 ---GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred ---cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 378899999987 55553 688899999999999999999999999999966553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=407.41 Aligned_cols=257 Identities=31% Similarity=0.497 Sum_probs=217.9
Q ss_pred CccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
.+..++.||+|.||.||+|+++....||+|.++.. ....+.|.+|+++|++|+|.|||+|+|+|..++.++||||||..
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 34556889999999999999977779999999865 34457899999999999999999999999998899999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.++|+..++..+...+++.++.|||+||+||+++ ++|||||.++||||++++.|||+||||++...++.+....
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 9999999987777799999999999999999999999 9999999999999999999999999999976666655555
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~ 606 (696)
.......|.|||.+..+.|+.|+|||||||+||||+| |+.||.... ..+.++. ++...+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms---n~ev~~~-----------------le~GyR 422 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS---NEEVLEL-----------------LERGYR 422 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC---HHHHHHH-----------------HhccCc
Confidence 5556789999999999999999999999999999999 888887543 1222221 111222
Q ss_pred CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 607 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
..-+..+...+.+|++.||..+|++|||++.+...|+++...
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 222333445788999999999999999999999999987653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=404.88 Aligned_cols=258 Identities=33% Similarity=0.549 Sum_probs=212.0
Q ss_pred ccccccccccCcEEEEEEEcCCCcE-EEEEEeecCCCcc--HHHHHHHHHHHHHccCCCceeEEeEEeeCC-ceeEEEEe
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGRE-VAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLVGYCISDD-RRLLIYDY 444 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~-vavK~l~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lV~E~ 444 (696)
+.+.+.||+|+||+||+|.+ .|+. ||||++....... .++|.+|+.+|.+++|+|||+|+|+|.+.. ..+|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~-~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKW-RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEe-CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 44456699999999999999 5555 9999997543222 458999999999999999999999999887 78999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eeeccCCCCceEECCCC-cEEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~-ivHrDLkp~NILl~~~~-~vkL~DfGls~~~~~~~ 522 (696)
+.+|+|.++++...+..+++..+++|+.||++||+|||++ + |||||||++||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999885455699999999999999999999999 7 99999999999999997 99999999998765432
Q ss_pred cceeeccccccccCchhhhc--cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 523 THITTRVMGTFGYMAPEYAS--SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~--~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.......||..|||||++. ...|+.|+|||||||+||||++|+.||..... ++....+..+
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~---------- 261 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVG---------- 261 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhc----------
Confidence 2233367999999999999 56999999999999999999999999986432 2221111111
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccc
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDL 650 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~ 650 (696)
..+..+.......+..|+.+||+.|+++||++.+|+..|+.+.....
T Consensus 262 ---~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 262 ---GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ---CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11111222234478899999999999999999999999998876444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=386.58 Aligned_cols=253 Identities=30% Similarity=0.461 Sum_probs=207.5
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc-eeEEEEec
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR-RLLIYDYV 445 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~lV~E~~ 445 (696)
++.+++||+|..|+|||++++ +++.+|+|++..... ...+++.+|++++++.+|+|||.+||+|+.++. +.|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 444788999999999999976 688999999965433 345789999999999999999999999999995 99999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
++|+|++++...++ +.+..+.+|+.+|++||.|||+ + +||||||||.||||+..|+|||||||.++...+.
T Consensus 161 DgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999987655 8999999999999999999996 5 9999999999999999999999999999887655
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
....++||..|||||.+.+..|+.++||||||+.|+||+.|++||...+.. .....+.+..+. ++.- +.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll~~Iv-----~~pp-----P~ 301 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELLCAIV-----DEPP-----PR 301 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHHHHHh-----cCCC-----CC
Confidence 345578999999999999999999999999999999999999999864210 111111111111 1111 12
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
+... ....++.+++..||++||.+|++++||+++-.
T Consensus 302 lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 302 LPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 2222 12236889999999999999999999997633
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=420.84 Aligned_cols=259 Identities=27% Similarity=0.478 Sum_probs=218.4
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
+.+....+.||+|+||+||+|+.. +...||||.++..... ..++|++|+++|..|+|+|||+|+|+|.+++-.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 355666788999999999999842 3568999999877665 678999999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc
Q 005443 439 LLIYDYVPNNTLYFHLHGEG------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (696)
+||||||..|+|.+||.... ...++..+.+.|+.|||.||+||-++ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 99999999999999996421 12378899999999999999999999 9999999999999999999
Q ss_pred EEEEeeccchhccccCcceee-ccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhH
Q 005443 507 AQVSDFGLAKLALDANTHITT-RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 584 (696)
Q Consensus 507 vkL~DfGls~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~ 584 (696)
|||+||||+|.....+++... +..-.++||+||.|+.++|+.++|||||||+|||+++ |+.||.+.. .++.++.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---n~EVIe~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---NQEVIECI 718 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---hHHHHHHH
Confidence 999999999987665554433 5567789999999999999999999999999999999 999987643 33333322
Q ss_pred HHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 585 RPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+ +.++ ..-.++...++.+|+.+||+.+|++||++.||-..|+....
T Consensus 719 ~----------------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 719 R----------------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred H----------------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 2 2222 22344556689999999999999999999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=384.47 Aligned_cols=201 Identities=32% Similarity=0.505 Sum_probs=180.7
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
..+|...+.||+|.||+||+|+++ ++..||||.+... +.+..+.+..|+++|+.|+|+|||+|+++++..+.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356788888999999999999964 6899999999766 3445567899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC------CcEEEEeeccch
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN------FEAQVSDFGLAK 516 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~------~~vkL~DfGls~ 516 (696)
|||+||+|.++++..++ +++..++.++.||+.||++||++ +||||||||.||||+.+ -.+||+|||++|
T Consensus 89 EyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999998775 99999999999999999999999 99999999999999754 468999999999
Q ss_pred hccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
...... .....+|+..|||||+++...|+.|+|+||+|+|||||++|+.||+...
T Consensus 164 ~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 876432 3445789999999999999999999999999999999999999998644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=397.84 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=209.5
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.+|+.+++||+|+|+.||+++. +.|+.||+|++... .....+++.+||+|.++|+|+|||+|+++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 78999999999643 3344567999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|+|.+++|..++.++ ..+++.+++.+++||+.||.|||++ +|||||||..||||+++.+|||+|||||..+....
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999988844 3599999999999999999999999 99999999999999999999999999998876554
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.... ..+||+.|+|||++....++..+||||+|||||-||.|+.||+... +.+....+. ..+..-
T Consensus 173 Erk~-TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik--------~~~Y~~ 237 (592)
T KOG0575|consen 173 ERKK-TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIK--------LNEYSM 237 (592)
T ss_pred cccc-eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHH--------hcCccc
Confidence 4333 3689999999999999999999999999999999999999998532 222211111 111111
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+........+||..+|+.||.+||++++|+..
T Consensus 238 -------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 -------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222367788999999999999999999954
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=367.01 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=208.4
Q ss_pred cCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEe-EEeeCCc-eeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVG-YCISDDR-RLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~~-~~lV 441 (696)
.+|++.++||+|.||.||++. +.+|..||.|.++.... +..+++..|+.+|++|+|+|||++++ .|.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 347788999999999999998 56899999999985533 34567899999999999999999998 4444444 7999
Q ss_pred EEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 442 YDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
||||.+|+|..+++. ..++.+.+..+|+++.|+++||.++|.+. ++ |+||||||.||+|+++|.|||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999888764 44567999999999999999999999942 25 99999999999999999999999999998
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
+.... ......+||+.||+||++++..|+.++||||+||++|||+.-+.||.+.+ +.+. .+.+++.++
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L-----~~KI~qgd~ 245 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSL-----CKKIEQGDY 245 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHH-----HHHHHcCCC
Confidence 76543 33455789999999999999999999999999999999999999998752 3322 223344443
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
..+.+ +....++.+||..|+..|++.||+...+++.+..
T Consensus 246 ~~~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPLPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 33332 2233478899999999999999985555554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=378.72 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=204.0
Q ss_pred HhcCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCC-------ccHHHHHHHHHHHHHccCCCceeEEeEEeeCC
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG-------QGEREFKAEVEIISRIHHRHLVSLVGYCISDD 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 436 (696)
..+.|.+.+.||+|+||.|-+|. .++|+.||||+++.... .....+++|+++|++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34678889999999999999998 55899999999963321 12334679999999999999999999999999
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC---CcEEEEeec
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDFG 513 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DfG 513 (696)
..||||||++||+|++++-..+. +.+.....+++||+.||.|||++ ||+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999987665 77778889999999999999999 99999999999999655 789999999
Q ss_pred cchhccccCcceeeccccccccCchhhhccCC---CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGK---LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
++++... ...+..++||+.|.|||++.+.. +..++|||||||+||-+|+|..||.+... +..+.+...
T Consensus 325 lAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQI~----- 395 (475)
T KOG0615|consen 325 LAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQIL----- 395 (475)
T ss_pred hhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHHHh-----
Confidence 9998763 33456689999999999998654 34588999999999999999999986543 221222111
Q ss_pred hhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 ALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+.+.. ..........+.+++|.+||..||++|++++|+|++
T Consensus 396 ---~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 ---KGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ---cCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111100 001112233468899999999999999999999865
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=384.28 Aligned_cols=265 Identities=29% Similarity=0.439 Sum_probs=220.4
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccH-HHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+..+.++++||+|.||.|.+++.+.+..||||+++....... .+|.+|+++|.+|+|+||++|+|+|..++.++||+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 356788899999999999999997789999999986655444 7899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc-Cc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA-NT 523 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~-~~ 523 (696)
|++|+|..+|.......+.....++|+.||+.||+||.+. +||||||.++|||+|.++++||+|||++|.+... .+
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999877555567778889999999999999998 9999999999999999999999999999966444 34
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh--CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt--g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
....+.+..++|||+|.+..++++.++|||+||+.|||+++ ...||.. +.++..++....++...- ...-+.
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~---lt~e~vven~~~~~~~~~---~~~~l~ 767 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ---LTDEQVVENAGEFFRDQG---RQVVLS 767 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh---hhHHHHHHhhhhhcCCCC---cceecc
Confidence 45667788899999999999999999999999999999754 7788875 334555554444433211 111111
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
. ...+...+.+++.+||+.+-++||++++|...|++..
T Consensus 768 ~-------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 768 R-------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred C-------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1 1223347889999999999999999999999888754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=361.66 Aligned_cols=269 Identities=21% Similarity=0.295 Sum_probs=209.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|+...++|+|+||+||+++.+ .|+.||||++..... ...+-.++|+++|++|+|+|+|.|+.+|.....++||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999965 599999999964432 223457899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
||+..-|+++-+...+ ++.+.+.++++|+++|+.|+|++ +||||||||+||||+.++.+||||||+||.....+
T Consensus 82 ~~dhTvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred ecchHHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 9988777665544433 88999999999999999999999 99999999999999999999999999999887643
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHH-hHHHHHHHhh----hhhhh
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE-WARPLLSHAL----ENEEF 597 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~-~~~~~~~~~~----~~~~~ 597 (696)
...+..+.|.+|+|||.+.+ ..|...+|||++||++.||++|...|-+....+..-++. .+..++.+.. .+..|
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 44566789999999999987 789999999999999999999999998765433222221 1112222111 12222
Q ss_pred hcccCcccC-----CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLADPRLG-----ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.-+... +........-++++++.||+.||.+|.+-++++.+
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 222111110 11111223368899999999999999999999853
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=370.34 Aligned_cols=241 Identities=30% Similarity=0.431 Sum_probs=202.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||+||.++.+ .++.+|+|+|+... ..+.+..++|..||.+++|++||+++..|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 57999999999999999999854 68999999997543 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.||.|+.+|++++. +.+..++-++.+|+.||.|||++ +||||||||+|||||++|+|+|+|||+++.....+
T Consensus 105 d~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred eccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999998776 89999999999999999999999 99999999999999999999999999998655443
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. ....++||..|||||++.+..|+..+|+|||||+||||++|..||...+ ..++...++... +.
T Consensus 180 ~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k--------~~- 243 (357)
T KOG0598|consen 180 D-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK--------LP- 243 (357)
T ss_pred C-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc--------CC-
Confidence 3 3344799999999999999999999999999999999999999998654 222222222111 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCC
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRP 633 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 633 (696)
....-...+..++++++|+.|+++|-
T Consensus 244 -----~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -----LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 00111122678889999999999996
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=398.57 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=217.0
Q ss_pred cCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
....+.++||.|.||.||+|+++ ....||||.++.... +...+|+.|+.||.+++|+||++|.|+....+-.+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34677899999999999999975 346899999997654 4456799999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
.|||++|.|+.||+.++.+ +.+.++..++++|+.||+||.+. ++|||||.++||||+.+..+||+||||+|+..++
T Consensus 709 TEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999999987765 89999999999999999999998 9999999999999999999999999999987655
Q ss_pred Ccceeec--cccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 522 NTHITTR--VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 522 ~~~~~~~--~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
....... ..-..+|.|||.|..++++.++|||||||+|||.|+ |..||.+-. ..+. +
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---NQdV-------I---------- 844 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDV-------I---------- 844 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---hHHH-------H----------
Confidence 4322222 223469999999999999999999999999999887 888886422 1111 1
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
+-++..++.....++...|.+|++.||++|=.+||.+.+|+..|++++.+
T Consensus 845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 11222333444556677899999999999999999999999999999853
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=366.18 Aligned_cols=268 Identities=24% Similarity=0.354 Sum_probs=207.1
Q ss_pred cCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 441 (696)
+.|+.+++||+|.||.||+|+ +++|+.||+|+++..+.+ .-.-..+||.||++|+|+||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 567778899999999999998 568999999999877643 335678999999999999999999998876 678999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
||||++ +|.-++...+ ..+++.++..+++||+.||+|||++ +|+|||||..|||||++|.+||+||||++++...
T Consensus 197 FeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999965 4555555432 3489999999999999999999999 9999999999999999999999999999988777
Q ss_pred CcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhH-HHhHHHHHHHhhhhhhhh-
Q 005443 522 NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL-VEWARPLLSHALENEEFD- 598 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l-~~~~~~~~~~~~~~~~~~- 598 (696)
.....+..+.|++|++||+|++ ..|+.++|+||.||||.||+.|+..|.+....+.... .+.+..--..+|....+.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 7666777889999999999987 6799999999999999999999999987653222111 111111111222211111
Q ss_pred -cccCc------ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 599 -NLADP------RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 599 -~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..+.. .+.+. ........++|+..+|..||.+|.++.++|+
T Consensus 352 ~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 11111 1111235788999999999999999998874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=359.82 Aligned_cols=269 Identities=24% Similarity=0.374 Sum_probs=215.1
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCcc-HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.+.|++.++||.|..+.||+|+. ..++.||||++....... .+.+++|+..|..++|+||++++..|..++.+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35799999999999999999984 568999999998765444 4789999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
||.+|++.+++...-...+++..+..|++++++||.|||++ |.||||||+.||||+++|.|||+|||++..+.+.+.
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999876666699999999999999999999999 999999999999999999999999999877766554
Q ss_pred cee---eccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 524 HIT---TRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 524 ~~~---~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
... ..++|++.|||||+++. ..|+.|+||||||+...||.+|+.||....... .+. ..+.+.- .
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl----~tLqn~p-p 250 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLL----LTLQNDP-P 250 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHH----HHhcCCC-C
Confidence 433 33689999999999654 569999999999999999999999998765321 111 1111110 0
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhhcc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV--FDSLATS 648 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~l~~~ 648 (696)
.+....+..+........+.+++..||+.||++||++.++++. +++....
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 0000011111111122278899999999999999999999964 5544433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=375.73 Aligned_cols=250 Identities=23% Similarity=0.390 Sum_probs=212.8
Q ss_pred cCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
..|...+.||+|..|.||.++ ...++.||||+|.......++-+.+|+.+|+.++|+|||++++.|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467778899999999999998 4578999999999888777888999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
+||+|.+.+.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999998887543 89999999999999999999999 999999999999999999999999999988765544 4
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....+||+.|||||++....|+.++||||||++++||+.|..||-.++.+...-+ +. . +...
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------Ia----~-------ng~P 487 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IA----T-------NGTP 487 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------Hh----h-------cCCC
Confidence 5557899999999999999999999999999999999999999976443211110 00 0 1111
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.....+.....+.+++.+||+.|+++|+++.|||++
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 112223334478899999999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=372.97 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=208.1
Q ss_pred hcCccccccccccCcEEEEEEE-cCCCcEEEEEEeecC---CCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIG---GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 440 (696)
-++|..+++||+|.|++||+|+ .+.+++||||++... ..+..+.+.+|-++|.+| +|+.|++||.-|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3678999999999999999998 457999999999633 223345678899999999 79999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|+||+.+|+|.++|++.+. +++..++.++.||+.||+|||++ |||||||||+|||||+|+++||.|||.++.+..
T Consensus 152 vLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 9999999999999998876 99999999999999999999999 999999999999999999999999999987643
Q ss_pred cCcc----------ee--eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 521 ANTH----------IT--TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 521 ~~~~----------~~--~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
.... .. ..++||..|++||+|..+..+..+|||+||||||+|+.|+.||.+.+...
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------------ 294 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------------ 294 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------------
Confidence 3211 11 44899999999999999999999999999999999999999998765210
Q ss_pred HHhhhhhhhhcccC--cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 589 SHALENEEFDNLAD--PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 589 ~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.|+++++ -.+...+. ..+.+|+++.|..|+.+|.+.++|.++
T Consensus 295 -------iFqkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 295 -------IFQKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------HHHHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111111 11222232 368899999999999999999888765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=372.22 Aligned_cols=268 Identities=23% Similarity=0.311 Sum_probs=211.3
Q ss_pred HhcCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCccHH-HHHHHHHHHHHcc-CCCceeEEeEEeeCC-ceeE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGER-EFKAEVEIISRIH-HRHLVSLVGYCISDD-RRLL 440 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~-~~~~E~~il~~l~-hpnIv~l~~~~~~~~-~~~l 440 (696)
..++|.+++.||.|.||.||+|. .+.|+.||||+|+.+....++ .-+||++.|++|+ |+|||+|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34689999999999999999998 557999999999865443332 3468999999999 999999999999888 8999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|||||+ .+|+.++..+ ++.+.+..++.|++||++||+|||++ |+.||||||+||||..+..|||+|||+||....
T Consensus 88 VfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 999995 5688888877 66799999999999999999999999 999999999999999888999999999997644
Q ss_pred cCcceeeccccccccCchhhhc-cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH----HHHhhhhh
Q 005443 521 ANTHITTRVMGTFGYMAPEYAS-SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL----LSHALENE 595 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~----~~~~~~~~ 595 (696)
.. -.+..+.|.+|+|||+|. .+.|+.+.|||++|||++||++-+..|-+.+..+ .+...+..+ ...+.+..
T Consensus 163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHHHHHHhCCCccccchhHH
Confidence 32 345567899999999875 5789999999999999999999999998765432 222222111 01111222
Q ss_pred hhhcccCcccCC-------CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGE-------NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
++...++-++.. +.......+.++++.+||.+||.+||++.|++++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 233333322211 1122245578899999999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=364.46 Aligned_cols=265 Identities=28% Similarity=0.492 Sum_probs=208.9
Q ss_pred HHHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 360 EELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 360 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
++.+.-.+.+.+.+.||+|.||+||+|++. ..||||+++...- ...+.|++|+.+|++-+|.||+-++|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444444566778899999999999999973 3699999986643 345679999999999999999999999987766
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.||..||+|.+|+.+||..+ ..++....+.|++||++||.|||.+ +|||||||..||||++++.|||+|||++..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999999765 3589999999999999999999999 999999999999999999999999999865
Q ss_pred ccccC-cceeeccccccccCchhhhcc---CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 518 ALDAN-THITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 518 ~~~~~-~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
..--. ......-.|...|||||+++. ..|+..+|||+|||++|||++|.+||...+.. ..+...-+.+
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIifmVGrG~------ 609 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIFMVGRGY------ 609 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEEEecccc------
Confidence 43221 111222347788999999864 56899999999999999999999999843321 1110000000
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..+++ .........+|.+|+..||..+.++||.+.+|+..|+.+..
T Consensus 610 -------l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 -------LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -------cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 00000 11122344578899999999999999999999999888775
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.52 Aligned_cols=265 Identities=23% Similarity=0.369 Sum_probs=208.3
Q ss_pred cCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCcc--HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|...++||+|.||.||+|+ .+.|+.||||+++..+..+ .....+|++.|+.++|+||+.|+++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999998 4579999999998764432 3457899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|| ..+|...+++.. ..+....+..++.++++||+|||++ .|+||||||.|+||+++|.+||+|||+++.+...+.
T Consensus 82 fm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99 456877776554 4688999999999999999999999 999999999999999999999999999998876655
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH-----Hhh-----
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS-----HAL----- 592 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~-----~~~----- 592 (696)
.... .+.|.+|+|||.+.+ ..|+..+||||.|||+.||+.|..-|.+....+ .+ ......+. ++-
T Consensus 157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL-~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QL-SKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HH-HHHHHHcCCCCcccCcccccc
Confidence 4333 368999999999887 679999999999999999999988777654221 11 11111111 010
Q ss_pred -hhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 593 -ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 593 -~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+..++..+-...+. .....+..+.++++..||..||.+|.++.|++++
T Consensus 233 pdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111112222 2333445567999999999999999999998864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=368.84 Aligned_cols=243 Identities=27% Similarity=0.439 Sum_probs=204.6
Q ss_pred ccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
.++.||.|+-|.||+|++ .++.||||+++. .-+.+|+-|++|+|+||+.|.|+|...-.++||||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 367899999999999999 789999998762 224578999999999999999999998899999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccc
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~ 530 (696)
+..|+.... +.......|.++||.||.|||.+ .|||||||.-||||..+..|||+|||.++...+..+. ..+.
T Consensus 200 ~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--MSFa 272 (904)
T KOG4721|consen 200 YEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--MSFA 272 (904)
T ss_pred HHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhh--hhhh
Confidence 999986554 88889999999999999999999 9999999999999999999999999999987665332 3468
Q ss_pred cccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcc
Q 005443 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610 (696)
Q Consensus 531 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (696)
||..|||||+|++..++.|+|||||||+|||||||..||.+.+.. .+ +..+-...|.....
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AI---------------IwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AI---------------IWGVGSNSLHLPVP 333 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----ee---------------EEeccCCcccccCc
Confidence 999999999999999999999999999999999999999753321 11 11111222223334
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 611 EGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 611 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..+...+.-|++.||+..+..||+|.+|+.+|+...-
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 4445578889999999999999999999999886543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=360.44 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=206.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC--ceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lV~E 443 (696)
.+|...++||+|.||.||++.+. +|+.+|||.+...+....+.+++|+.+|.+|+|+|||+++|.....+ .++|+||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999965 49999999998764444667999999999999999999999755444 5889999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-CCcEEEEeeccchhccc--
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALD-- 520 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls~~~~~-- 520 (696)
|+.+|+|.+++.+.+. .+.+..++++++||++||+|||++ ||||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998776 699999999999999999999999 9999999999999999 79999999999987653
Q ss_pred cCcceeeccccccccCchhhhccCC-CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
..........||..|||||++.++. ...++|||||||+++||+||+.||... ....+++..+. .+. .
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig---~~~-~--- 240 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIG---RED-S--- 240 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHh---ccC-C---
Confidence 2222234568999999999999643 345999999999999999999999853 11111111111 011 0
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.+ .+......+..+++.+||+.|+++||++.++|++.....
T Consensus 241 --~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 241 --LP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred --CC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 11 122223336788999999999999999999998765444
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=399.94 Aligned_cols=261 Identities=29% Similarity=0.486 Sum_probs=213.5
Q ss_pred hcCccccccccccCcEEEEEEEcCC--Cc----EEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD--GR----EVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~--g~----~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
..+.+..+.||+|.||.||+|.+.+ |. .||||.++... .++..+|.+|..+|++++|+|||+++|+|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456677899999999999999643 33 58999987543 45567899999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 439 LLIYDYVPNNTLYFHLHGE-----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
+|++|||++|+|..+|++. ....+...+++.|+.|||+|+.||+++ ++|||||..+|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999865 234588999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCcceeecc-ccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 514 LAKLALDANTHITTRV-MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
+||++.+..+...... ....+|||||.++.+.|+.|+|||||||+|||||+ |..||...... ++ +...
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v-------~~~~ 917 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EV-------LLDV 917 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HH-------HHHH
Confidence 9997655554433322 44579999999999999999999999999999999 89999765421 11 1111
Q ss_pred hhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 592 LENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
.+.. ++ .....+...+.+|+..||+.+|++||++..|++++.++....
T Consensus 918 ~~gg---RL-------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 918 LEGG---RL-------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HhCC---cc-------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 1222 11 222333347889999999999999999999999988887533
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=366.47 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=203.0
Q ss_pred hcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCC-
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDD- 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~- 436 (696)
.++|++.++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+.+|+++ +|+||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999973 2356899999875432 2345689999999999 8999999999887654
Q ss_pred ceeEEEEecCCCchhhccccCC----------------------------------------------------------
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEG---------------------------------------------------------- 458 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 458 (696)
..++||||+.+|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999988876422
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc-eeecccccccc
Q 005443 459 --RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGY 535 (696)
Q Consensus 459 --~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y 535 (696)
...+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12377888899999999999999999 9999999999999999999999999999865332221 12223456789
Q ss_pred CchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHH
Q 005443 536 MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEM 614 (696)
Q Consensus 536 ~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 614 (696)
+|||++.+..++.++|||||||+||||++ |+.||..... .+.+.+. +....... ......
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~--~~~~~~~--------~~~~~~~~---------~~~~~~ 303 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--NEEFCQR--------LKDGTRMR---------APENAT 303 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHH--------HhcCCCCC---------CCCCCC
Confidence 99999999999999999999999999997 9999976432 1111110 01110000 011122
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 615 FRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 615 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..+.+|+.+||+.||++||++.||++.|+++..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 368899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=369.58 Aligned_cols=266 Identities=25% Similarity=0.397 Sum_probs=228.7
Q ss_pred CHHHHHHHhcCccccccccccCcEEEEEEEcCC-CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC
Q 005443 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD 436 (696)
Q Consensus 358 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 436 (696)
.+++++-.+.++.+.++||.|.||.||.|.++. .-.||||.++.+. ...++|++|+.+|+.++|+|+|+|+|+|..+-
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 345666666778888999999999999999754 6689999998543 44688999999999999999999999999999
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
-+|||.|||.+|+|.++|++..+..+....+++++.||..||+||..+ ++|||||..+|+||.++..|||+||||+|
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999999999888889999999999999999999999 99999999999999999999999999999
Q ss_pred hccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
++..+.+.........+.|.|||.|..+.++.|+|||+|||+||||.| |-.||-+.+ ..
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------------------lS 473 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------------------LS 473 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------------------HH
Confidence 987766655555556789999999999999999999999999999998 777776532 11
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
...++++..++.+-.+++...+.+|++.||+++|.+||+++||.+.|+.+..
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 1222333344445566677789999999999999999999999999988764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=363.38 Aligned_cols=250 Identities=25% Similarity=0.401 Sum_probs=205.0
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC----CC-ccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCc
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG----GG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDR 437 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 437 (696)
..++|.+++.||+|.||.|++|.+ ..|+.||||+++.. .. ...+.+.+|+.+|++++ |+||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456899999999999999999974 47899999977643 11 23456778999999999 9999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC-CcEEEEeeccch
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAK 516 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DfGls~ 516 (696)
.+|||||+.||+|++++...++ +.+.++.++++||+.||+|||++ ||+|||||++|||++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999988544 88899999999999999999999 99999999999999999 999999999998
Q ss_pred hccccCcceeeccccccccCchhhhccCC-CC-ccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSGK-LT-EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
... .........+|+..|+|||++.+.. |+ .++||||+||+||.|++|+.||++.+ .......+ ..
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki-----~~ 237 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKI-----RK 237 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHH-----hc
Confidence 764 2233445578999999999999877 76 78999999999999999999998732 11111111 11
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.. +. +...+. ..++.+++.+||+.||.+|.++.+|++
T Consensus 238 ~~---~~---~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GE---FK---IPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CC---cc---CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 10 10 011110 336889999999999999999999994
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=347.17 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=208.7
Q ss_pred hcCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCcc---HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQG---EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
..+|++.+.||+|.||.|-+|+ +..|+.||||.++....++ .-.+++|++||..|+|+||+.+|.+|+..+.++||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4678899999999999999998 4689999999997554443 44688999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||..+|.|++++..++. +.+.+++.|++||..|+.|+|++ ++||||||.+|||||+|+++||+|||++..+.+.
T Consensus 132 MEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999987765 99999999999999999999999 9999999999999999999999999999877654
Q ss_pred CcceeeccccccccCchhhhccCCCC-ccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.. ...++|...|.+||++.+..|. ..+|.|||||+||.|+.|..||++.+ ...++. . +..+.+.+-
T Consensus 207 kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvr---Q-----Is~GaYrEP 273 (668)
T KOG0611|consen 207 KF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVR---Q-----ISRGAYREP 273 (668)
T ss_pred cH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHH---H-----hhcccccCC
Confidence 33 3457899999999999998885 68999999999999999999999753 111111 1 112222211
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
....+..-||++||..||++|-++.+|..+.+
T Consensus 274 -----------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 274 -----------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -----------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11124667889999999999999998886543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.07 Aligned_cols=260 Identities=24% Similarity=0.326 Sum_probs=205.3
Q ss_pred HHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--------------ccHHHHHHHHHHHHHccCCCceeE
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--------------QGEREFKAEVEIISRIHHRHLVSL 428 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--------------~~~~~~~~E~~il~~l~hpnIv~l 428 (696)
+..|.|++++.||+|.||.|-+|+. .+++.||||++..... ...++.++||.+|++|+|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999995 4799999999953311 123578999999999999999999
Q ss_pred EeEEee--CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc
Q 005443 429 VGYCIS--DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (696)
Q Consensus 429 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (696)
+.+..+ .+.+|||+|||..|.+...-... ..+.+.++++++++++.||+|||.+ |||||||||.|+||+++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 998875 46789999999998775443322 2289999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccchhccc----cCcceeeccccccccCchhhhccCC----CCccccccchHHHHHHHHhCCCCCCCCCCCCch
Q 005443 507 AQVSDFGLAKLALD----ANTHITTRVMGTFGYMAPEYASSGK----LTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578 (696)
Q Consensus 507 vkL~DfGls~~~~~----~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~ 578 (696)
|||+|||.+..... +......+.+||+.|||||.+.++. .+.+.||||+||+||.|+.|+.||.+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----- 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----- 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----
Confidence 99999999976521 1222234478999999999987633 3568899999999999999999998533
Q ss_pred hHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 579 SLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 579 ~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.++. ++.+++..+.-....++..++.+||+++|+.||++|.+..+|..+......
T Consensus 324 -~~~l-------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 -ELEL-------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -HHHH-------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 2222 223333333222222344578999999999999999999999887665553
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=369.68 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=209.9
Q ss_pred HhcCccccccccccCcEEEEEEEcCC--C--cE-EEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLPD--G--RE-VAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~~--g--~~-vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 436 (696)
..++....++||+|+||.||+|.++. + .. ||||..+... .....+|++|+++|++++|+|||+|||++..+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34566777899999999999999643 2 23 8999998532 345578999999999999999999999999999
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
-++||||+|.||+|.++|+..+. .++..++++++++.+.||+|||++ ++|||||..+|||++.++.+||+|||+++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999998765 589999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCcceee-ccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 517 LALDANTHITT-RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 517 ~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
.... ..... ...-..+|+|||.+..+.|+.++|||+|||++||+++ |..||.+... ..+.. .++
T Consensus 311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~---kI~------ 376 (474)
T KOG0194|consen 311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKA---KIV------ 376 (474)
T ss_pred CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHH---HHH------
Confidence 6541 11111 1234679999999999999999999999999999999 7888876431 11111 110
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
...++..........+..++.+||..++++|++|.++.+.|+.+....
T Consensus 377 -------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 377 -------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred -------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 111112222233446778888999999999999999999999888543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=349.68 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=199.7
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCCcc---HHHHHHHHHHHHHccCCCceeEEeEEee----CCceeEEEEe
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG---EREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLLIYDY 444 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 444 (696)
...||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|++++|+||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 89999999997543333 3568899999999999999999999877 3467899999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+|+|.+++.... .+++..+++++.|++.||.|||+.. +++|||||++|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999997654 4889999999999999999999742 78899999999999999999999999998654322
Q ss_pred eeeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 525 ITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.+ .++. .. . .
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~---~i~~----~~-~-~--- 240 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYD---LIIN----KN-N-S--- 240 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHH---HHHh----cC-C-C---
Confidence 12457889999999976 689999999999999999999999998542 111111 1111 00 0 0
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. .........+.+++.+||+.||++||++.||++.|+++..
T Consensus 241 ~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 L----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred C----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0 0111123368899999999999999999999999998753
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=376.69 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=213.9
Q ss_pred hcCccccccccccCcEEEEEEEcCCC-cEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEE-ee---C---C
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDG-REVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYC-IS---D---D 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~-~~---~---~ 436 (696)
..++++.++|.+|||+.||+|.+..+ .+||+|++-..+....+.+.+|+++|++|+ |+|||.++|.. .. + .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 46788999999999999999997665 999999998887777888999999999998 99999999932 21 1 2
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
+++|+||||.||.|.+++..+....|++.++++|++|+++|+.+||.. .+.|||||||-+||||++++++||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 568999999999999999876666699999999999999999999986 6679999999999999999999999999986
Q ss_pred hccccCcce--------eeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHH
Q 005443 517 LALDANTHI--------TTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 585 (696)
Q Consensus 517 ~~~~~~~~~--------~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~ 585 (696)
.....-... .....-|+.|++||++. +..++.|+|||+|||+||.||....||++...+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 443222111 11235688999999874 567899999999999999999999999875322
Q ss_pred HHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 586 PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
.|++..+...........|.+||+.||+.||.+||++.+|++.+.+++...
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 123333322223345568999999999999999999999999999888544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=357.82 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=209.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|.+.+.||+|.||+||||+.+ +.+.||||.+.... .++.+.+++|++|+++|+|+|||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999854 68899999986432 3345679999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.| +|+.+|...+. +.++.+..|+.|++.||.|||++ +|+|||+|+.|||++.++.+|+||||+++.+.. +.
T Consensus 82 ~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9977 99999987766 99999999999999999999999 999999999999999999999999999998765 44
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.......||+.|||||++.+..|+..+|+||||||+|||+.|+.||... .+.+.+..++ .+ .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~----~d----~---- 216 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSIL----KD----P---- 216 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHh----cC----C----
Confidence 5566678999999999999999999999999999999999999999742 2222222211 11 0
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.......+..++...|++||.+|-+-.+++.+
T Consensus 217 ---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 ---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 01122344578899999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=360.66 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=207.6
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+-|+.++-||.|+.|.|.+|++ +.|+.+|||++..... .....+++|+.||+.|.|+||++||+++++..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577889999999999999985 5799999999965422 22456899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|.|++++.+.+. +.+.++.++++||+.|+.|+|.. +|+|||||++|+|||++++|||+|||+|.....
T Consensus 92 Eyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-- 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP-- 164 (786)
T ss_pred EecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence 99999999999988776 89999999999999999999998 999999999999999999999999999975433
Q ss_pred cceeeccccccccCchhhhccCCCC-ccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
..+....||.++|.+||++++..|+ .++||||+|||||.||+|++||++++ +.. ++.+. ..+.|+.
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~----LLlKV-~~G~f~M-- 231 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRV----LLLKV-QRGVFEM-- 231 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHH----HHHHH-HcCcccC--
Confidence 3344556899999999999999886 58999999999999999999999543 111 11111 1122211
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
......+..+|+++|+..||++|.+++||+++-.
T Consensus 232 --------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 232 --------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred --------CCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 1122336788999999999999999999998743
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=345.30 Aligned_cols=266 Identities=27% Similarity=0.402 Sum_probs=204.2
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHH--ccCCCceeEEeEEeeCC----cee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR--IHHRHLVSLVGYCISDD----RRL 439 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~----~~~ 439 (696)
...+.+++.||+|+||.||+|.+ .|+.||||++.. .+++.+.+|.+|++. |+|.||+.|++.-..++ .+|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 35788899999999999999999 899999999863 456788999999986 58999999998765443 468
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED-----CHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-----~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
||.+|.++|+|+|+|.+. .++.+..+++++.++.||+|||.. +++.|.|||||..||||..++.+.|+||||
T Consensus 286 LvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999864 489999999999999999999954 588999999999999999999999999999
Q ss_pred chhccccCcc---eeeccccccccCchhhhccCC----CC--ccccccchHHHHHHHHhC----------CCCCCCCCCC
Q 005443 515 AKLALDANTH---ITTRVMGTFGYMAPEYASSGK----LT--EKSDVFSFGVVLLELITG----------RKPVDASQPL 575 (696)
Q Consensus 515 s~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~----~s--~~sDVwSlGvll~eLltg----------~~Pf~~~~~~ 575 (696)
+......... .....+||.+|||||+|.... +. ..+||||||++|||+..+ +.||.+-...
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9776544322 223468999999999986422 22 368999999999999763 3444332211
Q ss_pred CchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 576 GDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 576 ~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
|-.+ +.+++++ -...+.-.+.. .......+..|.+|++.||..||..|-++-.|.+.|.++..
T Consensus 443 -DPs~-eeMrkVV----Cv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 -DPSF-EEMRKVV----CVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred -CCCH-HHHhcce----eecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1111 1111110 01111111111 12345677889999999999999999999999999998874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.50 Aligned_cols=268 Identities=30% Similarity=0.465 Sum_probs=201.8
Q ss_pred CccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHH--ccCCCceeEEeEEeeCC----ceeEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR--IHHRHLVSLVGYCISDD----RRLLI 441 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~----~~~lV 441 (696)
.+...++||+|+||.||||.+ +++.||||++.. +..+.|.+|-+|++. ++|+||++|+++-.... +.+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 344567899999999999999 679999999874 456678899988886 57999999999876544 77999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
+||..+|+|.++|..+ .++|...++|+..|++||+|||+. +++.|+|||||.+||||.+|+.+.|+|||++
T Consensus 287 t~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999999865 489999999999999999999975 4778999999999999999999999999999
Q ss_pred hhccccC-cceeeccccccccCchhhhccCC-CC-----ccccccchHHHHHHHHhCCCCCCC-CCCC---------Cch
Q 005443 516 KLALDAN-THITTRVMGTFGYMAPEYASSGK-LT-----EKSDVFSFGVVLLELITGRKPVDA-SQPL---------GDE 578 (696)
Q Consensus 516 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~-~s-----~~sDVwSlGvll~eLltg~~Pf~~-~~~~---------~~~ 578 (696)
..+.... .......+||.+|||||+|.+.. +. .+.||||+|++||||+++...++. .... +..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8765322 12233478999999999997632 22 378999999999999997765531 1110 111
Q ss_pred hHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 579 SLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 579 ~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
--++.++.+.- ..+..-.+.+. +... ..+..+.+.+..||+.|++.|-|+.=+-+++.++...+
T Consensus 444 Pt~e~mq~~VV---~kK~RP~~p~~-W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 444 PTLEEMQELVV---RKKQRPKIPDA-WRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCHHHHHHHHH---hhccCCCChhh-hhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11111111111 11111111111 1111 33557889999999999999999998888888877543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=362.29 Aligned_cols=242 Identities=29% Similarity=0.439 Sum_probs=201.1
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 440 (696)
.++|..+++||+|.||+|+++.++ +++.+|||+++... ..+.+..+.|.+|+...+ ||.|++|+.+|.+.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467999999999999999999965 68899999998653 234566788999988886 9999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.||++..+.+. ..+++..++-++..|+.||+|||++ +|||||||.+|||||.+|++||+|||+++....
T Consensus 447 vmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999995444442 2389999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.+. .+..++||+.|||||++.+..|+.++|.|+|||+|||||.|+.||.+++ ++++ ++.+
T Consensus 521 ~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd---Eee~----------------FdsI 580 (694)
T KOG0694|consen 521 QGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD---EEEV----------------FDSI 580 (694)
T ss_pred CCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC---HHHH----------------HHHH
Confidence 333 4556899999999999999999999999999999999999999998754 1222 1111
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
+... -.+......+.+.|++++|..+|++|--+
T Consensus 581 ~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111 11233344578889999999999999866
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=345.86 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=200.0
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.|++.++||+|+||.||+|.+ .+|+.||||++.... ......+.+|+++|++++|+||++++++|.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999985 478999999986432 2233467899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+|+|.+++.......+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999998877654444589999999999999999999999 99999999999999999999999999997643222
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......|+..|+|||++.+..++.++|||||||+||||++|+.||......... +.....+ .... .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~----~~~~------~ 222 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRV----KEDQ------E 222 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHh----hccc------c
Confidence 223356899999999999999999999999999999999999999865422111 1000000 0000 0
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVR 640 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~ 640 (696)
.+... ....+.+|+++||+.||++|++ ++++++
T Consensus 223 ~~~~~----~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEK----FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCcc----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01111 2236889999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=329.01 Aligned_cols=236 Identities=26% Similarity=0.376 Sum_probs=198.1
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+.++.||.|+||+|.+++.+ +|..+|+|+++..... ..+...+|..+|+.+.|++++++++.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45778899999999999999854 6899999999755332 2345778999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.||.|+.++++.++ +++..++-++.||+.||+|||++ +|++|||||+|||||.+|.+||+|||+++...+.
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999998777 99999999999999999999999 9999999999999999999999999999876554
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
+-..+||+.|+|||++....|..++|.|+|||++|||+.|..||...+. ++....+ ..
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI-------------~~ 255 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKI-------------LE 255 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHH-------------Hh
Confidence 3346899999999999999999999999999999999999999987653 1111111 11
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCC
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKR 632 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 632 (696)
.++ .+..-...++.+|++.+|+.|-.+|
T Consensus 256 ~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Ccc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 111 1111122267788889999888877
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.69 Aligned_cols=269 Identities=20% Similarity=0.263 Sum_probs=202.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++.+.||+|+||.||+|+.+ +++.||||+++.... ...+.+.+|++++++++|+||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999975 688999999975432 334568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.++.|..+.... ..+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99988776554332 2488999999999999999999998 999999999999999999999999999987644333
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH-----HHHHhhhhhhhh
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP-----LLSHALENEEFD 598 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~-----~~~~~~~~~~~~ 598 (696)
.......|+..|+|||++.+..++.++|||||||+||||++|+.+|......+....+..... .+........+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 233345689999999999998899999999999999999999999976432111111111000 000000111111
Q ss_pred cccCcccCC------CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 599 NLADPRLGE------NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 599 ~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
......... .+.......+.+|+++||+.||++|++++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 100000000 001112236899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=360.90 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=202.2
Q ss_pred hcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 437 (696)
.++|++.++||+|+||.||+|+. +.+..||||+++... ....+.+.+|+.+|+.+ +|+||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35688899999999999999963 245689999987443 23345788999999999 89999999999999999
Q ss_pred eeEEEEecCCCchhhccccCC-----------------------------------------------------------
Q 005443 438 RLLIYDYVPNNTLYFHLHGEG----------------------------------------------------------- 458 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 458 (696)
.++||||+.+|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999988875422
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 459 --------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 459 --------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
...+++..+++|+.||++||+|||++ +|+|||||++|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478888999999999999999998 9999999999999999999999999999765433221
Q ss_pred -eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 525 -ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 525 -~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
......++..|+|||++.+..++.++|||||||+||||++ |..||..... +..+.++. . .. .. ...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~~----~----~~-~~-~~~ 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMI----K----EG-YR-MLS 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHHH----H----hC-cc-CCC
Confidence 1122334567999999999999999999999999999998 8888865321 11111111 1 00 00 000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
......++.+|+.+||+.||++||+|.||++.|++.
T Consensus 339 -------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 -------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011123688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=332.70 Aligned_cols=266 Identities=21% Similarity=0.276 Sum_probs=201.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccH--HHHHHHHHHHHHccCCCceeEEeEEeeC--CceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 441 (696)
++|++++.|++|.||.||+|+++ +++.||+|+++......- -..++||.+|.+++|+|||.+-.+.... +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34667788999999999999964 688999999986543221 2468999999999999999998887643 568999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
||||+ .+|..+++...+ .+...++.-++.|+++||+|||.+ .|+|||||++|+|+++.|.+||+|||+||.+...
T Consensus 156 Me~~E-hDLksl~d~m~q-~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMKQ-PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHH-hhHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99995 468888877663 478889999999999999999999 8999999999999999999999999999988766
Q ss_pred CcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----Hhhhh--
Q 005443 522 NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----HALEN-- 594 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~~-- 594 (696)
.. ..+..+-|++|+|||++.+ ..|+..+|+||+|||+.||+.++..|.+....+..+ .+..++. ..|..
T Consensus 231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~---~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD---KIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH---HHHHHhCCCccccCCCcc
Confidence 43 3556778999999999887 679999999999999999999999998755332222 1111111 01110
Q ss_pred -------hhhhcccCcccCCCcchH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 -------EEFDNLADPRLGENYVEG-EMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 -------~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.......++..|... ....-.+|+..+|..||++|-|+.|.|++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 011111111222222221 22345678889999999999999888753
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=348.29 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=210.0
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCcc-HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
..|...++||+|.||.||+|.. +.++.||||++......+ .+++++|+.+|.+++++||.++||.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577789999999999999995 468999999998765544 47799999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
|.||++.+.|....- +++..+..|+++++.||.|||.+ +.+|||||+.||||..+|.|||+|||++.........
T Consensus 93 ~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999976543 58888888999999999999999 9999999999999999999999999999876554433
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
...++||..|||||++++..|+.|+||||||++.+||++|..||.....+.... .+.+-.-+.
T Consensus 168 -r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------------lIpk~~PP~ 230 (467)
T KOG0201|consen 168 -RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------------LIPKSAPPR 230 (467)
T ss_pred -cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------eccCCCCCc
Confidence 356889999999999999899999999999999999999999998655421110 011112233
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.+++.. .+.+++..||+.||+.||++.+||++
T Consensus 231 L~~~~S~----~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LDGDFSP----PFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccccCH----HHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3343333 68999999999999999999999965
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=339.57 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=207.7
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++++.||+|+||.||+|.++++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5789999999999999999998888899999886432 335688999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.++++......+.+..++.++.||+.||+|||++ +++|||||++||++++++.+||+|||+++...+......
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999998765545588999999999999999999998 999999999999999999999999999986544332222
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ......... +.. .. ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~----~~~---~~------~~ 225 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSALQ----RGY---RM------PR 225 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHHH----cCC---CC------CC
Confidence 23345678999999998889999999999999999998 999997532 111111111 000 00 00
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.. .....+.+++.+||+.+|++||++++|++.|+++
T Consensus 226 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 ME----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01 1223688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=345.60 Aligned_cols=262 Identities=25% Similarity=0.420 Sum_probs=201.9
Q ss_pred cCccccccccccCcEEEEEEEcCC-----------------CcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD-----------------GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSL 428 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l 428 (696)
++|.+.++||+|+||.||+|.+++ +..||||+++..... ...+|.+|+++|.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 336999998754322 34579999999999999999999
Q ss_pred EeEEeeCCceeEEEEecCCCchhhccccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 005443 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEG-----------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491 (696)
Q Consensus 429 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH 491 (696)
+++|.+.+..+|||||+.+|+|.+++.... ...+.+..+++++.||+.||.|||++ +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999988775421 12367788999999999999999999 9999
Q ss_pred ccCCCCceEECCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh--CCCC
Q 005443 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKP 568 (696)
Q Consensus 492 rDLkp~NILl~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt--g~~P 568 (696)
||||++||||++++.+||+|||+++....... .......++..|||||++.++.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999976533222 12233455788999999998899999999999999999987 5567
Q ss_pred CCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 569 VDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 569 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
|.... ....++.....+... ...... .........+.+|+.+||+.||++||++.+|++.|++
T Consensus 242 ~~~~~---~~~~~~~~~~~~~~~----~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT---DEQVIENAGEFFRDQ----GRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC---HHHHHHHHHHHhhhc----cccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 76432 233333322222111 000000 0011122368899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.43 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=212.2
Q ss_pred HhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
..++|+++++||+|+||.||+|..++++.|++|+++........++.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578889999999999999999888999999999876655667899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.++++......+++..+++++.||+.||+|||++ +|+||||+++||||++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999876555689999999999999999999999 9999999999999999999999999999766443222
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.....++..|++||++.+..++.++|||+|||+||+|++ |+.||.... .....+... . . ..
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~---~----~--~~----- 222 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQIT---A----G--YR----- 222 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHH---h----C--Cc-----
Confidence 223345678999999998899999999999999999998 899996533 111111111 0 0 00
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
..........+.+++.+||+.||++||++++|++.|+.+
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 001112223688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=341.04 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=203.5
Q ss_pred cCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.++||+|+||.||+|.++ .+..||+|+++.... .....|.+|+.++++++|+||+++++++...+..+||
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56889999999999999999753 466899999875533 2345789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.+++..... .+.+..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999999998876432 488999999999999999999999 9999999999999999999999999987654322
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+.+.. +... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~---~~~~~~~~--------~~~~--~~ 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---GQDVIKAV--------EDGF--RL 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHH--------HCCC--CC
Confidence 2111222335678999999999999999999999999999875 999997542 11111111 1100 00
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112234688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=394.36 Aligned_cols=261 Identities=29% Similarity=0.544 Sum_probs=211.0
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
..|...++||+|+||.||+|+. .+|+.||||+++.... ...+|+++|++++|+|||+++|+|.+++..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4677889999999999999986 5789999999864322 2245688999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+|+|.++++. ++|..+++|+.||++||+|||.++..+|+|||||++||++++++..++. ||........
T Consensus 766 ~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 766 EGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 99999999863 7899999999999999999996655699999999999999999888875 6665433211
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....++..|||||++.+..++.++|||||||+||||++|+.||+... .....+++|.+.... ......++++.+
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 909 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYS----DCHLDMWIDPSI 909 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcC----ccchhheeCccc
Confidence 12357889999999999999999999999999999999999996533 233456666654332 222334445444
Q ss_pred CC--CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 606 GE--NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 606 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.. .....+..++.+++.+||+.||++||+|+||++.|+++..
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 32 2344566788999999999999999999999999998864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=351.85 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=195.5
Q ss_pred ccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCC
Q 005443 373 NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
++||+|+||.||+++. .+|+.||||+++... ......+.+|+++|++++|+||++++++|..++..+|||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999997532 223356788999999999999999999999999999999999999
Q ss_pred chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeec
Q 005443 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (696)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~ 528 (696)
+|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence 9988887654 488999999999999999999999 999999999999999999999999999875432222 2233
Q ss_pred cccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCC
Q 005443 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608 (696)
Q Consensus 529 ~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (696)
.+|+..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.+. +. .+. ..+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~---~~-----~~~------~~~p~- 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---IL-----MEE------IRFPR- 216 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHH---HH-----cCC------CCCCC-
Confidence 5689999999999999999999999999999999999999975321 111111 10 000 01111
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 609 YVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 609 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.....+.+++++||+.||++|+ ++.+|+++
T Consensus 217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 ---TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1223688999999999999999 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.67 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=215.6
Q ss_pred HHhcCccccccccccCcEEEEEEEcC---CCc--EEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP---DGR--EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~---~g~--~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
..++.+...++||+|.||.||+|.+. .|+ .||||..+.+.. .+.+.|+.|..+|++++|+|||+|+|+|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 34456677789999999999999853 233 588999886443 456789999999999999999999999975 67
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.|||||.+..|.|+.+|+.+.. .++...+..+++||+.+|.|||+. ++|||||..+||||....-|||+|||++|.
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 8999999999999999987654 488999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
+.+..+...........|||||.+..++++.++|||.|||+|||+|. |..||.+-...+.... +++
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-----------iEn-- 607 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-----------IEN-- 607 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-----------ecC--
Confidence 98877766655566789999999999999999999999999999876 9999986443221110 111
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.-+......+...|..|+.+||..+|.+||++.||...|.++...
T Consensus 608 -------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 608 -------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred -------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 111222334455788999999999999999999999999988764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=337.92 Aligned_cols=256 Identities=26% Similarity=0.461 Sum_probs=207.7
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+++|++.+.||+|+||.||+|.+++++.||||.++... ...+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46789999999999999999998788899999987543 34567999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.......+++..+++++.||+.||.|||++ +|+|||||++|||+++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999998765545689999999999999999999999 99999999999999999999999999998665332222
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.........|++||++.+..++.++|||||||++|||++ |+.+|.... ...+.... . .. . ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~----~---~~--~-~~---- 223 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQV----D---QG--Y-RM---- 223 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH----H---cC--C-CC----
Confidence 222223457999999998899999999999999999999 999987532 11111110 0 00 0 00
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 ---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01111224688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=352.37 Aligned_cols=245 Identities=27% Similarity=0.365 Sum_probs=199.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56899999999999999999864 68899999997432 233456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+. +.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999998876543 78889999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
....|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +....+. . ..+
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~---~~~~~i~----~-~~~----- 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---F---RIYEKIL----A-GRL----- 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---H---HHHHHHh----c-CCc-----
Confidence 234689999999999999999999999999999999999999975321 1 1111111 1 000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 641 (696)
.+.. .....+.+|+++||+.||++|++ +++|+.+
T Consensus 233 -~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -KFPN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0001 11235789999999999999996 5666644
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=337.98 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=206.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.+|.+.+.||+|+||.||+|..+ .++.||+|+++.. ....+++.+|++++++++|+||++++++|..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888899999999999999864 5889999998743 334567899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.......+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999998766555689999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|++||++.+..++.++|||||||++|||++ |..+|.... .+.+.+ . +....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~~~---~-~~~~~------------ 222 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYE---L-LEKGY------------ 222 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH---H-HHCCC------------
Confidence 222334568999999998999999999999999999998 899886532 111111 1 11000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
...........+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 223 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011112234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=353.24 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=203.2
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|..++|+||+++++++...+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999965 58999999997442 223456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++...+ .+.+..++.++.||+.||.|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999987654 388999999999999999999999 999999999999999999999999999976543
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... ....+.... .. ..+. .
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~----~~--~~~~---~ 219 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKY----WK--ETLQ---R 219 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHh----cc--cccc---C
Confidence 22335689999999999999999999999999999999999999975431 111111110 00 0000 0
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
... .........++.+++.+||+.++++|+++++|+++
T Consensus 220 ~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 00001123368899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=351.15 Aligned_cols=200 Identities=29% Similarity=0.417 Sum_probs=175.8
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++++.||+|+||.||+++.+ +|..||+|+++.... ...+++.+|+++|++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 688999999875432 234579999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++..... +.+..+.+++.||+.||.|||+++ +|+|||||++||||++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999998876543 889999999999999999999852 69999999999999999999999999987653322
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCC
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~ 572 (696)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23356899999999999999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=336.43 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=203.0
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++.+.||+|+||.||++.++++..+|+|.++.. .....++.+|+++|++++|+||++++++|...+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458888999999999999999888889999988633 3345678999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+|+|.++++.... .+++..+++++.||+.||+|||++ +|+|||||++||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999998875432 488999999999999999999999 999999999999999999999999999976543322222
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...++.. . ... ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i---~----~~~---~~~~~~- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMI---S----RGF---RLYRPK- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---H----CCC---CCCCCC-
Confidence 22345668999999998889999999999999999999 8999875331 1111111 1 000 011111
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
.....+.+++.+||+.+|++||++++|++.|
T Consensus 225 ------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1123688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=357.97 Aligned_cols=258 Identities=24% Similarity=0.418 Sum_probs=201.6
Q ss_pred cCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCCc-cHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 438 (696)
++|+++++||+|+||.||+|.. .+++.||||+++..... ....+.+|+++|+.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 5688999999999999999873 23458999999754332 345688999999999 899999999999999999
Q ss_pred eEEEEecCCCchhhccccCC------------------------------------------------------------
Q 005443 439 LLIYDYVPNNTLYFHLHGEG------------------------------------------------------------ 458 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 458 (696)
++||||+.+|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999988775321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc-eeecc
Q 005443 459 --------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRV 529 (696)
Q Consensus 459 --------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~-~~~~~ 529 (696)
...+++..+++|+.||++||+|||++ +|+|||||++|||+++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 12367888999999999999999998 9999999999999999999999999999765433221 11223
Q ss_pred ccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCC
Q 005443 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608 (696)
Q Consensus 530 ~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (696)
.++..|||||++.+..++.++|||||||+||||++ |+.||..... ...+.+ .+... + .. ..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--~~~~~~----~~~~~-----~-~~---~~--- 336 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--NSKFYK----MVKRG-----Y-QM---SR--- 336 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--cHHHHH----HHHcc-----c-Cc---cC---
Confidence 35568999999999999999999999999999997 9999975321 111111 11100 0 00 00
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 609 YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 609 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
......++.+++.+||+.||++||++.+|++.|+++.
T Consensus 337 -~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 -PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0011236889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=354.72 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=191.5
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
|+.+++||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++|++++|+||+++++++..++..++||||+.
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 455688999999999999854 689999999865432 234678999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 225 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC 225 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence 99986533 256778889999999999999999 999999999999999999999999999976543222 12
Q ss_pred eccccccccCchhhhcc-----CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 527 TRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
...+|+..|+|||++.. ...+.++|||||||+||||++|+.||..........+.. .. . ....
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~---~--~~~~---- 293 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AI---C--MSQP---- 293 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HH---h--ccCC----
Confidence 33578999999998753 223468999999999999999999998433211111110 00 0 0000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ........++.+|+.+||+.|+++||++.||+++
T Consensus 294 -~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -P----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111122368899999999999999999999975
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=347.05 Aligned_cols=246 Identities=23% Similarity=0.292 Sum_probs=197.3
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|+++++||+|+||.||+|+. ..|+.+|+|+++.... ...+.++.|-.+|...++++||+||-.|.+.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 47899999999999999999984 4699999999985532 3345688899999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc-
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD- 520 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~- 520 (696)
|||+.||++..+|.+.+- |.+..++..+.+++.||+.||+. |||||||||+|+|||.+|++||+||||+.-+..
T Consensus 220 MEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999987664 99999999999999999999999 999999999999999999999999999842211
Q ss_pred --------------c-------Ccc-----e-------------------eeccccccccCchhhhccCCCCccccccch
Q 005443 521 --------------A-------NTH-----I-------------------TTRVMGTFGYMAPEYASSGKLTEKSDVFSF 555 (696)
Q Consensus 521 --------------~-------~~~-----~-------------------~~~~~gt~~y~aPE~l~~~~~s~~sDVwSl 555 (696)
. ... . ....+||+.|||||++++..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 000 0 012579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC
Q 005443 556 GVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR 634 (696)
Q Consensus 556 Gvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 634 (696)
||||||||.|..||...... +..+.++... +. +..-.+. ....+.++||.+||. |+++|--
T Consensus 375 G~ImyEmLvGyPPF~s~tp~------~T~rkI~nwr-~~--l~fP~~~--------~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQ------ETYRKIVNWR-ET--LKFPEEV--------DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHH------HHHHHHHHHh-hh--ccCCCcC--------cccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999875532 1111111110 00 0000011 111367889999999 9999975
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=351.26 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=213.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc-eeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR-RLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~lV~ 442 (696)
++|+.+++||+|+||.+++++++ ++..|++|.+..... ...+...+|+.++++++|||||.+++.|++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999999865 678999999976543 334568899999999999999999999999988 89999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
+||+||+|.+.+...++..+.++.+++|+.||+.||.|||++ +|+|||||..|||++.++.|||+|||+++......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999887777899999999999999999999998 99999999999999999999999999999876654
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. ....++||..||.||++.+..|..|+|||+|||++|||++-+..|...+. .. ++. +.+..++
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~----Li~-----ki~~~~~- 223 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SE----LIL-----KINRGLY- 223 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HH----HHH-----HHhhccC-
Confidence 2 34457899999999999999999999999999999999999999987541 11 111 1111111
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.........++..+++.||+.+|+.||++.+||.+
T Consensus 224 ----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 ----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12233445579999999999999999999999976
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=346.30 Aligned_cols=245 Identities=23% Similarity=0.350 Sum_probs=199.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||+|..+ +|+.||||+++.... ...+.+.+|+++|++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999964 689999999974322 23456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 99999999998876543 88999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+. ..+... ..
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~---~~i~~~-----~~----- 215 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIY---EKILAG-----KL----- 215 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhC-----Cc-----
Confidence 234689999999999998899999999999999999999999975431 1111 111110 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 641 (696)
.+...+ ...+.+++++||+.||.+|++ +++++++
T Consensus 216 -~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -EFPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111 236789999999999999995 6666643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.87 Aligned_cols=271 Identities=20% Similarity=0.299 Sum_probs=207.7
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEee--cCCCccHHHHHHHHHHHHHccCCCceeEEeEEee-----CC
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLK--IGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS-----DD 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~ 436 (696)
....|..++.||+|+||.|+.+.. .+|+.||||++. ..+....++..+|+++|+.++|.||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345666678999999999999985 478999999997 5555667889999999999999999999998875 34
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..|+|+|+| +.+|...++.+.. +....+..+++||++||.|+|+. +|+|||||+.|+|++.+..+||||||+||
T Consensus 100 DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 679999999 7788888876554 88999999999999999999999 99999999999999999999999999999
Q ss_pred hcccc-CcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----H
Q 005443 517 LALDA-NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----H 590 (696)
Q Consensus 517 ~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~ 590 (696)
..... .....+..+.|.+|+|||++.. ..|+.+.||||+||||.|||+|+.-|.+.+......++-....... .
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 77532 1223455778999999998765 7899999999999999999999999987665433222221110000 0
Q ss_pred hhhhhhhhcccCc--cc-C---CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 ALENEEFDNLADP--RL-G---ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 ~~~~~~~~~~~d~--~l-~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+..++....+.. .. . ...........++|+.+||..||.+|.|++|.|++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0111111111110 00 0 00111223367899999999999999999999975
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.71 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=207.7
Q ss_pred ccccccccccCcEEEEEEEcC--CC--cEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 369 FADQNLLGEGGFGSVYKGYLP--DG--REVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++..++||+|.||.|++|.++ +| ..||||+++..... ...+|++|+.+|.+|+|+|+++|||+..+ ....||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 445688999999999999975 34 47899999866544 56789999999999999999999999887 78899999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
++.+|+|.+.|++..+..|-...++.++.||+.||.||..+ ++|||||..+||||-....|||+||||.|-+..+..
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999986677788899999999999999999999 999999999999999899999999999998765544
Q ss_pred ce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 524 HI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 524 ~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.. .......+.|+|||.|+.+.|+.++|||+|||.|||||+ |..||.+.... + ++++
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------q----IL~~---------- 327 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------Q----ILKN---------- 327 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------H----HHHh----------
Confidence 32 223344678999999999999999999999999999999 78888764321 1 1111
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
+|..-+..-.+.+..+|.+++++||..++++||+|..|++.+-...
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 1111111223445568999999999999999999999986544333
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=320.21 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=208.7
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++++.||+|.||.||+|+. +++--||+|++... ..+..+++.+|++|...|+|+||+++|+||.++...||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5689999999999999999985 46778999999543 2344678999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||..+|.|+..|+......+++.....++.|++.||.|+|.+ +|||||||++|+|++.++.+||+|||.+....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 999999999999866556699999999999999999999999 99999999999999999999999999997643
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.......+||+.|.+||...+..++..+|+|++|++.||++.|..||.... .++. .+.++ + -++.
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~et-YkrI~-------k----~~~~- 240 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSET-YKRIR-------K----VDLK- 240 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHH-HHHHH-------H----cccc-
Confidence 223445789999999999999999999999999999999999999998643 1111 11111 0 0111
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
+.........++|.+|+..++.+|....|+++.-.
T Consensus 241 ------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 241 ------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ------CCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11222336788999999999999999999887644
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=340.41 Aligned_cols=250 Identities=31% Similarity=0.552 Sum_probs=193.7
Q ss_pred cccccccccCcEEEEEEEcC-----CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 370 ADQNLLGEGGFGSVYKGYLP-----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++.+.||.|.||.||+|.+. .+..|+||+++.... ...++|.+|+++|++++|+||++++|+|...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35688999999999999975 357899999965433 236789999999999999999999999998888999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+|+|.++|+......+++..+++|+.||++||.|||++ +|+||||+++||||++++.+||+|||+++.......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999999887555699999999999999999999999 999999999999999999999999999976622221
Q ss_pred -ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 524 -HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 524 -~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.......+...|+|||.+.+..++.++||||||++||||++ |+.+|.... ...+.+.+. +... ..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~-------~~~~-~~-- 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLK-------QGQR-LP-- 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHH-------TTEE-TT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc-------cccc-ce--
Confidence 22223456789999999999999999999999999999999 678876432 222211110 1111 00
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
........+.+++.+||..+|++||+|.+|++.|
T Consensus 226 -------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111123688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.90 Aligned_cols=196 Identities=27% Similarity=0.367 Sum_probs=170.2
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|++.++||+|+||.||++.. ..++.||||+.. ...+.+|+++|++|+|+||++++++|..++..++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36799999999999999999985 468899999754 34578999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+. ++|..++.... .+.+..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++........
T Consensus 165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 95 67877776543 378999999999999999999999 9999999999999999999999999999754333322
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
......|+..|+|||++.+..++.++|||||||+||||++|+.+|....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~ 287 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcc
Confidence 3334579999999999999999999999999999999999998876443
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=346.63 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=198.3
Q ss_pred CccccccccccCcEEEEEEEc----CCCcEEEEEEeecCC----CccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCce
Q 005443 368 GFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRR 438 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 438 (696)
+|+++++||+|+||.||+++. .+|+.||||+++... ....+.+.+|+++|++++ |+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999874 358899999996432 223456888999999995 99999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+.+|+|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999998886544 388999999999999999999999 9999999999999999999999999999765
Q ss_pred cccCcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
............|+..|||||++.+. .++.++|||||||+||||++|+.||.......... +....+. .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~----~---- 225 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRIL----K---- 225 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHh----c----
Confidence 44333333345789999999999865 47889999999999999999999997543221111 1111110 0
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.+..+... ....+.+++.+||+.||++|+ ++++++++
T Consensus 226 ---~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01111111 123578899999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.89 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=204.8
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|++.++||+|+||.||+|..+++..||+|.++.... ..+.+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 356888999999999999999988888999999875433 4567999999999999999999999885 45679999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.++++......+++..+++++.||+.||+|||++ +|+|||||++|||+++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999998765545589999999999999999999999 99999999999999999999999999997654433222
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.... .....+... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~-------~~~~-------- 221 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQVE-------RGYR-------- 221 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH-------cCCC--------
Confidence 222345678999999988899999999999999999999 888886532 111111110 0000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
..........+.+++.+||+.+|++||++++|++.|++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 --MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00111223468999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.19 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=203.2
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++.+.||+|+||.||+|.++++..||||.++.. .....++.+|+.++++++|+||++++++|...+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 457888999999999999999877778999988743 2345679999999999999999999999998888999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++..... .+.+..+++++.||+.||+|||++ +|+|+|||++|||+++++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999998876433 489999999999999999999999 999999999999999999999999999876544332222
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....++..|++||++.+..++.++|||||||+||||++ |+.||..... ....+. +. . .....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~---~~----~-~~~~~------ 221 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEK---VS----Q-GLRLY------ 221 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHH---Hh----c-CCCCC------
Confidence 22345678999999998889999999999999999998 9999875331 111111 10 0 00000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 ---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00111247889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=352.54 Aligned_cols=252 Identities=24% Similarity=0.306 Sum_probs=203.2
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+|+.. +|+.||||+++... ......+.+|+++|..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999964 68999999997432 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++...+ .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999987653 489999999999999999999998 99999999999999999999999999997654433
Q ss_pred ----------------------------cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCC
Q 005443 523 ----------------------------THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574 (696)
Q Consensus 523 ----------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~ 574 (696)
........|+..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122335689999999999999999999999999999999999999986431
Q ss_pred CCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 005443 575 LGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-MGQVVRV 641 (696)
Q Consensus 575 ~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~ 641 (696)
.+....+.. +.....+.. .......+.+++++||+ |+++|++ +++|+++
T Consensus 236 ------~~~~~~i~~-~~~~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 ------QETYNKIIN-WKESLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHHHHhc-cCCcccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111111 000000000 00022368889999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=339.62 Aligned_cols=266 Identities=22% Similarity=0.337 Sum_probs=200.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++.++||+|+||.||+|+.+ +++.||||+++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56999999999999999999864 688999999875432 2345678999999999999999999999998899999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+ +|.+++...+. .+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 975 78777765432 478899999999999999999999 999999999999999999999999999975432221
Q ss_pred eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH--------Hhhhhh
Q 005443 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS--------HALENE 595 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~--------~~~~~~ 595 (696)
......++..|+|||++.+ ..++.++|||||||++|||++|+.+|..... ...+......+. ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV---KEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHHhhccccch
Confidence 1233467899999999875 5689999999999999999999999976432 111111111110 111111
Q ss_pred hhhcccCcccCCCc----chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGENY----VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
++..+......... ......++++++++||+.||++|++++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 12211111111100 01112367899999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=327.48 Aligned_cols=266 Identities=22% Similarity=0.309 Sum_probs=199.7
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCC-ceeEEeEEeeCC------
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRH-LVSLVGYCISDD------ 436 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~------ 436 (696)
..|+.+++||+|.||+||+|+. .+|+.||+|+++..... .-....+|+.+|++|+|.| ||+|++++..++
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3456667799999999999984 47899999999876542 2345689999999999999 999999999877
Q ss_pred ceeEEEEecCCCchhhccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGR--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
.++|||||+ ..+|..++..... ..++...++.+++||++||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 678999999 4567777765443 3577788999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
++...-.. ......++|++|+|||++.+. .|+...||||+|||++||++++..|.+... .+.+.....++..- .
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP-~ 241 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTP-N 241 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCC-C
Confidence 99654332 234557899999999999885 799999999999999999999999987553 11111111111100 0
Q ss_pred hhhhhccc---Ccc--cC-----CCcch---HHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 NEEFDNLA---DPR--LG-----ENYVE---GEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 ~~~~~~~~---d~~--l~-----~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+.+..+. +.. +. ..+.. ....+..+++.+||+.++++|-+++..+.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 01111110 100 00 00111 111367888889999999999988888764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=338.01 Aligned_cols=255 Identities=30% Similarity=0.516 Sum_probs=203.7
Q ss_pred cCccccccccccCcEEEEEEEcCC------CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
++|++.+.||+|+||.||+|.+.. +..|++|.++.... ....+|.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998532 25799999874432 23456899999999999999999999999988999
Q ss_pred EEEEecCCCchhhccccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC
Q 005443 440 LIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~ 505 (696)
++|||+.+++|.+++..... ..+++..++.++.||+.||.|||++ +|+|||||++||||++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999988865321 3478899999999999999999999 999999999999999999
Q ss_pred cEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHh
Q 005443 506 EAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEW 583 (696)
Q Consensus 506 ~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~ 583 (696)
.+||+|||+++....... .......++..|+|||++.++.++.++|||||||+||||++ |..||..... .++.+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999976533322 22233456788999999998999999999999999999998 9999875431 122111
Q ss_pred HHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 584 ARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
+. ...... .......++.+|+++||+.||++||++.||+++|+.
T Consensus 239 i~--------~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IR--------SRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH--------cCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 111100 111223478899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.21 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=194.6
Q ss_pred ccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCC
Q 005443 373 NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
++||+|+||.||+++. .+|+.||||+++... ......+.+|++++++++|+||++++++|..++..+|||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999997532 223456778999999999999999999999999999999999999
Q ss_pred chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeec
Q 005443 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (696)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~ 528 (696)
+|.+++...+ .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence 9988886554 389999999999999999999999 999999999999999999999999999875322221 2233
Q ss_pred cccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCC
Q 005443 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608 (696)
Q Consensus 529 ~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (696)
..|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+.+ .+. .... .+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~---~~~-----~~~~------~~p~~ 217 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFE---LIL-----MEEI------RFPRT 217 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHH---HHh-----cCCC------CCCCC
Confidence 5689999999999999999999999999999999999999975321 11111 110 0000 01111
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 609 YVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 609 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
....+.+++++||+.||++|+ ++.+++++
T Consensus 218 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 ----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ----CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 123678999999999999998 78887754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=345.76 Aligned_cols=242 Identities=27% Similarity=0.386 Sum_probs=195.4
Q ss_pred ccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCC
Q 005443 373 NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
++||+|+||.||+++. .+|+.||||+++... ......+.+|+++|+.++|+||+++++++..++..+|||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999997432 233456889999999999999999999999999999999999999
Q ss_pred chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeec
Q 005443 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (696)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~ 528 (696)
+|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 9988886554 389999999999999999999999 99999999999999999999999999987533222 12234
Q ss_pred cccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCC
Q 005443 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608 (696)
Q Consensus 529 ~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (696)
.+|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+. ..+. ... ..+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~---~~~~-----~~~------~~~p~~ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLF---ELIL-----MED------IKFPRT 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHH---HHhc-----cCC------ccCCCC
Confidence 5689999999999999999999999999999999999999975321 1111 1110 000 011111
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 609 YVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 609 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
...++.+++++||+.||++|+ ++.||+++
T Consensus 218 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 ----LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223688999999999999997 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=331.63 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=206.4
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|+++++||+|+||.||+|..++++.||||.+.... ....++.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46789999999999999999998889999999987443 34568999999999999999999999874 56789999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999988765555689999999999999999999998 99999999999999999999999999997654332222
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|++||++....++.++|||||||++|||++ |+.||.... ...+.+... .. ....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~--------~~-----~~~~ 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQNLE--------RG-----YRMP 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHH--------cC-----CCCC
Confidence 223345678999999998889999999999999999998 999997533 112211110 00 0000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
... ....++.+++.+||+.+|++||++++|++.|+.
T Consensus 224 ~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011 112368999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.05 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=205.9
Q ss_pred cCccccccccccCcEEEEEEEcCC-CcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+.|++++.||.|..|+||++++++ +..+|+|+|..... +...+.+.|-+||+.++|+.|..||..|+.++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346678899999999999999754 58999999975432 33356778999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc--
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD-- 520 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~-- 520 (696)
|||.||+|+.+++++....+.+..++-++.+|+.||+|||.. |||+|||||+||||.++|+|.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999998888899999999999999999999998 999999999999999999999999999753210
Q ss_pred -------------------------------cCc----------------------ceeeccccccccCchhhhccCCCC
Q 005443 521 -------------------------------ANT----------------------HITTRVMGTFGYMAPEYASSGKLT 547 (696)
Q Consensus 521 -------------------------------~~~----------------------~~~~~~~gt~~y~aPE~l~~~~~s 547 (696)
... .....++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011236899999999999999999
Q ss_pred ccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhcc
Q 005443 548 EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRH 627 (696)
Q Consensus 548 ~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~ 627 (696)
.++|+|+|||+|||||.|+.||.+.+.. +. +.+++...+.-.........+.+||+++|..
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~--~T-----------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK--ET-----------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch--hh-----------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence 9999999999999999999999876531 11 1222222221111123455789999999999
Q ss_pred CCCCCCC----HHHHHH
Q 005443 628 SAAKRPR----MGQVVR 640 (696)
Q Consensus 628 dP~~RPs----~~ell~ 640 (696)
||++|-- +.||.+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999987 666654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=332.38 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=204.4
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++.++||+|+||.||+|.++++..||||+++... ...+++.+|++++++++|+||+++++++. ++..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5689999999999999999998777789999987433 33567899999999999999999999875 456799999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++.......+++..+++++.||++||+|||+. +|+|||||++|||+++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999765444578999999999999999999999 999999999999999999999999999976544332222
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....++..|++||++.+..++.++|||||||++|||++ |+.+|.... ...+.+ ...... .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~~~~~~-------~~~~~~------~--- 221 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLD-------QVERGY------R--- 221 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---hHHHHH-------HHhcCC------C---
Confidence 23346678999999998899999999999999999999 888886432 111111 000000 0
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
..........+.+++.+||+.++++||+++++++.|++.
T Consensus 222 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 001112334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=344.00 Aligned_cols=200 Identities=28% Similarity=0.436 Sum_probs=174.9
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++.++||+|+||.||++.++ +|..||+|+++.... .....+.+|+++|++++|+||++++++|.+++..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999865 688899998875432 234568999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++...+. +.+..++.++.||+.||.|||+++ +|+|||||++||||++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999876543 788999999999999999999742 79999999999999999999999999987653321
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCC
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~ 572 (696)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22346889999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.83 Aligned_cols=243 Identities=27% Similarity=0.402 Sum_probs=194.6
Q ss_pred cccccccCcEEEEEEEc----CCCcEEEEEEeecCC----CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 372 QNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
+++||+|+||.||+++. .+++.||||+++... ......+.+|+++|++++|+||++++++|..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36799999999999984 357899999997432 2233567889999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 81 YLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999998876543 78888899999999999999999 999999999999999999999999999875433222
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...+. .+....+.. ..+
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~-----~~~------ 217 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILK-----GKL------ 217 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHc-----CCC------
Confidence 22335689999999999988899999999999999999999999975431 111111111 000
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.+ .......+.+++++||+.+|++|+ ++.+++++
T Consensus 218 ~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NL----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CC----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 01 111123678999999999999999 78877764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=349.09 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=198.6
Q ss_pred cCccccccccccCcEEEEEEEcCC--CcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD--GREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.+.||+|+||.||+|.+++ +..||||++.... ....+.+.+|+++++.++|+||+++++++.+++..+||
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468899999999999999998543 3689999986432 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.+++..... +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999876543 88999999999999999999999 9999999999999999999999999999765322
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.....|+..|||||++.+..++.++|||||||+||||++|+.||..... ..+.+ .+. . ...
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~---~i~----~-~~~---- 245 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQ---KIL----E-GII---- 245 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHH---HHh----c-CCC----
Confidence 1235689999999999998899999999999999999999999975431 11111 111 0 000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.+.... ...+.+++++||+.|+++|. ++++|+++
T Consensus 246 --~~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 --YFPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011111 22578899999999999996 78887754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.55 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=198.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||+|+.. +|+.||||+++... ......+.+|+++|+.++|+||++++++|.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999864 68999999997532 223456788999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999887654 389999999999999999999999 99999999999999999999999999986542211
Q ss_pred cc-------------------------------------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhC
Q 005443 523 TH-------------------------------------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565 (696)
Q Consensus 523 ~~-------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg 565 (696)
.. .....+||..|+|||++.+..++.++|||||||+||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 005443 566 RKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR---MGQVVRV 641 (696)
Q Consensus 566 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~ 641 (696)
+.||..... .+....++. + ...+ .+.+ . ......+.+++++|+. ++.+|++ ++|++++
T Consensus 236 ~~Pf~~~~~------~~~~~~i~~-~--~~~~-~~~~-----~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNP------QETYRKIIN-W--KETL-QFPD-----E--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCH------HHHHHHHHc-C--CCcc-CCCC-----C--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999975431 111111110 0 0000 0000 0 0112257788889996 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=331.56 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=201.5
Q ss_pred CccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
+|++.+.||+|+||.||+|.+++++.+|||+++... ....++.+|++++++++|+||+++++++...+..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999998777899999986432 3456788999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
++|.+++..... .+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999998875433 489999999999999999999999 9999999999999999999999999999765433222222
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~ 606 (696)
...++..|++||++.+..++.++|||||||+||||++ |+.||..... ....+... ... .. .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~-------~~~---~~---~-- 221 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVS-------AGY---RL---Y-- 221 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHH-------cCC---cC---C--
Confidence 2234467999999999999999999999999999998 8999875321 11111110 000 00 0
Q ss_pred CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 607 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
........+.+++.+||+.++++||++.||++.|
T Consensus 222 --~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 --RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0111233788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=342.58 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=203.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCc----EEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|++.+.||+|+||.||+|.+. +|+ .||||+++.... ...+++.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999853 333 489999874432 3456788999999999999999999998764 5789
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|+||+.+|+|.++++.... .+.+..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999998876432 478899999999999999999999 999999999999999999999999999987643
Q ss_pred cCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
..... .....++..|++||++.+..++.++|||||||+||||++ |+.||+... ...+.+. + ....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~~~~----~----~~~~-- 228 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSI----L----EKGE-- 228 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----H----hCCC--
Confidence 32221 122234678999999999999999999999999999998 999987532 1111111 1 1100
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
.+.. ......++.+++.+||+.+|.+||++.+|+..|.++....
T Consensus 229 ~~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 RLPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0000 1112236889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.45 Aligned_cols=255 Identities=25% Similarity=0.470 Sum_probs=204.5
Q ss_pred cCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
++|.+.+.||+|+||.||+|.+. +++.||||+++..... ..+.+.+|+++|++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45888899999999999999853 3478999998755443 3568999999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 440 LIYDYVPNNTLYFHLHGEG------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
+||||+.+++|.++++..+ ...+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999886432 23478889999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHH
Q 005443 508 QVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWAR 585 (696)
Q Consensus 508 kL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~ 585 (696)
||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.... .....+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~---~~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH
Confidence 9999999875432221 11223345678999999999999999999999999999998 999987543 122222111
Q ss_pred HHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 586 PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
...... ........+.+++++||+.||++||++.||++.|++
T Consensus 239 --------~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 --------QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --------cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111100 011123468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=342.26 Aligned_cols=238 Identities=26% Similarity=0.377 Sum_probs=191.4
Q ss_pred ccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
||+|+||.||+|+.. +++.||||+++... ......+.+|+++|++++|+||++++++|...+..++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999864 58899999987432 23345688999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccc
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~ 530 (696)
.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... ......+
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQREGR--FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 998876543 89999999999999999999999 99999999999999999999999999997543222 2233456
Q ss_pred cccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcc
Q 005443 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610 (696)
Q Consensus 531 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (696)
|+..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....++... + .+ .
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~-----~------~~----~ 213 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEP-----L------RF----P 213 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCC-----C------CC----C
Confidence 8999999999999999999999999999999999999997532 111111111100 0 01 1
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 005443 611 EGEMFRMIEAAAACVRHSAAKRPRMGQVV 639 (696)
Q Consensus 611 ~~~~~~l~~li~~cl~~dP~~RPs~~ell 639 (696)
......+.+++.+||+.||++|+++..+.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~ 242 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQ 242 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHH
Confidence 11223678999999999999998643333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=332.17 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=204.5
Q ss_pred cCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.++||+|+||.||+|.++ +...||||+++.... ....+|.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56889999999999999999864 245899999875433 2345789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++..... .+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999876443 489999999999999999999998 9999999999999999999999999999876522
Q ss_pred Ccc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 522 NTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 522 ~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
... ......++..|++||.+.+..++.++|||+|||++|||++ |..||.... ...+.+... .....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~-------~~~~~-- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAVE-------DGYRL-- 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHH-------cCCCC--
Confidence 221 1222334678999999998899999999999999999998 999886432 111111110 00000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.........+.+++.+||+.+|++||++.||++.|+++
T Consensus 228 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 --------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111223688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=353.00 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=203.4
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 437 (696)
.++|.++++||+|+||.||+|.+. .+..||||+++.... ...+.+.+|+++|++++ |+||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 568899999999999999999842 234799999975433 23457899999999996 9999999999999999
Q ss_pred eeEEEEecCCCchhhccccCC-----------------------------------------------------------
Q 005443 438 RLLIYDYVPNNTLYFHLHGEG----------------------------------------------------------- 458 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 458 (696)
.+||||||.+|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999988775421
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC
Q 005443 459 -----------------------------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN 503 (696)
Q Consensus 459 -----------------------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~ 503 (696)
...+++..+++++.||++||+|||++ +|+|||||++|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12367888899999999999999998 9999999999999999
Q ss_pred CCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 005443 504 NFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLV 581 (696)
Q Consensus 504 ~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~ 581 (696)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||..... +..+.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~--~~~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV--DSTFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch--hHHHH
Confidence 999999999999765432221 1223456778999999999999999999999999999997 9999875321 11111
Q ss_pred HhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 582 EWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.. + .... ...........+.+++.+||+.||++||++.+|++.|+++.
T Consensus 351 ~~----~----~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NK----I----KSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH----H----hcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 10 0 0000 00011122346889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=350.08 Aligned_cols=253 Identities=21% Similarity=0.254 Sum_probs=197.7
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++|+||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 478999999999999999999964 5889999998642 122345688999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.+++... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999988643 378889999999999999999999 9999999999999999999999999999865443
Q ss_pred CcceeeccccccccCchhhhccC----CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 522 NTHITTRVMGTFGYMAPEYASSG----KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
........+|+..|||||++.+. .++.++|||||||+||||++|+.||..... ......++ .....
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~----~~~~~ 265 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIM----DHKNS 265 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHH----hCCcc
Confidence 33223345799999999998753 378899999999999999999999975431 11111111 11000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAK--RPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 641 (696)
..+. . .......+.+++.+||+.+.++ |+++.|++++
T Consensus 266 ~~~p-----~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LNFP-----E--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCC-----C--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000 0 0111235778888999755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=337.05 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=196.2
Q ss_pred cCccccccccccCcEEEEEEEc-C-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHc---cCCCceeEEeEEee-----
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-P-DGREVAIKQLKIGGG--QGEREFKAEVEIISRI---HHRHLVSLVGYCIS----- 434 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~----- 434 (696)
++|++.+.||+|+||.||+|+. . +|+.||||+++.... .....+.+|+++++.+ +|+||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999985 2 468899999875432 2234567788887776 69999999999863
Q ss_pred CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
....++||||+. ++|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 345789999996 5788888765555589999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
++..... .......|+..|+|||++.+..++.++|||||||++|||++|+.+|..... .+.+......... ...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~---~~~~~~i~~~~~~-~~~ 230 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGL-PGE 230 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCC-CCh
Confidence 9765433 223345689999999999988999999999999999999999999986442 1221111111100 000
Q ss_pred hhhhc---ccCcccC----C---CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 595 EEFDN---LADPRLG----E---NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 595 ~~~~~---~~d~~l~----~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..+.. +....+. . .........+.+++.+||+.||++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0000000 0 000112235779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=351.37 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=199.6
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|++.++||+|+||.||+++.+ +++.||||+++... ......+.+|+.+++.++|+||+++++++.+++..+||
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 467999999999999999999864 68899999996431 22334578899999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.+++... .+.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999888643 378888999999999999999999 9999999999999999999999999999765433
Q ss_pred CcceeeccccccccCchhhhccC----CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 522 NTHITTRVMGTFGYMAPEYASSG----KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
........+|+..|+|||++.+. .++.++|||||||+||||++|+.||..... ......++ .....
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~----~~~~~ 265 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM----DHKNS 265 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHH----cCCCc
Confidence 32222345789999999998653 478899999999999999999999986431 11111111 10000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAK--RPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 641 (696)
..+. .. ......+.+++++||+.++++ |++++||+++
T Consensus 266 ~~~~-----~~--~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFP-----DD--IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCC-----Cc--CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000 00 011236788999999999988 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=315.18 Aligned_cols=263 Identities=23% Similarity=0.316 Sum_probs=208.4
Q ss_pred hcCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----cee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRL 439 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 439 (696)
.++|.+.+.||+|||+.||+++ +.+++.||+|++.....++.+..++|++..++++|+||+++++++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999998 6689999999999888788889999999999999999999999876543 479
Q ss_pred EEEEecCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 440 LIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
|++.|...|+|.+.+... ++..+++.++++|+.+|++||++||+. .+.++|||||+.|||+.+++.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999998888653 344699999999999999999999998 22499999999999999999999999999864
Q ss_pred ccccCc---ce-----eeccccccccCchhhhcc---CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH
Q 005443 518 ALDANT---HI-----TTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 518 ~~~~~~---~~-----~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
..-... .. -.....+.-|+|||.+.- ...+.++|||||||+||+||.|..||+.....++--.+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL----- 253 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL----- 253 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-----
Confidence 321110 00 112357889999998853 45788999999999999999999999854321110000
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.+.+.++...-.......+.+++++|++.||.+||+..+|+.+++++.
T Consensus 254 ------------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 ------------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 011111111111112337899999999999999999999999998764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=355.38 Aligned_cols=200 Identities=28% Similarity=0.378 Sum_probs=175.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-C-----CCceeEEeEEeeCCcee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-H-----RHLVSLVGYCISDDRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~~~~~~ 439 (696)
-+|++.++||+|.||.|.+|.+ +.++.||||+++.. .....+...|+++|..|+ | -|||++++||...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3899999999999999999984 56999999999843 233456678999999997 4 38999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC--CcEEEEeeccchh
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN--FEAQVSDFGLAKL 517 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~--~~vkL~DfGls~~ 517 (696)
||+|.+ ..+|+++|+.+....++...++.|+.||+.||.+||+. +|||+||||+||||.+- .+|||+|||.+..
T Consensus 265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999998 67899999988888899999999999999999999999 99999999999999643 4799999999986
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCC
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~ 575 (696)
...... ..+.+..|+|||+|.+..|+.+.||||||||+.||++|...|.+.+..
T Consensus 341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 544322 456788999999999999999999999999999999998888876543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=348.53 Aligned_cols=201 Identities=25% Similarity=0.367 Sum_probs=174.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||+|+.. +++.||||+++... ......+.+|+.++.+++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999854 68999999997432 222356788999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999999876543 89999999999999999999999 99999999999999999999999999987543211
Q ss_pred c----------------------------------ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCC
Q 005443 523 T----------------------------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568 (696)
Q Consensus 523 ~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~P 568 (696)
. ......+||..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234799999999999999999999999999999999999999
Q ss_pred CCCC
Q 005443 569 VDAS 572 (696)
Q Consensus 569 f~~~ 572 (696)
|...
T Consensus 236 f~~~ 239 (363)
T cd05628 236 FCSE 239 (363)
T ss_pred CCCC
Confidence 9754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=329.30 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=207.8
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|++.++||+|+||.||+|.+++++.||||.++... ...+++.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46899999999999999999998888899999987433 34578999999999999999999999999888999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.......+++..++.++.||+.||.|||++ +|+|||||++||+|++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999876555689999999999999999999999 99999999999999999999999999987654322222
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|++||.+.+..++.++|||||||++|||++ |+.||.... .....+... .. +..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~-------~~--~~~----- 223 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQVE-------RG--YRM----- 223 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH-------cC--CCC-----
Confidence 222334568999999998889999999999999999998 999986432 111111110 00 000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
.........+.+++.+||+.+|++||++++|++.|+.
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 ---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0001112368899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=350.82 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=195.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||++.. .+|+.||||++.... ....+.+++|+++|++++|+||++++++|.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999985 478999999986432 223456888999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999887544 378899999999999999999999 99999999999999999999999999986322100
Q ss_pred cc----------------------------------------------eeeccccccccCchhhhccCCCCccccccchH
Q 005443 523 TH----------------------------------------------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFG 556 (696)
Q Consensus 523 ~~----------------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlG 556 (696)
.. .....+|+..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCC---C
Q 005443 557 VVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKR---P 633 (696)
Q Consensus 557 vll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---P 633 (696)
|+||||++|+.||..... ... ...++. ... .+ .+.+ . ......+.+++.+||+ ++.+| +
T Consensus 236 vil~elltG~~Pf~~~~~---~~~---~~~i~~-~~~--~~-~~p~-----~--~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 236 AIMFECLIGWPPFCSENS---HET---YRKIIN-WRE--TL-YFPD-----D--IHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred hhhhhhhcCCCCCCCCCH---HHH---HHHHHc-cCC--cc-CCCC-----C--CCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999975431 111 111110 000 00 0000 0 0112357788999997 66665 5
Q ss_pred CHHHHHHH
Q 005443 634 RMGQVVRV 641 (696)
Q Consensus 634 s~~ell~~ 641 (696)
++.|++++
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 88888765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.78 Aligned_cols=265 Identities=20% Similarity=0.326 Sum_probs=196.4
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----cee
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRL 439 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 439 (696)
+|++.++||+|+||.||+|.. .+|+.||||+++... .....++.+|+++|++++|+||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999985 468999999987432 233456889999999999999999999886432 479
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+||||+. ++|.+++..... +++..++.++.||++||.|||++ +|+|||||++|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 678887765443 89999999999999999999999 99999999999999999999999999997543
Q ss_pred ccCc--ceeeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH-----
Q 005443 520 DANT--HITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH----- 590 (696)
Q Consensus 520 ~~~~--~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~----- 590 (696)
.... ......+|+..|+|||++.+ ..++.++|||||||++|||++|+.+|...... ...+.+...+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV---HQLDLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCCHHH
Confidence 2221 11233578999999999876 67899999999999999999999999764321 111111111000
Q ss_pred --hhhhhhhhcc---cCcccCCCc---chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 --ALENEEFDNL---ADPRLGENY---VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 --~~~~~~~~~~---~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+......++ +.......+ .......+.+++.+||+.||++||+++||+++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 000000000 00112357899999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.65 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=203.7
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++.+.||+|+||.||+|.++++..||+|++.... ...+.+.+|++++++++|+||+++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998777789999886433 34567899999999999999999999875 456789999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.++++......+++..++.++.||+.||+|||++ +|+|||||++||||++++.++|+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999998765555588999999999999999999998 999999999999999999999999999976543322222
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....++..|++||++.+..++.++|||||||++|||++ |+.||.... .....++.. .. ..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~-------~~--~~------- 221 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NREVLEQVE-------RG--YR------- 221 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH-------cC--CC-------
Confidence 22345678999999998899999999999999999999 899987532 111111110 00 00
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
..........+.+++++||+.||++||++++|++.|++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 -MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=344.59 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=202.1
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHc-cCCCceeEEeEEeeC-C
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISD-D 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-~ 436 (696)
.++|++.++||+|+||.||+|... .++.||||+++..... ..+.+.+|+++++++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999999632 2478999998754322 235678899999999 799999999988754 4
Q ss_pred ceeEEEEecCCCchhhccccCC----------------------------------------------------------
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEG---------------------------------------------------------- 458 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 458 (696)
..+++|||+.+++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999988775321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce-eeccccccccC
Q 005443 459 -RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYM 536 (696)
Q Consensus 459 -~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~-~~~~~gt~~y~ 536 (696)
...+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 12478899999999999999999999 99999999999999999999999999998754332221 22234567899
Q ss_pred chhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHH
Q 005443 537 APEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMF 615 (696)
Q Consensus 537 aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 615 (696)
|||++.+..++.++|||||||+||||++ |+.||..... ++.+.+. + ....... .......
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--~~~~~~~----~----~~~~~~~---------~~~~~~~ 303 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--DEEFCRR----L----KEGTRMR---------APEYATP 303 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc--cHHHHHH----H----hccCCCC---------CCccCCH
Confidence 9999999999999999999999999998 9999975321 1111111 1 1100000 0111223
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 616 RMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 616 ~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.+.+++.+||+.+|++||++.||+++|+++..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 68899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=349.47 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=194.3
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.|+++++||+|+||.||+|+. ++++.||||+++... ......+.+|+++|++++|+||+++++++.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999985 468899999997542 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+|+|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999998876543 78889999999999999999998 999999999999999999999999999753211000
Q ss_pred ----------------------------------------------ceeeccccccccCchhhhccCCCCccccccchHH
Q 005443 524 ----------------------------------------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGV 557 (696)
Q Consensus 524 ----------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGv 557 (696)
......+|+..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012347999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHH--hccCCCCCCCH
Q 005443 558 VLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAAC--VRHSAAKRPRM 635 (696)
Q Consensus 558 ll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~c--l~~dP~~RPs~ 635 (696)
+||||++|+.||...... ... ..++ .......+.. ... ...++.+++.+| +..+...|+++
T Consensus 237 il~elltG~~Pf~~~~~~---~~~---~~i~----~~~~~~~~~~---~~~----~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPT---ETQ---LKVI----NWENTLHIPP---QVK----LSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred HHHHHHhCCCCCcCCCHH---HHH---HHHH----ccccccCCCC---CCC----CCHHHHHHHHHHccCcccccCCCCH
Confidence 999999999999764311 100 0000 0000000000 001 122566777774 45555569999
Q ss_pred HHHHHH
Q 005443 636 GQVVRV 641 (696)
Q Consensus 636 ~ell~~ 641 (696)
.||+++
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=321.38 Aligned_cols=255 Identities=21% Similarity=0.300 Sum_probs=204.0
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
+.+.|++.++||+|.|+.||++.+ ..|+.+|+|++..+ ...+.+++.+|+.|.+.|+|+|||+|.+.+.+++..|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346788889999999999999975 47999999988643 334678899999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC---CCCcEEEEeeccchhc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKLA 518 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DfGls~~~ 518 (696)
||+|.|++|..-+-.+ ..+++..+-..++||+++|.|+|.+ +|||||+|++|+||- ..--+||+|||++...
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999996555433 3478888889999999999999999 999999999999993 3446999999999887
Q ss_pred cccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
. +...-...+|+++||+||+++...|+..+|||+.|||||-||.|..||.+... ..+.+.. +. ..+
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~I---~~-----g~y- 229 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQI---KA-----GAY- 229 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHH---hc-----ccc-
Confidence 6 33334557899999999999999999999999999999999999999986431 2222211 11 111
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
-++. ........+..+|+++||..||.+|.++.|.|++-.
T Consensus 230 -d~~~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 230 -DYPS----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred -CCCC----cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 0111 111112236788999999999999999999986544
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.17 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=201.2
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+++.. +|+.||||+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999854 789999999975422 23456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999887652 2489999999999999999999999 99999999999999999999999999997665443
Q ss_pred cceeeccccccccCchhhhc------cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 523 THITTRVMGTFGYMAPEYAS------SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
........|+..|+|||++. ...++.++|||||||+||||++|+.||..... .+....++ ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~----~~~~ 226 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIM----NFQR 226 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHH----cCCC
Confidence 33333456899999999987 45678899999999999999999999975431 11111111 1111
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.+ .......+.+++.+||+ ++++|+++++++++
T Consensus 227 ~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 001100 00112367888999998 99999999999854
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.92 Aligned_cols=267 Identities=27% Similarity=0.381 Sum_probs=202.2
Q ss_pred ccccccccccCcEEEEEEEc-----CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeE
Q 005443 369 FADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLL 440 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l 440 (696)
|++.++||+|+||+||++.+ .+++.||+|+++.... .....+.+|+++|++++|+||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988652 3678999999875433 3456788999999999999999999988764 35789
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999988653 389999999999999999999999 999999999999999999999999999976543
Q ss_pred cCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... ......++..|++||++.+..++.++|||||||++|||++|+.||....... ..+..+... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~----~~~~~~~~ 234 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQG----QMTVVRLI 234 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccc----ccchhhhh
Confidence 2221 1122235667999999998899999999999999999999999986533110 111111100 00001111
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
++.+..............+.+++.+||+.+|++||++++|++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111111112222347899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=344.01 Aligned_cols=242 Identities=26% Similarity=0.392 Sum_probs=194.4
Q ss_pred ccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCC
Q 005443 373 NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
++||+|+||.||+++. .+|+.||||+++... .....++.+|+++++.++|+||+++++++..++..+|||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999997432 223456788999999999999999999999999999999999999
Q ss_pred chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
+|.+++.... .+.+..++.++.||+.||+|||+ + +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9988886544 38999999999999999999997 6 899999999999999999999999999875332222 223
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... +.+.+. +. ...+ .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~---i~-----~~~~------~~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---IL-----MEEI------RFPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHH---Hh-----cCCC------CCCC
Confidence 35689999999999999999999999999999999999999975331 111111 00 0000 0111
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
. ....+.+++++||+.||++|+ ++.+++++
T Consensus 218 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 T----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 123688999999999999997 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.33 Aligned_cols=267 Identities=20% Similarity=0.311 Sum_probs=197.3
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999965 689999999875432 233467899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+. ++|.+++.... ..+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 995 56766665432 2378899999999999999999999 999999999999999999999999999875432221
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh----hhh-hhh
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA----LEN-EEF 597 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~----~~~-~~~ 597 (696)
......++..|+|||++.+ ..++.++|||||||+||||++|+.||...... ...++.....+... +.. ...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhc
Confidence 2233467899999999875 45888999999999999999999999864321 11111111111000 000 000
Q ss_pred hcccCcccCCCcc---h------HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 598 DNLADPRLGENYV---E------GEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 598 ~~~~d~~l~~~~~---~------~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..+....+..... . .....+.+++.+||+.||++|+++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000 0 01135778999999999999999999885
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.61 Aligned_cols=260 Identities=25% Similarity=0.450 Sum_probs=207.2
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
.++|.+.+.||+|+||.||++... ++..||||.++.......+.+.+|+++|++++|+||++++++|...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999742 34568999987655555667999999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEE
Q 005443 440 LIYDYVPNNTLYFHLHGEG-----------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (696)
+||||+.+++|.+++...+ ...+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999988886432 12489999999999999999999999 999999999999999999999
Q ss_pred EEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHH
Q 005443 509 VSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 509 L~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~--- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIEC--- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---
Confidence 9999999755332211 1122345678999999998899999999999999999998 8998865331 111111
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
. ....... .... ....+.+|+.+||+.||.+||++.||++.|+++...
T Consensus 235 ----i-~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ----I-TQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ----H-HcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1 1111100 1111 123689999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=335.57 Aligned_cols=258 Identities=25% Similarity=0.452 Sum_probs=207.1
Q ss_pred cCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
.+|.+.+.||+|+||.||+|+.. ++..|++|.++.......+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888899999999999999742 356789999876555555779999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc
Q 005443 441 IYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (696)
||||+.+++|.+++.... ...+++..+++++.||+.||+|||++ +|+|||||++|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999998886432 23478999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhH
Q 005443 507 AQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 584 (696)
Q Consensus 507 vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~ 584 (696)
+||+|||++........ .......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ...++.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH-
Confidence 99999999976543322 11223456788999999999999999999999999999998 9999875431 111111
Q ss_pred HHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 585 RPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+........ .......+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 238 -------~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 -------ITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -------HhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111110 11122368899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=336.05 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=204.4
Q ss_pred HhcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCC
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 436 (696)
..++|++.+.||+|+||.||++... ....||+|+++.... +...++.+|+++++++ +|+||++++++|..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3467889999999999999999853 236899999875422 3345688999999999 7999999999999999
Q ss_pred ceeEEEEecCCCchhhccccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC
Q 005443 437 RRLLIYDYVPNNTLYFHLHGE--------------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~ 502 (696)
..++||||+.+|+|..+++.. ....+++..+++++.||+.||+|||++ +|+|||||++|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999998888532 234588999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhH
Q 005443 503 NNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESL 580 (696)
Q Consensus 503 ~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l 580 (696)
+++.+||+|||+++........ ......++..|++||++.+..++.++|||||||++|||++ |..+|..... ..+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~ 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EEL 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HHH
Confidence 9999999999999865443221 1122234568999999998899999999999999999997 8888865321 111
Q ss_pred HHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 581 VEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.+. +. ... ...........+.+|+.+||+.+|++||++.||++.|+++.
T Consensus 244 ~~~----~~---~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKL----LK---EGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH----HH---cCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 10 000 00111122346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.20 Aligned_cols=250 Identities=29% Similarity=0.459 Sum_probs=206.0
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++.++||+|+||.||+|.. .|+.||||.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4688899999999999999987 589999999976543 46789999999999999999999999999899999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++.......+.+..++.++.||+.||.|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 99999999776655689999999999999999999999 999999999999999999999999999986633221
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
...+...|++||++..+.++.++|||||||++|||++ |+.+|.... ...+.+.. .. ...
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~----~~----~~~-------- 217 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPHV----EK----GYR-------- 217 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH----hc----CCC--------
Confidence 2234668999999998889999999999999999997 999986532 11111111 10 000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
..........+.+++++||+.+|++||++.||+++|+.+
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 000111224688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=341.56 Aligned_cols=244 Identities=28% Similarity=0.434 Sum_probs=192.2
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHH---HHccCCCceeEEeEEeeCCceeEE
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEII---SRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
|++.++||+|+||.||+|.+. +|+.||||+++... ....+.+.+|++++ ++++|+||+++++++...+..+||
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999854 68999999997432 22334566776665 456799999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|..+++.. .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999998887643 489999999999999999999999 9999999999999999999999999998754322
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.. .....+|+..|||||++.+..++.++|||||||+||||++|+.||..... ..+ ...+.. ...
T Consensus 155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~---~~~i~~-----~~~---- 218 (324)
T cd05589 155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEV---FDSIVN-----DEV---- 218 (324)
T ss_pred CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHH---HHHHHh-----CCC----
Confidence 22 22345689999999999999999999999999999999999999975431 111 111111 000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVR 640 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~ 640 (696)
.+... ....+.+++++||+.||.+|++ +.++++
T Consensus 219 --~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 --RYPRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01111 1236788999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.69 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=209.6
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc---cHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCcee
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 439 (696)
..+.|++.+.||+|.||.||++..+ +|+.||+|++...... ..+.+.+|+++|++|. |+|||.++++|++.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4467888999999999999999965 4999999999755433 3468999999999998 999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC----CCcEEEEeeccc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN----NFEAQVSDFGLA 515 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~----~~~vkL~DfGls 515 (696)
+|||++.||.|++.+... .+++..+..++.||+.+++|||+. ||||||||++|||+.. ++.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999988766 289999999999999999999998 9999999999999953 357999999999
Q ss_pred hhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
..... .......+|+..|+|||++....|+..+||||+||++|.|++|..||.+...... +.+ +. ..
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--~~~----i~-----~~ 253 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--FLA----IL-----RG 253 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--HHH----HH-----cC
Confidence 87765 3345567899999999999999999999999999999999999999987553211 111 11 11
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
++ ++ ...........+.+++++|+..|+.+|.++.++|++
T Consensus 254 ~~-~f-----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 DF-DF-----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC-CC-----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 11 112222234478899999999999999999999986
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=358.51 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=202.0
Q ss_pred CccccccccccCcEEEEEEEcC-C-CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-D-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.|.+.++||+|+||.||+|... + ++.||+|++..........+++|+.+|+.++|+||++++++|..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999843 3 6788999876555454567888999999999999999999999999999999999
Q ss_pred CCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 446 PNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 446 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
.+|+|.++++.. ....+++..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999998877532 233478899999999999999999999 999999999999999999999999999986544322
Q ss_pred -ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 524 -HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 524 -~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
......+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+....++. .....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~-----~~~~~--- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLY-----GKYDP--- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-----CCCCC---
Confidence 123345689999999999999999999999999999999999999975321 111111111 00000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.......+.+++.+||+.||++||++.++++.
T Consensus 291 ------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 ------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 011112368899999999999999999999753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.17 Aligned_cols=252 Identities=29% Similarity=0.383 Sum_probs=200.2
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.|++.++||+|+||.||++... +++.||||++..... .....+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999854 689999999864322 223457889999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+|+|.+++.......+++..++.++.||+.||+|||++ +|+|||||++|||+++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999998888655445589999999999999999999999 999999999999999999999999999876533221
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.....|+..|++||++.+..++.++|||||||++|||++|+.||...... ...+.....+. ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~~~~~~~----~~-------- 220 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREEVERRVK----ED-------- 220 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHHHHHHhh----hc--------
Confidence 22346889999999999889999999999999999999999999864321 11111111000 00
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
...+.......+.+|+.+||+.||++|+ ++++|+++
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0011112233678999999999999999 67777643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.15 Aligned_cols=254 Identities=24% Similarity=0.423 Sum_probs=205.7
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|++.+.||+|+||.||++.+.++..|++|.++.. ....+.+.+|++++++++|+||+++++++.. +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4679999999999999999999878888999988643 2235678999999999999999999999887 7789999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.......+++..++.++.||+.||+|||++ +++||||+++||+++.++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999998765555688999999999999999999998 99999999999999999999999999997654433222
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|++||++....++.++|||||||++|||++ |+.||.... ...+.++.. ... ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~--------~~~----~~-- 222 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALE--------RGY----RM-- 222 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHh--------CCC----CC--
Confidence 223345678999999998889999999999999999998 899987532 112221111 100 00
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
.........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 223 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011222368899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.16 Aligned_cols=271 Identities=24% Similarity=0.359 Sum_probs=201.8
Q ss_pred cCccccccccccCcEEEEEEEc-----CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeC--Ccee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 439 (696)
++|++.++||+|+||.||++.+ .+++.||||+++.......+.+.+|++++++++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999974 25789999998766555567899999999999999999999987643 4578
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+||||+.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986543 2489999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCccee--eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 520 DANTHIT--TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 520 ~~~~~~~--~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
....... ....+...|++||++.+..++.++|||||||++|||++|..++..... .+.+..............+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA----EFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch----hhhhhcccccccccchHHH
Confidence 3322211 112234569999999988999999999999999999998776543211 0000000000000000000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.++++..............+.+|+.+||+.+|++||++.||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000110000011112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=326.57 Aligned_cols=259 Identities=20% Similarity=0.370 Sum_probs=205.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+|+.. +++.||||.++... ......+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999854 78999999886432 223356889999999999999999999999999999999
Q ss_pred EecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 443 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||+.+++|.+++.. .....+++..++.++.||+.||+|||++ +|+|||||++||||+.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999887753 2234478899999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
... ......|+..|+|||++.+..++.++|||+|||++|||++|+.||..... ...++...+ .......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-----~~~~~~~- 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-----EQCDYPP- 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-----hcCCCCC-
Confidence 221 12234578899999999988899999999999999999999999864321 111111110 1101100
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 228 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 -------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 011122346889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.90 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=204.7
Q ss_pred cCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 438 (696)
++|.+.++||+|+||.||++.. ..+..||||+++.... ...+.+.+|+++++++ +|+||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5689999999999999999973 1355899999875432 2345689999999999 799999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+.+|+|.++++......+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999998765544589999999999999999999999 9999999999999999999999999999765
Q ss_pred cccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 519 LDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 519 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
...... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...+.+. +...
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~~~----~~~~----- 260 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFYKL----IKEG----- 260 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHHHH----HHcC-----
Confidence 433221 1222345678999999999999999999999999999998 9999875331 1111111 1100
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
+ ...........+.+++.+||+.+|++||++.||++.|+++
T Consensus 261 ~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 Y--------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C--------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 0000111123688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=341.80 Aligned_cols=238 Identities=28% Similarity=0.382 Sum_probs=192.3
Q ss_pred ccccccCcEEEEEEEc----CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 373 NLLGEGGFGSVYKGYL----PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++||+|+||.||+++. .+|+.||||+++.... .....+.+|+++|++++|+||+++++++.+++..+|||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 3688999999975322 234567889999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+|+|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 999998886544 389999999999999999999999 999999999999999999999999999976543322 23
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccC
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~ 606 (696)
....|+..|+|||++.+..++.++|||||||+||||++|+.||..... .... ..+.. ..+ .+
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~---~~i~~-----~~~------~~- 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETM---TMILK-----AKL------GM- 217 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHH---HHHHc-----CCC------CC-
Confidence 345789999999999988899999999999999999999999975321 1111 11110 000 01
Q ss_pred CCcchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 005443 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQ 637 (696)
Q Consensus 607 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 637 (696)
.......+.+++++||+.||++|+++.+
T Consensus 218 ---p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 ---PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111236788999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=349.18 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=195.4
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++++.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++|++++|+||++++++|.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999985 468999999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999987654 378889999999999999999999 99999999999999999999999999974321000
Q ss_pred ------------------------------------------cceeeccccccccCchhhhccCCCCccccccchHHHHH
Q 005443 523 ------------------------------------------THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLL 560 (696)
Q Consensus 523 ------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ 560 (696)
.......+|+..|||||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011246899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCC---CHHH
Q 005443 561 ELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP---RMGQ 637 (696)
Q Consensus 561 eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~e 637 (696)
||++|+.||...... +....+.. +. ..+ .+ . ... .....+.+++.+|+ .++.+|+ ++.|
T Consensus 236 ell~G~~Pf~~~~~~------~~~~~i~~--~~-~~~-~~--~-~~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 236 EMLVGQPPFLADTPA------ETQLKVIN--WE-TTL-HI--P-SQA----KLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred ehhhCCCCCCCCCHH------HHHHHHhc--cC-ccc-cC--C-CCC----CCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 999999999764321 11111100 00 000 00 0 001 11225667777876 5999999 8888
Q ss_pred HHHH
Q 005443 638 VVRV 641 (696)
Q Consensus 638 ll~~ 641 (696)
++++
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=338.94 Aligned_cols=243 Identities=22% Similarity=0.360 Sum_probs=191.3
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+++ +++.||||+++... ....+.+.+|+.+++++ +|+||++++++|.+.+..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 68899999997532 22335678899999998 699999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-ccc
Confidence 99988886554 389999999999999999999999 999999999999999999999999999874322221 223
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCC--chhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG--DESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
..+|+..|+|||++.+..++.++|||||||++|||++|+.||+...... .....++....+. .... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~~------~~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL----EKQI------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH----cCCC------CC
Confidence 3578999999999999999999999999999999999999997533211 1111222211111 1000 01
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
.. .....+.+++++||+.||.+|+++
T Consensus 225 p~----~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 225 PR----SLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CC----CCCHHHHHHHHHHhccCHHHcCCC
Confidence 11 112368899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.73 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=200.4
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC-----ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-----QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|++.++||+|+||.||+|.. ++++.|+||.+..... ...+.+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999985 4689999999864422 123468899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|+||+.+++|.+++.... .+.+..+++++.||+.||.|||+. +|+||||+++||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999998887544 378899999999999999999999 999999999999999999999999999875433
Q ss_pred cCccee--eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTHIT--TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~~~--~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
...... ....++..|+|||++.+..++.++|||||||++|||++|+.||...... . . ..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~--~-~~~~~----~~~--- 223 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---A--A-IFKIA----TQP--- 223 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---H--H-HHHHh----ccC---
Confidence 221111 2345778999999999988999999999999999999999999753211 0 0 00000 000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....+.......+.+++++||+.+|++||++.+|+++
T Consensus 224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011111223368899999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.38 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=201.5
Q ss_pred cCccccccccccCcEEEEEEEc-----CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|++.++||+|+||.||+|.+ .+++.|+||.++.... ....++.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999973 3567899999874332 233578899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC
Q 005443 441 IYDYVPNNTLYFHLHGEG---------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~ 505 (696)
||||+.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999988875321 23478889999999999999999999 999999999999999999
Q ss_pred cEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHh
Q 005443 506 EAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEW 583 (696)
Q Consensus 506 ~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~ 583 (696)
.+||+|||+++....... .......++..|++||++.+..++.++|||||||+||||++ |..||.... ...+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence 999999999976543321 11222345678999999998889999999999999999998 988886532 1122221
Q ss_pred HHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 584 ARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
.. ...... ........+.+++.+||+.||++||++.+|+++|+.
T Consensus 239 ~~--------~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR--------KRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH--------cCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 000000 011122368889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=338.83 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=192.8
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCC-CceeEEeEEeeCCceeEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHR-HLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~ 442 (696)
+|++++.||+|+||.||+|+.+ +++.||||+++... ....+.+..|++++..++|. +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999864 57899999997432 23345678899999999764 6888999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++..... +.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999988876543 78999999999999999999999 99999999999999999999999999986432222
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...+.+. +. . ..
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~---i~----~-~~------ 217 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQS---IM----E-HN------ 217 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHH---HH----c-CC------
Confidence 1 2233568999999999999999999999999999999999999997543 1111111 10 0 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
.. +.......+.+++++||+.||.+|++.
T Consensus 218 ~~----~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VS----YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 111122367899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.25 Aligned_cols=241 Identities=27% Similarity=0.449 Sum_probs=189.9
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|++. +++.||||+++... ....+.+..|..++..+ +|+||+++++++..++..++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57899999997532 22334556677777654 799999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.+++..... +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 999988876543 88999999999999999999998 99999999999999999999999999997543322 2233
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||...+ ...+.+ .+. .. ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~---~i~-----~~------~~~~-- 215 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFD---SIL-----ND------RPHF-- 215 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHH---HHH-----cC------CCCC--
Confidence 4568999999999999899999999999999999999999997543 111111 110 00 0001
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMG-QVVR 640 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~ 640 (696)
.......+.+++.+||+.||++|+++. ++++
T Consensus 216 --~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 --PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111123578899999999999999875 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=338.31 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=193.0
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+.+ +|+.||||+++... ....+.+..|++++..+ +|+||+++++++...+..+|||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 57899999997532 23345577899999876 799999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
++|..++..... +.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 999888865543 88999999999999999999999 999999999999999999999999999875432222 223
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
...|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+. +. ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~---i~----~~~----~~~----- 215 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFES---IL----HDD----VLY----- 215 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHH---HH----cCC----CCC-----
Confidence 4568999999999999999999999999999999999999997543 1111111 11 100 000
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCC-------CHHHHHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRP-------RMGQVVRV 641 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~ell~~ 641 (696)
.......+.+++++||+.||++|+ ++.+++++
T Consensus 216 --p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 --PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 011123688999999999999999 66777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=337.27 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=190.5
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++.++ +|+||+++++++...+..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 67899999997532 23345677899988877 799999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|..++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 99988876554 389999999999999999999999 999999999999999999999999999875332221 123
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCc--hhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD--ESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
...|+..|+|||++.+..++.++|||||||++|||++|+.||........ ....++....+. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~----~~~~-------- 222 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----EKQI-------- 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh----cCCC--------
Confidence 35689999999999999999999999999999999999999964322111 111111111110 0000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
.+.......+.+++++||+.||++|+++
T Consensus 223 --~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 --RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0111122367899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.97 Aligned_cols=200 Identities=27% Similarity=0.363 Sum_probs=172.0
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
+|+++++||+|+||.||+|+. .+++.||||++.... ......+.+|+++|++++|+||++++++|.+++..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999985 468899999987432 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC-
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN- 522 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~- 522 (696)
|+.+|+|.+++...+ .+.+..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999887654 378889999999999999999999 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------cceeeccccccccCchhhhccCCCCccccccchHH
Q 005443 523 ---------------------------------------------THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGV 557 (696)
Q Consensus 523 ---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGv 557 (696)
.......+|+..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 005443 558 VLLELITGRKPVDAS 572 (696)
Q Consensus 558 ll~eLltg~~Pf~~~ 572 (696)
+||||++|+.||...
T Consensus 237 il~elltG~~Pf~~~ 251 (382)
T cd05625 237 ILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.82 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=202.6
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCcc-HHHHHHHHHHHHHcc-CCCceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQG-EREFKAEVEIISRIH-HRHLVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 437 (696)
.++|.++++||+|+||.||+|++. .++.||||+++...... .+.+.+|+++|.++. |+||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345778899999999999999853 34689999997543322 346889999999998 9999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCC----------------------------------------------------------
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGR---------------------------------------------------------- 459 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 459 (696)
.+|||||+.+|+|.++++..+.
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999988864321
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 460 --------------------------------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 460 --------------------------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
..+++..+++|+.||+.||+|||+. +|+|||||++|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 2356778889999999999999998 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchh
Q 005443 502 DNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~ 579 (696)
++++.+||+|||+++....... ......+++..|++||++.+..++.++|||+|||+||||++ |+.||..... .+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--~~~ 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--NEQ 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--hHH
Confidence 9999999999999976432221 11223456788999999998889999999999999999998 8888865321 111
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
+ ...+.... . . .........+.+|+.+||+.+|.+||+++||++.|+++.
T Consensus 351 ~----~~~~~~~~---~---~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 F----YNAIKRGY---R---M-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H----HHHHHcCC---C---C-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 11111000 0 0 011112236889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.42 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=197.6
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCchh
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLY 451 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 451 (696)
++||+|+||.||+|.+.+++.||+|+++.... .....+.+|++++++++|+||++++++|...+..++||||+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988899999999875432 22346889999999999999999999999999999999999999999
Q ss_pred hccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeecccc
Q 005443 452 FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531 (696)
Q Consensus 452 ~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~g 531 (696)
+++.... ..+++..+++++.||+.+|.|||++ +++|||||++||++++++.+||+|||+++..............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 8886543 2478999999999999999999998 99999999999999999999999999987543332222222234
Q ss_pred ccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcc
Q 005443 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610 (696)
Q Consensus 532 t~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (696)
...|++||++.++.++.++|||||||++|||++ |..||..... ...... + .... . ....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~~----~----~~~~-----~----~~~~ 216 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAREQ----V----EKGY-----R----MSCP 216 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHH----H----HcCC-----C----CCCC
Confidence 567999999998899999999999999999998 9999865321 111110 0 0000 0 0011
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 611 EGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 611 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
......+.+++.+||+.+|++||++.||++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 112347889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.83 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=201.8
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|++.+.||+|+||.||+|+. .+|+.||||+++.........+++|+.++++++|+||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5789999999999999999995 478899999998665555667889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.++++..+ .+++..++.++.||+.||+|||++ +|+||||+++||++++++.+||+|||+++....... .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999887544 378999999999999999999998 999999999999999999999999999976533221 1
Q ss_pred eeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 526 TTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.....|+..|++||++. ...++.++|||||||++|||++|+.||........ ...+ .... +..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~---------~~~~---~~~ 228 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLM---------SKSN---FQP 228 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heee---------ecCC---CCC
Confidence 22345788999999884 34578899999999999999999999864321110 0000 0000 000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
..+.. .......+.+++++||+.+|++||++++|++.|
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11100 011223688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=327.97 Aligned_cols=246 Identities=26% Similarity=0.344 Sum_probs=194.6
Q ss_pred ccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
||+|+||.||+++.+ +|+.||+|++..... .....+..|++++++++|+||+++++++..++..++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999854 689999999864321 2234566799999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccc
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~ 530 (696)
.+++.......+++..++.++.||+.||+|||++ +|+|||||++|||+++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 8888766555689999999999999999999999 99999999999999999999999999987654322 223346
Q ss_pred cccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcc
Q 005443 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610 (696)
Q Consensus 531 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (696)
|+..|+|||++.+..++.++|||||||+||||++|+.||....... ...+.....+. ..+ ... ...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~-----~~~----~~~-~~~-- 221 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE-----DEV----KFE-HQN-- 221 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc-----ccc----ccc-ccc--
Confidence 8899999999999889999999999999999999999997543211 11111111111 000 000 001
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 611 EGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 611 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...++.+++.+||+.||++|++++|+++.
T Consensus 222 --~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 --FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred --CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 12257899999999999999999887644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.58 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=200.1
Q ss_pred hcCccccccccccCcEEEEEEEcCC------CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|.+.+.||+|+||.||+|.+.+ +..|++|.+..... ..+..|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3678899999999999999998643 56789998864432 2345689999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC---cEEEE
Q 005443 439 LLIYDYVPNNTLYFHLHGEGR-----PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EAQVS 510 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~ 510 (696)
++||||+.+++|.++++.... ..+++..+++++.||+.||+|||++ +|+|||||++|||+++++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999998865431 2488999999999999999999999 999999999999998654 59999
Q ss_pred eeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHH
Q 005443 511 DFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 511 DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
|||+++......... .....++..|++||++.+..++.++|||||||++|||++ |+.||..... ..+.+. +
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~----~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEF----V 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----H
Confidence 999998653322111 112234568999999999999999999999999999997 9999875331 111111 1
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
. .... ..........+.+++.+||+.+|++||++.+|+++|+
T Consensus 235 ~---~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 T---GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H---cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0000 0011112236889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.59 Aligned_cols=257 Identities=23% Similarity=0.413 Sum_probs=201.2
Q ss_pred HhcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
..++|++.+.||+|+||.||+|.+. .+..||||+++.... ....++.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999998742 356899999864322 234568899999999999999999999999899
Q ss_pred eeEEEEecCCCchhhccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEE
Q 005443 438 RLLIYDYVPNNTLYFHLHGEG--------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV 509 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL 509 (696)
.++||||+.+++|.++++... ...+++..+++++.||++||+|||+. +|+|||||++||||++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999998886432 12357888999999999999999998 9999999999999999999999
Q ss_pred EeeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHH
Q 005443 510 SDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPL 587 (696)
Q Consensus 510 ~DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~ 587 (696)
+|||+++......... .....++..|+|||++.++.++.++|||||||+||||++ |..+|.... .+...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~~~~~~--- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQVLRFV--- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH---
Confidence 9999987553322211 112345678999999998899999999999999999999 788886532 11111110
Q ss_pred HHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
....+..+ .......+.+++.+||+.+|++||++.|+++.|++
T Consensus 235 -----~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -----MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -----HcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 01111110 11122368899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=337.99 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=195.6
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++++.||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.++..++|+||++++++|.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999954 6899999999742 1223456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+ ..+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999886532 2488999999999999999999999 99999999999999999999999999987654433
Q ss_pred cceeeccccccccCchhhhcc-----CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 523 THITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
.......+|+..|||||++.. ..++.++|||||||+||||++|+.||.... ..+....++. ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~----~~~~ 226 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMN----HKEH 226 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHc----CCCc
Confidence 322233468999999999863 457889999999999999999999997532 1121111111 1110
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCC--CCCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAA--KRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~ell~~ 641 (696)
..+... ... ....+.+++++||..+.+ .|+++++++++
T Consensus 227 ~~~~~~--~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQFPPD--VTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccCCCc--cCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111000 001 122567788887765443 37788888865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.18 Aligned_cols=248 Identities=20% Similarity=0.279 Sum_probs=206.9
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.-|...+.||+|.|++|-+|++ -.|..||||++...... ....+.+|++.|+.++|+|||+||.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4466678899999999999984 47999999999754332 33568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC-CCCcEEEEeeccchhccccC
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DfGls~~~~~~~ 522 (696)
+-++|+|+++|.+.+. .+.+..+.++++||+.||.|+|+. .+||||||++||++. .-|.|||.|||++..+....
T Consensus 98 LGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999976543 389999999999999999999998 899999999999885 55789999999997654432
Q ss_pred cceeeccccccccCchhhhccCCCCc-cccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTE-KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~-~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.....+|.+.|.|||+|.+..|+. ++||||||||||.|++|+.||...+.. +.+..++
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------------------ETLTmIm 232 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------------------ETLTMIM 232 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-------------------hhhhhhh
Confidence 234468999999999999999975 889999999999999999999876532 2333444
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
|-++ ........++.+||..||..||++|-+.+||+..
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 4332 2344455678999999999999999999998854
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=331.00 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=202.8
Q ss_pred CccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
+|++.++||+|+||.||+|... ....|++|.+..... ....++.+|+.+++.++|+||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999852 235788988864432 234578899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCc
Q 005443 441 IYDYVPNNTLYFHLHGE----------------------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSN 498 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~N 498 (696)
||||+.+++|.+++... ....+++..++.++.||+.||+|||++ +|+|||||++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999998876532 113478899999999999999999998 99999999999
Q ss_pred eEECCCCcEEEEeeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCC
Q 005443 499 ILLDNNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLG 576 (696)
Q Consensus 499 ILl~~~~~vkL~DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~ 576 (696)
|||++++.+||+|||+++......... .....++..|++||++.+..++.++|||||||++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999997654332211 122345678999999998899999999999999999998 999986532
Q ss_pred chhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 577 DESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.+.+.++.. +.. ...........+.+++.+||+.+|++||+++||++.|+++..
T Consensus 235 ~~~~~~~~~----~~~-------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 PERLFNLLK----TGY-------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHh----CCC-------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 122222111 000 000111122368899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.11 Aligned_cols=241 Identities=25% Similarity=0.378 Sum_probs=192.7
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+|++.++||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +|++|+++++++...+..+|||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999864 57899999997532 22234567788888877 4889999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999888866543 88999999999999999999999 99999999999999999999999999987533222
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...+.+. +.. ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~---i~~-----~~~----- 218 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQS---IME-----HNV----- 218 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHH---HHh-----CCC-----
Confidence 1 2234568999999999999999999999999999999999999997543 1111111 110 000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
. +.......+.+++++||+.+|.+|++.
T Consensus 219 -~----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -A----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -C----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 111122367899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.47 Aligned_cols=259 Identities=28% Similarity=0.402 Sum_probs=203.8
Q ss_pred cCccccccccccCcEEEEEEEcC--------CCcEEEEEEeecCC-CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 436 (696)
++|.+.+.||+|+||.||+++.. ++..||+|+++... .....++.+|+++++++ +|+||++++++|..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57899999999999999999742 23579999997542 23345688999999999 7999999999999999
Q ss_pred ceeEEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~ 502 (696)
..++||||+.+|+|.+++.... ...+.+..+++++.||+.||+|||++ +|+|||||++|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 9999999999999998886532 12478899999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhH
Q 005443 503 NNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESL 580 (696)
Q Consensus 503 ~~~~vkL~DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l 580 (696)
+++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.+|.... .+.+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---~~~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEEL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHH
Confidence 99999999999987654322111 111234568999999999899999999999999999998 888886432 1111
Q ss_pred HHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 581 VEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.+. +.. .. ...........+.+++.+||..+|++||+|.+|++.|+++...
T Consensus 252 ~~~----~~~----~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 FKL----LKE----GH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHH----HHc----CC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111 110 00 0011112234788899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=323.16 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=204.4
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.+.||+|+||.||+|..+ +|+.|++|.+.... ....+++.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999864 68999999987542 34456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.++++......+++..+++++.||+.||.|||++ +|+||||+++||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999998875445689999999999999999999998 999999999999999999999999999876543322
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.... .....+. .. ...+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~---~~-----~~~~~------ 219 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILK---II-----RGVFP------ 219 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHH---HH-----cCCCC------
Confidence 1223467889999999999889999999999999999999999997543 1111111 10 01111
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.........+.+++.+||+.+|++||++.+|++.
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111223468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.64 Aligned_cols=259 Identities=22% Similarity=0.393 Sum_probs=207.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999975 78999999886432 223567899999999999999999999999999999999
Q ss_pred EecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 443 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||+.+++|..++.. ..+..+.+..+++++.||+.||.|||+. +|+||||+++||++++++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999888754 2234578999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
... ......++..|++||++.+..++.++|||+|||++|||++|+.||.... ..+.+....+ ....+..+
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-----~~~~~~~~ 228 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKI-----EKCDYPPL 228 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhh-----hcCCCCCC
Confidence 222 1223457889999999998889999999999999999999999986432 1111111111 01111000
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 229 --------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 --------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01122346889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.44 Aligned_cols=260 Identities=20% Similarity=0.246 Sum_probs=200.0
Q ss_pred HHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeC
Q 005443 360 EELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (696)
Q Consensus 360 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 435 (696)
.++....++|++.+.||+|+||.||+++.+ +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344444588999999999999999999865 68899999986422 22334578899999999999999999999999
Q ss_pred CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
+..++||||+.+|+|.+++... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999888643 278888999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCcceeeccccccccCchhhhccC----CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSG----KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
+.............+|+..|||||++.+. .++.++|||||||+||||++|+.||..... ......++
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~--- 260 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM--- 260 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHH---
Confidence 86644333233345799999999998753 378899999999999999999999975431 11111111
Q ss_pred hhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHHH
Q 005443 592 LENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAK--RPRMGQVVRVF 642 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L 642 (696)
.......+.+ .......+.+++.+||+.+..+ |+++.||+++.
T Consensus 261 -~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 -NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1110001111 0112235778889999844433 67888888653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.32 Aligned_cols=238 Identities=28% Similarity=0.413 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+.+ +++.||||+++... ....+.+.+|+.++..+ +|+||+++++++...+..+|||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68899999987432 23345677888888877 699999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.+++..... +++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (320)
T cd05590 81 GDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS 154 (320)
T ss_pred chHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence 999988876543 88999999999999999999999 999999999999999999999999999875432222 223
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...+ ...+.+ .+. . .. .. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~---~i~----~-~~---~~---~-- 215 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFE---AIL----N-DE---VV---Y-- 215 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHH---HHh----c-CC---CC---C--
Confidence 3568999999999999999999999999999999999999997543 111111 111 0 00 00 0
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMGQ 637 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 637 (696)
......++.+++++||+.||++|+++.+
T Consensus 216 --~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 216 --PTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred --CCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 1111236789999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=328.95 Aligned_cols=256 Identities=28% Similarity=0.470 Sum_probs=199.1
Q ss_pred cCccccccccccCcEEEEEEEcC-CCc----EEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|++.++||+|+||.||+|.+. +|+ .|++|++..... ....++.+|+.++++++|+||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999853 444 477787754332 22356888888999999999999999875 455788
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|+||+.+|+|.++++.... .+++..+++|+.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999875433 489999999999999999999998 999999999999999999999999999976543
Q ss_pred cCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... ......++..|++||++.++.++.++|||||||++|||++ |+.||..... ..+.+. + ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~----~----~~~~-- 228 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDL----L----EKGE-- 228 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----H----HCCC--
Confidence 3221 1223456778999999998999999999999999999998 9999875321 111111 1 1111
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
....... ....+.+++.+||..||++||++.||++.|..+..
T Consensus 229 ~~~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 RLAQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred cCCCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111111 12357888999999999999999999999888664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=325.48 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=199.0
Q ss_pred ccccccccccCcEEEEEEEcCC----CcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc-----
Q 005443 369 FADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR----- 437 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 437 (696)
|.++++||+|+||.||+|.+.. +..||||+++.... .....+.+|+++++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998642 36899999875432 234578999999999999999999998876554
Q ss_pred -eeEEEEecCCCchhhccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEee
Q 005443 438 -RLLIYDYVPNNTLYFHLHGE----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (696)
Q Consensus 438 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~Df 512 (696)
.++||||+.+++|..++... ....+++..++.++.||+.||+|||++ +|+|||||++||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 68999999999998777432 233588999999999999999999998 9999999999999999999999999
Q ss_pred ccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 513 GLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 513 Gls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
|+++......... .....++..|++||++.+..++.++|||||||++|||++ |..+|.... ...+.++..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~----- 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLR----- 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH-----
Confidence 9998654333221 111234668999999988899999999999999999999 888886532 111111111
Q ss_pred hhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 591 ALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.. .... ........+.+++.+||+.||++||++.||++.|+++
T Consensus 230 --~~-~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 --HG-NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --cC-CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0000 1112234789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=324.70 Aligned_cols=259 Identities=21% Similarity=0.351 Sum_probs=206.7
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.+.||+|+||.||+|.. .+|+.|+||.+..... ....++.+|+.+++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 4789999998864322 23457889999999999999999999999999999999
Q ss_pred EecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 443 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||+.+++|.+++.. .....+.+..+++++.||+.||.|||++ +|+|+|||++||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999888763 2234588999999999999999999999 999999999999999999999999999876543
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
... ......++..|+|||++.+..++.++||||||+++|||++|..||..... ...+....+. ..
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~----------~~ 223 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE----------QC 223 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhh----------cC
Confidence 322 12234688899999999988899999999999999999999999964321 1111111110 00
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
....+ ........+.+++.+||+.+|.+||+|.+|++.++++.
T Consensus 224 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 DYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00101 01122336889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=323.29 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=200.8
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee-CCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~ 445 (696)
++|++.++||+|+||.||++.. .|+.|++|.++.. ...+.+.+|+.++++++|+||+++++++.. ++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688899999999999999987 5888999998643 335678999999999999999999997654 45689999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.++++......+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999998766555688999999999999999999998 99999999999999999999999999987543322
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
....++..|++||++.+..++.++|||+|||++|||++ |+.||.... ...+.... . .....
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~----~----~~~~~------ 218 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV----E----KGYKM------ 218 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----h----cCCCC------
Confidence 12234568999999998889999999999999999997 999886432 11111111 0 00000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01111233688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=321.58 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=213.0
Q ss_pred CHHHHHHHhcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCcc-HHHHHHHHHHHHHccCCCceeEEe
Q 005443 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVG 430 (696)
Q Consensus 358 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~ 430 (696)
...++...++++....++.+|.||+||+|.+. +.+.|.||.++....+. ...++.|..++..+.|+|+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34556666788888899999999999999643 45678889887654443 356889999999999999999999
Q ss_pred EEeeCC-ceeEEEEecCCCchhhcccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC
Q 005443 431 YCISDD-RRLLIYDYVPNNTLYFHLHG------EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN 503 (696)
Q Consensus 431 ~~~~~~-~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~ 503 (696)
++.++. .-+++|.++..|+|..||.. ...+.+...++..++.||+.||+|||++ +|||.||..+|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 998765 55888999999999988872 2334577788889999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccchhccccCccee-eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHH
Q 005443 504 NFEAQVSDFGLAKLALDANTHIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLV 581 (696)
Q Consensus 504 ~~~vkL~DfGls~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~ 581 (696)
..+|||+|-.++|.....++... .+......||++|.+.+..|+.++|||||||+||||++ |+.|+.+.+..+ +.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m~ 508 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---ME 508 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---HH
Confidence 99999999999998876666543 33456779999999999999999999999999999999 999987644321 11
Q ss_pred HhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 582 EWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.+ +....+.....++..+|..++.-||..+|++||++++++..|.+..
T Consensus 509 ~y-----------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 509 HY-----------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HH-----------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11 1111111222333447889999999999999999999999988765
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=336.99 Aligned_cols=237 Identities=29% Similarity=0.423 Sum_probs=188.0
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHH-HHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVE-IISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+.. +|+.||||++.... ....+++.+|.. +++.++|+||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999997432 222344555554 56789999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 99998887654 388899999999999999999999 99999999999999999999999999987543222 2233
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
...|+..|+|||++.+..++.++|||||||+||||++|+.||.... ..+....++.. .. .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~-----~~------~~~~ 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNK-----PL------RLKP 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcC-----CC------CCCC
Confidence 4568999999999999999999999999999999999999997532 11111111110 00 0111
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMG 636 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 636 (696)
.. ...+.+++++||+.|+++|+++.
T Consensus 218 ~~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NI----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 23688999999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=329.71 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=205.7
Q ss_pred hcCccccccccccCcEEEEEEEcCC-----CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEee-CCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD-----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 438 (696)
.++|++.++||+|+||.||+|.+.+ ++.|++|+++.... ...+.+.+|+.+|++++|+||+++++++.. .+..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4679999999999999999999755 68899998874432 334568899999999999999999998876 4678
Q ss_pred eEEEEecCCCchhhccccCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEee
Q 005443 439 LLIYDYVPNNTLYFHLHGEGR------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~Df 512 (696)
++++||+.+++|.+++..... ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999988865322 3588999999999999999999998 9999999999999999999999999
Q ss_pred ccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 513 GLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 513 Gls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
|+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...+. ..+..+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~----- 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK----- 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH-----
Confidence 9998654332221 122345678999999998889999999999999999998 9999975331 12211111
Q ss_pred hhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 591 ALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
... .+. ... .....+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 234 ---~~~--~~~---~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 ---DGY--RLA---QPI----NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---cCC--CCC---CCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 100 000 001 112368899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.56 Aligned_cols=247 Identities=25% Similarity=0.409 Sum_probs=194.9
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
+.||+|+||.||+|.+. +|+.||+|.++.... .....+.+|++++++++|+||++++++|...+..++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 789999998764332 3346799999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee-ecc
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT-TRV 529 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~-~~~ 529 (696)
.+++...+ ..+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...+...... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99886543 2478999999999999999999999 999999999999999999999999999876443211111 111
Q ss_pred ccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCC
Q 005443 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608 (696)
Q Consensus 530 ~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (696)
.++..|+|||.+.++.++.++|||||||++|||++ |..+|..... ... ...+.. . ....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~----~~~~~~----~---------~~~~ 216 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQT----REAIEQ----G---------VRLP 216 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHH----HHHHHc----C---------CCCC
Confidence 23457999999999899999999999999999998 8888864321 111 111100 0 0001
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 609 YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 609 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
........+.+++++||+.+|++||++.+|++.|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11112336889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.41 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=197.8
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----cee
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRL 439 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 439 (696)
+|+++++||+|+||.||++.. .+|+.||||++.... ....+++.+|+++|+.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999985 478999999986432 223467889999999999999999999998766 789
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+||||+. ++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 56776665443 389999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH--------H
Q 005443 520 DANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS--------H 590 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~--------~ 590 (696)
...........++..|+|||++.+ ..++.++|||||||++|||++|+.+|....... .++.....+. .
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHH
Confidence 333333334567889999999887 457899999999999999999999998654321 1111111000 0
Q ss_pred hh---hhhhhhcccCc-ccC--CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 AL---ENEEFDNLADP-RLG--ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 ~~---~~~~~~~~~d~-~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. ........... .+. ..........+.+|+.+||+.||++|+++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 00000000000 000 00111123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=337.58 Aligned_cols=241 Identities=26% Similarity=0.376 Sum_probs=188.6
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHH-HHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEV-EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+.+ +++.||||++.... .....++.+|. .+++.++|+||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 67889999997432 12233444444 456788999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
++|.+++..... +.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 81 GELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 999988876543 77888889999999999999999 999999999999999999999999999875432222 223
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+. ..+... .. .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~---~~i~~~-----~~------~~~~ 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMY---DNILNK-----PL------QLKP 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHH---HHHHhC-----Cc------CCCC
Confidence 45689999999999999999999999999999999999999975331 1111 111110 00 0111
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
. ....+.+++.+||+.|+.+|+++.+.+.
T Consensus 218 ~----~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 N----ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred C----CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1 1236889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=323.06 Aligned_cols=252 Identities=28% Similarity=0.490 Sum_probs=202.7
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
.+|++.+.||+|+||.||+|.+.+++.+|||+++... ....++.+|++++++++|+||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3578889999999999999998778899999886432 335679999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++..... .+.+..++.++.||+.||+|||++ +|+|||||++||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999988875433 378899999999999999999999 999999999999999999999999999876543322222
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....++.+|++||++.++.++.++|||+|||++|||++ |+.||.... ...+.+.. .+. ........
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~-------~~~---~~~~~~~~ 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVETI-------NAG---FRLYKPRL 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHH-------hCC---CCCCCCCC
Confidence 22345678999999998899999999999999999998 999987532 11111111 000 01111111
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
....+.+|+.+||+.+|++||++.||+++|.
T Consensus 226 -------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1236889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.72 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=189.3
Q ss_pred ccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHH-HHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVE-IISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+. .+|+.||||++.... .....++.+|.. +++.++|+||+++++++..++..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 468999999997432 223345555655 46779999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|..++.... .+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT 154 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence 99988886544 388999999999999999999999 999999999999999999999999999875322221 223
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+....++ .. .+ .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~----~~-~~------~~~~ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNIL----HK-PL------VLRP 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHH----cC-Cc------cCCC
Confidence 45689999999999999999999999999999999999999975421 11111111 10 00 0111
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.....+.+++++||+.++++|+++.+.++
T Consensus 218 ----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 ----GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ----CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 11236788999999999999998864443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=325.48 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=202.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CC---cEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DG---REVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|+..++||+|+||.||+|.+. ++ ..|+||+++... ....+++.+|++++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46888899999999999999864 33 379999887543 23346789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++.... ..+++..++.++.|++.||+|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999887543 2488999999999999999999999 9999999999999999999999999999765433
Q ss_pred Ccceee--ccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 522 NTHITT--RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 522 ~~~~~~--~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
...... .......|++||++.+..++.++|||||||+||||++ |+.||.... ...+... + . ...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~---~~~~~~~---i-~---~~~--- 227 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHEVMKA---I-N---DGF--- 227 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHH---H-h---cCC---
Confidence 222111 1223457999999998889999999999999999997 999996532 1111111 1 0 000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
. ..........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 ~-------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 R-------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 001111234688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=329.64 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=199.5
Q ss_pred CccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
+|.+.+.||+|+||.||+|... +++.||||+++..... ..+.+.+|+.++.+++|+||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667889999999999999853 3578999999754332 23568899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc
Q 005443 441 IYDYVPNNTLYFHLHGE--------------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (696)
++||+.+++|.+++... .+..+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999998887421 123478888999999999999999999 9999999999999999999
Q ss_pred EEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhH
Q 005443 507 AQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 584 (696)
Q Consensus 507 vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~ 584 (696)
+||+|||+++....... .......++..|+|||++.++.++.++|||||||+||||++ |..+|.... ...+.+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~- 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVIEM- 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH-
Confidence 99999999876543322 11223345778999999998899999999999999999998 777876532 1111111
Q ss_pred HHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 585 RPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
+. ..... ....+....+.+++.+||+.+|++||++++|+..|+.
T Consensus 239 --i~-----~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 --IR-----NRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HH-----cCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 11000 0111223368899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=326.49 Aligned_cols=268 Identities=26% Similarity=0.392 Sum_probs=198.9
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----ceeEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRLLI 441 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~lV 441 (696)
.|...++||.|.||.||+|.+ +.++.||||+.-.+ .+.-.+|+++|++++|+|||+|+-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 467789999999999999995 46799999998643 223457999999999999999998887533 23579
Q ss_pred EEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC-CcEEEEeeccchhc
Q 005443 442 YDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKLA 518 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DfGls~~~ 518 (696)
||||.. +|++.++. ..+..++...+.-+.+||++||.|||+. +|+||||||.|||||.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999954 56666653 1233477788888999999999999998 99999999999999866 89999999999887
Q ss_pred cccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH---HHHhhh-
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL---LSHALE- 593 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~---~~~~~~- 593 (696)
..+... .....+..|+|||.+.+ .+|+.+.||||.||+|.||+-|+.-|.+... ...+++.++-+ -.+.+.
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHhh
Confidence 554433 33567889999999887 6799999999999999999999999987542 22233322211 001110
Q ss_pred ------hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhhc
Q 005443 594 ------NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV--FDSLAT 647 (696)
Q Consensus 594 ------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~l~~ 647 (696)
...+.++....+..-+......++++++.++|+.+|.+|-++.|++.+ ++++..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 111222222222222334445578999999999999999999999854 555443
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=326.39 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=199.1
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeC------C
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISD------D 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~------~ 436 (696)
..+.|++.+.||+|+||.||+|... +++.||||++.... ....++.+|+.+++++ +|+||++++++|... +
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999854 68899999987543 4456788999999998 699999999998753 3
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..++||||+.+++|.+++.......+.+..++.++.||+.||+|||++ +|+|||||++||++++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999988765555689999999999999999999999 99999999999999999999999999987
Q ss_pred hccccCcceeeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
...... .......|+..|++||++. +..++.++|||||||+||||++|+.||...... ..... +
T Consensus 160 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~--~--- 228 (272)
T cd06637 160 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL--I--- 228 (272)
T ss_pred eccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHH--H---
Confidence 643322 1223356888999999986 345788999999999999999999999643211 00000 0
Q ss_pred hhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 592 LENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......+.. . .....+.+++.+||+.++.+||++.+|+++
T Consensus 229 -~~~~~~~~~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 -PRNPAPRLKS----K----KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -hcCCCCCCCC----C----CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0000011111 1 112368899999999999999999999853
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=331.33 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=200.7
Q ss_pred cCccccccccccCcEEEEEEEcCC---------------CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD---------------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVG 430 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~ 430 (696)
++|++.+.||+|+||.||+++..+ ...||||+++.... .....|.+|+++|++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 23589999875432 23456899999999999999999999
Q ss_pred EEeeCCceeEEEEecCCCchhhccccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceE
Q 005443 431 YCISDDRRLLIYDYVPNNTLYFHLHGEG----------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 500 (696)
Q Consensus 431 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NIL 500 (696)
++...+..++||||+.+++|.+++.... ...+.+..+++++.||+.||+|||++ +|+|||||++|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999988875432 12367889999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh--CCCCCCCCCCCCc
Q 005443 501 LDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKPVDASQPLGD 577 (696)
Q Consensus 501 l~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt--g~~Pf~~~~~~~~ 577 (696)
|++++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..+|.... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~---~ 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS---D 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---h
Confidence 99999999999999976533221 12223345678999999998899999999999999999998 566776432 2
Q ss_pred hhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 578 ESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 578 ~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
...++....+... ........ ........+.+|+.+||+.||++||+|++|++.|++
T Consensus 239 ~~~~~~~~~~~~~----~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRN----QGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhh----ccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2222222111110 00000000 001112379999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=322.28 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=194.9
Q ss_pred cccccCcEEEEEEEc---CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCC
Q 005443 374 LLGEGGFGSVYKGYL---PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 374 ~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
.||+|+||.||+|.+ ++++.||||+++.... ...+++.+|+.++++++|+||+++++++. .+..++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 3578999999875432 23467899999999999999999999885 45678999999999
Q ss_pred chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee--
Q 005443 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT-- 526 (696)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~-- 526 (696)
+|.+++.... .+++..+++++.||+.||+|||++ +|+|||||+.|||+++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999887544 388999999999999999999999 999999999999999999999999999976544332211
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ...+.+.. +....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~i--------~~~~~-------- 216 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK---GNEVTQMI--------ESGER-------- 216 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH--------HCCCC--------
Confidence 12234578999999988889999999999999999998 999997532 11111111 11110
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
..........+.+++.+||+.|+++||++.+|++.|++.
T Consensus 217 -~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 -MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.72 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=204.9
Q ss_pred HHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc----c----HHHHHHHHHHHHHcc-CCCceeEEeE
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ----G----EREFKAEVEIISRIH-HRHLVSLVGY 431 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~----~~~~~~E~~il~~l~-hpnIv~l~~~ 431 (696)
-...-++|+-.++||+|..+.|.++.++ .|+++|+|++...... . .+.-.+|+.||+++. |+||+.|.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3445577888899999999999998754 6899999999644321 1 234567999999985 9999999999
Q ss_pred EeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEe
Q 005443 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (696)
Q Consensus 432 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (696)
++.+...++|+|.|..|.|+|+|...- .+++++.++|++||++|++|||.+ +|||||||++|||+|++.++||+|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 999999999999999999999997654 389999999999999999999999 999999999999999999999999
Q ss_pred eccchhccccCcceeeccccccccCchhhhcc------CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHH
Q 005443 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASS------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 585 (696)
Q Consensus 512 fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~ 585 (696)
||++..+..+. .....+||++|+|||.++. ..|+..+|+|++|||||.||.|..||....++ -.++
T Consensus 167 FGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm------lMLR 238 (411)
T KOG0599|consen 167 FGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM------LMLR 238 (411)
T ss_pred cceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH------HHHH
Confidence 99998765432 3455789999999999864 34778999999999999999999999864311 1111
Q ss_pred HHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 586 PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
-++.. ...+..+.| .+......+||.+||+.|+.+|-+++|+|++
T Consensus 239 ~ImeG------kyqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIMEG------KYQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHhc------ccccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11111 111111111 2223368899999999999999999999975
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=331.15 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=200.0
Q ss_pred cCccccccccccCcEEEEEEEcCC-C--cEEEEEEeecCC-CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD-G--REVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~-g--~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.++||+|+||.||+|.+++ + ..+++|.++... ....+.+.+|++++.++ +|+||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998643 3 357888887432 23346789999999999 699999999999999999999
Q ss_pred EEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 442 YDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
|||+.+++|.++++... ...+.+..+++++.||+.||+|||++ +|+|||||++||||++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999998886432 12478899999999999999999998 99999999999999999999
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
||+|||++........ ......+..|++||++.+..++.++|||||||++|||++ |+.||..... ..+. ..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~---~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELY---EK 230 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH---HH
Confidence 9999999864321111 111123557999999998889999999999999999997 9999975321 1111 11
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+. ... ...........+.+|+.+||+.+|.+||++++|++.|+++..
T Consensus 231 ~~----~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 LP----QGY----------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred Hh----cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 10 000 000111122368899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=335.29 Aligned_cols=240 Identities=25% Similarity=0.402 Sum_probs=190.8
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+++ +|+.||||+++... ......+..|..++..+ +|+||+++++++.+++..+|||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999997532 22345567788888764 899999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.+++..... +++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 999888876543 88999999999999999999999 99999999999999999999999999987432221 2233
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
...|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+... .. ...+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~--------~~------~~~~~~ 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIR--------VD------TPHYPR 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHH--------hC------CCCCCC
Confidence 4568999999999999999999999999999999999999997532 111111110 00 001111
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMG-QVV 639 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell 639 (696)
.....+.+++++||+.||++|+++. +|+
T Consensus 218 ----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 ----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1123678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=336.36 Aligned_cols=202 Identities=25% Similarity=0.322 Sum_probs=173.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++|+||+++++++.+++..+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999864 67899999986421 223345788999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++..... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999876332 478899999999999999999999 99999999999999999999999999997654433
Q ss_pred cceeeccccccccCchhhhcc-----CCCCccccccchHHHHHHHHhCCCCCCCC
Q 005443 523 THITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~eLltg~~Pf~~~ 572 (696)
........|+..|+|||++.+ +.++.++|||||||+||||++|+.||...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 322233568999999999875 46788999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.52 Aligned_cols=241 Identities=27% Similarity=0.395 Sum_probs=191.0
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|++. +++.||||+++... ......+..|..++..+ +|+||+++++++.+.+..+|||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57899999997542 22344567788888764 899999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 99998887543 388999999999999999999999 99999999999999999999999999987432222 1223
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
...|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+... .. . ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i~--------~~---~---~~~~~ 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSIR--------MD---N---PCYPR 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHH--------hC---C---CCCCc
Confidence 4568999999999999899999999999999999999999997543 111111110 00 0 00111
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMG-QVVR 640 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~ 640 (696)
.....+.+++.+||+.||++|+++. ++++
T Consensus 218 ----~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 ----WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ----cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1123578899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=335.35 Aligned_cols=242 Identities=27% Similarity=0.414 Sum_probs=193.7
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|++. +++.||||+++... ......+.+|+++++.+ +|+||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999997532 23345677899999888 699999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.+++...+. +++..++.++.||+.||.|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 999888876543 89999999999999999999999 999999999999999999999999999875322221 223
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
..+|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+ .+.. ... .+
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~---~i~~-----~~~------~~-- 215 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQ---SILE-----DEV------RY-- 215 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHH---HHHc-----CCC------CC--
Confidence 3468999999999999999999999999999999999999997533 111111 1110 000 00
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRM-----GQVVRV 641 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 641 (696)
.......+.+|+++||+.||++|+++ .++++.
T Consensus 216 --~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 --PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11122368899999999999999999 666643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=324.35 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=195.3
Q ss_pred ccccccccccCcEEEEEEEcCCC-c--EEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeC------Cc
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDG-R--EVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD------DR 437 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g-~--~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~ 437 (696)
|.+.++||+|+||.||+|.+.++ + .||||.++... ....+.+.+|+++++.++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999986543 2 68999887542 23346788999999999999999999987532 24
Q ss_pred eeEEEEecCCCchhhccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 438 RLLIYDYVPNNTLYFHLHGE----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
.++||||+.+|+|.+++... ....+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 58999999999998776321 223478999999999999999999998 99999999999999999999999999
Q ss_pred cchhccccCccee-eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 514 LAKLALDANTHIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 514 ls~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
+++.......... ....++..|++||++.+..++.++|||||||++|||++ |+.+|.... ...+.+. +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~----~--- 227 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDY----L--- 227 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----H---
Confidence 9986543322111 12235678999999999999999999999999999999 788886532 1111111 1
Q ss_pred hhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 592 LENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
....... ........+.+++.+||+.||++||++.+|++.|+++
T Consensus 228 -~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 -RQGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -HcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111000 0111223688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=348.50 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=195.4
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
..+|.+.++||+|+||.||+|.+. .++.||||... ...+.+|+++|++|+|+|||++++++..++..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357899999999999999999964 57899999643 23467899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+. ++|..++..... .+++..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 677777754332 489999999999999999999999 9999999999999999999999999999765433221
Q ss_pred -eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCC-CchhHHHhHHHHHHHhhh-hhhhh---
Q 005443 525 -ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL-GDESLVEWARPLLSHALE-NEEFD--- 598 (696)
Q Consensus 525 -~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~-~~~~~--- 598 (696)
......|+..|+|||++.+..++.++|||||||+||||++|..++...... ......+.+..++.+... ..++.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 222356899999999999999999999999999999999988765432211 111111111111111000 00000
Q ss_pred ---------c----ccCcccCCC-cc--hHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 599 ---------N----LADPRLGEN-YV--EGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 599 ---------~----~~d~~l~~~-~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ......... +. ......+.+|+.+||+.|+++||++.|||++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000000000 00 0112257889999999999999999999864
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=321.32 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=202.6
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+|++.++||+|+||.||++... +++.||+|.++... ....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999854 68999999986533 234567889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.......+++..+++++.||+.||.|||++ +|+|+|||++|||+++++.++|+|||+++....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999998888655445588999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||..... ......+. ......+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~-----~~~~~~~----- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVC-----QGSYKPL----- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHh-----cCCCCCC-----
Confidence 2335688899999999988899999999999999999999999975321 11111110 1111111
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......+.+++++||+.||++||++.||+..
T Consensus 221 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122367899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.78 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=205.6
Q ss_pred ccccccccccCcEEEEEEEc-CCC----cEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 369 FADQNLLGEGGFGSVYKGYL-PDG----REVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~-~~g----~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++..++||.|+||+||+|.+ .+| -.||||++..... +..++|++|+.+|.+|+|+||+||+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44568999999999999984 344 3689998875544 34578999999999999999999999998766 78999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
+||.+|.|.++++..+. .+..+..+.|.+||++||.|||++ ++|||||..+||||..-.++||.|||+++......
T Consensus 777 q~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999986543 488899999999999999999999 99999999999999999999999999998775544
Q ss_pred ccee-eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 523 THIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 523 ~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.... ....-.+.|||-|.+....|+.++|||+|||.+||||| |..|+++....+ +.++
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------------------I~dl 912 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------------------IPDL 912 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------------------hhHH
Confidence 3322 22233568999999999999999999999999999999 888887643211 1111
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
++...+.........++..++.+||-.|.+.||.++++...+.+++.
T Consensus 913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 11111122233444578899999999999999999999998888764
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=335.77 Aligned_cols=237 Identities=27% Similarity=0.405 Sum_probs=186.7
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHH-HHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVE-IISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+.. +|+.||||++.... .....++.+|.. +++.++|+||+++++++.+.+..+|||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68899999986432 122334555554 67889999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
++|..++.... .+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 99988876543 378888999999999999999998 99999999999999999999999999987532222 2233
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
..+|+..|+|||++.+..++.++|||||||++|||++|+.||...+ ..+....++. .. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~-----~~--------~-- 213 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILH-----KP--------L-- 213 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhc-----CC--------C--
Confidence 4568999999999999899999999999999999999999997542 1111111110 00 0
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMG 636 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 636 (696)
.+.......+.+++.+||+.|+++|+++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01111223688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=328.14 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=202.1
Q ss_pred cCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
.+|...++||+|+||.||++.. .++..|++|.++.........+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4677889999999999999963 2456899998876655556789999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 441 IYDYVPNNTLYFHLHGEGR-------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
||||+.+++|.++++.... ..+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999988865321 2478899999999999999999998 99999999999999999999
Q ss_pred EEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHH
Q 005443 508 QVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWAR 585 (696)
Q Consensus 508 kL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~ 585 (696)
||+|||+++....... .......++..|++||++.+..++.++|||||||++|||++ |+.||..... ....+.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~-- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIEC-- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHH--
Confidence 9999999875433221 11222345678999999999999999999999999999998 8998864321 111111
Q ss_pred HHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 586 PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
.. ..... . ........+.+++.+||+.||.+||+++||++.|++
T Consensus 237 -~~----~~~~~---~-------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 -IT----QGREL---E-------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -HH----cCccC---C-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00 00000 0 001112368899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=331.97 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=204.3
Q ss_pred hcCccccccccccCcEEEEEEEc--------CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeC
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL--------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 435 (696)
.++|.+.+.||+|+||.||+|++ .++..||||+++... ....+++.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 46788899999999999999973 134579999986432 23446789999999999 799999999999999
Q ss_pred CceeEEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
+..++||||+.+++|.+++.... ...+++..++.++.||++||+|||++ +|+|||||++|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999998886532 13478888999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchh
Q 005443 502 DNNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~ 579 (696)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..+|.... ...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~ 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HHH
Confidence 999999999999998654332221 122345678999999998889999999999999999998 778876432 111
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
+.+ .+ . ..... .........+.+++.+||+.+|++||++.||++.|+++...
T Consensus 248 ~~~---~~-~---~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 LFK---LL-K---EGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHH---HH-H---cCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 111 11 0 10000 01112234688899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=324.55 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=202.8
Q ss_pred cCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.++||+|+||.||+|.+. .+..||||.++.... ...+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999853 234799998865432 2345789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++..... .+++.++++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999876543 478999999999999999999999 9999999999999999999999999999876543
Q ss_pred Ccceee--ccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 522 NTHITT--RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 522 ~~~~~~--~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
...... ...++..|++||++.+..++.++|||+|||++|||++ |+.+|..... ....+... +....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~-------~~~~~- 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIE-------EGYRL- 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHh-------CCCcC-
Confidence 322211 1223568999999998899999999999999999886 9999875431 11111111 00000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.........+.+++.+||+.++.+||+|.+|++.|+++
T Consensus 229 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ---------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111223678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=326.39 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=203.1
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|.+.+.||+|+||.||+|... .+..||||.+..... .....+.+|+.+|+.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467889999999999999999863 246899999864432 3345688999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEE
Q 005443 439 LLIYDYVPNNTLYFHLHGEG--------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (696)
++||||+.+++|.+++.... ...+.+..+++++.||+.||.|||++ +|+|||||++|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999998886432 22368889999999999999999998 99999999999999999999999
Q ss_pred eeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHH
Q 005443 511 DFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 511 DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
|||+++........ ......++..|+|||++.++.++.++|||+|||++|||++ |+.+|.... ...+.++..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVLKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHHHHHHh---
Confidence 99999765433221 1223346788999999998889999999999999999998 888886432 122221111
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
...... ........+.+++.+||+.+|++||++.+|++.|++
T Consensus 236 -----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -----DGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -----cCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 110000 011113478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=352.78 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=201.9
Q ss_pred HHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCC----
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDD---- 436 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---- 436 (696)
...++|.+.++||+|+||.||+|+. .+|+.||||+++.... .....+++|+.+|..++|.||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3346899999999999999999984 4799999999975432 33456889999999999999999988775432
Q ss_pred ----ceeEEEEecCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEE
Q 005443 437 ----RRLLIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (696)
Q Consensus 437 ----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (696)
..++||||+.+|+|.++++.. ....+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 257999999999999888643 234588999999999999999999999 99999999999999999999999
Q ss_pred eeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH
Q 005443 511 DFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589 (696)
Q Consensus 511 DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (696)
|||+++....... ......+|+..|+|||++.+..++.++|||||||+||||++|+.||.... ..+.....+.
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhc
Confidence 9999976543221 12234578999999999999999999999999999999999999997532 1111111111
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.. + .......+.+++.+||+.||++||++.+|+++
T Consensus 260 -----~~~~~-----~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 -----GRYDP-----L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----CCCCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00000 1 11122368899999999999999999999864
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=334.89 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=195.7
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+++++ .++.||||++... .......+.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999865 5788999998632 1222345888999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.++++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999975332 388899999999999999999998 99999999999999999999999999987654333
Q ss_pred cceeeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 523 THITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
.......+|+..|+|||++. ...++.++|||||||+||||++|+.||.... ..+....+.. ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~----~~~~ 226 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMN----HKER 226 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhC----CCcc
Confidence 33333457999999999986 3468889999999999999999999997532 1222211111 0000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAK--RPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 641 (696)
..+. .. .......+.+++++|+..++++ |++++|++++
T Consensus 227 ~~~p--~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQFP--AQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCC--Cc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 00 0112235778888888655444 6788888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.05 Aligned_cols=253 Identities=30% Similarity=0.477 Sum_probs=200.4
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHH--HHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGER--EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
|+++++||+|+||.||++... +++.||+|++......... ...+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999965 5678999999866443332 3456999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.... .+++..++.++.||++||+|||++ +|+|||||++|||+++++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred ccccccccccccc--cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999887333 389999999999999999999999 99999999999999999999999999987541 22223
Q ss_pred eeccccccccCchhhhc-cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYAS-SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|+|||++. +..++.++||||||+++|+|++|..+|.... ..+...................
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~------ 225 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN---SDDQLEIIEKILKRPLPSSSQQ------ 225 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS---HHHHHHHHHHHHHTHHHHHTTS------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc---chhhhhhhhhcccccccccccc------
Confidence 34456889999999998 7889999999999999999999999998641 1122222211111111100000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......+.+++++||+.||++||++.+|+++
T Consensus 226 -----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 -----SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -----cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001479999999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.16 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=197.8
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCcc---HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQG---EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.|..++.||.|.||.||-|++ .+.+.||||+|.....+. ..++.+|+.+|++|+|+|+|.+-|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 477788999999999999995 478899999998765544 3568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
||- |+-.|++....+ .+.+.++..|+.+.+.||+|||++ +.||||||..||||.+.|.|||+|||.+......+
T Consensus 107 YCl-GSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn- 180 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN- 180 (948)
T ss_pred HHh-ccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence 995 455555544332 488899999999999999999999 99999999999999999999999999997655433
Q ss_pred ceeeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 524 HITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.++||+.|||||+|. .+.|+-++|||||||++.||..++.|+...+. + ..+.. + ...+
T Consensus 181 ----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------M---SALYH-I-AQNe---- 241 (948)
T KOG0577|consen 181 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------M---SALYH-I-AQNE---- 241 (948)
T ss_pred ----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------H---HHHHH-H-HhcC----
Confidence 478999999999985 47899999999999999999999998764321 1 11111 0 0011
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
.+.|.. .+....++.++..||+.-|.+||+.++++.+..
T Consensus 242 -sPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 242 -SPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred -CCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 111211 122335788889999999999999999987533
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.50 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=199.0
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.|++.++||+|+||.||++... +++.||||.+...... ....+.+|+.++++++|+||+.+++++..++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3777899999999999999854 6899999998644322 23457789999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++.......+.+..++.++.||+.||.|||++ +|+|||||++||++++++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999998888655545589999999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........... ...++... ..
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~~------~~---- 222 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEV------QE---- 222 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhhh------hh----
Confidence 1234689999999999999999999999999999999999999976432111111 11111100 00
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVR 640 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~ 640 (696)
.+... ....+.+|+.+||+.||++|++ ++|+++
T Consensus 223 ~~~~~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEK----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCcc----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01111 1235789999999999999999 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=325.80 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=201.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCc----EEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|++.++||+|+||.||+|++ .+|+ .||||+++.... ...+++.+|+.+++.++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 5688899999999999999984 3444 489999875433 334678899999999999999999999875 45789
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
++||+.+|+|.++++... ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999887543 2488999999999999999999999 999999999999999999999999999976543
Q ss_pred cCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
..... .....++..|++||++.+..++.++|||||||+||||++ |..+|+... ...+.++.. .....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~--------~~~~~ 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLLE--------KGERL 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHH--------CCCcC
Confidence 22211 112234678999999998999999999999999999998 889886532 112211111 10000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.. ......++.+++.+||+.|+++||++.+|++.|+++...
T Consensus 231 ~~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 PQ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 00 011223688999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=350.32 Aligned_cols=272 Identities=21% Similarity=0.255 Sum_probs=194.5
Q ss_pred HHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC------CceeEEeEE
Q 005443 360 EELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR------HLVSLVGYC 432 (696)
Q Consensus 360 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp------nIv~l~~~~ 432 (696)
+++....++|+++++||+|+||.||+|.+. .++.||||+++... ...+++..|++++++++|. +|++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344455688999999999999999999854 67899999996432 2344567788888887654 588899988
Q ss_pred eeC-CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC------
Q 005443 433 ISD-DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF------ 505 (696)
Q Consensus 433 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~------ 505 (696)
..+ +..+||||++ +++|.+++...+ .+.+..++.|+.||+.||+|||+++ +|||||||++||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 765 4678899988 677877776543 3899999999999999999999732 899999999999998665
Q ss_pred ----------cEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCC
Q 005443 506 ----------EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575 (696)
Q Consensus 506 ----------~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~ 575 (696)
.+||+|||++..... .....+|+..|||||++.+..|+.++|||||||+||||++|+.+|+.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998864322 123457899999999999999999999999999999999999999865432
Q ss_pred CchhHHHhHHH-HHHHhhh---hhhhhcccCc--ccCCC--------------c-chHHHHHHHHHHHHHhccCCCCCCC
Q 005443 576 GDESLVEWARP-LLSHALE---NEEFDNLADP--RLGEN--------------Y-VEGEMFRMIEAAAACVRHSAAKRPR 634 (696)
Q Consensus 576 ~~~~l~~~~~~-~~~~~~~---~~~~~~~~d~--~l~~~--------------~-~~~~~~~l~~li~~cl~~dP~~RPs 634 (696)
+...+++.... +...+.. ..+..++++. .+... . .......+++|+.+||+.||++|++
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 21111111100 0000000 0000000000 00000 0 0011235779999999999999999
Q ss_pred HHHHHHH
Q 005443 635 MGQVVRV 641 (696)
Q Consensus 635 ~~ell~~ 641 (696)
++|++++
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999864
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=330.58 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=199.1
Q ss_pred cCccccccccccCcEEEEEEEcC-CCc--EEEEEEeecCC-CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGR--EVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.+.||+|+||.||+|.++ +|. .+++|.++... .....++.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56888999999999999999864 454 45777765432 22345788999999999 899999999999999999999
Q ss_pred EEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 442 YDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
|||+.+++|.++++..+ ...+++..++.++.||+.||+|||++ +|+|||||++||||++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999998886432 22478899999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
||+|||+++...... ......++..|++||++.+..++.++|||||||+||||++ |..||..... ....+.
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~--- 235 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEK--- 235 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHHH---
Confidence 999999986432111 1111234567999999988889999999999999999998 9999864321 111111
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+ ... ............+.+|+.+||+.+|++||+++++++.|+++..
T Consensus 236 ~-----~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 236 L-----PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred H-----hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 000 0000001112367899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.43 Aligned_cols=201 Identities=25% Similarity=0.377 Sum_probs=174.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||++..+ +++.||||+++... ......+.+|+.++.+++|+||+++++++.+++..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999864 68999999997432 233456888999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999998876543 88999999999999999999999 99999999999999999999999999986442211
Q ss_pred c----------------------------------ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCC
Q 005443 523 T----------------------------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568 (696)
Q Consensus 523 ~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~P 568 (696)
. ......+|+..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001134689999999999999999999999999999999999999
Q ss_pred CCCC
Q 005443 569 VDAS 572 (696)
Q Consensus 569 f~~~ 572 (696)
|...
T Consensus 236 f~~~ 239 (360)
T cd05627 236 FCSE 239 (360)
T ss_pred CCCC
Confidence 9754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.86 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=191.7
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++.++ +|+||+++++++...+..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999854 678999999975422 2335578899999888 599999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|..++...+. +++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (327)
T cd05617 81 GDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTS 154 (327)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-cee
Confidence 999888765443 89999999999999999999999 999999999999999999999999999875332222 223
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||............++....+.. ... .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~------~~p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE----KPI------RIPR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh----CCC------CCCC
Confidence 457899999999999999999999999999999999999999753322222222222111110 000 0111
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMG 636 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 636 (696)
. ....+.+++++||+.||++|+++.
T Consensus 225 ~----~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 F----LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred C----CCHHHHHHHHHHhccCHHHcCCCC
Confidence 1 123578999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.88 Aligned_cols=252 Identities=21% Similarity=0.364 Sum_probs=203.3
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecC--CCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 442 (696)
...|++.+.||+||.+.||++...+.+.||+|++... +.+....|.+|++.|.+|+ |.+||+||+|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3568999999999999999999888889999887543 3344567999999999997 999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||- ..+|..+|........+| +++.+..||+.++.++|++ ||||.||||.|+|+-+ |++||+|||++..+....
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 986 567888887766654555 8888999999999999999 9999999999999975 489999999998776555
Q ss_pred cce-eeccccccccCchhhhccCC-----------CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 523 THI-TTRVMGTFGYMAPEYASSGK-----------LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 523 ~~~-~~~~~gt~~y~aPE~l~~~~-----------~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
..+ ....+||+.||+||.+.... ++.++||||||||||+|+.|+.||.....
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------------- 577 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------------- 577 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------------
Confidence 443 34578999999999986433 45689999999999999999999975210
Q ss_pred hhhhhhhhcccCcccCCCcchHH-HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 ALENEEFDNLADPRLGENYVEGE-MFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....+..++++.....|..-- ..+++++++.||.+||++|++..|||++
T Consensus 578 --~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 --QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 012234455554433332211 1239999999999999999999999964
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.25 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=201.5
Q ss_pred cCccccccccccCcEEEEEEEcC-----------------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-----------------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSL 428 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l 428 (696)
++|++.+.||+|+||.||+++.+ ++..||||+++.... ....++.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998632 244789999875432 234678999999999999999999
Q ss_pred EeEEeeCCceeEEEEecCCCchhhccccCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCce
Q 005443 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNI 499 (696)
Q Consensus 429 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NI 499 (696)
++++..++..++||||+.+++|.+++..... ..+++..+++++.||+.||+|||++ +|+|||||++||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999888865321 2367788999999999999999999 999999999999
Q ss_pred EECCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh--CCCCCCCCCCCC
Q 005443 500 LLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKPVDASQPLG 576 (696)
Q Consensus 500 Ll~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt--g~~Pf~~~~~~~ 576 (696)
||++++.++|+|||+++....... .......++..|++||++.++.++.++|||||||+||||++ |..||....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~--- 238 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS--- 238 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC---
Confidence 999999999999999976533221 11222344678999999988889999999999999999998 778886432
Q ss_pred chhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 577 DESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
....++....++.... ..... . ........+.+++.+||+.||++||++.||++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~----~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQVIENTGEFFRDQG----RQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHHHHHHHHHHHhhcc----ccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1222221111111000 00000 0 011122478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.96 Aligned_cols=265 Identities=22% Similarity=0.365 Sum_probs=197.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|.+.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56899999999999999999864 678899999975433 2335678999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+ +|..++...+ ..+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 6766665443 2478899999999999999999999 999999999999999999999999999875433222
Q ss_pred eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH--------Hhhhhh
Q 005443 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS--------HALENE 595 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~--------~~~~~~ 595 (696)
......++..|+|||++.+ ..++.++|||||||++|||++|+.+|......+. .......+. ......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE---LHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhhcchh
Confidence 1223457889999999865 5688999999999999999999999976442211 111111110 000000
Q ss_pred hhhcccCcccCC----CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 596 EFDNLADPRLGE----NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 596 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.+.......... .........+.+++++||+.||++|+++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 000111235789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=326.78 Aligned_cols=245 Identities=28% Similarity=0.369 Sum_probs=191.2
Q ss_pred ccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
||+|+||.||++..+ +|+.||||++..... ...+.+..|+++|++++|+||+++++++..++..++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 689999999864322 2234577899999999999999999999999999999999999999
Q ss_pred hhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeec
Q 005443 451 YFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (696)
Q Consensus 451 ~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~ 528 (696)
.+++.. .....+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 877643 2234589999999999999999999999 999999999999999999999999999976543322 2233
Q ss_pred cccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCC
Q 005443 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608 (696)
Q Consensus 529 ~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (696)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+..... ..... .
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~-------------~~~~~--~ 219 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRI-------------LNDSV--T 219 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhh-------------cccCC--C
Confidence 5688999999999999999999999999999999999999975432111 00100000 00000 1
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005443 609 YVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVR 640 (696)
Q Consensus 609 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~ 640 (696)
+.......+.+++.+||+.||++|+ +++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1112233688999999999999999 4455553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=327.78 Aligned_cols=260 Identities=23% Similarity=0.435 Sum_probs=203.0
Q ss_pred HhcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
..++|++.++||+|+||.||+|..+ .+..||||.++.... ....++.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3568999999999999999999743 245899998864432 233468899999999999999999999999999
Q ss_pred eeEEEEecCCCchhhccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEE
Q 005443 438 RLLIYDYVPNNTLYFHLHGEG--------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV 509 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL 509 (696)
.++||||+.+|+|.++++... ...+.+..+++++.||+.||.|||++ +|+|||||++|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999886432 23356778899999999999999999 9999999999999999999999
Q ss_pred EeeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHH
Q 005443 510 SDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPL 587 (696)
Q Consensus 510 ~DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~ 587 (696)
+|||+++......... .....++..|++||.+.++.++.++|||||||++|||++ |..+|.... .+.+.+. +
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---~~~~~~~---~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---NEQVLKF---V 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH---H
Confidence 9999987653322211 122345678999999998899999999999999999998 788886422 1111111 1
Q ss_pred HHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. ... ... ........+.+++.+||+.+|++||++.++++.|++...
T Consensus 235 ~----~~~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 235 M----DGG-YLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred H----cCC-CCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 0 110 000 011112478999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.14 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=202.6
Q ss_pred hcCccccccccccCcEEEEEEEcC--------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeC
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 435 (696)
.++|.+.+.||+|+||.||+|+.. .+..||+|+++.... ....++.+|+++++++ +|+||++++++|..+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999741 245799999874432 2345688999999999 599999999999988
Q ss_pred CceeEEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
+..++||||+.+|+|.+++.... ...+.+..+++++.||+.||+|||++ +|+|||||++|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 89999999999999988885432 23488899999999999999999998 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchh
Q 005443 502 DNNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~ 579 (696)
++++.+||+|||+++......... .....++..|++||++.+..++.++|||||||++|||++ |+.+|.... ...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VEE 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HHH
Confidence 999999999999998654322211 111234467999999999899999999999999999999 888886432 111
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+.+. +. . ... . .........+.+++.+||+.+|++||++.||++.|+++..
T Consensus 245 ~~~~----~~---~-~~~---~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKL----LR---E-GHR---M------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHH----HH---c-CCC---C------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111 11 0 000 0 0111122368899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=323.92 Aligned_cols=255 Identities=27% Similarity=0.460 Sum_probs=200.9
Q ss_pred cCccccccccccCcEEEEEEEcCC-C---cEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD-G---REVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~-g---~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.+.||+|+||.||+|.+.. + ..||||+++... .....+|.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998643 3 369999987542 23346799999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++..... .+++..++.++.|++.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999988875433 488999999999999999999998 9999999999999999999999999998765432
Q ss_pred Cccee-ec-c--ccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 522 NTHIT-TR-V--MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 522 ~~~~~-~~-~--~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
..... .. . ..+..|++||++.+..++.++|||||||++|||++ |..||.... .....++.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i~-------~~~~ 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAIE-------QDYR 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHHH-------cCCc
Confidence 22111 11 1 12457999999999999999999999999999886 999987532 112211111 0000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
+ ....+....+.+++.+||+.++.+||++++|+..|+++
T Consensus 230 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 L----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00111223678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=324.35 Aligned_cols=253 Identities=24% Similarity=0.393 Sum_probs=200.5
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|++.+.||+|+||.||+|.. .+++.||||+++.........+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4678889999999999999985 468899999998765555567889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++...+. +++..++.++.||+.||.|||++ +|+|+|||++|||++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 99999998876543 89999999999999999999999 99999999999999999999999999987553322 12
Q ss_pred eeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 526 TTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||........ +.. .. ... +..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~----~~-----~~~---~~~ 228 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL----MT-----KSN---FQP 228 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHh----hh-----ccC---CCC
Confidence 23346889999999974 45688899999999999999999999865332110 000 00 000 000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.... .....+.+++++||+.+|++||++++|+++
T Consensus 229 ~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CcccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0010000 011257889999999999999999998853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.59 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=201.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++.+.||+|+||.||++... +|+.||+|.++..... ...++.+|++++++++|+||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999854 6788999988754322 235688999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.++++..+. +.+..+..++.||++||.|||+.+ +|+|||||++|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 999999999876543 789999999999999999999732 89999999999999999999999999987543322
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh----------
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN---------- 594 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~---------- 594 (696)
.....|+..|++||++.+..++.++|||||||++|||++|+.||....... +..+...........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCC
Confidence 223468889999999988889999999999999999999999997543211 111111000000000
Q ss_pred ----------hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 ----------EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+....+................+.+++.+||+.+|++||++.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000000122358899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.46 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=197.6
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|+++++||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++|+||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 478899999987542 23345788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|..+. .+++..+..++.||+.||+|||++ +|+|+|||++|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999886543 267888899999999999999999 99999999999999999999999999997654322
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchh-HHHhHHHHHHHhhhhhhhhcccCc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES-LVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
....+|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ..++.. .+.... ..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~-----~~ 218 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-----CIVDED-----PP 218 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-----HHhccC-----CC
Confidence 223468899999999999899999999999999999999999997533211111 011111 000000 00
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+.. .....++.+++.+||+.+|++||+++|+++.
T Consensus 219 ~~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLPV---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1100 1112368899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.67 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=203.4
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.+|++.+.||+|+||.||+|.. .+++.|+||.+........+.+.+|+.+++.++|+||++++++|...+..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788999999999999999984 478999999998766666678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++... .+++.+++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++........ .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999999988643 378899999999999999999999 999999999999999999999999999876433221 1
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
.....++..|++||.+.+..++.++|||+|||++|||++|+.||...... ..+.. .. ... ...+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~----~~----~~~-~~~~----- 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL----IA----TNG-TPEL----- 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHH----Hh----cCC-CCCC-----
Confidence 22346788999999999888999999999999999999999999754321 10000 00 000 0000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.........+.+++.+||+.++++||++.||++.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0111223468899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.60 Aligned_cols=247 Identities=25% Similarity=0.410 Sum_probs=193.5
Q ss_pred ccccCcEEEEEEEcC---CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 375 LGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
||+|+||.||+|.+. .+..||||++...... ..+++.+|+.++++++|+||++++++|. .+..++||||+.+++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999753 4567999998755332 3456899999999999999999999885 4577999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee--ec
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT--TR 528 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~--~~ 528 (696)
.+++.... ..+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.......... ..
T Consensus 82 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 82 NKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 98886433 3489999999999999999999998 999999999999999999999999999975543322111 11
Q ss_pred cccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 529 ~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.... ....... +.+ ... .
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~----~~~---~~~----------~ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK---GPEVMSF----IEQ---GKR----------L 217 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHH----HHC---CCC----------C
Confidence 223568999999988889999999999999999996 999997532 1111111 110 000 0
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
........++.+++.+||+.++++||++.+|++.|+.+.
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 111122347889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.27 Aligned_cols=248 Identities=26% Similarity=0.429 Sum_probs=198.6
Q ss_pred ccccccCcEEEEEEEcCC--C--cEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLPD--G--REVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|.+.+ + ..||||.++.... ...+++.+|++++++++|+||+++++++.. ...++||||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999986655 456789999999999999999999999988 888999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc--e
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH--I 525 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~--~ 525 (696)
++|.+++.......+.+..++.++.||+.||+|||++ +|+||||+++|||++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999988765434589999999999999999999999 9999999999999999999999999999876442221 1
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|++||++.+..++.++|||||||++|||++ |+.+|.... ..++.+... . . ...+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~---~----~--~~~~~--- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS---GSQILKKID---K----E--GERLE--- 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH---h----c--CCcCC---
Confidence 122456788999999998899999999999999999998 999986432 111111111 0 0 00000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
........+.+++.+||+.+|++||++.+|++.|.
T Consensus 222 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.41 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=198.2
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCchh
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLY 451 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 451 (696)
++||+|+||.||++.+.+++.|++|+++..... ....+.+|++++++++|+||+++++++...+..++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999867999999998755443 4567999999999999999999999999999999999999999999
Q ss_pred hccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee-eccc
Q 005443 452 FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT-TRVM 530 (696)
Q Consensus 452 ~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~-~~~~ 530 (696)
+++..... .+++..++.++.|++.||+|||++ +|+||||+++||||++++.+||+|||+++.......... ....
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 98865433 478899999999999999999999 999999999999999999999999999976543222111 1123
Q ss_pred cccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCc
Q 005443 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENY 609 (696)
Q Consensus 531 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (696)
++..|++||++.++.++.++|||||||++|||++ |..+|..... ....+.. ... ..+ ..
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~~--------~~~--~~~-------~~ 216 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRERI--------ESG--YRM-------PA 216 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHHH--------hcC--CCC-------CC
Confidence 3567999999998899999999999999999999 8888865321 1111110 000 000 01
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 610 VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 610 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
.......+.+++.+||+.+|++||++.||++.|++
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 11122368899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.88 Aligned_cols=248 Identities=28% Similarity=0.455 Sum_probs=196.9
Q ss_pred ccccccCcEEEEEEEcC--C--CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP--D--GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|.+. + +..||+|.++.... ...+++.+|++++++++|+||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999742 2 36899999875543 24567899999999999999999999876 4567999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
++|.+++.... .+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997655 489999999999999999999998 9999999999999999999999999999866443322211
Q ss_pred --ccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 528 --RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 528 --~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
...++..|++||.+.+..++.++|||||||+||||++ |+.||.... ...+.++.. + ... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~~~----~---~~~---~---- 217 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAMLE----S---GER---L---- 217 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHH----c---CCc---C----
Confidence 1223467999999998999999999999999999998 999997542 122222111 0 000 0
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 218 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011112236889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.36 Aligned_cols=263 Identities=26% Similarity=0.407 Sum_probs=203.7
Q ss_pred hcCccccccccccCcEEEEEEEcCC-----------------CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCcee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD-----------------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVS 427 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~ 427 (696)
.++|++++.||+|+||.||+|.+.+ +..||+|++..... ...+.+.+|+++|++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999988532 24689999875433 33567899999999999999999
Q ss_pred EEeEEeeCCceeEEEEecCCCchhhccccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCc
Q 005443 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEG---------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSN 498 (696)
Q Consensus 428 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~N 498 (696)
++++|..++..++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999998886543 12488999999999999999999998 99999999999
Q ss_pred eEECCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh--CCCCCCCCCCC
Q 005443 499 ILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT--GRKPVDASQPL 575 (696)
Q Consensus 499 ILl~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt--g~~Pf~~~~~~ 575 (696)
||+++++.++|+|||+++....... .......++..|++||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999876533322 12233456778999999998889999999999999999998 677776432
Q ss_pred CchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 576 GDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 576 ~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
....++.....+ .......... .......++.+++.+||+.||++||++.||++.|++
T Consensus 239 -~~~~~~~~~~~~----~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 -DQQVIENAGHFF----RDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -hHHHHHHHHhcc----ccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 222222221111 0000000000 011112378999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.42 Aligned_cols=256 Identities=24% Similarity=0.423 Sum_probs=203.0
Q ss_pred cCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 3467999988654333 3467999999999999999999999999989999
Q ss_pred EEEEecCCCchhhccccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEee
Q 005443 440 LIYDYVPNNTLYFHLHGEGR-------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~Df 512 (696)
+||||+.+++|.++++.... ..+.+..++.++.||+.||+|||++ +|+|||||++||||++++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999998875441 1489999999999999999999999 9999999999999999999999999
Q ss_pred ccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 513 GLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
|+++..............++..|++||.+.+..++.++|||||||++|||++ |..+|.... +..++...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~~~~~------- 231 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEVLNRL------- 231 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHHHHHH-------
Confidence 9987543332222233456778999999988888999999999999999998 788886432 11211111
Q ss_pred hhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 592 LENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
....+... ........+.+++.+||+.+|++||++.||++.|.+
T Consensus 232 -~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 232 -QAGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -HcCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00111000 011122368899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.51 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=200.7
Q ss_pred CccccccccccCcEEEEEEEc-----CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeC--Ccee
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRL 439 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 439 (696)
.|++++.||+|+||.||++++ .+++.||||.++... ......+.+|++++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999973 357899999987443 23346799999999999999999999998875 4678
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+||||+.+++|.+++..... .+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999998865432 479999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCC--------chhHHHhHHHHHH
Q 005443 520 DANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG--------DESLVEWARPLLS 589 (696)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~--------~~~l~~~~~~~~~ 589 (696)
..... ......++..|+|||++.+..++.++|||||||++|||++++.++....... .+.........+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL- 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-
Confidence 33221 1223446678999999998889999999999999999999876543211100 000000000000
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.... ...........+.+|+.+||+.+|++||++++|++.|+++
T Consensus 240 ---~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 ---EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ---HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 0001112234789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.00 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=199.9
Q ss_pred hcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCCc-cHHHHHHHHHHHHHc-cCCCceeEEeEEeeC-C
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSLVGYCISD-D 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-~ 436 (696)
.++|+++++||+|+||.||+|.. .+++.||||+++..... ....+.+|+.+|.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999973 35788999999754332 345688999999999 689999999988754 4
Q ss_pred ceeEEEEecCCCchhhccccCC----------------------------------------------------------
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEG---------------------------------------------------------- 458 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 458 (696)
..++||||+.+|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 5789999999999988875421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc-eeeccc
Q 005443 459 -------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVM 530 (696)
Q Consensus 459 -------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~-~~~~~~ 530 (696)
...+++..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12367788899999999999999999 9999999999999999999999999999765332221 112233
Q ss_pred cccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCc
Q 005443 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENY 609 (696)
Q Consensus 531 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (696)
++..|++||++.+..++.++|||+|||+||||++ |..||..... ...+.+. + ........ . .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~----~~~~~~~~--~---~-- 305 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCRR----L----KEGTRMRA--P---D-- 305 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc--cHHHHHH----H----hccCCCCC--C---C--
Confidence 5677999999998899999999999999999997 8888865321 1111110 0 01000000 0 0
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 610 VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 610 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.....+.+++.+||+.+|++||++.||++.|+.+..
T Consensus 306 --~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 --YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111258899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.30 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=195.2
Q ss_pred ccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
|+..++||+|+||+||+|.. .+|+.||||++..... .....+.+|+++|++++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67788999999999999985 4688999999864422 2234578899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++...+...+++..++.++.||+.||.|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999998888765545689999999999999999999998 999999999999999999999999999865432221
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.... ... . ..
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~~----~~~---~----~~ 223 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRRV----LET---E----EV 223 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhh----hcc---c----cc
Confidence 223468999999999998999999999999999999999999997543111 111111100 000 0 00
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMG 636 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 636 (696)
+.. .....+.+|+.+||+.||++|+++.
T Consensus 224 ~~~----~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 224 YSA----KFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred cCc----cCCHHHHHHHHHHccCCHhHcCCCc
Confidence 111 1123578899999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.40 Aligned_cols=242 Identities=25% Similarity=0.395 Sum_probs=192.8
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+|+..++||+|+||.||+|+.. +|+.||||+++... ....+.+..|+.+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999854 68999999997432 223456778999998886 567888999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999988876543 89999999999999999999999 99999999999999999999999999987543222
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...+.+ .++. ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~---~i~~-----~~~----- 218 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQ---SIME-----HNV----- 218 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHH---HHHh-----CCC-----
Confidence 1 1233568999999999999999999999999999999999999997543 111111 1111 000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMG 636 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 636 (696)
. +.......+.+++.+||+.+|.+|++..
T Consensus 219 -~----~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 -S----YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -C----CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0 1111123678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=334.54 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=196.5
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD----- 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 436 (696)
..++|++.+.||+|+||.||++... .|+.||||++.... .....++.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999854 68999999986432 233457889999999999999999999986543
Q ss_pred -ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 437 -RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 437 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
..++||||+.++ |...++. .+++..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 468999999764 5444432 278888999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCc------------hhHHHh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD------------ESLVEW 583 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~------------~~l~~~ 583 (696)
+...... ......|+..|+|||++.+..++.++|||||||++|||++|+.+|...+.... ..+.+.
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 7543321 22334688999999999999999999999999999999999999986432110 000000
Q ss_pred HHHHHHHhhhhh------hhhcccCcccC---CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 584 ARPLLSHALENE------EFDNLADPRLG---ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 584 ~~~~~~~~~~~~------~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....+....... .+.++...... ..........+.+|+.+||+.||++|+++.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000111110000 00000000000 00001112357899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.00 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=204.3
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|+..++||+|+||.||.++. ++++.|++|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999984 468999999987543 33456788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++.......+++..++.++.|++.||.|||+. +|+||||+++||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999998765445689999999999999999999998 999999999999999999999999999876544332
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
......++..|++||++.+..++.++|||||||++|||++|+.+|..... .+....+.. ..+...
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-----~~~~~~---- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQ-----GNYTPV---- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHc-----CCCCCC----
Confidence 22335688999999999888899999999999999999999999975321 111111111 111100
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
.......+.+++.+||+.++++|+++.++++++
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112233688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=337.37 Aligned_cols=264 Identities=22% Similarity=0.258 Sum_probs=198.9
Q ss_pred hcCccccccccccCcEEEEEEEcC---CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
..+|++++.||+|+||.||++... .++.|+||.+... +.+.+|+++|++|+|+||+++++++..++..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999743 3578999987632 34578999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+. ++|.+++... ..+.+..++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 5777777433 3489999999999999999999999 99999999999999999999999999997654432
Q ss_pred cc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh----hhh---
Q 005443 523 TH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA----LEN--- 594 (696)
Q Consensus 523 ~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~----~~~--- 594 (696)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.||...........+..+...+... ...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 22 2234579999999999999999999999999999999999999997655432222111111111000 000
Q ss_pred ---hhhhcccCcccCCCcc-------hHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 ---EEFDNLADPRLGENYV-------EGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ---~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+..+ ....+..+. .....++.+++++||+.||++|+++.||+.+
T Consensus 320 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000000000 0112367789999999999999999999865
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.14 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=203.0
Q ss_pred cCccccccccccCcEEEEEEEcCC----CcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|.+.++||+|+||.||+|.+.+ ...|+||...... ....+.+.+|+.++++++|+||++++++|.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458888999999999999998543 2468999887554 2345679999999999999999999998875 567899
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++..... .+++..++.++.||+.||+|||++ +++|||||++|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999875433 489999999999999999999998 9999999999999999999999999999765444
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.........+...|+|||++....++.++|||||||++|||++ |+.||..... .....+.. ... .+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~-------~~~---~~ 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIE-------NGE---RL 227 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHH-------cCC---cC
Confidence 3222222334568999999988889999999999999999986 9999975431 11111110 000 00
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
. ........+.+++.+||..+|.+||++.++++.|+++...
T Consensus 228 ~-------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 P-------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred C-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0111223788999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=321.24 Aligned_cols=249 Identities=28% Similarity=0.458 Sum_probs=193.7
Q ss_pred ccccccCcEEEEEEEcCC-Cc--EEEEEEeecCC-CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLPD-GR--EVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|.+++ |. .+++|.++... ....+.+.+|+++++++ +|+||++++++|...+..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999643 43 56888876432 23346788999999999 799999999999999999999999999
Q ss_pred CchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 448 NTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 448 gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
|+|.++++... ...+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99998886432 12478899999999999999999998 99999999999999999999999999
Q ss_pred cchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhh
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHAL 592 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 592 (696)
+++....... ......+..|+|||++.+..++.++|||||||+||||++ |+.||.... .....+ . ..
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~---~----~~ 225 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE---K----LP 225 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHHHH---H----Hh
Confidence 9863221111 111223567999999988889999999999999999997 999996532 111111 1 10
Q ss_pred hhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
..... .........+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 226 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 10000 001112236889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.25 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=200.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.+.||+|+||.||+|... +++.||||.+...... ..+.+.+|+++++.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46889999999999999999865 5899999999754332 3456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++.......+++..++.++.||++||+|||+. +|+|||||++||||++++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999988765445689999999999999999999998 99999999999999999999999999987543221
Q ss_pred cc----------------------------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCC
Q 005443 523 TH----------------------------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574 (696)
Q Consensus 523 ~~----------------------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~ 574 (696)
.. .....+|+..|++||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11124678899999999998899999999999999999999999975431
Q ss_pred CCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC----HHHHHH
Q 005443 575 LGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR----MGQVVR 640 (696)
Q Consensus 575 ~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ell~ 640 (696)
...+ ..++ +..............+.+++++||+.++++|++ ++||++
T Consensus 238 --~~~~----~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 --DETF----SNIL-------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred --HHHH----HHHh-------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111 0011 000000001112347899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.84 Aligned_cols=256 Identities=24% Similarity=0.427 Sum_probs=201.2
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|++++.||+|+||.||+|.+. ++..||||+++.... ....++.+|+.++++++|+||++++++|..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 467899999875432 3346799999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCc
Q 005443 439 LLIYDYVPNNTLYFHLHGEG--------------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSN 498 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~N 498 (696)
++||||+.+++|.+++.... ...+.+..+++++.||+.||+|||++ +|+|||||++|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999988886321 12467888999999999999999999 99999999999
Q ss_pred eEECCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCC
Q 005443 499 ILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLG 576 (696)
Q Consensus 499 ILl~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~ 576 (696)
||+++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..+|....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--- 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--- 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 9999999999999999875432211 11122334667999999998899999999999999999997 878886432
Q ss_pred chhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 577 DESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
... ....+ ...+... ........+.+++.+||+.+|++||++.||++.|++
T Consensus 238 ~~~---~~~~~-----~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEE---VIYYV-----RDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHH---HHHHH-----hcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 11111 1111100 011122468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=316.30 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=202.5
Q ss_pred cCccccccccccCcEEEEEEEcCC-CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|++.++||+|+||.||+|...+ ++.|++|.++.... .+++.+|++++++++|+||+++++++.+++..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999754 88999999875432 678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++...+ ..+++..++.++.||++||.|||+. +|+||||+++||++++++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999886543 3589999999999999999999999 999999999999999999999999999986644332 2
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
.....++..|++||++.+..++.++|||+|||++|||++|+.||........ ... . ... ....+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~----~-----~~~-----~~~~~ 219 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFM----I-----PNK-----PPPTL 219 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhh----h-----ccC-----CCCCC
Confidence 2234578899999999988999999999999999999999999975432110 000 0 000 00000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.........+.+++.+||+.+|++||++.||++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011112236889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=346.64 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=191.4
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeC--------C
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISD--------D 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--------~ 436 (696)
.++|+++++||+|+||.||+|.. ..++.||||++... .....+|+.+|++++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 46799999999999999999986 46889999988632 23456799999999999999999887542 1
Q ss_pred ceeEEEEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-cEEEEeec
Q 005443 437 RRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFG 513 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfG 513 (696)
..++||||+.+ +|.+++.. .....+.+..++.++.||+.||+|||++ +|||||||++||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999975 55554432 2234588999999999999999999999 999999999999998654 79999999
Q ss_pred cchhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH---H
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL---S 589 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~---~ 589 (696)
+++....... .....|+..|+|||++.+ ..|+.++|||||||+||||++|..+|.+.... +.+.+....+- .
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCH
Confidence 9986543322 223468899999999876 46899999999999999999999999764321 11111111000 0
Q ss_pred Hhhh--hhhhhc-----ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 590 HALE--NEEFDN-----LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 590 ~~~~--~~~~~~-----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.+. ...+.+ +....+...+......++++|+.+||+.||++|+++.|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 000001 000111111111122468899999999999999999999964
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=318.94 Aligned_cols=250 Identities=27% Similarity=0.483 Sum_probs=199.8
Q ss_pred CccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC------ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
+|++.++||+|+||.||+|...+|+.||||.++.... +....+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999988899999999875432 1224588999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++.+.. .+.+..++.++.||+.||+|||+. +|+|+||+++||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999987544 378899999999999999999998 9999999999999999999999999998764321
Q ss_pred C-----cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 522 N-----THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 522 ~-----~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
. ........|+..|++||++.+..++.++|||+|||++|||++|+.||....... .... . ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~-~----~~~-- 223 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFY-I----GAH-- 223 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHH-h----hhc--
Confidence 1 112223468889999999998889999999999999999999999997532111 0000 0 000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
... ...+.. .....+.+++++||+.++.+||++.|+++
T Consensus 224 -~~~-~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 -RGL-MPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -cCC-CCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 011111 12236789999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.70 Aligned_cols=248 Identities=30% Similarity=0.514 Sum_probs=201.3
Q ss_pred ccccccCcEEEEEEEcCC----CcEEEEEEeecCCCcc-HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|...+ +..|+||+++...... .+++.+|+++++.++|+||+++++++...+..++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999643 8899999997654433 57899999999999999999999999998999999999999
Q ss_pred CchhhccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 448 NTLYFHLHGEG-------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 448 gsL~~~l~~~~-------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
++|.+++.... ...+++..+++++.||+.||+|||++ +|+||||+++||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999987652 24589999999999999999999998 999999999999999999999999999987654
Q ss_pred cCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
... .......++..|+|||.+....++.++|||||||++|||++ |..||.... ...+.+... . ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~-------~-~~-- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEYLR-------K-GY-- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHH-------c-CC--
Confidence 331 12233457889999999998889999999999999999999 699987642 112211111 0 00
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
. .........++.+++.+||+.++++||++.+|++.|+
T Consensus 225 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 R-------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C-------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0011111347889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.42 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=199.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|+++++||+|+||.||+|+.. +++.|++|++........+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999864 58999999998665555677899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|..++.... ..+++..++.++.||+.||+|||++ +|+|||||++||+++.++++||+|||++.........
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~- 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR- 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc-
Confidence 9999987775433 2489999999999999999999998 9999999999999999999999999998654332211
Q ss_pred eeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 526 TTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.....++..|++||++. ...++.++|||||||++|||++|+.+|..... .+....+. ... ...+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~----~~~-~~~~ 235 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA----KSE-PPTL 235 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHh----cCC-CccC
Confidence 22345788999999985 34567899999999999999999999875331 11111110 000 0000
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........++.+++++||+.+|++||++.+|++.
T Consensus 236 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 -------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0011122368899999999999999999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=322.93 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=203.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++.+.||+|+||.||++... +|+.||+|++..... ...+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999854 688999999875432 3356789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++...+ .+.+..++.++.||+.||.|||+.. +|+||||+++||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999988887644 3889999999999999999999732 89999999999999999999999999986543222
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCc-----hhHHHhHHHHHHHhhhhhhhhc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-----ESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.....|+..|++||++.+..++.++|||||||++|||++|+.||.......+ ..+.++....+. ...
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-- 230 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-----EPP-- 230 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-----ccC--
Confidence 1234688999999999888999999999999999999999999986543211 111111111110 000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
..+.. ......+.+++.+||+.||++||++.||++++
T Consensus 231 ---~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00000 11223688999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.22 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=193.8
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHc---cCCCceeEEeEEeeC-----C
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRI---HHRHLVSLVGYCISD-----D 436 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~-----~ 436 (696)
+|++.+.||+|+||.||+|+.. +|+.||||.++..... ....+.+|+++++++ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999864 6889999998754322 234566777777765 699999999988643 3
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..++||||+.+ +|.+++.......+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 46899999975 787777665545589999999999999999999999 99999999999999999999999999997
Q ss_pred hccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.+|...... .........+... ....
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~-~~~~ 230 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLP-PEDD 230 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH---HHHHHHHHHhCCC-Chhh
Confidence 654322 122346789999999999889999999999999999999999998754321 1111111110000 0000
Q ss_pred hhcc-------cCcccC---CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 597 FDNL-------ADPRLG---ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 597 ~~~~-------~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
+... ...... ..........+.+++.+||+.||++|+++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 000000 0001112235789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.37 Aligned_cols=247 Identities=26% Similarity=0.482 Sum_probs=198.8
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++.+.||+|+||.||++.. +++.||+|+++.. ...+.+.+|+.++++++|+||+++++++.. +..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4588899999999999999986 7888999998643 234678999999999999999999999865 45799999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++.......+.+..+++++.||+.||.|||++ +++|||||++|||++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999998766555689999999999999999999998 99999999999999999999999999987543221
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
........|++||++.++.++.++|||||||++|||++ |+.||..... ..+.+ .+. .. +
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~----~~-~-------- 214 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKE----CVE----KG-Y-------- 214 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHH----HHh----CC-C--------
Confidence 11234567999999998899999999999999999997 9999875321 11111 111 00 0
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
...........+.+++.+||+.++++||++++|++.|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 000111122368899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=317.47 Aligned_cols=248 Identities=27% Similarity=0.466 Sum_probs=198.3
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCcc---------HHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQG---------EREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
+|.+.+.||+|+||.||+|.. .+++.||||.+....... .+.+.+|++++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999985 468899999886543221 2458899999999999999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.++||||+.+++|.+++...+. +++..++.++.||+.||+|||++ +|+||||+++|||+++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999998876543 78889999999999999999998 999999999999999999999999999876
Q ss_pred ccccCcc-----eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhh
Q 005443 518 ALDANTH-----ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592 (696)
Q Consensus 518 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 592 (696)
....... ......|+..|++||++.+..++.++|||+|||++|||++|+.||...... +..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~----~ 225 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKI----G 225 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHH----h
Confidence 6432111 112245788999999999888999999999999999999999999753210 000000 0
Q ss_pred hhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
......+ .......+.+++++||+.|+.+||++.||++
T Consensus 226 ------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ------ENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------ccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0011111 1122336889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.95 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=202.3
Q ss_pred cCccccccccccCcEEEEEEEcC--------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 436 (696)
.+|++++.||+|+||.||+|... ++..||+|+++.... ...+++.+|+++++++ +|+||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 123789998874432 2346789999999999 7999999999999999
Q ss_pred ceeEEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~ 502 (696)
..++||||+.+|+|.+++.... ...+.+..+++++.||+.||+|||++ +|+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999998886431 23478889999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhH
Q 005443 503 NNFEAQVSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESL 580 (696)
Q Consensus 503 ~~~~vkL~DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l 580 (696)
+++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..+|.... .+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEE- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---HHH-
Confidence 99999999999997654322111 112234567999999999999999999999999999998 888886532 111
Q ss_pred HHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 581 VEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+...+ . .... ..........+.+++++||+.+|++||++.||++.|+++..
T Consensus 245 --~~~~~-~----~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 245 --LFKLL-K----EGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred --HHHHH-H----cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11111 0 0000 00111223368899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=331.18 Aligned_cols=193 Identities=24% Similarity=0.358 Sum_probs=164.1
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
..+|++++.||+|+||.||+|+.. +++.||+|+... .....|+.++++++|+||++++++|...+..++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 467999999999999999999864 577899997542 2345799999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+. ++|.+++.... ..+++..+++|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 139 YS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred cC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 95 57777775433 2489999999999999999999999 99999999999999999999999999997533221
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCC
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~ 571 (696)
......|+..|+|||++.+..++.++|||||||+||||+++..++..
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 12235689999999999999999999999999999999986655533
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=324.22 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=203.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.+|++.+.||+|+||.||+|.. .+|+.||||.+........+.+.+|+.+++.++|+||++++++|..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6799999999999999999985 579999999998766666677899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++... .+++..+++++.|++.||.|||+. +|+|||||++||||++++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 999999988643 378899999999999999999998 999999999999999999999999999875433222 1
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
.....++..|++||.+.+..++.++|||+|||++|+|++|+.||...+.... +.. ..... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~--------~~~~~-~~~------ 234 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL--------IATNG-TPE------ 234 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee--------eccCC-CCC------
Confidence 2234678899999999988899999999999999999999999975432110 000 00000 000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..........+.+++.+||+.+|++|+++++|++.
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 -LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111122357889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=320.47 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=204.0
Q ss_pred cCccccccccccCcEEEEEEEcC-----CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEee--CCce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-----DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 438 (696)
+.|++.+.||+|+||.||+|.+. .++.||||+++..... ..++|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777899999999999999853 3689999999755443 45679999999999999999999999887 5578
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+.+++|.+++..... .+++..++.++.||+.||+|||++ +|+|||||++|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999876543 489999999999999999999998 9999999999999999999999999999876
Q ss_pred cccCcce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHH----HhHHHHHHHhh
Q 005443 519 LDANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV----EWARPLLSHAL 592 (696)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~----~~~~~~~~~~~ 592 (696)
....... .....+...|++||.+.+..++.++|||+|||++|||++|+.+|..........+. .+....+.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 5332211 11223456799999999889999999999999999999999988643211100000 00000000011
Q ss_pred hhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
... ............+.+++.+||+.+|++||+|.||+++|+++
T Consensus 240 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 100 00011111224688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=315.64 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=204.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|++.+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999864 57899999998766566678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||+++||++++++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 9999998887542 2488999999999999999999998 999999999999999999999999999876543221 1
Q ss_pred eeccccccccCchhhhccC---CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 526 TTRVMGTFGYMAPEYASSG---KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~---~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.....++..|++||++.+. .++.++|||+|||++|||++|+.||...... ..... . .... +..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--~~~~~----~-----~~~~---~~~ 223 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALFL----I-----SKSN---FPP 223 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----H-----Hhcc---CCC
Confidence 2234678899999999776 8899999999999999999999999754311 11100 0 0000 000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..+. ........+.+++++||+.+|.+||++.+|+.
T Consensus 224 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0110 11223346889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.58 Aligned_cols=267 Identities=21% Similarity=0.312 Sum_probs=197.5
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999864 689999999875432 2346788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 445 VPNNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 445 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
+. ++|.++++... ...+++..++.++.||++||+|||++ +|+||||+++|||+++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 57777765432 24589999999999999999999999 99999999999999999999999999987543322
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH---HHhh----hhh
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL---SHAL----ENE 595 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~----~~~ 595 (696)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.+|...... ..+......+. ...+ ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchhhH
Confidence 12233457889999998865 45788999999999999999999999754321 11111111000 0000 000
Q ss_pred hhhcccCcccCC---CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGE---NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+.......... ........++.+++++||+.||++||++.+|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 0001122367899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=321.99 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=197.1
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||++++++|..++..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999965 5778899988755545566789999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
++|..++.... ..+++..++.++.||++||+|||++ +|+|||||++|||++.++++||+|||+++....... ...
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence 99988776532 2489999999999999999999999 999999999999999999999999999875433221 122
Q ss_pred ccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 528 RVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
...++..|++||++. +..++.++|||||||++|||++|+.||..... .+..... .. .....+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~----~~-----~~~~~~~~ 230 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLKI----AK-----SEPPTLAQ 230 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHHH----hh-----cCCCCCCC
Confidence 346888999999984 34577899999999999999999999875331 0111111 00 00000000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. .....+.+++++||+.++.+||++.+|+++
T Consensus 231 ---~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 ---PS----RWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---cc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01 112368899999999999999999988754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.57 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=197.1
Q ss_pred HHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC----
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD---- 436 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---- 436 (696)
...++|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++|+||+++++++...+
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999854 68899999986432 223456889999999999999999999886543
Q ss_pred --ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 437 --RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 437 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
..++||||+.+ +|...+.. .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999976 45555532 278889999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHH---------
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR--------- 585 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~--------- 585 (696)
++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.+|....... .+.....
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence 97653322 2233568999999999999999999999999999999999999997643211 1110000
Q ss_pred -----HHHHHhhhh-hhhhcccCc-----cc---CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 586 -----PLLSHALEN-EEFDNLADP-----RL---GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 586 -----~~~~~~~~~-~~~~~~~d~-----~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+....+. ..+..+... .+ ...........+.+++.+||+.||++|+++.||+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 000000000 00 000111123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=315.69 Aligned_cols=251 Identities=30% Similarity=0.497 Sum_probs=201.5
Q ss_pred ccccccccccCcEEEEEEEcCC-----CcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 369 FADQNLLGEGGFGSVYKGYLPD-----GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
|++.+.||+|+||.||++...+ +..||+|+++..... ..+.+.+|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998643 488999999755443 4568999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++.......+.+..++.++.||+.||+|||++ +|+||||+++||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998765443389999999999999999999999 99999999999999999999999999997665442
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
........++..|++||.+.+..++.++|||+|||++|||++ |+.+|.... ...+.+... ......
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~--------~~~~~~-- 224 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLEYLK--------KGYRLP-- 224 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHh--------cCCCCC--
Confidence 222212336789999999988889999999999999999998 788876522 112211111 110000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
.......++.+++.+||+.+|++||++.++++.|
T Consensus 225 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111234688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=318.14 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=200.1
Q ss_pred HHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 363 VKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 363 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
+..++++....+||+|+||.||+|++. +++.|++|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344566666788999999999999854 6788999998766656667899999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-CCcEEEEeeccchhcc
Q 005443 442 YDYVPNNTLYFHLHGEGRP-VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLAL 519 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls~~~~ 519 (696)
+||+.+++|.++++..... ..++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999988754221 237888899999999999999998 9999999999999976 6799999999987653
Q ss_pred ccCcceeeccccccccCchhhhccCC--CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 520 DANTHITTRVMGTFGYMAPEYASSGK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
.... ......|+..|++||++.+.. ++.++|||||||++|||++|+.||...... ....+......
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~-------- 228 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFK-------- 228 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhc--------
Confidence 3222 122345788999999987643 788999999999999999999999753211 11111000000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ...+......++.+++++||+.+|++||++.||+++
T Consensus 229 -~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -I------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -c------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 001111122368889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.37 Aligned_cols=240 Identities=23% Similarity=0.392 Sum_probs=188.1
Q ss_pred ccccccCcEEEEEEEcCC-------------CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 373 NLLGEGGFGSVYKGYLPD-------------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
+.||+|+||.||+|++.. +..|++|++..........|.+|+.+++.++|+||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899887655455567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc-------EEEEee
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE-------AQVSDF 512 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~-------vkL~Df 512 (696)
+||||+.+++|..+++.... .+++..+++|+.||++||+|||++ +|+|||||++||||+.++. +||+||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999888765432 489999999999999999999999 9999999999999986654 899999
Q ss_pred ccchhccccCcceeeccccccccCchhhhc-cCCCCccccccchHHHHHHHH-hCCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 513 GLAKLALDANTHITTRVMGTFGYMAPEYAS-SGKLTEKSDVFSFGVVLLELI-TGRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~eLl-tg~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
|++...... ....++..|+|||++. +..++.++|||||||+||||+ .|+.||...... +. ..+..
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~-~~~~~- 223 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------EK-ERFYE- 223 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------HH-HHHHh-
Confidence 998654322 1235788899999987 467899999999999999998 588877643211 00 00000
Q ss_pred hhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 591 ALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
..+ .+ .. ....++.+|+.+||+.||++||++.+|++.|+
T Consensus 224 ----~~~-~~-----~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 ----GQC-ML-----VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ----cCc-cC-----CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 00 00 11236789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=328.47 Aligned_cols=266 Identities=17% Similarity=0.268 Sum_probs=195.1
Q ss_pred cccccccc--CcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 371 DQNLLGEG--GFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 371 ~~~~LG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++++||+| +|++||++.. .+|+.||||+++.... ...+.+.+|+++++.++|+||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7889999985 4789999999975432 23356788999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc-
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH- 524 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~- 524 (696)
.+|+|.+++.......+++..+++++.||+.||+|||++ +|+|||||++||||+.++.++|+||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999988654444589999999999999999999998 9999999999999999999999999875443221111
Q ss_pred -----eeeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh----
Q 005443 525 -----ITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE---- 593 (696)
Q Consensus 525 -----~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~---- 593 (696)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+.....+....+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHHhcCCccccccccch
Confidence 1112346778999999976 45889999999999999999999999753211 1111111000000000
Q ss_pred -hhhhh-----cccCccc-----------------CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 -NEEFD-----NLADPRL-----------------GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 -~~~~~-----~~~d~~l-----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+++. ...+..+ ...+.......+.+++++||+.||++||+++||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000 0000000 000111223468899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=314.98 Aligned_cols=250 Identities=23% Similarity=0.390 Sum_probs=200.6
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-ceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDD-RRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lV~E 443 (696)
+|++.+.||+|+||.||++..+ +++.||||++..... ...+.+.+|++++++++|+||+++++.+...+ ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999854 578999999875432 33456889999999999999999999876544 5789999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++.......+++.++++++.||+.||+|||++ +|+|||||++||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999988765455689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.......++..|+|||++.+..++.++|||||||++|||++|+.+|...+ ..++...+... .+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~-----~~~----- 220 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEG-----KLP----- 220 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc-----CCC-----
Confidence 22233567889999999999999999999999999999999999987532 11111111110 000
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ........+.+++.+||+.+|++||++.+|+++
T Consensus 221 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 P----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred C----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 111222368899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=325.63 Aligned_cols=283 Identities=27% Similarity=0.440 Sum_probs=209.3
Q ss_pred cCccccccccccCcEEEEEEEcC-CCc----EEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|+..++||+|+||.||+|.+. +|+ .||+|++..... ....++.+|+.++++++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46788899999999999999853 444 578888864433 2234688999999999999999999998754 5679
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|+||+.+|+|.+++..... .+.+..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999988875432 478899999999999999999999 999999999999999999999999999986543
Q ss_pred cCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... ......++..|++||++.+..++.++|||||||++|||++ |+.||.... ...+.+++ .. ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~----~~---~~~-- 229 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLL----EK---GER-- 229 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HC---CCC--
Confidence 2221 1122345678999999998899999999999999999997 899986532 11121111 10 000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccccCCCccCcccccchhhhhHHHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQQSAEIRWFRR 676 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~~~~~~~~~~~~sa~~~~~~~~~r~ 676 (696)
+.. .......+.+++.+||..++++||++++|++.|+++...... ......+.+..+.......+|.+
T Consensus 230 -~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 297 (303)
T cd05110 230 -LPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR--YLVIQGDDRMKLPSPNDSKFFQN 297 (303)
T ss_pred -CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhh--heeeccCCcCCCCCCchhhHHhc
Confidence 000 011123688999999999999999999999999987643221 22233333333444444444443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=320.83 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=201.7
Q ss_pred CHHHHHHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEee-
Q 005443 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCIS- 434 (696)
Q Consensus 358 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~- 434 (696)
++.++....+.|++.+.||+|+||.||+|.+ ++++.||+|++.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3455555668899999999999999999986 468899999986543 2345688999999998 69999999999863
Q ss_pred -----CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEE
Q 005443 435 -----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV 509 (696)
Q Consensus 435 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL 509 (696)
.+..++||||+.+|+|.+++.......+.+..++.++.||+.||.|||++ +|+||||+++||+|++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 35679999999999999888765555588889999999999999999999 9999999999999999999999
Q ss_pred EeeccchhccccCcceeeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhH
Q 005443 510 SDFGLAKLALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWA 584 (696)
Q Consensus 510 ~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~ 584 (696)
+|||+++....... ......|+..|+|||++. +..++.++|||||||++|||++|+.||....... .+..
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~~~~-- 237 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--ALFL-- 237 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--hhhh--
Confidence 99999875532221 122346888999999986 3467889999999999999999999996532110 0000
Q ss_pred HHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 585 RPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
+ .......+. .......+.+++.+||+.||.+||++.||++
T Consensus 238 ---~---------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ---I---------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---H---------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000000000 0112236889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=331.95 Aligned_cols=267 Identities=21% Similarity=0.286 Sum_probs=196.5
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeC------
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD------ 435 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 435 (696)
..++|++.++||+|+||.||++... .++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999854 68899999986432 23345788999999999999999999987643
Q ss_pred CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
...++||||+.+ +|...+.. .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 346899999965 56555542 278889999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhH------------HHh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL------------VEW 583 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l------------~~~ 583 (696)
+...... ......|+..|+|||++.+..++.++|||||||+||||++|+.+|........... ...
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 7653322 12334689999999999999999999999999999999999999976432111000 000
Q ss_pred HHHHHHHhhhhh------hhhcccCccc---CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 584 ARPLLSHALENE------EFDNLADPRL---GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 584 ~~~~~~~~~~~~------~~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....+....++. .+..+....+ ...........+.+++.+||+.||++|+++.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 0000000000 000011122367899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.69 Aligned_cols=267 Identities=21% Similarity=0.315 Sum_probs=201.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++.++||+|+||.||+|.++ +|+.||+|++..... ...+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47889999999999999999865 689999999864432 234568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.++.|..++.... .+++..+++++.||+.||+|||++ +|+|||||++||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999998887765443 389999999999999999999998 999999999999999999999999999986644332
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHH---HHHHHh---hhhhh
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR---PLLSHA---LENEE 596 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~---~~~~~~---~~~~~ 596 (696)
......++..|++||++.+ ..++.++|||||||++|||++|+.||......+ .+..+.. .++... +....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhccccc
Confidence 1223457789999999876 557889999999999999999999997644211 1111111 000000 00000
Q ss_pred h-hcccCcccCCCc-----chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 597 F-DNLADPRLGENY-----VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 597 ~-~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+ ..+......... .......+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000000000000 01112468899999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=316.29 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=193.8
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC-----ccHHHHHHHHHHHHHccCCCceeEEeEEeeC--Cce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-----QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 438 (696)
.+|+..++||+|+||.||+|.. ..|+.|++|+++.... +..+.+.+|+.++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999985 4689999999864322 2234688999999999999999999988753 467
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++++||+.+++|.+++..... +++..++.++.||+.||+|||++ +|+||||+++||++++++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 899999999999998876543 78899999999999999999998 9999999999999999999999999998754
Q ss_pred cccC--cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 519 LDAN--THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 519 ~~~~--~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
.... ........++..|+|||++.+..++.++|||+|||++|||++|+.||..... .+...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~----~--- 223 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIA----T--- 223 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHh----c---
Confidence 3211 1112234578899999999988899999999999999999999999975321 11111000 0
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
......+ .......+.+++ +||..+|++||+|+||+++
T Consensus 224 --~~~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 224 --QPTNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --CCCCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0001111 111222455566 6888999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=314.54 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=200.1
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-----ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-----QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
+|++.++||+|+||.||+|... +++.|+||.+..... +..+.+.+|++++++++|+||+++++++..++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999965 789999999875432 2346789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
+||+.+++|.+++.... .+++..++.++.||+.||+|||+. +|+|+||+++||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999887654 378999999999999999999999 9999999999999999999999999998765433
Q ss_pred CcceeeccccccccCchhhhccCC-CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
. ......++..|++||.+.... ++.++|||+|||++|+|++|+.||..... .+.... .........
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~----~~~~~~~~~- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFK----IGRSKELPP- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHH----HHhcccCCC-
Confidence 2 223356788999999988766 89999999999999999999999975431 010000 000001111
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.......+.+++++||+.+|.+||++.+++..
T Consensus 223 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 --------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111122367889999999999999999999853
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.14 Aligned_cols=256 Identities=28% Similarity=0.448 Sum_probs=202.3
Q ss_pred cCccccccccccCcEEEEEEEcC-CCc----EEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|++.+.||+|+||.||+|.++ +|+ .||+|+++.... ....++.+|++++++++|+||++++++|.. +..++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888899999999999999854 333 589998865533 234678899999999999999999999987 78899
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+|+|.++++.... .+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999998876433 389999999999999999999998 999999999999999999999999999986543
Q ss_pred cCccee-eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTHIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
...... ....++..|++||.+....++.++|||||||++|||++ |+.+|+... .+++.+... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~-------~~~--- 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP---AVEIPDLLE-------KGE--- 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHh-------CCC---
Confidence 322111 11223568999999988899999999999999999998 999997532 111111110 000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.+.. .......+.+++.+||..++.+||++.+|++.|+++..
T Consensus 229 ~~~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 RLPQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0000 11112367889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=314.82 Aligned_cols=250 Identities=21% Similarity=0.389 Sum_probs=202.8
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.+.||+|+||.||++.. .+|+.|+||++.... ....+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999985 468999999987542 23345789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++.......+.+..+++++.||+.||.|||++ +|+|+||+++|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999888765544578999999999999999999998 999999999999999999999999999976543322
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
......|+..|++||++.+..++.++|||+|||++|+|++|+.+|.... ..+.....+. .....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~-----~~~~~----- 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIR-----GSYPP----- 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhc-----CCCCC-----
Confidence 1223457889999999998889999999999999999999999987432 1111111111 00000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........+.+++.+||+.+|.+||+|.+|+++
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111123368899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=320.35 Aligned_cols=266 Identities=24% Similarity=0.358 Sum_probs=202.3
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++.+.||+|+||.||+|..+ +++.|+||+++... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999865 58899999987542 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.++.|..++.... .+++..++.++.||+.||+|||++ +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999877766554433 388999999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh----hh----h
Q 005443 524 HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA----LE----N 594 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~----~~----~ 594 (696)
.......++..|++||++.+. .++.++|||+||++||||++|+.+|...... +.+......+... .. .
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcccC
Confidence 233345678899999999887 8899999999999999999999999754321 1111111100000 00 0
Q ss_pred hhhhc--ccCcc----cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 595 EEFDN--LADPR----LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 595 ~~~~~--~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..+.. +.+.. +...+.......+.+++++||+.+|++||++++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00000 000111112356899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=322.89 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=203.3
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.+|++.+.||.|+||.||+|.. .+|+.|+||.+........+.+.+|+++++.++|+||++++++|...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999984 578999999998666566678899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++... .+++..+++++.||+.||+|||++ +|+|||||++||++++++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999888643 379999999999999999999999 999999999999999999999999999876543322 1
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
.....++..|++||.+.+..++.++|||||||++|+|++|+.||...... +...... .. ....+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~----~~-~~~~~~---- 236 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIA----TN-GTPELQ---- 236 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH----hc-CCcccC----
Confidence 22346788999999999888999999999999999999999999764321 1100000 00 000000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........+.+++++||+.||++|+++.+|++.
T Consensus 237 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 011122368889999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.18 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=190.4
Q ss_pred ccccccCcEEEEEEEcCC---CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCC
Q 005443 373 NLLGEGGFGSVYKGYLPD---GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
+.||+|+||.||+|.+.+ +..+++|.++.... .....+.+|+.++++++|+||+++++++.+....++||||+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998543 46799998875443 23457889999999999999999999999988999999999999
Q ss_pred chhhccccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 449 TLYFHLHGEG---RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 449 sL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
+|.++++... ....++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9998886432 22456778889999999999999999 99999999999999999999999999997543332211
Q ss_pred -eeccccccccCchhhhccC-------CCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 526 -TTRVMGTFGYMAPEYASSG-------KLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 526 -~~~~~gt~~y~aPE~l~~~-------~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
.....++..|+|||++.+. .++.++|||||||++|||++ |+.||..... ....... + ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~~~~---~-----~~~ 226 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD---EQVLTYT---V-----REQ 226 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH---h-----hcc
Confidence 1234567889999998642 35789999999999999996 9999965321 1111110 0 011
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
...+.+..+... ....+.+++.+|| .+|++||+++||+..|.
T Consensus 227 ~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111122222111 1225677888998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.05 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=202.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++.+.||.|+||.||+|... +++.|+||++.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999854 68899999997654 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.++++.. .+++..++.++.||+.||.|||++ +|+||||+++||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999988754 489999999999999999999998 999999999999999999999999999977654321
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
......++..|++||++.+..++.++|||+|||++|||++|+.||...+.. +....+ .......
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~-----~~~~~~~----- 217 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLI-----PKNNPPS----- 217 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHh-----hhcCCCC-----
Confidence 223346788899999999888999999999999999999999999754311 111100 0000111
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+... .....+.+++.+||..+|++||++++|+++
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 022368889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=325.74 Aligned_cols=196 Identities=26% Similarity=0.408 Sum_probs=159.3
Q ss_pred cccccccCcEEEEEEEcC---CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee--CCceeEEEEecC
Q 005443 372 QNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLLIYDYVP 446 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~ 446 (696)
.++||+|+||.||+|+.. +++.||||.++.. .....+.+|+++|++++|+||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999854 4678999988643 234567899999999999999999998864 345789999986
Q ss_pred CCchhhccccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE----CCCCcEEEEeeccc
Q 005443 447 NNTLYFHLHGE-------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLA 515 (696)
Q Consensus 447 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DfGls 515 (696)
+ +|.+++... ....+.+..++.++.||+.||+|||++ +|+|||||++|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 666555321 122478899999999999999999999 99999999999999 45678999999999
Q ss_pred hhccccCcc--eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 516 KLALDANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 516 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
+........ ......|+..|+|||++.+ ..++.++|||||||++|||++|+.+|....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 865433221 1234578999999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=315.49 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=191.3
Q ss_pred ccccccCcEEEEEEEcC----CCcEEEEEEeecC-CCccHHHHHHHHHHHHHccCCCceeEEeEEee-CCceeEEEEecC
Q 005443 373 NLLGEGGFGSVYKGYLP----DGREVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLLIYDYVP 446 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~ 446 (696)
++||+|+||.||+|.+. ++..||||++... .....+.+.+|+.+++.++|+||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988533 22335678899999999999999999998764 456789999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc--
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-- 524 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~-- 524 (696)
+++|.+++..... .+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...+....
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999875432 367788899999999999999998 9999999999999999999999999999755332211
Q ss_pred -eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCC-CCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 525 -ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK-PVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 525 -~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~-Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
......++..|+|||++.+..++.++|||||||++|||++|.. +|...+ ...+.+. +. ... ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~---~~----~~~---~~~- 222 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVY---LL----QGR---RLL- 222 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH---Hh----cCC---CCC-
Confidence 1112345678999999998899999999999999999999654 454321 1111111 10 000 000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
... .....+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 223 --~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 --QPE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001 11236889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=353.35 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=201.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+|... .|+.||||+++.... ...+++.+|++++++++|+||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999854 689999999974322 22457899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 443 DYVPNNTLYFHLHGEG---------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
||+.|++|.+++.... ...+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999988875311 12356677899999999999999999 99999999999999999999999999
Q ss_pred cchhccccCc-----------------ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCC
Q 005443 514 LAKLALDANT-----------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576 (696)
Q Consensus 514 ls~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~ 576 (696)
+++....... ......+|+..|||||++.+..++.++|||||||+||||++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9976521110 0112346899999999999999999999999999999999999999753211
Q ss_pred chhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhhc
Q 005443 577 DESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-RMGQVVRVFDSLAT 647 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l~~ 647 (696)
.+.. . .. +.+..... ........+.+++.+||+.||++|+ +++++++.|+....
T Consensus 238 --ki~~--~----~~--------i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 --KISY--R----DV--------ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred --hhhh--h----hh--------ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 0 00 00000000 0011123578899999999999996 67777777777654
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=320.65 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=199.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+.|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++|+||++++++|..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34667788999999999999854 57899999987543 23345789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++... .+.+..++.++.||++||.|||++ +|+|+||+++||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 84 LGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred cCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999998888642 378999999999999999999998 999999999999999999999999999976543321
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
......++..|++||++.+..++.++|||||||++|||++|+.||...... ....+ + ... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~----~----~~~-----~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLFL----I----PKN-----SPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHhh----h----hcC-----CCCC
Confidence 122245788999999999989999999999999999999999998743211 11100 0 000 0011
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........+.+++.+||+.+|.+||+|.+|+++
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 ----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111223468899999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.12 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=195.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC-----ccHHHHHHHHHHHHHccCCCceeEEeEEeeC--Cce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-----QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 438 (696)
++|++.++||+|+||.||+|.. .+|+.|+||+++.... ...+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999985 4689999999864321 1235688899999999999999999988764 456
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+.+++|.+++..... +++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 799999999999988875433 78888999999999999999999 9999999999999999999999999998754
Q ss_pred cccCc--ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 519 LDANT--HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 519 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .... .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~-~~~~----~~~- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAAI-FKIA----TQP- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHHH-HHHh----cCC-
Confidence 32211 112234588899999999888899999999999999999999999974311 1110 0000 000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
............+.+++.+||. ++++||+++||++.
T Consensus 226 --------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 --------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0011122233467788899985 89999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=320.12 Aligned_cols=263 Identities=24% Similarity=0.382 Sum_probs=202.0
Q ss_pred cCHHHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEee
Q 005443 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCIS 434 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 434 (696)
+.++.+....++|++.+.||+|+||.||+++.. +++.||||+++... ....++.+|+.+++++ +|+||++++++|..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445667777899999999999999999999854 68899999876432 2345788999999999 69999999998853
Q ss_pred -----CCceeEEEEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 435 -----DDRRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 435 -----~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
++..++||||+.+++|.++++. .....+.+..++.++.||++||.|||++ +|+|||||++||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 3467999999999999887653 2233478899999999999999999998 99999999999999999999
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhcc-----CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~ 582 (696)
||+|||+++........ .....|+..|+|||++.. ..++.++|||||||++|||++|+.+|....... .+.+
T Consensus 164 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK 240 (286)
T ss_pred EEccCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh
Confidence 99999998765432221 223458899999999853 457889999999999999999999997543110 0000
Q ss_pred hHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 583 WARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
.... ....+.+. . .....+.+++.+||+.||++||++.||++.+
T Consensus 241 --------~~~~-~~~~~~~~---~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 --------IPRN-PPPTLHQP---E----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --------cccc-CCCcccCC---C----CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 00001111 0 1122588999999999999999999999753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.30 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=204.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++.+.||.|+||.||+|.. .+++.|++|++..... .....+.+|+++|+.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4789999999999999999985 4688999999865432 3456799999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 445 VPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
+.+++|.++++.... ..+++..++.++.||+.||+|||++ +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999875432 4589999999999999999999998 999999999999999999999999999976654433
Q ss_pred c---eeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 524 H---ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 524 ~---~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
. ......|+..|++||++... .++.++|||+|||++|||++|+.||...... ..+.+.. .. ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~--------~~-~~-- 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTL--------QN-DP-- 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHh--------cC-CC--
Confidence 2 22334688899999998876 7899999999999999999999999754321 1111110 00 00
Q ss_pred ccCcccCCCc-chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LADPRLGENY-VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.... .......+.+++.+||+.||++||++.+|++.
T Consensus 225 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 ---PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ---CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0010000 01223468899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=318.72 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=201.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|++.+.||+|+||.||+|... +++.||+|+++.......+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56888999999999999999864 68899999998765556678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++...+. .+++..+++++.||+.||.|||++ +|+||||+++||++++++.++|+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 85 DGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred CCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 99999988865433 489999999999999999999999 999999999999999999999999999876433222 2
Q ss_pred eeccccccccCchhhhcc-----CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 526 TTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.....++..|++||++.. ..++.++|||||||++|||++|+.||...... +....+. . .....+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~----~-~~~~~~ 228 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKIL----K-SEPPTL 228 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHh----c-CCCCCc
Confidence 233468889999999853 44678999999999999999999999754211 1111110 0 000000
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ........+.+++.+||+.+|.+||++.+|++.
T Consensus 229 ~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 D-------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred C-------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 001112367889999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=317.27 Aligned_cols=249 Identities=29% Similarity=0.526 Sum_probs=195.5
Q ss_pred ccccccCcEEEEEEEcCC-------CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 373 NLLGEGGFGSVYKGYLPD-------GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+.||+|+||.||+|+..+ ++.|+||.+..... ....++.+|+++++.++|+||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 25799998864432 3456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-----cEEEEeecc
Q 005443 445 VPNNTLYFHLHGE-----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-----EAQVSDFGL 514 (696)
Q Consensus 445 ~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-----~vkL~DfGl 514 (696)
+.+++|.++++.. ....+.+..++.++.||+.||+|||+. +|+|+|||++|||++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999888643 223478899999999999999999998 999999999999998877 899999999
Q ss_pred chhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhh
Q 005443 515 AKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHAL 592 (696)
Q Consensus 515 s~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 592 (696)
++........ ......++..|++||++.++.++.++|||||||++|||++ |+.||.... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~-------- 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHV-------- 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHH--------
Confidence 9765332211 1122345678999999999999999999999999999998 999987532 11111111
Q ss_pred hhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
.... .+ .........+.+++.+||+.+|.+||++++|++.|++
T Consensus 227 ~~~~--~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 TAGG--RL-------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hcCC--cc-------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0000 00 0111123468899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.67 Aligned_cols=266 Identities=21% Similarity=0.305 Sum_probs=202.4
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.+.||+|+||.||+|.. .+|+.|+||++.... ....+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588899999999999999985 478999999997654 23356799999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+ +++|.+++.... ..+++..+++++.||++||+|||++ +|+|+|||++||++++++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999998886544 3489999999999999999999999 9999999999999999999999999999876544322
Q ss_pred eeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH-----hhhh---h
Q 005443 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH-----ALEN---E 595 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~-----~~~~---~ 595 (696)
......++..|+|||++.+. .++.++|||+|||++|||++|+.+|..... .....+....+.. +.+. .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccCcc
Confidence 23335688999999998654 468899999999999999999877764331 1212111111100 0000 0
Q ss_pred hhhcccCcccC----CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLG----ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+..+...... .....+....+.+++.+||+.+|++|+++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00011223578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=320.66 Aligned_cols=239 Identities=23% Similarity=0.397 Sum_probs=186.7
Q ss_pred cccccCcEEEEEEEcC-------------------------CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeE
Q 005443 374 LLGEGGFGSVYKGYLP-------------------------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428 (696)
Q Consensus 374 ~LG~G~~g~Vy~~~~~-------------------------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l 428 (696)
+||+|+||.||+|.+. .+..|+||++.........+|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999741 123588998875544445678899999999999999999
Q ss_pred EeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC---
Q 005443 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF--- 505 (696)
Q Consensus 429 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~--- 505 (696)
+++|..+...+|||||+.+|+|..++.... ..+.+..+++++.||++||+|||++ +|+|||||++||||++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 999999999999999999999988886533 2478999999999999999999998 999999999999997543
Q ss_pred ----cEEEEeeccchhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHH-hCCCCCCCCCCCCchh
Q 005443 506 ----EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELI-TGRKPVDASQPLGDES 579 (696)
Q Consensus 506 ----~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLl-tg~~Pf~~~~~~~~~~ 579 (696)
.+||+|||++...... ....++..|++||.+.+ ..++.++|||||||++|||+ +|+.||...... .
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~ 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS---E 229 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH---H
Confidence 4899999998643221 12346788999998875 56899999999999999985 689988754321 1
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
..+. +... . .+ .. .....+.+++.+||+.+|++||+|.+|++.|.
T Consensus 230 ~~~~----~~~~---~---~~-----~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERF----YEKK---H---RL-----PE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH----HHhc---c---CC-----CC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 1100 0 00 01 11126889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.76 Aligned_cols=269 Identities=24% Similarity=0.373 Sum_probs=200.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++.++||+|+||.||+|.++ +++.||||++...... ..+.+.+|+++++.++|+||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999975 5899999988643322 34568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.++.|.++...... +++..++.++.||++||+|||+. +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 9999988877654433 89999999999999999999998 999999999999999999999999999876544332
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCch-hHHHhHHHHHHHh---hh-hhhh
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEWARPLLSHA---LE-NEEF 597 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~-~l~~~~~~~~~~~---~~-~~~~ 597 (696)
......++..|++||++.+ ..++.++|||||||++|||++|+.+|......... .+..+...+.... .. ...+
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2233467889999999875 45788999999999999999999988654321100 0000000000000 00 0000
Q ss_pred hcccCcccCCC-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLADPRLGEN-----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........... ........+.+++.+||+.+|++||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000 001123468899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.05 Aligned_cols=266 Identities=22% Similarity=0.360 Sum_probs=199.1
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++.+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999864 688999999875432 3345678999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+. ++|..++..... .+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 578777765432 478999999999999999999999 999999999999999999999999999975433222
Q ss_pred eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH--------Hhhhhh
Q 005443 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS--------HALENE 595 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~--------~~~~~~ 595 (696)
......++..|++||++.+ ..++.++|||||||+||||++|+.+|..... ...+......+. ......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCChhhchhhhccc
Confidence 1223456889999999875 4578899999999999999999999975432 122211111111 000111
Q ss_pred hhhcccCcccCCC----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGEN----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+........... ........+.+|+.+||+.||++|++++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111000110000 001112357899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.35 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=198.8
Q ss_pred CccccccccccCcEEEEEEEcCC--CcEEEEEEeecCCC----------ccHHHHHHHHHHHHH-ccCCCceeEEeEEee
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPD--GREVAIKQLKIGGG----------QGEREFKAEVEIISR-IHHRHLVSLVGYCIS 434 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~~----------~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~ 434 (696)
+|++.+.||+|+||.||+|.++. ++.||||.+..... ....++.+|+.++.+ ++|+||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999754 68899998864321 123457788888875 789999999999999
Q ss_pred CCceeEEEEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEee
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~Df 512 (696)
++..++||||+.+++|.+++.. .....+++..+++++.||+.||.|||+.. +|+||||+++|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999887743 22335889999999999999999999632 8999999999999999999999999
Q ss_pred ccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhh
Q 005443 513 GLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592 (696)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 592 (696)
|++....... ......|+..|++||++.+..++.++||||||+++|||++|+.||..... ......+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~---- 226 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIV---- 226 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHh----
Confidence 9997654432 22345688899999999988899999999999999999999999864321 11111111
Q ss_pred hhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
...+..+. .. .....+.+++++||+.||++||++.||.++|+
T Consensus 227 -~~~~~~~~----~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 -EAVYEPLP----EG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -hccCCcCC----cc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111100 00 11236889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=315.41 Aligned_cols=238 Identities=26% Similarity=0.455 Sum_probs=189.3
Q ss_pred ccccccCcEEEEEEEcCCCc-----------EEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 373 NLLGEGGFGSVYKGYLPDGR-----------EVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++||+|+||.||+|.+.+.. .|++|.++..... ...+.+|+.+|++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975432 5788877644333 6789999999999999999999999988 778999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-------cEEEEeecc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-------EAQVSDFGL 514 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-------~vkL~DfGl 514 (696)
|||+.+|+|.+++..... .+++..+++++.||+.||+|||++ +|+|||||++|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999998876543 488999999999999999999998 999999999999999887 799999999
Q ss_pred chhccccCcceeeccccccccCchhhhccC--CCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
+..... .....+...|++||++.+. .++.++|||||||++|||++ |..+|...... ....+.
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~~------- 219 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERFY------- 219 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHHH-------
Confidence 976543 1223466789999999876 78999999999999999999 57777653211 111100
Q ss_pred hhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 592 LENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
... ..+.. .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 220 -~~~--~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 -QDQ--HRLPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -hcC--CCCCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00000 00147889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=310.88 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=207.2
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+-|.++++||+|.||.||++.++ .|+.||||.+-.. .+.+++.+|+.+|++++.++||++||.+..+..+|||||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34777889999999999999864 6999999998754 45788999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
..|++.+.++.+++ .+.++++..|++..++||+|||.. .-||||||..||||+.+|.+||+|||++..+.+.-. .
T Consensus 111 GAGSiSDI~R~R~K-~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K 185 (502)
T KOG0574|consen 111 GAGSISDIMRARRK-PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K 185 (502)
T ss_pred CCCcHHHHHHHhcC-CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence 99999999876554 589999999999999999999998 889999999999999999999999999976654332 2
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
...++||..|||||++..-.|+.++||||||+...||..|+.||.+........++- .-.-+.+
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP----------------T~PPPTF 249 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP----------------TKPPPTF 249 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc----------------CCCCCCC
Confidence 344789999999999999999999999999999999999999998644321110000 0000111
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+....++-++++.||..+|++|-++.+|+++
T Consensus 250 --~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 --KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1123334478899999999999999999988875
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.05 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=203.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++.+.||+|+||.||++.++ +++.|++|++..... ...+++.+|++++++++|+||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999865 689999999876533 3446789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
+.+++|.+++.... ..+.+..+++++.||+.||+|||+ . +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999887653 348899999999999999999999 7 999999999999999999999999999876543322
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
. ...++..|++||++.+..++.++|||||||+||+|++|+.||...... .....+.....+.. . . .
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~----~-~-----~ 222 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNE----P-P-----P 222 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcC----C-C-----C
Confidence 1 156788999999999999999999999999999999999999754321 12222222211110 0 0 0
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+... .....+.+++.+||..+|++||++.+|+.+
T Consensus 223 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01010 022368899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.66 Aligned_cols=240 Identities=27% Similarity=0.342 Sum_probs=184.9
Q ss_pred ccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHc---cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRI---HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
||+|+||.||+|+.+ +|+.||||++..... .....+.+|..++.++ +|+||+++++++.+.+..+|||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 689999999864321 2223455677777665 699999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.+++...+. +++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 999888876543 89999999999999999999999 999999999999999999999999999875432222 223
Q ss_pred ccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccC
Q 005443 528 RVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~ 606 (696)
..+|+..|+|||++.+. .++.++|||||||+||||++|+.||..... . +....+. .... .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~---~~~~~i~-----~~~~-~~~----- 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---Q---QMYRNIA-----FGKV-RFP----- 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---H---HHHHHHH-----cCCC-CCC-----
Confidence 45689999999998764 488999999999999999999999975321 1 1111110 0000 011
Q ss_pred CCcchHHHHHHHHHHHHHhccCCCCCCC----HHHHHH
Q 005443 607 ENYVEGEMFRMIEAAAACVRHSAAKRPR----MGQVVR 640 (696)
Q Consensus 607 ~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ell~ 640 (696)
.. .....+.+++++||+.||++|++ +.++++
T Consensus 218 ~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred Cc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 10 01225778999999999999995 455543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.45 Aligned_cols=267 Identities=28% Similarity=0.392 Sum_probs=210.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+.|..-++||+|+||.||-+... .|+.||+|++..+ ..+.+...++|-.||.+++.+.||.+--.|++.+.+++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 67888999999999999999854 6999999998533 3344556789999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
..|+||+|..+|.+.+...+++..++-++.+|+.||++||+. +||+|||||+|||||+.|+|+|+|+||+..+.+..
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999999988888899999999999999999999999 99999999999999999999999999998776543
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. ....+||.+|||||+++++.|+...|.|+|||+||||+.|+.||.....-...+ +.-+..+. ..
T Consensus 342 ~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e--Evdrr~~~-----------~~ 406 (591)
T KOG0986|consen 342 P--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE--EVDRRTLE-----------DP 406 (591)
T ss_pred c--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH--HHHHHHhc-----------ch
Confidence 3 233489999999999999999999999999999999999999997654211110 00011110 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH--HHhhhcccccCCCc
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVRV--FDSLATSDLNNGMK 655 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~--L~~l~~~~~~~~~~ 655 (696)
..+...| ..+..+|.+..|..|+++|-- +++|.++ ++.+..+.+..+|.
T Consensus 407 ~ey~~kF----S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml 462 (591)
T KOG0986|consen 407 EEYSDKF----SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGML 462 (591)
T ss_pred hhccccc----CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCC
Confidence 1112222 236777888999999999963 4455543 34444334444443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=319.62 Aligned_cols=266 Identities=20% Similarity=0.279 Sum_probs=196.1
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.++||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888899999999999999864 689999999975432 2235678899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+ +|.+++.... ..+++..++.++.||++||.|||++ +|+|||||++|||++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 975 6766665432 2389999999999999999999999 999999999999999999999999999976533221
Q ss_pred eeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh--hhhhhccc
Q 005443 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE--NEEFDNLA 601 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~ 601 (696)
......++..|+|||++.+. .++.++|||||||++|||++|+.||..... .....+.....+..... ...+..+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 22234578899999998764 478999999999999999999999754332 11111111111100000 00000000
Q ss_pred Ccc----cCC-----CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPR----LGE-----NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~----l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.. ... .........+.+++++||+.||.+|+++++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 000 0001122467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.32 Aligned_cols=248 Identities=24% Similarity=0.404 Sum_probs=202.1
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+.|+..+.||.|+||.||+|..+ +++.||||+++... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999864 68899999987543 23456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++... .+++..++.++.|++.||+|||++ +|+|+||+++||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999988643 378889999999999999999998 999999999999999999999999999976543321
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
......++..|++||++.+..++.++|||||||++|||++|+.||....... ... .+ ...
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~-------------~~~ 216 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLF----LI-------------PKN 216 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhh----hh-------------hcC
Confidence 1223457889999999998889999999999999999999999997543210 000 00 000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
............+.+++++||+.+|++||++.+|++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1112223345578899999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=344.45 Aligned_cols=273 Identities=18% Similarity=0.250 Sum_probs=189.1
Q ss_pred HHhcCccccccccccCcEEEEEEEcCC--CcEEEEE------------------EeecCCCccHHHHHHHHHHHHHccCC
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLPD--GREVAIK------------------QLKIGGGQGEREFKAEVEIISRIHHR 423 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~il~~l~hp 423 (696)
...++|+++++||+|+||.||++.++. +..+++| .++ ........+++|+++|++++|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987532 2222222 111 1112235688999999999999
Q ss_pred CceeEEeEEeeCCceeEEEEecCCCchhhccccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceE
Q 005443 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEG---RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 500 (696)
Q Consensus 424 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NIL 500 (696)
||+++++++...+..++|+|++.+ +|..++.... ........+++|+.||+.||+|||++ +|||||||++|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 999999999999999999999854 5555543321 11234566788999999999999998 9999999999999
Q ss_pred ECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCC-CCchh
Q 005443 501 LDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP-LGDES 579 (696)
Q Consensus 501 l~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~-~~~~~ 579 (696)
|++++.+||+|||+++.+...........+|+..|+|||++.+..++.++|||||||+||||++|..++..... .....
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999987654443333446799999999999999999999999999999999998865433222 11122
Q ss_pred HHHhHHHHH---HHhhh-hhhhhcccCc-cc---CCCcc-----hHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 580 LVEWARPLL---SHALE-NEEFDNLADP-RL---GENYV-----EGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 580 l~~~~~~~~---~~~~~-~~~~~~~~d~-~l---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.+....+. .+... ...+.++++. .+ ...+. .....++.+++.+||+.||++|+++.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 222211100 00000 0000000000 00 00000 0011246778999999999999999999864
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.82 Aligned_cols=263 Identities=27% Similarity=0.382 Sum_probs=204.5
Q ss_pred ccCHHHHHHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEe
Q 005443 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCI 433 (696)
Q Consensus 356 ~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~ 433 (696)
++.++++....++|++.+.||+|+||.||++.. ++++.||||++.... .....+.+|+.+++++ +|+||++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 466677777889999999999999999999986 468899999986432 2346788999999999 7999999999987
Q ss_pred eCC-----ceeEEEEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc
Q 005443 434 SDD-----RRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (696)
Q Consensus 434 ~~~-----~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (696)
..+ ..++||||+.+++|.++++. .....+.+..++.++.||+.||+|||++ +|+|||||++||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 543 57999999999999888753 1233488999999999999999999998 9999999999999999999
Q ss_pred EEEEeeccchhccccCcceeeccccccccCchhhhccC-----CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHH
Q 005443 507 AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-----KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581 (696)
Q Consensus 507 vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~ 581 (696)
+||+|||+++........ .....|+..|++||++... .++.++|||||||++|||++|+.||...... ..+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 999999998765432221 2234578899999998643 3678999999999999999999999753211 1111
Q ss_pred HhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 582 EWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
++. . .....+.+ .......+.+++.+||+.+|++||++.||+++
T Consensus 244 ~~~--------~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIP--------R-NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHh--------c-CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 110 0 00001111 11122368899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.06 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=201.0
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.+.||+|+||.||+|... +++.|+||+++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999854 7899999999866543 456799999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.++++... .+.+..+++|+.||+.||+|||++ +|+|+||+++||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999987653 378899999999999999999999 9999999999999999999999999999876543332
Q ss_pred eee---ccccccccCchhhhccCC---CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 525 ITT---RVMGTFGYMAPEYASSGK---LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 525 ~~~---~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
... ...++..|++||++.+.. ++.++|||+|||++|||++|+.||..... . ........ .....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~--~~~~~~~~-----~~~~~ 225 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---E--FQIMFHVG-----AGHKP 225 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---h--HHHHHHHh-----cCCCC
Confidence 211 345788999999998766 88999999999999999999999975321 0 11110000 00000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.+.. .......+.+++++||+.+|.+||++.+++.
T Consensus 226 -----~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 -----PIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 0111336789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.41 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=197.6
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---c-------cHHHHHHHHHHHHHccCCCceeEEeEEeeCC
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---Q-------GEREFKAEVEIISRIHHRHLVSLVGYCISDD 436 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 436 (696)
+|.+.+.||+|+||.||+|.. .+|+.||||.++.... . ..+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999985 4689999998864211 1 1235788999999999999999999999999
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..++||||+.+++|.++++..+ .+++..++.++.||+.||.|||++ +++||||+++||++++++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999887664 488999999999999999999998 99999999999999999999999999997
Q ss_pred hccccCcc-eeeccccccccCchhhhccCC--CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 517 LALDANTH-ITTRVMGTFGYMAPEYASSGK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 517 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
........ ......|+..|++||++.... ++.++||||||+++|||++|..+|..... .+...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~----~ 226 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLG----N 226 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhh----c
Confidence 64332211 122345788999999987654 88999999999999999999999864321 11111100 0
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. .....+.... .......+.+++.+||+.+|++||++++|++.
T Consensus 227 ~-~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 K-RSAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-ccCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 0000111111 11123468899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=329.44 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=195.4
Q ss_pred HHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC----
Q 005443 363 VKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD---- 435 (696)
Q Consensus 363 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---- 435 (696)
....++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++|++++|+||++++++|...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34557899999999999999999985 4688999999864322 2345678999999999999999999987643
Q ss_pred --CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 436 --DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 436 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
...++++|++ +++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468899988 77887766532 389999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH------
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP------ 586 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~------ 586 (696)
+++..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.+|...+... .+..+...
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 237 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSP 237 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 99765432 223468999999999877 568899999999999999999999997543211 11111000
Q ss_pred -HHHHhhhhhhhhcccC-------cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 587 -LLSHALENEEFDNLAD-------PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 587 -~~~~~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
++... .......... ..+.. ........+.+|+.+||+.||++|+++.|++++
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKI-SSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhc-chhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000 00000 000111247799999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.75 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=202.9
Q ss_pred cCccccccccccCcEEEEEEEcCC-CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+.|+++..||.|+||.||+|..++ +...|.|++........++|+-||+||..++|++||+||+.|+.++.+||++|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457788899999999999998654 4566788888777777889999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.||-++.++..-++ .+.+.++..+++|++.||.|||++ +|||||||..|||++-+|.|+|+|||++...... ...
T Consensus 112 ~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred CCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 99988777655443 589999999999999999999999 9999999999999999999999999998643222 223
Q ss_pred eeccccccccCchhhhcc-----CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 526 TTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
...++||++|||||+++. ..|+.++||||||+.|.||..+..|-...+. ++.++. ..+.+ -..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---------MRVllK-iaKSe-PPTL 255 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLLK-IAKSE-PPTL 255 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---------HHHHHH-HhhcC-CCcc
Confidence 455789999999998753 5689999999999999999999887664332 111111 11111 1111
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+. .......+.+++++||..|++.||++.+|+++
T Consensus 256 lq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 LQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11 12234478899999999999999999999964
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=311.54 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=187.3
Q ss_pred ccccccCcEEEEEEEcCC---CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCC
Q 005443 373 NLLGEGGFGSVYKGYLPD---GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
+.||+|+||.||+|...+ ...+++|.+..... .....+.+|+++++.++|+||++++++|...+..++||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999997533 35688887764332 23456889999999999999999999999999999999999999
Q ss_pred chhhccccCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc-
Q 005443 449 TLYFHLHGEGR---PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH- 524 (696)
Q Consensus 449 sL~~~l~~~~~---~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~- 524 (696)
+|.+++..... ....+..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99998865432 2346788899999999999999999 9999999999999999999999999998754332211
Q ss_pred eeeccccccccCchhhhcc-------CCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 525 ITTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
......++..|+|||++.. ..++.++|||||||++|||++ |..+|.... ...... . ... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~---~----~~~-~~ 226 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS---DEQVLK---Q----VVR-EQ 226 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHH---H----Hhh-cc
Confidence 1122345678999998753 356789999999999999999 778876432 111111 1 111 11
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
...+.+..+...+ ...+.+++..|| .||++||++++|++.|.
T Consensus 227 ~~~~~~~~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 DIKLPKPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CccCCCCcccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1112222222222 235667888888 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.65 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=198.3
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++++.||+|+||.||++... +|+.||+|.++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999965 789999999875422 2345788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 445 VPNNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 445 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
+.+++|..+++... ...+++..+++++.||+.||.|||+.+ +|+|||||++|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 99999988876531 235899999999999999999999632 89999999999999999999999999987653322
Q ss_pred ceeeccccccccCchhhhccC------CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 524 HITTRVMGTFGYMAPEYASSG------KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
.....++..|++||++.+. .++.++|||||||+||||++|+.||..... ........... . ...
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~----~-~~~ 227 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAIV----D-GDP 227 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHHh----h-cCC
Confidence 2223577899999998553 357899999999999999999999975321 11111111100 0 000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. .......++.+++.+||+.+|++||++++|+..
T Consensus 228 -----~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 -----PT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----CC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 01 111223467899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.05 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=205.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++.++||+|++|.||+|... +|+.|+||++..... ...+.+.+|++++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999965 599999999976544 3457799999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
+.+++|.+++.... .+++..+++++.||++||+|||+ . +++||||+++||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999987653 48999999999999999999999 8 999999999999999999999999999876543332
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
. .....++..|++||++.+..++.++|||+||+++|||++|+.||..........+.++. .. ... .
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------~~-~~~-----~ 221 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-------CD-GPP-----P 221 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-------hc-CCC-----C
Confidence 2 22345788999999999989999999999999999999999999765431111111111 10 000 0
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+... .....+.+++.+||..++++||++.+|++.
T Consensus 222 ~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAE---EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcc---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 022378899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.22 Aligned_cols=252 Identities=24% Similarity=0.432 Sum_probs=199.8
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC------ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
+|+..++||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999984 5789999999874331 123578999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-cEEEEeeccchhcc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLAL 519 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfGls~~~~ 519 (696)
||||+.+++|.+++...+ .+++..+++++.||+.||+|||++ +|+||||+++||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999887544 378999999999999999999999 999999999999998765 59999999987654
Q ss_pred ccCcc---eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 520 DANTH---ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 520 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
..... ......++..|++||++.+..++.++|||+|||++|+|++|+.+|........... ..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~----~--- 225 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIA----S--- 225 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHh----c---
Confidence 33211 12234678899999999888899999999999999999999999975432111111 00000 0
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..............+.+++.+||+.+|.+|+++.+|++
T Consensus 226 ------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011122223347889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.66 Aligned_cols=253 Identities=29% Similarity=0.441 Sum_probs=198.6
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCC------
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDD------ 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~------ 436 (696)
..++|++.+.||+|+||.||+|..+ +++.|++|++..... ..+++.+|+.+++++ +|+||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999964 678999999875433 356799999999999 6999999999997644
Q ss_pred ceeEEEEecCCCchhhccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
..++||||+.+++|.+++.... +..+++..++.++.||++||+|||++ +|+||||+++||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4799999999999988876533 34589999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhcc-----CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (696)
+....... .......|+..|+|||++.. ..++.++|||+|||+||||++|+.||...... ..+.+ +.
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~- 231 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP- 231 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh-
Confidence 87543322 22233468889999998753 34678899999999999999999999743211 11111 00
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
. ..... + .........+.+++.+||..||++||++.+|++
T Consensus 232 ---~-~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 ---R-NPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---c-cCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 00000 0 011112346889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.77 Aligned_cols=249 Identities=23% Similarity=0.412 Sum_probs=200.9
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+++|++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999985 468899999987542 23356789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC-CcEEEEeeccchhccccCc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DfGls~~~~~~~~ 523 (696)
+.+++|.+++.......+++..+++++.||++||+|||++ +|+||||+++||+++++ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999776555689999999999999999999998 99999999999999855 4689999999976543322
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.....++..|++||.+.+..++.++||||||+++|+|++|+.+|...+. .... .... ......+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~---~~~~-----~~~~~~~~-- 222 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALV---LKIM-----SGTFAPIS-- 222 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHH---HHHH-----hcCCCCCC--
Confidence 2234678899999999988899999999999999999999999975431 1111 1110 01111111
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
......+.+++.+||+.+|++||++.||+++
T Consensus 223 -------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 -------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -------CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1122368899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.78 Aligned_cols=244 Identities=27% Similarity=0.366 Sum_probs=198.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||++... +++.||||+++... ....+.+.+|+++|++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999854 68999999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||+++||||++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999887654 388999999999999999999998 9999999999999999999999999999865443
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.....++..|++||.+.+..++.++|||+||+++|+|++|+.||.... .....+ ... ...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~---~~~-----~~~------ 214 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYE---KIL-----EGK------ 214 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHh-----cCC------
Confidence 223457889999999988888999999999999999999999997543 111111 000 000
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVR 640 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~ 640 (696)
..+... ....+.+++.+||+.||.+|+ +++|+++
T Consensus 215 ~~~~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 VRFPSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCcc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 001111 123688999999999999998 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.12 Aligned_cols=247 Identities=27% Similarity=0.390 Sum_probs=198.9
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHH---HHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGER---EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+.+++||+|.||.|.+++- ..|+.||||+++......+. .-+.|-++|+..+|+.+..|--.|...+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 6788899999999999999984 47999999999855433333 3467889999999999999988899999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||..||.|+.+|.+++ .+++...+-+...|+.||.|||++ +||+||||.+|+|||.+|++||.|||+++..-..+
T Consensus 248 eyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 9999999999997754 488888889999999999999999 99999999999999999999999999998654333
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. .+..++||+.|+|||++..+.|+.++|.|.+||+||||++|++||...+... +.+. ++ ..++
T Consensus 323 ~-t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeL---Il--------~ed~-- 385 (516)
T KOG0690|consen 323 D-TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFEL---IL--------MEDL-- 385 (516)
T ss_pred c-eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHH---HH--------hhhc--
Confidence 3 3455899999999999999999999999999999999999999998643211 1110 00 1111
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVR 640 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~ 640 (696)
.|......+...|+..+|..||++|- .++||.+
T Consensus 386 -----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 -----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 11111222566777789999999996 4555543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.32 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=197.9
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
|.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+||+++++++...+..++||||+.+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334466999999999999854 6889999998765555566789999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||++++++.+||+|||++........ ...
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 9998887542 378999999999999999999999 999999999999999999999999999875533222 122
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
...|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+. . +. ..+...+..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~---~-~~---------~~~~~~~~~ 240 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMR---R-IR---------DNLPPRVKD 240 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---H-HH---------hcCCCcccc
Confidence 34688999999999988899999999999999999999999975321 11111 0 00 001111111
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ......+.+++.+||+.||.+||+++||++.
T Consensus 241 ~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 S--HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 0112257788999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.92 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=187.7
Q ss_pred ccccccCcEEEEEEEcCCC---cEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCC
Q 005443 373 NLLGEGGFGSVYKGYLPDG---REVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g---~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
+.||+|+||.||+|++.++ ..+++|.++.... ...+.+.+|+.+++.++|+||++++++|......++||||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3599999999999975443 3456676654332 34567999999999999999999999999999999999999999
Q ss_pred chhhccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc-ce
Q 005443 449 TLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HI 525 (696)
Q Consensus 449 sL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~-~~ 525 (696)
+|.++++... ...+.+..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999887542 23356777889999999999999998 999999999999999999999999999864322211 11
Q ss_pred eeccccccccCchhhhcc-------CCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 526 TTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
.....++..|++||++.. ..++.++|||||||++|||++ |..||.... ... ....++. +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~---~~~~~~~-----~~~ 226 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DRE---VLNHVIK-----DQQ 226 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---HHH---HHHHHHh-----hcc
Confidence 223467889999999853 245778999999999999997 566775432 111 1111111 111
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
..+.+..+...+. ..+.+++.+|| .+|++||++++|++.|.
T Consensus 227 ~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 VKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2223333332222 25778888999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=354.59 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=197.1
Q ss_pred HHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC--Cc
Q 005443 363 VKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DR 437 (696)
Q Consensus 363 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~ 437 (696)
....++|+++++||+|+||.||+|++. .++.||+|++..... .....|.+|+.+|++|+|+|||+++++|... +.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999864 577899999875432 3345789999999999999999999988654 46
Q ss_pred eeEEEEecCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCceeeccCCCCceEECC--------
Q 005443 438 RLLIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDC----HPRIIHRDIKSSNILLDN-------- 503 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~----~~~ivHrDLkp~NILl~~-------- 503 (696)
+||||||+.+++|.++|... ....+++..++.|+.||+.||+|||+.+ ..+|||||||++||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 79999999999999888642 1234899999999999999999999852 125999999999999964
Q ss_pred ---------CCcEEEEeeccchhccccCcceeeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCCCCC
Q 005443 504 ---------NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (696)
Q Consensus 504 ---------~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf~~~ 572 (696)
.+.+||+|||+++...... .....+|+..|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999997653322 2234578999999999864 45889999999999999999999999753
Q ss_pred CCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 573 QPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 573 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.. +.+.+.. +.. . ..+ .+ ......+.+||.+||+.+|.+||++.++|.
T Consensus 247 ~~-----~~qli~~-lk~---~---p~l---pi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-----FSQLISE-LKR---G---PDL---PI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-----HHHHHHH-Hhc---C---CCC---Cc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 31 1111111 110 0 000 00 011236889999999999999999999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=317.41 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=200.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.+.||+|+||.||++... .++.|+||.+..... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999864 578999999875432 23456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999987654 388999999999999999999998 99999999999999999999999999986421110
Q ss_pred c--------------ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 523 T--------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 523 ~--------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
. .......++..|+|||++.+..++.++|||||||++|||++|+.||..... . +......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~---~~~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---E---ELFGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHH
Confidence 0 011123577889999999888899999999999999999999999974321 1 1111111
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
. .. +....... .....+.+++++||+.+|++|+++.++++.|+.-
T Consensus 230 ~-----~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 230 S-----DD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred h-----cc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 0 00 00000000 1123578999999999999999977777666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.26 Aligned_cols=266 Identities=23% Similarity=0.349 Sum_probs=196.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++.+.||+|+||.||+|..+ +++.||||.++..... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999865 6899999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+ +|.+++..... .+.+..++.++.||++||.|||++ +|+|||||++|||+++++.+||+|||+++........
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 975 88887765443 578999999999999999999999 9999999999999999999999999998754322111
Q ss_pred eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----Hhh----hhh
Q 005443 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----HAL----ENE 595 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~----~~~ 595 (696)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.+|...... ...++.....+. ..+ ...
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 122346788999999875 45889999999999999999999999754311 111111110000 000 000
Q ss_pred hhhcc-----cCcccCCCc-chHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 596 EFDNL-----ADPRLGENY-VEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 596 ~~~~~-----~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.+... ....+.... .......+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000000000 0011246789999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.59 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=199.7
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc-----cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-----GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
+|++.++||+|+||.||+|... +|+.|+||+++..... ....+.+|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999854 6899999999755432 234577899999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+ +++|..++.... ..+++..+++++.||++||.|||++ +|+||||+++|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999887654 3589999999999999999999999 9999999999999999999999999999765443
Q ss_pred CcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH----hh-hhh
Q 005443 522 NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH----AL-ENE 595 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~----~~-~~~ 595 (696)
... .....++..|+|||.+.+ ..++.++|||+|||++|||++|..+|...... ...+.....+.. .+ ...
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhhcc
Confidence 222 222356788999998865 56788999999999999999997777654321 111111111100 00 000
Q ss_pred hhhcccCcccCCC-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGEN-----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+........... ........+.+++.+||+.+|++|+++.||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 111223468899999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=316.40 Aligned_cols=240 Identities=22% Similarity=0.418 Sum_probs=188.3
Q ss_pred ccccccCcEEEEEEEcCC--------CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 373 NLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+.||+|+||.||+|..+. ...|++|++........+++.+|+.+++.++|+||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888888655444556789999999999999999999999998999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc--------EEEEeeccch
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE--------AQVSDFGLAK 516 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~--------vkL~DfGls~ 516 (696)
+.+|+|..+++..+. .+++..+++++.||+.||+|||++ +|+|||||++|||++.++. ++|+|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999876543 488999999999999999999999 9999999999999987664 6999999986
Q ss_pred hccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCC-CCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGR-KPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~-~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
..... ....++..|++||++.+ ..++.++|||||||++|||++|. .+|..... ..... +.. ..
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~~----~~~---~~ 221 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKLQ----FYE---DR 221 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHHH----HHH---cc
Confidence 54322 12357788999999986 45789999999999999999985 44443211 11000 000 00
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
.. +......++.+++.+||+.||++||++++|++.|+
T Consensus 222 ---~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ---HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 11111236889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.85 Aligned_cols=196 Identities=26% Similarity=0.404 Sum_probs=158.7
Q ss_pred cccccccCcEEEEEEEcC---CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee--CCceeEEEEecC
Q 005443 372 QNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLLIYDYVP 446 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~ 446 (696)
.++||+|+||.||+|+.+ +++.||+|.++.. .....+.+|+++|++++|+||++++++|.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 4578999988643 234568899999999999999999999864 456789999986
Q ss_pred CCchhhcccc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE----CCCCcEEEEeeccc
Q 005443 447 NNTLYFHLHG-------EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLA 515 (696)
Q Consensus 447 ~gsL~~~l~~-------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DfGls 515 (696)
+ +|.+++.. .....+.+..+++++.||+.||+|||++ +|+|||||++|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 56555431 1223478899999999999999999999 99999999999999 56678999999999
Q ss_pred hhccccCcc--eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 516 KLALDANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 516 ~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
+........ ......|+..|+|||++.+ ..++.++|||||||+||||++|+.+|....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 865443221 1233568899999999876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.50 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=199.1
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
|+....||+|+||.||+|... +++.||||+++.......+.+.+|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444567999999999999854 6899999999766555667789999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
++|..++... .+++..++.++.||+.||+|||++ +|+||||+++|||+++++.+||+|||++........ ...
T Consensus 103 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 103 GALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 9998877542 378999999999999999999999 999999999999999999999999999875543322 123
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... ........ .... ..+..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~--------~~~~-----~~~~~ 239 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLR--------DSPP-----PKLKN 239 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh--------ccCC-----CCccc
Confidence 35688999999999988899999999999999999999999975321 11111110 0000 00000
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......+.+++.+||+.+|++||++.+|++.
T Consensus 240 --~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 --AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00112357889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.04 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=195.7
Q ss_pred ccccccccccCcEEEEEEEcC----CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC------
Q 005443 369 FADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 436 (696)
|.+.++||+|+||.||+|.+. .++.||||+++... ....+++.+|+++|++++|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 36899999987542 233456889999999999999999999886542
Q ss_pred ceeEEEEecCCCchhhccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEee
Q 005443 437 RRLLIYDYVPNNTLYFHLHGE----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~Df 512 (696)
..++++||+.+|+|.+++... ....+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 236889999999998776422 122478899999999999999999998 9999999999999999999999999
Q ss_pred ccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 513 GLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 513 Gls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
|+++........ ......+...|++||.+.+..++.++|||||||++|||++ |+.+|..... ..+..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~------- 227 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY------- 227 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH-------
Confidence 999865432211 1122335578999999999999999999999999999999 8888864321 111111
Q ss_pred hhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 591 ALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
......+. . .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 ~~~~~~~~------~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 LIKGNRLK------Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHcCCcCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10111000 0 011223788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=316.21 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=202.6
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|++.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++|+||++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788899999999999999985 468899999987655555677899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++... .+.+..++.++.||+.||.|||++ +|+||||+++||++++++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999988643 378899999999999999999999 999999999999999999999999999875543322 2
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
.....++..|++||++.+..++.++|||+|||++|||++|+.||...+.... +... .... ..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~--------~~~~--------~~ 233 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI--------ATNG--------TP 233 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeeh--------hcCC--------CC
Confidence 2234678899999999888899999999999999999999999975432110 0000 0000 00
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...........+.+++.+||+.++++|+++.+|+.+
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111122368889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=304.75 Aligned_cols=250 Identities=28% Similarity=0.471 Sum_probs=203.9
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
+|+..+.||+|++|.||++... +++.|++|+++.......+.+.+|++++++++|+||+++++++..++..++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999965 688999999986655566789999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++.... ..+++..++.++.||++||+|||++ +++||||+++||++++++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999998887653 3489999999999999999999998 999999999999999999999999999977654332 2
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccC
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~ 606 (696)
....++..|++||++.+..++.++|||+||++||+|++|+.+|..... .+...... ......+...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-----~~~~~~~~~~--- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIA-----TNGPPGLRNP--- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHH-----hcCCCCcCcc---
Confidence 335678899999999988899999999999999999999999975321 11100000 0111111110
Q ss_pred CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 607 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
......+.+++.+||+.||++||++.+|+++
T Consensus 221 ----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 ----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ----cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0012368899999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=312.61 Aligned_cols=258 Identities=26% Similarity=0.348 Sum_probs=200.2
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 442 (696)
++|++.+.||.|.+|.||++.++ +++.||+|++..... ....++.+|++++++++|+||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999964 688999999875433 3456789999999999999999999998654 3679999
Q ss_pred EecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 443 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||+.+++|.+++.. .....+.+..+++|+.||+.||.|||+. +|+|+||+++||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999877643 2233478899999999999999999999 999999999999999999999999999875433
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCC--CCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP--LGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
... ....++..|++||.+.+..++.++|||+|||++|||++|+.||..... ....++.++... ....
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--------MPNP 226 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc--------CCch
Confidence 221 234577889999999999999999999999999999999999986532 111122221111 0000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+.+ .... .......+.+++.+||+.++.+||++.||++.
T Consensus 227 ~~~~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 ELKD-EPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhcc-CCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0100 0000 01123468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=317.76 Aligned_cols=251 Identities=28% Similarity=0.402 Sum_probs=196.3
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+.|+..+.||+|+||.||+|+. .+|+.||||++..... ....++.+|++++++++|+||++++++|.+++..+|||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477889999999999999985 4688999999874432 22356889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+ +|.+++.... ..+++..++.++.||+.||.|||++ +|+||||+++||++++++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred eCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 99965 6666654332 3489999999999999999999999 9999999999999999999999999998654322
Q ss_pred cceeeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
....|+..|++||++. .+.++.++|||+|||++|||++|+.||..... ......... .. ...
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~----~~-~~~ 243 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ----NE-SPT 243 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHh----cc-CCC
Confidence 2245788999999974 45688899999999999999999999865321 111111110 00 000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
. ........+.+++.+||+.+|.+||++.+|++++..+.
T Consensus 244 -----~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 -----L---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----C---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0 01112235889999999999999999999998766544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.72 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=199.6
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIY 442 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 442 (696)
+|++.+.||.|+||.||++.. .+|+.||+|+++.... ...+++.+|++++++++|+||+++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 4688999999875432 3345688999999999999999999988643 4568999
Q ss_pred EecCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 443 DYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLH-----EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 443 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH-----~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
||+.+++|.+++... ....+++..++.++.||+.||+||| +. +|+||||+++||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999998888642 2345899999999999999999999 66 9999999999999999999999999999
Q ss_pred hhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
........ ......++..|++||++.+..++.++|||+||+++|+|++|+.+|.... ...+.+.. ...
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~--------~~~ 225 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI--------KEG 225 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHH--------hcC
Confidence 87644332 1223468899999999998889999999999999999999999997643 11111111 111
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+. .........+.+++.+||+.+|++||++++|+++
T Consensus 226 ~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 KFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 1112223478899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.68 Aligned_cols=266 Identities=21% Similarity=0.303 Sum_probs=198.1
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++++.||+|+||.||+|+.+ +|+.||||+++.... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999864 689999999875432 2335788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+. ++|..++.......+++..++.++.||+.||+|||++ +|+||||+++||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 5788877665555689999999999999999999998 999999999999999999999999999876533222
Q ss_pred eeeccccccccCchhhhccCC-CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH---HHhh----hh--
Q 005443 525 ITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL---SHAL----EN-- 594 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~----~~-- 594 (696)
......++..|++||++.+.. ++.++|||+|||++|||++|+.+|..... ...+.+....+- ...+ ..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 122335678899999887644 58899999999999999999999975431 111111111000 0000 00
Q ss_pred --hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 --EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 --~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.......+. .........+.+++.+||+.||++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 0000112357789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=310.83 Aligned_cols=248 Identities=26% Similarity=0.459 Sum_probs=198.7
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHcc---CCCceeEEeEEeeCCceeEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.|++.+.||+|+||.||+|.+ .+|+.|+||+++... .....++.+|++++++++ |+||++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999995 578999999987543 234567889999999997 999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.++++.. .+++..++.++.||+.||.|||+. +|+||||+++||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999888653 488999999999999999999999 99999999999999999999999999997665433
Q ss_pred cceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
. ......|+..|+|||.+.++ .++.++|||+|||++|+|++|+.||...... ++.. .+....
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~-----~~~~~~----- 218 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMM-----LIPKSK----- 218 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhh-----ccccCC-----
Confidence 2 22334688899999998754 4688999999999999999999999754311 1100 000000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+... .....+.+++.+||+.||++|+++.|+++.
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0111111 122368899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=311.98 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=204.2
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..+.|+..+.||+|+||.||+|.++ +++.|++|+++.... ..+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3466888899999999999999975 689999999986544 46678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++.... ..+++..++.++.||+.||.|||++ +|+|+||+++||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999998654 3489999999999999999999998 999999999999999999999999999875543221
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......++..|++||++.+..++.++|||+|||+||+|++|+.||...... .. ..... ......+.+
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~---~~~~~-----~~~~~~~~~- 238 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RA---LFLIT-----TKGIPPLKN- 238 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHH-----hcCCCCCcc-
Confidence 122345778999999999888999999999999999999999998753311 10 00000 000001000
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......+.+++.+||+.++.+||++.+|++.
T Consensus 239 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 ------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01122368899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=314.88 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=199.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 441 (696)
++|++.+.||+|+||.||+|..+ +++.|+||.++..... ....+.+|+.++++++|+||+++++++... +..+||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999965 5889999999754332 234577899999999999999999999877 789999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+ +|.+++..... .+++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999974 88777765432 589999999999999999999999 9999999999999999999999999999866543
Q ss_pred CcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----Hhh----
Q 005443 522 NTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----HAL---- 592 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~---- 592 (696)
... .....++..|+|||++.+. .++.++|||||||++|||++|+.+|...... ...+.....+. ..+
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHHHHHhh
Confidence 221 2234578899999998764 4688999999999999999999999764321 11111110000 000
Q ss_pred -----hhhhhhcccCcccCCCcchH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 593 -----ENEEFDNLADPRLGENYVEG-EMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 593 -----~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....+.......+...+... ....+.+++++||+.+|++|+++.||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000011111111111111 23467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=308.23 Aligned_cols=250 Identities=23% Similarity=0.396 Sum_probs=201.7
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.+.||+|+||.||+|..+ +|+.||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999964 58899999987542 23445788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-cEEEEeeccchhccccCc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDANT 523 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfGls~~~~~~~~ 523 (696)
+.+++|.+++.......+++..+++++.||++||.|||++ +|+|+||+++||++++++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999988765555689999999999999999999998 999999999999998875 469999999976643322
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......|+..|+|||++.+..++.++|||+|||++|||++|+.||...+ ..++...... ..+..+
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-----~~~~~~--- 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-----GYFAPI--- 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-----ccCCCC---
Confidence 2223458889999999988889999999999999999999999987532 1111111111 111111
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......+.+++.+||+.+|++||++.||+++
T Consensus 223 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01112368899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=314.65 Aligned_cols=267 Identities=19% Similarity=0.276 Sum_probs=194.7
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|.+.+.||+|+||.||+|.. .+|+.|+||+++..... ....+.+|+++++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999985 46899999998754332 23467899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+. ++|.+++.... ..+.+..++.++.||+.||.|||++ +|+|||||++|||++.++++||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 996 56655554332 2367888899999999999999999 999999999999999999999999999875433222
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH--------Hhhhh
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS--------HALEN 594 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~--------~~~~~ 594 (696)
. .....++..|++||++.+ ..++.++|||||||+||||++|+.+|...... .+.+.+. ...+. .....
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKI-WTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHH-HHHcCCCChhhhhhhhhc
Confidence 1 223457889999999875 45788999999999999999999999754321 1111110 00000 00000
Q ss_pred hhh-hccc----CcccCCCc-chHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 595 EEF-DNLA----DPRLGENY-VEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 595 ~~~-~~~~----d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..+ ..+. ...+.... .......+.+++++|++.||++|++++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 0000 00000000 0011236788999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.12 Aligned_cols=268 Identities=22% Similarity=0.346 Sum_probs=207.4
Q ss_pred cCHHHHHHHhcCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEee
Q 005443 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCIS 434 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 434 (696)
-+++|+.+.++ ++||+|+|+.|--+. +.+|.+||||++.........++.+|++++.+.+ |+||+.|+++|++
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 45788887774 789999999998886 6689999999998766677788999999999986 9999999999999
Q ss_pred CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC---cEEEEe
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EAQVSD 511 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~D 511 (696)
++.+|||||.|.||.|..+++.+.. +++.++.+++++|+.||.|||.+ ||.|||||++|||..+-. -|||||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999999986554 99999999999999999999999 999999999999996544 489999
Q ss_pred eccchhccccCc------ceeeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCC----CC
Q 005443 512 FGLAKLALDANT------HITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQP----LG 576 (696)
Q Consensus 512 fGls~~~~~~~~------~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~----~~ 576 (696)
|.+..-...... .....-+|+..|||||+.. ...|+.++|.||||||||-||+|..||.+.-. .+
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 998754322211 1112347889999999864 35689999999999999999999999975432 11
Q ss_pred chhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 577 DESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..+..+.+...+-+.+..+ ..++-|..| .....+..+++..+|..|+.+|-++.++++
T Consensus 303 rGe~Cr~CQ~~LFesIQEG-kYeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEG-KYEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhcc-CCcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 2223333333332222221 122222221 112234568888999999999999998886
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.39 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=199.5
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+-|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3467788999999999999985 4688999999865432 3345788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++... .+++..++.++.||+.||.|||++ +|+|+||+++||++++++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 84 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999888643 378999999999999999999998 999999999999999999999999999875533221
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
......++..|++||++.+..++.++|||||||++|||++|..||..... ...... . ..... .
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~---~-----~~~~~-----~- 219 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFL---I-----PKNNP-----P- 219 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHH---H-----hcCCC-----C-
Confidence 12224578899999999888899999999999999999999999975321 111110 0 00000 0
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.........+.+++.+||+.+|.+||++.+++++
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111223468899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.65 Aligned_cols=268 Identities=22% Similarity=0.318 Sum_probs=198.0
Q ss_pred HHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC----
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD---- 436 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---- 436 (696)
...++|++.+.||+|+||.||+|... +|+.||||++... ......++.+|++++++++|+||++++++|...+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34578999999999999999999854 7899999998643 2233456788999999999999999999886443
Q ss_pred --ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 437 --RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 437 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
..++||||+.+ +|.+.+... +++..+..++.||+.||+|||++ +|+|||||++|||++.++.+||+|||+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 46899999964 676666532 78899999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCc------------hhHHH
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD------------ESLVE 582 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~------------~~l~~ 582 (696)
++....... .....++..|+|||++.+..++.++|||||||++|+|++|+.+|...+.... ..+.+
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 976543221 2234578899999999999999999999999999999999999975432110 00000
Q ss_pred hHHHHHHHhhhhh------hhhcccCccc----CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 583 WARPLLSHALENE------EFDNLADPRL----GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 583 ~~~~~~~~~~~~~------~~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.....+..+.... .+.++....+ ...........+.+++++||+.||++|+++.|+|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000111110000 0011111100 000011223467899999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=327.57 Aligned_cols=243 Identities=26% Similarity=0.456 Sum_probs=197.0
Q ss_pred ccccccCcEEEEEEEcC-CCcEEEEEEe---ecC-CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc--eeEEEEec
Q 005443 373 NLLGEGGFGSVYKGYLP-DGREVAIKQL---KIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR--RLLIYDYV 445 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l---~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~~lV~E~~ 445 (696)
.+||+|.|-+||+|.+. +|.+||=-.+ +.. ..+..++|..|+.+|+.|+|+||+++|++|.+.+. +.+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 57999999999999964 5777763322 222 22334789999999999999999999999987765 67899999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-CCcEEEEeeccchhccccCcc
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls~~~~~~~~~ 524 (696)
..|+|+.++.+.++ ++.+.+..|++||++||.|||++ .+.|||||||-+||||+. .|.|||+|+|||........
T Consensus 126 TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a- 201 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA- 201 (632)
T ss_pred cCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence 99999999988776 88899999999999999999997 779999999999999975 57999999999987655433
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
..++||+.|||||++. ..|+..+||||||++|+||+|+..||..-. +-.+..++++. ..+-..+..+-|+
T Consensus 202 --ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~S-GiKP~sl~kV~dP- 271 (632)
T KOG0584|consen 202 --KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTS-GIKPAALSKVKDP- 271 (632)
T ss_pred --ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHc-CCCHHHhhccCCH-
Confidence 3378999999999887 889999999999999999999999997532 22333333332 2233344444332
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
++.+||.+||.. .++|+++.|||+.
T Consensus 272 -----------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 -----------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 688899999999 8999999999964
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.09 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=191.3
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHH-HHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEI-ISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++.+.||+|+||.||+|..+ +|+.||||+++.... ....++..|+.+ ++.++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999864 699999999875432 334456667665 566789999999999999999999999
Q ss_pred ecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 444 YVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 444 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|+. |+|.+++.. .....+++..+++++.||+.||+|||+++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 566655543 22345899999999999999999999854 8999999999999999999999999999765432
Q ss_pred CcceeeccccccccCchhhhcc----CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 522 NTHITTRVMGTFGYMAPEYASS----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~----~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
.. .....++..|++||++.+ ..++.++|||+|||++|||++|+.||..... . .+.....+ . ...
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~-~~~~~~~~----~-~~~ 225 (283)
T cd06617 158 VA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----P-FQQLKQVV----E-EPS 225 (283)
T ss_pred cc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----C-HHHHHHHH----h-cCC
Confidence 21 222457889999998865 4468899999999999999999999964221 0 11111111 0 000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.. ..+ ...+.+++.+||..+|++||++++|++.
T Consensus 226 ~~~~~----~~~----~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 PQLPA----EKF----SPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCc----ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01100 011 2368899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=308.27 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=197.2
Q ss_pred ccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
||+|+||.||+++.. +|+.|+||++..... ...+.+.+|++++++++|+||+++++++..++..++||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 499999999865433 3456789999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc-------
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT------- 523 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~------- 523 (696)
.+++.+.+ .+++..+++++.||++||+|||++ +|+||||+++|||+++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99887654 489999999999999999999999 999999999999999999999999999876543321
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.......++..|++||++.+..++.++|||+||+++|||++|+.+|.... ...+.+. +. . ..+.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~---~~----~-~~~~----- 219 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQN---IL----N-GKIE----- 219 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHH---Hh----c-CCcC-----
Confidence 12233467889999999998889999999999999999999999997543 1111111 10 0 0000
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
+... ......+.+++++||+.++++||++.++.+.|+.-.
T Consensus 220 -~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 220 -WPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred -CCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 0000 001346889999999999999999977766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.48 Aligned_cols=247 Identities=26% Similarity=0.326 Sum_probs=200.3
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
+|++.++||.|+||.||+|..+ +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999965 589999999975432 345678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++... ..+.+..+++++.||++||.|||++ +|+|+||+++||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999988765 3488999999999999999999998 99999999999999999999999999987654432
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......|+..|++||++.+..++.++|||+|||++|+|++|+.||..........+ ..... . . .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~----~--~----~- 218 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQE----T--A----D- 218 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhc----c--c----c-
Confidence 12334578899999999988899999999999999999999999986543211111 11100 0 0 0
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCH--HHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRM--GQVV 639 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~ell 639 (696)
..........+.+++.+||+.||.+|+++ +|++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 ---VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00111122478899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.87 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=200.0
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
+|...+.||+|++|.||++.. .+++.|+||+++.......+.+.+|+.+++.++|+||+++++++...+..++|+||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567999999999999985 4788999999876555556678999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++.. . .+++..++.++.||+.||+|||++ +|+||||+++||++++++.++|+|||++........ ..
T Consensus 100 ~~~L~~~~~~-~--~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 100 GGALTDIVTH-T--RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 9999998876 2 378999999999999999999999 999999999999999999999999998875443221 12
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccC
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~ 606 (696)
....|+..|++||++.+..++.++|||+|||++|||++|+.+|...+. .+....+.. .... .+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~-----~~~~-----~~~ 236 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRD-----NLPP-----KLK 236 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHh-----cCCC-----CCc
Confidence 234688899999999988899999999999999999999999875321 111111111 0000 000
Q ss_pred CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 607 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
. .......+.+++.+||+.+|++||++.+|++
T Consensus 237 ~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 N--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred c--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 0011236889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.69 Aligned_cols=245 Identities=25% Similarity=0.388 Sum_probs=201.9
Q ss_pred cccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCchhh
Q 005443 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452 (696)
Q Consensus 374 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 452 (696)
+||+|.||+||-|++. +...+|||.+...+.+..+-+..|+.+.++|+|.|||+++|.|.+++.+.|.||.+.||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 456899999987777777778999999999999999999999999999999999999999999
Q ss_pred ccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC-CCCcEEEEeeccchhccccCcceeeccc
Q 005443 453 HLHGE-GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVM 530 (696)
Q Consensus 453 ~l~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DfGls~~~~~~~~~~~~~~~ 530 (696)
+|+.. +.-.-++..+-.+.+||++||.|||++ .|||||||-+||||+ -.|.+||+|||.++.... ...++..+-
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccccc
Confidence 88754 222236777778899999999999999 999999999999996 578999999999987644 334556678
Q ss_pred cccccCchhhhccC--CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCC
Q 005443 531 GTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608 (696)
Q Consensus 531 gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (696)
||+.|||||++..+ .|..++|||||||.+.||.||+.||.+...- +..+.++-.-+.-..
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------------------qAAMFkVGmyKvHP~ 799 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------------------QAAMFKVGMYKVHPP 799 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------------------hHhhhhhcceecCCC
Confidence 99999999999864 5889999999999999999999999753311 011111111122234
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 609 YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 609 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..++...+...+|++|+..++.+|+++.++|+
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 45666778899999999999999999999985
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=322.34 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=206.9
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
....|.+.+.||+|.|+.|.+|++. .|.+||||+++.... ...+.+.+|+++|..|+|+|||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467889999999999999999853 699999999975533 2335589999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|.+++++.+.++ +.+.++..++.|+..+++|||++ +|||||||.+||||+.+.++||+|||++.++...
T Consensus 134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999998877 56688999999999999999999 9999999999999999999999999999876532
Q ss_pred CcceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
......+|+..|.|||++++..| ..++|+|++|++||-|++|.+||++.+--+ ..++.
T Consensus 209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~rv 267 (596)
T KOG0586|consen 209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPRV 267 (596)
T ss_pred --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccchh
Confidence 23445789999999999998776 469999999999999999999999754110 01111
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
+..+++..+. ...++.++++++|..+|.+|.+++++.+.-
T Consensus 268 l~gk~rIp~~--ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 268 LRGKYRIPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeeeecccce--eechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 1122222221 122577889999999999999999998653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=295.22 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=193.2
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC-CccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEEec
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++.+..||.|..|.||++++. .|..+|||.|.... .++.++++..+.++.+-+ .++||+.+|||..+...+|.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344677999999999999964 58999999997543 344567888888877765 899999999999999999999987
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.. -+..++.+. +..+.+..+-++...++.||.||.+++ +|+|||+|++|||||+.|++||||||++.++.+...
T Consensus 174 s~-C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 174 ST-CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HH-HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 32 233333332 334888888999999999999999876 999999999999999999999999999987765543
Q ss_pred eeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 526 TTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
..+..|+..|||||.+. ...|+.++||||||+.|+||.||+.||...+. +. +.+..+++ ++ -
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dF---e~ltkvln----~e-P----- 312 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DF---EVLTKVLN----EE-P----- 312 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cH---HHHHHHHh----cC-C-----
Confidence 34457999999999986 35789999999999999999999999986442 11 11111111 10 0
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.|.... +....+++++..||+.|..+||...+|+++
T Consensus 313 P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1121110 122368899999999999999999998865
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.71 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=193.4
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|+..++||+|+||.||++... +|+.||||++..... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999854 689999999875432 34457889999999996 99999999999998899999999
Q ss_pred cCCC--chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 445 VPNN--TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~g--sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
+... +|...+.......+.+..+.+++.|++.||+|||+.. +|+|||||++|||+++++.+||+|||+++......
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 8642 2333333333345899999999999999999999743 89999999999999999999999999997654332
Q ss_pred cceeeccccccccCchhhhccC---CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 523 THITTRVMGTFGYMAPEYASSG---KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.. ....|+..|++||++.+. .++.++|||||||++|||++|+.||.... ...+...... .. .
T Consensus 163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~----~~-~--- 227 (288)
T cd06616 163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVV----KG-D--- 227 (288)
T ss_pred cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhc----CC-C---
Confidence 21 223578899999999876 68899999999999999999999997532 1111111110 00 0
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+...........+.+++.+||+.+|++||++++|++.
T Consensus 228 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 --PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111111233468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.86 Aligned_cols=251 Identities=28% Similarity=0.407 Sum_probs=204.1
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIY 442 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 442 (696)
+|.+.+.||+|++|.||+|... +++.|+||+++.... ...+.+.+|++++++++|+||+++++++... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999965 689999999976543 3456789999999999999999999999988 7889999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++.... .+++..++.++.|+++||+|||++ +++|+||+++||++++++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999887654 489999999999999999999998 99999999999999999999999999998765443
Q ss_pred cc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 TH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.. ......++..|++||.+.+..++.++|||+||++||+|++|+.+|.... ........ .......
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~----~~~~~~~---- 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYK----IGSSGEP---- 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHh----ccccCCC----
Confidence 21 1223467889999999998889999999999999999999999997644 11111100 0000011
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..........+.+++.+||+.++++||++.++++.
T Consensus 223 -----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 -----PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11111223478999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.82 Aligned_cols=264 Identities=24% Similarity=0.327 Sum_probs=199.1
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeEEEE
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIYD 443 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~E 443 (696)
|++.+.||+|+||.||+|... +|+.||||+++... ......+.+|++++++++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999865 58999999998653 33345788999999999999999999999988 78999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+ +|..++.... ..+++..++.++.||++||+|||++ +++|+||+++|||+++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 7877776543 3589999999999999999999998 999999999999999999999999999987655432
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.......++..|++||.+.+ ..++.++|||+|||++|||++|+.+|..... ...+......... .....+..+.+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---LEQLEKIFELCGS-PTDENWPGVSK 231 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC-Cchhhcccccc
Confidence 22333456788999998765 4578999999999999999999999976442 1111111111000 00000000000
Q ss_pred --------------cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 --------------PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 --------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+...+...+...+++++++||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000111124478999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.65 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=198.0
Q ss_pred ccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
|++.++||+|++|.||+|.. .+|+.||||++..... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 66788999999999999985 4799999999875432 23356889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
. ++|.+++.......+++..+++++.||++||+|||++ +++||||+++||++++++.++|+|||+++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 6888888765544589999999999999999999998 999999999999999999999999999975433221 1
Q ss_pred eeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH---HHhh----hhhhh
Q 005443 526 TTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL---SHAL----ENEEF 597 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~---~~~~----~~~~~ 597 (696)
.....++..|+|||++.+. .++.++|||||||++|||++|+.+|...... ..+.+..+... ...+ ...++
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 2223568899999988664 5788999999999999999999999754321 11111111000 0000 00000
Q ss_pred ----hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 ----DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ----~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........ ..........+.+++.+||+.+|++||+++|+++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 00011122468899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=310.95 Aligned_cols=246 Identities=27% Similarity=0.389 Sum_probs=193.3
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|.+.++||+|+||.||+|... +|+.||||++...... ..+++.+|+++++.++|+||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999864 6899999998644332 2356889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+. |+|.+++.... ..+.+..++.++.||+.||.|||+. +|+||||+++||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 45655554332 2489999999999999999999998 9999999999999999999999999998754322
Q ss_pred cceeeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
....++..|+|||++. .+.++.++|||+|||++|||++|+.+|...+. .. ....+. ......
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~---~~~~~~-----~~~~~~ 233 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MS---ALYHIA-----QNDSPT 233 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HH---HHHHHh-----cCCCCC
Confidence 1245778899999874 35688899999999999999999999865321 11 000000 000000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+ ........+.+++.+||+.+|++||++.+|+.+
T Consensus 234 ~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 L--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred C--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 011123368899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.15 Aligned_cols=269 Identities=22% Similarity=0.308 Sum_probs=196.0
Q ss_pred CccccccccccCcEEEEEEEcC---CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeC--Ccee
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRL 439 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 439 (696)
+|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++|+||++++++|.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999997633 33446788999999999999999999999988 7789
Q ss_pred EEEEecCCCchhhcccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC----CCcEEEEee
Q 005443 440 LIYDYVPNNTLYFHLHG---EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN----NFEAQVSDF 512 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~----~~~vkL~Df 512 (696)
+||||+.+ +|.+++.. .....+.+..++.++.||+.||+|||++ +|+|||||++|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 45444432 1223578899999999999999999999 9999999999999998 899999999
Q ss_pred ccchhccccCcc--eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCc-------hhHHH
Q 005443 513 GLAKLALDANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-------ESLVE 582 (696)
Q Consensus 513 Gls~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~-------~~l~~ 582 (696)
|+++........ ......++..|+|||++.+ ..++.++|||||||+||||++|+.+|........ ..+.+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 999865443221 1223467889999998876 4578999999999999999999999976543220 01111
Q ss_pred hHHHHHH--------HhhhhhhhhcccCcccCCCcc----h-------HHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 583 WARPLLS--------HALENEEFDNLADPRLGENYV----E-------GEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 583 ~~~~~~~--------~~~~~~~~~~~~d~~l~~~~~----~-------~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+ ..+. ...+..++..+.+......+. . .....+.+++.+||+.||++||++.||+++
T Consensus 237 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 10 0000 000000001100000000000 0 223468899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=303.94 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=195.5
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC-----CccHHHHHHHHHHHHHccCCCceeEEeEEeeC--Cce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 438 (696)
++|++.++||+|+||.||+|+. .+++.|++|++.... ......+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999985 468999999885431 22335788999999999999999999998764 357
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++|+||+.+++|.+++...+. +.+..+++++.||+.||.|||++ +|+|||||++||++++++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999988875443 78899999999999999999999 9999999999999999999999999999765
Q ss_pred cccCc--ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 519 LDANT--HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 519 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
..... .......++..|++||++.+..++.++|||||||++|||++|+.||..... ... ... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~-~~~----~~~~-- 224 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----MAA-IFK----IATQ-- 224 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----HHH-HHH----HHcC--
Confidence 32111 111234588899999999988899999999999999999999999975321 111 000 0000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.....+.......+.+++.+||+. +.+||+..+++.+
T Consensus 225 -------~~~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~ 261 (264)
T cd06653 225 -------PTKPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRH 261 (264)
T ss_pred -------CCCCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcC
Confidence 000111222334688999999995 5999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=305.93 Aligned_cols=264 Identities=22% Similarity=0.363 Sum_probs=197.8
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+|++.+.||+|++|.||+|+.. +|+.||||+++..... ....+.+|++++++++|+||++++++|...+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999964 6889999999765433 3456788999999999999999999999999999999999
Q ss_pred CCCchhhccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 446 PNNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 446 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
.+ +|.+++.... ...+++..+++++.||+.||+|||++ +|+||||+++||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 7777665433 23589999999999999999999998 999999999999999999999999999976533221
Q ss_pred eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC-
Q 005443 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD- 602 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d- 602 (696)
......++..|++||++.+ ..++.++|||+|||++|||++|+.+|...... ............ .....+..+.+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE---DQLLKIFRIMGT-PTESTWPGISQL 231 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCC-CChhhHHHHhcC
Confidence 1223456888999998865 45788999999999999999999999764321 111111100000 00000000000
Q ss_pred cccC-----------CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 603 PRLG-----------ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 603 ~~l~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..+. ..........+.+++.+||+.||.+|+++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0001112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=309.23 Aligned_cols=257 Identities=19% Similarity=0.255 Sum_probs=182.7
Q ss_pred cCccccccccccCcEEEEEEEcCC----CcEEEEEEeecCCCccH-----------HHHHHHHHHHHHccCCCceeEEeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQGE-----------REFKAEVEIISRIHHRHLVSLVGY 431 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~-----------~~~~~E~~il~~l~hpnIv~l~~~ 431 (696)
++|++.++||+|+||.||+|...+ +..+|+|+......... .....++..+..++|.||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 679999999999999999998644 45667776543332211 112233344556689999999997
Q ss_pred EeeCC----ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 432 CISDD----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 432 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
+.... ..++++|++.. ++.+.+.... ...+..++.|+.||++||+|||++ +|+|||||++|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 76543 23677777633 4444444322 256788899999999999999999 99999999999999999999
Q ss_pred EEEeeccchhccccCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHH
Q 005443 508 QVSDFGLAKLALDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~ 581 (696)
||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++|+.||....... .++
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~~ 243 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NLI 243 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HHH
Confidence 99999999765432211 1122468999999999999999999999999999999999999998653221 111
Q ss_pred HhHH-HHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 582 EWAR-PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 582 ~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
.... .++.+... . .+.. ......+.+++..|++.++++||++.+|++.|+
T Consensus 244 ~~~~~~~~~~~~~-~--------~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHE-G--------KIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhh-h--------hhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111 11111111 0 0000 011236889999999999999999999998763
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.82 Aligned_cols=250 Identities=23% Similarity=0.406 Sum_probs=203.9
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.+.||+|+||.||++... +++.|++|++..... ...+++.+|++++++++|+|++++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999964 689999999976543 4456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
+.+++|.+++.... ...+++..+++++.||+.||.|||++ +|+|+||+++||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999998887642 34589999999999999999999999 99999999999999999999999999997654433
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.......|+..|++||.+.+..++.++|||+||+++|+|++|+.+|.... ..+...... ......
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~-----~~~~~~--- 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKIL-----KGQYPP--- 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHh-----cCCCCC---
Confidence 22333467889999999998889999999999999999999999987543 111111111 111111
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.. .....+.+++++||+.+|++||++.||++.
T Consensus 223 --~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 --IPS----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 122368899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.59 Aligned_cols=241 Identities=27% Similarity=0.371 Sum_probs=190.9
Q ss_pred ccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 375 LGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 375 LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
||+|+||.||++.. .+|+.||||++.... ......+.+|+++|++++|+||+++++++...+..++||||+.+++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 468999999986432 22344577899999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccc
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~ 530 (696)
.+++.......+.+..++.++.||+.||.|||++ +|+||||+++|||+++++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 9988776655689999999999999999999999 99999999999999999999999999987654321 222345
Q ss_pred cccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcc
Q 005443 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610 (696)
Q Consensus 531 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (696)
++..|++||++.++.++.++|||+|||++|+|++|+.||...........+ .... ... ...+ .
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~-----~~~--~~~~----~ 218 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL------KRRT-----LEM--AVEY----P 218 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH------Hhcc-----ccc--cccC----C
Confidence 778999999998888999999999999999999999999764431111100 0000 000 0001 1
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCHHH
Q 005443 611 EGEMFRMIEAAAACVRHSAAKRPRMGQ 637 (696)
Q Consensus 611 ~~~~~~l~~li~~cl~~dP~~RPs~~e 637 (696)
......+.+++++||+.+|++|+++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 111236889999999999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=302.72 Aligned_cols=242 Identities=26% Similarity=0.323 Sum_probs=193.8
Q ss_pred ccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
||.|+||.||+++.. +++.|+||++..... ...+.+.+|++++++++|+||+++++++.+++..++||||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999964 489999999875432 3346799999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccc
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~ 530 (696)
.+++.+... +.+..++.++.||+.||+|||++ +++|+||+++||+|++++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRGL--FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 999976543 88999999999999999999998 99999999999999999999999999998664432 122346
Q ss_pred cccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcc
Q 005443 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610 (696)
Q Consensus 531 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (696)
++..|++||++.+..++.++|||+|||++|||++|+.||..... +..+...... . ......+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~----~---------~~~~~~~~ 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDIL----K---------GNGKLEFP 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHh----c---------cCCCCCCC
Confidence 78899999999888899999999999999999999999976432 1111111111 0 00001111
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005443 611 EGEMFRMIEAAAACVRHSAAKRPR-----MGQVVR 640 (696)
Q Consensus 611 ~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~ 640 (696)
......+.+++.+||+.++++|++ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111347899999999999999999 555553
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.75 Aligned_cols=266 Identities=21% Similarity=0.333 Sum_probs=195.3
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++.+.||+|.||.||+|..+ +|+.||||+++.... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999864 688999999865432 234568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-CCcEEEEeeccchhccccC
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls~~~~~~~ 522 (696)
|+. ++|.+++.......+++..++.++.||+.||+|||++ +|+||||+++||++++ ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5677766554444468888899999999999999999 9999999999999985 5679999999997543321
Q ss_pred cceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----Hhhhh-hh
Q 005443 523 THITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----HALEN-EE 596 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~~-~~ 596 (696)
.......++..|++||++.+ ..++.++|||||||++|+|++|+.+|...... +.+.+.. ..+. ..+.. ..
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIF-RILGTPNEETWPGVTS 233 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-HHhCCCChhhcccccc
Confidence 11223457889999999876 45788999999999999999999999754321 1111110 0000 00000 00
Q ss_pred hhcccC--cccCC----CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 597 FDNLAD--PRLGE----NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 597 ~~~~~d--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
+.+... ..+.. .........+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00000 000111235789999999999999999999985
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.81 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=202.1
Q ss_pred CHHHHHHHhcCccc--cccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEE
Q 005443 358 TYEELVKATDGFAD--QNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432 (696)
Q Consensus 358 ~~~~l~~~~~~~~~--~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 432 (696)
+.++-..+.+-|.+ .++||.|.||+||-|++ ++|+.||||++.... .+.+..+++|+.||++++|+.||+|...|
T Consensus 553 qiqe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ 632 (888)
T KOG4236|consen 553 QIQENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF 632 (888)
T ss_pred hhhhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee
Confidence 33443334333433 37899999999999985 579999999996442 24457799999999999999999999999
Q ss_pred eeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC---CcEEE
Q 005443 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQV 509 (696)
Q Consensus 433 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL 509 (696)
+..+..++|||.+.|.-|.-+|. .++..+.+.....++.||+.||.|||.+ ||||+|||++||||.+. -++||
T Consensus 633 ET~ervFVVMEKl~GDMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKl 708 (888)
T KOG4236|consen 633 ETPERVFVVMEKLHGDMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKL 708 (888)
T ss_pred cCCceEEEEehhhcchHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceee
Confidence 99999999999996555544444 4444588888899999999999999999 99999999999999543 47999
Q ss_pred EeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH
Q 005443 510 SDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589 (696)
Q Consensus 510 ~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (696)
||||++|.+.+... ...++||+.|+|||++++..|...-|+||+|||+|--|+|.+||+++.. +-+.
T Consensus 709 CDFGfARiIgEksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQ------ 775 (888)
T KOG4236|consen 709 CDFGFARIIGEKSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQ------ 775 (888)
T ss_pred ccccceeecchhhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHH------
Confidence 99999998866443 4557899999999999999999999999999999999999999986432 2211
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.+. .++-+ .....+.....++||...|+..-++|-+.+..+.+
T Consensus 776 --IQNA---aFMyP---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 776 --IQNA---AFMYP---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred --hhcc---ccccC---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1111 11111 11112233467899999999999999988776644
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=324.12 Aligned_cols=274 Identities=24% Similarity=0.344 Sum_probs=208.5
Q ss_pred ccccccccccCcEEEEEEE-cCCCcEEEEEEeecC-CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC------ceeE
Q 005443 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------RRLL 440 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------~~~l 440 (696)
|...+.||+|+||.||+|+ .+.|+.||||.++.. ..+..+.+.+|+++|++|+|+|||+++++-++.. ..++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4455789999999999999 557999999999753 3455678999999999999999999999766543 4589
Q ss_pred EEEecCCCchhhccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC--CCC--cEEEEeeccc
Q 005443 441 IYDYVPNNTLYFHLHGE-GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD--NNF--EAQVSDFGLA 515 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~--~~~--~vkL~DfGls 515 (696)
|||||.||+|+..|.+- ....+.+.+.+.++.++..||.|||++ ||||||||+.||++. ++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999763 334699999999999999999999999 999999999999993 323 4799999999
Q ss_pred hhccccCcceeeccccccccCchhhhc-cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYAS-SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
+...++. ....++||..|++||++. .+.|+..+|.|||||++||+.||.+||....... +..+.....+.+....
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHIITKKPSG 247 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhhccCCCc
Confidence 9876654 566789999999999998 4889999999999999999999999997654322 2222222222211111
Q ss_pred hhhh--cccC------ccc--CCCcchHHHHHHHHHHHHHhccCCCCCC--CHHHHHHHHHhhhccc
Q 005443 595 EEFD--NLAD------PRL--GENYVEGEMFRMIEAAAACVRHSAAKRP--RMGQVVRVFDSLATSD 649 (696)
Q Consensus 595 ~~~~--~~~d------~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~ell~~L~~l~~~~ 649 (696)
..+. ...+ ..+ ...........+-..+..+|..++++|. .+.+....+.+|....
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 0000 0000 000 1123344555677778888999999999 7777777777776543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.94 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=193.7
Q ss_pred cccccc--CcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEG--GFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
+.||+| +||+||++++ .+|+.||||+++.... ...+.+.+|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999986 4799999999875432 2235688999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce--
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-- 525 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~-- 525 (696)
++|.+++.......+++..++.++.||+.||+|||++ +|+|||||++|||+++++.++|+||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999888765544588999999999999999999998 99999999999999999999999998764432211110
Q ss_pred ----eeccccccccCchhhhccC--CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH---------HHH
Q 005443 526 ----TTRVMGTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL---------LSH 590 (696)
Q Consensus 526 ----~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~---------~~~ 590 (696)
.....++..|++||++.+. .++.++|||||||++|||++|+.||...... ..+.+..... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccch
Confidence 0112345679999999763 4788999999999999999999999754311 1111111000 000
Q ss_pred ----------hhh----hhhh-----hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 ----------ALE----NEEF-----DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 ----------~~~----~~~~-----~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
... ...+ ..+.+..+...........+.+|+++||+.||++||++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0000 00111111122223344578999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.57 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=195.2
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l 440 (696)
.++|++.++||+|+||.||+|... +|+.||+|+++..... ....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367999999999999999999964 6899999999754332 234567899999999999999999998765 45799
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+ +|.+++.... ..+.+..++.++.||++||+|||++ +|+|||||++||++++++.+||+|||+++....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999965 6776665432 3489999999999999999999999 999999999999999999999999999986544
Q ss_pred cCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----Hhhhh-
Q 005443 521 ANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----HALEN- 594 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~~- 594 (696)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|+.+|..... ...+......+. ..+..
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChhhchhh
Confidence 3221 222345778999999875 5678999999999999999999999975432 111111111100 00000
Q ss_pred ---hhhhc--ccCcccCC--CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 595 ---EEFDN--LADPRLGE--NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 595 ---~~~~~--~~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..... +....+.. .........+.+++.+||+.||++|+++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 00000000 000011335788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.68 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=201.5
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.++||+|+||.||++.. .+++.|+||++.... .....++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999974 478899999987543 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
+.+++|.+++... ....+++..++.++.||+.||+|||++ +++||||+++||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999998887652 224588999999999999999999999 9999999999999999999999999999876543
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
......++..|++||.+.+..++.++|+|+||+++|||++|+.||..... ..+.. ......+..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~--------~~~~~~~~~--- 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRY--------KVQRGKYPP--- 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH--------HHhcCCCCC---
Confidence 22234578899999999998899999999999999999999999975431 11111 011111111
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......++.+++.+||+.++++||++.+|++.
T Consensus 221 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 ------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112233468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.37 Aligned_cols=265 Identities=22% Similarity=0.349 Sum_probs=195.5
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----ce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 438 (696)
.++|++.++||+|+||.||+|.. .+|+.||||+++... ......+.+|+.++++++|+||+++++++...+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 478999999986432 234456889999999999999999999876543 47
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++|+||+.+ +|..++... .+.+..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 899999964 676666432 388999999999999999999999 9999999999999999999999999998765
Q ss_pred cccCcc--eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 519 LDANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
...... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.+|...+. .........++.... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~-~~ 232 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPS-QE 232 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCC-HH
Confidence 332211 1123467889999998765 5688999999999999999999999975432 111111111111000 00
Q ss_pred hhhcccCcc---------cCCC-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPR---------LGEN-----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~---------l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+..+.+.. .... .......++.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011000000 0000 001123468899999999999999999999976
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=304.52 Aligned_cols=262 Identities=19% Similarity=0.244 Sum_probs=193.5
Q ss_pred ccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHcc-CCCceeEEeEEeeC--CceeEEEE
Q 005443 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIH-HRHLVSLVGYCISD--DRRLLIYD 443 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~~lV~E 443 (696)
|++++.||+|+||.||+|.. .+++.||||+++... ........+|+.+++++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 66789999999999999985 468999999987542 222334567999999986 99999999999987 88899999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+. ++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||+++||++++ +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 46766665433 3489999999999999999999999 9999999999999999 9999999999976543322
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh----hhhhh
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE----NEEFD 598 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~----~~~~~ 598 (696)
.....++..|++||++.. ..++.++|||||||++|||++|+.+|...+. .+.+.+....+..... .....
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhccc
Confidence 122457889999998754 5578899999999999999999999976432 2222222211110000 00000
Q ss_pred cccCcccCC-------CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 599 NLADPRLGE-------NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 599 ~~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+..+.. .........+.+++++||+.+|++||++++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0011224578999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=310.22 Aligned_cols=268 Identities=20% Similarity=0.292 Sum_probs=194.5
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCC------
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 436 (696)
.++|++.++||+|+||.||+|... +++.||||++..... .....+.+|++++++++|+||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999864 689999999865432 22345678999999999999999999987654
Q ss_pred --ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 437 --RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 437 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
..++||||+.+ +|.+++.... ..+.+.++++++.||+.||+|||++ +|+|+|||++|||+++++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 34999999964 6766665443 2489999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcc---eeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH-
Q 005443 515 AKLALDANTH---ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS- 589 (696)
Q Consensus 515 s~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~- 589 (696)
+......... ......++..|+|||++.+. .++.++|||||||++|||++|+.+|...........++.+...+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9765432221 12234577889999988764 478899999999999999999999976442211111111110000
Q ss_pred Hhhhh----hhhhcc---------cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 590 HALEN----EEFDNL---------ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 590 ~~~~~----~~~~~~---------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.. ..+..+ ....+... .....+.+++.+||+.||++||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 000000 00000000 012356789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.53 Aligned_cols=242 Identities=26% Similarity=0.345 Sum_probs=185.6
Q ss_pred cccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHHHH---ccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 374 LLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISR---IHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 374 ~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~---l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
+||+|+||.||++.. .+|+.||||+++.... .....+.+|..+++. .+|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 4689999999864322 122334455544444 469999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999998887554 389999999999999999999999 99999999999999999999999999987543322 1
Q ss_pred eccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+.+. . . ..+..+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~---~-------~~~~~~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----T---L-------TVNVEL 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----h---h-------cCCcCC
Confidence 23468999999999864 5688999999999999999999999975432211111110 0 0 001111
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.......+.+++++||+.|+++|+ +++|++++
T Consensus 219 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112233688999999999999999 58877764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.55 Aligned_cols=267 Identities=25% Similarity=0.333 Sum_probs=197.8
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDD----- 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 436 (696)
..++|++.++||+|+||.||+|.++ +|+.||||+++.... .....+.+|++++++++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999965 688999999975432 23356788999999999999999999987654
Q ss_pred -----ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEe
Q 005443 437 -----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (696)
Q Consensus 437 -----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (696)
..++|+||+.+ +|..++... ...+++..++.++.||+.||+|||+. +|+|||||++||++++++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 68999999976 565555543 23489999999999999999999999 999999999999999999999999
Q ss_pred eccchhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 512 fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
||++...............++..|++||++.+ ..++.++|||+|||++|||++|+.+|..... ....+.+......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~~~~ 236 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRLCGS 236 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Confidence 99998664433222233346778999998865 4578899999999999999999999975432 1111111111100
Q ss_pred hhhhhhhhccc--------C------cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 ALENEEFDNLA--------D------PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 ~~~~~~~~~~~--------d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ....+..+. + ..+...+ ......+.+++.+||+.+|.+||++++|++.
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 P-CPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred C-Chhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000000000 0 0000000 0113468899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.65 Aligned_cols=266 Identities=17% Similarity=0.230 Sum_probs=195.3
Q ss_pred cccccccccCcEEEEEEEcCCCcEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
.+.+.+|.|+++.||++.. +|+.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||+.+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566666666666665 7999999999754 234456799999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc---
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH--- 524 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~--- 524 (696)
++|.+++.......+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999998765444588999999999999999999999 9999999999999999999999999988654332211
Q ss_pred ---eeeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 525 ---ITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 525 ---~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+.+.....+...+....+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence 1122346778999999876 35888999999999999999999999754311 1111111110000000000000
Q ss_pred -----------ccC----cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 -----------LAD----PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 -----------~~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+ .............++.+++.+||+.||++||++++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000111122223468899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.51 Aligned_cols=266 Identities=20% Similarity=0.309 Sum_probs=197.7
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeC----Ccee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD----DRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----~~~~ 439 (696)
++|++.++||+|+||.||+|..+ +|+.||||++.... ....+.+.+|+.+|++++|+||++++++|... ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67999999999999999999854 68999999987542 23446678899999999999999999987643 4579
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+||||+. ++|.+++..... +++..+++++.||+.||+|||++ +|+|||||++|||+++++.+||+|||++....
T Consensus 85 lv~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 9999995 678888865543 89999999999999999999998 99999999999999999999999999987653
Q ss_pred ccCcc---eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----Hh
Q 005443 520 DANTH---ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----HA 591 (696)
Q Consensus 520 ~~~~~---~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~ 591 (696)
..... .....+|+..|++||++.+ ..++.++|||+|||++|||++|+.+|....... .+......+. +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSEEV 235 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChhHh
Confidence 32211 1123468889999999865 568899999999999999999999997643211 1111110000 00
Q ss_pred h---hhhhhhcccCc-ccCCC-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 592 L---ENEEFDNLADP-RLGEN-----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 592 ~---~~~~~~~~~d~-~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+ ....+.+..+. ..... ........+.+++++||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00000000000 00000 011123468999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=314.29 Aligned_cols=267 Identities=21% Similarity=0.337 Sum_probs=197.0
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC--CCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCC--ce
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDD--RR 438 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~--~~ 438 (696)
+.++|++.++||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++++ +|+||++++++|...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567899999999999999999865 6889999988532 223345677899999999 9999999999987543 57
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+. ++|..++... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 5888777654 478899999999999999999998 9999999999999999999999999999865
Q ss_pred cccCc----ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----
Q 005443 519 LDANT----HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS---- 589 (696)
Q Consensus 519 ~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~---- 589 (696)
..... .......|+..|++||++.+ ..++.++|||||||++|||++|+.+|...... ...+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL---NQLEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCH
Confidence 44322 12233568889999998765 56788999999999999999999999754321 11111000000
Q ss_pred -------HhhhhhhhhcccCcccC--CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 590 -------HALENEEFDNLADPRLG--ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 590 -------~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......+..+...... ..........+.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000000 00001123468899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=307.22 Aligned_cols=259 Identities=27% Similarity=0.330 Sum_probs=201.6
Q ss_pred CccccccccccCcEEEEEEEc----CCCcEEEEEEeecCC----CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCce
Q 005443 368 GFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 438 (696)
+|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +|+||+++++++..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999874 357889999987432 12335688999999999 599999999999998999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+.+++|.+++.... .+.+..++.++.||++||+|||+. +++||||+++||++++++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999998887543 378899999999999999999998 9999999999999999999999999998765
Q ss_pred cccCcceeeccccccccCchhhhccCC--CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSGK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
............|+..|++||.+.+.. .+.++|||+||+++|||++|..||....... ...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~------- 226 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILK------- 226 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHc-------
Confidence 443322223346788999999987655 7889999999999999999999996432111 11111111110
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.. ... .......+.+++.+||+.++++||++.++.+.|+...++
T Consensus 227 --~~--~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~ 270 (288)
T cd05583 227 --SK--PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270 (288)
T ss_pred --cC--CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccc
Confidence 00 001 111123678899999999999999999888877765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.98 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=195.8
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHc---cCCCceeEEeEEeeCCc-----
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRI---HHRHLVSLVGYCISDDR----- 437 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~----- 437 (696)
|++.++||+|+||.||+|+.+ +++.||||+++..... ....+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999975 4899999999754332 234567788887776 59999999999988776
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+++|||+.+ +|.+++.......+++..+++++.||+.||+|||++ +|+|+||+++|||+++++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999974 787777665444589999999999999999999999 999999999999999999999999999876
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh--h
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN--E 595 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~--~ 595 (696)
...... .....++..|++||++.+..++.++|||||||++|||++|+.+|..... .+....++...... .
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE------ADQLDKIFDVIGLPSEE 228 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh------HHHHHHHHHHcCCCChH
Confidence 533321 1223578889999999998999999999999999999999998875432 11111111111000 0
Q ss_pred hhh-------cccCcccCC---CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 596 EFD-------NLADPRLGE---NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 596 ~~~-------~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.+. ......... .........+.+++++||+.||++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000000000 011122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.63 Aligned_cols=264 Identities=19% Similarity=0.277 Sum_probs=194.3
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCc-----
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDR----- 437 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~----- 437 (696)
++|++.++||+|+||.||+|... +|+.||||+++.... .....+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999854 689999999865432 23457889999999995 6999999999987665
Q ss_pred eeEEEEecCCCchhhccccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-CCcEEEEeec
Q 005443 438 RLLIYDYVPNNTLYFHLHGEG---RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFG 513 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DfG 513 (696)
.++||||+.+ +|.+++.... ...+++..++.++.||++||+|||++ +|+||||+++|||+++ ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 6777665432 23579999999999999999999999 9999999999999998 8899999999
Q ss_pred cchhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhh
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 592 (696)
+++........ .....++..|+|||++.+ ..++.++|||+|||++|||++|..+|...... +....++....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL------QQLLHIFKLLG 229 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHhC
Confidence 98754332211 122356788999998865 45789999999999999999999999754321 11111111000
Q ss_pred --hhhhhhcccC-------cccC----CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 593 --ENEEFDNLAD-------PRLG----ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 593 --~~~~~~~~~d-------~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....+....+ ..+. ..........+.+++.+||+.||++|++++|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 0000 00001123468899999999999999999998853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=296.57 Aligned_cols=206 Identities=26% Similarity=0.402 Sum_probs=169.4
Q ss_pred HHhcCccccccccccCcEEEEEEEcC---C--CcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEee-C
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP---D--GREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCIS-D 435 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~---~--g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 435 (696)
.....|+.++.||+|.||.||+|..+ + .+.+|||+++..... ......+|+.+++.|+|+||+.|..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34457999999999999999999632 2 337999999754322 22456799999999999999999999988 6
Q ss_pred CceeEEEEecCCCchhhcccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC----CcEE
Q 005443 436 DRRLLIYDYVPNNTLYFHLHG---EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN----FEAQ 508 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~----~~vk 508 (696)
...+|+|||.+.. |+..++- .....+....+..|++||+.|+.|||++ -|+|||||+.||||..+ |.||
T Consensus 101 ~~v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 7789999999664 5444431 2234688899999999999999999999 79999999999999766 8999
Q ss_pred EEeeccchhccccCcce--eeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 509 VSDFGLAKLALDANTHI--TTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 509 L~DfGls~~~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
|+|||++|.+.+..... ...++.|++|+|||.+.+ ..|+.+.|||++|||+.||++-..-|.+..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999999887654433 344678999999999887 679999999999999999999888886543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.23 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=196.2
Q ss_pred cccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 372 QNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
..+||+|+||.||++.. .+|+.||||++..........+.+|+.++++++|+||+++++++...+..++||||+.+++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999986 47899999998765555566799999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccc
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~ 530 (696)
.+++... .+++..++.++.||+.||+|||++ +|+||||+++||++++++.++|+|||++........ ......
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 8877532 378999999999999999999999 999999999999999999999999999875543221 122346
Q ss_pred cccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcc
Q 005443 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610 (696)
Q Consensus 531 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (696)
|+..|++||++.+..++.++|||+|||++|||++|+.||..... ........ ..+ . ..+.. .
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~----~~~-----~----~~~~~--~ 239 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR----DNL-----P----PKLKN--L 239 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hhC-----C----cccCC--c
Confidence 78899999999888899999999999999999999999875321 11111111 000 0 00000 0
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 611 EGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 611 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
......+.+++.+||+.+|.+|+++.+|+++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1112357888999999999999999998863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=297.69 Aligned_cols=247 Identities=28% Similarity=0.465 Sum_probs=201.4
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|++.+.||+|.+|.||++... +++.|+||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999854 678999999976543 3456799999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++.... .+++..++.++.|++.||.|||++ +|+||||+++||++++++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999887653 489999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|++||.+.+..++.++|||+||+++|+|++|+.+|..... ... .+ .. .......
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~-~~--~~-----~~~~~~~----- 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAA-LF--RI-----VQDDHPP----- 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHH-HH--HH-----hccCCCC-----
Confidence 2334678899999999888889999999999999999999999975321 000 00 00 0001111
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
+ .......+.+++.+||+.++++||++.+++.
T Consensus 219 ~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 L----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1112236889999999999999999999884
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=309.36 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=194.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+.|+..+.||+|+||.||+|+.. +++.|+||.+..... ....++.+|+++++.++|+||+++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999954 678999999864322 23356788999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+. |+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||+++|||+++++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 56766664333 2378999999999999999999998 9999999999999999999999999998754322
Q ss_pred cceeeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
....++..|+|||++. .+.++.++|||||||++|||++|+.||..... .+...... . .....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~----~-~~~~~ 233 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIA----Q-NESPA 233 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHh----h-cCCCC
Confidence 2245788999999975 35678899999999999999999999865321 01111000 0 00000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
. ........+.+++++||+.+|++||++.+|++....+.
T Consensus 234 -----~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 234 -----L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -----c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0 01122236889999999999999999999997755444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=304.87 Aligned_cols=250 Identities=27% Similarity=0.379 Sum_probs=194.5
Q ss_pred CccccccccccCcEEEEEEEc----CCCcEEEEEEeecCC----CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCce
Q 005443 368 GFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 438 (696)
+|++.+.||+|+||.||+++. .+|+.||+|+++... ....+.+.+|+++++++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 368999999997432 22346688999999999 599999999999998899
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+.+++|.+++.... .+.+..+..++.||++||.|||++ +|+||||+++|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999887654 378899999999999999999998 9999999999999999999999999999765
Q ss_pred cccCcceeeccccccccCchhhhccC--CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
............|+..|++||++.+. .++.++|||+|||++|+|++|+.||...... ....++...+.. .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~----~-- 227 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILK----S-- 227 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhc----c--
Confidence 44332223345688899999998753 4678999999999999999999999743221 111111111110 0
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVV 639 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell 639 (696)
... +.......+.+++++||+.||++|+ ++.+++
T Consensus 228 -----~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 228 -----EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred -----CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 000 1111223678999999999999997 555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=305.22 Aligned_cols=263 Identities=20% Similarity=0.285 Sum_probs=198.8
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
|++.+.||+|++|.||+|... +|+.|++|+++..... ....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 7889999998754332 3467889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+ +|..++.... ..+++..++.++.||+.||.|||++ +|+|+||+++||++++++.+||+|||++....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 7777766543 3489999999999999999999999 99999999999999999999999999997665433 12
Q ss_pred eeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC--
Q 005443 526 TTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD-- 602 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d-- 602 (696)
.....++..|++||.+.+. .++.++|||+|||++|+|++|+.+|...+.. +.+......+... ..+.+..+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTP-DPEVWPKFTSLA 230 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCC-chHhcccchhhh
Confidence 2234578889999998876 7899999999999999999999999764421 1111110000000 0000000000
Q ss_pred ---------cccC--CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 ---------PRLG--ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ---------~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.... ..........+.+++.+||+.||.+||++.+|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00111233478899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=313.34 Aligned_cols=270 Identities=21% Similarity=0.320 Sum_probs=198.0
Q ss_pred CHHHHHHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEee
Q 005443 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (696)
Q Consensus 358 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 434 (696)
..+++....++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456667789999999999999999999984 478999999986432 2234568889999999999999999998864
Q ss_pred C------CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEE
Q 005443 435 D------DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (696)
Q Consensus 435 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (696)
. +..+++++++ +++|.+++... .+++..++.++.||++||+|||++ +|+|||||++||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3 2357788776 77887776543 388999999999999999999999 999999999999999999999
Q ss_pred EEeeccchhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH
Q 005443 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587 (696)
Q Consensus 509 L~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~ 587 (696)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.+|....... .+.......
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLV 234 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence 9999998764322 223457889999999876 568889999999999999999999996543211 111100000
Q ss_pred ------HHHhhhhhh-------hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 588 ------LSHALENEE-------FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 588 ------~~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+...+.... +..+....+.. ........+.+++.+||+.|+.+|+++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000 00000000000 000112357899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=336.19 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=208.0
Q ss_pred HhcCccccccccccCcEEEEEEEcC----C----CcEEEEEEeecCCC-ccHHHHHHHHHHHHHcc-CCCceeEEeEEee
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP----D----GREVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRHLVSLVGYCIS 434 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~----~----g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 434 (696)
..+++++.+.||+|.||.||+|... . ...||||.++.... .+.+.+..|+++|+.+. |+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3455566679999999999999843 1 45799999975543 44577999999999995 9999999999999
Q ss_pred CCceeEEEEecCCCchhhccccCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceE
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGEG------------R--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 500 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NIL 500 (696)
.+..++|+||+..|+|..+|+..+ . ..+...+++.+++||+.||+||++. ++|||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence 889999999999999999997655 0 1378899999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeeccchhccccCcceeeccc--cccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCc
Q 005443 501 LDNNFEAQVSDFGLAKLALDANTHITTRVM--GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGD 577 (696)
Q Consensus 501 l~~~~~vkL~DfGls~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~ 577 (696)
|.++..+||+|||+++.............. -...|||||.+....|+.++|||||||+||||++ |..||.+.. ..
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--~~ 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--PT 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--cH
Confidence 999999999999999976555444333222 3557999999999999999999999999999999 888886511 12
Q ss_pred hhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 578 ESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 578 ~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.+++++++ .+ .+......+..++.+|++.||+.+|++||++.++++.|+.+.
T Consensus 529 ~~l~~~l~--------~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 EELLEFLK--------EG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHHh--------cC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 22222211 11 111122233447889999999999999999999999999853
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=292.83 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=199.8
Q ss_pred hcCcccc-ccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeC----Cce
Q 005443 366 TDGFADQ-NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISD----DRR 438 (696)
Q Consensus 366 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~----~~~ 438 (696)
+++|.+- ++||-|-.|.|..+.++ .|+.+|+|++. +..+.++|+++..... |+|||+++++|+.. +.+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556544 57999999999998854 68999999986 3456788999888775 99999999998743 456
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC---CCCcEEEEeeccc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLA 515 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DfGls 515 (696)
+||||+|+||.|+..++.++...+++.++.+|++||..|+.|||+. +|.|||||++|+|+. .|..+||+|||++
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence 8999999999999999999888899999999999999999999999 999999999999995 4557999999999
Q ss_pred hhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
+.....+. ...-+.|+.|.|||++....|+...|+||+||+||-||+|..||....... +-..++.. +...
T Consensus 212 K~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~r----I~~g 282 (400)
T KOG0604|consen 212 KETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRR----IRTG 282 (400)
T ss_pred cccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhH----hhcc
Confidence 87654333 223467999999999999999999999999999999999999997544211 11111111 1111
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
..++-++.| .....+..++|+.+|+.+|.+|-++.+++..-.
T Consensus 283 -qy~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 283 -QYEFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred -CccCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 111111111 122346789999999999999999999986533
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=299.30 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=192.7
Q ss_pred HHHHHHHhcCccccccc--cccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEee
Q 005443 359 YEELVKATDGFADQNLL--GEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCIS 434 (696)
Q Consensus 359 ~~~l~~~~~~~~~~~~L--G~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 434 (696)
..++....++|++.+.+ |+|+||.||++.. .+++.+|+|++....... .|+.++..+ +|+||++++++|..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34555566788888877 9999999999985 468899999986432211 123333323 69999999999999
Q ss_pred CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-cEEEEeec
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFG 513 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfG 513 (696)
.+..++||||+.+++|.+++.... .+++..++.++.||++||.|||+. +|+|||||++||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999987654 489999999999999999999999 999999999999999988 99999999
Q ss_pred cchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||..... .+....++....
T Consensus 156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~------ 223 (267)
T PHA03390 156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ------ 223 (267)
T ss_pred cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh------
Confidence 987543221 23578899999999998999999999999999999999999974321 111111111110
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-MGQVVR 640 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~ 640 (696)
.... .........+.+++.+||+.+|.+|++ ++|+++
T Consensus 224 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 QKKL----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccC----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 001122336889999999999999995 688874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.27 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=200.6
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV 441 (696)
++|.+.+.||+|+||.||+|... +|+.|+||++.... ....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999864 78999999986432 233467889999999999 99999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++...+ .+.+..++.|+.||+.||.|||++ +++|+||+++||+|+.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999887654 489999999999999999999998 9999999999999999999999999998765443
Q ss_pred Cc-------------------ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 005443 522 NT-------------------HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582 (696)
Q Consensus 522 ~~-------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~ 582 (696)
.. .......++..|++||++....++.++|||+|||++|+|++|+.+|..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~- 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF- 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH-
Confidence 21 122234578899999999988899999999999999999999999985431 1111
Q ss_pred hHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCH----HHHHH
Q 005443 583 WARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM----GQVVR 640 (696)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ell~ 640 (696)
..... . ...+.......+.+++++||+.+|.+||++ ++|++
T Consensus 232 --~~~~~-------~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 --QKILK-------L--------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHh-------c--------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11000 0 001111113368899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.84 Aligned_cols=269 Identities=20% Similarity=0.318 Sum_probs=199.6
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeC-----Cc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 437 (696)
.++|.+.++||+|+||.||+|+. .+|+.||||.++.. .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999985 46899999998643 223345678899999999999999999988654 24
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+|||||+. ++|.+++...+ .+.+..++.++.||+.||.|||++ +|+|||||++|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 67877776544 389999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH------
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH------ 590 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~------ 590 (696)
..... .......++..|+|||++.+ ..++.++|||+|||++|+|++|+.+|...+... ........+..
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEEDL 233 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHHh
Confidence 54332 22233457889999998875 468899999999999999999999997543211 11111110000
Q ss_pred -hhhhhhhhcc-------cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhh
Q 005443 591 -ALENEEFDNL-------ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV--FDSL 645 (696)
Q Consensus 591 -~~~~~~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~l 645 (696)
........+. .+..+.. ........+.+++++||+.+|++||+++||++. ++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000000 0000000 011223468899999999999999999999976 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=305.40 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=197.5
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEEec
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
|++.+.||+|+||.||+|... +++.|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999975 578999999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
+++|.+++.......+++..++.++.||+.+|.|||++ +|+|+||+++||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 88898888765544589999999999999999999998 999999999999999999999999999976543222
Q ss_pred eeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH-----hhhhhhhhc
Q 005443 526 TTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH-----ALENEEFDN 599 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~~~ 599 (696)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.+|......+ .+......+.. +.+...+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID---QLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH---HHHHHHHhcCCCChhhhhhHhhhhc
Confidence 223457889999998754 557899999999999999999999996543211 11111100000 000000001
Q ss_pred ccCcccC-------CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LADPRLG-------ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.++..+. ..........+.+++++||+.+|++||+++||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1110000 00001113468899999999999999999999853
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.83 Aligned_cols=245 Identities=27% Similarity=0.331 Sum_probs=187.8
Q ss_pred ccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHH-HHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEII-SRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
+.||+|+||.||+|.. .+|+.||||+++.... .....+..|..++ ..++|+||+++++++..++..++|+||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999986 4689999999864321 1223345555544 345899999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
++|.+++...+ .+++..+.+++.||+.||.|||+. +|+||||+++|||+++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999887554 378999999999999999999998 999999999999999999999999999875433 12
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
...++..|++||.+.+..++.++|||+||+++|||++|..||...+. ....+ .+.. .... +..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~---~~~~-----~~~~------~~~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFD---NILS-----RRIN------WPE 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHh-----cccC------CCC
Confidence 24578899999999888899999999999999999999999975331 11111 1100 0000 000
Q ss_pred CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 608 NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 608 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
.........+.+++.+||+.+|++|+++.++.+.|..
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0111122368899999999999999987666554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=336.12 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=190.3
Q ss_pred HHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeC-----
Q 005443 363 VKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISD----- 435 (696)
Q Consensus 363 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 435 (696)
.+-.++|++.++||+|+||.||+++.+ ||++||||++.... ......+.+|+++|++|+|+|||++|..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 344567888899999999999999955 89999999997654 23345789999999999999999987321000
Q ss_pred --------------------------------------------------------------------------------
Q 005443 436 -------------------------------------------------------------------------------- 435 (696)
Q Consensus 436 -------------------------------------------------------------------------------- 435 (696)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005443 436 ----------------------------------DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481 (696)
Q Consensus 436 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~L 481 (696)
..+||-||||+...|+++++++... -.....++++++|++||.|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence 0136789999888888888765431 14778899999999999999
Q ss_pred HhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc------c-----------cCcceeeccccccccCchhhhccC
Q 005443 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL------D-----------ANTHITTRVMGTFGYMAPEYASSG 544 (696)
Q Consensus 482 H~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~------~-----------~~~~~~~~~~gt~~y~aPE~l~~~ 544 (696)
|+. |||||||||.||+|++++.|||+|||++.... + .+....+..+||..|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 99999999999999999999999999998621 0 011123456899999999999764
Q ss_pred ---CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHH
Q 005443 545 ---KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAA 621 (696)
Q Consensus 545 ---~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 621 (696)
.|+.|+|+|||||||+||+. ||.-.. +....+.. ++...+... .++....+..-..+|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~--------LR~g~iP~~------~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTN--------LRKGSIPEP------ADFFDPEHPEEASLI 851 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHh--------cccCCCCCC------cccccccchHHHHHH
Confidence 49999999999999999996 354321 11111111 111111111 122333344556889
Q ss_pred HHHhccCCCCCCCHHHHHH
Q 005443 622 AACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 622 ~~cl~~dP~~RPs~~ell~ 640 (696)
++|++.||.+||++.|||.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999985
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=312.91 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=195.0
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC------
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 436 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.++++++|+||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999985 468999999986432 223456889999999999999999999987543
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..++|+||+.+ +|..++. ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 45899999864 5655442 2378899999999999999999999 99999999999999999999999999987
Q ss_pred hccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH------HHH
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP------LLS 589 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~------~~~ 589 (696)
...... ....++..|+|||++.+ ..++.++|||||||+||||++|+.+|....... .+...... -+.
T Consensus 166 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHH
Confidence 643221 23457888999999876 468899999999999999999999997643211 11000000 000
Q ss_pred Hhhhhhhhhccc---CcccCCCc---chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhhc
Q 005443 590 HALENEEFDNLA---DPRLGENY---VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV--FDSLAT 647 (696)
Q Consensus 590 ~~~~~~~~~~~~---d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~l~~ 647 (696)
+.+......... ........ .......+.+++.+||+.||++|+++++|+.+ ++++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000000 00000000 00122357899999999999999999999955 665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.65 Aligned_cols=267 Identities=22% Similarity=0.289 Sum_probs=193.3
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCC------
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 436 (696)
.++|++.++||+|+||.||+|... +++.||||++...... ....+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999854 6899999998654332 2346789999999999999999999876543
Q ss_pred --ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 437 --RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 437 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
..++|+||+.+ +|...+.... ..+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 35899999965 5655554432 2489999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcc----------eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHh
Q 005443 515 AKLALDANTH----------ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583 (696)
Q Consensus 515 s~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~ 583 (696)
++........ ......++..|+|||++.+ ..++.++|||||||++|||++|+.+|........ .+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~~ 238 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LHL 238 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 9765432211 1122456788999998865 4578999999999999999999999975442211 111
Q ss_pred HHHHHHH----hhh-hhhhhccc----CcccCCC---cchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 584 ARPLLSH----ALE-NEEFDNLA----DPRLGEN---YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 584 ~~~~~~~----~~~-~~~~~~~~----d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
....... .+. ...+.... ....... ........+.+++++||+.||++|+++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1100000 000 00000000 0000000 00111246889999999999999999999885
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.95 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=191.8
Q ss_pred cCccccccccccCcEEEEEEEcCC-CcEEEEEEeecCCC-ccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGG-QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++.+.||+|+||.||+|.+++ ++.||||+++.... ....++.+|+.++.++. |+||++++++|.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568889999999999999999754 89999999975432 23455777888777775 9999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+. ++|.+++.... ..+++..+++++.||+.||+|||+.+ +|+||||+++||++++++.+||+|||++........
T Consensus 95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 985 45655554322 25889999999999999999999732 899999999999999999999999999876543222
Q ss_pred ceeeccccccccCchhhhccCC----CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 524 HITTRVMGTFGYMAPEYASSGK----LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
. ....++..|+|||++.+.. ++.++|||||||+||||++|+.||..... . .+.....+ ... ...
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~---~~~~~~~~----~~~-~~~ 238 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--E---FEVLTKIL----QEE-PPS 238 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--H---HHHHHHHh----cCC-CCC
Confidence 1 2235778999999987554 78899999999999999999999964321 0 11111111 110 000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+... . ....++.+++.+||+.||++||++++|+++
T Consensus 239 ~~~~---~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 LPPN---E----GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC---C----CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0 122368899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.35 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=196.6
Q ss_pred cCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCc-------cHHHHHHHHHHHHHccCCCceeEEeEEee-CCc
Q 005443 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQ-------GEREFKAEVEIISRIHHRHLVSLVGYCIS-DDR 437 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 437 (696)
++|.++++||+|+|+.||+|. +...+.||||+-..+... ..+...+|..|.+.|+|+.||++|+||.. .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 568888999999999999998 557889999987644321 22346789999999999999999999975 567
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC---CCCcEEEEeecc
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGL 514 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DfGl 514 (696)
+|-|+|||+|.+|+.+|.... .+++++++.|++||+.||.||.+. ++.|||-|||+.||||. .-|.+||.||||
T Consensus 543 FCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 889999999999999997654 489999999999999999999996 67999999999999994 457899999999
Q ss_pred chhccccCcc------eeeccccccccCchhhhccC----CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhH
Q 005443 515 AKLALDANTH------ITTRVMGTFGYMAPEYASSG----KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWA 584 (696)
Q Consensus 515 s~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~ 584 (696)
++.+.+..+. .+....||.+|++||.+.-+ .++.|+||||+|||+|+++.|+.||..... ..++++..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILqeN 697 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQEN 697 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHhhh
Confidence 9988665443 33456899999999977543 578899999999999999999999986432 11111110
Q ss_pred HHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 005443 585 RPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVV 639 (696)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell 639 (696)
..+...++..-..+ ....+...+|++||...-++|-+..+|.
T Consensus 698 -----TIlkAtEVqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 -----TILKATEVQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -----chhcceeccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 01111111111111 1223577889999999999997766554
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=311.69 Aligned_cols=265 Identities=22% Similarity=0.296 Sum_probs=200.7
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----cee
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-----RRL 439 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 439 (696)
+|++.+.||+|+||.||+|+.. +|+.|+||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999964 58999999987543 344567999999999999999999999988765 789
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+||||+. ++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 47888776544 489999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCc--ceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH----hh
Q 005443 520 DANT--HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH----AL 592 (696)
Q Consensus 520 ~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~----~~ 592 (696)
.... .......++..|++||++.+. .++.++|||+|||++|+|++|+.+|..... ....+.....+.. .+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY---IDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHhcCCCChhHh
Confidence 4321 122334678899999999887 789999999999999999999999976542 1111111111000 00
Q ss_pred ---hhhhhhcccCc-ccCCC-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 593 ---ENEEFDNLADP-RLGEN-----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 593 ---~~~~~~~~~d~-~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
......+.+.. ..... ........+.+++++||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 00000 001123468899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.61 Aligned_cols=267 Identities=20% Similarity=0.304 Sum_probs=203.0
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC------CceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR------HLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp------nIv~l~~~~~~~~~~ 438 (696)
.++|++++.+|+|.||.|..+.+. .+..||||+++.- .+..+..+-|+++|++|++. -+|.+.+||...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 689999999999999999999853 4789999999743 23345567799999999421 367788899999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC----------------
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---------------- 502 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---------------- 502 (696)
+||+|.+ |-+++++|..+.-..+....++.|++||+++++|||+. +++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 67899999988888899999999999999999999999 999999999999993
Q ss_pred ----CCCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCch
Q 005443 503 ----NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578 (696)
Q Consensus 503 ----~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~ 578 (696)
.+..|||+|||.++...... ...+.|..|+|||++++-.++..+||||+||||+||++|...|......+..
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 13468999999998654332 3356899999999999999999999999999999999999999876533222
Q ss_pred hHHHhHHH-----HHHHh-----hhhhhhh--c---------ccCcc----cCCCcchHHHHHHHHHHHHHhccCCCCCC
Q 005443 579 SLVEWARP-----LLSHA-----LENEEFD--N---------LADPR----LGENYVEGEMFRMIEAAAACVRHSAAKRP 633 (696)
Q Consensus 579 ~l~~~~~~-----~~~~~-----~~~~~~~--~---------~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RP 633 (696)
.+++.+.. ++.+. ...+.++ + ..+.. ........+...|++|+++||..||.+|.
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 22222211 11111 0000000 0 00000 00112234556799999999999999999
Q ss_pred CHHHHHHH
Q 005443 634 RMGQVVRV 641 (696)
Q Consensus 634 s~~ell~~ 641 (696)
|+.|++.+
T Consensus 399 Tl~EAL~H 406 (415)
T KOG0671|consen 399 TLREALSH 406 (415)
T ss_pred cHHHHhcC
Confidence 99998854
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=344.37 Aligned_cols=251 Identities=27% Similarity=0.373 Sum_probs=200.4
Q ss_pred cCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
-+|.....||.|.||.||.|. .++|+..|||.+++.... ....+.+|+++|..|+|+|||++||+-...+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 467777899999999999998 567999999988755433 33568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
||++|+|.+.++..+. +++.....+..|++.||.|||++ ||||||||+.||||+.+|.+|++|||.++.+.....
T Consensus 1315 yC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 9999999998875433 67777778899999999999999 999999999999999999999999999988765532
Q ss_pred ce---eeccccccccCchhhhccC---CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 524 HI---TTRVMGTFGYMAPEYASSG---KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 524 ~~---~~~~~gt~~y~aPE~l~~~---~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
.. ....+||..|||||++.+. ....++|||||||+++||+||+.||...+. -.+.+.++- .+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~V~-----~g-- 1457 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYHVA-----AG-- 1457 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhHHh-----cc--
Confidence 22 2246899999999999763 355689999999999999999999975432 111111110 00
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
-.++ +.+....+-.+++.+||+.||+.|.++.||++.
T Consensus 1458 ---h~Pq----~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 ---HKPQ----IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---CCCC----CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 0111 222334456788899999999999888877754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.84 Aligned_cols=269 Identities=21% Similarity=0.305 Sum_probs=197.4
Q ss_pred HHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEee-CCc
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDR 437 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 437 (696)
+..+.++|++.++||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++|+||++++++|.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4456789999999999999999999854 78999999885432 2334678899999999999999999999876 457
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.++|+||+ +++|..++... .+.+..+..++.||++||+|||++ +|+||||+++|||+++++.+||+|||+++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 88999998 56787777532 367888889999999999999999 999999999999999999999999999875
Q ss_pred ccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchh-HHHhHHH----HHHHh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES-LVEWARP----LLSHA 591 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~-l~~~~~~----~~~~~ 591 (696)
.... .....++..|++||++.+ ..++.++|||+|||++|||++|+.+|.......... +.+++.. +....
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4322 122456788999998766 568999999999999999999999997543211100 0111000 00000
Q ss_pred hhhhhhhcccCcccCCCcc-----hHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 592 LENEEFDNLADPRLGENYV-----EGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........+.+-....... ......+.+++.+||+.+|++|+++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000001 1122478899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=298.91 Aligned_cols=241 Identities=26% Similarity=0.351 Sum_probs=185.6
Q ss_pred cccccCcEEEEEEEcC-CCcEEEEEEeecCCCc---cHHHHHHHHHH---HHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 374 LLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEI---ISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 374 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~i---l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
+||+|+||.||++... +|+.||||++...... ....+..|..+ ++..+|+||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 6889999998654221 12234444444 444579999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
|++|.+++...+ .+.+..++.++.||+.||+|||+. +|+|||||++|||+++++.+||+|||+++...... .
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 999988886543 489999999999999999999998 99999999999999999999999999987553322 1
Q ss_pred eccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....|+..|++||++.++ .++.++|||||||++|||++|+.||............+. . . .....+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---~-----~------~~~~~~ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---T-----L------TMAVEL 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---h-----h------ccCCCC
Confidence 234688999999998754 689999999999999999999999976432221111000 0 0 001111
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVR 640 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~ 640 (696)
... ....+.+++++||+.++.+|+ ++.++++
T Consensus 219 ~~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCc----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111 123688999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.92 Aligned_cols=264 Identities=23% Similarity=0.289 Sum_probs=194.6
Q ss_pred cCccc-cccccccCcEEEEEEEcC-CCcEEEEEEeecCCCcc--------------HHHHHHHHHHHHHccCCCceeEEe
Q 005443 367 DGFAD-QNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG--------------EREFKAEVEIISRIHHRHLVSLVG 430 (696)
Q Consensus 367 ~~~~~-~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~il~~l~hpnIv~l~~ 430 (696)
++|.. .++||+|+||.||+|... +|+.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45653 477999999999999854 68999999986543221 125789999999999999999999
Q ss_pred EEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEE
Q 005443 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (696)
Q Consensus 431 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (696)
++..++..++||||+. ++|.+++..... +.+..++.++.||+.||+|||++ +|+||||+++|||+++++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 578888765433 88999999999999999999998 99999999999999999999999
Q ss_pred eeccchhccccC-------------cceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCC
Q 005443 511 DFGLAKLALDAN-------------THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576 (696)
Q Consensus 511 DfGls~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~ 576 (696)
|||+++...... ........++..|++||++.+. .++.++|||||||++|||++|+.+|...+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-- 239 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE-- 239 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 999997654111 0111123467789999998764 468899999999999999999999976542
Q ss_pred chhHHHhHHHHHHHhhhhhhhhc------------ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 577 DESLVEWARPLLSHALENEEFDN------------LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..........+.... ...+.. .....+.. ........+.+++++||+.+|++|++++||+..
T Consensus 240 -~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 -IDQLGRIFELLGTPN-EDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred -HHHHHHHHHHhCCCc-hhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111111111111000 000000 00000000 001112368899999999999999999999853
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=302.41 Aligned_cols=244 Identities=26% Similarity=0.402 Sum_probs=190.9
Q ss_pred ccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
|...+.||+|+||.||+|+. .+|+.|+||++...... ..+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999985 46889999998754332 234688899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+. ++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||+++||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 56666665433 2488999999999999999999999 999999999999999999999999999864322
Q ss_pred eeeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 525 ITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.....|+..|++||++. ...++.++|||||||++|||++|..||...+.. ....... ........
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~-----~~~~~~~~ 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-----QNDSPTLQ 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHH-----hcCCCCCC
Confidence 12346788999999984 456888999999999999999999998754311 1111110 00011111
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. . .....+.+++.+||+.+|.+||++.+++..
T Consensus 242 ~----~----~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 S----N----EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred c----c----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 1 112257889999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.53 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=195.2
Q ss_pred HHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC----
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD---- 436 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---- 436 (696)
...++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+++|++++|+||+++++++..++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999984 478999999986432 223456889999999999999999999987654
Q ss_pred --ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 437 --RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 437 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
..++||||+ +++|.+++... .+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 348999998 77887777532 388999999999999999999998 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHH-------H
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR-------P 586 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~-------~ 586 (696)
++...... ....++..|++||++.+ ..++.++|||+|||++|+|++|+.+|...... ..+.+... .
T Consensus 165 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence 97653321 22356889999999876 45888999999999999999999999754321 11111000 0
Q ss_pred HHHHhhhhhhhhcccC--cccC----CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 587 LLSHALENEEFDNLAD--PRLG----ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+... +.......+.. .... ..........+.+++.+|++.||++|+++.+++++
T Consensus 239 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 239 FVQK-LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHh-hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000000000 0000 00011122357899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.81 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=199.1
Q ss_pred ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 369 FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
|+..++||+|.||.||+|+.. +++.|++|+++... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999998653 333467889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
. ++|.+++.... ..+++..+++++.||++||+|||++ +|+||||+++||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 58988887653 2489999999999999999999999 999999999999999999999999999976544322 1
Q ss_pred eeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh-------
Q 005443 526 TTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF------- 597 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~------- 597 (696)
.....++..|+|||++.+. .++.++|||+|||++|||++|+.+|...... ..+......+... ....+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTP-TEESWPGVTKLP 230 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCC-cHHHHHhhcccc
Confidence 2234467789999998776 7899999999999999999999999754321 1111111111000 00000
Q ss_pred --hcccCcccCC---CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 --DNLADPRLGE---NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 --~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......... .........+.+++++||+.+|++||++.+|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000 0001113468999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.49 Aligned_cols=266 Identities=19% Similarity=0.286 Sum_probs=193.5
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeC----------
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISD---------- 435 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---------- 435 (696)
.+|.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6799999999999999999985 46899999999876666667889999999999999999999876543
Q ss_pred ----CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC-CCCcEEEE
Q 005443 436 ----DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVS 510 (696)
Q Consensus 436 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL~ 510 (696)
...++||||+. ++|.+++... .+.+..++.++.||++||.|||++ +|+|||||++||||+ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 34689999996 5787776532 378999999999999999999998 999999999999997 55678999
Q ss_pred eeccchhccccCcc--eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH
Q 005443 511 DFGLAKLALDANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587 (696)
Q Consensus 511 DfGls~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~ 587 (696)
|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||++|+.+|........ +.......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~~ 235 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILESV 235 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhc
Confidence 99998754322111 1122357889999998754 5688899999999999999999999975442111 11100000
Q ss_pred H------HHhhhhhhhhcccCcccCCC-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 588 L------SHALENEEFDNLADPRLGEN-----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 588 ~------~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ...........+.+...... .......++.+++++||+.||++|+++.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 00000000000000000000 001122468899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=317.23 Aligned_cols=264 Identities=24% Similarity=0.382 Sum_probs=213.9
Q ss_pred cccCHHHHHHHhcCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEE
Q 005443 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYC 432 (696)
Q Consensus 355 ~~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~ 432 (696)
+++.++.+-.-.+.|++.++||.|.+|.||+++ .++|+.+|||++.... ...++++.|.++|+.+. |+|++.+||+|
T Consensus 7 ~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 7 MDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred cccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 345566666667889999999999999999998 4579999999987543 34567888999999885 99999999998
Q ss_pred ee-----CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 433 IS-----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 433 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
.. ++.+|||||||.+|+.-|++.+-....+.|..+..|++.+++||.+||++ .++|||||-.|||+++++.|
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 74 46789999999999999988876666799999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhcc-----CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~ 582 (696)
||+|||++....... ......+||+.|||||++.. ..|+.++|+||||++..||-.|..|+.+-....
T Consensus 163 KLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------ 235 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------ 235 (953)
T ss_pred EEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------
Confidence 999999998754433 23444689999999999854 457889999999999999999999987543211
Q ss_pred hHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 583 WARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+ |...-++.....-......++.++|..||..|.++||++.++|++
T Consensus 236 ---aL---------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ---AL---------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---hh---------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 00 111112222222234445689999999999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.40 Aligned_cols=264 Identities=20% Similarity=0.244 Sum_probs=192.0
Q ss_pred CccccccccccCcEEEEEEEcC-C--CcEEEEEEeecCC--CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeC----Cc
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-D--GREVAIKQLKIGG--GQGEREFKAEVEIISRI-HHRHLVSLVGYCISD----DR 437 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~--g~~vavK~l~~~~--~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~----~~ 437 (696)
+|++.++||+|+||.||++... . +..||||++.... ....+.+.+|+++++++ +|+||+++++++... +.
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999964 3 7799999986432 22345788999999999 599999999976533 34
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.++++||+. ++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 678888885 67887776543 489999999999999999999998 999999999999999999999999999976
Q ss_pred ccccCcc---eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----
Q 005443 518 ALDANTH---ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS---- 589 (696)
Q Consensus 518 ~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~---- 589 (696)
....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.+|...+. ....+.....+.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY---VDQLNQILQVLGTPDE 231 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 5432211 1223568899999998765 4688999999999999999999999976432 111111111000
Q ss_pred ----Hhhhhh------hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 590 ----HALENE------EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 590 ----~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...... .+.......+. .........+.+++.+||+.||++|+++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000000000 0001112468899999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=295.70 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=193.3
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecC-----CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG-----GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
+|.+.+.||+|+||.||++... .+..+++|+++.. ......++.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999854 3455666665421 112334577899999999999999999999998999999
Q ss_pred EEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 442 YDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
|||+.+++|.++++. .....+++..++.++.||++||.|||++ +|+|+||+++||+++++ .+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~-~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecC-CEeecccCceeecC
Confidence 999999999888753 2234589999999999999999999998 99999999999999864 69999999987654
Q ss_pred ccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.... ......|+..|++||.+.+..++.++|||+||+++|+|++|+.+|.... ..+...... . ...
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~----~-~~~-- 222 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIV----E-GPT-- 222 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH----c-CCC--
Confidence 3322 2223457889999999988888999999999999999999999986432 111111111 0 000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ........++.+++.+||+.+|++||++.|+++.
T Consensus 223 ---~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 ---P----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---C----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0 1112233478899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=329.77 Aligned_cols=145 Identities=29% Similarity=0.407 Sum_probs=130.7
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|.++++||+|+||.||+|++. +++.||||+++.... ...+.+.+|+.+++.++|+||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999965 689999999975432 22367889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
||+.+++|.++++..+ .+.+..+++|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999887654 378899999999999999999998 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=290.69 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=193.9
Q ss_pred ccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 371 DQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
.+..||.|.||+|+|..++ .|+.+|||+++..+. +++++++.|.+...+- +.+|||++||.+..++..||.||.|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 3567999999999999864 699999999987655 5567788888865554 69999999999999999999999995
Q ss_pred Cch---hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 448 NTL---YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 448 gsL---~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
.+| +.++..-.+..+.+..+-.|....+.||.||.+.+ +||||||||+|||||..|.|||||||++..+.+...
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA- 223 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA- 223 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH-
Confidence 333 33334444445888888999999999999999876 899999999999999999999999999977655433
Q ss_pred eeeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 525 ITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.+...|+.-|||||.+.. ..|+.++||||||++|||+.||++|+..- .++.+.+..+... ....+..
T Consensus 224 -kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----~svfeql~~Vv~g-----dpp~l~~ 292 (361)
T KOG1006|consen 224 -KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----DSVFEQLCQVVIG-----DPPILLF 292 (361)
T ss_pred -hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----HHHHHHHHHHHcC-----CCCeecC
Confidence 333468999999999864 34899999999999999999999998742 2233322222211 1111111
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..- .......++.+|..|+..|-.+||.+.+|+++
T Consensus 293 ~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccc----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 11223478999999999999999999988764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=290.08 Aligned_cols=236 Identities=31% Similarity=0.408 Sum_probs=191.6
Q ss_pred ccccCcEEEEEEEcC-CCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCch
Q 005443 375 LGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
||+|+||.||++... +++.|++|+++..... ....+.+|++++++++|+||+++++++..++..++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999864 5899999998754332 345789999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccc
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~ 530 (696)
.+++.... .+++..++.++.||+.||.|||+. +++|+||+++||++++++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99887654 389999999999999999999998 99999999999999999999999999997654432 1223356
Q ss_pred cccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcc
Q 005443 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610 (696)
Q Consensus 531 gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (696)
++..|++||.+.+..++.++|+|+||+++|||++|+.+|..... ..+.+ .+. . . .+ .+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~----~-~---~~-------~~~ 213 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KIL----K-D---PL-------RFP 213 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHh----c-C---CC-------CCC
Confidence 78899999999988889999999999999999999999975431 11111 111 0 0 00 011
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCHHH
Q 005443 611 EGEMFRMIEAAAACVRHSAAKRPRMGQ 637 (696)
Q Consensus 611 ~~~~~~l~~li~~cl~~dP~~RPs~~e 637 (696)
......+.+++++||..|+++|+++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111236889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=263.26 Aligned_cols=198 Identities=23% Similarity=0.375 Sum_probs=167.2
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|...++||+|.||+||+|+. +.++.||+|.++..... .-....+|+.+|+.++|.|||+++++...++...+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678899999999999995 46889999999865433 235688999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
|+. +|..++..... .++.+.++.++.|+++||.|+|++ ++.|||||+.|+||+.+|++||+|||+++.+.-. ..
T Consensus 83 cdq-dlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-vr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VR 156 (292)
T ss_pred hhH-HHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-eE
Confidence 954 56555544322 388899999999999999999999 9999999999999999999999999999876433 33
Q ss_pred eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHh-CCCCCCC
Q 005443 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELIT-GRKPVDA 571 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLlt-g~~Pf~~ 571 (696)
.....+.|++|++|+++.+ ..|+...|+||-|||+.||.. |+..|.+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 4555678999999999987 568899999999999999998 5555554
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=328.44 Aligned_cols=258 Identities=24% Similarity=0.284 Sum_probs=208.4
Q ss_pred HHHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEee
Q 005443 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (696)
Q Consensus 359 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 434 (696)
..++....++|+++++||+|+||.|.+++++ .++.||+|+++.. .......|+.|-.+|..-+..=|++|.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4455555689999999999999999999965 5889999999742 22334568899999999999999999999999
Q ss_pred CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
++++|||||||.||+|..++.+.+ .+.+..++.++..|+.||.-||+. |+|||||||+|||||..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999998877 489999999999999999999998 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhc----c-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYAS----S-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (696)
+..+..++.-.....+||+.|++||+|+ + +.|+..+|.||+||+||||+.|..||.. +.+++....+++
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm~ 295 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIMN 295 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHhc
Confidence 9888777766666679999999999985 2 6799999999999999999999999974 445555444443
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC---HHHHH
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR---MGQVV 639 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell 639 (696)
+ .+...+.+. .+...+..+||.+.+. +++.|-. ++++.
T Consensus 296 h----k~~l~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 296 H----KESLSFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred h----hhhcCCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 3 222222211 1122356677777664 5566765 44444
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.62 Aligned_cols=263 Identities=23% Similarity=0.347 Sum_probs=196.2
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc----
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR---- 437 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---- 437 (696)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999864 57899999886432 2233567889999999999999999998876554
Q ss_pred --eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 438 --RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 438 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
.++|+||+ +++|.+++... .+++..+++++.||++||+|||++ +|+||||+++||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 79999998 66888877642 389999999999999999999998 9999999999999999999999999999
Q ss_pred hhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH-----
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----- 589 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----- 589 (696)
...... .....++..|++||++.+ ..++.++|||||||++|||++|+.+|...... ..+........
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCHH
Confidence 765432 223457888999999865 46788999999999999999999999754321 11111100000
Q ss_pred --HhhhhhhhhcccCc---ccCCCc---chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 590 --HALENEEFDNLADP---RLGENY---VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 590 --~~~~~~~~~~~~d~---~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.......++.. .....+ .......+.+++++||+.+|++||++.||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000001000 000000 01123478899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=318.16 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=171.7
Q ss_pred HhcCccccccccccCcEEEEEEEcC-C----CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeE------Ee
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-D----GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY------CI 433 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~------~~ 433 (696)
..++|++.++||+|+||.||+|++. + ++.||||+++.... .+.+..| .++...+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3578999999999999999999964 4 68999998753211 1111111 1222222222222211 23
Q ss_pred eCCceeEEEEecCCCchhhccccCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCC
Q 005443 434 SDDRRLLIYDYVPNNTLYFHLHGEGRP------------------VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495 (696)
Q Consensus 434 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLk 495 (696)
.++..+|||||+.+++|.++++..... ......+..|+.||+.||+|||++ +|||||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 556789999999999998888643211 012334567999999999999999 99999999
Q ss_pred CCceEECC-CCcEEEEeeccchhccccCcceeeccccccccCchhhhccC----------------------CCCccccc
Q 005443 496 SSNILLDN-NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG----------------------KLTEKSDV 552 (696)
Q Consensus 496 p~NILl~~-~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~s~~sDV 552 (696)
++||||++ ++.+||+|||+++.............+++..|||||.+... .+..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57999999999986544433344456789999999976432 24456799
Q ss_pred cchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCC------cchHHHHHHHHHHHHHhc
Q 005443 553 FSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN------YVEGEMFRMIEAAAACVR 626 (696)
Q Consensus 553 wSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~------~~~~~~~~l~~li~~cl~ 626 (696)
|||||+||||+++..+++. .+......+.........+..........+ .........++|+++||+
T Consensus 363 wSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 9999999999998776542 111111111110000011111111110000 001112245689999999
Q ss_pred cCCCCCCCHHHHHHH
Q 005443 627 HSAAKRPRMGQVVRV 641 (696)
Q Consensus 627 ~dP~~RPs~~ell~~ 641 (696)
.||++|++++|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.93 Aligned_cols=241 Identities=26% Similarity=0.389 Sum_probs=195.3
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 440 (696)
..+|..+.+||+|.||.|.+|+.+ ..+.||||+++..-. .+.+--+.|-++|... +-+.++.|..+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 356888999999999999999864 567899999975422 2223345567777665 46789999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.||+|..+++.-++ +.+..+.-++.+|+-||-|||++ +||+||||.+|||||.+|+|||+|||+++....
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999999987776 77888889999999999999999 999999999999999999999999999975433
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.+. .+..++||+.|+|||++....|+..+|.|+|||+|||||.|+.||++.+ +++ .++.+
T Consensus 503 ~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~e----------------lF~aI 562 (683)
T KOG0696|consen 503 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDE----------------LFQAI 562 (683)
T ss_pred CCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHH----------------HHHHH
Confidence 332 2445789999999999999999999999999999999999999999754 122 22223
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCC
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP 633 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 633 (696)
++... .+......+.++|++..|..+|.+|.
T Consensus 563 ~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 563 MEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 32221 23334445678888999999999996
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=290.20 Aligned_cols=267 Identities=21% Similarity=0.305 Sum_probs=202.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHcc--------CCCceeEEeEEeeC--
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH--------HRHLVSLVGYCISD-- 435 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~--------hpnIv~l~~~~~~~-- 435 (696)
.+|.++++||.|.|++||++.+. +.+.||+|+.+.. ....+..+.||++|++++ ..+||+|+++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68999999999999999999954 6789999999743 344566789999999984 24799999999753
Q ss_pred --CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC---------
Q 005443 436 --DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN--------- 504 (696)
Q Consensus 436 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~--------- 504 (696)
.+++||||++ |.+|..+|....-+.+....+.+|++||+.||.|||.+| +|||-|||++||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence 5789999999 777888888777777999999999999999999999998 99999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 005443 505 -------------------------------------------------------------------------------- 504 (696)
Q Consensus 505 -------------------------------------------------------------------------------- 504 (696)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CcE
Q 005443 505 -----------------------------------------------------------------------------FEA 507 (696)
Q Consensus 505 -----------------------------------------------------------------------------~~v 507 (696)
.+|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 014
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCC---CCCCchhHHHhH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS---QPLGDESLVEWA 584 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~---~~~~~~~l~~~~ 584 (696)
||+|||.+.-... ..+..+.|..|+|||++.+..|+..+||||++|++|||+||...|+-. +...+++.+..+
T Consensus 394 KIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 394 KIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 4555555443211 122235678899999999999999999999999999999999999643 334455555444
Q ss_pred HHHHHHhh-----hhhhhhcccCccc-------------------CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 585 RPLLSHAL-----ENEEFDNLADPRL-------------------GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 585 ~~~~~~~~-----~~~~~~~~~d~~l-------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..++.... ......++++.+- .-.+..+++.++.+++.-||+.+|++|+++.+.|+
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 44433221 1111222222111 12366788889999999999999999999999886
Q ss_pred H
Q 005443 641 V 641 (696)
Q Consensus 641 ~ 641 (696)
+
T Consensus 550 h 550 (590)
T KOG1290|consen 550 H 550 (590)
T ss_pred C
Confidence 4
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.10 Aligned_cols=265 Identities=20% Similarity=0.266 Sum_probs=180.1
Q ss_pred hcCccccccccccCcEEEEEEEc-----------------CCCcEEEEEEeecCCCccHHH--------------HHHHH
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-----------------PDGREVAIKQLKIGGGQGERE--------------FKAEV 414 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E~ 414 (696)
.++|++.++||+|+||.||+|.+ .+++.||||+++.......++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999963 245689999987543332223 34477
Q ss_pred HHHHHccCCCc-----eeEEeEEee--------CCceeEEEEecCCCchhhccccCCC----------------------
Q 005443 415 EIISRIHHRHL-----VSLVGYCIS--------DDRRLLIYDYVPNNTLYFHLHGEGR---------------------- 459 (696)
Q Consensus 415 ~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~---------------------- 459 (696)
.++.+++|.++ +++++||.. ++..+|||||+.+++|.++++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77778876654 677887753 3467999999999999888864211
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccCchh
Q 005443 460 PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539 (696)
Q Consensus 460 ~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE 539 (696)
..+++..++.|+.||++||.|||++ +|+|||||++|||++.++.+||+|||+++..............++..|++||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1246778889999999999999998 9999999999999999999999999999765432222222233578999999
Q ss_pred hhccCC--------------------C--CccccccchHHHHHHHHhCCC-CCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 540 YASSGK--------------------L--TEKSDVFSFGVVLLELITGRK-PVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 540 ~l~~~~--------------------~--s~~sDVwSlGvll~eLltg~~-Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
.+.... | ..+.||||+||+||||++|.. +|........ .+.+ ....+..+
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~-~~~~~~~~----- 453 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQ-YDNDLNRW----- 453 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhh-ccchHHHH-----
Confidence 876432 1 124799999999999999876 6643221111 1100 00000000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCC---CCCCCHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSA---AKRPRMGQVVRV 641 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ell~~ 641 (696)
..+....+.-..........++|+.+||..++ .+|.+++|+|++
T Consensus 454 -r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 454 -RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00000001001111122367888889998765 689999988854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=282.96 Aligned_cols=266 Identities=21% Similarity=0.278 Sum_probs=198.7
Q ss_pred ccccccccCcEEEEEEEc-CCCcEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeC-----CceeEEE
Q 005443 371 DQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DRRLLIY 442 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~lV~ 442 (696)
-.+-||.|+||.||.+.+ ++|+.|++|++..- +....+++.+|+++|..++|.|++..+++..-. +++|+|.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 347799999999999985 48999999988522 223456788999999999999999998866533 3567888
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|.| ..+|+.++-.-. .++.+.+.-+++||++||.|||+. +|.|||||+.|+||+.|..+||||||++|......
T Consensus 137 ELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 887 566777775443 377888889999999999999999 99999999999999999999999999999876666
Q ss_pred cceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH-----HHHHhhhhhh
Q 005443 523 THITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP-----LLSHALENEE 596 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~-----~~~~~~~~~~ 596 (696)
...++..+.|..|+|||++++ +.|+.+.||||+|||+.||+.++..|...+.....+++..+.. .+....+..+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 666777788999999999987 6799999999999999999999999988776544433322211 1111111111
Q ss_pred hhccc----CcccC----CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 597 FDNLA----DPRLG----ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 597 ~~~~~----d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
...+. .+.+. ........++.+.+...+|..|+++|-+..+.+..+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11110 01110 001112334566777889999999999988887654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=278.32 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=198.7
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|...++||+|.|++|.+++++ ..+-||+|+++.. ..++..-.+.|-.++.+. +|+.+|-|..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 367999999999999999999965 5788999999743 233344566777887776 69999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|.||+.||+|..++++.++ +.++.++.+..+|+.||.|||++ |||+||||.+|||||.+|++||.|||+++....
T Consensus 329 vieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999988877655 89999999999999999999999 999999999999999999999999999986554
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCC-CchhHHHhHHHHHHHhhhhhhhhc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL-GDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.+. .+..++||+.|+|||++++.+|...+|.|+|||+|+|||.|+.||+.-... .+.+-.+++..++
T Consensus 404 ~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi----------- 471 (593)
T KOG0695|consen 404 PGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI----------- 471 (593)
T ss_pred CCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-----------
Confidence 443 345589999999999999999999999999999999999999999864321 1222333332222
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCC
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP 633 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 633 (696)
++.+++. ..........+++..|+.||++|-
T Consensus 472 -lekqiri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 -LEKQIRI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -hhhcccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 1111111 111222456778899999999885
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=299.83 Aligned_cols=242 Identities=24% Similarity=0.304 Sum_probs=198.9
Q ss_pred cCccccccccccCcEEEEEEEcCCCc-EEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGR-EVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~-~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.+++++..||-|+||.|-++..++.+ .+|+|+++... .+.++.+..|-.||...+.+.||+||.-|.+++..||+|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666777999999999999975433 38888886443 344556888999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|-|-||.|+..|++++. ++...+..++..+++|++|||.+ |||+|||||+|+||+.+|-+||.|||+++.+....
T Consensus 500 EaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999987765 89999999999999999999999 99999999999999999999999999999876655
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.. -.++||..|+|||++.+..++.++|.|+||+++||||+|..||.+.+.+..-++ .++..+.
T Consensus 575 KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~----------ILkGid~----- 637 (732)
T KOG0614|consen 575 KT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL----------ILKGIDK----- 637 (732)
T ss_pred ce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH----------HHhhhhh-----
Confidence 43 346899999999999999999999999999999999999999997654322111 1111111
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCC
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPR 634 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 634 (696)
..+.........++++++++.+|.+|--
T Consensus 638 ----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 ----IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1122233346778899999999999853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.39 Aligned_cols=243 Identities=22% Similarity=0.261 Sum_probs=194.4
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+.+.|+....||.|+|+.|-++.+ ..++..+||++... ..+..+|+.++... +|+||+++.+++.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356788888899999999998885 46899999998743 23345677666655 6999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE-CCCCcEEEEeeccchhcccc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL-DNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl-~~~~~vkL~DfGls~~~~~~ 521 (696)
|++.|+.|.+.+..... ....+..|+++|+.+|.|||++ ||||||||++|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999988777765443 2277778999999999999998 99999999999999 68999999999999876544
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
...-+-|..|.|||++....|+.++||||||++||+||+|+.+|...... .++.. ++-
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----------------~i~ 527 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----------------RIQ 527 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----------------hhc
Confidence 12234588999999999999999999999999999999999999865432 11111 011
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
...+.........+|+.+||+.||.+|++|.+++..-.
T Consensus 528 ----~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 528 ----MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred ----CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 11112233346788999999999999999999987644
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=295.27 Aligned_cols=204 Identities=27% Similarity=0.354 Sum_probs=173.5
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
-|.+++.||-|+||.|+++.. +....||+|.|+..+.. .....+.|-.||...+..-||+||-.|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 478888999999999999984 45678999999755432 23457889999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc---
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--- 520 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~--- 520 (696)
|+.||++..+|.+.+- +.+..++.++.+|..|+++.|+. |+||||||++|||||.+|+|||.||||+.-+..
T Consensus 710 YIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999888877664 78888888999999999999998 999999999999999999999999999843210
Q ss_pred -----cCcce---------------------------------eeccccccccCchhhhccCCCCccccccchHHHHHHH
Q 005443 521 -----ANTHI---------------------------------TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLEL 562 (696)
Q Consensus 521 -----~~~~~---------------------------------~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eL 562 (696)
.+... ...++||..|+|||+|....|+.-+|.|+.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 00000 0125799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCC
Q 005443 563 ITGRKPVDASQPLG 576 (696)
Q Consensus 563 ltg~~Pf~~~~~~~ 576 (696)
+.|+.||......+
T Consensus 865 ~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGE 878 (1034)
T ss_pred hhCCCCccCCCCCc
Confidence 99999998766544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=274.07 Aligned_cols=238 Identities=28% Similarity=0.365 Sum_probs=192.9
Q ss_pred CcEEEEEEEcC-CCcEEEEEEeecCCCcc-HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCchhhcccc
Q 005443 379 GFGSVYKGYLP-DGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456 (696)
Q Consensus 379 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 456 (696)
+||.||+|... +|+.|++|++....... .+.+.+|++++++++|+||+++++++......+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 58999999998665544 67899999999999999999999999999999999999999999998876
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccC
Q 005443 457 EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536 (696)
Q Consensus 457 ~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~ 536 (696)
... +++..+++++.+++++|.|||+. +|+|+||+++||++++++.++|+|||++....... ......+...|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 544 78999999999999999999999 99999999999999999999999999998765432 233456788999
Q ss_pred chhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHH
Q 005443 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFR 616 (696)
Q Consensus 537 aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 616 (696)
+||.+.+..++.++|||+||+++|+|++|..+|.... ....+.++.. ....... . ........
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~--------~~~~~~~-~------~~~~~~~~ 216 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIG--------KPKPPFP-P------PEWKISPE 216 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHh--------ccCCCCc-c------ccccCCHH
Confidence 9999998889999999999999999999999987531 1111111111 0000000 0 00002236
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHH
Q 005443 617 MIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 617 l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-34 Score=275.78 Aligned_cols=267 Identities=20% Similarity=0.340 Sum_probs=193.2
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeC--------
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISD-------- 435 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-------- 435 (696)
+.|+...+||+|.||.||+|+.+ .|+.||+|++-..+.+ .-....+|+++|+.|+|.|+++|+.+|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666788999999999999954 5788899877543332 234578999999999999999999988642
Q ss_pred CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
..++|||++|+. +|.-+|.+.. ..+...++.+++.+++.||.|+|.. .|+|||+|+.||||+.++.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 247999999964 5665665432 3488999999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCcc---eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH-HHHH
Q 005443 516 KLALDANTH---ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP-LLSH 590 (696)
Q Consensus 516 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~-~~~~ 590 (696)
|.+...... ..++.+.|++|+.||.+.+ ..|+...|||.-||||.||++|..-|.+........++..+-. +-.+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 766433221 2344567999999999876 6799999999999999999999988876443222222221111 1111
Q ss_pred hhhhh----hhhcc------------cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 ALENE----EFDNL------------ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 ~~~~~----~~~~~------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.|-+. .+..+ +..++......+ ..++|+..++..||.+|+++++++.+
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~---~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDD---EALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCCh---hHHHHHHHHhccCcccCcchHhhhch
Confidence 11110 00000 001111111111 46678889999999999999998854
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=278.82 Aligned_cols=221 Identities=22% Similarity=0.229 Sum_probs=175.5
Q ss_pred cCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCchhhcccc
Q 005443 378 GGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456 (696)
Q Consensus 378 G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 456 (696)
|.||.||++.. .+|+.||+|+++... .+.+|...+....|+||+++++++...+..++||||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 79999999985 478999999987432 344556666667799999999999999999999999999999988865
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccC
Q 005443 457 EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536 (696)
Q Consensus 457 ~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~ 536 (696)
... +++..++.++.||++||+|||++ +|+|||||++||++++++.++|+|||++....... ....++..|+
T Consensus 79 ~~~--l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 79 FLN--IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred hcC--CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 443 89999999999999999999998 99999999999999999999999999886543321 2234567799
Q ss_pred chhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHH
Q 005443 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFR 616 (696)
Q Consensus 537 aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 616 (696)
+||++.+..++.++|||+|||++|||++|+.+|....... . .. ....+ .......
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~---~~------~~~~~----~~~~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N---TH------TTLNI----PEWVSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c---cc------cccCC----cccCCHH
Confidence 9999988889999999999999999999998765321100 0 00 00001 1111236
Q ss_pred HHHHHHHHhccCCCCCCCHHH
Q 005443 617 MIEAAAACVRHSAAKRPRMGQ 637 (696)
Q Consensus 617 l~~li~~cl~~dP~~RPs~~e 637 (696)
+.+++.+||+.||++|+++.+
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCc
Confidence 788999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=286.84 Aligned_cols=211 Identities=24% Similarity=0.262 Sum_probs=175.0
Q ss_pred cccCHHHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHcc------CCCcee
Q 005443 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH------HRHLVS 427 (696)
Q Consensus 355 ~~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~------hpnIv~ 427 (696)
.+|.+..-+..-++|.+....|+|-|++|.+|... .|+.||||+++.+ ....+.=++|++||++|+ .-|+++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 34444444445578999999999999999999853 5889999999843 334556678999999995 348899
Q ss_pred EEeEEeeCCceeEEEEecCCCchhhccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC-C
Q 005443 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-F 505 (696)
Q Consensus 428 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~ 505 (696)
|+..|...+++|||||-+ .-+|.++|...++ ..|....+..++.||+.||.+|.++ ||+|+||||+||||++. .
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 999999999999999987 5678888876543 3578888999999999999999998 99999999999999875 4
Q ss_pred cEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 506 ~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
.+||||||.|....++.. +-+..+..|.|||+|.+..|+...|+||+||+||||+||++.|.+..
T Consensus 575 iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred eeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 689999999977655432 22345667999999999999999999999999999999999998754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=298.23 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=186.5
Q ss_pred CccccccccccCcE-EEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEEec
Q 005443 368 GFADQNLLGEGGFG-SVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 368 ~~~~~~~LG~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
-|...+++|.|..| .||+|.+ +|+.||||++-.. ......+|+..|+.-+ |+||||+|+.-.+.+..||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35556789999988 5799999 8999999988532 2345678999999875 999999999888888999999999
Q ss_pred CCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-----CCcEEEEeeccchhc
Q 005443 446 PNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-----NFEAQVSDFGLAKLA 518 (696)
Q Consensus 446 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DfGls~~~ 518 (696)
..+|.+++... +.........+.++.|++.||++||+. +||||||||.||||+. ..+++|+|||+++..
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 56788888763 222222255688999999999999997 9999999999999964 357999999999887
Q ss_pred cccCcce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHhC-CCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 519 LDANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG-RKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
....... .....||-+|+|||++....-+.++|||+|||++|+.++| .+||+.... +. ..++.. +.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-------R~-~NIl~~---~~ 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-------RQ-ANILTG---NY 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-------hh-hhhhcC---cc
Confidence 6544332 3345789999999999998888899999999999998885 999975321 00 001110 11
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.+..+. . ..++ ...+||.+|++.+|..||++.+|+.
T Consensus 731 ~L~~L~-----~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 TLVHLE-----P--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ceeeec-----c--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111110 0 0111 5678889999999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=254.45 Aligned_cols=198 Identities=25% Similarity=0.402 Sum_probs=161.9
Q ss_pred ccccccccccCcEEEEEEEc-CCCcEEEEEEeecC-CCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEec
Q 005443 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG-GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+..+..||+|+||.|-+.++ .+|...|+|.++.. +.+.++++++|+.+..+. .++.+|.+||....+...+|.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34456799999999988875 47999999999754 345566788888876654 6999999999999999999999999
Q ss_pred CCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 446 PNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 446 ~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
+ .+|..+... .....+.+..+-+|+..|++||+|||++. .|||||+|++||||+.+|+|||||||.+..+.+...
T Consensus 128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 4 445433321 22334888999999999999999999986 999999999999999999999999999987665443
Q ss_pred ceeeccccccccCchhhhcc----CCCCccccccchHHHHHHHHhCCCCCCC
Q 005443 524 HITTRVMGTFGYMAPEYASS----GKLTEKSDVFSFGVVLLELITGRKPVDA 571 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~----~~~s~~sDVwSlGvll~eLltg~~Pf~~ 571 (696)
.. -..|+..|||||.+.. ..|+.++||||||+.|+||.++++||+.
T Consensus 205 kt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 205 KT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 22 2358889999999853 4689999999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=252.72 Aligned_cols=194 Identities=21% Similarity=0.363 Sum_probs=164.0
Q ss_pred cCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCC--ceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDD--RRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~--~~~lV~ 442 (696)
++|++++.+|+|.|+.||.|. ..+++.++||+++. ...+.+.+|++||+.|. |+||+.|+++..+.. ...||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 678999999999999999998 55889999999974 34678999999999998 999999999987654 457999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC-CcEEEEeeccchhcccc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKLALDA 521 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DfGls~~~~~~ 521 (696)
||+++.+...+.. .+....++..+.+|+.||.|+|+. ||.|||+|+.|||||.. ..++|+|||++.+....
T Consensus 115 E~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999888765553 266778889999999999999999 99999999999999854 56999999999887554
Q ss_pred CcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 522 NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
..... .+.+..|.-||.+.. ..|+..-|+|||||+|.+|+..+.||....
T Consensus 187 ~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 187 KEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred ceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 33222 245677999999875 567888999999999999999999997654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=247.55 Aligned_cols=210 Identities=34% Similarity=0.549 Sum_probs=182.7
Q ss_pred ccccCcEEEEEEEcCC-CcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCchhh
Q 005443 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 452 (696)
||+|.+|.||++...+ |+.++||++...... ..+.+.+|+++++.++|.+|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999755432 34679999999999999999999999999899999999999999999
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-CCcEEEEeeccchhccccCcceeecccc
Q 005443 453 HLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDANTHITTRVMG 531 (696)
Q Consensus 453 ~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls~~~~~~~~~~~~~~~g 531 (696)
++.... ..+++..++.++.+++++|+|||++ +++|+||++.||++++ +++++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 887542 2478999999999999999999999 9999999999999999 89999999999976544321 1223457
Q ss_pred ccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcc
Q 005443 532 TFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYV 610 (696)
Q Consensus 532 t~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (696)
...|++||.+... .++.+.|+|+||++|++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999999887 888999999999999999
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 611 EGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 611 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.+++.+|++.++++|+++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 267889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=257.92 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=195.6
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeC------Cc
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISD------DR 437 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~ 437 (696)
.+|...+.+|.|.- .|..+.+ -.++.||+|++... +....++..+|+.++..++|.||++++.+|.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46667778898888 6666653 26889999988533 334456788999999999999999999998643 35
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.|+||||| ..+|...++.+ ++.+.+..|++|++.|++|||+. +|+||||||+||+|..++.+||.|||+++.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 69999999 45677666632 78889999999999999999999 999999999999999999999999999985
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCc------------hhHHHhHH
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD------------ESLVEWAR 585 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~------------~~l~~~~~ 585 (696)
.... ...+..+.+..|.|||++.+..|...+||||+||++.||++|+.-|.+....+. ..+.+.+.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 4332 345567789999999999998899999999999999999999999986443221 11111111
Q ss_pred HHHHHhhhh------hhhhc-ccCcccCCC--cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 586 PLLSHALEN------EEFDN-LADPRLGEN--YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 586 ~~~~~~~~~------~~~~~-~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.....+.+. ..+.+ +.|..+... ........+.+++.+||..||++|-+++++|++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111111 11111 111111111 112234457788999999999999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=248.81 Aligned_cols=199 Identities=32% Similarity=0.472 Sum_probs=173.4
Q ss_pred ccccccccccCcEEEEEEEcCC-CcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 369 FADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
|.+.+.||.|++|.||++.+.+ ++.|+||.+...... ..+.+.+|++.+++++|+||+++++++...+..++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999764 899999999866554 56789999999999999999999999999899999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++...... +++..++.++.+++.+|.|||++ +++|+||++.||++++++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999988765432 78899999999999999999998 999999999999999999999999999987654431122
Q ss_pred eccccccccCchhhh-ccCCCCccccccchHHHHHHHHhCCCCCCC
Q 005443 527 TRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGRKPVDA 571 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l-~~~~~s~~sDVwSlGvll~eLltg~~Pf~~ 571 (696)
....+...|++||.+ ....++.++|||+||+++|||++|+.+|..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=280.36 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=203.1
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|+....||.|.||.|||++++ .++..|||+++.....+...+.+|+.+++..+|+|||.++|-+...+..+|+|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888999999999999999954 6899999999988888888899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
|.+|+|.+..+.-+- +.+.++..+++..++||+|||+. +-+|||||-.|||+++.|.+||.|||.+..+.... .
T Consensus 94 cgggslQdiy~~Tgp--lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A 167 (829)
T ss_pred cCCCcccceeeeccc--chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-h
Confidence 999999998886654 88999999999999999999999 88999999999999999999999999987654432 2
Q ss_pred eeeccccccccCchhhh---ccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 525 ITTRVMGTFGYMAPEYA---SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l---~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
....++||..|||||+. +.+.|...+|||++|+...||-.-+-|....... +. -++. .... +-
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm------r~--l~Lm---TkS~---~q 233 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM------RA--LFLM---TKSG---FQ 233 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH------HH--HHHh---hccC---CC
Confidence 34557899999999975 4577999999999999999987655554322110 10 0111 0000 11
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
-+.+.... .....+.++++.|+..+|++||+++.+|.
T Consensus 234 pp~lkDk~--kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKDKT--KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccCCc--cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111111 11235789999999999999999988773
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=247.22 Aligned_cols=253 Identities=19% Similarity=0.355 Sum_probs=185.8
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeE-EeeCCceeEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGY-CISDDRRLLI 441 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~-~~~~~~~~lV 441 (696)
..+.|.+.+.||+|.||.+.+++++ ...++++|.+... ....++|.+|+.---.|. |.||+.-|++ |+..+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4478999999999999999999976 4678999988632 234567888877655554 8999988764 6667778899
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC--CCCcEEEEeeccchhcc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD--NNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DfGls~~~~ 519 (696)
+||+..|+|..-+...+ +.+....+++.|++.||+|||++ ++||||||.+||||- +..+|||||||+.+..+
T Consensus 101 qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999988887644 78888999999999999999999 999999999999993 44589999999997543
Q ss_pred ccCcceeeccccccccCchhhhcc---C--CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 520 DANTHITTRVMGTFGYMAPEYASS---G--KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~---~--~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
.. .....-...|.+||++.. + .....+|||.||+|+|.+|+|+.||.. ....+..+.+|..-......
T Consensus 175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhcccCc--
Confidence 22 122234567999998643 2 245678999999999999999999983 34556666666542211111
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. -++.-..+.. .++++.++-|..++++|=-..++.++
T Consensus 248 ----~--~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ----A--LPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ----c--CchhhcccCH----HHHHHHHHhcCCcccccchhHHHHHH
Confidence 1 1111112222 56677778888888888444444433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=268.74 Aligned_cols=196 Identities=24% Similarity=0.392 Sum_probs=167.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--------ccHHHHHHHHHHHHHcc---CCCceeEEeEEee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--------QGEREFKAEVEIISRIH---HRHLVSLVGYCIS 434 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~ 434 (696)
..|..++.||+|+||.|++|.++ +..+|+||.+..... +..-.+-.|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999975 466889998853321 11112456999999998 9999999999999
Q ss_pred CCceeEEEEec-CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 435 DDRRLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 435 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
++..||+||-. ++.+|++++....+ +++.++..|++||+.|+++||+. +|||||||-+||.|+.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 99999999965 45688999987665 89999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCcceeeccccccccCchhhhccCCCC-ccccccchHHHHHHHHhCCCCCC
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVD 570 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~eLltg~~Pf~ 570 (696)
.+......... .++||..|.|||++.+..|. ..-|||+||++||.++....||.
T Consensus 716 saa~~ksgpfd---~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPFD---VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCcc---eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99876554433 35799999999999998875 56899999999999998888874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=251.30 Aligned_cols=269 Identities=25% Similarity=0.333 Sum_probs=198.3
Q ss_pred HHHHhcCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCC
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDD 436 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~ 436 (696)
+....+.|..+++||+|.|+.||++.+. .++.||+|.+... ..-..+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344578999999999999999999853 4678999988654 33456899999999996 899999999999999
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-CCcEEEEeeccc
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLA 515 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls 515 (696)
..++|+||+++....+++.. ++..++...++.++.||.++|++ ||||||||+.|+|++. .++-.|+|||++
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 99999999999988877753 67889999999999999999999 9999999999999974 467899999999
Q ss_pred hhccccC------------------c-------------------------ceeeccccccccCchhhhcc-CCCCcccc
Q 005443 516 KLALDAN------------------T-------------------------HITTRVMGTFGYMAPEYASS-GKLTEKSD 551 (696)
Q Consensus 516 ~~~~~~~------------------~-------------------------~~~~~~~gt~~y~aPE~l~~-~~~s~~sD 551 (696)
....... . .......||.+|+|||++.. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6211000 0 00012469999999999875 56788999
Q ss_pred ccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHH-----------HHHHH--hhhhh----------hhhcc-cCccc--
Q 005443 552 VFSFGVVLLELITGRKPVDASQPLGDESLVEWAR-----------PLLSH--ALENE----------EFDNL-ADPRL-- 605 (696)
Q Consensus 552 VwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~-----------~~~~~--~~~~~----------~~~~~-~d~~l-- 605 (696)
|||.|||++.+++++.||....... ..+.+.+. .+... .++.. .++.+ .....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999997544321 12222211 11111 11100 11111 01000
Q ss_pred ------CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 ------GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.....+.....+++++.+|+..||.+|-++++.|++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 011111122367899999999999999999998854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=234.18 Aligned_cols=262 Identities=21% Similarity=0.244 Sum_probs=196.8
Q ss_pred CccccccccccCcEEEEEEEcCCC--cEEEEEEeecCCCccHHHHHHHHHHHHHccC----CCceeEEeEE-eeCCceeE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPDG--REVAIKQLKIGGGQGEREFKAEVEIISRIHH----RHLVSLVGYC-ISDDRRLL 440 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~il~~l~h----pnIv~l~~~~-~~~~~~~l 440 (696)
+|.+.+.||+|+||.||++...+. ..+|+|+...........+..|+.+|..+.. .++.++++.. ..++..+|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 5889998876543333378889999999873 6889999988 46778899
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC-----CcEEEEeeccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-----FEAQVSDFGLA 515 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-----~~vkL~DfGls 515 (696)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+. |+||||||+.|+++... ..++|+|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 88898877655555699999999999999999999999 99999999999999754 46999999999
Q ss_pred h--hccccCcc----e---eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH
Q 005443 516 K--LALDANTH----I---TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 516 ~--~~~~~~~~----~---~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
+ .+...... . .....||.+|++.+...+.+.+.+.|+||++.++.||+.|.+||.......... ....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~---~~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS---KFEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH---HHHH
Confidence 8 33222211 1 123569999999999999999999999999999999999999996544221111 1100
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
... ...... + .... ...+.++...+-..+..++|....+...|+++....
T Consensus 252 ----~~~----~~~~~~-~-~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 ----DPR----KLLTDR-F-GDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ----Hhh----hhcccc-c-cCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 011110 0 1111 124555555666689999999999999888776543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=273.90 Aligned_cols=196 Identities=15% Similarity=0.181 Sum_probs=136.7
Q ss_pred HccC-CCceeEEeEE-------eeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 005443 419 RIHH-RHLVSLVGYC-------ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490 (696)
Q Consensus 419 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~iv 490 (696)
.++| .||++++++| ...+.++++|||+ +++|+++|.... ..+++.+++.|++||++||+|||++ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 3444 5788888877 2234567788887 669999997543 3489999999999999999999998 999
Q ss_pred eccCCCCceEECCCCcE-------------------EEEeeccchhccccCc---------------ceeeccccccccC
Q 005443 491 HRDIKSSNILLDNNFEA-------------------QVSDFGLAKLALDANT---------------HITTRVMGTFGYM 536 (696)
Q Consensus 491 HrDLkp~NILl~~~~~v-------------------kL~DfGls~~~~~~~~---------------~~~~~~~gt~~y~ 536 (696)
||||||+||||+..+++ ||+|||+++....... ......+||..||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654444 5555555543211000 0001135788899
Q ss_pred chhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHH
Q 005443 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFR 616 (696)
Q Consensus 537 aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 616 (696)
|||++.+..|+.++|||||||+||||++|..+|.... .. ...+... +..... ......
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~---~~~~~~~---------~~~~~~-----~~~~~~ 240 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RT---MSSLRHR---------VLPPQI-----LLNWPK 240 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HH---HHHHHHh---------hcChhh-----hhcCHH
Confidence 9999999999999999999999999999887764211 11 1111000 011100 011224
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 617 MIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 617 l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.+++.+||+.+|++||+|.||+++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhc
Confidence 5678889999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-25 Score=218.33 Aligned_cols=259 Identities=21% Similarity=0.287 Sum_probs=194.4
Q ss_pred CccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEEec
Q 005443 368 GFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.|.++++||+|.||++|.|+ +-+++.||||.--.. .+.-++..|.+.++.|. ..+|...|-|..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 58899999999999999998 558999999975432 23456888999999886 678888887777777889999988
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC-----CCCcEEEEeeccchhccc
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-----NNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-----~~~~vkL~DfGls~~~~~ 520 (696)
|-+|.|++.-+++. ++.+.++.|+.||+.-|+|+|++ .+|.|||||+|+||. +...|.|+|||+++.+.+
T Consensus 107 -GPSLEDLFD~CgR~-FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRR-FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhcCc-ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 78888887766654 89999999999999999999999 999999999999995 344699999999998877
Q ss_pred cCcce------eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 521 ANTHI------TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 521 ~~~~~------~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
..+.. .....||.+||+-...++.+.+.+.|+-+||-+++.+|-|.+||.+..........+.+.. .-..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe----~Kr~ 257 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE----TKRS 257 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc----cccc
Confidence 65432 2346799999999999999999999999999999999999999987654332222221110 0001
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
-.+++ |+..+. .+....++ -.-+.+-.+-|+.+-+...+.++.
T Consensus 258 T~i~~-----Lc~g~P-~efa~Yl~---yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 258 TPIEV-----LCEGFP-EEFATYLR---YVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred CCHHH-----HHhcCH-HHHHHHHH---HHHhcCcccCCCHHHHHHHHHHHH
Confidence 11111 122222 22333333 444566778888877766655555
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=211.98 Aligned_cols=169 Identities=22% Similarity=0.234 Sum_probs=126.7
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceee
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT 527 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~ 527 (696)
|+|.++++..+ ..+++..++.|+.||++||+|||++ + |++|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 67888887543 3489999999999999999999998 5 999999999999999 99987654322
Q ss_pred ccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC
Q 005443 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE 607 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~ 607 (696)
..|+..|||||++.+..++.++|||||||+||||++|+.||...... .+....++....... ... .
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~-------~~~-~ 129 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMPADD-------PRD-R 129 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhccCC-------ccc-c
Confidence 25789999999999999999999999999999999999999753321 111111111111000 000 0
Q ss_pred CcchHHH--HHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 608 NYVEGEM--FRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 608 ~~~~~~~--~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
....... ..+.+++++||+.+|++||++.||++++..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0011111 258999999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=208.88 Aligned_cols=261 Identities=21% Similarity=0.261 Sum_probs=197.9
Q ss_pred hcCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC-CCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH-RHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|.+++.||.|.||.+|+|. ..+|.+||||+-+.. ...-++..|.++++.|++ ..|..+..|..+.+...||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999998 668999999986533 334568889999999985 578888888888888999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC---CcEEEEeeccchhccc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDFGLAKLALD 520 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DfGls~~~~~ 520 (696)
.+ |-+|.+++.-+.+ .++.++.+-++-|++.-|+|+|.+ ++|||||||+|+|+.-+ ..+.|+|||+++.+.+
T Consensus 92 LL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 88 7888877765544 388899999999999999999999 99999999999999643 4689999999988766
Q ss_pred cCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 521 ANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 521 ~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
.... ...+..||.+|.+-....+.+.+.+.|+-|+|.+|..+.-|.+||.+..........+.. . +
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI---~----E- 238 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI---S----E- 238 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---H----H-
Confidence 5432 234567999999988888888888999999999999999999999875432222111111 0 0
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
..+... -..++.-+ ..++...+.-|-...-++-|+...|.+.+..+.
T Consensus 239 kK~s~~-ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 239 KKMSTP-IEVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred hhcCCC-HHHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 000000 01122222 335667778898999999999876665554433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=231.32 Aligned_cols=164 Identities=20% Similarity=0.250 Sum_probs=128.6
Q ss_pred HHhcCccccccccccCcEEEEEEEcC--CCcEEEEEEeecCC-----CccHHHHHHHHHHHHHccCCCcee-EEeEEeeC
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP--DGREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLVS-LVGYCISD 435 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~-----~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~ 435 (696)
...++|.+.++||+|+||+||+|.++ +++.||||++.... ....+.|.+|+++|++|+|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34578999999999999999999864 57778999875321 122456899999999999999985 4432
Q ss_pred CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccC-CCCceEECCCCcEEEEeecc
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI-KSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDL-kp~NILl~~~~~vkL~DfGl 514 (696)
+..+|||||+.|++|... ... . ...++.|++++|.|||++ +|+|||| |++|||++.++++||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 457999999999998632 111 1 146789999999999999 9999999 99999999999999999999
Q ss_pred chhccccCcce-------eeccccccccCchhhhcc
Q 005443 515 AKLALDANTHI-------TTRVMGTFGYMAPEYASS 543 (696)
Q Consensus 515 s~~~~~~~~~~-------~~~~~gt~~y~aPE~l~~ 543 (696)
++.+....... ....+++..|++||++.-
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 98664433211 134578889999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=215.36 Aligned_cols=246 Identities=24% Similarity=0.409 Sum_probs=195.2
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCc
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNT 449 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 449 (696)
..+|.+...|..|+|++ .|..+++|+++... .+..++|..|+-.|+.+.|+||+.++|.|...-+..++..||..|+
T Consensus 195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34678888999999999 77778888886432 3345689999999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEE--eeccchhccccCcceee
Q 005443 450 LYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS--DFGLAKLALDANTHITT 527 (696)
Q Consensus 450 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~--DfGls~~~~~~~~~~~~ 527 (696)
|+..||.......+..++.+++.+|++|++|||+. .+-|.---|..+.|+||++.+++|. |--++.. . .
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---e-----~ 344 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---E-----V 344 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee---c-----c
Confidence 99999998887889999999999999999999986 3334455689999999999887764 3332211 1 1
Q ss_pred ccccccccCchhhhccCCCC---ccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 528 RVMGTFGYMAPEYASSGKLT---EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 528 ~~~gt~~y~aPE~l~~~~~s---~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
...-.+.||+||.+....-+ .++|+|||+++||||.|+..||.+-...+... ++.-..
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-------------------kialeg 405 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-------------------KIALEG 405 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-------------------hhhhcc
Confidence 11235689999999865433 47899999999999999999998654432211 112223
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
++.....+....+.+|+.-|++.||.+||.++.|+-.|++++
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 445556666778999999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-23 Score=214.70 Aligned_cols=259 Identities=28% Similarity=0.373 Sum_probs=197.5
Q ss_pred ccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCC-CceeEEeEEeeCCceeEEEEe
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHR-HLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~E~ 444 (696)
|.+.+.||.|.||.||++... ..+++|.+...... ....+.+|+.+++.+.|. +|+++++++...+..+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999975 88999999755443 367799999999999988 799999999777778999999
Q ss_pred cCCCchhhccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-cEEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfGls~~~~~~~ 522 (696)
+.+++|.+++..... ..+.......++.|++.+|.|+|+. +++|||||++|||++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999866654432 2488899999999999999999999 899999999999999988 79999999997554433
Q ss_pred cc-----eeeccccccccCchhhhcc---CCCCccccccchHHHHHHHHhCCCCCCCCCCC-CchhHHHhHHHHHHHhhh
Q 005443 523 TH-----ITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPL-GDESLVEWARPLLSHALE 593 (696)
Q Consensus 523 ~~-----~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~ 593 (696)
.. ......|+..|++||.+.+ ..+....|+|++|+++++++.|..||...... ......+... ....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL----ELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH----hcCC
Confidence 22 2345679999999999987 57888999999999999999999997654321 0111111111 1000
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. .................+.+++.+|+..++..|.++.+....
T Consensus 233 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000010002223467889999999999999999887764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=205.37 Aligned_cols=171 Identities=13% Similarity=0.134 Sum_probs=135.1
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHH---------HHHHHHHHHHccCCCceeEEeEEeeC-
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE---------FKAEVEIISRIHHRHLVSLVGYCISD- 435 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~- 435 (696)
.++|..+++||.|+||.||+... +++.+|||+++......... +++|+..+.+++|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 48999999999999999999776 67789999997544333322 68999999999999999999886643
Q ss_pred -------CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEE
Q 005443 436 -------DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (696)
Q Consensus 436 -------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (696)
+..+|||||++|.+|.++.. ++. .++.+|+.+|..||++ ||+|||||++||+++.++ ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 35789999999999977632 222 3466999999999999 999999999999999888 99
Q ss_pred EEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh
Q 005443 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564 (696)
Q Consensus 509 L~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt 564 (696)
|+|||........... . .+++...|..++|+|+||+.+..+..
T Consensus 175 liDfg~~~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEECCCcccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHHH
Confidence 9999998755322111 0 13444557789999999998876653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-24 Score=241.04 Aligned_cols=253 Identities=22% Similarity=0.277 Sum_probs=186.6
Q ss_pred cccccccccCcEEEEEEEc-CCCcEEEEEEeecC--CCccH----HHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 370 ADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGE----REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
...+++|.|.+|.|+.... .....++.|.++.. ..... ..+..|+.+-..|+|+|++..+..+.+.+..+.+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999997777763 34444455543311 11111 22566788888899999998888777777766679
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|||.+ +|+.++...++ +...++..++.||+.||+|||+. ||.|||||++|+|+..++.+||+|||.+..+.-..
T Consensus 401 E~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 99998876543 78889999999999999999999 99999999999999999999999999997764433
Q ss_pred c---ceeeccccccccCchhhhccCCCCc-cccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 523 T---HITTRVMGTFGYMAPEYASSGKLTE-KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 523 ~---~~~~~~~gt~~y~aPE~l~~~~~s~-~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
. ......+|.-.|+|||++.+..|+. ..||||.|+++..|++|+.+|......++.. .+ .....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~-----------~~~~~ 542 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT-----------NNYSD 542 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh-----------hcccc
Confidence 3 3455678999999999999999986 5799999999999999999997654332211 00 00000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
......-..........+...++.+||+.+|++|-++++|++
T Consensus 543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000000011122233446778899999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=195.33 Aligned_cols=139 Identities=15% Similarity=0.171 Sum_probs=108.5
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCCc--c-------H-----------------HHHHHHHHHHHHccCCCc
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--G-------E-----------------REFKAEVEIISRIHHRHL 425 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~-------~-----------------~~~~~E~~il~~l~hpnI 425 (696)
.++||+|+||.||+|.+.+|+.||||+++..... . . ....+|+++|.++.+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999999754211 1 0 122459999999988776
Q ss_pred eeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceeeccCCCCceEECCC
Q 005443 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL-HEDCHPRIIHRDIKSSNILLDNN 504 (696)
Q Consensus 426 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~~~ivHrDLkp~NILl~~~ 504 (696)
.....+.. ...+|||||+.+++|...+.... .+++..+++++.||+.+|.|| |+. +|+|||||++||||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~- 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-
Confidence 44333222 23489999999887754432222 478899999999999999999 687 9999999999999984
Q ss_pred CcEEEEeeccchhc
Q 005443 505 FEAQVSDFGLAKLA 518 (696)
Q Consensus 505 ~~vkL~DfGls~~~ 518 (696)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 68999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-22 Score=228.82 Aligned_cols=198 Identities=23% Similarity=0.272 Sum_probs=158.8
Q ss_pred HHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc---CCCceeEEeEEeeCCce
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRR 438 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~ 438 (696)
++...+.|.+.+.||+|+||.||+|...+|+.||||+-+..+.. +|.--.+++.+|+ -+.|..+..++...+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 33445789999999999999999999888999999987654332 1222234444444 23445555556667888
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC-------CCCcEEEEe
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-------NNFEAQVSD 511 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-------~~~~vkL~D 511 (696)
+||+||...|+|.+++...+ .++|...+.|++||++.|++||.. +||||||||+|+||. +...++|+|
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence 99999999999999998544 499999999999999999999999 999999999999993 344699999
Q ss_pred eccchhccc-cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCC
Q 005443 512 FGLAKLALD-ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK 567 (696)
Q Consensus 512 fGls~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~ 567 (696)
||.+..+.- .+.......++|-.+-..|+..++.++..+|.|.|+-+++-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999975532 12234455678889999999999999999999999999999999876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=218.46 Aligned_cols=225 Identities=28% Similarity=0.334 Sum_probs=178.2
Q ss_pred cccccCcEEEEEEE----cCCCcEEEEEEeecCCCc--cHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEEecC
Q 005443 374 LLGEGGFGSVYKGY----LPDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 374 ~LG~G~~g~Vy~~~----~~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|+|.||.|++++ .+.|..+|+|+++..... .......|..++..++ |+.+|++.-.+..+...+++++|+.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999876 345788999988654322 1225567888898887 9999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
||.|...+..... +++.....+...++.+++++|+. +|+|||+|.+||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 9999888876554 77777788889999999999999 9999999999999999999999999999876554332
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccC
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~ 606 (696)
+|+..|||||++. .+..++|.|+||++++||++|..+|.. +.+..++.. ++
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~--------~~------ 204 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA--------EL------ 204 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh--------cc------
Confidence 7899999999998 567789999999999999999999975 111111110 01
Q ss_pred CCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 607 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
.+.......+.+++..++..++.+|--.
T Consensus 205 -~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 -EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1122333456677778888888888644
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=188.48 Aligned_cols=141 Identities=15% Similarity=0.147 Sum_probs=111.1
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCCc---------------------c-----HHHHHHHHHHHHHccCCCc
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ---------------------G-----EREFKAEVEIISRIHHRHL 425 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~E~~il~~l~hpnI 425 (696)
.+.||+|+||.||+|.+.+|+.||||+++..... . ...+++|++.+.++.|.+|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999878999999999754211 0 1124678999999999987
Q ss_pred eeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECCC
Q 005443 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNN 504 (696)
Q Consensus 426 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~ 504 (696)
.....+... ..+|||||+.|+.+...+.... .++...+.+++.|++.+|.+||+ + ||+|||||++||||+ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 554443332 3489999998885543322222 36788899999999999999999 8 999999999999999 7
Q ss_pred CcEEEEeeccchhccc
Q 005443 505 FEAQVSDFGLAKLALD 520 (696)
Q Consensus 505 ~~vkL~DfGls~~~~~ 520 (696)
++++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=226.65 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=179.7
Q ss_pred CccccccccccCcEEEEEEEcCCCcEEEEEEeecCC-CccHHHHHHHHHH--HHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG-GQGEREFKAEVEI--ISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~i--l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+|...+.||.++|=+|++|++++|. |+||++-... ....+.|.++++- ...++|+|++.+..+...++..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999997777 9999985433 3334444444333 4456899999998887777778888888
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc--cccC
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA--LDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~--~~~~ 522 (696)
+ ..+|+|.+.. +..+...+.+.|+.||+.||.-+|+. ||+|||||.+||||+.=.-+.|+||.--+-. ..++
T Consensus 103 v-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 V-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred H-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 8 5578888864 45688899999999999999999999 9999999999999998778999999865422 1111
Q ss_pred cceeecc----ccccccCchhhhccC-----------CCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHH
Q 005443 523 THITTRV----MGTFGYMAPEYASSG-----------KLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 523 ~~~~~~~----~gt~~y~aPE~l~~~-----------~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
-....-+ ..-..|+|||.+... ..+.+.||||+||+++||++ |+.+|.-. .+..+-+.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~ 250 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSG 250 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhcc
Confidence 1111111 223469999987542 15678999999999999988 67777521 11111000
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
- .......++++- ...+..++..|++.||++|-++++.|+.-..+.+
T Consensus 251 ~--~~~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 251 N--ADDPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred C--ccCHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 0 000000111111 1158889999999999999999999988655553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=186.31 Aligned_cols=187 Identities=18% Similarity=0.138 Sum_probs=140.6
Q ss_pred cccccccccCcEEEEEEEcCCCcEEEEEEeecCCCcc----HHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEEe
Q 005443 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG----EREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.+...|++|+||+||.+.. .+..++.+.+....... ...+.+|+++|++|+ |.+|.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998877 78888888776443211 125889999999996 5789999886 456999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccC-CCCceEECCCCcEEEEeeccchhccccCc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI-KSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDL-kp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
+.|.+|...+.. ....++.|++++|++||++ ||||||| |+.|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999988654321 1135788999999999999 9999999 79999999999999999999985443221
Q ss_pred c----e--------eeccccccccCchhhhcc-CCCC-ccccccchHHHHHHHHhCCCCCCCCC
Q 005443 524 H----I--------TTRVMGTFGYMAPEYASS-GKLT-EKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 524 ~----~--------~~~~~gt~~y~aPE~l~~-~~~s-~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
. . ......+..|+.|+...- ...+ .+.+.++.|+.+|.++||+.++..++
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 001224667777775432 1222 46789999999999999998876544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=205.20 Aligned_cols=217 Identities=24% Similarity=0.405 Sum_probs=164.7
Q ss_pred HHHccCCCceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce-eeccCC
Q 005443 417 ISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI-IHRDIK 495 (696)
Q Consensus 417 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~i-vHrDLk 495 (696)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.+.+... ...+++.....++++|+.||+|||+- .| .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 45788999999999999999999999999999999999874 34599999999999999999999987 34 999999
Q ss_pred CCceEECCCCcEEEEeeccchhcccc-CcceeeccccccccCchhhhccCC-------CCccccccchHHHHHHHHhCCC
Q 005443 496 SSNILLDNNFEAQVSDFGLAKLALDA-NTHITTRVMGTFGYMAPEYASSGK-------LTEKSDVFSFGVVLLELITGRK 567 (696)
Q Consensus 496 p~NILl~~~~~vkL~DfGls~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~-------~s~~sDVwSlGvll~eLltg~~ 567 (696)
..|+++|..+.+||.|||+.....+. .............|.|||.+.+.. .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998766421 111112223456799999997632 4667999999999999999999
Q ss_pred CCCCCCCCCch-hHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 568 PVDASQPLGDE-SLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 568 Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
+|+......+. +++..+.. .....+.+.+.... +....++.++++||..+|++||+++.|...++.+.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~---------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK---------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHHHHh---------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99875543332 22222111 01111111111111 12226889999999999999999999998888776
Q ss_pred cc
Q 005443 647 TS 648 (696)
Q Consensus 647 ~~ 648 (696)
..
T Consensus 226 ~~ 227 (484)
T KOG1023|consen 226 KG 227 (484)
T ss_pred cc
Confidence 53
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=192.87 Aligned_cols=197 Identities=22% Similarity=0.259 Sum_probs=135.3
Q ss_pred cCCCceeEEeEEeeC---------------------------CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHH
Q 005443 421 HHRHLVSLVGYCISD---------------------------DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAG 473 (696)
Q Consensus 421 ~hpnIv~l~~~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q 473 (696)
+|+|||+++++|.+. ...|+||..+ ..+|+.++..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 599999999887542 2347787766 346777776544 456677788999
Q ss_pred HHHHHHHHHhcCCCceeeccCCCCceEE--CCCC--cEEEEeeccchhccccCc-----ceeeccccccccCchhhhccC
Q 005443 474 AARGLAYLHEDCHPRIIHRDIKSSNILL--DNNF--EAQVSDFGLAKLALDANT-----HITTRVMGTFGYMAPEYASSG 544 (696)
Q Consensus 474 ia~gL~~LH~~~~~~ivHrDLkp~NILl--~~~~--~vkL~DfGls~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~ 544 (696)
+++|+.|||++ ||.|||||.+|||| |+|+ .++|+|||++.-....+. ......-|....||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 3333 578999999854332111 112233477789999987532
Q ss_pred --C----CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHH
Q 005443 545 --K----LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMI 618 (696)
Q Consensus 545 --~----~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 618 (696)
. --.|+|.|+.|.+.||++....||..... .+++ ...+++---+.+ .+.....+.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe----m~L~-----------~r~Yqe~qLPal----p~~vpp~~r 487 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE----MLLD-----------TRTYQESQLPAL----PSRVPPVAR 487 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch----heec-----------hhhhhhhhCCCC----cccCChHHH
Confidence 1 12489999999999999999999986321 1111 111111111112 222333678
Q ss_pred HHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 619 EAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 619 ~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
+++...|+.|+.+|++..-....|+
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHHH
Confidence 8999999999999998765544433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=190.40 Aligned_cols=232 Identities=22% Similarity=0.291 Sum_probs=145.8
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHcc----------CCCceeEEeEEe
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIH----------HRHLVSLVGYCI 433 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~----------hpnIv~l~~~~~ 433 (696)
.+..++.||.|+++.||.+++. .|+.+|||++..... ...+++++|...+..+. |-.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4566789999999999999964 589999999865542 23355666665444432 222222222221
Q ss_pred ---------eCC--------ceeEEEEecCCCchhhccc---cCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 005443 434 ---------SDD--------RRLLIYDYVPNNTLYFHLH---GEGR--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491 (696)
Q Consensus 434 ---------~~~--------~~~lV~E~~~~gsL~~~l~---~~~~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH 491 (696)
... +.+++|.-+ .++|.+++. .... ..+....++.+..|+++.+++||.+ ||||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 111 235667766 566655543 2211 1244555677789999999999999 9999
Q ss_pred ccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhcc--------CCCCccccccchHHHHHHHH
Q 005443 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS--------GKLTEKSDVFSFGVVLLELI 563 (696)
Q Consensus 492 rDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~sDVwSlGvll~eLl 563 (696)
+||+++|+|++.+|.++|+||+..+..+... .. ...+..|.+||.... ..++.+.|.|+||++||.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999999876543321 11 234578999997744 24788999999999999999
Q ss_pred hCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCC
Q 005443 564 TGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKR 632 (696)
Q Consensus 564 tg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 632 (696)
||+.||+......+... .+.. +. +....+.+||+.+|+.|+++|
T Consensus 245 C~~lPf~~~~~~~~~~~---------------~f~~------C~----~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW---------------DFSR------CR----DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG---------------GGTT------SS-------HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc---------------cchh------cC----CcCHHHHHHHHHHccCCcccC
Confidence 99999986432211110 1111 11 333478899999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=179.43 Aligned_cols=137 Identities=23% Similarity=0.291 Sum_probs=107.5
Q ss_pred ccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-----cCCCceeEEeEEeeCC---c-ee
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-----HHRHLVSLVGYCISDD---R-RL 439 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---~-~~ 439 (696)
+...++||+|+||.||. .-+++.. +||++........+++.+|+++|+.+ +|+||++++|+++++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 3334444 79998765555667899999999999 5799999999999874 2 23
Q ss_pred EEEEe--cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceeeccCCCCceEECC----CCcEEEEee
Q 005443 440 LIYDY--VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGL-AYLHEDCHPRIIHRDIKSSNILLDN----NFEAQVSDF 512 (696)
Q Consensus 440 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL-~~LH~~~~~~ivHrDLkp~NILl~~----~~~vkL~Df 512 (696)
+|+|| +.+++|.+++.+. . +++. ..++.|++.++ +|||++ +|||||||++|||++. +++++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~--~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-R--YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-c--ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 4479999999653 2 4444 35678888777 999999 9999999999999963 348999995
Q ss_pred ccc
Q 005443 513 GLA 515 (696)
Q Consensus 513 Gls 515 (696)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=180.57 Aligned_cols=142 Identities=15% Similarity=0.158 Sum_probs=112.2
Q ss_pred cCccccccccccCcEEEEEEE--cCCCcEEEEEEeecCCCc------------------------cHHHHHHHHHHHHHc
Q 005443 367 DGFADQNLLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQ------------------------GEREFKAEVEIISRI 420 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~il~~l 420 (696)
..|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+.+|++++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 568999999999754210 012357899999999
Q ss_pred cCCC--ceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eeeccCCCC
Q 005443 421 HHRH--LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR-IIHRDIKSS 497 (696)
Q Consensus 421 ~hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~-ivHrDLkp~ 497 (696)
.+.+ +.+++++ +..+|||||+.+++|...+.... .+....+.+++.||+.+|++||++ + |+|||||++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 8633 3444443 23589999999988866543322 255666789999999999999999 8 999999999
Q ss_pred ceEECCCCcEEEEeeccchhc
Q 005443 498 NILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 498 NILl~~~~~vkL~DfGls~~~ 518 (696)
||||+ +++++|+|||++...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 789999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=173.61 Aligned_cols=134 Identities=22% Similarity=0.357 Sum_probs=113.9
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCCc--------cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
+.||+|++|.||+|.. +|..|+||+....... ....+.+|++++..++|.||.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999988 7888999986533211 124578899999999999988877777777888999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
+.|++|.+++.... . .+..++.+|+.+|.+||+. +|+||||+++|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999988875422 2 7789999999999999999 999999999999999 77899999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-18 Score=170.70 Aligned_cols=147 Identities=20% Similarity=0.221 Sum_probs=115.7
Q ss_pred HHHHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCc----------------------cHHHHHHHHHH
Q 005443 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ----------------------GEREFKAEVEI 416 (696)
Q Consensus 359 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~i 416 (696)
.+++......|.+.+.||+|+||.||++...+|+.||||+++..... ....+.+|+.+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 44555555568889999999999999999888999999987643210 11236778999
Q ss_pred HHHccCCC--ceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccC
Q 005443 417 ISRIHHRH--LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494 (696)
Q Consensus 417 l~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDL 494 (696)
+..+.|.+ +..+++ .+..++||||+.|++|..+... ....+++.+|+.+|.+||+. +|+||||
T Consensus 87 l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 87 LKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 99998874 444444 2455899999999988765431 33567899999999999998 9999999
Q ss_pred CCCceEECCCCcEEEEeeccchhccc
Q 005443 495 KSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 495 kp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|++||+|++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=172.82 Aligned_cols=130 Identities=22% Similarity=0.361 Sum_probs=107.1
Q ss_pred cccccCcEEEEEEEcCCCcEEEEEEeecCCCc--------cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 374 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+||+|+||.||+|.+ +|..|+||+....... ...++.+|++++..++|.++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 7789999986533211 1245778999999999887665555566677789999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.|++|.+++..... .++.+|+.+|.+||+. +|+||||+++|||++ ++.++|+|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887753211 7899999999999999 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-19 Score=202.48 Aligned_cols=227 Identities=23% Similarity=0.337 Sum_probs=149.1
Q ss_pred hcCccccccccccCcEEEEEEEcCC-CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|+.+++|..|+||.||.++++. .+.+|+|+=+. ..+.+ ||..+. +..++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq------~lilR-----------nilt~a------~npfvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ------NLILR-----------NILTFA------GNPFVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc------chhhh-----------cccccc------CCccee---
Confidence 3689999999999999999998753 56788853221 11111 122221 122222
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
|+-...+...+. +.. +++.+++|||+. +|||||+|++|+||+.-|++|+.|||+++...-....
T Consensus 136 ---gDc~tllk~~g~--lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP--LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC--Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 444444444333 222 227899999999 9999999999999999999999999998754322111
Q ss_pred --------------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 525 --------------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 525 --------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
....++||..|+|||++....|..-+|+|++|+|+||++-|+.+|+++.. ++++. .++..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg---~visd 273 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFG---QVISD 273 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHh---hhhhh
Confidence 11346899999999999999999999999999999999999999987542 22222 12211
Q ss_pred hhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccccC
Q 005443 591 ALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNN 652 (696)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~ 652 (696)
.++ +.+- | +....+..+++.++|+.++.+|---...++..+.-.++++++
T Consensus 274 ~i~---wpE~-d--------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 274 DIE---WPEE-D--------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred hcc---cccc-C--------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 111 1110 1 111236778888999999999964333343333333444443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=195.23 Aligned_cols=139 Identities=22% Similarity=0.351 Sum_probs=113.1
Q ss_pred HHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCC--C------ccHHHHHHHHHHHHHccCCCceeEEeEEeeC
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--G------QGEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 435 (696)
.....|...++||+|+||.||+|.+. ++.+++|+..... . ...+++.+|++++++++|.||+..+.++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33455677899999999999999874 4445555432111 1 1124688999999999999999888888877
Q ss_pred CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
+..++||||+.+++|.+++. ...+++.||+++|.|||++ +|+|||||++|||| +++.++|+|||++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 78899999999999988774 3568899999999999999 99999999999999 5779999999999
Q ss_pred hh
Q 005443 516 KL 517 (696)
Q Consensus 516 ~~ 517 (696)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-19 Score=191.85 Aligned_cols=188 Identities=20% Similarity=0.247 Sum_probs=132.5
Q ss_pred ccccccccCcEEEEEEEcCCC----cEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEe-------EEee-----
Q 005443 371 DQNLLGEGGFGSVYKGYLPDG----REVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG-------YCIS----- 434 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~~g----~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-------~~~~----- 434 (696)
+.+.++...++.++.....++ ..+..|..+.++........+++-.+....|.+..-+.+ .+..
T Consensus 248 ~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~ 327 (516)
T KOG1033|consen 248 ISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGK 327 (516)
T ss_pred ccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccc
Confidence 334455555555555443222 233344433333222333444555555555444333332 1111
Q ss_pred CCceeEEEEecCCCchhhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
....+|.|++|...+|.++|.+ ......++...+.++.|++.|++| + +.+|+|||+.||++..+..+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 1246899999999999999963 333446788889999999999999 5 89999999999999999999999999
Q ss_pred cchhccccC-----cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh
Q 005443 514 LAKLALDAN-----THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 564 (696)
Q Consensus 514 ls~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt 564 (696)
+........ .......+||..||+||.|.+..|+.++|||+||+||+||+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987654443 223455689999999999999999999999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=8e-17 Score=150.69 Aligned_cols=135 Identities=21% Similarity=0.181 Sum_probs=114.9
Q ss_pred ccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC--CCceeEEeEEeeCCceeEEEEecCCC
Q 005443 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH--RHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
+++.||+|.++.||++.. +++.++||.+..... ...+.+|+.+++.++| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT-KDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEe-cCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 457899999999999998 448899999865433 5678999999999987 58999999888888899999999888
Q ss_pred chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+..+ +......++.+++++|++||.....+++|+||+++|||+++++.++|+|||+++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77544 4566678899999999999986334799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.6e-17 Score=157.55 Aligned_cols=137 Identities=18% Similarity=0.232 Sum_probs=100.8
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCCcc--HHH----------------------HHHHHHHHHHccCCC--c
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG--ERE----------------------FKAEVEIISRIHHRH--L 425 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~----------------------~~~E~~il~~l~hpn--I 425 (696)
.++||+|+||.||+|.+.+|+.||||+++...... ... ...|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 47899999999999998789999999987432111 111 135666676665443 4
Q ss_pred eeEEeEEeeCCceeEEEEecCCCchhh-ccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECC
Q 005443 426 VSLVGYCISDDRRLLIYDYVPNNTLYF-HLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDN 503 (696)
Q Consensus 426 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~ 503 (696)
.+++++ ...++||||+.++.+.. .+.... .. ..+.+++.+++.+|.+||. + +|+|||||++||+|+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 445443 34589999999865432 221111 11 5678899999999999999 7 999999999999999
Q ss_pred CCcEEEEeeccchhccc
Q 005443 504 NFEAQVSDFGLAKLALD 520 (696)
Q Consensus 504 ~~~vkL~DfGls~~~~~ 520 (696)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.2e-16 Score=158.65 Aligned_cols=137 Identities=18% Similarity=0.255 Sum_probs=106.4
Q ss_pred ccccc-ccCcEEEEEEEcCCCcEEEEEEeecCC-------------CccHHHHHHHHHHHHHccCCCc--eeEEeEEeeC
Q 005443 372 QNLLG-EGGFGSVYKGYLPDGREVAIKQLKIGG-------------GQGEREFKAEVEIISRIHHRHL--VSLVGYCISD 435 (696)
Q Consensus 372 ~~~LG-~G~~g~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~~ 435 (696)
..+|| .|+.|+||+++. ++..++||.++... ......+.+|++++.+|+|.+| ++.++++..+
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 888999999988 57889999885321 1223467889999999998775 7777775543
Q ss_pred Cc----eeEEEEecCC-CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEE
Q 005443 436 DR----RLLIYDYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (696)
Q Consensus 436 ~~----~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (696)
.. .+|||||+.| .+|.+++... .+... ++.+|+.+|.+||++ ||+|||||++||||+.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 32 2599999997 6888777542 13332 367899999999999 99999999999999988899999
Q ss_pred eeccchhcc
Q 005443 511 DFGLAKLAL 519 (696)
Q Consensus 511 DfGls~~~~ 519 (696)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999987643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.6e-17 Score=183.91 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=187.5
Q ss_pred CccccccccccCcEEEEEEEcCC--CcEEEEEEeecCC--CccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPD--GREVAIKQLKIGG--GQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.|.+.+-||+|.|+.|-+..... ...+|+|.+.... ....+.+..|..+-..+. |.|++++++.....+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 46667779999999998887533 4456666665443 223345566888888887 999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceeeccCCCCceEECCCC-cEEEEeeccchhccc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH-EDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALD 520 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfGls~~~~~ 520 (696)
+|..++++++.+...+........+-.++.|+..+|.|+| +. ++.|+|||++|.+++..+ .+++.|||++..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999998883222223566777889999999999999 77 999999999999999999 999999999987655
Q ss_pred --cCcceeecccc-ccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 521 --ANTHITTRVMG-TFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 521 --~~~~~~~~~~g-t~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
+........+| +..|+|+|...+. ......|+|++|+++.-+++|..+++...... ..+..|.. ...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~--------~~~ 248 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKS--------NKG 248 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecc--------ccc
Confidence 22333445678 9999999998874 45678999999999999999999998654322 11111111 100
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
. .............++++.+++..++..|-+.+++..
T Consensus 249 ~-------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 R-------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c-------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 001111122235667777888889999988877753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8e-15 Score=160.92 Aligned_cols=166 Identities=18% Similarity=0.252 Sum_probs=129.3
Q ss_pred cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHH
Q 005443 388 LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467 (696)
Q Consensus 388 ~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~ 467 (696)
..++..|.|+.++..+........+-++.|+.|+|+||+++++.++.++..|||+|.+. -|..++.. +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence 44788999999987766445668888999999999999999999999999999999874 34444433 234566
Q ss_pred HHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCC
Q 005443 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547 (696)
Q Consensus 468 ~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s 547 (696)
...++||+.||.|||+.| +++|++|.-..|+|+..|++||++|.++....+.+. .......-..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 778999999999999776 999999999999999999999999999865543332 111122233466676654433
Q ss_pred ccccccchHHHHHHHHhC
Q 005443 548 EKSDVFSFGVVLLELITG 565 (696)
Q Consensus 548 ~~sDVwSlGvll~eLltg 565 (696)
-..|.|.|||++||++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.1e-14 Score=158.55 Aligned_cols=140 Identities=23% Similarity=0.253 Sum_probs=101.0
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCCcc----------------------------------------HHHHHH
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG----------------------------------------EREFKA 412 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------~~~~~~ 412 (696)
+.||.|++|.||+|++++|+.||||+.+...... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986431100 012555
Q ss_pred HHHHHHHcc----CCCceeEEeEEe-eCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 005443 413 EVEIISRIH----HRHLVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR-GLAYLHEDCH 486 (696)
Q Consensus 413 E~~il~~l~----hpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~-gL~~LH~~~~ 486 (696)
|++.+.+++ |.+-+.+-.++. .....+|||||++|++|.+++..... .. ...+++.++++ .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC--
Confidence 666666663 333344433333 34567999999999999876643211 12 23456666665 46788888
Q ss_pred CceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 487 ~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
|++|+|+|+.||+++++++++|+|||++....
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.6e-15 Score=160.45 Aligned_cols=248 Identities=22% Similarity=0.222 Sum_probs=182.6
Q ss_pred cCccccccccc--cCcEEEEEEEc---CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCce
Q 005443 367 DGFADQNLLGE--GGFGSVYKGYL---PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~--G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 438 (696)
..|.+.+.+|. |.+|.||.+.. ++++.+|+|+-+.... .....-.+|+....+++ |.|.++.+..+++.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666788999 99999999986 4688999998554332 33334456777777775 99999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceeeccCCCCceEECCC-CcEEEEeec
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFG 513 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~----gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DfG 513 (696)
+|-+|++. .+|..+.+.... .+....++.++.++.+ ||.++|.. +|+|-|+|+.||++.++ ..++++|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 99999995 777777765433 3677788888888888 99999999 99999999999999999 899999999
Q ss_pred cchhccccCcce----eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH
Q 005443 514 LAKLALDANTHI----TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589 (696)
Q Consensus 514 ls~~~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (696)
+...+.+..... ..+..|...|+++|+++ +.++...|||+||.++.+-.++...+..+.......+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--------- 338 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--------- 338 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---------
Confidence 998876655321 12335778899999876 6788899999999999998888776554321111110
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
-...+..++...-..++..++..|++.++..|++.++++.
T Consensus 339 -----------r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 -----------RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----------ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000111222222234555888999999999988776553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.5e-13 Score=132.63 Aligned_cols=138 Identities=14% Similarity=0.148 Sum_probs=102.3
Q ss_pred cccccccCcEEEEEEEcCC-------CcEEEEEEeecCCC----------------------ccHHHH----HHHHHHHH
Q 005443 372 QNLLGEGGFGSVYKGYLPD-------GREVAIKQLKIGGG----------------------QGEREF----KAEVEIIS 418 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~----------------------~~~~~~----~~E~~il~ 418 (696)
..+||.|.-+.||.|...+ +..+|||+++.... ...+.+ ++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998643 57999999863210 001223 37999999
Q ss_pred HccC--CCceeEEeEEeeCCceeEEEEecCCCchhh-ccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceeeccC
Q 005443 419 RIHH--RHLVSLVGYCISDDRRLLIYDYVPNNTLYF-HLHGEGRPVLDWATRVKIAAGAARGLAYL-HEDCHPRIIHRDI 494 (696)
Q Consensus 419 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~~~ivHrDL 494 (696)
++.. -++.+++++ ...+|||||+.++.+.. .+.+ ..++.....+++.+++.+|..| |+. +||||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9963 566777764 56689999997764422 2221 1245566778899999999999 777 9999999
Q ss_pred CCCceEECCCCcEEEEeeccchhccc
Q 005443 495 KSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 495 kp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
+..|||+++ +.++|+|||.+.....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCCC
Confidence 999999974 5799999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-13 Score=151.16 Aligned_cols=143 Identities=18% Similarity=0.185 Sum_probs=94.5
Q ss_pred cCccccccccccCcEEEEEEEcCC-CcEEEEEEeecCCCc----------------------------------cH----
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQ----------------------------------GE---- 407 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~----------------------------------~~---- 407 (696)
..|+. +-||.|++|.||+|++++ |+.||||+++.+... ..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999877 999999999633100 00
Q ss_pred --HHHHHHHHHHHHcc----CCCceeEEeEEee-CCceeEEEEecCCCchhhc--cccCCC--CCCCHHHHHHHHHHHHH
Q 005443 408 --REFKAEVEIISRIH----HRHLVSLVGYCIS-DDRRLLIYDYVPNNTLYFH--LHGEGR--PVLDWATRVKIAAGAAR 476 (696)
Q Consensus 408 --~~~~~E~~il~~l~----hpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~~--~~l~~~~~~~i~~qia~ 476 (696)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.|.++ +...+. ..+....+..++.||
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 12455555555553 4444444444432 4567899999999999764 222211 011122222233333
Q ss_pred HHHHHHhcCCCceeeccCCCCceEECCCC----cEEEEeeccchhccc
Q 005443 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGLAKLALD 520 (696)
Q Consensus 477 gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DfGls~~~~~ 520 (696)
+.. |++|+|+|+.||+|+.++ +++++|||++.....
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 344 999999999999999888 999999999976543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-13 Score=131.70 Aligned_cols=130 Identities=17% Similarity=0.113 Sum_probs=97.9
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEEEecCCCch
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
++.|+.|.++.||+++. .|+.|+||+...... ....+.+|+++++.+.+.++ .+++++. .+..++||||++|..+
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 46789999999999997 588999998764322 23457889999999976554 4555443 3346899999999887
Q ss_pred hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 451 YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC--HPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 451 ~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
.... .....++.+|+++|+.||+.. ..+++||||++.||+++ ++.++|+|||.+.
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5430 011345789999999999872 12369999999999999 5689999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.8e-13 Score=137.87 Aligned_cols=208 Identities=20% Similarity=0.276 Sum_probs=140.1
Q ss_pred HHHHHHHHHHHccCCCceeEEeEEeeCC-----ceeEEEEecCCCchhhccccCC--CCCCCHHHHHHHHHHHHHHHHHH
Q 005443 409 EFKAEVEIISRIHHRHLVSLVGYCISDD-----RRLLIYDYVPNNTLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYL 481 (696)
Q Consensus 409 ~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~L 481 (696)
..+.-+..|-++.|.|||++..|+.+.+ ...++.|||..|+|..+|++.. ...+......+|+.||+.||.||
T Consensus 113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 3444455566778999999999887643 4578999999999999997633 23467777889999999999999
Q ss_pred HhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc--c-cCcceeeccccccccCchhhhccCCCCccccccchHHH
Q 005443 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL--D-ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVV 558 (696)
Q Consensus 482 H~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~--~-~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvl 558 (696)
|+. .+.|+|++|..+-|++..++-+||.--.-..... . ..........+-.+|.++|+-.....+.++|||+||++
T Consensus 193 hs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 193 HSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC 271 (458)
T ss_pred hcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence 994 7899999999999999999988875322111100 0 00011111235678999998666667778999999999
Q ss_pred HHHHHhCCCCCCCCC-CCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 005443 559 LLELITGRKPVDASQ-PLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQ 637 (696)
Q Consensus 559 l~eLltg~~Pf~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 637 (696)
.+||.-+..--.... ....+..+... + ..+++. .=.+++..|++-.|..||+|++
T Consensus 272 AlemailEiq~tnseS~~~~ee~ia~~--i--~~len~--------------------lqr~~i~kcl~~eP~~rp~ar~ 327 (458)
T KOG1266|consen 272 ALEMAILEIQSTNSESKVEVEENIANV--I--IGLENG--------------------LQRGSITKCLEGEPNGRPDARL 327 (458)
T ss_pred HHHHHHheeccCCCcceeehhhhhhhh--e--eeccCc--------------------cccCcCcccccCCCCCCcchhh
Confidence 999988765321111 01001100000 0 000000 1124567899999999999999
Q ss_pred HHHH
Q 005443 638 VVRV 641 (696)
Q Consensus 638 ll~~ 641 (696)
++.+
T Consensus 328 llfH 331 (458)
T KOG1266|consen 328 LLFH 331 (458)
T ss_pred hhcC
Confidence 8854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-13 Score=148.85 Aligned_cols=247 Identities=19% Similarity=0.171 Sum_probs=175.1
Q ss_pred HHhcCccccccccccCcEEEEEEEc--CCCcEEEEEEeecCCCccHH--HHHHHHHHHHHcc-CCCceeEEeEEeeCCce
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYL--PDGREVAIKQLKIGGGQGER--EFKAEVEIISRIH-HRHLVSLVGYCISDDRR 438 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~--~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 438 (696)
....+|..+..||.|.|+.||+... .++..|++|.+......... .-..|+.+...+. |.++++++..|...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3446788999999999999999874 36789999988654333222 2346777777765 89999998888888888
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC-CcEEEEeeccchh
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKL 517 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DfGls~~ 517 (696)
+|-.|||+++++...+. -...++...++++..|++.++.++|+. .++|+|+++.||++..+ +..++.|||+...
T Consensus 342 ~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 99999999998865552 223478888999999999999999998 99999999999999875 7889999999864
Q ss_pred ccccCcceeeccccccccC--chhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYM--APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
+.-. ... ....-+++ +++.+....+-.+.|+|+||+-+.|.++|..--... .+|.
T Consensus 417 ~~~~---~~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~----------- 473 (524)
T KOG0601|consen 417 LAFS---SGV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSL----------- 473 (524)
T ss_pred ccee---ccc-ccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccce-----------
Confidence 2111 111 11222344 455556677889999999999999999876532221 1111
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
.+....+..- . .....+..+.+.++..+...|+.+.++....+
T Consensus 474 ---~i~~~~~p~~-~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 ---TIRSGDTPNL-P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ---eeecccccCC-C-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111111000 0 11135677788899999999998887765543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.8e-12 Score=127.72 Aligned_cols=143 Identities=21% Similarity=0.281 Sum_probs=112.0
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCC--CceeEEeEEeeCC---ceeEEEEec
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHR--HLVSLVGYCISDD---RRLLIYDYV 445 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~~---~~~lV~E~~ 445 (696)
.+.|+.|.++.||+++..+|+.++||+...... ....++.+|+++++.+++. ++.+++.++...+ ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 366899999999999987778999999764332 1345789999999999764 4677887776543 568999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED----------------------------------------- 484 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~----------------------------------------- 484 (696)
.|.+|.+.+.. ..++...+..++.+++++|.+||+.
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988776542 2367777888888888888888842
Q ss_pred ------------CCCceeeccCCCCceEECC--CCcEEEEeeccchh
Q 005443 485 ------------CHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKL 517 (696)
Q Consensus 485 ------------~~~~ivHrDLkp~NILl~~--~~~vkL~DfGls~~ 517 (696)
....++|+|++++|||+++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.7e-12 Score=120.35 Aligned_cols=143 Identities=19% Similarity=0.240 Sum_probs=110.0
Q ss_pred ccccccccCcEEEEEEEcCCCcEEEEEEeecC--------CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIG--------GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~--------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
...+|-+|+-+.|+++.+ .|+.++||.--.+ .....++.++|+++|.++.--.|..-.-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999998 7888888754221 1123456789999999998666666555677778889999
Q ss_pred EecCC-CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC---cEEEEeeccchh
Q 005443 443 DYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EAQVSDFGLAKL 517 (696)
Q Consensus 443 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DfGls~~ 517 (696)
||++| .++.+++...............++.+|-+.|.-||.+ +||||||..+||+|..++ .+.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 3667777654433344444578899999999999999 999999999999995443 358999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.6e-12 Score=118.10 Aligned_cols=131 Identities=21% Similarity=0.328 Sum_probs=102.2
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCC--------ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.+|++|+-+.+|.+.+ .|..+++|.-..+.- -..++..+|+.+|.+++--.|..-+-|+.+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4688999999999977 455577775432211 1123567899999999866665555566677888999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
++|..|.+.+... ...++..|-..+.-||.. +|||+||..+||++.++. +.++||||+.+
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888644 256777888888999999 999999999999998774 99999999974
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.2e-11 Score=130.02 Aligned_cols=169 Identities=21% Similarity=0.280 Sum_probs=127.9
Q ss_pred CcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee----CCceeEEEEecCC-Cchhh
Q 005443 379 GFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLLIYDYVPN-NTLYF 452 (696)
Q Consensus 379 ~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~~-gsL~~ 452 (696)
.-.+.|++.. .||..|++|+++............-+++++++.|.|||.|.++|.. +..+++||+|+.+ ++|++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457888874 4899999999965544444445567889999999999999988873 3457899999876 45644
Q ss_pred cccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 453 HLHG-------------EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 453 ~l~~-------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+.-. .......+..+|.++.||..||.++|+. |+..+-|.+++||++.+.+++|...|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 3321 1123467789999999999999999999 99999999999999999999999888876554
Q ss_pred ccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCC
Q 005443 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~P 568 (696)
.+..... |. -.+.|.=.||.+++.|.+|...
T Consensus 445 ~d~~~~l------------e~------~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEPL------------ES------QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcch------------hH------HhhhhHHHHHHHHHHHhhcccc
Confidence 4331100 11 1256889999999999999664
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.1e-11 Score=115.97 Aligned_cols=126 Identities=25% Similarity=0.331 Sum_probs=84.6
Q ss_pred EEEEEEcCCCcEEEEEEeecCC-------------Cc-------------cHHHHHHHHHHHHHccCC--CceeEEeEEe
Q 005443 382 SVYKGYLPDGREVAIKQLKIGG-------------GQ-------------GEREFKAEVEIISRIHHR--HLVSLVGYCI 433 (696)
Q Consensus 382 ~Vy~~~~~~g~~vavK~l~~~~-------------~~-------------~~~~~~~E~~il~~l~hp--nIv~l~~~~~ 433 (696)
.||.|...+|..||||+.+... .. .....++|+++|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999986431 00 012467899999999855 567777553
Q ss_pred eCCceeEEEEecC--CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCceeeccCCCCceEECCCCcEEEE
Q 005443 434 SDDRRLLIYDYVP--NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY-LHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (696)
Q Consensus 434 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~-LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (696)
..+|||||+. |..+..+.... ++......++.+++..+.. ||+. |||||||...|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 4589999998 55454333211 1234556788888886666 4676 99999999999999988 99999
Q ss_pred eeccchhcc
Q 005443 511 DFGLAKLAL 519 (696)
Q Consensus 511 DfGls~~~~ 519 (696)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999986543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-10 Score=119.44 Aligned_cols=141 Identities=17% Similarity=0.097 Sum_probs=102.7
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCCc-----------cHHHHHHHHHHHHHccCC--CceeEEeEEee-----
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ-----------GEREFKAEVEIISRIHHR--HLVSLVGYCIS----- 434 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~il~~l~hp--nIv~l~~~~~~----- 434 (696)
+++-+.....|+++.+ +|+.|.||........ -...+.+|+..+.+|... .+..++++++.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777777 7889999977433211 112478999999998643 44556666543
Q ss_pred CCceeEEEEecCCC-chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-------CCc
Q 005443 435 DDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-------NFE 506 (696)
Q Consensus 435 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-------~~~ 506 (696)
....+||+|++.+. +|.+++........+...+..++.+|+..+.-||++ ||+|+||++.||||+. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999886 788777532222345677789999999999999999 9999999999999975 468
Q ss_pred EEEEeeccchh
Q 005443 507 AQVSDFGLAKL 517 (696)
Q Consensus 507 vkL~DfGls~~ 517 (696)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.6e-10 Score=117.97 Aligned_cols=260 Identities=18% Similarity=0.225 Sum_probs=159.3
Q ss_pred cccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEE------eeC-CceeEE
Q 005443 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYC------ISD-DRRLLI 441 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~------~~~-~~~~lV 441 (696)
...+-||+|+.+.+|-.. .-+..+.|+++.-.-..+. +.+..|.+. .|+-+..-+.+- -+. +...++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345679999999999653 2223455777533222221 223333333 344333211111 111 224567
Q ss_pred EEecCCCc-hhhccc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 442 YDYVPNNT-LYFHLH----GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 442 ~E~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
|..+.+.. +.+++. ++.....+|..++++++.|+.+.+-||+. |.+-||++.+||||.+++.|.|+|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77766542 233332 22334589999999999999999999999 99999999999999999999999876543
Q ss_pred hccccCcceeeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhC-CCCCCCCCCCCchh--HH-HhHHHH
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITG-RKPVDASQPLGDES--LV-EWARPL 587 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg-~~Pf~~~~~~~~~~--l~-~~~~~~ 587 (696)
.. .+......-+|...|..||... +..-+...|.|.|||+||+||.| ++||.+.....+.. +. ++..
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~-- 241 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH-- 241 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc--
Confidence 32 2223344457889999999765 34456688999999999998885 99998755433321 11 1111
Q ss_pred HHHhhhhhhhhcccCccc-----CCCcc-hHHHHHHHHHHHHHhccCC--CCCCCHHHHHHHHHhhhcc
Q 005443 588 LSHALENEEFDNLADPRL-----GENYV-EGEMFRMIEAAAACVRHSA--AKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l-----~~~~~-~~~~~~l~~li~~cl~~dP--~~RPs~~ell~~L~~l~~~ 648 (696)
..+..-.+... ..... .....++.-+..+|+...- .-||+++.++..|..+..+
T Consensus 242 -------g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 -------GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred -------ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11111111000 00111 1112245566678887654 5899999999888777643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.4e-10 Score=114.21 Aligned_cols=139 Identities=22% Similarity=0.275 Sum_probs=104.4
Q ss_pred CccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC----------------------ccHHHHHHHHHHHHHccCC--
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG----------------------QGEREFKAEVEIISRIHHR-- 423 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~il~~l~hp-- 423 (696)
-..+++.||.|.-+.||.|...+|..+|||.-+.... ......++|+++|++|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3566789999999999999999999999998753310 0112357899999999754
Q ss_pred CceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC
Q 005443 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN 503 (696)
Q Consensus 424 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~ 503 (696)
.|.+.+++ +...+||||++|.-|...- ++....-.|+..|++-+..+-.. |||||||..-||||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 66666653 5568999999987665433 13344455666666666666666 9999999999999999
Q ss_pred CCcEEEEeeccchhccc
Q 005443 504 NFEAQVSDFGLAKLALD 520 (696)
Q Consensus 504 ~~~vkL~DfGls~~~~~ 520 (696)
||.++|+||--+.....
T Consensus 238 dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 238 DGDIVVIDWPQAVPISH 254 (304)
T ss_pred CCCEEEEeCcccccCCC
Confidence 99999999988765443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=8.1e-12 Score=142.85 Aligned_cols=248 Identities=20% Similarity=0.231 Sum_probs=169.7
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
..+.|.+.+-+-+|.++.++.+.- ..|...++|+...... ...+...++-.++-..+++.+++..--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 345677778889999999998873 2455566665543221 112223333333333344555554433344567799
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|++|+.+++|...||..+. .+.+.....+..+..+++|||.. .++|+|+++.|+|+..+++.++.|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999999988763 56666677788889999999998 799999999999999999999999984321110
Q ss_pred c------------------------------CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCC
Q 005443 521 A------------------------------NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (696)
Q Consensus 521 ~------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~ 570 (696)
. ........+|+..|.+||.+.+......+|+|++|++++|.++|..+|+
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0011223578999999999999999999999999999999999999998
Q ss_pred CCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCC-CcchHHHHHHHHHHHHHhccCCCCCCCHH
Q 005443 571 ASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGE-NYVEGEMFRMIEAAAACVRHSAAKRPRMG 636 (696)
Q Consensus 571 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 636 (696)
....... ++.+.+..... ........+..+++.+.+..++.+|-.|.
T Consensus 1037 a~tpq~~-------------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI-------------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhh-------------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 6542111 11111111100 01112223567788889999999998776
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.8e-10 Score=126.62 Aligned_cols=142 Identities=19% Similarity=0.206 Sum_probs=95.2
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCC----------------------------------------ccHHHHHH
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG----------------------------------------QGEREFKA 412 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~----------------------------------------~~~~~~~~ 412 (696)
+-|+.++.|.||+|++++|+.||||+.+-+-. ..+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999999999999999863210 01112455
Q ss_pred HHHHHHHcc----CCCceeEEeEE-eeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 005443 413 EVEIISRIH----HRHLVSLVGYC-ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487 (696)
Q Consensus 413 E~~il~~l~----hpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~ 487 (696)
|+..+.+++ +..-+++=.+| +.....+|+|||++|..+.+...... ..++.+.+.+.+.++.- ..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~d--- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRD--- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhc---
Confidence 666666653 22223333333 34577899999999998877743222 22554444443333322 222223
Q ss_pred ceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 488 ~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|++|+|.++.||+|+.++++.+.|||+......
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.2e-09 Score=103.19 Aligned_cols=138 Identities=14% Similarity=0.113 Sum_probs=104.2
Q ss_pred ccccCcEEEEEEEcCCCcEEEEEEeecCC------CccHHHHHHHHHHHHHccCC--CceeEEeEEe-eC----CceeEE
Q 005443 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG------GQGEREFKAEVEIISRIHHR--HLVSLVGYCI-SD----DRRLLI 441 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~-~~----~~~~lV 441 (696)
-|+||.+.|++..+ +|+.+-||.-.... ......|.+|+..|++|..- .+.+++ ++. .. ...+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46789999999887 56678888764211 22456799999999999743 345555 332 11 235799
Q ss_pred EEecCC-CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc--EEEEeeccchh
Q 005443 442 YDYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE--AQVSDFGLAKL 517 (696)
Q Consensus 442 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DfGls~~ 517 (696)
+|.+.| .+|.+++........+...+..++.+|++.|.-||+. |+.|+|+.+.|||++.++. |+++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998865 4777777654443467788889999999999999999 9999999999999986666 99999998864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.5e-09 Score=106.52 Aligned_cols=106 Identities=26% Similarity=0.285 Sum_probs=86.0
Q ss_pred HHHHHHHHHHHHHcc--CCCceeEEeEEeeCC----ceeEEEEecCCC-chhhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 005443 407 EREFKAEVEIISRIH--HRHLVSLVGYCISDD----RRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479 (696)
Q Consensus 407 ~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~ 479 (696)
.....+|...+.+|. .-.+.+.+++.+... ..+||+|++++. +|.+++..... ++......++.+|++.+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 446888999988886 445567777766533 348999999884 78888875333 566778899999999999
Q ss_pred HHHhcCCCceeeccCCCCceEECCCC---cEEEEeeccchh
Q 005443 480 YLHEDCHPRIIHRDIKSSNILLDNNF---EAQVSDFGLAKL 517 (696)
Q Consensus 480 ~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DfGls~~ 517 (696)
-||++ ||+|+||++.||||+.++ .+.|+||+.++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999998887 899999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=6.9e-09 Score=102.93 Aligned_cols=154 Identities=18% Similarity=0.211 Sum_probs=106.4
Q ss_pred cCHHHHHHHhcCccccc---cccccCcEEEEEEEcCCCcEEEEEEeecCCCc-------------------cHH-----H
Q 005443 357 FTYEELVKATDGFADQN---LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ-------------------GER-----E 409 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~~---~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-------------------~~~-----~ 409 (696)
.+++.+....++..+.. +|+.|.-+.||+|...++..||||+++..... ..+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34556666655555444 46678888999999888999999999743211 111 1
Q ss_pred HHHHHHHHHHcc--CCCceeEEeEEeeCCceeEEEEecCCCchh-hccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005443 410 FKAEVEIISRIH--HRHLVSLVGYCISDDRRLLIYDYVPNNTLY-FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486 (696)
Q Consensus 410 ~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ 486 (696)
.++|+..|+++. +-.+.+-+++. ...|||||+....+- =.|..- .+...+...+..++++.+.-|...+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 346777777775 44555556554 348999999655221 112111 1333367788889999999998743
Q ss_pred CceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 487 ~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
++||+||..-|||+. ++.+.|||||-+.....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 999999999999999 77999999999976543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.8e-10 Score=126.08 Aligned_cols=150 Identities=23% Similarity=0.368 Sum_probs=102.8
Q ss_pred HHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc--------eeeccccccccCchhhhcc
Q 005443 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH--------ITTRVMGTFGYMAPEYASS 543 (696)
Q Consensus 472 ~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~ 543 (696)
.+++.||.|+|..- ++||++|.+++|.++.++.+||+.|+++......... ..........|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34458999999764 9999999999999999999999999998654432111 1111234568999999999
Q ss_pred CCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHH
Q 005443 544 GKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAA 622 (696)
Q Consensus 544 ~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~ 622 (696)
...+.++|+|||||++|.++. |+.-|...+......+.. ...+.- ...+......++.+-++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~----~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAG----AFGYSNNLPSELRESLK 246 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccc----cccccccCcHHHHHHHH
Confidence 888999999999999999994 555444432211111000 000000 01111233346788888
Q ss_pred HHhccCCCCCCCHHHHHH
Q 005443 623 ACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 623 ~cl~~dP~~RPs~~ell~ 640 (696)
+++..+...||++.+++.
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999998877663
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.8e-08 Score=101.65 Aligned_cols=133 Identities=18% Similarity=0.177 Sum_probs=87.8
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC--ceeEEeEEeeCCceeEEEEecCCCc-
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH--LVSLVGYCISDDRRLLIYDYVPNNT- 449 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs- 449 (696)
..||+|..+.||+. .|+.+++|+.... .....+.+|+++++.+..-+ +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 3556888987642 23456799999999997543 4778888877777889999999863
Q ss_pred hhhccccCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHhc-CCCce
Q 005443 450 LYFHLHGEGRPVLDWATRVKIAAGAARG---------------------------------------LAYLHED-CHPRI 489 (696)
Q Consensus 450 L~~~l~~~~~~~l~~~~~~~i~~qia~g---------------------------------------L~~LH~~-~~~~i 489 (696)
+...+.. .......++.++++. +.+|... ....+
T Consensus 82 ~~~~~~~------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 82 FSRIISD------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred hhhhhcC------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 2111110 001111111111111 1222211 12367
Q ss_pred eeccCCCCceEECCCCcEEEEeeccchh
Q 005443 490 IHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 490 vHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
+|+|+++.||++++++ +.|+||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999887 99999998853
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.7e-08 Score=97.92 Aligned_cols=137 Identities=16% Similarity=0.201 Sum_probs=95.5
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHH---------HHHHHHHHHccCC---CceeEEeEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREF---------KAEVEIISRIHHR---HLVSLVGYCI 433 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~il~~l~hp---nIv~l~~~~~ 433 (696)
.++|+..+++-......|.+-.. +|+.+++|..+......++.| .+++..+.+++.. .+..++.+.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 37788888888888777877777 789999999875544333332 3444555555432 2333333322
Q ss_pred e-----CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEE
Q 005443 434 S-----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (696)
Q Consensus 434 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (696)
. ....+|||||++|..|.++.. ++. .++..|.++|.-||+. |++|+|+++.|++++++ .++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEE
Confidence 2 234468999999998876543 222 2456677889999999 99999999999999966 499
Q ss_pred EEeeccchh
Q 005443 509 VSDFGLAKL 517 (696)
Q Consensus 509 L~DfGls~~ 517 (696)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999988764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.3e-08 Score=98.86 Aligned_cols=142 Identities=20% Similarity=0.218 Sum_probs=85.9
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC--CceeEEeEEeeC---CceeEEEEecC
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSLVGYCISD---DRRLLIYDYVP 446 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~---~~~~lV~E~~~ 446 (696)
++.|+.|..+.||++...+ +.++||+.... .....+.+|+.+++.|... .+.+++.++... ...+++|+|+.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999866 69999987633 3456788999999998644 356777655332 34589999999
Q ss_pred CCchhh----------------cc---ccC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005443 447 NNTLYF----------------HL---HGE--GRPVLDWAT---------RVKI------------AAGAAR-GLAYLHE 483 (696)
Q Consensus 447 ~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~qia~-gL~~LH~ 483 (696)
|..+.. .+ |.. ....+.... .... +..+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987766 00 111 000011000 0000 112222 3333332
Q ss_pred c----CCCceeeccCCCCceEEC-CCCcEEEEeeccch
Q 005443 484 D----CHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAK 516 (696)
Q Consensus 484 ~----~~~~ivHrDLkp~NILl~-~~~~vkL~DfGls~ 516 (696)
. ....++|+|+++.|||++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 234799999999999999 66677899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.9e-08 Score=90.81 Aligned_cols=129 Identities=21% Similarity=0.258 Sum_probs=92.6
Q ss_pred cccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEEEecCCC
Q 005443 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~g 448 (696)
...+.||+|.+|.||+|.+ .|..+|+|+-+.. .....++.|+++|..++.-++ .++|.|-. .++.|||++|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 3457899999999999999 6668999987643 345679999999999987665 35555433 34569999998
Q ss_pred chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCC--CceEECCCCcEEEEeeccchhc
Q 005443 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKS--SNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp--~NILl~~~~~vkL~DfGls~~~ 518 (696)
.|.+..... + .+-+..+++.-.-|... ||-|+.|.- .||++.++ .+.|+||.-+.+.
T Consensus 98 ~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIGG-----D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDR-DVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhcc-----c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCC-cEEEEEccchhhc
Confidence 886655422 1 23344555554555555 999999963 56666665 8999999998743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.9e-08 Score=108.45 Aligned_cols=144 Identities=19% Similarity=0.194 Sum_probs=93.4
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCC-------------------------------------ccHHHHHHHHH
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG-------------------------------------QGEREFKAEVE 415 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-------------------------------------~~~~~~~~E~~ 415 (696)
+-||.-..|.||+|++++|+.||||+-+..-. ..+-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56899999999999999999999998753210 01123556666
Q ss_pred HHHHc----cCCCc---eeEEeEE-eeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 005443 416 IISRI----HHRHL---VSLVGYC-ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487 (696)
Q Consensus 416 il~~l----~hpnI---v~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~ 487 (696)
...++ +|-++ |.+=.++ ......+|+||||+|..+.+.-.-. +..++...+...+.++..-+-+ ..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~qIf-----~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLEQIF-----KT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHHHHH-----hc
Confidence 55554 34451 1122222 2345789999999998875543211 1225555444444333222222 22
Q ss_pred ceeeccCCCCceEEC----CCCcEEEEeeccchhccccC
Q 005443 488 RIIHRDIKSSNILLD----NNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 488 ~ivHrDLkp~NILl~----~~~~vkL~DfGls~~~~~~~ 522 (696)
|++|+|-+|.||+|+ .++++.|.|||+........
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 899999999999998 36789999999998765543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.61 E-value=4e-07 Score=93.13 Aligned_cols=138 Identities=21% Similarity=0.175 Sum_probs=85.8
Q ss_pred ccccCc-EEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEEecCCCchhh
Q 005443 375 LGEGGF-GSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYVPNNTLYF 452 (696)
Q Consensus 375 LG~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 452 (696)
|-.|.+ ..||+... ++..++||+..... ..++.+|+++++.+. +--+.++++++..++..++||||+.|..|..
T Consensus 6 ~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 78999987 45788889875332 345778999999885 4456678887776667899999999877653
Q ss_pred cc-------------------ccCCC--CCCCH--HHHHHHHH--------------------HHHHHHHHHHhc----C
Q 005443 453 HL-------------------HGEGR--PVLDW--ATRVKIAA--------------------GAARGLAYLHED----C 485 (696)
Q Consensus 453 ~l-------------------~~~~~--~~l~~--~~~~~i~~--------------------qia~gL~~LH~~----~ 485 (696)
.. |.... ..+.. ...+.... .+...++.|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100 00000 00000000 011112222111 1
Q ss_pred CCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 486 ~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
...++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2469999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.2e-07 Score=87.22 Aligned_cols=104 Identities=18% Similarity=0.211 Sum_probs=82.7
Q ss_pred HHHHHHHHHccC-CCceeEEeEEeeCCceeEEEEecCCCchhhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 005443 411 KAEVEIISRIHH-RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488 (696)
Q Consensus 411 ~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ 488 (696)
..|..+|+.+++ .++.+++|+|. .++|.||+..+.++..... ..-....|..+.+|+.++++.+++|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468899999986 59999999994 4789999987766422100 01112689999999999999999999853336
Q ss_pred eeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 489 ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
+..+|++++|+.|++++++|++|.+.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999987544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.1e-08 Score=112.18 Aligned_cols=184 Identities=16% Similarity=0.147 Sum_probs=135.3
Q ss_pred ccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC-ceeEEeEEeeCCceeEEEEecCC
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH-LVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
+...+-+++|+++.+||.+-...+....|++... ....-++++|.+++|+| .++.++-+..++..+++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 4444568999999999988545555556666532 45566899999999999 77777777778888999999988
Q ss_pred C-chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 448 N-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 448 g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+ +..+.+... ...+...+...+++.-+++|++||+. .-+|+| ||+..+ +..|+.||+....+.... ..
T Consensus 319 ~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 319 GRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred CccccccCChh-hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 7 222222111 11244445556777788899999986 458998 887776 478999999987654432 23
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCC
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~P 568 (696)
....++..|++||++..+.++.+.|+|++|+--.+|--|..|
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 445789999999999999999999999999866666665544
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.2e-06 Score=90.17 Aligned_cols=76 Identities=13% Similarity=0.198 Sum_probs=55.4
Q ss_pred cccccccCcEEEEEEEcCCC-cEEEEEEeecC-----C--CccHHHHHHHHHHHHHcc---CCCceeEEeEEeeCCceeE
Q 005443 372 QNLLGEGGFGSVYKGYLPDG-REVAIKQLKIG-----G--GQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l 440 (696)
.+.||.|.++.||++...+| +.|+||.-... . ....+++..|.+.|+.+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35689999999999998777 58999974311 1 123456778888888864 3467788876 4466789
Q ss_pred EEEecCCCc
Q 005443 441 IYDYVPNNT 449 (696)
Q Consensus 441 V~E~~~~gs 449 (696)
||||+.+..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.54 E-value=1e-06 Score=105.74 Aligned_cols=146 Identities=15% Similarity=0.275 Sum_probs=92.6
Q ss_pred cccccccCcEEEEEEEcCCC---cEEEEEEeecCC-CccHHHHHHHHHHHHHcc-CCCc--eeEEeEEeeC---CceeEE
Q 005443 372 QNLLGEGGFGSVYKGYLPDG---REVAIKQLKIGG-GQGEREFKAEVEIISRIH-HRHL--VSLVGYCISD---DRRLLI 441 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~---~~~~lV 441 (696)
++.|+.|.++.+|+....++ ..+++|+..... ......+.+|+++|+.|. |.+| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999886554 467888764322 123457899999999996 6655 7888888664 456899
Q ss_pred EEecCCCchhhc-----------------------cccCCCC---------CCCH--HHHHHHH---------------H
Q 005443 442 YDYVPNNTLYFH-----------------------LHGEGRP---------VLDW--ATRVKIA---------------A 472 (696)
Q Consensus 442 ~E~~~~gsL~~~-----------------------l~~~~~~---------~l~~--~~~~~i~---------------~ 472 (696)
|||+.|..+.+. ||.-... ...+ .++.++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988654221 1111000 0000 1111111 1
Q ss_pred HHHHHHHHHHhcCC--------CceeeccCCCCceEECC-CCc-EEEEeeccchh
Q 005443 473 GAARGLAYLHEDCH--------PRIIHRDIKSSNILLDN-NFE-AQVSDFGLAKL 517 (696)
Q Consensus 473 qia~gL~~LH~~~~--------~~ivHrDLkp~NILl~~-~~~-vkL~DfGls~~ 517 (696)
.+.+.+++|..+.. ..+||+|+++.|||++. +.+ +-|+||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12334566644321 35999999999999974 334 57999999864
|
|
| >PHA03247 large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.7e-05 Score=91.81 Aligned_cols=10 Identities=30% Similarity=0.491 Sum_probs=4.8
Q ss_pred HHHHHHHHhc
Q 005443 617 MIEAAAACVR 626 (696)
Q Consensus 617 l~~li~~cl~ 626 (696)
|.-||..|..
T Consensus 3111 lAlLi~ACr~ 3120 (3151)
T PHA03247 3111 LAVLIEACRR 3120 (3151)
T ss_pred HHHHHHHHHH
Confidence 4444555543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.1e-06 Score=90.51 Aligned_cols=80 Identities=9% Similarity=0.117 Sum_probs=60.3
Q ss_pred CccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC---CCceeEEeEEeeC---CceeEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH---RHLVSLVGYCISD---DRRLLI 441 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~~---~~~~lV 441 (696)
.....+.||.|..+.||+....++ .+++|..+. ......+.+|++.|+.|.. -.+.+++++|..+ +..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 445567799999999999987555 577787542 1234588999999999963 3678899887643 567999
Q ss_pred EEecCCCch
Q 005443 442 YDYVPNNTL 450 (696)
Q Consensus 442 ~E~~~~gsL 450 (696)
||+++++.+
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.8e-06 Score=84.94 Aligned_cols=129 Identities=20% Similarity=0.331 Sum_probs=93.8
Q ss_pred ccccccccCcEEEEEEEcCCCcEEEEEEeecCC----------------CccHHHHHHHHHHHHHcc------CCCceeE
Q 005443 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG----------------GQGEREFKAEVEIISRIH------HRHLVSL 428 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~il~~l~------hpnIv~l 428 (696)
....||+|+.-.||.- .++...+||+++... ....++..+|+.-+..+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4567999999999973 456778899887554 123456777887777776 7899999
Q ss_pred EeEEeeCCceeEEEEecCCC------chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC
Q 005443 429 VGYCISDDRRLLIYDYVPNN------TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD 502 (696)
Q Consensus 429 ~~~~~~~~~~~lV~E~~~~g------sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~ 502 (696)
+|+.+++....+|+|.+.+. +|.+++.... ++. .+...+-+-.+||-++ +|+.+||++.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 99999999999999987542 4566664332 443 3344444556777777 899999999999994
Q ss_pred CC---C-cEEEEe
Q 005443 503 NN---F-EAQVSD 511 (696)
Q Consensus 503 ~~---~-~vkL~D 511 (696)
.+ . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 577776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=6.8e-07 Score=92.91 Aligned_cols=143 Identities=17% Similarity=0.238 Sum_probs=101.7
Q ss_pred ccccccccccCcEEEEEEEcCCCcEEEEEEeecCC------------------C---cc-----HHHHHHHHHHHHHccC
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG------------------G---QG-----EREFKAEVEIISRIHH 422 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~------------------~---~~-----~~~~~~E~~il~~l~h 422 (696)
-++..+|..|.-+.||.+.-.+|..+|||+++-.. + .. ....+.|++.|.+|+.
T Consensus 146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 45567899999999999999999999999986221 0 00 0123567778888875
Q ss_pred CCceeEEeEEeeCCceeEEEEecCCCchhh-ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYF-HLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 423 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
-.|..---+. -...+|||+|+.....-. .|. ...+....+..+..|++.-|.-|.+.| ++||.||.--|+|+
T Consensus 226 aGIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 226 AGIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred cCCCCCCcee--eecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 5543221111 134579999996433221 222 122667788889999999999999888 99999999999999
Q ss_pred CCCCcEEEEeeccchhcc
Q 005443 502 DNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~ 519 (696)
.++ .+.|+|.+-+....
T Consensus 299 hdG-~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 HDG-KLYIIDVSQSVEHD 315 (520)
T ss_pred ECC-EEEEEEccccccCC
Confidence 865 89999999886543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.47 E-value=1e-06 Score=92.86 Aligned_cols=141 Identities=18% Similarity=0.177 Sum_probs=88.1
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC--ceeEEeE------EeeCCceeEEEE
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH--LVSLVGY------CISDDRRLLIYD 443 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~------~~~~~~~~lV~E 443 (696)
++.|..|....+|+... ++..+++|+... ....++..|+++++.|.+.+ +.+++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677788889999887 445788898763 34566788999999886443 4555432 223455689999
Q ss_pred ecCCCchhh--------------ccccC----CC-----CCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 005443 444 YVPNNTLYF--------------HLHGE----GR-----PVLDWATRV----------KIAAGAARGLAYLHE----DCH 486 (696)
Q Consensus 444 ~~~~gsL~~--------------~l~~~----~~-----~~l~~~~~~----------~i~~qia~gL~~LH~----~~~ 486 (696)
|++|..+.. .+|.. .. ....|.... .....+..++.+|.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876532 01110 00 011221110 011223344455543 123
Q ss_pred CceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 487 ~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
.+++|+|+++.|||+++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999885
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.5e-06 Score=84.73 Aligned_cols=125 Identities=27% Similarity=0.450 Sum_probs=91.7
Q ss_pred cCccccccccccCc-EEEEEEEcCCCcEEEEEEeecC---CC------------------ccHHHHHHHHHHHHHcc---
Q 005443 367 DGFADQNLLGEGGF-GSVYKGYLPDGREVAIKQLKIG---GG------------------QGEREFKAEVEIISRIH--- 421 (696)
Q Consensus 367 ~~~~~~~~LG~G~~-g~Vy~~~~~~g~~vavK~l~~~---~~------------------~~~~~~~~E~~il~~l~--- 421 (696)
.+|+.++.||.|.. |.||++++ +|+.||||+++.. .. ....-|.+|.+.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67889999999999 99999999 8889999994321 00 11124788999888886
Q ss_pred CCCc--eeEEeEEeeCC------------------ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005443 422 HRHL--VSLVGYCISDD------------------RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481 (696)
Q Consensus 422 hpnI--v~l~~~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~L 481 (696)
+.++ |+.+||..-.. .+.||.||+.... ....+-+.+|.+-|..|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhHHHHHHHHHHHH
Confidence 4455 89999885431 1246777665432 11234466788888999
Q ss_pred HhcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 482 H~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
|+. ||+-+|++.+|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 998 9999999999985 4589999965
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-06 Score=88.78 Aligned_cols=73 Identities=11% Similarity=0.234 Sum_probs=47.5
Q ss_pred ccccccCcE-EEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC---CceeEEeEEeeCC---ceeEEEEec
Q 005443 373 NLLGEGGFG-SVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR---HLVSLVGYCISDD---RRLLIYDYV 445 (696)
Q Consensus 373 ~~LG~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~~---~~~lV~E~~ 445 (696)
+.|+.|+.. .||+. +..+++|+.+. .....++.+|+++|+.|... .+.++++.....+ ..++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766665 58975 34677887553 22345789999999988632 3455555443322 347899999
Q ss_pred CCCchh
Q 005443 446 PNNTLY 451 (696)
Q Consensus 446 ~~gsL~ 451 (696)
.|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.2e-06 Score=89.27 Aligned_cols=156 Identities=17% Similarity=0.185 Sum_probs=89.3
Q ss_pred cCHHHHHHHhcCccc-----cccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC--ceeEE
Q 005443 357 FTYEELVKATDGFAD-----QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH--LVSLV 429 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~ 429 (696)
++.+++......|.+ .+.|+.|....+|+....+| .+++|++. . ...+.+..|+.+++.|...+ +.+++
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 445556555555644 34566788789999987555 68899875 1 23445566777777775322 34444
Q ss_pred e------EEeeCCceeEEEEecCCCchhh--------------ccccCCC---------CCC-CHHHHHH----------
Q 005443 430 G------YCISDDRRLLIYDYVPNNTLYF--------------HLHGEGR---------PVL-DWATRVK---------- 469 (696)
Q Consensus 430 ~------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~---------~~l-~~~~~~~---------- 469 (696)
. +....+..++++||++|..+.. .+|.... ..+ .|.....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 1223456789999998874421 1111100 001 1111111
Q ss_pred --HHHH-HHHHHHHHHhc----CCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 470 --IAAG-AARGLAYLHED----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 470 --i~~q-ia~gL~~LH~~----~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
.+.+ +...++.+.+. ...++||+|+++.|||++++...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11222333211 34489999999999999977556899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.3e-06 Score=88.73 Aligned_cols=157 Identities=19% Similarity=0.224 Sum_probs=93.7
Q ss_pred cCHHHHHHHhcCccc-----cccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC--CceeEE
Q 005443 357 FTYEELVKATDGFAD-----QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSLV 429 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~ 429 (696)
...++|....++|.+ ++.|+.|....+|+....+| .+++|+.+.. ....++..|++++..|... .+.+++
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 345666666555644 45577787789999886444 6888987542 2245567788888888533 345554
Q ss_pred eEE------eeCCceeEEEEecCCCchhh--------------ccccCCC----------CCCCHHHHH-----------
Q 005443 430 GYC------ISDDRRLLIYDYVPNNTLYF--------------HLHGEGR----------PVLDWATRV----------- 468 (696)
Q Consensus 430 ~~~------~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~----------~~l~~~~~~----------- 468 (696)
... ..++..++||||++|..+.. .+|.... ....|....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 421 12345689999998865421 1121000 001111110
Q ss_pred -HHHHHHHHHHHHHHh----cCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 469 -KIAAGAARGLAYLHE----DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 469 -~i~~qia~gL~~LH~----~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
.....+.+.+++|.. ....+++|+|++..||++++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011223344555543 223589999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.5e-07 Score=93.53 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=100.1
Q ss_pred CccccccccccCcEEEEEEEcCCCcEEEEEEeecCC--------Cc----------c----HHHHHHHHHHHHHccCC--
Q 005443 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--------GQ----------G----EREFKAEVEIISRIHHR-- 423 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--------~~----------~----~~~~~~E~~il~~l~hp-- 423 (696)
-+.+++.||-|.-+.||++-..+|+..++|+-+... .+ + .-...+|+..|+.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 478889999999999999999999999999754321 00 0 11245788888888632
Q ss_pred CceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC
Q 005443 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN 503 (696)
Q Consensus 424 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~ 503 (696)
-|.+.+++ +..++|||++.|..|...-+-. +. -.|...+..-|.-|..+ |+||||+.--||+|++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~---~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DP---PTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecC-----Ch---HHHHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence 23444443 4568999999988886554322 22 34445555556677777 9999999999999999
Q ss_pred CCcEEEEeeccchhcccc
Q 005443 504 NFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 504 ~~~vkL~DfGls~~~~~~ 521 (696)
++.+++|||--.......
T Consensus 238 d~~i~vIDFPQmvS~sh~ 255 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVSTSHP 255 (465)
T ss_pred CCCEEEeechHhhccCCC
Confidence 999999999766544443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.4e-06 Score=88.10 Aligned_cols=137 Identities=12% Similarity=0.073 Sum_probs=81.1
Q ss_pred ccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEEEecCCCchhhc
Q 005443 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNNTLYFH 453 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~gsL~~~ 453 (696)
+..|-.+.+|+... +|+.+++|+..........+..+|+++++.+...++ .++++++. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55688889999884 677899997653322221246789999999875433 45554432 3789999998765321
Q ss_pred -----------------cccCC--CCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCceeeccCCCCce
Q 005443 454 -----------------LHGEG--RPVLDWATR-VKIAAG---------AARGLAYLHED-----CHPRIIHRDIKSSNI 499 (696)
Q Consensus 454 -----------------l~~~~--~~~l~~~~~-~~i~~q---------ia~gL~~LH~~-----~~~~ivHrDLkp~NI 499 (696)
+|... ...++.... .+...+ +...++.+... ....++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12111 111121111 111111 11112222111 123689999999999
Q ss_pred EECCCCcEEEEeeccchh
Q 005443 500 LLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 500 Ll~~~~~vkL~DfGls~~ 517 (696)
++++++ ++|+||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.6e-06 Score=84.05 Aligned_cols=140 Identities=19% Similarity=0.187 Sum_probs=83.7
Q ss_pred cccccccCcEEEEEEEcCC--CcEEEEEEeecCCCccHHHHHHHHHHHHHccCC-CceeEEeEEeeCCceeEEEEecCCC
Q 005443 372 QNLLGEGGFGSVYKGYLPD--GREVAIKQLKIGGGQGEREFKAEVEIISRIHHR-HLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
++.|..|-...+|+....+ ++.|++|+....... ..+..+|+.+++.+... ...++++.+. ..+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567888899999998754 678999987643221 22345789999988533 3455554432 24899999887
Q ss_pred chhhc-----------------cccCCCC---------CCC-HHHHHHHHH----------------------HHHHHHH
Q 005443 449 TLYFH-----------------LHGEGRP---------VLD-WATRVKIAA----------------------GAARGLA 479 (696)
Q Consensus 449 sL~~~-----------------l~~~~~~---------~l~-~~~~~~i~~----------------------qia~gL~ 479 (696)
.+... +|..... ... +..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65211 1111110 111 111111111 1111122
Q ss_pred HHHhc-----CCCceeeccCCCCceEECC-CCcEEEEeeccch
Q 005443 480 YLHED-----CHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAK 516 (696)
Q Consensus 480 ~LH~~-----~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls~ 516 (696)
.|-+. ....++|+||++.|||+++ ++.+.|+||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22111 1247999999999999997 5789999999885
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.1e-06 Score=100.61 Aligned_cols=198 Identities=20% Similarity=0.212 Sum_probs=137.8
Q ss_pred HHHHHHHHHHHccCCCceeEEeEEeeCCce----eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 005443 409 EFKAEVEIISRIHHRHLVSLVGYCISDDRR----LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484 (696)
Q Consensus 409 ~~~~E~~il~~l~hpnIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~ 484 (696)
..+.|++.+.++.|.|++.+++|..+.... .+.-|++...++...+..-+. +.....+.+..++++||.|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHh
Confidence 345677888889999999999987765433 244577888788777765544 77888889999999999999998
Q ss_pred CCCceeeccCCCC---ceEECCCCcEEEE--eeccchhccccCcceeeccccccccCchhhhccCCCCcc--ccccchHH
Q 005443 485 CHPRIIHRDIKSS---NILLDNNFEAQVS--DFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK--SDVFSFGV 557 (696)
Q Consensus 485 ~~~~ivHrDLkp~---NILl~~~~~vkL~--DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~--sDVwSlGv 557 (696)
...|.-|..+ +..++.++.+.+. ||+..+...+...... ......|.+.|.+....++.+ .|+|.+|.
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence 6666666555 5555667777777 9988877655443322 234556788888777666654 79999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 005443 558 VLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQ 637 (696)
Q Consensus 558 ll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 637 (696)
++..+..|...-... .. ...+++ ..... .+.+....|+..+.++|..+.+
T Consensus 381 l~~~~~~~~~i~~~~---------~~-------------~~~~l~----~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS---------AV-------------PVSLLD----VLSTS----ELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHhhhhhcCcccccc---------cc-------------hhhhhc----cccch----hhhhhhhhhcchhhhhccchhh
Confidence 999998875532110 00 000111 00000 3566777999999999999999
Q ss_pred HHHHHH
Q 005443 638 VVRVFD 643 (696)
Q Consensus 638 ll~~L~ 643 (696)
++....
T Consensus 431 ll~~~f 436 (1351)
T KOG1035|consen 431 LLTHPF 436 (1351)
T ss_pred hhhchh
Confidence 997643
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2e-05 Score=82.14 Aligned_cols=117 Identities=19% Similarity=0.256 Sum_probs=75.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccCchhhh
Q 005443 462 LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541 (696)
Q Consensus 462 l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l 541 (696)
..+++++.|+++.+..|+-|..++ .+-||||...||||+ +|+|-|+||-++|.....+.....+ .--|..+
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~~isy~r------ldhp~lF 388 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQGIISYNR------LDHPDLF 388 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecccCCceeeccc------cCchhhh
Confidence 578999999999999999998876 899999999999999 8999999999999544333222211 1222233
Q ss_pred ccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 542 ~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
. +.-+.+-|||-+ |-.|+.|+.- ...-...+-|+..+....+..++
T Consensus 389 ~-G~dd~QFeIYrl---Mr~l~~g~wa-----~F~P~TNvlWL~yLs~~llkk~~ 434 (488)
T COG5072 389 N-GVDDYQFEIYRL---MRRLLKGRWA-----QFEPITNVLWLYYLSHQLLKKKN 434 (488)
T ss_pred c-CccceeeeHHHH---HHHHhcCcHH-----hcccchhhHHHHHHHHHHHhhcc
Confidence 3 222444455543 3333333321 11223456677777776665544
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.7e-05 Score=83.84 Aligned_cols=140 Identities=26% Similarity=0.336 Sum_probs=85.9
Q ss_pred cccccccCcEEEEEEEcCC-------CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEEE
Q 005443 372 QNLLGEGGFGSVYKGYLPD-------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E 443 (696)
++.|..|-...||+....+ ++.|++|+..... ....+..+|++++..+...++ .++++++. ..+|+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence 3456677788999998755 5789999976432 223456789999998864333 45665553 246899
Q ss_pred ecCCCchhhc-----------------cccCCCC-------CCC--HHHHHH--------------------------HH
Q 005443 444 YVPNNTLYFH-----------------LHGEGRP-------VLD--WATRVK--------------------------IA 471 (696)
Q Consensus 444 ~~~~gsL~~~-----------------l~~~~~~-------~l~--~~~~~~--------------------------i~ 471 (696)
|++|..+... +|..... ... +..+.+ +.
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9988765321 1111110 000 111100 11
Q ss_pred HHHHHHHHHHHh------cCCCceeeccCCCCceEECCC----CcEEEEeeccch
Q 005443 472 AGAARGLAYLHE------DCHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAK 516 (696)
Q Consensus 472 ~qia~gL~~LH~------~~~~~ivHrDLkp~NILl~~~----~~vkL~DfGls~ 516 (696)
.++...+++|.. .....++|+||.+.|||++++ +.++|+||+.+.
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 222233444432 134579999999999999874 789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.1e-05 Score=80.66 Aligned_cols=70 Identities=13% Similarity=0.038 Sum_probs=42.2
Q ss_pred ccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC-C--ceeEEeEEeeCCceeEEEEecCCCch
Q 005443 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR-H--LVSLVGYCISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 375 LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp-n--Iv~l~~~~~~~~~~~lV~E~~~~gsL 450 (696)
+++|....||.....+|+.+++|+-+. ......+++|+++|+.|... . +.+++.. +..+++|+++.|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~----~~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRVH----TPELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceeee----cCceEEEeccCCCcc
Confidence 455555667766555788999998752 22345689999999998631 1 1222211 123556766666544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.3e-05 Score=80.26 Aligned_cols=141 Identities=18% Similarity=0.235 Sum_probs=90.1
Q ss_pred ccccccccccCcEEEEEEEcCCCcEEEEEEee--cCCCccHHHHHHHHHHHHHccC--CCceeEEeEEeeCC--ceeEEE
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLK--IGGGQGEREFKAEVEIISRIHH--RHLVSLVGYCISDD--RRLLIY 442 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~--~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~--~~~lV~ 442 (696)
..+++.+..|.-..+|.... .++.++|. .. .......+...+|+++|+.+.- --+.+.+++|.++. ..+.||
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34445554454455555554 37888888 32 2223445678889999998863 33456677777766 569999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHH-HHHHHHHHHHHhc-------------------------------------
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIA-AGAARGLAYLHED------------------------------------- 484 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~-~qia~gL~~LH~~------------------------------------- 484 (696)
+|++|..+...+..... . .+++ ..+++.|.-||+.
T Consensus 105 ~~veGe~~~~~~~~~~~---~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 105 EWVEGEVVWSALPPESL---G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEecceeccCcCCcccc---h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 99998655444332211 0 1111 2444444444432
Q ss_pred ------------------CCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 485 ------------------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 485 ------------------~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
....+||||++..||+|++++.+-|+||+++...
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1357999999999999999888999999999653
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00033 Score=74.66 Aligned_cols=73 Identities=15% Similarity=0.258 Sum_probs=49.1
Q ss_pred cccccCcEEEEEEEcCCC-cEEEEEEee----c-CC--CccHHHHHHHHHHHHHcc--CC-CceeEEeEEeeCCceeEEE
Q 005443 374 LLGEGGFGSVYKGYLPDG-REVAIKQLK----I-GG--GQGEREFKAEVEIISRIH--HR-HLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 374 ~LG~G~~g~Vy~~~~~~g-~~vavK~l~----~-~~--~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV~ 442 (696)
.||.|....||++...+| +.|+||.-. . .. .....+...|.+.|+.+. -+ .+.++|. .+.+..++||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999997654 689999753 1 11 223345567778887664 23 4556653 4456667999
Q ss_pred EecCCC
Q 005443 443 DYVPNN 448 (696)
Q Consensus 443 E~~~~g 448 (696)
|++...
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00029 Score=76.40 Aligned_cols=73 Identities=16% Similarity=0.135 Sum_probs=51.3
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecC----CC---ccHHHHHHHHHHHHHcc---CCCceeEEeEEeeCCceeEE
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIG----GG---QGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~----~~---~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV 441 (696)
.+.||.|....||+... .++.|+||.-... .. ....+...|++.|+.+. .-++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46789999999999987 4567999976411 11 12334445667776654 357888998876 556889
Q ss_pred EEecCC
Q 005443 442 YDYVPN 447 (696)
Q Consensus 442 ~E~~~~ 447 (696)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.90 E-value=6.9e-05 Score=78.24 Aligned_cols=76 Identities=16% Similarity=0.283 Sum_probs=50.6
Q ss_pred ccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc---CCCceeEEeEEeeCCceeEEEEec
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.+..+.|+.|....+|+... +++.+.||+-. ......|..|++-|+.|. --.+.+++++...++..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~~-~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT-DGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEET-TS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEEC-CCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 45556789999999999884 88899999876 233456888999888884 456788999888888889999999
Q ss_pred CCC
Q 005443 446 PNN 448 (696)
Q Consensus 446 ~~g 448 (696)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00077 Score=72.75 Aligned_cols=75 Identities=11% Similarity=0.178 Sum_probs=51.1
Q ss_pred cccccccCcEEEEEEEcCC-CcEEEEEEee----cCC--CccHHHHHHHHHHHHHcc--CC-CceeEEeEEeeCCceeEE
Q 005443 372 QNLLGEGGFGSVYKGYLPD-GREVAIKQLK----IGG--GQGEREFKAEVEIISRIH--HR-HLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~----~~~--~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV 441 (696)
.+.||.|....||++.+.+ ++.|+||.-. ... ....++...|.+.|+.+. -+ ++.++|. .+.+..++|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 4578999999999999743 6789999653 111 123456677888888764 23 5666764 345667889
Q ss_pred EEecCCC
Q 005443 442 YDYVPNN 448 (696)
Q Consensus 442 ~E~~~~g 448 (696)
||++...
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00017 Score=77.68 Aligned_cols=139 Identities=18% Similarity=0.226 Sum_probs=82.3
Q ss_pred ccccccCcEEEEEEEcCC-----CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEEEecC
Q 005443 373 NLLGEGGFGSVYKGYLPD-----GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 446 (696)
+.|-.|-...+|++...+ ++.|++|+....... .-+..+|+.+++.+...++ .++++++.. + .|+||+.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345557888999987532 368999987644322 2234779999999875554 466665532 2 5899998
Q ss_pred CCchhhc-----------------cccCC---CC-CCCHHHHHHHHHH-----------------HHHHHHHHHh-----
Q 005443 447 NNTLYFH-----------------LHGEG---RP-VLDWATRVKIAAG-----------------AARGLAYLHE----- 483 (696)
Q Consensus 447 ~gsL~~~-----------------l~~~~---~~-~l~~~~~~~i~~q-----------------ia~gL~~LH~----- 483 (696)
+..|... +|... .. ..-+..+.+++.+ +...+..|.+
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665311 12211 00 1112222222211 1112222221
Q ss_pred cCCCceeeccCCCCceEECC-CCcEEEEeeccch
Q 005443 484 DCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAK 516 (696)
Q Consensus 484 ~~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls~ 516 (696)
.....++|+||+..|||+++ ++.++|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12337899999999999976 4689999999885
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00023 Score=75.55 Aligned_cols=140 Identities=23% Similarity=0.311 Sum_probs=86.1
Q ss_pred cccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCcee------EEeE--EeeCC--ceeEEEE
Q 005443 374 LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS------LVGY--CISDD--RRLLIYD 443 (696)
Q Consensus 374 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~------l~~~--~~~~~--~~~lV~E 443 (696)
.|.+ .-..||+...++|+. ++|+.+.. ....++..|+.+|+.|.-.+|.- +=|- ....+ ..+.|++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556789998877776 99988754 55677888999999885333321 1111 01123 5678999
Q ss_pred ecCCCchhh-cc--------------cc----------CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhc-
Q 005443 444 YVPNNTLYF-HL--------------HG----------EGRPVLDWAT-------------RVKIAAGAARGLAYLHED- 484 (696)
Q Consensus 444 ~~~~gsL~~-~l--------------~~----------~~~~~l~~~~-------------~~~i~~qia~gL~~LH~~- 484 (696)
|+.|..+.. .. |. .......|.. ......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 998887762 11 10 0011123320 012344455555555543
Q ss_pred ---CCCc---eeeccCCCCceEECCCCc-EEEEeeccchh
Q 005443 485 ---CHPR---IIHRDIKSSNILLDNNFE-AQVSDFGLAKL 517 (696)
Q Consensus 485 ---~~~~---ivHrDLkp~NILl~~~~~-vkL~DfGls~~ 517 (696)
.... |||+|+.+.|||++++.. +.++|||.+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1223 999999999999999875 89999998853
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00067 Score=72.53 Aligned_cols=160 Identities=18% Similarity=0.189 Sum_probs=90.1
Q ss_pred cccCHHHHHHHhcCcccc---c-cccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC--CceeE
Q 005443 355 SMFTYEELVKATDGFADQ---N-LLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSL 428 (696)
Q Consensus 355 ~~~~~~~l~~~~~~~~~~---~-~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp--nIv~l 428 (696)
+.++-+.+..+.+.+.+. + .+-.+.-..||+...++|+.+++|+.+.. .....++..|++++..|... .++..
T Consensus 9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p 87 (325)
T PRK11768 9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAP 87 (325)
T ss_pred CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 346666777666555331 1 12234556899999878889999988632 23566788899988887532 22332
Q ss_pred E---e--EEeeCCceeEEEEecCCCchhh--------------cccc--C-----CCCCCCHHHH---------------
Q 005443 429 V---G--YCISDDRRLLIYDYVPNNTLYF--------------HLHG--E-----GRPVLDWATR--------------- 467 (696)
Q Consensus 429 ~---~--~~~~~~~~~lV~E~~~~gsL~~--------------~l~~--~-----~~~~l~~~~~--------------- 467 (696)
+ | +...++..+.|++++.|..+.. .||. . .+..++....
T Consensus 88 ~~~~G~~~~~~~g~~~~l~~~~~G~~~~~~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~ 167 (325)
T PRK11768 88 LAFNGQTLHEHQGFRFALFPRRGGRAPELDNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIP 167 (325)
T ss_pred ccCCCCEEEEECCEEEEEEeeeCCCCCCCCCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCC
Confidence 2 1 2223456678999998764311 1122 1 0111221110
Q ss_pred -------HHHHHHHHHHHHH-HHh-cCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 468 -------VKIAAGAARGLAY-LHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 468 -------~~i~~qia~gL~~-LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+++.++...++- +.. ....++||+|+..+|||++ + .+.|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 168 SDLRPAYLAAADQLLAAVEACWARGDVRLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhcCCCCccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 0112222111111 111 1234789999999999995 4 578999998853
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00026 Score=75.14 Aligned_cols=64 Identities=8% Similarity=0.171 Sum_probs=41.2
Q ss_pred EEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC--CceeEEeE------EeeCCceeEEEEecCCCch
Q 005443 382 SVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSLVGY------CISDDRRLLIYDYVPNNTL 450 (696)
Q Consensus 382 ~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~------~~~~~~~~lV~E~~~~gsL 450 (696)
.||+....+| .+++|++.. ....+..|+.++..|... .|.+++.. ...++..++|+||+.|..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4899886455 688898752 234566678888777533 34444432 2234567899999988554
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=2.8e-05 Score=93.08 Aligned_cols=157 Identities=13% Similarity=0.050 Sum_probs=110.7
Q ss_pred HHHHHHHHccCCCceeEEeEEe--eCCceeEEEEecCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhc--C
Q 005443 412 AEVEIISRIHHRHLVSLVGYCI--SDDRRLLIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHED--C 485 (696)
Q Consensus 412 ~E~~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~--~ 485 (696)
.|...++...|.++.+.+.-.. +....+.+++|+.+|.++..+.+. +...++...+.....+......-+|.. .
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444455567888777655433 234568999999999998877543 222344444444444435555555543 1
Q ss_pred CCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhC
Q 005443 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565 (696)
Q Consensus 486 ~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg 565 (696)
..-.+|++||.-|.+|..+.++|+.++|+.+.. .......+..+++..|+.+++...-.++.++|+|..|+.+|++..|
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 224689999999999999999999999999832 2233344556778889999998888899999999999999998877
Q ss_pred CCCC
Q 005443 566 RKPV 569 (696)
Q Consensus 566 ~~Pf 569 (696)
...|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 5544
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00052 Score=68.50 Aligned_cols=121 Identities=16% Similarity=0.172 Sum_probs=60.9
Q ss_pred CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEEEecCCCchhh-ccc-------------
Q 005443 391 GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNNTLYF-HLH------------- 455 (696)
Q Consensus 391 g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~------------- 455 (696)
++.|+||+..... ...-...+|+.+++.+..-++ .++++++.. .+|+||+.+..|.. .+.
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888886542 334567789999998874444 566665532 36779997766522 111
Q ss_pred ---cC-----CCCCCCHHHHHHH----------------------HHHHHHHHHHHHhc-----CCCceeeccCCCCceE
Q 005443 456 ---GE-----GRPVLDWATRVKI----------------------AAGAARGLAYLHED-----CHPRIIHRDIKSSNIL 500 (696)
Q Consensus 456 ---~~-----~~~~l~~~~~~~i----------------------~~qia~gL~~LH~~-----~~~~ivHrDLkp~NIL 500 (696)
.. .....-+..+.++ +..+..-+..+.+. ....++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 00 0000001111111 11122222222210 0126899999999999
Q ss_pred E-CCCCcEEEEeeccch
Q 005443 501 L-DNNFEAQVSDFGLAK 516 (696)
Q Consensus 501 l-~~~~~vkL~DfGls~ 516 (696)
+ +.++.++|+||..+.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888899999999985
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00079 Score=72.14 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=80.5
Q ss_pred ccccccCcEEEEEEEcCC----CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~ 447 (696)
+.|..|-...+|+....+ +..|+||+...... ..-+..+|+.+++.+..-+| .++++++. +. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence 345557788899987533 34899998754332 22334679999999976555 46666652 22 58999977
Q ss_pred Cchhh-----------------ccccCC---CCCC-CHHHHHHHHHH----------------------HHHHHHHHHhc
Q 005443 448 NTLYF-----------------HLHGEG---RPVL-DWATRVKIAAG----------------------AARGLAYLHED 484 (696)
Q Consensus 448 gsL~~-----------------~l~~~~---~~~l-~~~~~~~i~~q----------------------ia~gL~~LH~~ 484 (696)
..|.. .+|... .... -+..+.++..+ +.+-+..+.+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 112211 0001 12222222111 11222222211
Q ss_pred -----CCCceeeccCCCCceEECC-CCcEEEEeeccch
Q 005443 485 -----CHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAK 516 (696)
Q Consensus 485 -----~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls~ 516 (696)
...-++|+||.+.|||+++ ++.++|+||+.+.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1124899999999999974 5789999999885
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00099 Score=70.73 Aligned_cols=31 Identities=19% Similarity=0.310 Sum_probs=28.4
Q ss_pred CceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 487 ~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+++|+|+..+|||+++++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.004 Score=76.39 Aligned_cols=142 Identities=18% Similarity=0.229 Sum_probs=81.1
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC--CC--ceeEEe--------EEee-CC--c
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH--RH--LVSLVG--------YCIS-DD--R 437 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h--pn--Iv~l~~--------~~~~-~~--~ 437 (696)
+.|+ |.+-.+|+....+|+.+++|+++.. .....+..|.++|..|.. +. +.+++- .+.. ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~--~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPS--EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCc--cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 4567889998878889999998754 233455556667766632 22 233321 1111 22 3
Q ss_pred eeEEEEecCCCchhhcc-----------------c--------cCCCCCCCHHH-----------------HHHHHHHHH
Q 005443 438 RLLIYDYVPNNTLYFHL-----------------H--------GEGRPVLDWAT-----------------RVKIAAGAA 475 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l-----------------~--------~~~~~~l~~~~-----------------~~~i~~qia 475 (696)
.+.+|+|+.|..|.+.. | ......+.|.. .+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999987664411 0 00011122211 122233333
Q ss_pred HHHHH-H---HhcCCCceeeccCCCCceEECCCC--cEE-EEeeccchh
Q 005443 476 RGLAY-L---HEDCHPRIIHRDIKSSNILLDNNF--EAQ-VSDFGLAKL 517 (696)
Q Consensus 476 ~gL~~-L---H~~~~~~ivHrDLkp~NILl~~~~--~vk-L~DfGls~~ 517 (696)
+.++- + ...+..++||+|++..|||++.++ ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 33221 1 112344899999999999998775 565 999998854
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00085 Score=71.31 Aligned_cols=59 Identities=17% Similarity=0.176 Sum_probs=41.9
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
.+|+-+|..|..+..++...++ .++...+++.-..+||.-|--.. +++|.||+++||++
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~---pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVli 378 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQ---PEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLI 378 (565)
T ss_pred ceeeeeccccccHHhhhhcccC---hHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEE
Confidence 3566678888888777765543 44556666666666666554332 89999999999999
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0026 Score=62.86 Aligned_cols=77 Identities=14% Similarity=0.222 Sum_probs=56.2
Q ss_pred ccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc---CCCceeEEeEEeeCCceeEEEEecCC
Q 005443 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
..+.|.-|..-..|+..+ ....|.||+=. ......|..|+.-|+.|. --+|.+++.+-.+.++.|+||||+..
T Consensus 20 er~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 20 EREEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred cccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 345566677777777765 66788888643 334467888888777775 45677888888888999999999987
Q ss_pred Cchh
Q 005443 448 NTLY 451 (696)
Q Consensus 448 gsL~ 451 (696)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 6553
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0012 Score=64.80 Aligned_cols=151 Identities=15% Similarity=0.173 Sum_probs=88.7
Q ss_pred cCcEEEEEEEcCCCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCCCchhhcccc
Q 005443 378 GGFGSVYKGYLPDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456 (696)
Q Consensus 378 G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 456 (696)
|+.++.-+++.+-|. ..+|+++... ......|.++..++++++ .|++|..- ......+++|+|.....
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 344555555543443 3445544322 224566788999999876 46777621 33345688999854321
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccC
Q 005443 457 EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536 (696)
Q Consensus 457 ~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~ 536 (696)
... .++.-=+..|.-+|+. +.+.+|||..++|||-|..|.+||.|=+.-..- +..|.
T Consensus 142 --------~~~-N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~-------------~V~~v 198 (308)
T PF07387_consen 142 --------NFS-NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN-------------QVNMV 198 (308)
T ss_pred --------chh-HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh-------------eeeEE
Confidence 111 1111224667778854 348999999999999999999999998765311 01111
Q ss_pred chhhhccCCCCccccccchHHHHHHHHhC
Q 005443 537 APEYASSGKLTEKSDVFSFGVVLLELITG 565 (696)
Q Consensus 537 aPE~l~~~~~s~~sDVwSlGvll~eLltg 565 (696)
- +.....+.++.+-+|=.-++++...
T Consensus 199 N---~~Y~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 199 N---IEYESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred e---eeccccChHHHHHHHHHHHHHHHHH
Confidence 1 0112345566666666666666653
|
The function of this family is unknown. |
| >KOG3021 consensus Predicted kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0018 Score=63.00 Aligned_cols=216 Identities=20% Similarity=0.180 Sum_probs=0.0
Q ss_pred HHHHHHHhcCccccccccccCcEEEEEEE--cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeE---EeEEe
Q 005443 359 YEELVKATDGFADQNLLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL---VGYCI 433 (696)
Q Consensus 359 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l---~~~~~ 433 (696)
++++..+.-+...++.+|.-+-|.+-.++ ..|...|.||+-+. ...+.|+-|+.-|..+..-+.|++ +++..
T Consensus 1 mee~l~ael~~~~vr~~gs~gggcI~~~r~ydtDaG~~FvK~nr~---~~~~mfeGE~~sLeAi~sT~tv~vprpikvid 77 (313)
T KOG3021|consen 1 MEELLRAELGLNNVRALGSVGGGCISDGRHYDTDAGKVFVKVNRS---IARDMFEGELASLEAIQSTETVLVPRPIKVID 77 (313)
T ss_pred ChHHHHHhcCcceeeeecCCCCceeccccccccCCccEEEEeccc---cchHHHhhHHHHHHHHHhcCceecCCceeeEe
Q ss_pred e-CCceeEEEEecCCCchhhccccCCCCC---------------------------------------------------
Q 005443 434 S-DDRRLLIYDYVPNNTLYFHLHGEGRPV--------------------------------------------------- 461 (696)
Q Consensus 434 ~-~~~~~lV~E~~~~gsL~~~l~~~~~~~--------------------------------------------------- 461 (696)
. .+..+|||||++.+.|......-+.+.
T Consensus 78 ~p~Ggs~lime~idf~~lr~~~a~lG~qlAdmHl~n~kl~e~r~~~~~tv~rgge~~e~~~v~~FGF~v~tccG~lpQvN 157 (313)
T KOG3021|consen 78 LPGGGSSLIMEHIDFQGLRSDAAKLGSQLADMHLKNEKLAEARRTEAGTVGRGGEEGEQIGVENFGFHVVTCCGRLPQVN 157 (313)
T ss_pred cCCCceeeeeehhhcccchhHHHHHHHHHHHHhhhhHHHHHHHHHhccccccCcccccccchhccceeeeeecccCcccc
Q ss_pred -------------------------CCHHHHHHHHHHHHHHHHHHHhcC--CCceeeccCCCCceEECCCCcEEEEe---
Q 005443 462 -------------------------LDWATRVKIAAGAARGLAYLHEDC--HPRIIHRDIKSSNILLDNNFEAQVSD--- 511 (696)
Q Consensus 462 -------------------------l~~~~~~~i~~qia~gL~~LH~~~--~~~ivHrDLkp~NILl~~~~~vkL~D--- 511 (696)
....++.++..-+..-+.-|-... .+.++|+||...||--|+.+...|.|
T Consensus 158 dW~edW~eFf~rhRlq~Qldl~~~~~~Dre~~el~~~L~~kia~Lf~~~eI~PaLlHGDLW~GNva~D~~~ePiIfDPas 237 (313)
T KOG3021|consen 158 DWQEDWEEFFARHRLQPQLDLLEKTYGDREAFELWSILQTKIADLFKCLEILPALLHGDLWSGNVAEDGAGEPIIFDPAS 237 (313)
T ss_pred cchhhHHHHHHHHhhhHHHHHHHHhhccHHHHHHHHHHHHhhHHHhccceeehhhhccccccCcccccCCCCceEeCchh
Q ss_pred --------eccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHh
Q 005443 512 --------FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583 (696)
Q Consensus 512 --------fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~ 583 (696)
||++..+..-........ ...-.+++-|---++||+|+.--.-|+..........++.
T Consensus 238 fYgh~Efefgia~mfGgf~~sF~naY--------------~k~ipka~G~eqR~~LYqLyhyLNHwNhFGs~YRs~sl~i 303 (313)
T KOG3021|consen 238 FYGHSEFEFGIAKMFGGFTQSFYNAY--------------HKKIPKAPGFEQRLLLYQLYHYLNHWNHFGSGYRSSSLDI 303 (313)
T ss_pred hcCCcHHHHHHHHHhCCCcHHHHHHH--------------hhhcCCCCcHHHHHHHHHHHHHhhhhhhhccccccchhHH
Q ss_pred HHHHHHHh
Q 005443 584 ARPLLSHA 591 (696)
Q Consensus 584 ~~~~~~~~ 591 (696)
++.++..+
T Consensus 304 ~~n~lk~~ 311 (313)
T KOG3021|consen 304 MRNLLKNC 311 (313)
T ss_pred HHHHHHHh
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 696 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-69 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-68 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-45 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-45 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-44 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-42 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-26 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-25 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 696 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 0.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 0.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-100 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-71 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-65 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-64 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-64 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-63 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 9e-63 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-61 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-60 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-60 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-59 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-59 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-58 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-57 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-56 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-44 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-43 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-43 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 9e-43 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-42 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 9e-42 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-41 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-41 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-41 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-41 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-41 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-40 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-40 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-40 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-40 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-40 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-40 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-40 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-40 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-40 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-40 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-40 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-40 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 6e-40 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-40 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-39 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-39 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-39 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-39 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-39 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 7e-39 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-38 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-38 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-38 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-38 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-38 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-38 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-38 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-38 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-37 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-37 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-37 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-37 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-37 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-37 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-37 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-37 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-36 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-36 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-36 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-36 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-36 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-36 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 9e-36 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-35 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-35 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-35 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-05 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-05 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-05 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-04 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-04 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-35 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 9e-35 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-34 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-34 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 7e-34 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-33 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-33 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-33 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-33 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-33 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-33 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-33 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-33 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 6e-33 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 7e-33 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-33 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-32 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-32 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-32 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-32 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 8e-32 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-31 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-31 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-31 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-30 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-30 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-30 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-30 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 8e-30 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-29 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-06 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-04 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-29 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-29 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-29 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-29 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-29 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-29 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 9e-29 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-28 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-28 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-28 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 8e-28 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-28 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-27 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-27 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-27 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-27 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-27 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-26 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-26 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-25 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-24 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 4e-22 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 2e-21 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 4e-21 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 2e-07 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-25 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-25 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-25 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 5e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-25 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-24 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-24 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 1e-24 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 4e-23 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 8e-23 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 3e-19 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 6e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-24 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-08 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-24 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-23 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-23 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-23 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-23 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-23 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-23 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 6e-23 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 7e-23 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-22 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-22 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-22 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-22 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-22 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-22 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-22 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 9e-22 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-21 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-21 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-21 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-21 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-21 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-21 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-21 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-21 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-21 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-21 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-21 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 8e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 9e-21 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-20 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-20 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-20 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-20 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-20 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-20 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-20 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-20 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 8e-20 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-19 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-18 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-18 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 5e-18 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-17 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-15 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 5e-06 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-19 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-19 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-19 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-19 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-19 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-19 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-19 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 6e-19 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 7e-19 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-19 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-18 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-18 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-18 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-18 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-18 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 6e-17 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 7e-17 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-16 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-16 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 4e-16 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 1e-14 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 4e-14 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 5e-13 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 2e-12 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 3e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-14 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-14 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-13 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-13 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-12 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-12 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 4e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 7e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 9e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-10 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 6e-10 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 4e-08 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 8e-08 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 6e-06 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 8e-05 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-14 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-14 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-14 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-14 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 6e-14 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 7e-14 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 7e-14 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 2e-12 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 4e-12 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 2e-11 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 3e-10 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 5e-10 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 5e-08 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 2e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-13 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-13 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-12 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-12 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 6e-12 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 9e-12 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-11 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-11 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 4e-11 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-10 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-10 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-09 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-09 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 4e-09 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-08 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-07 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 7e-05 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-13 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-13 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-12 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-12 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-12 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-12 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-11 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-11 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 2e-11 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 5e-11 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 6e-11 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 2e-09 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 3e-09 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 8e-09 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 1e-08 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 2e-07 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 9e-04 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-11 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 1e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 1e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 2e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 6e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 6e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 7e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 7e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 2e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 4e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 7e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-06 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 4e-04 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-10 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 3e-10 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 5e-10 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 7e-10 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 2e-09 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 1e-08 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 5e-08 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 4e-06 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 3e-10 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 2e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 2e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 4e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 5e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 2e-07 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 6e-07 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 7e-07 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 1e-06 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 6e-06 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 8e-06 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 3e-05 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-10 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 9e-10 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-09 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 5e-09 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 2e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 3e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 4e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 4e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 6e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 4e-07 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-06 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 2e-06 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 2e-06 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 8e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-04 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 2e-09 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 3e-09 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 2e-06 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 2e-06 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 1e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 8e-09 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-07 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-08 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-08 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-07 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 3e-07 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-06 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-06 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 4e-06 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 7e-05 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 8e-05 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-04 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 7e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-08 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 5e-08 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 4e-07 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 3e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 4e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 4e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 7e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-05 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 6e-08 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 1e-07 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 4e-07 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 3e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 3e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 3e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 5e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 5e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 8e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 8e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 9e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 1e-05 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-05 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 8e-05 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-04 | |
| 1w7p_D | 566 | VPS36P, YLR417W; ESCRT-II complex, endosomal prote | 8e-08 | |
| 1w7p_D | 566 | VPS36P, YLR417W; ESCRT-II complex, endosomal prote | 8e-06 | |
| 1ej6_B | 1275 | Lambda1; icosahedral, non-equivalence, dsRNA virus | 2e-07 | |
| 1ej6_B | 1275 | Lambda1; icosahedral, non-equivalence, dsRNA virus | 3e-06 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 3e-06 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 6e-06 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 1e-05 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 6e-05 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 1e-04 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 2e-04 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 5e-04 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 6e-04 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 7e-04 | |
| 2kr0_A | 411 | Proteasomal ubiquitin receptor ADRM1; proteasome, | 8e-06 | |
| 2kr0_A | 411 | Proteasomal ubiquitin receptor ADRM1; proteasome, | 5e-04 | |
| 2j63_A | 467 | AP-endonuclease; base excision repair, lyase; 2.48 | 4e-05 | |
| 2j63_A | 467 | AP-endonuclease; base excision repair, lyase; 2.48 | 7e-05 | |
| 2j63_A | 467 | AP-endonuclease; base excision repair, lyase; 2.48 | 3e-04 | |
| 2j63_A | 467 | AP-endonuclease; base excision repair, lyase; 2.48 | 8e-04 | |
| 2j63_A | 467 | AP-endonuclease; base excision repair, lyase; 2.48 | 9e-04 | |
| 2qlv_B | 252 | Protein SIP2, protein SPM2; heterotrimer, ATP-bind | 4e-05 | |
| 2qlv_B | 252 | Protein SIP2, protein SPM2; heterotrimer, ATP-bind | 2e-04 | |
| 2qlv_B | 252 | Protein SIP2, protein SPM2; heterotrimer, ATP-bind | 9e-04 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 4e-05 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 8e-04 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 8e-04 | |
| 1pcx_A | 810 | Protein transport protein SEC24; 2.50A {Saccharomy | 6e-05 | |
| 1pcx_A | 810 | Protein transport protein SEC24; 2.50A {Saccharomy | 7e-04 | |
| 1pcx_A | 810 | Protein transport protein SEC24; 2.50A {Saccharomy | 9e-04 | |
| 1x9d_A | 538 | Endoplasmic reticulum mannosyl-oligosaccharide 1, | 6e-05 | |
| 1x9d_A | 538 | Endoplasmic reticulum mannosyl-oligosaccharide 1, | 1e-04 | |
| 1x9d_A | 538 | Endoplasmic reticulum mannosyl-oligosaccharide 1, | 3e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 7e-05 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 1e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 2e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 2e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 7e-05 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 3e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 3e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 4e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 5e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 7e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 7e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 8e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 8e-04 | |
| 1zvo_C | 512 | Myeloma immunoglobulin D delta; immunoglobulin fol | 2e-04 | |
| 3u3p_A | 313 | Tumor necrosis factor receptor superfamily member; | 2e-04 | |
| 3vf0_A | 283 | Vinculin, metavinculin; cytoskeletal F-actin bindi | 3e-04 | |
| 3q2s_C | 229 | Cleavage and polyadenylation specificity factor S; | 3e-04 | |
| 2krg_A | 216 | Na(+)/H(+) exchange regulatory cofactor NHE-RF1; a | 4e-04 | |
| 1kxf_A | 264 | Sindbis virus capsid protein; chymotrypsin-like se | 4e-04 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 5e-04 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 7e-04 | |
| 1rh1_A | 511 | Colicin B; FEPA, cytotoxic bacterial protein, TONB | 7e-04 | |
| 2j89_A | 261 | Methionine sulfoxide reductase A; MSRA, poplar, ox | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 583 bits (1504), Expect = 0.0
Identities = 144/306 (47%), Positives = 205/306 (66%), Gaps = 11/306 (3%)
Query: 341 VNSPQDPG-GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQL 399
V + +DP LG + F+ EL A+D F+++N+LG GGFG VYKG L DG VA+K+L
Sbjct: 4 VPAEEDPEVHLGQLKR-FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 400 KIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG-- 456
K QG E +F+ EVE+IS HR+L+ L G+C++ RLL+Y Y+ N ++ L
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 457 EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516
E +P LDW R +IA G+ARGLAYLH+ C P+IIHRD+K++NILLD FEA V DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
L +TH+TT V GT G++APEY S+GK +EK+DVF +GV+LLELITG++ D ++
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 577 DES--LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR 634
D+ L++W + L L+ ++ + L D L NY + E+ ++I+ A C + S +RP+
Sbjct: 243 DDDVMLLDWVKGL----LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298
Query: 635 MGQVVR 640
M +VVR
Sbjct: 299 MSEVVR 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 542 bits (1398), Expect = 0.0
Identities = 120/310 (38%), Positives = 170/310 (54%), Gaps = 10/310 (3%)
Query: 334 SGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGRE 393
S + ++ + +L +AT+ F + L+G G FG VYKG L DG +
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 394 VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFH 453
VA+K+ QG EF+ E+E +S H HLVSL+G+C + +LIY Y+ N L H
Sbjct: 66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 454 LHGEGRPV--LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511
L+G P + W R++I GAARGL YLH IIHRD+KS NILLD NF +++D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182
Query: 512 FGLAKLALDA-NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570
FG++K + TH++T V GT GY+ PEY G+LTEKSDV+SFGVVL E++ R +
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 571 ASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAA 630
S P +L EWA N + + + DP L + + + + A C+ S+
Sbjct: 243 QSLPREMVNLAEWAVES----HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 631 KRPRMGQVVR 640
RP MG V+
Sbjct: 299 DRPSMGDVLW 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 524 bits (1353), Expect = 0.0
Identities = 111/304 (36%), Positives = 174/304 (57%), Gaps = 23/304 (7%)
Query: 357 FTYEELVKATDGFADQ------NLLGEGGFGSVYKGYLPDGREVAIKQLKIG----GGQG 406
F++ EL T+ F ++ N +GEGGFG VYKGY+ + VA+K+L +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWA 465
+++F E++++++ H +LV L+G+ D L+Y Y+PN +L L +G P L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-LDANTH 524
R KIA GAA G+ +LHE+ IHRDIKS+NILLD F A++SDFGLA+ + A T
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWA 584
+T+R++GT YMAPE G++T KSD++SFGVVLLE+ITG VD + + L++
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIK 247
Query: 585 RPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644
+ E + ++ D ++ + + M A+ C+ KRP + +V ++
Sbjct: 248 EEIED---EEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 645 LATS 648
+ S
Sbjct: 304 MTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-100
Identities = 83/317 (26%), Positives = 114/317 (35%), Gaps = 26/317 (8%)
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKA 412
S E L + + G FG V+K VA+K I Q + +
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEY 67
Query: 413 EVEIISRIHHRHLVSLVGYCI----SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV 468
EV + + H +++ +G D LI + +L L V+ W
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELC 124
Query: 469 KIAAGAARGLAYLHED-------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521
IA ARGLAYLHED P I HRDIKS N+LL NN A ++DFGLA
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 522 NTHI-TTRVMGTFGYMAPEYASSG-----KLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ T +GT YMAPE + D+++ G+VL EL + D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 576 GDESLVE--WARPLLSHALENEEFDNLADPRLGENYVEGEMFR-MIEAAAACVRHSAAKR 632
E P L E P L + + + + E C H A R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKK-RPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 633 PRMGQVVRVFDSLATSD 649
G V +
Sbjct: 304 LSAGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 1e-71
Identities = 70/325 (21%), Positives = 114/325 (35%), Gaps = 41/325 (12%)
Query: 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI 416
E D L+G G +G+VYKG L D R VA+K + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKNI 58
Query: 417 --ISRIHHRHLVSLVGYCI-----SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
+ + H ++ + LL+ +Y PN +L +L DW + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 470 IAAGAARGLAYLHED------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL------ 517
+A RGLAYLH + P I HRD+ S N+L+ N+ +SDFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 518 -ALDANTHITTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELITGRKPV 569
+ +GT YMAPE ++ D+++ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 570 DASQPLGDESL----VEWARPLLSHALENEEFDNLADPRLGENYVEGE--MFRMIEAAAA 623
+ + + + P + P+ E + E + + E
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ-RPKFPEAWKENSLAVRSLKETIED 294
Query: 624 CVRHSAAKRPRMGQVVRVFDSLATS 648
C A R L
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMI 319
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-65
Identities = 71/212 (33%), Positives = 120/212 (56%), Gaps = 23/212 (10%)
Query: 372 QNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGE-------REFKAEVEIISRIHHR 423
+ +G+GGFG V+KG + D VAIK L +G +GE +EF+ EV I+S ++H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++V L G + ++ ++VP LY L + P + W+ ++++ A G+ Y+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ- 139
Query: 484 DCHPRIIHRDIKSSNILLDNNFE-----AQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
+ +P I+HRD++S NI L + E A+V+DFGL++ + H + ++G F +MAP
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAP 195
Query: 539 E--YASSGKLTEKSDVFSFGVVLLELITGRKP 568
E A TEK+D +SF ++L ++TG P
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-64
Identities = 69/197 (35%), Positives = 107/197 (54%), Gaps = 6/197 (3%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+V++ G +VA+K L + EF EV I+ R+ H ++V +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
++ +Y+ +LY LH R LD R+ +A A+G+ YLH +P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
R++KS N+L+D + +V DFGL++L + + GT +MAPE EKSD
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 552 VFSFGVVLLELITGRKP 568
V+SFGV+L EL T ++P
Sbjct: 222 VYSFGVILWELATLQQP 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-64
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLV 429
L E G ++KG G ++ +K LK+ + R+F E + H +++ ++
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 430 GYCIS--DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G C S LI ++P +LY LH V+D + VK A ARG+A+LH P
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE---YASSG 544
I + S ++++D + A++S + + + M ++APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPED 186
Query: 545 KLTEKSDVFSFGVVLLELITGRKP 568
+D++SF V+L EL+T P
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP 210
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-63
Identities = 86/306 (28%), Positives = 136/306 (44%), Gaps = 42/306 (13%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V K ++VAIKQ++ + F E+ +SR++H ++V L G C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 435 DDRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+ L+ +Y +LY LHG E P A + ++G+AYLH +IHRD
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 494 IKSSNILLDNNFE-AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
+K N+LL ++ DFG A D TH+T G+ +MAPE +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNK-GSAAWMAPEVFEGSNYSEKCDV 186
Query: 553 FSFGVVLLELITGRKP-VDASQPLGDESLVEWA-----RPLLSHALENEEFDNLADPRLG 606
FS+G++L E+IT RKP + P + WA RP L L + ++L
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGP---AFRIMWAVHNGTRPPLIKNL-PKPIESL------ 236
Query: 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQ 666
+ C ++RP M ++V++ L + + +S
Sbjct: 237 -----------MT---RCWSKDPSQRPSMEEIVKIMTHLMRY-FPGADEPLQYPCQHSLP 281
Query: 667 QSAEIR 672
+ R
Sbjct: 282 PGEDGR 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 9e-63
Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVSLVG 430
+G GGFG VY+ + G EVA+K + Q + E ++ + + H ++++L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C+ + L+ ++ L L G+ + V A ARG+ YLH++ II
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 491 HRDIKSSNILLDNNFEAQ--------VSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
HRD+KSSNIL+ E ++DFGLA+ T + G + +MAPE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMAPEVIR 187
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
+ ++ SDV+S+GV+L EL+TG P
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-61
Identities = 67/200 (33%), Positives = 109/200 (54%), Gaps = 13/200 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ + ++ + ++LY HLH + + IA ARG+ YLH IIHR
Sbjct: 90 -TAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHA---KSIIHR 144
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFGYMAPE---YASSGKLTE 548
D+KS+NI L + ++ DFGLA + + +H ++ G+ +MAPE S +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 549 KSDVFSFGVVLLELITGRKP 568
+SDV++FG+VL EL+TG+ P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-60
Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG+G FG K + G + +K+L + +R F EV+++ + H +++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
D R I +Y+ TL + W+ RV A A G+AYLH IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MNIIHRD 133
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR-------------VMGTFGYMAPEY 540
+ S N L+ N V+DFGLA+L +D T V+G +MAPE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKP---VDASQPLGDESLVEWARPLLSHALENEEF 597
+ EK DVFSFG+VL E+I ++ + F
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC-PPSF 252
Query: 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648
+ R C KRP ++ ++L
Sbjct: 253 FPI-------------TVR-------CCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 9e-59
Identities = 70/306 (22%), Positives = 120/306 (39%), Gaps = 44/306 (14%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI--ISRIHHRHLVSLV 429
+G+G +G V+ G G +VA+K E + E EI + H +++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 430 GYCISDDRR----LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED- 484
I LI DY N +LY +L LD + +K+A + GL +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 485 ----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI---TTRVMGTFGYMA 537
P I HRD+KS NIL+ N ++D GLA + + +GT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 538 PE------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA 591
PE + + +D++SFG++L E+ + E+ P
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS--------GGIVEEYQLPYHDLV 266
Query: 592 LENEEFDNLAD--------PRLGENYVEGEMFR-MIEAAAACVRHSAAKRPRMGQVVRVF 642
+ ++++ + P + E R M + C H+ A R +V +
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 643 DSLATS 648
++ S
Sbjct: 327 AKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-58
Identities = 63/307 (20%), Positives = 121/307 (39%), Gaps = 52/307 (16%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI--ISRIHHRHLVSLV 429
+G+G +G V++G G VA+K + E+ + E E+ + H +++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 430 GYCISDDRR----LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED- 484
++ LI Y +LY +L LD + ++I A GLA+LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 485 ----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL----ALDANTHITTRVMGTFGYM 536
P I HRD+KS NIL+ N + ++D GLA + + RV GT YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 537 APE------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590
APE ++ D+++FG+VL E+ + + ++ P
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--------NGIVEDYKPPFYDV 236
Query: 591 ALENEEFDNLAD------------PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQV 638
+ F+++ R + + ++++ C + + R ++
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRI 293
Query: 639 VRVFDSL 645
+ +
Sbjct: 294 KKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-57
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLVG 430
L+G+G FG VY G EVAI+ + I + + FK EV + H ++V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C+S +I TLY + + VLD +IA +G+ YLH I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKL----ALDANTHITTRVMGTFGYMAPEYASSGKL 546
H+D+KS N+ DN + ++DFGL + G ++APE
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 547 ---------TEKSDVFSFGVVLLELITGRKP 568
++ SDVF+ G + EL P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-56
Identities = 84/368 (22%), Positives = 140/368 (38%), Gaps = 60/368 (16%)
Query: 308 MPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATD 367
+ P S TT I +++ GSG G + +V
Sbjct: 5 LDRPFISEGTTLKDLIYDMTTS---GSGSGLPLLVQRTIA------------RTIVL--- 46
Query: 368 GFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI--ISRIHHRHL 425
Q +G+G FG V++G G EVA+K + ER + E EI + H ++
Sbjct: 47 ----QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENI 98
Query: 426 VSLVGYCISDDRR----LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
+ + D+ L+ DY + +L+ +L+ R + +K+A A GLA+L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHL 155
Query: 482 HED-----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI----TTRVMGT 532
H + P I HRD+KS NIL+ N ++D GLA A I RV GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GT 214
Query: 533 FGYMAPE------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP--LGDESLVEWA 584
YMAPE + +++D+++ G+V E+ + L LV +
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV-PS 273
Query: 585 RPLLSHALENEEFDNL---ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641
P + + L R M +++ C + A R ++ +
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKT 330
Query: 642 FDSLATSD 649
L+ +
Sbjct: 331 LSQLSQQE 338
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 375 LGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG V+ G L D VA+K + + +F E I+ + H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
++ + V L EG L T +++ AA G+ YL IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKS 550
D+ + N L+ ++SDFG+++ D + + + APE + G+ + +S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 551 DVFSFGVVLLELIT-GRKP 568
DV+SFG++L E + G P
Sbjct: 297 DVWSFGILLWETFSLGASP 315
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 87/295 (29%), Positives = 127/295 (43%), Gaps = 42/295 (14%)
Query: 375 LGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV Y P G VA+KQL+ G +R+F+ E++I+ +H +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G R+ L+ +Y+P+ L L R LD + + ++ +G+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGK 545
R +HRD+ + NIL+++ +++DFGLAKL + R G + APE S
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 546 LTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604
+ +SDV+SFGVVL EL T K S E P LS LE E
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE-------- 258
Query: 605 LGENYVEGEMFRMIEAAAACV-----------RHSAAKRPRMGQVVRVFDSLATS 648
EG+ R+ A AC S RP + D L +
Sbjct: 259 ------EGQ--RL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 66/199 (33%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 375 LGEGGFGSVYKGY---LPDGRE--VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV L D VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G C S RR LI +Y+P +L +L + + +D ++ + +G+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGK 545
R IHRD+ + NIL++N ++ DFGL K+ + G + APE + K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 546 LTEKSDVFSFGVVLLELIT 564
+ SDV+SFGVVL EL T
Sbjct: 194 FSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 375 LGEGGFGSVYKGY---LPDGRE--VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FGSV L D VA+K+L+ + R+F+ E+EI+ + H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 430 GYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
G C S RR LI +Y+P +L +L + + +D ++ + +G+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGK 545
R IHRD+ + NIL++N ++ DFGL K+ + + G + APE + K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 546 LTEKSDVFSFGVVLLELIT 564
+ SDV+SFGVVL EL T
Sbjct: 225 FSVASDVWSFGVVLYELFT 243
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-42
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 15/203 (7%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHLVSLVG 430
+G G F +VYKG EVA +L+ + FK E E++ + H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 431 YCIS---DDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
S + +++ + + + TL +L + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-RT 149
Query: 487 PRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
P IIHRD+K NI + ++ D GLA L V+GT +MAPE
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYEEK- 205
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
E DV++FG+ +LE+ T P
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYP 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-42
Identities = 61/201 (30%), Positives = 109/201 (54%), Gaps = 12/201 (5%)
Query: 375 LGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVG 430
LG G FGSV +G ++ VAIK LK G + + E E +I+ ++ + ++V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C + +L+ + L+ L G+ + + ++ + G+ YL E+ + +
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL-EEKN--FV 132
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLTE 548
HRD+ + N+LL N A++SDFGL+K +++ T R G + + APE + K +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 549 KSDVFSFGVVLLELIT-GRKP 568
+SDV+S+GV + E ++ G+KP
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP 213
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
+G G FG V+ GY + +VAIK ++ G E +F E E++ ++ H LV L G C+
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
L+ +++ + L +L R + T + + G+AYL E+ +IHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIHRDL 130
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKSDV 552
+ N L+ N +VSDFG+ + LD T+ F +PE S + + KSDV
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 553 FSFGVVLLELIT-GRKP 568
+SFGV++ E+ + G+ P
Sbjct: 189 WSFGVLMWEVFSEGKIP 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-41
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VA+K +K G E EF E + + ++ H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+ ++ +Y+ N L +L G+ L+ + +++ G+A+L E IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL-ESHQ--FIHRDL 130
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT---FGYMAPEYASSGKLTEKSD 551
+ N L+D + +VSDFG+ + LD +GT + APE K + KSD
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 552 VFSFGVVLLELIT-GRKP 568
V++FG+++ E+ + G+ P
Sbjct: 188 VWAFGILMWEVFSLGKMP 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-41
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 375 LGEGGFGSVYKGYLP-----DGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LGEG FG V G +VA+K LK G + K E+EI+ ++H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C D LI +++P+ +L +L + ++ ++K A +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSG 544
+ +HRD+ + N+L+++ + ++ DFGL K + T + + APE
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 545 KLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDE 578
K SDV+SFGV L EL+T
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 375 LGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LG G FG+VYKG ++P+G + VAIK+L+ E E +++ + + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G C LI +P L ++ E + + + A+G+ YL + R
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKL 546
++HRD+ + N+L+ +++DFGLAKL L A G +MA E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 547 TEKSDVFSFGVVLLELIT-GRKP 568
T +SDV+S+GV + EL+T G KP
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 363 VKATDGFAD------------QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREF 410
V A D F +G+G FG V G G +VA+K +K + F
Sbjct: 5 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAF 61
Query: 411 KAEVEIISRIHHRHLVSLVGYCISDDRRLLI-YDYVPNNTLYFHLHGEGRPVLDWATRVK 469
AE +++++ H +LV L+G + + L I +Y+ +L +L GR VL +K
Sbjct: 62 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
+ + YL + +HRD+ + N+L+ + A+VSDFGL K +A++ T+
Sbjct: 122 FSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASS---TQD 172
Query: 530 MGTFGY--MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
G APE K + KSDV+SFG++L E+ + GR P
Sbjct: 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 79/290 (27%), Positives = 121/290 (41%), Gaps = 33/290 (11%)
Query: 375 LGEGGFGSVYKGYL---PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LGEG FG V DG VA+K LK G R +K E++I+ ++H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 429 VGYCISDDRR--LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C L+ +YVP +L +L R + A + A G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSG 544
IHRD+ + N+LLDN+ ++ DFGLAK + + + R G + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 545 KLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALEN-EEFDNLAD 602
K SDV+SFGV L EL+T + + + + E E + L
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272
Query: 603 PRLGENYVEG---EMFR-MIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648
P + E++ M C A+ RP ++ + ++
Sbjct: 273 P-------DKCPAEVYHLMKN----CWETEASFRPTFENLIPILKTVHEK 311
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 13/208 (6%)
Query: 374 LLGEGGFGSVYKGYLPD---GREVAIKQLKIGGGQGE---REFKAEVEIISRIHHRHLVS 427
LG GG +VY D +VAIK + I + E + F+ EV S++ H+++VS
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
++ DD L+ +Y+ TL ++ G L T + G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM--- 130
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
RI+HRDIK NIL+D+N ++ DFG+AK + + T V+GT Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQPL 575
E +D++S G+VL E++ G P + +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 373 NLLGEGGFGSVYKG-YLPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LG+G FG+VY +A+K L ++ E + + EVEI S + H +++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 429 VGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
GY D R+ LI +Y P T+Y L + D A L+Y H
Sbjct: 75 YGY-FHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK--- 128
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
R+IHRDIK N+LL + E +++DFG + A ++ GT Y+ PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDL--CGTLDYLPPEMIEGRMHD 185
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQP 574
EK D++S GV+ E + G+ P +A+
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTY 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G+G FG V G G +VA+K +K + F AE +++++ H +LV L+G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 432 CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + L ++ +Y+ +L +L GR VL +K + + YL + +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTE 548
HRD+ + N+L+ + A+VSDFGL K +A++ T+ G APE K +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASS---TQDTGKLPVKWTAPEALREKKFST 365
Query: 549 KSDVFSFGVVLLELIT-GRKP 568
KSDV+SFG++L E+ + GR P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V+ GY +VA+K LK G + F AE ++ ++ H+ LV L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV-T 78
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+ +I +Y+ N +L L L + +AA A G+A++ E IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKSDV 552
+++NIL+ + +++DFGLA+L D T R F APE + G T KSDV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 553 FSFGVVLLELIT-GRKP 568
+SFG++L E++T GR P
Sbjct: 194 WSFGILLTEIVTHGRIP 210
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 69/198 (34%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+ LG+G FG V+ G VAIK LK G F E +++ ++ H LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S++ ++ +Y+ +L L GE L V +AA A G+AY+ +H
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD++++NIL+ N +V+DFGLA+L D + APE A G+ T KSD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L EL T GR P
Sbjct: 364 VWSFGILLTELTTKGRVP 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 494
+I +Y+ N L +L E R +++ + YL E +HRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLHRDL 146
Query: 495 KSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKSDV 552
+ N L+++ +VSDFGL++ LD T+ V F PE K + KSD+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 553 FSFGVVLLELIT-GRKP 568
++FGV++ E+ + G+ P
Sbjct: 205 WAFGVLMWEIYSLGKMP 221
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGG-GQGEREF-KAEVEIISRIHHRHLVSLVG 430
+G G +G K DG+ + K+L G + E++ +EV ++ + H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 431 -YCISDDRRLLIY-DYVPNNTLYFHL---HGEGRP-----VLDWATRVKIAAGAARGLAY 480
+ L I +Y L + E + VL T++ L
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL------TLALKE 126
Query: 481 LHE--DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
H D ++HRD+K +N+ LD ++ DFGLA++ L+ +T +GT YM+P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKTFVGTPYYMSP 185
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572
E + EKSD++S G +L EL P A
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-40
Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+ LG G FG V+ +VA+K +K G F AE ++ + H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
+ + +I +++ +L L + + +A A G+A++ + IH
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEK 549
RD++++NIL+ + +++DFGLA++ D T R F APE + G T K
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 550 SDVFSFGVVLLELIT-GRKP 568
SDV+SFG++L+E++T GR P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 375 LGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLV 429
+GEG FG V++G P+ VAIK K R +F E + + H H+V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G +++ +I + L L + LD A+ + A + LAYL R
Sbjct: 83 GVI-TENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
+HRDI + N+L+ +N ++ DFGL++ D+ + ++ +MAPE + + T
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 550 SDVFSFGVVLLELIT-GRKP 568
SDV+ FGV + E++ G KP
Sbjct: 198 SDVWMFGVCMWEILMHGVKP 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 375 LGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLV 429
LGEG FG VY+G G + VA+K K + +F +E I+ + H H+V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G ++ +I + P L +L + L T V + + +AYL E +
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL-ESIN--C 134
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
+HRDI NIL+ + ++ DFGL++ D + + + +M+PE + + T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 550 SDVFSFGVVLLELIT-GRKP 568
SDV+ F V + E+++ G++P
Sbjct: 195 SDVWMFAVCMWEILSFGKQP 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 372 QNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
++G G FG VY G L DG++ A+K L GE +F E I+ H +++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 427 SLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
SL+G C+ S+ L++ Y+ + L + E + A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK- 147
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG------YMAPE 539
+ +HRD+ + N +LD F +V+DFGLA+ D V G +MA E
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 540 YASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ K T KSDV+SFGV+L EL+T G P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 375 LGEGGFGSVYKGYLPDGR---EVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLV 429
LG G FG+V KGY + VA+K LK + E AE ++ ++ + ++V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G C + +L+ + L +L + +++ + G+ YL E+ +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL-EESN--F 138
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKLT 547
+HRD+ + N+LL A++SDFGL+K + + G + + APE + K +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 548 EKSDVFSFGVVLLELIT-GRKP 568
KSDV+SFGV++ E + G+KP
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP 220
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 375 LGEGGFGSVYKGYL--PDGRE--VAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVS 427
LG+G FG V +G P G+ VA+K LK + +F EV + + HR+L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
L G ++ + P +L L + + T + A A G+ YL
Sbjct: 86 LYGVV-LTPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGK 545
R IHRD+ + N+LL ++ DFGL + + H + + APE +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 546 LTEKSDVFSFGVVLLELIT-GRKP 568
+ SD + FGV L E+ T G++P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-39
Identities = 72/314 (22%), Positives = 120/314 (38%), Gaps = 24/314 (7%)
Query: 266 GTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKT 325
G + + IA ++ L+ R S + +
Sbjct: 292 GAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEK 351
Query: 326 QSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNL-----LGEGGF 380
Q S +D D TY + + +GEG F
Sbjct: 352 QGVRSHTVSVSETDDYAEIIDEED--------TYTMPSTRDYEIQRERIELGRCIGEGQF 403
Query: 381 GSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVGYCISD 435
G V++G P+ VAIK K R +F E + + H H+V L+G ++
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 462
Query: 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495
+ +I + L L + LD A+ + A + LAYL R +HRDI
Sbjct: 463 NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIA 518
Query: 496 SSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSF 555
+ N+L+ +N ++ DFGL++ D+ + ++ +MAPE + + T SDV+ F
Sbjct: 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 556 GVVLLELIT-GRKP 568
GV + E++ G KP
Sbjct: 579 GVCMWEILMHGVKP 592
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 372 QNLLGEGGFGSVYKGYLPDGRE----VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLV 426
++G+G FG VY G D + AIK L + F E ++ ++H +++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 427 SLVGYCISDD-RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
+L+G + + ++ Y+ + L + + + ARG+ YL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ- 143
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG-----YMAPEY 540
+ +HRD+ + N +LD +F +V+DFGLA+ LD + + A E
Sbjct: 144 --KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTALES 199
Query: 541 ASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+ + T KSDV+SFGV+L EL+T G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
F + L+G GGFG V+K DG+ IK++K + + EV+ ++++ H ++V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVH 68
Query: 428 LVGY---------------CISDDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVKIA 471
G S + L I ++ TL + LD +++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
+G+ Y+H ++I+RD+K SNI L + + ++ DFGL +L + T G
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT-SLKNDGKRTRSK-G 183
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T YM+PE SS ++ D+++ G++L EL+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 375 LGEGGFGSVYKGYLPDGR-EVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G +G VY+G VA+K LK + E EF E ++ I H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493
+ +I +++ L +L R + + +A + + YL + IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTEKSD 551
+ + N L+ N +V+DFGL++L +T+ T F APE + K + KSD
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 552 VFSFGVVLLELIT-GRKP 568
V++FGV+L E+ T G P
Sbjct: 195 VWAFGVLLWEIATYGMSP 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 7/225 (3%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGG-GQGEREF-K 411
+ T ++ + + +GEG FG DGR+ IK++ I ERE +
Sbjct: 12 DLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR 71
Query: 412 AEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIA 471
EV +++ + H ++V + ++ DY L+ ++ + + +
Sbjct: 72 REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
L ++H+ +I+HRDIKS NI L + Q+ DFG+A++ L++ + +G
Sbjct: 132 VQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV-LNSTVELARACIG 187
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
T Y++PE + KSD+++ G VL EL T + +A
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 48/215 (22%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHH 422
F + +G G F VY+ L DG VA+K+++I + E++++ +++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 423 RHLVSLVGYCISDDRRLLIY-DYVPNNTLYFHLHGEGRP--------VLDWATRVKIAAG 473
+++ I D+ L I + L + + V + ++
Sbjct: 92 PNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL----- 145
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
L ++H R++HRDIK +N+ + ++ D GL + + T ++GT
Sbjct: 146 -CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTP 200
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
YM+PE KSD++S G +L E+ + P
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 372 QNLLGEGGFGSVYKG-YLPDGR----EVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHL 425
+LG G FG+V+KG ++P+G V IK ++ G+ + I + H H+
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
V L+G C L+ Y+P +L H+ + R L + A+G+ YL E
Sbjct: 78 VRLLGLC-PGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH- 134
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASS 543
++HR++ + N+LL + + QV+DFG+A L L + +MA E
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADL-LPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 544 GKLTEKSDVFSFGVVLLELIT-GRKP 568
GK T +SDV+S+GV + EL+T G +P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 375 LGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLV 429
+G G G V G L P R+ VAIK LK G + +R +F +E I+ + H +++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G +++ +Y+ N +L L V + G G+ YL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL-SDLG--Y 172
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLT 547
+HRD+ + N+L+D+N +VSDFGL+++ D T G APE + +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 548 EKSDVFSFGVVLLELIT-GRKP 568
SDV+SFGVV+ E++ G +P
Sbjct: 233 SASDVWSFGVVMWEVLAYGERP 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 375 LGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLV 429
+G G FG V G L P +E VAIK LK+G + +R +F E I+ + H +++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
G +++ +Y+ N +L L + V + G A G+ YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL-SDMG--Y 168
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLT 547
+HRD+ + NIL+++N +VSDFGL ++ D T G +PE + K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 548 EKSDVFSFGVVLLELIT-GRKP 568
SDV+S+G+VL E+++ G +P
Sbjct: 229 SASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 375 LGEGGFGSVYKGYL--PDGRE---VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
+G G FG VYKG L G++ VAIK LK G + +R +F E I+ + H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G ++I +Y+ N L L E V + G A G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL-ANMN-- 167
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKL 546
+HRD+ + NIL+++N +VSDFGL+++ D T G APE S K
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 547 TEKSDVFSFGVVLLELIT-GRKP 568
T SDV+SFG+V+ E++T G +P
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERP 250
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 64/313 (20%), Positives = 113/313 (36%), Gaps = 61/313 (19%)
Query: 354 RSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FK 411
R + +E + LG GGFG V++ D AIK++++ + RE
Sbjct: 2 RYLTDFEPI----------QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM 51
Query: 412 AEVEIISRIHHRHLVSLVGYCISDD---------RRLLIY---DYVPNNTLYFHLHG-EG 458
EV+ ++++ H +V + + ++ +Y L ++G
Sbjct: 52 REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT 111
Query: 459 RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-- 516
+ + + I A + +LH ++HRD+K SNI + +V DFGL
Sbjct: 112 IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
Query: 517 ---------LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK 567
L T +GT YM+PE + K D+FS G++L EL+
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--- 225
Query: 568 PVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRH 627
P + R + N +F P L + M+ +
Sbjct: 226 ------PFSTQME----RVRTLTDVRNLKF-----PPLFTQKYP-CEYVMV---QDMLSP 266
Query: 628 SAAKRPRMGQVVR 640
S +RP ++
Sbjct: 267 SPMERPEAINIIE 279
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 31/289 (10%)
Query: 292 LRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLG 351
+ R + G+ + + + L + +++ Y + ++ + S + V + Q +G
Sbjct: 27 VPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVV-IG 85
Query: 352 HSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYL--PDGRE--VAIKQLKIGGGQGE 407
S + + E+ +G G FG VY G L DG++ A+K L GE
Sbjct: 86 PSSLIVHFNEV------------IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 408 R-EFKAEVEIISRIHHRHLVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWA 465
+F E I+ H +++SL+G C+ S+ L++ Y+ + L + E
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK 192
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
+ A+G+ +L + +HRD+ + N +LD F +V+DFGLA+ D
Sbjct: 193 DLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249
Query: 526 TTRVMGTFG-----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
T +MA E + K T KSDV+SFGV+L EL+T G P
Sbjct: 250 VHN--KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 58/222 (26%), Positives = 90/222 (40%), Gaps = 21/222 (9%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LGEGGF V L DG A+K++ Q E + E ++ +H +++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 433 ISDDRR----LLIYDYVPNNTLYFHL--HGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
+ + L+ + TL+ + + L + + G RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM--------GTFGYMAP 538
HRD+K +NILL + + + D G A + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 539 E---YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD 577
E S + E++DV+S G VL ++ G P D GD
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-38
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 6/199 (3%)
Query: 372 QNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
++ LG G +G VY+G + VA+K LK + E EF E ++ I H +LV L+G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 283
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C + +I +++ L +L R + + +A + + YL + I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
HR++ + N L+ N +V+DFGL++L + APE + K + KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 551 DVFSFGVVLLELIT-GRKP 568
DV++FGV+L E+ T G P
Sbjct: 401 DVWAFGVLLWEIATYGMSP 419
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-37
Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 12/201 (5%)
Query: 375 LGEGGFGSVYKGYLPDGRE---VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSLVG 430
LG G FGSV +G ++ VAIK LK G + + E E +I+ ++ + ++V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
C + +L+ + L+ L G+ + + ++ + G+ YL E +
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY--MAPEYASSGKLTE 548
HR++ + N+LL N A++SDFGL+K +++ T R G + APE + K +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 549 KSDVFSFGVVLLELIT-GRKP 568
+SDV+S+GV + E ++ G+KP
Sbjct: 519 RSDVWSYGVTMWEALSYGQKP 539
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 374 LLGEGGFGSVYKGYLPD---GREVAIKQLKIGGGQGE---REFKAEVEIISRIHHRHLVS 427
+LG GG V+ D R+VA+K L+ + F+ E + + ++H +V+
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 428 LVGYCISDDRRLLIY----DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
+ ++ + +YV TL +H EG + +++ A A + L + H+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 134
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITT--RVMGTFGYMAPEYA 541
+ IIHRD+K +NI++ +V DFG+A+ D+ +T V+GT Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ +SDV+S G VL E++TG P P+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 369 FADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
F + +LG+G FG V K D R AIK+++ + +EV +++ ++H+++V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 428 LVGYCISDDRRLL----------IY---DYVPNNTLYFHLHGEGRP-----VLDWATRVK 469
+ + ++ +Y N TLY +H E ++
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI- 125
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL------------ 517
L+Y+H IIHRD+K NI +D + ++ DFGLAK
Sbjct: 126 -----LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 518 --ALDANTHITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITG 565
++ ++T+ + GT Y+A E +G EK D++S G++ E+I
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 375 LGEGGFGSVYKG-YLPDGRE----VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVSL 428
LG G FG+VYKG ++P+G + VAIK+L+ E E +++ + + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G C LI +P L ++ E + + + A+G+ YL + R
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF--GYMAPEYASSGKL 546
++HRD+ + N+L+ +++DFGLAKL L A G +MA E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 547 TEKSDVFSFGVVLLELIT-GRKP 568
T +SDV+S+GV + EL+T G KP
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 2e-37
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LLG+G F VY+ + G EVAIK + + + + EV+I ++ H ++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y D + L+ + N + +L +P + R G+ YLH
Sbjct: 78 NY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH---G 132
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
I+HRD+ SN+LL N +++DFGLA +L + H T GT Y++PE A+
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATRSAHG 190
Query: 548 EKSDVFSFGVVLLELITGRKPVDAS 572
+SDV+S G + L+ GR P D
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTD 215
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 59/237 (24%), Positives = 87/237 (36%), Gaps = 16/237 (6%)
Query: 344 PQDPGGLGHSRSMFTYEELVKATDGFAD---QNLLGEGGFGSVYKGYLPD---GREVAIK 397
GL S + F + L+G GG G VY+ D R VA+K
Sbjct: 8 HHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAE--DTVRERIVALK 65
Query: 398 QLK--IGGGQGERE-FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL 454
+ + R + E R+ H+V + + D + + + L L
Sbjct: 66 LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML 125
Query: 455 HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
+G L V I L H HRD+K NIL+ + A + DFG+
Sbjct: 126 RRQGP--LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGI 180
Query: 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
A D +GT YMAPE S T ++D+++ VL E +TG P
Sbjct: 181 ASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+G FG+VY + +A+K L ++ E + + E+EI S + H +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y D +R+ L+ ++ P LY L GR D A L Y HE +
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHER---K 134
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+IHRDIK N+L+ E +++DFG + A T GT Y+ PE E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPEMIEGKTHDE 191
Query: 549 KSDVFSFGVVLLELITGRKPVDASQP 574
K D++ GV+ E + G P D+
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSH 217
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 375 LGEGGFGSVYKGYL--------PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV 426
LG+G F ++KG EV +K L F ++S++ H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
G C+ D +L+ ++V +L +L + + ++ ++++A A + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-EENT 133
Query: 487 PRIIHRDIKSSNILLDNNFEAQ--------VSDFGLAKLALDANTHITTRVMGTFGY--- 535
+IH ++ + NILL + + +SD G++ L +
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQER 180
Query: 536 ---MAPEYASSGKL-TEKSDVFSFGVVLLELIT-GRKP 568
+ PE + K +D +SFG L E+ + G KP
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+LG+G +G VY G L + +AIK++ + + E+ + + H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87
Query: 433 ISDDRRLLIY-DYVPNNTLYFHLHGEGRPVLDWATRVK-IAAGAARGLAYLHEDCHPRII 490
S++ + I+ + VP +L L + P+ D + GL YLH++ +I+
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 491 HRDIKSSNILLDN-NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE--YASSGKLT 547
HRDIK N+L++ + ++SDFG +K N T GT YMAPE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203
Query: 548 EKSDVFSFGVVLLELITGRKP 568
+ +D++S G ++E+ TG+ P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVYKGYLPDGRE----VAIKQLKIGG-GQGER-EFKAEVEIISRIHHRHLVSL 428
LGEG FGSV +G L VA+K +K+ Q E EF +E + H +++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 429 VGYCISDD-----RRLLIYDYVPN----NTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+G CI + ++I ++ L + G + T +K A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG----- 534
YL +HRD+ + N +L ++ V+DFGL+K + + G
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVK 214
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
++A E + T KSDV++FGV + E+ T G P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 60/271 (22%), Positives = 93/271 (34%), Gaps = 35/271 (12%)
Query: 308 MPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATD 367
LG+ + S + Q + DP S +++ L
Sbjct: 9 SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSR-PESFFQQSFQRL----- 62
Query: 368 GFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRI-HHR 423
+ LG G +G V+K DGR A+K+ G + AEV ++ H
Sbjct: 63 -----SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 424 HLVSLVGYCISDDRRLLIY-DYVPNNTLYFHLHGEGRP-----VLDWATRVKIAAGAARG 477
V L + L + + +L H G V +
Sbjct: 118 CCVRLEQ-AWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT------LLA 169
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
LA+LH ++H D+K +NI L ++ DFGL L + G YMA
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMA 224
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
PE G +DVFS G+ +LE+ +
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 375 LGEGGFGSVYKGYLPDGREVAIKQL-----------------KIGGGQGEREFKAEVEII 417
L +G F + D + A+K+ KI +FK E++II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 418 SRIHHRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRV------KI 470
+ I + + ++ G I++ + +IY+Y+ N+++ ++ + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
+Y+H I HRD+K SNIL+D N ++SDFG ++ +D +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS--R 211
Query: 531 GTFGYMAPEYASSGKLT---EKSDVFSFGVVLLELITGRKPVDAS 572
GT+ +M PE S + + K D++S G+ L + P
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 372 QNLLGEGGFGSVYKGYLPDGRE----VAIKQLKIGGGQGER--EFKAEVEIISRIHHRHL 425
+LG+G FGSV + L VA+K LK EF E + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 426 VSLVGYCISDDRR------LLIYDYVPNNTLYFHL----HGEGRPVLDWATRVKIAAGAA 475
LVG + + ++I ++ + L+ L GE L T V+ A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG- 534
G+ YL IHRD+ + N +L + V+DFGL++ + + G
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASK 200
Query: 535 ----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
++A E + T SDV++FGV + E++T G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRI--HHRHLVSL 428
+G GG V++ + AIK + + + ++ E+ ++++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y I+D ++ + N L L + +D R + +H+
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPE------- 539
I+H D+K +N L+ + ++ DFG+A + +T + +GT YM PE
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 540 ----YASSGKLTEKSDVFSFGVVLLELITGRKP 568
S K++ KSDV+S G +L + G+ P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRI--HHRHLVSL 428
+G GG V++ + AIK + + + ++ E+ ++++ H ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y I+D ++ + N L L + +D R + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPE------- 539
I+H D+K +N L+ + ++ DFG+A + +T + +GT YM PE
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 540 ----YASSGKLTEKSDVFSFGVVLLELITGRKP 568
S K++ KSDV+S G +L + G+ P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ + VA+K LK ++F+ E E+++ + H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 429 VGYCISDDRRLLIYDYVPN--------------NTLYFHLHGEGRPVLDWATRVKIAAGA 474
G C D +++++Y+ + L + + L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
A G+ YL +HRD+ + N L+ N ++ DFG+++ + + +G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHT 195
Query: 535 -----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG+G FG VY+G + VAIK + ER EF E ++ + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL--------HGEGRPVLDWATRVKIAAGAARGLA 479
L+G L+I + + L +L + + +++A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY---- 535
YL+ + + +HRD+ + N ++ +F ++ DFG+ + D R G G
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR-KGGKGLLPVR 205
Query: 536 -MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
M+PE G T SDV+SFGVVL E+ T +P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 69/198 (34%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+ LG+G FG V+ G VAIK LK G F E +++ ++ H LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S++ ++ +Y+ +L L GE L V +AA A G+AY+ +H
Sbjct: 331 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD++++NIL+ N +V+DFGLA+L D + APE A G+ T KSD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 552 VFSFGVVLLELIT-GRKP 568
V+SFG++L EL T GR P
Sbjct: 447 VWSFGILLTELTTKGRVP 464
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 19/91 (20%), Positives = 32/91 (35%), Gaps = 5/91 (5%)
Query: 11 ANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPA 70
+N S P ++ P V + P T S P S P+++ PA
Sbjct: 2 SNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQ-----TPSKPASADGHRGPSAAFAPA 56
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
++ P S+ +SP + P + T
Sbjct: 57 AAEPKLFGGFNSSDTVTSPQRAGPLAGGVTT 87
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 14/80 (17%), Positives = 22/80 (27%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
P ++ S PA + + T S P S P+ + P + P
Sbjct: 6 KPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGG 65
Query: 116 PPPSSTPPPNSPPSPPSDPP 135
S T P +
Sbjct: 66 FNSSDTVTSPQRAGPLAGGV 85
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 14/89 (15%), Positives = 24/89 (26%), Gaps = 6/89 (6%)
Query: 37 KSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
KS P + PA N + + T S P +++ PA+
Sbjct: 4 KSKPKD------ASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAA 57
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
+ P + S+ T
Sbjct: 58 AEPKLFGGFNSSDTVTSPQRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 13/83 (15%), Positives = 20/83 (24%), Gaps = 1/83 (1%)
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP-PSPPSDPPANSPPPSNPPSNLPPPPPS 154
S P + S P + P S PS P+ + P + P
Sbjct: 4 KSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLF 63
Query: 155 SVEPPKRSPPSVPPQNPPPPPSS 177
+ S P +
Sbjct: 64 GGFNSSDTVTSPQRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 17/88 (19%), Positives = 25/88 (28%), Gaps = 7/88 (7%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
S P S +S P V + P S S P ++ P A P
Sbjct: 5 SKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHR-------GPSAAFAPAA 57
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRS 114
+ P +S T++ P
Sbjct: 58 AEPKLFGGFNSSDTVTSPQRAGPLAGGV 85
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 17/82 (20%), Positives = 22/82 (26%), Gaps = 3/82 (3%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSS---PPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
S P +S S PA N + P S S P + S + P
Sbjct: 3 NKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKL 62
Query: 121 TPPPNSPPSPPSDPPANSPPPS 142
NS + S A
Sbjct: 63 FGGFNSSDTVTSPQRAGPLAGG 84
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 17/87 (19%), Positives = 23/87 (26%), Gaps = 4/87 (4%)
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP 184
S P S + P N P+S P K P+ + P + +P P
Sbjct: 4 KSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSK---PASADGHRGPSAAFAPAAAEP 60
Query: 185 PAPIAVPPS-NVPPPPTQTPPTPASPI 210
S V P P
Sbjct: 61 KLFGGFNSSDTVTSPQRAGPLAGGVTT 87
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
LGEG FG V+ + VA+K LK ++F+ E E+++ + H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 429 VGYCISDDRRLLIYDYV-------------PNNTLYFHLHGEGRPVLDWATRVKIAAGAA 475
G C L++++Y+ P+ L L + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG- 534
G+ YL +HRD+ + N L+ ++ DFG+++ D + R +G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYR-VGGRTM 221
Query: 535 ----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+M PE K T +SDV+SFGVVL E+ T G++P
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 50/229 (21%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LGE FG VYKG+L VAIK LK R EF+ E + +R+ H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 428 LVGYCISDDRRLLIYDYVPN--------------NTLYFHLHGEGRPVLDWATRVKIAAG 473
L+G D +I+ Y + + + L+ V + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
A G+ YL ++H+D+ + N+L+ + ++SD GL R +
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF------------REVYAA 181
Query: 534 GY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
Y MAPE GK + SD++S+GVVL E+ + G +P
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 29/219 (13%)
Query: 372 QNLLGEGGFGSVYKGYL-PDGRE--VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRHLV 426
Q+++GEG FG V K + DG AIK++K + + +F E+E++ ++ HH +++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 427 SLVGYCISDDRRLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKIAA 472
+L+G C L +Y P+ L F + L + AA
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
ARG+ YL + + IHRD+ + NIL+ N+ A+++DFGL++ ++ MG
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT-MGR 202
Query: 533 F--GYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MA E + T SDV+S+GV+L E+++ G P
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-34
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 17/212 (8%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLV--- 429
LG GGFG V + G +VAIKQ + RE + E++I+ +++H ++VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 430 ---GYCISDDRRLLIYDYVPNNTLYFHLHGEGRP-VLDWATRVKIAAGAARGLAYLHEDC 485
+D LL +Y L +L+ L + + + L YLHE+
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 140
Query: 486 HPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
RIIHRD+K NI+L + + D G AK LD T V GT Y+APE
Sbjct: 141 --RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEFV-GTLQYLAPELLE 196
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
K T D +SFG + E ITG +P +
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 375 LGEGGFGSVYKGYLPDGR------EVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LG G FG VY+G + +VA+K L + + +F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHL-----HGEGRPVLDWATRVKIAAGAARGLAYLH 482
+G + R ++ + + L L L + +A A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 483 EDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGLAKLALDANTHITTRVMGTFGY---- 535
E+ IHRDI + N LL A++ DFG+A+ D R G
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRASYYR-KGGCAMLPVK 210
Query: 536 -MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
M PE G T K+D +SFGV+L E+ + G P
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 373 NLLGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRH 424
LG G FG V + + VA+K LK E+ +E++I+S + H +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL------------YFHLHGEGRPVLDWATRVKIAA 472
+V+L+G C L+I +Y L + ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMG 531
A+G+A+L IHRD+ + N+LL N A++ DFGLA + D+N +
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
+MAPE T +SDV+S+G++L E+ + G P
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 69/303 (22%), Positives = 109/303 (35%), Gaps = 41/303 (13%)
Query: 288 VVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDP 347
++ +Y + + + K ++S + P F
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSI 62
Query: 348 GGLGH-SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGR------EVAIKQLK 400
L R T LG G FG VY+G + +VA+K L
Sbjct: 63 SDLKEVPRKNITLIRG------------LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 110
Query: 401 IGGGQGER-EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL----- 454
+ + +F E IIS+ +H+++V +G + R ++ + + L L
Sbjct: 111 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 170
Query: 455 HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSD 511
L + +A A G YL E+ IHRDI + N LL A++ D
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227
Query: 512 FGLAKLALDANTHITTRVMGTFGY-----MAPEYASSGKLTEKSDVFSFGVVLLELIT-G 565
FG+A+ D R G M PE G T K+D +SFGV+L E+ + G
Sbjct: 228 FGMAR---DIYRAGYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 283
Query: 566 RKP 568
P
Sbjct: 284 YMP 286
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 53/232 (22%)
Query: 375 LGEGGFGSVYKGYLPDGRE--------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRH 424
LGEG FG V + VA+K LK + + + +E+E++ I H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKI 470
+++L+G C D +I +Y L + ++ + + V
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
ARG+ YL + IHRD+ + N+L+ N +++DFGLA R +
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLA------------RDI 207
Query: 531 GTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
Y MAPE T +SDV+SFGV++ E+ T G P
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
LGEG FG V K + VA+K LK E + +E ++ +++H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 428 LVGYCISDDRRLLIYDYVPN----------------------NTLYFHLHGEGRPVLDWA 465
L G C D LLI +Y + L L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
+ A ++G+ YL E +++HRD+ + NIL+ + ++SDFGL++ + +++
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 526 TTRVMGTFG-----YMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
V + G +MA E T +SDV+SFGV+L E++T G P
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 53/232 (22%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRHLV 426
LG G FG V + + VA+K LK ER +E++++S + +H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 427 SLVGYCISDDRRLLIYDYVPN----------------NTLYFHLHGEGRPVLDWATRVKI 470
+L+G C L+I +Y + + + LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
+ A+G+A+L IHRD+ + NILL + ++ DFGLA R +
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA------------RDI 195
Query: 531 GTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
MAPE + T +SDV+S+G+ L EL + G P
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 32/217 (14%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+LG+G +V++G G AIK I + E E++ +++H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 432 CISDDRRLLIY---DYVPNNTLYFHLHGEGRPVL---DWATRV--KIAAGAARGLAYLHE 483
+ ++ P +LY L V + G + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG----MNHLRE 130
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+ I+HR+IK NI+ + Q ++DFG A+ L+ + + GT Y+ P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPD 185
Query: 540 --------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
K D++S GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 53/232 (22%)
Query: 375 LGEGGFGSVYKGYLPDGRE--------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRH 424
LGEG FG V + VA+K LK + + + +E+E++ I H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKI 470
+++L+G C D +I +Y L + ++ + + V
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
ARG+ YL + IHRD+ + N+L+ N +++DFGLA R +
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLA------------RDI 253
Query: 531 GTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
Y MAPE T +SDV+SFGV++ E+ T G P
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 45/213 (21%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGE--REFKAEVEIISRIHH--RHLVSL 428
+G GG V++ + AIK + + + ++ E+ ++++ ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y I+D ++ + N L L + +D R + +H+
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPE------- 539
I+H D+K +N L+ + ++ DFG+A + +T + +G YM PE
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 540 ----YASSGKLTEKSDVFSFGVVLLELITGRKP 568
S K++ KSDV+S G +L + G+ P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRIHHRHLVS 427
+GEG FG V++ P VA+K LK + +F+ E +++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 428 LVGYCISDDRRLLIYDYVPN----------------------NTLYFHLHGEGRPVLDWA 465
L+G C L+++Y+ + + G P L A
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
++ IA A G+AYL E + +HRD+ + N L+ N +++DFGL++ A+ +
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230
Query: 526 TTRVMGTFGY-----MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
M PE + T +SDV+++GVVL E+ + G +P
Sbjct: 231 ---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 55/263 (20%), Positives = 101/263 (38%), Gaps = 17/263 (6%)
Query: 313 GSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKA-TDGFAD 371
GS S+ + + + + GS +D G+ + + + +
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62
Query: 372 QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
Q +G G FG V++ G + A+K++++ E E+ + + +V L G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLYG 117
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + + +L + G L + A GL YLH RI+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTR---RIL 172
Query: 491 HRDIKSSNILLDNN-FEAQVSDFGLAKLALDANTHITTR----VMGTFGYMAPEYASSGK 545
H D+K+ N+LL ++ A + DFG A + + GT +MAPE
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
K D++S ++L ++ G P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 59/231 (25%), Positives = 90/231 (38%), Gaps = 52/231 (22%)
Query: 375 LGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRI-HHRHLV 426
LG G FG V + R VA+K LK G E +E++I+ I HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 427 SLVGYCISDDR-RLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKIA 471
+L+G C ++I ++ L + L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMG 531
A+G+ +L + IHRD+ + NILL ++ DFGLA R +
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA------------RDIY 199
Query: 532 TFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
MAPE T +SDV+SFGV+L E+ + G P
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 58/237 (24%)
Query: 375 LGEGGFGSVYKGYLPDGRE------VAIKQLKIGGGQGER-EFKAEVEIISRI-HHRHLV 426
LG G FG V + VA+K LK ER +E+++++++ H ++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 427 SLVGYCISDDRRLLIYDYVPN---------------------NTLYFHLHGEGRPVLDWA 465
+L+G C LI++Y E VL +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
+ A A+G+ +L +HRD+ + N+L+ + ++ DFGLA
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA---------- 219
Query: 526 TTRVMGTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
R + + MAPE G T KSDV+S+G++L E+ + G P
Sbjct: 220 --RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 53/232 (22%)
Query: 375 LGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGER-EFKAEVEIISRI-HHRH 424
LGEG FG V +VA+K LK + + + +E+E++ I H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTL--------------YFHLHGEGRPVLDWATRVKI 470
+++L+G C D +I +Y L ++ L V
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM 530
A ARG+ YL + IHRD+ + N+L+ + +++DFGLA R +
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLA------------RDI 241
Query: 531 GTFGY-------------MAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
Y MAPE T +SDV+SFGV+L E+ T G P
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+GGF ++ A K + + + E+ I + H+H+V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G+ D+ + ++ + +L LH + + + R G YLH + R
Sbjct: 82 GF-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---R 135
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+IHRD+K N+ L+ + E ++ DFGLA K+ D GT Y+APE S +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 193
Query: 548 EKSDVFSFGVVLLELITGRKPVDAS 572
+ DV+S G ++ L+ G+ P + S
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETS 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 6e-32
Identities = 42/250 (16%), Positives = 78/250 (31%), Gaps = 35/250 (14%)
Query: 347 PGGLGHSRSMFTYE---ELVKATDGFADQNLLGEGGFGSVYKGY------LPDGREVAIK 397
P + + E + +LLGEG F VY+ + ++ +K
Sbjct: 42 PNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK 101
Query: 398 QLKIGGGQGEREFKAEVEIISRI---HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHL 454
K EF +++ R+ + + + +L+ + TL +
Sbjct: 102 VQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 455 HGEGRP---VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA---- 507
+ V+ + A + +H+ IIH DIK N +L N F
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215
Query: 508 -------QVSDFGLAK--LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVV 558
+ D G + T T + T G+ E S+ + D F
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 559 LLELITGRKP 568
+ ++ G
Sbjct: 275 VYCMLFGTYM 284
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 47/240 (19%), Positives = 77/240 (32%), Gaps = 48/240 (20%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIG--GGQGEREFKAEVEIISRI-HHRH 424
F + +G G FGSV+K DG AIK+ K G E+ EV + + H H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 425 LVSLVGYCISDDRRLLIY-DYVPNNTLYFHL--HGEGRPVLDWATRVKIAAGAARGLAYL 481
+V ++D +LI +Y +L + + A + RGL Y+
Sbjct: 73 VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVS-------------------DFGLAKLALDAN 522
H ++H DIK SNI + + D G
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 523 THITTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
G ++A E + K+D+F+ + ++
Sbjct: 189 VEE-----GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPLPRNGDQW 237
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 49/232 (21%), Positives = 89/232 (38%), Gaps = 33/232 (14%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL-KIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+LG+G +V++G G AIK I + E E++ +++H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 432 CISDDRRLLIY---DYVPNNTLYFHLHGEGRPVL---DWATRV--KIAAGAARGLAYLHE 483
+ ++ P +LY L V + G + +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG----MNHLRE 130
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+ I+HR+IK NI+ + Q ++DFG A+ L+ + + GT Y+ P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPD 185
Query: 540 --------YASSGKLTEKSDVFSFGVVLLELITGRKP-VDASQPLGDESLVE 582
K D++S GV TG P P ++ ++
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 27/248 (10%)
Query: 333 GSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATD---GFADQNLLGEGGFGSVYKGY-L 388
SG N G + H + +V D +GEG G V
Sbjct: 8 SSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 389 PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN 448
GR+VA+K + + Q EV I+ H ++V + + + ++ +++
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL--- 124
Query: 449 TLYFHLHGEGRPVLDWATRVK-----IAA---GAARGLAYLHEDCHPRIIHRDIKSSNIL 500
+G + D ++V+ IA + LAYLH +IHRDIKS +IL
Sbjct: 125 --------QGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173
Query: 501 LDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLL 560
L + ++SDFG + V GT +MAPE S + D++S G++++
Sbjct: 174 LTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 561 ELITGRKP 568
E++ G P
Sbjct: 233 EMVDGEPP 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 57/226 (25%), Positives = 89/226 (39%), Gaps = 25/226 (11%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
+L EGGF VY+ + GRE A+K+L + R EV + ++ H ++V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 432 CISDDRR--------LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
LL+ + + F E R L T +KI R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-----------GT 532
P IIHRD+K N+LL N ++ DFG A + + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 533 FGYMAPE---YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
Y PE S+ + EK D+++ G +L L + P + L
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 62/255 (24%), Positives = 107/255 (41%), Gaps = 19/255 (7%)
Query: 367 DGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREF-KAEVEIISRIHHRH 424
D F + LG G G V+K + P G +A K + + R E++++ + +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---PVLDWATRVKIAAGAARGLAYL 481
+V G SD + +++ +L L GR +L K++ +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYL 147
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYMAPE 539
E I+HRD+K SNIL+++ E ++ DFG++ +D AN+ + GT YM+PE
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPE 200
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599
+ +SD++S G+ L+E+ GR P+ E + +
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 600 LADPRLGENYVEGEM 614
M
Sbjct: 261 GRPLNKFGMDSRPPM 275
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG+GGF ++ A K + + + E+ I + H+H+V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G+ D+ + ++ + +L LH + + + R G YLH + R
Sbjct: 108 GF-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---R 161
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLA-KLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+IHRD+K N+ L+ + E ++ DFGLA K+ D GT Y+APE S +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 219
Query: 548 EKSDVFSFGVVLLELITGRKPVDAS 572
+ DV+S G ++ L+ G+ P + S
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETS 244
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
+ +G+G G+VY + G+EVAI+Q+ + + E+ ++ + ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK-----IAA---GAARGLA 479
+ + D ++ +Y+ G + D T IAA + L
Sbjct: 82 YLDSYLVGDELWVVMEYL-----------AGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+LH + ++IHRDIKS NILL + +++DFG + +T V GT +MAPE
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPE 186
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ K D++S G++ +E+I G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 28/224 (12%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVS 427
F +++LG G G++ + D R+VA+K++ + EV+++ H +++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 428 LVGYCISDDRRLLIYDYVPNNTL--YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
+ + + TL Y L+ + + GLA+LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL- 137
Query: 486 HPRIIHRDIKSSNILLDNNFE-----AQVSDFGLAKLALDANTHITTR--VMGTFGYMAP 538
I+HRD+K NIL+ A +SDFGL K + R V GT G++AP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 539 EY---ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579
E T D+FS G V +I+ P G
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSL 234
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLV 426
F +G+G FG V+KG + VAIK + + + E E + E+ ++S+ ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR-----VKIAA---GAARGL 478
G + D + +I +Y+ G LD +IA +GL
Sbjct: 84 KYYGSYLKDTKLWIIMEYL-----------GGGSALDLLEPGPLDETQIATILREILKGL 132
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
YLH + + IHRDIK++N+LL + E +++DFG+A D T +GT +MAP
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAP 188
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E K+D++S G+ +EL G P
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 42/209 (20%), Positives = 77/209 (36%), Gaps = 22/209 (10%)
Query: 374 LLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL-- 428
+ GG G +Y +GR V +K L G + AE + ++ + H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 429 VGYCISDDRRLLIY---DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
+ Y +YV +L + L A + L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK 545
+++ D+K NI+L + ++ D G +++ + GT G+ APE
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINS----FGYLYGTPGFQAPEIVR-TG 252
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDASQP 574
T +D+++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRNGRYV 281
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 17/159 (10%), Positives = 29/159 (18%), Gaps = 10/159 (6%)
Query: 29 PPPVSNPPKSSPPPPPVSKPP---------TTSPPPSP-PASNPPTSSSPPASSPPTSSP 78
P P PV K P P + S+ +
Sbjct: 274 PTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQ 333
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
P S SP S+ T
Sbjct: 334 DTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVDPTD 393
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
S + + P +++ + + + S
Sbjct: 394 VAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSES 432
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 17/162 (10%), Positives = 28/162 (17%), Gaps = 19/162 (11%)
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISP-------PPPVSNPPT-----------RSPP 116
P P P + + P P T
Sbjct: 271 LDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
T P S P ++ ++ V K + + P
Sbjct: 331 VAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVD 390
Query: 177 SSPPK-NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNS 217
+ + A + P S S
Sbjct: 391 PTDVAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSES 432
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 18/238 (7%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQL- 399
+ G L + MF + ++ + LG G +G V E AIK +
Sbjct: 12 ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71
Query: 400 --KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE 457
+ + EV ++ + H +++ L + L+ + L+ +
Sbjct: 72 KTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130
Query: 458 GR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFG 513
+ +D A +K + YLH+ I+HRD+K N+LL++ + ++ DFG
Sbjct: 131 MKFNEVDAAVIIKQVLSG---VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 571
L+ + + + R+ GT Y+APE K EK DV+S GV+L L+ G P
Sbjct: 185 LSAV-FENQKKMKERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGG 239
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 63/243 (25%), Positives = 114/243 (46%), Gaps = 26/243 (10%)
Query: 335 GPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGRE 393
GPGS + PG MF +D + Q +LG+G FG V G+E
Sbjct: 1 GPGSMMDHLHATPG-------MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQE 53
Query: 394 VAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL-LIYDYVPNNT 449
A+K + ++ + EV+++ ++ H +++ L + D L+ +
Sbjct: 54 CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGE 112
Query: 450 LYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NF 505
L+ + R +D A ++ + Y+H++ +I+HRD+K N+LL++ +
Sbjct: 113 LFDEIISRKRFSEVDAARIIRQVLSG---ITYMHKN---KIVHRDLKPENLLLESKSKDA 166
Query: 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565
++ DFGL+ +A+ + ++ GT Y+APE G EK DV+S GV+L L++G
Sbjct: 167 NIRIIDFGLSTH-FEASKKMKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
Query: 566 RKP 568
P
Sbjct: 224 CPP 226
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 60/244 (24%), Positives = 95/244 (38%), Gaps = 51/244 (20%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
+LG G G+V GR VA+K++ I E+++++ H +++ Y
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRY--Y 75
Query: 432 CISDDRRLL----------IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
C R L + D V + + E + + + A G+A+L
Sbjct: 76 CSETTDRFLYIALELCNLNLQDLVESKNVS----DENLKLQKEYNPISLLRQIASGVAHL 131
Query: 482 HEDCHPRIIHRDIKSSNILLDN-------------NFEAQVSDFGLAKLALDANTHITTR 528
H +IIHRD+K NIL+ N +SDFGL K + T
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 529 VM---GTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578
+ GT G+ APE + +LT D+FS G V +++ K P GD+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-----PFGDK 243
Query: 579 SLVE 582
E
Sbjct: 244 YSRE 247
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 359 YEELVKATD---GFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEV 414
YE + + D + LG+G FG VYK G A K ++ + ++ E+
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAA-- 472
EI++ H ++V L+G D + ++ ++ P + + R + T +I
Sbjct: 68 EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVC 123
Query: 473 -GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG----LAKLALDANTHITT 527
L +LH RIIHRD+K+ N+L+ + +++DFG K ++ I
Sbjct: 124 RQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178
Query: 528 RVMGTFGYMAPEYASSGKLTE-----KSDVFSFGVVLLELITGRKP 568
GT +MAPE + + K+D++S G+ L+E+ P
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 69/243 (28%), Positives = 109/243 (44%), Gaps = 22/243 (9%)
Query: 336 PGSDFVNSPQDPGGLGHSRSM-FTYEELVKAT-DGFADQNLLGEGGFGSVYKGYLPDGRE 393
P +F++S R + + + E D F D +LG GGFG V+ + +
Sbjct: 158 PFQEFLDSLY------FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGK 211
Query: 394 V-AIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL-LIYDYVPNN 448
+ A K+L + +G + E +I++++H R +VSL Y L L+ +
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGG 270
Query: 449 TLYFHLH--GEGRPVLDWATRVKI-AAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505
+ +H++ E P R A GL +LH+ II+RD+K N+LLD++
Sbjct: 271 DIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDG 326
Query: 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565
++SD GLA T GT G+MAPE + D F+ GV L E+I
Sbjct: 327 NVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 566 RKP 568
R P
Sbjct: 386 RGP 388
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 352 HSRSMFTYEELVKATDG---FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE 407
R + +E F LGEG +GSVYK G+ VAIKQ+ +
Sbjct: 11 PRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDL 68
Query: 408 REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
+E E+ I+ + H+V G + ++ +Y ++ + + + T
Sbjct: 69 QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL----TE 124
Query: 468 VKIAA---GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524
+IA +GL YLH R IHRDIK+ NILL+ A+++DFG+A D
Sbjct: 125 DEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181
Query: 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T + GT +MAPE +D++S G+ +E+ G+ P
Sbjct: 182 RNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-29
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 369 FADQNLLGEGGFGSVYKGYLPD-GREVAIKQLK---IGGGQGEREFKAEVEIISRIH--- 421
F+ ++G GGFG VY D G+ A+K L I QGE E ++S +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 422 HRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLA 479
+V + Y +L I D + L++HL G ++ AA GL
Sbjct: 251 CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILGLE 306
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
++H +++RD+K +NILLD + ++SD GLA H V GT GYMAPE
Sbjct: 307 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPE 360
Query: 540 YASSGKLTEKS-DVFSFGVVLLELITGRKP 568
G + S D FS G +L +L+ G P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 69/200 (34%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 374 LLGEGGFGSVYKGYLPDGREV-AIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSLV 429
+LG+GGFG V + ++ A K+L+ I +GE E +I+ +++ R +VSL
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 430 GYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
Y L L+ + L FH++ G+ A V AA GL LH + R
Sbjct: 251 -YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---R 306
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
I++RD+K NILLD++ ++SD GLA + T I RV GT GYMAPE + + T
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTF 364
Query: 549 KSDVFSFGVVLLELITGRKP 568
D ++ G +L E+I G+ P
Sbjct: 365 SPDWWALGCLLYEMIAGQSP 384
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRH 424
D + Q ++G G V Y P +VAIK++ + Q + E++ +S+ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 425 LVSLVGYCISDDRRLLIYDYVPN---NTLYFHLHGEGRPVLDWATRVKIAA---GAARGL 478
+VS + D L+ + + H+ +G IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF-G--- 534
YLH++ IHRD+K+ NILL + Q++DFG++ +V TF G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 535 YMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKP 568
+MAPE + K+D++SFG+ +EL TG P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 58/245 (23%), Positives = 97/245 (39%), Gaps = 27/245 (11%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLK 400
G+ + M+ ++ K + + LG G +G V E AIK +K
Sbjct: 11 RENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70
Query: 401 -------------IGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447
+ E E+ ++ + H +++ L L+ ++
Sbjct: 71 KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG 130
Query: 448 NTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--- 503
L+ + + D A +K + YLH+ I+HRDIK NILL+N
Sbjct: 131 GELFEQIINRHKFDECDAANIMKQILSG---ICYLHKH---NIVHRDIKPENILLENKNS 184
Query: 504 NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELI 563
++ DFGL+ + + R+ GT Y+APE K EK DV+S GV++ L+
Sbjct: 185 LLNIKIVDFGLSSF-FSKDYKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILL 241
Query: 564 TGRKP 568
G P
Sbjct: 242 CGYPP 246
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 62/291 (21%)
Query: 367 DGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKAEVEIISR-IHHR 423
D LG G +G V K ++P G+ +A+K+++ E++ +++I R +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 424 HLVSLVG-------------YC-ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
V+ G S D+ Y V + E +L K
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDK---FYKQVIDKGQTI---PE--DIL-----GK 113
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTR 528
IA + L +LH +IHRD+K SN+L++ + ++ DFG+ L +
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDI 168
Query: 529 VMGTFGYMAPE----YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWA 584
G YMAPE + + KSD++S G+ ++EL R P W
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP-----------YDSWG 217
Query: 585 RP--LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP 633
P L +E P+L + E C++ ++ +RP
Sbjct: 218 TPFQQLKQVVEEP------SPQLPADKFSAEFVDFTS---QCLKKNSKERP 259
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-28
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G FG V K +E A+K + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLFE 88
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
++ + L+ + R D A +K + Y+H+ I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---ITYMHKH---NI 142
Query: 490 IHRDIKSSNILLDN---NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
+HRD+K NILL++ + + ++ DFGL+ NT + R+ GT Y+APE G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDRI-GTAYYIAPE-VLRGTY 199
Query: 547 TEKSDVFSFGVVLLELITGRKP 568
EK DV+S GV+L L++G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 15/221 (6%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISR-IHHR 423
+ D +G G +GSV K P G+ +A+K+++ + E++ +++++ R
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 424 HLVSLVGYCISDDRRLLIYDYVPN--NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
++V G + + + + + Y +++ V+ KI + L +L
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTRVMGTFGYMAPE- 539
E+ IIHRDIK SNILLD + ++ DFG+ +L ++ TR G YMAPE
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPER 196
Query: 540 ---YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD 577
AS +SDV+S G+ L EL TGR P + D
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 374 LLGEGGFGSVYKG-YLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
+LGEG F +V L RE AIK L+ I + E +++SR+ H V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDHPFFVKL 95
Query: 429 VGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHEDCH 486
+ DD +L Y N L ++ G + A L YLH
Sbjct: 96 Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSALEYLHGK-- 149
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASSGK 545
IIHRD+K NILL+ + Q++DFG AK+ + GT Y++PE +
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 546 LTEKSDVFSFGVVLLELITGRKP 568
+ SD+++ G ++ +L+ G P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 23/242 (9%), Positives = 47/242 (19%), Gaps = 43/242 (17%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
L G V+ + + A+K +R+
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 430 GYC--------------------------ISDDRRLLIYDYVPNNTLY----FHLHGEGR 459
+ LL+ + R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 460 PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519
+ A R A L ++H N+ + + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 520 DANTHITTRVMGTFGYMAPEYASSGKL--TEKSDVFSFGVVLLELITGRKPVDASQPLGD 577
Y E+ ++ T + + G+ + + P P
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 578 ES 579
S
Sbjct: 302 GS 303
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFK---AEVEIISRIHHRH 424
F+D +G G FG+VY + + VAIK++ G Q +++ EV + ++ H +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV----KIAA---GAARG 477
+ G + + L+ +Y G +L+ + +IAA GA +G
Sbjct: 116 TIQYRGCYLREHTAWLVMEY---------CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
LAYLH +IHRD+K+ NILL ++ DFG A + AN+ +GT +MA
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMA 218
Query: 538 PEYASSGKLTE---KSDVFSFGVVLLELITGRKP 568
PE + + K DV+S G+ +EL + P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLV 426
F L+G G +G VYKG + G+ AIK + + G E E K E+ ++ + HHR++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 427 S-----LVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAA---GAARG 477
+ + D +L L+ ++ ++ + L IA RG
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREILRG 141
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
L++LH+ ++IHRDIK N+LL N E ++ DFG++ T +GT +MA
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMA 197
Query: 538 PEYASSGKLTE-----KSDVFSFGVVLLELITGRKP 568
PE + + + KSD++S G+ +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 30/199 (15%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+LG G F V+ G+ A+K +K + + E+ ++ +I H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYLHE 483
S L+ V G + D K A+ + + YLHE
Sbjct: 76 ESTTHYYLVMQLV-----------SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 484 DCHPRIIHRDIKSSNILLDNNFEA---QVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
+ I+HRD+K N+L E ++DFGL+K+ + N ++T GT GY+APE
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC-GTPGYVAPEV 178
Query: 541 ASSGKLTEKSDVFSFGVVL 559
+ ++ D +S GV+
Sbjct: 179 LAQKPYSKAVDCWSIGVIT 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 34/268 (12%), Positives = 67/268 (25%), Gaps = 51/268 (19%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+LG+ + + G + K E + R+ +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 433 ISDDRRLLIYD--------------------YVPNNTLYFHL--------------HGEG 458
R + +D +V + + H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 459 RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518
L R+++ R LA LH ++H ++ +I+LD ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 519 LDANTHITTRVMGTFGYMAPE-----YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573
+ R A +T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 574 PLGDESLV--------EWARPLLSHALE 593
LG + + R LL L
Sbjct: 322 ALGGSEWIFRSCKNIPQPVRALLEGFLR 349
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 39/274 (14%), Positives = 77/274 (28%), Gaps = 62/274 (22%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRI--------- 420
+LG+ + + G + + ++ K EV + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 421 --HHRHLVSLVGYCISDDR---RLLIYDYVPNNTLYFHL-----------------HGEG 458
H R + + R+ + + F L H
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 459 RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518
L R+++ R LA LH H ++H ++ +I+LD ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 519 LDANTHITTRVMGTFGYMAPEYASS-----------GKLTEKSDVFSFGVVLLELITGRK 567
+ G+ PE + +T D ++ G+V+ +
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 568 PVDASQPLGDESLV--------EWARPLLSHALE 593
P+ LG + + R LL L
Sbjct: 312 PITKDAALGGSEWIFRSCKNIPQPVRALLEGFLR 345
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 36/234 (15%), Positives = 82/234 (35%), Gaps = 19/234 (8%)
Query: 351 GHSRSMFTYEELVKATDG---FADQNLLGEG--GFGSVYKGY-LPDGREVAIKQLKIGGG 404
H ++ + + ++G+G +V P G V ++++ +
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65
Query: 405 QGER--EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL 462
E + E+ + +H ++V I+D+ ++ ++ + + +
Sbjct: 66 SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM 125
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522
+ I G + L Y+H +HR +K+S+IL+ + + +S +
Sbjct: 126 NELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182
Query: 523 THITTRVM------GTFGYMAPEYASSGKL--TEKSDVFSFGVVLLELITGRKP 568
+++PE KSD++S G+ EL G P
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 66/254 (25%), Positives = 88/254 (34%), Gaps = 20/254 (7%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ SP + ++ P P S
Sbjct: 1479 LVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVS 1538
Query: 61 NPPTSSSPPASSP--PTSSPPPASNPPTS------SPPPSP--PASSP------PTISPP 104
+P S + P SP P SP S PTS SP SP P+ SP PT
Sbjct: 1539 SPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1598
Query: 105 PPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
P S + + P S T P SP SP P + S P++P + P P S P SP
Sbjct: 1599 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS-PTSPSYSPTSPSYSPT 1657
Query: 165 SVPPQNPPPPPSSSPPKNSPPAPIAVPPSNV--PPPPTQTPPTPA-SPIAPRPSNSSPNS 221
S P S + P SP +P P S P P +P +P+ SP +P S SP
Sbjct: 1658 SPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAY 1717
Query: 222 PPPPSTKRLSPPPG 235
P ++ +
Sbjct: 1718 SPKQDEQKHNENEN 1731
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 69/263 (26%), Positives = 100/263 (38%), Gaps = 12/263 (4%)
Query: 2 SAPSPGPPAANSSSPPP---PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPP 58
S S A P+ + + + S P+ P
Sbjct: 1474 SNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSP 1533
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP--PTISPPPPVSNPPTRSPP 116
+S +SP S PA +P + S P+ P+ SP P+ SP P +P + S
Sbjct: 1534 -GFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1592
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
P S + P SP P+ P + PS P++ P S P + PS P +P P+
Sbjct: 1593 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP--TSPSYSPTSPSYSPT 1650
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA-SPIAPRPSNSSPN-SPPPPSTKRLSPP- 233
S + PA PS P P+ +P +P+ SP +P S +SPN SP PS SP
Sbjct: 1651 SPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGY 1710
Query: 234 -PGIPVPSTENTPGNGTNPSSPE 255
PG P S + +
Sbjct: 1711 SPGSPAYSPKQDEQKHNENENSR 1733
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 60/241 (24%), Positives = 90/241 (37%), Gaps = 10/241 (4%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P + SP + + + + + P +
Sbjct: 1468 GGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYG 1527
Query: 91 PSPPASSPPTISPPP-PVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
+P + SP P S + + P S T P SP SP P + S P++P + P
Sbjct: 1528 EAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS-P 1586
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSP--PKNSPPAPIAVPPSNVPPP--PTQTPPT 205
P S P SP S P P PS SP P SP +P P S P P+ +P +
Sbjct: 1587 TSPSYSPTSPSYSPTS--PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1644
Query: 206 PA-SPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPE-SSSSPSNN 263
P+ SP +P S +SP P + + P P + + +P+SP S +SPS +
Sbjct: 1645 PSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYS 1704
Query: 264 G 264
Sbjct: 1705 P 1705
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 2e-21
Identities = 59/245 (24%), Positives = 82/245 (33%), Gaps = 17/245 (6%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
+ P ++ + SP S +
Sbjct: 1457 QKITEIEDGQDGGVTPYSNESGLVNADLDVK---DELMFSPLVDSGSNDAMAGGFTA--Y 1511
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
A+SP P S S P S T P SP SP P + S P PS
Sbjct: 1512 GGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSP-TSPSY 1570
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVP--PSNVPPPPTQTPPT 205
P P S P SP S P S + P SP +P P PS P P+ +P +
Sbjct: 1571 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1630
Query: 206 PASPIAPRPSNSSPNSPP-PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPE-SSSSPSNN 263
P+ P + SP SP P++ SP P++ +P+SP S +SPS +
Sbjct: 1631 PSYS--PTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSP-----SYSPTSPSYSPTSPSYS 1683
Query: 264 GIGTA 268
+
Sbjct: 1684 PTSPS 1688
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 4e-21
Identities = 63/228 (27%), Positives = 88/228 (38%), Gaps = 7/228 (3%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKS--SPPPPPVSKPPTTSPPPSPP 58
+ G ++ P SP VS+P S SP P S + + P P
Sbjct: 1506 GGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSP 1565
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
S P S + P+ SP + S P S + + P P S + + P P+ SP P
Sbjct: 1566 TS-PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1624
Query: 119 SSTPP-PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
S +P P+ P+ PS P + PS P P S P SP S P S
Sbjct: 1625 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSP 1684
Query: 178 SPPKNSPPAPIAVP--PSNVPPPPTQTPPTPA-SPIAPRPSNSSPNSP 222
+ P SP +P P PS P P +P +PA SP ++ +
Sbjct: 1685 TSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 22/143 (15%), Positives = 35/143 (24%), Gaps = 9/143 (6%)
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
P +P + + SP N +
Sbjct: 1455 PEQKITEIEDGQDGGVTPYSNESGL--VNADLDVKDELMFSPLVDSGSNDAMAGGFTAYG 1512
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASP-IAPRPSNSSPNSPPPPSTKRLSPPPGIPVPS 240
+ P PT +SP +P SP SP SP P+
Sbjct: 1513 GADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAY------SPTSPSYSPT 1566
Query: 241 TENTPGNGTNPSSPESSSSPSNN 263
+ + + S S SP++
Sbjct: 1567 SPSYSPTSPSYSPTSPSYSPTSP 1589
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 367 DGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKAEVEIISR-IHHR 423
+ + +G G G V+K + G +A+KQ++ G + E + +++++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR---PVLDWATRVKIAAGAARGLAY 480
++V G I++ + + + +G +L K+ + L Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL-----GKMTVAIVKALYY 139
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL-AKLALDANTHITTRVMGTFGYMAPE 539
L E +IHRD+K SNILLD + ++ DFG+ +L + R G YMAPE
Sbjct: 140 LKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPE 194
Query: 540 -----YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
+ ++DV+S G+ L+EL TG+ P +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 57/249 (22%), Positives = 102/249 (40%), Gaps = 61/249 (24%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL------KIGGGQGEREFKA-------------- 412
+G+G +G V Y D A+K L + G +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 413 ------EVEIISRIHHRHLVSL--VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDW 464
E+ I+ ++ H ++V L V ++D ++++ V PV++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV-----------NQGPVMEV 128
Query: 465 ATRVKIAAGAAR--------GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516
T ++ AR G+ YLH +IIHRDIK SN+L+ + +++DFG++
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 517 LALDANTHITTRVMGTFGYMAPEYASSGKLT---EKSDVFSFGVVLLELITGRKPVDASQ 573
++ ++ V GT +MAPE S + + DV++ GV L + G+ P
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM--- 241
Query: 574 PLGDESLVE 582
DE ++
Sbjct: 242 ---DERIMC 247
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 43/219 (19%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGERE-----FKAEVEIISRIHHRHL 425
LG G G V + ++VAI+ + K G + E+EI+ +++H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDW-ATRVKIAAGAAR------- 476
+ + + D ++ + + GE + D ++ +
Sbjct: 203 IKIKNFF--DAEDYYIVLELMEG--------GE---LFDKVVGNKRLKEATCKLYFYQML 249
Query: 477 -GLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
+ YLHE+ IIHRD+K N+LL + + +++DFG +K+ L + + T GT
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GT 304
Query: 533 FGYMAPE---YASSGKLTEKSDVFSFGVVLLELITGRKP 568
Y+APE + D +S GV+L ++G P
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLV 426
+G+G FG V + A+K + R E++I+ + H LV
Sbjct: 22 AIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHED 484
+L Y D+ + ++ D + L +HL + VK+ L YL
Sbjct: 79 NLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMALDYLQNQ 134
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
RIIHRD+K NILLD + ++DF +A + T + GT YMAPE SS
Sbjct: 135 ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSR 189
Query: 545 KLTE--KS-DVFSFGVVLLELITGRKP 568
K + D +S GV EL+ GR+P
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 50/246 (20%), Positives = 81/246 (32%), Gaps = 56/246 (22%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
+G+G +G V AIK +++ + K EV ++ ++HH ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAG--------------- 473
+ L+ + L L+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 474 ----------------AAR-------GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV- 509
+ L YLH I HRDIK N L N ++
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 510 -SDFGLAKL----ALDANTHITTRVMGTFGYMAPE--YASSGKLTEKSDVFSFGVVLLEL 562
DFGL+K +TT+ GT ++APE ++ K D +S GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 563 ITGRKP 568
+ G P
Sbjct: 270 LMGAVP 275
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G+G F V + GREVAIK + ++ ++ F+ EV I+ ++H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79
Query: 431 Y-CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLAY 480
+ I ++ L LI +Y ++ +L GR + AR + Y
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGR----------MKEKEARSKFRQIVSAVQY 129
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
H+ I+HRD+K+ N+LLD + +++DFG + + G Y APE
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPEL 184
Query: 541 ASSGKLTE--KSDVFSFGVVLLELITGRKPVDAS 572
GK + + DV+S GV+L L++G P D
Sbjct: 185 F-QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 374 LLGEGGFGSVY---KGYLPDGREV-AIKQLK---IGGGQGEREFKAEVEIISRIHHRHLV 426
+LG+G FG V+ K D R++ A+K LK + K E +I+ ++H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIV 89
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHED 484
L Y + +L LI D++ L+ L E + VK A A L +LH
Sbjct: 90 KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELALALDHLHSL 145
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASS 543
II+RD+K NILLD +++DFGL+K ++D GT YMAPE +
Sbjct: 146 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNR 200
Query: 544 GKLTEKSDVFSFGVVLLELITGRKP 568
T+ +D +SFGV++ E++TG P
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 109 bits (272), Expect = 1e-24
Identities = 72/241 (29%), Positives = 99/241 (41%), Gaps = 22/241 (9%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP--P 58
A+ P P S P +SP P S +TSP P P
Sbjct: 1519 FGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGL--TSPSYSPSSPGYSTSPAYMPSSP 1576
Query: 59 ASNP------PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP--PTISPPPPVSNP 110
+ +P PTS S +SP S P+ + + S P+ P+ SP P+ SP P +P
Sbjct: 1577 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSP 1636
Query: 111 PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS---NLPPPPPSSVEPPKRSPPSVP 167
+ S P S + P SP P+ P + PS P+ P P S P SP S
Sbjct: 1637 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1696
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPA-SPIAPRPSNSSPN-SPPPP 225
P S + P SP +P P S P+ +P +P+ SP +P S +SP+ SP P
Sbjct: 1697 YSPTSPSYSPTSPSYSPTSPSYSPTS-----PSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1751
Query: 226 S 226
S
Sbjct: 1752 S 1752
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 72/241 (29%), Positives = 94/241 (39%), Gaps = 17/241 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ P P P SS P + P SP S
Sbjct: 1508 LVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYST 1567
Query: 62 -PPTSSSPPASSP--PTSSPPPASNPPTSSPP-PSPPASSP--PTISPPPPVSNPPTRSP 115
P S P+ SP P+ SP S PTS P+ P+ S P+ SP P +P +
Sbjct: 1568 SPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSP---TS 1624
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P S T P SP SP P + S P++P + P P S P SP S P
Sbjct: 1625 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS-PTSPSYSPTSPSYSPTSPSYSPTSPSY 1683
Query: 176 SSSPPKNSPPAPIAVP--PSNVPPPPTQTPPTPA-SPIAPRPSNSSPNSPP-PPSTKRLS 231
S + P SP +P P PS P P+ +P +P+ SP +P SP SP P++ S
Sbjct: 1684 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY---SPTSPSYSPTSPSYS 1740
Query: 232 P 232
P
Sbjct: 1741 P 1741
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-23
Identities = 77/279 (27%), Positives = 104/279 (37%), Gaps = 24/279 (8%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
M A P V + SP +P AS
Sbjct: 1473 MGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGR---EGFGDYGLLGAAS 1529
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP-PTISPPPPVSNP--PTRSPPP 117
SP +SP +S+ P + S PS P S P P P +P P+ SP
Sbjct: 1530 PYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTS 1589
Query: 118 P--SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
P S T P SP SP + S P++P + P P S P SP S P P P
Sbjct: 1590 PSYSPTSPSYSPTSPSYSATSPSYSPTSPSYS-PTSPSYSPTSPSYSPTS--PSYSPTSP 1646
Query: 176 SSSP--PKNSPPAPIAVPPSNVPPP--PTQTPPTPA--------SPIAPRPSNSSPNSPP 223
S SP P SP +P P S P P+ +P +P+ SP +P S +SP+ P
Sbjct: 1647 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1706
Query: 224 PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPE-SSSSPS 261
+ + P P + + +P+SP S +SPS
Sbjct: 1707 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1745
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 92.1 bits (228), Expect = 3e-19
Identities = 54/234 (23%), Positives = 81/234 (34%), Gaps = 13/234 (5%)
Query: 41 PPPPVSKPPTTSPPPSPPASNPPTSS--SPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
P P SP P ++ SP + P SP
Sbjct: 1478 LPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPYKGVQSP 1537
Query: 99 PTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEP 158
SP +P S + P+SP S S P +P S P P+S
Sbjct: 1538 GYTSPFSSAMSP---GYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTS--PSYSPTS--- 1589
Query: 159 PKRSPPSVPPQNPPPPPSSSPPKNSP--PAPIAVPPSNVPPPPTQTPPTPA-SPIAPRPS 215
P SP S P S++ P SP P+ PS P P+ +P +P+ SP +P S
Sbjct: 1590 PSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1649
Query: 216 NSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAG 269
+SP+ P + + P P + + +P+SP S + + +
Sbjct: 1650 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1703
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 6e-17
Identities = 59/235 (25%), Positives = 82/235 (34%), Gaps = 15/235 (6%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
S P P + P SP S SP A+ P
Sbjct: 1460 SLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGF 1519
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPA--NSPPPSNPPSNLPPPPPSS 155
+SP S SP + P +SP S P+ +P P S
Sbjct: 1520 GDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYS 1579
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSP--PKNSPPAPIAVP--PSNVPPPPTQTPPTPA-SPI 210
P SP S P P PS SP P S +P P PS P P+ +P +P+ SP
Sbjct: 1580 PTSPSYSPTS--PSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPT 1637
Query: 211 APRPSNSSPNSPPP-PSTKRLSPPPGIPVPSTENTPGNGT--NPSSPESSSSPSN 262
+P + SP SP P++ SP P++ + +P+SP S + +
Sbjct: 1638 SP---SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1689
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 374 LLGEGGFGSVY---KGYLPDGREV-AIKQLK---IGGGQGEREF-KAEVEIISRIHHRHL 425
+LG+GG+G V+ K + ++ A+K LK I + KAE I+ + H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
V L+ Y +L LI +Y+ L+ L EG + D A + L +LH+
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEISMALGHLHQ 139
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
II+RD+K NI+L++ +++DFGL K ++ T T GT YMAPE
Sbjct: 140 K---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILM 194
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
D +S G ++ +++TG P
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LLGEG +G V + A+K LK GE K E++++ R+ H++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 429 --VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GL 478
V Y + ++ +Y + +LD + A GL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCV---------CGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD-ANTHITTRVMGTFGYMA 537
YLH I+H+DIK N+LL ++S G+A+ A G+ +
Sbjct: 123 EYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 538 PEYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
PE A+ K D++S GV L + TG P +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 35/172 (20%), Positives = 60/172 (34%), Gaps = 17/172 (9%)
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLY-FHLHGEGRPVLDWA 465
++ + ++ V + + L + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL-------- 517
+ I A + +LH ++HRD+K SNI + +V DFGL
Sbjct: 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 518 ----ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565
+ A T +V GT YM+PE + K D+FS G++L EL+
Sbjct: 222 TVLTPMPAYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 19/86 (22%), Positives = 37/86 (43%), Gaps = 12/86 (13%)
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-F 410
SR + +E + +G GGFG V++ D AIK++++ + RE
Sbjct: 2 SRYLTDFEPI----------QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV 51
Query: 411 KAEVEIISRIHHRHLVSLVGYCISDD 436
EV+ ++++ H +V +
Sbjct: 52 MREVKALAKLEHPGIVRYFNAWLETP 77
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 65/257 (25%), Positives = 110/257 (42%), Gaps = 44/257 (17%)
Query: 332 IGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDG 391
+ + P + +P D + + + + ++G G FG V++ L +
Sbjct: 5 MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES 64
Query: 392 REVAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLVSLVGYCISDDRRL------LIYDY 444
EVAIK++ ++ FK E++I+ + H ++V L + S+ + L+ +Y
Sbjct: 65 DEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAA----------RGLAYLHEDCHPRIIHRDI 494
VP T+Y ++K R LAY+H I HRDI
Sbjct: 120 VPE-TVY--------RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDI 167
Query: 495 KSSNILLD-NNFEAQVSDFGLAK--LALDANTH-ITTRVMGTFGYMAPE-YASSGKLTEK 549
K N+LLD + ++ DFG AK +A + N I +R Y APE + T
Sbjct: 168 KPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTN 222
Query: 550 SDVFSFGVVLLELITGR 566
D++S G V+ EL+ G+
Sbjct: 223 IDIWSTGCVMAELMQGQ 239
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGEREFKAEVEIISRIHHRHLVSL 428
+G+G F V + G++ A+K + G + K E I + H H+V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR----GLAYLHED 484
+ SD ++++++ L F + ++ V A+ R L Y H++
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYCHDN 149
Query: 485 CHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
IIHRD+K +LL +N+ ++ FG+A ++ RV GT +MAPE
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVV 205
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573
+ DV+ GV+L L++G P ++
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 35/210 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G FG V++ GR K + + K E+ I++++HH L++L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------KIAAGAAR----GLAY 480
+LI +++ G + D R+ R GL +
Sbjct: 119 DKYEMVLILEFL-----------SGGELFD---RIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGTFGYMAP 538
+HE I+H DIK NI+ + + V DFGLA L+ + + T + AP
Sbjct: 165 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK-LNPDEIVKVTT-ATAEFAAP 219
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E + +D+++ GV+ L++G P
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 46/235 (19%)
Query: 364 KATDGFADQ----NLLGEGGFGSVYKG-YLPDGREVAIK---------QLKIGGGQGERE 409
+T GF + +LG G V + + P +E A+K +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 410 FKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV 468
EV+I+ ++ H +++ L ++ L++D + GE + D+ T
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK--------GE---LFDYLTEK 118
Query: 469 -----KIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519
K R + LH+ I+HRD+K NILLD++ +++DFG + L
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ-L 174
Query: 520 DANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
D + GT Y+APE + ++ D++S GV++ L+ G P
Sbjct: 175 DPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G FG V K +E A+K + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLFE 88
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYL 481
++ + G + D + AA + G+ Y+
Sbjct: 89 ILEDSSSFYIVGELY-----------TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAP 538
H+ I+HRD+K NILL++ + + DFGL+ NT + R+ GT Y+AP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDRI-GTAYYIAP 192
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E G EK DV+S GV+L L++G P
Sbjct: 193 EVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V+ G E IK + Q E +AE+E++ + H +++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAG------AAR-------GLA 479
++ + GE +L+ + A LA
Sbjct: 90 EDYHNMYIVMETCEG--------GE---LLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYM 536
Y H ++H+D+K NIL + + DFGLA+L ++ H T GT YM
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNAA-GTALYM 193
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
APE +T K D++S GVV+ L+TG P
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
++G G FG V K + A+K L + + F+ E +++ + +
Sbjct: 81 VIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSKWI 136
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLH-GEGRPVLDWATRVKI-AAGAARGLAYLH 482
+L Y DD L L+ DY L L E R + A + A + +H
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA---RFYLAEMVIAIDSVH 192
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE--- 539
+ +HRDIK NIL+D N +++DFG ++ T ++ +GT Y++PE
Sbjct: 193 QL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 540 --YASSGKLTEKSDVFSFGVVLLELITGRKP 568
G+ + D +S GV + E++ G P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 374 LLGEGGFGSVY---KGYLPDGREV-AIKQLK---IGGGQGEREF-KAEVEIISRI-HHRH 424
+LG G +G V+ K D ++ A+K LK I E + E +++ I
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 425 LVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLH 482
LV+L Y + +L LI DY+ L+ HL R V+I L +LH
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLH 176
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE--- 539
+ II+RDIK NILLD+N ++DFGL+K + T GT YMAP+
Sbjct: 177 KL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 540 YASSGKLTEKS-DVFSFGVVLLELITGRKP 568
SG +K+ D +S GV++ EL+TG P
Sbjct: 234 GGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 41/218 (18%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGERE-----FKAEVEIISRIHHRHL 425
LG G G V + ++VAIK + K G + E+EI+ +++H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR---- 476
+ + + + ++ + + GE + D
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEG--------GE---LFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTF 533
+ YLHE+ IIHRD+K N+LL + E ++DFG +K+ L + + T GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTP 180
Query: 534 GYMAPE---YASSGKLTEKSDVFSFGVVLLELITGRKP 568
Y+APE + D +S GV+L ++G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 42/210 (20%), Positives = 82/210 (39%), Gaps = 36/210 (17%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G FG V++ + K +K+ G + K E+ I++ HR+++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------KIAAGAAR----GLAY 480
S + ++I++++ G + + R+ + L +
Sbjct: 72 SMEELVMIFEFI-----------SGLDIFE---RINTSAFELNEREIVSYVHQVCEALQF 117
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGTFGYMAP 538
LH I H DI+ NI+ + + +FG A+ L + Y AP
Sbjct: 118 LHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAP 172
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKP 568
E ++ +D++S G ++ L++G P
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLKIGGGQGEREF---KAEVEIISRIHHRHLV 426
LLG+G FG V K GR A+K LK + E E ++ H L
Sbjct: 155 LLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 427 SLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHED 484
+L Y RL + +Y L+FHL E D R + A L YLH +
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVSALDYLHSE 267
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYASS 543
+ +++RD+K N++LD + +++DFGL K + T + GT Y+APE
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLED 323
Query: 544 GKLTEKSDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 45/207 (21%), Positives = 78/207 (37%), Gaps = 30/207 (14%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G +G V A K++ + FK E+EI+ + H +++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYLHED 484
+ L+ + G + + AA + +AY H+
Sbjct: 77 DNTDIYLVMELC-----------TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
+ HRD+K N L + + DFGLA + T+V GT Y++P+
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTKV-GTPYYVSPQ-V 179
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
G + D +S GV++ L+ G P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-23
Identities = 44/200 (22%), Positives = 80/200 (40%), Gaps = 30/200 (15%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL--KIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
LG+G F V + + G+E A + K + ++ + E I + H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYLH 482
+ LI+D V G + + A+ + + + H
Sbjct: 79 ISEEGHHYLIFDLV-----------TGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 483 EDCHPRIIHRDIKSSNILLDNNFE-AQV--SDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+ ++HR++K N+LL + + A V +DFGLA GT GY++PE
Sbjct: 128 QM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183
Query: 540 YASSGKLTEKSDVFSFGVVL 559
+ D+++ GV+L
Sbjct: 184 VLRKDPYGKPVDLWACGVIL 203
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-23
Identities = 59/276 (21%), Positives = 109/276 (39%), Gaps = 36/276 (13%)
Query: 309 PSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDG 368
+ + S P+ + V+ P P H +
Sbjct: 32 SRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT- 90
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
+ +LG G FG V+K G ++A K +K G + + E K E+ +++++ H +L+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------KIAAGAAR-- 476
L S + +L+ +YV +G + D R+ +
Sbjct: 151 LYDAFESKNDIVLVMEYV-----------DGGELFD---RIIDESYNLTELDTILFMKQI 196
Query: 477 --GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGT 532
G+ ++H+ I+H D+K NIL N Q+ DFGLA+ + GT
Sbjct: 197 CEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GT 251
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
++APE + ++ +D++S GV+ L++G P
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 58/259 (22%), Positives = 102/259 (39%), Gaps = 35/259 (13%)
Query: 327 SSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQ----NLLGEGGFGS 382
S L ++S G + + Y D +D + LG G
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68
Query: 383 VYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441
VY+ + A+K LK ++ + E+ ++ R+ H +++ L + L+
Sbjct: 69 VYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126
Query: 442 YDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYLHEDCHPRIIHR 492
+ V G + D + AA A + +AYLHE+ I+HR
Sbjct: 127 LELV-----------TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHR 172
Query: 493 DIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
D+K N+L ++DFGL+K+ ++ + T GT GY APE +
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC-GTPGYCAPEILRGCAYGPE 230
Query: 550 SDVFSFGVVLLELITGRKP 568
D++S G++ L+ G +P
Sbjct: 231 VDMWSVGIITYILLCGFEP 249
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG+G F V + G E A K + K+ ++ + E I ++ H ++V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHD 72
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GLAYL 481
+ L++D V GE + + A+ + +AY
Sbjct: 73 SIQEESFHYLVFDLVTG--------GE---LFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAP 538
H + I+HR++K N+LL + + ++DFGLA ++ + GT GY++P
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPGYLSP 176
Query: 539 EYASSGKLTEKSDVFSFGVVL 559
E ++ D+++ GV+L
Sbjct: 177 EVLKKDPYSKPVDIWACGVIL 197
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG G FG V G G +VA+K L KI + K E++ + H H++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 430 GY-CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
Y IS ++ +YV L+ ++ GR + AR +
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHGR----------VEEMEARRLFQQILSAVD 125
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
Y CH ++HRD+K N+LLD + A+++DFGL+ + D T+ G+ Y AP
Sbjct: 126 Y----CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAP 179
Query: 539 EYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
E SG+L + D++S GV+L L+ G P D
Sbjct: 180 EVI-SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 36/214 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGERE-FKAEVEIISRIHHRHLVS 427
LG G F V K G E A K Q + RE + EV I+ ++ H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GL 478
L + +LI + V GE + D+ + + A + G+
Sbjct: 80 LHDVYENRTDVVLILELVSG--------GE---LFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMGTFG 534
YLH +I H D+K NI+L + + DFGLA ++ GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPE 183
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
++APE + L ++D++S GV+ L++G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 28/209 (13%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKI--GGGQGEREFKAEVEIISRI-HHRHLVSLVG 430
LG G F V + G+E A K LK G E E+ ++ +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGE--GRPVLDWATRV--KIAAGAAR----GLAYLH 482
+ +LI +Y GE + + A V + G+ YLH
Sbjct: 97 VYENTSEIILILEYAA--------GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
++ I+H D+K NILL + + + DFG+++ + + + GT Y+APE
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELREIM-GTPEYLAPE 203
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ +T +D+++ G++ L+T P
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 25/220 (11%)
Query: 367 DGFADQNLLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIIS 418
D F LG G FG V K G A+K L + Q E E I+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEH-TLNEKRILQ 96
Query: 419 RIHHRHLVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAAR 476
++ LV L + D+ L ++ +YV ++ HL GR A + AA
Sbjct: 97 AVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---RFYAAQIVL 152
Query: 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYM 536
YLH +I+RD+K N+L+D QV+DFG AK T + GT +
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEAL 205
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
APE S + D ++ GV++ E+ G P A QP+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 53/238 (22%), Positives = 97/238 (40%), Gaps = 40/238 (16%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQ----NLLGEGGFGSVYKGY-LPDGREVAI 396
+ GG R E ++ A+ F+D LG+G F V + G E A
Sbjct: 3 HMASMTGGQQMGRGS---EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 397 KQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFH 453
K + K+ ++ + E I ++ H ++V L + L++D V
Sbjct: 60 KIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG------ 112
Query: 454 LHGEGRPVLDWATRV-----KIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNN 504
GE + + A+ + +AY H + I+HR++K N+LL +
Sbjct: 113 --GE---LFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK 164
Query: 505 FEAQ---VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVL 559
+ ++DFGLA ++ + GT GY++PE ++ D+++ GV+L
Sbjct: 165 AKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 374 LLGEGGFGSV----YKGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
LLG+G FG V K GR A+K L+ I + E ++ H L
Sbjct: 12 LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFL 67
Query: 426 VSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
+L Y + DR + +Y L+FHL E + R + A L YLH
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVSALEYLHS 123
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
+++RDIK N++LD + +++DFGL K + T + GT Y+APE
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV-- 176
Query: 543 SGKLTEKS-----DVFSFGVVLLELITGRKP 568
L + D + GVV+ E++ GR P
Sbjct: 177 ---LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 6e-22
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 29/213 (13%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
++G G F V K G+ A+K + + G+ F+ E +++ R +
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWI 123
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
L + D+ L L+ +Y L L G + + A + +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA--EMARFYLAEIVMAIDSVHR 180
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPE--- 539
+HRDIK NILLD +++DFG L A+ + + V GT Y++PE
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCL-KLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 540 ----YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+G + D ++ GV E+ G+ P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 50/228 (21%), Positives = 86/228 (37%), Gaps = 38/228 (16%)
Query: 360 EELVKATDGFADQ----NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEV 414
++L + + F D +G G + + E A+K + E +
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66
Query: 415 EIISR-IHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV----- 468
EI+ R H ++++L ++ + + GE +LD R
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG--------GE---LLDKILRQKFFSE 115
Query: 469 KIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALD 520
+ A+ + YLH ++HRD+K SNIL + + DFG AK
Sbjct: 116 REASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
N + T T ++APE D++S GV+L ++TG P
Sbjct: 173 ENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 9e-22
Identities = 55/282 (19%), Positives = 98/282 (34%), Gaps = 41/282 (14%)
Query: 309 PSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHS--RSMFTYEELVKAT 366
P + K + + G + + + +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 367 DGFADQ----NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH 421
D D LG G FG V++ G A K + + + E++ +S +
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------KIAA 472
H LV+L D+ ++IY+++ G + + +V A
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFM-----------SGGELFE---KVADEHNKMSEDEAV 258
Query: 473 GAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHIT 526
R GL ++HE+ +H D+K NI+ ++ DFGL LD +
Sbjct: 259 EYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVK 314
Query: 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
GT + APE A + +D++S GV+ L++G P
Sbjct: 315 VTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 47/211 (22%), Positives = 86/211 (40%), Gaps = 38/211 (18%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYC 432
LGEG F K + A+K + + E + E+ + H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV--------KIAAGAAR----GLAY 480
L+ + + G + + R+ A+ R +++
Sbjct: 76 HDQLHTFLVMELL-----------NGGELFE---RIKKKKHFSETEASYIMRKLVSAVSH 121
Query: 481 LHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
+H+ ++HRD+K N+L ++N E ++ DFG A+L N + T T Y A
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
PE + E D++S GV+L +++G+ P
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
++G G FG V K + A+K L I F E +I++ + +
Sbjct: 76 VIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWV 131
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
V L Y DDR L ++ +Y+P L + WA + A L +H
Sbjct: 132 VQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWA---RFYTAEVVLALDAIHS 186
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPE--- 539
IHRD+K N+LLD + +++DFG ++ + GT Y++PE
Sbjct: 187 M---GFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 540 -YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
G + D +S GV L E++ G P A
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-- 409
YE+L LGEG F +VYK + VAIK++K+G ++
Sbjct: 6 KSRAKRYEKLDF----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI 55
Query: 410 -FKA--EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWAT 466
A E++++ + H +++ L+ L++D++ + L + L +
Sbjct: 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLV-LTPSH 113
Query: 467 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526
+GL YLH+ I+HRD+K +N+LLD N +++DFGLAK N T
Sbjct: 114 IKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170
Query: 527 TRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
+V+ T Y APE Y D+++ G +L EL+
Sbjct: 171 HQVV-TRWYRAPELLFGARMYGVG------VDMWAVGCILAELLLRV 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 53/219 (24%), Positives = 83/219 (37%), Gaps = 42/219 (19%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQL---KIGGGQGEREFKA-----EVEIISRIHHRHL 425
LG G FG V+ +EV +K + K+ + K E+ I+SR+ H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYF---HLHGEGRPVLDW-ATRVKIAAGAAR----- 476
+ + D N + HG G + + ++ A
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 477 ---GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTF 533
+ YL IIHRDIK NI++ +F ++ DFG A L+ T GT
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTFC-GTI 193
Query: 534 GYMAPEYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
Y APE G + +++S GV L L+ P
Sbjct: 194 EYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 39/216 (18%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGG--GQGEREFKAEVEIISRIHHRHLVS 427
LGEG +G V VA+K + + ++E + I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
G+ + + L +Y L+ + + + A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLMAGVV 119
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT--HITTRVMGTFGYM 536
Y H I HRDIK N+LLD ++SDFGLA + N + GT Y+
Sbjct: 120 Y----LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174
Query: 537 APEYASSGKL--TEKSDVFSFGVVLLELITGRKPVD 570
APE + E DV+S G+VL ++ G P D
Sbjct: 175 APELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 42/217 (19%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGERE-FKAEVEIISRIHHRHLVS 427
LG G F V K G + A K + K RE + EV I+ I H ++++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV--------KIAAGAAR--- 476
L + +LI + V G + D + + A +
Sbjct: 79 LHEVYENKTDVILILELV-----------AGGELFD---FLAEKESLTEEEATEFLKQIL 124
Query: 477 -GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMG 531
G+ YLH +I H D+K NI+L + + + DFGLA +D G
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIF-G 179
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T ++APE + L ++D++S GV+ L++G P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 48/215 (22%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE---FKA--EVEIISRI 420
+ +GEG +G+V+K VA+K++++ + E A E+ ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKEL 58
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
H+++V L SD + L++++ + L + LD +GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGD-LDPEIVKSFLFQLLKGLGF 116
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE- 539
H ++HRD+K N+L++ N E ++++FGLA+ + V+ T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 540 ------YASSGKLTEKSDVFSFGVVLLELITGRKP 568
Y++S D++S G + EL +P
Sbjct: 173 LFGAKLYSTS------IDMWSAGCIFAELANAGRP 201
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRIHHRHL 425
LG G FG V+ + +GR A+K LK + Q E E ++S + H +
Sbjct: 13 TLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVTHPFI 68
Query: 426 VSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLHE 483
+ + D +++ +I DY+ L+ L R K AA L YLH
Sbjct: 69 IRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCLALEYLHS 124
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
II+RD+K NILLD N +++DFG AK D T + GT Y+APE S
Sbjct: 125 K---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVS 176
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576
+ + D +SFG+++ E++ G P S +
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 63/237 (26%), Positives = 111/237 (46%), Gaps = 37/237 (15%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKI 401
+ L M Y++L K +GEG +G VYK GR VA+K++++
Sbjct: 6 HHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAKDSQGRIVALKRIRL 55
Query: 402 GGGQGERE---FKA--EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG 456
E E A E+ ++ +HH ++VSL+ S+ L+++++ + L L
Sbjct: 56 DA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDE 111
Query: 457 EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516
L + RG+A+ H+ RI+HRD+K N+L++++ +++DFGLA+
Sbjct: 112 NKTG-LQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167
Query: 517 LALDANTHITTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
T V+ T Y AP+ Y++S D++S G + E+ITG+
Sbjct: 168 AFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS------VDIWSIGCIFAEMITGK 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGER------EFKAEVEIISRIHHRHLVS 427
LG G F V K G E A K +K + R E + EV I+ ++ H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV-----KIAAGAAR----GL 478
L + +LI + V GE + D+ + + A + G+
Sbjct: 80 LHDVYENRTDVVLILELVSG--------GE---LFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 479 AYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMGTFG 534
YLH +I H D+K NI+L + + DFGLA ++ GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPE 183
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
++APE + L ++D++S GV+ L++G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 48/241 (19%)
Query: 349 GLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE 407
G S + YE + + +G G +G+VYK G VA+K +++
Sbjct: 1 GPLGSMATSRYEPVAE----------IGVGAYGTVYKARDPHSGHFVALKSVRVPN---G 47
Query: 408 REFKAEV------EI-----ISRIHHRHLVSL----VGYCISDDRRL-LIYDYVPNNTLY 451
+ E+ + H ++V L + ++ L++++V + L
Sbjct: 48 GGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LR 106
Query: 452 FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511
+L P L T + RGL +LH + I+HRD+K NIL+ + +++D
Sbjct: 107 TYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163
Query: 512 FGLAKLALDANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELITG 565
FGLA+ +T V+ T Y APE YA+ D++S G + E+
Sbjct: 164 FGLAR-IYSYQMALTPVVV-TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRR 215
Query: 566 R 566
+
Sbjct: 216 K 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-21
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 42/217 (19%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIK-----QLKIGGGQGERE-FKAEVEIISRIHHRHLVS 427
LG G F V K G+E A K +L RE + EV I+ I H ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV--------KIAAGAAR--- 476
L + +LI + V GE + D + A +
Sbjct: 73 LHDIFENKTDVVLILELVSG--------GE---LFD---FLAEKESLTEDEATQFLKQIL 118
Query: 477 -GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKLALDANTHITTRVMG 531
G+ YLH RI H D+K NI+L + + DFG+A ++A G
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNIF-G 173
Query: 532 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T ++APE + L ++D++S GV+ L++G P
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-21
Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGERE---FKA--EVEIISRIH 421
+ + +GEG +G VYK G A+K++++ E E E+ I+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELK 58
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
H ++V L + R +L+++++ + + G L+ T G+AY
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAY 115
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE- 539
H+ R++HRD+K N+L++ E +++DFGLA+ T ++ T Y AP+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDV 171
Query: 540 ------YASSGKLTEKSDVFSFGVVLLELITGR 566
Y+++ D++S G + E++ G
Sbjct: 172 LMGSKKYSTT------IDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 38/227 (16%)
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-F 410
+SM YE L +GEG +G V K GR VAIK+ + +
Sbjct: 21 FQSMEKYENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMV 67
Query: 411 KA----EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWAT 466
K E++++ ++ H +LV+L+ C R L++++V + + L LD+
Sbjct: 68 KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNG-LDYQV 125
Query: 467 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526
K G+ + H H IIHRDIK NIL+ + ++ DFG A+
Sbjct: 126 VQKYLFQIINGIGFCHS--H-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 527 TRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
V T Y APE Y + DV++ G ++ E+ G
Sbjct: 183 DEVA-TRWYRAPELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LGEG FG V ++VA+K + + + E+ + + H H++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 430 GY-CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
Y I+ + ++ +Y L+ ++ + R + R +
Sbjct: 75 -YDVITTPTDIVMVIEYA-GGELFDYIVEKKR----------MTEDEGRRFFQQIICAIE 122
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
Y CH I+HRD+K N+LLD+N +++DFGL+ + D N T+ G+ Y AP
Sbjct: 123 Y----CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAP 176
Query: 539 EYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
E +GKL + DV+S G+VL ++ GR P D
Sbjct: 177 EVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 61/292 (20%), Positives = 113/292 (38%), Gaps = 41/292 (14%)
Query: 293 RRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGH 352
RR ++E+ L + S D A +G
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79
Query: 353 SRSMFTYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIK-------QLKIGGG 404
+ + + + ++++G G V + + G E A+K +L
Sbjct: 80 EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139
Query: 405 QGERE-FKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL 462
+ RE + E I+ ++ H H+++L+ S L++D + GE +
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK--------GE---LF 188
Query: 463 DWATRV-----KIAAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513
D+ T K R +++LH + I+HRD+K NILLD+N + ++SDFG
Sbjct: 189 DYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245
Query: 514 LAKLALDANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVL 559
+ L+ + GT GY+APE + ++ D+++ GV+L
Sbjct: 246 FSCH-LEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 39/216 (18%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGG--GQGEREFKAEVEIISRIHHRHLVS 427
LGEG +G V VA+K + + ++E + I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
G+ + + L +Y L+ + + + A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLMAGVV 119
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT--HITTRVMGTFGYM 536
Y H I HRDIK N+LLD ++SDFGLA + N + GT Y+
Sbjct: 120 Y----LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174
Query: 537 APEYASSGKL--TEKSDVFSFGVVLLELITGRKPVD 570
APE + E DV+S G+VL ++ G P D
Sbjct: 175 APELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 58/256 (22%), Positives = 98/256 (38%), Gaps = 55/256 (21%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
+LGEG V L +E A+K ++ G EVE++ + HR+++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI----------AAGAAR----G 477
+DR L+++ + G +L I A+ +
Sbjct: 80 FEEEDRFYLVFEKM-----------RGGSILS-----HIHKRRHFNELEASVVVQDVASA 123
Query: 478 LAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAK-------LALDANTHITT 527
L +LH I HRD+K NIL + ++ DF L + + + T
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 528 RVMGTFGYMAPE-----YASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582
G+ YMAPE + ++ D++S GV+L L++G P S
Sbjct: 181 PC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC----GSDCG 235
Query: 583 WARPLLSHALENEEFD 598
W R A +N F+
Sbjct: 236 WDRGEACPACQNMLFE 251
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 47/230 (20%)
Query: 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKA-EVEII---S 418
K D F + + G+G FG+V G G VAIK K+ + F+ E++I+ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK--KV---IQDPRFRNRELQIMQDLA 74
Query: 419 RIHHRHLVSLVGYCISDDRR-------LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIA 471
+HH ++V L Y + R ++ +YVP+ TL+ R ++A
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLH--------RCCRNYYRRQVA 125
Query: 472 AGAA----------RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLA-- 518
R + LH + HRDIK N+L++ + ++ DFG AK
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 519 LDANTH-ITTRVMGTFGYMAPEY-ASSGKLTEKSDVFSFGVVLLELITGR 566
+ N I +R Y APE + T D++S G + E++ G
Sbjct: 185 SEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 58/250 (23%), Positives = 92/250 (36%), Gaps = 56/250 (22%)
Query: 342 NSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQL- 399
P + Y+ VK +G G FG VA+K +
Sbjct: 5 PVTTGPLDMPIMHDSDRYD-FVK---------DIGSGNFGVARLMRDKLTKELVAVKYIE 54
Query: 400 --KIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE 457
+RE + + H ++V ++ +I +Y LY +
Sbjct: 55 RGAAIDENVQRE----IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA 110
Query: 458 GRPVLDWATRVKIAAGAAR--------GLAYLHEDCHPR-IIHRDIKSSNILLDNNFEAQ 508
GR + AR G++Y CH I HRD+K N LLD + +
Sbjct: 111 GR----------FSEDEARFFFQQLLSGVSY----CHSMQICHRDLKLENTLLDGSPAPR 156
Query: 509 --VSDFGLAKLALDANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLL 560
+ DFG +K ++ + +T +GT Y+APE Y GK +DV+S GV L
Sbjct: 157 LKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLY 209
Query: 561 ELITGRKPVD 570
++ G P +
Sbjct: 210 VMLVGAYPFE 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL------KIGGGQGEREFKAEVEIISRIHHR--H 424
LLG GGFGSVY G + D VAIK + G EV ++ ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 425 LVSLVGYCISDDRRLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++ L+ + D +LI + P L+ + G L + +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRH--- 164
Query: 484 DCHPR-IIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
CH ++HRDIK NIL+D N E ++ DFG AL +T T GT Y PE+
Sbjct: 165 -CHNCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFD-GTRVYSPPEWI 220
Query: 542 SSGKLT-EKSDVFSFGVVLLELITGRKPVD 570
+ + V+S G++L +++ G P +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLV 429
LG G FG V G G +VA+K L KI + + E++ + H H++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 430 GY-CISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAAR--------GLA 479
Y IS + ++ +YV L+ ++ GR + +R G+
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNGR----------LDEKESRRLFQQILSGVD 130
Query: 480 YLHEDCHPR-IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP 538
Y CH ++HRD+K N+LLD + A+++DFGL+ + D T+ G+ Y AP
Sbjct: 131 Y----CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAP 184
Query: 539 EYASSGKLTE--KSDVFSFGVVLLELITGRKPVD 570
E SG+L + D++S GV+L L+ G P D
Sbjct: 185 EVI-SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 56/254 (22%), Positives = 96/254 (37%), Gaps = 48/254 (18%)
Query: 333 GSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDG 391
G+ + S+ Y + K LGEG +G VYK
Sbjct: 10 GTLEAQTQGPGSMSVSAAPSATSIDRYRRITK----------LGEGTYGEVYKAIDTVTN 59
Query: 392 REVAIKQLKIGGGQGERE---FKA--EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446
VAIK++++ E E A EV ++ + HR+++ L + R LI++Y
Sbjct: 60 ETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116
Query: 447 NNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504
N+ L + P + G+ + H R +HRD+K N+LL +
Sbjct: 117 ND-----LKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVS 168
Query: 505 FEAQ-----VSDFGLAKLALDANTHITTRVMGTFGYMAPE-------YASSGKLTEKSDV 552
++ + DFGLA+ T ++ T Y PE Y++S D+
Sbjct: 169 DASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTS------VDI 221
Query: 553 FSFGVVLLELITGR 566
+S + E++
Sbjct: 222 WSIACIWAEMLMKT 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 59/237 (24%), Positives = 105/237 (44%), Gaps = 46/237 (19%)
Query: 351 GHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKG--YLPDGREVAIKQLKIGGGQGER 408
G R+ YE + + +GEG +G V+K GR VA+K++++ Q
Sbjct: 5 GLCRADQQYECVAE----------IGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGE 51
Query: 409 E---FKAEVEI-----ISRIHHRHLVSL----VGYCISDDRRL-LIYDYVPNNTLYFHLH 455
E E+ + H ++V L + +L L++++V + L +L
Sbjct: 52 EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLD 110
Query: 456 GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515
P + T + RGL +LH R++HRD+K NIL+ ++ + +++DFGLA
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 516 KLALDANTHITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELITGR 566
+ +T+ V+ T Y APE YA+ D++S G + E+ +
Sbjct: 168 R-IYSFQMALTSVVV-TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRRK 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 374 LLGEGGFGSV----YKGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRI-HHRH 424
+LG+G FG V KG A+K LK I E E +++
Sbjct: 27 VLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECT-MVEKRVLALPGKPPF 82
Query: 425 LVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
L L C + DR + +YV L +H+ GR A V AA A GL +L
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQS 139
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
II+RD+K N++LD+ +++DFG+ K + TT+ GT Y+APE +
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIA 194
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
+ D ++FGV+L E++ G+ P
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 93.0 bits (230), Expect = 1e-19
Identities = 29/168 (17%), Positives = 46/168 (27%), Gaps = 6/168 (3%)
Query: 19 PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSP 78
P + P+ P + PP P + + PP P+ +P
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQL 69
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
+ T+S + P P P P P P + P
Sbjct: 70 HQQIDQATTSMNDMHLHNVPL---VDPNAYMQP---QVPVQMGTPLQQQQQPMAAPAYGQ 123
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
P + + P ++ PP + PPPP PP+
Sbjct: 124 PSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVP 171
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 89.9 bits (222), Expect = 1e-18
Identities = 32/190 (16%), Positives = 48/190 (25%), Gaps = 6/190 (3%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ P ++ P PA P P + PP + P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIA 189
+++ + P P P P P P+A
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHN--VPLVDPN--AYMQPQVPVQMGTPLQQQQQPMA 117
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGT 249
P P P + P + PPP + L PPP + P P +
Sbjct: 118 APAYGQPSAAMGQNMRPMNQ--LYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELS 175
Query: 250 NPSSPESSSS 259
N S S+
Sbjct: 176 NASPDYIRST 185
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 88.3 bits (218), Expect = 3e-18
Identities = 32/206 (15%), Positives = 53/206 (25%), Gaps = 7/206 (3%)
Query: 1 MSAPSPG---PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSP 57
MS P+ P PP P + + PP + P
Sbjct: 1 MSHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQD---PAAAGMSYGQMGMPPQGAVPSMG 57
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
+ ++ + P P A P + + P
Sbjct: 58 QQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMA 117
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS 177
+ P++ P N P + + LPPP PP P S+
Sbjct: 118 APAYGQPSAAMGQNMRPM-NQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSN 176
Query: 178 SPPKNSPPAPIAVPPSNVPPPPTQTP 203
+ P AVP ++ ++ P
Sbjct: 177 ASPDYIRSTLNAVPKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 88.0 bits (217), Expect = 5e-18
Identities = 23/185 (12%), Positives = 35/185 (18%)
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
S + P + PP S P P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 147 NLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P + + + P P P+ + P
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAY 121
Query: 207 ASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIG 266
P A N P + P PP I + P S + +
Sbjct: 122 GQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDY 181
Query: 267 TAGTV 271
T+
Sbjct: 182 IRSTL 186
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 86.0 bits (212), Expect = 2e-17
Identities = 26/188 (13%), Positives = 48/188 (25%), Gaps = 5/188 (2%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
P + + P PP P + P P + +P
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQD-PAAAGMSYGQMGMPPQ--GAVPSMGQQQFLTPAQ 66
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP--KRSPPSVPPQNPPPPP 175
+ + +D ++ P +P + + P P + P ++ P P P
Sbjct: 67 EQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSA 126
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPG 235
+ + PPP P P+ P S ++
Sbjct: 127 AMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTL 186
Query: 236 IPVPSTEN 243
VP +
Sbjct: 187 NAVPKNSS 194
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 79.9 bits (196), Expect = 1e-15
Identities = 32/210 (15%), Positives = 46/210 (21%), Gaps = 5/210 (2%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS- 60
+A PA P + P S ++ A+
Sbjct: 19 NATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATT 78
Query: 61 --NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
N + P P P + + P P R
Sbjct: 79 SMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQL 138
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS--VPPQNPPPPPS 176
P P +D PP PP + P S P + P+N
Sbjct: 139 YPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNAVPKNSSLLKK 198
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
S P P ++ PPP
Sbjct: 199 SKLPFGLVIRPYQHLYDDIDPPPLNEDGLI 228
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 5e-06
Identities = 15/153 (9%), Positives = 25/153 (16%), Gaps = 26/153 (16%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
S P N+ P P +PP P++ Q PP
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAA-------AGMSYGQMGMPPQG--- 51
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P + + P P
Sbjct: 52 ----------------AVPSMGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNA 95
Query: 240 STENTPGNGTNPSSPESSSSPSNNGIGTAGTVV 272
+ + + G +
Sbjct: 96 YMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAM 128
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 38/224 (16%)
Query: 356 MFTYEELVKATDGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE-FKA- 412
M YE++ K +GEG +G V+K G+ VAIK+ + K
Sbjct: 2 MEKYEKIGK----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKI 48
Query: 413 ---EVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
E+ ++ ++ H +LV+L+ R L+++Y + + L R +
Sbjct: 49 ALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDRYQRG-VPEHLVKS 106
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRV 529
I + + + H+ H IHRD+K NIL+ + ++ DFG A+L + + V
Sbjct: 107 ITWQTLQAVNFCHK--H-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 530 MGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
T Y +PE Y DV++ G V EL++G
Sbjct: 164 A-TRWYRSPELLVGDTQYGPP------VDVWAIGCVFAELLSGV 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 45/221 (20%)
Query: 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLV 426
+ D ++G G FG VY+ L G VAIK++ ++ FK E++I+ ++ H ++V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 427 SLVGYCISDDRRL------LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA----- 475
L + S + L+ DYVP T+Y V +R K
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY--------RVARHYSRAKQTLPVIYVKLY 161
Query: 476 -----RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLAL--DANTH-IT 526
R LAY+H I HRDIK N+LLD + ++ DFG AK + + N I
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 527 TRVMGTFGYMAPEY-ASSGKLTEKSDVFSFGVVLLELITGR 566
+R Y APE + T DV+S G VL EL+ G+
Sbjct: 219 SRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 40/228 (17%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE-----R 408
S +++L K LG G + +VYKG G VA+K++K+ +G R
Sbjct: 3 SSSQFKQLEK----------LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR 52
Query: 409 EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNN--TLYFHLHGEGRPVLDWAT 466
E + ++ + H ++V L ++++ L+++++ N+ P
Sbjct: 53 E----ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELN 108
Query: 467 RVK-IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
VK +GLA+ HE+ +I+HRD+K N+L++ + ++ DFGLA+
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165
Query: 526 TTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
++ V+ T Y AP+ Y++S D++S G +L E+ITG+
Sbjct: 166 SSEVV-TLWYRAPDVLMGSRTYSTS------IDIWSCGCILAEMITGK 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQL------KIGGGQGEREFKAEVEIISRIH----H 422
LLG+GGFG+V+ G+ L D +VAIK + EV ++ ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 423 RHLVSLVGYCISDDRRLLIYDY-VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
++ L+ + + + +L+ + +P L+ ++ +G L + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQH- 154
Query: 482 HEDCHPR-IIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
CH R ++HRDIK NIL+D A++ DFG AL + T GT Y PE
Sbjct: 155 ---CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDFD-GTRVYSPPE 208
Query: 540 YASSGKLT-EKSDVFSFGVVLLELITGRKPVD 570
+ S + + V+S G++L +++ G P +
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISR-IHHRH 424
++G+G FG V K + A+K L+ + + + +E ++ + + H
Sbjct: 45 VIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHI-MSERNVLLKNVKHPF 100
Query: 425 LVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLH 482
LV L + +L + DY+ L++HL E + R + AA A L YLH
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASALGYLH 156
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYA 541
I++RD+K NILLD+ ++DFGL K ++ N+ TT GT Y+APE
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVL 211
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
D + G VL E++ G P
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 46/220 (20%)
Query: 371 DQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSL 428
+ +LG G G V + + G++ A+K L + + EV+ + H+V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCI 87
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGE---GRPVLDWATRV----------KIAAGAA 475
+ +Y+ + + + E G + R+ + AA
Sbjct: 88 LD----------VYENMHHGKRCLLIIMECMEGGELFS---RIQERGDQAFTEREAAEIM 134
Query: 476 R----GLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTR 528
R + +LH I HRD+K N+L + + +++DFG AK + T
Sbjct: 135 RDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTP 189
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T Y+APE K + D++S GV++ L+ G P
Sbjct: 190 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRI-HHRH 424
++G G + V K R A+K +K + + E + + +H
Sbjct: 16 VIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWV-QTEKHVFEQASNHPF 71
Query: 425 LVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLH 482
LV L C ++ R + +YV L FH+ + + + + +A + L YLH
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLALNYLH 127
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYA 541
E II+RD+K N+LLD+ +++D+G+ K L TT GT Y+APE
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEIL 182
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
D ++ GV++ E++ GR P
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 6e-19
Identities = 79/415 (19%), Positives = 140/415 (33%), Gaps = 32/415 (7%)
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
PS+ + + + + P S +
Sbjct: 149 PSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSE 208
Query: 224 PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAVAVGIIAFS 283
+ P + + S + + + + +++ GI
Sbjct: 209 SKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQ 268
Query: 284 LIGLVVWCLRRRKKEVSGLNGVYIMPSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNS 343
G+ W ++E N +P P S + K + + G+ + +
Sbjct: 269 KAGVDGWFKLLSQEEGEYFN----VPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTAN 324
Query: 344 PQDPGGLGHSRSMFTYE--ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREV-AIKQLK 400
+R + +LG+G FG V E+ A+K LK
Sbjct: 325 TISKFDNNGNRDRMKLTDFNFLM---------VLGKGSFGKVMLSERKGTDELYAVKILK 375
Query: 401 ----IGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCI-SDDRRLLIYDYVPNNTLYFHL 454
I E E +++ L L C + DR + +YV L +H+
Sbjct: 376 KDVVIQDDDVECT-MVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI 433
Query: 455 HGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
GR A V AA A GL +L II+RD+K N++LD+ +++DFG+
Sbjct: 434 QQVGRFKEPHA--VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 488
Query: 515 AKLALDANTHITTRVM-GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
K + TT+ GT Y+APE + + D ++FGV+L E++ G+ P
Sbjct: 489 CKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 23/206 (11%)
Query: 374 LLGEGGFGSV----YKGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISR-IHHRH 424
+LG+G FG V +K + AIK LK + E E ++S H
Sbjct: 24 MLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEHPF 79
Query: 425 LVSLVGYCISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
L + L + +Y+ L +H+ + L A AA GL +LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA--TFYAAEIILGLQFLHS 136
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
I++RD+K NILLD + +++DFG+ K + + T GT Y+APE
Sbjct: 137 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILL 191
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
K D +SFGV+L E++ G+ P
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGE-----REFKAEVEIISRI 420
+ + + LGEG + +VYKG VA+K++++ +G RE ++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
H ++V+L ++ L+++Y+ + L +L G ++ RGLAY
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNI-INMHNVKLFLFQLLRGLAY 115
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE- 539
H +++HRD+K N+L++ E +++DFGLA+ V+ T Y P+
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171
Query: 540 ------YASSGKLTEKSDVFSFGVVLLELITGR 566
Y++ D++ G + E+ TGR
Sbjct: 172 LLGSTDYSTQ------IDMWGVGCIFYEMATGR 198
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRI-HHRH 424
+LG+G FG V K G A+K LK + E E I+S +H
Sbjct: 30 VLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPF 85
Query: 425 LVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
L L C + DR + ++V L FH+ R A AA L +LH+
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA--RFYAAEIISALMFLHD 142
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYAS 542
II+RD+K N+LLD+ +++DFG+ K + TT GT Y+APE
Sbjct: 143 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQ 197
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
D ++ GV+L E++ G P
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 56/246 (22%), Positives = 106/246 (43%), Gaps = 50/246 (20%)
Query: 346 DPGGLGHSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG 404
D + YE+L K +G+G FG V+K G++VA+K++ +
Sbjct: 6 DSVECPFCDEVSKYEKLAK----------IGQGTFGEVFKARHRKTGQKVALKKVLM--- 52
Query: 405 QGERE---FKA--EVEIISRIHHRHLVSLVGYCISDDRRL--------LIYDYVPNNTLY 451
+ E+E A E++I+ + H ++V+L+ C + L++D+ ++ L
Sbjct: 53 ENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LA 111
Query: 452 FHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511
L + ++ GL Y+H + +I+HRD+K++N+L+ + +++D
Sbjct: 112 GLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167
Query: 512 FGLAKL----ALDANTHITTRVMGTFGYMAPE-------YASSGKLTEKSDVFSFGVVLL 560
FGLA+ T RV+ T Y PE Y D++ G ++
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMA 220
Query: 561 ELITGR 566
E+ T
Sbjct: 221 EMWTRS 226
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 374 LLGEGGFGSVY----KGYLPDGREVAIKQLK----IGGGQGEREFKAEVEIISRI-HHRH 424
++G G + V K R A++ +K + + E + + +H
Sbjct: 59 VIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWV-QTEKHVFEQASNHPF 114
Query: 425 LVSLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKI-AAGAARGLAYLH 482
LV L C ++ R + +YV L FH+ + + + + +A + L YLH
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLALNYLH 170
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVM-GTFGYMAPEYA 541
E II+RD+K N+LLD+ +++D+G+ K L TT GT Y+APE
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEIL 225
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKP 568
D ++ GV++ E++ GR P
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 28/207 (13%), Positives = 56/207 (27%), Gaps = 43/207 (20%)
Query: 374 LLGEGGFGSVYKGYLPD---GREVAIKQLKIGGGQGE---REFKAEVEIISRIHHRHLVS 427
G ++ D R+VA+ + G + +E + +SRI +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
++ + L++ +++ +L P ++ A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA--- 148
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT 547
+ S + VS G LA M
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVLA-------------YPATMPDA-------N 180
Query: 548 EKSDVFSFGVVLLELITGRKPVDASQP 574
+ D+ G L L+ R P+ +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGV 207
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 7e-18
Identities = 42/167 (25%), Positives = 67/167 (40%), Gaps = 5/167 (2%)
Query: 404 GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLD 463
G R+ K V I R L S+ S + + + + L
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 464 WATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523
+ + A+G+ +L + IHRD+ + NILL ++ DFGLA+
Sbjct: 192 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 524 HI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKP 568
++ +MAPE T +SDV+SFGV+L E+ + G P
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 54/252 (21%), Positives = 91/252 (36%), Gaps = 55/252 (21%)
Query: 349 GLGHSRSMFTYE---ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ 405
G+ + EL + Q + G +G+V G +G VAIK ++
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIK--RVFNTV 58
Query: 406 GEREFKA-------------EVEIISRIHHRHLVSLVGYCISDDRRLL--IYDYVPNNTL 450
+ E+ +++ HH +++ L + + + +Y L
Sbjct: 59 SDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY-------L 111
Query: 451 YFHLHGEGRPVLDWATRVKIAAGAA---------------RGLAYLHEDCHPRIIHRDIK 495
L D A +V I GL LHE ++HRD+
Sbjct: 112 VTELMRT-----DLA-QV-IHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLH 161
Query: 496 SSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY-ASSGKLTEKSDVFS 554
NILL +N + + DF LA+ A+ + T V Y APE T+ D++S
Sbjct: 162 PGNILLADNNDITICDFNLAR-EDTADANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWS 219
Query: 555 FGVVLLELITGR 566
G V+ E+ +
Sbjct: 220 AGCVMAEMFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 50/244 (20%), Positives = 90/244 (36%), Gaps = 59/244 (24%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA-EVEIISRIHHRHLV 426
++ LG G FG V + + + G+ A+K++ + +K E++I+ + H +++
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNII 63
Query: 427 SL--VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---------------- 468
L Y D+ +N L +G
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 469 --KIAAGAA-------------------RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFE 506
K+ R + ++H I HRDIK N+L++ +
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNT 180
Query: 507 AQVSDFGLAKLAL--DANTH-ITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLEL 562
++ DFG AK + + + I +R Y APE + + T D++S G V EL
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 563 ITGR 566
I G+
Sbjct: 236 ILGK 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 41/219 (18%)
Query: 375 LGEGGFGSVYKG---YLPDGREVAIKQLKIGGGQGEREFKA--EVEIISRIHHRHLVSLV 429
+G G +G VYK D ++ A+KQ++ G A E+ ++ + H +++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQ 84
Query: 430 GYCISD-DRRL-LIYDYVPNN-TLYFHLHGEGR-----PVLDWATRVKIAAGAARGLAYL 481
+S DR++ L++DY ++ H + L + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQ----VSDFGLAKL---ALDANTHITTRVMGTFG 534
H + ++HRD+K +NIL+ + ++D G A+L L + V+ TF
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 535 YMAPE-------YASSGKLTEKSDVFSFGVVLLELITGR 566
Y APE Y T+ D+++ G + EL+T
Sbjct: 201 YRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 58/297 (19%), Positives = 102/297 (34%), Gaps = 60/297 (20%)
Query: 309 PSPLGSSSTTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFT--YEELVKAT 366
P P + + P P GL ++ Y+ +
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ-- 68
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRH 424
+LG G G V + + + A+K L+ + + EVE+ R H
Sbjct: 69 -------VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPH 116
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE---GRPVLDWATRVKI----------- 470
+V +V +Y+ + + E G + +I
Sbjct: 117 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS-----RIQDRGDQAFTER 161
Query: 471 -AAGAAR----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEA---QVSDFGLAKLALDAN 522
A+ + + YLH I HRD+K N+L + +++DFG AK ++
Sbjct: 162 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSH 217
Query: 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579
+TT T Y+APE K + D++S GV++ L+ G P ++ L
Sbjct: 218 NSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 81.5 bits (200), Expect = 4e-16
Identities = 21/215 (9%), Positives = 39/215 (18%), Gaps = 3/215 (1%)
Query: 10 AANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPP 69
++ P +N +S S ++ ++SP
Sbjct: 21 GEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVAT--ASETASPA 78
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
++ T+ A++ S + P+ P P +
Sbjct: 79 SNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAE 138
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-SSPPKNSPPAPI 188
P P + P + S S
Sbjct: 139 ANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGH 198
Query: 189 AVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
V Q S S
Sbjct: 199 LVNEKASKEAKVQALSNTNSKAKDHASVGGEEFKA 233
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 76.9 bits (188), Expect = 1e-14
Identities = 17/194 (8%), Positives = 41/194 (21%), Gaps = 3/194 (1%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
+ S N + + S+ + + +
Sbjct: 29 NSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASNEAATT--- 85
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
T+ + A+ P + + P++ P + + +
Sbjct: 86 ETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEANKTEKE 145
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
P N L P + E + SV + + +
Sbjct: 146 VQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGHLVNEKAS 205
Query: 183 SPPAPIAVPPSNVP 196
A+ +N
Sbjct: 206 KEAKVQALSNTNSK 219
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 75.4 bits (184), Expect = 4e-14
Identities = 21/213 (9%), Positives = 49/213 (23%), Gaps = 10/213 (4%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP 94
P++S + + + + A+ T+SP +
Sbjct: 26 VPENSGANTELVSGESEHSTNEAD---KQNEGEHARENKLEKAEGVATASETASPASNEA 82
Query: 95 ASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
A++ + P ++ + TP + P + A +
Sbjct: 83 ATTETA--EAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQ-----GDESKP 135
Query: 155 SVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
+ E K P + P + + + + +A R
Sbjct: 136 AAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRR 195
Query: 215 SNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGN 247
+ N K + + G
Sbjct: 196 TGHLVNEKASKEAKVQALSNTNSKAKDHASVGG 228
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 71.5 bits (174), Expect = 5e-13
Identities = 17/208 (8%), Positives = 46/208 (22%), Gaps = 2/208 (0%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ + T+ P + S +++ +
Sbjct: 8 HGHHHQLENLYFQGEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEG 67
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-- 176
+T + P+ + ++ E P + P
Sbjct: 68 VATASETASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEAT 127
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ ++ P A V P + P + ++ P +
Sbjct: 128 NQGDESKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRG 187
Query: 237 PVPSTENTPGNGTNPSSPESSSSPSNNG 264
V G+ N + + + + +
Sbjct: 188 SVVLASRRTGHLVNEKASKEAKVQALSN 215
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 69.6 bits (169), Expect = 2e-12
Identities = 22/206 (10%), Positives = 44/206 (21%), Gaps = 2/206 (0%)
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
+ P +S S + + + S + +
Sbjct: 21 GEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASN 80
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
++T S S + PS P K + ++ P +
Sbjct: 81 EAATTETAE-AASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEA 139
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
+ K P P + + P ++ S S G
Sbjct: 140 NKTEKEVQPDV-PKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRRTGH 198
Query: 237 PVPSTENTPGNGTNPSSPESSSSPSN 262
V + S+ S +
Sbjct: 199 LVNEKASKEAKVQALSNTNSKAKDHA 224
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 62.7 bits (151), Expect = 3e-10
Identities = 17/172 (9%), Positives = 32/172 (18%), Gaps = 3/172 (1%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P ++ S N A S P +
Sbjct: 24 TAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAE---GVATASETASPASN 80
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
+ + K S P +T P + S + +
Sbjct: 81 EAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAAEAN 140
Query: 223 PPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIA 274
+ P + + + G+VV+A
Sbjct: 141 KTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLA 192
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 2e-15
Identities = 42/261 (16%), Positives = 71/261 (27%), Gaps = 60/261 (22%)
Query: 352 HSRSMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG-------- 403
+ + + T+ +GEG FG V++ D VAIK + I G
Sbjct: 6 SQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 404 GQGEREFKAEVEIISRIH---------HRHLVSLVGYCISDDRR----LLIYDYV----- 445
+ E E+ I + + L L +D+
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 446 ---------PNNTLYFH---------LHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
++ L+ L + AT I LA
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR- 182
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAP--EYASSGK 545
HRD+ N+LL ++ K + + + G +Y S
Sbjct: 183 -FEHRDLHWGNVLLKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDYTLSRL 231
Query: 546 LTEKSDVFSFGVVLLELITGR 566
+ VF + +L TG
Sbjct: 232 ERDGIVVFCDVSMDEDLFTGD 252
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ + +T V+ T Y
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVV-TRYY 192
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
APE E D++S G ++ E+I G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 38/219 (17%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVE 415
+ +G G +GSV G +VAIK K+ R F++ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLS-----RPFQSEIFAKRAYRELL 75
Query: 416 IISRIHHRHLVSLVGYCISDDRRL------LIYDYVPNNTLYFHLHGEGRPVLDWATRVK 469
++ + H +++ L+ L+ ++ + L
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQKIMGLKFSEEKIQY 130
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTR 528
+ +GL Y+H ++HRD+K N+ ++ + E ++ DFGLA+ A T + TR
Sbjct: 131 LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187
Query: 529 VMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
Y APE S + D++S G ++ E++TG+
Sbjct: 188 W-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 3e-14
Identities = 24/124 (19%), Positives = 36/124 (29%), Gaps = 3/124 (2%)
Query: 15 SPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPP 74
S + + P P +S PP + P PP +P A +PP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS---TPPPNSPPSPP 131
+ + P P +S P + PP++ P P P
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 132 SDPP 135
DP
Sbjct: 123 PDPV 126
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 25/130 (19%), Positives = 36/130 (27%), Gaps = 3/130 (2%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
SS + P P S + AS + PP + P + PPP PA+
Sbjct: 3 SSHHHHH---HSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAG 59
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P + P T P +P + P + P
Sbjct: 60 NPPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHP 119
Query: 158 PPKRSPPSVP 167
P+ P V
Sbjct: 120 VPEPDPVRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 26/140 (18%), Positives = 36/140 (25%), Gaps = 11/140 (7%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS-NPPTSSPPPSPPASSPPTISP 103
+ S P AS +S A+ +PP + P P+PP P
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGN 60
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
PP S P+ P S P+ P P + PP
Sbjct: 61 PPD--------TVTGDSVLQR--ILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGR 110
Query: 164 PSVPPQNPPPPPSSSPPKNS 183
+ P P
Sbjct: 111 AVPGLYHHPVPEPDPVRVEE 130
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 28/134 (20%), Positives = 43/134 (32%), Gaps = 3/134 (2%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+ SS P S S + AS+ + PP + P + PPP + + P
Sbjct: 6 HHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTV 65
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
S I P + P T + P+ P P+ P + + P P
Sbjct: 66 TGDSVLQRILRGP--TGPGT-TSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 153 PSSVEPPKRSPPSV 166
P V + S
Sbjct: 123 PDPVRVEEVSRRIK 136
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 24/131 (18%), Positives = 37/131 (28%), Gaps = 5/131 (3%)
Query: 80 PASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP--SDPPAN 137
+ +S P P+ S S+ PP + P PP P +PP
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDT 64
Query: 138 SPPPSNPPSNLPPP---PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
S L P +S+ P R P+ P P ++ VP +
Sbjct: 65 VTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEPD 124
Query: 195 VPPPPTQTPPT 205
+
Sbjct: 125 PVRVEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 3e-11
Identities = 26/129 (20%), Positives = 35/129 (27%), Gaps = 7/129 (5%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
SS + P S+ S + AS PP P PPP P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDP---APPPPPAPAAG 59
Query: 126 SPPSPPSDPPANSPPPSNP-PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSS-SPPKNS 183
+P P + + P+ + R P P + PP P
Sbjct: 60 NP--PDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYH 117
Query: 184 PPAPIAVPP 192
P P P
Sbjct: 118 HPVPEPDPV 126
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 4e-11
Identities = 27/132 (20%), Positives = 40/132 (30%), Gaps = 6/132 (4%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
S+ V + P AS +S A+ P + P + PP +P
Sbjct: 3 SSHHHHHHSSGLVPRGS---HMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAG 59
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP--PSNLPP 150
P + S + PT P S P P + PA++PP + P
Sbjct: 60 NPPDTVTGDSVLQRILRGPTG-PGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHH 118
Query: 151 PPPSSVEPPKRS 162
P P
Sbjct: 119 PVPEPDPVRVEE 130
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 22/124 (17%), Positives = 32/124 (25%), Gaps = 2/124 (1%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP--PNSPPSPPSDPPANSPPPS 142
S + P P P+ P PP P A +PP +
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDT 64
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
++ P + + + P +P P A AVP P P
Sbjct: 65 VTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEPD 124
Query: 203 PPTP 206
P
Sbjct: 125 PVRV 128
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 9e-11
Identities = 21/127 (16%), Positives = 29/127 (22%), Gaps = 1/127 (0%)
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP-PSDPPANSPPPSNPPSNLPPPPPSS 155
S P PS++ + PP P P+ PP P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
S + P P ++S P + PP P P P
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 216 NSSPNSP 222
Sbjct: 123 PDPVRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 2e-10
Identities = 24/140 (17%), Positives = 37/140 (26%), Gaps = 11/140 (7%)
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
S P S PS + + S+ + L PP P P P
Sbjct: 7 HHHHSSGLVPRGSHMVIPS--ASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDT 64
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
S + P + PA +P +P S PP + + +
Sbjct: 65 VTGDSVLQRILRGPTGPGTT---------SLAPAVRYGRQPGPEAPASAPPAAGRAVPGL 115
Query: 234 PGIPVPSTENTPGNGTNPSS 253
PVP + +
Sbjct: 116 YHHPVPEPDPVRVEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 24/123 (19%), Positives = 29/123 (23%), Gaps = 2/123 (1%)
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKR 161
S + P P S S SD A PP P P PPP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPD--PAPPPPPAPAAGN 60
Query: 162 SPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNS 221
P +V + P + P P P + P
Sbjct: 61 PPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPV 120
Query: 222 PPP 224
P P
Sbjct: 121 PEP 123
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 20/112 (17%), Positives = 27/112 (24%), Gaps = 2/112 (1%)
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP--PPPTQTPPTPAS 208
SS P+ S +P + S PP + P P P P T
Sbjct: 8 HHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTG 67
Query: 209 PIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
+ P P S P P + + P P
Sbjct: 68 DSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHP 119
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 8e-08
Identities = 23/112 (20%), Positives = 31/112 (27%), Gaps = 8/112 (7%)
Query: 137 NSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ---NPPPPPSSSPPKNSPPAPIAVPPS 193
+S + S L P V P + PP P PPAP A P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 194 NVPPPPTQTPPTPASPI-----APRPSNSSPNSPPPPSTKRLSPPPGIPVPS 240
+ + P + P+ P P + P G VP
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPG 114
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 6e-06
Identities = 12/98 (12%), Positives = 21/98 (21%), Gaps = 1/98 (1%)
Query: 165 SVPPQNPPP-PPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
S + P+ ++ P T P P P + +PP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 224 PPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
T + P+ T +
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEA 100
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 8e-05
Identities = 19/102 (18%), Positives = 29/102 (28%), Gaps = 2/102 (1%)
Query: 161 RSPPSVP-PQNPPPP-PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSS 218
S P P S + + + + PP T P P P AP N
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 219 PNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSP 260
+R+ P P ++ PE+ +S
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASA 104
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 44/205 (21%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYC 432
LG G + V++ + + +V +K LK +++ K E++I+ + ++++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITL--AD 98
Query: 433 I----SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRV---KIAAGAARGLAYLHEDC 485
I L++++V N + + D+ R +I + L Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEIL----KALDYCHSM- 149
Query: 486 HPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
I+HRD+K N+++D + + ++ D+GLA+ + RV + + PE
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYFKGPELLVDY 205
Query: 545 KLTEKS-DVFSFGVVLLELITGRKP 568
++ + S D++S G +L +I ++P
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 42/228 (18%), Positives = 88/228 (38%), Gaps = 44/228 (19%)
Query: 375 LGEGGFGSVYKGY---------LPDGREVAIK------QLKIGGGQGEREFKA-EVEIIS 418
G +Y+ P ++ ++K +L +R K +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 419 RIHHRHLV---SLVGYCISDDR-RLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAG 473
+++ L+ + +G+ + D+ R L+ + + L L + VL + +++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKHVLSERSVLQVACR 167
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTR--- 528
L +LHE+ +H ++ + NI +D ++QV + +G A + H+
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 529 ---VMGTFGYMAPEYAS----SGK-LTEKSDVFSFGVVLLELITGRKP 568
G E+ S G + +SD+ S G +L+ + G P
Sbjct: 225 RSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 44/229 (19%), Positives = 86/229 (37%), Gaps = 58/229 (25%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIH-------- 421
LG G F +V+ + + VA+K ++ + +A E++++ R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR----GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 422 ---HRHLVSLVGY-----------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLD 463
H++ L+ + + + +L + + L
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKYEHRGIPLI-------- 131
Query: 464 WATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ------VSDFGLAKL 517
+ +I+ GL Y+H C IIH DIK N+L++ + ++D G
Sbjct: 132 -YVK-QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG---N 184
Query: 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
A + H T + Y +PE +D++S ++ ELITG
Sbjct: 185 ACWYDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 55/213 (25%), Positives = 85/213 (39%), Gaps = 34/213 (15%)
Query: 375 LGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G FG +Y G + G EVAIK + + E +I + + + +C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 434 SDDR-RLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
++ +++ + + P+ F+ T + +A + Y+H IH
Sbjct: 75 AEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIH 128
Query: 492 RDIKSSNILL---DNNFEAQVSDFGLAKLALDANT--HITTR----VMGTFGYMAPEYAS 542
RD+K N L+ + DFGLAK DA T HI R + GT YAS
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT-----ARYAS 183
Query: 543 ----SGKLTEKS---DVFSFGVVLLELITGRKP 568
G E+S D+ S G VL+ G P
Sbjct: 184 INTHLGI--EQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 50/215 (23%), Positives = 82/215 (38%), Gaps = 36/215 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQ--LKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+GEG FG +++G L + ++VAIK + Q E++ + + V Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR----TYKLLAGCTGIPNVYY 73
Query: 432 CISDDR-RLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
+ +L+ D + P+ L G T A + +HE +
Sbjct: 74 FGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---L 127
Query: 490 IHRDIKSSNILLDNNFEAQ-----VSDFGLAKLALDANT--HITTR----VMGTFGYMAP 538
++RDIK N L+ V DFG+ K D T HI R + GT
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----A 182
Query: 539 EYAS----SGK-LTEKSDVFSFGVVLLELITGRKP 568
Y S G+ + + D+ + G V + + G P
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 44/217 (20%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHR----- 423
+L+G+G FG V K Y + VAIK +K + EV ++ ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 424 -HLVSLVGY-------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLDWATRVKIA 471
++V L + C+ + +L +YD + N L+ TR K A
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLN---------LTR-KFA 163
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ--VSDFGLAKLALDANTHITTRV 529
L +L IIH D+K NILL N + + DFG + I +
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYI 219
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
F Y +PE D++S G +L+E+ TG
Sbjct: 220 QSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 45/230 (19%), Positives = 80/230 (34%), Gaps = 46/230 (20%)
Query: 374 LLGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGEREFK-----AEVEIISRIHH 422
+G+GGFG +Y + +K G E K A+ E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 423 RHLVSLVG-----YCISDDRRLLIYDYV------PNNTLYFHLHGEGRPVLDWATRVKIA 471
+ +G D+ Y ++ + + + + T ++++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK---RFSRKTVLQLS 158
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANT--HITT 527
L Y+HE +H DIK+SN+LL+ QV D+GLA
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 528 R----VMGTFGYMAPEYAS----SGK-LTEKSDVFSFGVVLLELITGRKP 568
GT E+ S +G + + D+ G +++ +TG P
Sbjct: 216 DPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 48/228 (21%), Positives = 84/228 (36%), Gaps = 45/228 (19%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKI---GGGQGEREFK-----AEVEIISRIHHRH 424
+G GGFG +Y + + A +K+ G E K A+ + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 425 LVSLVG-----YCISDDRRLLIYDYV------PNNTLYFHLHGEGRPVLDWATRVKIAAG 473
+ +G + + Y ++ + +G +T +++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----FKKSTVLQLGIR 159
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV--SDFGLAKLALDANTHI------ 525
L Y+HE+ +H DIK++N+LL QV +D+GL+ H
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 526 TTRVMGTFGYMAPEYAS----SGK-LTEKSDVFSFGVVLLELITGRKP 568
GT E+ S G L+ +SDV G +L + G+ P
Sbjct: 217 RKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 2e-13
Identities = 24/137 (17%), Positives = 37/137 (27%), Gaps = 2/137 (1%)
Query: 51 TSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNP 110
+ S+ SS + + + P+ P P SP + P +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 111 PTR--SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
P PP + P P +P + P P SS E K
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 169 QNPPPPPSSSPPKNSPP 185
P PS + +
Sbjct: 122 LKVPAHPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 2e-12
Identities = 27/137 (19%), Positives = 39/137 (28%), Gaps = 3/137 (2%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
+ S PT + P+ +P + S S+P
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
PP SSP P +S P T + + +P +SP +P S PP
Sbjct: 66 MGPPFSVISSP---MGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVL 122
Query: 148 LPPPPPSSVEPPKRSPP 164
P PS
Sbjct: 123 KVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 2e-12
Identities = 28/138 (20%), Positives = 34/138 (24%), Gaps = 3/138 (2%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
+ V + PT A+ S P P P SS
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P PP SP P S P +P S P NP S+ P
Sbjct: 62 PINGMGPPF---SVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGL 118
Query: 158 PPKRSPPSVPPQNPPPPP 175
P+ P N
Sbjct: 119 NGVLKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 22/135 (16%), Positives = 32/135 (23%), Gaps = 1/135 (0%)
Query: 11 ANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPA 70
+ + + S + + P S P P + SS
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
PP S P + S P +P SP P S N
Sbjct: 66 MGPPFSVISSPMGPHSMSVPTTPTLGFSTG-SPQLSSPMNPVSSSEDIKPPLGLNGVLKV 124
Query: 131 PSDPPANSPPPSNPP 145
P+ P N +
Sbjct: 125 PAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 23/132 (17%), Positives = 32/132 (24%)
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
+ +S SP P P SP S S P
Sbjct: 7 HHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGM 66
Query: 133 DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP 192
PP + P ++ P ++ SP P NP P + VP
Sbjct: 67 GPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPA 126
Query: 193 SNVPPPPTQTPP 204
+ T
Sbjct: 127 HPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 24/139 (17%), Positives = 40/139 (28%), Gaps = 4/139 (2%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSS--PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
++ + +SS P ++P + P S T+S
Sbjct: 1 MAHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLS 60
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P PP P + P +P SP S+P + P ++PP
Sbjct: 61 SPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMN--PVSSSEDIKPPLGL 118
Query: 163 PPSVPPQNPPPPPSSSPPK 181
+ P +S K
Sbjct: 119 NGVLKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 29/142 (20%), Positives = 41/142 (28%), Gaps = 7/142 (4%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSP--PA 70
+ S N +SP P+ P P +P SP
Sbjct: 3 HHHHHHVDDDDKMFSTQV---NSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTL 59
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
SSP PP S + P S + PT+ +P SP P S+ PP
Sbjct: 60 SSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTG--SPQLSSPMNPVSSSEDIKPPLG 117
Query: 131 PSDPPANSPPPSNPPSNLPPPP 152
+ PS ++
Sbjct: 118 LNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 21/138 (15%), Positives = 35/138 (25%), Gaps = 2/138 (1%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
+ ++ +S P ++P P P I P + +P +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLG--PGIGSPGQLHSPISTL 59
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P + PP S S P P + S P + P S S
Sbjct: 60 SSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLN 119
Query: 175 PSSSPPKNSPPAPIAVPP 192
P + +
Sbjct: 120 GVLKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 23/131 (17%), Positives = 31/131 (23%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ +SS P +P S P P S T S P +
Sbjct: 9 VDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGP 68
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
SSP + P T SP S P + + P P
Sbjct: 69 PFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHP 128
Query: 121 TPPPNSPPSPP 131
+ S
Sbjct: 129 SGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 19/128 (14%), Positives = 32/128 (25%), Gaps = 1/128 (0%)
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSP-PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
S S P+ +P P P SP + P + P + + PP
Sbjct: 11 DDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPF 70
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN 220
S + P++ S +P P N P +
Sbjct: 71 SVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSG 130
Query: 221 SPPPPSTK 228
+ +
Sbjct: 131 NMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 24/142 (16%), Positives = 33/142 (23%), Gaps = 4/142 (2%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
A + S+ S P +P S P P P +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
P N PP S + P P P S+ P+ S P ++ PP
Sbjct: 62 PINGMG----PPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLG 117
Query: 201 QTPPTPASPIAPRPSNSSPNSP 222
S
Sbjct: 118 LNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 17/133 (12%), Positives = 34/133 (25%)
Query: 110 PPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
+ NS + P+ + + P +P P + P + S
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 170 NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
PP S P + P+ + +P +P++ P
Sbjct: 66 MGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVP 125
Query: 230 LSPPPGIPVPSTE 242
P + +
Sbjct: 126 AHPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 24/136 (17%), Positives = 38/136 (27%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+ + P+ S+ P P Q P + S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P N P +V S + P P TP + S P S++ + PP G+
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 240 STENTPGNGTNPSSPE 255
+G S +
Sbjct: 122 LKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 22/137 (16%), Positives = 36/137 (26%), Gaps = 5/137 (3%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSP--PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
+ S SS P + PS P+ P P L P + P
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIG-SPGQLHSPISTLSSPIN 64
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN 220
P + P P S +P + + P P + + I P +
Sbjct: 65 GMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPM--NPVSSSEDIKPPLGLNGVL 122
Query: 221 SPPPPSTKRLSPPPGIP 237
P + ++
Sbjct: 123 KVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 20/130 (15%), Positives = 31/130 (23%), Gaps = 1/130 (0%)
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS-SSPPKNSPPAPIAVPPSNVP 196
+ S P R + P +P P SP + P P N
Sbjct: 7 HHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGM 66
Query: 197 PPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPES 256
PP +P P + + S + SP + P +
Sbjct: 67 GPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPA 126
Query: 257 SSSPSNNGIG 266
S +
Sbjct: 127 HPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 21/99 (21%), Positives = 35/99 (35%)
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSP 222
V + + SP ++ ++ P +P +P + SSP +
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 223 PPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPS 261
P +S P G S TP G + SP+ SS +
Sbjct: 66 MGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMN 104
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVE 415
+ + +G G G V Y R VAIK K+ R F+ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLS-----RPFQNQTHAKRAYRELV 113
Query: 416 IISRIHHRHLVSLVGYCISDDRRLLIYD-YVPNNTLYFHLHGEGRPVLDWATRVKIAAGA 474
++ ++H++++SL+ D Y+ + +L + LD +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
G+ +LH IIHRD+K SNI++ ++ ++ DFGLA+ A + +T V+ T
Sbjct: 174 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV-TRY 228
Query: 535 YMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
Y APE E D++S G ++ E++ +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFG 534
RGL Y+H IIHRD+K SN+ ++ + E ++ DFGLA+ D T ++ TR
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 535 YMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
Y APE + + D++S G ++ EL+TGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFG 534
+GL Y+H IIHRD+K N+ ++ + E ++ DFGLA+ A T ++ TR
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 535 YMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
Y APE + + T+ D++S G ++ E+ITG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 61/230 (26%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE-------REFKAEVEIISRI 420
+ + + +GEG +G V Y + VAIK KI + + RE K I+ R
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLREIK----ILLRF 82
Query: 421 HHRHLVSLVGYCISDDRRLL--IYDYVPNNTLYFH-----LHGEGRPVLDWATRVKIAAG 473
H +++ + + + +Y + L+ ++ +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVY-------IVQDLMETDLY-----------KL-LKTQ 123
Query: 474 A-------------ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA-- 518
RGL Y+H ++HRD+K SN+LL+ + ++ DFGLA++A
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 519 -LDANTHITTRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGR 566
D +T V T Y APE +S T+ D++S G +L E+++ R
Sbjct: 181 DHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 50/215 (23%), Positives = 80/215 (37%), Gaps = 36/215 (16%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G FG + G L VAIK + + E ++ + V Y
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 434 SDDR-RLLIYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
+ ++ + + P+ F L T + IA + Y+H +I+
Sbjct: 75 PCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSKN---LIY 128
Query: 492 RDIKSSNILL---DNNFEAQV--SDFGLAKLALDANT--HITTR----VMGTFGYMAPEY 540
RD+K N L+ N + + DF LAK +D T HI R + GT Y
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----ARY 183
Query: 541 AS----SGKLTEKS---DVFSFGVVLLELITGRKP 568
S GK E+S D+ + G + + + G P
Sbjct: 184 MSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 46/216 (21%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHR------ 423
++G+G FG V K Y + VA+K ++ +R + E+ I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 424 HLVSLVGY-------CISDDRRLL---IYDYVPNNTL-YFHLHGEGRPVLDWATRVKIAA 472
+++ ++ C++ + LL +Y+ + N F L R K A
Sbjct: 160 NVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLP---------LVR-KFAH 207
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ--VSDFGLAKLALDANTHITTRVM 530
+ L LH+ RIIH D+K NILL + V DFG + + + T +
Sbjct: 208 SILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQ 261
Query: 531 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566
F Y APE + D++S G +L EL+TG
Sbjct: 262 SRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 48/231 (20%), Positives = 91/231 (39%), Gaps = 54/231 (23%)
Query: 369 FADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA-----EVEIISRIHH 422
+ D LG GG G V+ + VAIK++ + E++II R+ H
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-----TDPQSVKHALREIKIIRRLDH 67
Query: 423 RHLVSL--VGYCISDDRRLLIYDYVPNNTLYF-------HLHGEGRPVLDWATRVKIAAG 473
++V + + + N++Y L V + G
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-----------NV-LEQG 115
Query: 474 AA-------------RGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLA- 518
RGL Y+H ++HRD+K +N+ ++ + ++ DFGLA++
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 519 --LDANTHITTRVMGTFGYMAPE-YASSGKLTEKSDVFSFGVVLLELITGR 566
H++ ++ T Y +P S T+ D+++ G + E++TG+
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 61/242 (25%), Positives = 93/242 (38%), Gaps = 72/242 (29%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVE 415
+ F ++LLGEG +G V P G VAIK KI F E++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KI------EPFDKPLFALRTLREIK 61
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL--IYDYVPNNTLYFH-----LHGEGRPVLDWATRV 468
I+ H +++++ D +Y + LH RV
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVY-------IIQELMQTDLH-----------RV 103
Query: 469 KIAAGAA-------------RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515
I+ R + LH +IHRD+K SN+L+++N + +V DFGLA
Sbjct: 104 -ISTQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 516 KLALDANTHITTRVMGTFGYM----------APEY-ASSGKLTEKSDVFSFGVVLLELIT 564
+ +D + + G M APE +S K + DV+S G +L EL
Sbjct: 160 R-IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 565 GR 566
R
Sbjct: 219 RR 220
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 2e-12
Identities = 50/374 (13%), Positives = 109/374 (29%), Gaps = 101/374 (27%)
Query: 287 LVVWCLRRRKKEV------SGLNGVY------IMPSPLGSSSTTDSSYIKTQSSAPLIGS 334
+ W L +++E+ L Y I S T YI+ + L
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR-MYIEQRD--RLYND 122
Query: 335 GP--GSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLL---GEGGFGSVYKGYLP 389
V+ Q Y +L +A + G G G K ++
Sbjct: 123 NQVFAKYNVSRLQ------------PYLKLRQALLELRPAKNVLIDGVLGSG---KTWV- 166
Query: 390 DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNT 449
A+ +K + ++ +I ++ + C S + L +
Sbjct: 167 -----ALDVC--------LSYKVQCKMDFKI---FWLN-LKNCNSPETVLEML-----QK 204
Query: 450 LYFHLHGEGRPVLDWATRVKIAAGAARG--LAYLHEDCHPR--IIHRDIKSSNILLDNNF 505
L + + D ++ +K+ + + L + ++ +++++ N F
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF 262
Query: 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSF--GVVLLELI 563
+ K+ L +TTR +++ + L S + LL
Sbjct: 263 -----NLS-CKI-L-----LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 564 TGRK----PVDASQ--PL-----GDESLVE-------WARPL---LSHALENEEFDNLAD 602
+ P + P ES+ + W L+ +E+ + L
Sbjct: 311 LDCRPQDLPREVLTTNPRRLSIIA-ESIRDGLATWDNWKHVNCDKLTTIIES-SLNVLEP 368
Query: 603 PRLGENYVEGEMFR 616
+ + +F
Sbjct: 369 AEYRKMFDRLSVFP 382
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 58/242 (23%), Positives = 90/242 (37%), Gaps = 82/242 (33%)
Query: 374 LLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHR----- 423
LGEG FG V + GR VA+K +K +R +A E++++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 424 -HLVSLVGY-------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLDWATRVKIA 471
V ++ + CI + LL YD++ N L F L R K+A
Sbjct: 77 FRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLD---------HIR-KMA 124
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS-------------------DF 512
+ + +LH ++ H D+K NIL + + DF
Sbjct: 125 YQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 513 GLAKLALDANTHIT---TRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELI 563
G A D H T TR Y APE + ++ DV+S G +L+E
Sbjct: 182 GSA--TYDDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIEYY 228
Query: 564 TG 565
G
Sbjct: 229 LG 230
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 44/230 (19%), Positives = 79/230 (34%), Gaps = 72/230 (31%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYC 432
LG G G V + + + A+K L+ + + EVE+ R H+V +V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVD-- 78
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWAT------RV----------KIAAGAAR 476
+Y+ + + V++ R+ + A+ +
Sbjct: 79 --------VYENLYAGRKCLLI------VMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 477 ----GLAYLHEDCHPRIIHRDIKSSNILLDNNFEA---QVSDFGLAKLALDANTHITTRV 529
+ YLH I HRD+K N+L + +++DFG AK
Sbjct: 125 SIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ET 170
Query: 530 MGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579
G Y + D++S GV++ L+ G P ++ L
Sbjct: 171 TGE-KY-----------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 53/262 (20%), Positives = 90/262 (34%), Gaps = 82/262 (31%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVE 415
D + ++L+G G +G VY Y + VAIK K+ R F+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KV-----NRMFEDLIDCKRILREIT 77
Query: 416 IISRIHHRHLVSLVGYCISDDRRLL--IYDYVPNNTLYFH-----LHGEGRPVLDWATRV 468
I++R+ +++ L I DD +Y + L ++
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELY-------IVLEIADSDLK-----------KL 119
Query: 469 KIAAGAA--------------RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514
G ++HE IIHRD+K +N LL+ + +V DFGL
Sbjct: 120 -FKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 515 A-KLALDANTHITTRVMGTFGYMAPEYASSGKLTE--------------------KS-DV 552
A + + +T+I + +LT KS D+
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235
Query: 553 FSFGVVLLELITGRKPVDASQP 574
+S G + EL+ +
Sbjct: 236 WSTGCIFAELLNMLQSHINDPT 257
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 53/246 (21%), Positives = 91/246 (36%), Gaps = 86/246 (34%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRI-----HHRH 424
+G+G FG V + + + A+K ++ ++ ++ E +I+ +I ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 425 LVSLVGY-------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLDWATRVKIAAG 473
+V G C+ + L +Y+ + NN FH+ +
Sbjct: 98 IVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIE---------DIK-LYCIE 145
Query: 474 AARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS----------------------- 510
+ L YL + + H D+K NILLD+ + +
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 511 --DFGLAKLALDANTH---ITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVL 559
DFG A ++ H I TR Y APE + SD++SFG VL
Sbjct: 203 LIDFGCA--TFKSDYHGSIINTR----Q-YRAPEVILNLGW------DVSSDMWSFGCVL 249
Query: 560 LELITG 565
EL TG
Sbjct: 250 AELYTG 255
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 24/157 (15%), Positives = 40/157 (25%), Gaps = 4/157 (2%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
V + + S N ++S + P P + P S
Sbjct: 5 EAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHG 64
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
++ + P+R+ P +SP S +S S+P S P +E
Sbjct: 65 SLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPAS----IPHLILELL 120
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVP 196
K P Q N +
Sbjct: 121 KCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMC 157
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 18/154 (11%), Positives = 34/154 (22%), Gaps = 12/154 (7%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP--PTSSSPPASSPPTSSP 78
+ I P + SK + PP P +SP + + P
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS----------PP 128
P + + P + P + +S+P P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P + + S+ +
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKM 159
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 21/142 (14%), Positives = 36/142 (25%), Gaps = 7/142 (4%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
P SS + + P + PP P V+ P + + PP T
Sbjct: 12 QAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQT 71
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPP-------VSNPPTRSPPP 117
P+ + + P P ++ P S S S + P P
Sbjct: 72 YGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQA 131
Query: 118 PSSTPPPNSPPSPPSDPPANSP 139
+ ++
Sbjct: 132 KIMAYLQQEQANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 23/150 (15%), Positives = 32/150 (21%), Gaps = 4/150 (2%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS---TPPPNSPPSPPSDPPANS 138
+ PS S + P P + P + P + PP S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 139 PPPSNPPSNLPPPPPSSVEP-PKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
+ P S P P S P + S P I P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 198 PPTQTPPTPASPIAPRPSNSSPNSPPPPST 227
P A + + S
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGL 155
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 16/150 (10%), Positives = 27/150 (18%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
+ S S+ + S PP P + P + PP S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 127 PPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPA 186
+ S + + P S+ P P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 187 PIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
V + +
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGL 155
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 27/181 (14%), Positives = 41/181 (22%), Gaps = 7/181 (3%)
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
+ S + S P N PP+ + + PP
Sbjct: 3 KLEAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPP 62
Query: 173 PPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRL-- 230
P S P P T +P + +S + P L
Sbjct: 63 HGSLQGYQTY-GHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLK 121
Query: 231 --SPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAV--AVGIIAFSLIG 286
P + N S E S+ T+ V A I F +
Sbjct: 122 CEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELK 181
Query: 287 L 287
+
Sbjct: 182 V 182
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 24/133 (18%), Positives = 35/133 (26%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
S+ +A+ P + PPT P P S PP S + P +
Sbjct: 21 SSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQTYGHFPSRAI 80
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P SSP + + +S P S P + P +
Sbjct: 81 KSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQAKIMAYLQQE 140
Query: 122 PPPNSPPSPPSDP 134
S S
Sbjct: 141 QANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 21/153 (13%), Positives = 35/153 (22%), Gaps = 15/153 (9%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD---PPANSPPPSNPPSN 147
+ P + ++ S P N PP+D P + P S
Sbjct: 5 EAMSQVIQAM--PSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMP- 61
Query: 148 LPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT----- 202
P + P P P +SSP + + ++ P
Sbjct: 62 -PHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELL 120
Query: 203 ---PPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
P P + K +
Sbjct: 121 KCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 12/102 (11%), Positives = 18/102 (17%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
S S P S + P+ + +P SSP + SP +
Sbjct: 53 TSPISMTMPPHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASI 112
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
T
Sbjct: 113 PHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFG 154
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 53/242 (21%), Positives = 86/242 (35%), Gaps = 82/242 (33%)
Query: 374 LLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQGEREFKA---EVEIISRIHHR----- 423
LGEG FG V + +VA+K ++ + +A E+ ++ +I +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENK 81
Query: 424 -HLVSLVGY-------CISDDRRLL---IYDYV-PNNTLYFHLHGEGRPVLDWATRVKIA 471
V + + CI+ + LL ++++ NN + L R +A
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLP---------HVR-HMA 129
Query: 472 AGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ-------------------VSDF 512
L +LHE ++ H D+K NIL N+ V+DF
Sbjct: 130 YQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 513 GLAKLALDANTH---ITTRVMGTFGYMAPE------YASSGKLTEKSDVFSFGVVLLELI 563
G A D H + TR Y PE + + DV+S G +L E
Sbjct: 187 GSA--TFDHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYY 233
Query: 564 TG 565
G
Sbjct: 234 RG 235
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 63.6 bits (153), Expect = 1e-10
Identities = 29/174 (16%), Positives = 45/174 (25%), Gaps = 4/174 (2%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS----NPPTSSSPPASSPPTSSPPPASN 83
P PP PPK + P ++P +P + S PP + + PP S
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
SSP P SP + + PP T +
Sbjct: 75 DEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELG 134
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
P+ P + + + A +P +P
Sbjct: 135 ARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPY 188
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 63.6 bits (153), Expect = 1e-10
Identities = 30/176 (17%), Positives = 48/176 (27%), Gaps = 3/176 (1%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
P P A +P + P +P A + S + P ++P PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASA---TSGSRKRARPPAAPGRDQARPPAR 67
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPP 168
S SS P +P P P S P + PP S+ + S +
Sbjct: 68 RRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCL 127
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPP 224
Q + + + + P +P R + P
Sbjct: 128 QRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 62.8 bits (151), Expect = 2e-10
Identities = 29/177 (16%), Positives = 42/177 (23%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
+ P PP ++ P PSP +S + S + PP A + PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
P P P S P+ P S + S L +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAP 212
E R + + P P P + P
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLP 187
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 61.3 bits (147), Expect = 6e-10
Identities = 24/173 (13%), Positives = 37/173 (21%)
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
PP +PP + S + P+ S + PP PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPK 181
S PS P A P P + P + S
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 182 NSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
A + ++ P +P + + P
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 61.3 bits (147), Expect = 6e-10
Identities = 28/180 (15%), Positives = 42/180 (23%), Gaps = 3/180 (1%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
P PP PP ++ P P P S + PPA+ + PPA
Sbjct: 13 RRPGPPRIAPPKLACRTP---SPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRR 69
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
S S+P T P P SP + + S
Sbjct: 70 LRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQR 129
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
++ S + P + P + +P
Sbjct: 130 ARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 61.3 bits (147), Expect = 7e-10
Identities = 21/179 (11%), Positives = 37/179 (20%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
+ P P P +P + P + A+S P + P P
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
++ S P P S +P + P + + +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
+ + S P+ P P P
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 60.9 bits (146), Expect = 7e-10
Identities = 23/174 (13%), Positives = 35/174 (20%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
P PP T SP + +S + P ++P P +
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
+ S P P SP P + P + S S L
Sbjct: 75 DEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELG 134
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASP 209
+ P + P+ P
Sbjct: 135 ARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPY 188
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 59.7 bits (143), Expect = 2e-09
Identities = 24/169 (14%), Positives = 40/169 (23%), Gaps = 7/169 (4%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPT-------TSPPP 55
+P A + SP P P + + P ++PP
Sbjct: 19 RIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVS 78
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
SP P + P+ PA+ P + S R
Sbjct: 79 SPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVR 138
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
+S +P ++ P P+ + P P
Sbjct: 139 ALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLP 187
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 58.6 bits (140), Expect = 4e-09
Identities = 18/179 (10%), Positives = 33/179 (18%)
Query: 84 PPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSN 143
PP +P P + S P +P D
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 144 PPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
S PS+ E P P Q ++ + + Q
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 204 PTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSN 262
+ + +++ P + + P
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 57.8 bits (138), Expect = 7e-09
Identities = 24/175 (13%), Positives = 33/175 (18%), Gaps = 8/175 (4%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
P P + P P P S PPA
Sbjct: 15 PGPPRIAPPKLACRTPSPA------RPALRAPASATSGSRKRARPPAAPGRDQARPPARR 68
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
S SSP T P P+ + + T S
Sbjct: 69 RLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQ 128
Query: 122 PP--PNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
+ ++ P + P P + P Q P
Sbjct: 129 RARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 49.3 bits (116), Expect = 3e-06
Identities = 17/151 (11%), Positives = 27/151 (17%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
AP+ + + PP PP P + P P
Sbjct: 38 RAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQK 97
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
S+ P +S + + + S P +
Sbjct: 98 IKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEG 157
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
P L P
Sbjct: 158 RPEEPCGEKAPAYQRFHALAQPGLPGLVLPY 188
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 42.4 bits (98), Expect = 4e-04
Identities = 20/129 (15%), Positives = 28/129 (21%)
Query: 135 PANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSN 194
P + P P S S + PP + + PPA + S
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 195 VPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSP 254
TP P P P P S P +E
Sbjct: 75 DEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELG 134
Query: 255 ESSSSPSNN 263
+ +
Sbjct: 135 ARVRALKAS 143
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 46/226 (20%), Positives = 84/226 (37%), Gaps = 50/226 (22%)
Query: 316 STTDSSYIKTQSSAPLIGSGPGSDFVNSPQDPGGLGHSRSMFTYEELVKATDGFADQNLL 375
S+ +++ + +S + + SM + D + ++L+
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 376 GEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKA---------EVEIISRIHHRHL 425
G G +G V + Y + R VAIK KI R F+ E+ I++R++H H+
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIK--KIL-----RVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 426 VSLVGYCISDDRRLL--IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA-------- 475
V ++ I D +Y + + D +
Sbjct: 115 VKVLDIVIPKDVEKFDELY-------VVLEI-------ADSDFKKLFRTPVYLTELHIKT 160
Query: 476 ------RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515
G+ Y+H I+HRD+K +N L++ + +V DFGLA
Sbjct: 161 LLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 62.7 bits (151), Expect = 3e-10
Identities = 23/171 (13%), Positives = 43/171 (25%), Gaps = 4/171 (2%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
+++ A++ T + S A+ P +S P V P P
Sbjct: 7 AAAAAAAAAAAATGTEAGPGTAGGSENGSE-VAAQPAGLSGPAEVGPGAVGERTPRKKEP 65
Query: 123 PPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
P SPP ++PP ++ P + P P + + +
Sbjct: 66 PRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEY---RE 122
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPP 233
+ + + P P +P S
Sbjct: 123 MDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSG 173
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 61.9 bits (149), Expect = 5e-10
Identities = 27/163 (16%), Positives = 44/163 (26%), Gaps = 7/163 (4%)
Query: 58 PASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPP 117
A+ +++ + S + S P + P P + PP
Sbjct: 7 AAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPP 66
Query: 118 PSSTPPPNSPP---SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP----PQN 170
+S P + P + P P P + P P +R V ++
Sbjct: 67 RASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDES 126
Query: 171 PPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
A +PPPP Q PP + P
Sbjct: 127 LANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPE 169
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 61.5 bits (148), Expect = 7e-10
Identities = 24/176 (13%), Positives = 42/176 (23%), Gaps = 3/176 (1%)
Query: 39 SPPPPPVSKPPTTSPPPSPPAS--NPPTSSSPPASSP-PTSSPPPASNPPTSSPPPSPPA 95
S + + A S + + P PA P + +P
Sbjct: 3 SGKKAAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRK 62
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
PP SPP ++ PP + P T P S +
Sbjct: 63 KEPPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYRE 122
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIA 211
++ + + + + + P P P P+ A
Sbjct: 123 MDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAA 178
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 59.6 bits (143), Expect = 2e-09
Identities = 27/173 (15%), Positives = 43/173 (24%), Gaps = 11/173 (6%)
Query: 7 GPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKP----PTTSPPPSPPASNP 62
AA +++ N + + P +S P P +P P
Sbjct: 6 KAAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEP 65
Query: 63 PTSSSPPASSPPTSSPPPASNP--PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P +S P + P S P + P S P + P R
Sbjct: 66 PRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGI-----AETPEGRRTSRRKRAKVEY 120
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
S + D + + PP + P P+ P
Sbjct: 121 REMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSG 173
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 57.3 bits (137), Expect = 1e-08
Identities = 32/205 (15%), Positives = 52/205 (25%), Gaps = 13/205 (6%)
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ T + P + + + P S P P + P EPP+ SPP
Sbjct: 15 AAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPPRASPPG-- 72
Query: 168 PQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR---PSNSSPNSPPP 224
PP S+ P+ P V P + P T TP R
Sbjct: 73 --GLAEPPGSAGPQAGPT----VVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDES 126
Query: 225 PSTKRLSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNGIG--TAGTVVIAVAVGIIAF 282
+ + + P P++ N +G A +
Sbjct: 127 LANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAAFQSRLPHD 186
Query: 283 SLIGLVVWCLRRRKKEVSGLNGVYI 307
+ C V++
Sbjct: 187 RMTSQEAACFPDIISGPQQTQKVFL 211
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 55.4 bits (132), Expect = 5e-08
Identities = 19/161 (11%), Positives = 37/161 (22%), Gaps = 5/161 (3%)
Query: 74 PTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSD 133
++ A+ T + + P ++ + + + P S P +
Sbjct: 7 AAAAAAAAAAAATGTE--AGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKE 64
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
PP SPP P + S + P + V
Sbjct: 65 PPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRA---KVEYR 121
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+ R + + PP + P
Sbjct: 122 EMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEE 162
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 4e-06
Identities = 20/131 (15%), Positives = 35/131 (26%), Gaps = 7/131 (5%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPP-------PPVSNPPKSSPPPPPVSKPPTTSPPPS 56
+P +SPP ++ PP + P P + P ++ P + +
Sbjct: 58 RTPRKKEPPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAK 117
Query: 57 PPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPP 116
S + + S + P PP +PP P
Sbjct: 118 VEYREMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGA 177
Query: 117 PPSSTPPPNSP 127
S P +
Sbjct: 178 AFQSRLPHDRM 188
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 32/153 (20%), Positives = 39/153 (25%), Gaps = 2/153 (1%)
Query: 32 VSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP 91
VS + PP + P PA P +P + P P
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGP 137
Query: 92 SPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
S +P + T S + PP PP PP P P
Sbjct: 138 SQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRP 197
Query: 152 PPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSP 184
P P P P PPP PP
Sbjct: 198 PMGP--PMGIPPGRGTPMGMPPPGMRPPPPGMR 228
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 25/151 (16%), Positives = 34/151 (22%), Gaps = 2/151 (1%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
S + P + P P
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGP 137
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
+ T + A+ + + P+ PP PP PP P
Sbjct: 138 SQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRP 197
Query: 124 PNSPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
P P PP P PP + PPPP
Sbjct: 198 P--MGPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 28/147 (19%), Positives = 38/147 (25%), Gaps = 3/147 (2%)
Query: 50 TTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPP---ASSPPTISPPPP 106
T P P + A+ P P P P P A + P
Sbjct: 80 MTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQ 139
Query: 107 VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
P ++ + + PP PPP + PP P +
Sbjct: 140 QVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPM 199
Query: 167 PPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P PP +P PP PP
Sbjct: 200 GPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 27/149 (18%), Positives = 37/149 (24%), Gaps = 3/149 (2%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
S PP + P P+ P + P +
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVP-MPQAPAGLAGPVRGVGG 136
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPI 210
P + P R + + +P + P PP PP P P
Sbjct: 137 PSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPP--PG 194
Query: 211 APRPSNSSPNSPPPPSTKRLSPPPGIPVP 239
P PP T PPPG+ P
Sbjct: 195 MRPPMGPPMGIPPGRGTPMGMPPPGMRPP 223
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 24/144 (16%), Positives = 34/144 (23%)
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
A P + P P ++ P P
Sbjct: 81 TVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQ 140
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPP 180
P + + A + + P+ PP P R P PPP
Sbjct: 141 VMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMG 200
Query: 181 KNSPPAPIAVPPSNVPPPPTQTPP 204
P P +PPP + PP
Sbjct: 201 PPMGIPPGRGTPMGMPPPGMRPPP 224
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 28/155 (18%), Positives = 41/155 (26%), Gaps = 2/155 (1%)
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
N + + PP + P + P P P P+
Sbjct: 76 NLVSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVG 135
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
P + P + + P PP PP + PP
Sbjct: 136 GPSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGM 195
Query: 203 PPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIP 237
P P+ P +P PPP + PPPG+
Sbjct: 196 RPPMGPPMGIPPGRGTPMGMPPPGMR--PPPPGMR 228
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 31/141 (21%), Positives = 44/141 (31%), Gaps = 11/141 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
A + G P ++ + P P ++ P + P P + A+
Sbjct: 97 LAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQGRGTVAAAAAA 156
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
S + + P P PPP + PP + PPP PP PP
Sbjct: 157 ATASIAGAPTQYPPGRGGP--------PPPMGRGAPPPGMMGPPPGMRPP---MGPPMGI 205
Query: 122 PPPNSPPSPPSDPPANSPPPS 142
PP P P PPP
Sbjct: 206 PPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 26/111 (23%), Positives = 33/111 (29%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ A P P A + P P+ P ++ + P
Sbjct: 114 IPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRG 173
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
PP A P PPP PP P PP P PPP + PP
Sbjct: 174 GPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGIPPGRGTPMGMPPPGMRPPP 224
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 26/119 (21%), Positives = 32/119 (26%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+A P P ++ P P + T+ P
Sbjct: 108 RAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQGRGTVAAAAAAATASIAGAPTQ 167
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
PP PP + PP PP PP P P P PP PPPP
Sbjct: 168 YPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 29/148 (19%), Positives = 42/148 (28%), Gaps = 2/148 (1%)
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPP 159
T+ PPP R P ++ P + P P P+ L P P
Sbjct: 81 TVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAG--VPMPQAPAGLAGPVRGVGGPS 138
Query: 160 KRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSP 219
++ +++ + P PPPP P + P P P
Sbjct: 139 QQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPP 198
Query: 220 NSPPPPSTKRLSPPPGIPVPSTENTPGN 247
PP P G+P P P
Sbjct: 199 MGPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 25/136 (18%), Positives = 36/136 (26%)
Query: 129 SPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPI 188
+ PP ++ P + P + P VP P + P+
Sbjct: 81 TVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQ 140
Query: 189 AVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG 248
+ P AS PPP R +PPPG+ P P G
Sbjct: 141 VMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMG 200
Query: 249 TNPSSPESSSSPSNNG 264
P +P
Sbjct: 201 PPMGIPPGRGTPMGMP 216
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 25/154 (16%), Positives = 36/154 (23%), Gaps = 8/154 (5%)
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPP 124
S + P + + P A+ + P P + P P
Sbjct: 79 SMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPS 138
Query: 125 NSPPSPPSDPPANSPPPSNPPSNLPPPP--PSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
+P + + S P P P PP PP
Sbjct: 139 QQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGP------PPPMGRGAPPPGMMGPP 192
Query: 183 SPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
P PP +PP P + P P
Sbjct: 193 PGMRPPMGPPMGIPPGRGTPMGMPPPGMRPPPPG 226
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 26/112 (23%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+ + YLH ++HRD+K SNILL+ +V+DFGL++ ++ +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 536 MAPEYASSGKLTE--------------------KS-DVFSFGVVLLELITGR 566
LT+ K D++S G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 19/93 (20%), Positives = 27/93 (29%)
Query: 40 PPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
P P P + P T + P + PT P P N +P P PA
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 100 TISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
T++ R ++ P P
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 20/110 (18%), Positives = 27/110 (24%), Gaps = 7/110 (6%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
+ P SP ++ P T +PP PT P P P P N
Sbjct: 3 AAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNAT 62
Query: 112 TRSPPPPSSTPPPNSPPSPPSDPPANSPPPS-------NPPSNLPPPPPS 154
+ + PPP+ P P P
Sbjct: 63 VAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEG 112
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 15/94 (15%), Positives = 22/94 (23%), Gaps = 1/94 (1%)
Query: 34 NPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSP 93
+P + P P T + P PP + P P NP P
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 94 -PASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
++ + PPP
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 21/110 (19%), Positives = 34/110 (30%), Gaps = 5/110 (4%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
P P ++ +N ++P PP + PT P P + PA T +
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPVS-----NPPTRSPPPPSSTP 122
A+ + + + PPP + P R P P
Sbjct: 65 AGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 25/112 (22%), Positives = 35/112 (31%), Gaps = 6/112 (5%)
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP-PTISPPPPVSNPPTRSPPPPSST 121
PTS P + T + P T +PP A + P NP P ++T
Sbjct: 5 PTSPGTPGVAAATQAANGG--PATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNAT 62
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV---EPPKRSPPSVPPQN 170
+ PPP ++V E P+R P QN
Sbjct: 63 VAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 19/115 (16%), Positives = 32/115 (27%), Gaps = 2/115 (1%)
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
P A + P + A+ + P +P + + P P P + P P
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALG--AAPTGDPKPKKNKKPKNPTPPRPAGD 59
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKN 182
+ + A V PP V + P P+ +N
Sbjct: 60 NATVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 16/113 (14%), Positives = 27/113 (23%), Gaps = 5/113 (4%)
Query: 28 PPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTS 87
P P S + +P P + P P + P + PP +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST-----PPPNSPPSPPSDPP 135
+ ++ PPP+ P P+ P
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 18/114 (15%), Positives = 30/114 (26%), Gaps = 1/114 (0%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
P +P + P ++ +N +P PP+ P P P + +P P P +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 150 PPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTP 203
+ PP + P P P
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFE-QPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 16/93 (17%), Positives = 28/93 (30%), Gaps = 2/93 (2%)
Query: 118 PSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV--PPQNPPPPP 175
P++ P +P + AN P + P L P +P K P PP+
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 176 SSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPAS 208
+ + + + + P P
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 18/111 (16%), Positives = 29/111 (26%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
+P P + +N +P PP + P P +K P PP P N
Sbjct: 4 APTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATV 63
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
++ + P P ++ P P
Sbjct: 64 AAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 20/107 (18%), Positives = 29/107 (27%), Gaps = 16/107 (14%)
Query: 128 PSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAP 187
P+ P+ P + +N P P+ P P P + PKN P
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAP------PALGAAPTGDPKPKKNKKPKNPTP-- 53
Query: 188 IAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P P A R + + + PPP
Sbjct: 54 --------PRPAGDNATVAAGHATLREHLRDIKAENTDANFYVCPPP 92
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 16/81 (19%), Positives = 28/81 (34%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+A + ++ PP + PT P P + PK+ PP P T + + +
Sbjct: 14 AAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVAAGHATLREH 73
Query: 62 PPTSSSPPASSPPTSSPPPAS 82
+ + PPP
Sbjct: 74 LRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 17/105 (16%), Positives = 25/105 (23%), Gaps = 6/105 (5%)
Query: 133 DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPP 192
DP A P P ++ P +PP++ P K P P
Sbjct: 1 DPAA--PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAG 58
Query: 193 SNVPPPPTQTPPTPASPIAPRPSNSSPNS--PPPPSTK--RLSPP 233
N + + PPP + P
Sbjct: 59 DNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQP 103
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 15/95 (15%), Positives = 22/95 (23%)
Query: 170 NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKR 229
+P P S P + A P PP P + +PP P+
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 230 LSPPPGIPVPSTENTPGNGTNPSSPESSSSPSNNG 264
+ G N + P
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 13/79 (16%), Positives = 24/79 (30%)
Query: 157 EPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSN 216
+P + P P ++ P P + P+ P P P +P P N
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 217 SSPNSPPPPSTKRLSPPPG 235
++ + + L
Sbjct: 61 ATVAAGHATLREHLRDIKA 79
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 15/96 (15%), Positives = 27/96 (28%)
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
++P P A + P T PP + P P P+ R +
Sbjct: 3 AAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNAT 62
Query: 237 PVPSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVV 272
+ + + + ++ T TVV
Sbjct: 63 VAAGHATLREHLRDIKAENTDANFYVCPPPTGATVV 98
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 25/160 (15%), Positives = 39/160 (24%), Gaps = 8/160 (5%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
N S P T + + + + P V + + P +
Sbjct: 10 RKKVMGNRRSDEPAK----TKKGLSSILDAARWNRGEPQVPDF---RHLKAEVDAEKPGA 62
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
+ S P +P S S + P P P P
Sbjct: 63 TDRKGGVGMPSRDRNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQG-PMSL 121
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPS 165
+PP + S P + P S +E PP
Sbjct: 122 ESLAPPESTDEGAETESPEPGDEGEPGRSGLELEPEEPPG 161
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 27/158 (17%), Positives = 43/158 (27%), Gaps = 6/158 (3%)
Query: 36 PKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPA 95
K +P T S + P A P +
Sbjct: 10 RKKVMGNRRSDEPAKTKKGLSSIL--DAARWNRGEPQVPDFRHLKAE-VDAEKPGATDRK 66
Query: 96 SSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
S + P + P + P S SP +P A++P S P S
Sbjct: 67 GGVGMPSRDRNIGAPGQDT---PGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLES 123
Query: 156 VEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
+ PP+ + ++P P P ++ PP
Sbjct: 124 LAPPESTDEGAETESPEPGDEGEPGRSGLELEPEEPPG 161
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 22/163 (13%), Positives = 35/163 (21%), Gaps = 11/163 (6%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP---------PPPSSTPPPNSPPSPP 131
N + P + S + P P +T P
Sbjct: 14 MGNRRSDEPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPS 73
Query: 132 SDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP--PPSSSPPKNSPPAPIA 189
D +P P +L P S + + + + P P S
Sbjct: 74 RDRNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDEG 133
Query: 190 VPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSP 232
+ P P + P PP + L
Sbjct: 134 AETESPEPGDEGEPGRSGLELEPEEPPGWRELVPPDTLHSLPK 176
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 23/146 (15%), Positives = 32/146 (21%)
Query: 6 PGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTS 65
SS N P + P + PS +
Sbjct: 23 AKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSRDRNIGAPG 82
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
P S S P + P SSP ++ P + + +P P
Sbjct: 83 QDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDEGAETESPEPG 142
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPP 151
P P L PP
Sbjct: 143 DEGEPGRSGLELEPEEPPGWRELVPP 168
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 26/152 (17%), Positives = 34/152 (22%), Gaps = 12/152 (7%)
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
R P+ T S + P + E P + +
Sbjct: 17 RRSDEPAKTKKGLSSILDAARWNRGEPQVPDFR-------HLKAEVDAEKPGATDRKGGV 69
Query: 173 PPPSSSPPKNSPP--APIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPN---SPPPPST 227
PS +P P P + P A S P S PP +
Sbjct: 70 GMPSRDRNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPES 129
Query: 228 KRLSPPPGIPVPSTENTPGNGTNPSSPESSSS 259
P P E PG PE
Sbjct: 130 TDEGAETESPEPGDEGEPGRSGLELEPEEPPG 161
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 20/206 (9%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
+G G FG +Y G + EVAIK + + E +I + + V +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 434 SDDR-RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ +L+ D + + L + R L T + +A + ++H +HR
Sbjct: 73 VEGDYNVLVMDLLGPS-LEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 493 DIKSSNILLDNNFEAQ---VSDFGLAKLALDANT--HITTR----VMGTFGYMAPEYASS 543
DIK N L+ A + DFGLAK D +T HI R + GT Y A
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHL 186
Query: 544 GK-LTEKSDVFSFGVVLLELITGRKP 568
G + + D+ S G VL+ + G P
Sbjct: 187 GIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 27/187 (14%), Positives = 51/187 (27%), Gaps = 13/187 (6%)
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
+ S+PP + + P+ PP + N ++ + P A+
Sbjct: 293 LKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIAS 352
Query: 138 SPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPP 197
+ + + S EP + S P +S S
Sbjct: 353 VGTLAKQKAPVGNDASFSKEP---VISASNFLGRSSGSSRRPAVSS---------SRDVM 400
Query: 198 PPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESS 257
P + P+ P S P S+ S P S ++ S+ +
Sbjct: 401 PIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPK-HSSSARHSSNVKNYESALKGI 459
Query: 258 SSPSNNG 264
+ +G
Sbjct: 460 EGLNFDG 466
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 25/116 (21%), Positives = 39/116 (33%), Gaps = 14/116 (12%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+ + + +S P+++ + + PP +
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPP------Q 391
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
PP PP P P PP PP PPPP + PP+ +PP+ PPQ
Sbjct: 392 GYAPPPQGYPPQGYP------PQGYPPQGYPPQGYPPPPQGA--PPQGAPPAAPPQ 439
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 21/99 (21%), Positives = 33/99 (33%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+ ++ ++ P + P+++ A A P +PPP
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ 398
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPP 131
PP PP PPPP PP +PP+ P
Sbjct: 399 GYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAP 437
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 22/108 (20%), Positives = 32/108 (29%), Gaps = 10/108 (9%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPP--SPPAS 96
+ P+ +S+ S+ + + PP +PP
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ 398
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
P PP PP PP PP P PP +PP + P
Sbjct: 399 GYPPQGYPPQ--------GYPPQGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 25/114 (21%), Positives = 33/114 (28%), Gaps = 6/114 (5%)
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
P + T P SS P++ + + A +
Sbjct: 331 PWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQA---A 387
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
PP PP + P PP PP+ PP P PP PP PP
Sbjct: 388 YPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPP---AAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 17/99 (17%), Positives = 25/99 (25%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ A + P S+ + + PP
Sbjct: 340 DDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQG 399
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPP 99
PP P P P PP +PP P ++PP
Sbjct: 400 YPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 27/120 (22%), Positives = 34/120 (28%), Gaps = 12/120 (10%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
P + T P S+ S+ A+ PP
Sbjct: 331 PWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPP 390
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
+PP P PP PP PP PPPP PP +PP + PP
Sbjct: 391 QGYAPPPQGYPPQGYPPQGYPPQGYPPQG---------YPPPPQGAPPQGAPP---AAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 25/107 (23%), Positives = 33/107 (30%), Gaps = 5/107 (4%)
Query: 7 GPPAANSSSPPPPVSNPPTI--SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
+ + P S P ++ + + K P PP
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPP 397
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPS--PPASSPPTISPPPPVSN 109
PP PP PP P PPP PP +PP +PP V N
Sbjct: 398 QGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPA-APPQGVDN 443
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 23/111 (20%), Positives = 41/111 (36%), Gaps = 9/111 (8%)
Query: 113 RSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPP 172
+ ++ P+ +++ P ++ + ++ ++ + PPQ
Sbjct: 337 CQFDDKETEDDKDAETEIPAGESSDAAPSADAAQM--KEMMAMMQKMQQQQAAYPPQGYA 394
Query: 173 PPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPP 223
PPP PP+ PP PP PP PP A P + P +PP
Sbjct: 395 PPPQGYPPQGYPPQG--YPPQGYPPQGYPPPPQGAP-----PQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 19/103 (18%), Positives = 23/103 (22%)
Query: 134 PPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPS 193
P SS P + PP A PP
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ 398
Query: 194 NVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGI 236
PP P P+ P PP +PP G+
Sbjct: 399 GYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPPQGV 441
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 21/84 (25%), Positives = 30/84 (35%), Gaps = 5/84 (5%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPP--PPPVSKPPTTSPPPSPPA 59
+ + + + PP + PP+ PP PP PP PP P
Sbjct: 363 APSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYP- 421
Query: 60 SNPPTSSSPPASSPPTSSPPPASN 83
PP +PP +PP + P N
Sbjct: 422 --PPPQGAPPQGAPPAAPPQGVDN 443
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 21/92 (22%), Positives = 25/92 (27%), Gaps = 5/92 (5%)
Query: 154 SSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPR 213
+ E +P + Q A PP PPP PP P
Sbjct: 355 PAGESSDAAPSADAAQMKEMMAMMQKM---QQQQAAYPPQGYAPPPQGYPPQGYPPQGYP 411
Query: 214 PSNSSPNSPPPPSTKRL--SPPPGIPVPSTEN 243
P P PPP PP P +N
Sbjct: 412 PQGYPPQGYPPPPQGAPPQGAPPAAPPQGVDN 443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 53/277 (19%), Positives = 82/277 (29%), Gaps = 94/277 (33%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI 433
LG G F +V+ + + + VA+K +K E E+ ++ + + + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSD-PNDPNREM 102
Query: 434 SDDRRLLIYDYVPNNTLYFHLHGE------------GRPVLDWATR----------VK-I 470
+LL D F + G G +L W + VK I
Sbjct: 103 V--VQLL--DD-------FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 471 AAGAARGLAYLHEDCHPRIIHRDIKSSNILL----------------------------- 501
+GL YLH C IIH DIK NILL
Sbjct: 152 IQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 502 --------------------DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEY 540
+ +++D G A T I TR Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEV 264
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD 577
+D++S + EL TG +
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 5e-08
Identities = 24/135 (17%), Positives = 36/135 (26%)
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
S P S ++P + PP P P P P P A
Sbjct: 18 SHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPV 77
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
P P P P + P ++ P P + + A ++ P
Sbjct: 78 VIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVT 137
Query: 199 PTQTPPTPASPIAPR 213
+ P S P+
Sbjct: 138 SVASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 4e-07
Identities = 27/143 (18%), Positives = 34/143 (23%)
Query: 44 PVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISP 103
P + PA P S + + P P P P
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P V P P P P S P S + P SS S
Sbjct: 75 APVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSK 134
Query: 164 PSVPPQNPPPPPSSSPPKNSPPA 186
P + P S + P+ A
Sbjct: 135 PVTSVASGPRALSRNQPQYPARA 157
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 24/128 (18%), Positives = 33/128 (25%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ AP+ + P P V P+ P P P + P P P
Sbjct: 28 LPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPK 87
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
P P P S P + +P + T + S P S
Sbjct: 88 PKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALS 147
Query: 121 TPPPNSPP 128
P P
Sbjct: 148 RNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 22/144 (15%), Positives = 31/144 (21%), Gaps = 3/144 (2%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
P S P + P + + ++ PP P P+ PP
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
+P P P P P P P P P
Sbjct: 75 APVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAP---ARLTSSTATAA 131
Query: 174 PPSSSPPKNSPPAPIAVPPSNVPP 197
S P ++ P
Sbjct: 132 TSKPVTSVASGPRALSRNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 18/134 (13%), Positives = 32/134 (23%)
Query: 8 PPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS 67
+ + P + P +++ P P + PPP P P
Sbjct: 19 HMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVV 78
Query: 68 PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSP 127
P P P SP + S ++T P +
Sbjct: 79 IEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTS 138
Query: 128 PSPPSDPPANSPPP 141
+ + + P
Sbjct: 139 VASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 2e-06
Identities = 19/128 (14%), Positives = 28/128 (21%)
Query: 15 SPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPP 74
+P P+S + P P +P P P + P P
Sbjct: 30 APAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPK 89
Query: 75 TSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
P P + P + P T + S P S
Sbjct: 90 PKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRN 149
Query: 135 PANSPPPS 142
P +
Sbjct: 150 QPQYPARA 157
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 27/141 (19%), Positives = 36/141 (25%), Gaps = 3/141 (2%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
P S P + P V+ PP + PP P P P P P
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
P PK P V P P ++ P +P T T
Sbjct: 75 A---PVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAA 131
Query: 205 TPASPIAPRPSNSSPNSPPPP 225
T + + + P
Sbjct: 132 TSKPVTSVASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 26/133 (19%), Positives = 32/133 (24%)
Query: 43 PPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
V + P + P S P P A PP P P P A
Sbjct: 23 HQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKP 82
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
P P P S P+ P N+ P S V
Sbjct: 83 KPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASG 142
Query: 163 PPSVPPQNPPPPP 175
P ++ P P
Sbjct: 143 PRALSRNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 28/150 (18%), Positives = 38/150 (25%), Gaps = 4/150 (2%)
Query: 85 PTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNP 144
+ P S I P P P PP P P P P
Sbjct: 10 SSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIP 69
Query: 145 PSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
PP + V K P P P P ++ P P +
Sbjct: 70 E----PPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTS 125
Query: 205 TPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
+ A+ +P S + P S + P
Sbjct: 126 STATAATSKPVTSVASGPRALSRNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 21/135 (15%), Positives = 30/135 (22%)
Query: 18 PPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSS 77
+S I P P + P + P PPP P P P
Sbjct: 18 SHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPV 77
Query: 78 PPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
P P PV + P + +S + + P
Sbjct: 78 VIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVT 137
Query: 138 SPPPSNPPSNLPPPP 152
S + P
Sbjct: 138 SVASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 22/125 (17%), Positives = 32/125 (25%)
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
P + P + +P P + P P P P P + P + P V + P P
Sbjct: 27 ELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKP 86
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
P V P A + ++ S P S
Sbjct: 87 KPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRAL 146
Query: 235 GIPVP 239
P
Sbjct: 147 SRNQP 151
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 26/142 (18%), Positives = 30/142 (21%)
Query: 4 PSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPP 63
S P + S + P P P PP V PP P P P
Sbjct: 10 SSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIP 69
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
P P P P + P T SST
Sbjct: 70 EPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTAT 129
Query: 124 PNSPPSPPSDPPANSPPPSNPP 145
+ S N P
Sbjct: 130 AATSKPVTSVASGPRALSRNQP 151
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 6e-08
Identities = 21/121 (17%), Positives = 28/121 (23%), Gaps = 3/121 (2%)
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
S N P +D PPP P + P P S P P++
Sbjct: 11 DSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERAS---TAAPVASPAAP 67
Query: 179 PPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPV 238
P +S SN T S S + + P
Sbjct: 68 SPGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDW 127
Query: 239 P 239
Sbjct: 128 A 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 1e-07
Identities = 17/115 (14%), Positives = 32/115 (27%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS 82
P PP P P ++ + AS +SP A SP +S
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPAN 137
+ +++ + A++ S R + P + +
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWAKYFKG 133
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 4e-07
Identities = 13/105 (12%), Positives = 23/105 (21%)
Query: 70 ASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPS 129
+ S ++ P P P PP S + P + + P +P
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 130 PPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
S SN ++ +
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 18/117 (15%), Positives = 35/117 (29%)
Query: 82 SNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPP 141
SN + P P PPPP + P +P +++ S +P + P A SP
Sbjct: 12 SNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGS 71
Query: 142 SNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
S + + + + Q + + + + +
Sbjct: 72 SGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.8 bits (118), Expect = 2e-06
Identities = 12/100 (12%), Positives = 23/100 (23%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
+ P+ PPPP + + P + P P S
Sbjct: 17 NLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGG 76
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
+S S ++ S + + +
Sbjct: 77 FFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 18/103 (17%), Positives = 27/103 (26%), Gaps = 2/103 (1%)
Query: 12 NSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPAS 71
N + P P PP P +SP P S + + P + SP +S
Sbjct: 13 NFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSS 72
Query: 72 SPPT--SSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPT 112
SS A T++ +
Sbjct: 73 GGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 14/116 (12%), Positives = 26/116 (22%), Gaps = 3/116 (2%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+N P P PPP++ P ++P + ++ P P S
Sbjct: 16 ANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERA---STAAPVASPAAPSPGSS 72
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPP 175
S S + + + V +
Sbjct: 73 GGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 17/102 (16%), Positives = 29/102 (28%), Gaps = 3/102 (2%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+N P +PP P + P T S AS+ S+ P ++P SP S
Sbjct: 16 ANLPNGYMTDLQRPQPPPPPPSAASP---GATPGSAAASAERASTAAPVASPAAPSPGSS 72
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDP 134
++S + + +
Sbjct: 73 GGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 3e-06
Identities = 14/124 (11%), Positives = 24/124 (19%)
Query: 71 SSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSP 130
S + P P PP P S + ++ + PSP
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 131 PSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAV 190
S + ++ + S + P A
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWAK 129
Query: 191 PPSN 194
Sbjct: 130 YFKG 133
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-06
Identities = 16/104 (15%), Positives = 27/104 (25%), Gaps = 3/104 (2%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
A P + P PP PP S P + P ++ S + P +P
Sbjct: 14 FMANLPNGYMTDLQRPQPP---PPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPG 70
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
+ + S A+ S + +
Sbjct: 71 SSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-06
Identities = 20/113 (17%), Positives = 30/113 (26%), Gaps = 2/113 (1%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P P PP S+ + P S+ A T++P SP A SP +
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
S+ ++ S A L + K
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGA--GRGGAAARVLLVIDEPHTDWAK 129
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 5e-06
Identities = 14/97 (14%), Positives = 28/97 (28%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPT 64
PPPP S + P + + + PV+ P SP S +
Sbjct: 21 GYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSS 80
Query: 65 SSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
S+ + ++ + S ++ +
Sbjct: 81 LSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVL 117
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 5e-06
Identities = 13/102 (12%), Positives = 25/102 (24%)
Query: 13 SSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASS 72
++ P PPP S P + + P ++P S +
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
S + T++ + + S R
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 8e-06
Identities = 14/114 (12%), Positives = 31/114 (27%)
Query: 86 TSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPP 145
++ P PPPP S + P ++ + + P PA P S+
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 146 SNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPP 199
++V+ + + + + + + V
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 8e-06
Identities = 11/97 (11%), Positives = 21/97 (21%)
Query: 104 PPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
P R PPP + +P S + + P P P
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 164 PSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPT 200
S+ +++ + +
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 9e-06
Identities = 14/114 (12%), Positives = 31/114 (27%), Gaps = 3/114 (2%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
++ P P P PP+++ P + P S+ + + + + P P S+
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 124 PNSPPSPPS---DPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
S + A + + R + +
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 1e-05
Identities = 15/106 (14%), Positives = 25/106 (23%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPP 80
S+ ++ P P PPP + A+ +S A ++P P
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
S+ A T + S
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 12/102 (11%), Positives = 23/102 (22%), Gaps = 2/102 (1%)
Query: 49 PTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
P P PP S+ + P ++ + P +SP +P P S
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPA--APSPGSS 72
Query: 109 NPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
++ + +
Sbjct: 73 GGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 8e-05
Identities = 21/116 (18%), Positives = 35/116 (30%), Gaps = 15/116 (12%)
Query: 142 SNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQ 201
SN +NLP + ++ P+ PP +P P S+
Sbjct: 12 SNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAA---------------SAERAS 56
Query: 202 TPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNGTNPSSPESS 257
T ASP AP P +S + + + G G+ + +
Sbjct: 57 TAAPVASPAAPSPGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGA 112
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 12/106 (11%), Positives = 22/106 (20%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
P P S ++P P + P +S +S
Sbjct: 23 MTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSSLS 82
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVS 108
A++ T S + + P +
Sbjct: 83 NAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 54.3 bits (129), Expect = 8e-08
Identities = 24/236 (10%), Positives = 42/236 (17%), Gaps = 15/236 (6%)
Query: 21 SNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSS------------- 67
S + P S + +T P SN
Sbjct: 87 SPRLILFFKDPSSKDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICINC 146
Query: 68 --PPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
P SS ++ ++ P + + I P +N P PN
Sbjct: 147 GVPADYELTKSSINCSNAIDPNANPQNQFGVNSENICPACTFANHPQIGNCEICGHRLPN 206
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
+ N + S + S K+
Sbjct: 207 ASKVRSKLNRLNFHDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLSFRKSDGV 266
Query: 186 APIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPST 241
+ T+ + + P S
Sbjct: 267 LFSQATERALENILTEKNKHIFNQNVVSVNGVDMRKGASSHEYNNEVPFIETKLSR 322
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 48.1 bits (113), Expect = 8e-06
Identities = 25/240 (10%), Positives = 47/240 (19%), Gaps = 22/240 (9%)
Query: 64 TSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP--SST 121
P + S S+ S +S P P +
Sbjct: 88 PRLILFFKDPSSKDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICINCG 147
Query: 122 PPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSS-------VEPPKRSPPSVPPQNPPPP 174
P + + S +N+ P+ P N + P+ + P
Sbjct: 148 VPADYELTKSSINCSNAIDPNANPQNQFGVNSENICPACTFANHPQIGNCEICGHRLPNA 207
Query: 175 PSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPP 234
N + + + S ++ S S S ++
Sbjct: 208 SKVRSKLNRLNFHDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLSFRKSDGVL 267
Query: 235 GIPV-------------PSTENTPGNGTNPSSPESSSSPSNNGIGTAGTVVIAVAVGIIA 281
N N +S +GI +
Sbjct: 268 FSQATERALENILTEKNKHIFNQNVVSVNGVDMRKGASSHEYNNEVPFIETKLSRIGISS 327
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 21/174 (12%), Positives = 36/174 (20%)
Query: 31 PVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPP 90
P KSS ++ N + A S
Sbjct: 5 PRKTKGKSSGKGNDSTERSDDGSSQLRDKQNNKAGPATTEPGTSNREQYRARPGIASVQR 64
Query: 91 PSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
+ A P + + + A S
Sbjct: 65 ATESAELPMKNNDEGTPDKKGNTRGDLVNEHSEAKDEADEATQKQAKDTDKSKAQVTYSD 124
Query: 151 PPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPP 204
++ RS P S+ + A ++ P+ V PPT +
Sbjct: 125 TGINNANELSRSGNVDNEGGSNQKPMSTRIAEATSAIVSKHPARVGLPPTASSG 178
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 3e-06
Identities = 21/183 (11%), Positives = 43/183 (23%), Gaps = 12/183 (6%)
Query: 52 SPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPP 111
P + S+ + S S +S N P S+ P +++
Sbjct: 4 IPRKTKGKSSGKGNDSTERSDDGSSQLRDKQNNKAGPATTEPGTSNREQYRARPGIASVQ 63
Query: 112 TRSPP--PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQ 169
+ P +P + + + + E ++
Sbjct: 64 RATESAELPMKNNDEGTPDKKGNTRG-------DLVNEHSEAKDEADEATQKQAKDTDKS 116
Query: 170 NPPPPPSSSPPKNSPPAPIAVPPSN---VPPPPTQTPPTPASPIAPRPSNSSPNSPPPPS 226
S + N+ + N P T A+ + PP S
Sbjct: 117 KAQVTYSDTGINNANELSRSGNVDNEGGSNQKPMSTRIAEATSAIVSKHPARVGLPPTAS 176
Query: 227 TKR 229
+
Sbjct: 177 SGH 179
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 49.1 bits (115), Expect = 3e-06
Identities = 19/110 (17%), Positives = 31/110 (28%), Gaps = 8/110 (7%)
Query: 81 ASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPP 140
S P + A++ +S P V P+ N + P
Sbjct: 391 MSGPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPK----- 445
Query: 141 PSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAV 190
P PP P K + + P P P + + +PP +
Sbjct: 446 ---VTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLEH 492
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 48.4 bits (113), Expect = 6e-06
Identities = 14/114 (12%), Positives = 29/114 (25%)
Query: 54 PPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTR 113
+P + + + + ++ T P +
Sbjct: 377 SDAPNSWYGAGAIKMSGPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNG 436
Query: 114 SPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ P+PP P A + P L P P + + +PP+
Sbjct: 437 KIRAVNVPKVTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRL 490
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 47.6 bits (111), Expect = 1e-05
Identities = 22/113 (19%), Positives = 37/113 (32%), Gaps = 1/113 (0%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
+P + +N T ++ P + P P + P+ S
Sbjct: 377 SDAPNSWYGAGAIKMSGPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNG 436
Query: 150 PPPPSSVEPPKRSPPSVPPQ-NPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQ 201
+V + P+ P + P P+ K PAP+A P PPT+
Sbjct: 437 KIRAVNVPKVTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTR 489
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 45.3 bits (105), Expect = 6e-05
Identities = 15/96 (15%), Positives = 20/96 (20%), Gaps = 4/96 (4%)
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSP 179
+T N P N+ + P V + P PP +
Sbjct: 402 ATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVN--VPKVTKEKPTPPVKPTA 459
Query: 180 PKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPS 215
P P P P P P
Sbjct: 460 PT--KPTYETEKPLKPAPVAPNYEKEPTPPTRLEHH 493
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 44.1 bits (102), Expect = 1e-04
Identities = 13/86 (15%), Positives = 22/86 (25%)
Query: 38 SSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASS 97
++ + P + + + P +PP P A +
Sbjct: 402 ATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKPTAPT 461
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPP 123
PT P+ P TPP
Sbjct: 462 KPTYETEKPLKPAPVAPNYEKEPTPP 487
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 43.3 bits (100), Expect = 2e-04
Identities = 14/104 (13%), Positives = 24/104 (23%), Gaps = 4/104 (3%)
Query: 60 SNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPS 119
+ S+ P + +++ N P
Sbjct: 393 GPNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPK--VTKEK 450
Query: 120 STPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
TPP P+ P+ P + P P P P +
Sbjct: 451 PTPPV--KPTAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLEH 492
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 42.2 bits (97), Expect = 5e-04
Identities = 13/96 (13%), Positives = 21/96 (21%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
++ + S P V P + T P P
Sbjct: 398 VTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKP 457
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPAS 96
PT + P +P + +PP
Sbjct: 458 TAPTKPTYETEKPLKPAPVAPNYEKEPTPPTRLEHH 493
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 41.8 bits (96), Expect = 6e-04
Identities = 12/86 (13%), Positives = 22/86 (25%)
Query: 33 SNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPS 92
+ + P + P + + + + PP P+
Sbjct: 402 ATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKPTAPT 461
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPP 118
P P PV+ + P PP
Sbjct: 462 KPTYETEKPLKPAPVAPNYEKEPTPP 487
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 41.8 bits (96), Expect = 7e-04
Identities = 18/105 (17%), Positives = 26/105 (24%), Gaps = 7/105 (6%)
Query: 42 PPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTI 101
P TS P S+ P + + + N + PT
Sbjct: 394 PNNYVTVGATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPT- 452
Query: 102 SPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
PP PT P+ P+P + P P
Sbjct: 453 --PPVKPTAPT----KPTYETEKPLKPAPVAPNYEKEPTPPTRLE 491
|
| >2kr0_A Proteasomal ubiquitin receptor ADRM1; proteasome, 19S regulator, protein binding; NMR {Homo sapiens} Length = 411 | Back alignment and structure |
|---|
Score = 47.8 bits (112), Expect = 8e-06
Identities = 31/164 (18%), Positives = 50/164 (30%)
Query: 1 MSAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPAS 60
+ G + P +++ S PP S+ S V+ TTS + PA
Sbjct: 176 IGPAGLGGLGGLGALTGPGLASLLGSSGPPGSSSSSSSRSQSAAVTPSSTTSSTRATPAP 235
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
+ P ++S + SP SS AS + + P + P + S
Sbjct: 236 SAPAAASATSPSPAPSSGNGASTAASPTQPIQLSDLQSILATMNVPAGPAGGQQVDLASV 295
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPP 164
P P + P P P ++ SP
Sbjct: 296 LTPEIMAPILANADVQERLLPYLPSGESLPQTADEIQNTLTSPQ 339
|
| >2kr0_A Proteasomal ubiquitin receptor ADRM1; proteasome, 19S regulator, protein binding; NMR {Homo sapiens} Length = 411 | Back alignment and structure |
|---|
Score = 42.0 bits (97), Expect = 5e-04
Identities = 28/205 (13%), Positives = 41/205 (20%)
Query: 19 PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSP 78
P + S S P T
Sbjct: 135 PPMPGALGASGSSGHELSALGGEGGLQSLLGNMSHSQLMQLIGPAGLGGLGGLGALTGPG 194
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
+ + P S +SS + P S + P S P S SP P + +
Sbjct: 195 LASLLGSSGPPGSSSSSSSRSQSAAVTPSSTTSSTRATPAPSAPAAASATSPSPAPSSGN 254
Query: 139 PPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPP 198
+ P P +S API
Sbjct: 255 GASTAASPTQPIQLSDLQSILATMNVPAGPAGGQQVDLASVLTPEIMAPILANADVQERL 314
Query: 199 PTQTPPTPASPIAPRPSNSSPNSPP 223
P + P ++ SP
Sbjct: 315 LPYLPSGESLPQTADEIQNTLTSPQ 339
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 15/144 (10%), Positives = 32/144 (22%), Gaps = 3/144 (2%)
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
S P + S + S PS PP P
Sbjct: 12 SGLVPRGSHMASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPI-TTD 70
Query: 147 NLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
++ K++ P + + A + + ++
Sbjct: 71 ATSATVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIW- 129
Query: 207 ASPIAPRPSNSSPNSPPPPSTKRL 230
S + P ++ + P +
Sbjct: 130 -SDVVPFVRRTTDSDFDPSRMYKF 152
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 16/135 (11%), Positives = 35/135 (25%), Gaps = 8/135 (5%)
Query: 3 APSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNP 62
A + S+ S P+ PP + + V+ T + + A+
Sbjct: 22 ASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTDATSATVTAAGG 81
Query: 63 PTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTP 122
+ ++ PA +++ + A + N S
Sbjct: 82 AKKKA--------TTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWSDVV 133
Query: 123 PPNSPPSPPSDPPAN 137
P + P+
Sbjct: 134 PFVRRTTDSDFDPSR 148
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 14/140 (10%), Positives = 29/140 (20%), Gaps = 6/140 (4%)
Query: 43 PPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
P + + +S+S P+ PP + T +
Sbjct: 15 VPRGSHMASKRCRQCSGDSASSSTSS---LSPSELPPSKKAAGGQRVTAEVEVAPITTDA 71
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
V+ + +P + + ++ + K
Sbjct: 72 TSATVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAE---ALAALNAKKSEKEI 128
Query: 163 PPSVPPQNPPPPPSSSPPKN 182
V P S P
Sbjct: 129 WSDVVPFVRRTTDSDFDPSR 148
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 14/134 (10%), Positives = 31/134 (23%), Gaps = 3/134 (2%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPT---SSPPPASNPPT 86
P + S ++S P+ PP+ + +P
Sbjct: 15 VPRGSHMASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTDATSA 74
Query: 87 SSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPS 146
+ T SP S+ + + + + S+
Sbjct: 75 TVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWSDVVP 134
Query: 147 NLPPPPPSSVEPPK 160
+ S +P +
Sbjct: 135 FVRRTTDSDFDPSR 148
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 15/133 (11%), Positives = 27/133 (20%), Gaps = 2/133 (1%)
Query: 35 PPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPA--SNPPTSSPPPS 92
P+ S + + S +S P+ P + P T+ +
Sbjct: 15 VPRGSHMASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTDATSA 74
Query: 93 PPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPP 152
++ S S + A + S P
Sbjct: 75 TVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWSDVVP 134
Query: 153 PSSVEPPKRSPPS 165
PS
Sbjct: 135 FVRRTTDSDFDPS 147
|
| >2qlv_B Protein SIP2, protein SPM2; heterotrimer, ATP-binding, carbohydrate metabolism, kinase, membrane, nucleotide-binding, nucleus; 2.60A {Saccharomyces cerevisiae} SCOP: b.1.18.21 d.353.1.1 Length = 252 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 4e-05
Identities = 15/138 (10%), Positives = 29/138 (21%), Gaps = 2/138 (1%)
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
P+ P ++ + P + PP
Sbjct: 84 EVRQPEKNPTNEKIRSKEADSMRPPTSDRSSIALQIGKDPDDFGDGYTRFHEDLSPRPPL 143
Query: 143 NPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQT 202
+++P + Q+ +PP P + N
Sbjct: 144 EYTTDIPAVFTDPSVMERYYYTLDRQQSNTDTSWLTPP--QLPPQLENVILNKYYATQDQ 201
Query: 203 PPTPASPIAPRPSNSSPN 220
S P P++ N
Sbjct: 202 FNENNSGALPIPNHVVLN 219
|
| >2qlv_B Protein SIP2, protein SPM2; heterotrimer, ATP-binding, carbohydrate metabolism, kinase, membrane, nucleotide-binding, nucleus; 2.60A {Saccharomyces cerevisiae} SCOP: b.1.18.21 d.353.1.1 Length = 252 | Back alignment and structure |
|---|
Score = 42.3 bits (98), Expect = 2e-04
Identities = 16/132 (12%), Positives = 28/132 (21%), Gaps = 1/132 (0%)
Query: 45 VSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPP 104
+ P + + S P +S +S P + PP
Sbjct: 83 IEVRQPEKNPTNEKIRSKEADSMRPPTSDRSSIALQIGKDPDDFGDGYTRFHEDLSPRPP 142
Query: 105 PPVSNP-PTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSP 163
+ P P + S+ + P P L + +
Sbjct: 143 LEYTTDIPAVFTDPSVMERYYYTLDRQQSNTDTSWLTPPQLPPQLENVILNKYYATQDQF 202
Query: 164 PSVPPQNPPPPP 175
P P
Sbjct: 203 NENNSGALPIPN 214
|
| >2qlv_B Protein SIP2, protein SPM2; heterotrimer, ATP-binding, carbohydrate metabolism, kinase, membrane, nucleotide-binding, nucleus; 2.60A {Saccharomyces cerevisiae} SCOP: b.1.18.21 d.353.1.1 Length = 252 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 9e-04
Identities = 22/138 (15%), Positives = 31/138 (22%), Gaps = 4/138 (2%)
Query: 19 PVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSP 78
V P + + S PP + P + P
Sbjct: 84 EVRQPEKNPTNEKIRSKEADSMRPPTSDRSSIALQIGKDPDDFGDGYTRFHEDLSPRPPL 143
Query: 79 PPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANS 138
++ P PS T+ N T PP PP + A
Sbjct: 144 EYTTDIPAVFTDPSVMERYYYTLDRQQS--NTDTSWLTPP--QLPPQLENVILNKYYATQ 199
Query: 139 PPPSNPPSNLPPPPPSSV 156
+ S P P V
Sbjct: 200 DQFNENNSGALPIPNHVV 217
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 15/88 (17%), Positives = 23/88 (26%)
Query: 98 PPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVE 157
P P + P P P PS + +
Sbjct: 5 PTQTFYGRRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRAQK 64
Query: 158 PPKRSPPSVPPQNPPPPPSSSPPKNSPP 185
PK++PP P + P + K+ P
Sbjct: 65 KPKKTPPPKPKKTQKPKKPTQKKKSKPG 92
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 12/97 (12%), Positives = 20/97 (20%), Gaps = 3/97 (3%)
Query: 55 PSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRS 114
P+ +P P PP ++ ++ P +
Sbjct: 5 PTQTFYGRRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRAQK 64
Query: 115 PPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPP 151
P PP P S P +
Sbjct: 65 KPKK---TPPPKPKKTQKPKKPTQKKKSKPGKRMRNC 98
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 17/98 (17%), Positives = 26/98 (26%), Gaps = 11/98 (11%)
Query: 117 PPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPS 176
P + P+P P P P PS ++ + ++ Q
Sbjct: 5 PTQTFYGRRWRPAPVQRYI---PQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKR 61
Query: 177 SSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRP 214
+ P P P TQ P P +P
Sbjct: 62 AQKKPKKTPPP--------KPKKTQKPKKPTQKKKSKP 91
|
| >1pcx_A Protein transport protein SEC24; 2.50A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 PDB: 1pd0_A 1pd1_A Length = 810 | Back alignment and structure |
|---|
Score = 45.4 bits (106), Expect = 6e-05
Identities = 23/112 (20%), Positives = 30/112 (26%), Gaps = 2/112 (1%)
Query: 97 SPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSV 156
+ P P R P P +D PP PP + P S
Sbjct: 1 AAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSN 60
Query: 157 EPPK--RSPPSVPPQNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTP 206
P RS + P+N S P P ++ PPP
Sbjct: 61 ASPDYIRSTLNAVPKNSSLLKKSKLPFGLVIRPYQHLYDDIDPPPLNEDGLI 112
|
| >1pcx_A Protein transport protein SEC24; 2.50A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 PDB: 1pd0_A 1pd1_A Length = 810 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 7e-04
Identities = 16/66 (24%), Positives = 21/66 (31%), Gaps = 2/66 (3%)
Query: 189 AVPPSNVPPPPTQTPPTPASPIAPRPSNSSPNSPPPPSTKRLSPPPGIPVPSTENTPGNG 248
A P P P + P + PPP + L PPP + P P
Sbjct: 1 AAPAYGQPSAAMGQNMRPMNQ--LYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSEL 58
Query: 249 TNPSSP 254
+N S
Sbjct: 59 SNASPD 64
|
| >1pcx_A Protein transport protein SEC24; 2.50A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 PDB: 1pd0_A 1pd1_A Length = 810 | Back alignment and structure |
|---|
Score = 41.5 bits (96), Expect = 9e-04
Identities = 33/189 (17%), Positives = 52/189 (27%), Gaps = 15/189 (7%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNP-PKSSPPPPPVSKPPTTSPPPSPPAS 60
+AP+ G P+A P++ I + P + PPPP+ PP PS ++
Sbjct: 1 AAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSN 60
Query: 61 NPP-----TSSSPPASSPPTSSP---------PPASNPPTSSPPPSPPASSPPTISPPPP 106
P T ++ P +S P PPP
Sbjct: 61 ASPDYIRSTLNAVPKNSSLLKKSKLPFGLVIRPYQHLYDDIDPPPLNEDGLIVRCRRCRS 120
Query: 107 VSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSV 166
NP + + P++P S +P
Sbjct: 121 YMNPFVTFIEQGRRWRCNFCRLANDVPMQMDQSDPNDPKSRYDRNEIKCAVMEYMAPKEY 180
Query: 167 PPQNPPPPP 175
+ PPP
Sbjct: 181 TLRQPPPAT 189
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 13/74 (17%), Positives = 21/74 (28%), Gaps = 2/74 (2%)
Query: 109 NPPTRSPPPPSSTPPPNSPPSP-PSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+PP++ + +P P + P E P R VP
Sbjct: 10 DPPSQDLKDGTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTELPSRRAE-VP 68
Query: 168 PQNPPPPPSSSPPK 181
+ P PP +
Sbjct: 69 TKPPLPPARTQGTP 82
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 13/72 (18%), Positives = 20/72 (27%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
PP + + + P P S P + P+ +
Sbjct: 10 DPPSQDLKDGTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTELPSRRAEVPT 69
Query: 89 PPPSPPASSPPT 100
PP PPA + T
Sbjct: 70 KPPLPPARTQGT 81
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 14/76 (18%), Positives = 22/76 (28%), Gaps = 1/76 (1%)
Query: 73 PPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
PP+ + + +P P P V + P T P+ P+
Sbjct: 11 PPSQDLKDGTQEEATKRQEAPVDP-RPEGDPQRTVISWRGAVIEPEQGTELPSRRAEVPT 69
Query: 133 DPPANSPPPSNPPSNL 148
PP P +L
Sbjct: 70 KPPLPPARTQGTPVHL 85
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 7e-05
Identities = 15/72 (20%), Positives = 23/72 (31%)
Query: 88 SPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSN 147
S P + PP P+ P+ ++ S PP +P S+ S+
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 148 LPPPPPSSVEPP 159
P E P
Sbjct: 61 FAVPTIHFKESP 72
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 17/95 (17%), Positives = 23/95 (24%), Gaps = 3/95 (3%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
S + T S P SP S+ + S PP +NP S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPS---VIRQSPTQRRKTSTTSSTSRAPPPTNPDASSS 57
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPP 150
+ P + SP P
Sbjct: 58 SSSFAVPTIHFKESPFYKIQRLIPELVMNVEVTGG 92
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 15/92 (16%), Positives = 26/92 (28%), Gaps = 2/92 (2%)
Query: 39 SPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSP 98
S P + PP+ +P P TS+ S P + P + +SS
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 99 PTISPPPPVSNP--PTRSPPPPSSTPPPNSPP 128
+ +P + P +
Sbjct: 61 FAVPTIHFKESPFYKIQRLIPELVMNVEVTGG 92
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 17/97 (17%), Positives = 35/97 (36%), Gaps = 2/97 (2%)
Query: 27 SPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPT 86
S P + +S PP V + + SP +++S + +PP ++P +S+ +
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 87 SSPPPSPPASSP--PTISPPPPVSNPPTRSPPPPSST 121
+ P SP P + + +
Sbjct: 61 FAVPTIHFKESPFYKIQRLIPELVMNVEVTGGRGMCS 97
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 7e-05
Identities = 11/89 (12%), Positives = 18/89 (20%)
Query: 66 SSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPN 125
S S P +S T + V + P +P +
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 126 SPPSPPSDPPANSPPPSNPPSNLPPPPPS 154
S + + P S
Sbjct: 292 SVNPVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 16/91 (17%), Positives = 29/91 (31%), Gaps = 3/91 (3%)
Query: 30 PPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSP 89
+ + S ++ P + P P SN T+++ S P S+P +
Sbjct: 233 LSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRS---E 289
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
S S P ++P +S
Sbjct: 290 TESVNPVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 14/81 (17%), Positives = 21/81 (25%)
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
+ ++ P S P S + + S P +P T S P S+
Sbjct: 240 ERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESVNPVSTP 299
Query: 122 PPPNSPPSPPSDPPANSPPPS 142
S A S
Sbjct: 300 ASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 4e-04
Identities = 10/89 (11%), Positives = 17/89 (19%)
Query: 67 SPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNS 126
S A + + + S P +
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 127 PPSPPSDPPANSPPPSNPPSNLPPPPPSS 155
+P S P + N P +S
Sbjct: 292 SVNPVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 5e-04
Identities = 11/80 (13%), Positives = 18/80 (22%)
Query: 14 SSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSP 73
P+ +P + S P+ T S P S+P
Sbjct: 240 ERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESVNPVSTP 299
Query: 74 PTSSPPPASNPPTSSPPPSP 93
+ +P S
Sbjct: 300 ASVEYHAGMKSLNKAPYSSN 319
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 41.5 bits (96), Expect = 7e-04
Identities = 8/85 (9%), Positives = 19/85 (22%)
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRS 162
+ + + + SP S+ N+ P + +
Sbjct: 234 SLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESV 293
Query: 163 PPSVPPQNPPPPPSSSPPKNSPPAP 187
P P + +P +
Sbjct: 294 NPVSTPASVEYHAGMKSLNKAPYSS 318
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 41.5 bits (96), Expect = 7e-04
Identities = 13/87 (14%), Positives = 24/87 (27%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS 82
+ P VS + + + + S A + T S
Sbjct: 233 LSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETES 292
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSN 109
P S+P + +++ P SN
Sbjct: 293 VNPVSTPASVEYHAGMKSLNKAPYSSN 319
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 8e-04
Identities = 10/87 (11%), Positives = 18/87 (20%)
Query: 101 ISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPK 160
+ + ++ P SP P+ + S P +
Sbjct: 231 WDLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSET 290
Query: 161 RSPPSVPPQNPPPPPSSSPPKNSPPAP 187
S V + N P
Sbjct: 291 ESVNPVSTPASVEYHAGMKSLNKAPYS 317
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 8e-04
Identities = 12/90 (13%), Positives = 23/90 (25%), Gaps = 2/90 (2%)
Query: 43 PPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTIS 102
+ S + + P + S + + ++ S P+ T S
Sbjct: 233 LSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETES 292
Query: 103 PPPPVSNPPTRSPPPPSSTPPPNSPPSPPS 132
P + P +P S S
Sbjct: 293 VNP--VSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >1zvo_C Myeloma immunoglobulin D delta; immunoglobulin fold, antibody, immune system; NMR {Homo sapiens} Length = 512 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 17/203 (8%), Positives = 35/203 (17%), Gaps = 6/203 (2%)
Query: 5 SPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPP------PVSKPPTTSPPPSPP 58
S P A P P + P ++ P ++ P
Sbjct: 128 SSAPTKAPDVFPIISGCRHPKDNSPVVLACLITGYHPTSVTVTWYMGTQSQPQRTFPEIQ 187
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
+ +S S+P P ++ + P
Sbjct: 188 RRDSYYMTSSQLSTPLQQWRQGEYKCVVQHTASKSKKEIFRWPESPKAQASSVPTAQPQA 247
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPPPSSS 178
+ + + + P+ + P P+
Sbjct: 248 EGSLAKATTAPATTRNTGRGGEEKKKEKEKEEQEERETKTPECPSHTQPLGVYLLTPAVQ 307
Query: 179 PPKNSPPAPIAVPPSNVPPPPTQ 201
A
Sbjct: 308 DLWLRDKATFTCFVVGSDLKDAH 330
|
| >3u3p_A Tumor necrosis factor receptor superfamily member; trigger apoptosis, apoptosis; 2.09A {Homo sapiens} PDB: 3u3q_A 3u3s_A 3u3t_A 3u3v_A 3qo4_A Length = 313 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 17/130 (13%), Positives = 30/130 (23%), Gaps = 2/130 (1%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
+ + P+ P +S + AS P +
Sbjct: 172 TLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQE 231
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
P + + P+ P + LP + E K S P
Sbjct: 232 GTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGE--KSSTPIKG 289
Query: 168 PQNPPPPPSS 177
P+ P +
Sbjct: 290 PKRGHPRQNL 299
|
| >3vf0_A Vinculin, metavinculin; cytoskeletal F-actin binding protein, CEL adhesion-protein binding complex; HET: EPE; 2.54A {Homo sapiens} Length = 283 | Back alignment and structure |
|---|
Score = 42.3 bits (98), Expect = 3e-04
Identities = 23/115 (20%), Positives = 32/115 (27%)
Query: 59 ASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPP 118
S+ + P P PPP PP P + I+ P ++
Sbjct: 1 GSHMDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQKAGEVINQPMMMAARQLHDEARK 60
Query: 119 SSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPP 173
S+ P A + +PP EP PS P N P
Sbjct: 61 WSSKPGIPAAEVGIGVVAEADAADAAGFPVPPDMEDDYEPELLLMPSNQPVNQPI 115
|
| >3q2s_C Cleavage and polyadenylation specificity factor S; CFIM, CFIM25, CFIM68, CPSF5, CPSF6, CPSF, 3' END processing, processing, cleavage factor; 2.90A {Homo sapiens} PDB: 3q2t_C Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 10/83 (12%), Positives = 17/83 (20%)
Query: 90 PPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLP 149
P + S + + + P P + P +
Sbjct: 146 PVNKQFLSQFEMQSRKTTQSGQMSGEGKAGPPGGSSRAAFPQGGRGRGRFPGAVPGGDRF 205
Query: 150 PPPPSSVEPPKRSPPSVPPQNPP 172
P P PP P +
Sbjct: 206 PGPAGPGGPPPPFPAGQTHHHHH 228
|
| >2krg_A Na(+)/H(+) exchange regulatory cofactor NHE-RF1; acetylation, cell projection, disease mutation, membrane, phosphoprotein, polymorphism; NMR {Homo sapiens} Length = 216 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 4e-04
Identities = 14/95 (14%), Positives = 18/95 (18%)
Query: 29 PPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSS 88
K P P P +S + SP PA SS
Sbjct: 90 DRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASS 149
Query: 89 PPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPP 123
S + + S P
Sbjct: 150 DTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNIS 184
|
| >1kxf_A Sindbis virus capsid protein; chymotrypsin-like serine proteinase, wild type, viral protein; 2.38A {Sindbis virus} SCOP: b.47.1.3 PDB: 1ld4_A 3j0f_A Length = 264 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 4e-04
Identities = 17/114 (14%), Positives = 23/114 (20%), Gaps = 2/114 (1%)
Query: 61 NPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSS 120
N PA + P + T + V TR P
Sbjct: 7 NMLGRRPFPAPTAMWRPRRRRQAAPMPARNGLASQIQQLTTAVSALVIGQATRPQNPRPR 66
Query: 121 TPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVPPQNPPPP 174
PP +P P P P P +R +
Sbjct: 67 PPPRQKKQAPKQPPKPKKPKPQEKKKKQPAKTKPG--KRQRMALKLEADRLFDV 118
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 41.2 bits (95), Expect = 5e-04
Identities = 18/143 (12%), Positives = 31/143 (21%)
Query: 48 PPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPV 107
P +P P + P ++ P S PP PP P+
Sbjct: 3 SPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLF 62
Query: 108 SNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPSNPPSNLPPPPPSSVEPPKRSPPSVP 167
+ + + P + PA + S + P+
Sbjct: 63 EDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATV 122
Query: 168 PQNPPPPPSSSPPKNSPPAPIAV 190
+ P V
Sbjct: 123 NGTVEGGSGAGRLDLPPGFMFKV 145
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 7e-04
Identities = 20/139 (14%), Positives = 33/139 (23%)
Query: 23 PPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASNPPTSSSPPASSPPTSSPPPAS 82
P +P V++ P+ + P + P + PP P+
Sbjct: 3 SPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLF 62
Query: 83 NPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSSTPPPNSPPSPPSDPPANSPPPS 142
S P S + P + P + + S P+ P
Sbjct: 63 EDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATV 122
Query: 143 NPPSNLPPPPPSSVEPPKR 161
N PP
Sbjct: 123 NGTVEGGSGAGRLDLPPGF 141
|
| >1rh1_A Colicin B; FEPA, cytotoxic bacterial protein, TONB, antibiotic; 2.50A {Escherichia coli} SCOP: b.110.1.1 f.1.1.1 Length = 511 | Back alignment and structure |
|---|
Score = 41.6 bits (96), Expect = 7e-04
Identities = 27/230 (11%), Positives = 46/230 (20%), Gaps = 14/230 (6%)
Query: 2 SAPSPGPPAANSSSPPPPVSNPPTISPPPPVSNPPKSSPPPPPVSKPPTTSPPPSPPASN 61
P A S P +P I+ V P S +
Sbjct: 33 VKPGGSSGLAPSMPPGWGDYSPQGIALVQSVLFPGIIRRIILDKELEEGDWSGWSVSVHS 92
Query: 62 PPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSPPPPSST 121
P + A+ + P S P A P + +
Sbjct: 93 PWGNEKVSAARTVLENGLRGGLPEPSRPAAVSFARLEPASGNEQKIIRLMVTQQLEQVTD 152
Query: 122 PPPNSPPSPPSDPPANSPPP-------------SNPPSNLPPPPPSSVEPPKRSPPSVPP 168
P + P+ ++ P P +P V R ++
Sbjct: 153 IPASQLPAAGNNVPVKYRLTDLMQNGTQYMAIIGGIPMTVPVVDAVPVPDRSRPGTNIKD 212
Query: 169 QNPPPPPSSSPPKNSPPAPIAVPPSNVPPPPTQTPPTPASPIAPRPSNSS 218
P + P P P + + +
Sbjct: 213 VYSAPVSPNLPDLVL-SVGQMNTPVRSNPEIQEDGVISETGNYVEAGYTM 261
|
| >2j89_A Methionine sulfoxide reductase A; MSRA, poplar, oxidoreductase; 1.7A {Populus trichocarpa} Length = 261 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 18/86 (20%), Positives = 34/86 (39%)
Query: 56 SPPASNPPTSSSPPASSPPTSSPPPASNPPTSSPPPSPPASSPPTISPPPPVSNPPTRSP 115
+ +S ++++P P A + + S P + P + P PP++N ++
Sbjct: 7 THLSSTSTSTTTPLLLLSKPFLSPSAKSQLSHSKPFNFPRTLKPISYYKPPMANILSKLG 66
Query: 116 PPPSSTPPPNSPPSPPSDPPANSPPP 141
S P P+ P P + P P
Sbjct: 67 FGTRSPDPSTMDPTIPQGPDDDLPAP 92
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 696 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.32 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.09 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.99 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.87 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.86 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.79 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.76 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.56 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.52 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.42 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.42 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 98.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 98.07 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 98.05 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 98.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.96 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.66 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.33 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.14 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.07 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.96 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.05 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 95.6 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 95.17 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 94.91 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.35 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.86 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.7 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 92.09 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.82 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.9 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 88.71 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 88.31 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 86.85 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 86.63 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 85.7 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.98 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=452.39 Aligned_cols=259 Identities=25% Similarity=0.451 Sum_probs=213.1
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
+++|.+.+.||+|+||.||+|++. +++.||||+++.......++|++|+++|++|+|+|||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 367889999999999999999853 47789999998666566678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEE
Q 005443 440 LIYDYVPNNTLYFHLHGEG-----------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQ 508 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vk 508 (696)
||||||.+|+|.++|+..+ ...++|.++++|+.||++||+|||++ +|||||||++||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 34589999999999999999999999 999999999999999999999
Q ss_pred EEeeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHH
Q 005443 509 VSDFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 509 L~DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
|+|||+++......... .....||..|||||++.++.|+.++|||||||+||||+| |+.||.... ...+++.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~--- 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIEC--- 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHH---
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH---
Confidence 99999998765443332 233568999999999999999999999999999999998 899997643 2222211
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+. . .... ........++.+|+.+||+.||++||+|.||++.|+++..
T Consensus 243 i~----~-~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 IT----Q-GRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HH----H-TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----c-CCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 1 1100 0111223368899999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=454.42 Aligned_cols=258 Identities=26% Similarity=0.456 Sum_probs=206.3
Q ss_pred cCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|++|+++|++|+|+|||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999853 478999999986665666789999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 441 IYDYVPNNTLYFHLHGEG-------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
|||||.+|+|.++++... ...++|.++++|+.||++||+|||++ +|||||||++||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999987542 23489999999999999999999998 99999999999999999999
Q ss_pred EEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHH
Q 005443 508 QVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWAR 585 (696)
Q Consensus 508 kL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~ 585 (696)
||+|||+++....... ......+||..|||||++.+..|+.++|||||||+||||+| |+.||.... ...+++.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~-- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAIDC-- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHHHHH--
Confidence 9999999987644332 23345679999999999999999999999999999999999 899997543 2222211
Q ss_pred HHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 586 PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+. .... + ........++.+|+++||+.||++||+|.||+++|+.+..
T Consensus 273 -i~----~g~~---~-------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 273 -IT----QGRE---L-------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -HH----HTCC---C-------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HH----cCCC---C-------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11 1110 0 0111222368899999999999999999999999998864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=446.51 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=209.7
Q ss_pred cCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
+++++.+.||+|+||.||+|++. +++.||||+++... ....++|++|+.+|++|+|+|||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677889999999999999852 46789999997543 344578999999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC
Q 005443 440 LIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~ 505 (696)
||||||.+|+|.++|+... +..+++..+++|+.||++||+|||++ +|||||||++||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999986432 23589999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHh
Q 005443 506 EAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEW 583 (696)
Q Consensus 506 ~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~ 583 (696)
++||+|||+++....... ......+||..|||||++.++.|+.++|||||||+||||++ |+.||.+.. ..++++.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHHHHH
Confidence 999999999987654332 23445679999999999999999999999999999999998 899997643 2222221
Q ss_pred HHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 584 ARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
+. ..... ....+....+.+|+.+||+.||++||+|.||+++|+..
T Consensus 260 i~--------~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IR--------NRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH--------TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH--------cCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 11110 11122334688999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=452.33 Aligned_cols=251 Identities=22% Similarity=0.413 Sum_probs=204.4
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++++.||+|+||+||+|++ .+|+.||||+++.... ...+++++|+++|++|+|+|||+++++|.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999985 4799999999975432 334679999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
||.||+|.++|...+...+++..++.|+.||+.||+|||++ +|||||||++||||++++++||+|||+++......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999876666689999999999999999999999 99999999999999999999999999998764332
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......+||..|||||++.+..|+.++|||||||+||||++|+.||...+ ..+.+..++. ..+..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~-----~~~~~---- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIIS-----GSFPP---- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHH-----TCCCC----
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHc-----CCCCC----
Confidence 22334679999999999999999999999999999999999999997643 1222222211 11111
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+...+ ..++.+|+.+||+.||++|++++||+++
T Consensus 245 -~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 -VSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112 2368899999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=438.44 Aligned_cols=260 Identities=29% Similarity=0.497 Sum_probs=202.7
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++.+.||+|+||+||+|++++ .||||+++.... ...++|++|+++|++|+|+|||+++|+|.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3578889999999999999998743 699999975432 334679999999999999999999998864 67899999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC-
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN- 522 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~- 522 (696)
||.||+|.++|+.... .+++..+++|+.||++||+|||++ +|||||||++||||++++++||+|||+++......
T Consensus 112 y~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999976533 489999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeeccccccccCchhhhcc---CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 523 THITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.......+||..|||||++.+ +.|+.++|||||||+||||++|+.||.+.+. .. .+...+.+..
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---~~---~~~~~~~~~~------- 254 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---RD---QIIFMVGRGY------- 254 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HH---HHHHHHHTTC-------
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---HH---HHHHHHhcCC-------
Confidence 223445689999999999964 4589999999999999999999999975431 11 1111111111
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..+.+. .........+.+|+.+||+.||++||+|.||++.|+.+..
T Consensus 255 -~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 255 -ASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp -CCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred -CCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111110 1111223468899999999999999999999999987753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=443.82 Aligned_cols=250 Identities=21% Similarity=0.319 Sum_probs=209.1
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+.|++.+.||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|++|+|+|||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999864 79999999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.||+|.+++... .+++..++.|+.||+.||+|||++ +|||||||++||||++++++||+|||+++....... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 999999988753 389999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....+||..|||||++.+..|+.++|||||||+||||++|+.||...+ ...++ ..+... . ...+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~---~~i~~~-----~-----~~~~ 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAM---KMIRDN-----L-----PPRL 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH---HHHHHS-----S-----CCCC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHH---HHHHcC-----C-----CCCC
Confidence 345689999999999999999999999999999999999999997543 11111 111110 0 0000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........++.+|+.+||+.||++|++++||+++
T Consensus 291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111122368899999999999999999998864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=449.83 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=209.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+.|++++.||+|+||.||+|++ .+|+.||||+++.......+.+.+|+++|++|+|+|||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5799999999999999999995 469999999998776666778999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.||+|.+++... .+++..++.|+.||+.||+|||++ +|||||||++||||+.++++||+|||+++....... .
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 999999988653 389999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ...++ ..+.. . . ...+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~---~~i~~----~-~-----~~~~ 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAM---KMIRD----N-L-----PPRL 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH---HHHHH----S-C-----CCCC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHH---HHHHc----C-C-----CCCC
Confidence 345689999999999999999999999999999999999999997543 11111 11111 0 0 0000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. .......++.+|+.+||+.||++|+++.||+++
T Consensus 368 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp S--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 001112368899999999999999999998864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=437.74 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=208.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++|+|+|||+++++|.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999985 47999999999743 2344577999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|||.||+|.+++...+. +++..++.++.||+.||+|||++ +|||||||++||||++++++||+|||+++......
T Consensus 112 Ey~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999976554 89999999999999999999999 99999999999999999999999999998765433
Q ss_pred c-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 T-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
. ......+||..|||||++.+..|+.++|||||||+||||++|+.||...+ .. +....++. ..+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~---~~~~~i~~-----~~~---- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EG---LIFAKIIK-----LEY---- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHH-----TCC----
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HH---HHHHHHHc-----CCC----
Confidence 2 23445789999999999999999999999999999999999999997543 11 11111111 111
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+...+ ..++.+|+++||+.||++|++++|++..
T Consensus 252 --~~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 252 --DFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp --CCCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred --CCCccc----CHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 111122 2368899999999999999999987643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=438.72 Aligned_cols=253 Identities=21% Similarity=0.221 Sum_probs=205.6
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+.|++.++||+|+||.||+|++ .+|+.||||+++.... +.+|+++|++|+|+|||+++++|.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 5688889999999999999995 4699999999985432 257999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-cEEEEeeccchhccccCcc
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfGls~~~~~~~~~ 524 (696)
.||+|.++|+..+. +++..++.|+.||+.||+|||++ +|||||||++||||+.++ ++||+|||+++........
T Consensus 133 ~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999999976544 89999999999999999999999 999999999999999887 6999999999876543221
Q ss_pred ----eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 525 ----ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 525 ----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.....+||..|||||++.+..|+.++|||||||+||||++|+.||........ .. .+.... ..+.+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~---~i~~~~---~~~~~- 277 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CL---KIASEP---PPIRE- 277 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HH---HHHHSC---CGGGG-
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---HHHcCC---CCchh-
Confidence 12235799999999999999999999999999999999999999986543221 11 111110 00111
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+.. .....+.+|+.+||+.||++|+++.||+++|++...
T Consensus 278 ----~~~----~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 278 ----IPP----SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp ----SCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 111 122368899999999999999999999999887764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=442.46 Aligned_cols=269 Identities=25% Similarity=0.383 Sum_probs=216.3
Q ss_pred cCHHHHHHHhcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccC-CCceeE
Q 005443 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHH-RHLVSL 428 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~h-pnIv~l 428 (696)
++.++.+...++|++++.||+|+||.||+|++. .++.||||+++..... ..++|.+|+++|.+++| +|||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 445556666789999999999999999999853 2468999999755433 34679999999999975 899999
Q ss_pred EeEEeeC-CceeEEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecc
Q 005443 429 VGYCISD-DRRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493 (696)
Q Consensus 429 ~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrD 493 (696)
+|+|.+. +..+||||||.+|+|.++|+... +..+++..++.|+.||++||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 56899999999999999996532 24589999999999999999999999 999999
Q ss_pred CCCCceEECCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCC
Q 005443 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDA 571 (696)
Q Consensus 494 Lkp~NILl~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~ 571 (696)
||++||||++++.+||+|||+++........ ......||..|||||++.+..|+.++|||||||+||||++ |+.||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 3445678999999999999999999999999999999998 9999976
Q ss_pred CCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 572 SQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 572 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
... .+.+.+ .+.+ ... + ........++.+|+.+||+.||++||+|.||+++|+++..
T Consensus 291 ~~~--~~~~~~----~i~~----g~~--~-------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 291 VKI--DEEFCR----RLKE----GTR--M-------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCC--SHHHHH----HHHH----TCC--C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCH--HHHHHH----HHHc----CCC--C-------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 432 111211 1111 100 0 0111122368899999999999999999999999998864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=431.95 Aligned_cols=273 Identities=23% Similarity=0.325 Sum_probs=202.2
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC----ceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD----RRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~lV~ 442 (696)
++|.+.++||+|+||.||+|++ +|+.||||+++... .....+++|+.++.+++|+|||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999998 78999999986432 11223345666667889999999999998765 468999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC-----HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
|||.+|+|.++|+.. .+++..+++|+.||++||+|||+++ .++|||||||++||||++++++||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999754 3899999999999999999999752 34899999999999999999999999999987
Q ss_pred ccccCcc---eeeccccccccCchhhhccC------CCCccccccchHHHHHHHHhCCCCCCCCCCCCch----hHHHhH
Q 005443 518 ALDANTH---ITTRVMGTFGYMAPEYASSG------KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE----SLVEWA 584 (696)
Q Consensus 518 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~----~l~~~~ 584 (696)
....... .....+||..|||||++.+. .|+.++|||||||+||||++|+.+|......... ...++.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6544332 12345799999999999754 3677999999999999999998877543321110 000000
Q ss_pred HHHHHHhhhhhhhhcccCcccCCCc-chHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 585 RPLLSHALENEEFDNLADPRLGENY-VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
...+.+.. .....++.+.... ..+....+.+|+.+||+.||++||||.||++.|+++..+
T Consensus 238 ~~~~~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 00000000 1111111221111 123456788999999999999999999999999988753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=423.02 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=194.9
Q ss_pred cccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEee----CCceeEEE
Q 005443 370 ADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLLIY 442 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~ 442 (696)
++.++||+|+||.||+|.+ .+++.||||++.... ....+.|.+|+++|++|+|+|||+++++|.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999985 468999999997542 2334679999999999999999999999875 24579999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeeccCCCCceEECC-CCcEEEEeeccchhcc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDN-NFEAQVSDFGLAKLAL 519 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~-~~~vkL~DfGls~~~~ 519 (696)
|||.||+|.+++++.+ .+++..++.|+.||+.||+|||++ + |||||||++||||++ ++.+||+|||+++...
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999997654 389999999999999999999998 7 999999999999974 7899999999998643
Q ss_pred ccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.. .....+||..|||||++.+ .|+.++|||||||+||||++|+.||..... ..+....+. . ...
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~----~-~~~-- 247 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVT----S-GVK-- 247 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHT----T-TCC--
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHH----c-CCC--
Confidence 32 2344689999999998875 699999999999999999999999975321 111111111 1 000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.. ....++.+|+.+||+.||++||+++||+++
T Consensus 248 --~~~~~~----~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 248 --PASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --CGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --CCCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111 112258899999999999999999999853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=417.84 Aligned_cols=246 Identities=22% Similarity=0.387 Sum_probs=190.6
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++++.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|+|||++++++.+++..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999985 479999999996432 234567999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+ +|+|.+++...+. +++.+++.++.||+.||+|||++ +|||||||++||||++++++||+|||+++...+..
T Consensus 93 Ey~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 6899888876554 99999999999999999999999 99999999999999999999999999998654432
Q ss_pred cceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 THITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.....+||..|||||++.+..| +.++|||||||+||||++|+.||...+ ..+....+.. ...
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~-----~~~---- 229 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISN-----GVY---- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-----TCC----
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHc-----CCC----
Confidence 2334679999999999998776 579999999999999999999997532 1111111111 110
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+...+ ..++.+|+++||+.||++|++++|++++
T Consensus 230 --~~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 --TLPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --CCCCCC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 011112 2367899999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=427.57 Aligned_cols=242 Identities=27% Similarity=0.342 Sum_probs=192.8
Q ss_pred cCccccccccccCcEEEEEEEc----CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|+++++||+|+||+||+|+. ..++.||||+++... .....++.+|+++|++|+|+|||+++++|.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5699999999999999999974 247899999996432 2233468899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|||||.||+|.+++.+.+. +++..++.++.||+.||+|||++ +|||||||++||||++++++||+|||+++...+
T Consensus 104 vmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999986554 89999999999999999999999 999999999999999999999999999986544
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
... .....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.+ ..+....++.. .+
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~-----~~--- 243 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------RKETMTMILKA-----KL--- 243 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-----CC---
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------HHHHHHHHHcC-----CC---
Confidence 332 2334689999999999999999999999999999999999999997543 11211111111 00
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
.+... ...++.+|+++||+.||++|+++
T Consensus 244 ---~~p~~----~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ---GMPQF----LSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CCCTT----SCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCCc----CCHHHHHHHHHHcccCHHHCCCC
Confidence 01111 22368899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=409.53 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=187.8
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCc-------
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDR------- 437 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~------- 437 (696)
++|+++++||+|+||.||+|+. .+|+.||||+++..... ..+.+++|+++|++|+|+|||+++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999985 47999999999765433 34678999999999999999999999876543
Q ss_pred -----eeEEEEecCCCchhhccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEe
Q 005443 438 -----RLLIYDYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (696)
Q Consensus 438 -----~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (696)
+|||||||.+|+|.+++..... ....+..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999976543 2345677889999999999999999 999999999999999999999999
Q ss_pred eccchhccccCcc-----------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhH
Q 005443 512 FGLAKLALDANTH-----------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 580 (696)
Q Consensus 512 fGls~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l 580 (696)
||+++........ .....+||..|||||++.+..|+.++|||||||+||||++ ||.. ..+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence 9999876543221 1223579999999999999999999999999999999996 6653 1111
Q ss_pred HHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 581 VEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.+.+..+ ....+.. ........+.+|+++||+.||++||++.||++
T Consensus 234 ~~~~~~~-----~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDV-----RNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHH-----HTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHH-----hcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 0100000 01122234678999999999999999999886
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=417.93 Aligned_cols=265 Identities=21% Similarity=0.311 Sum_probs=200.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC------Cc
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD------DR 437 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~ 437 (696)
++|+++++||+|+||+||+|++ .+|+.||||+++.... ...+.+.+|+++|++|+|+|||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999985 4799999999964432 2345688999999999999999999987643 56
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.|||||||. |+|.+++...+ .+++..++.|++||+.||+|||++ +|||||||++||||+.++.+||+|||+++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 799999995 67988887654 499999999999999999999999 999999999999999999999999999986
Q ss_pred ccccC---cceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 518 ALDAN---THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 518 ~~~~~---~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
+.... .......+||..|||||++.+. .|+.++|||||||+||||++|+.||.+.+. .+.++.+....... .
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~p-~ 283 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGTP-S 283 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCC-C
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCC-C
Confidence 64332 2223456899999999998875 569999999999999999999999986432 12211111110000 0
Q ss_pred hhhhhc--------c---cCcccCCC---cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 NEEFDN--------L---ADPRLGEN---YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 ~~~~~~--------~---~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.. . +....... .......++++|+.+||+.||++|+|+.|+|++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0 00000000 000112367899999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=397.35 Aligned_cols=282 Identities=41% Similarity=0.716 Sum_probs=239.5
Q ss_pred HHHHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 359 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
+.++....++|++.++||+|+||.||+|.+++|+.||||++........+++.+|+++|++++|+||++++++|...+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33455567899999999999999999999888999999998876666677899999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 439 LLIYDYVPNNTLYFHLHGEGR--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
++||||+.+|+|.+++..... ..+++..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999876432 3489999999999999999999999 99999999999999999999999999997
Q ss_pred hccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 517 LALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 517 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
....... .......|+..|+|||++.+..++.++|||||||+||||++|+.||..........+.+|.... ....
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----~~~~ 263 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES----HNNG 263 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH----HTTT
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc----cccc
Confidence 6443222 2233356899999999999999999999999999999999999999876655555555554432 2233
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.+..+++..+...........+.+++.+||+.||++||++.||++.|+.+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 4555666666666777888899999999999999999999999999998874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=402.82 Aligned_cols=200 Identities=25% Similarity=0.375 Sum_probs=171.9
Q ss_pred HHhcCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCce
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 438 (696)
...++|+++++||+|+||.||+|+.+ .++.||||++... ....++.+|+++|+.+ +|+|||+++++|.+++..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45688999999999999999999742 4789999998643 3456788999999998 699999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC-CcEEEEeeccchh
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAKL 517 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DfGls~~ 517 (696)
+||||||.+|+|.+++. .+++.+++.+++||+.||+|||++ ||||||||++||||+.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999884 288999999999999999999999 99999999999999876 7999999999975
Q ss_pred ccccCc---------------------------ceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCC
Q 005443 518 ALDANT---------------------------HITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPV 569 (696)
Q Consensus 518 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf 569 (696)
..+... ......+||..|||||++.+. .|+.++||||+||+||||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 433211 112235799999999999875 5899999999999999999999999
Q ss_pred CCCC
Q 005443 570 DASQ 573 (696)
Q Consensus 570 ~~~~ 573 (696)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=397.37 Aligned_cols=288 Identities=47% Similarity=0.822 Sum_probs=243.1
Q ss_pred cccCHHHHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEe
Q 005443 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCI 433 (696)
Q Consensus 355 ~~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 433 (696)
..|.++++....++|++.++||+|+||.||+|++.+|+.||||+++.... .....+.+|++++++++|+||++++++|.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 35788999999999999999999999999999988899999999975432 22346899999999999999999999999
Q ss_pred eCCceeEEEEecCCCchhhccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEe
Q 005443 434 SDDRRLLIYDYVPNNTLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (696)
Q Consensus 434 ~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (696)
..+..++||||+.+|+|.++++... ...+++..++.|+.||+.||+|||+++..+|+|||||++||||++++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999987643 23489999999999999999999998666899999999999999999999999
Q ss_pred eccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCC--CCchhHHHhHHHHHH
Q 005443 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP--LGDESLVEWARPLLS 589 (696)
Q Consensus 512 fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~--~~~~~l~~~~~~~~~ 589 (696)
||+++..............|+..|+|||++.+..++.++|||||||++|||++|+.||+.... ..+..+.+|..
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---- 253 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK---- 253 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT----
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH----
Confidence 999987655555555556799999999999988899999999999999999999999963211 12223334333
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
..+....+..+.+..+...+...+...+.+++.+||+.||++||++.||+++|++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 333445556667777777788888899999999999999999999999999999754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=424.80 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=208.1
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|++++.||+|+||.||+|+. .+|+.||||+++.......+.+++|+++|+.|+|+|||+|+++|.+++..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999985 47999999999876655667899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC--CcEEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN--FEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~--~~vkL~DfGls~~~~~~~ 522 (696)
|.||+|+++|..... .+++.+++.++.||+.||+|||++ +|+|||||++||||+.+ +.+||+|||+++.+....
T Consensus 236 ~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999999998865432 489999999999999999999999 99999999999999754 899999999998765432
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.+ ...+ +..+....+ .+ .
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~---~~~i~~~~~------~~-~ 376 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDET---LRNVKSCDW------NM-D 376 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHH---HHHHHTTCC------CC-C
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHH---HHHHHhCCC------CC-C
Confidence 2334579999999999999999999999999999999999999997643 1111 111111000 00 0
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..... ....++.+|+++||+.||++|+++.|++++
T Consensus 377 ~~~~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 DSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SGGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111 112367899999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=416.90 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=199.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHH---HHHHHHccCCCceeEEeEEeeCCcee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAE---VEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E---~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
++|+++++||+|+||.||+|+.+ +|+.||||+++... ......+.+| +.+++.++|+|||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999854 69999999996431 2223334444 55666678999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
||||||.||+|.++|...+. +++..++.++.||+.||+|||++ +|||||||++||||+++|++||+|||+++...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999986554 89999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 520 DANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
... ....+||..|||||++.+ ..|+.++||||||||||||++|+.||......... +.....+. . .
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~----~-~-- 410 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLT----M-A-- 410 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHH----C-C--
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcC----C-C--
Confidence 432 234689999999999975 57999999999999999999999999764322211 11111111 0 0
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVRV 641 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 641 (696)
..+...+ ..++.+||.+||+.||++|++ ++||+++
T Consensus 411 ----~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 ----VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ----CCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ----CCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 0111112 236889999999999999998 6777753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=381.43 Aligned_cols=285 Identities=27% Similarity=0.402 Sum_probs=222.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|++.++||+|+||.||+|.+. +|+.||||++........+.+.+|+++|++++|+||++++++|.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57999999999999999999864 68999999987655566678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++..... .+++..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999976433 489999999999999999999999 99999999999999999999999999998654332211
Q ss_pred -------------eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhh
Q 005443 526 -------------TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592 (696)
Q Consensus 526 -------------~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 592 (696)
....+|+..|+|||++.+..++.++|||||||+||||++|..+|........... ......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~~--- 241 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LNVRGFLD--- 241 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BCHHHHHH---
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hhhhcccc---
Confidence 1145799999999999999999999999999999999999999875433211110 00111111
Q ss_pred hhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccccCCCccCcccccchhhhhHHHH
Q 005443 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEVFNSAQQSAEIR 672 (696)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~~~~~~~~~~~~sa~~~~~~~ 672 (696)
...... .. ..+.+++.+||+.||++||++.||++.|+++...... ........+.....
T Consensus 242 ------~~~~~~----~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~-------~~~~~~~~~~~~~~ 300 (310)
T 3s95_A 242 ------RYCPPN----CP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG-------HLPLGPQLEQLDRG 300 (310)
T ss_dssp ------HTCCTT----CC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH-------CCCCHHHHHHHHHH
T ss_pred ------ccCCCC----CC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC-------cccCCcchhhccch
Confidence 001111 11 2588899999999999999999999999988753211 11123344555566
Q ss_pred HHHHHhcC
Q 005443 673 WFRRMAFG 680 (696)
Q Consensus 673 ~~r~~~~~ 680 (696)
||+....+
T Consensus 301 ~w~~~~~~ 308 (310)
T 3s95_A 301 FWETYRRG 308 (310)
T ss_dssp HHHHHHHT
T ss_pred HHHhhhcc
Confidence 66665544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=380.04 Aligned_cols=262 Identities=29% Similarity=0.441 Sum_probs=204.3
Q ss_pred HHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 363 VKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 363 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
....++|++.++||+|+||.||+|++ +|+.||||++..... ...+++.+|+++|++++|+||+++++++...+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 33457899999999999999999987 789999999875433 223578999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 441 IYDYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
||||+.+|+|.+++..... ..+++..++.|+.||+.||+|||++ + |+|||||++||||++++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999976432 2388999999999999999999998 8 99999999999999999999999999976
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||.... ......... ..
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~---~~~~~~~~~-------~~--- 254 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVG-------FK--- 254 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHHH-------HS---
T ss_pred ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH-------hc---
Confidence 44332 22334578999999999999999999999999999999999999997543 111111110 00
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.....+.. .....+.+|+++||+.||++||++.+|++.|+.+...
T Consensus 255 --~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 255 --CKRLEIPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --CCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --CCCCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00011111 1223688999999999999999999999999988754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.37 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=208.7
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|++.++||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++|+||++++++|...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36899999999999999999985 57899999999877666778899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999998754 389999999999999999999999 999999999999999999999999999876544332
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+......... ...+
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~-----~~~~---- 236 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNG-----TPEL---- 236 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHC-----SCCC----
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-----CCCC----
Confidence 23345799999999999999999999999999999999999999975431 11111111100 0000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.........+.+++.+||+.||++||++.|++++
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 ---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111222368899999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=386.77 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=209.9
Q ss_pred hcCccccccccccCcEEEEEEEc--------CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeC
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL--------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 435 (696)
.++|++++.||+|+||.||+|++ .++..||||+++.... ...+++.+|+++|+++ +|+||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46799999999999999999974 2456799999975533 2345799999999999 899999999999999
Q ss_pred CceeEEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
+..+|||||+.+|+|.+++.... ...+++..+++|+.||++||+|||++ +|||||||++||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999987543 13478999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchh
Q 005443 502 DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~ 579 (696)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~---~~~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC---HHH
Confidence 99999999999999865443221 2233456789999999999999999999999999999999 999997643 122
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+.+.+ . .... ..........+.+++++||+.||++||++.||++.|+++..
T Consensus 314 ~~~~~----~----~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 LFKLL----K----EGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHHHH----H----TTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH----h----cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 21111 0 0000 01111222368899999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=367.86 Aligned_cols=257 Identities=28% Similarity=0.479 Sum_probs=213.1
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++.+.||+|+||.||+|.+.+++.||||+++... ...+++.+|++++++++|+||+++++++.+++..++||||+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5799999999999999999998889999999997543 346789999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+++|.+++..... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 9999999875433 489999999999999999999999 999999999999999999999999999986654433333
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+.+. +. .. . ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~---~~~~~~~---~~----~~--~-~~~~--- 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVED---IS----TG--F-RLYK--- 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH---HH----TT--C-CCCC---
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC---HHHHHHH---Hh----cC--c-cCCC---
Confidence 34556788999999999999999999999999999999 999997533 1111111 10 00 0 0000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.. .....+.+++++||+.||++||++.||+++|+++...
T Consensus 229 ~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC----cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11 1123688999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=365.21 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=212.7
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|++.+.||+|+||.||+|.++++..||||+++... ...+++.+|++++++++|+||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46799999999999999999998888899999997543 34577999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++...+ ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.........
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999887543 2489999999999999999999999 99999999999999999999999999998765544433
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...... ... .. ......
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~---~~~----~~---~~~~~~- 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT---NSEVVL---KVS----QG---HRLYRP- 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHH---HHH----TT---CCCCCC-
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC---hHHHHH---HHH----cC---CCCCCC-
Confidence 344456778999999998899999999999999999999 999997543 111111 000 00 001111
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
.. ....+.+++++||+.||++||++.||++.|+++..++
T Consensus 228 --~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 228 --HL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --TT----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --Cc----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 11 1226889999999999999999999999999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=369.11 Aligned_cols=258 Identities=23% Similarity=0.382 Sum_probs=210.0
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|++++.||+|+||.||+|.+.+++.||||+++... ...+++.+|++++++++|+||++++++|.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46799999999999999999998888899999997543 34678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++..... .+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 99999999876332 389999999999999999999999 99999999999999999999999999998765443333
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.... .....+. +. .. ....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~---~~~~~~~---~~----~~------~~~~ 241 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEH---IA----QG------LRLY 241 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHH---HH----TT------CCCC
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC---hhHHHHH---Hh----cc------cCCC
Confidence 333456788999999999999999999999999999998 999997543 1111111 10 00 0000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
... .....+.+++.+||+.||++||++.||+++|+++..+
T Consensus 242 ~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 242 RPH----LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 011 1123688999999999999999999999999988754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=376.77 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=207.8
Q ss_pred hcCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|++.++||+|+||.||+|.+. .+..||||+++.... ...++|.+|+++|++++|+||++++++|.+.+..+|
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 367999999999999999999963 345699999975433 334679999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+++|.++++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 9999999999999865432 489999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 521 ANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 521 ~~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
..... .....++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+... ...
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~~~-------~~~-- 271 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT---NRDVISSVE-------EGY-- 271 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHH-------TTC--
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHH-------cCC--
Confidence 33221 222346778999999999999999999999999999999 999997532 111111110 000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
. ..........+.+|+.+||+.||++||++.||++.|+++...
T Consensus 272 ----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 ----R----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ----C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----C----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0 001112223688999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=382.42 Aligned_cols=270 Identities=26% Similarity=0.387 Sum_probs=215.6
Q ss_pred cCHHHHHHHhcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeE
Q 005443 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSL 428 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l 428 (696)
+...++....++|+++++||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++|+++ +|+||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 55667777789999999999999999999972 3568999999975433 2345799999999999 78999999
Q ss_pred EeEEeeCCc-eeEEEEecCCCchhhccccCCC------------------------------------------------
Q 005443 429 VGYCISDDR-RLLIYDYVPNNTLYFHLHGEGR------------------------------------------------ 459 (696)
Q Consensus 429 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 459 (696)
+++|.+.+. .++||||+.+|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999998876432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 460 ----------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 460 ----------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
..+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1288999999999999999999999 999999999999999999999999999986543322
Q ss_pred -ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 524 -HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 524 -~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.......|+..|+|||++.+..++.++|||||||+||||++ |+.||...... ..+.+. +. ....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~----~~----~~~~---- 314 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRR----LK----EGTR---- 314 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHH----HH----HTCC----
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHH----HH----cCCC----
Confidence 22334568889999999999999999999999999999998 99999764321 111111 11 1000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
...... ....+.+++.+||+.||++||++.||+++|+++...
T Consensus 315 -~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 315 -MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 001111 123688999999999999999999999999988753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=373.80 Aligned_cols=274 Identities=25% Similarity=0.366 Sum_probs=206.3
Q ss_pred hcCccccccccccCcEEEEEEEc-----CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeC--Cce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 438 (696)
.++|+++++||+|+||.||+|++ .+|+.||||+++.......+.+.+|+++|++++|+||++++++|... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36799999999999999999983 36889999999866555567899999999999999999999998654 458
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
+|||||+.+++|.+++..... .+++..+++|+.||+.||+|||++ +|+|||||++||||++++++||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999876533 489999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 519 LDANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
...... ......++..|+|||++.+..++.++|||||||+||||++|..+|.... ..+.+..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP----AEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH----HHHHHHHCTTCCTHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh----HHHHhhhcCccccchhHHH
Confidence 443221 2223457778999999999999999999999999999999999886421 1111100000000000000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+.+.+...............+.+|+++||+.||++||++.||++.|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 000000000111112223478899999999999999999999999998864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=364.99 Aligned_cols=281 Identities=38% Similarity=0.678 Sum_probs=226.5
Q ss_pred cccCHHHHHHHhcCcccc------ccccccCcEEEEEEEcCCCcEEEEEEeecCC----CccHHHHHHHHHHHHHccCCC
Q 005443 355 SMFTYEELVKATDGFADQ------NLLGEGGFGSVYKGYLPDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRH 424 (696)
Q Consensus 355 ~~~~~~~l~~~~~~~~~~------~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~hpn 424 (696)
..|.++++..++++|... ++||+|+||.||+|.+ +++.||||++.... ....+.+.+|++++++++|+|
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 358999999999988877 8999999999999998 78999999986432 233567999999999999999
Q ss_pred ceeEEeEEeeCCceeEEEEecCCCchhhccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC
Q 005443 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGE-GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN 503 (696)
Q Consensus 425 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~ 503 (696)
|+++++++.+.+..++||||+.+++|.+++... ....+++..+++|+.||+.||+|||++ +|+|||||++||||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 999999999999999999999999999888643 233589999999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHH
Q 005443 504 NFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVE 582 (696)
Q Consensus 504 ~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~ 582 (696)
++.+||+|||+++........ ......|+..|+|||++.+ .++.++|||||||++|||++|+.||........ +.+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 999999999999765443222 2334578999999998865 588999999999999999999999986543221 112
Q ss_pred hHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 583 WARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
+...+.. ....+..+++..+ ..........+.+++.+||+.||++||++.+|++.|+++.
T Consensus 246 ~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIED---EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHT---TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhh---hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111111 1122233333333 2234556678999999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=362.20 Aligned_cols=264 Identities=18% Similarity=0.220 Sum_probs=213.3
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++++ +|+||+++++++...+..++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 36799999999999999999994 579999999986432 334688999999999 79999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc-----EEEEeeccchhc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE-----AQVSDFGLAKLA 518 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~-----vkL~DfGls~~~ 518 (696)
|+ +++|.+++...+. .+++..+++|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 9999999976543 489999999999999999999999 9999999999999987765 999999999876
Q ss_pred cccCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhh
Q 005443 519 LDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592 (696)
Q Consensus 519 ~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 592 (696)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||............+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 238 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--- 238 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH---
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc---
Confidence 543321 22345799999999999999999999999999999999999999987654333333222211110
Q ss_pred hhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
......+ ...+ ...+.+++.+||+.||++||++++|++.|+++..+.
T Consensus 239 -~~~~~~~-----~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 239 -STPLREL-----CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp -HSCHHHH-----TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -CccHHHH-----HhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 0001111 1111 236889999999999999999999999999987643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=394.53 Aligned_cols=261 Identities=24% Similarity=0.421 Sum_probs=214.1
Q ss_pred HHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.+...++|++.++||+|+||.||+|.+++++.||||+++... ...++|.+|+++|++++|+||+++++++. .+..+||
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344457899999999999999999999888999999997543 45778999999999999999999999986 6678999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.++++......+++..+++|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999999765444588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.........++..|+|||++..+.++.++|||||||+||||++ |+.||.... ...+.+.+ ... . .+
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i----~~~---~---~~ 404 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRAL----ERG---Y---RM 404 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHH----HHT---C---CC
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HcC---C---CC
Confidence 3222333456788999999999999999999999999999999 999997532 12221111 100 0 00
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. ........+.+|+.+||+.||++||+|.+|++.|+++..
T Consensus 405 ~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 P-------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp C-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred C-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0 111122368899999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=369.15 Aligned_cols=263 Identities=17% Similarity=0.216 Sum_probs=211.7
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++.++||+|+||.||+|+. .+|+.||||++..... .+++.+|+++|++| +|+||+++++++...+..+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36799999999999999999984 5789999999875432 34688999999999 89999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc-----EEEEeeccchhc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE-----AQVSDFGLAKLA 518 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~-----vkL~DfGls~~~ 518 (696)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 999999887642 3489999999999999999999999 9999999999999998887 999999999865
Q ss_pred cccCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhh
Q 005443 519 LDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592 (696)
Q Consensus 519 ~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 592 (696)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||............+.. .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~~~~ 237 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---GDTKR 237 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH---HHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH---Hhhhc
Confidence 443321 123467999999999999999999999999999999999999999875433222222211 11110
Q ss_pred hhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
.. ... .+...+ . .+.+++.+||+.|+.+||++++|++.|+++..+.
T Consensus 238 ~~-~~~-----~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 238 AT-PIE-----VLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HS-CHH-----HHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cC-CHH-----HHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00 000 001111 1 6889999999999999999999999999887543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=397.92 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=214.3
Q ss_pred HhcCccccccccccCcEEEEEEEcCC-CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..++|++.++||+|+||.||+|.+++ ++.||||+++... ...++|.+|+++|++++|+||++++++|...+..+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 45678999999999999999999754 8899999997543 346789999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+|+|.++++......+++..++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999999876666689999999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.......++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+. +...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~---~~~~~~~----~~~~----------- 435 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYEL----LEKD----------- 435 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHH----HHTT-----------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HHcC-----------
Confidence 33333456789999999999999999999999999999999 999997643 1122111 1110
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
+...........+.+|+++||+.||++||+|.+|++.|+.+.
T Consensus 436 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 000111122236889999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=371.48 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=203.2
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|+++++||+|+||.||+|.+. +++.||||+++..... ..+.+.+|+.+++.++|+||+++++++.+++..+||||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999864 7899999999754332 34568999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++..... +++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999999999976544 89999999999999999999999 999999999999999999999999999976543322
Q ss_pred -ceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 524 -HITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 524 -~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.......|+..|+|||++.+..+ +.++|||||||+||||++|+.||....... ..+.++. .... ..
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~--------~~~~---~~ 228 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK--------EKKT---YL 228 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHH--------TTCT---TS
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHh--------cccc---cC
Confidence 22334679999999999988765 778999999999999999999997644221 1111111 0000 00
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ........+.+|+++||+.||++|+++.||++.
T Consensus 229 ~------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 N------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp T------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 011122367899999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=383.18 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=198.5
Q ss_pred cCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.++||+|+||.||+|++. ++..||||+++.... ...++|.+|+++|++++|+||++++++|.+.+..+||
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57999999999999999999864 577899999976533 3346799999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.++++..+ ..+++..+++|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999997653 2489999999999999999999999 9999999999999999999999999999876543
Q ss_pred Ccce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 522 NTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 522 ~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... .....++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+.+ . ....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~~~i----~---~~~~-- 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVIKAV----D---EGYR-- 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHHHHH----H---TTEE--
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----H---cCCC--
Confidence 3221 122345678999999999999999999999999999998 999997532 11111111 0 0000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
..........+.+++.+||+.||++||++.+|++.|+++...
T Consensus 269 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 --------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 001112223688999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=366.35 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=206.3
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|+++++||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++|+||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999985 46899999998654332 235789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999876543 89999999999999999999999 9999999999999999999999999999876554
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.....+... ...+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-----~~~~- 232 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-----VPNV- 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-----CCCH-
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-----CCCc-
Confidence 44444456799999999999999999999999999999999999999976431 11111111100 0000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhhcc
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-RMGQVVRVFDSLATS 648 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l~~~ 648 (696)
...+... ....+.+++.+||+.||++|+ +++++++.|+.+...
T Consensus 233 ~~~~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 233 TTDVRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHSCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred chhcccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0001111 123688999999999999998 899999999887643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=366.78 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=214.7
Q ss_pred ccCHHHHHHHhcC----------ccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC
Q 005443 356 MFTYEELVKATDG----------FADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH 424 (696)
Q Consensus 356 ~~~~~~l~~~~~~----------~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn 424 (696)
.+.++++..+.+. |+..+.||+|+||.||+|++. +|+.||||+++.......+.+.+|+.+|++++|+|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4778888877754 777889999999999999965 79999999998777677788999999999999999
Q ss_pred ceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC
Q 005443 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504 (696)
Q Consensus 425 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~ 504 (696)
|++++++|...+..+|||||+.+++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||+.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 999999999999999999999999999988643 389999999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhH
Q 005443 505 FEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWA 584 (696)
Q Consensus 505 ~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~ 584 (696)
+.+||+|||+++....... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.... .....+.
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~~~- 252 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKR- 252 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHH-
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH-
Confidence 9999999999976544322 2334579999999999999999999999999999999999999997532 1111111
Q ss_pred HHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 585 RPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.. . ....+.. .......+.+++.+||+.||++||++.||++.
T Consensus 253 --~~~-----~-----~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 --LRD-----S-----PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHH-----S-----SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --Hhc-----C-----CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 0 0000100 11112368899999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=372.89 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=205.6
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
..++|++++.||+|+||.||+|.+ .+|+.||||++.... ....+++.+|+++|++++|+||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999986 579999999997543 23346788999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999876544 89999999999999999999999 9999999999999999999999999999765433
Q ss_pred CcceeeccccccccCchhhhccCCCC-ccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
. .....+|+..|+|||++.+..+. .++|||||||+||||++|+.||...+ ..+....+.. ..+
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~-----~~~--- 231 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLR-----GKY--- 231 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-----CCC---
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHh-----CCC---
Confidence 2 23345799999999999988775 79999999999999999999997643 1111111111 000
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+ .......+.+++++||+.||++|++++|++++
T Consensus 232 ---~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ---RI----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CC----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CC----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01 11112368899999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=372.72 Aligned_cols=277 Identities=28% Similarity=0.359 Sum_probs=209.3
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc----eeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR----RLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----~~lV 441 (696)
.++|+++++||+|+||.||+|++ .++.||||+++... .....+++|+.+|++++|+||+++++++...+. .+||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 46899999999999999999998 58999999997542 233456779999999999999999999987553 5999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED-------CHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-------~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
|||+.+|+|.++++... +++..+++|+.||+.||+|||++ +..+|+|||||++||||++++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999999999997543 89999999999999999999975 123799999999999999999999999999
Q ss_pred chhccccCcc-eeeccccccccCchhhhccC-----CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 515 AKLALDANTH-ITTRVMGTFGYMAPEYASSG-----KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 515 s~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-----~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
++........ ......|+..|+|||++.+. .++.++|||||||+||||++|+.||..........+........
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9765443322 22335789999999999863 45568899999999999999999998654432222211100000
Q ss_pred H-HhhhhhhhhcccCcccCCCc-chHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 589 S-HALENEEFDNLADPRLGENY-VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 589 ~-~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. ..+............+...+ .......+.+|+++||+.||++||++.||++.|+++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 00000000111111111111 12344569999999999999999999999999998874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=387.74 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=209.9
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-ceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD-RRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lV~E~ 444 (696)
.++|++.++||+|+||.||+|.+ .|+.||||+++... ..+.|.+|+++|++++|+||++++++|...+ ..+|||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46788999999999999999998 58899999997543 4578999999999999999999999987765 68999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+|+|.++++..+...+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 9999999999876665689999999999999999999999 9999999999999999999999999999754322
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+.+.+ . ...
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~---~~~-------- 403 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----E---KGY-------- 403 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHHH----H---TTC--------
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----H---cCC--------
Confidence 112356889999999999999999999999999999998 99999764321 111111 0 000
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccc
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDL 650 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~ 650 (696)
...........+.+|+++||+.||++||++.+|++.|+++...++
T Consensus 404 --~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 404 --KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 001111223478899999999999999999999999999876544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=375.05 Aligned_cols=263 Identities=25% Similarity=0.437 Sum_probs=211.5
Q ss_pred HHHhcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeC
Q 005443 363 VKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (696)
Q Consensus 363 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 435 (696)
....++|++++.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++|++++|+||++++++|.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 334588999999999999999999863 348999999975433 2346799999999999999999999999999
Q ss_pred CceeEEEEecCCCchhhccccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecc
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEG----------------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrD 493 (696)
+..+|||||+.+++|.+++.... ...+++.++++|+.||++||+|||++ +|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 99999999999999999887532 14589999999999999999999999 999999
Q ss_pred CCCCceEECCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCC
Q 005443 494 IKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDA 571 (696)
Q Consensus 494 Lkp~NILl~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~ 571 (696)
||++||||++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999986543322 22334567889999999999999999999999999999999 9999975
Q ss_pred CCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 572 SQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 572 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.. ...+... + ....... + .......+.+++++||+.||++||++.+|++.|+++..+
T Consensus 280 ~~---~~~~~~~---~-----~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MA---HEEVIYY---V-----RDGNILA-----C----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SC---HHHHHHH---H-----HTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CC---hHHHHHH---H-----hCCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 32 1111111 1 1111111 1 111223688999999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=368.35 Aligned_cols=252 Identities=17% Similarity=0.286 Sum_probs=205.3
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|++++.||+|+||.||+|... +|+.||+|+++.. ......+.+|+++|+.++|+||++++++|.+.+..+|||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999864 6889999998744 23456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC--CCcEEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DfGls~~~~~~~ 522 (696)
+.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999887543 2489999999999999999999999 9999999999999987 7899999999998764432
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
......|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...+ ...+...... ..
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~---~~~i~~~~~~-------~~ 223 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQI---IENIMNAEYT-------FD 223 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHH---HHHHHHTCCC-------CC
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHH---HHHHHcCCCC-------CC
Confidence 2334578999999999998889999999999999999999999997643 1111 1111111100 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..... .....+.+++.+||+.||++||++.|++++
T Consensus 224 ~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 EEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00000 112368899999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=400.34 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=211.7
Q ss_pred HhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
..++|++.++||+|+||.||+|.++++..||||+++... ...++|++|+++|++|+|+||++++++|.+ +..+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456788999999999999999999888899999998543 346789999999999999999999999876 678999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+|+|.++++......+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999764444589999999999999999999999 9999999999999999999999999999876543322
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......++..|+|||++.++.++.++|||||||+||||++ |+.||.... ...+.+.+ . ....
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~~~~~~i----~---~~~~------- 482 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQV----E---RGYR------- 482 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HHHHHHHH----H---TTCC-------
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----H---cCCC-------
Confidence 2333456789999999999999999999999999999999 999997532 11211111 0 0000
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..........+.+|+.+||+.||++||++++|++.|+++..
T Consensus 483 ---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 00111222368899999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=383.44 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=208.1
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++.+.||+|+||.||+|.+. +|+.||||+++..... ..++|.+|+++|++++|+||++++++|..++..+||||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467899999999999999999975 7899999998754322 23468899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+|+|.++++..+ ..+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...+...
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999987543 2488999999999999999999999 999999999999999999999999999976433221
Q ss_pred cee-eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 524 HIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 524 ~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
... ....++..|+|||++.++.++.++|||||||+||||++ |+.||.... .....+. +. ... .+
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~~~~~~~----~~----~~~--~~- 334 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---NQQTREF----VE----KGG--RL- 334 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---HHHHHHH----HH----TTC--CC-
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HH----cCC--CC-
Confidence 111 11235678999999999999999999999999999998 999997532 1111111 11 100 00
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.........+.+|+.+||+.||++||++.+|++.|+++..
T Consensus 335 ------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 335 ------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 0111122368899999999999999999999999998864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=367.01 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=216.2
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..++|++.++||+|+||.||+|.+. +++.||||+++.. ....+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999965 4889999999743 3345779999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++.......+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999876666799999999999999999999999 999999999999999999999999999987665544
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.......++..|+|||++.+..++.++|||||||++|||++ |+.+|..... ..+.+... .. ..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---~~~~~~~~----~~---------~~ 230 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLE----KD---------YR 230 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHH----TT---------CC
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh----cc---------CC
Confidence 44445567889999999999999999999999999999999 9999975431 11111111 00 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
... .......+.+++++||+.||++||++.+|++.|+++..
T Consensus 231 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 231 MER----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 011 11122368899999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=378.06 Aligned_cols=261 Identities=28% Similarity=0.397 Sum_probs=211.4
Q ss_pred hcCccccccccccCcEEEEEEEc--------CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeC
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL--------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 435 (696)
.++|.+.++||+|+||.||+|++ .++..||||+++.... ...+++.+|+++++++ +|+||++++++|..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 46899999999999999999984 2346899999975533 2346789999999999 899999999999999
Q ss_pred CceeEEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
+..+|||||+.+|+|.+++.... ...+++..+++|+.||+.||+|||++ +|||||||++||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999987543 23489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchh
Q 005443 502 DNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~ 579 (696)
++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~~~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEE 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHH
Confidence 9999999999999986544322 22333457889999999999999999999999999999999 999997532 112
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
+.+.+ . .... ..... .....+.+|+++||+.||++||+++||++.|+++....
T Consensus 302 ~~~~~----~---~~~~------~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 302 LFKLL----K---EGHR------MDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHH----H---TTCC------CCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHH----H---cCCC------CCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11111 1 1000 00111 12236889999999999999999999999999988543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=372.10 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=205.2
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|+++++||+|+||.||+|+.+ +|+.||||+++.. .......+.+|+++|++++|+||++++++|.+.+..+||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999864 6899999999743 234456789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.+++...+ .+++..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999998887644 389999999999999999999999 9999999999999999999999999999754332
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.. .....+||..|+|||++.+..++.++|||||||+||||++|+.||...+ ...+ ...++. ..+
T Consensus 159 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~---~~~i~~-----~~~---- 222 (337)
T 1o6l_A 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERL---FELILM-----EEI---- 222 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---HHHHHH-----CCC----
T ss_pred CC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHH---HHHHHc-----CCC----
Confidence 22 2334679999999999999999999999999999999999999997532 1111 111111 000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.+... ....+.+|+++||+.||++|+ +++||+++
T Consensus 223 --~~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 --RFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 01111 123688999999999999999 89998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=357.62 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=194.5
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC----ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG----QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|++.++||+|+||.||+|.+ .|+.||||+++.... ...+.+++|+++++.++|+||++++++|...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36799999999999999999998 589999999875432 2346789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC--------CCcEEEEeec
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--------NFEAQVSDFG 513 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~--------~~~vkL~DfG 513 (696)
|||+.+++|.+++... .+++..+++++.||+.||+|||+++..+|+|||||++||||++ ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999888643 4899999999999999999999982112999999999999986 6789999999
Q ss_pred cchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
+++....... ....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...... .. .
T Consensus 162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~---~~-----~ 227 (271)
T 3dtc_A 162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID---GLAVAY---GV-----A 227 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHH---HH-----H
T ss_pred cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---hh-----h
Confidence 9976543322 23468999999999999999999999999999999999999997532 111100 00 0
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.. .............+.+++.+||+.||++||++.||+++|+++
T Consensus 228 ~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 MN--------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TS--------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cC--------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00 001111112223688999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=378.99 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=208.1
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|+++++||+|+||.||+|.+. +++.||||+++... .....++.+|+.+|++++|+||++++++|...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999842 46789999996442 23445789999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC---cEEEE
Q 005443 439 LLIYDYVPNNTLYFHLHGEG-----RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EAQVS 510 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~ 510 (696)
+|||||+.+|+|.+++.... ...+.+..+++|+.||+.||+|||++ +|+|||||++||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999887532 23489999999999999999999999 999999999999998544 59999
Q ss_pred eeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHH
Q 005443 511 DFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 511 DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+.+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~i~--- 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVT--- 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHH---
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH---
Confidence 9999986543322 22334567889999999999999999999999999999998 999997543 111111110
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..... .........+.+|+++||+.||++||++.+|++.|+.+..
T Consensus 301 ----~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 301 ----SGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ----TTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cCCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 10000 0111122368899999999999999999999999998874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=359.19 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=212.5
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|++.+.||+|+||.||+|.+.+++.||||+++... ...+++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 36799999999999999999998888999999997543 34578999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.... ..+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999987643 2488999999999999999999999 99999999999999999999999999998664433222
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+.+ .+. .. .. ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~---~i~----~~--~~-~~~-- 226 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVE---DIS----TG--FR-LYK-- 226 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHH---HHH----TT--CC-CCC--
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHH---HHh----cC--Cc-CCC--
Confidence 333457788999999999999999999999999999999 899997532 111111 110 00 00 000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.......+.+++.+||+.||++||++.+|++.|+++...
T Consensus 227 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 227 -----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111123688999999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=361.19 Aligned_cols=260 Identities=24% Similarity=0.423 Sum_probs=203.2
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHH--ccCCCceeEEeEEeeC----Ccee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR--IHHRHLVSLVGYCISD----DRRL 439 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~----~~~~ 439 (696)
.++|++.++||+|+||.||+|++ +|+.||||++.. .....+.+|.+++.. ++|+||+++++++... +..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 799999999864 345567778888877 7899999999987653 3578
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeeccCCCCceEECCCCcEEEEe
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH--------EDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH--------~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (696)
+||||+.+|+|.++++.. .+++..+++|+.||+.||+||| ++ +|+|||||++||||+.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999643 4899999999999999999999 77 999999999999999999999999
Q ss_pred eccchhccccCcce---eeccccccccCchhhhccC------CCCccccccchHHHHHHHHhC----------CCCCCCC
Q 005443 512 FGLAKLALDANTHI---TTRVMGTFGYMAPEYASSG------KLTEKSDVFSFGVVLLELITG----------RKPVDAS 572 (696)
Q Consensus 512 fGls~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~------~~s~~sDVwSlGvll~eLltg----------~~Pf~~~ 572 (696)
||+++......... .....|+..|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997655443322 2234789999999999876 455799999999999999999 7777654
Q ss_pred CCCCchhHHHhHHHHHHHhhhhhhhhcccCcccC-CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 573 QPLGDESLVEWARPLLSHALENEEFDNLADPRLG-ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 573 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
..... .. +.....+. ... ....+. ..+.......+.+|+++||+.||++||++.||++.|+++
T Consensus 237 ~~~~~-~~-~~~~~~~~---~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDP-SF-EDMRKVVC---VDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSC-CH-HHHHHHHT---TSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc-ch-hhhhHHHh---ccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 32211 11 11111110 000 011111 112234556899999999999999999999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=388.75 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=206.5
Q ss_pred HhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
..++|++.++||+|+||.||+|.++++..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..+|||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456789999999999999999998888899999997543 346789999999999999999999999876 678999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+|+|.++++......+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999764444589999999999999999999999 9999999999999999999999999999876544333
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......++..|+|||++.++.++.++|||||||+||||++ |+.||.... ...+.+.+ . ... .
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i----~---~~~---~---- 399 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQV----E---RGY---R---- 399 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHH----H---TTC---C----
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----H---cCC---C----
Confidence 3334457789999999999999999999999999999999 999997532 11111111 0 000 0
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
..........+.+|+.+||+.||++||++++|++.|+++...
T Consensus 400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 001112233688999999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=371.84 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=205.9
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc------cHHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ------GEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
..++|+++++||+|+||.||+|..+ +|+.||||+++..... ..+.+.+|+.+|++++|+||++++++|.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3468999999999999999999864 6899999999754322 35789999999999999999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC----cEEEEeec
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFG 513 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DfG 513 (696)
.+|||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++ +|+|||||++||||++++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999997654 489999999999999999999999 999999999999998776 79999999
Q ss_pred cchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
+++...... .....+|+..|+|||++.+..++.++|||||||++|||++|..||.... ...+.+ .+......
T Consensus 165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~---~i~~~~~~ 236 (361)
T 2yab_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLA---NITAVSYD 236 (361)
T ss_dssp SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHH---HHHTTCCC
T ss_pred CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHhcCCC
Confidence 998654432 2334579999999999999999999999999999999999999997642 111111 11110000
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
++... .......+.+|+++||+.||++|+++.|++++
T Consensus 237 -------~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 237 -------FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -------CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -------CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 01112368899999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=361.50 Aligned_cols=274 Identities=20% Similarity=0.275 Sum_probs=214.5
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC--ceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lV 441 (696)
.++|++.++||+|+||.||+|.+. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++...+ ..+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367999999999999999999965 58999999997543 244577889999999999999999999998765 67999
Q ss_pred EEecCCCchhhccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE----CCCCcEEEEeeccch
Q 005443 442 YDYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLAK 516 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DfGls~ 516 (696)
|||+.+++|.+++..... ..+++..++.|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999876433 2389999999999999999999999 99999999999999 788889999999998
Q ss_pred hccccCcceeeccccccccCchhhhc--------cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYAS--------SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
....... .....|+..|+|||++. +..++.++|||||||+||||++|+.||..... .....+....++
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG--PRRNKEVMYKII 240 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC--GGGCHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--cchhHHHHHHHh
Confidence 6644332 23356899999999986 57789999999999999999999999975432 122222233322
Q ss_pred HHhhhh--hhhhccc--------CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 589 SHALEN--EEFDNLA--------DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 589 ~~~~~~--~~~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
...... ..+.... +-.....+.......+.+++++||+.||++|++++|+++...+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 221110 0000000 001112344566678899999999999999999999999887654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=370.85 Aligned_cols=262 Identities=23% Similarity=0.387 Sum_probs=209.0
Q ss_pred HhcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCC
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 436 (696)
..++|++.++||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.+|+++ +|+||++++++|...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 347899999999999999999985 246689999997442 23456799999999999 8999999999999999
Q ss_pred ceeEEEEecCCCchhhccccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCC
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGR---------------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLk 495 (696)
..+|||||+.+|+|.+++..... ..+++..+++|+.||+.||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999876532 2378999999999999999999999 99999999
Q ss_pred CCceEECCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCC
Q 005443 496 SSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQ 573 (696)
Q Consensus 496 p~NILl~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~ 573 (696)
++||||+.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999866443322 2334567889999999999999999999999999999998 999997643
Q ss_pred CCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 574 PLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 574 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
. ...+.+. +.... .. .........+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 280 ~--~~~~~~~----~~~~~---------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 V--DANFYKL----IQNGF---------KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp C--SHHHHHH----HHTTC---------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred c--HHHHHHH----HhcCC---------CC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2 1111111 11100 00 01111123688999999999999999999999999988753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=365.44 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=212.3
Q ss_pred hcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 437 (696)
.++|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++|+++ +|+||++++++|...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999974 3578999999975543 2346799999999999 89999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGR----------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
.++||||+.+|+|.+++..... ..+++..+++++.||++||+|||++ +|+|||||++||||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999998876542 2489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchh
Q 005443 502 DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~ 579 (696)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ...
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DSK 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--SHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc--hhH
Confidence 99999999999999876544322 2233457789999999999999999999999999999998 9999976432 111
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
+.+ .+... .... . .......+.+++.+||+.||++||++.||++.|+++..+
T Consensus 257 ~~~----~~~~~-----~~~~----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 FYK----MIKEG-----FRML----S----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHH----HHHHT-----CCCC----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----HhccC-----CCCC----C----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111 11111 0000 0 111123688999999999999999999999999988754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.14 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=211.2
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|++++.||+|+||.||+|.+++++.||||+++... ...+.+.+|+++|++++|+||+++++++. ++..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46899999999999999999998888899999997543 34678999999999999999999999886 45689999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+++|.+++.......+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 999999999765433589999999999999999999999 99999999999999999999999999998765443333
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+.. . .. . ...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~----~---~~--~----~~~ 230 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQNL----E---RG--Y----RMV 230 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHH----H---TT--C----CCC
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC---HHHHHHHH----h---cc--c----CCC
Confidence 334456788999999998889999999999999999999 999997532 11111111 0 00 0 000
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
... .....+.+++++||+.||++||++.+|++.|+++...
T Consensus 231 ~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 RPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Ccc----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 111 1123688999999999999999999999999988753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=372.84 Aligned_cols=280 Identities=17% Similarity=0.195 Sum_probs=208.7
Q ss_pred hcCccccccccccCcEEEEEEEcCC------CcEEEEEEeecCCCcc-----------HHHHHHHHHHHHHccCCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQG-----------EREFKAEVEIISRIHHRHLVSL 428 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~-----------~~~~~~E~~il~~l~hpnIv~l 428 (696)
.++|+++++||+|+||.||+|.+.+ ++.||||++....... ...+.+|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999998654 4789999987543211 1123345556666789999999
Q ss_pred EeEEeeC----CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC--
Q 005443 429 VGYCISD----DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-- 502 (696)
Q Consensus 429 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-- 502 (696)
++++... ...+|||||+ +++|.+++.... ..+++..+++|+.||+.||+|||++ +|+|||||++||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 9999875 3479999999 999999987643 3489999999999999999999999 999999999999998
Q ss_pred CCCcEEEEeeccchhccccCcce------eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCC
Q 005443 503 NNFEAQVSDFGLAKLALDANTHI------TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576 (696)
Q Consensus 503 ~~~~vkL~DfGls~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~ 576 (696)
+++.+||+|||+++......... .....||..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~-- 266 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK-- 266 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT--
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--
Confidence 88999999999997664432211 1234599999999999999999999999999999999999999985322
Q ss_pred chhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccccCCCcc
Q 005443 577 DESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKV 656 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~~~~~ 656 (696)
+..+..+...... ..+..+++..+... .....+.+++.+||+.|+++||++.+|++.|+++...........
T Consensus 267 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~ 338 (364)
T 3op5_A 267 DPKYVRDSKIRYR-----ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK 338 (364)
T ss_dssp CHHHHHHHHHHHH-----HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred CHHHHHHHHHHhh-----hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence 2222222221111 11222222222111 112368899999999999999999999999999886543333333
Q ss_pred Cccc
Q 005443 657 GESE 660 (696)
Q Consensus 657 ~~~~ 660 (696)
.|+.
T Consensus 339 ~dw~ 342 (364)
T 3op5_A 339 LDLS 342 (364)
T ss_dssp CCC-
T ss_pred cceE
Confidence 3433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.23 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=205.8
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 442 (696)
++|++.++||+|+||.||+|++ +|+.||||+++.... ...+++.+|++++++++|+||++++++|.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5799999999999999999998 589999999976532 3345799999999999999999999999877 6789999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||+.+|+|.++++......+++..+++|+.||+.||+|||++ + |+|||||++||||++++.++|+|||+......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999877665689999999999999999999998 8 99999999999999999999999998754322
Q ss_pred cCcceeeccccccccCchhhhccCCCCc---cccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTE---KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~---~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
....|+..|+|||++.+..++. ++|||||||++|||++|+.||.... ... ....... ..
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~---~~~~~~~----~~-- 227 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---NME---IGMKVAL----EG-- 227 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC---HHH---HHHHHHH----SC--
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC---hHH---HHHHHHh----cC--
Confidence 2246889999999998765544 7999999999999999999997532 111 1111110 00
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
....+.. .....+.+++.+||+.||++||++.||++.|+++..
T Consensus 228 ---~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 ---LRPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---CCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0111111 122368899999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=368.97 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=200.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCc----EEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|++.++||+|+||.||+|++. +|+ .||+|.++... ....+++.+|+++|++++|+||++++++|... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 57999999999999999999853 444 35888875432 34567899999999999999999999999865 4789
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|+||+.+|+|.+++..... .+++..+++|+.||+.||+|||++ +|+|||||++||||++++++||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999998876433 489999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.+.+ . ...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~----~~~-- 236 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL----E----KGE-- 236 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH----H----TTC--
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHHH----H----cCC--
Confidence 3322 2233456889999999999999999999999999999999 9999976432 1111111 1 000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
...........+.+++.+||+.||++||++.||++.|+++..
T Consensus 237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000111122368899999999999999999999999998874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.23 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=201.7
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|+++++||+|+||.||+|++.+|+.||||+++.... ...+.+.+|+++|++++|+||+++++++.+++..+||||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 478999999999999999999988899999999975432 224678899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+ +|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9975 6766665443 3489999999999999999999999 999999999999999999999999999986543322
Q ss_pred ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc--
Q 005443 524 HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL-- 600 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-- 600 (696)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........+.... ...+..+
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~-~~~~~~~~~ 249 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPN-PREWPQVQE 249 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCC-TTTSGGGTT
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCC-hHHhhhhhc
Confidence 2334568999999999876 568999999999999999999999998654322 2221111111000 0000000
Q ss_pred ----cC---cccCCC----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ----AD---PRLGEN----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ----~d---~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+ ..+... .......++.+|+++||+.||++|++++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 000000 001112367899999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.21 Aligned_cols=271 Identities=24% Similarity=0.360 Sum_probs=205.4
Q ss_pred cCccccccccccCcEEEEEEEc-----CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeC--Cce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 438 (696)
++|+++++||+|+||.||+|++ .+|+.||||+++... ....+.+.+|+++|++++|+||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4589999999999999999983 468999999997443 34457899999999999999999999999876 567
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+.+++|.+++..... .+++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 999999999999999854432 389999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 519 LDANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.++.... ....+..... ........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-~~~~~~~~ 251 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----ALFLKMIGPT-HGQMTVTR 251 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HHHHHHHCSC-CGGGHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----hHHhhccCCc-ccccCHHH
Confidence 544321 2233567888999999999999999999999999999999998864311 0000000000 00000000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
+...+...............+.+|+++||+.||++||++.+|++.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000001111111222347889999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=365.53 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=210.3
Q ss_pred hcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... ...+++.+|+++|++++|+||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46799999999999999999985 2458999999975433 3346789999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCC
Q 005443 439 LLIYDYVPNNTLYFHLHGEGR----------------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKS 496 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp 496 (696)
++||||+.+++|.+++..... ..+++..+++++.||++||+|||++ +|+|||||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999875432 3488999999999999999999999 999999999
Q ss_pred CceEECCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCC
Q 005443 497 SNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQP 574 (696)
Q Consensus 497 ~NILl~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~ 574 (696)
+||||++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865443322 1223456788999999999899999999999999999999 9999976432
Q ss_pred CCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 575 LGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 575 ~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..+.+.. . .... ... .......+.+++.+||+.||++||++.||++.|+++..
T Consensus 259 ---~~~~~~~----~----~~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ---ERLFNLL----K----TGHR-----MER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp ---GGHHHHH----H----TTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHh----h----cCCc-----CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 1 1000 001 11122368899999999999999999999999998865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=360.73 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=196.9
Q ss_pred hcCccccccccccCcEEEEEEEcCC----CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|++.++||+|+||.||+|.+.. +..||||+++.... ...+.+.+|+.++++++|+||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4689999999999999999998642 45799999875433 23467899999999999999999999984 567899
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999987543 2489999999999999999999999 999999999999999999999999999987655
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.. ......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~~~~i--------~~~~~~- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI--------ENGERL- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH--------HTTCCC-
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHHHHHH--------HcCCCC-
Confidence 43333334456788999999999999999999999999999996 9999976431 2221111 010000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.+ .......+.+++.+||+.||++||++.||++.|+++..+
T Consensus 237 ----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 ----PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01 111223688999999999999999999999999988753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=374.78 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=199.3
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|+++++||+|+||.||+|+++ +|+.||||+++.. .....+.+.+|+++|+.+ +|+||++++++|.+.+..+|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999854 6899999999743 223456688999999998 69999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999876544 89999999999999999999999 999999999999999999999999999975433
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.. ......+||..|+|||++.+..|+.++|||||||+||||++|+.||...+ ... ....++.. . +
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~---~~~~i~~~-----~---~ 241 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDD---LFEAILND-----E---V 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH---HHHHHHHC-----C---C
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHH---HHHHHHcC-----C---C
Confidence 22 22344679999999999999889999999999999999999999997643 111 11111110 0 0
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCH------HHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM------GQVVR 640 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~ 640 (696)
. +.......+.+|+++||+.||++|+++ +||++
T Consensus 242 ---~----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ---V----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---C----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---C----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 111122368899999999999999998 66664
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.89 Aligned_cols=266 Identities=21% Similarity=0.298 Sum_probs=209.6
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEE-eeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC-ISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~lV~E 443 (696)
.++|++.++||+|+||.||+|+. .+|+.||||++.... ..+++.+|++++++++|.+++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999995 579999999987543 234689999999999988877666655 45667799999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE---CCCCcEEEEeeccchhccc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DfGls~~~~~ 520 (696)
|+ +++|.+++..... .+++..+++++.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 9999998874332 489999999999999999999999 99999999999999 4888999999999987654
Q ss_pred cCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 521 ANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 521 ~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
.... ......|+..|+|||++.+..++.++|||||||+||||++|+.||............+..... ....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~ 237 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---KMST 237 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH---HHHS
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc---ccCC
Confidence 4321 123457899999999999999999999999999999999999999875543333322221111 0000
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccccc
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLN 651 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~ 651 (696)
.... +...+. ..+.+++++||+.||++||++.+|++.|+++......
T Consensus 238 -~~~~-----~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 238 -PIEV-----LCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -CHHH-----HTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -chHH-----HHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0000 011111 2688999999999999999999999999998865433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=386.54 Aligned_cols=264 Identities=21% Similarity=0.281 Sum_probs=209.7
Q ss_pred CHHHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEe
Q 005443 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCI 433 (696)
Q Consensus 358 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 433 (696)
.+.++....++|+++++||+|+||.||+|+++ +|+.||||+++... ......+.+|+.+|..++|+||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455555689999999999999999999965 57899999997421 122334889999999999999999999999
Q ss_pred eCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 434 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
+.+..+|||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999997642 2489999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCcceeeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
+++.............+||..|+|||++. .+.|+.++|||||||+||||++|+.||...+ ..+....++
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~------~~~~~~~i~ 294 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIM 294 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC------hhHHHHhhh
Confidence 99876554444444568999999999987 4678999999999999999999999997543 111111111
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAK--RPRMGQVVRV 641 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 641 (696)
... . .+.-+...... ...+.+|+++||+.++++ |++++||+++
T Consensus 295 ~~~----~--~~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHK----E--RFQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THH----H--HCCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hcc----c--cccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 110 0 00001111111 226888999999988888 9999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.98 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=205.9
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEE-eeCCceeEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC-ISDDRRLLIY 442 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~lV~ 442 (696)
..++|+++++||+|+||.||+|+. .+++.||||++..... ..++.+|++++++++|.|++..++++ ...+..+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999985 5789999998764432 24588999999999988877776665 5566779999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE---CCCCcEEEEeeccchhcc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DfGls~~~~ 519 (696)
||+ +++|.+++..... .+++..+++++.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 9999998875433 389999999999999999999999 99999999999999 788999999999998765
Q ss_pred ccCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 520 DANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 520 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
..... ......|+..|+|||++.+..++.++|||||||+||||++|+.||............+..... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~ 236 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---KMS 236 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH---HHH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc---ccc
Confidence 43321 123457899999999999999999999999999999999999999875543333322221111 000
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccc
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDL 650 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~ 650 (696)
. .... +...+ ...+.+++.+||+.||++||++.+|++.|+++..+.-
T Consensus 237 ~-~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 237 T-PIEV-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp S-CHHH-----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred c-hhhh-----hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0 0000 00111 1268899999999999999999999999999886443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=359.75 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=195.9
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc--------------------------cHHHHHHHHHHHH
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ--------------------------GEREFKAEVEIIS 418 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--------------------------~~~~~~~E~~il~ 418 (696)
.++|++.++||+|+||.||+|+. .+|+.||||+++..... ..+++.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999985 46889999999754311 1246889999999
Q ss_pred HccCCCceeEEeEEee--CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCC
Q 005443 419 RIHHRHLVSLVGYCIS--DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKS 496 (696)
Q Consensus 419 ~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp 496 (696)
+++|+||+++++++.+ .+..+|||||+.+++|.+++.. ..+++..++.++.||+.||+|||++ +|+|||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999986 5678999999999999887653 2489999999999999999999999 999999999
Q ss_pred CceEECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhccCC---CCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 497 SNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGK---LTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 497 ~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
+||||+.++.+||+|||+++....... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999986544332 233457999999999998755 3778999999999999999999997532
Q ss_pred CCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 574 PLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 574 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.......+.. ..+. +. ..... ...+.+++.+||+.||++||++.||+++
T Consensus 245 ------~~~~~~~~~~-----~~~~-~~---~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 ------IMCLHSKIKS-----QALE-FP---DQPDI----AEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ------HHHHHHHHHH-----CCCC-CC---SSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ------HHHHHHHHhc-----ccCC-CC---Ccccc----CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1111111111 0000 00 01111 2368899999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=382.25 Aligned_cols=260 Identities=21% Similarity=0.267 Sum_probs=208.0
Q ss_pred HHHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEee
Q 005443 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (696)
Q Consensus 359 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 434 (696)
+.++....++|+++++||+|+||.||+|+++ +|+.||||+++.. .....+.+.+|+.+|+.++|+||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3444455689999999999999999999965 6889999999642 12233458899999999999999999999999
Q ss_pred CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
.+..+|||||+.||+|.++++.. .+++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999988754 389999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCC----CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGK----LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
++.............+||..|+|||++.+.. |+.++|||||||+||||++|+.||...+ ..+....++..
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNH 288 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHHHHHhc
Confidence 9876554433344568999999999998655 7889999999999999999999997543 11111111111
Q ss_pred hhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005443 591 ALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAK--RPRMGQVVRV 641 (696)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 641 (696)
.....+.+ ...+ ...+.+|+++||+.++++ |++++||+++
T Consensus 289 ----~~~~~~p~---~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 289 ----KNSLTFPD---DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----HHHCCCCT---TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----cccccCCC---cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000100 0011 236889999999999988 9999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=376.08 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=193.0
Q ss_pred cCcccc-ccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHH-ccCCCceeEEeEEee----CCcee
Q 005443 367 DGFADQ-NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISR-IHHRHLVSLVGYCIS----DDRRL 439 (696)
Q Consensus 367 ~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~----~~~~~ 439 (696)
++|.+. ++||+|+||.||+|.+. +|+.||||+++. ...+.+|++++.+ ++|+||++++++|.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 457666 78999999999999864 689999999862 3567889998755 479999999999875 55689
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC---CCcEEEEeeccch
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAK 516 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DfGls~ 516 (696)
|||||+.+|+|.+++.......+++..++.|+.||+.||+|||++ +|||||||++||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999876656699999999999999999999999 9999999999999987 7899999999998
Q ss_pred hccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCch-hHHHhHHHHHHHhhhhh
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-SLVEWARPLLSHALENE 595 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~ 595 (696)
...... .....+|+..|+|||++.+..|+.++|||||||+||||++|+.||......... .+... +. ..
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~-----~~ 282 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IR-----MG 282 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HH-----HT
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HH-----cC
Confidence 654322 223457899999999999999999999999999999999999999865433211 11111 00 00
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
.+ .+....+ ......+.+|+++||+.||++|+++.||+++-
T Consensus 283 ~~-~~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 283 QY-EFPNPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CC-CCCTTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cc-cCCCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 0000000 11123688999999999999999999999763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=364.94 Aligned_cols=269 Identities=26% Similarity=0.395 Sum_probs=206.5
Q ss_pred ccccccccccCcEEEEEEEc-----CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeC--CceeE
Q 005443 369 FADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD--DRRLL 440 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l 440 (696)
|+++++||+|+||.||++.+ .+|+.||||+++.... ...+.+.+|+++|++++|+||+++++++.+. ...+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999988864 2688999999975533 3346799999999999999999999999874 56789
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+++|.+++.... +++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999997643 89999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... ......++..|+|||++.+..++.++|||||||++|||++|+.+|.... ....+... ..........+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~----~~~~~~~~-~~~~~~~~~~~~ 261 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP----TKFLELIG-IAQGQMTVLRLT 261 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HHHHHHHC-SCCHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccc----hhhhhhhc-ccccchhHHHHH
Confidence 3321 2233467888999999999899999999999999999999999986421 01000000 000000000111
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
+.++..............+.+|+++||+.||++||++.||++.|+++..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 11111111111222234789999999999999999999999999988753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=378.58 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=210.5
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC-CCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH-RHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|+++++||+|+||.||+|++ .+|+.||||+++.... ..++.+|+++++.|+| .+|..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999985 5799999999875433 3458899999999987 556666666777788899999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE---CCCCcEEEEeeccchhccc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DfGls~~~~~ 520 (696)
|+ +++|.+++....+ .+++..++.|+.||+.||+|||++ +|||||||++|||| ++++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 9999999875433 489999999999999999999999 99999999999999 5888999999999987654
Q ss_pred cCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 521 ANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 521 ~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
.... ......|+..|+|||++.+..++.++|||||||+||||++|+.||...........++.... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---~~~~- 234 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---KKVA- 234 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH---HHHH-
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh---cccc-
Confidence 4322 12246799999999999999999999999999999999999999987554333332222111 1110
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccccc
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLN 651 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~ 651 (696)
..+..+ ...+ ..++.+|+.+||+.++++||++.+|++.|+++......
T Consensus 235 ~~~~~l-----~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 235 TSIEAL-----CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp SCHHHH-----HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccHHHH-----hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 001111 0111 23688999999999999999999999999998764433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.75 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=204.6
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC------ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|++.+.||+|+||.||+|... +|+.||||+++.... ...+++.+|+.+|++++|+||++++++|.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999864 689999999975432 2457899999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC----cEEEEeecc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGL 514 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DfGl 514 (696)
+|||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||++++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999987544 489999999999999999999999 999999999999998887 899999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...... .+.....
T Consensus 165 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~---~~~~~~~-- 234 (326)
T 2y0a_A 165 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLA---NVSAVNY-- 234 (326)
T ss_dssp CEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHH---HHHHTCC--
T ss_pred CeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHH---HHHhcCC--
Confidence 986543322 234579999999999999999999999999999999999999997532 111111 1110000
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ..... .......+.+|+++||+.||++||++.|++++
T Consensus 235 -~----~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 -E----FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -C----CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -C----cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00000 01112367899999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=369.33 Aligned_cols=263 Identities=23% Similarity=0.371 Sum_probs=195.4
Q ss_pred HHhcCccccccccccCcEEEEEEEcCCC----cEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLPDG----REVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~g----~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
...++|+++++||+|+||.||+|++..+ ..||||+++.. .....+++.+|++++++++|+||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3457899999999999999999996543 27999999754 23445779999999999999999999999987765
Q ss_pred e------eEEEEecCCCchhhccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 438 R------LLIYDYVPNNTLYFHLHGEG----RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 438 ~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
. ++||||+.+|+|.+++.... ...+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 89999999999988885421 22489999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHH
Q 005443 508 QVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWAR 585 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~ 585 (696)
||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~-- 251 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNY-- 251 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHH--
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh---HHHHHH--
Confidence 99999999865443322 2223456778999999999999999999999999999999 9999976432 111111
Q ss_pred HHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 586 PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
+. ..... . ........+.+|+++||+.||++||++.+|++.|+++..+.
T Consensus 252 -~~----~~~~~------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 -LI----GGNRL------K----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HH----TTCCC------C----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -Hh----cCCCC------C----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 10 00000 0 01112236889999999999999999999999999988644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=369.84 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=205.5
Q ss_pred HHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
...++|++.++||+|+||.||+|..+ +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+.+..+|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999864 689999999975432 234578999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC---CcEEEEeeccchh
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDFGLAKL 517 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DfGls~~ 517 (696)
||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.+ +.+||+|||+++.
T Consensus 106 v~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998887654 489999999999999999999999 99999999999999765 4599999999986
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
...... .....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+ .+... .+
T Consensus 181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~---~i~~~-----~~ 247 (362)
T 2bdw_A 181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYA---QIKAG-----AY 247 (362)
T ss_dssp CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHT-----CC
T ss_pred ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHH---HHHhC-----CC
Confidence 653322 234579999999999999999999999999999999999999997532 111111 11111 00
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+.... .......+.+|+.+||+.||++|+++.|++++
T Consensus 248 -~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 -DYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CCCTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCCccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 01122368899999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=371.88 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=198.8
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|+++++||+|+||.||+|+++ +++.||||+++.... ...+.+.+|+.+|.++ +|+||++++++|.+.+..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 367999999999999999999864 588999999975422 2234588999999887 89999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999998876543 89999999999999999999999 999999999999999999999999999975332
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCch--hHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE--SLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~ 598 (696)
... .....+||..|+|||++.+..++.++|||||||+||||++|+.||......... ...+.+...+ ....+
T Consensus 206 ~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i----~~~~~- 279 (396)
T 4dc2_A 206 PGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI----LEKQI- 279 (396)
T ss_dssp TTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH----HHCCC-
T ss_pred CCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH----hcccc-
Confidence 222 234467999999999999999999999999999999999999999754321111 1111111111 01100
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
.+ .......+.+|+++||+.||++|+++
T Consensus 280 -----~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -----RI----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CC----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CC----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 11122368899999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=356.16 Aligned_cols=252 Identities=31% Similarity=0.572 Sum_probs=201.0
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccH-------HHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGE-------REFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
++|++.++||+|+||.||+|++ .+++.||||++........ +++.+|++++++++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6799999999999999999986 4789999999965433221 67899999999999999999999986544
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeeccCCCCceEECCCCc-----EEEEe
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFE-----AQVSD 511 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~-----vkL~D 511 (696)
++||||+.+++|.+++..... .+++..+++++.||+.||+|||++ + |+|||||++||||+.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcccC-CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888865433 489999999999999999999998 8 999999999999987776 99999
Q ss_pred eccchhccccCcceeeccccccccCchhhhc--cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH
Q 005443 512 FGLAKLALDANTHITTRVMGTFGYMAPEYAS--SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589 (696)
Q Consensus 512 fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (696)
||+++.... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....... ..+.. ....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~---~~~~ 244 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFIN---MIRE 244 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHHHH---HHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHHHH---HHhc
Confidence 999975432 233457899999999984 4567889999999999999999999997644211 11111 1110
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
. .....+. ......+.+++++||+.||++||++.||++.|+++
T Consensus 245 -----~----~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 -----E----GLRPTIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----S----CCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----c----CCCCCCC----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 0111111 12223688999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=367.58 Aligned_cols=253 Identities=19% Similarity=0.326 Sum_probs=197.2
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccC--CCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHH--RHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV 441 (696)
.++|+++++||+|+||.||++...+++.||||+++..... ..+.+.+|+++|++++| +||+++++++..++..+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3579999999999999999999888999999999755332 33678999999999986 9999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|| +.+++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 56889999987654 389999999999999999999999 999999999999997 568999999999876443
Q ss_pred Ccc-eeeccccccccCchhhhcc-----------CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH
Q 005443 522 NTH-ITTRVMGTFGYMAPEYASS-----------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589 (696)
Q Consensus 522 ~~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (696)
... .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ........
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~-- 233 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI-- 233 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHH--
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHH--
Confidence 322 2334579999999999865 6788999999999999999999999975321 11111111
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
++......+.......+.+|+.+||+.||++||++.||+++..
T Consensus 234 -----------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 234 -----------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp -----------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -----------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1111111111111236889999999999999999999997633
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.84 Aligned_cols=265 Identities=22% Similarity=0.348 Sum_probs=200.1
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++++.||+|+||.||+|+..+|+.||||+++.... ...+.+.+|+++|++++|+||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999987899999999975432 2346788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+ +|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 975 8887776543 2488999999999999999999999 999999999999999999999999999986543222
Q ss_pred eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh---cc
Q 005443 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD---NL 600 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~---~~ 600 (696)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...........+... ....+. ++
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTP-NSKNWPNVTEL 231 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC-CTTTSTTGGGS
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHHCCC-Chhhchhhhcc
Confidence 2233568999999999976 458999999999999999999999997643 122111111111000 000000 00
Q ss_pred --cCcccC-------CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 --ADPRLG-------ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 --~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+..+. ..+.......+.+++++||+.||++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00111223467899999999999999999999853
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=370.59 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=203.3
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC-----CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-----GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
.++|++.++||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+++|++++|+||++++++|.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999985 468999999996421 234678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc---EEEEeecc
Q 005443 440 LIYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGL 514 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DfGl 514 (696)
|||||+.+++|.+++... ....+++..++.++.||+.||+|||++ +|+|||||++||||+.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998777542 223489999999999999999999999 9999999999999976554 99999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
++....... .....+|+..|+|||++.+..++.++|||||||+||||++|+.||.... ..+.+ .++.....
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~---~i~~~~~~- 250 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFE---GIIKGKYK- 250 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHH---HHHHTCCC-
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHH---HHHcCCCC-
Confidence 987654332 2334579999999999999999999999999999999999999997531 11111 11111000
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........ ....+.+|+++||+.||++|+++.|++++
T Consensus 251 ------~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 ------MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ------CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000001 12368899999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.35 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=200.7
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|+++++||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|+||+++++++.+++..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999864 6899999999755432 24678899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.++.+..+....+ .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 997654444433333 389999999999999999999999 99999999999999999999999999998654332
Q ss_pred ceeeccccccccCchhhhccCC-CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh---hc
Q 005443 524 HITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF---DN 599 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~---~~ 599 (696)
.......|+..|+|||++.+.. ++.++|||||||++|||++|..||..... ...........+... ....+ ..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~-~~~~~~~~~~ 232 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTP-TEEQWPSMTK 232 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCC-CTTTCTTGGG
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCC-Chhhhhhhcc
Confidence 2233457899999999998765 89999999999999999999998754321 222222211111100 00000 00
Q ss_pred ccC---------cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LAD---------PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.+ ..............+.+|+++||+.||++|++++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000001111223467899999999999999999999853
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=365.78 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=193.8
Q ss_pred hcCccccccccccCcEEEEEEEc----CCCcEEEEEEeecCC----CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
.++|++.++||+|+||.||+|+. .+|+.||||+++... ......+.+|+++|++++|+||++++++|..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999986 478999999997542 2334568899999999999999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+|||||+.+++|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999998876543 88999999999999999999999 999999999999999999999999999975
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
...... .....+|+..|+|||++.+..++.++|||||||+||||++|+.||.... .. +....++... +
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~---~~~~~i~~~~-----~ 238 (327)
T 3a62_A 171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RK---KTIDKILKCK-----L 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HH---HHHHHHHHTC-----C
T ss_pred cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HH---HHHHHHHhCC-----C
Confidence 433222 2334579999999999999999999999999999999999999997543 11 1111111110 0
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.+.. .....+.+++++||+.||++|+ ++.||+++
T Consensus 239 ------~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ------NLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------CCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------CCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0111 1123688999999999999999 66677654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=363.58 Aligned_cols=246 Identities=27% Similarity=0.374 Sum_probs=203.9
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|+++++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|+.++|+||+++++++.+.+..+||
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999864 79999999997432 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.+++..... +++..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999976544 89999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||...+ ..+....++.. .+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~-----~~---- 220 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNA-----EL---- 220 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHC-----CC----
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhC-----CC----
Confidence 234579999999999999999999999999999999999999997532 11111111111 00
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.+...+ ..++.+++.+||+.|+++|+ +++||+++
T Consensus 221 --~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 --RFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 011111 23688999999999999999 78888754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=363.72 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=197.2
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc-----
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR----- 437 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 437 (696)
..++|+++++||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+.+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999965 799999999975543 345679999999999999999999999866432
Q ss_pred ----------------------------------------------------eeEEEEecCCCchhhccccCCC-CCCCH
Q 005443 438 ----------------------------------------------------RLLIYDYVPNNTLYFHLHGEGR-PVLDW 464 (696)
Q Consensus 438 ----------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~-~~l~~ 464 (696)
.++||||+.+++|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 7899999999999999876433 23566
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc-----------ceeecccccc
Q 005443 465 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT-----------HITTRVMGTF 533 (696)
Q Consensus 465 ~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~-----------~~~~~~~gt~ 533 (696)
..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....... .......|+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 67899999999999999999 999999999999999999999999999987654321 1223356999
Q ss_pred ccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHH
Q 005443 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGE 613 (696)
Q Consensus 534 ~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 613 (696)
.|+|||++.+..++.++|||||||+||||++|..++. ...+...... ...+ .......
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~-----~~~~---------~~~~~~~ 298 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVR-----NLKF---------PLLFTQK 298 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHH-----TTCC---------CHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhh-----ccCC---------CcccccC
Confidence 9999999999999999999999999999999865432 1111111000 0000 0011122
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 614 MFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 614 ~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.+++.+||+.||++||++.||+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 3467899999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=368.09 Aligned_cols=273 Identities=25% Similarity=0.342 Sum_probs=208.9
Q ss_pred cCccccccccccCcEEEEEEEc-----CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee--CCcee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~ 439 (696)
++|+++++||+|+||.||+|++ .+++.||||+++.......+.+.+|+++|++++|+||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5799999999999999999983 3688999999986655556779999999999999999999999874 45678
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
|||||+.+++|.+++..... .+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 99999999999999875332 389999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 520 DANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
..... ......|+..|+|||++.+..++.++|||||||+||||++|+.+|..... ........ .........+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~----~~~~~~~~-~~~~~~~~~~ 253 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA----EFLRMMGC-ERDVPALSRL 253 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHCC-----CCHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc----hhhhhccc-ccccccHHHH
Confidence 43322 12234578889999999999999999999999999999999999864211 00000000 0000000000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.+.+...............+.+|+++||+.||++||++.||+++|+++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 001111111111222234688999999999999999999999999988753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=362.77 Aligned_cols=270 Identities=26% Similarity=0.393 Sum_probs=215.4
Q ss_pred cCHHHHHHHhcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCCc-cHHHHHHHHHHHHHc-cCCCceeE
Q 005443 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQ-GEREFKAEVEIISRI-HHRHLVSL 428 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l-~hpnIv~l 428 (696)
+...++....++|++.+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|+++|+++ +|+||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45556666678999999999999999999973 35689999999754432 345789999999999 69999999
Q ss_pred EeEEeeCC-ceeEEEEecCCCchhhccccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecc
Q 005443 429 VGYCISDD-RRLLIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRD 493 (696)
Q Consensus 429 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrD 493 (696)
+++|...+ ..++||||+.+++|.+++..... ..+++..++.++.||+.||+|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988765 48999999999999999876543 2278999999999999999999999 999999
Q ss_pred CCCCceEECCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCC
Q 005443 494 IKSSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDA 571 (696)
Q Consensus 494 Lkp~NILl~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~ 571 (696)
||++||||+.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999865443322 2334567889999999999999999999999999999998 9999976
Q ss_pred CCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 572 SQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 572 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
... ...+.... . .... ...... ....+.+++.+||+.||++||++.||+++|+++...
T Consensus 254 ~~~--~~~~~~~~----~----~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKI--DEEFCRRL----K----EGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCC--SHHHHHHH----H----HTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cch--hHHHHHHh----c----cCcc-----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 432 11111111 1 0000 001111 123688999999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=365.36 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=208.7
Q ss_pred hcCccccccccccCcEEEEEEEc--------CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeC
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL--------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 435 (696)
.++|++++.||+|+||.||+|++ .+++.||||+++.... ...+++.+|+++|+++ +|+||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46899999999999999999985 2467899999975433 3346789999999999 899999999999999
Q ss_pred CceeEEEEecCCCchhhccccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEGR--------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
+..+|||||+.+|+|.+++..... ..+++..+++++.||+.||+|||++ +|+|||||++||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999875432 2488999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchh
Q 005443 502 DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~ 579 (696)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HHH
Confidence 99999999999999865443321 1223456788999999998889999999999999999999 999997532 111
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
+.+. +. .... ... .......+.+++++||+.||++||++.||++.|+++...
T Consensus 268 ~~~~----~~----~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 268 LFKL----LK----EGHR-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHH----HH----HTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----Hh----cCCC-----CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 11 0000 001 111223688999999999999999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.63 Aligned_cols=271 Identities=15% Similarity=0.245 Sum_probs=205.5
Q ss_pred hcCcccccccccc--CcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEG--GFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|+++++||+| +||.||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+++..+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3679999999999 99999999965 699999999975532 234568899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+|+|.+++.......+++..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999876555699999999999999999999999 999999999999999999999999999865433
Q ss_pred cCcc------eeeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhh
Q 005443 521 ANTH------ITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592 (696)
Q Consensus 521 ~~~~------~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 592 (696)
.... .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... .+.+.....+...+
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLL 258 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC---------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCccc
Confidence 2211 1122468899999999987 678999999999999999999999997654322 11111111110000
Q ss_pred hh-----hhh-------------hcccC---------cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 593 EN-----EEF-------------DNLAD---------PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 593 ~~-----~~~-------------~~~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. +.+ .+... ......+.......+.+|+++||+.||++|+++.||+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 000 00000 000000111222368899999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=366.80 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=202.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcE----EEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGRE----VAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|+++++||+|+||.||+|.+. +|+. ||+|++.... ....+++.+|+.++++++|+||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57999999999999999999853 4443 7888775433 233456889999999999999999999886 567899
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+|+|.+++.... ..+++..+++|+.||+.||+|||++ +|+|||||++||||+.++++||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999887643 3488999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... ......|+..|+|||++.+..++.++|||||||+||||++ |+.||...... .+.+... ...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~--------~~~-- 234 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLLE--------KGE-- 234 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHHH--------TTC--
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHHH--------cCC--
Confidence 3322 2334567889999999999999999999999999999999 99999864321 1111110 000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
...... .....+.+++.+||+.||++||++.||++.|+++..
T Consensus 235 ~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 RLAQPQ-------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp BCCCCT-------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCC-------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000000 011257789999999999999999999999998874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=369.73 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=206.2
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|+++++||+|+||.||+|... +|+.||+|++..........+.+|+++|++++|+||++++++|.+.+..+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999864 6899999999865555566799999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC--CCcEEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DfGls~~~~~~~ 522 (696)
+.+|+|.+++...+ ..+++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999887543 2489999999999999999999999 9999999999999974 5789999999998664432
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. .....|+..|+|||++.+..++.++|||||||+||||++|+.||.... ..... ..+.... + ..+
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~---~~i~~~~-----~--~~~ 270 (387)
T 1kob_A 206 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETL---QNVKRCD-----W--EFD 270 (387)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHH---HHHHHCC-----C--CCC
T ss_pred c--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHH---HHHHhCC-----C--CCC
Confidence 2 233468999999999999999999999999999999999999997643 11111 1111100 0 011
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.... ......+.+|+++||+.||++|+++.||++.
T Consensus 271 ~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 EDAF----SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SSTT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111 1122368899999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=365.26 Aligned_cols=261 Identities=23% Similarity=0.272 Sum_probs=202.0
Q ss_pred HHHHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC-----CCccHHHHHHHHHHHHHccCCCceeEEeEEee
Q 005443 361 ELVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG-----GGQGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (696)
Q Consensus 361 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 434 (696)
++..+.++|+++++||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+++|++++|+||++++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4566778999999999999999999985 46889999999643 23445679999999999999999999999999
Q ss_pred CCceeEEEEecCCCchhhccccC--------------------------------------CCCCCCHHHHHHHHHHHHH
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGE--------------------------------------GRPVLDWATRVKIAAGAAR 476 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~qia~ 476 (696)
.+..+|||||+.+|+|.+++... ....+++..+++|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999998888521 0112457778899999999
Q ss_pred HHHHHHhcCCCceeeccCCCCceEECCCC--cEEEEeeccchhccccCc---ceeeccccccccCchhhhcc--CCCCcc
Q 005443 477 GLAYLHEDCHPRIIHRDIKSSNILLDNNF--EAQVSDFGLAKLALDANT---HITTRVMGTFGYMAPEYASS--GKLTEK 549 (696)
Q Consensus 477 gL~~LH~~~~~~ivHrDLkp~NILl~~~~--~vkL~DfGls~~~~~~~~---~~~~~~~gt~~y~aPE~l~~--~~~s~~ 549 (696)
||+|||++ +|+|||||++||||+.++ .+||+|||+++....... .......|+..|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998766 899999999986543222 12334578999999999975 678999
Q ss_pred ccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCC
Q 005443 550 SDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSA 629 (696)
Q Consensus 550 sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP 629 (696)
+|||||||+||||++|+.||.... .. +....++..... +.... .......+.+|+.+||+.||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~---~~---~~~~~~~~~~~~------~~~~~-----~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVN---DA---DTISQVLNKKLC------FENPN-----YNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHCCCC------TTSGG-----GGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCC---hH---HHHHHHHhcccc------cCCcc-----cccCCHHHHHHHHHHcCCCh
Confidence 999999999999999999997543 11 111111111100 00000 01112368899999999999
Q ss_pred CCCCCHHHHHHH
Q 005443 630 AKRPRMGQVVRV 641 (696)
Q Consensus 630 ~~RPs~~ell~~ 641 (696)
++||++.|+++.
T Consensus 320 ~~Rps~~~~l~h 331 (345)
T 3hko_A 320 DERFDAMRALQH 331 (345)
T ss_dssp TTSCCHHHHHHS
T ss_pred hHCCCHHHHhcC
Confidence 999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=369.18 Aligned_cols=208 Identities=25% Similarity=0.356 Sum_probs=181.1
Q ss_pred cCHHHHHHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-----CCCceeEEe
Q 005443 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-----HRHLVSLVG 430 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~~ 430 (696)
+.+++.....++|+++++||+|+||.||+|++ .+++.||||+++.. ....+.+.+|+++|++++ |+||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34444445568999999999999999999986 47899999998632 233456888999999996 999999999
Q ss_pred EEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-------
Q 005443 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN------- 503 (696)
Q Consensus 431 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~------- 503 (696)
++...+..+|||||+ +++|.+++.......+++..++.|+.||+.||+|||++ +|||||||++||||++
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence 999999999999999 99999999876655689999999999999999999999 9999999999999975
Q ss_pred ------------------CCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhC
Q 005443 504 ------------------NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 565 (696)
Q Consensus 504 ------------------~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg 565 (696)
++.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999764332 2345689999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 005443 566 RKPVDASQ 573 (696)
Q Consensus 566 ~~Pf~~~~ 573 (696)
+.||....
T Consensus 256 ~~pf~~~~ 263 (360)
T 3llt_A 256 SLLFRTHE 263 (360)
T ss_dssp SCSCCCSS
T ss_pred CCCCCCCc
Confidence 99997643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=377.18 Aligned_cols=255 Identities=19% Similarity=0.299 Sum_probs=205.1
Q ss_pred HHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
...++|+++++||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+++|++++|+||++++++|.+++..+|
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3457899999999999999999985 4789999999975432 234568999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC---CCCcEEEEeeccchh
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKL 517 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DfGls~~ 517 (696)
||||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+ +++.+||+|||+++.
T Consensus 88 v~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999988876544 89999999999999999999999 999999999999998 567899999999976
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
...... ......|+..|+|||++.+..|+.++|||||||+||||++|+.||.... ...+.+ .+.. ..+
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~---~i~~-----~~~ 230 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQ---QIKA-----GAY 230 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHH---HHHH-----TCC
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHH---HHHh-----CCC
Confidence 654332 2334679999999999999999999999999999999999999997532 111111 1111 110
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+....+ ......+.+|+.+||+.||++|+++.|++++
T Consensus 231 -~~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 -DFPSPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CCCTTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCcccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0111111 1112368899999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=368.41 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=203.5
Q ss_pred HHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCce
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 438 (696)
...++|++.++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|..+|..+ +|+||++++++|.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999964 68999999997532 23456788999999987 899999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
+|||||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999876543 89999999999999999999999 9999999999999999999999999999754
Q ss_pred cccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
..... .....+|+..|+|||++.+..++.++|||||||+||||++|+.||...+ ...+.+ .+.. ..
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~---~i~~-----~~-- 234 (345)
T 1xjd_A 169 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFH---SIRM-----DN-- 234 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHH-----CC--
T ss_pred ccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHH---HHHh-----CC--
Confidence 32222 2344679999999999999999999999999999999999999997543 111111 1110 00
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMG-QVVR 640 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~ 640 (696)
..+... ....+.+++++||+.||++|+++. +|++
T Consensus 235 ----~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ----PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----CCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 011111 123688999999999999999997 6653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=363.85 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=198.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|+++++||+|+||.||+|+++ +|+.||||+++.... ...+.+.+|+.+|+++ +|+||++++++|.+.+..+||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999964 688999999975432 2235688999999998 899999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999998876543 89999999999999999999999 9999999999999999999999999999754332
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCch--hHHHhHHHHHHHhhhhhhhhc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE--SLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.. .....+|+..|+|||++.+..++.++|||||||+||||++|+.||......... ...+..... . ....+
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---i-~~~~~-- 236 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV---I-LEKQI-- 236 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH---H-HHCCC--
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH---H-HcCCC--
Confidence 22 234467999999999999999999999999999999999999999753321111 111111111 1 11100
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
.+ .......+.+++++||+.||++|+++
T Consensus 237 ----~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----RI----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CC----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CC----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 11122368899999999999999996
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.12 Aligned_cols=260 Identities=29% Similarity=0.530 Sum_probs=195.7
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++.++||+|+||.||+|++. ..||||+++.... ...+.|.+|+++|++++|+||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999863 3599999975533 2346799999999999999999999965 4567899999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC-
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN- 522 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~- 522 (696)
|+.+++|.+++.... ..+++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999886543 3489999999999999999999999 99999999999999999999999999997654321
Q ss_pred cceeeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
........|+..|+|||++. +..++.++|||||||++|||++|+.||..... ...+.+. +.. ..+..
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~----~~~----~~~~~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEM----VGR----GSLSP 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHH----HHH----TSCCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHH----hcc----cccCc
Confidence 22233456899999999986 56788899999999999999999999976432 1111111 111 11100
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
... .+. ......+.+|+.+||+.||++||++.||++.|+++..
T Consensus 246 ~~~-~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLS-KVR----SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTT-SSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chh-hcc----ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 000 111 1122368899999999999999999999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=355.16 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=203.0
Q ss_pred hcCccccccccccCcEEEEEEEcCC----CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|++.++||+|+||.||+|.+.+ +..||||+++.... ...+.+.+|++++++++|+||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4679999999999999999998532 34699999875432 345679999999999999999999999864 56789
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999887543 2489999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+... ... .
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~---~~~~~~~~--------~~~--~ 232 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN---KDVIGVLE--------KGD--R 232 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG---GGHHHHHH--------HTC--C
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh---HHHHHHHh--------cCC--C
Confidence 43333334557889999999999999999999999999999998 9999975331 22211111 000 0
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.. ... .....+.+++.+||+.||++||++.||++.|+++..
T Consensus 233 ~~---~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 LP---KPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CC---CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---CCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 00 001 112368899999999999999999999999998864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.28 Aligned_cols=260 Identities=23% Similarity=0.289 Sum_probs=199.2
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|++.++||+|+||.||+|... +|+.||||+++..... ..+.+.+|++++++++|+||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999964 6889999999754322 236789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++...+ .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999987654 389999999999999999999999 9999999999999999999999999999876554
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||.... .. .....+..... ...
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~---~~~~~~~~~~~---~~~-- 255 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ----LS---VMGAHINQAIP---RPS-- 255 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH----HH---HHHHHHHSCCC---CGG--
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch----HH---HHHHHhccCCC---Ccc--
Confidence 4333445578999999999999999999999999999999999999997532 11 11111111000 000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhhcc
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-RMGQVVRVFDSLATS 648 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l~~~ 648 (696)
.+...+ ...+.+++.+||+.||++|| ++++|++.|+++...
T Consensus 256 --~~~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 256 --TVRPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp --GTSTTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred --ccCCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 011111 12688999999999999999 999999999987643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.72 Aligned_cols=265 Identities=17% Similarity=0.264 Sum_probs=200.2
Q ss_pred cCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCCc-----------cHHHHHHHHHHHHHccCCCceeEEeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGGQ-----------GEREFKAEVEIISRIHHRHLVSLVGY 431 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~il~~l~hpnIv~l~~~ 431 (696)
++|+++++||+|+||.||+|... .+..||||++...... ....+.+|+.+++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 67999999999999999999965 5789999998754321 12346678888999999999999999
Q ss_pred Eee----CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC--
Q 005443 432 CIS----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-- 505 (696)
Q Consensus 432 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-- 505 (696)
+.. .+..+|||||+ +++|.+++...+ .+++..+++|+.||+.||+|||++ +|+|||||++||||+.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 988 67789999999 999999997655 489999999999999999999999 999999999999998777
Q ss_pred cEEEEeeccchhccccCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchh
Q 005443 506 EAQVSDFGLAKLALDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579 (696)
Q Consensus 506 ~vkL~DfGls~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~ 579 (696)
.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~ 268 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK--DPV 268 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT--CHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--ccH
Confidence 9999999999766433211 11335789999999999999999999999999999999999999964321 111
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
........+...+... +..... ... ....+.+++.+||+.||++||++.+|++.|+++..
T Consensus 269 ~~~~~~~~~~~~~~~~-~~~~~~---~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNLLDELPQS-VLKWAP---SGS----SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHTTTHH-HHHHSC---TTS----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhhcccccHH-HHhhcc---ccc----cHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111111100 001000 001 12268899999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=367.83 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=203.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||+|... +|+.||||+++.. .....+.+.+|+++|++++|+||++++++|.+.+..+|||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999854 6889999999643 2334567899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++..... +++..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999986544 89999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeeccccccccCchhhhcc---CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 523 THITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.....+||..|+|||++.+ ..|+.++|||||||+||||++|+.||..........+..... . ..
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~-----~~--- 236 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---T-----TV--- 236 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---H-----CC---
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---h-----cc---
Confidence 2344679999999999874 458899999999999999999999998654333222222111 0 00
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-MGQVVR 640 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~ 640 (696)
..+ .......+.+|+++||+.||++|++ +++|++
T Consensus 237 ---~~~----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ---VTY----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCC----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---cCC----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 001 1111236889999999999999998 677664
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=379.88 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=206.5
Q ss_pred CHHHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEe
Q 005443 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCI 433 (696)
Q Consensus 358 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 433 (696)
.++++....++|+++++||+|+||.||+|+.+ +|+.||||+++... ....+.+++|+.+|.+++|+||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34444555689999999999999999999964 79999999997421 122345889999999999999999999999
Q ss_pred eCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 434 SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 434 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
+.+..+|||||+.+|+|.+++.+.+. .+++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999976432 489999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCcceeeccccccccCchhhhc-------cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYAS-------SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
+++.............+||..|+|||++. ...|+.++|||||||+||||++|+.||...+. . +....
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~---~~~~~ 281 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---A---ETYGK 281 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---H---HHHHH
Confidence 99876544433334467999999999987 35689999999999999999999999976431 1 11111
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCC---CCHHHHHHH
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKR---PRMGQVVRV 641 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ell~~ 641 (696)
++.. .. .+..+.+...+ ..++.+|+++||+ ++++| ++++||+++
T Consensus 282 i~~~----~~--~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHY----KE--HLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTH----HH--HCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhc----cc--CcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1110 00 00001111112 2368899999999 99998 588888754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.74 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=189.5
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..++|++.++||+|+||.||+|++. +++.||||+++.. ...+.+.+|+++|++++|+||++++++|.+.+..+||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999965 5889999999754 234678899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC---CCcEEEEeeccchhccc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAKLALD 520 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DfGls~~~~~ 520 (696)
|+.+++|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999998876543 89999999999999999999999 9999999999999975 88999999999986543
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ...+. ..+.. ... .+
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~---~~i~~-----~~~-~~ 270 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMF---RRILN-----CEY-YF 270 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHH---HHHHT-----TCC-CC
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHH---HHHHh-----CCC-cc
Confidence 22 22345689999999999999999999999999999999999999975431 11111 11111 000 00
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
... ........+.+|+++||+.||++||++.|+++.
T Consensus 271 ~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 111122368899999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=367.29 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=194.2
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|+++++||+|+||.||+++.. +|+.||||++.... ...+.+.+|+.++++++|+||+++++++.+.+..+|||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 367999999999999999999965 78999999997543 3346788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc--EEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE--AQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DfGls~~~~~~~ 522 (696)
+.+|+|.+++...+. +++..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 98 ASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 999999998876543 89999999999999999999999 9999999999999987765 9999999997433222
Q ss_pred cceeeccccccccCchhhhccCCCCcc-ccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEK-SDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~-sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.....+|+..|+|||++.+..+..+ +|||||||+||||++|+.||........ +.+....++... + .+.
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~-----~-~~~ 242 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVK-----Y-SIP 242 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTC-----C-CCC
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCC-----C-CCC
Confidence 2233569999999999988887665 8999999999999999999986443221 111111111100 0 000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+ ... ....+.+|+++||+.||++|+++.||+++
T Consensus 243 ~---~~~----~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 D---DIR----ISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp T---TSC----CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C---cCC----CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 001 12368899999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=361.58 Aligned_cols=257 Identities=29% Similarity=0.451 Sum_probs=201.0
Q ss_pred cCccccccccccCcEEEEEEEcCC-----CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD-----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|++.++||+|+||.||+|.+.. +..||||+++.... ....++.+|++++++++|+||+++++++...+..+|
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 578889999999999999998542 24699999975433 234568999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+++|.+++.... ..+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999987543 2489999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 521 ANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 521 ~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+.+ .....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~~~~-------~~~~~- 268 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAI-------NDGFR- 268 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH-------HTTCC-
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC---HHHHHHHH-------HCCCc-
Confidence 3221 1222346778999999999999999999999999999999 999997532 11111110 01000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. .. .......+.+++++||+.||++||++.+|++.|+++..
T Consensus 269 --~---~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 --L---PT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp --C---CC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --C---CC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 00 11122368899999999999999999999999998874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=369.69 Aligned_cols=250 Identities=20% Similarity=0.343 Sum_probs=196.9
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHcc--CCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIH--HRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||+|...+++.||||+++.... ...+.+.+|+++|++|+ |+||+++++++..++..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 46999999999999999999988899999999975432 33467899999999997 599999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
| +.+++|.+++.... .+++..++.|+.||+.||+|||++ +|||||||++||||+ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56889999987654 488999999999999999999999 999999999999996 5789999999998764433
Q ss_pred cc-eeeccccccccCchhhhcc-----------CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 523 TH-ITTRVMGTFGYMAPEYASS-----------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 523 ~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
.. .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ....+..++
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~-- 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII-- 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH--
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh--
Confidence 22 2334579999999999875 3688999999999999999999999975321 111111111
Q ss_pred hhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 ALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+......+.......+.+|+++||+.||++||++.||++.
T Consensus 282 -----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 -----------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111112368899999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.92 Aligned_cols=254 Identities=30% Similarity=0.495 Sum_probs=198.2
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++.++||+|+||.||+|++ .++.||||+++.. ...+.|.+|+++|++++|+||+++++++. +..+|||||+.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5789999999999999999998 5889999998632 34567999999999999999999999886 45899999999
Q ss_pred CCchhhccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc-EEEEeeccchhccccCcc
Q 005443 447 NNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE-AQVSDFGLAKLALDANTH 524 (696)
Q Consensus 447 ~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~-vkL~DfGls~~~~~~~~~ 524 (696)
+++|.++++.... ..+++..+++++.||++||+|||+.+..+|+|||||++||||++++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976543 24788999999999999999999932128999999999999988876 799999999755332
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... . .+..... .... ...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~--~~~~~~~-----~~~~-----~~~ 224 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--A--FRIMWAV-----HNGT-----RPP 224 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--H--HHHHHHH-----HTTC-----CCC
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--H--HHHHHHH-----hcCC-----CCC
Confidence 22345899999999999999999999999999999999999999754321 1 1111000 0000 011
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+.... ...+.+++.+||+.||++||+++||++.|+++..
T Consensus 225 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 225 LIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CBTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ccccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111 2368899999999999999999999999998874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.10 Aligned_cols=245 Identities=25% Similarity=0.322 Sum_probs=203.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+.+..+|||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999964 68999999996432 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 99999999999976543 89999999999999999999999 9999999999999999999999999999865432
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||.... . .+....+... .+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~---~~~~~~i~~~-----~~----- 255 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---P---IQIYEKIVSG-----KV----- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHC-----CC-----
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---H---HHHHHHHHcC-----CC-----
Confidence 223578999999999999999999999999999999999999997542 1 1111111110 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 641 (696)
.+...+ ...+.+++++||+.||++|++ ++||+++
T Consensus 256 -~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -RFPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 011112 236889999999999999998 7777753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.84 Aligned_cols=245 Identities=23% Similarity=0.256 Sum_probs=191.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||+||+|++. +|+.||||++..... ....++.+|+..+.++ +|+||++++++|.+++..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 799999999864432 2234456666666665 8999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+ +++|.+++...+ ..+++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 668877776543 2489999999999999999999999 99999999999999999999999999987654332
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
......|+..|+|||++.+ .++.++|||||||+||||++|..+|... ....+ +.... ..
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~----~~~~~---------~~ 270 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQ----LRQGY---------LP 270 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHH----HTTTC---------CC
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHH----HhccC---------CC
Confidence 2233568999999999875 7999999999999999999997766531 11110 00000 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+ .......+.+++++||+.||++||+++||++.
T Consensus 271 ~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 001 11112368899999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.18 Aligned_cols=265 Identities=15% Similarity=0.221 Sum_probs=208.0
Q ss_pred cCccccccccccCcEEEEEEEcCC---------CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCcee----------
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD---------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS---------- 427 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~---------- 427 (696)
++|++.++||+|+||.||+|+... ++.||||+++.. +.+.+|++++++++|+||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 679999999999999999999653 789999998743 46889999999999999887
Q ss_pred -----EEeEEee-CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 428 -----LVGYCIS-DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 428 -----l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
+++++.. ++..+|||||+ +++|.+++.......+++..+++|+.||+.||+|||++ +|+|||||++||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6777776 66789999999 99999999876445699999999999999999999999 99999999999999
Q ss_pred CCCC--cEEEEeeccchhccccCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 502 DNNF--EAQVSDFGLAKLALDANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 502 ~~~~--~vkL~DfGls~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
+.++ .+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999766443221 1133478999999999999999999999999999999999999998643
Q ss_pred CCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccc
Q 005443 574 PLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDL 650 (696)
Q Consensus 574 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~ 650 (696)
.. ...+.+....+.. ....+.+..... ......+.+|+++||+.||++||++.+|++.|+++....-
T Consensus 273 ~~-~~~~~~~~~~~~~------~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PN-TEDIMKQKQKFVD------KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TC-HHHHHHHHHHHHH------SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cC-HHHHHHHHHhccC------Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 21 1222222111111 111111111100 0112368899999999999999999999999999886543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=366.89 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=202.3
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|+++++||+|+||.||+|+.+ +|+.||||+++.. .....+.+.+|..+|..+ +|+||+++++++.+.+..+|
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 478999999999999999999965 4789999999753 223456788999999988 79999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.||+|.+++...+. +++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999876543 89999999999999999999999 999999999999999999999999999975432
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
... .....+|+..|+|||++.+..++.++|||||||+||||++|+.||...+ ...+ ...++.. .+
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~---~~~i~~~-----~~--- 238 (353)
T 2i0e_A 174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDEL---FQSIMEH-----NV--- 238 (353)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---HHHHHHC-----CC---
T ss_pred CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHH---HHHHHhC-----CC---
Confidence 222 2334679999999999999999999999999999999999999997532 1111 1111110 00
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM-----GQVVR 640 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~ 640 (696)
.+ .......+.+|+++||+.||++|+++ ++|++
T Consensus 239 ---~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ---AY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---CC----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---CC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01 11122368899999999999999964 55654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=355.42 Aligned_cols=255 Identities=28% Similarity=0.443 Sum_probs=201.8
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeC-CceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISD-DRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~ 444 (696)
.++|++.+.||+|+||.||+|++ +|+.||||+++.. ...+.+.+|++++++++|+||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46799999999999999999988 6899999998743 3457799999999999999999999997654 478999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++.......+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999999998765444478899999999999999999999 99999999999999999999999999997554322
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+. + ... ...
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~----~----~~~-----~~~ 233 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----V----EKG-----YKM 233 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHH----H----TTT-----CCC
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----H----hcC-----CCC
Confidence 22356889999999999999999999999999999998 9999975431 111111 0 000 000
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccc
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDL 650 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~ 650 (696)
. ........+.+++++||+.||++||++.||++.|+++...++
T Consensus 234 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~ 276 (278)
T 1byg_A 234 D----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276 (278)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred C----CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence 1 111122368899999999999999999999999999876543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=365.58 Aligned_cols=265 Identities=23% Similarity=0.400 Sum_probs=211.6
Q ss_pred HHHHHhcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEe
Q 005443 361 ELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCI 433 (696)
Q Consensus 361 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 433 (696)
++....++|++.++||+|+||.||+|.+. .++.||||+++.... ....++.+|+++|++++|+||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445678999999999999999999853 368899999975433 23456899999999999999999999999
Q ss_pred eCCceeEEEEecCCCchhhccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC
Q 005443 434 SDDRRLLIYDYVPNNTLYFHLHGEG--------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF 505 (696)
Q Consensus 434 ~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~ 505 (696)
+.+..++||||+.+|+|.++++... ...+++..+++++.||+.||+|||++ +|+|||||++||||++++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 9999999999999999999886421 13468999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHh
Q 005443 506 EAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEW 583 (696)
Q Consensus 506 ~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~ 583 (696)
.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~ 252 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLRF 252 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HHHHHHH
Confidence 9999999999865443321 1223456889999999999999999999999999999999 899987532 1111111
Q ss_pred HHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 584 ARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
+. ...+.. ........+.+++.+||+.||++||++.||++.|+++...
T Consensus 253 ---~~-----~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 ---VM-----EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ---HH-----TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ---HH-----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11 111100 0111223688999999999999999999999999987653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=390.77 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=203.2
Q ss_pred cCccccc-cccccCcEEEEEEEcC---CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQN-LLGEGGFGSVYKGYLP---DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|.+.+ .||+|+||.||+|.+. ++..||||+++.... ...++|.+|+++|++++|+||++++++|.. +..+||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444455 7999999999999753 466899999976533 356789999999999999999999999976 668999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.+++.... ..+++..+++|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999987543 3489999999999999999999999 9999999999999999999999999999876433
Q ss_pred Ccce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 522 NTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 522 ~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... .....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.+.+ ....
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i--------~~~~-- 556 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFI--------EQGK-- 556 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHH--------HTTC--
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHH--------HcCC--
Confidence 3221 122345688999999999999999999999999999998 9999976432 2222111 1110
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
...........+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus 557 -------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 557 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 00111122347889999999999999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=353.45 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=208.1
Q ss_pred hcCccccc-cccccCcEEEEEEEcC---CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQN-LLGEGGFGSVYKGYLP---DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|.+.+ .||+|+||.||+|.+. +++.||||+++.... ...+++.+|+++|++++|+||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35676766 9999999999999853 578899999976533 3456799999999999999999999999 5567899
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+++|.+++.... ..+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999886543 3489999999999999999999999 999999999999999999999999999986643
Q ss_pred cCcce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 521 ANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 521 ~~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.+ .....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i--------~~~~~ 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFI--------EQGKR 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHH--------HTTCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH--------hcCCc
Confidence 33221 223356789999999998889999999999999999998 9999976431 2221111 11100
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
.. +.......+.+++.+||+.||++||++.+|++.|+++....
T Consensus 232 -----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 232 -----ME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -----CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 11122237889999999999999999999999999988644
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=369.47 Aligned_cols=277 Identities=20% Similarity=0.264 Sum_probs=215.5
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCC--ceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lV 441 (696)
.++|++.++||+|+||.||+|.+. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++...+ ..+||
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 367999999999999999999865 58999999997543 234577889999999999999999999998765 67999
Q ss_pred EEecCCCchhhccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE----CCCCcEEEEeeccch
Q 005443 442 YDYVPNNTLYFHLHGEGR-PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQVSDFGLAK 516 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL~DfGls~ 516 (696)
|||+.+|+|.+++..... ..+++..++.|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999876433 2389999999999999999999999 99999999999999 778889999999998
Q ss_pred hccccCcceeeccccccccCchhhhcc--------CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASS--------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
....... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... ...+....++
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKII 240 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT--TCHHHHHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc--chHHHHHHHh
Confidence 6544322 233568999999999865 567789999999999999999999997543221 1122222222
Q ss_pred HHhhhh--hhhhccc--------CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 589 SHALEN--EEFDNLA--------DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 589 ~~~~~~--~~~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
...... ..+.... +..............+.+++++||+.||++|++++|+++.|+++....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 211100 0000000 001112334566678899999999999999999999999999888654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=356.16 Aligned_cols=271 Identities=26% Similarity=0.400 Sum_probs=204.4
Q ss_pred HHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHc--cCCCceeEEeEEeeC---
Q 005443 361 ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI--HHRHLVSLVGYCISD--- 435 (696)
Q Consensus 361 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~~~~~--- 435 (696)
......++|+++++||+|+||.||+|++ .|+.||||++... ....+.+|.+++..+ +|+||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3344557899999999999999999998 5999999998643 344556666666655 899999999999887
Q ss_pred -CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeeccCCCCceEECCCCcEEE
Q 005443 436 -DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC-----HPRIIHRDIKSSNILLDNNFEAQV 509 (696)
Q Consensus 436 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-----~~~ivHrDLkp~NILl~~~~~vkL 509 (696)
+..+|||||+.+|+|.++++.. .+++..+++++.||+.||+|||+++ ..+|+|||||++||||+.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 6789999999999999999654 3899999999999999999999751 237999999999999999999999
Q ss_pred EeeccchhccccCcce---eeccccccccCchhhhccCCCCcc------ccccchHHHHHHHHhC----------CCCCC
Q 005443 510 SDFGLAKLALDANTHI---TTRVMGTFGYMAPEYASSGKLTEK------SDVFSFGVVLLELITG----------RKPVD 570 (696)
Q Consensus 510 ~DfGls~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~s~~------sDVwSlGvll~eLltg----------~~Pf~ 570 (696)
+|||+++......... .....|+..|+|||++.+..+..+ +|||||||+||||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997654333221 123578999999999988766665 9999999999999999 55554
Q ss_pred CCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCc-chHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 571 ASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENY-VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 571 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
....... .. +..... .... .....+...+ .......+.+|+++||+.||++||++.||+++|+++...
T Consensus 264 ~~~~~~~-~~-~~~~~~----~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 264 DLVPSDP-SY-EDMREI----VCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTSCSSC-CH-HHHHHH----HTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhcCCCC-ch-hhhHHH----Hhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 4322111 11 111110 0011 1111111111 124556799999999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.81 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=196.7
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCcc---HHHHHHHHHHHHHccCCCceeEEeEEeeCCce---
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQG---EREFKAEVEIISRIHHRHLVSLVGYCISDDRR--- 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~--- 438 (696)
.++|+++++||+|+||.||+|++ .+|+.||||+++...... ...+.+|++++++++|+||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999995 578999999997653332 35688999999999999999999998876544
Q ss_pred -eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 439 -LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 439 -~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
+|||||+.+++|.++++..+. +++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 999999999999999976543 89999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 518 ALDANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 518 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
....... .....+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.....+... .
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~---~ 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRED---P 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCC---C
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCC---C
Confidence 6443222 22335689999999999999999999999999999999999999975431 11111111100 0
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH-HHHhhh
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR-VFDSLA 646 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~-~L~~l~ 646 (696)
.... ..... ....+.+|+.+||+.||++|+++.++++ .|.++.
T Consensus 237 ~~~~----~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 237 IPPS----ARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCHH----HHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCcc----cccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0000 00011 1236889999999999999997776654 454443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=365.70 Aligned_cols=252 Identities=16% Similarity=0.162 Sum_probs=204.6
Q ss_pred hcCccccccccccCcEEEEEEE------cCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc---CCCceeEEeEEeeCC
Q 005443 366 TDGFADQNLLGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDD 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~ 436 (696)
.++|.+.++||+|+||.||+|. ..+++.||||+++.. ...++.+|++++++++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4679999999999999999994 446899999998743 4567888999998887 999999999999999
Q ss_pred ceeEEEEecCCCchhhccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC----------
Q 005443 437 RRLLIYDYVPNNTLYFHLHGE---GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---------- 503 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---------- 503 (696)
..+|||||+.+|+|.++++.. ....+++..++.|+.||+.||+|||++ +|||||||++||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 999999999999999998642 234599999999999999999999998 9999999999999988
Q ss_pred -CCcEEEEeeccchhcccc-CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHH
Q 005443 504 -NFEAQVSDFGLAKLALDA-NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581 (696)
Q Consensus 504 -~~~vkL~DfGls~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~ 581 (696)
++.+||+|||+++..... ........+||..|+|||++.+..|+.++|||||||+||||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 899999999999754322 2233445679999999999999999999999999999999999999996432100
Q ss_pred HhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCC-CCHHHHHHHHHhhhcc
Q 005443 582 EWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKR-PRMGQVVRVFDSLATS 648 (696)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~ell~~L~~l~~~ 648 (696)
. ..+..+..... ...+.+++..|++.++.+| ++++++.+.|+++...
T Consensus 293 -------------~----~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 -------------C----KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -------------E----EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------------e----eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 01111111111 2256788889999999998 5788888888887754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.20 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=209.5
Q ss_pred HhcCccccccccccCcEEEEEEEcCC------CcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCC
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDD 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 436 (696)
..++|++.++||+|+||.||+|.... ++.||||+++.... ...+.+.+|+++|+++ +|+||++++++|...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34789999999999999999998532 24899999975433 2346789999999999 8999999999999999
Q ss_pred ceeEEEEecCCCchhhccccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEG------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN 504 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~ 504 (696)
..+|||||+.+|+|.+++.... ...+++..+++++.||+.||+|||++ +|+|||||++||||+++
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 9999999999999998886431 23478999999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHH
Q 005443 505 FEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVE 582 (696)
Q Consensus 505 ~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~ 582 (696)
+.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||...... ..+.+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SKFYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HHHHH
Confidence 99999999999865443322 2233457789999999999999999999999999999998 99999754321 11111
Q ss_pred hHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 583 WARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.+.... . .. . .......+.+++.+||+.||.+||++.||++.|+++...
T Consensus 279 ----~~~~~~-----~-~~---~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 ----LVKDGY-----Q-MA---Q----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ----HHHHTC-----C-CC---C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHhcCC-----C-CC---C----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 111110 0 00 0 011123688999999999999999999999999988753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=356.73 Aligned_cols=270 Identities=25% Similarity=0.365 Sum_probs=211.9
Q ss_pred HHHHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHH--ccCCCceeEEeEEeeCC
Q 005443 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISR--IHHRHLVSLVGYCISDD 436 (696)
Q Consensus 359 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~ 436 (696)
+..-....++|++.++||+|+||.||+|++ +|+.||||+++. .....+.+|++++.. ++|+||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 334445567899999999999999999998 699999999863 345678899999988 78999999999998876
Q ss_pred ----ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeeccCCCCceEECCC
Q 005443 437 ----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH--------EDCHPRIIHRDIKSSNILLDNN 504 (696)
Q Consensus 437 ----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH--------~~~~~~ivHrDLkp~NILl~~~ 504 (696)
..++||||+.+|+|.+++... .+++..+++++.||+.||+||| ++ +|+|||||++||||+.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 789999999999999999754 3899999999999999999999 77 99999999999999999
Q ss_pred CcEEEEeeccchhccccCcc---eeeccccccccCchhhhccCC------CCccccccchHHHHHHHHhC----------
Q 005443 505 FEAQVSDFGLAKLALDANTH---ITTRVMGTFGYMAPEYASSGK------LTEKSDVFSFGVVLLELITG---------- 565 (696)
Q Consensus 505 ~~vkL~DfGls~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~------~s~~sDVwSlGvll~eLltg---------- 565 (696)
+++||+|||+++........ ......|+..|+|||++.+.. ++.++|||||||+||||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999999766544322 123457899999999998652 33689999999999999999
Q ss_pred CCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCC-cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 566 RKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN-YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 566 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
+.||....... ....++...+. . ......+... ........+.+|+.+||+.||++||++.||+++|++
T Consensus 264 ~~p~~~~~~~~-~~~~~~~~~~~-----~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 264 QLPYYDLVPSD-PSVEEMRKVVC-----E----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCTTTTTSCSS-CCHHHHHHHHT-----T----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccCccccCcCc-ccHHHHHHHHH-----H----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 77776543211 11111111111 0 1111111111 123455679999999999999999999999999999
Q ss_pred hhcc
Q 005443 645 LATS 648 (696)
Q Consensus 645 l~~~ 648 (696)
+..+
T Consensus 334 i~~~ 337 (342)
T 1b6c_B 334 LSQQ 337 (342)
T ss_dssp HHHT
T ss_pred HHHH
Confidence 8764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=355.78 Aligned_cols=261 Identities=21% Similarity=0.378 Sum_probs=198.3
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.... ...+++.+|++++++++|+||++++++|..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999985 5799999999975332 3345789999999999999999999999999999999
Q ss_pred EEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 442 YDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
|||+.+++|.+++.. .....+++..+++++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999988864 2234589999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+....+ ....+..
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-----~~~~~~~ 257 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-----EQCDYPP 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHH-----HTTCSCC
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHh-----hcccCCC
Confidence 4322 22335689999999999999999999999999999999999999975321 111111111 1111111
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+. ...+ ...+.+++.+||+.||++||++.+|++.|+++..
T Consensus 258 ~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 258 LP----SDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp CC----TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Cc----cccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11 0111 2368899999999999999999999999998874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=363.79 Aligned_cols=274 Identities=25% Similarity=0.359 Sum_probs=208.5
Q ss_pred hcCccccccccccCcEEEEEEEc-----CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC--ce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-----PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD--RR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~ 438 (696)
.++|+++++||+|+||.||+|++ .+|+.||||+++.......+.+.+|+++|++++|+||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36799999999999999999983 368899999998766566678999999999999999999999987654 67
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+.+++|.+++..... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999999876532 489999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 519 LDANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
....... .....++..|+|||++.+..++.++|||||||+||||++|+.+|.... ..+.+..............
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP----AEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH----HHHHHHHCTTCCTHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH----HHHHHhhccccchhhhHHH
Confidence 4433221 222356778999999998889999999999999999999998876321 0011000000000000000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+.+.+...............+.+++++||+.||++||++.||++.|+++..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000000000001111223468899999999999999999999999998864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=353.48 Aligned_cols=249 Identities=23% Similarity=0.413 Sum_probs=205.0
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee---------
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--------- 434 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--------- 434 (696)
..++|+++++||+|+||.||+|.+. +|+.||||+++... +.+.+|++++++++|+||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467999999999999999999965 79999999997542 457899999999999999999998864
Q ss_pred -------CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 435 -------DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 435 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
.+..++||||+.+++|.+++.......+++..+++|+.||+.||.|||++ +|+|||||++||||++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 34578999999999999999765445689999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~ 587 (696)
||+|||+++....... .....|+..|+|||++.+..++.++|||||||+||||++|..+|... .+....
T Consensus 162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~- 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTD- 230 (284)
T ss_dssp EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHH-
T ss_pred EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHH-
Confidence 9999999976544322 23346899999999999999999999999999999999998876420 111110
Q ss_pred HHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+.. ..+...+. ..+.+++.+||+.||++||++.||++.|+.+..
T Consensus 231 ----~~~--------~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 231 ----LRD--------GIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp ----HHT--------TCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ----hhc--------ccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 011 11111122 257899999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=357.51 Aligned_cols=268 Identities=21% Similarity=0.332 Sum_probs=189.5
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++++.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+++|++++|+||+++++++..++..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357899999999999999999864 689999999975533 334678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 444 YVPNNTLYFHLHGE----GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 444 ~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
|+. ++|.+++... ....+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5887777532 123488999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh----hhh
Q 005443 520 DANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA----LEN 594 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~----~~~ 594 (696)
.... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... +..........+... +..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN---DEEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhHhhh
Confidence 3222 2234568999999999976 468999999999999999999999997643 222222221111100 000
Q ss_pred -hhhhcc---cCcccCC--------CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 -EEFDNL---ADPRLGE--------NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 -~~~~~~---~d~~l~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+..+ +...... .........+.+|+.+||+.||++|++++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 0000000 0000112368899999999999999999998853
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.20 Aligned_cols=252 Identities=22% Similarity=0.392 Sum_probs=204.1
Q ss_pred hcCccccccccccCcEEEEEEEcCC-C-------cEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD-G-------REVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
.++|++.+.||+|+||.||+|.+.. + +.||||+++.......+.+.+|+++|++++|+||++++++|...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3679999999999999999998542 3 5799999976666667889999999999999999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc--------EEE
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE--------AQV 509 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~--------vkL 509 (696)
.+|||||+.+++|.+++..... .+++..+++|+.||+.||+|||++ +|+|||||++||||+.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999999976532 389999999999999999999999 9999999999999988877 999
Q ss_pred EeeccchhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 510 SDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 510 ~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
+|||+++..... ....|+..|+|||++.+ ..++.++|||||||+||||++|..++..... .....+. .
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~~~~----~ 231 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRKLQF----Y 231 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHH----H
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hHHHHHH----h
Confidence 999999754332 22457889999999987 7799999999999999999996655543221 1111110 0
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. ... . .. ... ...+.+++++||+.||++||++.||++.|+++..
T Consensus 232 ~---~~~---~-~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 E---DRH---Q-LP----APK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp H---TTC---C-CC----CCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred h---ccC---C-CC----CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 000 0 00 111 1257889999999999999999999999998874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=368.49 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=197.6
Q ss_pred ccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 369 FADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
|...++||+|+||.||+|.. .+|+.||||+++.......+++.+|+++|++++|+||++++++|.+.+..+|||||+.+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 34467899999999999985 47899999999876555667899999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE--CCCCcEEEEeeccchhccccCcce
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL--DNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl--~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++|||| ++++.+||+|||+++.......
T Consensus 171 ~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 171 GELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp CEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99988886543 2489999999999999999999999 99999999999999 6778999999999986644322
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....+|+..|+|||++.+..++.++|||||||+||||++|+.||.... +. +....++...+. +....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~---~~~~~i~~~~~~------~~~~~- 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DA---ETLNNILACRWD------LEDEE- 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HH---HHHHHHHHTCCC------SCSGG-
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HH---HHHHHHHhccCC------CChhh-
Confidence 233468999999999999999999999999999999999999997643 11 111111111110 00000
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. .....+.+|+.+||+.||++|+++.|+++.
T Consensus 312 ~~----~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQ----DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hc----cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01 112368899999999999999999999973
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=353.09 Aligned_cols=267 Identities=21% Similarity=0.314 Sum_probs=199.4
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.++|+++++||+|+||.||+|.+. +|+.||||++...... ..+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999964 5899999998654332 2456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 82 e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999999888765543 89999999999999999999999 99999999999999999999999999997654332
Q ss_pred cceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh-------hhh
Q 005443 523 THITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA-------LEN 594 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~-------~~~ 594 (696)
. ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..........+... +..
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD---VDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhccccccccccccc
Confidence 2 2234568999999999976 6789999999999999999999999976432 22222221111110 000
Q ss_pred hh-hhc--ccCcccCCC---cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 EE-FDN--LADPRLGEN---YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ~~-~~~--~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. +.. +.+...... ........+.+++++||+.||++||+++||+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 000 000000000 001122358899999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=364.86 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=201.7
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+.++|++.+.||+|+||.||+|..+ +|+.||||+++.... .+.+|+++|.++ +|+||++++++|.+.+..+|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999864 689999999975432 345788888888 7999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC----CcEEEEeeccchhc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAKLA 518 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~----~~vkL~DfGls~~~ 518 (696)
||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999998876543 89999999999999999999999 99999999999998443 35999999999865
Q ss_pred cccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
..... .....+|+..|+|||++.+..|+.++|||||||+||||++|+.||..........+.+. +.. ..+.
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~~-----~~~~ 241 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---IGS-----GKFS 241 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH---HHH-----CCCC
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH---Hcc-----CCcc
Confidence 44332 23345789999999999888899999999999999999999999986432222222211 111 1110
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
+ ...+.......+.+|+++||+.||++|+++.||+++-
T Consensus 242 -~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 242 -L-----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp -C-----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred -c-----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 0 0001111223688999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=346.67 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=204.6
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
..++|++++.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467999999999999999999864 789999999975433 33567999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999999987654 389999999999999999999999 99999999999999999999999999997654322
Q ss_pred c-ceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 523 T-HITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 523 ~-~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
. .......|+..|+|||++.+..+ +.++|||||||++|||++|+.||....... ..+..+. .....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~--------~~~~~--- 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK--------EKKTY--- 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHH--------TTCTT---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhh--------hcccc---
Confidence 1 22334568999999999987665 779999999999999999999998654221 1111111 00000
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.. ........+.+++.+||+.||++||+++||++
T Consensus 228 ~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 LN------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 00111236889999999999999999999885
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=352.99 Aligned_cols=266 Identities=22% Similarity=0.311 Sum_probs=202.1
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC-----ccHHHHHHHHHHHHHcc---CCCceeEEeEEeeCC
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-----QGEREFKAEVEIISRIH---HRHLVSLVGYCISDD 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~ 436 (696)
.++|+++++||+|+||.||+|++ .+|+.||||+++.... .....+.+|++++++++ |+||++++++|...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 57899999999999999999995 4789999999974332 22356778888888775 999999999998765
Q ss_pred -----ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEe
Q 005443 437 -----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (696)
Q Consensus 437 -----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (696)
..++||||+. ++|.+++.......+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 4789999996 5899988877666699999999999999999999999 999999999999999999999999
Q ss_pred eccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 512 fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
||+++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.+|.... ...........+...
T Consensus 164 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 164 FGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDLIGLP 238 (308)
T ss_dssp CSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS---HHHHHHHHHHHHCCC
T ss_pred CccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCC
Confidence 99998654332 2334578999999999999999999999999999999999999997643 222222111111100
Q ss_pred hhhhhhhccc---CcccCC-------CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 592 LENEEFDNLA---DPRLGE-------NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 592 ~~~~~~~~~~---d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....+.... ...+.. .........+.+|+++||+.||++|+++.|++++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 -PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp -CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000000 000000 0001122368899999999999999999999853
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=370.17 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=193.1
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHH-HHHccCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEI-ISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|+++++||+|+||.||+|+.+ +++.||||+++.... ...+.+.+|..+ ++.++|+||++++++|.+.+..+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999964 588999999975432 233456677776 567899999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.||+|.+++...+. +.+..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999876543 88999999999999999999999 999999999999999999999999999986433
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
... .....+||..|+|||++.+..++.++|||||||+||||++|+.||...+ ..+....++... +
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~-----~--- 256 (373)
T 2r5t_A 192 HNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKP-----L--- 256 (373)
T ss_dssp CCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHHHHSC-----C---
T ss_pred CCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcc-----c---
Confidence 322 2344679999999999999999999999999999999999999997532 111111111110 0
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVV 639 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell 639 (696)
.+...+ ...+.+|+++||+.|+++|+++.+.+
T Consensus 257 ---~~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 ---QLKPNI----TNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ---CCCSSS----CHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ---CCCCCC----CHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 111112 23688999999999999999986443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=352.60 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=204.5
Q ss_pred CccccccccccCcEEEEEEEcC-C---CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce-eEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-D---GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR-LLI 441 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~---g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-~lV 441 (696)
.|...++||+|+||.||+|.+. + +..||||+++.... ...+.+.+|++++++++|+||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666799999999999999843 2 33799999875433 3346789999999999999999999999876665 999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999987643 3489999999999999999999999 9999999999999999999999999999765433
Q ss_pred Cc---ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 522 NT---HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 522 ~~---~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.. .......++..|+|||.+.+..++.++|||||||++|||++|..+|..... ...+.+... ...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~--------~~~-- 245 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA--------QGR-- 245 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH--------TTC--
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh--------cCC--
Confidence 21 122334678899999999999999999999999999999997666543321 111111111 000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDL 650 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~ 650 (696)
....... ....+.+++++||+.||++||++.+|++.|+++.....
T Consensus 246 ---~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 ---RLPQPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ---CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ---CCCCCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 0000111 12368899999999999999999999999999886543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=363.55 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=202.1
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|.+++.||+|+||.||+|.+ .+|+.||||++... .......+.+|+++|+.++|+||+++++++...+..+||
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999995 57899999999643 223346789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+ +|+|.+++...+. +++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 7888888765543 89999999999999999999999 9999999999999999999999999999865443
Q ss_pred CcceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.. ....+|+..|+|||++.+..+ +.++|||||||+||||++|+.||........ +..+
T Consensus 162 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------------~~~i 220 (336)
T 3h4j_B 162 NF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------------FKKV 220 (336)
T ss_dssp BT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------------BCCC
T ss_pred cc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------------HHHH
Confidence 32 233579999999999988776 6899999999999999999999976432110 0000
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..... .........+.+|+++||+.||++||+++||++.
T Consensus 221 ~~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 221 NSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CSSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HcCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00000 0111122368899999999999999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=360.70 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=199.4
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcE----EEEEEeecC-CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGRE----VAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
.++|+++++||+|+||.||+|.+. +++. |++|.++.. .....+++.+|+.+|++++|+||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 367999999999999999999853 4543 577777533 334567899999999999999999999999865 478
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+|+||+.+|+|.+++..... .+++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999998876433 489999999999999999999999 99999999999999999999999999998764
Q ss_pred ccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 520 DANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 520 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
..... ......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.+... ....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~--------~~~~ 237 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILE--------KGER 237 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHH--------TTCC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH--------cCCC
Confidence 33222 2223456788999999999999999999999999999999 9999976432 12111110 0000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..........+.+++++||+.||++||++.||++.|+++..
T Consensus 238 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 ---------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 00111122368899999999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=348.13 Aligned_cols=251 Identities=19% Similarity=0.254 Sum_probs=204.0
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..++|++.++||+|+||.||+|... +++.||+|++........+.+.+|++++++++|+||++++++|.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467999999999999999999864 578999999987666677889999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE---CCCCcEEEEeeccchhccc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DfGls~~~~~ 520 (696)
|+.+++|.+++..... +++..+++|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999888876543 89999999999999999999999 99999999999999 7889999999999976543
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.. ......|+..|+|||++.+. ++.++|||||||++|||++|+.||.... ...... .+...... +
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~---~~~~~~~~------~ 226 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVML---KIREGTFT------F 226 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHCCCC------C
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHH---HHHhCCCC------C
Confidence 32 22335689999999998754 8999999999999999999999997533 111111 11110000 0
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.... .. .....+.+++++||+.||++||++.++++
T Consensus 227 ~~~~-~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKD-WL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHH-HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cchh-hh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 11236889999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=353.24 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=199.2
Q ss_pred hcCcccc-ccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEE
Q 005443 366 TDGFADQ-NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 366 ~~~~~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.++|++. ++||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|.++ +|+||+++++++.+++..+|||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3568774 7899999999999985 47899999999876666678899999999995 7999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc---EEEEeeccchhcc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGLAKLAL 519 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DfGls~~~~ 519 (696)
||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++. +||+|||+++...
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999987654 389999999999999999999999 9999999999999988766 9999999987653
Q ss_pred ccCc------ceeeccccccccCchhhhcc-----CCCCccccccchHHHHHHHHhCCCCCCCCCCCCch----h-HHHh
Q 005443 520 DANT------HITTRVMGTFGYMAPEYASS-----GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE----S-LVEW 583 (696)
Q Consensus 520 ~~~~------~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~----~-l~~~ 583 (696)
.... ......+|+..|+|||++.+ ..++.++|||||||+||||++|+.||......... . ....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11223468999999999875 45788999999999999999999999865432210 0 0000
Q ss_pred HHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 584 ARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...++.. +....+ .+....+ ......+.+|+++||+.||++||++.||+++
T Consensus 246 ~~~~~~~-i~~~~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFES-IQEGKY-EFPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHH-HHHCCC-CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHH-HhccCc-ccCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0001111 111000 0000000 0112368899999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=375.08 Aligned_cols=193 Identities=26% Similarity=0.391 Sum_probs=153.1
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeC-----Cce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 438 (696)
++|+++++||+|+||.||+|.+. +|+.||||++.... ....+++.+|+++|++++|+||++++++|... +..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999854 78999999986432 23346789999999999999999999999543 468
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
||||||+ +++|.+++.... .+++..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 578888887654 389999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCc--------------------------ceeeccccccccCchhhh-ccCCCCccccccchHHHHHHHHhC
Q 005443 519 LDANT--------------------------HITTRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITG 565 (696)
Q Consensus 519 ~~~~~--------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwSlGvll~eLltg 565 (696)
..... ......+||..|+|||++ .+..|+.++||||||||||||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 42211 122345789999999986 456799999999999999999993
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=378.90 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=194.7
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|+++++||+|+||.||+|.. .+|+.||||+++.. .......+.+|+++|++++|+||++++++|...+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999985 47899999999743 233345678999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|||+.+|+|.+++.... .+++..++.++.||+.||+|||+ + +|||||||++||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999998887654 38999999999999999999998 7 999999999999999999999999999976433
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
... .....+||..|+|||++.+..++.++|||||||+||||++|+.||.... ...+.+ .+.. ..+
T Consensus 302 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~---~i~~-----~~~--- 366 (446)
T 4ejn_A 302 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFE---LILM-----EEI--- 366 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHH-----CCC---
T ss_pred CCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHH---HHHh-----CCC---
Confidence 322 2334679999999999999999999999999999999999999997532 111111 1111 000
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.+... ....+.+|+.+||+.||++|+ +++||+++
T Consensus 367 ---~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 ---RFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 01111 123688999999999999999 99998864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=351.20 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=203.9
Q ss_pred hcCccccc-cccccCcEEEEEEEc---CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 366 TDGFADQN-LLGEGGFGSVYKGYL---PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 366 ~~~~~~~~-~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
.++|.+.+ +||+|+||.||+|.+ ..++.||||+++.... ...+++.+|++++++++|+||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999953 3478999999975432 2246799999999999999999999999 567789
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+||||+.+++|.+++..... +++..+++++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999976543 89999999999999999999999 99999999999999999999999999998664
Q ss_pred ccCcce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 520 DANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 520 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
...... .....++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+.. ....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~--------~~~~ 237 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAML--------EKGE 237 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHH--------HTTC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH--------HcCC
Confidence 433222 122345688999999998889999999999999999999 999997643 11111111 1110
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. ..+ .......+.+++++||+.||++||++.+|++.|+++..
T Consensus 238 ~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 238 R-----MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp C-----CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 001 11122368899999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=366.96 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=195.9
Q ss_pred cCccccccccccCcEEEEEEEcC--CC--cEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEee-CCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP--DG--REVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l 440 (696)
..|++.++||+|+||.||+|++. ++ ..||||+++... ....++|.+|+.+|++++|+||++++++|.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34777899999999999999853 22 468999986433 2345679999999999999999999998764 457799
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+|+|.++++.... .+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 169 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999975433 478999999999999999999999 999999999999999999999999999986543
Q ss_pred cCcc---eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 521 ANTH---ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 521 ~~~~---~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
.... ......++..|+|||++.+..++.++|||||||+||||++ |..+|....... +.... . ...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~---~----~~~- 313 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---L----QGR- 313 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---H----TTC-
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---H----cCC-
Confidence 3221 1223456788999999999999999999999999999999 667776543221 11110 0 000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccc
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDL 650 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~ 650 (696)
.... .......+.+++.+||+.||++||++.||++.|+++.....
T Consensus 314 --~~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 --RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --CCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0111 01112368899999999999999999999999999886443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=358.35 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=204.1
Q ss_pred hcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|++++.||+|+||.||+|++ .+++.||||++.... .....++.+|+.++++++|+||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999984 247789999996443 23456789999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC---CCcEEEE
Q 005443 439 LLIYDYVPNNTLYFHLHGEGR-----PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVS 510 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~ 510 (696)
+|||||+.+++|.+++..... ..+++..+++++.||+.||+|||++ +|+|||||++||||+. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999876432 3488999999999999999999999 9999999999999984 4569999
Q ss_pred eeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHH
Q 005443 511 DFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 511 DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~~--- 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVT--- 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHH---
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHHHHHh---
Confidence 9999986543322 22233567889999999999999999999999999999998 999997532 111111110
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
..... .. .......+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 260 -----~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 -----SGGRM-----DP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -----TTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cCCCC-----CC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 00000 01 11122368899999999999999999999999998774
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=389.44 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=198.7
Q ss_pred ccccccCcEEEEEEEc---CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYL---PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|.+ +.++.||||+++.... ...+++.+|+++|++++|+|||+++++|. .+..+|||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 5799999999999964 2467899999975432 34578999999999999999999999986 4568999999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc--ce
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT--HI 525 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~--~~ 525 (696)
|+|.++++.... +++..++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999976543 89999999999999999999999 999999999999999999999999999987654332 12
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+.+ .....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~---~~~~~~~i--------~~~~~------- 590 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAML--------EKGER------- 590 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHH--------HTTCC-------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH--------HcCCC-------
Confidence 233456788999999999999999999999999999998 999997643 11111111 11100
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
..........+.+|+++||+.||++||++.+|++.|+++...
T Consensus 591 --~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 591 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 011112234788999999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.89 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=205.0
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc------cHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|++.+.||+|+||.||+|... +|+.||||+++..... ..+++.+|+++|++++|+||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999864 6899999999754322 357899999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC----cEEEEeecc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGL 514 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DfGl 514 (696)
++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||++++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999997644 389999999999999999999999 999999999999999887 799999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...... .+.....
T Consensus 166 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~---~i~~~~~-- 235 (321)
T 2a2a_A 166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLA---NITSVSY-- 235 (321)
T ss_dssp CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHH---HHHTTCC--
T ss_pred ceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHH---HHHhccc--
Confidence 976544322 234568999999999999999999999999999999999999997532 111111 1110000
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+..+... ....+.+++++||+.||++||++.|++++
T Consensus 236 -----~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 -----DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -----CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -----ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000011 12368899999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.86 Aligned_cols=263 Identities=25% Similarity=0.400 Sum_probs=198.0
Q ss_pred HHHHhcCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 435 (696)
+....++|.+.++||+|+||.||+|.+. .++.||||+++.... ...+.+.+|+.++++++|+||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3344578999999999999999999753 345899999975532 2346789999999999999999999999875
Q ss_pred Cc-----eeEEEEecCCCchhhcccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc
Q 005443 436 DR-----RLLIYDYVPNNTLYFHLHG----EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE 506 (696)
Q Consensus 436 ~~-----~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~ 506 (696)
+. .++||||+.+++|.+++.. .....+++..+++|+.||++||.|||++ +|+|||||++||||++++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 53 4999999999999888742 2334589999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhH
Q 005443 507 AQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWA 584 (696)
Q Consensus 507 vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~ 584 (696)
+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.+|..... ..+.+..
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~ 262 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDYL 262 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHH
Confidence 999999999865443221 2223456789999999999999999999999999999999 8888875431 1111111
Q ss_pred HHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 585 RPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. ... . .. ........+.+++.+||+.||++||++.+|++.|+++..
T Consensus 263 ---~----~~~-~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 263 ---L----HGH-R-----LK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---H----TTC-C-----CC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---H----cCC-C-----CC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 000 0 00 111122368899999999999999999999999998874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=364.78 Aligned_cols=267 Identities=22% Similarity=0.366 Sum_probs=191.9
Q ss_pred HHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC--CCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCC--c
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDD--R 437 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~--~ 437 (696)
...++|+++++||+|+||.||+|.+ .+|+.||||++... .....+++.+|+.+|+++. |+||++++++|...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 47899999998533 2234466889999999997 999999999997654 6
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+|||||+. ++|..++... .+++..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 799999997 5888888653 488999999999999999999999 999999999999999999999999999976
Q ss_pred cccc--------------------CcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCC
Q 005443 518 ALDA--------------------NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576 (696)
Q Consensus 518 ~~~~--------------------~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~ 576 (696)
.... ........+||..|+|||++.+ ..++.++|||||||+||||++|+.+|.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-- 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-- 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 5321 1112234579999999999986 6789999999999999999999999986432
Q ss_pred chhHHHhHHHHHHHhhhhhhhhcc------------------cCcccCCCcc------------hHHHHHHHHHHHHHhc
Q 005443 577 DESLVEWARPLLSHALENEEFDNL------------------ADPRLGENYV------------EGEMFRMIEAAAACVR 626 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~~------------------~d~~l~~~~~------------~~~~~~l~~li~~cl~ 626 (696)
...++.....+.. ...+.+..+ ....+...+. ......+++|+++||+
T Consensus 237 -~~~~~~i~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 237 -MNQLERIIGVIDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp -HHHHHHHHHHHCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred -HHHHHHHHHhcCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 1111111111100 000000000 0000000000 0112368899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 005443 627 HSAAKRPRMGQVVRV 641 (696)
Q Consensus 627 ~dP~~RPs~~ell~~ 641 (696)
.||++|++++|++++
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=357.96 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=179.6
Q ss_pred cccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEEecCCCc
Q 005443 372 QNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYDYVPNNT 449 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gs 449 (696)
.++||+|+||.||+|.+. +|+.||||++.. .....+.+|+.+|++++ |+||++++++|.+++..+|||||+.+|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999864 689999999974 34567889999999997 9999999999999999999999999999
Q ss_pred hhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC---cEEEEeeccchhccccCccee
Q 005443 450 LYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 450 L~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~vkL~DfGls~~~~~~~~~~~ 526 (696)
|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++ .+||+|||+++....... ..
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~ 166 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL 166 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence 999997654 389999999999999999999999 999999999999997665 899999999976543332 23
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCc-hhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD-ESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
...+|+..|+|||++.+..++.++|||||||++|||++|+.||........ ....+....+. ...+ .+
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~-----~~~~------~~ 235 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK-----KGDF------SF 235 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT-----TTCC------CC
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH-----cCCC------CC
Confidence 345689999999999999999999999999999999999999986443211 11111111111 0000 00
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...........+.+|+++||+.||++|+++.||+++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 000001122368899999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.94 Aligned_cols=261 Identities=24% Similarity=0.337 Sum_probs=203.5
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee----CCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~l 440 (696)
.++|++.++||+|+||.||+++. .+|+.||||++........+.+.+|++++++++|+||+++++++.. .+..++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999995 5799999999976655566789999999999999999999999873 346789
Q ss_pred EEEecCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 441 IYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
||||+.+++|.+++... ....+++..+++|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999998888652 234589999999999999999999999 9999999999999999999999999998654
Q ss_pred cccCcc--------eeeccccccccCchhhhccCC---CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH
Q 005443 519 LDANTH--------ITTRVMGTFGYMAPEYASSGK---LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587 (696)
Q Consensus 519 ~~~~~~--------~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~ 587 (696)
...... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||.......+ .+.. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----A 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----H
Confidence 321110 011235789999999987544 68899999999999999999999853111000 0000 0
Q ss_pred HHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+. . .. .+ .........+.+++.+||+.||++||++.+|++.|+++..
T Consensus 260 ~~----~-~~-~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQ----N-QL-SI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HH----C-C---C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hh----c-cC-CC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00 0 00 00 0001112368899999999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.66 Aligned_cols=276 Identities=25% Similarity=0.390 Sum_probs=201.2
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHH--HHHccCCCceeEEeEEee-----CCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEI--ISRIHHRHLVSLVGYCIS-----DDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~i--l~~l~hpnIv~l~~~~~~-----~~~~ 438 (696)
.++|+++++||+|+||.||+|++ +++.||||+++.. ....+..|.++ +..++|+||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36899999999999999999987 7899999999743 23445555555 445899999999986543 2246
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCceeeccCCCCceEECCCCcEEEEee
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC------HPRIIHRDIKSSNILLDNNFEAQVSDF 512 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~------~~~ivHrDLkp~NILl~~~~~vkL~Df 512 (696)
+|||||+.+|+|.+++.... .++..+++|+.||++||+|||+++ ..+|||||||++||||++++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999997543 588999999999999999999862 237999999999999999999999999
Q ss_pred ccchhccccCc-------ceeeccccccccCchhhhcc-------CCCCccccccchHHHHHHHHhCCCCCCCCCCCCch
Q 005443 513 GLAKLALDANT-------HITTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578 (696)
Q Consensus 513 Gls~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~ 578 (696)
|+++....... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.+|.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99976543221 11223569999999999986 35567899999999999999998877544332211
Q ss_pred h-HHHhHH------HHHHHhhhhhhhhcccCcccCCC--cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 579 S-LVEWAR------PLLSHALENEEFDNLADPRLGEN--YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 579 ~-l~~~~~------~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
. ...... ..+....... .....+... ........+.+|+.+||+.||++||++.||++.|+++...+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSRE----KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTS----CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHhhhcccCCCchHHHHHhhhccc----ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1 000000 0000000000 001111111 11234557999999999999999999999999999998655
Q ss_pred ccC
Q 005443 650 LNN 652 (696)
Q Consensus 650 ~~~ 652 (696)
..+
T Consensus 321 ~~~ 323 (336)
T 3g2f_A 321 ERN 323 (336)
T ss_dssp CC-
T ss_pred Hhc
Confidence 443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=355.35 Aligned_cols=260 Identities=20% Similarity=0.304 Sum_probs=205.0
Q ss_pred HHHHHHhcCcccc-ccccccCcEEEEEEEcC-CCcEEEEEEeecC--CCccHHHHHHHHHHHHHcc-CCCceeEEeEEee
Q 005443 360 EELVKATDGFADQ-NLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIH-HRHLVSLVGYCIS 434 (696)
Q Consensus 360 ~~l~~~~~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 434 (696)
.....+.++|.+. ++||+|+||.||+|... +|+.||||+++.. ......++.+|+.++++++ |+||++++++|..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3344556778887 89999999999999864 6899999999743 2344678999999999995 6999999999999
Q ss_pred CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC---CCcEEEEe
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSD 511 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~D 511 (696)
.+..++||||+.+|+|.+++.......+++..+++|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 99999999999999999998776556699999999999999999999999 9999999999999987 78999999
Q ss_pred eccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 512 fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
||+++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...... .+..
T Consensus 178 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~---~i~~-- 247 (327)
T 3lm5_A 178 FGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYL---NISQ-- 247 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHH--
T ss_pred CccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHH---HHHh--
Confidence 999986543322 233578999999999999999999999999999999999999997543 111111 1100
Q ss_pred hhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 592 LENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
... . ............+.+++++||+.||++||+++||++.
T Consensus 248 ---~~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 ---VNV-D-----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ---TCC-C-----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ---ccc-c-----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000 0 0011111122368899999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=359.07 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=204.1
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|.++++||+|+||.||++.+. +++.||+|++..... ...+.+.+|+.++++++|+||++++++|.+.+..+||
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999964 578999999875422 2346789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++.... .+++..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999998886543 389999999999999999999999 9999999999999999999999999999765433
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.+|.... .. +....+.. ..+
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~---~~~~~~~~-----~~~---- 258 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LK---ETYLRIKK-----NEY---- 258 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HH---HHHHHHHH-----TCC----
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HH---HHHHHHhc-----CCC----
Confidence 22 2234568999999999999999999999999999999999999997532 11 11111110 000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+...+ ...+.+|+++||+.||++||++.||++.
T Consensus 259 --~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 --SIPKHI----NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111 2367889999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=373.29 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=204.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|.+++.||+|+||.||+|++. +|+.||||+++... ......+.+|+++|+.++|+||+++++++...+..+|||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67999999999999999999964 79999999997432 233567899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999976544 89999999999999999999999 99999999999999999999999999998654432
Q ss_pred cceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 THITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.....+|+..|+|||++.+..+ +.++|||||||+||||++|+.||..... ..+. ..+.. ..+ .
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~---~~i~~-----~~~---~ 234 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLF---KKICD-----GIF---Y 234 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHH---HHHHT-----TCC---C
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHH---HHHhc-----CCc---C
Confidence 2234579999999999988765 6899999999999999999999975431 1111 11111 000 0
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..... ...+.+|+++||+.||++||++.||+++
T Consensus 235 ---~p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 ---TPQYL----NPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---CCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---CCccC----CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 00111 2368899999999999999999999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=357.20 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=203.6
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcE--EEEEEeecCC-CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGRE--VAIKQLKIGG-GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~--vavK~l~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.++||+|+||.||+|++. +|+. ||||+++... ....+.+.+|+++|+++ +|+||+++++++.+.+..+||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999864 5554 4999887432 23445789999999999 899999999999999999999
Q ss_pred EEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 442 YDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
|||+.+++|.+++.... ...+++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999987643 23589999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
||+|||+++....... .....++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.+ .
T Consensus 182 kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~~---~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE---K 253 (327)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHH---H
T ss_pred EEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HHHHHH---H
Confidence 9999999974332211 222356789999999998889999999999999999998 999997543 111111 1
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.... ..... .......+.+|+.+||+.||++||++.||++.|+++...
T Consensus 254 ----~~~~------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 254 ----LPQG------YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ----GGGT------CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----hhcC------CCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1000 00001 111123688999999999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=372.85 Aligned_cols=263 Identities=22% Similarity=0.258 Sum_probs=194.7
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC------
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 436 (696)
.++|+++++||+|+||.||+|.+ .+|+.||||++... .....+++.+|+++|+.++|+||++++++|...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999985 46899999999743 2233567889999999999999999999997553
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..+|||||+.++ |.+.+.. .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 469999999765 5555542 288999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH-------
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS------- 589 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~------- 589 (696)
...... .....+||..|+|||++.+..|+.++|||||||+||||++|+.+|.+.+. .+.+......+.
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 213 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp ----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHHHH
T ss_pred ecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHH
Confidence 654332 23446799999999999999999999999999999999999999976432 111111110000
Q ss_pred --------Hhhhh------hhhhcccCcccCC---CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 590 --------HALEN------EEFDNLADPRLGE---NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 590 --------~~~~~------~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+.+. ..+..++...+.. .........+++|+++||+.||++|++++|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000000 0011124568999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=366.63 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=203.0
Q ss_pred cCccccccccccCcEEEEEEEc----CCCcEEEEEEeecCC----CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCc
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIGG----GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 437 (696)
++|+++++||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|+++ +|+||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999986 478999999986432 23345678899999999 59999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+|||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++++||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999987654 389999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCcceeeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
............+|+..|+|||++.+ ..++.++|||||||+||||++|+.||........ ..+....++..
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~----- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS----- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC-----
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc-----
Confidence 65444333445679999999999986 3478899999999999999999999976443221 11111111110
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRVF 642 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 642 (696)
...+.. .....+.+|+.+||+.||++|+ +++||+++.
T Consensus 282 ------~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ------EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 001111 1223678999999999999999 888888653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=357.82 Aligned_cols=267 Identities=19% Similarity=0.263 Sum_probs=193.5
Q ss_pred HHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 363 VKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 363 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
....++|+++++||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|+||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34457899999999999999999984 47899999999754332 2456789999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE-----CCCCcEEEEeecc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL-----DNNFEAQVSDFGL 514 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl-----~~~~~vkL~DfGl 514 (696)
|||||+. |+|.+++..... +++..+++|+.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+
T Consensus 110 lv~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999997 589888876554 89999999999999999999999 99999999999999 4556699999999
Q ss_pred chhccccCcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
++....... .....+|+..|+|||++.+. .++.++|||||||+||||++|+.+|.... ....+......+.. ..
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~~~~~~~~-~~ 258 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS---EIDQLFKIFEVLGL-PD 258 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCC-CC
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC---HHHHHHHHHHHhCC-Cc
Confidence 987643322 23345689999999999874 58999999999999999999999997643 11111111111000 00
Q ss_pred hhhhh-------------cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 594 NEEFD-------------NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 594 ~~~~~-------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
...+. .+....+...........+.+|+++||+.||++|++++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 000000000000112246789999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=378.61 Aligned_cols=253 Identities=29% Similarity=0.411 Sum_probs=207.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+|++. +|+.||||+++.. .......+.+|+++|++++|+||++++++|.+.+..+|||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67999999999999999999864 7999999999643 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.||+|.+++...+...+++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+++......
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 999999999998876666699999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. ....+||..|+|||++.+..|+.++|||||||+||||++|+.||...........+ .. .+... .
T Consensus 341 ~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i--~~-~i~~~----------~ 405 (576)
T 2acx_A 341 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ER-LVKEV----------P 405 (576)
T ss_dssp C--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH--HH-HHHHC----------C
T ss_pred c--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH--HH-Hhhcc----------c
Confidence 2 23457999999999999989999999999999999999999999865432221111 11 11000 0
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
..+...+ ...+.+|+++||+.||++|+ +++||+++
T Consensus 406 ~~~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 EEYSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0111111 23688999999999999999 67888754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.91 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=203.6
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
..++|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999854 689999999975432 2346788999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc---EEEEeeccchhc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGLAKLA 518 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DfGls~~~ 518 (696)
|||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++. +||+|||++...
T Consensus 84 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999988886554 389999999999999999999999 9999999999999976655 999999999765
Q ss_pred cccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...+.+ .+.. ..+.
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~---~~~~-----~~~~ 225 (284)
T 3kk8_A 159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYA---QIKA-----GAYD 225 (284)
T ss_dssp CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHH-----TCCC
T ss_pred ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHH---HHHh-----cccc
Confidence 43322 233568999999999999999999999999999999999999997532 111111 1111 1000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.....+ . .....+.+++.+||+.||++||++.|++++
T Consensus 226 -~~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 -YPSPEW-D----TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -CCTTTT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CCchhh-c----ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 1 112368899999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=349.98 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=201.0
Q ss_pred cCccccccccccCcEEEEEEEcCC----CcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEee-CCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l 440 (696)
.+|++.++||+|+||.||+|.+.+ +..||||+++.... ...+.+.+|++++++++|+||++++++|.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468889999999999999998532 23589998875333 334678999999999999999999998654 557799
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+++|.+++.... ..+++..+++|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997543 3478999999999999999999999 999999999999999999999999999986544
Q ss_pred cCcc---eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhC-CCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 521 ANTH---ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG-RKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 521 ~~~~---~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
.... ......++..|+|||++.+..++.++|||||||++|||++| ..+|...... .+.... . ...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~---~----~~~- 249 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYL---L----QGR- 249 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHH---H----TTC-
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHH---h----cCC-
Confidence 3221 12334577889999999999999999999999999999995 4555443221 111110 0 000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.... .... ...+.+++++||+.||++||++.||++.|+++...
T Consensus 250 --~~~~---~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 --RLLQ---PEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp --CCCC---CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCC---CccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 1111 23688999999999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=359.45 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=198.8
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc---cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++++.||+|+||.||+|+. .+|+.||||++...... ..+++.+|+++|++++|+||++++++|..++..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999985 57899999999754332 2356889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+. |+|.+++.... ..+++..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 57766665332 2489999999999999999999999 9999999999999999999999999999765432
Q ss_pred cceeeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 523 THITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
....|+..|+|||++. ++.++.++|||||||+||||++|+.||..... .+....+.. . ....
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~----~-~~~~ 272 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ----N-ESPA 272 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH----S-CCCC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh----c-CCCC
Confidence 2356899999999985 56789999999999999999999999975321 111111111 1 0001
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
+. ...+ ...+.+++.+||+.||++||++++|++...
T Consensus 273 ~~----~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 273 LQ----SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp CC----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CC----CCCC----CHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 11 1111 225789999999999999999999987543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=352.21 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=196.3
Q ss_pred hcCccccccccccCcEEEEEEEcC--CCc--EEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP--DGR--EVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~--~g~--~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|++.++||+|+||.||+|++. +++ .||||+++... ....+++.+|++++++++|+||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 367999999999999999999842 333 68999987542 234567899999999999999999999998654 8
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+.+++|.+++.... ..+++..+++++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999998887542 2488999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 519 LDANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 519 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
...... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+.. .+. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~---~~~----~~~ 241 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILH---KID----KEG 241 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHH---HHH----TSC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHHH---HHH----ccC
Confidence 443322 1223457788999999998889999999999999999999 999997543 111111 110 000
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcccc
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDL 650 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~ 650 (696)
. .. . ........+.+++.+||+.||++||++.+|++.|+++...+.
T Consensus 242 ~--~~---~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 242 E--RL---P----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp C--CC---C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred C--CC---C----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 0 00 0 111122368899999999999999999999999998876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.02 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=196.0
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|.+.++||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++|++++|+||++++++|.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5799999999999999999985 468999999997553 34567899999999999999999999999999999999999
Q ss_pred cCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE---CCCCcEEEEeeccchhcc
Q 005443 445 VPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 445 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DfGls~~~~ 519 (696)
+.+++|.+++... ....+++..+++|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999998887542 223489999999999999999999999 99999999999999 456789999999997654
Q ss_pred ccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.... .....|+..|+|||++. +.++.++|||||||+||||++|+.||.... ...+.+.. .......
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~---~~~~~~~~--------~~~~~~~ 244 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQQKA--------TYKEPNY 244 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH--------HHCCCCC
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC---HHHHHhhh--------ccCCccc
Confidence 3322 23456899999999886 568999999999999999999999997532 11111100 0000000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
....... ...+.+++++||+.||++||++.||++
T Consensus 245 ---~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 ---AVECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---ccccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000111 236789999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=357.84 Aligned_cols=267 Identities=24% Similarity=0.358 Sum_probs=200.4
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.++|+++++||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|+||++++++|.+.+..+|||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367999999999999999999964 5899999998654332 2356889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++..... +++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999999887665443 89999999999999999999999 99999999999999999999999999997654433
Q ss_pred cceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH-------h-hh
Q 005443 523 THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH-------A-LE 593 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~-------~-~~ 593 (696)
. ......|+..|+|||++.+. .++.++|||||||+||||++|+.||..... ..........+.. . ..
T Consensus 179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD---IDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhhhHhhh
Confidence 2 22345689999999999875 789999999999999999999999976432 1111111110000 0 00
Q ss_pred hhhhhcccCcccCCCcc-----hHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 NEEFDNLADPRLGENYV-----EGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.......+..... ......+.+|+++||+.||++||++.||+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111111111111100 1123468899999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=346.88 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=206.6
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.+.|++++.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35799999999999999999985 468999999997654 3445789999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999988643 489999999999999999999999 999999999999999999999999999976544322
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......|+..|+|||++.+..++.++|||||||+||||++|+.||.... ....... + .... ..
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~----~----~~~~-----~~ 237 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH---PMKVLFL----I----PKNN-----PP 237 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHH----H----HHSC-----CC
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC---HHHHHHH----h----hcCC-----CC
Confidence 2234568999999999999999999999999999999999999997532 1111111 0 0000 11
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFD 643 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 643 (696)
.+...+. ..+.+|+.+||+.||++||++.||++...
T Consensus 238 ~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 238 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCCSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CCccccC----HHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1112222 36889999999999999999999997644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.79 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=183.5
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|++.++||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999985 579999999996432 23346789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999887543 3489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ . .+.. . .
T Consensus 166 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-------~~~~----~---~ 227 (278)
T 3cok_A 166 HEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L-------NKVV----L---A 227 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CC----S---S
T ss_pred CCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H-------HHHh----h---c
Confidence 221 2235689999999999988899999999999999999999999976432110 0 0000 0 0
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+..+... ....+.+++.+||+.||++||++++|+++
T Consensus 228 ~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 DYEMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccCCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0011111 12368899999999999999999998853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.48 Aligned_cols=247 Identities=28% Similarity=0.441 Sum_probs=200.0
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|++++.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||++++++|.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999854 57899999986432 23356789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++..... +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999988876543 89999999999999999999998 9999999999999999999999999998654332
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.... .....+ .+. ..
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~---~~~-----~~------ 222 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYK---RIS-----RV------ 222 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHH---HHH-----HT------
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHH---HHH-----hC------
Confidence 2 233568999999999999999999999999999999999999997532 111111 110 00
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.. .....+.+|+.+||+.||++||++.||+++
T Consensus 223 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 EFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCCCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCC----cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000111 112368899999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=357.32 Aligned_cols=243 Identities=21% Similarity=0.326 Sum_probs=201.4
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc--------cHHHHHHHHHHHHHccCCCceeEEeEEeeC
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ--------GEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 435 (696)
..++|+++++||+|+||.||+|.. .+|+.||||+++..... ....+.+|+++|++++|+||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999984 57899999999754321 234578899999999999999999999999
Q ss_pred CceeEEEEecCCC-chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 436 DRRLLIYDYVPNN-TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 436 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
+..++||||+.+| +|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 89888876544 89999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
++....... .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||..... .
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~-- 236 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------T-- 236 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------G--
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------H--
Confidence 986544332 233568999999999988776 7899999999999999999999964210 0
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....... ...+ ...+.+|+++||+.||++||++.||++.
T Consensus 237 ---~~~~~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---VEAAIHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTTCCCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HhhccCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0011 2368899999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=357.46 Aligned_cols=256 Identities=24% Similarity=0.325 Sum_probs=188.1
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEee--------C
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCIS--------D 435 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--------~ 435 (696)
..+|++.++||+|+||.||+|++ .+|+.||||++........+.+.+|+.+++++. |+||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35799999999999999999995 478999999997665556678999999999996 9999999999853 3
Q ss_pred CceeEEEEecCCCchhhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeeccCCCCceEECCCCcEEEEee
Q 005443 436 DRRLLIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLDNNFEAQVSDF 512 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~~~~~vkL~Df 512 (696)
...++||||+. |+|.+++.. .....+++..+++|+.||+.||+|||++ + |+|||||++||||++++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 34689999995 788777754 2233489999999999999999999998 8 999999999999999999999999
Q ss_pred ccchhccccCcce-----------eeccccccccCchhhh---ccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCch
Q 005443 513 GLAKLALDANTHI-----------TTRVMGTFGYMAPEYA---SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578 (696)
Q Consensus 513 Gls~~~~~~~~~~-----------~~~~~gt~~y~aPE~l---~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~ 578 (696)
|+++......... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 9998654432211 1134589999999998 5667889999999999999999999999753211
Q ss_pred hHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 579 SLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 579 ~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
+. +... +.... .... ...+.+|+++||+.||++||++.||++.|+++...
T Consensus 260 ---~~----~~~~-----~~~~~----~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 ---RI----VNGK-----YSIPP----HDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ------------------CCCCT----TCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---Hh----hcCc-----ccCCc----cccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 0000 00000 0111 11477899999999999999999999999988753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.06 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=203.7
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|.+.++||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367999999999999999999965 588999999875432 2345788999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++.... .+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999998886544 389999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.. ......|+..|+|||++.+..++.++|||+|||++|||++|+.||.... .. +....+. ....
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~---~~~~~~~-----~~~~---- 232 (294)
T 2rku_A 169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LK---ETYLRIK-----KNEY---- 232 (294)
T ss_dssp TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HH---HHHHHHH-----TTCC----
T ss_pred cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HH---HHHHHHh-----hccC----
Confidence 22 2233568999999999999889999999999999999999999997533 11 1111110 0000
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+... ....+.+++++||+.||++||+++||++.
T Consensus 233 --~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 --SIPKH----INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCccc----cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01111 12368899999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.39 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=201.3
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC------ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|++++.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|+||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999965 689999999975432 2367899999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC----cEEEEeecc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGL 514 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DfGl 514 (696)
++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||++++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999887543 389999999999999999999999 999999999999998877 899999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
++....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...... .+..
T Consensus 159 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~---~~~~----- 225 (283)
T 3bhy_A 159 AHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLT---NISA----- 225 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHH---HHHT-----
T ss_pred ceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHH---HhHh-----
Confidence 976543322 233568999999999999999999999999999999999999997543 111111 1100
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
... ........ .....+.+++++||+.||++||++.|++++
T Consensus 226 ~~~--~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 226 VNY--DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp TCC--CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ccc--CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 000 00000001 112368899999999999999999999973
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=354.40 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=197.0
Q ss_pred HHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc-----cHHHHHHHHHHHHHccCCCceeEEeEEeeCCc
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-----GEREFKAEVEIISRIHHRHLVSLVGYCISDDR 437 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 437 (696)
...++|+++++||+|+||.||+|.+. +|+.||||+++..... ..+.+.+|+++|++++|+||++++++|...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999964 6899999999753221 12468899999999999999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.++||||+.+ +|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999976 7877776543 3488899999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh--h
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE--N 594 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~--~ 594 (696)
...... ......|+..|+|||++.+. .++.++|||||||+||||++|..+|.... ... ....++..... .
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~---~~~---~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLD---QLTRIFETLGTPTE 234 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHH---HHHHHHHHHCCCCT
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHH---HHHHHHHHcCCCCh
Confidence 644332 23345789999999999764 58999999999999999999999987543 111 11112211100 0
Q ss_pred hhhhc---ccCcccCCC---c-----chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 EEFDN---LADPRLGEN---Y-----VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ~~~~~---~~d~~l~~~---~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.+ +.+...... . .......+.+|+++||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00100 000000000 0 01122468999999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.61 Aligned_cols=266 Identities=22% Similarity=0.372 Sum_probs=196.0
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCcc-HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG-EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|+++++||+|+||.||+|+.. +|+.||||+++...... ...+.+|+++|++++|+||+++++++...+..+|||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999964 78999999997543221 12456899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+. |+|.+++...+. .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 97 578777765433 489999999999999999999999 999999999999999999999999999976543322
Q ss_pred eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH--------hhhhh
Q 005443 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH--------ALENE 595 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~--------~~~~~ 595 (696)
......|+..|+|||++.+ ..++.++|||||||+||||++|+.||.... ...........+.. .+...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST---VEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2334568999999999876 668999999999999999999999997643 22222222221110 00111
Q ss_pred hhhcccCcccCCCc----chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGENY----VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+..+......... .......+.+|+++||+.||++|++++||+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 11111000000000 01112367899999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.26 Aligned_cols=252 Identities=22% Similarity=0.365 Sum_probs=202.1
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|+||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999964 789999999986555555679999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE---CCCCcEEEEeeccchhccc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DfGls~~~~~ 520 (696)
|+.+++|.+++...+ .+++..++.++.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999988886544 389999999999999999999999 99999999999999 7888999999999975433
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+ .+..... .+
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~---~i~~~~~------~~ 226 (304)
T 2jam_A 162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFE---KIKEGYY------EF 226 (304)
T ss_dssp BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH---HHHHCCC------CC
T ss_pred Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHH---HHHcCCC------CC
Confidence 21 223468999999999999999999999999999999999999997532 111111 1111000 00
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+ .......+.+++.+||+.||++||++.|+++.
T Consensus 227 -~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 -ESPF----WDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -CTTT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -Cccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011 11122368899999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.62 Aligned_cols=246 Identities=27% Similarity=0.422 Sum_probs=202.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999864 67899999996432 234567999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++...+. +++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 99999999998876543 89999999999999999999999 99999999999999999999999999986543322
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... .. +....+.. . +
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~---~~~~~~~~-----~------~ 228 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HT---ETHRRIVN-----V------D 228 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HH---HHHHHHHT-----T------C
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---Hh---HHHHHHhc-----c------c
Confidence 233568999999999999999999999999999999999999997532 11 11111110 0 0
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+...+ ...+.+++.+||+.||++||++++|+++
T Consensus 229 ~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 LKFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0111111 2368899999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.81 Aligned_cols=260 Identities=21% Similarity=0.377 Sum_probs=206.4
Q ss_pred CHHHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc--------cHHHHHHHHHHHHHc-cCCCcee
Q 005443 358 TYEELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ--------GEREFKAEVEIISRI-HHRHLVS 427 (696)
Q Consensus 358 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~E~~il~~l-~hpnIv~ 427 (696)
.++....+.++|++.+.||+|+||.||+|.+. +|+.||||+++..... ..+.+.+|+.+++++ +|+||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34445556688999999999999999999975 7999999999755421 134678999999999 7999999
Q ss_pred EEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 428 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
++++|...+..+|||||+.+++|.+++.... .+++..++.++.||+.||+|||++ ||+|||||++||||++++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999887543 389999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhcc------CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 581 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~ 581 (696)
||+|||++........ .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||.... .....
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~ 314 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILML 314 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHH
Confidence 9999999976543322 234578999999999863 357889999999999999999999997532 11111
Q ss_pred HhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 582 EWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+...... +....+ . .....+.+++++||+.||++||++.||++.
T Consensus 315 ---~~i~~~~~~------~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 ---RMIMEGQYQ------FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ---HHHHHTCCC------CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHHHhCCCC------CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111110000 000000 0 112358899999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=362.99 Aligned_cols=199 Identities=28% Similarity=0.440 Sum_probs=175.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|+++++||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|+++|++++|+||++++++|..++..+|||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 67999999999999999999964 689999999986533 3346789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.+++|.+++...+. +++..+++|+.||+.||+|||+++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 113 ~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 999999999876543 899999999999999999999842 79999999999999999999999999997654332
Q ss_pred eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCC
Q 005443 525 ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDAS 572 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~ 572 (696)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 187 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred -ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 23356899999999999999999999999999999999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=355.68 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=198.5
Q ss_pred HHHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEee-----
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCIS----- 434 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----- 434 (696)
+....++|+++++||+|+||.||+|++ .+|+.||||++.... ...+++.+|+.+++++ +|+||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 344567899999999999999999986 478999999997543 3457899999999999 79999999999987
Q ss_pred -CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 435 -DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 435 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
.+..+|||||+.+++|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCc
Confidence 45789999999999999999866555689999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCcceeeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
++........ ......|+..|+|||++. +..++.++|||||||+||||++|+.||..... ... ...+.
T Consensus 175 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~~~ 247 (326)
T 2x7f_A 175 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRA---LFLIP 247 (326)
T ss_dssp TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHH
T ss_pred CceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHH---HHHhh
Confidence 9976543221 223356899999999987 56788999999999999999999999975321 111 11000
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. .....+.. ..+ ...+.+++.+||+.||++||++.+|+++
T Consensus 248 ----~-~~~~~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 ----R-NPAPRLKS----KKW----SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ----H-SCCCCCSC----SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ----c-CccccCCc----ccc----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00111111 111 2368899999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=349.65 Aligned_cols=256 Identities=22% Similarity=0.364 Sum_probs=202.9
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEee--CCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 440 (696)
.++|++++.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999864 789999999975432 334578999999999999999999998864 567899
Q ss_pred EEEecCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-----eeeccCCCCceEECCCCcEEEEeec
Q 005443 441 IYDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDCHPR-----IIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~-----ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
||||+.+++|.+++... .+..+++..+++|+.||+.||+|||++ + |+|||||++||||++++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999988643 233489999999999999999999998 7 9999999999999999999999999
Q ss_pred cchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
+++....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+ .+ .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~---~i-----~ 229 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG---KI-----R 229 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HH-----H
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHH---HH-----h
Confidence 9987543322 1223468999999999999999999999999999999999999997642 111111 11 1
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
...+.. +...+ ...+.+++.+||+.||++||++.||++.+...
T Consensus 230 ~~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 230 EGKFRR-----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp HTCCCC-----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred hccccc-----CCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 111111 11112 23688999999999999999999999866543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=360.50 Aligned_cols=268 Identities=19% Similarity=0.259 Sum_probs=202.6
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc--------CCCceeEEeEEe---
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH--------HRHLVSLVGYCI--- 433 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~--------hpnIv~l~~~~~--- 433 (696)
.++|+++++||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+++|++++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999985 46889999999733 233567889999999996 778999999988
Q ss_pred -eCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-------
Q 005443 434 -SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF------- 505 (696)
Q Consensus 434 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~------- 505 (696)
.....+|||||+ +++|.+++.......+++..+++|+.||+.||+|||+++ +|||||||++||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 445789999999 555655555444445899999999999999999999864 799999999999998775
Q ss_pred ------------------------------------------cEEEEeeccchhccccCcceeeccccccccCchhhhcc
Q 005443 506 ------------------------------------------EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543 (696)
Q Consensus 506 ------------------------------------------~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 543 (696)
.+||+|||+++..... ....+|+..|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999765432 233568999999999999
Q ss_pred CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH---Hh----hhhhhh-hcccCcc--c--------
Q 005443 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS---HA----LENEEF-DNLADPR--L-------- 605 (696)
Q Consensus 544 ~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~---~~----~~~~~~-~~~~d~~--l-------- 605 (696)
..++.++|||||||+||||++|+.||............+....+.. .. +....+ ..++... +
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999986554332211121111111 00 000000 0000000 0
Q ss_pred ---------CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 ---------GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.......+.+|+++||+.||++||+++||+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012234556678999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=342.57 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=197.9
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 440 (696)
..++|++.++||+|+||.||+|... +|+.||||+++... .....++.+|+.++.++ +|+||+++++++.+.+..+|
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999865 79999999997543 23456788999999999 89999999999999999999
Q ss_pred EEEecCCCchhhccccCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC---------------
Q 005443 441 IYDYVPNNTLYFHLHGEGR--PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--------------- 503 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~--------------- 503 (696)
||||+.+++|.+++..... ..+++..+++|+.||+.||+|||++ +|+|||||++||||+.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999998875321 3489999999999999999999999 9999999999999984
Q ss_pred ----CCcEEEEeeccchhccccCcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCch
Q 005443 504 ----NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578 (696)
Q Consensus 504 ----~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~ 578 (696)
+..+||+|||++....... ...|+..|+|||++.+. .++.++|||||||++|||++|..++... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----D 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----H
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----h
Confidence 4489999999997654332 23589999999999875 5678999999999999999998766432 1
Q ss_pred hHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 579 SLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 579 ~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+ + ....+. .+...+ ...+.+++++||+.||++||++.||+++
T Consensus 236 ~~~~----~-----~~~~~~-----~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 QWHE----I-----RQGRLP-----RIPQVL----SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHH----H-----HTTCCC-----CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHH----H-----HcCCCC-----CCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1100 0 111111 111112 2368899999999999999999999854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=345.59 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=198.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|....+||+|+||.||+|.. .+++.||||+++.......+.+.+|+.++++++|+||++++++|...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455667999999999999985 578899999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhhccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-CCcEEEEeeccchhccccCc
Q 005443 446 PNNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 446 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DfGls~~~~~~~~ 523 (696)
.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999887542 33467889999999999999999999 9999999999999987 88999999999976543221
Q ss_pred ceeeccccccccCchhhhccCC--CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 524 HITTRVMGTFGYMAPEYASSGK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
......|+..|+|||++.+.. ++.++|||||||+||||++|+.||..... ... .... .. .. ..
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~-~~~~----~~----~~--~~ 243 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE---PQA-AMFK----VG----MF--KV 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS---HHH-HHHH----HH----HH--CC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc---hhH-HHHh----hc----cc--cc
Confidence 223356899999999997643 88999999999999999999999964321 110 0000 00 00 00
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+... ....+.+++.+||+.||++||++.||++.
T Consensus 244 ~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 HPEIPES----MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCTT----SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccccc----CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111 22368899999999999999999999853
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=353.87 Aligned_cols=267 Identities=19% Similarity=0.300 Sum_probs=200.0
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC-------
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD------- 435 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------- 435 (696)
.++|+++++||+|+||.||+|+. .+|+.||||++..... .....+.+|+++|++++|+||++++++|...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999996 5789999999865432 2346788999999999999999999999873
Q ss_pred -CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 436 -DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 436 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
+..+|||||+.+ +|.+.+..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 457999999975 66665554332 389999999999999999999999 999999999999999999999999999
Q ss_pred chhccccC---cceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH
Q 005443 515 AKLALDAN---THITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH 590 (696)
Q Consensus 515 s~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~ 590 (696)
++...... ........|+..|+|||++.+ ..++.++|||||||+||||++|+.+|.... ..............
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLCGS 247 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCC
Confidence 97654222 122234578999999999876 558999999999999999999999998643 22222222211110
Q ss_pred hhhhhhhhcc-----cC----cccCCCcchHH------HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 ALENEEFDNL-----AD----PRLGENYVEGE------MFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 ~~~~~~~~~~-----~d----~~l~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ....+..+ .+ ........... ...+.+|+++||+.||++|++++|++++
T Consensus 248 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 I-TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp C-CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 00000000 00 00000001111 1247899999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=369.90 Aligned_cols=251 Identities=22% Similarity=0.380 Sum_probs=204.6
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|+||++++++|.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999964 78999999996543 34567899999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE---CCCCcEEEEeeccchhc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---~~~~~vkL~DfGls~~~ 518 (696)
|||+.+|+|.+++..... +++..+++|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999988876544 89999999999999999999999 99999999999999 56789999999999876
Q ss_pred cccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
..... ....+|+..|+|||++.+ .++.++|||||||++|||++|+.||.... ...+.+ .+.. ..+.
T Consensus 180 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~---~i~~-----~~~~ 245 (484)
T 3nyv_A 180 EASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILK---KVEK-----GKYT 245 (484)
T ss_dssp CCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHH-----CCCC
T ss_pred ccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHH---HHHc-----CCCC
Confidence 44332 233579999999999876 69999999999999999999999997643 111111 1111 0000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.... .......+.+|+++||+.||++|+++.|++++
T Consensus 246 -~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 -FELPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -CCSGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00000 01122368899999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.56 Aligned_cols=248 Identities=26% Similarity=0.376 Sum_probs=196.5
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeC----Ccee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISD----DRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----~~~~ 439 (696)
+.|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+++|++++|+||++++++|... +..+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3478888999999999999985 468899999997543 23346789999999999999999999998753 4578
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeeccCCCCceEEC-CCCcEEEEeeccch
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLD-NNFEAQVSDFGLAK 516 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~-~~~~vkL~DfGls~ 516 (696)
+||||+.+++|.+++.... .+++..+++|+.||+.||+|||++ + |+|||||++||||+ +++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999997643 389999999999999999999998 7 99999999999997 78899999999997
Q ss_pred hccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
...... .....|+..|+|||++. +.++.++|||||||++|||++|+.||..... ..+....+.. ...
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~-~~~--- 247 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTS-GVK--- 247 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTT-TCC---
T ss_pred cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHhc-cCC---
Confidence 544332 23356899999999887 4589999999999999999999999975331 1111111110 000
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+ .......+.+++.+||+.||++||++.||+++
T Consensus 248 -----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 -----PASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----CGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----cccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0001 11112368899999999999999999999853
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=363.07 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=192.3
Q ss_pred HHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--------ccHHHHHHHHHHHHHccCCCceeEEeEEee
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--------QGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 434 (696)
...++|.+.++||+|+||.||+|.. .+++.||||++..... .....+.+|+++|++++|+||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4468999999999999999999985 4689999999974321 11234889999999999999999999975
Q ss_pred CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC---CcEEEEe
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSD 511 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~D 511 (696)
.+..+|||||+.+|+|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 4567999999999999998876544 89999999999999999999999 99999999999999654 4599999
Q ss_pred eccchhccccCcceeeccccccccCchhhhcc---CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 512 fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
||+++...... .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... .+.+...
T Consensus 286 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~--- 358 (419)
T 3i6u_A 286 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT--- 358 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH---
T ss_pred cccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh---
Confidence 99998764332 2334579999999999863 678889999999999999999999997643211 1111110
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.. . .... ......+.+|+++||+.||++|++++|++++
T Consensus 359 -----~~~~~~-~-~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 -----SGKYNF-I-PEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -----TTCCCC-C-HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----cCCCCC-C-chhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 0 0000 0112368899999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=347.19 Aligned_cols=261 Identities=18% Similarity=0.266 Sum_probs=199.7
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEee--CCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCIS--DDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~~~lV~ 442 (696)
++|+++++||+|+||.||+|.. .+|+.||||+++. ...+.+.+|+++|++++ |+||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999984 5789999999873 34678999999999997 9999999999987 56789999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-cEEEEeeccchhcccc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDA 521 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfGls~~~~~~ 521 (696)
||+.+++|.+++.. +++..++.++.||+.||+|||++ +|+|||||++||||+.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999888853 78899999999999999999999 999999999999998666 8999999999765433
Q ss_pred CcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----Hhhhhh-
Q 005443 522 NTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----HALENE- 595 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~~~~~- 595 (696)
.. .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ...+......+-. ..+...
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHhc
Confidence 22 233468999999999987 67899999999999999999999999654321 1111111110000 000000
Q ss_pred -----hhhcccC--------cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 -----EFDNLAD--------PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 -----~~~~~~d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+.++.. ..............+.+|+++||+.||++|++++||+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 000011111123478899999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=365.76 Aligned_cols=241 Identities=15% Similarity=0.170 Sum_probs=188.2
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHH---HHHHccCCCceeEE-------eE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVE---IISRIHHRHLVSLV-------GY 431 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~---il~~l~hpnIv~l~-------~~ 431 (696)
.++|++.++||+|+||.||+|++ .+|+.||||+++.. .....+.+.+|++ +|++++|+||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36789999999999999999996 46999999999743 2334577899994 55555799999998 66
Q ss_pred EeeCC-----------------ceeEEEEecCCCchhhccccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 005443 432 CISDD-----------------RRLLIYDYVPNNTLYFHLHGEGR-----PVLDWATRVKIAAGAARGLAYLHEDCHPRI 489 (696)
Q Consensus 432 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~gL~~LH~~~~~~i 489 (696)
+.+.+ ..+|||||+ +|+|.+++...+. ..+.+..+++|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 65543 278999999 6899998875322 1233588889999999999999999 99
Q ss_pred eeccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhccC-----------CCCccccccchHHH
Q 005443 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-----------KLTEKSDVFSFGVV 558 (696)
Q Consensus 490 vHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~~sDVwSlGvl 558 (696)
+|||||++||||+.++.+||+|||+++.... ......| ..|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985322 2334567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHH
Q 005443 559 LLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQV 638 (696)
Q Consensus 559 l~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el 638 (696)
||||++|+.||......... ..+... ...+ ...+.+|+.+||+.||++||++.|+
T Consensus 303 l~elltg~~Pf~~~~~~~~~-------------------~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS-------------------EWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHSSCCC------CCS-------------------GGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHCCCCCcccccccch-------------------hhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHH
Confidence 99999999999754321110 001110 0111 2368899999999999999999999
Q ss_pred HH
Q 005443 639 VR 640 (696)
Q Consensus 639 l~ 640 (696)
++
T Consensus 358 l~ 359 (377)
T 3byv_A 358 ME 359 (377)
T ss_dssp HT
T ss_pred hh
Confidence 86
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=344.98 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=198.6
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..++|++++.||+|+||.||+|.+. +|+.||||++........+++.+|+++|++++|+||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3478999999999999999999965 589999999987666677889999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++..... .+++..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|||++........
T Consensus 97 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp CCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999888765322 389999999999999999999999 999999999999999999999999999864332211
Q ss_pred ceeeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 524 HITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
......|+..|+|||++. +..++.++|||||||++|||++|+.||..... . +...... ... ..
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~----~~~-~~ 240 (302)
T 2j7t_A 173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---M---RVLLKIA----KSD-PP 240 (302)
T ss_dssp -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHHHHHH----HSC-CC
T ss_pred -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---H---HHHHHHh----ccC-Cc
Confidence 122346899999999984 56788999999999999999999999975431 1 1111111 000 00
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.+. ........+.+++.+||+.||++||++.+|++
T Consensus 241 ~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 TLL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 01111236889999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=345.12 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=197.5
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC----CccHHHHHHHHHHHHHccCCCceeEEeEEe--eCCc
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG----GQGEREFKAEVEIISRIHHRHLVSLVGYCI--SDDR 437 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~ 437 (696)
..++|+++++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++|++++|+||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999996 468899999997432 234567999999999999999999999985 4457
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+|||||+.++ |.+++.......+++..+++++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999877 66666554445689999999999999999999999 999999999999999999999999999976
Q ss_pred ccccC-cceeeccccccccCchhhhccCC--CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 518 ALDAN-THITTRVMGTFGYMAPEYASSGK--LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 518 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
..... ........|+..|+|||++.+.. ++.++|||||||++|||++|+.||.... .. +....+. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~---~~~~~i~-----~ 227 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IY---KLFENIG-----K 227 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HH---HHHHHHH-----H
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HH---HHHHHHh-----c
Confidence 54322 22233456899999999998644 3779999999999999999999997532 11 1111111 1
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+ .+.... ...+.+++++||+.||++||++.||+++
T Consensus 228 ~~~------~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 GSY------AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCC------CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCC------CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 100 111111 2368899999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.41 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=204.8
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCcc-----------------HHHHHHHHHHHHHccCCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQG-----------------EREFKAEVEIISRIHHRHLVSL 428 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~il~~l~hpnIv~l 428 (696)
.++|+++++||+|+||.||+|.. +|+.||||++....... .+.+.+|++++++++|+||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 99999999997432111 1789999999999999999999
Q ss_pred EeEEeeCCceeEEEEecCCCchhhc------cccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEE
Q 005443 429 VGYCISDDRRLLIYDYVPNNTLYFH------LHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 429 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl 501 (696)
++++.+.+..++||||+.+++|.++ +.......+++..++.++.||+.||+|||+ + +|+|||||++||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 665445569999999999999999999999 8 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCcceeeccccccccCchhhhccC-CCCc-cccccchHHHHHHHHhCCCCCCCCCCCCchh
Q 005443 502 DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-KLTE-KSDVFSFGVVLLELITGRKPVDASQPLGDES 579 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~ 579 (696)
+.++.+||+|||+++..... ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 99999999999999765433 23445789999999999887 6666 999999999999999999999864321 12
Q ss_pred HHHhHHHHHHHhhhhhh-hhcccCccc---CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 580 LVEWARPLLSHALENEE-FDNLADPRL---GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~-~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
+.+. +......... ...+..... ...........+.+|+++||+.||++||++.|+++
T Consensus 261 ~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNN---IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHH---HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHH---HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2111 1110000000 000000000 00000112236889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=355.51 Aligned_cols=275 Identities=20% Similarity=0.250 Sum_probs=200.4
Q ss_pred cCHHHHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCc-----------cHHHHHHHHHHHHHccCCCc
Q 005443 357 FTYEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ-----------GEREFKAEVEIISRIHHRHL 425 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~il~~l~hpnI 425 (696)
..++++....++|+++++||+|+||.||+|...+|+.||||++...... ..+.+.+|+++|++++|+||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3466788888999999999999999999999888999999998643221 12679999999999999999
Q ss_pred eeEEeEEeeC-----CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceE
Q 005443 426 VSLVGYCISD-----DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 500 (696)
Q Consensus 426 v~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NIL 500 (696)
++++++|... ...+|||||+. |+|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 9999998643 35699999997 57777776443 3489999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchh
Q 005443 501 LDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES 579 (696)
Q Consensus 501 l~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~ 579 (696)
|+.++.+||+|||+++...... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~ 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---FYN 241 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHH
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC---HHH
Confidence 9999999999999997543322 2233568899999999887 678999999999999999999999997643 111
Q ss_pred HHHhHHHHHHHh-------hhhhhhhcccCcccCCC-------cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 580 LVEWARPLLSHA-------LENEEFDNLADPRLGEN-------YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 580 l~~~~~~~~~~~-------~~~~~~~~~~d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+......... +......+.....+... ........+.+|+.+||+.||++||++.||+++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111111000 00000001111000000 001112358899999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=367.75 Aligned_cols=263 Identities=27% Similarity=0.361 Sum_probs=192.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC------cee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD------RRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------~~~ 439 (696)
.+|+++++||+|+||.||+|++. +|+.||||++.... +.+.+|+++|++|+|+||++++++|...+ ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999964 68999999987432 23457999999999999999999986432 257
Q ss_pred EEEEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC-CcEEEEeeccch
Q 005443 440 LIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN-FEAQVSDFGLAK 516 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~-~~vkL~DfGls~ 516 (696)
|||||+.+ +|.+++.. .....+++..++.++.||++||+|||++ +|+|||||++||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999976 45444432 2233589999999999999999999998 99999999999999854 678999999998
Q ss_pred hccccCcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH---Hhh
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS---HAL 592 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~---~~~ 592 (696)
....... ....+|+..|+|||++.+. .|+.++|||||||+||||++|+.+|..... .+.+.+++..+-. +.+
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 6543322 2335789999999999764 799999999999999999999999986431 1222222211000 000
Q ss_pred h--hhhhhcccCcccCCC-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 593 E--NEEFDNLADPRLGEN-----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 593 ~--~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ...+.++....+... +......++++|+.+||+.||++|+++.|++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 001111111111000 111123478899999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=364.54 Aligned_cols=199 Identities=26% Similarity=0.364 Sum_probs=166.5
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC-----Cc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 437 (696)
.++|+++++||+|+||.||+|.. .+|+.||||+++.... ...+++.+|+++|++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999985 4688999999974322 3346789999999999999999999999876 56
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+|||||+. ++|.+++.... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999986 58988887654 389999999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcc---------------------eeeccccccccCchhhh-ccCCCCccccccchHHHHHHHHhCCCCCC
Q 005443 518 ALDANTH---------------------ITTRVMGTFGYMAPEYA-SSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (696)
Q Consensus 518 ~~~~~~~---------------------~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwSlGvll~eLltg~~Pf~ 570 (696)
....... .....+||..|+|||++ .+..|+.++|||||||+||||++|..+|.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6433211 12456799999999986 55679999999999999999998655543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.82 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=195.6
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++... ....+.+.+|++++++++|+||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999965 79999999996432 23456789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.+++..... +++..+++++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999999876543 89999999999999999999999 9999999999999999999999999999865443
Q ss_pred CcceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.. .....|+..|+|||++.+..+ +.++|||||||++|||++|+.||.... ...+.+. +. ... .
T Consensus 165 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~---~~-----~~~---~ 228 (276)
T 2h6d_A 165 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKK---IR-----GGV---F 228 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HH-----HCC---C
T ss_pred cc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHH---hh-----cCc---c
Confidence 22 233468999999999987765 689999999999999999999997532 1111111 10 000 0
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+... ....+.+++.+||+.||++||++.||+++
T Consensus 229 ---~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ---YIPEY----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---cCchh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111 12368899999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=362.53 Aligned_cols=199 Identities=23% Similarity=0.337 Sum_probs=173.4
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHc------cCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRI------HHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~~~~~~~~~ 438 (696)
.++|+++++||+|+||.||+|... +++.||||+++.. ....+++.+|+++++.+ +|+||++++++|...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999854 6899999999742 23346788899999988 466999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc--EEEEeeccch
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE--AQVSDFGLAK 516 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~--vkL~DfGls~ 516 (696)
+|||||+. ++|.+++.......+++..+++|+.||+.||+|||++ +|||||||++||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 6888888776655689999999999999999999999 9999999999999999887 9999999997
Q ss_pred hccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
..... ....+|+..|+|||++.+..++.++|||||||+||||++|+.+|....
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 54322 223578999999999999999999999999999999999999997643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=370.26 Aligned_cols=252 Identities=21% Similarity=0.355 Sum_probs=202.0
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC--CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
+.++|+++++||+|+||.||+|+.. +|+.||||++... .......+.+|+++|++++|+||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999864 7899999999643 234567899999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC---CCCcEEEEeeccchhc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKLA 518 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DfGls~~~ 518 (696)
|||+.+++|.+++..... +++..+++|+.||+.||+|||++ +|||||||++||||+ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999888866543 89999999999999999999999 999999999999994 5567999999999865
Q ss_pred cccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... .....+|+..|+|||++.+ .|+.++|||||||+||+|++|+.||.... ...+. ..+.. ..+.
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~---~~i~~-----~~~~ 240 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDIL---KRVET-----GKYA 240 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHH-----TCCC
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH---HHHHh-----CCCC
Confidence 4332 2334579999999999875 59999999999999999999999997543 11111 11111 0000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+.... .......+.+++++||+.||++|+++.|++++
T Consensus 241 -~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 -FDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -SCSGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCCcc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 01112368899999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.73 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=194.5
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc------ee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR------RL 439 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~------~~ 439 (696)
..+|+++++||+|+||.||+|++.++..||||++..... ...+|+++|+.++|+||++++++|...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999987777899998864322 23479999999999999999999976543 68
Q ss_pred EEEEecCCCchhhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC-CCCcEEEEeeccchh
Q 005443 440 LIYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKL 517 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL~DfGls~~ 517 (696)
|||||+.++.+....+. .....+++..++.++.||++||+|||++ +|+|||||++||||+ +++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655433321 1233489999999999999999999999 999999999999998 799999999999986
Q ss_pred ccccCcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH---Hhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS---HALE 593 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~---~~~~ 593 (696)
...... ....+|+..|+|||++.+. .++.++|||||||+||||++|+.||..... ...+.+....+-. ..+.
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG--IDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHH
Confidence 543322 2345689999999998764 589999999999999999999999986431 1112221111000 0000
Q ss_pred --hhhhhc-----ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 --NEEFDN-----LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 --~~~~~~-----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..++.+ +....+...+......++.+|+.+||+.||++|+++.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000 000000000111123478899999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=370.89 Aligned_cols=251 Identities=22% Similarity=0.380 Sum_probs=197.9
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.++|+++++||+|+||.||+|+.. +++.||||+++... ......+.+|+++|++++|+||++++++|.+.+..+|||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999964 68999999997543 234567999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC---CCcEEEEeeccchhcc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLAKLAL 519 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DfGls~~~~ 519 (696)
||+.+|+|.+++..... +++..++.|+.||+.||+|||++ +|||||||++||||+. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999888865543 89999999999999999999999 9999999999999976 4559999999998664
Q ss_pred ccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
... .....+|+..|+|||++. +.|+.++|||||||++|+|++|+.||.... ...+. ..+... .+ .
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~---~~i~~~-----~~-~ 255 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEIL---RKVEKG-----KY-T 255 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHHT-----CC-C
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHH---HHHHhC-----CC-C
Confidence 432 233457999999999986 569999999999999999999999997643 11111 111111 00 0
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+....+ . .....+.+|+++||+.||++|+++.|++++
T Consensus 256 ~~~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 FDSPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCchhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 001111 1 112368899999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.10 Aligned_cols=265 Identities=22% Similarity=0.343 Sum_probs=200.2
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeC-----Cce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 438 (696)
.++|+++++||+|+||.||+|... +++.||||++..... ...+.+.+|+++|++++|+||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999854 688999999974332 2336789999999999999999999999754 367
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+. ++|.+++... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 5888888653 389999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCcce--eeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 519 LDANTHI--TTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 519 ~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
....... ....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ..++.....+... ..+
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~-~~~ 254 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSP-SQE 254 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG---GHHHHHHHHHCSC-CHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHHHhCCC-CHH
Confidence 4332221 234578999999998765 55899999999999999999999999765422 2222111111000 000
Q ss_pred hhhc------------ccCcccC--CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDN------------LADPRLG--ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~------------~~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+.. +...... ..........+.+|+++||+.||++|+++.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000 00001112368899999999999999999999964
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.72 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=199.1
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..++|++.+.||+|+||.||+|.+. +|+.||||++... ...+++.+|+++|++++|+||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3478999999999999999999864 5899999999754 345678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+++|.+++.... ..+++..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999886322 2489999999999999999999999 999999999999999999999999999976544322
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ... ...+. ......+.
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~~~-----~~~~~~~~-- 246 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRA---IFMIP-----TNPPPTFR-- 246 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHH-----HSCCCCCS--
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHH---HHHHh-----cCCCcccC--
Confidence 22345689999999999999999999999999999999999999975321 111 10000 00000000
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........+.+++.+||+.||++||++.+|++.
T Consensus 247 -----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 247 -----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011112368899999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=369.48 Aligned_cols=253 Identities=27% Similarity=0.370 Sum_probs=204.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|++++|+||++++++|.+.+..+|||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67899999999999999999964 69999999996432 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 443 DYVPNNTLYFHLHGEG--RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||+.||+|.+++.... ...+++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999998886543 34589999999999999999999999 999999999999999999999999999986544
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
... .....+||..|+|||++.+..|+.++|||||||+||||++|+.||........ ..+....++...
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~--------- 409 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQA--------- 409 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCC---------
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcc---------
Confidence 332 23345799999999999999999999999999999999999999986543211 111111111100
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM-----GQVVR 640 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~ 640 (696)
..+.. .....+.+|+++||+.||++|+++ ++|++
T Consensus 410 --~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 --VTYPD----KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCCCT----TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --cCCCc----ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 00111 122368899999999999999976 55553
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=346.43 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=195.4
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--------ccHHHHHHHHHHHHHccCCCceeEEeEEeeC
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--------QGEREFKAEVEIISRIHHRHLVSLVGYCISD 435 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 435 (696)
..++|++.+.||+|+||.||+|... +|+.||||+++.... .....+.+|+++|++++|+||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999854 688999999864321 1224588999999999999999999998765
Q ss_pred CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc---EEEEee
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDF 512 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~Df 512 (696)
+ .++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 899999999999999887654 389999999999999999999999 9999999999999987654 999999
Q ss_pred ccchhccccCcceeeccccccccCchhhhc---cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH
Q 005443 513 GLAKLALDANTHITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589 (696)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (696)
|+++...... ......|+..|+|||++. ...++.++|||||||+||||++|+.||....... .+.+...
T Consensus 162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~---- 233 (322)
T 2ycf_A 162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT---- 233 (322)
T ss_dssp TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH----
T ss_pred ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH----
Confidence 9997654321 123356899999999974 4678899999999999999999999997644221 1111111
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
...+. + ...... .....+.+++++||+.||++||++.|+++
T Consensus 234 ----~~~~~-~-~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 ----SGKYN-F-IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----HTCCC-C-CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----hCccc-c-Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0 000000 11236889999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=354.00 Aligned_cols=261 Identities=22% Similarity=0.322 Sum_probs=194.9
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCC------
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 436 (696)
.++|++++.||+|+||.||+|.. .+|+.||||++..... ...+++.+|+++|++++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999986 4799999999864322 23467889999999999999999999998653
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..+|||||+ +++|.+++... .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 88998888753 389999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH------
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS------ 589 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~------ 589 (696)
..... ....+++..|+|||++.+ ..++.++|||||||+||||++|+.+|.+.+. .+.+......+.
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHH
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHH
Confidence 65432 234578999999999887 7899999999999999999999999986432 111111111000
Q ss_pred -Hhhhhhh-------hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 590 -HALENEE-------FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 590 -~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.... +.......+.. ........+++|+.+||+.||++|++++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000 00000011100 111223468899999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=383.39 Aligned_cols=243 Identities=25% Similarity=0.379 Sum_probs=200.7
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|+++++||+|+||.||+|+++ +++.||||+++.. .....+.+.+|..+|..+ +|+||+++++++.+.+..+|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 478999999999999999999964 6889999999743 233456788899999987 69999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+|+|.++++..+. +++..++.|+.||+.||+|||++ +|||||||++||||+.++++||+|||+++....
T Consensus 420 V~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999986544 89999999999999999999999 999999999999999999999999999985433
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
... .....+||..|+|||++.+..|+.++|||||||+||||++|+.||...+ ...+ ...++. .
T Consensus 495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~---~~~i~~----~------ 557 (674)
T 3pfq_A 495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDEL---FQSIME----H------ 557 (674)
T ss_dssp TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---HHHHHS----S------
T ss_pred CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHH---HHHHHh----C------
Confidence 322 2344679999999999999999999999999999999999999997643 1111 111111 0
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRM 635 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 635 (696)
.+ .+......++.+|+++||+.||++|+++
T Consensus 558 ---~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 558 ---NV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ---CC--CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ---CC--CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 00 1111222368899999999999999997
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=347.68 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=204.3
Q ss_pred hcCccccccccccCcEEEEEEEc--CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC------ceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL--PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH------LVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l~~~~~~~~~ 437 (696)
.++|+++++||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+++++.++|.| |+++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999985 36889999998643 233567889999999997654 9999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC--------------
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-------------- 503 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-------------- 503 (696)
.+|||||+ +++|.+++...+...+++..+++++.||+.||+|||++ +|+|||||++||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 88999888876655689999999999999999999999 9999999999999987
Q ss_pred -----CCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCch
Q 005443 504 -----NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578 (696)
Q Consensus 504 -----~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~ 578 (696)
++.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|+.+|.... ..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~ 240 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD---SK 240 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC---HH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---hH
Confidence 668999999999764332 233568999999999999999999999999999999999999997643 22
Q ss_pred hHHHhHHHHHHHh----hhh---hhhh------------------cccCcc-cCCCcchHHHHHHHHHHHHHhccCCCCC
Q 005443 579 SLVEWARPLLSHA----LEN---EEFD------------------NLADPR-LGENYVEGEMFRMIEAAAACVRHSAAKR 632 (696)
Q Consensus 579 ~l~~~~~~~~~~~----~~~---~~~~------------------~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~R 632 (696)
.........+... +.. ..+. +..... ............+.+|+.+||+.||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 2222221111100 000 0000 000000 0001122345578999999999999999
Q ss_pred CCHHHHHHH
Q 005443 633 PRMGQVVRV 641 (696)
Q Consensus 633 Ps~~ell~~ 641 (696)
|++.||+++
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999854
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=347.04 Aligned_cols=268 Identities=24% Similarity=0.338 Sum_probs=202.3
Q ss_pred HHhcCccccccccccCcEEEEEEEc--CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHc---cCCCceeEEeEEe---
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYL--PDGREVAIKQLKIGGG--QGEREFKAEVEIISRI---HHRHLVSLVGYCI--- 433 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l---~hpnIv~l~~~~~--- 433 (696)
...++|++++.||+|+||.||+|++ .+|+.||||+++.... .....+.+|+.+++.+ +|+||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999986 4688999999974332 2234567788887776 7999999999987
Q ss_pred --eCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEe
Q 005443 434 --SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSD 511 (696)
Q Consensus 434 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~D 511 (696)
..+..++||||+. |+|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4556799999997 6898888776555689999999999999999999999 999999999999999999999999
Q ss_pred eccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 512 FGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 512 fGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
||+++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.+|.... ....+......+...
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHHcCCC
Confidence 99997654322 2233568999999999999999999999999999999999999997643 122221111111000
Q ss_pred hhhhhhhcc-------cC---cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 592 LENEEFDNL-------AD---PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 592 ~~~~~~~~~-------~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....+... +. ......+.......+.+|+++||+.||++||++.|++++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 -GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp -CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 00 000001111223468899999999999999999999853
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.26 Aligned_cols=253 Identities=22% Similarity=0.336 Sum_probs=202.3
Q ss_pred HHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC---------ccHHHHHHHHHHHHHcc-CCCceeEEeEE
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG---------QGEREFKAEVEIISRIH-HRHLVSLVGYC 432 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~il~~l~-hpnIv~l~~~~ 432 (696)
...++|++.++||+|+||.||+|..+ +|+.||||+++.... ...+.+.+|+++|+++. |+||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999964 689999999975431 12356789999999996 99999999999
Q ss_pred eeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEee
Q 005443 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDF 512 (696)
Q Consensus 433 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~Df 512 (696)
...+..++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999987643 389999999999999999999999 9999999999999999999999999
Q ss_pred ccchhccccCcceeeccccccccCchhhhc------cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH
Q 005443 513 GLAKLALDANTHITTRVMGTFGYMAPEYAS------SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 513 Gls~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
|+++...... ......|+..|+|||++. ...++.++|||||||+||||++|+.||.... ... ....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~---~~~~ 240 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QML---MLRM 240 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH---HHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHH---HHHH
Confidence 9997654332 223356899999999985 4568889999999999999999999997532 111 1111
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
+... .+. +... ........+.+++.+||+.||++||++.||++
T Consensus 241 ~~~~-----~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSG-----NYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHT-----CCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcC-----Ccc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1110 000 0000 01112236889999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.50 Aligned_cols=255 Identities=20% Similarity=0.337 Sum_probs=196.8
Q ss_pred HHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHcc--CCCceeEEeEEeeCCc
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIH--HRHLVSLVGYCISDDR 437 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~ 437 (696)
+....++|+++++||+|+||.||++...+|+.||||+++.... ...+.+.+|++++++++ |+||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3334578999999999999999999988899999999975432 23467899999999997 5999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.+|||| +.+++|.+++.... .+++..++.|+.||++||+|||++ +|+|||||++||||++ +.+||+|||+++.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999999 56889999987654 389999999999999999999999 9999999999999965 7999999999986
Q ss_pred ccccCcc-eeeccccccccCchhhhcc-----------CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHH
Q 005443 518 ALDANTH-ITTRVMGTFGYMAPEYASS-----------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 585 (696)
Q Consensus 518 ~~~~~~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~ 585 (696)
....... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ......
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~ 250 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH 250 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHH
Confidence 5443222 2234568999999999875 4688899999999999999999999975321 111111
Q ss_pred HHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 586 PLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+ +......+.......+.+++++||+.||++||++.||++.
T Consensus 251 ~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 AII-------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHH-------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHH-------------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111 1111111111112368899999999999999999999865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=358.91 Aligned_cols=266 Identities=22% Similarity=0.315 Sum_probs=194.1
Q ss_pred HHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----
Q 005443 363 VKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDD----- 436 (696)
Q Consensus 363 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 436 (696)
....++|+++++||+|+||.||+|.+ .+|+.||||++..... .+.+|+++|+.++|+||++++++|...+
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999985 5799999999874422 2347999999999999999999985432
Q ss_pred ---------------------------------ceeEEEEecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHH
Q 005443 437 ---------------------------------RRLLIYDYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYL 481 (696)
Q Consensus 437 ---------------------------------~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~L 481 (696)
..+|||||+. ++|.+.+.. .....+++..++.++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3789999997 466665542 2233589999999999999999999
Q ss_pred HhcCCCceeeccCCCCceEEC-CCCcEEEEeeccchhccccCcceeeccccccccCchhhhccC-CCCccccccchHHHH
Q 005443 482 HEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVL 559 (696)
Q Consensus 482 H~~~~~~ivHrDLkp~NILl~-~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll 559 (696)
|++ +|+|||||++||||+ +++.+||+|||+++....... .....|+..|+|||++.+. .++.++|||||||+|
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 999999999999997 688999999999986543332 2335689999999998874 589999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhHHHhHHHHHHH----hhh--hhhhhc-----ccCcccCCCcchHHHHHHHHHHHHHhccC
Q 005443 560 LELITGRKPVDASQPLGDESLVEWARPLLSH----ALE--NEEFDN-----LADPRLGENYVEGEMFRMIEAAAACVRHS 628 (696)
Q Consensus 560 ~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~----~~~--~~~~~~-----~~d~~l~~~~~~~~~~~l~~li~~cl~~d 628 (696)
|||++|+.+|..... .+.+.+... .+.. .+. +..+.+ +....+...+.......+.+|+.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~--~~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETS--IDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSH--HHHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCCh--HHHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999986431 111111111 1100 000 000001 01111111111222346889999999999
Q ss_pred CCCCCCHHHHHHH
Q 005443 629 AAKRPRMGQVVRV 641 (696)
Q Consensus 629 P~~RPs~~ell~~ 641 (696)
|++|+++.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.25 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=186.1
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
..++|++.++||+|+||.||+|... +|+.||||++.... ....+++.+|++++++++|+||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999854 68999999986543 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhcccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 443 DYVPNNTLYFHLHG------EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 443 E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
||+.+++|.+++.. .....+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999888863 1233489999999999999999999999 99999999999999999999999999997
Q ss_pred hccccCc----ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 517 LALDANT----HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 517 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
....... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ... ...+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~---~~~~~~~ 243 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---KVL---MLTLQND 243 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHH---HHHHTSS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh---hHH---HHHhccC
Confidence 6543321 11233568999999999876 56899999999999999999999999764321 111 1011100
Q ss_pred hhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 592 LENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. .......+..+...+ ...+.+++.+||+.||++||++.||+++
T Consensus 244 ~~-~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 244 PP-SLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CC-CTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CC-ccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 000001111111122 2368899999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.44 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=199.1
Q ss_pred HhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
..++|++.++||+|+||.||+|.+++ .||||+++.... ...+.+.+|+.++++++|+||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35789999999999999999998743 499999875432 23456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+++|.+++...+ ..+++..+++|+.||+.||+|||++ +|+|||||++||||+ ++.+||+|||+++......
T Consensus 109 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999997644 3489999999999999999999999 999999999999998 5799999999986543211
Q ss_pred ----cceeeccccccccCchhhhcc---------CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH
Q 005443 523 ----THITTRVMGTFGYMAPEYASS---------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589 (696)
Q Consensus 523 ----~~~~~~~~gt~~y~aPE~l~~---------~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~ 589 (696)
........|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.. .+
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~---~~-- 255 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---AEAIIW---QM-- 255 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---HHHHHH---HH--
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---Hh--
Confidence 112223458899999999874 457889999999999999999999997532 111111 11
Q ss_pred HhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.......+... .+. ..+.+++.+||+.||++||++.+|++.|+++...
T Consensus 256 ---~~~~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 256 ---GTGMKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---HTTCCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---ccCCCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111111 111 2588999999999999999999999999988754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.45 Aligned_cols=253 Identities=11% Similarity=0.033 Sum_probs=181.7
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC---ccHHHHHHHHHHHHHc--cCCCceeEE-------eEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG---QGEREFKAEVEIISRI--HHRHLVSLV-------GYCI 433 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l--~hpnIv~l~-------~~~~ 433 (696)
.+|++.++||+|+||.||+|++ .+|+.||||+++.... ...+.+++|+++++.| +|+||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4588999999999999999995 4789999999986543 2345678887666666 599988755 4444
Q ss_pred eC-----------------CceeEEEEecCCCchhhccccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCcee
Q 005443 434 SD-----------------DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR------VKIAAGAARGLAYLHEDCHPRII 490 (696)
Q Consensus 434 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qia~gL~~LH~~~~~~iv 490 (696)
.. +..+|||||+. |+|.+++...+. .+.+..+ +.|+.||+.||+|||++ +||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 33 23799999998 899999876432 2355555 77889999999999999 999
Q ss_pred eccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCC
Q 005443 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKP 568 (696)
Q Consensus 491 HrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~P 568 (696)
|||||++||||+.++.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999865322 213457799999999987 6799999999999999999999999
Q ss_pred CCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 569 VDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 569 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
|..........+ ....+.......+...........+.+|+.+||+.||++||++.|+++
T Consensus 293 f~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSW------------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCC------------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccch------------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 986542211100 000000000111111111122346889999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=350.76 Aligned_cols=263 Identities=21% Similarity=0.253 Sum_probs=191.8
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCC------
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDD------ 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 436 (696)
.++|++++.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+.+++.++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999985 4689999999975432 23456889999999999999999999998655
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..+|||||+.+ +|.+++.. .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 67999999975 67776652 288999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH----------
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP---------- 586 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~---------- 586 (696)
...... .....+|+..|+|||++.+..++.++|||||||+||||++|+.||...+. .........
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCCCHHHH
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHH
Confidence 654322 22345789999999999999999999999999999999999999976431 111111000
Q ss_pred -----HHHHhhhh------hhhhcccCcccCC---CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 587 -----LLSHALEN------EEFDNLADPRLGE---NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 587 -----~~~~~~~~------~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+...... ..+..+....+.. .........+.+|+++||+.||++|++++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 0000000000000 0112224578999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.17 Aligned_cols=254 Identities=19% Similarity=0.275 Sum_probs=174.4
Q ss_pred HhcCcccc-ccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee----CCce
Q 005443 365 ATDGFADQ-NLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRR 438 (696)
Q Consensus 365 ~~~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~ 438 (696)
..++|.+. ++||+|+||.||+|.+. +|+.||||++... .....+....++.++|+||+++++++.. .+..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 34678885 47999999999999865 6999999998632 2233333344667789999999999876 3457
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC---CCcEEEEeeccc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLA 515 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DfGls 515 (696)
+|||||+.+|+|.+++.......+++..+++|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999999877666799999999999999999999999 9999999999999976 455999999999
Q ss_pred hhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
+...... .....|+..|+|||++.+..++.++|||||||+||||++|+.||........ ...... .....
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~----~~~~~ 248 (336)
T 3fhr_A 179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKR----RIRLG 248 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHH----hhhcc
Confidence 7654322 2335689999999999888899999999999999999999999975432111 000000 00000
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+ .+... ........+.+|+++||+.||++||++.||+++
T Consensus 249 ~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 QY-GFPNP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---CCCTT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cc-ccCch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 00000 001122368899999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=340.92 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=183.5
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc-cH-HHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ-GE-REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.++|+++++||+|+||.||+|+. .+|+.||||+++..... .. +.+.++..+++.++|+||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999985 57899999999754322 22 23445555677889999999999999999999999
Q ss_pred EecCCCchhhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 443 DYVPNNTLYFHLHG--EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 443 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||+.+ +|.+++.. .....+++..+++|+.||+.||+|||+++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 77666543 12335899999999999999999999853 899999999999999999999999999976544
Q ss_pred cCcceeeccccccccCchhhh----ccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 521 ANTHITTRVMGTFGYMAPEYA----SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
... .....|+..|+|||++ .+..++.++|||||||++|||++|+.||..... .. +.....+. ..
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~-~~~~~~~~----~~- 230 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----PF-QQLKQVVE----EP- 230 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----HH-HHHHHHHH----SC-
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----hH-HHHHHHhc----cC-
Confidence 322 2234689999999996 456789999999999999999999999975321 11 11111111 10
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
...+. ... ....+.+++.+||+.||++||++.||++
T Consensus 231 ~~~~~----~~~----~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 SPQLP----ADK----FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCC----TTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcc----ccc----CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00000 011 1236889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=365.17 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=200.0
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-------------ccHHHHHHHHHHHHHccCCCceeEEe
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-------------QGEREFKAEVEIISRIHHRHLVSLVG 430 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~E~~il~~l~hpnIv~l~~ 430 (696)
..++|.++++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+++|++++|+||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999964 688999999974321 33567899999999999999999999
Q ss_pred EEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC---cE
Q 005443 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF---EA 507 (696)
Q Consensus 431 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~---~v 507 (696)
+|.+.+..+||||||.+|+|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999888876543 89999999999999999999999 999999999999998775 69
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~ 587 (696)
||+|||+++...... .....+|+..|+|||++. +.++.++|||||||++|+|++|+.||.... ...+++ .+
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~---~i 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIK---KV 259 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HH
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HH
Confidence 999999998654432 233457999999999987 468999999999999999999999998643 111111 11
Q ss_pred HHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. ..+. .+..... .....+.+|+++||+.||++||++.|++++
T Consensus 260 ~~-----~~~~--~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 EK-----GKYY--FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HH-----CCCC--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hc-----CCCC--CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 0000 0000000 112368899999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=358.53 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=154.6
Q ss_pred cCccc-cccccccCcEEEEEEEcC---CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee--CCceeE
Q 005443 367 DGFAD-QNLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLL 440 (696)
Q Consensus 367 ~~~~~-~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 440 (696)
+.|++ .++||+|+||.||+|++. +++.||||+++.. .....+.+|+++|++|+|+||++++++|.. ++..+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45665 458999999999999954 5789999998643 334578899999999999999999999965 567899
Q ss_pred EEEecCCCchhhcccc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE----CCCCcEEE
Q 005443 441 IYDYVPNNTLYFHLHG-------EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL----DNNFEAQV 509 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~-------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl----~~~~~vkL 509 (696)
||||+.+ +|.+++.. .....+++..++.|+.||+.||+|||++ +|||||||++|||| ++++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999964 66665542 1122489999999999999999999999 99999999999999 67789999
Q ss_pred EeeccchhccccCc--ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 510 SDFGLAKLALDANT--HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 510 ~DfGls~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
+|||+++....... ......+|+..|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987643322 22334678999999999987 458999999999999999999999997654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.31 Aligned_cols=273 Identities=19% Similarity=0.228 Sum_probs=190.7
Q ss_pred HHHHHHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc-
Q 005443 360 EELVKATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDR- 437 (696)
Q Consensus 360 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~- 437 (696)
++.....++|++.++||+|+||.||+|++. +|+.||||++.... .....+.+|++.++.++|+||++++++|...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456667789999999999999999999964 68999999986443 334467788999999999999999999976443
Q ss_pred ------eeEEEEecCCCchhhccc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCceeeccCCCCceEECC-CCcE
Q 005443 438 ------RLLIYDYVPNNTLYFHLH-GEGRPVLDWATRVKIAAGAARGLAYLH--EDCHPRIIHRDIKSSNILLDN-NFEA 507 (696)
Q Consensus 438 ------~~lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~qia~gL~~LH--~~~~~~ivHrDLkp~NILl~~-~~~v 507 (696)
.+|||||+.++.+..+.. ......+.+..++.++.||+.||.||| ++ +|+|||||++||||+. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 789999998754332221 122334889999999999999999999 77 9999999999999986 8999
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
||+|||+++....... .....|+..|+|||++.+. .++.++|||||||+||||++|+.||.... ....+.....
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN---SAGQLHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC---hHHHHHHHHH
Confidence 9999999986654332 2345689999999998764 48999999999999999999999998643 1222211111
Q ss_pred HHH----Hhhhh----hhhhcccCc------ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 587 LLS----HALEN----EEFDNLADP------RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 587 ~~~----~~~~~----~~~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+. ..+.. .....+.+. .+...........+.+|+.+||+.||++|+++.||+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 110 00000 000000000 00011111234578999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.73 Aligned_cols=262 Identities=22% Similarity=0.326 Sum_probs=183.3
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC------C
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD------D 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 436 (696)
.++|++++.||+|+||.||+|.. .+|+.||||++..... ...+++.+|+++|++++|+||+++++++... +
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999984 4789999999864322 3346788999999999999999999998754 4
Q ss_pred ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 437 RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 437 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..++|+||+ +++|.+++... .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 579999999 78898888652 489999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH-----
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH----- 590 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~----- 590 (696)
..... ....+|+..|+|||++.+ ..++.++|||||||+||||++|+.+|.+.+. ...+......+..
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHH
Confidence 65432 234578999999999987 6789999999999999999999999976432 1222111111100
Q ss_pred --hhhhhhhhcccC---cccCCCc---chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 --ALENEEFDNLAD---PRLGENY---VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 --~~~~~~~~~~~d---~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+......+++. ..-...+ .......+.+|+.+||+.||++|+++.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000 0000000 00112368899999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=377.58 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=204.6
Q ss_pred HHhcCccccccccccCcEEEEEEEcC----CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP----DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
...++|++.++||+|+||.||+|.+. .+..||||+++.... ...+.+.+|+.+|++++|+||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34578999999999999999999863 256799999875433 23467999999999999999999999985 5678
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
+|||||+.+|+|.++++... ..+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999987543 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
............++..|+|||++.+..++.++|||||||+||||++ |+.||.... ...+.... .....
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~---~~~~~~~i--------~~~~~ 610 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRI--------ENGER 610 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH--------HHTCC
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH--------HcCCC
Confidence 5444333334457789999999999999999999999999999997 999997543 11211111 01000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. .+ .......+.+|+.+||+.||++||++.||++.|+++..
T Consensus 611 ~-----~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 611 L-----PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp C-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-----CC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0 01 11122368899999999999999999999999998864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.75 Aligned_cols=263 Identities=21% Similarity=0.310 Sum_probs=192.8
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEe-----------
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCI----------- 433 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----------- 433 (696)
.++|+++++||+|+||.||+|... +|+.||||++........+++.+|++++++++|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999965 58999999998665555678999999999999999999999874
Q ss_pred ---eCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC-CCCcEEE
Q 005443 434 ---SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQV 509 (696)
Q Consensus 434 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vkL 509 (696)
+.+..++||||+. |+|.+++... .+.+..++.++.||++||+|||++ +|+|||||++||||+ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3356789999997 6898888642 388999999999999999999999 999999999999997 5679999
Q ss_pred EeeccchhccccCc--ceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH
Q 005443 510 SDFGLAKLALDANT--HITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 586 (696)
Q Consensus 510 ~DfGls~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~ 586 (696)
+|||+++....... .......++..|+|||++.+ ..++.++|||||||+||||++|+.||..... ....+ .
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~---~ 236 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQ---L 236 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---H
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHH---H
Confidence 99999986543211 11233467889999998876 7789999999999999999999999986431 11111 1
Q ss_pred HHHHhh--hhhhhhccc-------CcccCC------CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 587 LLSHAL--ENEEFDNLA-------DPRLGE------NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 587 ~~~~~~--~~~~~~~~~-------d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
++.... ..+...++. ...+.. .........+.+++++||+.||++||++.||+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 111000 000000000 000000 0001122468899999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.08 Aligned_cols=202 Identities=24% Similarity=0.309 Sum_probs=172.1
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CC-----CceeEEeEEeeCCc
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HR-----HLVSLVGYCISDDR 437 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hp-----nIv~l~~~~~~~~~ 437 (696)
..++|++.++||+|+||.||+|... +|+.||||+++.. .....++.+|+++++.++ |. +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999854 6889999999732 223456788999999886 55 49999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC--CCCcEEEEeeccc
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD--NNFEAQVSDFGLA 515 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DfGls 515 (696)
.+|||||+. ++|.+++.......+++..+++|+.||+.||.|||.+ ..+|||||||++||||+ +++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 5898888776555689999999999999999999952 12899999999999994 5778999999999
Q ss_pred hhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
+..... ....+|+..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 765432 233578999999999999999999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=336.64 Aligned_cols=253 Identities=21% Similarity=0.351 Sum_probs=201.9
Q ss_pred HHhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 364 KATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 364 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
...++|+++++||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++|+||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999964 78999999997542 3456789999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCC---CcEEEEeeccchh
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN---FEAQVSDFGLAKL 517 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~---~~vkL~DfGls~~ 517 (696)
||||+.+++|.+++.... .+++..+++++.||+.||+|||++ +|+|||||++||||+.+ +.+||+|||+++.
T Consensus 99 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999988876544 389999999999999999999999 99999999999999654 4799999999986
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
...... .....|+..|+|||++.+ .++.++|||||||+||||++|+.||.... ...+. ..+.. ..+
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~---~~~~~-----~~~ 239 (287)
T 2wei_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDIL---KRVET-----GKY 239 (287)
T ss_dssp BCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHH-----CCC
T ss_pred ecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHH---HHHHc-----CCC
Confidence 543322 223458899999999875 48999999999999999999999997643 11111 11111 100
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. +....+ . .....+.+++++||+.||++||++.||++.
T Consensus 240 ~-~~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 240 A-FDLPQW-R----TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp C-CCSGGG-T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred C-CCchhh-h----hcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 000000 1 112368899999999999999999999873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=337.35 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=192.4
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee---------
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS--------- 434 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--------- 434 (696)
..++|+++++||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|++++++++|+||++++++|.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 456899999999999999999995 47999999999643 2334678999999999999999999998865
Q ss_pred ----CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEE
Q 005443 435 ----DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (696)
Q Consensus 435 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (696)
.+..++||||+.+++|.+++.... ..+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 345689999999999999997543 3478899999999999999999999 99999999999999999999999
Q ss_pred eeccchhccccC-------------cceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCC
Q 005443 511 DFGLAKLALDAN-------------THITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLG 576 (696)
Q Consensus 511 DfGls~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~ 576 (696)
|||+++...... ........|+..|+|||++.+. .++.++|||||||++|||++ +|..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~----- 230 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST----- 230 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS-----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC-----
Confidence 999997654221 1122335689999999999864 78999999999999999998 4432
Q ss_pred chhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 577 DESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.....+....+. .. ...+...+.......+.+++++||+.||++||++.+|+++
T Consensus 231 ~~~~~~~~~~~~-----~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 231 GMERVNILKKLR-----SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHHHH-----ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chhHHHHHHhcc-----cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111110 00 0111112222333468899999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.60 Aligned_cols=245 Identities=23% Similarity=0.379 Sum_probs=191.1
Q ss_pred HHHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc------cHHHHHHHHHHHHHc----cCCCceeEEe
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ------GEREFKAEVEIISRI----HHRHLVSLVG 430 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~il~~l----~hpnIv~l~~ 430 (696)
.....++|+++++||+|+||.||+|++ .+|+.||||+++..... ....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999985 47899999999754322 223466899999999 8999999999
Q ss_pred EEeeCCceeEEEEe-cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC-CCCcEE
Q 005443 431 YCISDDRRLLIYDY-VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQ 508 (696)
Q Consensus 431 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vk 508 (696)
++...+..++|||| +.+++|.+++...+. +++..+++++.||+.||+|||++ +|+|||||++||||+ +++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 99999999999999 789999999876443 89999999999999999999999 999999999999998 889999
Q ss_pred EEeeccchhccccCcceeeccccccccCchhhhccCCCC-ccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH
Q 005443 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLT-EKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587 (696)
Q Consensus 509 L~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~ 587 (696)
|+|||+++...... .....|+..|+|||++.+..+. .++|||||||+||||++|+.+|... ...
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~------- 245 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEI------- 245 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHH-------
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HHH-------
Confidence 99999998664432 2345689999999999876664 5899999999999999999999642 110
Q ss_pred HHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. ... .+... ....+.+++++||+.|+++||+++||+++
T Consensus 246 ~~-----~~~------~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 LE-----AEL------HFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HH-----TCC------CCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hh-----hcc------CCccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000 01111 12368899999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=347.92 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=197.9
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeC-----Cce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 438 (696)
.++|++.++||+|+||.||+|.+. +|+.||||+++.... ....++.+|+++|++++|+||+++++++... +..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999964 689999999964332 2345688999999999999999999988764 567
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
++||||+. ++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6888887653 389999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCcc---------eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 519 LDANTH---------ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 519 ~~~~~~---------~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
...... .....+|+..|+|||++.+ ..++.++|||||||+||||++|+.+|..... ..........+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQLLLIFGII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHh
Confidence 432211 1123468999999998765 7789999999999999999999999986431 11111111111
Q ss_pred HHhhhhhhh--------hcccCc--ccCC----CcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 589 SHALENEEF--------DNLADP--RLGE----NYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 589 ~~~~~~~~~--------~~~~d~--~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........+ .+.... .... .........+.+|+++||+.||++||++.||+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 100000000 000000 0000 0001122367899999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=347.92 Aligned_cols=268 Identities=19% Similarity=0.285 Sum_probs=200.9
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-----------CCCceeEEeEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-----------HRHLVSLVGYCI 433 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l~~~~~ 433 (696)
.++|+++++||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36799999999999999999985 57899999998732 233567889999999886 789999999998
Q ss_pred eCC----ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC------C
Q 005443 434 SDD----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD------N 503 (696)
Q Consensus 434 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~------~ 503 (696)
..+ ..++||||+ +++|.+++.......+++..+++|+.||+.||+|||+++ +|||||||++||||+ +
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 654 678999999 899999887765556899999999999999999999953 899999999999994 4
Q ss_pred CCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHh
Q 005443 504 NFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583 (696)
Q Consensus 504 ~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~ 583 (696)
++.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||............+.
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999765432 2334689999999999999999999999999999999999999986543211111111
Q ss_pred HHHHHHHh-------hhhhh-----------hhcccCcc---------cCCCcchHHHHHHHHHHHHHhccCCCCCCCHH
Q 005443 584 ARPLLSHA-------LENEE-----------FDNLADPR---------LGENYVEGEMFRMIEAAAACVRHSAAKRPRMG 636 (696)
Q Consensus 584 ~~~~~~~~-------~~~~~-----------~~~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 636 (696)
...++... +.... +..+.... ....+.......+.+|+++||+.||++||+++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 11111100 00000 00000000 01123445667899999999999999999999
Q ss_pred HHHHH
Q 005443 637 QVVRV 641 (696)
Q Consensus 637 ell~~ 641 (696)
||+++
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.44 Aligned_cols=264 Identities=19% Similarity=0.280 Sum_probs=200.5
Q ss_pred hcCccccccccccCcEEEEEEEcC-CC-cEEEEEEeecCCCccHHHHHHHHHHHHHccCCC------ceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DG-REVAIKQLKIGGGQGEREFKAEVEIISRIHHRH------LVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l~~~~~~~~~ 437 (696)
.++|+++++||+|+||.||+|... ++ +.||||+++.. ....+.+.+|+++|++++|.| |+.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999853 34 68999998632 234567889999999998765 8999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE----------------
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL---------------- 501 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl---------------- 501 (696)
.+|||||+ +++|.+++.......+++..+++|+.||+.||+|||++ +|+|||||++||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 66666666655545689999999999999999999999 99999999999999
Q ss_pred ---CCCCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCch
Q 005443 502 ---DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578 (696)
Q Consensus 502 ---~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~ 578 (696)
+.++.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.... ..
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~ 245 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE---NR 245 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HH
Confidence 56789999999999764332 233568999999999999999999999999999999999999998643 22
Q ss_pred hHHHhHHHHHHH----hhhhhhhhc-ccCcc---------------------cCCCcchHHHHHHHHHHHHHhccCCCCC
Q 005443 579 SLVEWARPLLSH----ALENEEFDN-LADPR---------------------LGENYVEGEMFRMIEAAAACVRHSAAKR 632 (696)
Q Consensus 579 ~l~~~~~~~~~~----~~~~~~~~~-~~d~~---------------------l~~~~~~~~~~~l~~li~~cl~~dP~~R 632 (696)
.........+.. .+....... +.... ........+...+.+|+++||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 222222211110 000000000 00000 0001112334578899999999999999
Q ss_pred CCHHHHHHH
Q 005443 633 PRMGQVVRV 641 (696)
Q Consensus 633 Ps~~ell~~ 641 (696)
|++.||+++
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999853
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.57 Aligned_cols=260 Identities=19% Similarity=0.286 Sum_probs=195.4
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce----
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR---- 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~---- 438 (696)
.++|.+.++||+|+||.||+|.. .+|+.||||+++.... ...+++.+|+.++++++|+||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999985 4689999999975432 2246788999999999999999999999877654
Q ss_pred --eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 439 --LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 439 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
++||||+. ++|.+++.. .+++..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 678777643 289999999999999999999999 99999999999999999999999999998
Q ss_pred hccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----Hh
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----HA 591 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~~ 591 (696)
..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ...+........ ..
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCHHH
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCcHHH
Confidence 65432 233568999999999987 7889999999999999999999999976431 111111111000 00
Q ss_pred ---hhhh----hhhcccCcccCCCc---chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 592 ---LENE----EFDNLADPRLGENY---VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 592 ---~~~~----~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
+... .+..+.. .....+ .......+.+|+++||+.||++|+++.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQ-TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCC-CcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 0000000 000000 01113468899999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.69 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=199.0
Q ss_pred HHHHHHhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc------cHHHHHHHHHHHHHcc--CCCceeEEe
Q 005443 360 EELVKATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ------GEREFKAEVEIISRIH--HRHLVSLVG 430 (696)
Q Consensus 360 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~il~~l~--hpnIv~l~~ 430 (696)
++.....++|+++++||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 33444568899999999999999999984 57899999999754322 2245778999999996 599999999
Q ss_pred EEeeCCceeEEEEecCC-CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC-CCCcEE
Q 005443 431 YCISDDRRLLIYDYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQ 508 (696)
Q Consensus 431 ~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~-~~~~vk 508 (696)
++...+..++||||+.+ ++|.+++...+ .+++..++.|+.||+.||+|||++ +|+|||||++||||+ +++.+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999999986 89998887644 389999999999999999999999 999999999999998 788999
Q ss_pred EEeeccchhccccCcceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHH
Q 005443 509 VSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587 (696)
Q Consensus 509 L~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~ 587 (696)
|+|||+++...... .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||.... ..
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~------- 255 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI------- 255 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh-------
Confidence 99999997654332 233568999999999987665 678999999999999999999996421 10
Q ss_pred HHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. .. .. +...+ ...+.+|+++||+.||++||+++||++.
T Consensus 256 ~~----~~---~~----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 IR----GQ---VF----FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HH----CC---CC----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hc----cc---cc----ccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 00 11112 2368899999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.98 Aligned_cols=260 Identities=19% Similarity=0.276 Sum_probs=195.6
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc-----
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR----- 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 437 (696)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++..... ...+++.+|+.+|++++|+||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36799999999999999999985 4689999999965432 224578899999999999999999999987654
Q ss_pred -eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 438 -RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 438 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
.++||||+. ++|.+++.. .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 688777643 389999999999999999999999 99999999999999999999999999997
Q ss_pred hccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHH-----
Q 005443 517 LALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSH----- 590 (696)
Q Consensus 517 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~----- 590 (696)
..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ...+.........
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCHHH
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHH
Confidence 64332 233568999999999887 6789999999999999999999999986431 1111111111000
Q ss_pred --hhhhh----hhhccc---CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 591 --ALENE----EFDNLA---DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 591 --~~~~~----~~~~~~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+... .+..+. ...+. .........+.+|+++||+.||++|+++.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000000 00000 0111223478899999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.22 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=176.4
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHH-HHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVE-IISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++++.||+|+||.||+|... +|+.||||+++.... ....++.+|+. +++.++|+||+++++++...+..+||||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67899999999999999999964 689999999975533 23345666666 6677899999999999999999999999
Q ss_pred ecCCCchhhcccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 444 YVPNNTLYFHLHG---EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 444 ~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
|+.+ +|.+++.. .....+++..+++++.||+.||.|||++. +|+|||||++||||+.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9975 66655542 22345899999999999999999999853 799999999999999999999999999976543
Q ss_pred cCcceeeccccccccCchhhh----ccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 521 ANTHITTRVMGTFGYMAPEYA----SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||....... +.. ..... ..
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~----~~~~~-~~ 246 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQL----TQVVK-GD 246 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCCCC-SC
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHH----HHHhc-CC
Confidence 322 2234689999999998 45678999999999999999999999997532110 000 00000 00
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ..+...........+.+|+++||+.||++||++.||++.
T Consensus 247 ~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 247 P-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp C-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred C-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0 011111111122368899999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=347.72 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=187.0
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++|+++ +|+||+++++++.+++..+|||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456667899999999998776668999999998743 345678999999987 8999999999999999999999999
Q ss_pred CCCchhhccccCCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-------------CCcE
Q 005443 446 PNNTLYFHLHGEGRPV-----LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-------------NFEA 507 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-------------~~~v 507 (696)
. |+|.+++....... ..+..+++|+.||+.||+|||++ +|||||||++||||+. ++.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999887643311 12334578999999999999999 9999999999999965 3589
Q ss_pred EEEeeccchhccccCcc---eeeccccccccCchhhhcc-------CCCCccccccchHHHHHHHHh-CCCCCCCCCCCC
Q 005443 508 QVSDFGLAKLALDANTH---ITTRVMGTFGYMAPEYASS-------GKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLG 576 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~ 576 (696)
||+|||+++........ ......|+..|+|||++.+ ..++.++|||||||+||||++ |+.||.....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-- 245 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-- 245 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT--
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh--
Confidence 99999999876543321 1233579999999999975 678999999999999999999 9999975321
Q ss_pred chhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 577 DESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 577 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
... .++....... .+...........+.+++.+||+.||++||++.||++
T Consensus 246 --~~~----~i~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 --RES----NIIRGIFSLD--------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHH----HHHHTCCCCC--------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hHH----HHhcCCCCcc--------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 001 1111111000 1111112334457899999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=331.76 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=178.5
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCcc-H-HHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG-E-REFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
.++|++++.||+|+||.||+|.+. +|+.||||+++...... . +.+.++..+++.++|+||+++++++...+..+|||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999964 78999999997553322 2 23445556778889999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
||+ ++.+..++... ...+++..+++++.||++||+|||+ + +|+|||||++||||+.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 45554444322 2348999999999999999999998 5 8999999999999999999999999999765443
Q ss_pred CcceeeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 522 NTHITTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
.. .....|+..|+|||++. ...++.++|||||||+||||++|+.||..... .. +.....+. . .
T Consensus 179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~---~~~~~~~~----~-~ 246 (318)
T 2dyl_A 179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DF---EVLTKVLQ----E-E 246 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HH---HHHHHHHH----S-C
T ss_pred cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cH---HHHHHHhc----c-C
Confidence 22 23346899999999994 46688999999999999999999999975321 11 11111111 0 0
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.. ...+ ...+.+++++||+.||++||+++||+++
T Consensus 247 ~~~~~~---~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 PPLLPG---HMGF----SGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCCCS---SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCCc---cCCC----CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000000 0011 2368899999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.79 Aligned_cols=231 Identities=11% Similarity=0.085 Sum_probs=183.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCcc---HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQG---EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++.++||+|+||.||+|++. +|+.||||+++...... .+++.+|++++++++|+||+++++++.+++..+|||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999964 58999999997554332 367899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.|++|.+++... ....++++|+.||+.||+|||++ +|+|||||++||||++++.+||+++|.
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~-------- 175 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT-------- 175 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC--------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc--------
Confidence 999999999998542 35567889999999999999999 999999999999999999999985432
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchh-HHHhHHHHHHHhhhhhhhhccc
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES-LVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
++ .++.++|||||||+||||++|+.||.......... ..+.. .. ...
T Consensus 176 -------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------~~---~~~ 223 (286)
T 3uqc_A 176 -------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT---------AG---QPI 223 (286)
T ss_dssp -------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT---------TS---CBC
T ss_pred -------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh---------cc---CCC
Confidence 22 36789999999999999999999998754321100 00000 00 000
Q ss_pred C-cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 602 D-PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 602 d-~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
. ..+.. .....+.+|+.+||+.||++| ++.|+++.|+++...+
T Consensus 224 ~~~~~~~----~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 224 EPADIDR----DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CHHHHCT----TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred Chhhccc----CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0 00011 112368899999999999999 9999999999987644
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=345.49 Aligned_cols=248 Identities=25% Similarity=0.312 Sum_probs=185.3
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.+|.+.++||+|+||.||.....+|+.||||++..... ..+.+|+++|+++ +|+||+++++++.+.+..+|||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 56899999999999986655555899999999864322 2367899999999 7999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-----CCcEEEEeeccchhccc
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-----NFEAQVSDFGLAKLALD 520 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DfGls~~~~~ 520 (696)
. |+|.+++...... +.+..++.|+.||+.||+|||++ +|||||||++||||+. +..+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6 6898888765432 44456678999999999999999 9999999999999943 34688999999986643
Q ss_pred cCc--ceeeccccccccCchhhhc---cCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 521 ANT--HITTRVMGTFGYMAPEYAS---SGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 521 ~~~--~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
... .......|+..|+|||++. ...++.++|||||||+||||++ |..||..... ... ... ...
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----~~~---~~~----~~~ 244 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQA---NIL----LGA 244 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----HHH---HHH----TTC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----HHH---HHH----hcc
Confidence 322 2233457999999999997 4567889999999999999999 9999864321 100 000 000
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.... .+ .........+.+|+.+||+.||++||++.||++
T Consensus 245 ~~~~-----~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLD-----CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCT-----TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc-----cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 00 111223345789999999999999999999994
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=358.68 Aligned_cols=274 Identities=26% Similarity=0.322 Sum_probs=205.4
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC-CccHHHHHHHHHHHHHccCCCceeEEeEEee------CCce
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG-GQGEREFKAEVEIISRIHHRHLVSLVGYCIS------DDRR 438 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~ 438 (696)
++|++.++||+|+||.||+|.+ .+|+.||||+++... ....+.+.+|+++|++++|+||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999986 468999999987542 2334678999999999999999999998765 5677
Q ss_pred eEEEEecCCCchhhccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCc---EEEEeecc
Q 005443 439 LLIYDYVPNNTLYFHLHGEG-RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFE---AQVSDFGL 514 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~---vkL~DfGl 514 (696)
+|||||+.+|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999987643 23488999999999999999999999 9999999999999987664 99999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.... ...+|...+.......
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC------
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccchh
Confidence 98654432 2234578999999999999999999999999999999999999997532 1222222111111111
Q ss_pred hhhhcccCc--------ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHH-----HHHHHHhhhcccc
Q 005443 595 EEFDNLADP--------RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQ-----VVRVFDSLATSDL 650 (696)
Q Consensus 595 ~~~~~~~d~--------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----ll~~L~~l~~~~~ 650 (696)
....+.... .............+.+++++||+.||++||++.| +++.++++....+
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ki 312 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCE
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccc
Confidence 000010000 0111233445568999999999999999999988 4566777665554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=360.01 Aligned_cols=240 Identities=20% Similarity=0.289 Sum_probs=192.3
Q ss_pred hcCccccccccccCcEEEEEEEcC--CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCc-----
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP--DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDR----- 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 437 (696)
.++|+++++||+|+||.||+|.+. +|+.||||++..... .....+.+|+++|++++|+||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999864 689999999864432 334578999999999999999999999988766
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.||||||+.|++|.+++.. .+++..+++|+.||+.||+|||++ +|||||||++||||+++ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999887754 489999999999999999999999 99999999999999986 899999999976
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
.... ...+||..|+|||++.++ ++.++|||||||+||||++|..+|........
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------------- 284 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------------- 284 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------------
T ss_pred cccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc--------------------
Confidence 5433 335689999999998765 48899999999999999999888764211000
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC-HHHHHHHHHhhh
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-MGQVVRVFDSLA 646 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~L~~l~ 646 (696)
. ...........+.+|+.+||+.||++|++ ++++.+.|..+.
T Consensus 285 ---~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 ---P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ---C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 00000111236889999999999999995 566666666554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.59 Aligned_cols=230 Identities=20% Similarity=0.274 Sum_probs=179.8
Q ss_pred hcCcccc-ccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHH-HHccCCCceeEEeEEee----CCce
Q 005443 366 TDGFADQ-NLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEII-SRIHHRHLVSLVGYCIS----DDRR 438 (696)
Q Consensus 366 ~~~~~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~----~~~~ 438 (696)
.++|.+. ++||+|+||.||+|.. .+|+.||||+++. ...+.+|++++ +.++|+||+++++++.. .+..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567777 7899999999999985 4789999999863 35678899988 55689999999999987 6678
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC---CCcEEEEeeccc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLA 515 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DfGls 515 (696)
+|||||+.+++|.+++.......+++..+++|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999876655699999999999999999999999 9999999999999988 789999999998
Q ss_pred hhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
.... +..++.++|||||||+||||++|+.||......... ..
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------------~~ 209 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------------PG 209 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------------CC
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------------HH
Confidence 6432 234677899999999999999999999754321100 00
Q ss_pred hhhcccCcccCCC--cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRLGEN--YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....+........ ........+.+++.+||+.||++||++.||+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000000000 001122368899999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=336.73 Aligned_cols=240 Identities=15% Similarity=0.171 Sum_probs=178.9
Q ss_pred cCccccccccccCcEEEEEEE-cCCCcEEEEEEeecCCC---ccHHHHHHHHHHHHHccC-CCcee--------------
Q 005443 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG---QGEREFKAEVEIISRIHH-RHLVS-------------- 427 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~h-pnIv~-------------- 427 (696)
..|...++||+|+||.||+|+ ..+|+.||||+++.... ...+.|++|+.+++.++| .|+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 457888999999999999999 45799999999874433 235679999999999987 22111
Q ss_pred -------EEeEEee-----CCceeEEEEecCCCchhhccc-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 005443 428 -------LVGYCIS-----DDRRLLIYDYVPNNTLYFHLH-----GEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490 (696)
Q Consensus 428 -------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~iv 490 (696)
++.++.. ....+++|+++ +++|.+++. ......+++..++.|+.||++||+|||++ +||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1111111 12345666655 688888774 23344578889999999999999999999 999
Q ss_pred eccCCCCceEECCCCcEEEEeeccchhccccCcceeeccccccccCchhhh----------ccCCCCccccccchHHHHH
Q 005443 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA----------SSGKLTEKSDVFSFGVVLL 560 (696)
Q Consensus 491 HrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s~~sDVwSlGvll~ 560 (696)
|||||++||||+.++.+||+|||+++..... ....+| ..|+|||++ .+..++.++|||||||+||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998764433 334567 999999999 5556888999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 561 ELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 561 eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
||++|+.||........ +..++... ..+. ..+.+|+.+||+.||++|+++.++++
T Consensus 309 elltg~~Pf~~~~~~~~-------------------~~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG-------------------SEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC-------------------SGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh-------------------HHHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999975431110 11111100 1112 36889999999999999999988865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.87 Aligned_cols=242 Identities=19% Similarity=0.236 Sum_probs=185.4
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC--------ccHHHHHHHHHHHHHcc---------CCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG--------QGEREFKAEVEIISRIH---------HRHLVSL 428 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~il~~l~---------hpnIv~l 428 (696)
.++|+++++||+|+||.||+|+. +|+.||||+++.... ...+.+.+|+++|++++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 36789999999999999999998 789999999976532 23478999999999986 7888877
Q ss_pred EeEEe------------------------------eCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHH
Q 005443 429 VGYCI------------------------------SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGL 478 (696)
Q Consensus 429 ~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL 478 (696)
++++. ..+..+|||||+.+|++.+.+.+ ..+++..++.|+.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77643 15788999999999987666643 3489999999999999999
Q ss_pred HHHH-hcCCCceeeccCCCCceEECCCC--------------------cEEEEeeccchhccccCcceeeccccccccCc
Q 005443 479 AYLH-EDCHPRIIHRDIKSSNILLDNNF--------------------EAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537 (696)
Q Consensus 479 ~~LH-~~~~~~ivHrDLkp~NILl~~~~--------------------~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~a 537 (696)
+||| ++ +|||||||++||||+.++ .+||+|||+++..... ..+||..|||
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 88 999999999999999886 8999999999865432 2368999999
Q ss_pred hhhhccCCCCccccccchHHH-HHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHH
Q 005443 538 PEYASSGKLTEKSDVFSFGVV-LLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFR 616 (696)
Q Consensus 538 PE~l~~~~~s~~sDVwSlGvl-l~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 616 (696)
||++.+.. +.++||||||++ .++++.|..||.. ..|.............+ ..............+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRK 311 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhcc----CcccchhhhhhcCHH
Confidence 99998665 889999998776 7778889888742 12222222221111111 111111122345567
Q ss_pred HHHHHHHHhccCCCCCCCHHHHH
Q 005443 617 MIEAAAACVRHSAAKRPRMGQVV 639 (696)
Q Consensus 617 l~~li~~cl~~dP~~RPs~~ell 639 (696)
+.+|+++||+.| +++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 888777
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=297.00 Aligned_cols=182 Identities=16% Similarity=0.131 Sum_probs=128.7
Q ss_pred ccccCcEEEEEEE-cCCCcEEEEEEeecCC----------CccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEEE
Q 005443 375 LGEGGFGSVYKGY-LPDGREVAIKQLKIGG----------GQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 375 LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~----------~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++.|++|.+..++ +-.|+.|+||++.... ....++|.+|+++|+++ +|.||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666655544 2358899999997432 12235699999999999 6999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||++|++|.++|...+. ++.. +|+.||+.||+|||++ ||||||||++||||++++++||+|||+++......
T Consensus 322 Eyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999987654 5543 5889999999999999 99999999999999999999999999998765443
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 566 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~ 566 (696)
.. ....+||..|||||++.+ .+..++|+|++|+++++|+++.
T Consensus 394 ~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 394 SW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CC-SHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 32 344679999999999875 4677899999999988876553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=269.82 Aligned_cols=184 Identities=17% Similarity=0.223 Sum_probs=145.7
Q ss_pred cccccccccCcEEEEEEEcCCCcEEEEEEeecCCCc--------cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQ--------GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
...++||+|+||.||+|.. .++.+++|++...... ..+++.+|+++|++++|+||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 6889999987543221 124589999999999999999666666678888999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+++|.++++. +++|+.||++||+|||++ +|+|||||++||||++ ++||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999875 568999999999999999 9999999999999998 9999999999876543
Q ss_pred Ccce------eeccccccccCchhhhcc--CCCCccccccchHHHHHHHHhCCCCC
Q 005443 522 NTHI------TTRVMGTFGYMAPEYASS--GKLTEKSDVFSFGVVLLELITGRKPV 569 (696)
Q Consensus 522 ~~~~------~~~~~gt~~y~aPE~l~~--~~~s~~sDVwSlGvll~eLltg~~Pf 569 (696)
.... .....||..|||||++.. ..|+...|+|+..+-.++.+.++-.|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 234679999999999986 66888899999998888887766544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=226.45 Aligned_cols=154 Identities=17% Similarity=0.179 Sum_probs=123.8
Q ss_pred HHHHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC------------------ccHHHHHHHHHHHHHc
Q 005443 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG------------------QGEREFKAEVEIISRI 420 (696)
Q Consensus 359 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~il~~l 420 (696)
+..+......|.++++||+|+||.||+|.+.+|+.||||+++.... .....+.+|+++|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344455567888899999999999999987799999999964321 1235689999999999
Q ss_pred cCCCceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceE
Q 005443 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 500 (696)
Q Consensus 421 ~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NIL 500 (696)
+ | +++++++.. +..++||||+.|++|.+ +.. .....++.||+.||+|||++ +|+|||||++|||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 9 5 777775543 56699999999999988 432 22457999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhcc
Q 005443 501 LDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543 (696)
Q Consensus 501 l~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 543 (696)
|+ ++.+||+|||+++. +..|+|+|++..
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99 99999999999963 334788888753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=193.62 Aligned_cols=138 Identities=18% Similarity=0.164 Sum_probs=107.3
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcE--EEEEEeecCCCc------------------------cHHHHHHHHHHHHH
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGRE--VAIKQLKIGGGQ------------------------GEREFKAEVEIISR 419 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~il~~ 419 (696)
..|++.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+.+|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999997 68888 999997543111 01368899999999
Q ss_pred ccCCCc--eeEEeEEeeCCceeEEEEecCC-C----chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceee
Q 005443 420 IHHRHL--VSLVGYCISDDRRLLIYDYVPN-N----TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH-EDCHPRIIH 491 (696)
Q Consensus 420 l~hpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~~~ivH 491 (696)
|+|.|| .+++++ +..+|||||+.+ | .|.+++.. ..+..+..++.||+.||.||| ++ +|||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 998754 444442 367899999942 4 45444321 234567889999999999999 87 9999
Q ss_pred ccCCCCceEECCCCcEEEEeeccchhc
Q 005443 492 RDIKSSNILLDNNFEAQVSDFGLAKLA 518 (696)
Q Consensus 492 rDLkp~NILl~~~~~vkL~DfGls~~~ 518 (696)
||||++||||++ .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=186.23 Aligned_cols=143 Identities=13% Similarity=0.120 Sum_probs=104.9
Q ss_pred HHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCC--------------CccHHH--------HHHHHHHHHH
Q 005443 362 LVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--------------GQGERE--------FKAEVEIISR 419 (696)
Q Consensus 362 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--------------~~~~~~--------~~~E~~il~~ 419 (696)
+.....-|++.++||.|+||.||+|...+|+.||||+++... ...... ..+|...|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 333334599999999999999999998899999999986321 011111 2346666777
Q ss_pred ccCCCce--eEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCC
Q 005443 420 IHHRHLV--SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 497 (696)
Q Consensus 420 l~hpnIv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~ 497 (696)
|.+.++. +.+++ ...+|||||+.|+.|..++.. ....+++.||+.+|.|||++ ||||||||+.
T Consensus 170 L~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~ 234 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEF 234 (397)
T ss_dssp HHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred HHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHH
Confidence 6544432 22222 234799999999988765432 22457889999999999998 9999999999
Q ss_pred ceEECCCC----------cEEEEeeccchhcc
Q 005443 498 NILLDNNF----------EAQVSDFGLAKLAL 519 (696)
Q Consensus 498 NILl~~~~----------~vkL~DfGls~~~~ 519 (696)
||||++++ .+.||||+-+....
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99998776 38999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.2e-14 Score=145.47 Aligned_cols=148 Identities=14% Similarity=0.069 Sum_probs=117.8
Q ss_pred HHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCcee
Q 005443 361 ELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 361 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 439 (696)
.+....++|++...++.|+++.||++.. +|+.++||+...........+.+|+++|+.|. +.++.++++++...+..+
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3445567899889999999999999986 47899999987532233446899999999995 677889999998888899
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED----------------------------------- 484 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~----------------------------------- 484 (696)
+||||+.|.+|.+.+.. ......++.+++++|..||+.
T Consensus 87 lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999999776421 122347888999999999981
Q ss_pred ---------------------CCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 485 ---------------------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 485 ---------------------~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
....++|||+++.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01369999999999999876566799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.41 E-value=3.7e-13 Score=136.77 Aligned_cols=137 Identities=17% Similarity=0.121 Sum_probs=103.5
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC--ceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH--LVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~ 444 (696)
.+|.+..+.+.|.++.||++...+|+.|+||+.... ....+.+|+++|+.+++.+ +.++++++...+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 445554444566779999998877889999997643 2346789999999997544 56789888877788999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC--------------------------------------- 485 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~--------------------------------------- 485 (696)
+.|..|. +.. .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9998884 221 11 2356777888888888641
Q ss_pred ----------------CCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 486 ----------------HPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 486 ----------------~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
...++||||+++|||+++++.++|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999975
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.32 E-value=6.7e-12 Score=134.45 Aligned_cols=143 Identities=17% Similarity=0.272 Sum_probs=108.2
Q ss_pred cccccccccCcEEEEEEEcCCCcEEEEEEee--cCC-CccHHHHHHHHHHHHHcc--CCCceeEEeEEeeC---CceeEE
Q 005443 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLK--IGG-GQGEREFKAEVEIISRIH--HRHLVSLVGYCISD---DRRLLI 441 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~---~~~~lV 441 (696)
..++.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+|+.|. +.++.++++++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34677899999999999874 5688888775 322 123457889999999997 45688999988766 347999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC------------------------------------ 485 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~------------------------------------ 485 (696)
|||+.|..+.+... ..++...+..++.++++.|..||+..
T Consensus 120 me~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999988754221 12677888899999999999999730
Q ss_pred -------------------CCceeeccCCCCceEECCCCc--EEEEeeccchh
Q 005443 486 -------------------HPRIIHRDIKSSNILLDNNFE--AQVSDFGLAKL 517 (696)
Q Consensus 486 -------------------~~~ivHrDLkp~NILl~~~~~--vkL~DfGls~~ 517 (696)
...+||||+++.|||+++++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987653 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.23 E-value=6.5e-12 Score=131.36 Aligned_cols=185 Identities=23% Similarity=0.261 Sum_probs=121.7
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCC--ceeEEeEEeeCC---ceeEEEEec
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRH--LVSLVGYCISDD---RRLLIYDYV 445 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpn--Iv~l~~~~~~~~---~~~lV~E~~ 445 (696)
++.|+.|.+..||++. +.++||+.... .....+.+|+++|+.+. +.. +.+++.++...+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4668999999999864 56889986522 33567899999999984 333 445555544333 348899999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED----------------------------------------- 484 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~----------------------------------------- 484 (696)
+|..|...... .++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888643321 256777788888888888888861
Q ss_pred --------------CCCceeeccCCCCceEECC--CCcEEEEeeccchhccccCcceeec--------------cccccc
Q 005443 485 --------------CHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKLALDANTHITTR--------------VMGTFG 534 (696)
Q Consensus 485 --------------~~~~ivHrDLkp~NILl~~--~~~vkL~DfGls~~~~~~~~~~~~~--------------~~gt~~ 534 (696)
....++|+||++.|||+++ +..+.|+||+.+..... ....... +....+
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1136899999999999988 55678999999865321 1110000 000011
Q ss_pred cCc-hhhhccCCCCccccccchHHHHHHHHhCCCCC
Q 005443 535 YMA-PEYASSGKLTEKSDVFSFGVVLLELITGRKPV 569 (696)
Q Consensus 535 y~a-PE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf 569 (696)
+.. ++.+.. .....++|++|.++|.+.+|+..|
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 222111 112358999999999999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.1e-08 Score=104.44 Aligned_cols=141 Identities=18% Similarity=0.191 Sum_probs=102.3
Q ss_pred cCccccccccccCcE-EEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFG-SVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..|+.. .+..|..| .||+.... ++..++||+.... ...++.+|+.+|+.|. +--+.++++++.+.+..++|||
T Consensus 25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 344433 34445554 68988754 5678999987632 3567889999999986 4457789999998899999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED--------------------------------------- 484 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~--------------------------------------- 484 (696)
++.|..+.+..... ......++.++++.|..||..
T Consensus 101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 99998876654321 122345667777777777743
Q ss_pred ----------------CCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 485 ----------------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 485 ----------------~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
....++|+|+++.|||+++++.+-|+||+.+..
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012489999999999999887777999998853
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=2.7e-08 Score=103.96 Aligned_cols=136 Identities=22% Similarity=0.216 Sum_probs=95.1
Q ss_pred cccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC---CceeEEeEEe-eCCceeEEEEecCC
Q 005443 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR---HLVSLVGYCI-SDDRRLLIYDYVPN 447 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E~~~~ 447 (696)
++.|+.|....||+. |+.++||+.. .......+.+|+++|+.|.+. .|.+++.++. ..+..++||||+.|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456889999999997 5778888853 222346789999999999753 3567777764 34567899999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED------------------------------------------- 484 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------------------------------------------- 484 (696)
..|...... .++......++.++.+.|..||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888652211 134444455555555555555532
Q ss_pred --------------CCCceeeccCCCCceEECC---CCc-EEEEeeccchh
Q 005443 485 --------------CHPRIIHRDIKSSNILLDN---NFE-AQVSDFGLAKL 517 (696)
Q Consensus 485 --------------~~~~ivHrDLkp~NILl~~---~~~-vkL~DfGls~~ 517 (696)
....++|+|+++.|||+++ ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2236799999999999987 455 48999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.6e-08 Score=107.80 Aligned_cols=82 Identities=7% Similarity=-0.044 Sum_probs=59.0
Q ss_pred ccccc-cccCcEEEEEEEcC-------CCcEEEEEEeecCC---CccHHHHHHHHHHHHHccC---CCceeEEeEEeeC-
Q 005443 371 DQNLL-GEGGFGSVYKGYLP-------DGREVAIKQLKIGG---GQGEREFKAEVEIISRIHH---RHLVSLVGYCISD- 435 (696)
Q Consensus 371 ~~~~L-G~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~~- 435 (696)
..+.| +.|..+.+|+.... +++.+++|+..... ......+.+|+.+|+.|.. -.+.++++++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 88999999998764 26789999875322 1112467889999998853 3577888887655
Q ss_pred --CceeEEEEecCCCchhh
Q 005443 436 --DRRLLIYDYVPNNTLYF 452 (696)
Q Consensus 436 --~~~~lV~E~~~~gsL~~ 452 (696)
+..++||||+.|..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 34689999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=2.1e-07 Score=100.70 Aligned_cols=75 Identities=13% Similarity=0.118 Sum_probs=51.4
Q ss_pred cccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-------ccHHHHHHHHHHHHHccC--C-CceeEEeEEeeCCceeE
Q 005443 372 QNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-------QGEREFKAEVEIISRIHH--R-HLVSLVGYCISDDRRLL 440 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~il~~l~h--p-nIv~l~~~~~~~~~~~l 440 (696)
.+.||.|.++.||++.+. +++.|+||....... ....++.+|+++|+.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999764 568999998642211 123457889999998853 2 34466654 3456789
Q ss_pred EEEecCCC
Q 005443 441 IYDYVPNN 448 (696)
Q Consensus 441 V~E~~~~g 448 (696)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.52 E-value=5.6e-07 Score=94.79 Aligned_cols=139 Identities=16% Similarity=0.235 Sum_probs=82.8
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc--CCCceeEEe------EEeeCCceeEEEEe
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH--HRHLVSLVG------YCISDDRRLLIYDY 444 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~------~~~~~~~~~lV~E~ 444 (696)
+.|+.|..+.||++...+| .+++|+... ...++..|+.+++.|. .-.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677899999987544 589998864 2345566777777764 223455553 12345667899999
Q ss_pred cCCCchh--------------hcccc----C--C------CCCCCHHHH-------------------------------
Q 005443 445 VPNNTLY--------------FHLHG----E--G------RPVLDWATR------------------------------- 467 (696)
Q Consensus 445 ~~~gsL~--------------~~l~~----~--~------~~~l~~~~~------------------------------- 467 (696)
++|..+. ..+|. . . .....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11121 0 0 001122211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 468 VKIAAGAARGLAYLHE----------DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 468 ~~i~~qia~gL~~LH~----------~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..+..++.+++++|++ .....++|||+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666653 023489999999999999888899999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.47 E-value=5.7e-07 Score=92.84 Aligned_cols=80 Identities=19% Similarity=0.201 Sum_probs=60.9
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC---CCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH---RHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~~~~~~lV~E 443 (696)
.++..++.+|.|..+.||+.++.||+.|+||+...........|.+|+..|+.|.. --+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 35666788999999999999999999999998765544445678999999999853 2345566542 3478999
Q ss_pred ecCCCch
Q 005443 444 YVPNNTL 450 (696)
Q Consensus 444 ~~~~gsL 450 (696)
|+.++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.42 E-value=2e-07 Score=101.84 Aligned_cols=74 Identities=18% Similarity=0.203 Sum_probs=48.2
Q ss_pred ccccccccCcEEEEEEEcCCCcEEEEEEeec-----CCC----ccHHHHHHHHHHHHH-ccCCCceeEEeEEeeCCceeE
Q 005443 371 DQNLLGEGGFGSVYKGYLPDGREVAIKQLKI-----GGG----QGEREFKAEVEIISR-IHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~-----~~~----~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~l 440 (696)
.++.||.|..+.||++.. +++.++||.... ... .....++.|+..+.. .....+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 456789999999999976 678899994321 111 123344445444332 2234667777765 567799
Q ss_pred EEEec-CC
Q 005443 441 IYDYV-PN 447 (696)
Q Consensus 441 V~E~~-~~ 447 (696)
||||+ .+
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.42 E-value=1.4e-06 Score=90.98 Aligned_cols=139 Identities=15% Similarity=0.147 Sum_probs=94.0
Q ss_pred cccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc---CCCceeEEeEEeeCCceeEEEEecC
Q 005443 370 ADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH---HRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
...+.|+.|.+..+|+... +++.++||+.... ....+.+|++.|+.|. .-.+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456789999999999987 5778999987632 3567899999999985 3568889998887788999999999
Q ss_pred CCchh-----------hccccCCC-C-------------------CCCHHHHH---HHHH----------------HHHH
Q 005443 447 NNTLY-----------FHLHGEGR-P-------------------VLDWATRV---KIAA----------------GAAR 476 (696)
Q Consensus 447 ~gsL~-----------~~l~~~~~-~-------------------~l~~~~~~---~i~~----------------qia~ 476 (696)
+..+. ..||.... . .-+|.... ++.. ++++
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87542 12222111 0 11343221 1111 1111
Q ss_pred H-HHHHHh-cCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 477 G-LAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 477 g-L~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
. ...|.. ...+.+||+|+...|||++.++ +.|+||+
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 1245899999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.22 E-value=4.1e-06 Score=87.56 Aligned_cols=157 Identities=13% Similarity=0.103 Sum_probs=92.4
Q ss_pred cCHHHHHHHhcCcccc-----ccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC--ceeEE
Q 005443 357 FTYEELVKATDGFADQ-----NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH--LVSLV 429 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~-----~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~ 429 (696)
++.+++.....+|.+. +.|+.|....+|+....+| .+++|+.... ....++..|+.+++.|...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 5567777777777652 3466788899999987555 6889988642 12345677888888885323 34444
Q ss_pred eE------EeeCCceeEEEEecCCCchhh--------------ccccC----CCC------CCCHHHHHH----------
Q 005443 430 GY------CISDDRRLLIYDYVPNNTLYF--------------HLHGE----GRP------VLDWATRVK---------- 469 (696)
Q Consensus 430 ~~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~------~l~~~~~~~---------- 469 (696)
.. ....+..++||+|+.|..+.. .+|.. ... ...|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 122355689999998865421 11210 000 011222110
Q ss_pred --HHHHHHHHHHHHHhc----CCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 470 --IAAGAARGLAYLHED----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 470 --i~~qia~gL~~LH~~----~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
+...+.+.+++|++. ...+++|+|+++.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455666532 13479999999999999987656899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.15 E-value=2.1e-05 Score=82.35 Aligned_cols=157 Identities=14% Similarity=0.126 Sum_probs=92.8
Q ss_pred cCHHHHHHHhcCccc-----cccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCC--CceeEE
Q 005443 357 FTYEELVKATDGFAD-----QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHR--HLVSLV 429 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~ 429 (696)
++.+++....+.|.+ ++.|+ |....||+....+|+.+++|+.+... .....+..|+.+++.|... .+.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 455556555544432 23466 88889999988778889999986321 2456778899999888632 345555
Q ss_pred eE-----EeeCCceeEEEEecCCCchhh--------------cccc----C---CCCCCCHHHH----HHH---------
Q 005443 430 GY-----CISDDRRLLIYDYVPNNTLYF--------------HLHG----E---GRPVLDWATR----VKI--------- 470 (696)
Q Consensus 430 ~~-----~~~~~~~~lV~E~~~~gsL~~--------------~l~~----~---~~~~l~~~~~----~~i--------- 470 (696)
.. ...++..++||||+.|..+.. .+|. . .+..+++... .++
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 43 122345578999998765421 0111 0 0111222211 011
Q ss_pred ------HHHHHHHHHHHHhc----CCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 471 ------AAGAARGLAYLHED----CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 471 ------~~qia~gL~~LH~~----~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
...+.+.++.|.+. ....++|||+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333321 234789999999999999 4 899999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.1e-05 Score=83.69 Aligned_cols=140 Identities=13% Similarity=0.114 Sum_probs=79.1
Q ss_pred ccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEEEec-C
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYV-P 446 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~-~ 446 (696)
+..++.|+.|....+|+. +.++||+....... .....+|+.+++.+...++ .++++++ .+..++|+||+ .
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 334678999999999998 56889987643211 1224578888888864333 4666543 44567899999 6
Q ss_pred CCchhh------------------ccccCCCC---CCCH-HHHHHHHH--------------HHHHHHHHHH----h-cC
Q 005443 447 NNTLYF------------------HLHGEGRP---VLDW-ATRVKIAA--------------GAARGLAYLH----E-DC 485 (696)
Q Consensus 447 ~gsL~~------------------~l~~~~~~---~l~~-~~~~~i~~--------------qia~gL~~LH----~-~~ 485 (696)
|..|.. .+|..... ..+. ..+.++.. .+.+.+..|. . ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 655421 11111100 0111 11111100 1111111111 1 12
Q ss_pred CCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 486 ~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
...++|+|+.+.||| .+++.+.|+||+.+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 336899999999999 5556789999998853
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.5e-05 Score=85.47 Aligned_cols=139 Identities=19% Similarity=0.205 Sum_probs=84.5
Q ss_pred ccccccCcEEEEEEEcC--------CCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEEE
Q 005443 373 NLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 443 (696)
+.|..|....+|++... +++.|+||+... .......+.+|+++++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888889999864 357899998632 1234567789999999986 3334677776643 39999
Q ss_pred ecCCCchhhc-----------------cccCC---CCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 005443 444 YVPNNTLYFH-----------------LHGEG---RPVLD--WATRVKIAAGAA-------------------RGLAYLH 482 (696)
Q Consensus 444 ~~~~gsL~~~-----------------l~~~~---~~~l~--~~~~~~i~~qia-------------------~gL~~LH 482 (696)
|++|..|... ||... ..... +..+.+++.++. ..++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 11111 01111 344444444332 2233333
Q ss_pred hc-----CCCceeeccCCCCceEECCC----CcEEEEeeccch
Q 005443 483 ED-----CHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAK 516 (696)
Q Consensus 483 ~~-----~~~~ivHrDLkp~NILl~~~----~~vkL~DfGls~ 516 (696)
+. ....++|+|+...|||++++ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 13479999999999999876 789999999885
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=98.05 E-value=8e-06 Score=89.28 Aligned_cols=73 Identities=21% Similarity=0.267 Sum_probs=51.7
Q ss_pred cccccccCcEEEEEEEcCC--------CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEE
Q 005443 372 QNLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIY 442 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~ 442 (696)
++.|+.|....||++...+ ++.|+||+.... .....+.+|+.+++.|...+| .++++++.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888899999998643 578999988421 122566689999999864344 677776542 3899
Q ss_pred EecCCCch
Q 005443 443 DYVPNNTL 450 (696)
Q Consensus 443 E~~~~gsL 450 (696)
||++|..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=98.01 E-value=2.1e-05 Score=82.64 Aligned_cols=141 Identities=16% Similarity=0.122 Sum_probs=75.1
Q ss_pred cccccccCcEE-EEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC--CCceeEEeEEeeCCceeEEEEecCCC
Q 005443 372 QNLLGEGGFGS-VYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH--RHLVSLVGYCISDDRRLLIYDYVPNN 448 (696)
Q Consensus 372 ~~~LG~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~g 448 (696)
.+.|+.|.... +|+....+|+.+++|...... ..++..|+.+++.|.. -.+.+++.+... ..++|||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCc
Confidence 34566565554 677776447788888654321 1345567778777753 345677766432 337899999765
Q ss_pred chhhccc---------------------cCC---CCCCCHHHHH-------H-------------HHHHHHHHHHHHHh-
Q 005443 449 TLYFHLH---------------------GEG---RPVLDWATRV-------K-------------IAAGAARGLAYLHE- 483 (696)
Q Consensus 449 sL~~~l~---------------------~~~---~~~l~~~~~~-------~-------------i~~qia~gL~~LH~- 483 (696)
.+.+++. ... ...++..... . ....+.+.++.|.+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 5533221 100 0111111110 0 00111222233311
Q ss_pred --cCCCceeeccCCCCceEECCC----CcEEEEeeccchh
Q 005443 484 --DCHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAKL 517 (696)
Q Consensus 484 --~~~~~ivHrDLkp~NILl~~~----~~vkL~DfGls~~ 517 (696)
.....++|||++++|||++++ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123489999999999999874 6899999999864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.96 E-value=4e-05 Score=84.23 Aligned_cols=74 Identities=9% Similarity=0.036 Sum_probs=49.4
Q ss_pred cccccccCcEEEEEEEcCC-CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCc-eeEEeEEeeCCceeEEEEecCCCc
Q 005443 372 QNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHL-VSLVGYCISDDRRLLIYDYVPNNT 449 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~gs 449 (696)
++.|+.|-...+|++...+ ++.|++|+....... ..+..+|+.+|+.|...++ .++++++. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3567888889999998754 478999987432211 1123689999999975554 57777763 2 35999998765
Q ss_pred h
Q 005443 450 L 450 (696)
Q Consensus 450 L 450 (696)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=2.6e-05 Score=83.32 Aligned_cols=74 Identities=11% Similarity=0.057 Sum_probs=46.6
Q ss_pred cccccccCcEEEEEEEcCC---------CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC-ceeEEeEEeeCCceeEE
Q 005443 372 QNLLGEGGFGSVYKGYLPD---------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH-LVSLVGYCISDDRRLLI 441 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV 441 (696)
++.|+.|....+|+....+ ++.|++|+....... ..+..+|+++++.|...+ +.++++.+ ..++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 4567888889999998644 278999987532211 113467888888886444 44777654 23789
Q ss_pred EEecCCCch
Q 005443 442 YDYVPNNTL 450 (696)
Q Consensus 442 ~E~~~~gsL 450 (696)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=6.2e-05 Score=79.48 Aligned_cols=68 Identities=12% Similarity=0.111 Sum_probs=45.1
Q ss_pred cccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC---CCceeEEeE------EeeCCceeEEEEecC
Q 005443 376 GEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH---RHLVSLVGY------CISDDRRLLIYDYVP 446 (696)
Q Consensus 376 G~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~------~~~~~~~~lV~E~~~ 446 (696)
|.|....||+....+| .+++|+...... .+|+.+++.|.. +++.+++.. +...+..++||+|+.
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444789999998677 999998865431 456677776642 224555532 223456789999999
Q ss_pred CCch
Q 005443 447 NNTL 450 (696)
Q Consensus 447 ~gsL 450 (696)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00059 Score=74.06 Aligned_cols=74 Identities=7% Similarity=0.030 Sum_probs=50.4
Q ss_pred cccccccCcEEEEEEEcCC--------CcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCceeEEE
Q 005443 372 QNLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++.|..|....+|+....+ ++.|+||+..... ....+..+|+.+++.|. +.-..++++.+. .++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4557778889999998753 6889999874332 11223468888888886 333456665432 37899
Q ss_pred EecCCCch
Q 005443 443 DYVPNNTL 450 (696)
Q Consensus 443 E~~~~gsL 450 (696)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0016 Score=70.16 Aligned_cols=30 Identities=27% Similarity=0.406 Sum_probs=25.4
Q ss_pred ceeeccCCCCceEE------CCCCcEEEEeeccchh
Q 005443 488 RIIHRDIKSSNILL------DNNFEAQVSDFGLAKL 517 (696)
Q Consensus 488 ~ivHrDLkp~NILl------~~~~~vkL~DfGls~~ 517 (696)
.++|+|+...|||+ +++..++|+||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567899999998853
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00045 Score=48.58 Aligned_cols=31 Identities=13% Similarity=0.255 Sum_probs=18.8
Q ss_pred ceeehhHHHHHHHHHHHHHHHHhhhhccccc
Q 005443 269 GTVVIAVAVGIIAFSLIGLVVWCLRRRKKEV 299 (696)
Q Consensus 269 ~~i~i~~~~~~~~~~l~~~~~~~~~rr~~~~ 299 (696)
..|++++++++++++++++++|+++|||++.
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3466777777776666666666555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00055 Score=48.00 Aligned_cols=31 Identities=23% Similarity=0.315 Sum_probs=19.0
Q ss_pred ceeehhHHHHHHHHHHHHHHHHhhhhccccc
Q 005443 269 GTVVIAVAVGIIAFSLIGLVVWCLRRRKKEV 299 (696)
Q Consensus 269 ~~i~i~~~~~~~~~~l~~~~~~~~~rr~~~~ 299 (696)
+.|+++++.++++++++++++|+++|||+++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 3466777777777666666666555555443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.05 E-value=0.021 Score=55.38 Aligned_cols=103 Identities=11% Similarity=0.016 Sum_probs=65.8
Q ss_pred chhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcceeec
Q 005443 449 TLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528 (696)
Q Consensus 449 sL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~~~ 528 (696)
+|.++|...+. .++++++|.++.|.+++|.-+-.+. .-..+=+.+..|+|..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence 57777776554 5999999999999999987763210 111233456899999999988764 2111
Q ss_pred cccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCC
Q 005443 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPV 569 (696)
Q Consensus 529 ~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf 569 (696)
.....+.+||... ...+.+.=||+||++||.-+.-.++-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0122356777653 34467788999999999998755543
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=95.60 E-value=0.0081 Score=42.02 Aligned_cols=21 Identities=33% Similarity=0.612 Sum_probs=9.1
Q ss_pred ehhHHHHHHHHHHHHHHHHhh
Q 005443 272 VIAVAVGIIAFSLIGLVVWCL 292 (696)
Q Consensus 272 ~i~~~~~~~~~~l~~~~~~~~ 292 (696)
+++.+++++++++++++++++
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~ 34 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGIL 34 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHhh
Confidence 344444444444444443333
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=95.17 E-value=0.012 Score=40.16 Aligned_cols=9 Identities=22% Similarity=0.154 Sum_probs=3.6
Q ss_pred HHHHhhhhc
Q 005443 287 LVVWCLRRR 295 (696)
Q Consensus 287 ~~~~~~~rr 295 (696)
+++||++||
T Consensus 29 ~l~~~~~rr 37 (38)
T 2k1k_A 29 GILVFRSRR 37 (38)
T ss_dssp HHHHHHHCC
T ss_pred HHHHHHeec
Confidence 333444444
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.91 E-value=0.012 Score=40.97 Aligned_cols=29 Identities=28% Similarity=0.440 Sum_probs=15.5
Q ss_pred cceeehhHHHHHHHHHHHHHHHHhhhhcc
Q 005443 268 AGTVVIAVAVGIIAFSLIGLVVWCLRRRK 296 (696)
Q Consensus 268 ~~~i~i~~~~~~~~~~l~~~~~~~~~rr~ 296 (696)
.+.+++++++++++++++++++|+++|||
T Consensus 12 ~~~I~~~vv~Gv~ll~~iv~~~~~~~rRr 40 (41)
T 2k9y_A 12 NLAVIGGVAVGVVLLLVLAGVGFFIHRRR 40 (41)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHSSSSSC
T ss_pred eEEEEeehhHHHHHHHHHHHHheeEeeec
Confidence 34456666666666553444444444444
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.35 E-value=0.032 Score=39.20 Aligned_cols=34 Identities=9% Similarity=-0.023 Sum_probs=23.5
Q ss_pred CccceeehhHHHHHHHHHHHHHHHHhhhhccccc
Q 005443 266 GTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEV 299 (696)
Q Consensus 266 ~~~~~i~i~~~~~~~~~~l~~~~~~~~~rr~~~~ 299 (696)
..++..+++.++++++++++.+++|++||+++++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~kR 44 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIVRKR 44 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCCSCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhhccC
Confidence 3455556665666666668888999988877653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.86 E-value=0.08 Score=51.22 Aligned_cols=116 Identities=9% Similarity=0.083 Sum_probs=76.6
Q ss_pred cCCCceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceE
Q 005443 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 500 (696)
Q Consensus 421 ~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NIL 500 (696)
.|++++.. .+-.+++.+.|.|+.-.++.=+..++ .++...+++++.+|+...++++.+ +|--|+|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEE
Confidence 57777755 44555565555554433222223333 267899999999999988777754 78889999999
Q ss_pred ECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCC
Q 005443 501 LDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (696)
Q Consensus 501 l~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~ 570 (696)
++.++.++|.-.|+-..+.... ++...=+-.+=|++..+++++..|+
T Consensus 112 f~~~~~p~i~~RGik~~l~P~~-----------------------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVDPLP-----------------------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTTBSCCC-----------------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccCCCCCC-----------------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999888754322111 1111112345688889999988765
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.70 E-value=0.03 Score=39.25 Aligned_cols=34 Identities=18% Similarity=-0.030 Sum_probs=24.5
Q ss_pred CccceeehhHHHHHHHHHHHHHHHHhhhhccccc
Q 005443 266 GTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKEV 299 (696)
Q Consensus 266 ~~~~~i~i~~~~~~~~~~l~~~~~~~~~rr~~~~ 299 (696)
+.++..+++.++++++++++.+++|++||+++++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhhcc
Confidence 4466666666666667778888999988877664
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=92.09 E-value=0.37 Score=49.57 Aligned_cols=139 Identities=14% Similarity=0.111 Sum_probs=74.0
Q ss_pred ccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEE----------------
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC---------------- 432 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~---------------- 432 (696)
++.++.+-.|.. .||.+.. ++..|+||-.. ....+.|..++...-.+.-++ .+++.+.
T Consensus 71 v~~I~~s~~Gst-gvff~~t-d~~~~VVK~s~---~l~~E~l~s~LA~~LGlpiP~-~Riv~~~~~E~~e~~~~L~~~~~ 144 (342)
T 1cja_A 71 FKGIERSEKGTE-GLFFVET-ESGVFIVKRST---NIESETFCSLLCMRLGLHAPK-VRVVSSNSEEGTNMLECLAAIDK 144 (342)
T ss_dssp EEEEEECCSTTS-CEEEEEE-SSCEEEEECCT---THHHHHHHHHHHHHHTCCCCC-EEEEESSSHHHHHHHHHHHHHCS
T ss_pred eeEEEeccCCCC-CeEEEEe-CCCEEEEeCcH---HHHHHHHHHHHHHHhCCCCCC-eeEEeeCcHHHHHHHHHHHHhhh
Confidence 444455555654 5555544 68899999542 223334445555544555555 2232222
Q ss_pred -------eeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHH--HHHHHHHHhcCCC-ceee-ccCCCCceEE
Q 005443 433 -------ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA--ARGLAYLHEDCHP-RIIH-RDIKSSNILL 501 (696)
Q Consensus 433 -------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi--a~gL~~LH~~~~~-~ivH-rDLkp~NILl 501 (696)
..++..+++|||..|..|...-+..-...+.. +.+.++ +-+++++..++.. .++. .--.+.|||+
T Consensus 145 ~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~----~~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~ 220 (342)
T 1cja_A 145 SFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTK----STMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIML 220 (342)
T ss_dssp SSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCH----HHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEE
T ss_pred hhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCH----HHHHhhchhheehhhhcCCccCcccccCCCChhheEE
Confidence 01224569999998777665443211111222 223332 3455666655321 1111 1247889999
Q ss_pred CCCC-cEEEEeeccchh
Q 005443 502 DNNF-EAQVSDFGLAKL 517 (696)
Q Consensus 502 ~~~~-~vkL~DfGls~~ 517 (696)
++++ .+.++|-+++..
T Consensus 221 ~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 221 SERGATVVPIDSKIIPL 237 (342)
T ss_dssp ESBTTCEEECSCCCCCC
T ss_pred eCCCCeEEEEcCCcccc
Confidence 7654 489999999854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.82 E-value=0.27 Score=47.72 Aligned_cols=115 Identities=10% Similarity=0.084 Sum_probs=75.3
Q ss_pred cCCCceeEEeEEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCceeeccCCCCce
Q 005443 421 HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA-YLHEDCHPRIIHRDIKSSNI 499 (696)
Q Consensus 421 ~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~-~LH~~~~~~ivHrDLkp~NI 499 (696)
.|+++ -..+-.+++.+.|.++.-.++.=+..++ .++...+++++.+|+.... +++. -+|--|+|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 46776 3333455666666666553443333333 2678999999999988777 6664 47888999999
Q ss_pred EECCCCcEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCC
Q 005443 500 LLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 570 (696)
Q Consensus 500 Ll~~~~~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~ 570 (696)
+++.++.++|.-.|+-..+.... +..|. =+-.+=|++..++.++.-|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~lpP~e-------------~~ee~----------fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESLPPDE-------------WDDER----------LLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTBSSCS-------------CCHHH----------HHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccCCCCC-------------CCHHH----------HHHHHHHHHHHHHcCCCCHH
Confidence 99999999999888754321111 01111 12245588888888887664
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.90 E-value=0.092 Score=36.72 Aligned_cols=32 Identities=9% Similarity=0.123 Sum_probs=23.0
Q ss_pred CccceeehhHHHHHHHHHHHHHHHHhhhhcccc
Q 005443 266 GTAGTVVIAVAVGIIAFSLIGLVVWCLRRRKKE 298 (696)
Q Consensus 266 ~~~~~i~i~~~~~~~~~~l~~~~~~~~~rr~~~ 298 (696)
..++..+++ ++.+++++++.++++++||.+++
T Consensus 12 ~~Ia~~vVG-vll~vi~~l~~~~~~RRR~~~~k 43 (44)
T 2jwa_A 12 TSIISAVVG-ILLVVVLGVVFGILIKRRQQKIR 43 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHHCSCCC
T ss_pred cchHHHHHH-HHHHHHHHHHHHhheehhhhhcc
Confidence 345666777 55777778888899998876643
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.71 E-value=0.33 Score=35.61 Aligned_cols=20 Identities=25% Similarity=0.740 Sum_probs=11.3
Q ss_pred eehhHHHHHHHHHHHHHHHH
Q 005443 271 VVIAVAVGIIAFSLIGLVVW 290 (696)
Q Consensus 271 i~i~~~~~~~~~~l~~~~~~ 290 (696)
+++++++|+++++++.+++|
T Consensus 15 Ii~svl~GLllL~li~~~Lw 34 (54)
T 2knc_A 15 VLVGVLGGLLLLTILVLAMW 34 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHH
Confidence 45555556666655555555
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.31 E-value=0.31 Score=35.60 Aligned_cols=21 Identities=19% Similarity=0.646 Sum_probs=12.0
Q ss_pred eeehhHHHHHHHHHHHHHHHH
Q 005443 270 TVVIAVAVGIIAFSLIGLVVW 290 (696)
Q Consensus 270 ~i~i~~~~~~~~~~l~~~~~~ 290 (696)
+|++++++|+++++++.+++|
T Consensus 11 iIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 11 VILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHH
Confidence 345555556666666655555
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=86.85 E-value=6 Score=44.93 Aligned_cols=45 Identities=24% Similarity=0.186 Sum_probs=32.3
Q ss_pred HHHHHHHHHHH--HHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 465 ATRVKIAAGAA--RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 465 ~~~~~i~~qia--~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
..+..+++.+| ..+.|+=. -+|=+.+||||+++|++.=+|||+..
T Consensus 529 ~ar~nF~~SlA~~Svv~YILG-------lGDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 529 EVMDTYIKSCAGYCVITYLLG-------VGDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT-------CCCCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHHHcc-------CCCCCCcceEEeCCCCEEEEeehhhh
Confidence 34445555544 33444443 36889999999999999999999985
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=86.63 E-value=0.19 Score=33.17 Aligned_cols=20 Identities=35% Similarity=0.575 Sum_probs=8.5
Q ss_pred HHHHHHHHHHHHHHHhhhhc
Q 005443 276 AVGIIAFSLIGLVVWCLRRR 295 (696)
Q Consensus 276 ~~~~~~~~l~~~~~~~~~rr 295 (696)
++++++++++++.+.++.||
T Consensus 14 Vvglll~vii~l~~~~~iRR 33 (35)
T 1iij_A 14 VVGVLLFLILVVVVGILIKR 33 (35)
T ss_dssp HHHHHHHHHHTTTTTHHHHH
T ss_pred HHHHHHHHHHHHHhheEEee
Confidence 33344444444444333333
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=85.70 E-value=7.8 Score=43.28 Aligned_cols=83 Identities=14% Similarity=0.114 Sum_probs=49.3
Q ss_pred eeEEeEEeeCCceeEEEEecCCCchhhccccCC-------------CC--CCCHHHHHHHHHHHH--HHHHHHHhcCCCc
Q 005443 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEG-------------RP--VLDWATRVKIAAGAA--RGLAYLHEDCHPR 488 (696)
Q Consensus 426 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~--~l~~~~~~~i~~qia--~gL~~LH~~~~~~ 488 (696)
++.|.+.-...... ++|++.+.++.+.+...+ .. ...+..+..+++.+| ..+.|+=..
T Consensus 402 i~~Y~Vipls~~~G-lIE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi---- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHG-FMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV---- 476 (614)
T ss_dssp CCCCCEEESSSSEE-EEECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred eeccEEEEecCCCc-eEEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec----
Confidence 34455554444433 357777655544432211 00 112445555655554 345555433
Q ss_pred eeeccCCCCceEECCCCcEEEEeeccch
Q 005443 489 IIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 489 ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
+|=+.+||||+.+|++.=+|||...
T Consensus 477 ---gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 ---GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp ---CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred ---cCCCCcceeEcCCCCEeeeehHHhh
Confidence 5778999999999999999999984
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.98 E-value=0.16 Score=55.48 Aligned_cols=61 Identities=5% Similarity=-0.005 Sum_probs=17.9
Q ss_pred ccccccccCcEEEEEEEcCC-CcEEEE------EEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEee
Q 005443 371 DQNLLGEGGFGSVYKGYLPD-GREVAI------KQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCIS 434 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~~-g~~vav------K~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 434 (696)
+.+.|| ||.||+|.+.. ...||| |.++.... +....|.+|..+++.++|+|+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999999754 357888 76653221 223468889999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 696 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-77 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-73 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-73 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-71 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-70 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-69 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-67 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-65 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-63 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-60 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-54 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-52 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-50 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-48 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-31 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 8e-77
Identities = 75/282 (26%), Positives = 135/282 (47%), Gaps = 28/282 (9%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVG 430
+G G FG+VYKG +VA+K L + Q + FK EV ++ + H +++ +G
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
Y + + ++ + ++LY HLH + + IA A+G+ YLH II
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFGYMAPEYA---SSGKL 546
HRD+KS+NI L + ++ DFGLA + + + +H ++ G+ +MAPE
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606
+ +SDV++FG+VL EL+TG+ P + + + ++ + + ++
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDL-----SKVR 235
Query: 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648
N + M A C++ +RP Q++ + LA S
Sbjct: 236 SNCPK----AMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 7e-75
Identities = 67/304 (22%), Positives = 121/304 (39%), Gaps = 27/304 (8%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
Q +G+G FG V++G G EVA+K + +AE+ + H +++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 65
Query: 432 CISDD----RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC-- 485
D+ + L+ DY + +L+ +L+ + +K+A A GLA+LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 486 ---HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL---ALDANTHITTRVMGTFGYMAPE 539
P I HRD+KS NIL+ N ++D GLA A D +GT YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 540 YASS------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593
+ +++D+++ G+V E+ + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 594 NEEFDNLADPRLGENYVEGEMFR-MIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNN 652
+ P + + E R M + C + A R ++ + L+ +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE--- 299
Query: 653 GMKV 656
G+K+
Sbjct: 300 GIKM 303
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 8e-75
Identities = 72/276 (26%), Positives = 117/276 (42%), Gaps = 24/276 (8%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V+ GY +VA+K LK G F AE ++ ++ H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ +I +Y+ N +L L L + +AA A G+A++ E IHR
Sbjct: 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
D++++NIL+ + +++DFGLA+L D + APE + G T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 553 FSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEG 612
+SFG++L E++T + P + E + L DN +
Sbjct: 194 WSFGILLTEIVTHGRI-----PYPGMTNPEVIQ-NLERGYRMVRPDNCPE---------- 237
Query: 613 EMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648
+ + C + RP + V + T+
Sbjct: 238 ---ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 3e-73
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 9/210 (4%)
Query: 365 ATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHH 422
D F + LG G G V+K P G +A K + + R E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
++V G SD + +++ +L L GR + K++ +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
E +I+HRD+K SNIL+++ E ++ DFG++ +D + +GT YM+PE
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQ 176
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDAS 572
+ +SD++S G+ L+E+ GR P+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (598), Expect = 7e-73
Identities = 71/276 (25%), Positives = 121/276 (43%), Gaps = 24/276 (8%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG V+ GY + +VAIK ++ G E +F E E++ ++ H LV L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ L+++++ + L +L + T + + G+AYL +IHR
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYL---EEACVIHR 125
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
D+ + N L+ N +VSDFG+ + LD +T + +PE S + + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 553 FSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEG 612
+SFGV++ E+ + K P + S E + + L PRL
Sbjct: 186 WSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTG-------FRLYKPRLAST---- 229
Query: 613 EMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648
+ + C + RP +++R +A S
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 1e-71
Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G+G FG V G G +VA+K +K + F AE +++++ H +LV L+G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 433 ISDDRRL-LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
+ + L ++ +Y+ +L +L GR VL +K + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD+ + N+L+ + A+VSDFGL K A + + APE K + KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 552 VFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVE 611
V+SFG++L E+ + + P L + ++ + + D +
Sbjct: 183 VWSFGILLWEIYSFGRV-----PYPRIPLKD----VVPRVEKGYKMD----------APD 223
Query: 612 GEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDL 650
G + E C AA RP Q+ + + T +L
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 230 bits (586), Expect = 2e-70
Identities = 76/307 (24%), Positives = 127/307 (41%), Gaps = 41/307 (13%)
Query: 357 FTYEELVKATDGFAD---------QNLLGEGGFGSVYKGYLP----DGREVAIKQLKIG- 402
FT+E+ +A FA + ++G G FG V G+L VAIK LK G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 403 GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVL 462
+ R+F +E I+ + H +++ L G ++I +++ N +L L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522
V + G A G+ YL +HRD+ + NIL+++N +VSDFGL++ D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 523 THITTR----VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE 578
+ T + APE K T SDV+S+G+V+ E+++ + P D
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYWDM 237
Query: 579 SLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQV 638
+ + + D RL + + C + RP+ GQ+
Sbjct: 238 TNQDVINAIEQ------------DYRL--PPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 639 VRVFDSL 645
V D +
Sbjct: 284 VNTLDKM 290
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 1e-69
Identities = 62/269 (23%), Positives = 106/269 (39%), Gaps = 26/269 (9%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V G +VAIK +K G E EF E +++ + H LV L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+I +Y+ N L +L +++ + YL + +HR
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 493 DIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDV 552
D+ + N L+++ +VSDFGL++ LD + + PE K + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 553 FSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVE 611
++FGV++ E+ + G+ P + + L L +E+ +
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI----------- 233
Query: 612 GEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
+C A +RP ++
Sbjct: 234 ---------MYSCWHEKADERPTFKILLS 253
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 8e-68
Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 32/289 (11%)
Query: 372 QNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQGE-REFKAEVEIISRIHHRHLV 426
++G G FG VY G L D A+K L GE +F E I+ H +++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 427 SLVGYCI-SDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
SL+G C+ S+ L++ Y+ + L + E + A+G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGM---KFLA 147
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN---THITTRVMGTFGYMAPEYAS 542
+ +HRD+ + N +LD F +V+DFGLA+ D H T +MA E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602
+ K T KSDV+SFGV+L EL+T P P D + + LL L
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQG-------RRLLQ 255
Query: 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLN 651
P Y ++ ++ C A RP ++V ++ ++ +
Sbjct: 256 P----EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (560), Expect = 7e-67
Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 24/288 (8%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEII 417
Y++ ++ LG G +G VY+G VA+K LK + E EF E ++
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 67
Query: 418 SRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
I H +LV L+G C + +I +++ L +L R + + +A +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
+ YL + IHRD+ + N L+ N +V+DFGL++L + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 538 PEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597
PE + K + KSDV++FGV+L E+ T ++ +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------------------PGIDLSQV 225
Query: 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
L + EG ++ E AC + + + RP ++ + F+++
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-66
Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 32/290 (11%)
Query: 371 DQNLLGEGGFGSVYKGYLPD---GREVAIKQLKIGGGQGE--REFKAEVEIISRIHHRHL 425
+ LG G FG+V KGY + VA+K LK E AE ++ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC 485
V ++G C + +L+ + L +L + +++ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124
Query: 486 HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGTFGYMAPEYASS 543
+HRD+ + N+LL A++SDFGL+K + + + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603
K + KSDV+SFGV++ E + + P E ++ LE E
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSE-----VTAMLEKGER-----M 229
Query: 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNG 653
EM+ ++ C + RP V + +N G
Sbjct: 230 GCPAGCPR-EMYDLMN---LCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 5e-66
Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 35/300 (11%)
Query: 360 EELVKATDGFADQNL-LGEGGFGSVYKGYL---PDGREVAIKQLKIGGGQGERE-FKAEV 414
++L D ++ LG G FGSV +G +VAIK LK G + + E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA 474
+I+ ++ + ++V L+G C + +L+ + L+ L G+ + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR--VMGT 532
+ G+ YL +HRD+ + N+LL N A++SDFGL+K +++ T R
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592
+ APE + K + +SDV+S+GV + E ++ + P E +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQG-- 228
Query: 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV----FDSLATS 648
+ E P L + C + RP V + + SLA+
Sbjct: 229 KRMECPPECPPEL------------YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 5e-66
Identities = 75/285 (26%), Positives = 119/285 (41%), Gaps = 31/285 (10%)
Query: 369 FADQNLLGEGGFGSVYKGYLPDG-----REVAIKQLKIGGGQGER-EFKAEVEIISRIHH 422
Q ++G G FG VYKG L VAIK LK G + +R +F E I+ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
+++ L G ++I +Y+ N E V + G A G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD--ANTHITTRVMGTFGYMAPEY 540
+ +HRD+ + NIL+++N +VSDFGL+++ D T+ T+ + APE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600
S K T SDV+SFG+V+ E++T + L N E
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPY-------------------WELSNHEVMKA 225
Query: 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
+ + + C + A+RP+ +V + D L
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 3e-65
Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 30/277 (10%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLV 429
+G G +G K DG+ + K+L G ++ +EV ++ + H ++V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 430 GYCI--SDDRRLLIYDYVPNNTLYFHLH--GEGRPVLDWATRVKIAAGAARGLAYLHE-- 483
I ++ ++ +Y L + + R LD +++ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
D ++HRD+K +N+ LD ++ DFGLA++ L+ +T +GT YM+PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603
EKSD++S G +L EL P A L+ + +F
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----------LAGKIREGKF-----R 232
Query: 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
R+ Y + E+ +I + RP + +++
Sbjct: 233 RIPYRYSD-ELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 4e-65
Identities = 70/298 (23%), Positives = 115/298 (38%), Gaps = 46/298 (15%)
Query: 373 NLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGERE-FKAEVEIISRI-HHRH 424
LG G FG V + VA+K LK ERE +E++++S + +H +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHG----------------EGRPVLDWATRV 468
+V+L+G C L+I +Y L L + LD +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITT 527
+ A+G+A+L IHRD+ + NILL + ++ DFGLA+ + D+N +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 528 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587
+MAPE + T +SDV+S+G+ L EL + P
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP------------- 252
Query: 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
+ +F + E M + C KRP Q+V++ +
Sbjct: 253 -----VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-64
Identities = 70/278 (25%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLK---IGGGQGEREFKAEVEIISRIHH 422
+ F LG+G FG+VY +A+K L + E + + EVEI S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
+++ L GY R LI +Y P T+Y L + D A L+Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
R+IHRDIK N+LL + E +++DFG + A + + GT Y+ PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIE 177
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602
EK D++S GV+ E + G+ P +A+ + + E +L
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV-TEGARDLIS 236
Query: 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
++H+ ++RP + +V+
Sbjct: 237 --------------------RLLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-64
Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 33/274 (12%)
Query: 375 LGEGGFGSVYKGYLPD-GREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G G F +VYKG + EVA +L+ + FK E E++ + H ++V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 432 CISDDRR----LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
S + +L+ + + + TL +L + +GL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-RTP 133
Query: 488 RIIHRDIKSSNILL-DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
IIHRD+K NI + ++ D GLA L V+GT +MAPE K
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EKY 189
Query: 547 TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606
E DV++FG+ +LE+ T P Q ++ ++ FD +A P +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFDKVAIPEV- 242
Query: 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
E C+R + +R + ++
Sbjct: 243 -----------KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 4e-64
Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 24/277 (8%)
Query: 372 QNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+ LG+G FG V+ G VAIK LK G F E +++ ++ H LV L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
S++ ++ +Y+ +L L GE L V +AA A G+AY+ +H
Sbjct: 81 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 136
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RD++++NIL+ N +V+DFGLA+L D + APE A G+ T KSD
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 552 VFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVE 611
V+SFG++L EL T + P E +L P E
Sbjct: 197 VWSFGILLTELTTKGRV-----PYPGMVNRE----VLDQVERGYRMP--CPPECPE---- 241
Query: 612 GEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648
+ + C R +RP + + TS
Sbjct: 242 ----SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (540), Expect = 1e-63
Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 36/282 (12%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE---REFKAEVEIISRIH 421
F+D +G G FG+VY + + VAIK++ G Q ++ EV + ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
H + + G + + L+ +Y + + L + GA +GLAYL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H +IHRD+K+ NILL ++ DFG A + AN+ +GT +MAPE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVI 183
Query: 542 SS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598
+ G+ K DV+S G+ +EL + P+ + L H +NE
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------ALYHIAQNE--- 230
Query: 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
P L + ++ +C++ RP +++
Sbjct: 231 ---SPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (538), Expect = 1e-63
Identities = 65/317 (20%), Positives = 113/317 (35%), Gaps = 52/317 (16%)
Query: 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQGER-EFK 411
L + +GEG FG V++ P VA+K LK + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 412 AEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR------------ 459
E +++ + ++V L+G C L+++Y+ L L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 460 ----------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQV 509
P L A ++ IA A G+AYL + +HRD+ + N L+ N ++
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 510 SDFGLAKLALDAN-THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
+DFGL++ A+ +M PE + T +SDV+++GVVL E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 569 VDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHS 628
P + E + + EN + C
Sbjct: 242 -----PYYGMAHEEVIYYVRDGNI----------LACPENCPL----ELYNLMRLCWSKL 282
Query: 629 AAKRPRMGQVVRVFDSL 645
A RP + R+ +
Sbjct: 283 PADRPSFCSIHRILQRM 299
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-63
Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 29/277 (10%)
Query: 374 LLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSL 428
+GEG FG V++G VAIK K RE F E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
+G +++ +I + L L LD A+ + A + LAYL R
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES---KR 128
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
+HRDI + N+L+ +N ++ DFGL++ D+ + ++ +MAPE + + T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608
SDV+ FGV + E++ P + + + + N
Sbjct: 189 ASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENG----------ERLPMPPN 233
Query: 609 YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
++ ++ C + ++RPR ++ ++
Sbjct: 234 CPP-TLYSLMT---KCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 7e-63
Identities = 65/297 (21%), Positives = 122/297 (41%), Gaps = 51/297 (17%)
Query: 374 LLGEGGFGSVYKGYLPD------GREVAIKQLKIGGGQGERE-FKAEVEIISRI-HHRHL 425
+LG G FG V +VA+K LK ERE +E+++++++ H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHG---------------------EGRPVLDW 464
V+L+G C LI++Y L +L E VL +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 465 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL-DANT 523
+ A A+G+ +L +HRD+ + N+L+ + ++ DFGLA+ + D+N
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
+ +MAPE G T KSDV+S+G++L E+ + P +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----PYPGIPVDAN 275
Query: 584 ARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
L+ + + ++ + E++ +++ +C + KRP +
Sbjct: 276 FYKLIQNGFKMDQPFYATE----------EIYIIMQ---SCWAFDSRKRPSFPNLTS 319
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 8e-63
Identities = 59/291 (20%), Positives = 115/291 (39%), Gaps = 32/291 (10%)
Query: 359 YEEL---VKATDGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEV 414
YE + + D + LG+G FG VYK + A K + + ++ E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA 474
+I++ H ++V L+ ++ ++ ++ + + RP L + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFG 534
L YLH+ +IIHRD+K+ NIL + + +++DFG++ + + GT
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175
Query: 535 YMAPEYA-----SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS 589
+MAPE K+DV+S G+ L+E+ P P+ +
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----------VL 224
Query: 590 HALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
+ E LA P + ++ C+ + R Q+++
Sbjct: 225 LKIAKSEPPTLAQP----SRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-61
Identities = 72/294 (24%), Positives = 129/294 (43%), Gaps = 34/294 (11%)
Query: 361 ELVKATDGFADQNLLGEGGFGSVYKG-YLPDGRE----VAIKQLKIGG-GQGEREFKAEV 414
++K T+ F +LG G FG+VYKG ++P+G + VAIK+L+ + +E E
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 415 EIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGA 474
+++ + + H+ L+G C++ +L I +P L ++ + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQI 120
Query: 475 ARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTF 533
A+G+ YL R++HRD+ + N+L+ +++DFGLAK L + +
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 534 GYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHAL 592
+MA E T +SDV+S+GV + EL+T G KP D S++E L +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237
Query: 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646
+ + C A RP+ +++ F +A
Sbjct: 238 CTIDVYMI--------------------MVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-60
Identities = 59/274 (21%), Positives = 99/274 (36%), Gaps = 32/274 (11%)
Query: 375 LGEGGFGSVYKGYLP----DGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVS 427
LG+G FG V +G VA+K LK + + +F EV + + HR+L+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 428 LVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
L G ++ + ++ + P +L L T + A A G+ YL
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES---K 130
Query: 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH--ITTRVMGTFGYMAPEYASSGK 545
R IHRD+ + N+LL ++ DFGL + + H + F + APE +
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 546 LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605
+ SD + FGV L E+ T + P + + + ++
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDCPQ--- 242
Query: 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVV 639
+ C H RP +
Sbjct: 243 ----------DIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-60
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 27/272 (9%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHRHLVSLVG 430
LGEG +G V VA+K + + E K E+ I ++H ++V G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ + + L +Y L+ + + + + G+ YLH I
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---GIGIT 125
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAK-LALDANTHITTRVMGTFGYMAPEYASSGKL-TE 548
HRDIK N+LLD ++SDFGLA + + ++ GT Y+APE + E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 549 KSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGEN 608
DV+S G+VL ++ G P D + S E + + N
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSD---------SCQEYSDWKEKKTYLNPWKK----- 231
Query: 609 YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
++ ++ + + + R + + +
Sbjct: 232 -IDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-60
Identities = 71/293 (24%), Positives = 121/293 (41%), Gaps = 43/293 (14%)
Query: 372 QNLLGEGGFGSVYKGYLPDG---REVAIKQLK-IGGGQGEREFKAEVEIISRI-HHRHLV 426
Q+++GEG FG V K + + AIK++K R+F E+E++ ++ HH +++
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHG--------------EGRPVLDWATRVKIAA 472
+L+G C L +Y P+ L L L + AA
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 473 GAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGT 532
ARG+ YL + + IHRD+ + NIL+ N+ A+++DFGL++ T
Sbjct: 135 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLP 189
Query: 533 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHAL 592
+MA E + T SDV+S+GV+L E+++ P + E L
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYE-KLPQGY 243
Query: 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
E+ N D + + C R +RP Q++ + +
Sbjct: 244 RLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (500), Expect = 3e-58
Identities = 68/297 (22%), Positives = 111/297 (37%), Gaps = 45/297 (15%)
Query: 373 NLLGEGGFGSVYKGY------LPDGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HHRH 424
LG G FG V + R VA+K LK G E R +E++I+ I HH +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 425 LVSLVGYCISDDRRLLI-YDYVPNNTLYFHLHGEG--------------RPVLDWATRVK 469
+V+L+G C L++ ++ L +L + + L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 470 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-TTR 528
+ A+G+ +L + IHRD+ + NILL ++ DFGLA+ ++
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 529 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588
+MAPE T +SDV+SFGV+L E+ + P + E L
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRL 250
Query: 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
D M + C ++RP ++V +L
Sbjct: 251 KEGTRMRAPDYTTP-------------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-58
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGY 431
+G+G G+VY + G+EVAI+Q+ + + E+ ++ + ++V+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 432 CISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491
+ D ++ +Y+ +L + + + L +LH + ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSD 551
RDIKS NILL + +++DFG + +T V GT +MAPE + K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 552 VFSFGVVLLELITGRKPVDASQPL 575
++S G++ +E+I G P PL
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPL 222
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-54
Identities = 71/298 (23%), Positives = 113/298 (37%), Gaps = 47/298 (15%)
Query: 373 NLLGEGGFGSVYKGYLP--------DGREVAIKQLKIGGGQGE-REFKAEVEIISRI-HH 422
LGEG FG V +VA+K LK + + + +E+E++ I H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRP--------------VLDWATRV 468
+++++L+G C D +I +Y L +L P L V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 469 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTR 528
A ARG+ YL + IHRD+ + N+L+ + +++DFGLA+ + + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 529 VM-GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 587
+MAPE T +SDV+SFGV+L E+ T P + E L
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVEE----L 246
Query: 588 LSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
E D + C ++RP Q+V D +
Sbjct: 247 FKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 7e-54
Identities = 57/282 (20%), Positives = 98/282 (34%), Gaps = 29/282 (10%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+G G FG +Y G + G EVAIK + + E +I + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
++ ++ + +L + R T + +A + Y+H IHR
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHS---KNFIHR 127
Query: 493 DIKSSNIL---LDNNFEAQVSDFGLAKLALDANTHI------TTRVMGTFGYMAPEYASS 543
D+K N L + DFGLAK DA TH + GT Y +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603
+ + + D+ S G VL+ G P + E +E+ +
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER---------ISEKKMSTPIE 238
Query: 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645
L + Y E + C +P + ++F +L
Sbjct: 239 VLCKGYPS-EFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-53
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 10/216 (4%)
Query: 364 KATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLK---IGGGQGEREFKAEVEIISR 419
K + F +LGEG F +V L RE AIK L+ I E +++SR
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 420 IHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+ H V L D++ Y N L ++ G D A L
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALE 122
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL-ALDANTHITTRVMGTFGYMAP 538
YLH IIHRD+K NILL+ + Q++DFG AK+ + ++ +GT Y++P
Sbjct: 123 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 539 EYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
E + + SD+++ G ++ +L+ G P A
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 183 bits (465), Expect = 2e-53
Identities = 52/301 (17%), Positives = 96/301 (31%), Gaps = 36/301 (11%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
+GEG FG +++G L + ++VAIK + + E + + V Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+ ++ + +L L GR T A + +HE +++R
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 493 DIKSSNILLDNNFEAQ-----VSDFGLAKLALDANTHI------TTRVMGTFGYMAPEYA 541
DIK N L+ V DFG+ K D T + GT YM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601
+ + + D+ + G V + + G P + ++ E E
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSDLNNGMKVGESEV 661
+ E ++ + + P + +F + + E E
Sbjct: 246 E----------EFYKYMH---YARNLAFDATPDYDYLQGLFSKVLER-----LNTTEDEN 287
Query: 662 F 662
F
Sbjct: 288 F 288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 184 bits (468), Expect = 5e-53
Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 9/205 (4%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V++ GR K + + K E+ I++++HH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
+LI +++ L+ + E + A + A GL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 493 DIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
DIK NI+ + + V DFGLA I T + APE + +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 551 DVFSFGVVLLELITGRKPVDASQPL 575
D+++ GV+ L++G P L
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDL 234
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 180 bits (458), Expect = 2e-52
Identities = 66/285 (23%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE---REFKAEVEIISRIH 421
+D + +LG GG V+ L R+VA+K L+ + F+ E + + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 422 HRHLVSLVGYCISDDRRL----LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
H +V++ ++ ++ +YV TL +H EG + +++ A A +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI--TTRVMGTFGY 535
L + H+ IIHRD+K +NI++ +V DFG+A+ D+ + T V+GT Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 536 MAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595
++PE A + +SDV+S G VL E++TG P P H E+
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---------VSVAYQHVREDP 231
Query: 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
+ L + + + + R + +R
Sbjct: 232 IPPSARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 180 bits (457), Expect = 3e-52
Identities = 56/280 (20%), Positives = 115/280 (41%), Gaps = 19/280 (6%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHRHLVSLVG 430
+GEG +G VYK G A+K++++ E+ I+ + H ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ R +L+++++ + EG L+ T G+AY H+ R++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
HRD+K N+L++ E +++DFGLA+ T ++ + S K +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 551 DVFSFGVVLLELITGRKPVDASQP----------LGDESLVEWARPLLSHALENEEFDNL 600
D++S G + E++ G LG + W P ++ + + +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW--PNVTELPKYDPNFTV 240
Query: 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
+P E++++G I+ + ++ +R Q +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 179 bits (454), Expect = 5e-52
Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 24/226 (10%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG---------QGEREFKAEVEI 416
+ + + +LG G V + P +E A+K + + GG + EV+I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 417 ISRIH-HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAA 475
+ ++ H +++ L ++ L++D + L+ +L + L KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 476 RGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGY 535
+ LH+ I+HRD+K NILLD++ +++DFG + V GT Y
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSY 175
Query: 536 MAPEYASSG------KLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+APE ++ D++S GV++ L+ G P + +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (459), Expect = 8e-52
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 9/204 (4%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V++ G A K + + + E++ +S + H LV+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
D+ ++IY+++ L+ + E + V+ +GL ++HE+ +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHL 148
Query: 493 DIKSSNILL--DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
D+K NI+ + E ++ DFGL + T GT + APE A + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 206
Query: 551 DVFSFGVVLLELITGRKPVDASQP 574
D++S GV+ L++G P
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGEND 230
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 8e-52
Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 38/284 (13%)
Query: 373 NLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGGQGER-EFKAEVEIISRIHHRHL 425
LG+G FG VY+G VAIK + ER EF E ++ + H+
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGR--------PVLDWATRVKIAAGAARG 477
V L+G L+I + + L +L + +++A A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN-THITTRVMGTFGYM 536
+AYL + +HRD+ + N ++ +F ++ DFG+ + + + + + +M
Sbjct: 146 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 537 APEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEE 596
+PE G T SDV+SFGVVL E+ T + P S + R ++ L ++
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQVLRFVMEGGLL-DK 256
Query: 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
DN D + E C +++ RP +++
Sbjct: 257 PDNCPD-------------MLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 1e-51
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 12/214 (5%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHR 423
D + +++LG G F V + VAIK + +G+ + E+ ++ +I H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++V+L S LI V L+ + +G ++ + YLH+
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHD 125
Query: 484 DCHPRIIHRDIKSSNILL---DNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEY 540
I+HRD+K N+L D + + +SDFGL+K+ D + ++T GT GY+APE
Sbjct: 126 LG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTAC-GTPGYVAPEV 180
Query: 541 ASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
+ ++ D +S GV+ L+ G P
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 181 bits (459), Expect = 1e-51
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 367 DGFADQNLLGEGGFGSVYKGYLPD-GREVAIKQLK---IGGGQGEREFKAEVEIISRIH- 421
+ F+ ++G GGFG VY D G+ A+K L I QGE E ++S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 422 --HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLA 479
+V + + D+ I D + L++HL G A AA GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLE 121
Query: 480 YLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
++H +++RD+K +NILLD + ++SD GLA D + +GT GYMAPE
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPE 175
Query: 540 YASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 583
G +D FS G +L +L+ G P + +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 42/204 (20%), Positives = 83/204 (40%), Gaps = 10/204 (4%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYC 432
LG G FG V++ + K +K+ G + K E+ I++ HR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF 70
Query: 433 ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHR 492
S + ++I++++ ++ ++ L+ V L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 493 DIKSSNILLDNNFEAQV--SDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
DI+ NI+ + + +FG A+ + Y APE ++ +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTAT 184
Query: 551 DVFSFGVVLLELITGRKPVDASQP 574
D++S G ++ L++G P A
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETN 208
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-49
Identities = 58/283 (20%), Positives = 104/283 (36%), Gaps = 22/283 (7%)
Query: 373 NLLGEGGFGSVYKGY--LPDGREVAIKQLKIGGGQG--EREFKAEVEIISRI---HHRHL 425
+GEG +G V+K GR VA+K++++ G+ EV ++ + H ++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 426 VSLVGYCISDDRRLLIYDYVPNNTL----YFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
V L C + + +L P + T + RGL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H ++HRD+K NIL+ ++ + +++DFGLA++ T V+ T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWA--RPLLSHALENEEFDN 599
D++S G + E+ + S + + P +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 600 LADPRLGENYVEGEMFRMIEAA----AACVRHSAAKRPRMGQV 638
A +E + + E C+ + AKR
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 11/234 (4%)
Query: 367 DGFADQNLLGEGGFGSVYKG-YLPDGREVAIKQLKIGGGQGERE---FKAEVEIISR-IH 421
+ F +LG+G FG V+ + + AIK LK + + E ++S
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 422 HRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
H L + + + + +Y+ L +H+ + D + AA GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYA 541
H I++RD+K NILLD + +++DFG+ K + + T GT Y+APE
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175
Query: 542 SSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595
K D +SFGV+L E++ G+ P + P LE E
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 229
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 55/276 (19%), Positives = 106/276 (38%), Gaps = 32/276 (11%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGY 431
+LG G G V + + + A+K L+ + + EVE+ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 432 C----ISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHP 487
L++ + + L+ + G +I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 488 RIIHRDIKSSNILLDNNFE---AQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
I HRD+K N+L + +++DFG AK N+ T T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604
K + D++S GV++ L+ G P ++ L ++ + + N E+ +++
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-- 246
Query: 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
E+ +I ++ +R + + +
Sbjct: 247 --------EVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 168 bits (426), Expect = 2e-47
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHHRHLVSL 428
LG G FG V+ +GR A+K LK + + E ++S + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 429 VGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR 488
G + +I DY+ L+ L R A AA L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALEYLHSKD 124
Query: 489 IIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTE 548
II+RD+K NILLD N +++DFG AK D + GT Y+APE S+ +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVSTKPYNK 180
Query: 549 KSDVFSFGVVLLELITGRKPVDASQP 574
D +SFG+++ E++ G P S
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNT 206
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 13/217 (5%)
Query: 366 TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE-FKAEVEIISRIHHR 423
+ + + +GEG +G V Y + VAIK++ Q + E++I+ R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 424 HLVSLVGYCISDDRRLLIYDYVPN---NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAY 480
+++ + + + Y+ + L L RGL Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124
Query: 481 LHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT--TRVMGTFGYMAP 538
+H ++HRD+K SN+LL+ + ++ DFGLA++A + H T + T Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 539 EYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQP 574
E + K T+ D++S G +L E+++ R
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-46
Identities = 41/212 (19%), Positives = 90/212 (42%), Gaps = 7/212 (3%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIG--GGQGEREFKAEVEIISRIHHR 423
+ F +GEG +G VYK G VA+K++++ E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 424 HLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE 483
++V L+ ++++ L+++++ + L + + +GLA+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 484 DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
++HRD+K N+L++ +++DFGLA+ T V+ +
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 544 GKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
+ D++S G + E++T R +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-46
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 21/231 (9%)
Query: 355 SMFTYEELVKATDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGER----- 408
++F E + D + LG G F V K G + A K +K + R
Sbjct: 1 TVFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 409 -EFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATR 467
+ + EV I+ I H ++++L + +LI + V L+ L + + AT
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 468 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNN----FEAQVSDFGLAKLALDANT 523
+ L ++ +I H D+K NI+L + ++ DFGLA N
Sbjct: 118 F-----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQP 574
+ GT ++APE + L ++D++S GV+ L++G P
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-45
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 24/237 (10%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGERE------FKAEVEIISRIHHRH-- 424
LLG GGFGSVY G + D VAIK ++ E EV ++ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 425 LVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
++ L+ + D +LI + F E L + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128
Query: 485 CHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASS 543
++HRDIK NIL+D N E ++ DFG L + T GT Y PE+
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 183
Query: 544 GKL-TEKSDVFSFGVVLLELITGRKPVDAS------QPLGDESLVEWARPLLSHALE 593
+ + V+S G++L +++ G P + Q + + + L+ L
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 240
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 369 FADQNLLGEGGFGSVYKGYLPD-GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVS 427
+ D ++G G FG VY+ L D G VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 428 LVGYCISDDRR------LLIYDYVPNNTLYFHLH-GEGRPVLDWATRVKIAAGAARGLAY 480
L + S + L+ DYVP H + L R LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 481 LHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPE 539
+H I HRDIK N+LLD + ++ DFG AK L + + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAPEL 193
Query: 540 YASSGKLTEKSDVFSFGVVLLELITGRKP 568
+ T DV+S G VL EL+ G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQG-----EREFKAEVEIISRIHHRHLV 426
+ LGEG F +VYK + VAIK++K+G R E++++ + H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 427 SLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCH 486
L+ L++D++ + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHI--KAYMLMTLQGLEYLHQHW- 120
Query: 487 PRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKL 546
I+HRD+K +N+LLD N +++DFGLAK + + T + T Y APE ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 547 -TEKSDVFSFGVVLLELITGRKPVDASQPL 575
D+++ G +L EL+ + L
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDL 207
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 3e-42
Identities = 44/280 (15%), Positives = 106/280 (37%), Gaps = 17/280 (6%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLV 429
+GEG +G+V+K VA+K++++ E+ ++ + H+++V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 430 GYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRI 489
SD + L++++ + + G + + L L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122
Query: 490 IHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEK 549
+HRD+K N+L++ N E ++++FGLA+ + V+ + + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 550 SDVFSFGVVLLELITGRKPVDASQPLGDE---------SLVEWARPLLSHALENEEFDNL 600
D++S G + EL +P+ + D+ + E P ++ + + +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640
N V + ++ + +R + ++
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 10/206 (4%)
Query: 367 DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLK---IGGGQGEREFKAEVEIISRIHH 422
+ F LLG+G FG V GR A+K L+ I E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
L +L + DR + +Y L+FHL E + A A ++ L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALE 119
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYAS 542
+++RDIK N++LD + +++DFGL K + GT Y+APE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLE 178
Query: 543 SGKLTEKSDVFSFGVVLLELITGRKP 568
D + GVV+ E++ GR P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-41
Identities = 50/235 (21%), Positives = 97/235 (41%), Gaps = 23/235 (9%)
Query: 354 RSMFTYEELVKATDGFADQ----NLLGEGGFGSVYKGY-LPDGREVAIKQLK--IGGGQG 406
RS F +E+ K +G G +G+V G +VAIK+L
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 407 EREFKAEVEIISRIHHRHLVSLVGYCISDDRR------LLIYDYVPNNTLYFHLHGEGRP 460
+ E+ ++ + H +++ L+ D+ L+ ++ + H +
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117
Query: 461 VLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520
L + +GL Y+H HRD+K N+ ++ + E ++ DFGLA+ A
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-- 171
Query: 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPL 575
++ +T V+ + + + T+ D++S G ++ E+ITG+ S L
Sbjct: 172 -DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 6e-41
Identities = 52/292 (17%), Positives = 115/292 (39%), Gaps = 31/292 (10%)
Query: 373 NLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQG--EREFKAEVEIISRIHHRHLVSLV 429
+G+G FG V+K G++VA+K++ + + E++I+ + H ++V+L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 430 GYCISDDRR--------LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYL 481
C + L++D+ ++ + + L RV L L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQMLLNGL 130
Query: 482 HEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK---LALDANTHITTRVMGTFGYMAP 538
+ +I+HRD+K++N+L+ + +++DFGLA+ LA ++ + T + T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 539 EYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLG-----DESLVEWARPLLSHAL 592
E + D++ G ++ E+ T + + + + +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 593 ENEEFDNLADPRLGENYVEGEMFRMIEAAAA------CVRHSAAKRPRMGQV 638
E ++ L + + V+ + + A + A+R
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (374), Expect = 5e-40
Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 13/205 (6%)
Query: 375 LGEGGFGSVYKGY-LPDGREVAIKQL---KIGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
LG G FG V G A+K L K+ + E I+ ++ LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRII 490
+ ++ +YV ++ HL GR AA YLH +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 491 HRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKS 550
+RD+K N+L+D QV+DFG AK T + GT +APE S +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 551 DVFSFGVVLLELITGRKPVDASQPL 575
D ++ GV++ E+ G P A QP+
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPI 244
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 367 DGFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLK----IGGGQGEREFKAEVEIIS 418
+ F +LG G +G V+ G+ A+K LK + + + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 419 RI-HHRHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARG 477
I LV+L ++ + LI DY+ L+ HL R
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEI 138
Query: 478 LAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMA 537
+ L II+RDIK NILLD+N ++DFGL+K + T GT YMA
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 538 PEYASSGK--LTEKSDVFSFGVVLLELITGRKP 568
P+ G + D +S GV++ EL+TG P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-36
Identities = 45/210 (21%), Positives = 82/210 (39%), Gaps = 19/210 (9%)
Query: 374 LLGEGGFGSVYKGY-LPDGREVAIKQLK--IGGGQGEREFKAEVEIISRIHHRHLVSLVG 430
+G G G V Y R VAIK+L + E+ ++ ++H++++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 431 YCISDDRR------LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED 484
L+ + + N D + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSA 138
Query: 485 CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSG 544
IHRD+K SNI++ ++ ++ DFGLA+ + + T + T Y APE
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 545 KLTEKSDVFSFGVVLLELITGRKPVDASQP 574
E D++S G ++ E++ +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 2e-35
Identities = 44/226 (19%), Positives = 93/226 (41%), Gaps = 22/226 (9%)
Query: 352 HSRSMFTYEELVKAT---DGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGE 407
R + YE V D + LG G + V++ + + +V +K LK +
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKK 73
Query: 408 REFKAEVEIISRI-HHRHLVSLVGYCISDDRRL--LIYDYVPNNTLYFHLHGEGRPVLDW 464
++ K E++I+ + ++++L R L++++V N L
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTD 128
Query: 465 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGLAKLALDANT 523
+ L Y H I+HRD+K N+++D+ + + ++ D+GLA+
Sbjct: 129 YDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 524 HITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKP 568
+ + + + PE ++ D++S G +L +I ++P
Sbjct: 186 Y--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (317), Expect = 2e-32
Identities = 42/233 (18%), Positives = 85/233 (36%), Gaps = 25/233 (10%)
Query: 363 VKATDGFAD-----QNLLGEGGFGSVYKGY-LPDGREVAIKQLKIGGGQGEREFKAEVEI 416
+ + D LG G F +V+ + + VA+K ++ E + E+++
Sbjct: 4 AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKL 62
Query: 417 ISRIHHRHLVSLVGYCISDDRRLLIY-DYVPNNTLYFHLHGE-------------GRPVL 462
+ R++ + +LL + ++ N ++ + E +
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122
Query: 463 DWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD-NNFEAQVSDFGLAKLALDA 521
+I+ GL Y+H IIH DIK N+L++ + + +A L
Sbjct: 123 PLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 522 NTHITTR-VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573
+ T Y +PE +D++S ++ ELITG + +
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 119 bits (300), Expect = 9e-32
Identities = 28/154 (18%), Positives = 50/154 (32%), Gaps = 19/154 (12%)
Query: 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGG----------GQGEREFKAEVEIISRIHH 422
L+GEG +V+ Y E +K K+G G+ F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 423 RHLVSLVGYCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLH 482
R L L G + Y + N L + + + ++ +A +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 483 EDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516
I+H D+ N+L+ + DF +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-31
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 19/223 (8%)
Query: 357 FTYEELVKA----TDGFADQNLLGEGGFGSVYKGY-LPDGREVAIKQLK--IGGGQGERE 409
F +EL K + + + + +G G +GSV + G VA+K+L +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 410 FKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV----PNNTLYFHLHGEGRPVLDWA 465
E+ ++ + H +++ L+ D ++ + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDD 121
Query: 466 TRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525
+ RGL Y+H HRD+K SN+ ++ + E ++ DFGLA+ + +
Sbjct: 122 HVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM 175
Query: 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 568
T V + + + D++S G ++ EL+TGR
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 696 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.95 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.8 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 92.1 | |
| d1e7ua4 | 369 | Phoshoinositide 3-kinase (PI3K), catalytic domain | 81.84 | |
| d1bo1a_ | 383 | Phosphatidylinositol phosphate kinase IIbeta, PIPK | 81.07 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=427.89 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=201.3
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|++++.||+|+||.||+|++.+++.||||+++.. ....++|.+|+++|++++|+|||+++|+|..++..+|||||+.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578999999999999999999888999999999753 3456789999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+|+|.++++... ..+++..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999887653 3488999999999999999999999 999999999999999999999999999987765544444
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccC
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRLG 606 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~ 606 (696)
....|+..|||||++.+..|+.++|||||||+||||+++..++.... ....+.+.+ ... .+...+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i----~~~------~~~~~p--- 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDI----STG------FRLYKP--- 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHH----HHT------CCCCCC---
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHH----Hhc------CCCCCc---
Confidence 45678999999999999999999999999999999999655543321 112222211 110 011111
Q ss_pred CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 607 ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 607 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.....++.+|+.+||+.||++||+|+||+++|++++.
T Consensus 225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1112368899999999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-52 Score=435.35 Aligned_cols=260 Identities=26% Similarity=0.394 Sum_probs=216.5
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
..++|++.+.||+|+||.||+|.++ +|+.||||+++... ...++|++|+++|++++|+|||+++|+|.+++..+||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467999999999999999999865 58899999987543 456789999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.+|+|.+++.......+++..+++|+.||++||+|||++ +|||||||++||||++++++||+|||+++.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999999876666799999999999999999999999 999999999999999999999999999998766555
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.......|+..|||||++.++.|+.++|||||||+||||++|..+|..... ...+.+ .+...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~----~i~~~------------ 232 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYE----LLEKD------------ 232 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHH----HHHTT------------
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHH----HHhcC------------
Confidence 445556688999999999999999999999999999999998887754321 111111 11110
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
...........++.+|+++||+.||++||+|+||++.|+.+..
T Consensus 233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111111222368899999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=426.10 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=211.0
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|++.+.||+|+||.||+|++++++.||||+++.. ....++|.+|+++|++++|+|||+++|+|. ++..+|||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence 4679999999999999999999988899999999754 345678999999999999999999999875 45679999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+|+|.+++.......+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999888765555589999999999999999999999 99999999999999999999999999998776554444
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
.....|+..|||||++.++.++.++|||||||+||||++|..+|..... ...+.+.+. ... .. ..
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~-------~~~---~~---~~ 231 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLE-------RGY---RM---VR 231 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH-------TTC---CC---CC
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHH-------hcC---CC---CC
Confidence 4556789999999999999999999999999999999997666543221 112211111 100 00 01
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.. .....+.+|+++||+.||++||+|+||++.|+++.
T Consensus 232 p~----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 PD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11 12236889999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=416.11 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=212.8
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecC
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVP 446 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 446 (696)
++|+++++||+|+||+||+|++++++.||||+++... ...++|++|+++|++++|+||++++|+|.+++..++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999888899999998543 356789999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCccee
Q 005443 447 NNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHIT 526 (696)
Q Consensus 447 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~~ 526 (696)
+|+|.+++..... .+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999888765433 378999999999999999999999 999999999999999999999999999987665554444
Q ss_pred eccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 527 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 527 ~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....|+..|+|||++.+..++.++|||||||++|||++ |+.||.... ..++.+ . +. ... ++..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~---~-i~---~~~---~~~~--- 222 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAE---H-IA---QGL---RLYR--- 222 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHH---H-HH---TTC---CCCC---
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHHH---H-HH---hCC---CCCC---
Confidence 55678999999999999999999999999999999998 899997543 122211 1 11 110 1111
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
.......+.+|+++||+.||++||+|+||+++|.++
T Consensus 223 ----p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 ----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 112223688999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=419.03 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=203.0
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|+++++||+|+||.||+|++ .+|+.||||+++.... ...+++++|+++|++++|+|||++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 36799999999999999999986 4799999999975533 234568999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
||.+|+|.+++...+ .+++.+++.|+.||+.||+|||++ +|||||||++||||++++++||+|||+++.......
T Consensus 84 y~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999997654 489999999999999999999999 999999999999999999999999999987654332
Q ss_pred -ceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 524 -HITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 524 -~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
......+||..|||||++.+..+ +.++|||||||+||||++|+.||....... ..+..+ . ..... .
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~~----~----~~~~~---~ 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----K----EKKTY---L 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHHH----H----TTCTT---S
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHHH----h----cCCCC---C
Confidence 23345689999999999988776 578999999999999999999997644211 111110 0 00000 0
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
........++.+|+.+||+.||++|++++||++
T Consensus 227 ------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000111236788999999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=420.50 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=208.4
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++|+|||+++++|.+++..+||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999985 479999999998776666788999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.||+|.+++... .+++.+++.|+.||+.||+|||++ ||||||||++||||+.++++||+|||+++....... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 999999887653 389999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
....+||..|||||++.+..|+.++|||||||+||||++|+.||...+. .+......... ...+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~-----~~~~----- 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNG-----TPEL----- 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHC-----SCCC-----
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCC-----CCCC-----
Confidence 3446799999999999999999999999999999999999999975331 11111111110 0001
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.........+.+|+.+||+.||++|++++|++++
T Consensus 237 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111122368899999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=419.41 Aligned_cols=260 Identities=28% Similarity=0.492 Sum_probs=202.8
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|++.++||+|+||.||+|+++ ..||||+++... ....++|++|+++|++++|+|||+++|++. ++..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467999999999999999999874 369999997543 344578999999999999999999999875 456899999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
||.+|+|.++++..+. .+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.......
T Consensus 84 y~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999975433 489999999999999999999999 999999999999999999999999999987644322
Q ss_pred -ceeeccccccccCchhhhcc---CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 524 -HITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 524 -~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.......||..|||||++.+ +.|+.++|||||||+||||++|+.||.+... .. .+...+.+......+..
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~---~~---~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RD---QIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HH---HHHHHHHHTSCCCCGGG
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh---HH---HHHHHHhcCCCCCcchh
Confidence 23345679999999999864 4589999999999999999999999976431 11 11111111111111111
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+.. .....+.+|+.+||+.||++||+|+||++.|+.+..
T Consensus 234 -----~~~----~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 234 -----VRS----NCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -----SCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----ccc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 122368899999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-51 Score=426.59 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=197.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CC---cEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DG---REVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.++||+|+||+||+|+++ +| ..||||++..... ...++|.+|+++|++++|+|||+++|+|.+++..+||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45777899999999999999864 23 2588998865433 3346799999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
||||.+|+|.+++..... .+++.++++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999998876433 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred Ccce----eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 522 NTHI----TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 522 ~~~~----~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
.... .....|+..|||||++.++.++.++|||||||+||||++ |+.||.... ...+++.+. ...
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~i~-------~~~- 250 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINAIE-------QDY- 250 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHH-------TTC-
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---HHHHHHHHH-------cCC-
Confidence 3221 122457899999999999999999999999999999998 899997543 122221111 110
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
...........+.+|+.+||+.||++||+|.||++.|+++..
T Consensus 251 ---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 ---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 001112223468899999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=412.44 Aligned_cols=245 Identities=29% Similarity=0.471 Sum_probs=204.8
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++++.||+|+||.||+|+++ +|+.||||++... .....+.+++|+++|++++|+|||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56999999999999999999964 6899999998632 2344677999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|||.+|+|.+++...+. +++..++.|+.||+.||+|||++ +|||||||++||||++++++||+|||+++......
T Consensus 86 Ey~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999876544 89999999999999999999999 99999999999999999999999999997654332
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
.....||..|||||++.+..|+.++|||||||+||||++|+.||.... ...+. ..+. ...+
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~---~~i~-----~~~~----- 221 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETY---KRIS-----RVEF----- 221 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH---HHHH-----TTCC-----
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHH---HHHH-----cCCC-----
Confidence 234579999999999999999999999999999999999999997532 11111 1111 1100
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.+.... ..++.+|+.+||+.||++|++++||++
T Consensus 222 -~~p~~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -TFPDFV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 011111 236888999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=416.96 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=206.1
Q ss_pred hcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
.++|++++.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.+|++++|+|||+++|+|. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3679999999999999999999988889999999754 345678999999999999999999999985 46689999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+|+|..++.......+++.++++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999998888765555699999999999999999999999 99999999999999999999999999998765554444
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCccc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPRL 605 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l 605 (696)
.....|+..|+|||++.++.++.++|||||||+||||++|..+|..... ...+++.+. ... .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~-------~~~------~--- 232 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE-------RGY------R--- 232 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH-------TTC------C---
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH-------hcC------C---
Confidence 4556789999999999999999999999999999999997777654321 222222211 000 0
Q ss_pred CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 606 GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 606 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.........++.+|+.+||+.||++||+|++|++.|++....
T Consensus 233 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 233 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 011112223688999999999999999999999999886643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=413.53 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=200.8
Q ss_pred cCccccccccccCcEEEEEEEcCCC-----cEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDG-----REVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g-----~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
+.|++.++||+|+||.||+|.++++ ..||||+++..... ...+|++|+++|++++|+|||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999986432 36999999754333 34578999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+++|.+++.... ..+++.++++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999988776543 3489999999999999999999999 999999999999999999999999999987644
Q ss_pred cCcc--eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTH--ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... ......||..|||||++.++.++.++|||||||+||||++|..+|.... ....+.+.+ . ..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i----~----~~--- 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAI----N----DG--- 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHH----H----TT---
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHH----h----cc---
Confidence 3322 2233568999999999999999999999999999999999777665432 112222111 1 00
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
............+.+|+.+||+.||++||+|.||++.|+++..
T Consensus 230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 0111112223468899999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-50 Score=414.26 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=205.4
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
+.|++++.||+|+||.||+|++ .+|+.||||+++.......+.+.+|+++|++++|+|||+++++|.+++..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999985 478999999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+|+|.+++...++ .+++..++.|+.||+.||+|||++ +|||||||++||||+.++++||+|||+++....... .
T Consensus 92 ~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp TTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-c
Confidence 99999988765332 489999999999999999999999 999999999999999999999999999975533221 2
Q ss_pred eeccccccccCchhhhc-----cCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 526 TTRVMGTFGYMAPEYAS-----SGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
.....||..|||||++. +..|+.++|||||||+||||++|+.||...+. ... +..+.. . ....+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~---~~~i~~----~-~~~~~ 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRV---LLKIAK----S-EPPTL 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGH---HHHHHH----S-CCCCC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHH---HHHHHc----C-CCCCC
Confidence 23457999999999984 45688999999999999999999999976432 111 111111 0 00011
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. .......++.+|+++||+.||++|++++||+++
T Consensus 236 ~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 A-------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp S-------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C-------ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 111122368899999999999999999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=424.72 Aligned_cols=200 Identities=28% Similarity=0.455 Sum_probs=178.7
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.++|+++++||+|+||+||+|++ .+|+.||||+++.... ...+++.+|+++|++++|+|||+++++|.+++..+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999995 4789999999976533 334678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|+.||+|.+++.+.+. +++..++.++.||+.||+|||+ + +|||||||++||||++++++||+|||+|+...+..
T Consensus 85 y~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999976554 8999999999999999999997 5 79999999999999999999999999998764432
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQ 573 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~ 573 (696)
....+||..|||||++.+..|+.++|||||||+||||++|+.||...+
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=412.93 Aligned_cols=253 Identities=22% Similarity=0.373 Sum_probs=192.5
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEee--CCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCIS--DDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV 441 (696)
++|++++.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|+|||+++++|.+ ++..+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999985 4789999999975532 234568999999999999999999999865 4567999
Q ss_pred EEecCCCchhhccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 442 YDYVPNNTLYFHLHGE--GRPVLDWATRVKIAAGAARGLAYLHEDC--HPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
||||.+|+|.+++... .+..+++..+++|+.||+.||+|||+++ ..+|||||||++||||++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988642 2345899999999999999999999872 11499999999999999999999999999987
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
...... .....+||..|||||++.+..|+.++|||||||+||||++|+.||.... ...+.+ .+. ...+
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~---~i~-----~~~~ 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG---KIR-----EGKF 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHH---HHH-----HTCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHH---HHH-----cCCC
Confidence 654332 2344679999999999999999999999999999999999999997532 111111 111 1111
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.. +...+. .++.+|+.+||+.||++||++.||++
T Consensus 232 ~~-----~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 RR-----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC-----CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-----CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 111222 26889999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=412.18 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=206.8
Q ss_pred hcCcccccc-ccccCcEEEEEEEcC---CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNL-LGEGGFGSVYKGYLP---DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~-LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
+++|.+.++ ||+|+||.||+|.++ ++..||||+++.... ...++|++|+++|++++|+|||+++|+|.+ +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456777775 999999999999753 355799999975543 334679999999999999999999999864 56899
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+++|+|.+++...+ ..+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++....
T Consensus 86 vmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999876543 2489999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhh
Q 005443 521 ANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEF 597 (696)
Q Consensus 521 ~~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 597 (696)
..... .....|+..|||||++.++.++.++|||||||+||||++ |+.||.... ..++.+.+ .....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~---~~~~~~~i--------~~~~~ 230 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFI--------EQGKR 230 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHH--------HTTCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHH--------HcCCC
Confidence 33322 233468899999999999999999999999999999998 999997643 12222111 11110
Q ss_pred hcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 598 DNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. ........++.+|+.+||+.||++||+|.+|++.|+.+..
T Consensus 231 ~---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 M---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 1111222368899999999999999999999999987764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=415.56 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=204.2
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|+|||+++++|.+++..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999986 47999999999743 2344567999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|||.||+|.+++...+. +++..++.++.||+.||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 88 Ey~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999998876554 89999999999999999999999 99999999999999999999999999998764332
Q ss_pred c-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 523 T-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 523 ~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
. ......+||..|||||++.+..|+.++|||||||+||||++|+.||...+ ...+ ...++. ..+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~---~~~i~~-----~~~---- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLI---FQKIIK-----LEY---- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---HHHHHT-----TCC----
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHH---HHHHHc-----CCC----
Confidence 2 22344679999999999999999999999999999999999999998643 1111 111111 110
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVF 642 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 642 (696)
.+...+ ..++.+|+.+||+.||++|+|++|+++..
T Consensus 228 --~~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 228 --DFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp --CCCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred --CCCccC----CHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 111112 23688999999999999999999986543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=419.44 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=206.0
Q ss_pred hcCccccccccccCcEEEEEEEcCC------CcEEEEEEeecC-CCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD------GREVAIKQLKIG-GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 437 (696)
.++|+++++||+|+||+||+|++.. +..||||++... .......+.+|+.+|.++ +|+|||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4679999999999999999998532 236999998643 233456799999999998 89999999999999999
Q ss_pred eeEEEEecCCCchhhccccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCC
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGR---------------------PVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKS 496 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp 496 (696)
.+||||||.+|+|.++|+.... ..+++..++.|+.||++||+|||++ +|||||||+
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999875432 2478999999999999999999999 999999999
Q ss_pred CceEECCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCC
Q 005443 497 SNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQP 574 (696)
Q Consensus 497 ~NILl~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~ 574 (696)
+|||++.++.+||+|||+++........ ......||..|||||++.++.|+.++|||||||+||||++ |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544433 3344568999999999999999999999999999999997 8999976432
Q ss_pred CCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005443 575 LGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDS 644 (696)
Q Consensus 575 ~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 644 (696)
...+.+. +.... ..........++.+|+.+||+.||++||||+||+++|..
T Consensus 273 --~~~~~~~----~~~~~-------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 --DANFYKL----IQNGF-------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp --SHHHHHH----HHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHH----HhcCC-------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1222211 11110 001111122368899999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=404.81 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=193.9
Q ss_pred cccccccccCcEEEEEEEcC-CCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEee----CCceeEEE
Q 005443 370 ADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS----DDRRLLIY 442 (696)
Q Consensus 370 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~ 442 (696)
+..++||+|+||+||+|++. +++.||||+++... ....+.|++|+++|++++|+|||+++++|.+ ++..+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999864 68899999997543 2334578999999999999999999999875 24578999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeeccCCCCceEEC-CCCcEEEEeeccchhcc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPR--IIHRDIKSSNILLD-NNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~--ivHrDLkp~NILl~-~~~~vkL~DfGls~~~~ 519 (696)
||+.+|+|.+++.... .+++..++.|+.||++||+|||++ + |||||||++||||+ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999987654 389999999999999999999998 6 99999999999996 57899999999998643
Q ss_pred ccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
... ....+||..|||||++.+ .|+.++|||||||+||||++|+.||..... ...+. ..+.. ...
T Consensus 167 ~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~---~~i~~-~~~------ 230 (270)
T d1t4ha_ 167 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIY---RRVTS-GVK------ 230 (270)
T ss_dssp TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHH---HHHTT-TCC------
T ss_pred CCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHH---HHHHc-CCC------
Confidence 322 234679999999999875 599999999999999999999999975321 11111 11110 000
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
...+.. ....++.+|+.+||+.||++||+++||++
T Consensus 231 --~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 --PASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CcccCc----cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 001111 11235889999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.9e-49 Score=417.82 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=207.6
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|+++++||+|+||.||+|+. .+|+.||||++........+.+++|+++|++|+|+|||+++++|.+++..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999985 47999999999766555567899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC--CCCcEEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD--NNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DfGls~~~~~~~ 522 (696)
|.||+|.+++..... .+++..++.|+.||+.||+|||++ +|||||||++||||+ .++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999998865433 489999999999999999999999 999999999999995 46789999999998765433
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. .....||..|||||++.+..|+.++|||||||+||||++|+.||.+.+ .. +.+..+...... + .
T Consensus 181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~---~~~~~i~~~~~~---~----~ 245 (350)
T d1koaa2 181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DD---ETLRNVKSCDWN---M----D 245 (350)
T ss_dssp C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHTCCC---S----C
T ss_pred c--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HH---HHHHHHHhCCCC---C----C
Confidence 2 334579999999999999999999999999999999999999997542 11 111111111100 0 0
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. .......++.+|+++||+.||++|++++||+++
T Consensus 246 ~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DS----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CG----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cc----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 011112368899999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=407.35 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=198.0
Q ss_pred ccccccCcEEEEEEEcC---CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEecCC
Q 005443 373 NLLGEGGFGSVYKGYLP---DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYVPN 447 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 447 (696)
++||+|+||.||+|.++ .++.||||+++.... ...++|.+|+++|++++|+|||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999853 356899999964332 234679999999999999999999999864 567899999999
Q ss_pred CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce--
Q 005443 448 NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI-- 525 (696)
Q Consensus 448 gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~-- 525 (696)
|+|.++++.... +++..+++|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999876544 89999999999999999999999 99999999999999999999999999998764433322
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
.....|+..|||||++.+..++.++|||||||+||||++ |+.||.+.. ...+.+. +. ....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~~----i~----~~~~------- 228 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAM----LE----KGER------- 228 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHH----HH----TTCC-------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHHHHHH----HH----cCCC-------
Confidence 233568999999999999999999999999999999998 899997532 1221111 11 1100
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.........++.+|+.+||+.||++||+|++|++.|+....
T Consensus 229 --~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 01111122368899999999999999999999998887643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-49 Score=410.33 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=190.6
Q ss_pred HhcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
+.+.|+++++||+|+||+||+|+++ +|+.||||++..... .....+++|+++|++++|+|||+++++|.+++..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999864 689999999975432 23456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC---CCCcEEEEeeccchhcc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DfGls~~~~ 519 (696)
|||.||+|.+++...+. +++..++.++.||+.||+|||++ +|||||||++|||+. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999976543 99999999999999999999999 999999999999994 57899999999998654
Q ss_pred ccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 520 DANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
.... ....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.. ...+. ..+.. . ..
T Consensus 162 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~---~~i~~----~-~~-- 226 (307)
T d1a06a_ 162 PGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLF---EQILK----A-EY-- 226 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH---HHHHT----T-CC--
T ss_pred CCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHH---HHHhc----c-CC--
Confidence 3322 234579999999999999999999999999999999999999997532 11111 11111 0 00
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...... .......+.+|+++||+.||++|++++||+++
T Consensus 227 ~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 EFDSPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCTTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCcc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000001 11122368899999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=403.71 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=200.6
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee-CCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS-DDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~ 445 (696)
++|+++++||+|+||.||+|.+ .|+.||||+++.. ...++|.+|+++|++++|+||++++|+|.+ .+..+|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5688899999999999999998 6889999999643 445789999999999999999999999865 45679999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcce
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTHI 525 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~~ 525 (696)
.+|+|.++++......+++..+++|+.||+.||+|||++ +|||||||++|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999999999765544589999999999999999999999 99999999999999999999999999998654322
Q ss_pred eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcc
Q 005443 526 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADPR 604 (696)
Q Consensus 526 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~ 604 (696)
....++..|+|||++.++.++.++|||||||+||||++ |+.||.... ..++.+++. ...
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i~--------~~~-------- 217 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVE--------KGY-------- 217 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHHT--------TTC--------
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC---HHHHHHHHH--------cCC--------
Confidence 22357889999999999999999999999999999998 677776432 222222211 100
Q ss_pred cCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhccc
Q 005443 605 LGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATSD 649 (696)
Q Consensus 605 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 649 (696)
+..+......++.+|+++||+.||++||+|.||+++|+++..++
T Consensus 218 -~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 218 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 01111122236889999999999999999999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=410.17 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=199.7
Q ss_pred CccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCcc---HHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 368 GFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQG---EREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
.|++++.||+|+||.||+|+. .+|+.||||+++...... .+++.+|+++|++|+|+|||+++++|.+++..+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 599999999999999999985 478999999997654332 3568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
||.+|+|..++...+ .+++..++.|+.||+.||+|||++ +|||||||++||||++++++||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 999999976665443 389999999999999999999999 9999999999999999999999999999865432
Q ss_pred ceeeccccccccCchhhhcc---CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcc
Q 005443 524 HITTRVMGTFGYMAPEYASS---GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNL 600 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 600 (696)
...+||..|||||++.+ +.|+.++|||||||+||||++|+.||..... .+....... . ....+
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~----~-~~~~~ 234 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ----N-ESPAL 234 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH----S-CCCCC
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh----C-CCCCC
Confidence 23579999999999864 4589999999999999999999999975321 111111111 1 11111
Q ss_pred cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. ..+ ...+.+|+.+||+.||++||+++||+++
T Consensus 235 ~~----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 235 QS----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp SC----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11 112 2368899999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-48 Score=413.89 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=207.0
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEec
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDYV 445 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 445 (696)
++|+++++||+|+||.||+|+. .+|+.||||+++.......+.+++|+++|++|+|+|||+++++|.+++..+||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999985 479999999998665555677899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC--CCCcEEEEeeccchhccccCc
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD--NNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~--~~~~vkL~DfGls~~~~~~~~ 523 (696)
.||+|.+++...+ ..+++.+++.|+.||+.||+|||++ ||||||||++||||+ +++.+||+|||+++.......
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999988776543 2489999999999999999999999 999999999999997 678999999999987654332
Q ss_pred ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCc
Q 005443 524 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLADP 603 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~ 603 (696)
.....|+..|||||++.+..|+.++|||||||+||||++|+.||.+.. ...+. ..+.. ..+
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~---~~i~~-----~~~------ 245 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETL---QNVKR-----CDW------ 245 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHH---HHHHH-----CCC------
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHH---HHHHh-----CCC------
Confidence 334578999999999999999999999999999999999999997533 11111 11111 000
Q ss_pred ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 604 RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 604 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+..........++.+|+++||+.||++|+++.||+++
T Consensus 246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011111122368899999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=402.25 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=196.3
Q ss_pred hcCccccccccccCcEEEEEEEcCC----CcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD----GREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
.++|+++++||+|+||.||+|++.. +..||||+++..... ..+.|.+|+++|++++|+|||+++|+|. ++..+|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998642 356888888644333 3457999999999999999999999985 567899
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
||||+.+|+|.+++.... ..+++..++.++.||++||+|||++ +|||||||++|||+++++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999988776543 2489999999999999999999999 999999999999999999999999999987655
Q ss_pred cCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhc
Q 005443 521 ANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFDN 599 (696)
Q Consensus 521 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 599 (696)
..........|+..|+|||++.+..|+.++|||||||+||||++ |+.||..... ..+.+.+ ..... ..
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i-------~~~~~-~~ 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI-------ENGER-LP 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH-------HTTCC-CC
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHH-------HcCCC-CC
Confidence 44444455678999999999999999999999999999999998 8888876432 2222111 11110 00
Q ss_pred ccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 600 LADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 600 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
........+.+|+.+||+.||++||++.||++.|+++..
T Consensus 230 ---------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 230 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111122368899999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=401.73 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=204.7
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC------ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG------QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|++++.||+|+||+||+|++ .+|+.||||+++.... ...+.+++|+++|++|+|+|||+++++|.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999996 4799999999964321 2357899999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC----cEEEEeecc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF----EAQVSDFGL 514 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~----~vkL~DfGl 514 (696)
+||||||.+|+|.+++...+ .+++..++.++.||+.||+|||++ +|||||||++||||+.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999987654 389999999999999999999999 999999999999998776 599999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN 594 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 594 (696)
++....... .....|+..|||||++.+..++.++|||||||+||||++|+.||.+.. ..... ..+.....
T Consensus 164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~---~~i~~~~~-- 233 (293)
T d1jksa_ 164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL---ANVSAVNY-- 233 (293)
T ss_dssp CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHTTCC--
T ss_pred hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHH---HHHHhcCC--
Confidence 987644322 234568999999999999999999999999999999999999998543 11111 11111000
Q ss_pred hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+. ... .......+.+|+++||+.||++|++++||+++
T Consensus 234 -~~~----~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 -EFE----DEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -CCC----HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCC----chh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000 01112367899999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-48 Score=406.37 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=210.4
Q ss_pred HHHHHhcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCCc-cHHHHHHHHHHHHHccCCCceeEEeEEe
Q 005443 361 ELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGGQ-GEREFKAEVEIISRIHHRHLVSLVGYCI 433 (696)
Q Consensus 361 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~ 433 (696)
+++.-+++|++++.||+|+||.||+|+++ +++.||||+++..... ..++|.+|+++|++++|+||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999853 4578999999754433 3467999999999999999999999999
Q ss_pred eCCceeEEEEecCCCchhhccccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 005443 434 SDDRRLLIYDYVPNNTLYFHLHGEG----------------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIH 491 (696)
Q Consensus 434 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH 491 (696)
..+..++||||+.+|+|.++++... ...+++..+++|+.||+.||+|||++ +|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 9999999999999999998885422 22478899999999999999999999 9999
Q ss_pred ccCCCCceEECCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCC-CC
Q 005443 492 RDIKSSNILLDNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK-PV 569 (696)
Q Consensus 492 rDLkp~NILl~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~-Pf 569 (696)
||||++||||+.++.+||+|||+++....... .......|+..|+|||++.+..|+.++|||||||+||||++|.. ||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999986644332 23334568899999999999999999999999999999999865 56
Q ss_pred CCCCCCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 570 DASQPLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 570 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
.... ...+.+.+ ....... .......++.+|+.+||+.||++||+|.||+++|+++.
T Consensus 244 ~~~~---~~e~~~~v--------~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMA---HEEVIYYV--------RDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSC---HHHHHHHH--------HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCC---HHHHHHHH--------HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 5432 22222211 1111111 11122236889999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=405.17 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=201.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCc----EEEEEEeecC-CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGR----EVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 440 (696)
++|+++++||+|+||.||+|.+. +|+ .||||+++.. ..+..++|.+|+++|++++|+|||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46999999999999999999854 444 5888988643 33456789999999999999999999999976 45678
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALD 520 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~ 520 (696)
++||+.+|+|.+++.... ..+++..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 899999999988776553 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred cCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 521 ANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 521 ~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
.... ......||..|||||++.++.|+.++|||||||+||||++ |+.||.+.. ...+.+. +.. ...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~---~~~~~~~----i~~---~~~-- 231 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSI----LEK---GER-- 231 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---GGGHHHH----HHH---TCC--
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC---HHHHHHH----HHc---CCC--
Confidence 4332 2334568999999999999999999999999999999998 788887543 1122111 111 000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
+ .........+.+|+++||+.||++||+|.||++.|+++..
T Consensus 232 -~-------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 -L-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -C-------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -C-------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 0 0111122368899999999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=405.96 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=206.0
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|+||++++++|.+++..+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999995 47999999999743 2344577899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|||.||+|.+++...+. +++..++.++.||+.||+|||++ +|||||||++||||++++++||+|||+++......
T Consensus 85 ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999886554 89999999999999999999999 99999999999999999999999999998654433
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
. .....+||..|||||++.+..|+.++|||||||+||||++|+.||.+.+ ...+. ..... ..+
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~---~~i~~-----~~~----- 222 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLF---ELILM-----EEI----- 222 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HHHHH-----CCC-----
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHH---HHHhc-----CCC-----
Confidence 2 2344679999999999999999999999999999999999999998643 11111 11111 110
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 641 (696)
.+...+ ..++.+|+++||+.||++|++ +.||+++
T Consensus 223 -~~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 -RFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111122 236789999999999999995 7777763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=403.34 Aligned_cols=267 Identities=25% Similarity=0.369 Sum_probs=200.4
Q ss_pred HHHHHHHhcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEe
Q 005443 359 YEELVKATDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVG 430 (696)
Q Consensus 359 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~ 430 (696)
.++++...++|+++++||+|+||.||+|++. +++.||||+++.... ...+++.+|++++.++ +|+||+++++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3444444578999999999999999999842 356899999975433 3345688888888887 5889999999
Q ss_pred EEeeCC-ceeEEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCC
Q 005443 431 YCISDD-RRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIK 495 (696)
Q Consensus 431 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLk 495 (696)
++...+ ..++|||||.+|+|.++++... +..+++..++.++.||++||+|||++ +|||||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence 987654 5799999999999999886432 23488999999999999999999999 99999999
Q ss_pred CCceEECCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCC-CCCCCCC
Q 005443 496 SSNILLDNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR-KPVDASQ 573 (696)
Q Consensus 496 p~NILl~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~-~Pf~~~~ 573 (696)
++||||++++++||+|||+++........ ......||..|||||++.++.++.++|||||||++|||++|. .||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999865443332 233457999999999999999999999999999999999875 5665432
Q ss_pred CCCchhHHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 574 PLGDESLVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 574 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. .+.+.+ .+.+. .... . ......++.+|+.+||+.||++||+|+||+++|+++..
T Consensus 242 ~--~~~~~~----~~~~~----~~~~-----~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 242 I--DEEFCR----RLKEG----TRMR-----A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp C--SHHHHH----HHHHT----CCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--HHHHHH----HHhcC----CCCC-----C----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 111111 11111 0000 1 11122368899999999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5e-47 Score=392.15 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=201.6
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCcc---HHHHHHHHHHHHHccCCCceeEEeEEeeCCc----
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQG---EREFKAEVEIISRIHHRHLVSLVGYCISDDR---- 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---- 437 (696)
.++|++.++||+|+||.||+|++ .+|+.||||+++...... .+.|.+|+++|++++|+||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46899999999999999999985 579999999997544332 3568999999999999999999999987543
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.||||||+.|++|.+++...+. +++.+++.|+.||+.||+|||++ +|||||||++||||+.++.++|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 6899999999999988876544 89999999999999999999999 999999999999999999999999999875
Q ss_pred ccccCc--ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 518 ALDANT--HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 518 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
...... ......+||..|||||++.+..++.++|||||||+||||++|+.||.... ..+.....+. ..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~----~~ 230 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVR----ED 230 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHH----CC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHh----cC
Confidence 433222 22344679999999999999999999999999999999999999997532 1111111111 11
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhh
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRP-RMGQVVRVFDSLA 646 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l~ 646 (696)
.. .......... ..+.+++++||+.||++|+ ++++|++.|.++.
T Consensus 231 ~~---~~~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 PI---PPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CC---CGGGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CC---CCchhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00 0001111122 3688999999999999999 8999999888765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=397.31 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=195.0
Q ss_pred cCccccccccccCcEEEEEEEcC--CC--cEEEEEEeecCC---CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCcee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP--DG--REVAIKQLKIGG---GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
++|++.+.||+|+||.||+|+++ ++ ..||||+++... ....++|.+|+++|++++|+||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56999999999999999999853 23 378999986432 2334679999999999999999999999965 5678
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
+||||+.+|+|.+++..... .+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999887765433 489999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCcce--eeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchhHHHhHHHHHHHhhhhhh
Q 005443 520 DANTHI--TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDESLVEWARPLLSHALENEE 596 (696)
Q Consensus 520 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~ 596 (696)
...... .....|+..|+|||++.+..++.++|||||||+||||++ |+.||.+.+ ......+ +. ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~---i~----~~~- 231 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHK---ID----KEG- 231 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH---HH----TSC-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHH---HH----hCC-
Confidence 443322 233467889999999999999999999999999999998 899997533 2222211 11 111
Q ss_pred hhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 005443 597 FDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSL 645 (696)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 645 (696)
............+.+|+.+||+.||++||+|.||++.|++.
T Consensus 232 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00011111223688999999999999999999999998875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-47 Score=401.08 Aligned_cols=245 Identities=27% Similarity=0.380 Sum_probs=204.3
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|+++++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|+|||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999996 46999999999743 2344678999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
|||.||+|..++..... +.+..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+++......
T Consensus 84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 99999999888876654 78889999999999999999999 99999999999999999999999999998754332
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
...+||..|||||++.+..|+.++|||||||+||||++|+.||...+ ..+....++. . ..
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~----~-~~----- 218 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILN----A-EL----- 218 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHH----C-CC-----
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHc----C-CC-----
Confidence 34579999999999999999999999999999999999999997643 1111111111 0 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 641 (696)
.+...+ ..++.+++++||+.||.+|+ +++||+++
T Consensus 219 -~~p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 -RFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111111 23688999999999999996 88888864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=401.37 Aligned_cols=271 Identities=24% Similarity=0.340 Sum_probs=202.4
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHH--HHHHHHHHccCCCceeEEeEEeeCC----ceeE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFK--AEVEIISRIHHRHLVSLVGYCISDD----RRLL 440 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~--~E~~il~~l~hpnIv~l~~~~~~~~----~~~l 440 (696)
++|.+.++||+|+||.||+|++ +|+.||||+++.. ..+++. +|+..+.+++|+|||+++++|.+++ ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5678889999999999999997 7899999998643 233444 4555556789999999999998765 4689
Q ss_pred EEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 441 IYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDC-----HPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-----~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
||||+.+|+|.+++++. .++|..+++++.|++.||+|||+.+ ..+|||||||++||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999864 3899999999999999999999731 249999999999999999999999999999
Q ss_pred hhccccCcc---eeeccccccccCchhhhccCC------CCccccccchHHHHHHHHhCCCCCCCCCCCCch--h--HHH
Q 005443 516 KLALDANTH---ITTRVMGTFGYMAPEYASSGK------LTEKSDVFSFGVVLLELITGRKPVDASQPLGDE--S--LVE 582 (696)
Q Consensus 516 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~------~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~--~--l~~ 582 (696)
+........ .....+||..|||||++.+.. ++.++|||||||+||||++|..+|......... . ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876544332 223467999999999987643 567899999999999999999887543321110 0 000
Q ss_pred hHHHHHHHhhhhhhhhcccCcccCCCc-chHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 583 WARPLLSHALENEEFDNLADPRLGENY-VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.....+.+. ......++.+.... .......+.+|+++||+.||++||+|.||++.|+++..+
T Consensus 236 ~~~~~~~~~----~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 236 PSVEEMRKV----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHH----HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chHHHHHHH----HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 000111111 11111112221111 233456789999999999999999999999999988753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=400.00 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=210.0
Q ss_pred hcCccccccccccCcEEEEEEEc------CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL------PDGREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISDDR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 437 (696)
.++|++.++||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.+++++ +|+|||+++|+|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46899999999999999999974 2467899999975443 3345789999999999 69999999999999999
Q ss_pred eeEEEEecCCCchhhccccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 438 RLLIYDYVPNNTLYFHLHGEG----------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
.+||||||.+|+|.++++... ...+++..+++|+.||++||+|||++ +|||||||++||||
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999886532 23588999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCc-ceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhH
Q 005443 502 DNNFEAQVSDFGLAKLALDANT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 580 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l 580 (696)
+.++.+||+|||+++....... .......|+..|+|||++.++.++.++|||||||+||||++++.+|...... .+.+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-SHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-HHHH
Confidence 9999999999999987655433 3334567899999999999999999999999999999999955554433221 1111
Q ss_pred HHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 581 VEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.+ ++.+.. .. .........+.+|+.+||+.||++||+|.||+++|++++..
T Consensus 258 ~~----~i~~~~-----~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YK----MIKEGF-----RM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HH----HHHHTC-----CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHhcCC-----CC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11 111110 00 11111223688999999999999999999999999987643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=397.03 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=201.4
Q ss_pred cccccccCcEEEEEEEcCCC----cEEEEEEeecC-CCccHHHHHHHHHHHHHccCCCceeEEeEEeeC-CceeEEEEec
Q 005443 372 QNLLGEGGFGSVYKGYLPDG----REVAIKQLKIG-GGQGEREFKAEVEIISRIHHRHLVSLVGYCISD-DRRLLIYDYV 445 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~~ 445 (696)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|+||++++|+|... +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999986432 25899998643 333456799999999999999999999998764 5789999999
Q ss_pred CCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc-
Q 005443 446 PNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH- 524 (696)
Q Consensus 446 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~- 524 (696)
.+|+|.++++.... .+.+..+++++.||++||.|||++ +|+|||||++||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999998875543 478889999999999999999999 9999999999999999999999999999876443222
Q ss_pred --eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 525 --ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 525 --~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
......|+..|+|||++.++.++.++|||||||+||||++|+.||..... ..++...+.. .. +...
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-----~~~~~~~i~~----g~---~~~~ 255 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQ----GR---RLLQ 255 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHT----TC---CCCC
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc----CC---CCCC
Confidence 22235689999999999999999999999999999999999888875331 1111111111 11 1111
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
+ ......+.+|+.+||+.||++||+|.||+++|+++...
T Consensus 256 p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 256 P-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred c-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1 11123688999999999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=397.73 Aligned_cols=252 Identities=18% Similarity=0.296 Sum_probs=204.6
Q ss_pred hcCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.++|++++.||+|+||.||+|... +|+.||||+++... .....+.+|+++|++++|+|||+++++|.+++..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999864 68899999997543 3345688999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC--CCcEEEEeeccchhccccC
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN--NFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~--~~~vkL~DfGls~~~~~~~ 522 (696)
|.||+|.+++...+. .+++.+++.|+.||+.||+|||++ +|+|||||++||||+. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999876542 489999999999999999999999 9999999999999974 4589999999998654332
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
......++..|+|||.+.+..|+.++|||||||+||||++|+.||..... . +....++..... + .
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~---~~~~~i~~~~~~---~----~ 223 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---Q---QIIENIMNAEYT---F----D 223 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHHHHHTCCC---C----C
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhCCCC---C----C
Confidence 23345689999999999999999999999999999999999999986431 1 111111111000 0 0
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....... ..++.+|+++||+.||++|++++|++++
T Consensus 224 ~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 EEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011 2257899999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=400.00 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=202.9
Q ss_pred cCccccccccccCcEEEEEEEcC-CCc--EEEEEEeecC-CCccHHHHHHHHHHHHHc-cCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGR--EVAIKQLKIG-GGQGEREFKAEVEIISRI-HHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|++.++||+|+||.||+|+++ +|. .||||+++.. .....++|.+|+++|+++ +|+|||+++|+|.+++..+||
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57889999999999999999865 344 4778887543 233456799999999999 799999999999999999999
Q ss_pred EEecCCCchhhccccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcE
Q 005443 442 YDYVPNNTLYFHLHGE--------------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEA 507 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~v 507 (696)
|||+.+|+|.++|+.. ....+++..+++++.||++||.|||++ +|||||||++|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998754 234589999999999999999999999 99999999999999999999
Q ss_pred EEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCC-CCCCCCCCCchhHHHhHHH
Q 005443 508 QVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK-PVDASQPLGDESLVEWARP 586 (696)
Q Consensus 508 kL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~-Pf~~~~~~~~~~l~~~~~~ 586 (696)
||+|||+++........ ....|+..|+|||.+.++.|+.++|||||||+||||++|.. +|...+ ...+.+.+
T Consensus 167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~i-- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKL-- 239 (309)
T ss_dssp EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHG--
T ss_pred EEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHHHH--
Confidence 99999999765443322 23458999999999999999999999999999999999765 554322 12221111
Q ss_pred HHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 587 LLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
.+... . ........++.+|+.+||+.||++||+|.||++.|+++..
T Consensus 240 -----~~~~~------~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 240 -----PQGYR------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -----GGTCC------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HhcCC------C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11110 0 1111122368899999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=396.24 Aligned_cols=258 Identities=29% Similarity=0.410 Sum_probs=204.6
Q ss_pred hcCccccccccccCcEEEEEEEcCC--------CcEEEEEEeecCCC-ccHHHHHHHHHHHHHc-cCCCceeEEeEEeeC
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGG-QGEREFKAEVEIISRI-HHRHLVSLVGYCISD 435 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 435 (696)
.++|++++.||+|+||.||+|++.. +..||||+++.... ....++.+|+..+.++ +|+|||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999998522 34799999976544 3346788999999998 799999999999999
Q ss_pred CceeEEEEecCCCchhhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEE
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEG--------------RPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 501 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl 501 (696)
+..++||||+.+|+|.+++.... ...+++.++++++.||+.||+|||++ +|||||||++|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 99999999999999999986543 23489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccchhccccCcc-eeeccccccccCchhhhccCCCCccccccchHHHHHHHHh-CCCCCCCCCCCCchh
Q 005443 502 DNNFEAQVSDFGLAKLALDANTH-ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT-GRKPVDASQPLGDES 579 (696)
Q Consensus 502 ~~~~~vkL~DfGls~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLlt-g~~Pf~~~~~~~~~~ 579 (696)
+.++.+||+|||+++........ ......|+..|+|||++.++.|+.++|||||||+||||++ |+.||.... ...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---~~~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEE 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---HHH
Confidence 99999999999999876554332 2344578899999999999999999999999999999998 688876533 111
Q ss_pred HHHhHHHHHHHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 005443 580 LVEWARPLLSHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLA 646 (696)
Q Consensus 580 l~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 646 (696)
+.+ .+ ..... ......+ ..++.+|+.+||+.||++||++.||++.|+++.
T Consensus 246 ~~~----~i----~~~~~-----~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 LFK----LL----KEGHR-----MDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHH----HH----HTTCC-----CCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH----HH----HcCCC-----CCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111 11 11100 0111112 236889999999999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.6e-47 Score=389.35 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=203.4
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCc---------cHHHHHHHHHHHHHcc-CCCceeEEeEEee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQ---------GEREFKAEVEIISRIH-HRHLVSLVGYCIS 434 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 434 (696)
.++|+++++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++ |+||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999985 57899999999754321 1235889999999997 9999999999999
Q ss_pred CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeecc
Q 005443 435 DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGL 514 (696)
Q Consensus 435 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGl 514 (696)
++..+||||||.+|+|.++++..+ .+++..++.++.||++||+|||++ +|||||||++||||++++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999997654 389999999999999999999999 999999999999999999999999999
Q ss_pred chhccccCcceeeccccccccCchhhhcc------CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASS------GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
++....... ....+||..|++||++.+ ..++.++|||||||+||||++|+.||.+.. .... ...++
T Consensus 157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~---~~~i~ 228 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLM---LRMIM 228 (277)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---HHHHH
T ss_pred eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHH---HHHHH
Confidence 987654322 334579999999999863 346789999999999999999999998643 1111 11111
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.. ... + ..........++.+|+++||+.||++|++++||+++
T Consensus 229 ~~-----~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SG-----NYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HT-----CCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hC-----CCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11 100 0 000111122368899999999999999999998753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=395.03 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=196.0
Q ss_pred ccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCc-----cHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 371 DQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQ-----GEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 371 ~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
.+++||+|+||+||+|++. +|+.||||+++..... ..+.+++|+++|++++|+|||+++++|.+++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4688999999999999964 6899999999654322 124688999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.++++..++.... .+++..++.+++||+.||+|||++ +|||||||++|||+++++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 99888776665443 388899999999999999999999 9999999999999999999999999999876544332
Q ss_pred eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc--
Q 005443 525 ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA-- 601 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-- 601 (696)
....+||..|||||++.+ ..|+.++|||||||+||||++|+.+|.... +.+.+......+... ..+.+....
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~---~~~~l~~i~~~~~~~-~~~~~~~~~~~ 231 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTP-TEEQWPDMCSL 231 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCC-CTTTSSSTTSS
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC---HHHHHHHHHHhcCCC-Chhhccchhcc
Confidence 233579999999999875 467999999999999999999999997543 222222111111000 000000000
Q ss_pred -C----cccCCC----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 602 -D----PRLGEN----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 602 -d----~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ..+... .......++++|+++||+.||++|+|++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 000000 001112368899999999999999999999853
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-47 Score=403.09 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=203.4
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecC---CCccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIG---GGQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 442 (696)
++|++++.||+|+||.||+|++ .+|+.||||+++.. .....+.+.+|+++|++++|+|||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999986 47999999998632 2344567899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccC
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDAN 522 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~ 522 (696)
||+.+|+|..++...+. +++..++.|+.||+.||.|||++ +|||||||++||||+.++++||+|||+++......
T Consensus 121 e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred ccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 99999999988876554 89999999999999999999999 99999999999999999999999999998764332
Q ss_pred cceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhcccC
Q 005443 523 THITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLAD 602 (696)
Q Consensus 523 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~d 602 (696)
....||..|||||++.+..|+.++|||||||+||||++|+.||.+.+ ..+....+... ..
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~-----~~----- 255 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSG-----KV----- 255 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-----CC-----
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcC-----CC-----
Confidence 23579999999999999999999999999999999999999997532 11111111111 00
Q ss_pred cccCCCcchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005443 603 PRLGENYVEGEMFRMIEAAAACVRHSAAKRP-----RMGQVVR 640 (696)
Q Consensus 603 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~ 640 (696)
.....+ ..++.+++++||+.||++|+ +++||++
T Consensus 256 -~~p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -RFPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011112 23688999999999999995 8888876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=400.74 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=199.5
Q ss_pred hcCccccc-cccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHc-cCCCceeEEeEEee----CCce
Q 005443 366 TDGFADQN-LLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRI-HHRHLVSLVGYCIS----DDRR 438 (696)
Q Consensus 366 ~~~~~~~~-~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~~~ 438 (696)
.++|++.+ +||+|+||.||+|++ .+|+.||||+++. ...+.+|++++.++ +|+|||+++++|.+ ++..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788764 699999999999985 5789999999862 45688999997665 79999999999875 3567
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC---CCcEEEEeeccc
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN---NFEAQVSDFGLA 515 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~---~~~vkL~DfGls 515 (696)
|||||||.||+|.+++...+...+++.+++.|+.||+.||+|||++ +|+|||||++||||++ ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876556699999999999999999999999 9999999999999975 567999999999
Q ss_pred hhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
+....... ....+||..|||||++.+..|+.++|||||||+||||++|+.||.+....... +.. ..
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~---~~------ 227 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGM---KT------ 227 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHH---HH------
Confidence 86654332 33457999999999999999999999999999999999999999764422111 000 00
Q ss_pred hhhcccCccc--CCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 596 EFDNLADPRL--GENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 596 ~~~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+..... ..........++.+|+++||+.||++|+++.||+++
T Consensus 228 ---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 ---RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000000 001111223468899999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-46 Score=400.66 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=197.7
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCC---CccHHHHHHH---HHHHHHccCCCceeEEeEEeeCCcee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGG---GQGEREFKAE---VEIISRIHHRHLVSLVGYCISDDRRL 439 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E---~~il~~l~hpnIv~l~~~~~~~~~~~ 439 (696)
++|+++++||+|+||.||+|+.. +|+.||||++.... ......+.+| +++++.++|+|||+++++|.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999854 69999999986321 2223344444 56666678999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
||||||.||+|.+++..... +.+..++.++.||+.||+|||++ +|||||||++||||++++.+||+|||+++...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999876544 88999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhh
Q 005443 520 DANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFD 598 (696)
Q Consensus 520 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 598 (696)
... ....+||..|||||++.+ ..|+.++|||||||+||||++|+.||..........+. . ....
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~----~~~~----- 223 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---R----MTLT----- 223 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---H----HSSS-----
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H----hccc-----
Confidence 432 234579999999999975 56899999999999999999999999865432211111 0 0000
Q ss_pred cccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 005443 599 NLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVRV 641 (696)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 641 (696)
....+...+. .++.+|+.+||+.||++|++ ++||+++
T Consensus 224 --~~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 --MAVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --CCCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --CCCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0001111122 36889999999999999999 5777753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=396.40 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=201.7
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecC---CCccHHHHHHHHHHHH-HccCCCceeEEeEEeeCCceeEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIG---GGQGEREFKAEVEIIS-RIHHRHLVSLVGYCISDDRRLLI 441 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~lV 441 (696)
++|+++++||+|+||+||+|++. +|+.||||+++.. .....+.+.+|..++. .++|+|||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999864 6899999999743 2334456677777665 68999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcccc
Q 005443 442 YDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 442 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~ 521 (696)
|||+.+|+|.++++.... +++.+++.++.||+.||+|||++ +|||||||++|||+++++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999976554 88999999999999999999999 9999999999999999999999999999865433
Q ss_pred CcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhhhhhccc
Q 005443 522 NTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENEEFDNLA 601 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 601 (696)
.. ......||..|+|||++.+..|+.++|||||||+||||++|+.||.+.. ...+.+ .+. ...
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~---~i~-----~~~----- 219 (320)
T d1xjda_ 157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFH---SIR-----MDN----- 219 (320)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHH-----HCC-----
T ss_pred cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHH---HHH-----cCC-----
Confidence 32 2344679999999999999999999999999999999999999997543 111111 111 110
Q ss_pred CcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 005443 602 DPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMG-QVVR 640 (696)
Q Consensus 602 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~ 640 (696)
..+.... ...+.+|+.+||+.||++|+++. ||++
T Consensus 220 -~~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -PFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111112 23688999999999999999995 6764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=391.22 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=208.1
Q ss_pred hcCccccccccccCcEEEEEEEcC------CCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCce
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYLP------DGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRR 438 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 438 (696)
.++|++++.||+|+||.||+|.+. +++.||||+++.... .....|.+|+++|++++|+|||+++|+|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 468899999999999999999863 357899999975432 3335689999999999999999999999999999
Q ss_pred eEEEEecCCCchhhccccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEE
Q 005443 439 LLIYDYVPNNTLYFHLHGE--------GRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (696)
+|||||+.+|+|.++++.. ....+++..+++++.||++||.|||++ +|||||||++||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 9999999999998887632 223478899999999999999999999 99999999999999999999999
Q ss_pred eeccchhccccCcce-eeccccccccCchhhhccCCCCccccccchHHHHHHHHhCC-CCCCCCCCCCchhHHHhHHHHH
Q 005443 511 DFGLAKLALDANTHI-TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR-KPVDASQPLGDESLVEWARPLL 588 (696)
Q Consensus 511 DfGls~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~-~Pf~~~~~~~~~~l~~~~~~~~ 588 (696)
|||+++......... .....|+..|+|||.+.++.++.++|||||||+||||++|. .||.... . .++...+.
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~---~~~~~~i~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---N---EQVLRFVM 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---H---HHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---H---HHHHHHHH
Confidence 999998765543332 23346899999999999999999999999999999999985 5564322 1 11111111
Q ss_pred HHhhhhhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhc
Q 005443 589 SHALENEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLAT 647 (696)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 647 (696)
. ..... ........+.+|+.+||+.||++||+|.+|+++|++...
T Consensus 250 ~-----~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 E-----GGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp T-----TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred h-----CCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 11100 011112368999999999999999999999999988764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=386.16 Aligned_cols=264 Identities=19% Similarity=0.298 Sum_probs=199.6
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++++.||+|+||.||+|++ .+|+.||||+++.... ...+++.+|+++|++++|+|||+++++|.+++..+||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999985 5799999999965432 335679999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
|+.++.+. ++.......+++..++.++.||+.||+|||++ +|||||||++|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~-~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEEHHH-HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCchhh-hhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99765444 44333344599999999999999999999999 999999999999999999999999999987654333
Q ss_pred ceeeccccccccCchhhhccCC-CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh--hh---hh
Q 005443 524 HITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE--NE---EF 597 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~--~~---~~ 597 (696)
. .....|+..|+|||++.... ++.++|||||||++|||++|+.||.+.+. ... ....+..... .. ..
T Consensus 158 ~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~---~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQ---LFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp C-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHHHHHCCCCTTTSTTG
T ss_pred c-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHH---HHHHHHhcCCCchhhcccc
Confidence 2 33357999999999987755 57899999999999999999999975431 111 1111111000 00 00
Q ss_pred hcccC--cc---cCCC----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 598 DNLAD--PR---LGEN----YVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 598 ~~~~d--~~---l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
..+.+ .. .... .......++.+|+++||+.||++|+|++||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 00 0000 001112367899999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.9e-46 Score=384.16 Aligned_cols=265 Identities=22% Similarity=0.337 Sum_probs=201.8
Q ss_pred cCccccccccccCcEEEEEEEcCCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|++++.||+|+||+||+|++++|+.||||+++... ....+.+.+|+.+|++++|+|||+++++|..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999998899999999996543 23357899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANTH 524 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~~ 524 (696)
+.++.+..+....+ .+++..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||++.........
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp CSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 98887777766554 399999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh----hh-hhhhh
Q 005443 525 ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA----LE-NEEFD 598 (696)
Q Consensus 525 ~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~----~~-~~~~~ 598 (696)
.....|+..|++||.+.+. .++.++|||||||+||||++|+.||...+ ..+........+... +. .....
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCCChhhccchhhhh
Confidence 3334688999999998764 56899999999999999999999997543 112111111111000 00 00000
Q ss_pred cc------cCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 599 NL------ADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 599 ~~------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
.. .+......+.......+.+|+++||+.||++|+++.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000001111122346889999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=382.80 Aligned_cols=241 Identities=24% Similarity=0.374 Sum_probs=195.4
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC------ccHHHHHHHHHHHHHcc--CCCceeEEeEEeeCC
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG------QGEREFKAEVEIISRIH--HRHLVSLVGYCISDD 436 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~ 436 (696)
.++|++.++||+|+||.||+|+. .+|+.||||+++.... ....++.+|+.+|++++ |+|||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36799999999999999999985 4789999999974321 11234778999999997 899999999999999
Q ss_pred ceeEEEEecCC-CchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-CCcEEEEeecc
Q 005443 437 RRLLIYDYVPN-NTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-NFEAQVSDFGL 514 (696)
Q Consensus 437 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-~~~vkL~DfGl 514 (696)
..++||||+.+ +++.+++.... .+++.+++.++.||++||+|||++ +|||||||++||||+. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 56777776544 389999999999999999999999 9999999999999984 57999999999
Q ss_pred chhccccCcceeeccccccccCchhhhccCCC-CccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 515 AKLALDANTHITTRVMGTFGYMAPEYASSGKL-TEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 515 s~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
++..... ......||..|||||++.+..+ +.++|||||||+||||++|+.||... ..+ +.
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~i-------~~---- 218 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEI-------IR---- 218 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHH-------HH----
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----hHH-------hh----
Confidence 9765432 2334679999999999987665 56799999999999999999999742 111 00
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. .. .+...+. .++.+|+++||+.||++|||++|++++
T Consensus 219 ~---~~----~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 G---QV----FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C---CC----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---cc----CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 00 1111222 368899999999999999999999853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-44 Score=373.31 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=197.4
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeE-EeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSL-VGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l-~~~~~~~~~~~lV~E~ 444 (696)
++|++++.||+|+||.||+|++ .+|+.||||++..... ..++.+|++++++++|.|++.+ .+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999985 5689999999875433 3457899999999987765554 5555667788899999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEEC---CCCcEEEEeeccchhcccc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLD---NNFEAQVSDFGLAKLALDA 521 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~---~~~~vkL~DfGls~~~~~~ 521 (696)
+. ++|.+.+.... ..+++..++.++.||+.||+|||++ +|||||||++|||++ .+..+||+|||+++...+.
T Consensus 85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 95 45544444332 2489999999999999999999999 999999999999985 4557999999999876544
Q ss_pred Ccc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 522 NTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 522 ~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
... .....+||..|||||++.+..++.++|||||||++|||++|+.||...........+..... .... .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---~~~~-~ 235 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---KKMS-T 235 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH---HHHH-S
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc---ccCC-C
Confidence 322 22345799999999999999999999999999999999999999986543322221111110 0000 0
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.... +...+. .++.+++.+||+.+|++||++.+|.+.|+++..+
T Consensus 236 ~~~~-----~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 PIEV-----LCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CHHH-----HTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ChhH-----hccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0000 111111 2688999999999999999999999988887643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-45 Score=381.36 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=197.0
Q ss_pred hcCccccccccccCcEEEEEEEc-CC-CcEEEEEEeecCC--CccHHHHHHHHHHHHHc---cCCCceeEEeEEee----
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PD-GREVAIKQLKIGG--GQGEREFKAEVEIISRI---HHRHLVSLVGYCIS---- 434 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~-g~~vavK~l~~~~--~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~---- 434 (696)
.++|++++.||+|+||+||+|++ ++ ++.||||+++... ......+.+|+++|+.| +|+||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999985 34 6679999996432 22334567788887776 79999999999864
Q ss_pred -CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeec
Q 005443 435 -DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFG 513 (696)
Q Consensus 435 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfG 513 (696)
+...+++|||+.++.+....... ...+++..++.++.||+.||+|||++ +|||||||++|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 24578999999988775444333 33489999999999999999999999 99999999999999999999999999
Q ss_pred cchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 514 LAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 514 ls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
+++...... ......||..|||||++.+..|+.++|||||||+||||++|+.||.... ....+......+... .
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~-~ 235 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIGLP-G 235 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC-C
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCC-c
Confidence 987654332 2344679999999999999999999999999999999999999997643 122111111111000 0
Q ss_pred hhhhhc-------ccC---cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 594 NEEFDN-------LAD---PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 594 ~~~~~~-------~~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
...+.. ... ......+.......+.+|+++||+.||++|+|+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000 000001111222367889999999999999999998864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-43 Score=368.55 Aligned_cols=262 Identities=18% Similarity=0.227 Sum_probs=208.1
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC-CCceeEEeEEeeCCceeEEEEe
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH-RHLVSLVGYCISDDRRLLIYDY 444 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~ 444 (696)
++|+++++||+|+||.||+|++ .+|+.||||++.... ....+++|+++++.|+| +||+.+++++..++..++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 6899999999999999999995 478999999986442 23457889999999975 8999999999999999999999
Q ss_pred cCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECC-----CCcEEEEeeccchhcc
Q 005443 445 VPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDN-----NFEAQVSDFGLAKLAL 519 (696)
Q Consensus 445 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~-----~~~vkL~DfGls~~~~ 519 (696)
+ +++|.++++..++ .+.+..+++++.|++.||+|||++ ||||||||++||||+. ++.+||+|||+++...
T Consensus 83 ~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 6888888765543 489999999999999999999999 9999999999999964 5789999999998765
Q ss_pred ccCcc------eeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhh
Q 005443 520 DANTH------ITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALE 593 (696)
Q Consensus 520 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 593 (696)
+.... .....+||..|||||++.+..++.++|||||||++|||++|+.||............+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~---- 233 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ---- 233 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH----
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC----
Confidence 43221 22345799999999999999999999999999999999999999986554333322221111100
Q ss_pred hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhcc
Q 005443 594 NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRVFDSLATS 648 (696)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 648 (696)
.....+ +..... .++.+++..|+..++++||+++.|.+.|+++..+
T Consensus 234 ~~~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 234 STPLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HSCHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 001111 111122 2688899999999999999999999888887643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=385.54 Aligned_cols=268 Identities=26% Similarity=0.326 Sum_probs=195.3
Q ss_pred CccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEeeC------CceeE
Q 005443 368 GFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCISD------DRRLL 440 (696)
Q Consensus 368 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~~l 440 (696)
+|+++++||+|+||+||+|++. +|+.||||+++.... .+.+|+++|++++|+||++++++|... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999964 699999999975432 335799999999999999999998643 23689
Q ss_pred EEEecCCCchhhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-cEEEEeeccchhc
Q 005443 441 IYDYVPNNTLYFHLHG-EGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLA 518 (696)
Q Consensus 441 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfGls~~~ 518 (696)
|||||.++.+..+.+. .....+++..++.|++||+.||+|||++ ||||||||++||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654443321 2233589999999999999999999998 999999999999998765 8999999999866
Q ss_pred cccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHH-------HHHH
Q 005443 519 LDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP-------LLSH 590 (696)
Q Consensus 519 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~-------~~~~ 590 (696)
..... ....+|+..|+|||.+.+ ..|+.++|||||||++|||++|+.||..... .+.+.+.... .+..
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~--~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH--HHHHHHHHHHhCCChHHhhhh
Confidence 44332 233579999999998875 5789999999999999999999999976432 1111111110 0000
Q ss_pred hhh---hhhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhh
Q 005443 591 ALE---NEEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV--FDSLA 646 (696)
Q Consensus 591 ~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~l~ 646 (696)
... ...+.......+..........++.+|+.+||+.||++|+|+.|++++ |+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 000001000001111111223368899999999999999999999964 55544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=376.87 Aligned_cols=266 Identities=19% Similarity=0.301 Sum_probs=196.0
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCC--CccHHHHHHHHHHHHHccCCCceeEEeEEee--------C
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGG--GQGEREFKAEVEIISRIHHRHLVSLVGYCIS--------D 435 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--------~ 435 (696)
++|++++.||+|+||+||+|++ ++|+.||||+++... ....+++.+|+++|++++|+||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999995 579999999986442 3345678999999999999999999998865 3
Q ss_pred CceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 436 DRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 436 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
+..++||||+.++.+..+..... .+.+..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 45789999998887765554433 388899999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCcc---eeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh
Q 005443 516 KLALDANTH---ITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA 591 (696)
Q Consensus 516 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~ 591 (696)
+........ .....+||..|+|||++.+. .|+.++|||||||+||||++|+.||.... +..........+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~---~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLCGSI 241 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC---HHHHHHHHHHhcCCC
Confidence 765433221 22335799999999998764 68999999999999999999999997543 222222222211110
Q ss_pred hhhhhhhcc--------cCcccCCCc-chH------HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 592 LENEEFDNL--------ADPRLGENY-VEG------EMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 592 ~~~~~~~~~--------~d~~l~~~~-~~~------~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
. ......+ ......... ... ....+++|+.+||+.||++|+|++||+++
T Consensus 242 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 T-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp C-TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0000000 000000000 000 01246789999999999999999999854
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=366.21 Aligned_cols=267 Identities=19% Similarity=0.295 Sum_probs=204.7
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCCceeEEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDDRRLLIYD 443 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 443 (696)
++|++++.||+|+||+||+|++ .+|+.||||+++.... ...+++++|+.+|++++|+||++++++|.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999995 5789999999975543 335678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhccccCc
Q 005443 444 YVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLALDANT 523 (696)
Q Consensus 444 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~~~~~ 523 (696)
++.+++|..+++..+. +.+..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999998887765544 78999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeccccccccCchhhhccCC-CCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh--hhhhcc
Q 005443 524 HITTRVMGTFGYMAPEYASSGK-LTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN--EEFDNL 600 (696)
Q Consensus 524 ~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~--~~~~~~ 600 (696)
......++..|++||++.+.. ++.++|||||||++|||++|+.||..... ..+..+..........+. .....+
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 233345788999999987654 68999999999999999999999864331 222222111111100000 000000
Q ss_pred cC---------cccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 601 AD---------PRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 601 ~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
.+ ..............+.+|+++||+.||++|+|++||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000111112223467899999999999999999998853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=376.02 Aligned_cols=267 Identities=21% Similarity=0.315 Sum_probs=196.4
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC-ccHHHHHHHHHHHHHccCCCceeEEeEEeeCC----cee
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG-QGEREFKAEVEIISRIHHRHLVSLVGYCISDD----RRL 439 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~ 439 (696)
.++|+++++||+|+||+||+|.. .+|+.||||+++.... ...+++++|+++|++|+|+||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999985 5799999999974432 33467899999999999999999999997653 235
Q ss_pred EEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchhcc
Q 005443 440 LIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKLAL 519 (696)
Q Consensus 440 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~~~ 519 (696)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +|||||||++||||++++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 666777899999998654 389999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCcc--eeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhh--
Q 005443 520 DANTH--ITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALEN-- 594 (696)
Q Consensus 520 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~-- 594 (696)
..... .....+|+..|+|||++.. ..++.++|||||||++|||++|+.||..... .+........+......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY---LDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH---HHHHHHHhhhccCCChhhh
Confidence 43222 2334578999999999854 5678899999999999999999999976432 11111111110000000
Q ss_pred ------hhhhccc-CcccCCCc----chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 595 ------EEFDNLA-DPRLGENY----VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 595 ------~~~~~~~-d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....... ........ ......++++|+.+||+.||++|+++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00000000 00111257899999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=376.58 Aligned_cols=267 Identities=22% Similarity=0.320 Sum_probs=195.4
Q ss_pred HhcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeCC-----
Q 005443 365 ATDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISDD----- 436 (696)
Q Consensus 365 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 436 (696)
..++|++++.||+|+||+||+|.+ .+|+.||||+++.... ...+.+.+|+++|++++|+|||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999995 4699999999974332 23457889999999999999999999998654
Q ss_pred -ceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccc
Q 005443 437 -RRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLA 515 (696)
Q Consensus 437 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls 515 (696)
..+|||||+ +++|..+++.. .+++..++.++.||+.||+|||++ ||||||||++|||++.++.+||+|||++
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 66676666543 389999999999999999999999 9999999999999999999999999999
Q ss_pred hhccccCcceeeccccccccCchhhhcc-CCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH----H
Q 005443 516 KLALDANTHITTRVMGTFGYMAPEYASS-GKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS----H 590 (696)
Q Consensus 516 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~----~ 590 (696)
+..... ....+|+..|+|||++.+ ..++.++|||||||+||||++|+.||...+. ...+........ +
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh---HHHHHHHHhccCCCcHH
Confidence 865432 234578999999999876 4578999999999999999999999976532 111111111000 0
Q ss_pred hhhh----------hhhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhh
Q 005443 591 ALEN----------EEFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV--FDSLA 646 (696)
Q Consensus 591 ~~~~----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~l~ 646 (696)
.+.. ..+..+....+.. ........+++|+.+||+.||++|+|+.|||++ |+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 0000000011100 111112357899999999999999999999975 54443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.9e-43 Score=368.62 Aligned_cols=259 Identities=17% Similarity=0.254 Sum_probs=196.6
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeC--CceeEEE
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISD--DRRLLIY 442 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~~lV~ 442 (696)
++|+++++||+|+||+||+|+. .+|+.||||+++. ...+++.+|+++|++++ |+||++++++|... +..++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999985 5789999999864 34567899999999996 99999999999754 4689999
Q ss_pred EecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC-cEEEEeeccchhcccc
Q 005443 443 DYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF-EAQVSDFGLAKLALDA 521 (696)
Q Consensus 443 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~-~vkL~DfGls~~~~~~ 521 (696)
|||.+++|..+.+ .+++..++.++.||+.||+|||++ ||||||||++||||+.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999977643 389999999999999999999999 999999999999998654 6999999999865443
Q ss_pred CcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHH-----Hhhhh-
Q 005443 522 NTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLS-----HALEN- 594 (696)
Q Consensus 522 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~-----~~~~~- 594 (696)
.. ....++|..|+|||.+.+. .++.++|||||||++|||++|+.||...... ..........+. .....
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh--HHHHHHHHHHHCCchhhhhhhhc
Confidence 22 3345789999999998765 4799999999999999999999999765421 111111111110 00000
Q ss_pred -----hhhhcccCc--------ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005443 595 -----EEFDNLADP--------RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVR 640 (696)
Q Consensus 595 -----~~~~~~~d~--------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 640 (696)
..+..+... ............++++|+++||+.||++|+|++|+|+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 0001111122246889999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=372.27 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=201.4
Q ss_pred cCccccccccccCcEEEEEEEc----CCCcEEEEEEeecC----CCccHHHHHHHHHHHHHccC-CCceeEEeEEeeCCc
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL----PDGREVAIKQLKIG----GGQGEREFKAEVEIISRIHH-RHLVSLVGYCISDDR 437 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~ 437 (696)
++|+++++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++| +||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 24889999998532 22345678899999999987 799999999999999
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.++||||+.+|+|.+++...+. +.+..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999876654 67889999999999999999999 999999999999999999999999999987
Q ss_pred ccccCcceeeccccccccCchhhhccC--CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHhhhhh
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSG--KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHALENE 595 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 595 (696)
.............|+..|++||.+.+. .++.++|||||||+||||++|+.||........... ....... .
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~~----~- 251 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILK----S- 251 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHH----C-
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhccc----C-
Confidence 655444444556799999999999764 467899999999999999999999986553322111 1111100 0
Q ss_pred hhhcccCcccCCCcchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005443 596 EFDNLADPRLGENYVEGEMFRMIEAAAACVRHSAAKRPR-----MGQVVR 640 (696)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~ 640 (696)
...+.. ....++.+|+++||+.||++|++ ++|+++
T Consensus 252 ------~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ------EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001111 12237889999999999999995 677775
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-42 Score=365.57 Aligned_cols=262 Identities=22% Similarity=0.261 Sum_probs=189.5
Q ss_pred cCccccccccccCcEEEEEEEcC-CCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC------Cc
Q 005443 367 DGFADQNLLGEGGFGSVYKGYLP-DGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD------DR 437 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~ 437 (696)
++|+++++||+|+||+||+|++. +|+.||||+++.... ...+++.+|+.+|++++|+|||+++++|... +.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999954 699999999975432 2335688999999999999999999999643 56
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.|+|||||.++.+.. ++. .+++..++.++.||+.||+|||++ ||+|||||++|||++.++.+||+|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~-~~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHH-HTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHh-hhc----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 799999997665544 332 378999999999999999999999 999999999999999999999999999876
Q ss_pred ccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHH---------
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL--------- 588 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~--------- 588 (696)
..... .....+||..|+|||++.+..++.++||||+||++|||++|+.||.+.+. ..........+
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHT
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCCCHHHHH
Confidence 54432 23445789999999999999999999999999999999999999975431 11111110000
Q ss_pred ------HHhhhhh------hhhcccCccc-C--CCcchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 589 ------SHALENE------EFDNLADPRL-G--ENYVEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 589 ------~~~~~~~------~~~~~~d~~l-~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
....... ....+..... . ..........+++|+++||+.||++|+|++|||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0000010000 0 11122334568999999999999999999999965
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=368.61 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=194.7
Q ss_pred hcCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCC--ccHHHHHHHHHHHHHccCCCceeEEeEEeeC-----Cc
Q 005443 366 TDGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGG--QGEREFKAEVEIISRIHHRHLVSLVGYCISD-----DR 437 (696)
Q Consensus 366 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 437 (696)
.++|++++.||+|+||+||+|++ .+|+.||||+++.... ...+++.+|+++|++++|+|||++++++... +.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999985 5799999999975432 2345688999999999999999999998643 34
Q ss_pred eeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 438 RLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 438 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
.++|++|+.+|+|.++++.. .+++.+++.|+.||+.||+|||++ +|||||||++|||++.++.+||+|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 57778888999999988643 389999999999999999999999 999999999999999999999999999975
Q ss_pred ccccCcceeeccccccccCchhhhccC-CCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHHHHHHHh----h
Q 005443 518 ALDANTHITTRVMGTFGYMAPEYASSG-KLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSHA----L 592 (696)
Q Consensus 518 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~~~~~~~----~ 592 (696)
.... .....|+..|+|||++.+. .++.++|||||||+||||++|+.||...+. .............. .
T Consensus 171 ~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 171 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCHHHH
T ss_pred cCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChHHh
Confidence 4332 2335689999999987765 468899999999999999999999976431 11111111100000 0
Q ss_pred ---hhhhhhcccCc--ccC-CCc---chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005443 593 ---ENEEFDNLADP--RLG-ENY---VEGEMFRMIEAAAACVRHSAAKRPRMGQVVRV 641 (696)
Q Consensus 593 ---~~~~~~~~~d~--~l~-~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 641 (696)
........... ... ..+ .......+++|+++||+.||++|+|+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000 000 000 01112357899999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-37 Score=333.47 Aligned_cols=268 Identities=18% Similarity=0.220 Sum_probs=191.1
Q ss_pred cCccccccccccCcEEEEEEEc-CCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-----------CCCceeEEeEEee
Q 005443 367 DGFADQNLLGEGGFGSVYKGYL-PDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-----------HRHLVSLVGYCIS 434 (696)
Q Consensus 367 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l~~~~~~ 434 (696)
++|+++++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999985 579999999997432 23456788999998875 4789999998865
Q ss_pred C--CceeEEEEecCCCch-hhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCC------
Q 005443 435 D--DRRLLIYDYVPNNTL-YFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNF------ 505 (696)
Q Consensus 435 ~--~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~------ 505 (696)
. ...+++|+++..+.. ...........+.+..++.+++||+.||+|||++. ||+|||||++||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 3 455677777665543 33333344455889999999999999999999832 899999999999997654
Q ss_pred cEEEEeeccchhccccCcceeeccccccccCchhhhccCCCCccccccchHHHHHHHHhCCCCCCCCCCCCchhHHHhHH
Q 005443 506 EAQVSDFGLAKLALDANTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 585 (696)
Q Consensus 506 ~vkL~DfGls~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~eLltg~~Pf~~~~~~~~~~l~~~~~ 585 (696)
.++|+|||.+...... ....+|+..|+|||++.+..++.++|||||||+++||++|+.||............+...
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 4999999999754432 234578999999999999999999999999999999999999997654322211111111
Q ss_pred HHHHH-------hhhhh-hhhcccC---------c----------ccCCCcchHHHHHHHHHHHHHhccCCCCCCCHHHH
Q 005443 586 PLLSH-------ALENE-EFDNLAD---------P----------RLGENYVEGEMFRMIEAAAACVRHSAAKRPRMGQV 638 (696)
Q Consensus 586 ~~~~~-------~~~~~-~~~~~~d---------~----------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el 638 (696)
..+.. ..... ......+ . .....+.......+++|+.+||+.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11110 00000 0000000 0 00122345566789999999999999999999999
Q ss_pred HHH
Q 005443 639 VRV 641 (696)
Q Consensus 639 l~~ 641 (696)
|++
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=8.9e-25 Score=211.50 Aligned_cols=170 Identities=17% Similarity=0.191 Sum_probs=122.6
Q ss_pred ccccccccccCcEEEEEEEcCCCcEEEEEEeecCCC-----c-------------cHHHHHHHHHHHHHccCCCceeEEe
Q 005443 369 FADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGG-----Q-------------GEREFKAEVEIISRIHHRHLVSLVG 430 (696)
Q Consensus 369 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~-------------~~~~~~~E~~il~~l~hpnIv~l~~ 430 (696)
+.+.+.||+|+||.||+|++.+|+.||||+++.... . ....+.+|+.+|.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999988999999998753211 0 0123456888999999999999886
Q ss_pred EEeeCCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEECCCCcEEEE
Q 005443 431 YCISDDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLDNNFEAQVS 510 (696)
Q Consensus 431 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDLkp~NILl~~~~~vkL~ 510 (696)
+. ..+|||||+.++.+..+ ......+++.||+++|+|||++ +|+|||||++||||+++ .++|+
T Consensus 82 ~~----~~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EE----TTEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ec----CCEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 53 34799999988765432 3334568899999999999999 99999999999999966 59999
Q ss_pred eeccchhccccCccee-eccccccccCchhhhccCCCCccccccchHHHHH
Q 005443 511 DFGLAKLALDANTHIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLL 560 (696)
Q Consensus 511 DfGls~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwSlGvll~ 560 (696)
|||+++.......... .+.+... -|. ..+.|..++|||++.--++
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~~~----~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVRNI----ITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHHHH----HHH-HHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHHHH----HHH-HcCCCCCcccHHHHHHHHh
Confidence 9999976543322110 0000000 011 2356788899999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.05 E-value=3.3e-10 Score=112.91 Aligned_cols=150 Identities=15% Similarity=0.080 Sum_probs=109.7
Q ss_pred HHHHHHhcCccccccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHcc-CCCceeEEeEEeeCCce
Q 005443 360 EELVKATDGFADQNLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIH-HRHLVSLVGYCISDDRR 438 (696)
Q Consensus 360 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 438 (696)
.++.+..+.|..++..+.+..+.||+... +++.++||+...........+.+|+.+++.|. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45667677888777766666789999876 66778888876544444456788999998885 44578889888888889
Q ss_pred eEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 005443 439 LLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHED---------------------------------- 484 (696)
Q Consensus 439 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~---------------------------------- 484 (696)
++||+++.|..+...+... ....+++.++++.|..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886544321 11234556666666667642
Q ss_pred ----------------------CCCceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 485 ----------------------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 485 ----------------------~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
....++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012489999999999999876667999998853
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.68 E-value=4.3e-08 Score=96.61 Aligned_cols=129 Identities=17% Similarity=0.113 Sum_probs=89.0
Q ss_pred ccccC-cEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccC--CCceeEEeEEeeCCceeEEEEecCCCchh
Q 005443 375 LGEGG-FGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHH--RHLVSLVGYCISDDRRLLIYDYVPNNTLY 451 (696)
Q Consensus 375 LG~G~-~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 451 (696)
+..|. .+.||+...+++..++||...... ...+.+|+.+|+.|.. -.+.++++++.+.+..++||+|++|..+.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34444 468999998788889999875432 3357788888888763 34577888888888889999999887764
Q ss_pred hccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 005443 452 FHLHGEGRPVLDWATRVKIAAGAARGLAYLHED----------------------------------------------- 484 (696)
Q Consensus 452 ~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~----------------------------------------------- 484 (696)
.... .. .+++.++.+.|.-||+.
T Consensus 95 ~~~~-------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 95 SSHL-------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TSCC-------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc-------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3221 11 11223333444444421
Q ss_pred --------CCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 485 --------CHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 485 --------~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
....+||+|+++.|||++++..+.|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 12348999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.49 E-value=3.2e-07 Score=96.62 Aligned_cols=77 Identities=16% Similarity=0.195 Sum_probs=50.9
Q ss_pred cccccccCcEEEEEEEcCC-CcEEEEEEeec----CC---CccHHHHHHHHHHHHHcc-C--CCceeEEeEEeeCCceeE
Q 005443 372 QNLLGEGGFGSVYKGYLPD-GREVAIKQLKI----GG---GQGEREFKAEVEIISRIH-H--RHLVSLVGYCISDDRRLL 440 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~----~~---~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~~~~~l 440 (696)
.+.||.|....||++...+ |+.|+||.-.. .. .....+...|+++|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 67899996531 11 112345667888888774 2 346666654 4566789
Q ss_pred EEEecCCCch
Q 005443 441 IYDYVPNNTL 450 (696)
Q Consensus 441 V~E~~~~gsL 450 (696)
||||+.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.17 E-value=4.3e-06 Score=85.35 Aligned_cols=136 Identities=14% Similarity=0.128 Sum_probs=81.4
Q ss_pred CcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCce--eEEe-----EEeeCCceeEEEEecCCCchh
Q 005443 379 GFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV--SLVG-----YCISDDRRLLIYDYVPNNTLY 451 (696)
Q Consensus 379 ~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv--~l~~-----~~~~~~~~~lV~E~~~~gsL~ 451 (696)
.-..||+++.++|+.|++|+.+.. ....+++..|+.+|..|...+|. ..+. .+..++..+.|++|+.|..+.
T Consensus 34 ~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 34 YENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 346899999999999999998743 23467788999999998643332 2111 223445668899999775432
Q ss_pred h----c----------ccc-------CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHhc----CCC
Q 005443 452 F----H----------LHG-------EGRPVLDWAT-------------------RVKIAAGAARGLAYLHED----CHP 487 (696)
Q Consensus 452 ~----~----------l~~-------~~~~~l~~~~-------------------~~~i~~qia~gL~~LH~~----~~~ 487 (696)
. . +|. ..+..++... ...+...+.+.++.+... ...
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 0 010 0111122111 111222222333333322 245
Q ss_pred ceeeccCCCCceEECCCCcEEEEeeccchh
Q 005443 488 RIIHRDIKSSNILLDNNFEAQVSDFGLAKL 517 (696)
Q Consensus 488 ~ivHrDLkp~NILl~~~~~vkL~DfGls~~ 517 (696)
++||+|+++.|||++++ ..|+||+.+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 89999999999999754 45899998863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.95 E-value=8.2e-06 Score=82.66 Aligned_cols=157 Identities=15% Similarity=0.073 Sum_probs=86.4
Q ss_pred cCHHHHHHHhcCccccccc-----cccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCce--eEE
Q 005443 357 FTYEELVKATDGFADQNLL-----GEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLV--SLV 429 (696)
Q Consensus 357 ~~~~~l~~~~~~~~~~~~L-----G~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv--~l~ 429 (696)
++.+|+..+..+|.+++++ ..|--.+.|+.+.++| .+++|++... ...+++..|+++|..|...++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 4678888888888776554 3566678899988555 5899988633 2334566778888887543322 111
Q ss_pred e------EEeeCCceeEEEEecCCCchhhcc--------------c----cC---CCCCCCH------------------
Q 005443 430 G------YCISDDRRLLIYDYVPNNTLYFHL--------------H----GE---GRPVLDW------------------ 464 (696)
Q Consensus 430 ~------~~~~~~~~~lV~E~~~~gsL~~~l--------------~----~~---~~~~l~~------------------ 464 (696)
. +....+....++.++.+....... + .. .......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 112234445667766654332100 0 00 0000000
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCceeeccCCCCceEECCCCcEEEEeeccch
Q 005443 465 ATRVKIAAGAARGLAYLHE-DCHPRIIHRDIKSSNILLDNNFEAQVSDFGLAK 516 (696)
Q Consensus 465 ~~~~~i~~qia~gL~~LH~-~~~~~ivHrDLkp~NILl~~~~~vkL~DfGls~ 516 (696)
......+..+...+...+. ....+|||+|+..+||+++++...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111122222222222221 134589999999999999988777899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.80 E-value=2.8e-05 Score=81.34 Aligned_cols=73 Identities=19% Similarity=0.244 Sum_probs=52.0
Q ss_pred cccccccCcEEEEEEEcCC--------CcEEEEEEeecCCCccHHHHHHHHHHHHHccCCC-ceeEEeEEeeCCceeEEE
Q 005443 372 QNLLGEGGFGSVYKGYLPD--------GREVAIKQLKIGGGQGEREFKAEVEIISRIHHRH-LVSLVGYCISDDRRLLIY 442 (696)
Q Consensus 372 ~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~ 442 (696)
++.|+.|-.-.+|++...+ .+.|++++.- . ........+|..+++.+.-.+ ..+++++|.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568889999999998643 3567777664 2 234456778999999986334 4588887743 6899
Q ss_pred EecCCCch
Q 005443 443 DYVPNNTL 450 (696)
Q Consensus 443 E~~~~gsL 450 (696)
||+.|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987655
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=92.10 E-value=0.18 Score=48.69 Aligned_cols=133 Identities=14% Similarity=0.078 Sum_probs=73.4
Q ss_pred ccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHHHHccCCCceeEEeEEee----------------------
Q 005443 377 EGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEIISRIHHRHLVSLVGYCIS---------------------- 434 (696)
Q Consensus 377 ~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---------------------- 434 (696)
+++.+.|+-+.. ++..++||... ....+.|..|+...-.+.-+... ++..+..
T Consensus 78 ~~Gs~Gv~FV~~-e~gaiVlK~s~---tta~E~y~~eLAr~LGvpvPqmR-vI~~~~~E~~~~~~~~l~~~e~d~~I~se 152 (342)
T d1cjaa_ 78 EKGTEGLFFVET-ESGVFIVKRST---NIESETFCSLLCMRLGLHAPKVR-VVSSNSEEGTNMLECLAAIDKSFRVITTL 152 (342)
T ss_dssp CSTTSCEEEEEE-SSCEEEEECCT---THHHHHHHHHHHHHHTCCCCCEE-EEESSSHHHHHHHHHHHHHCSSSCHHHHH
T ss_pred ecCCceEEEEEc-CCceEEEecCC---chHHHHHHHHHHHHhCCCCCceE-EecCCCHHHHHHHHHHhcCCChhHHHHHH
Confidence 334444444455 56678888633 23445677777777777777743 3432211
Q ss_pred -CCceeEEEEecCCCchhhccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccC-CCCceEECCCC-cEEEEe
Q 005443 435 -DDRRLLIYDYVPNNTLYFHLHGEGRPVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI-KSSNILLDNNF-EAQVSD 511 (696)
Q Consensus 435 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivHrDL-kp~NILl~~~~-~vkL~D 511 (696)
.+..+++|||+.|..|.+.-.......+..+.+.++ -.|+-.=.++++.....+++|+- .+.|||+++++ .+..+|
T Consensus 153 l~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~L-GkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~ID 231 (342)
T d1cjaa_ 153 ANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQL-GSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPID 231 (342)
T ss_dssp TTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHH-HHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECS
T ss_pred HhcccceeeeccCCccccccccccchhhhcHHHHHHh-hhHHHHHHHHcCCccccccccCCCCccceEEecCCcEEEEec
Confidence 134578999998887766543221111222222211 11222223555544335677643 78999997766 677888
Q ss_pred eccc
Q 005443 512 FGLA 515 (696)
Q Consensus 512 fGls 515 (696)
=|..
T Consensus 232 s~i~ 235 (342)
T d1cjaa_ 232 SKII 235 (342)
T ss_dssp CCCC
T ss_pred CCcc
Confidence 5554
|
| >d1bo1a_ d.143.1.2 (A:) Phosphatidylinositol phosphate kinase IIbeta, PIPK IIbeta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SAICAR synthase-like superfamily: SAICAR synthase-like family: Phosphatidylinositol phosphate kinase IIbeta, PIPK IIbeta domain: Phosphatidylinositol phosphate kinase IIbeta, PIPK IIbeta species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.07 E-value=1.5 Score=43.72 Aligned_cols=110 Identities=13% Similarity=0.118 Sum_probs=57.5
Q ss_pred ccccccCcEEEEEEEcCCCcEEEEEEeecCCCccHHHHHHHHHHH-HH-ccCCCceeEEeEEee----CCceeEEEEecC
Q 005443 373 NLLGEGGFGSVYKGYLPDGREVAIKQLKIGGGQGEREFKAEVEII-SR-IHHRHLVSLVGYCIS----DDRRLLIYDYVP 446 (696)
Q Consensus 373 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il-~~-l~hpnIv~l~~~~~~----~~~~~lV~E~~~ 446 (696)
+..+.|..|..|.-. .+.+++||.+.....+...++..+.-.. .+ -.+--|++++|++.. ....++||+.+-
T Consensus 95 ~~~s~GkSGs~F~~t--~D~rfiiKti~~~E~~~l~~~l~~Y~~h~~~~n~~TLL~k~~Gly~i~~~~~~~~fvVM~Nlf 172 (383)
T d1bo1a_ 95 NSDSQGRCGTRFLTT--YDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVF 172 (383)
T ss_dssp ECCCC----CCEEEC--TTSSEEEECCCHHHHHHHHHHHHHHHHHHHTTTTCCSSCCEEEEEEEEETTEEEEEEEEECSS
T ss_pred cccccCCcCCeEEEe--cCCcEEEEEeCHHHHHHHHHHHHHHHHHHHhcCCCcCHHhhheeeEEEeCCceEEEEEEeccc
Confidence 345668888777644 3457899988632111111222222111 11 124568899998743 234578999875
Q ss_pred CCchhhc----cc---------------------------cCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 005443 447 NNTLYFH----LH---------------------------GEGRPVLDWATRVKIAAGAARGLAYLHED 484 (696)
Q Consensus 447 ~gsL~~~----l~---------------------------~~~~~~l~~~~~~~i~~qia~gL~~LH~~ 484 (696)
.+.+..+ |. ....-.++...+..++.||-+-.+||.+.
T Consensus 173 ~~~~~i~~~yDLKGS~~~R~~~~~~~~~~~~~lKD~df~~~~~~i~l~~~~k~~l~~ql~~D~~fL~~~ 241 (383)
T d1bo1a_ 173 SHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQL 241 (383)
T ss_dssp CSSSCCSEEEEECCCSSSSCSCSGGGSSSCCEECHHHHHHTTCCCCCCSSHHHHHHHHHHHHHHHHHHH
T ss_pred cCCcccceeEeccCcccccCcCcccccccchhhhhHHHHhccCCeeeCHHHHHHHHHHHHHHHHHHHHC
Confidence 4332110 00 01111233455677899999999999988
|